Citrus Sinensis ID: 002061
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 973 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LJM4 | 991 | Receptor-like protein kin | no | no | 0.938 | 0.921 | 0.419 | 0.0 | |
| Q9SGP2 | 996 | Receptor-like protein kin | no | no | 0.952 | 0.930 | 0.400 | 0.0 | |
| C0LGX3 | 993 | LRR receptor-like serine/ | no | no | 0.914 | 0.896 | 0.387 | 1e-178 | |
| P47735 | 999 | Receptor-like protein kin | no | no | 0.956 | 0.931 | 0.391 | 1e-178 | |
| Q9SYQ8 | 980 | Receptor protein kinase C | no | no | 0.918 | 0.912 | 0.383 | 1e-172 | |
| O49545 | 1003 | Leucine-rich repeat recep | no | no | 0.940 | 0.912 | 0.387 | 1e-169 | |
| Q9M0G7 | 1013 | Leucine-rich repeat recep | no | no | 0.950 | 0.913 | 0.361 | 1e-167 | |
| Q9M2Z1 | 1002 | Leucine-rich repeat recep | no | no | 0.921 | 0.895 | 0.382 | 1e-167 | |
| Q9FRS6 | 1029 | Leucine-rich repeat recep | no | no | 0.946 | 0.895 | 0.347 | 1e-159 | |
| Q9FII5 | 1041 | Leucine-rich repeat recep | no | no | 0.934 | 0.873 | 0.354 | 1e-158 |
| >sp|Q9LJM4|IKU2_ARATH Receptor-like protein kinase HAIKU2 OS=Arabidopsis thaliana GN=IKU2 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 674 bits (1739), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 409/974 (41%), Positives = 577/974 (59%), Gaps = 61/974 (6%)
Query: 32 ETQALIQFKSKLKDPHG--VLDSWKESADSPCGFSGITCDSVTGRVTEISFDNKSL---- 85
E + L++ KS + V +W +S C F+GI C+S G V EI+ ++SL
Sbjct: 26 EVENLLKLKSTFGETKSDDVFKTWTHR-NSACEFAGIVCNS-DGNVVEINLGSRSLINRD 83
Query: 86 -SGEISS----SISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDL 140
G + SI L+ L L L N L G++ L C+ L+ L++ N G P +
Sbjct: 84 DDGRFTDLPFDSICDLKLLEKLVLGNNSLRGQIGTNLGKCNRLRYLDLGINNFSGEFPAI 143
Query: 141 SALKNLEIFDLSINYFTGRFPRW--VVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYL 198
+L+ LE L+ + +G FP W + +L +L LS+GDN + P I NL L ++
Sbjct: 144 DSLQLLEFLSLNASGISGIFP-WSSLKDLKRLSFLSVGDNRFGSHPFPREILNLTALQWV 202
Query: 199 FLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELP 258
+L++ ++ G+IPE I L L L++ N+ISGE P+ I +L+ L ++E+Y+N+LTG+LP
Sbjct: 203 YLSNSSITGKIPEGIKNLVRLQNLELSDNQISGEIPKEIVQLKNLRQLEIYSNDLTGKLP 262
Query: 259 AELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAF 318
NLT L+ FD S+N + G L E+ LKNL F+N +GE P FGD + L A
Sbjct: 263 LGFRNLTNLRNFDASNNSLEGDL-SELRFLKNLVSLGMFENRLTGEIPKEFGDFKSLAAL 321
Query: 319 SIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVP 378
S+Y N+ +G P LG +TA +D+SEN G P Y+C+K + +LL L N F+G+ P
Sbjct: 322 SLYRNQLTGKLPRRLGSWTAFKYIDVSENFLEGQIPPYMCKKGVMTHLLMLQNRFTGQFP 381
Query: 379 NSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQL 438
SYA CKT+ RLR+S+N LSG IP G+W LPN+ LD N F G ++ IG + SL L
Sbjct: 382 ESYAKCKTLIRLRVSNNSLSGMIPSGIWGLPNLQFLDLASNYFEGNLTGDIGNAKSLGSL 441
Query: 439 VLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIP 498
L NNRFSG LP ++ +L + L N FSG +P + G L++LSSL L++N L+G+IP
Sbjct: 442 DLSNNRFSGSLPFQISGANSLVSVNLRMNKFSGIVPESFGKLKELSSLILDQNNLSGAIP 501
Query: 499 NEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSID 558
+G C +VDLN A NSLS IP SL L LN+LNLSGNKL+G IP L LKLS +D
Sbjct: 502 KSLGLCTSLVDLNFAGNSLSEEIPESLGSLKLLNSLNLSGNKLSGMIPVGLSALKLSLLD 561
Query: 559 LSENQLSGSVPLDFLRMGGDGAFAGNEGLCLDQSTKMLMNSKLTACPAIQKQKGGFKDKL 618
LS NQL+GSVP + G+F GN GLC S+K+ L CP + G + L
Sbjct: 562 LSNNQLTGSVPESLV----SGSFEGNSGLC---SSKI---RYLRPCPLGKPHSQGKRKHL 611
Query: 619 --VLFCIIAVALAAFLAGLLLVSYKNFKLSADMENGEKEVSSKWKLASFHHIDIDAEQIC 676
V C I +AA LA L SY FK+ D N + + W+++SF ++ + +I
Sbjct: 612 SKVDMCFI---VAAILALFFLFSYVIFKIRRDKLNKTVQKKNDWQVSSFRLLNFNEMEII 668
Query: 677 N-LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLW---------------KGDGVKV--- 717
+ ++ +N+IG GG G VY++ L ++ T+AVK +W DG
Sbjct: 669 DEIKSENIIGRGGQGNVYKVSL-RSGETLAVKHIWCPESSHESFRSSTAMLSDGNNRSNN 727
Query: 718 --FAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDW 775
F AE+ L I+H N++KL+ + S LV EYMPNG+L++ LH+R G+ E+ W
Sbjct: 728 GEFEAEVATLSNIKHINVVKLFCSITCEDSKLLVYEYMPNGSLWEQLHER--RGEQEIGW 785
Query: 776 FRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV 835
R +ALGAAKG+ YLHH P+IHRD+KSSNILLDE++ P+IADFG+AKI +
Sbjct: 786 RVRQALALGAAKGLEYLHHGLDRPVIHRDVKSSNILLDEEWRPRIADFGLAKIIQADSVQ 845
Query: 836 SDYSC--FAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVY 893
D+S GT GYIAPE AYT KV+EKSDV+SFGVVL+ELVTG+KP+E ++G+ DIV
Sbjct: 846 RDFSAPLVKGTLGYIAPEYAYTTKVNEKSDVYSFGVVLMELVTGKKPLETDFGENNDIVM 905
Query: 894 WV--STHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951
WV + N E ++K++D + E KED +K+L IA++CT K P RP M+ VV ML
Sbjct: 906 WVWSVSKETNREMMMKLIDTSIEDE-YKEDALKVLTIALLCTDKSPQARPFMKSVVSMLE 964
Query: 952 DADPCTDKSPDNSS 965
+P +K+ +S
Sbjct: 965 KIEPSYNKNSGEAS 978
|
Modulates the seed size by negatively regulating the cellularization of syncytial endosperm. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SGP2|HSL1_ARATH Receptor-like protein kinase HSL1 OS=Arabidopsis thaliana GN=HSL1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 661 bits (1705), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 398/994 (40%), Positives = 575/994 (57%), Gaps = 67/994 (6%)
Query: 24 PPSLSLNVETQALIQFKSKLKDPHGVLDSWKESADSPCGFSGITCDSVTGRVTEISFDNK 83
P SLN + L Q K L DP L SW + SPC +SG++C VT + +
Sbjct: 11 PTVFSLNQDGFILQQVKLSLDDPDSYLSSWNSNDASPCRWSGVSCAGDFSSVTSVDLSSA 70
Query: 84 SLSGEISS------------------------SISALQSLTVLSLPFNVLSGKLPLELSN 119
+L+G S +I+A +SL L L N+L+G+LP L++
Sbjct: 71 NLAGPFPSVICRLSNLAHLSLYNNSINSTLPLNIAACKSLQTLDLSQNLLTGELPQTLAD 130
Query: 120 CSNLKVLNVTGNAMVGSVP-DLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDN 178
L L++TGN G +P +NLE+ L N G P ++ N++ L L++ N
Sbjct: 131 IPTLVHLDLTGNNFSGDIPASFGKFENLEVLSLVYNLLDGTIPPFLGNISTLKMLNLSYN 190
Query: 179 VYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIR 238
+ + IP GNL NL ++L C+L G+IP+S+ +L +L LD+ N + G P S+
Sbjct: 191 PFSPSRIPPEFGNLTNLEVMWLTECHLVGQIPDSLGQLSKLVDLDLALNDLVGHIPPSLG 250
Query: 239 KLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFK 298
L + +IELY N+LTGE+P ELGNL L+ D S NQ+ GK+P+E+ + L ++
Sbjct: 251 GLTNVVQIELYNNSLTGEIPPELGNLKSLRLLDASMNQLTGKIPDELCRVP-LESLNLYE 309
Query: 299 NNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLC 358
NN GE P+ L+ I+GNR +G P++LG + L +D+SEN+FSG P LC
Sbjct: 310 NNLEGELPASIALSPNLYEIRIFGNRLTGGLPKDLGLNSPLRWLDVSENEFSGDLPADLC 369
Query: 359 EKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGD 418
K +L LL + N+FSG +P S ADC+++ R+R++ N SG +P G W LP+V +L+ +
Sbjct: 370 AKGELEELLIIHNSFSGVIPESLADCRSLTRIRLAYNRFSGSVPTGFWGLPHVNLLELVN 429
Query: 419 NDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALG 478
N F+G IS IG +++LS L+L NN F+G LP E+G L NL +L + N FSG +P +L
Sbjct: 430 NSFSGEISKSIGGASNLSLLILSNNEFTGSLPEEIGSLDNLNQLSASGNKFSGSLPDSLM 489
Query: 479 ALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSG 538
+L +L +L L N +G + + + ++ +LNLA N +G IP + LS LN L+LSG
Sbjct: 490 SLGELGTLDLHGNQFSGELTSGIKSWKKLNELNLADNEFTGKIPDEIGSLSVLNYLDLSG 549
Query: 539 NKLTGSIPDNLMKLKLSSIDLSENQLSGSVPLDFLRMGGDGAFAGNEGLCLDQSTKMLMN 598
N +G IP +L LKL+ ++LS N+LSG +P + +F GN GLC D K L
Sbjct: 550 NMFSGKIPVSLQSLKLNQLNLSYNRLSGDLPPSLAKDMYKNSFIGNPGLCGD--IKGLCG 607
Query: 599 SKLTACPAIQKQKGGFKDKLVLFCIIAVALAAFLAGLLLVSYKNFKLSADMENGEKEVSS 658
S+ A K++G +F + A+ L A +A Y+ FK + ME S
Sbjct: 608 SENEA-----KKRGYVWLLRSIFVLAAMVLLAGVA-WFYFKYRTFKKARAMER------S 655
Query: 659 KWKLASFHHIDIDAEQIC-NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD---- 713
KW L SFH + +I +L+EDN+IG+G +GKVY++ L N TVAVK+LW G
Sbjct: 656 KWTLMSFHKLGFSEHEILESLDEDNVIGAGASGKVYKVVL-TNGETVAVKRLWTGSVKET 714
Query: 714 -----------GVK--VFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQ 760
GV+ F AE+E LGKIRH+NI+KL+ C LV EYMPNG+L
Sbjct: 715 GDCDPEKGYKPGVQDEAFEAEVETLGKIRHKNIVKLWCCCSTRDCKLLVYEYMPNGSLGD 774
Query: 761 ALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKI 820
LH K G L W R+KI L AA+G++YLHHD PPI+HRDIKS+NIL+D DY ++
Sbjct: 775 LLHSS-KGGM--LGWQTRFKIILDAAEGLSYLHHDSVPPIVHRDIKSNNILIDGDYGARV 831
Query: 821 ADFGVAKIAENSPKV-SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRK 879
ADFGVAK + + K S AG+ GYIAPE AYT +V+EKSD++SFGVV+LE+VT ++
Sbjct: 832 ADFGVAKAVDLTGKAPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILEIVTRKR 891
Query: 880 PVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNL 939
PV+ E G+ KD+V WV + L + + + V+D ++ S KE++ K+L + ++CT+ LP
Sbjct: 892 PVDPELGE-KDLVKWVCSTL-DQKGIEHVIDPKLDS-CFKEEISKILNVGLLCTSPLPIN 948
Query: 940 RPPMREVVKMLADADPCTDKSPDN-SSDKSGKIS 972
RP MR VVKML + + S DK GK++
Sbjct: 949 RPSMRRVVKMLQEIGGGDEDSLHKIRDDKDGKLT 982
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGX3|HSL2_ARATH LRR receptor-like serine/threonine-protein kinase HSL2 OS=Arabidopsis thaliana GN=HSL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 626 bits (1614), Expect = e-178, Method: Compositional matrix adjust.
Identities = 378/976 (38%), Positives = 548/976 (56%), Gaps = 86/976 (8%)
Query: 40 KSKLKDPHGVLDSWKESAD--SPCGFSGITCDSVTGR---VTEISFDNKSLSGEISSSIS 94
K++L DP G L W + D SPC ++GITC G VT I ++SG
Sbjct: 36 KTRLFDPDGNLQDWVITGDNRSPCNWTGITCHIRKGSSLAVTTIDLSGYNISGGFPYGFC 95
Query: 95 ALQSLTVLSLPFNVLSGKL---PLELSNCSNLKVLNVTGNAMVGSVPDLSA-LKNLEIFD 150
+++L ++L N L+G + PL L CS L+ L + N G +P+ S + L + +
Sbjct: 96 RIRTLINITLSQNNLNGTIDSAPLSL--CSKLQNLILNQNNFSGKLPEFSPEFRKLRVLE 153
Query: 151 LSINYFTGRFPR--------WVVNL----------------TQLVSLSIGDNVYDEAEIP 186
L N FTG P+ V+NL T+L L + +D + IP
Sbjct: 154 LESNLFTGEIPQSYGRLTALQVLNLNGNPLSGIVPAFLGYLTELTRLDLAYISFDPSPIP 213
Query: 187 ESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKI 246
++GNL NLT L L H NL G IP+SI L L LD+ N ++GE P SI +L+ +++I
Sbjct: 214 STLGNLSNLTDLRLTHSNLVGEIPDSIMNLVLLENLDLAMNSLTGEIPESIGRLESVYQI 273
Query: 247 ELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFP 306
ELY N L+G+LP +GNLT L+ FD+S N + G+LPE+I L+ L F N F+G P
Sbjct: 274 ELYDNRLSGKLPESIGNLTELRNFDVSQNNLTGELPEKIAALQ-LISFNLNDNFFTGGLP 332
Query: 307 SGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNL 366
L F I+ N F+G P NLG+++ +++ D+S N+FSG P YLC +RKL +
Sbjct: 333 DVVALNPNLVEFKIFNNSFTGTLPRNLGKFSEISEFDVSTNRFSGELPPYLCYRRKLQKI 392
Query: 367 LALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGIS 426
+ SN SGE+P SY DC ++ +R++DN LSG++P W LP + +N G I
Sbjct: 393 ITFSNQLSGEIPESYGDCHSLNYIRMADNKLSGEVPARFWELPLTRLELANNNQLQGSIP 452
Query: 427 PLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSL 486
P I + LSQL + N FSG +P +L L +L + L+ N+F G IPS + L+ L +
Sbjct: 453 PSISKARHLSQLEISANNFSGVIPVKLCDLRDLRVIDLSRNSFLGSIPSCINKLKNLERV 512
Query: 487 HLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIP 546
++EN L G IP+ + C + +LNL+ N L G IP L L LN L+LS N+LTG IP
Sbjct: 513 EMQENMLDGEIPSSVSSCTELTELNLSNNRLRGGIPPELGDLPVLNYLDLSNNQLTGEIP 572
Query: 547 DNLMKLKLSSIDLSENQLSGSVPLDFLRMGGDGAFAGNEGLCLDQSTKMLMNSKLTACPA 606
L++LKL+ ++S+N+L G +P F + +F GN LC + P
Sbjct: 573 AELLRLKLNQFNVSDNKLYGKIPSGFQQDIFRPSFLGNPNLCAPNLDPIR--------PC 624
Query: 607 IQKQKGGFKDKLVLFCIIAVALAAFLAGLLLVSYKNFKLSADMENGEKEVSSKWKLASFH 666
K++ + + + CI VAL L L + + FK N K+ F
Sbjct: 625 RSKRETRYILPISILCI--VALTGALVWLFIKTKPLFKRKPKRTN---------KITIFQ 673
Query: 667 HIDIDAEQIC-NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVK-----VFAA 720
+ E I L EDN+IGSGG+G VYR+ L K+ T+AVK+LW G K VF +
Sbjct: 674 RVGFTEEDIYPQLTEDNIIGSGGSGLVYRVKL-KSGQTLAVKKLWGETGQKTESESVFRS 732
Query: 721 EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALH-KRVKEGKPELDWFRRY 779
E+E LG++RH NI+KL C FLV E+M NG+L LH ++ LDW R+
Sbjct: 733 EVETLGRVRHGNIVKLLMCCNGEEFRFLVYEFMENGSLGDVLHSEKEHRAVSPLDWTTRF 792
Query: 780 KIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI--AENSPKVSD 837
IA+GAA+G++YLHHD PPI+HRD+KS+NILLD + +P++ADFG+AK E++ VSD
Sbjct: 793 SIAVGAAQGLSYLHHDSVPPIVHRDVKSNNILLDHEMKPRVADFGLAKPLKREDNDGVSD 852
Query: 838 --YSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWV 895
SC AG++GYIAPE YT KV+EKSDV+SFGVVLLEL+TG++P + +G+ KDIV +
Sbjct: 853 VSMSCVAGSYGYIAPEYGYTSKVNEKSDVYSFGVVLLELITGKRPNDSSFGENKDIVKFA 912
Query: 896 ------------------STHLNNHENVLKVLDCEVA-SESIKEDMIKLLKIAVVCTTKL 936
L N+ ++ K++D ++ S E++ K+L +A++CT+
Sbjct: 913 MEAALCYPSPSAEDGAMNQDSLGNYRDLSKLVDPKMKLSTREYEEIEKVLDVALLCTSSF 972
Query: 937 PNLRPPMREVVKMLAD 952
P RP MR+VV++L +
Sbjct: 973 PINRPTMRKVVELLKE 988
|
Receptor-like serine/threonine-kinase acting on substrates that controls floral organ abscission. Regulated by the 'INFLORESCENCE DEFICIENT IN ABSCISSION' (IDA) family of ligands. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P47735|RLK5_ARATH Receptor-like protein kinase 5 OS=Arabidopsis thaliana GN=RLK5 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 625 bits (1612), Expect = e-178, Method: Compositional matrix adjust.
Identities = 391/998 (39%), Positives = 571/998 (57%), Gaps = 67/998 (6%)
Query: 21 SVFPPSLSLNVETQALIQFKSKLKDPHGVLDSWKESAD-SPCGFSGITCDSVTGRVT--- 76
S + PSLSLN + L Q K L DP L SW ++ D +PC + G++CD+ + V+
Sbjct: 13 STYLPSLSLNQDATILRQAKLGLSDPAQSLSSWSDNNDVTPCKWLGVSCDATSNVVSVDL 72
Query: 77 --------------------EISFDNKSLSGEISSS-ISALQSLTVLSLPFNVLSGKLPL 115
+S N S++G +S+ +L L L N+L G +P
Sbjct: 73 SSFMLVGPFPSILCHLPSLHSLSLYNNSINGSLSADDFDTCHNLISLDLSENLLVGSIPK 132
Query: 116 ELS-NCSNLKVLNVTGNAMVGSVPD-LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSL 173
L N NLK L ++GN + ++P + LE +L+ N+ +G P + N+T L L
Sbjct: 133 SLPFNLPNLKFLEISGNNLSDTIPSSFGEFRKLESLNLAGNFLSGTIPASLGNVTTLKEL 192
Query: 174 SIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEF 233
+ N++ ++IP +GNL L L+LA CNL G IP S+S L L LD+ N+++G
Sbjct: 193 KLAYNLFSPSQIPSQLGNLTELQVLWLAGCNLVGPIPPSLSRLTSLVNLDLTFNQLTGSI 252
Query: 234 PRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTV 293
P I +L+ + +IEL+ N+ +GELP +GN+T L+ FD S N++ GK+P+ + L ++
Sbjct: 253 PSWITQLKTVEQIELFNNSFSGELPESMGNMTTLKRFDASMNKLTGKIPDNLNLLNLESL 312
Query: 294 FQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSF 353
F+N G P + L ++ NR +G P LG + L VD+S N+FSG
Sbjct: 313 NL-FENMLEGPLPESITRSKTLSELKLFNNRLTGVLPSQLGANSPLQYVDLSYNRFSGEI 371
Query: 354 PKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGM 413
P +C + KL L+ + N+FSGE+ N+ CK++ R+R+S+N LSG+IP G W LP + +
Sbjct: 372 PANVCGEGKLEYLILIDNSFSGEISNNLGKCKSLTRVRLSNNKLSGQIPHGFWGLPRLSL 431
Query: 414 LDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKI 473
L+ DN FTG I I + +LS L + NRFSG +P+E+G L + + N+FSG+I
Sbjct: 432 LELSDNSFTGSIPKTIIGAKNLSNLRISKNRFSGSIPNEIGSLNGIIEISGAENDFSGEI 491
Query: 474 PSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNA 533
P +L L+QLS L L +N L+G IP E+ + +LNLA N LSG IP+ + +L LN
Sbjct: 492 PESLVKLKQLSRLDLSKNQLSGEIPRELRGWKNLNELNLANNHLSGEIPKEVGILPVLNY 551
Query: 534 LNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSGSVPLDFLRMGGDGAFAGNEGLCLDQST 593
L+LS N+ +G IP L LKL+ ++LS N LSG +P + F GN GLC+D
Sbjct: 552 LDLSSNQFSGEIPLELQNLKLNVLNLSYNHLSGKIPPLYANKIYAHDFIGNPGLCVDLD- 610
Query: 594 KMLMNSKLTACPAIQKQKG-GFKDKLVLFCIIAVALAAFLAGLLLVSYKNFKLSADMENG 652
C I + K G+ +L I +A F+ G+++ K KL A
Sbjct: 611 --------GLCRKITRSKNIGY--VWILLTIFLLAGLVFVVGIVMFIAKCRKLRA--LKS 658
Query: 653 EKEVSSKWKLASFHHIDIDAEQICN-LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK 711
+SKW+ SFH + +I + L+E N+IG G +GKVY+++L + VAVK+L K
Sbjct: 659 STLAASKWR--SFHKLHFSEHEIADCLDEKNVIGFGSSGKVYKVEL-RGGEVVAVKKLNK 715
Query: 712 ----GD--------GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLF 759
GD VFAAE+E LG IRH++I++L+ C G LV EYMPNG+L
Sbjct: 716 SVKGGDDEYSSDSLNRDVFAAEVETLGTIRHKSIVRLWCCCSSGDCKLLVYEYMPNGSLA 775
Query: 760 QALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPK 819
LH ++G L W R +IAL AA+G++YLHHDC PPI+HRD+KSSNILLD DY K
Sbjct: 776 DVLHGD-RKGGVVLGWPERLRIALDAAEGLSYLHHDCVPPIVHRDVKSSNILLDSDYGAK 834
Query: 820 IADFGVAKIAE--NSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTG 877
+ADFG+AK+ + S S AG+ GYIAPE YT +V+EKSD++SFGVVLLELVTG
Sbjct: 835 VADFGIAKVGQMSGSKTPEAMSGIAGSCGYIAPEYVYTLRVNEKSDIYSFGVVLLELVTG 894
Query: 878 RKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLP 937
++P + E GD KD+ WV T L+ + V+D ++ + KE++ K++ I ++CT+ LP
Sbjct: 895 KQPTDSELGD-KDMAKWVCTALDKC-GLEPVIDPKLDLK-FKEEISKVIHIGLLCTSPLP 951
Query: 938 NLRPPMREVVKMLAD---ADPCTDKSPDNSSDKSGKIS 972
RP MR+VV ML + A PC+ + S GK+S
Sbjct: 952 LNRPSMRKVVIMLQEVSGAVPCSSPNTSKRSKTGGKLS 989
|
Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates that controls floral organ abscission. May interact with the 'INFLORESCENCE DEFICIENT IN ABSCISSION' (IDA) ligands family. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SYQ8|CLV1_ARATH Receptor protein kinase CLAVATA1 OS=Arabidopsis thaliana GN=CLV1 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 606 bits (1563), Expect = e-172, Method: Compositional matrix adjust.
Identities = 373/972 (38%), Positives = 546/972 (56%), Gaps = 78/972 (8%)
Query: 31 VETQALIQFKSKLKDP--HGVLDSWKESA--DSPCGFSGITCDSVTGRVTEISFDNKSLS 86
+ + L+ KS + P HG+ D W S+ D+ C FSG++CD RV ++ L
Sbjct: 26 TDMEVLLNLKSSMIGPKGHGLHD-WIHSSSPDAHCSFSGVSCDD-DARVISLNVSFTPLF 83
Query: 87 GEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNA-MVGSVPD--LSAL 143
G IS I L L L+L N +G+LPLE+ + ++LKVLN++ N + G+ P L A+
Sbjct: 84 GTISPEIGMLTHLVNLTLAANNFTGELPLEMKSLTSLKVLNISNNGNLTGTFPGEILKAM 143
Query: 144 KNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHC 203
+LE+ D N F G+ P + L +L LS G N + EIPES G++++L YL L
Sbjct: 144 VDLEVLDTYNNNFNGKLPPEMSELKKLKYLSFGGNFFS-GEIPESYGDIQSLEYLGLNGA 202
Query: 204 NLRGRIPESISELR-------------------------ELGTLDICRNKISGEFPRSIR 238
L G+ P +S L+ +L LD+ ++GE P S+
Sbjct: 203 GLSGKSPAFLSRLKNLREMYIGYYNSYTGGVPPEFGGLTKLEILDMASCTLTGEIPTSLS 262
Query: 239 KLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFK 298
L+ L + L+ NNLTG +P EL L L+ D+S NQ+ G++P+ NL N+T+ F+
Sbjct: 263 NLKHLHTLFLHINNLTGHIPPELSGLVSLKSLDLSINQLTGEIPQSFINLGNITLINLFR 322
Query: 299 NNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLC 358
NN G+ P G++ KL F ++ N F+ P NLGR L +D+S+N +G PK LC
Sbjct: 323 NNLYGQIPEAIGELPKLEVFEVWENNFTLQLPANLGRNGNLIKLDVSDNHLTGLIPKDLC 382
Query: 359 EKRKLLNLLALSNN-FSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFG 417
K L +L LSNN F G +P CK++ ++RI N L+G +P GL+ LP V +++
Sbjct: 383 RGEK-LEMLILSNNFFFGPIPEELGKCKSLTKIRIVKNLLNGTVPAGLFNLPLVTIIELT 441
Query: 418 DNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSAL 477
DN F+G + P+ L Q+ L NN FSGE+P +G NL+ L L N F G IP +
Sbjct: 442 DNFFSGEL-PVTMSGDVLDQIYLSNNWFSGEIPPAIGNFPNLQTLFLDRNRFRGNIPREI 500
Query: 478 GALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLS 537
L+ LS ++ N +TG IP+ + C+ ++ ++L+RN ++G IP+ ++ + +L LN+S
Sbjct: 501 FELKHLSRINTSANNITGGIPDSISRCSTLISVDLSRNRINGEIPKGINNVKNLGTLNIS 560
Query: 538 GNKLTGSIPDNLMKL-KLSSIDLSENQLSGSVPL--DFLRMGGDGAFAGNEGLCLDQSTK 594
GN+LTGSIP + + L+++DLS N LSG VPL FL + +FAGN LCL
Sbjct: 561 GNQLTGSIPTGIGNMTSLTTLDLSFNDLSGRVPLGGQFLVF-NETSFAGNTYLCLPHR-- 617
Query: 595 MLMNSKLTACPAIQKQKGGFKDKLVLFCI--IAVALAAFLAGLLLVSYKNFKLSADMENG 652
+CP Q + LF I + + A + GL+L+S M
Sbjct: 618 -------VSCPTRPGQTSD-HNHTALFSPSRIVITVIAAITGLILISVA----IRQMNKK 665
Query: 653 EKEVSSKWKLASFHHIDIDAEQICN-LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL-W 710
+ + S WKL +F +D +E + L+E+N+IG GG G VYR + N VA+K+L
Sbjct: 666 KNQKSLAWKLTAFQKLDFKSEDVLECLKEENIIGKGGAGIVYRGSMPNNV-DVAIKRLVG 724
Query: 711 KGDGV--KVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKE 768
+G G F AE++ LG+IRHR+I++L + ++ L+ EYMPNG+L + LH K
Sbjct: 725 RGTGRSDHGFTAEIQTLGRIRHRHIVRLLGYVANKDTNLLLYEYMPNGSLGELLHGS-KG 783
Query: 769 GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
G L W R+++A+ AAKG+ YLHHDCSP I+HRD+KS+NILLD D+E +ADFG+AK
Sbjct: 784 G--HLQWETRHRVAVEAAKGLCYLHHDCSPLILHRDVKSNNILLDSDFEAHVADFGLAKF 841
Query: 829 AENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDG 888
+ S AG++GYIAPE AYT KV EKSDV+SFGVVLLEL+ G+KPV E+G+G
Sbjct: 842 LVDGAASECMSSIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPV-GEFGEG 900
Query: 889 KDIVYWVSTHLNNHENVLKVLDCEVASESIK--------EDMIKLLKIAVVCTTKLPNLR 940
DIV WV N E + + D + + +I + KIA++C + R
Sbjct: 901 VDIVRWVR---NTEEEITQPSDAAIVVAIVDPRLTGYPLTSVIHVFKIAMMCVEEEAAAR 957
Query: 941 PPMREVVKMLAD 952
P MREVV ML +
Sbjct: 958 PTMREVVHMLTN 969
|
Involved in the detection of CLV3 and CLV3-like peptides, that act as extracellular signals regulating meristem maintenance. Acts with CLV3 as a ligand-receptor pair in a signal transduction pathway coordinating growth between adjacent meristematic regions and controlling the balance between meristem cell proliferation and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49545|BAME1_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1 OS=Arabidopsis thaliana GN=BAM1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 597 bits (1538), Expect = e-169, Method: Compositional matrix adjust.
Identities = 384/992 (38%), Positives = 546/992 (55%), Gaps = 77/992 (7%)
Query: 32 ETQALIQFKSKLK----DPHGVLDSWKESADSPCGFSGITCDSVTGRVTEISFDNKSLSG 87
E +AL+ K+ L D + L SWK S S C + G+TCD VT + +LSG
Sbjct: 25 EFRALLSLKTSLTGAGDDKNSPLSSWKVST-SFCTWIGVTCDVSRRHVTSLDLSGLNLSG 83
Query: 88 EISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD--LSALKN 145
+S +S L+ L LSL N++SG +P E+S+ S L+ LN++ N GS PD S L N
Sbjct: 84 TLSPDVSHLRLLQNLSLAENLISGPIPPEISSLSGLRHLNLSNNVFNGSFPDEISSGLVN 143
Query: 146 LEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDE----------------------- 182
L + D+ N TG P V NLTQL L +G N +
Sbjct: 144 LRVLDVYNNNLTGDLPVSVTNLTQLRHLHLGGNYFAGKIPPSYGSWPVIEYLAVSGNELV 203
Query: 183 AEIPESIGNLKNLTYLFLAHCN-LRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQ 241
+IP IGNL L L++ + N +P I L EL D ++GE P I KLQ
Sbjct: 204 GKIPPEIGNLTTLRELYIGYYNAFEDGLPPEIGNLSELVRFDGANCGLTGEIPPEIGKLQ 263
Query: 242 KLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNF 301
KL + L N +G L ELG L+ L+ D+S+N G++P LKNLT+ F+N
Sbjct: 264 KLDTLFLQVNVFSGPLTWELGTLSSLKSMDLSNNMFTGEIPASFAELKNLTLLNLFRNKL 323
Query: 302 SGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKR 361
GE P GD+ +L ++ N F+G P+ LG L VD+S N+ +G+ P +C
Sbjct: 324 HGEIPEFIGDLPELEVLQLWENNFTGSIPQKLGENGKLNLVDLSSNKLTGTLPPNMCSGN 383
Query: 362 KLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDF 421
KL L+ L N G +P+S C+++ R+R+ +N L+G IP GL+ LP + ++ DN
Sbjct: 384 KLETLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKGLFGLPKLTQVELQDNYL 443
Query: 422 TGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALR 481
+G + G+S +L Q+ L NN+ SG LP +G T +++L+L N F G IPS +G L+
Sbjct: 444 SGELPVAGGVSVNLGQISLSNNQLSGPLPPAIGNFTGVQKLLLDGNKFQGPIPSEVGKLQ 503
Query: 482 QLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKL 541
QLS + N +G I E+ C + ++L+RN LSG IP ++ + LN LNLS N L
Sbjct: 504 QLSKIDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGEIPNEITAMKILNYLNLSRNHL 563
Query: 542 TGSIPDNLMKLK-LSSIDLSENQLSGSVP-------LDFLRMGGDGAFAGNE-GLCLDQS 592
GSIP ++ ++ L+S+D S N LSG VP ++ G+ G G C D
Sbjct: 564 VGSIPGSISSMQSLTSLDFSYNNLSGLVPGTGQFSYFNYTSFLGNPDLCGPYLGPCKDGV 623
Query: 593 TKMLMNSKLTACPAIQKQKGGFKDKLVLFCIIAVALAAFLAGLLLVSYKNFKLSADMENG 652
K S + P K +L C IA A+ A ++ ++ K +++
Sbjct: 624 AKGGHQSH-SKGPLSASMK-LLLVLGLLVCSIAFAVVA------IIKARSLKKASE---- 671
Query: 653 EKEVSSKWKLASFHHIDIDAEQICN-LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLW- 710
S W+L +F +D + + + L+EDN+IG GG G VY+ + N VAVK+L
Sbjct: 672 ----SRAWRLTAFQRLDFTCDDVLDSLKEDNIIGKGGAGIVYK-GVMPNGDLVAVKRLAA 726
Query: 711 --KGDGV-KVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVK 767
+G F AE++ LG+IRHR+I++L ++ LV EYMPNG+L + LH + K
Sbjct: 727 MSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGK-K 785
Query: 768 EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
G L W RYKIAL AAKG+ YLHHDCSP I+HRD+KS+NILLD ++E +ADFG+AK
Sbjct: 786 GG--HLHWDTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAK 843
Query: 828 IAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGD 887
++S S AG++GYIAPE AYT KV EKSDV+SFGVVLLELVTGRKPV E+GD
Sbjct: 844 FLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELVTGRKPV-GEFGD 902
Query: 888 GKDIVYWVSTHLN-NHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREV 946
G DIV WV + N ++VLKVLD ++S I E + + +A++C + RP MREV
Sbjct: 903 GVDIVQWVRKMTDSNKDSVLKVLDPRLSSIPIHE-VTHVFYVAMLCVEEQAVERPTMREV 961
Query: 947 VKMLADA--------DPCTDKSPDNS-SDKSG 969
V++L + P T+ +P++ S KSG
Sbjct: 962 VQILTEIPKLPPSKDQPMTESAPESELSPKSG 993
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M0G7|PXL2_ARATH Leucine-rich repeat receptor-like protein kinase PXL2 OS=Arabidopsis thaliana GN=PXL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 588 bits (1516), Expect = e-167, Method: Compositional matrix adjust.
Identities = 356/984 (36%), Positives = 544/984 (55%), Gaps = 59/984 (5%)
Query: 32 ETQALIQFKSKLKDPHGVLDSWKESADSP-CGFSGITCDSVTGRVTEISFDNKSLSGEIS 90
E L+ KS L DP L WK S S C ++G+ C+S G V ++ +L+G+IS
Sbjct: 30 ELSVLLSVKSTLVDPLNFLKDWKLSDTSDHCNWTGVRCNS-NGNVEKLDLAGMNLTGKIS 88
Query: 91 SSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKV---------------------LNVT 129
SIS L SL ++ N LP + ++ + LN +
Sbjct: 89 DSISQLSSLVSFNISCNGFESLLPKSIPPLKSIDISQNSFSGSLFLFSNESLGLVHLNAS 148
Query: 130 GNAMVGSVP-DLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSI-GDNVYDEAEIPE 187
GN + G++ DL L +LE+ DL N+F G P NL +L L + G+N+ E+P
Sbjct: 149 GNNLSGNLTEDLGNLVSLEVLDLRGNFFQGSLPSSFKNLQKLRFLGLSGNNL--TGELPS 206
Query: 188 SIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIE 247
+G L +L L + +G IP + L LD+ K+SGE P + KL+ L +
Sbjct: 207 VLGQLPSLETAILGYNEFKGPIPPEFGNINSLKYLDLAIGKLSGEIPSELGKLKSLETLL 266
Query: 248 LYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPS 307
LY NN TG +P E+G++T L+ D S N + G++P EI LKNL + +N SG P
Sbjct: 267 LYENNFTGTIPREIGSITTLKVLDFSDNALTGEIPMEITKLKNLQLLNLMRNKLSGSIPP 326
Query: 308 GFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLL 367
+ +L ++ N SG P +LG+ + L +D+S N FSG P LC K L L+
Sbjct: 327 AISSLAQLQVLELWNNTLSGELPSDLGKNSPLQWLDVSSNSFSGEIPSTLCNKGNLTKLI 386
Query: 368 ALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISP 427
+N F+G++P + + C+++ R+R+ +N L+G IP G L + L+ N +GGI
Sbjct: 387 LFNNTFTGQIPATLSTCQSLVRVRMQNNLLNGSIPIGFGKLEKLQRLELAGNRLSGGIPG 446
Query: 428 LIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLH 487
I S SLS + N+ LPS + + NL+ ++ +N SG++P LS+L
Sbjct: 447 DISDSVSLSFIDFSRNQIRSSLPSTILSIHNLQAFLVADNFISGEVPDQFQDCPSLSNLD 506
Query: 488 LEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPD 547
L N LTG+IP+ + C ++V LNL N+L+G IPR ++ +S+L L+LS N LTG +P+
Sbjct: 507 LSSNTLTGTIPSSIASCEKLVSLNLRNNNLTGEIPRQITTMSALAVLDLSNNSLTGVLPE 566
Query: 548 NL-MKLKLSSIDLSENQLSGSVPLD-FLRMGGDGAFAGNEGLCLDQSTKMLMNSKLTACP 605
++ L +++S N+L+G VP++ FL+ GN GLC L C
Sbjct: 567 SIGTSPALELLNVSYNKLTGPVPINGFLKTINPDDLRGNSGLC---------GGVLPPCS 617
Query: 606 AIQKQKGGFKD----KLVLFCIIAVALAAFLAGLLLVSYKNFKLSADMENGEKEVSSK-- 659
Q+ ++V +I +A L L +V+ +K E +SK
Sbjct: 618 KFQRATSSHSSLHGKRIVAGWLIGIASVLALGILTIVTRTLYKKWYSNGFCGDETASKGE 677
Query: 660 --WKLASFHHIDIDAEQICN-LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---- 712
W+L +FH + A I ++E N+IG G TG VY+ ++ +++ +AVK+LW+
Sbjct: 678 WPWRLMAFHRLGFTASDILACIKESNMIGMGATGIVYKAEMSRSSTVLAVKKLWRSAADI 737
Query: 713 -DGVKV-FAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGK 770
DG F E+ +LGK+RHRNI++L L + +V E+M NGNL A+H + G+
Sbjct: 738 EDGTTGDFVGEVNLLGKLRHRNIVRLLGFLYNDKNMMIVYEFMLNGNLGDAIHGKNAAGR 797
Query: 771 PELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830
+DW RY IALG A G+AYLHHDC PP+IHRDIKS+NILLD + + +IADFG+A++
Sbjct: 798 LLVDWVSRYNIALGVAHGLAYLHHDCHPPVIHRDIKSNNILLDANLDARIADFGLARMM- 856
Query: 831 NSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKD 890
+ K S AG++GYIAPE YT KV EK D++S+GVVLLEL+TGR+P+E E+G+ D
Sbjct: 857 -ARKKETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSYGVVLLELLTGRRPLEPEFGESVD 915
Query: 891 IVYWVSTHLNNHENVLKVLDCEVAS-ESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949
IV WV + ++ ++ + LD V + ++E+M+ +L+IA++CTTKLP RP MR+V+ M
Sbjct: 916 IVEWVRRKIRDNISLEEALDPNVGNCRYVQEEMLLVLQIALLCTTKLPKDRPSMRDVISM 975
Query: 950 LADADPCTDKSPDNSSDKSGKISL 973
L +A P + NS++++ SL
Sbjct: 976 LGEAKP---RRKSNSNEENTSRSL 996
|
Involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M2Z1|BAME2_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM2 OS=Arabidopsis thaliana GN=BAM2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 588 bits (1516), Expect = e-167, Method: Compositional matrix adjust.
Identities = 368/963 (38%), Positives = 528/963 (54%), Gaps = 66/963 (6%)
Query: 31 VETQALIQFKSKLK-DPHG-VLDSWKESADSPCGFSGITCDSVTGRVTEISFDNKSLSGE 88
E AL+ KS D H +L SW S + C ++G+TCD VT + +LSG
Sbjct: 26 TELHALLSLKSSFTIDEHSPLLTSWNLST-TFCSWTGVTCDVSLRHVTSLDLSGLNLSGT 84
Query: 89 ISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD--LSALKNL 146
+SS ++ L L LSL N +SG +P ++SN L+ LN++ N GS PD S L NL
Sbjct: 85 LSSDVAHLPLLQNLSLAANQISGPIPPQISNLYELRHLNLSNNVFNGSFPDELSSGLVNL 144
Query: 147 EIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYD-----------------------EA 183
+ DL N TG P + NLTQL L +G N +
Sbjct: 145 RVLDLYNNNLTGDLPVSLTNLTQLRHLHLGGNYFSGKIPATYGTWPVLEYLAVSGNELTG 204
Query: 184 EIPESIGNLKNLTYLFLAHCN-LRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQK 242
+IP IGNL L L++ + N +P I L EL D ++GE P I KLQK
Sbjct: 205 KIPPEIGNLTTLRELYIGYYNAFENGLPPEIGNLSELVRFDAANCGLTGEIPPEIGKLQK 264
Query: 243 LWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFS 302
L + L N TG + ELG ++ L+ D+S+N G++P LKNLT+ F+N
Sbjct: 265 LDTLFLQVNAFTGTITQELGLISSLKSMDLSNNMFTGEIPTSFSQLKNLTLLNLFRNKLY 324
Query: 303 GEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRK 362
G P G+M +L ++ N F+G P+ LG L +D+S N+ +G+ P +C +
Sbjct: 325 GAIPEFIGEMPELEVLQLWENNFTGSIPQKLGENGRLVILDLSSNKLTGTLPPNMCSGNR 384
Query: 363 LLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFT 422
L+ L+ L N G +P+S C+++ R+R+ +N L+G IP L+ LP + ++ DN T
Sbjct: 385 LMTLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKELFGLPKLSQVELQDNYLT 444
Query: 423 GGISPLI--GLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGAL 480
G + P+ G+S L Q+ L NN+ SG LP+ +G L+ +++L+L N FSG IP +G L
Sbjct: 445 GEL-PISGGGVSGDLGQISLSNNQLSGSLPAAIGNLSGVQKLLLDGNKFSGSIPPEIGRL 503
Query: 481 RQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNK 540
+QLS L N +G I E+ C + ++L+RN LSG+IP L+ + LN LNLS N
Sbjct: 504 QQLSKLDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGDIPNELTGMKILNYLNLSRNH 563
Query: 541 LTGSIPDNLMKLK-LSSIDLSENQLSGSVP-LDFLRMGGDGAFAGNEGLC---LDQSTKM 595
L GSIP + ++ L+S+D S N LSG VP +F GN LC L K
Sbjct: 564 LVGSIPVTIASMQSLTSVDFSYNNLSGLVPSTGQFSYFNYTSFVGNSHLCGPYLGPCGKG 623
Query: 596 LMNSKLTACPAIQKQKGGFKDKLVLFCIIAVALAAFLAGLLLVSYKNFKLSADMENGEKE 655
S + A K +LFC + A+ A + + + N +
Sbjct: 624 THQSHVKPLSATTKLL---LVLGLLFCSMVFAIVAIIK------------ARSLRNASE- 667
Query: 656 VSSKWKLASFHHIDIDAEQICN-LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK--- 711
+ W+L +F +D + + + L+EDN+IG GG G VY+ + K VAVK+L
Sbjct: 668 -AKAWRLTAFQRLDFTCDDVLDSLKEDNIIGKGGAGIVYKGTMPK-GDLVAVKRLATMSH 725
Query: 712 -GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGK 770
F AE++ LG+IRHR+I++L ++ LV EYMPNG+L + LH + K G
Sbjct: 726 GSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGK-KGG- 783
Query: 771 PELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830
L W RYKIAL AAKG+ YLHHDCSP I+HRD+KS+NILLD ++E +ADFG+AK +
Sbjct: 784 -HLHWNTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQ 842
Query: 831 NSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKD 890
+S S AG++GYIAPE AYT KV EKSDV+SFGVVLLEL+TG+KPV E+GDG D
Sbjct: 843 DSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGKKPV-GEFGDGVD 901
Query: 891 IVYWVSTHLN-NHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949
IV WV + + N + VLKV+D ++S + E + + +A++C + RP MREVV++
Sbjct: 902 IVQWVRSMTDSNKDCVLKVIDLRLSSVPVHE-VTHVFYVALLCVEEQAVERPTMREVVQI 960
Query: 950 LAD 952
L +
Sbjct: 961 LTE 963
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FRS6|PXL1_ARATH Leucine-rich repeat receptor-like protein kinase PXL1 OS=Arabidopsis thaliana GN=PXL1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 563 bits (1452), Expect = e-159, Method: Compositional matrix adjust.
Identities = 360/1037 (34%), Positives = 536/1037 (51%), Gaps = 116/1037 (11%)
Query: 1 MAKIPFLCFHL-LALLCFILVSVFPPSLSLNVETQALIQFKSKLKDPHGVLDSWKESADS 59
+ ++ FL +++ AL F+ F N E + L+ FKS L DP L WK ++
Sbjct: 3 IPRLFFLFYYIGFALFPFVSSETFQ-----NSEQEILLAFKSDLFDPSNNLQDWKRPENA 57
Query: 60 P-------CGFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGK 112
C ++G+ CD+ G V ++ N +LSG +S I + SL L L N
Sbjct: 58 TTFSELVHCHWTGVHCDA-NGYVAKLLLSNMNLSGNVSDQIQSFPSLQALDLSNNAFESS 116
Query: 113 LPLELSNCSNLKVLNVTGNAMVGSVP-------------------------DLSALKNLE 147
LP LSN ++LKV++V+ N+ G+ P DL LE
Sbjct: 117 LPKSLSNLTSLKVIDVSVNSFFGTFPYGLGMATGLTHVNASSNNFSGFLPEDLGNATTLE 176
Query: 148 IFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRG 207
+ D YF G P NL L L + N + ++P+ IG L +L + L + G
Sbjct: 177 VLDFRGGYFEGSVPSSFKNLKNLKFLGLSGNNFG-GKVPKVIGELSSLETIILGYNGFMG 235
Query: 208 RIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLL 267
IPE +L L LD+ ++G+ P S+ +L++L + LY N LTG+LP ELG +T L
Sbjct: 236 EIPEEFGKLTRLQYLDLAVGNLTGQIPSSLGQLKQLTTVYLYQNRLTGKLPRELGGMTSL 295
Query: 268 QEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSG 327
D+S NQ+ G++P E+G LKNL + +N +G PS ++ L ++ N G
Sbjct: 296 VFLDLSDNQITGEIPMEVGELKNLQLLNLMRNQLTGIIPSKIAELPNLEVLELWQNSLMG 355
Query: 328 PFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTI 387
P +LG+ + L +D+S N+ SG P LC R L L+ +N+FSG++P C T+
Sbjct: 356 SLPVHLGKNSPLKWLDVSSNKLSGDIPSGLCYSRNLTKLILFNNSFSGQIPEEIFSCPTL 415
Query: 388 QRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLS----------- 436
R+RI NH+SG IP G LP + L+ N+ TG I I LSTSLS
Sbjct: 416 VRVRIQKNHISGSIPAGSGDLPMLQHLELAKNNLTGKIPDDIALSTSLSFIDISFNHLSS 475
Query: 437 ------------QLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLS 484
+ +N F+G++P+++ +L L L+ N+FSG IP + + +L
Sbjct: 476 LSSSIFSSPNLQTFIASHNNFAGKIPNQIQDRPSLSVLDLSFNHFSGGIPERIASFEKLV 535
Query: 485 SLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGS 544
SL+L+ N L G IP + + L+L+ NSL+GNIP L +L LN+S NKL G
Sbjct: 536 SLNLKSNQLVGEIPKALAGMHMLAVLDLSNNSLTGNIPADLGASPTLEMLNVSFNKLDGP 595
Query: 545 IPDNLMKLKLSSIDLSENQLSGSVPLDFLRMGGDGAFAGNEGLC---LDQSTKMLMNSKL 601
IP N++ ++ID P D + GN GLC L +K L S
Sbjct: 596 IPSNML---FAAID----------PKDLV---------GNNGLCGGVLPPCSKSLALSAK 633
Query: 602 TACPA-IQKQKGGFKDKLVLFCIIAVALAAFLAGLLLVS----YKNFKLSADMENGEKEV 656
P I F + I+A+ + FLAG + + Y NF +E
Sbjct: 634 GRNPGRIHVNHAVFGFIVGTSVIVAMGM-MFLAGRWIYTRWDLYSNFAREYIFCKKPRE- 691
Query: 657 SSKWKLASFHHIDIDAEQI-CNLEEDNLIGSGGTGKVYRLD-LKKNAGTVAVKQLWKGDG 714
W+L +F + A I +++E N+IG G G VY+ + +++ TVAVK+LW+
Sbjct: 692 EWPWRLVAFQRLCFTAGDILSHIKESNIIGMGAIGIVYKAEVMRRPLLTVAVKKLWRSPS 751
Query: 715 VK--------------VFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQ 760
+ E+ +LG +RHRNI+K+ + +V EYMPNGNL
Sbjct: 752 PQNDIEDHHQEEDEEDDILREVNLLGGLRHRNIVKILGYVHNEREVMMVYEYMPNGNLGT 811
Query: 761 ALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKI 820
ALH + E DW RY +A+G +G+ YLH+DC PPIIHRDIKS+NILLD + E +I
Sbjct: 812 ALHSK-DEKFLLRDWLSRYNVAVGVVQGLNYLHNDCYPPIIHRDIKSNNILLDSNLEARI 870
Query: 821 ADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKP 880
ADFG+AK+ + K S AG++GYIAPE YT K+ EKSD++S GVVLLELVTG+ P
Sbjct: 871 ADFGLAKMMLH--KNETVSMVAGSYGYIAPEYGYTLKIDEKSDIYSLGVVLLELVTGKMP 928
Query: 881 VEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASE--SIKEDMIKLLKIAVVCTTKLPN 938
++ + D D+V W+ + +E++ +V+D +A + + E+M+ L+IA++CT KLP
Sbjct: 929 IDPSFEDSIDVVEWIRRKVKKNESLEEVIDASIAGDCKHVIEEMLLALRIALLCTAKLPK 988
Query: 939 LRPPMREVVKMLADADP 955
RP +R+V+ MLA+A P
Sbjct: 989 DRPSIRDVITMLAEAKP 1005
|
Involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FII5|TDR_ARATH Leucine-rich repeat receptor-like protein kinase TDR OS=Arabidopsis thaliana GN=TDR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 559 bits (1440), Expect = e-158, Method: Compositional matrix adjust.
Identities = 344/971 (35%), Positives = 518/971 (53%), Gaps = 62/971 (6%)
Query: 46 PHGVLDSWKESADSP-----CGFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLT 100
P WK + C +SG+ CD+VT +V + +++LSG I I L SL
Sbjct: 49 PPSAFQDWKVPVNGQNDAVWCSWSGVVCDNVTAQVISLDLSHRNLSGRIPIQIRYLSSLL 108
Query: 101 VLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVP-DLSALKNLEIFDLSINYFTGR 159
L+L N L G P + + + L L+++ N+ S P +S LK L++F+ N F G
Sbjct: 109 YLNLSGNSLEGSFPTSIFDLTKLTTLDISRNSFDSSFPPGISKLKFLKVFNAFSNNFEGL 168
Query: 160 FPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELREL 219
P V L L L+ G + Y E EIP + G L+ L ++ LA L G++P + L EL
Sbjct: 169 LPSDVSRLRFLEELNFGGS-YFEGEIPAAYGGLQRLKFIHLAGNVLGGKLPPRLGLLTEL 227
Query: 220 GTLDICRNK------------------------ISGEFPRSIRKLQKLWKIELYANNLTG 255
++I N +SG P+ + L L + L+ N TG
Sbjct: 228 QHMEIGYNHFNGNIPSEFALLSNLKYFDVSNCSLSGSLPQELGNLSNLETLFLFQNGFTG 287
Query: 256 ELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKL 315
E+P NL L+ D SSNQ+ G +P LKNLT NN SGE P G G++ +L
Sbjct: 288 EIPESYSNLKSLKLLDFSSNQLSGSIPSGFSTLKNLTWLSLISNNLSGEVPEGIGELPEL 347
Query: 316 FAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSG 375
++ N F+G P LG L +D+S N F+G+ P LC KL L+ SN F G
Sbjct: 348 TTLFLWNNNFTGVLPHKLGSNGKLETMDVSNNSFTGTIPSSLCHGNKLYKLILFSNMFEG 407
Query: 376 EVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSL 435
E+P S C+++ R R +N L+G IP G +L N+ +D +N FT I + L
Sbjct: 408 ELPKSLTRCESLWRFRSQNNRLNGTIPIGFGSLRNLTFVDLSNNRFTDQIPADFATAPVL 467
Query: 436 SQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTG 495
L L N F +LP + + NL+ + +N G+IP+ +G + + L+ N+L G
Sbjct: 468 QYLNLSTNFFHRKLPENIWKAPNLQIFSASFSNLIGEIPNYVGC-KSFYRIELQGNSLNG 526
Query: 496 SIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLK-L 554
+IP ++G C +++ LNL++N L+G IP +S L S+ ++LS N LTG+IP + K +
Sbjct: 527 TIPWDIGHCEKLLCLNLSQNHLNGIIPWEISTLPSIADVDLSHNLLTGTIPSDFGSSKTI 586
Query: 555 SSIDLSENQLSGSVPLDFLRMGGDGAFAGNEGLCLDQSTKMLMNSKLTACPA-IQKQKGG 613
++ ++S NQL G +P F+ NEGLC D K + + A A I
Sbjct: 587 TTFNVSYNQLIGPIPSGSFAHLNPSFFSSNEGLCGDLVGKPCNSDRFNAGNADIDGHHKE 646
Query: 614 FKDKLVLFCIIAVALAAFLAG--LLLVSYKNFKLS----ADMENGEKEVSSKWKLASFHH 667
+ K I+ + AA G +L+ + + F+ S D WKL +F
Sbjct: 647 ERPKKTAGAIVWILAAAIGVGFFVLVAATRCFQKSYGNRVDGGGRNGGDIGPWKLTAFQR 706
Query: 668 IDIDAEQI--CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLW-----------KGDG 714
++ A+ + C + DN++G G TG VY+ ++ N +AVK+LW + G
Sbjct: 707 LNFTADDVVECLSKTDNILGMGSTGTVYKAEMP-NGEIIAVKKLWGKNKENGKIRRRKSG 765
Query: 715 VKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELD 774
V AE+++LG +RHRNI++L C + L+ EYMPNG+L LH K +
Sbjct: 766 V---LAEVDVLGNVRHRNIVRLLGCCTNRDCTMLLYEYMPNGSLDDLLHGGDKTMTAAAE 822
Query: 775 WFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK 834
W Y+IA+G A+GI YLHHDC P I+HRD+K SNILLD D+E ++ADFGVAK+ +
Sbjct: 823 WTALYQIAIGVAQGICYLHHDCDPVIVHRDLKPSNILLDADFEARVADFGVAKLIQTDES 882
Query: 835 VSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYW 894
+ S AG++GYIAPE AYT +V +KSD++S+GV+LLE++TG++ VE E+G+G IV W
Sbjct: 883 M---SVVAGSYGYIAPEYAYTLQVDKKSDIYSYGVILLEIITGKRSVEPEFGEGNSIVDW 939
Query: 895 VSTHLNNHENVLKVLDCEVASES--IKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952
V + L E+V +VLD + I+E+M ++L+IA++CT++ P RPPMR+V+ +L +
Sbjct: 940 VRSKLKTKEDVEEVLDKSMGRSCSLIREEMKQMLRIALLCTSRSPTDRPPMRDVLLILQE 999
Query: 953 ADPCTDKSPDN 963
A P DN
Sbjct: 1000 AKPKRKTVGDN 1010
|
Acts with CLE41p and CLE44p peptides as a ligand-receptor pair in a signal transduction pathway involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Mediates repression of tracheary element differentiation and the promotion of procambial cells formation and polar division adjacent to phloem cells in the veins. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 973 | ||||||
| 224146319 | 977 | predicted protein [Populus trichocarpa] | 0.998 | 0.994 | 0.692 | 0.0 | |
| 359493408 | 974 | PREDICTED: receptor-like protein kinase | 0.993 | 0.992 | 0.683 | 0.0 | |
| 359807055 | 955 | receptor-like protein kinase HSL1-like [ | 0.976 | 0.994 | 0.654 | 0.0 | |
| 449494090 | 976 | PREDICTED: LRR receptor-like serine/thre | 0.955 | 0.952 | 0.657 | 0.0 | |
| 449446347 | 976 | PREDICTED: LRR receptor-like serine/thre | 0.955 | 0.952 | 0.657 | 0.0 | |
| 255561534 | 919 | Receptor protein kinase CLAVATA1 precurs | 0.941 | 0.996 | 0.628 | 0.0 | |
| 296089466 | 892 | unnamed protein product [Vitis vinifera] | 0.909 | 0.992 | 0.623 | 0.0 | |
| 297839079 | 977 | hypothetical protein ARALYDRAFT_476351 [ | 0.981 | 0.977 | 0.586 | 0.0 | |
| 15218385 | 977 | leucine-rich receptor-like protein kinas | 0.973 | 0.969 | 0.578 | 0.0 | |
| 110738078 | 977 | putative leucine-rich receptor-like prot | 0.973 | 0.969 | 0.578 | 0.0 |
| >gi|224146319|ref|XP_002325963.1| predicted protein [Populus trichocarpa] gi|222862838|gb|EEF00345.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1332 bits (3447), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 677/978 (69%), Positives = 807/978 (82%), Gaps = 6/978 (0%)
Query: 1 MAKIPFLCFH-LLALLCFILVSVFPPSLSLNVETQALIQFKSKLKDPHGVLDSWKESADS 59
MAK L ++ ++C + +S FPPSLSL+VETQAL+ FKS+LKDP VL SWKES +S
Sbjct: 1 MAKTSVLSLQFIITVICLLSLSSFPPSLSLDVETQALLDFKSQLKDPLNVLKSWKES-ES 59
Query: 60 PCGFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSN 119
PC FSGITCD ++G+VT ISFDN+SLSG IS SISAL+SL L LP N +SGKLP + N
Sbjct: 60 PCEFSGITCDPLSGKVTAISFDNQSLSGVISPSISALESLMSLWLPSNAISGKLPDGVIN 119
Query: 120 CSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNV 179
CS L+VLN+TGN MVG +PDLS+L+NLEI DLS NYF+GRFP W+ NL+ L++L +G N
Sbjct: 120 CSKLRVLNLTGNKMVGVIPDLSSLRNLEILDLSENYFSGRFPSWIGNLSGLLALGLGTNE 179
Query: 180 YDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRK 239
Y EIPESIGNLKNLT+LFLA+ +LRG IPESI EL L TLDI RNKISG+FP+SI K
Sbjct: 180 YHVGEIPESIGNLKNLTWLFLANSHLRGEIPESIFELENLQTLDISRNKISGQFPKSISK 239
Query: 240 LQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKN 299
L+KL KIEL+ NNLTGE+P EL NLTLLQEFD+SSNQ+YGKLPE IG+LK+LTVFQ +N
Sbjct: 240 LRKLTKIELFYNNLTGEIPPELANLTLLQEFDVSSNQLYGKLPEGIGSLKSLTVFQGHQN 299
Query: 300 NFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCE 359
NFSGE P+GFG+MR L FSIY N FSG FP N GR++ L +DISENQFSGSFP++LCE
Sbjct: 300 NFSGEIPAGFGEMRYLNGFSIYQNNFSGEFPTNFGRFSPLNSIDISENQFSGSFPRFLCE 359
Query: 360 KRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDN 419
++L LLAL N FSG +P+SYA+CKT+ R R++ N L+GKIP+G+WA+P ++DF DN
Sbjct: 360 SKQLQYLLALGNRFSGVLPDSYAECKTLWRFRVNKNQLTGKIPEGVWAMPLASIIDFSDN 419
Query: 420 DFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGA 479
DFTG +SP I LSTSL+QL+LQNNRFSG+LPSELG+L NLE+L L NNNFSG IPS +G+
Sbjct: 420 DFTGEVSPQIRLSTSLNQLILQNNRFSGQLPSELGKLMNLEKLYLNNNNFSGVIPSDIGS 479
Query: 480 LRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGN 539
L+QLSSLHLEEN+LTGSIP+E+GDCAR+VDLN+A NSLSG IP +++L+SSLN+LNLS N
Sbjct: 480 LQQLSSLHLEENSLTGSIPSELGDCARVVDLNIASNSLSGRIPSTITLMSSLNSLNLSRN 539
Query: 540 KLTGSIPDNLMKLKLSSIDLSENQLSGSVPLDFLRMGGDGAFAGNEGLCLDQSTKMLMNS 599
K+TG IP+ L KLKLSSIDLSENQLSG VP L MGGD AF GN+ LC+D+++K ++NS
Sbjct: 540 KITGLIPEGLEKLKLSSIDLSENQLSGRVPSVLLTMGGDRAFIGNKELCVDENSKTIINS 599
Query: 600 KLTACPAIQKQKGGFKDKLVLFCIIAVALAAFLAGLLLVSYKNFKL-SADMEN---GEKE 655
+ C Q Q+ F DKLVLF IIA L L G+LL+SY+NFK A+M+N G+KE
Sbjct: 600 GIKVCLGRQDQERKFGDKLVLFSIIACVLVFVLTGMLLLSYRNFKHGQAEMKNDLEGKKE 659
Query: 656 VSSKWKLASFHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGV 715
KW+++SFH +DIDA++IC+LEEDNLIG GGTGKVYRLDLKKN G VAVKQLWKGDG+
Sbjct: 660 GDPKWQISSFHQLDIDADEICDLEEDNLIGCGGTGKVYRLDLKKNRGAVAVKQLWKGDGL 719
Query: 716 KVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDW 775
K AEMEILGKIRHRNILKLYA LLKG SSFLV EYMPNGNLFQALH R+K+G+PELDW
Sbjct: 720 KFLEAEMEILGKIRHRNILKLYASLLKGESSFLVFEYMPNGNLFQALHTRIKDGQPELDW 779
Query: 776 FRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV 835
+RYKIALGAAKGIAYLHHDCSPPI+HRDIKSSNILLDED EPKIADFGVAK+AE S K
Sbjct: 780 NQRYKIALGAAKGIAYLHHDCSPPILHRDIKSSNILLDEDNEPKIADFGVAKLAEMSLKG 839
Query: 836 SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWV 895
D S F GTHGYIAPE+AY+ KV+EKSDV+SFGVVLLELVTG++P+EE YG+GKDI YWV
Sbjct: 840 CDNSSFTGTHGYIAPEMAYSLKVTEKSDVYSFGVVLLELVTGKRPIEEAYGEGKDIAYWV 899
Query: 896 STHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADP 955
+HLN+ EN+LKVLD EVAS S +E+MIK+LKI V+CTTKLPNLRP MREVVKML DAD
Sbjct: 900 LSHLNDRENLLKVLDEEVASGSAQEEMIKVLKIGVLCTTKLPNLRPTMREVVKMLVDADS 959
Query: 956 CTDKSPDNSSDKSGKISL 973
C +SPD SSDK+ K+ L
Sbjct: 960 CAYRSPDYSSDKNEKVFL 977
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493408|ref|XP_003634589.1| PREDICTED: receptor-like protein kinase HSL1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1295 bits (3352), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 666/974 (68%), Positives = 777/974 (79%), Gaps = 7/974 (0%)
Query: 1 MAKIPFLCFHLLALLCFILVSVFPPSLSLNVETQALIQFKSKLKDPHGVLDSWKESADSP 60
MAK P H L CF + +VE +AL+QFK +LKDP LDSWK+S DSP
Sbjct: 1 MAKHPLSFLHFLLCCCFFSTLLS--PSLSSVEVEALLQFKKQLKDPLHRLDSWKDS-DSP 57
Query: 61 CGFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNC 120
C F G++CD +TG V E+S DNKSLSGEISSS+SAL+SLT L LP N LSG LP EL+ C
Sbjct: 58 CKFFGVSCDPITGLVNELSLDNKSLSGEISSSLSALRSLTHLVLPSNSLSGYLPSELNKC 117
Query: 121 SNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVY 180
SNL+VLNVT N ++G+VPDLS L NL DLSINYF+G FP WV NLT LVSLS+G+N Y
Sbjct: 118 SNLQVLNVTCNNLIGTVPDLSELSNLRTLDLSINYFSGPFPSWVTNLTGLVSLSLGENHY 177
Query: 181 DEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKL 240
DE EIPESIGNLKNL+Y+F AH LRG IPES E+ + +LD N ISG FP+SI KL
Sbjct: 178 DEGEIPESIGNLKNLSYIFFAHSQLRGEIPESFFEITAMESLDFSGNNISGNFPKSIAKL 237
Query: 241 QKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNN 300
QKL+KIEL+ N LTGE+P EL NLTLLQE DIS NQ+YGKLPEEIG LK L VF+ + NN
Sbjct: 238 QKLYKIELFDNQLTGEIPPELANLTLLQEIDISENQLYGKLPEEIGRLKKLVVFESYDNN 297
Query: 301 FSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEK 360
FSGE P+ FGD+ L FSIY N FSG FP N GR++ L DISENQFSG+FPKYLCE
Sbjct: 298 FSGEIPAAFGDLSNLTGFSIYRNNFSGEFPANFGRFSPLNSFDISENQFSGAFPKYLCEN 357
Query: 361 RKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDND 420
+LL LLAL N FSGE P+SYA CK++QRLRI++N LSG+IP+G+WALPNV M+DFGDN
Sbjct: 358 GRLLYLLALGNRFSGEFPDSYAKCKSLQRLRINENQLSGEIPNGIWALPNVQMIDFGDNG 417
Query: 421 FTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGAL 480
F+G ISP IG ++SL+QL+L NNRFSG+LPSELG L NL +L L N FSGKIPS LGAL
Sbjct: 418 FSGRISPDIGTASSLNQLILANNRFSGKLPSELGSLANLGKLYLNGNEFSGKIPSELGAL 477
Query: 481 RQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNK 540
+QLSSLHLEEN+LTGSIP E+G CAR+VDLNLA NSLSGNIP S SLL+ LN+LNLSGNK
Sbjct: 478 KQLSSLHLEENSLTGSIPAELGKCARLVDLNLAWNSLSGNIPDSFSLLTYLNSLNLSGNK 537
Query: 541 LTGSIPDNLMKLKLSSIDLSENQLSGSVPLDFLRMGGDGAFAGNEGLCLDQSTKMLMNSK 600
LTGS+P NL KLKLSSIDLS NQLSG V D L+MGGD AF GN+GLC++QS K+ ++S
Sbjct: 538 LTGSLPVNLRKLKLSSIDLSRNQLSGMVSSDLLQMGGDQAFLGNKGLCVEQSYKIQLHSG 597
Query: 601 LTACPAIQKQKGGFKDKLVLFCIIAVALAAFLAGLLLVSYKNFKLSADM-EN---GEKEV 656
L C K K+KL LFCIIA AL L GLL+VSY+NFK + EN G KE
Sbjct: 598 LDVCTGNNDPKRVAKEKLFLFCIIASALVILLVGLLVVSYRNFKHNESYAENELEGGKEK 657
Query: 657 SSKWKLASFHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVK 716
KWKL SFH ++ AE +CNLEEDNLIGSGGTGKVYRLDLK+N G VAVKQLWKG GVK
Sbjct: 658 DLKWKLESFHPVNFTAEDVCNLEEDNLIGSGGTGKVYRLDLKRNGGPVAVKQLWKGSGVK 717
Query: 717 VFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWF 776
VF AE+EIL KIRHRNI+KLYACL KGGSSFLVLEYM NGNLFQALH+++KEG PELDW
Sbjct: 718 VFTAEIEILRKIRHRNIMKLYACLKKGGSSFLVLEYMSNGNLFQALHRQIKEGVPELDWH 777
Query: 777 RRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVS 836
+RYKIALGAAKGIAYLHHDCSPPIIHRDIKS+NILLDE+YEPKIADFGVAKIA+NS S
Sbjct: 778 QRYKIALGAAKGIAYLHHDCSPPIIHRDIKSTNILLDEEYEPKIADFGVAKIADNSSTES 837
Query: 837 DYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVS 896
SCFAGTHGYIAPELAYT KV+EKSD++SFGVVLLELVTGR+P+EEEYG+GKDIVYWV
Sbjct: 838 YSSCFAGTHGYIAPELAYTLKVTEKSDIYSFGVVLLELVTGRRPIEEEYGEGKDIVYWVG 897
Query: 897 THLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPC 956
THL++ ENV K+LD ++ S+ ++EDM+K+LK+A++CT KLP RP MR+VVKM+ DAD C
Sbjct: 898 THLSDQENVQKLLDRDIVSDLVQEDMLKVLKVAILCTNKLPTPRPTMRDVVKMIIDADSC 957
Query: 957 TDKSPDNSSDKSGK 970
T KSP+++ +K+ K
Sbjct: 958 TLKSPESNPEKNVK 971
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359807055|ref|NP_001241340.1| receptor-like protein kinase HSL1-like [Glycine max] gi|223452422|gb|ACM89538.1| leucine-rich repeat transmembrane protein kinase [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1264 bits (3272), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 624/953 (65%), Positives = 756/953 (79%), Gaps = 3/953 (0%)
Query: 14 LLCFILVSVFPPSLSLNVETQALIQFKSKLKDPHGVLDSWKESADSPCGFSGITCDSVTG 73
+L S+FPP +SL +ETQAL+QFK+ LKD L SW ES DSPC F GITCD V+G
Sbjct: 1 MLLLTSYSIFPPCVSLTLETQALLQFKNHLKDSSNSLASWNES-DSPCKFYGITCDPVSG 59
Query: 74 RVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAM 133
RVTEIS DNKSLSG+I S+S LQSL VLSLP N++SGKLP E+S C++L+VLN+TGN +
Sbjct: 60 RVTEISLDNKSLSGDIFPSLSILQSLQVLSLPSNLISGKLPSEISRCTSLRVLNLTGNQL 119
Query: 134 VGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLK 193
VG++PDLS L++L++ DLS NYF+G P V NLT LVSL +G+N Y+E EIP ++GNLK
Sbjct: 120 VGAIPDLSGLRSLQVLDLSANYFSGSIPSSVGNLTGLVSLGLGENEYNEGEIPGTLGNLK 179
Query: 194 NLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNL 253
NL +L+L +L G IPES+ E++ L TLDI RNKISG RSI KL+ L+KIEL++NNL
Sbjct: 180 NLAWLYLGGSHLIGDIPESLYEMKALETLDISRNKISGRLSRSISKLENLYKIELFSNNL 239
Query: 254 TGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMR 313
TGE+PAEL NLT LQE D+S+N MYG+LPEEIGN+KNL VFQ ++NNFSGE P+GF DMR
Sbjct: 240 TGEIPAELANLTNLQEIDLSANNMYGRLPEEIGNMKNLVVFQLYENNFSGELPAGFADMR 299
Query: 314 KLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNF 373
L FSIY N F+G P N GR++ L +DISENQFSG FPK+LCE RKL LLAL NNF
Sbjct: 300 HLIGFSIYRNSFTGTIPGNFGRFSPLESIDISENQFSGDFPKFLCENRKLRFLLALQNNF 359
Query: 374 SGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLST 433
SG P SY CK+++R RIS N LSGKIPD +WA+P V ++D NDFTG + IGLST
Sbjct: 360 SGTFPESYVTCKSLKRFRISMNRLSGKIPDEVWAIPYVEIIDLAYNDFTGEVPSEIGLST 419
Query: 434 SLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENAL 493
SLS +VL NRFSG+LPSELG+L NLE+L L+NNNFSG+IP +G+L+QLSSLHLEEN+L
Sbjct: 420 SLSHIVLTKNRFSGKLPSELGKLVNLEKLYLSNNNFSGEIPPEIGSLKQLSSLHLEENSL 479
Query: 494 TGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLK 553
TGSIP E+G CA +VDLNLA NSLSGNIP+S+SL+SSLN+LN+SGNKL+GSIP+NL +K
Sbjct: 480 TGSIPAELGHCAMLVDLNLAWNSLSGNIPQSVSLMSSLNSLNISGNKLSGSIPENLEAIK 539
Query: 554 LSSIDLSENQLSGSVPLDFLRMGGDGAFAGNEGLCLDQSTKMLMNSKLTACPAIQKQKGG 613
LSS+D SENQLSG +P +GG+ AF GN+GLC++ + K MNS L C Q
Sbjct: 540 LSSVDFSENQLSGRIPSGLFIVGGEKAFLGNKGLCVEGNLKPSMNSDLKICAKNHGQPSV 599
Query: 614 FKDKLVLFCIIAVALAAFLAGLLLVSYKNFKLSADME-NGEKEVSSKWKLASFHHIDIDA 672
DK VLF IA LAGL+ +S ++ K A+ G+KEVS KWKLASFH +DIDA
Sbjct: 600 SADKFVLFFFIASIFVVILAGLVFLSCRSLKHDAEKNLQGQKEVSQKWKLASFHQVDIDA 659
Query: 673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRN 732
++IC L+EDNLIGSGGTGKVYR++L+KN VAVKQL K DGVK+ AAEMEILGKIRHRN
Sbjct: 660 DEICKLDEDNLIGSGGTGKVYRVELRKNGAMVAVKQLGKVDGVKILAAEMEILGKIRHRN 719
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
ILKLYA LLKGGS+ LV EYMPNGNLFQALH+++K+GKP LDW +RYKIALGA KGIAYL
Sbjct: 720 ILKLYASLLKGGSNLLVFEYMPNGNLFQALHRQIKDGKPNLDWNQRYKIALGAGKGIAYL 779
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL 852
HHDC+PP+IHRDIKSSNILLDEDYE KIADFG+A+ AE S K YSC AGT GYIAPEL
Sbjct: 780 HHDCNPPVIHRDIKSSNILLDEDYESKIADFGIARFAEKSDKQLGYSCLAGTLGYIAPEL 839
Query: 853 AYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCE 912
AY ++EKSDV+SFGVVLLELV+GR+P+EEEYG+ KDIVYWV ++LN+ E++L +LD
Sbjct: 840 AYATDITEKSDVYSFGVVLLELVSGREPIEEEYGEAKDIVYWVLSNLNDRESILNILDER 899
Query: 913 VASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPCTDKSPDNSS 965
V SES+ EDMIK+LKIA+ CTTKLP+LRP MREVVKML DA+PC KSP+ +
Sbjct: 900 VTSESV-EDMIKVLKIAIKCTTKLPSLRPTMREVVKMLIDAEPCAFKSPNKDT 951
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449494090|ref|XP_004159444.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1223 bits (3164), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 615/935 (65%), Positives = 759/935 (81%), Gaps = 5/935 (0%)
Query: 25 PSLSLNVETQALIQFKSKLKDPHGVLDSWKESADSPCGFSGITCDSVTGRVTEISFDNKS 84
PS+ L ETQAL++FK LKDP G L+SW +S +SPCGFSGITCD +G+V EIS +NKS
Sbjct: 24 PSMPLPTETQALLRFKENLKDPTGFLNSWIDS-ESPCGFSGITCDRASGKVVEISLENKS 82
Query: 85 LSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALK 144
LSGEIS SIS LQ LT LSL N +SG+LP +L NCSNL+VLN+T N MV +PDLS L+
Sbjct: 83 LSGEISPSISVLQWLTTLSLASNHISGELPNQLINCSNLRVLNLTDNEMVKRIPDLSQLR 142
Query: 145 NLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCN 204
LE+ DLSIN+F+G+FP WV NLT LVSL +G N ++ EIPESIGNLKNLT+L+LA+
Sbjct: 143 KLEVLDLSINFFSGQFPIWVGNLTGLVSLGLGQNEFEAGEIPESIGNLKNLTWLYLANAQ 202
Query: 205 LRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNL 264
LRG IPES+ EL+ L TLD+ RN++SG+ +SI KLQ L K+EL+ N LTGE+P E+ NL
Sbjct: 203 LRGEIPESLFELKALKTLDLSRNELSGKISKSISKLQNLNKLELFVNKLTGEIPPEISNL 262
Query: 265 TLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNR 324
TLLQE DIS+N +YG+LPEE+GNL+NL VFQ ++NNFSG+ P GFG+M+ L AFSIY N
Sbjct: 263 TLLQEIDISANSLYGQLPEEVGNLRNLVVFQLYENNFSGKLPEGFGNMQNLIAFSIYRNN 322
Query: 325 FSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADC 384
FSG FP N GR++ L+ +DISENQFSGSFP++LCE RKL LLAL N FSGE+P + A+C
Sbjct: 323 FSGDFPVNFGRFSPLSSIDISENQFSGSFPQFLCENRKLEFLLALENRFSGELPFALAEC 382
Query: 385 KTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNR 444
K++QR RI++N +SG IPDG+WALPN M+DF DN+F G ISP IGLSTSLSQLVL NN+
Sbjct: 383 KSLQRFRINNNQMSGSIPDGVWALPNAKMIDFSDNEFIGIISPNIGLSTSLSQLVLPNNK 442
Query: 445 FSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDC 504
FSG LPSELG+LTNLERL L+NN F+G+IPS +G LRQLSS HLE N+L GSIP E+G+C
Sbjct: 443 FSGNLPSELGKLTNLERLYLSNNEFNGEIPSEIGFLRQLSSFHLEVNSLNGSIPLEIGNC 502
Query: 505 ARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQL 564
R+VD+N A+NSLSG+IP S SL+SSLN+LNLS NKL+G IP++L K+KLSSIDLS NQL
Sbjct: 503 ERLVDVNFAQNSLSGSIPSSFSLISSLNSLNLSSNKLSGIIPESLEKMKLSSIDLSGNQL 562
Query: 565 SGSVPLDFLRMGGDGAFAGNEGLCLDQSTKMLMNSKLTACPAIQKQKGGFKDKLVLFCII 624
G VP L M GD AF N+ LC+D++ + +N+ L C KG D+++ F II
Sbjct: 563 FGRVPSSLLAMSGDKAFLDNKELCVDENYRDRINTTLVTCTGKNSHKGVLNDEILFFSII 622
Query: 625 AVALAAFLAGLLLVSYKNFKLS-ADME---NGEKEVSSKWKLASFHHIDIDAEQICNLEE 680
L LAGL LVS K+S D E G+++ + +WK+ASFH ++IDA++IC+ EE
Sbjct: 623 VSILVCVLAGLALVSCNCLKISQTDPEASWEGDRQGAPQWKIASFHQVEIDADEICSFEE 682
Query: 681 DNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACL 740
+NLIGSGGTGKVYRLDLKKN TVAVKQLWKGD +KV AAEMEILGKIRHRNILKLYACL
Sbjct: 683 ENLIGSGGTGKVYRLDLKKNGYTVAVKQLWKGDAMKVLAAEMEILGKIRHRNILKLYACL 742
Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
++ GSS+LV EYM NGNL++AL +++K G+PEL+W++RYKIALGAA+GIAYLHHDCSPPI
Sbjct: 743 MREGSSYLVFEYMTNGNLYEALQRQIKSGQPELNWYQRYKIALGAARGIAYLHHDCSPPI 802
Query: 801 IHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSE 860
IHRDIKS+NILLD DYEPKIADFGVAK+A+ S++S AGTHGYIAPELAYT KVSE
Sbjct: 803 IHRDIKSTNILLDGDYEPKIADFGVAKVADQFQSASEHSSLAGTHGYIAPELAYTPKVSE 862
Query: 861 KSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESIKE 920
KSDV+S+GVVLLEL+TGR+P+E+EYG+GKDIVYW+STHL++ ++ LK+LD VASE+I+
Sbjct: 863 KSDVYSYGVVLLELITGRRPIEDEYGEGKDIVYWISTHLDDRDHALKLLDIRVASEAIQN 922
Query: 921 DMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADP 955
DMIK+LKIAV+CTTKLP+LRP MREVVKML+DADP
Sbjct: 923 DMIKVLKIAVLCTTKLPSLRPSMREVVKMLSDADP 957
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449446347|ref|XP_004140933.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1222 bits (3162), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 615/935 (65%), Positives = 758/935 (81%), Gaps = 5/935 (0%)
Query: 25 PSLSLNVETQALIQFKSKLKDPHGVLDSWKESADSPCGFSGITCDSVTGRVTEISFDNKS 84
PS+ L ETQAL++FK LKDP G L+SW +S +SPCGFSGITCD +G+V EIS +NKS
Sbjct: 24 PSMPLPTETQALLRFKENLKDPTGFLNSWIDS-ESPCGFSGITCDRASGKVVEISLENKS 82
Query: 85 LSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALK 144
LSGEIS SIS LQ LT LSL N +SG+LP +L NCSNL+VLN+T N MV +PDLS L+
Sbjct: 83 LSGEISPSISVLQWLTTLSLASNHISGELPNQLINCSNLRVLNLTDNEMVKRIPDLSQLR 142
Query: 145 NLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCN 204
LE+ DLSIN+F+G+FP WV NLT LVSL +G N ++ EIPESIGNLKNLT+L+LA+
Sbjct: 143 KLEVLDLSINFFSGQFPIWVGNLTGLVSLGLGQNEFEAGEIPESIGNLKNLTWLYLANAQ 202
Query: 205 LRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNL 264
LRG IPES+ EL+ L TLD+ RN++SG+ SI KLQ L K+EL+ N LTGE+P E+ NL
Sbjct: 203 LRGEIPESLFELKALKTLDLSRNELSGKISNSISKLQNLNKLELFVNKLTGEIPPEISNL 262
Query: 265 TLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNR 324
TLLQE DIS+N +YG+LPEE+GNL+NL VFQ ++NNFSG+ P GFG+M+ L AFSIY N
Sbjct: 263 TLLQEIDISANSLYGQLPEEVGNLRNLVVFQLYENNFSGKLPEGFGNMQNLIAFSIYRNN 322
Query: 325 FSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADC 384
FSG FP N GR++ L+ +DISENQFSGSFP++LCE RKL LLAL N FSGE+P + A+C
Sbjct: 323 FSGDFPVNFGRFSPLSSIDISENQFSGSFPQFLCENRKLEFLLALENRFSGELPFALAEC 382
Query: 385 KTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNR 444
K++QR RI++N +SG IPDG+WALPN M+DF DN+F G ISP IGLSTSLSQLVL NN+
Sbjct: 383 KSLQRFRINNNQMSGSIPDGVWALPNAKMIDFSDNEFIGIISPNIGLSTSLSQLVLPNNK 442
Query: 445 FSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDC 504
FSG LPSELG+LTNLERL L+NN F+G+IPS +G LRQLSS HLE N+L GSIP E+G+C
Sbjct: 443 FSGNLPSELGKLTNLERLYLSNNEFNGEIPSEIGFLRQLSSFHLEVNSLNGSIPLEIGNC 502
Query: 505 ARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQL 564
R+VD+N A+NSLSG+IP S SL+SSLN+LNLS NKL+G IP++L K+KLSSIDLS NQL
Sbjct: 503 ERLVDVNFAQNSLSGSIPSSFSLISSLNSLNLSSNKLSGIIPESLEKMKLSSIDLSGNQL 562
Query: 565 SGSVPLDFLRMGGDGAFAGNEGLCLDQSTKMLMNSKLTACPAIQKQKGGFKDKLVLFCII 624
G VP L M GD AF N+ LC+D++ + +N+ L C KG D+++ F II
Sbjct: 563 FGRVPSSLLAMSGDKAFLDNKELCVDENYRDRINTTLVTCTGKNSHKGVLNDEILFFSII 622
Query: 625 AVALAAFLAGLLLVSYKNFKLS-ADME---NGEKEVSSKWKLASFHHIDIDAEQICNLEE 680
L LAGL LVS K+S D E G+++ + +WK+ASFH ++IDA++IC+ EE
Sbjct: 623 VSILVCVLAGLALVSCNCLKISQTDPEASWEGDRQGAPQWKIASFHQVEIDADEICSFEE 682
Query: 681 DNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACL 740
+NLIGSGGTGKVYRLDLKKN TVAVKQLWKGD +KV AAEMEILGKIRHRNILKLYACL
Sbjct: 683 ENLIGSGGTGKVYRLDLKKNGYTVAVKQLWKGDAMKVLAAEMEILGKIRHRNILKLYACL 742
Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
++ GSS+LV EYM NGNL++AL +++K G+PEL+W++RYKIALGAA+GIAYLHHDCSPPI
Sbjct: 743 MREGSSYLVFEYMTNGNLYEALQRQIKSGQPELNWYQRYKIALGAARGIAYLHHDCSPPI 802
Query: 801 IHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSE 860
IHRDIKS+NILLD DYEPKIADFGVAK+A+ S++S AGTHGYIAPELAYT KVSE
Sbjct: 803 IHRDIKSTNILLDGDYEPKIADFGVAKVADQFQSASEHSSLAGTHGYIAPELAYTPKVSE 862
Query: 861 KSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESIKE 920
KSDV+S+GVVLLEL+TGR+P+E+EYG+GKDIVYW+STHL++ ++ LK+LD VASE+I+
Sbjct: 863 KSDVYSYGVVLLELITGRRPIEDEYGEGKDIVYWISTHLDDRDHALKLLDIRVASEAIQN 922
Query: 921 DMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADP 955
DMIK+LKIAV+CTTKLP+LRP MREVVKML+DADP
Sbjct: 923 DMIKVLKIAVLCTTKLPSLRPSMREVVKMLSDADP 957
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255561534|ref|XP_002521777.1| Receptor protein kinase CLAVATA1 precursor, putative [Ricinus communis] gi|223538990|gb|EEF40587.1| Receptor protein kinase CLAVATA1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1158 bits (2996), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 610/970 (62%), Positives = 719/970 (74%), Gaps = 54/970 (5%)
Query: 1 MAKIPFLCFHLLALLCFILVSVFPPSLSLNVETQALIQFKSKLKDPHGVLDSWKESADSP 60
MA+ FL L+LL ++ SV PS LN+ETQAL+QFK +LKDP VL SWKES SP
Sbjct: 1 MARKCFLSVQFLSLLSILVFSVCLPSFGLNIETQALLQFKRQLKDPLNVLGSWKESESSP 60
Query: 61 CGFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNC 120
C FSGITCDS++G+VT ISFDNKSLSGEIS SISAL+SLT LSLP N LSGKLP EL NC
Sbjct: 61 CKFSGITCDSISGKVTAISFDNKSLSGEISPSISALESLTTLSLPSNALSGKLPYELINC 120
Query: 121 SNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVY 180
SNLKVLN+TGN M+G +PDLS+L+NLEI DL+ NYF+GRFP WV NLT LV+L+IG N +
Sbjct: 121 SNLKVLNLTGNQMIGVLPDLSSLRNLEILDLTKNYFSGRFPAWVGNLTGLVALAIGQNEF 180
Query: 181 DEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKL 240
D+ EIPESIGNLKNLTYLFLA +L+G IPESI L EL TLDI RNKISG FP+SI KL
Sbjct: 181 DDGEIPESIGNLKNLTYLFLADAHLKGEIPESIFGLWELETLDISRNKISGHFPKSISKL 240
Query: 241 QKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNN 300
+KL+KIEL+ NNLTGE+P EL NLTLL+E DISSNQ+YGKLPE IG LKNL VFQ + N
Sbjct: 241 KKLYKIELFLNNLTGEIPPELANLTLLREIDISSNQLYGKLPEGIGKLKNLVVFQMYNNR 300
Query: 301 FSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEK 360
FSGE P+GFG M L FSIYGN FSG FP N GR++ L DISENQFSGSFPK+LCE
Sbjct: 301 FSGELPAGFGQMHNLNGFSIYGNNFSGEFPANFGRFSPLNSFDISENQFSGSFPKFLCEG 360
Query: 361 RKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDND 420
+KL LLAL N FSGE+ SYA CKT++R RI++N +SG+IPDG+WALP V +LDF +N
Sbjct: 361 KKLQYLLALGNRFSGELSYSYAKCKTLERFRINNNMMSGQIPDGVWALPLVLLLDFSNNA 420
Query: 421 FTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGAL 480
F+G ISP IGLS T+L +LIL NN FSG++PS LG L
Sbjct: 421 FSGQISPNIGLS------------------------TSLTQLILQNNRFSGQLPSELGKL 456
Query: 481 RQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNK 540
L L+L+ N+ +G IP+E+G ++ L+L +NSL+G IP L + L LNL+ N
Sbjct: 457 MNLQKLYLDNNSFSGEIPSEIGALKQLSSLHLVQNSLTGAIPSELGECARLVDLNLASNS 516
Query: 541 LTGSIPDNL-MKLKLSSIDLSENQLSGSVPLDFLRMGGDGAFAGNEGLCLDQSTKMLMNS 599
L+G IP + + L+S++LS N+L+G +P + L
Sbjct: 517 LSGHIPHSFSLMTSLNSLNLSHNRLTGLIP------------------------EYLEKL 552
Query: 600 KLTACPAIQKQKGGFKDKLVLFCIIAVALAAFLAGLLLVSYKNF-KLSADMENG-EKEVS 657
KL+ + + G DK + L L GLLL SY+NF AD EN E
Sbjct: 553 KLSXXHSQDRTIG---DKWCCSPSSYLPLVIILVGLLLASYRNFINGKADRENDLEARRD 609
Query: 658 SKWKLASFHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV 717
+KWKLASFH +D+DA++ICNLEE NLIGSGGTGKVYRL+LK++ TVAVKQLWKGD +KV
Sbjct: 610 TKWKLASFHQLDVDADEICNLEEGNLIGSGGTGKVYRLELKRSGCTVAVKQLWKGDYLKV 669
Query: 718 FAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFR 777
AEMEILGKIRHRNILKLYA LLKGGSS+LVLEYM GNLFQAL +R+K+ KPELDW +
Sbjct: 670 SEAEMEILGKIRHRNILKLYASLLKGGSSYLVLEYMAKGNLFQALQRRIKDEKPELDWLQ 729
Query: 778 RYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSD 837
RYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK+ E S K D
Sbjct: 730 RYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKLVEVSYKGCD 789
Query: 838 YSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVST 897
S AGTHGYIAPE+AYT KV+EKSDV+SFGVVLLELVTGR+P+EE YG+ KDIVYWV T
Sbjct: 790 SSSVAGTHGYIAPEMAYTLKVTEKSDVYSFGVVLLELVTGRRPIEEAYGESKDIVYWVWT 849
Query: 898 HLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPCT 957
HLN+ ENV+KVLD EVASES++ DMIK+LKIA++CTTKLPNLRP MREVVKML DADP
Sbjct: 850 HLNDRENVIKVLDHEVASESLQGDMIKVLKIAILCTTKLPNLRPNMREVVKMLVDADPYI 909
Query: 958 DKSPDNSSDK 967
S +K
Sbjct: 910 TVSRQQFGEK 919
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296089466|emb|CBI39285.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1130 bits (2923), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 607/974 (62%), Positives = 710/974 (72%), Gaps = 89/974 (9%)
Query: 1 MAKIPFLCFHLLALLCFILVSVFPPSLSLNVETQALIQFKSKLKDPHGVLDSWKESADSP 60
MAK P H L CF + +VE +AL+QFK +LKDP LDSWK+S DSP
Sbjct: 1 MAKHPLSFLHFLLCCCFFSTLLS--PSLSSVEVEALLQFKKQLKDPLHRLDSWKDS-DSP 57
Query: 61 CGFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNC 120
C F G++CD +TG V E+S DNKSLSGEISSS+SAL+SLT L LP N LSG LP EL+ C
Sbjct: 58 CKFFGVSCDPITGLVNELSLDNKSLSGEISSSLSALRSLTHLVLPSNSLSGYLPSELNKC 117
Query: 121 SNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVY 180
SNL+VLNVT N ++G+VPDLS L NL DLSINYF+G FP WV NLT LVSLS+G+N Y
Sbjct: 118 SNLQVLNVTCNNLIGTVPDLSELSNLRTLDLSINYFSGPFPSWVTNLTGLVSLSLGENHY 177
Query: 181 DEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKL 240
DE EIPESIGNLKNL+Y+F AH LRG IPES E+ + +LD N ISG FP+SI KL
Sbjct: 178 DEGEIPESIGNLKNLSYIFFAHSQLRGEIPESFFEITAMESLDFSGNNISGNFPKSIAKL 237
Query: 241 QKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNN 300
QKL+KIEL+ N LTGE+P EL NLTLLQE DIS NQ+YGKLPEEIG LK L VF+ + NN
Sbjct: 238 QKLYKIELFDNQLTGEIPPELANLTLLQEIDISENQLYGKLPEEIGRLKKLVVFESYDNN 297
Query: 301 FSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEK 360
FSGE P+ FGD+ L FSIY N FSG FP N GR++ L DISENQFSG+FPKYLCE
Sbjct: 298 FSGEIPAAFGDLSNLTGFSIYRNNFSGEFPANFGRFSPLNSFDISENQFSGAFPKYLCEN 357
Query: 361 RKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDND 420
+LL LLAL N FSGE P+SYA CK++QRLRI++N LSG+IP+G+WALPNV M+DFGDN
Sbjct: 358 GRLLYLLALGNRFSGEFPDSYAKCKSLQRLRINENQLSGEIPNGIWALPNVQMIDFGDNG 417
Query: 421 FTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGAL 480
F+G ISP IG ++SL+QL+L NNRFSG+LPSELG L NL +L L N FSGKIPS LGAL
Sbjct: 418 FSGRISPDIGTASSLNQLILANNRFSGKLPSELGSLANLGKLYLNGNEFSGKIPSELGAL 477
Query: 481 RQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNK 540
+QLSSLHLEEN+LTGSIP E+G CAR+VDLNLA NSLSGNIP S SLL+ LN+LNLSGNK
Sbjct: 478 KQLSSLHLEENSLTGSIPAELGKCARLVDLNLAWNSLSGNIPDSFSLLTYLNSLNLSGNK 537
Query: 541 LTGSIPDNLMKLKLSSIDLSENQLSGSVPLDFLRMGGDGAFAGNEGLCLDQSTKMLMNSK 600
LTGS+P NL KLKLSSIDLS NQLSG V D L+MGGD AF GN+GLC++Q
Sbjct: 538 LTGSLPVNLRKLKLSSIDLSRNQLSGMVSSDLLQMGGDQAFLGNKGLCVEQK-------- 589
Query: 601 LTACPAIQKQKGGFKDKLVLFCIIAVALAAFLAGLLLVSYKNFKLSADM-EN---GEKEV 656
KL LFCIIA AL L GLL+VSY+NFK + EN G KE
Sbjct: 590 ----------------KLFLFCIIASALVILLVGLLVVSYRNFKHNESYAENELEGGKEK 633
Query: 657 SSKWKLASFHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVK 716
KWKL SFH ++ AE +CNLEEDNLIGSGGTGKVYRLDLK+N G VAVKQLWKG GVK
Sbjct: 634 DLKWKLESFHPVNFTAEDVCNLEEDNLIGSGGTGKVYRLDLKRNGGPVAVKQLWKGSGVK 693
Query: 717 VFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWF 776
VF AE+EIL KIRHRNI+KLYACL KGGSSFLVLEYM NGNLFQALH+++KEG
Sbjct: 694 VFTAEIEILRKIRHRNIMKLYACLKKGGSSFLVLEYMSNGNLFQALHRQIKEG------- 746
Query: 777 RRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVS 836
IAD NS S
Sbjct: 747 -------------------------------------------IAD--------NSSTES 755
Query: 837 DYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVS 896
SCFAGTHGYIAPELAYT KV+EKSD++SFGVVLLELVTGR+P+EEEYG+GKDIVYWV
Sbjct: 756 YSSCFAGTHGYIAPELAYTLKVTEKSDIYSFGVVLLELVTGRRPIEEEYGEGKDIVYWVG 815
Query: 897 THLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPC 956
THL++ ENV K+LD ++ S+ ++EDM+K+LK+A++CT KLP RP MR+VVKM+ DAD C
Sbjct: 816 THLSDQENVQKLLDRDIVSDLVQEDMLKVLKVAILCTNKLPTPRPTMRDVVKMIIDADSC 875
Query: 957 TDKSPDNSSDKSGK 970
T KSP+++ +K+ K
Sbjct: 876 TLKSPESNPEKNVK 889
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297839079|ref|XP_002887421.1| hypothetical protein ARALYDRAFT_476351 [Arabidopsis lyrata subsp. lyrata] gi|297333262|gb|EFH63680.1| hypothetical protein ARALYDRAFT_476351 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1129 bits (2921), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 571/973 (58%), Positives = 726/973 (74%), Gaps = 18/973 (1%)
Query: 11 LLALLCFILVSVFPPSLSLNVETQALIQFKSKLKDPHGVLDSWKESADSPCGFSGITCDS 70
L + IL S+FPP++ VE QAL +FK+ L DPH +L SWK S DSPC F G+TCD
Sbjct: 13 LATVAATILFSMFPPNVESTVEKQALFRFKNHLDDPHNILQSWKPS-DSPCVFRGVTCDP 71
Query: 71 VTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTG 130
++G V IS N +LSG IS SISAL L+ LSLP N +SG++P E+ NC+NLKVLN+T
Sbjct: 72 LSGEVIGISLGNANLSGTISPSISALTKLSTLSLPSNFISGRIPPEIVNCTNLKVLNLTS 131
Query: 131 NAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIG 190
N + G++P+LS LKNLEI D+S N+ TG F W+ N+TQL SL +G+N Y+E IPESIG
Sbjct: 132 NRISGTIPNLSPLKNLEILDISGNFLTGEFQSWIGNMTQLFSLGLGNNHYEEGMIPESIG 191
Query: 191 NLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYA 250
LK LT+LFLA NL G+IP SI +L L T DI N ISG+FP I + L KIEL+
Sbjct: 192 GLKKLTWLFLARSNLTGKIPNSIFDLNALDTFDIANNAISGDFPVLITRFVNLTKIELFN 251
Query: 251 NNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFG 310
N LTG++P E+ NLT L+E D+SSNQ+ G LPEE+GNLK L VF C +NNF+GEFPSG G
Sbjct: 252 NRLTGKIPPEIKNLTRLREIDVSSNQLSGALPEELGNLKELRVFHCHENNFTGEFPSGLG 311
Query: 311 DMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALS 370
D+R L + SIY N FSG FP N+GR++ L VDISEN+F+G FP++LC+ +KL LLAL
Sbjct: 312 DLRHLTSLSIYRNNFSGEFPVNIGRFSPLDTVDISENEFTGPFPRFLCQNKKLQFLLALQ 371
Query: 371 NNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIG 430
NNFSGE+P SYADCK++ RLRI+ N LSG + +G WALP MLD DN+ TG ISP IG
Sbjct: 372 NNFSGEIPRSYADCKSLLRLRINKNRLSGHVTEGFWALPLAKMLDLSDNELTGEISPQIG 431
Query: 431 LSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEE 490
LST LSQL+LQNNRFSG++P ELGRLTN+ER+ L+NN SG+IP +G L++LSSLHLE
Sbjct: 432 LSTELSQLILQNNRFSGKIPRELGRLTNIERIYLSNNKISGEIPMEVGDLKELSSLHLEN 491
Query: 491 NALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLM 550
N+LTG IP E+ +C ++VDLNLA+N L+G IP SLS ++SLN+L+ SGNKLTG IP +L+
Sbjct: 492 NSLTGFIPVELTNCVKLVDLNLAKNFLTGEIPNSLSQIASLNSLDFSGNKLTGEIPASLV 551
Query: 551 KLKLSSIDLSENQLSGSVPLDFLRMGGDGAFAGNEGLCLD-QSTKMLMNSKLTACPAIQK 609
KLKLS IDLS NQLSG +P D L +GG AF+ NE LC+D Q+ K N +L+ C Q
Sbjct: 552 KLKLSFIDLSGNQLSGRIPPDLLAVGGSTAFSRNEKLCVDKQNAKTSQNLRLSICSGDQH 611
Query: 610 -QKGGFKDKLVLFCIIAVALAAFLAGLLLVSYKNFKLSA-DMENGE-KEVSSKWKLASFH 666
Q+ G D +LF +A+ + + GL + Y+ K+ D ENG+ + +KWK+ASFH
Sbjct: 612 VQRNGSLDGTLLFLALAIVVVVLVTGLFALRYRVLKIRELDSENGDINKADAKWKIASFH 671
Query: 667 HIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAE 721
+++DAE+IC L+ED++IG+G GKVYR+DLKK GTVAVK L + DG +V AE
Sbjct: 672 QMELDAEEICRLDEDHVIGAGSAGKVYRVDLKKGGGTVAVKWLKRAGGEEVDGTEVSVAE 731
Query: 722 MEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKI 781
MEILGKIRHRN+LKLYACL+ GS +LV E+M NGNL+QAL +K G PELDW +RYKI
Sbjct: 732 MEILGKIRHRNVLKLYACLVGRGSRYLVFEFMENGNLYQALRNNIKGGLPELDWLKRYKI 791
Query: 782 ALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCF 841
A+GAAKGIAYLHHDC PPIIHRDIKSSNILLD DYE KIADFGVAK+A+ K ++SC
Sbjct: 792 AVGAAKGIAYLHHDCCPPIIHRDIKSSNILLDGDYESKIADFGVAKVAD---KGYEWSCV 848
Query: 842 AGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHL-N 900
AGTHGY+APELAY+ K +EKSDV+SFGVVLLELVTG +P+E+E+G+GKDIV +V + +
Sbjct: 849 AGTHGYMAPELAYSFKATEKSDVYSFGVVLLELVTGLRPMEDEFGEGKDIVDYVYSQIQQ 908
Query: 901 NHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPCTDKS 960
+ N+ VLD +V S ++E MI++LK+ ++CTTKLPNLRP MREVV+ L DADPC
Sbjct: 909 DRRNLRNVLDKQVLSSYVEESMIRVLKMGLLCTTKLPNLRPSMREVVRKLDDADPCV--- 965
Query: 961 PDNSSDKSGKISL 973
NS D++GKI++
Sbjct: 966 -SNSLDRTGKITV 977
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15218385|ref|NP_177363.1| leucine-rich receptor-like protein kinase [Arabidopsis thaliana] gi|12323667|gb|AAG51800.1|AC067754_16 leucine-rich receptor-like protein kinase, putative; 28019-31149 [Arabidopsis thaliana] gi|224589477|gb|ACN59272.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332197165|gb|AEE35286.1| leucine-rich receptor-like protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1090 bits (2819), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 558/965 (57%), Positives = 719/965 (74%), Gaps = 18/965 (1%)
Query: 19 LVSVFPPSLSLNVETQALIQFKSKLKDPHGVLDSWKESADSPCGFSGITCDSVTGRVTEI 78
L+ +FPP++ VE QAL +FK++L D H +L SWK S DSPC F GITCD ++G V I
Sbjct: 21 LLFIFPPNVESTVEKQALFRFKNRLDDSHNILQSWKPS-DSPCVFRGITCDPLSGEVIGI 79
Query: 79 SFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVP 138
S N +LSG IS SISAL L+ LSLP N +SG++P E+ NC NLKVLN+T N + G++P
Sbjct: 80 SLGNVNLSGTISPSISALTKLSTLSLPSNFISGRIPPEIVNCKNLKVLNLTSNRLSGTIP 139
Query: 139 DLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYL 198
+LS LK+LEI D+S N+ G F W+ N+ QLVSL +G+N Y+E IPESIG LK LT+L
Sbjct: 140 NLSPLKSLEILDISGNFLNGEFQSWIGNMNQLVSLGLGNNHYEEGIIPESIGGLKKLTWL 199
Query: 199 FLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELP 258
FLA NL G+IP SI +L L T DI N IS +FP I +L L KIEL+ N+LTG++P
Sbjct: 200 FLARSNLTGKIPNSIFDLNALDTFDIANNAISDDFPILISRLVNLTKIELFNNSLTGKIP 259
Query: 259 AELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAF 318
E+ NLT L+EFDISSNQ+ G LPEE+G LK L VF C +NNF+GEFPSGFGD+ L +
Sbjct: 260 PEIKNLTRLREFDISSNQLSGVLPEELGVLKELRVFHCHENNFTGEFPSGFGDLSHLTSL 319
Query: 319 SIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVP 378
SIY N FSG FP N+GR++ L VDISEN+F+G FP++LC+ +KL LLAL N FSGE+P
Sbjct: 320 SIYRNNFSGEFPVNIGRFSPLDTVDISENEFTGPFPRFLCQNKKLQFLLALQNEFSGEIP 379
Query: 379 NSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQL 438
SY +CK++ RLRI++N LSG++ +G W+LP M+D DN+ TG +SP IGLST LSQL
Sbjct: 380 RSYGECKSLLRLRINNNRLSGQVVEGFWSLPLAKMIDLSDNELTGEVSPQIGLSTELSQL 439
Query: 439 VLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIP 498
+LQNNRFSG++P ELGRLTN+ER+ L+NNN SG+IP +G L++LSSLHLE N+LTG IP
Sbjct: 440 ILQNNRFSGKIPRELGRLTNIERIYLSNNNLSGEIPMEVGDLKELSSLHLENNSLTGFIP 499
Query: 499 NEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSID 558
E+ +C ++VDLNLA+N L+G IP SLS ++SLN+L+ SGN+LTG IP +L+KLKLS ID
Sbjct: 500 KELKNCVKLVDLNLAKNFLTGEIPNSLSQIASLNSLDFSGNRLTGEIPASLVKLKLSFID 559
Query: 559 LSENQLSGSVPLDFLRMGGDGAFAGNEGLCLD-QSTKMLMNSKLTACPAIQK-QKGGFKD 616
LS NQLSG +P D L +GG AF+ NE LC+D ++ K N L+ C Q ++ D
Sbjct: 560 LSGNQLSGRIPPDLLAVGGSTAFSRNEKLCVDKENAKTNQNLGLSICSGYQNVKRNSSLD 619
Query: 617 KLVLFCIIAVALAAFLAGLLLVSYKNFKLSA-DMENGE-KEVSSKWKLASFHHIDIDAEQ 674
+LF +A+ + ++GL + Y+ K+ D EN + + +KWK+ASFH +++D ++
Sbjct: 620 GTLLFLALAIVVVVLVSGLFALRYRVVKIRELDSENRDINKADAKWKIASFHQMELDVDE 679
Query: 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKIR 729
IC L+ED++IGSG GKVYR+DLKK GTVAVK L + GDG +V AEMEILGKIR
Sbjct: 680 ICRLDEDHVIGSGSAGKVYRVDLKKGGGTVAVKWLKRGGGEEGDGTEVSVAEMEILGKIR 739
Query: 730 HRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGI 789
HRN+LKLYACL+ GS +LV E+M NGNL+QAL +K G PELDW +RYKIA+GAAKGI
Sbjct: 740 HRNVLKLYACLVGRGSRYLVFEFMENGNLYQALGNNIKGGLPELDWLKRYKIAVGAAKGI 799
Query: 790 AYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIA 849
AYLHHDC PPIIHRDIKSSNILLD DYE KIADFGVAK+A+ K ++SC AGTHGY+A
Sbjct: 800 AYLHHDCCPPIIHRDIKSSNILLDGDYESKIADFGVAKVAD---KGYEWSCVAGTHGYMA 856
Query: 850 PELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNH-ENVLKV 908
PELAY+ K +EKSDV+SFGVVLLELVTG +P+E+E+G+GKDIV +V + + N+ V
Sbjct: 857 PELAYSFKATEKSDVYSFGVVLLELVTGLRPMEDEFGEGKDIVDYVYSQIQQDPRNLQNV 916
Query: 909 LDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPCTDKSPDNSSDKS 968
LD +V S I+E MI++LK+ ++CTTKLPNLRP MREVV+ L DADPC NS D +
Sbjct: 917 LDKQVLSTYIEESMIRVLKMGLLCTTKLPNLRPSMREVVRKLDDADPCV----SNSQDTT 972
Query: 969 GKISL 973
GKI++
Sbjct: 973 GKITV 977
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|110738078|dbj|BAF00973.1| putative leucine-rich receptor-like protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1090 bits (2819), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 558/965 (57%), Positives = 719/965 (74%), Gaps = 18/965 (1%)
Query: 19 LVSVFPPSLSLNVETQALIQFKSKLKDPHGVLDSWKESADSPCGFSGITCDSVTGRVTEI 78
L+ +FPP++ VE QAL +FK++L D H +L SWK S DSPC F GITCD ++G V I
Sbjct: 21 LLFIFPPNVESTVEKQALFRFKNRLDDSHNILQSWKPS-DSPCVFRGITCDPLSGEVIGI 79
Query: 79 SFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVP 138
S N +LSG IS SISAL L+ LSLP N +SG++P E+ NC NLKVLN+T N + G++P
Sbjct: 80 SLGNVNLSGTISPSISALTKLSTLSLPSNFISGRIPPEIVNCKNLKVLNLTSNRLSGTIP 139
Query: 139 DLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYL 198
+LS LK+LEI D+S N+ G F W+ N+ QLVSL +G+N Y+E IPESIG LK LT+L
Sbjct: 140 NLSPLKSLEILDISGNFLNGEFQSWIGNMNQLVSLGLGNNHYEEGIIPESIGGLKKLTWL 199
Query: 199 FLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELP 258
FLA NL G+IP SI +L L T DI N IS +FP I +L L KIEL+ N+LTG++P
Sbjct: 200 FLARSNLTGKIPNSIFDLNALDTFDIANNAISDDFPILISRLVNLTKIELFNNSLTGKIP 259
Query: 259 AELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAF 318
E+ NLT L+EFDISSNQ+ G LPEE+G LK L VF C +NNF+GEFPSGFGD+ L +
Sbjct: 260 PEIKNLTRLREFDISSNQLSGVLPEELGVLKELRVFHCHENNFTGEFPSGFGDLSHLTSL 319
Query: 319 SIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVP 378
SIY N FSG FP N+GR++ L VDISEN+F+G FP++LC+ +KL LLAL N FSGE+P
Sbjct: 320 SIYRNNFSGEFPVNIGRFSPLDTVDISENEFTGPFPRFLCQNKKLQFLLALQNEFSGEIP 379
Query: 379 NSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQL 438
SY +CK++ RLRI++N LSG++ +G W+LP M+D DN+ TG +SP IGLST LSQL
Sbjct: 380 RSYGECKSLLRLRINNNRLSGQVVEGFWSLPLAKMIDLSDNELTGEVSPQIGLSTELSQL 439
Query: 439 VLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIP 498
+LQNNRFSG++P ELGRLTN+ER+ L+NNN SG+IP +G L++LSSLHLE N+LTG IP
Sbjct: 440 ILQNNRFSGKIPRELGRLTNIERIYLSNNNLSGEIPMEVGDLKELSSLHLENNSLTGFIP 499
Query: 499 NEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSID 558
E+ +C ++VDLNLA+N L+G IP SLS ++SLN+L+ SGN+LTG IP +L+KLKLS ID
Sbjct: 500 KELENCVKLVDLNLAKNFLTGEIPNSLSQIASLNSLDFSGNRLTGEIPASLVKLKLSFID 559
Query: 559 LSENQLSGSVPLDFLRMGGDGAFAGNEGLCLD-QSTKMLMNSKLTACPAIQK-QKGGFKD 616
LS NQLSG +P D L +GG AF+ NE LC+D ++ K N L+ C Q ++ D
Sbjct: 560 LSGNQLSGRIPPDLLAVGGSTAFSRNEKLCVDKENAKTNQNLGLSICSGYQNVKRNSSLD 619
Query: 617 KLVLFCIIAVALAAFLAGLLLVSYKNFKLSA-DMENGE-KEVSSKWKLASFHHIDIDAEQ 674
+LF +A+ + ++GL + Y+ K+ D EN + + +KWK+ASFH +++D ++
Sbjct: 620 GTLLFLALAIVVVVLVSGLFALRYRVVKIRELDSENRDINKADAKWKIASFHQMELDVDE 679
Query: 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKIR 729
IC L+ED++IGSG GKVYR+DLKK GTVAVK L + GDG +V AEMEILGKIR
Sbjct: 680 ICRLDEDHVIGSGSAGKVYRVDLKKGGGTVAVKWLKRGGGEEGDGTEVSVAEMEILGKIR 739
Query: 730 HRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGI 789
HRN+LKLYACL+ GS +LV E+M NGNL+QAL +K G PELDW +RYKIA+GAAKGI
Sbjct: 740 HRNVLKLYACLVGRGSRYLVFEFMENGNLYQALGNNIKGGLPELDWLKRYKIAVGAAKGI 799
Query: 790 AYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIA 849
AYLHHDC PPIIHRDIKSSNILLD DYE KIADFGVAK+A+ K ++SC AGTHGY+A
Sbjct: 800 AYLHHDCCPPIIHRDIKSSNILLDGDYESKIADFGVAKVAD---KGYEWSCVAGTHGYMA 856
Query: 850 PELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNH-ENVLKV 908
PELAY+ K +EKSDV+SFGVVLLELVTG +P+E+E+G+GKDIV +V + + N+ V
Sbjct: 857 PELAYSFKATEKSDVYSFGVVLLELVTGLRPMEDEFGEGKDIVDYVYSQIQQDPRNLQNV 916
Query: 909 LDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPCTDKSPDNSSDKS 968
LD +V S I+E MI++LK+ ++CTTKLPNLRP MREVV+ L DADPC NS D +
Sbjct: 917 LDKQVLSTYIEESMIRVLKMGLLCTTKLPNLRPSMREVVRKLDDADPCV----SNSQDTT 972
Query: 969 GKISL 973
GKI++
Sbjct: 973 GKITV 977
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 973 | ||||||
| TAIR|locus:2207036 | 977 | AT1G72180 [Arabidopsis thalian | 0.970 | 0.966 | 0.545 | 9.8e-277 | |
| TAIR|locus:2024432 | 977 | LRR XI-23 [Arabidopsis thalian | 0.567 | 0.564 | 0.396 | 2.7e-180 | |
| TAIR|locus:2091206 | 991 | IKU2 "HAIKU2" [Arabidopsis tha | 0.940 | 0.923 | 0.387 | 1.1e-167 | |
| TAIR|locus:2032553 | 996 | HSL1 "HAESA-like 1" [Arabidops | 0.872 | 0.852 | 0.394 | 1.6e-159 | |
| TAIR|locus:2005540 | 999 | HAE "HAESA" [Arabidopsis thali | 0.501 | 0.488 | 0.380 | 9.8e-159 | |
| TAIR|locus:2169975 | 993 | HSL2 "HAESA-like 2" [Arabidops | 0.499 | 0.489 | 0.377 | 4.2e-155 | |
| TAIR|locus:2139885 | 1013 | AT4G28650 [Arabidopsis thalian | 0.493 | 0.473 | 0.335 | 5.3e-147 | |
| TAIR|locus:2204350 | 980 | CLV1 "AT1G75820" [Arabidopsis | 0.908 | 0.902 | 0.360 | 4e-145 | |
| TAIR|locus:2169965 | 1003 | BAM1 "BARELY ANY MERISTEM 1" [ | 0.499 | 0.484 | 0.341 | 2.1e-143 | |
| TAIR|locus:2097310 | 1002 | BAM2 "BARELY ANY MERISTEM 2" [ | 0.497 | 0.483 | 0.341 | 1.9e-140 |
| TAIR|locus:2207036 AT1G72180 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2660 (941.4 bits), Expect = 9.8e-277, P = 9.8e-277
Identities = 525/962 (54%), Positives = 671/962 (69%)
Query: 22 VFPPSLSLNVETQALIQFKSKLKDPHGVLDSWKESADSPCGFSGITCDSVTGRVTEISFD 81
+FPP++ VE QAL +FK++L D H +L SWK S DSPC F GITCD ++G V IS
Sbjct: 24 IFPPNVESTVEKQALFRFKNRLDDSHNILQSWKPS-DSPCVFRGITCDPLSGEVIGISLG 82
Query: 82 NKXXXXXXXXXXXXXXXXTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLS 141
N + LSLP N +SG++P E+ NC NLKVLN+T N + G++P+LS
Sbjct: 83 NVNLSGTISPSISALTKLSTLSLPSNFISGRIPPEIVNCKNLKVLNLTSNRLSGTIPNLS 142
Query: 142 ALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLA 201
LK+LEI D+S N+ G F W+ N+ QLVSL +G+N Y+E IPESIG LK LT+LFLA
Sbjct: 143 PLKSLEILDISGNFLNGEFQSWIGNMNQLVSLGLGNNHYEEGIIPESIGGLKKLTWLFLA 202
Query: 202 HCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAEL 261
NL G+IP SI +L L T DI N IS +FP I +L L KIEL+ N+LTG++P E+
Sbjct: 203 RSNLTGKIPNSIFDLNALDTFDIANNAISDDFPILISRLVNLTKIELFNNSLTGKIPPEI 262
Query: 262 GNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIY 321
NLT L+EFDISSNQ+ G LPEE+G LK L VF C +NNF+GEFPSGFGD+ L + SIY
Sbjct: 263 KNLTRLREFDISSNQLSGVLPEELGVLKELRVFHCHENNFTGEFPSGFGDLSHLTSLSIY 322
Query: 322 GNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKXXXXXXXXXXFSGEVPNSY 381
N FSG FP N+GR++ L VDISEN+F+G FP++LC+ +K FSGE+P SY
Sbjct: 323 RNNFSGEFPVNIGRFSPLDTVDISENEFTGPFPRFLCQNKKLQFLLALQNEFSGEIPRSY 382
Query: 382 ADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQ 441
+CK++ RLRI++N LSG++ +G W+LP M+D DN+ TG +SP IGLST LSQL+LQ
Sbjct: 383 GECKSLLRLRINNNRLSGQVVEGFWSLPLAKMIDLSDNELTGEVSPQIGLSTELSQLILQ 442
Query: 442 NNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEM 501
NNRFSG++P ELGRLTN+ER+ L+NNN SG+IP +G L++LSSLHLE N+LTG IP E+
Sbjct: 443 NNRFSGKIPRELGRLTNIERIYLSNNNLSGEIPMEVGDLKELSSLHLENNSLTGFIPKEL 502
Query: 502 GDCARIVDLNLARNSLSGNIPRXXXXXXXXXXXXXXXXXXTGSIPDNLMKLKLSSIDLSE 561
+C ++VDLNLA+N L+G IP TG IP +L+KLKLS IDLS
Sbjct: 503 KNCVKLVDLNLAKNFLTGEIPNSLSQIASLNSLDFSGNRLTGEIPASLVKLKLSFIDLSG 562
Query: 562 NQLSGSVPLDFLRMGGDGAFAGNEGLCLD-QSTKMLMNSKLTACPAIQKQKGGFK-DKXX 619
NQLSG +P D L +GG AF+ NE LC+D ++ K N L+ C Q K D
Sbjct: 563 NQLSGRIPPDLLAVGGSTAFSRNEKLCVDKENAKTNQNLGLSICSGYQNVKRNSSLDGTL 622
Query: 620 XXXXXXXXXXXXXXXXXXVSYKNFKL-SADMENGE-KEVSSKWKLASFHHIDIDAEQICN 677
+ Y+ K+ D EN + + +KWK+ASFH +++D ++IC
Sbjct: 623 LFLALAIVVVVLVSGLFALRYRVVKIRELDSENRDINKADAKWKIASFHQMELDVDEICR 682
Query: 678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRN 732
L+ED++IGSG GKVYR+DLKK GTVAVK L +G DG +V AEMEILGKIRHRN
Sbjct: 683 LDEDHVIGSGSAGKVYRVDLKKGGGTVAVKWLKRGGGEEGDGTEVSVAEMEILGKIRHRN 742
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
+LKLYACL+ GS +LV E+M NGNL+QAL +K G PELDW +RYKIA+GAAKGIAYL
Sbjct: 743 VLKLYACLVGRGSRYLVFEFMENGNLYQALGNNIKGGLPELDWLKRYKIAVGAAKGIAYL 802
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL 852
HHDC PPIIHRDIKSSNILLD DYE KIADFGVAK+A+ K ++SC AGTHGY+APEL
Sbjct: 803 HHDCCPPIIHRDIKSSNILLDGDYESKIADFGVAKVAD---KGYEWSCVAGTHGYMAPEL 859
Query: 853 AYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNH-ENVLKVLDC 911
AY+ K +EKSDV+SFGVVLLELVTG +P+E+E+G+GKDIV +V + + N+ VLD
Sbjct: 860 AYSFKATEKSDVYSFGVVLLELVTGLRPMEDEFGEGKDIVDYVYSQIQQDPRNLQNVLDK 919
Query: 912 EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPCTDKSPDNSSDKSGKI 971
+V S I+E MI++LK+ ++CTTKLPNLRP MREVV+ L DADPC NS D +GKI
Sbjct: 920 QVLSTYIEESMIRVLKMGLLCTTKLPNLRPSMREVVRKLDDADPCVS----NSQDTTGKI 975
Query: 972 SL 973
++
Sbjct: 976 TV 977
|
|
| TAIR|locus:2024432 LRR XI-23 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1058 (377.5 bits), Expect = 2.7e-180, Sum P(2) = 2.7e-180
Identities = 223/563 (39%), Positives = 325/563 (57%)
Query: 32 ETQALIQFKSKLKDPH-GVLDSWK-ESADSPCGFSGITCDSVTGRVTEISFDNKXXXXXX 89
+ Q L++ KS D + V DSWK S PC F G+TC+S G VTEI +
Sbjct: 30 DLQVLLKLKSSFADSNLAVFDSWKLNSGIGPCSFIGVTCNS-RGNVTEIDLSRRGLSGNF 88
Query: 90 XXXXX-XXXXXTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEI 148
LSL FN LSG +P +L NC++LK L++ N G+ P+ S+L L+
Sbjct: 89 PFDSVCEIQSLEKLSLGFNSLSGIIPSDLKNCTSLKYLDLGNNLFSGAFPEFSSLNQLQF 148
Query: 149 FDLSINYFTGRFPRW--VVNLTQLVSLSIGDNVYDE-AEIPESIGNLKNLTYLFLAHCNL 205
L+ + F+G FP W + N T LV LS+GDN +D A+ P + +LK L++L+L++C++
Sbjct: 149 LYLNNSAFSGVFP-WKSLRNATSLVVLSLGDNPFDATADFPVEVVSLKKLSWLYLSNCSI 207
Query: 206 RGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLT 265
G+IP +I +L EL L+I + ++GE P I KL LW++ELY N+LTG+LP GNL
Sbjct: 208 AGKIPPAIGDLTELRNLEISDSGLTGEIPSEISKLTNLWQLELYNNSLTGKLPTGFGNLK 267
Query: 266 LLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRF 325
L D S+N + G L E+ +L NL Q F+N FSGE P FG+ + L S+Y N+
Sbjct: 268 NLTYLDASTNLLQGDL-SELRSLTNLVSLQMFENEFSGEIPLEFGEFKDLVNLSLYTNKL 326
Query: 326 SGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKXXXXXXXXXXFSGEVPNSYADCK 385
+G P+ LG +D SEN +G P +C+ K +G +P SYA+C
Sbjct: 327 TGSLPQGLGSLADFDFIDASENLLTGPIPPDMCKNGKMKALLLLQNNLTGSIPESYANCL 386
Query: 386 TIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRF 445
T+QR R+S+N+L+G +P GLW LP + ++D N+F G I+ I L L L N+
Sbjct: 387 TLQRFRVSENNLNGTVPAGLWGLPKLEIIDIEMNNFEGPITADIKNGKMLGALYLGFNKL 446
Query: 446 SGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCA 505
S ELP E+G +L ++ L NN F+GKIPS++G L+ LSSL ++ N +G IP+ +G C+
Sbjct: 447 SDELPEEIGDTESLTKVELNNNRFTGKIPSSIGKLKGLSSLKMQSNGFSGEIPDSIGSCS 506
Query: 506 RIVDLNLARNSLSGNIPRXXXXXXXXXXXXXXXXXXTGSIPDNLMKLKLSSIDLSENQLS 565
+ D+N+A+NS+SG IP +G IP++L L+LS +DLS N+LS
Sbjct: 507 MLSDVNMAQNSISGEIPHTLGSLPTLNALNLSDNKLSGRIPESLSSLRLSLLDLSNNRLS 566
Query: 566 GSVPLDFLRMGGDGAFAGNEGLC 588
G +PL +G+F GN GLC
Sbjct: 567 GRIPLSLSSY--NGSFNGNPGLC 587
|
|
| TAIR|locus:2091206 IKU2 "HAIKU2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1631 (579.2 bits), Expect = 1.1e-167, P = 1.1e-167
Identities = 377/972 (38%), Positives = 539/972 (55%)
Query: 32 ETQALIQFKSKLKDPHG--VLDSWKESADSPCGFSGITCDSVTGRVTEISFDNKXXXXXX 89
E + L++ KS + V +W +S C F+GI C+S G V EI+ ++
Sbjct: 26 EVENLLKLKSTFGETKSDDVFKTWTHR-NSACEFAGIVCNS-DGNVVEINLGSRSLINRD 83
Query: 90 XXXXXXXX-XXTVLSLPF--------NVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDL 140
++ L N L G++ L C+ L+ L++ N G P +
Sbjct: 84 DDGRFTDLPFDSICDLKLLEKLVLGNNSLRGQIGTNLGKCNRLRYLDLGINNFSGEFPAI 143
Query: 141 SALKNLEIFDLSINYFTGRFPRW--VVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYL 198
+L+ LE L+ + +G FP W + +L +L LS+GDN + P I NL L ++
Sbjct: 144 DSLQLLEFLSLNASGISGIFP-WSSLKDLKRLSFLSVGDNRFGSHPFPREILNLTALQWV 202
Query: 199 FLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELP 258
+L++ ++ G+IPE I L L L++ N+ISGE P+ I +L+ L ++E+Y+N+LTG+LP
Sbjct: 203 YLSNSSITGKIPEGIKNLVRLQNLELSDNQISGEIPKEIVQLKNLRQLEIYSNDLTGKLP 262
Query: 259 AELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAF 318
NLT L+ FD S+N + G L E+ LKNL F+N +GE P FGD + L A
Sbjct: 263 LGFRNLTNLRNFDASNNSLEGDL-SELRFLKNLVSLGMFENRLTGEIPKEFGDFKSLAAL 321
Query: 319 SIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKXXXXXXXXXXFSGEVP 378
S+Y N+ +G P LG +TA +D+SEN G P Y+C+K F+G+ P
Sbjct: 322 SLYRNQLTGKLPRRLGSWTAFKYIDVSENFLEGQIPPYMCKKGVMTHLLMLQNRFTGQFP 381
Query: 379 NSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQL 438
SYA CKT+ RLR+S+N LSG IP G+W LPN+ LD N F G ++ IG + SL L
Sbjct: 382 ESYAKCKTLIRLRVSNNSLSGMIPSGIWGLPNLQFLDLASNYFEGNLTGDIGNAKSLGSL 441
Query: 439 VLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIP 498
L NNRFSG LP ++ +L + L N FSG +P + G L++LSSL L++N L+G+IP
Sbjct: 442 DLSNNRFSGSLPFQISGANSLVSVNLRMNKFSGIVPESFGKLKELSSLILDQNNLSGAIP 501
Query: 499 NEMGDCARIVDLNLARNSLSGNIPRXXXXXXXXXXXXXXXXXXTGSIPDNLMKLKLSSID 558
+G C +VDLN A NSLS IP +G IP L LKLS +D
Sbjct: 502 KSLGLCTSLVDLNFAGNSLSEEIPESLGSLKLLNSLNLSGNKLSGMIPVGLSALKLSLLD 561
Query: 559 LSENQLSGSVPLDFLRMGGDGAFAGNEGLCLDQSTKMLMNSKLTACPAIQKQKGGFKDKX 618
LS NQL+GSVP + G+F GN GLC S+K+ L CP + G K K
Sbjct: 562 LSNNQLTGSVPESLV----SGSFEGNSGLC---SSKIRY---LRPCPLGKPHSQG-KRKH 610
Query: 619 XXXXXXXXXXXXXXXXXXXVSYKNFKLSADMENGEKEVSSKWKLASFHHIDIDAEQICN- 677
SY FK+ D N + + W+++SF ++ + +I +
Sbjct: 611 LSKVDMCFIVAAILALFFLFSYVIFKIRRDKLNKTVQKKNDWQVSSFRLLNFNEMEIIDE 670
Query: 678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLW---------------KGDGVK-----V 717
++ +N+IG GG G VY++ L+ T+AVK +W DG
Sbjct: 671 IKSENIIGRGGQGNVYKVSLRSGE-TLAVKHIWCPESSHESFRSSTAMLSDGNNRSNNGE 729
Query: 718 FAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFR 777
F AE+ L I+H N++KL+ + S LV EYMPNG+L++ LH+R G+ E+ W
Sbjct: 730 FEAEVATLSNIKHINVVKLFCSITCEDSKLLVYEYMPNGSLWEQLHER--RGEQEIGWRV 787
Query: 778 RYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSD 837
R +ALGAAKG+ YLHH P+IHRD+KSSNILLDE++ P+IADFG+AKI + D
Sbjct: 788 RQALALGAAKGLEYLHHGLDRPVIHRDVKSSNILLDEEWRPRIADFGLAKIIQADSVQRD 847
Query: 838 YSC--FAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWV 895
+S GT GYIAPE AYT KV+EKSDV+SFGVVL+ELVTG+KP+E ++G+ DIV WV
Sbjct: 848 FSAPLVKGTLGYIAPEYAYTTKVNEKSDVYSFGVVLMELVTGKKPLETDFGENNDIVMWV 907
Query: 896 --STHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953
+ N E ++K++D + E KED +K+L IA++CT K P RP M+ VV ML
Sbjct: 908 WSVSKETNREMMMKLIDTSIEDE-YKEDALKVLTIALLCTDKSPQARPFMKSVVSMLEKI 966
Query: 954 DPCTDKSPDNSS 965
+P +K+ +S
Sbjct: 967 EPSYNKNSGEAS 978
|
|
| TAIR|locus:2032553 HSL1 "HAESA-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1554 (552.1 bits), Expect = 1.6e-159, P = 1.6e-159
Identities = 352/892 (39%), Positives = 509/892 (57%)
Query: 102 LSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVP-DLSALKNLEIFDLSINYFTGRF 160
L L N+L+G+LP L++ L L++TGN G +P +NLE+ L N G
Sbjct: 113 LDLSQNLLTGELPQTLADIPTLVHLDLTGNNFSGDIPASFGKFENLEVLSLVYNLLDGTI 172
Query: 161 PRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELG 220
P ++ N++ L L++ N + + IP GNL NL ++L C+L G+IP+S+ +L +L
Sbjct: 173 PPFLGNISTLKMLNLSYNPFSPSRIPPEFGNLTNLEVMWLTECHLVGQIPDSLGQLSKLV 232
Query: 221 TLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGK 280
LD+ N + G P S+ L + +IELY N+LTGE+P ELGNL L+ D S NQ+ GK
Sbjct: 233 DLDLALNDLVGHIPPSLGGLTNVVQIELYNNSLTGEIPPELGNLKSLRLLDASMNQLTGK 292
Query: 281 LPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALT 340
+P+E+ + L ++NN GE P+ L+ I+GNR +G P++LG + L
Sbjct: 293 IPDELCRVP-LESLNLYENNLEGELPASIALSPNLYEIRIFGNRLTGGLPKDLGLNSPLR 351
Query: 341 DVDISENQFSGSFPKYLCEKRKXXXXXXXXXXFSGEVPNSYADCKTIQRLRISDNHLSGK 400
+D+SEN+FSG P LC K + FSG +P S ADC+++ R+R++ N SG
Sbjct: 352 WLDVSENEFSGDLPADLCAKGELEELLIIHNSFSGVIPESLADCRSLTRIRLAYNRFSGS 411
Query: 401 IPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLE 460
+P G W LP+V +L+ +N F+G IS IG +++LS L+L NN F+G LP E+G L NL
Sbjct: 412 VPTGFWGLPHVNLLELVNNSFSGEISKSIGGASNLSLLILSNNEFTGSLPEEIGSLDNLN 471
Query: 461 RLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGN 520
+L + N FSG +P +L +L +L +L L N +G + + + ++ +LNLA N +G
Sbjct: 472 QLSASGNKFSGSLPDSLMSLGELGTLDLHGNQFSGELTSGIKSWKKLNELNLADNEFTGK 531
Query: 521 IPRXXXXXXXXXXXXXXXXXXTGSIPDNLMKLKLSSIDLSENQLSGSVPLDFLRMGGDGA 580
IP +G IP +L LKL+ ++LS N+LSG +P + +
Sbjct: 532 IPDEIGSLSVLNYLDLSGNMFSGKIPVSLQSLKLNQLNLSYNRLSGDLPPSLAKDMYKNS 591
Query: 581 FAGNEGLCLDQSTKMLMNSKLTACPAIQKQKGGFKDKXXXXXXXXXXXXXXXXXXXXVSY 640
F GN GLC D K L S+ A +K G+ Y
Sbjct: 592 FIGNPGLCGD--IKGLCGSENEA------KKRGYVWLLRSIFVLAAMVLLAGVAWFYFKY 643
Query: 641 KNFKLSADMENGEKEVSSKWKLASFHHIDIDAEQIC-NLEEDNLIGSGGTGKVYRLDLKK 699
+ FK + ME SKW L SFH + +I +L+EDN+IG+G +GKVY++ L
Sbjct: 644 RTFKKARAMER------SKWTLMSFHKLGFSEHEILESLDEDNVIGAGASGKVYKVVLT- 696
Query: 700 NAGTVAVKQLWKGD---------------GVK--VFAAEMEILGKIRHRNILKLYACLLK 742
N TVAVK+LW G GV+ F AE+E LGKIRH+NI+KL+ C
Sbjct: 697 NGETVAVKRLWTGSVKETGDCDPEKGYKPGVQDEAFEAEVETLGKIRHKNIVKLWCCCST 756
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIH 802
LV EYMPNG+L LH K G L W R+KI L AA+G++YLHHD PPI+H
Sbjct: 757 RDCKLLVYEYMPNGSLGDLLHSS-KGGM--LGWQTRFKIILDAAEGLSYLHHDSVPPIVH 813
Query: 803 RDIKSSNILLDEDYEPKIADFGVAKIAENSPKV-SDYSCFAGTHGYIAPELAYTCKVSEK 861
RDIKS+NIL+D DY ++ADFGVAK + + K S AG+ GYIAPE AYT +V+EK
Sbjct: 814 RDIKSNNILIDGDYGARVADFGVAKAVDLTGKAPKSMSVIAGSCGYIAPEYAYTLRVNEK 873
Query: 862 SDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESIKED 921
SD++SFGVV+LE+VT ++PV+ E G+ KD+V WV + L+ + + V+D ++ S KE+
Sbjct: 874 SDIYSFGVVILEIVTRKRPVDPELGE-KDLVKWVCSTLDQ-KGIEHVIDPKLDS-CFKEE 930
Query: 922 MIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPCTDKSPDN-SSDKSGKIS 972
+ K+L + ++CT+ LP RP MR VVKML + + S DK GK++
Sbjct: 931 ISKILNVGLLCTSPLPINRPSMRRVVKMLQEIGGGDEDSLHKIRDDKDGKLT 982
|
|
| TAIR|locus:2005540 HAE "HAESA" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 878 (314.1 bits), Expect = 9.8e-159, Sum P(2) = 9.8e-159
Identities = 187/491 (38%), Positives = 274/491 (55%)
Query: 102 LSLPFNVLSGKLPLELS-NCSNLKVLNVTGNAMVGSVPD-LSALKNLEIFDLSINYFTGR 159
L L N+L G +P L N NLK L ++GN + ++P + LE +L+ N+ +G
Sbjct: 119 LDLSENLLVGSIPKSLPFNLPNLKFLEISGNNLSDTIPSSFGEFRKLESLNLAGNFLSGT 178
Query: 160 FPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELREL 219
P + N+T L L + N++ ++IP +GNL L L+LA CNL G IP S+S L L
Sbjct: 179 IPASLGNVTTLKELKLAYNLFSPSQIPSQLGNLTELQVLWLAGCNLVGPIPPSLSRLTSL 238
Query: 220 GTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYG 279
LD+ N+++G P I +L+ + +IEL+ N+ +GELP +GN+T L+ FD S N++ G
Sbjct: 239 VNLDLTFNQLTGSIPSWITQLKTVEQIELFNNSFSGELPESMGNMTTLKRFDASMNKLTG 298
Query: 280 KLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTAL 339
K+P+ + NL NL F+N G P + L ++ NR +G P LG + L
Sbjct: 299 KIPDNL-NLLNLESLNLFENMLEGPLPESITRSKTLSELKLFNNRLTGVLPSQLGANSPL 357
Query: 340 TDVDISENQFSGSFPKYLCEKRKXXXXXXXXXXFSGEVPNSYADCKTIQRLRISDNHLSG 399
VD+S N+FSG P +C + K FSGE+ N+ CK++ R+R+S+N LSG
Sbjct: 358 QYVDLSYNRFSGEIPANVCGEGKLEYLILIDNSFSGEISNNLGKCKSLTRVRLSNNKLSG 417
Query: 400 KIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNL 459
+IP G W LP + +L+ DN FTG I I + +LS L + NRFSG +P+E+G L +
Sbjct: 418 QIPHGFWGLPRLSLLELSDNSFTGSIPKTIIGAKNLSNLRISKNRFSGSIPNEIGSLNGI 477
Query: 460 ERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSG 519
+ N+FSG+IP +L L+QLS L L +N L+G IP E+ + +LNLA N LSG
Sbjct: 478 IEISGAENDFSGEIPESLVKLKQLSRLDLSKNQLSGEIPRELRGWKNLNELNLANNHLSG 537
Query: 520 NIPRXXXXXXXXXXXXXXXXXXTGSIPDNLMKLKLSSIDLSENQLSGSVPLDFLRMGGDG 579
IP+ +G IP L LKL+ ++LS N LSG +P +
Sbjct: 538 EIPKEVGILPVLNYLDLSSNQFSGEIPLELQNLKLNVLNLSYNHLSGKIPPLYANKIYAH 597
Query: 580 AFAGNEGLCLD 590
F GN GLC+D
Sbjct: 598 DFIGNPGLCVD 608
|
|
| TAIR|locus:2169975 HSL2 "HAESA-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 860 (307.8 bits), Expect = 4.2e-155, Sum P(3) = 4.2e-155
Identities = 184/488 (37%), Positives = 268/488 (54%)
Query: 102 LSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD-LSALKNLEIFDLSINYFTGRF 160
L L N SGKLP L+VL + N G +P L L++ +L+ N +G
Sbjct: 128 LILNQNNFSGKLPEFSPEFRKLRVLELESNLFTGEIPQSYGRLTALQVLNLNGNPLSGIV 187
Query: 161 PRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELG 220
P ++ LT+L L + +D + IP ++GNL NLT L L H NL G IP+SI L L
Sbjct: 188 PAFLGYLTELTRLDLAYISFDPSPIPSTLGNLSNLTDLRLTHSNLVGEIPDSIMNLVLLE 247
Query: 221 TLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGK 280
LD+ N ++GE P SI +L+ +++IELY N L+G+LP +GNLT L+ FD+S N + G+
Sbjct: 248 NLDLAMNSLTGEIPESIGRLESVYQIELYDNRLSGKLPESIGNLTELRNFDVSQNNLTGE 307
Query: 281 LPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALT 340
LPE+I L+ L F N F+G P L F I+ N F+G P NLG+++ ++
Sbjct: 308 LPEKIAALQ-LISFNLNDNFFTGGLPDVVALNPNLVEFKIFNNSFTGTLPRNLGKFSEIS 366
Query: 341 DVDISENQFSGSFPKYLCEKRKXXXXXXXXXXFSGEVPNSYADCKTIQRLRISDNHLSGK 400
+ D+S N+FSG P YLC +RK SGE+P SY DC ++ +R++DN LSG+
Sbjct: 367 EFDVSTNRFSGELPPYLCYRRKLQKIITFSNQLSGEIPESYGDCHSLNYIRMADNKLSGE 426
Query: 401 IPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLE 460
+P W LP + +N G I P I + LSQL + N FSG +P +L L +L
Sbjct: 427 VPARFWELPLTRLELANNNQLQGSIPPSISKARHLSQLEISANNFSGVIPVKLCDLRDLR 486
Query: 461 RLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGN 520
+ L+ N+F G IPS + L+ L + ++EN L G IP+ + C + +LNL+ N L G
Sbjct: 487 VIDLSRNSFLGSIPSCINKLKNLERVEMQENMLDGEIPSSVSSCTELTELNLSNNRLRGG 546
Query: 521 IPRXXXXXXXXXXXXXXXXXXTGSIPDNLMKLKLSSIDLSENQLSGSVPLDFLRMGGDGA 580
IP TG IP L++LKL+ ++S+N+L G +P F + +
Sbjct: 547 IPPELGDLPVLNYLDLSNNQLTGEIPAELLRLKLNQFNVSDNKLYGKIPSGFQQDIFRPS 606
Query: 581 FAGNEGLC 588
F GN LC
Sbjct: 607 FLGNPNLC 614
|
|
| TAIR|locus:2139885 AT4G28650 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 730 (262.0 bits), Expect = 5.3e-147, Sum P(2) = 5.3e-147
Identities = 163/486 (33%), Positives = 250/486 (51%)
Query: 107 NVLSGKLPLELSNCSNLKVLNVTGNAMVGSVP-DLSALKNLEIFDLSINYFTGRFPRWVV 165
N SG L L + L LN +GN + G++ DL L +LE+ DL N+F G P
Sbjct: 126 NSFSGSLFLFSNESLGLVHLNASGNNLSGNLTEDLGNLVSLEVLDLRGNFFQGSLPSSFK 185
Query: 166 NLTQLVSLSI-GDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDI 224
NL +L L + G+N+ E+P +G L +L L + +G IP + L LD+
Sbjct: 186 NLQKLRFLGLSGNNL--TGELPSVLGQLPSLETAILGYNEFKGPIPPEFGNINSLKYLDL 243
Query: 225 CRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEE 284
K+SGE P + KL+ L + LY NN TG +P E+G++T L+ D S N + G++P E
Sbjct: 244 AIGKLSGEIPSELGKLKSLETLLLYENNFTGTIPREIGSITTLKVLDFSDNALTGEIPME 303
Query: 285 IGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDI 344
I LKNL + +N SG P + +L ++ N SG P +LG+ + L +D+
Sbjct: 304 ITKLKNLQLLNLMRNKLSGSIPPAISSLAQLQVLELWNNTLSGELPSDLGKNSPLQWLDV 363
Query: 345 SENQFSGSFPKYLCEKRKXXXXXXXXXXFSGEVPNSYADCKTIQRLRISDNHLSGKIPDG 404
S N FSG P LC K F+G++P + + C+++ R+R+ +N L+G IP G
Sbjct: 364 SSNSFSGEIPSTLCNKGNLTKLILFNNTFTGQIPATLSTCQSLVRVRMQNNLLNGSIPIG 423
Query: 405 LWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLIL 464
L + L+ N +GGI I S SLS + N+ LPS + + NL+ ++
Sbjct: 424 FGKLEKLQRLELAGNRLSGGIPGDISDSVSLSFIDFSRNQIRSSLPSTILSIHNLQAFLV 483
Query: 465 TNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRX 524
+N SG++P LS+L L N LTG+IP+ + C ++V LNL N+L+G IPR
Sbjct: 484 ADNFISGEVPDQFQDCPSLSNLDLSSNTLTGTIPSSIASCEKLVSLNLRNNNLTGEIPRQ 543
Query: 525 XXXXXXXXXXXXXXXXXTGSIPDNL-MKLKLSSIDLSENQLSGSVPLD-FLRMGGDGAFA 582
TG +P+++ L +++S N+L+G VP++ FL+
Sbjct: 544 ITTMSALAVLDLSNNSLTGVLPESIGTSPALELLNVSYNKLTGPVPINGFLKTINPDDLR 603
Query: 583 GNEGLC 588
GN GLC
Sbjct: 604 GNSGLC 609
|
|
| TAIR|locus:2204350 CLV1 "AT1G75820" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1418 (504.2 bits), Expect = 4.0e-145, P = 4.0e-145
Identities = 342/948 (36%), Positives = 502/948 (52%)
Query: 47 HGVLD-SWKESADSPCGFSGITCDSVTGRVTEISFDNKXXXXXXXXXXXXXXXXTVLSLP 105
HG+ D S D+ C FSG++CD RV ++ L+L
Sbjct: 44 HGLHDWIHSSSPDAHCSFSGVSCDD-DARVISLNVSFTPLFGTISPEIGMLTHLVNLTLA 102
Query: 106 FNVLSGKLPLELSNCSNLKVLNVTGNA-MVGSVPD--LSALKNLEIFDLSINYFTGRFPR 162
N +G+LPLE+ + ++LKVLN++ N + G+ P L A+ +LE+ D N F G+ P
Sbjct: 103 ANNFTGELPLEMKSLTSLKVLNISNNGNLTGTFPGEILKAMVDLEVLDTYNNNFNGKLPP 162
Query: 163 WVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYL-------------FLAHC-NLR-- 206
+ L +L LS G N + EIPES G++++L YL FL+ NLR
Sbjct: 163 EMSELKKLKYLSFGGNFFS-GEIPESYGDIQSLEYLGLNGAGLSGKSPAFLSRLKNLREM 221
Query: 207 ---------GRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGEL 257
G +P L +L LD+ ++GE P S+ L+ L + L+ NNLTG +
Sbjct: 222 YIGYYNSYTGGVPPEFGGLTKLEILDMASCTLTGEIPTSLSNLKHLHTLFLHINNLTGHI 281
Query: 258 PAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFA 317
P EL L L+ D+S NQ+ G++P+ NL N+T+ F+NN G+ P G++ KL
Sbjct: 282 PPELSGLVSLKSLDLSINQLTGEIPQSFINLGNITLINLFRNNLYGQIPEAIGELPKLEV 341
Query: 318 FSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKXXXXXXXXXXFSGEV 377
F ++ N F+ P NLGR L +D+S+N +G PK LC K F G +
Sbjct: 342 FEVWENNFTLQLPANLGRNGNLIKLDVSDNHLTGLIPKDLCRGEKLEMLILSNNFFFGPI 401
Query: 378 PNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQ 437
P CK++ ++RI N L+G +P GL+ LP V +++ DN F+G + P+ L Q
Sbjct: 402 PEELGKCKSLTKIRIVKNLLNGTVPAGLFNLPLVTIIELTDNFFSGEL-PVTMSGDVLDQ 460
Query: 438 LVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSI 497
+ L NN FSGE+P +G NL+ L L N F G IP + L+ LS ++ N +TG I
Sbjct: 461 IYLSNNWFSGEIPPAIGNFPNLQTLFLDRNRFRGNIPREIFELKHLSRINTSANNITGGI 520
Query: 498 PNEMGDCARIVDLNLARNSLSGNIPRXXXXXXXXXXXXXXXXXXTGSIPDNLMKL-KLSS 556
P+ + C+ ++ ++L+RN ++G IP+ TGSIP + + L++
Sbjct: 521 PDSISRCSTLISVDLSRNRINGEIPKGINNVKNLGTLNISGNQLTGSIPTGIGNMTSLTT 580
Query: 557 IDLSENQLSGSVPL--DFLRMGGDGAFAGNEGLCLDQSTKMLMNSKLTACPAIQKQKGGF 614
+DLS N LSG VPL FL + + +FAGN LCL +CP Q
Sbjct: 581 LDLSFNDLSGRVPLGGQFL-VFNETSFAGNTYLCLPHRV---------SCPTRPGQTSDH 630
Query: 615 KDKXXXXXXXXXXXXXXXXXXXXVSYKNFKLSADMENGEKEVSSKWKLASFHHIDIDAEQ 674
+ + M + + S WKL +F +D +E
Sbjct: 631 NHTALFSPSRIVITVIAAITGLILISVAIR---QMNKKKNQKSLAWKLTAFQKLDFKSED 687
Query: 675 ICN-LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL-WKGDGVKV--FAAEMEILGKIRH 730
+ L+E+N+IG GG G VYR + N VA+K+L +G G F AE++ LG+IRH
Sbjct: 688 VLECLKEENIIGKGGAGIVYRGSMPNNVD-VAIKRLVGRGTGRSDHGFTAEIQTLGRIRH 746
Query: 731 RNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
R+I++L + ++ L+ EYMPNG+L + LH K G L W R+++A+ AAKG+
Sbjct: 747 RHIVRLLGYVANKDTNLLLYEYMPNGSLGELLHGS-KGG--HLQWETRHRVAVEAAKGLC 803
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
YLHHDCSP I+HRD+KS+NILLD D+E +ADFG+AK + S AG++GYIAP
Sbjct: 804 YLHHDCSPLILHRDVKSNNILLDSDFEAHVADFGLAKFLVDGAASECMSSIAGSYGYIAP 863
Query: 851 ELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVS------THLNNHEN 904
E AYT KV EKSDV+SFGVVLLEL+ G+KPV E +G+G DIV WV T ++
Sbjct: 864 EYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGE-FGEGVDIVRWVRNTEEEITQPSDAAI 922
Query: 905 VLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952
V+ ++D + + +I + KIA++C + RP MREVV ML +
Sbjct: 923 VVAIVDPRLTGYPLTS-VIHVFKIAMMCVEEEAAARPTMREVVHMLTN 969
|
|
| TAIR|locus:2169965 BAM1 "BARELY ANY MERISTEM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 734 (263.4 bits), Expect = 2.1e-143, Sum P(2) = 2.1e-143
Identities = 168/492 (34%), Positives = 251/492 (51%)
Query: 102 LSLPFNVLSGKLPLELSN-CSNLKVLNVTGNAMVGSVP-DLSALKNLEIFDLSINYFTGR 159
L+L NV +G P E+S+ NL+VL+V N + G +P ++ L L L NYF G+
Sbjct: 122 LNLSNNVFNGSFPDEISSGLVNLRVLDVYNNNLTGDLPVSVTNLTQLRHLHLGGNYFAGK 181
Query: 160 FPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCN-LRGRIPESISELRE 218
P + + L++ N +IP IGNL L L++ + N +P I L E
Sbjct: 182 IPPSYGSWPVIEYLAVSGNEL-VGKIPPEIGNLTTLRELYIGYYNAFEDGLPPEIGNLSE 240
Query: 219 LGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMY 278
L D ++GE P I KLQKL + L N +G L ELG L+ L+ D+S+N
Sbjct: 241 LVRFDGANCGLTGEIPPEIGKLQKLDTLFLQVNVFSGPLTWELGTLSSLKSMDLSNNMFT 300
Query: 279 GKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTA 338
G++P LKNLT+ F+N GE P GD+ +L ++ N F+G P+ LG
Sbjct: 301 GEIPASFAELKNLTLLNLFRNKLHGEIPEFIGDLPELEVLQLWENNFTGSIPQKLGENGK 360
Query: 339 LTDVDISENQFSGSFPKYLCEKRKXXXXXXXXXXFSGEVPNSYADCKTIQRLRISDNHLS 398
L VD+S N+ +G+ P +C K G +P+S C+++ R+R+ +N L+
Sbjct: 361 LNLVDLSSNKLTGTLPPNMCSGNKLETLITLGNFLFGSIPDSLGKCESLTRIRMGENFLN 420
Query: 399 GKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTN 458
G IP GL+ LP + ++ DN +G + G+S +L Q+ L NN+ SG LP +G T
Sbjct: 421 GSIPKGLFGLPKLTQVELQDNYLSGELPVAGGVSVNLGQISLSNNQLSGPLPPAIGNFTG 480
Query: 459 LERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLS 518
+++L+L N F G IPS +G L+QLS + N +G I E+ C + ++L+RN LS
Sbjct: 481 VQKLLLDGNKFQGPIPSEVGKLQQLSKIDFSHNLFSGRIAPEISRCKLLTFVDLSRNELS 540
Query: 519 GNIPRXXXXXXXXXXXXXXXXXXTGSIPDNLMKLK-LSSIDLSENQLSGSVP-LDFLRMG 576
G IP GSIP ++ ++ L+S+D S N LSG VP
Sbjct: 541 GEIPNEITAMKILNYLNLSRNHLVGSIPGSISSMQSLTSLDFSYNNLSGLVPGTGQFSYF 600
Query: 577 GDGAFAGNEGLC 588
+F GN LC
Sbjct: 601 NYTSFLGNPDLC 612
|
|
| TAIR|locus:2097310 BAM2 "BARELY ANY MERISTEM 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 727 (261.0 bits), Expect = 1.9e-140, Sum P(2) = 1.9e-140
Identities = 169/495 (34%), Positives = 253/495 (51%)
Query: 102 LSLPFNVLSGKLPLELSN-CSNLKVLNVTGNAMVGSVP-DLSALKNLEIFDLSINYFTGR 159
L+L NV +G P ELS+ NL+VL++ N + G +P L+ L L L NYF+G+
Sbjct: 122 LNLSNNVFNGSFPDELSSGLVNLRVLDLYNNNLTGDLPVSLTNLTQLRHLHLGGNYFSGK 181
Query: 160 FPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCN-LRGRIPESISELRE 218
P L L++ N +IP IGNL L L++ + N +P I L E
Sbjct: 182 IPATYGTWPVLEYLAVSGNELT-GKIPPEIGNLTTLRELYIGYYNAFENGLPPEIGNLSE 240
Query: 219 LGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMY 278
L D ++GE P I KLQKL + L N TG + ELG ++ L+ D+S+N
Sbjct: 241 LVRFDAANCGLTGEIPPEIGKLQKLDTLFLQVNAFTGTITQELGLISSLKSMDLSNNMFT 300
Query: 279 GKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTA 338
G++P LKNLT+ F+N G P G+M +L ++ N F+G P+ LG
Sbjct: 301 GEIPTSFSQLKNLTLLNLFRNKLYGAIPEFIGEMPELEVLQLWENNFTGSIPQKLGENGR 360
Query: 339 LTDVDISENQFSGSFPKYLCEKRKXXXXXXXXXXFSGEVPNSYADCKTIQRLRISDNHLS 398
L +D+S N+ +G+ P +C + G +P+S C+++ R+R+ +N L+
Sbjct: 361 LVILDLSSNKLTGTLPPNMCSGNRLMTLITLGNFLFGSIPDSLGKCESLTRIRMGENFLN 420
Query: 399 GKIPDGLWALPNVGMLDFGDNDFTGGISPLIG--LSTSLSQLVLQNNRFSGELPSELGRL 456
G IP L+ LP + ++ DN TG + P+ G +S L Q+ L NN+ SG LP+ +G L
Sbjct: 421 GSIPKELFGLPKLSQVELQDNYLTGEL-PISGGGVSGDLGQISLSNNQLSGSLPAAIGNL 479
Query: 457 TNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNS 516
+ +++L+L N FSG IP +G L+QLS L N +G I E+ C + ++L+RN
Sbjct: 480 SGVQKLLLDGNKFSGSIPPEIGRLQQLSKLDFSHNLFSGRIAPEISRCKLLTFVDLSRNE 539
Query: 517 LSGNIPRXXXXXXXXXXXXXXXXXXTGSIPDNLMKLK-LSSIDLSENQLSGSVPL--DFL 573
LSG+IP GSIP + ++ L+S+D S N LSG VP F
Sbjct: 540 LSGDIPNELTGMKILNYLNLSRNHLVGSIPVTIASMQSLTSVDFSYNNLSGLVPSTGQFS 599
Query: 574 RMGGDGAFAGNEGLC 588
+F GN LC
Sbjct: 600 YFNYT-SFVGNSHLC 613
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 973 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-160 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-49 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-48 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 8e-47 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-44 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-43 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-43 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-43 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-37 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 7e-36 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-35 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-33 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-32 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 7e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 9e-31 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-30 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-29 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-28 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-28 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-27 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-27 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-27 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-26 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-26 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-26 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-26 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 8e-26 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-26 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-25 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-24 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-24 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-24 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-24 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-24 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-23 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-23 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-23 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-23 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-23 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-23 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-22 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-22 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-22 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-22 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-22 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 7e-22 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-22 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 8e-22 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 8e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-21 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-21 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-21 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-21 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-21 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 8e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 9e-21 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-20 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-20 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-20 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-20 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-20 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-20 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-20 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-20 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 6e-20 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-20 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 8e-20 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 9e-20 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 9e-20 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-19 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-19 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-19 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-19 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-19 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-19 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-19 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-19 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 6e-19 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-19 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 8e-19 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 8e-19 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-19 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 8e-19 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-18 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-18 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-18 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-18 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-18 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-18 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-18 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-18 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 7e-18 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 9e-18 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-17 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-17 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-17 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-17 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-17 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-17 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-17 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-17 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-17 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-17 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-17 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 8e-17 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 8e-17 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 9e-17 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-16 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-16 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-16 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-16 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-16 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-16 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-16 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-16 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-16 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 9e-16 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-15 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-15 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-15 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-15 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-15 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-15 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-15 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-15 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-15 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-15 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 7e-15 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-14 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-14 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-14 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-14 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-14 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-14 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-14 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-14 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-14 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-14 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 6e-14 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-14 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 9e-14 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-13 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-13 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-13 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-13 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-13 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-13 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-13 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-13 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-13 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-13 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-13 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 8e-13 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 8e-13 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 8e-13 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 8e-13 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 9e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-12 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-12 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-12 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-12 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-12 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-12 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-12 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-12 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-12 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-12 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-12 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 7e-12 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 7e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 8e-12 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 9e-12 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-11 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-11 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-11 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-11 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-11 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-11 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-11 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-11 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 8e-11 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 9e-11 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-10 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-10 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-10 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-10 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 9e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-09 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-09 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 1e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-09 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-09 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-09 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 7e-09 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 7e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 8e-09 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 9e-09 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-08 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-08 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-08 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-07 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-07 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-07 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-07 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 7e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 1e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 5e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-06 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 1e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| PRK15387 | 788 | PRK15387, PRK15387, E3 ubiquitin-protein ligase Ss | 0.002 | |
| PLN03210 | 1153 | PLN03210, PLN03210, Resistant to P | 0.003 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 494 bits (1274), Expect = e-160
Identities = 318/987 (32%), Positives = 507/987 (51%), Gaps = 73/987 (7%)
Query: 2 AKIPFLCFHLLALLCFILVSVFPPSLSLNVETQALIQFKSKLKDPHGVLDSWKESADSPC 61
K P C +L+ +L F+ ++ S+ E + L+ FKS + DP L +W SAD C
Sbjct: 3 KKGPQHCPYLIFMLFFLFLNF---SMLHAEELELLLSFKSSINDPLKYLSNWNSSADV-C 58
Query: 62 GFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLP------- 114
+ GITC++ + RV I K++SG+ISS+I L + ++L N LSG +P
Sbjct: 59 LWQGITCNNSS-RVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTS 117
Query: 115 -----LELSN-----------CSNLKVLNVTGNAMVGSVP-DLSALKNLEIFDLSINYFT 157
L LSN NL+ L+++ N + G +P D+ + +L++ DL N
Sbjct: 118 SSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLV 177
Query: 158 GRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELR 217
G+ P + NLT L L++ N +IP +G +K+L +++L + NL G IP I L
Sbjct: 178 GKIPNSLTNLTSLEFLTLASNQL-VGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLT 236
Query: 218 ELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQM 277
L LD+ N ++G P S+ L+ L + LY N L+G +P + +L L D+S N +
Sbjct: 237 SLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSL 296
Query: 278 YGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYT 337
G++PE + L+NL + F NNF+G+ P + +L ++ N+FSG P+NLG++
Sbjct: 297 SGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHN 356
Query: 338 ALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHL 397
LT +D+S N +G P+ LC L L+ SN+ GE+P S C++++R+R+ DN
Sbjct: 357 NLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSF 416
Query: 398 SGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLT 457
SG++P LP V LD +N+ G I+ SL L L N+F G LP G
Sbjct: 417 SGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-K 475
Query: 458 NLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSL 517
LE L L+ N FSG +P LG+L +L L L EN L+G IP+E+ C ++V L+L+ N L
Sbjct: 476 RLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQL 535
Query: 518 SGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLK-LSSIDLSENQLSGSVPLD--FLR 574
SG IP S S + L+ L+LS N+L+G IP NL ++ L +++S N L GS+P FL
Sbjct: 536 SGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLA 595
Query: 575 MGGDGAFAGNEGLCLDQSTKMLMNSKLTACPAIQKQKGGFKDKLVLFCIIAVALAAFLAG 634
+ A AGN LC +T S L C ++K + + C + L L
Sbjct: 596 INAS-AVAGNIDLCGGDTT-----SGLPPCKRVRKTPSWW---FYITCTLGAFLVLALVA 646
Query: 635 LLLVSYKNFKLSADMENGEKEVSSKWKLASFH-----HIDIDAEQICNLEEDNLIGSGGT 689
V + +++ E E W+L F I I+ + +L+E+N+I G
Sbjct: 647 FGFVFIRGRNNL-ELKRVENE-DGTWELQFFDSKVSKSITIND-ILSSLKEENVISRGKK 703
Query: 690 GKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEI--LGKIRHRNILKLYACLLKGGSSF 747
G Y+ KN VK++ + + EI +GK++H NI+KL ++
Sbjct: 704 GASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAY 759
Query: 748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKS 807
L+ EY+ NL + L L W RR KIA+G AK + +LH CSP ++ ++
Sbjct: 760 LIHEYIEGKNLSEVLRN--------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSP 811
Query: 808 SNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSF 867
I++D EP + +++ +D CF + Y+APE T ++EKSD++ F
Sbjct: 812 EKIIIDGKDEPHL------RLSLPGLLCTDTKCFISS-AYVAPETRETKDITEKSDIYGF 864
Query: 868 GVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESIKE-DMIKLL 926
G++L+EL+TG+ P + E+G IV W ++ + + S+ + ++++++
Sbjct: 865 GLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVM 924
Query: 927 KIAVVCTTKLPNLRPPMREVVKMLADA 953
+A+ CT P RP +V+K L A
Sbjct: 925 NLALHCTATDPTARPCANDVLKTLESA 951
|
Length = 968 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 174 bits (444), Expect = 3e-49
Identities = 93/275 (33%), Positives = 129/275 (46%), Gaps = 35/275 (12%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKIRHRNILKLYAC 739
+GSG G VY+ K VAVK L K + E+ IL ++ H NI++L
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP 799
+LV+EY G+LF L + L KIAL +G+ YLH S
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSRGGP-----LSEDEAKKIALQILRGLEYLH---SNG 118
Query: 800 IIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPE-LAYTCKV 858
IIHRD+K NILLDE+ KIADFG+AK S S + F GT Y+APE L
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSS--SSLTTFVGTPWYMAPEVLLGGNGY 176
Query: 859 SEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASE-- 916
K DV+S GV+L EL+TG+ P E L+ + + ++L + +
Sbjct: 177 GPKVDVWSLGVILYELLTGKPPFSGE------------NILDQLQLIRRILGPPLEFDEP 224
Query: 917 ---SIKEDMIKLLKIAVVCTTKLPNLRPPMREVVK 948
S E+ L+K C K P+ RP E+++
Sbjct: 225 KWSSGSEEAKDLIK---KCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 5e-48
Identities = 73/196 (37%), Positives = 102/196 (52%), Gaps = 14/196 (7%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAAEMEILGKIRHRNILKLYACL 740
+G GG G VY KK VA+K + ++ E+EIL K+ H NI+KLY
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
+LV+EY G+L L + + +L +I L +G+ YLH S I
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKEN----EGKLSEDEILRILLQILEGLEYLH---SNGI 113
Query: 801 IHRDIKSSNILLDED-YEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPE-LAYTCKV 858
IHRD+K NILLD D + K+ADFG++K+ + + GT Y+APE L
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV--GTPAYMAPEVLLGKGYY 171
Query: 859 SEKSDVFSFGVVLLEL 874
SEKSD++S GV+L EL
Sbjct: 172 SEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 167 bits (426), Expect = 8e-47
Identities = 87/271 (32%), Positives = 124/271 (45%), Gaps = 27/271 (9%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRHRNILKLYA 738
+G G GKVY KK VA+K + K K E++IL K++H NI++LY
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
+LV+EY G+LF L KR G+ D R Y + YLH S
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKR---GRLSEDEARFY--LRQILSALEYLH---SK 116
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKV 858
I+HRD+K NILLDED K+ADFG+A+ + K++ F GT Y+APE+
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTT---FVGTPEYMAPEVLLGKGY 173
Query: 859 SEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESI 918
+ D++S GV+L EL+TG+ P GD + + + S
Sbjct: 174 GKAVDIWSLGVILYELLTGKPPF---PGDDQLLELF---KKIGKPKPPFPPPEWDISPEA 227
Query: 919 KEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949
K+ + KLL K P R E ++
Sbjct: 228 KDLIRKLL-------VKDPEKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 6e-44
Identities = 82/287 (28%), Positives = 131/287 (45%), Gaps = 44/287 (15%)
Query: 678 LEEDNLIGSGGTGKVYRLDLKKNAG----TVAVKQLWKGD----GVKVFAAEMEILGKIR 729
L +G G G+VY+ LK G VAVK L K D ++ F E I+ K+
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL-KEDASEQQIEEFLREARIMRKLD 59
Query: 730 HRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGI 789
H N++KL + ++V+EYM G+ L +++ +P+L AL A+G+
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGD----LLSYLRKNRPKLSLSDLLSFALQIARGM 115
Query: 790 AYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI- 848
YL S IHRD+ + N L+ E+ KI+DFG+++ + DY G I
Sbjct: 116 EYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD----DDYYRKRGGKLPIR 168
Query: 849 --APELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGD--GKDIVYWVSTHLNNHE 903
APE K + KSDV+SFGV+L E+ T G +P Y ++++ ++
Sbjct: 169 WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQP----YPGMSNEEVLEYLKN-----G 219
Query: 904 NVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950
L + ++ L+ C + P RP E+V++L
Sbjct: 220 YRLP------QPPNCPPELYDLMLQ---CWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 3e-43
Identities = 86/292 (29%), Positives = 129/292 (44%), Gaps = 53/292 (18%)
Query: 678 LEEDNLIGSGGTGKVYR----LDLKKNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRH 730
LE +G G G+VY+ D + VAVK L +G + F E I+ K+ H
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60
Query: 731 RNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
NI++L +G ++V EYMP G+L L K +L ++AL AKG+
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKH----GEKLTLKDLLQMALQIAKGME 116
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI-- 848
YL S +HRD+ + N L+ E+ KI+DFG+++ DY G +
Sbjct: 117 YLE---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYE----DDYYR-KRGGGKLPI 168
Query: 849 ---APELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHEN 904
APE K + KSDV+SFGV+L E+ T G +P Y ++N E
Sbjct: 169 KWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQP----YPG-----------MSNEEV 213
Query: 905 VLKV-----LDC-EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950
+ + L E + + E M++ C P RP E+V+ L
Sbjct: 214 LELLEDGYRLPRPENCPDELYELMLQ-------CWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 4e-43
Identities = 71/216 (32%), Positives = 102/216 (47%), Gaps = 25/216 (11%)
Query: 678 LEEDNLIGSGGTGKVYRLDLKKNAG----TVAVKQLWKG---DGVKVFAAEMEILGKIRH 730
L +G G G+VY+ LK VAVK L + ++ F E I+ K+ H
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDH 60
Query: 731 RNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
NI+KL + +V+EYMP G+L L K EL AL A+G+
Sbjct: 61 PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKN---RPKELSLSDLLSFALQIARGME 117
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI-- 848
YL S IHRD+ + N L+ E+ KI+DFG+++ + D + G +
Sbjct: 118 YLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSR------DLYDDDYYKVKGGKLPI 168
Query: 849 ---APELAYTCKVSEKSDVFSFGVVLLELVT-GRKP 880
APE K + KSDV+SFGV+L E+ T G +P
Sbjct: 169 RWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEP 204
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 156 bits (398), Expect = 6e-43
Identities = 90/294 (30%), Positives = 125/294 (42%), Gaps = 56/294 (19%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGDG----VKVFAAEMEILGKIRHRNIL 734
+G G G+VY+ LK G VAVK L K D K F E ++ K+ H N++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTL-KEDASEEERKDFLKEARVMKKLGHPNVV 59
Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQALHKR----VKEGKPELDWFRRYKIALGAAKGIA 790
+L + +LVLEYM G+L L K K L A+ AKG+
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI-- 848
YL S +HRD+ + N L+ ED KI+DFG+++ + DY T G +
Sbjct: 120 YLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD----DDYYR-KKTGGKLPI 171
Query: 849 ---APELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHEN 904
APE + KSDV+SFGV+L E+ T G P Y L+N E
Sbjct: 172 RWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATP----YPG-----------LSNEE- 215
Query: 905 VLK------VLDC-EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951
VL+ L E + + E M+ C P RP E+V+ L
Sbjct: 216 VLEYLRKGYRLPKPEYCPDELYELMLS-------CWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 1e-37
Identities = 87/284 (30%), Positives = 132/284 (46%), Gaps = 50/284 (17%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQL-WKG--DGVKVFA-AEMEILGKIRHRNILKLY 737
IG G GKVY + K + +K++ + + A E++IL K+ H NI+K Y
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGK--PE---LDWFRRYKIALGAAKGIAYL 792
+ G +V+EY G+L Q + K+ KEGK PE LDWF ++ L + YL
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWF--VQLCLA----LKYL 119
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSC-FAGTHGYIAPE 851
H S I+HRDIK NI L + K+ DFG++K+ ++ D + GT Y++PE
Sbjct: 120 H---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST---VDLAKTVVGTPYYLSPE 173
Query: 852 L----AYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLK 907
L Y + KSD++S G VL EL T + P E E N E LK
Sbjct: 174 LCQNKPY----NYKSDIWSLGCVLYELCTLKHPFEGE---------------NLLELALK 214
Query: 908 VLDCEVA--SESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949
+L + ++ L+ K P RP + ++++
Sbjct: 215 ILKGQYPPIPSQYSSELRNLVSS---LLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 7e-36
Identities = 65/205 (31%), Positives = 99/205 (48%), Gaps = 14/205 (6%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQL----WKGDGVKVFAAEMEILGKIRHRNILKLY 737
L+G G G VY K +AVK + + ++ E+ IL ++H NI++ Y
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 738 ACLLKGGSSFL--VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHD 795
+ L LEY+ G+L L K GK R+Y + +G+AYLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKF---GKLPEPVIRKYTRQI--LEGLAYLH-- 118
Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYT 855
S I+HRDIK +NIL+D D K+ADFG AK + GT ++APE+
Sbjct: 119 -SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177
Query: 856 CKVSEKSDVFSFGVVLLELVTGRKP 880
+ +D++S G ++E+ TG+ P
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 66/206 (32%), Positives = 101/206 (49%), Gaps = 26/206 (12%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLW--KGDGVKVFAAEMEILGKIRHRNILKLYACLL 741
IG GG G+VY+ K+ VA+K + + + E++IL K +H NI+K Y L
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIA---LGAAKGIAYLHHDCSP 798
K ++V+E+ G+L L + +IA KG+ YLH S
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKSTNQT-------LTESQIAYVCKELLKGLEYLH---SN 117
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL----AY 854
IIHRDIK++NILL D E K+ DFG++ ++ + GT ++APE+ Y
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT---MVGTPYWMAPEVINGKPY 174
Query: 855 TCKVSEKSDVFSFGVVLLELVTGRKP 880
K D++S G+ +EL G+ P
Sbjct: 175 DYKA----DIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 73/210 (34%), Positives = 106/210 (50%), Gaps = 18/210 (8%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVF----AAEMEILGKIRHRN 732
+LE ++G G +G VY++ K A+K++ DG + F E++ L
Sbjct: 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKI-HVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
++K Y K G +VLEYM G+L L K K +P L IA KG+ YL
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLA-----YIARQILKGLDYL 115
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS--PKVSDYSCFAGTHGYIAP 850
H IIHRDIK SN+L++ E KIADFG++K+ EN+ + F GT Y++P
Sbjct: 116 HTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT----FVGTVTYMSP 169
Query: 851 ELAYTCKVSEKSDVFSFGVVLLELVTGRKP 880
E S +D++S G+ LLE G+ P
Sbjct: 170 ERIQGESYSYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 5e-32
Identities = 69/205 (33%), Positives = 112/205 (54%), Gaps = 18/205 (8%)
Query: 682 NLIGSGGTGKVYR-LDLKKNAGTVAVKQL----WKGDGVKVFAAEMEILGKIRHRNILKL 736
+LIG G G VY+ L+ + VA+KQ+ K + +K E+++L ++H NI+K
Sbjct: 6 DLIGRGAFGVVYKGLN-LETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKY 64
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
+ S +++LEY NG+L Q + K + + + Y++ +G+AYLH
Sbjct: 65 IGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYV-YQVL----QGLAYLH--- 116
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVA-KIAENSPKVSDYSCFAGTHGYIAPELAYT 855
+IHRDIK++NIL +D K+ADFGVA K+ + S + GT ++APE+
Sbjct: 117 EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS---VVGTPYWMAPEVIEM 173
Query: 856 CKVSEKSDVFSFGVVLLELVTGRKP 880
S SD++S G ++EL+TG P
Sbjct: 174 SGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 7e-32
Identities = 76/215 (35%), Positives = 108/215 (50%), Gaps = 22/215 (10%)
Query: 679 EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQ--LWKGDGVKVFAA--EMEILGKIRHRNIL 734
E N IG G G V+++ K + A+KQ L K + + A E +L K+ I+
Sbjct: 3 EILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYII 62
Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPE-LDWFRRYKIALGAAKGIAYLH 793
+ Y L G +V+EY NG+L + L + PE W + + G+A+LH
Sbjct: 63 RYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW----RFFIQILLGLAHLH 118
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFA----GTHGYIA 849
S I+HRDIKS N+ LD KI D GVAK+ +SD + FA GT Y++
Sbjct: 119 ---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKL------LSDNTNFANTIVGTPYYLS 169
Query: 850 PELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEE 884
PEL +EKSDV++ GVVL E TG+ P +
Sbjct: 170 PELCEDKPYNEKSDVWALGVVLYECCTGKHPFDAN 204
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 125 bits (313), Expect = 9e-31
Identities = 87/280 (31%), Positives = 119/280 (42%), Gaps = 26/280 (9%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQL-----WKGDGVKVFAAEMEILGKIRH-RNILKL 736
+G G G+VY L ++ VA+K L K V+ F E++IL + H NI+KL
Sbjct: 7 KLGEGSFGEVY---LARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
Y GS +LV+EY+ G+L L K ++G + + YLH
Sbjct: 64 YDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQI--LSALEYLH--- 118
Query: 797 SPPIIHRDIKSSNILLDEDY-EPKIADFGVAKIA----ENSPKVSDYSCFAGTHGYIAPE 851
S IIHRDIK NILLD D K+ DFG+AK+ S + S GT GY+APE
Sbjct: 119 SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178
Query: 852 LA---YTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKV 908
+ S SD++S G+ L EL+TG P E E ++
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238
Query: 909 LDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVK 948
L E I + LLK K P R +
Sbjct: 239 LSPSN-PELISKAASDLLK---KLLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 119 bits (302), Expect = 6e-30
Identities = 71/226 (31%), Positives = 101/226 (44%), Gaps = 40/226 (17%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVK-----QLWKGDGVKVFAAEMEILGKI-RHRNILKL 736
+IG G V K+ A+K QL K VK E E+L ++ H I+KL
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAA---KGIAYLH 793
Y + + VLEY PNG L Q + K G + R Y AA + YLH
Sbjct: 68 YYTFQDEENLYFVLEYAPNGELLQYIRKY---GSLDEKCTRFY-----AAEILLALEYLH 119
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSC------------- 840
S IIHRD+K NILLD+D KI DFG AK+ + + +
Sbjct: 120 ---SKGIIHRDLKPENILLDKDMHIKITDFGTAKV-LDPNSSPESNKGDATNIDSQIEKN 175
Query: 841 ------FAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKP 880
F GT Y++PEL + SD+++ G ++ +++TG+ P
Sbjct: 176 RRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 67/211 (31%), Positives = 111/211 (52%), Gaps = 23/211 (10%)
Query: 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL-WKGDGVKVFAAEMEILGKIRHRNIL 734
NLE+ IG G +G+VY+ + VA+K++ + ++ E+ I+ +H NI+
Sbjct: 22 KNLEK---IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIV 78
Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQAL-HKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
Y L G ++V+EYM G+L + V+ +P++ + + +G+ YLH
Sbjct: 79 DYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAY-----VCREVLQGLEYLH 133
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL- 852
S +IHRDIKS NILL +D K+ADFG A A+ + + S + GT ++APE+
Sbjct: 134 ---SQNVIHRDIKSDNILLSKDGSVKLADFGFA--AQLTKEKSKRNSVVGTPYWMAPEVI 188
Query: 853 ---AYTCKVSEKSDVFSFGVVLLELVTGRKP 880
Y KV D++S G++ +E+ G P
Sbjct: 189 KRKDYGPKV----DIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 80/284 (28%), Positives = 123/284 (43%), Gaps = 41/284 (14%)
Query: 678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA---EMEILGKIRHRNIL 734
LE +G+G +G V ++ + +AVK + + E++IL K I+
Sbjct: 3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIV 62
Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRY--KIALGAAKGIAYL 792
Y G + +EYM G+L + K V+ PE R KIA+ KG+ YL
Sbjct: 63 GFYGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPE-----RILGKIAVAVLKGLTYL 116
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL 852
H IIHRD+K SNIL++ + K+ DFGV+ NS + F GT Y+APE
Sbjct: 117 HEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT----FVGTSSYMAPER 170
Query: 853 AYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCE 912
S KSD++S G+ L+EL TGR P + + + ++L
Sbjct: 171 IQGNDYSVKSDIWSLGLSLIELATGRFP--------------YPPENDPPDGIFELLQYI 216
Query: 913 VASESIK-------EDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949
V + D + +C K P RP +E+++
Sbjct: 217 VNEPPPRLPSGKFSPDFQDFVN---LCLIKDPRERPSYKELLEH 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 7e-28
Identities = 60/211 (28%), Positives = 107/211 (50%), Gaps = 17/211 (8%)
Query: 673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRN 732
E++ ++ E +G G G VY+ K+ VA+K + + ++ E+ IL +
Sbjct: 2 EEVFDILE--KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPY 59
Query: 733 ILKLYACLLKGGSSFLVLEYMPNG---NLFQALHKRVKEGKPELDWFRRYKIALGAAKGI 789
I+K Y K ++V+EY G ++ + +K + E + I KG+
Sbjct: 60 IVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAA-------ILYQTLKGL 112
Query: 790 AYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIA 849
YLH S IHRDIK+ NILL+E+ + K+ADFGV+ ++ ++ + GT ++A
Sbjct: 113 EYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT--MAKRNTVIGTPFWMA 167
Query: 850 PELAYTCKVSEKSDVFSFGVVLLELVTGRKP 880
PE+ + K+D++S G+ +E+ G+ P
Sbjct: 168 PEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 79/207 (38%), Positives = 106/207 (51%), Gaps = 25/207 (12%)
Query: 684 IGSGGTGKVYRLDLKKNAGTV-AVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLY 737
+G G GKV L KK+ G + A+K L K V+ E IL +I H I+KL+
Sbjct: 1 LGKGSFGKVL-LVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH 59
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGK-PELDWFRRY--KIALGAAKGIAYLH- 793
+LVLEY P G LF L K EG+ E + R Y +I L + YLH
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSK---EGRFSE-ERARFYAAEIVLA----LEYLHS 111
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELA 853
II+RD+K NILLD D K+ DFG+AK E S + S + F GT Y+APE+
Sbjct: 112 LG----IIYRDLKPENILLDADGHIKLTDFGLAK--ELSSEGSRTNTFCGTPEYLAPEVL 165
Query: 854 YTCKVSEKSDVFSFGVVLLELVTGRKP 880
+ D +S GV+L E++TG+ P
Sbjct: 166 LGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 74/206 (35%), Positives = 107/206 (51%), Gaps = 24/206 (11%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLK 742
+G+G G+V+ L N VAVK L G K F AE +I+ K+RH +++LYA
Sbjct: 14 LGAGQFGEVWE-GLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGK----PELDWFRRYKIALGAAKGIAYLHHDCSP 798
++V E M G+L + L G+ P+L +A A G+AYL +
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGG--AGRALKLPQL-----IDMAAQVASGMAYLE---AQ 122
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI---APELAYT 855
IHRD+ + N+L+ E+ K+ADFG+A++ K Y G I APE A
Sbjct: 123 NYIHRDLAARNVLVGENNICKVADFGLARVI----KEDIYEAREGAKFPIKWTAPEAALY 178
Query: 856 CKVSEKSDVFSFGVVLLELVT-GRKP 880
+ S KSDV+SFG++L E+VT GR P
Sbjct: 179 NRFSIKSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 67/201 (33%), Positives = 100/201 (49%), Gaps = 17/201 (8%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG--VKVFAAEMEILGKIRHRNILKLYACL 740
IG G G V D + VAVK L K D + F AE ++ +RH N+++L +
Sbjct: 13 TIGKGEFGDVMLGDYRGQ--KVAVKCL-KDDSTAAQAFLAEASVMTTLRHPNLVQLLGVV 69
Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
L+G ++V EYM G+L L R G+ + ++ AL +G+ YL
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYLRSR---GRAVITLAQQLGFALDVCEGMEYLE---EKNF 123
Query: 801 IHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSE 860
+HRD+ + N+L+ ED K++DFG+AK A + APE K S
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPV-----KWTAPEALREKKFST 178
Query: 861 KSDVFSFGVVLLELVT-GRKP 880
KSDV+SFG++L E+ + GR P
Sbjct: 179 KSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 67/214 (31%), Positives = 101/214 (47%), Gaps = 40/214 (18%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIRHRNILKLYAC 739
IG G G+VY+ KK VA+K++ + +G + A E+++L K+RH NI++L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66
Query: 740 LL--KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAK--------GI 789
+ GS ++V EYM + L + K K G+
Sbjct: 67 VTSKGKGSIYMVFEYMDHD--LTGLLDSPE-----------VKFTESQIKCYMKQLLEGL 113
Query: 790 AYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIA 849
YLH + I+HRDIK SNIL++ D K+ADFG+A+ +DY+ T Y
Sbjct: 114 QYLHSN---GILHRDIKGSNILINNDGVLKLADFGLAR-PYTKRNSADYTNRVITLWYRP 169
Query: 850 PEL-----AYTCKVSEKSDVFSFGVVLLELVTGR 878
PEL Y +V D++S G +L EL G+
Sbjct: 170 PELLLGATRYGPEV----DMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 75/206 (36%), Positives = 111/206 (53%), Gaps = 24/206 (11%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLK 742
+G+G G+V+ + VAVK L G + F E +I+ K+RH +++LYA +
Sbjct: 14 LGAGQFGEVW-MGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGK----PELDWFRRYKIALGAAKGIAYLHHDCSP 798
++V EYM G+L L EGK P+L +A A+G+AYL S
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKS--GEGKKLRLPQL-----VDMAAQIAEGMAYLE---SR 122
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI---APELAYT 855
IHRD+ + NIL+ E+ KIADFG+A++ E+ +Y+ G I APE A
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGLARLIED----DEYTAREGAKFPIKWTAPEAANY 178
Query: 856 CKVSEKSDVFSFGVVLLELVT-GRKP 880
+ + KSDV+SFG++L E+VT GR P
Sbjct: 179 GRFTIKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 4e-26
Identities = 74/221 (33%), Positives = 105/221 (47%), Gaps = 38/221 (17%)
Query: 679 EEDNL-----IGSGGTGKVY--RLDLKKNAGT--VAVKQLWKGDGVKV----FAAEMEIL 725
E+ +L +G G GKV R D + VAVK L G + F E+EIL
Sbjct: 2 EKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL-NHSGEEQHRSDFEREIEIL 60
Query: 726 GKIRHRNILKL-YACLLKGGSSF-LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL 783
+ H NI+K C GG S L++EY+P+G+L L + + +++ R +
Sbjct: 61 RTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRH----RDQINLKRLLLFSS 116
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE--------NSPKV 835
KG+ YL S IHRD+ + NIL++ + KI+DFG+AK+ P
Sbjct: 117 QICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPG- 172
Query: 836 SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT 876
+ F + APE T K S SDV+SFGV L EL T
Sbjct: 173 -ESPIF-----WYAPECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 71/213 (33%), Positives = 108/213 (50%), Gaps = 21/213 (9%)
Query: 682 NLIGSGGTGKVYR-LDLKKNAGTVAVKQLWKGDG----VKVFAAEMEILGKIRHRNILKL 736
N IG G GKVY ++L +AVK++ D +K A EM++L ++H N++K
Sbjct: 6 NKIGGGTFGKVYTAVNLDTG-ELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPE-LDWFRRYKIALGAAKGIAYLHHD 795
Y + ++ +EY G L + L G+ R Y + L +G+AYLH
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEELLE----HGRILDEHVIRVYTLQL--LEGLAYLH-- 116
Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAK-IAENS-PKVSDYSCFAGTHGYIAPELA 853
S I+HRDIK +NI LD + K+ DFG A + N+ + AGT Y+APE+
Sbjct: 117 -SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI 175
Query: 854 YTCKVSEK---SDVFSFGVVLLELVTGRKPVEE 883
K +D++S G V+LE+ TG++P E
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGKRPWSE 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 70/202 (34%), Positives = 108/202 (53%), Gaps = 12/202 (5%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV--FAAEMEILGKIRHRNILKLYACLL 741
+GSG G+V+ L KN VA+K L D +K F E++ L ++RH++++ L+A
Sbjct: 14 LGSGYFGEVWE-GLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS 72
Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPII 801
G +++ E M G+L L R EG+ L +A A+G+AYL I
Sbjct: 73 VGEPVYIITELMEKGSLLAFL--RSPEGQ-VLPVASLIDMACQVAEGMAYLE---EQNSI 126
Query: 802 HRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEK 861
HRD+ + NIL+ ED K+ADFG+A++ + +S + + APE A S K
Sbjct: 127 HRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIP--YKWTAPEAASHGTFSTK 184
Query: 862 SDVFSFGVVLLELVT-GRKPVE 882
SDV+SFG++L E+ T G+ P
Sbjct: 185 SDVWSFGILLYEMFTYGQVPYP 206
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 84/294 (28%), Positives = 135/294 (45%), Gaps = 64/294 (21%)
Query: 681 DNLIGSGGTGKVYRLDLKKNAG---TVAVKQLWKG--DGVKV-FAAEMEILGKIRHRNIL 734
+ +IG G G+V R LK VA+K L G D ++ F E I+G+ H NI+
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHH 794
+L + K ++ EYM NG+L + L R +GK + + G A G+ YL
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFL--RENDGK--FTVGQLVGMLRGIASGMKYLSE 124
Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHG------YI 848
+HRD+ + NIL++ + K++DFG+++ E+S T G +
Sbjct: 125 MNY---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYT------TKGGKIPIRWT 175
Query: 849 APE-LAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVL 906
APE +AY K + SDV+SFG+V+ E+++ G +P YW ++N + V+
Sbjct: 176 APEAIAYR-KFTSASDVWSFGIVMWEVMSYGERP------------YW---DMSNQD-VI 218
Query: 907 KVL----------DCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950
K + DC A L ++ + C K N RP ++V L
Sbjct: 219 KAVEDGYRLPPPMDCPSA----------LYQLMLDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 60/207 (28%), Positives = 92/207 (44%), Gaps = 22/207 (10%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA-----EMEILGKIRHRNILKL 736
+IG G GKV + + A+K + K V+ + E IL ++ H ++ L
Sbjct: 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAK---GIAYLH 793
+ + +LV++ + G+L L ++VK F ++ + + YLH
Sbjct: 66 WYSFQDEENMYLVVDLLLGGDLRYHLSQKVK--------FSEEQVKFWICEIVLALEYLH 117
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELA 853
S IIHRDIK NILLDE I DF +A + S GT GY+APE+
Sbjct: 118 ---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS---GTPGYMAPEVL 171
Query: 854 YTCKVSEKSDVFSFGVVLLELVTGRKP 880
S D +S GV E + G++P
Sbjct: 172 CRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 75/217 (34%), Positives = 104/217 (47%), Gaps = 21/217 (9%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLW---KGDGVKVFAAEMEILGKIRHRNI 733
+ E + +G G G V + LK A+K + D K E+EI + I
Sbjct: 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYI 61
Query: 734 LKLY-ACLLKGGSSF-LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAY 791
+K Y A L + SS + +EY G+L +++K+VK+ + KIA KG++Y
Sbjct: 62 VKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120
Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPE 851
LH S IIHRDIK SNILL + K+ DFGV+ NS F GT Y+APE
Sbjct: 121 LH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA----GTFTGTSFYMAPE 173
Query: 852 ----LAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEE 884
Y+ SDV+S G+ LLE+ R P E
Sbjct: 174 RIQGKPYSI----TSDVWSLGLTLLEVAQNRFPFPPE 206
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 68/208 (32%), Positives = 101/208 (48%), Gaps = 30/208 (14%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV-----FAAEMEILGKIRHRNILKLYA 738
+G+G G+V + K + A+K L K VK+ E IL IRH ++ LY
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRY--KIALGAAKGIAYLHHDC 796
+ +LV+EY+P G LF L K G+ R Y ++ L + YLH
Sbjct: 69 SFQDDSNLYLVMEYVPGGELFSHL---RKSGRFPEPVARFYAAQVVLA----LEYLHS-L 120
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSD--YS-CFAGTHGYIAPELA 853
I++RD+K N+LLD D KI DFG AK +V Y+ C GT Y+APE+
Sbjct: 121 D--IVYRDLKPENLLLDSDGYIKITDFGFAK------RVKGRTYTLC--GTPEYLAPEI- 169
Query: 854 YTCKVSEKS-DVFSFGVVLLELVTGRKP 880
K K+ D ++ G+++ E++ G P
Sbjct: 170 ILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 67/215 (31%), Positives = 102/215 (47%), Gaps = 34/215 (15%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVK--------QLWKGDGVKVFAAEMEILGKIRHRNIL 734
+G G G VY++ + A+K Q + D V E+ IL + H NI+
Sbjct: 7 KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVN----EIRILASVNHPNII 62
Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKP---ELDWFRRYKIALGAAKGIAY 791
L G +V+EY P G+L +A+ KR K+ K + W +I + +G+
Sbjct: 63 SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW----RIFIQLLRGLQA 118
Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFA----GTHGY 847
LH I+HRD+KS+NILL + KI D G++K+ + + A GT Y
Sbjct: 119 LH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--------MAKTQIGTPHY 167
Query: 848 IAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVE 882
+APE+ S KSD++S G +L E+ T P E
Sbjct: 168 MAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 6e-24
Identities = 68/205 (33%), Positives = 105/205 (51%), Gaps = 20/205 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQ--LWKGDGVKVFAAEMEILGKIRHRNILKLYACLL 741
IGSG G VY+ VA+K L GD ++ E+ +L + RH NI+ + L
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL---GAAKGIAYLHHDCSP 798
+ ++V+EY G+L Q +++ + EL +IA KG+AYLH
Sbjct: 71 RRDKLWIVMEYCGGGSL-QDIYQVTRGPLSEL------QIAYVCRETLKGLAYLHET--- 120
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELA---YT 855
IHRDIK +NILL ED + K+ADFGV+ A+ + ++ F GT ++APE+A
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVS--AQLTATIAKRKSFIGTPYWMAPEVAAVERK 178
Query: 856 CKVSEKSDVFSFGVVLLELVTGRKP 880
K D+++ G+ +EL + P
Sbjct: 179 GGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 63/209 (30%), Positives = 101/209 (48%), Gaps = 33/209 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIRHRNILKLYAC 739
+G G G VY+ KK VA+K++ + +G+ A E+ +L +++H NI+KL
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDV 66
Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP 799
+ +LV EY +L + L KR G + + L +G+AY H
Sbjct: 67 IHTERKLYLVFEYCDM-DLKKYLDKR--PGPLSPNLIKSIMYQL--LRGLAYCHSHR--- 118
Query: 800 IIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHG-----YIAPEL-- 852
I+HRD+K NIL++ D K+ADFG+A+ + Y TH Y APE+
Sbjct: 119 ILHRDLKPQNILINRDGVLKLADFGLARAF--GIPLRTY-----THEVVTLWYRAPEILL 171
Query: 853 ---AYTCKVSEKSDVFSFGVVLLELVTGR 878
Y+ V D++S G + E++TG+
Sbjct: 172 GSKHYSTAV----DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 73/237 (30%), Positives = 125/237 (52%), Gaps = 33/237 (13%)
Query: 683 LIGSGGTGKVYRLDLK---KNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRHRNILKL 736
+IG+G G+V+R LK + VA+K L G K F +E I+G+ H NI++L
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
+ K + ++ EYM NG AL K +++ E ++ + G A G+ YL
Sbjct: 72 EGVVTKFKPAMIITEYMENG----ALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL---S 124
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHG--YIAPELAY 854
+HRD+ + NIL++ + E K++DFG++++ E+ P+ + Y+ G + APE
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGT-YTTSGGKIPIRWTAPEAIA 183
Query: 855 TCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLD 910
K + SDV+SFG+V+ E+++ G +P YW ++NHE V+K ++
Sbjct: 184 YRKFTSASDVWSFGIVMWEVMSFGERP------------YW---DMSNHE-VMKAIN 224
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 65/201 (32%), Positives = 106/201 (52%), Gaps = 18/201 (8%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV--FAAEMEILGKIRHRNILKLYAC 739
+ +G G G+VY KK + TVAVK L K D ++V F E ++ +I+H N+++L
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP 799
+ +++ E+M GNL L + + E++ +A + + YL
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLR---ECNRQEVNAVVLLYMATQISSAMEYLE---KKN 124
Query: 800 IIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTH---GYIAPE-LAYT 855
IHRD+ + N L+ E++ K+ADFG++++ Y+ AG + APE LAY
Sbjct: 125 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIKWTAPESLAYN 180
Query: 856 CKVSEKSDVFSFGVVLLELVT 876
K S KSDV++FGV+L E+ T
Sbjct: 181 -KFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 71/210 (33%), Positives = 101/210 (48%), Gaps = 25/210 (11%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL----WKGDGVKVFAAEMEILGKIRHRNILKLYAC 739
IG G T VY N VA+K++ + V E++ + + H N++K Y
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTS-VDELRKEVQAMSQCNHPNVVKYYTS 67
Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP 799
+ G +LV+ Y+ G+L + G LD + KG+ YLH S
Sbjct: 68 FVVGDELWLVMPYLSGGSLLDIMKSSYPRGG--LDEAIIATVLKEVLKGLEYLH---SNG 122
Query: 800 IIHRDIKSSNILLDEDYEPKIADFGV-AKIAEN---SPKVSDYSCFAGTHGYIAPEL--- 852
IHRDIK+ NILL ED KIADFGV A +A+ + KV F GT ++APE+
Sbjct: 123 QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVR--KTFVGTPCWMAPEVMEQ 180
Query: 853 --AYTCKVSEKSDVFSFGVVLLELVTGRKP 880
Y K+D++SFG+ +EL TG P
Sbjct: 181 VHGYD----FKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 4e-23
Identities = 70/215 (32%), Positives = 104/215 (48%), Gaps = 25/215 (11%)
Query: 673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQ--LWKG-DGVKVFAAEMEILGKIR 729
E LE IG G G+VY+ K+ VA+K L + D ++ E++ L + R
Sbjct: 1 ELFTLLEC---IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCR 57
Query: 730 HRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIA---LGAA 786
I K Y LKG ++++EY G+ L K GK IA
Sbjct: 58 SPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL----KPGK-----LDETYIAFILREVL 108
Query: 787 KGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA-KIAENSPKVSDYSCFAGTH 845
G+ YLH + IHRDIK++NILL E+ + K+ADFGV+ ++ K + F GT
Sbjct: 109 LGLEYLHEEGK---IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT---FVGTP 162
Query: 846 GYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKP 880
++APE+ EK+D++S G+ +EL G P
Sbjct: 163 FWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 71/219 (32%), Positives = 105/219 (47%), Gaps = 29/219 (13%)
Query: 684 IGSGGTGKVYR-----LDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILK 735
+G G GKV+ L+ + + VAVK L + D K F E E+L +H NI+K
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQAL--HKR-----VKEGKP--ELDWFRRYKIALGAA 786
Y +G +V EYM +G+L + L H P EL + +IA+ A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 787 KGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTH- 845
G+ YL S +HRD+ + N L+ D KI DFG+++ +DY G
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR----DVYTTDYYRVGGHTM 185
Query: 846 ---GYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKP 880
++ PE K + +SDV+SFGVVL E+ T G++P
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 8e-23
Identities = 61/200 (30%), Positives = 102/200 (51%), Gaps = 15/200 (7%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFA-AEMEILGKIRHRNILKLYAC 739
IG G G VY+ K VA+K++ +G+ A E+++L ++ H NI+KL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP 799
G +LV E+M + +L++ + R + L Y++ +G+A+ H S
Sbjct: 67 FRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLL----QGLAFCH---SHG 118
Query: 800 IIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKV- 858
I+HRD+K N+L++ + K+ADFG+A+ V Y+ + T Y APEL K
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSF--GSPVRPYTHYVVTRWYRAPELLLGDKGY 176
Query: 859 SEKSDVFSFGVVLLELVTGR 878
S D++S G + EL++ R
Sbjct: 177 STPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 71/217 (32%), Positives = 99/217 (45%), Gaps = 31/217 (14%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVK-QLWKGDGVKVFAAEMEILGKI-RHRNILKLYACL 740
+IG G GKVY+ KK VA+K D + E IL K H NI Y
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 741 LKGGSS------FLVLEYMPNG---NLFQALHKRVKEGKPELDWFRRYKIAL---GAAKG 788
+K +LV+E G +L + L K+ K K E IA +G
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW-------IAYILRETLRG 125
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
+AYLH +IHRDIK NILL ++ E K+ DFGV+ A+ + + F GT ++
Sbjct: 126 LAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVS--AQLDSTLGRRNTFIGTPYWM 180
Query: 849 APEL-----AYTCKVSEKSDVFSFGVVLLELVTGRKP 880
APE+ +SDV+S G+ +EL G+ P
Sbjct: 181 APEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 1e-22
Identities = 65/202 (32%), Positives = 113/202 (55%), Gaps = 17/202 (8%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLK 742
+G+G G+V+ + VA+K L +G + F AE ++ +++H +++LYA + +
Sbjct: 14 LGAGQFGEVW-MGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ 72
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIH 802
+++ EYM NG+L L + EG +L + +A A+G+A++ IH
Sbjct: 73 E-PIYIITEYMENGSLVDFL--KTPEGI-KLTINKLIDMAAQIAEGMAFIERKNY---IH 125
Query: 803 RDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTH---GYIAPELAYTCKVS 859
RD++++NIL+ E KIADFG+A++ E+ ++Y+ G + APE +
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLIED----NEYTAREGAKFPIKWTAPEAINYGTFT 181
Query: 860 EKSDVFSFGVVLLELVT-GRKP 880
KSDV+SFG++L E+VT GR P
Sbjct: 182 IKSDVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 3e-22
Identities = 75/287 (26%), Positives = 128/287 (44%), Gaps = 60/287 (20%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVK--QLWKGDGVKVFAAEMEILGKIRHRNILKLYACLL 741
+G G GKVY+ K+ A K Q+ + ++ F E++IL + +H NI+ LY
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 742 KGGSSFLVLEYMPNG---NLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
++++E+ G ++ L + + E P++ + R + + + +LH S
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTE--PQIRYVCRQML-----EALNFLH---SH 122
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL------ 852
+IHRD+K+ NILL D + K+ADFGV+ A+N + F GT ++APE+
Sbjct: 123 KVIHRDLKAGNILLTLDGDVKLADFGVS--AKNKSTLQKRDTFIGTPYWMAPEVVACETF 180
Query: 853 ---AYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVL 909
Y K+D++S G+ L+EL P ++ N ++VL
Sbjct: 181 KDNPYDY----KADIWSLGITLIELAQMEPP-------------------HHELNPMRVL 217
Query: 910 DCEVASESIK--------EDMIKLLKIAVVCTTKLPNLRPPMREVVK 948
+ SE LK +V K P+ RP E++K
Sbjct: 218 LKILKSEPPTLDQPSKWSSSFNDFLKSCLV---KDPDDRPTAAELLK 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 3e-22
Identities = 66/216 (30%), Positives = 104/216 (48%), Gaps = 23/216 (10%)
Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKI 728
ID ++ L+E +GSG G V L + VA+K + +G F E +++ K+
Sbjct: 1 IDPSELTFLKE---LGSGQFGVV-HLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKL 56
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
H N+++LY K F+V EYM NG L L +R + E + +
Sbjct: 57 SHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEW----LLDMCSDVCEA 112
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSD--YSCFAGTHG 846
+ YL + IHRD+ + N L+ ED K++DFG+A+ V D Y+ GT
Sbjct: 113 MEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARY------VLDDQYTSSQGTKF 163
Query: 847 YI---APELAYTCKVSEKSDVFSFGVVLLELVTGRK 879
+ PE+ + S KSDV+SFGV++ E+ + K
Sbjct: 164 PVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 6e-22
Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 20/203 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLW---KGDGV-KVFAAEMEILGKIRHRNILKLYAC 739
IG G G V++ ++ TVA+K++ G+ E++ L +H ++KL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGK---PELDWFRRYKIALGAAKGIAYLHHDC 796
G LV+EYMP+ L + +++ + PE + Y L KG+AY+H
Sbjct: 68 FPHGSGFVLVMEYMPSD-----LSEVLRDEERPLPEAQ-VKSYMRML--LKGVAYMH--- 116
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTC 856
+ I+HRD+K +N+L+ D KIADFG+A++ + + YS T Y APEL Y
Sbjct: 117 ANGIMHRDLKPANLLISADGVLKIADFGLARLF-SEEEPRLYSHQVATRWYRAPELLYGA 175
Query: 857 -KVSEKSDVFSFGVVLLELVTGR 878
K D+++ G + EL+ G
Sbjct: 176 RKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 96.1 bits (240), Expect = 7e-22
Identities = 66/206 (32%), Positives = 100/206 (48%), Gaps = 24/206 (11%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKIRHRNILKLYA 738
+G GG G+V + +K T A+K + K + +E EIL + H I+KLY
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
++++EY G L+ L R + + R+ IA YLH+
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDE----YTARFYIA-CVVLAFEYLHNR--- 112
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL----AY 854
II+RD+K N+LLD + K+ DFG AK ++ K ++ F GT Y+APE+ Y
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKT--WT-FCGTPEYVAPEIILNKGY 169
Query: 855 TCKVSEKSDVFSFGVVLLELVTGRKP 880
V D +S G++L EL+TGR P
Sbjct: 170 DFSV----DYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 8e-22
Identities = 69/215 (32%), Positives = 99/215 (46%), Gaps = 25/215 (11%)
Query: 684 IGSGGTGKVYRLDLKKNAG-TVAVKQLWKGD-----GVKVFAAEMEILGKIRHRNILKLY 737
I G G+V+ L KK+ G A+K + K D V E +IL + + ++KLY
Sbjct: 1 ISKGAYGRVF-LAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY 59
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRY--KIALGAAKGIAYLHHD 795
+ +LV+EY+P G+L L G + D R Y +I L + YLH
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLEN---VGSLDEDVARIYIAEIVLA----LEYLH-- 110
Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI-----AENSPKVSDYSC-FAGTHGYIA 849
S IIHRD+K NIL+D + K+ DFG++K+ N GT YIA
Sbjct: 111 -SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIA 169
Query: 850 PELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEE 884
PE+ S+ D +S G +L E + G P E
Sbjct: 170 PEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGE 204
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 8e-22
Identities = 80/232 (34%), Positives = 115/232 (49%), Gaps = 53/232 (22%)
Query: 671 DAEQI-CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL----------WKGDGVKVFA 719
D E++ +L E IG G G VY + VA+K++ W+ D +K
Sbjct: 12 DPEKLFTDLRE---IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQ-DIIK--- 64
Query: 720 AEMEILGKIRHRNILKLYACLLKGGSSFLVLEY-MPNGNLFQALHKRVKEGKPELDWFRR 778
E+ L ++RH N ++ C L+ +++LV+EY + + + +HK KP +
Sbjct: 65 -EVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHK-----KP----LQE 114
Query: 779 YKIA---LGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV 835
+IA GA +G+AYLH IHRDIK+ NILL E K+ADFG A + SP
Sbjct: 115 VEIAAICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLV--SPAN 169
Query: 836 SDYSCFAGTHGYIAPE--LA-----YTCKVSEKSDVFSFGVVLLELVTGRKP 880
S F GT ++APE LA Y KV DV+S G+ +EL RKP
Sbjct: 170 S----FVGTPYWMAPEVILAMDEGQYDGKV----DVWSLGITCIELAE-RKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 8e-22
Identities = 72/226 (31%), Positives = 108/226 (47%), Gaps = 37/226 (16%)
Query: 678 LEEDNLIGSGGTGKVYR-----LDLKKNAGTVAVKQLWKGDG----VKVFAAEMEILGKI 728
L +G G G+V + LD TVAVK L K D + +EME++ I
Sbjct: 14 LTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKML-KDDATEKDLSDLVSEMEMMKMI 72
Query: 729 -RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEG---KPELDWFRRYKI--- 781
+H+NI+ L + G ++V+EY +GNL L R G P+ +
Sbjct: 73 GKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQK 132
Query: 782 -----ALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK-IAENSPKV 835
A A+G+ +L S IHRD+ + N+L+ ED+ KIADFG+A+ I
Sbjct: 133 DLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHI---- 185
Query: 836 SDYSCFAGTHG-----YIAPELAYTCKVSEKSDVFSFGVVLLELVT 876
DY T+G ++APE + + +SDV+SFGV+L E+ T
Sbjct: 186 -DYY-RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 67/216 (31%), Positives = 103/216 (47%), Gaps = 27/216 (12%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG-------VKVFAAEMEILGKIRHRNILK 735
L+GSG G VY + AVK++ D VK E+ +L K++H NI++
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAA---KGIAYL 792
+ + ++ LE +P G+L + L K F I L G+ YL
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKK--------YGSFPEPVIRLYTRQILLGLEYL 118
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK-IAENSPKVSDYSCFAGTHGYIAPE 851
H +HRDIK +NIL+D + K+ADFG+AK + E S S F G+ ++APE
Sbjct: 119 H---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS----FKGSPYWMAPE 171
Query: 852 -LAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYG 886
+A +D++S G +LE+ TG+ P + G
Sbjct: 172 VIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG 207
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 1e-21
Identities = 67/213 (31%), Positives = 109/213 (51%), Gaps = 24/213 (11%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTV-AVKQL------------WKGDGVKVFAAEMEILGKIR 729
LIG G G+VY L L G + AVKQ+ + D VK +E+E L +
Sbjct: 8 LIGKGTYGRVY-LALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 730 HRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGI 789
H NI++ + LEY+P G++ L + + + +F + +G+
Sbjct: 67 HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL-----EGL 121
Query: 790 AYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIA 849
AYLH S I+HRD+K+ N+L+D D KI+DFG++K +++ G+ ++A
Sbjct: 122 AYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMA 178
Query: 850 PEL--AYTCKVSEKSDVFSFGVVLLELVTGRKP 880
PE+ +Y+ S K D++S G V+LE+ GR+P
Sbjct: 179 PEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 1e-21
Identities = 77/291 (26%), Positives = 129/291 (44%), Gaps = 35/291 (12%)
Query: 669 DIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV---FAAEMEIL 725
D+ E + + + +G+G G V ++ +A K + G V E++I+
Sbjct: 1 DLRNEDLETISD---LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIM 57
Query: 726 GKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGA 785
+ R I+ Y L + + +E+M G+L ++K+ E+ KIA+
Sbjct: 58 HECRSPYIVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEI----LGKIAVAV 112
Query: 786 AKGIAYL---HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFA 842
+G+ YL H I+HRDIK SNIL++ + K+ DFGV+ NS ++D F
Sbjct: 113 VEGLTYLYNVHR-----IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--IAD--TFV 163
Query: 843 GTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNH 902
GT Y++PE K + KSDV+S G+ ++EL G+ P D +
Sbjct: 164 GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMG------ 217
Query: 903 ENVLKVLDCEVASESIK---EDMIKLLKIAV-VCTTKLPNLRPPMREVVKM 949
+L +L V + D + L+ V C K P RP +++ M
Sbjct: 218 --ILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 4e-21
Identities = 67/210 (31%), Positives = 110/210 (52%), Gaps = 25/210 (11%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEME-------ILGKIRHRNILKL 736
IG G GK+Y K ++ +K++ D K+ E E +L K++H NI+
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEI---DLTKMPVKEKEASKKEVILLAKMKHPNIVTF 64
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKR---VKEGKPELDWFRRYKIALGAAKGIAYLH 793
+A + G F+V+EY G+L + ++++ + L WF +I+LG L
Sbjct: 65 FASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWF--VQISLG-------LK 115
Query: 794 HDCSPPIIHRDIKSSNILLDED-YEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL 852
H I+HRDIKS NI L ++ K+ DFG+A+ +S +++ Y+C GT Y++PE+
Sbjct: 116 HIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA-YTC-VGTPYYLSPEI 173
Query: 853 AYTCKVSEKSDVFSFGVVLLELVTGRKPVE 882
+ K+D++S G VL EL T + P E
Sbjct: 174 CQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 5e-21
Identities = 69/210 (32%), Positives = 102/210 (48%), Gaps = 42/210 (20%)
Query: 748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKS 807
LVL+Y G+L Q + R K + FR ++ L + + +HH S +IHRDIKS
Sbjct: 116 LVLDYANAGDLRQEIKSRAKTNRT----FREHEAGLLFIQVLLAVHHVHSKHMIHRDIKS 171
Query: 808 SNILLDEDYEPKIADFGVAKIAENSPKVSD--YSCFAGTHGYIAPELAYTCKVSEKSDVF 865
+NILL + K+ DFG +K+ + VSD F GT Y+APE+ S+K+D+F
Sbjct: 172 ANILLCSNGLVKLGDFGFSKMYAAT--VSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMF 229
Query: 866 SFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKL 925
S GV+L EL+T ++P DG E+++E M K
Sbjct: 230 SLGVLLYELLTLKRPF-----DG---------------------------ENMEEVMHKT 257
Query: 926 LKIAVVCTTKLPNLRPPMREVVKMLADADP 955
L A P++ P M+E+V L +DP
Sbjct: 258 L--AGRYDPLPPSISPEMQEIVTALLSSDP 285
|
Length = 496 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 5e-21
Identities = 78/219 (35%), Positives = 105/219 (47%), Gaps = 39/219 (17%)
Query: 678 LEEDNLIGSGGTGKV--YRLDLKKNAGT---VAVKQLWKGDGVKV---FAAEMEILGKIR 729
L++ ++G G GKV Y D N GT VAVK L + G + + E+ IL +
Sbjct: 6 LKKIRVLGEGHFGKVSLYCYD-PANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLY 64
Query: 730 HRNILKLYACLLKGG--SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAK 787
H NI+K C + G L++EY+P G+L L K K +L F A +
Sbjct: 65 HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLF-----AQQICE 118
Query: 788 GIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK----------IAENSPKVSD 837
G+AYLH S IHRD+ + N+LLD D KI DFG+AK + E+ D
Sbjct: 119 GMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED----GD 171
Query: 838 YSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT 876
F + A E K S SDV+SFGV L EL+T
Sbjct: 172 SPVF-----WYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 8e-21
Identities = 48/165 (29%), Positives = 84/165 (50%), Gaps = 14/165 (8%)
Query: 721 EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPE---LDWFR 777
E+ IL ++H NI+ Y + + + +EY G L+ + ++ + E L +
Sbjct: 49 EIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYL- 107
Query: 778 RYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSD 837
++I ++Y+H I+HRDIK+ NI L + K+ DFG++KI S
Sbjct: 108 -FQIV----SAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKIL-GSEYSMA 158
Query: 838 YSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVE 882
+ GT Y++PEL K + KSD+++ G VL EL+T ++ +
Sbjct: 159 ETV-VGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFD 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 9e-21
Identities = 64/198 (32%), Positives = 102/198 (51%), Gaps = 15/198 (7%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKG 743
IG G G V + + VAVK + + F E ++ K+ H+N+++L +L
Sbjct: 14 IGEGEFGAVLQGEYTGQ--KVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHN 71
Query: 744 GSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHR 803
G ++V+E M GNL L R G+ + + + +L A+G+ YL S ++HR
Sbjct: 72 GL-YIVMELMSKGNLVNFLRTR---GRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHR 124
Query: 804 DIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSD 863
D+ + NIL+ ED K++DFG+A++ D S + APE K S KSD
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARV---GSMGVDNSKLPVK--WTAPEALKHKKFSSKSD 179
Query: 864 VFSFGVVLLELVT-GRKP 880
V+S+GV+L E+ + GR P
Sbjct: 180 VWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 1e-20
Identities = 66/216 (30%), Positives = 104/216 (48%), Gaps = 20/216 (9%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL----WKGDGVKVFAAEMEILGKIRHRN 732
E+ ++G G G V+ K + V +KQ+ D E ++L + H N
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPE---LDWFRRYKIALGAAKGI 789
I++ Y L+ + +V+EY P G L + + KR E L +F + +A
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA------- 113
Query: 790 AYLHHDCSPPIIHRDIKSSNILLDEDYEP-KIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
LHH + I+HRD+K+ NILLD+ KI DFG++KI + K GT YI
Sbjct: 114 --LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA---YTVVGTPCYI 168
Query: 849 APELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEE 884
+PEL ++KSD+++ G VL EL + ++ E
Sbjct: 169 SPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-20
Identities = 63/207 (30%), Positives = 105/207 (50%), Gaps = 14/207 (6%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGT-VAVKQLWKGDGVKVFAAEMEILGKIRHRNILK 735
N++E L+ + G G+ + L G VAVK + + F AE ++ ++RH N+++
Sbjct: 4 NMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQ 63
Query: 736 LYACLLK-GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHH 794
L +++ G ++V EYM G+L L R G+ L K +L + + YL
Sbjct: 64 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLE- 119
Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAY 854
+ +HRD+ + N+L+ ED K++DFG+ K A ++ + APE
Sbjct: 120 --ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTAPEALR 172
Query: 855 TCKVSEKSDVFSFGVVLLELVT-GRKP 880
K S KSDV+SFG++L E+ + GR P
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 1e-20
Identities = 74/288 (25%), Positives = 122/288 (42%), Gaps = 38/288 (13%)
Query: 678 LEEDNLIGSGGTGKVY----RLDLKKNAGTVAVKQLWKGDGVKVFAA---EMEILGKIRH 730
LE+ ++GSG G VY + +K VA+K L + K E ++ + H
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDH 68
Query: 731 RNILKLYA-CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGI 789
++++L CL L+ + MP G L V+ K + + AKG+
Sbjct: 69 PHVVRLLGICL--SSQVQLITQLMPLGCLLD----YVRNHKDNIGSQYLLNWCVQIAKGM 122
Query: 790 AYL--HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTH-- 845
+YL ++HRD+ + N+L+ KI DFG+AK+ + +Y G
Sbjct: 123 SYLEEKR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLD--VDEKEYHAEGGKVPI 175
Query: 846 GYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHEN 904
++A E + KSDV+S+GV + EL+T G KP E +I L E
Sbjct: 176 KWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI--PAVEI----PDLLEKGER 229
Query: 905 VLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952
+ + C +I M+ L+K ++ P + + E KM D
Sbjct: 230 LPQPPIC-----TIDVYMV-LVKCWMIDAESRPTFKELINEFSKMARD 271
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 2e-20
Identities = 71/215 (33%), Positives = 115/215 (53%), Gaps = 22/215 (10%)
Query: 683 LIGSGGTGKVY--RLDLKKNAGTVAVKQLWKGDGVKV-----FAAEMEILGKIRHRNILK 735
++G G GKV+ R +AG + ++ K +KV E +IL ++ H I+K
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHD 795
L+ G +L+L+++ G+LF L K V + ++ F ++AL L H
Sbjct: 63 LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVK-FYLAELALA-------LDHL 114
Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYT 855
S II+RD+K NILLDE+ K+ DFG++K + + K + YS F GT Y+APE+
Sbjct: 115 HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA-YS-FCGTVEYMAPEVVNR 172
Query: 856 CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKD 890
++ +D +SFGV++ E++TG P + GKD
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTGSLPFQ-----GKD 202
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 2e-20
Identities = 65/208 (31%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 684 IGSGGTGKVYRLDLKKNAGT-VAVKQLWKGD-----GVKVFAAEMEILGKIRHR-NILKL 736
I G G VY L K++ G A+K L K D V AE I+ + KL
Sbjct: 4 ISKGAFGSVY-LAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL 62
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
Y +LV+EY+ G+ +L K + G DW ++Y + G+ LH
Sbjct: 63 YYSFQSKDYLYLVMEYLNGGDC-ASLIKTL--GGLPEDWAKQYIAEV--VLGVEDLHQR- 116
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTC 856
IIHRDIK N+L+D+ K+ DFG+++ + K F GT Y+APE
Sbjct: 117 --GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK------FVGTPDYLAPETILGV 168
Query: 857 KVSEKSDVFSFGVVLLELVTGRKPVEEE 884
+ SD +S G V+ E + G P E
Sbjct: 169 GDDKMSDWWSLGCVIFEFLFGYPPFHAE 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 2e-20
Identities = 70/278 (25%), Positives = 126/278 (45%), Gaps = 33/278 (11%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQL-----WKGDGVKVFAA---EMEILGKIRHRNIL 734
+G+G Y+ K +AVKQ+ + +V A E+ ++ ++ H +I+
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHH 794
++ + L +E+M G++ L K G + Y L +G++YLH
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKY---GAFKEAVIINYTEQL--LRGLSYLHE 121
Query: 795 DCSPPIIHRDIKSSNILLDED-YEPKIADFGVA-KIAENSPKVSDYSC-FAGTHGYIAPE 851
+ IIHRD+K +N+L+D +IADFG A ++A ++ GT ++APE
Sbjct: 122 N---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178
Query: 852 LAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDC 911
+ + DV+S G V++E+ T + P W + +NH ++ +
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAKPP-------------WNAEKHSNHLALIFKIAS 225
Query: 912 EVASESIKEDMIKLLK-IAVVCTTKLPNLRPPMREVVK 948
+ SI E + L+ + + C P RPP RE++K
Sbjct: 226 ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 3e-20
Identities = 66/206 (32%), Positives = 98/206 (47%), Gaps = 20/206 (9%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAAEMEILGKIRH---RNILKL 736
LIG G G VYR VA+K + D V E+ +L ++R NI K
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
Y LKG ++++EY G++ + K R +AL Y+H
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVAL------KYIHKV- 120
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGV-AKIAENSPKVSDYSCFAGTHGYIAPELAYT 855
+IHRDIK++NIL+ K+ DFGV A + +NS K S F GT ++APE+
Sbjct: 121 --GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK---RSTFVGTPYWMAPEVITE 175
Query: 856 CKVSE-KSDVFSFGVVLLELVTGRKP 880
K + K+D++S G+ + E+ TG P
Sbjct: 176 GKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 79/303 (26%), Positives = 125/303 (41%), Gaps = 59/303 (19%)
Query: 677 NLEEDNLIGSGGTGKVYR---LDLKKNA--GTVAVKQLWKGDGVK---VFAAEMEILGKI 728
+ +G G G VY + K VA+K + + ++ F E ++ +
Sbjct: 7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEF 66
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKE-----GKPELDWFRRYKIAL 783
++++L + G + +V+E M G+L L R E G + ++A
Sbjct: 67 NCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAA 126
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK-IAENSPKVSDYSCFA 842
A G+AYL + +HRD+ + N ++ ED KI DFG+ + I E +DY
Sbjct: 127 EIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYE-----TDYYRKG 178
Query: 843 GTH----GYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKP--------VEEEYGDGK 889
G ++APE + KSDV+SFGVVL E+ T +P V + DG
Sbjct: 179 GKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGG 238
Query: 890 DIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949
HL+ EN C KLL++ +C P +RP E+V
Sbjct: 239 --------HLDLPEN------CPD----------KLLELMRMCWQYNPKMRPTFLEIVSS 274
Query: 950 LAD 952
L D
Sbjct: 275 LKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 4e-20
Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 16/212 (7%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-------DGVKVFAAEMEILGKIR 729
N L+G G G+VY +AVKQ+ V E+++L ++
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 730 HRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGI 789
H I++ Y CL + + +EYMP G ++ ++K + R K +G+
Sbjct: 63 HERIVQYYGCLRDDETLSIFMEYMPGG----SVKDQLKAYGALTETVTR-KYTRQILEGV 117
Query: 790 AYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK-IAENSPKVSDYSCFAGTHGYI 848
YLH S I+HRDIK +NIL D K+ DFG +K + + GT ++
Sbjct: 118 EYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWM 174
Query: 849 APELAYTCKVSEKSDVFSFGVVLLELVTGRKP 880
+PE+ K+DV+S G ++E++T + P
Sbjct: 175 SPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 4e-20
Identities = 66/202 (32%), Positives = 111/202 (54%), Gaps = 16/202 (7%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLK 742
+G+G G+V+ + N+ VAVK L G V+ F E ++ ++H +++LYA + K
Sbjct: 14 LGAGQFGEVW-MGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIH 802
+++ EYM G+L L K + GK L + + A+G+AY+ IH
Sbjct: 73 EEPIYIITEYMAKGSLLDFL-KSDEGGKVLLP--KLIDFSAQIAEGMAYIERK---NYIH 126
Query: 803 RDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTH---GYIAPELAYTCKVS 859
RD++++N+L+ E KIADFG+A++ E+ ++Y+ G + APE +
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIED----NEYTAREGAKFPIKWTAPEAINFGSFT 182
Query: 860 EKSDVFSFGVVLLELVT-GRKP 880
KSDV+SFG++L E+VT G+ P
Sbjct: 183 IKSDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 6e-20
Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 41/221 (18%)
Query: 679 EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG------DGVKVFAA--EMEILGKIRH 730
E+ +G G VY+ K+ VA+K++ G DG+ F A E+++L +++H
Sbjct: 3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGIN-FTALREIKLLQELKH 61
Query: 731 RNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAA---- 786
NI+ L + LV E+M +L + + + I L A
Sbjct: 62 PNIIGLLDVFGHKSNINLVFEFME-TDL-EKV-------------IKDKSIVLTPADIKS 106
Query: 787 ------KGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSC 840
+G+ YLH + I+HRD+K +N+L+ D K+ADFG+A+ + + +
Sbjct: 107 YMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK--MTH 161
Query: 841 FAGTHGYIAPELAYTCKV-SEKSDVFSFGVVLLELVTGRKP 880
T Y APEL + + D++S G + EL+ R P
Sbjct: 162 QVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLL-RVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 7e-20
Identities = 61/215 (28%), Positives = 102/215 (47%), Gaps = 21/215 (9%)
Query: 679 EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGV----KVFAAEMEILGKIRHRNIL 734
E IG G G V ++ K + + K++ G+ + +E+ IL +++H NI+
Sbjct: 3 EVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV 62
Query: 735 KLYACLLKGGSS--FLVLEYMPNGNLFQALHKRVKEGK--PE---LDWFRRYKIALGAAK 787
+ Y ++ + ++V+EY G+L Q + K KE K E + +AL
Sbjct: 63 RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLAL---- 118
Query: 788 GIAYLHH--DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTH 845
H+ D ++HRD+K +NI LD + K+ DFG+AKI + S + GT
Sbjct: 119 --YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD--SSFAKTYVGTP 174
Query: 846 GYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKP 880
Y++PE EKSD++S G ++ EL P
Sbjct: 175 YYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 8e-20
Identities = 84/293 (28%), Positives = 127/293 (43%), Gaps = 44/293 (15%)
Query: 669 DIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG---VKVFAAEMEIL 725
D + NL E IGSG G+VY++ KK +AVKQ+ + K +++++
Sbjct: 11 PADLNDLENLGE---IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVV 67
Query: 726 GKIRHR--NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL 783
K H I+K Y + F+ +E M L KR++ PE K+ +
Sbjct: 68 LK-SHDCPYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPE---DILGKMTV 121
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAG 843
K + YL +IHRD+K SNILLD K+ DFG++ +S K S AG
Sbjct: 122 AIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS-KAKTRS--AG 176
Query: 844 THGYIAPEL----AYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHL 899
Y+APE K ++DV+S G+ L+EL TG+ P + +
Sbjct: 177 CAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE------------ 224
Query: 900 NNHENVLKVLDCEVAS----ESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVK 948
E + K+L E S E D + + C TK RP RE+++
Sbjct: 225 --FEVLTKILQEEPPSLPPNEGFSPDFCSFVDL---CLTKDHRKRPKYRELLQ 272
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 9e-20
Identities = 65/203 (32%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVK----QLWKGDGVKVFAAEMEILGKIRHRNILKLYA 738
IG G G VY+ LK N VAVK L K F E EIL + H NI+KL
Sbjct: 2 KIGKGNFGDVYKGVLKGN-TEVAVKTCRSTLPPDLKRK-FLQEAEILKQYDHPNIVKLIG 59
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
++ ++V+E +P G+L L K+ K L + +++L AA G+ YL
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKK----KNRLTVKKLLQMSLDAAAGMEYLESKNC- 114
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTH----GYIAPELAY 854
IHRD+ + N L+ E+ KI+DFG+++ E Y+ G + APE
Sbjct: 115 --IHRDLAARNCLVGENNVLKISDFGMSREEEG----GIYTVSDGLKQIPIKWTAPEALN 168
Query: 855 TCKVSEKSDVFSFGVVLLELVTG 877
+ + +SDV+S+G++L E +
Sbjct: 169 YGRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 9e-20
Identities = 74/215 (34%), Positives = 101/215 (46%), Gaps = 26/215 (12%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILG-KIRHRNILKL 736
++G G GKV+ +LK A+K L K D V+ E +L H + L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 737 YACLLKGGSSFLVLEYMPNGNLF---QALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
Y + F V+EY+ G+L Q+ HK D R A G+ +LH
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQSCHK--------FDLPRATFYAAEIICGLQFLH 113
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELA 853
S I++RD+K NILLD D KIADFG+ K EN + F GT YIAPE+
Sbjct: 114 ---SKGIVYRDLKLDNILLDTDGHIKIADFGMCK--ENMLGDAKTCTFCGTPDYIAPEIL 168
Query: 854 YTCKVSEKSDVFSFGVVLLELVTGRKPV----EEE 884
K + D +SFGV+L E++ G+ P EEE
Sbjct: 169 LGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 73/206 (35%), Positives = 112/206 (54%), Gaps = 25/206 (12%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLK 742
+G+G G+V+ N VAVK L G + F E +I+ K+RH +++LYA ++
Sbjct: 14 LGNGQFGEVWMGTWNGNT-KVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYA-VVS 71
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGK----PELDWFRRYKIALGAAKGIAYLHHDCSP 798
++V EYM G+L L + EG+ P L +A A G+AY+
Sbjct: 72 EEPIYIVTEYMSKGSLLDFL--KDGEGRALKLPNL-----VDMAAQVAAGMAYIER---M 121
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTH---GYIAPELAYT 855
IHRD++S+NIL+ + KIADFG+A++ E+ ++Y+ G + APE A
Sbjct: 122 NYIHRDLRSANILVGDGLVCKIADFGLARLIED----NEYTARQGAKFPIKWTAPEAALY 177
Query: 856 CKVSEKSDVFSFGVVLLELVT-GRKP 880
+ + KSDV+SFG++L ELVT GR P
Sbjct: 178 GRFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 1e-19
Identities = 63/207 (30%), Positives = 100/207 (48%), Gaps = 29/207 (14%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL------WKGDGVKVFAAEMEILGKI-RHRNILKL 736
+G G G VY K+ VA+K++ W+ + + + E++ L K+ H NI+KL
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNL--REVKSLRKLNEHPNIVKL 63
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
+ + V EYM GNL+Q + R +GKP I +G+A++H
Sbjct: 64 KEVFRENDELYFVFEYM-EGNLYQLMKDR--KGKP-FSESVIRSIIYQILQGLAHIHKH- 118
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL---- 852
HRD+K N+L+ KIADFG+A+ + P +DY T Y APE+
Sbjct: 119 --GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDY---VSTRWYRAPEILLRS 173
Query: 853 -AYTCKVSEKSDVFSFGVVLLELVTGR 878
+Y+ V D+++ G ++ EL T R
Sbjct: 174 TSYSSPV----DIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 1e-19
Identities = 70/214 (32%), Positives = 101/214 (47%), Gaps = 22/214 (10%)
Query: 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKV-FAAEMEILGKIRHR 731
+ LE N IGSG G VY++ + A+K ++ D V+ E+EIL + H
Sbjct: 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHP 132
Query: 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAY 791
N++K + G ++LE+M G+L EG D +A GIAY
Sbjct: 133 NVVKCHDMFDHNGEIQVLLEFMDGGSL---------EGTHIADEQFLADVARQILSGIAY 183
Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPE 851
LH I+HRDIK SN+L++ KIADFGV++I + + S GT Y++PE
Sbjct: 184 LH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS--VGTIAYMSPE 238
Query: 852 LAYTCKVSEK-----SDVFSFGVVLLELVTGRKP 880
T D++S GV +LE GR P
Sbjct: 239 RINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 3e-19
Identities = 70/219 (31%), Positives = 104/219 (47%), Gaps = 23/219 (10%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKI-RHRNILKL 736
++G G GKV +LK AVK L K D V+ E +L +H + +L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHK--RVKEGKPELDWFRRYKIALGAAKGIAYLHH 794
++C F V+EY+ G+L + + R E + F +I LG + +LH
Sbjct: 62 HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRAR---FYAAEIVLG----LQFLH- 113
Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAY 854
II+RD+K N+LLD + KIADFG+ K E S F GT YIAPE+
Sbjct: 114 --ERGIIYRDLKLDNVLLDSEGHIKIADFGMCK--EGILGGVTTSTFCGTPDYIAPEILS 169
Query: 855 TCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVY 893
D ++ GV+L E++ G+ P E GD +D ++
Sbjct: 170 YQPYGPAVDWWALGVLLYEMLAGQSPFE---GDDEDELF 205
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 89.5 bits (223), Expect = 4e-19
Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 26/211 (12%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLY 737
IGSG G V K+ VA+K++ + A E+++L +RH NI+ L
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLL 65
Query: 738 ACLL-KGGSSF----LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
L F +V E M LHK +K +P D +Y +G+ YL
Sbjct: 66 DILRPPSPEDFNDVYIVTELMETD-----LHKVIKSPQPLTDDHIQY-FLYQILRGLKYL 119
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK----VSDYSCFAGTHGYI 848
H S +IHRD+K SNIL++ + + KI DFG+A+ + +++Y T Y
Sbjct: 120 H---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV---TRWYR 173
Query: 849 APELAYTCKVSEKS-DVFSFGVVLLELVTGR 878
APEL + K+ D++S G + EL+T +
Sbjct: 174 APELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 4e-19
Identities = 83/299 (27%), Positives = 138/299 (46%), Gaps = 54/299 (18%)
Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLK---KNAGTVAVKQLWKGDGVKV---FAAEME 723
IDA I + + +IG+G G+V LK K VA+K L G K F +E
Sbjct: 1 IDASCI---KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEAS 57
Query: 724 ILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL 783
I+G+ H NI+ L + K +V EYM NG+L L K + + +
Sbjct: 58 IMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKH----DGQFTVIQLVGMLR 113
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAG 843
G A G+ YL D +HRD+ + NIL++ + K++DFG++++ E+ P+ + Y+ G
Sbjct: 114 GIASGMKYL-SDMG--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA-YTTRGG 169
Query: 844 THG--YIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLN 900
+ APE K + SDV+S+G+V+ E+++ G +P YW ++
Sbjct: 170 KIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP------------YW---EMS 214
Query: 901 NHENVLKV---------LDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950
N + + + +DC A L ++ + C K N RP ++V +L
Sbjct: 215 NQDVIKAIEEGYRLPAPMDCPAA----------LHQLMLDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 5e-19
Identities = 70/221 (31%), Positives = 104/221 (47%), Gaps = 25/221 (11%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILG-KIRHRNILKL 736
++G G GKV +LK A+K L K D V+ E +L H + L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAK---GIAYLH 793
+ F V+EY+ G+L + + F + AA+ G+ +LH
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR--------FDEARARFYAAEIICGLQFLH 113
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELA 853
II+RD+K N+LLD+D KIADFG+ K EN S F GT YIAPE+
Sbjct: 114 ---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCK--ENMNGEGKASTFCGTPDYIAPEIL 168
Query: 854 YTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYW 894
K +E D +SFGV+L E++ G+ P +G+ +D ++
Sbjct: 169 KGQKYNESVDWWSFGVLLYEMLIGQSPF---HGEDEDELFD 206
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 5e-19
Identities = 70/223 (31%), Positives = 98/223 (43%), Gaps = 37/223 (16%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAE--------MEILGKIRHRNILK 735
+G G GKV + KK A+K L KGD + E E RH ++
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAK---GIAYL 792
L+AC V+EY G+L +H V F + AA G+ YL
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHIHTDV---------FSEPRAVFYAACVVLGLQYL 117
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL 852
H + I++RD+K N+LLD + KIADFG+ K E S F GT ++APE+
Sbjct: 118 HEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK--EGMGFGDRTSTFCGTPEFLAPEV 172
Query: 853 ----AYTCKVSEKSDVFSFGVVLLELVTGRKPV----EEEYGD 887
+YT V D + GV++ E++ G P EEE D
Sbjct: 173 LTETSYTRAV----DWWGLGVLIYEMLVGESPFPGDDEEEVFD 211
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 5e-19
Identities = 71/210 (33%), Positives = 115/210 (54%), Gaps = 19/210 (9%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGV-KVFAAEMEILGKIRHRNILK 735
+L D +G G G+V+ + VA+K L G + + F E +I+ K+RH ++
Sbjct: 7 SLRLDVKLGQGCFGEVW-MGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVP 65
Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPE-LDWFRRYKIALGAAKGIAYLHH 794
LYA ++ ++V E+M G+L L KEG + L + +A A G+AY+
Sbjct: 66 LYA-VVSEEPIYIVTEFMGKGSLLDFL----KEGDGKYLKLPQLVDMAAQIADGMAYIER 120
Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTH---GYIAPE 851
IHRD++++NIL+ ++ KIADFG+A++ E+ ++Y+ G + APE
Sbjct: 121 ---MNYIHRDLRAANILVGDNLVCKIADFGLARLIED----NEYTARQGAKFPIKWTAPE 173
Query: 852 LAYTCKVSEKSDVFSFGVVLLELVT-GRKP 880
A + + KSDV+SFG++L ELVT GR P
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 6e-19
Identities = 73/211 (34%), Positives = 106/211 (50%), Gaps = 35/211 (16%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL----------WKGDGVKVFAAEMEILGKIRHRNI 733
IG G G VY VAVK++ W+ D +K E++ L +++H N
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQ-DIIK----EVKFLQQLKHPNT 83
Query: 734 LKLYACLLKGGSSFLVLEY-MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
++ C LK +++LV+EY + + + +HK KP L I GA +G+AYL
Sbjct: 84 IEYKGCYLKEHTAWLVMEYCLGSASDLLEVHK-----KP-LQEVEIAAITHGALQGLAYL 137
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL 852
H +IHRDIK+ NILL E + K+ADFG A + SP S F GT ++APE+
Sbjct: 138 HSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKS--SPANS----FVGTPYWMAPEV 188
Query: 853 AYTCKVSE---KSDVFSFGVVLLELVTGRKP 880
+ K DV+S G+ +EL RKP
Sbjct: 189 ILAMDEGQYDGKVDVWSLGITCIELAE-RKP 218
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 7e-19
Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 15/204 (7%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQ--LWKGDGVKVFAAEMEILGKIRHRNILKLYACLL 741
IG G TG V +K + VAVK+ L K ++ E+ I+ +H N++++Y L
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 742 KGGSSFLVLEYMPNGNLFQAL-HKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
G ++V+E++ G L + H R+ E + + L K ++ LH + +
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-------AVCLAVLKALSVLH---AQGV 137
Query: 801 IHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSE 860
IHRDIKS +ILL D K++DFG A+ S +V GT ++APEL
Sbjct: 138 IHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMAPELISRLPYGP 195
Query: 861 KSDVFSFGVVLLELVTGRKPVEEE 884
+ D++S G++++E+V G P E
Sbjct: 196 EVDIWSLGIMVIEMVDGEPPYFNE 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 8e-19
Identities = 54/175 (30%), Positives = 97/175 (55%), Gaps = 16/175 (9%)
Query: 721 EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPE---LDWFR 777
E+ +L ++H NI++ + G+ ++V++Y G+L++ ++ + PE LDWF
Sbjct: 49 EVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWF- 107
Query: 778 RYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSD 837
+I L L H I+HRDIKS NI L +D K+ DFG+A++ ++ +++
Sbjct: 108 -VQICLA-------LKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR 159
Query: 838 YSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIV 892
+C GT Y++PE+ + KSD+++ G VL E+ T + E G+ K++V
Sbjct: 160 -TCI-GTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA--GNMKNLV 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 8e-19
Identities = 73/213 (34%), Positives = 102/213 (47%), Gaps = 34/213 (15%)
Query: 682 NLIGSGGTGKVYR---LDLKKNAGTVAVKQLWK---GDGVKVFAAEMEILGKIRHRNILK 735
+IG G G VY +D AVK L + + V+ F E I+ H N+L
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 736 LYA-CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKP---ELDWFRRYKIALGAAKGIAY 791
L CL GS +VL YM +G+L + R + P +L F L AKG+ Y
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFI--RSETHNPTVKDLIGF-----GLQVAKGMEY 113
Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSD---YSCFAGTHG-- 846
L S +HRD+ + N +LDE + K+ADFG+A+ + D YS T
Sbjct: 114 L---ASKKFVHRDLAARNCMLDESFTVKVADFGLAR------DIYDKEYYSVHNHTGAKL 164
Query: 847 ---YIAPELAYTCKVSEKSDVFSFGVVLLELVT 876
++A E T K + KSDV+SFGV+L EL+T
Sbjct: 165 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 8e-19
Identities = 67/206 (32%), Positives = 111/206 (53%), Gaps = 25/206 (12%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLK 742
+G G G+V+ VA+K L G + F E +++ K+RH +++LYA ++
Sbjct: 14 LGQGCFGEVWM-GTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 71
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGK----PELDWFRRYKIALGAAKGIAYLHHDCSP 798
++V EYM G+L L + + GK P+L +A A G+AY+
Sbjct: 72 EEPIYIVTEYMSKGSLLDFL--KGEMGKYLRLPQL-----VDMAAQIASGMAYVER---M 121
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTH---GYIAPELAYT 855
+HRD++++NIL+ E+ K+ADFG+A++ E+ ++Y+ G + APE A
Sbjct: 122 NYVHRDLRAANILVGENLVCKVADFGLARLIED----NEYTARQGAKFPIKWTAPEAALY 177
Query: 856 CKVSEKSDVFSFGVVLLELVT-GRKP 880
+ + KSDV+SFG++L EL T GR P
Sbjct: 178 GRFTIKSDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 8e-19
Identities = 62/208 (29%), Positives = 107/208 (51%), Gaps = 17/208 (8%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQ--LWKGDGVKVFAAEMEILGKIRHRNIL 734
L+ IG G TG V K VAVK+ L K ++ E+ I+ +H NI+
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIV 79
Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQAL-HKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
++Y+ L G ++V+E++ G L + H R+ E ++ + L K +++LH
Sbjct: 80 EMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNE--EQIA-----TVCLAVLKALSFLH 132
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFG-VAKIAENSPKVSDYSCFAGTHGYIAPEL 852
+ +IHRDIKS +ILL D K++DFG A++++ P+ GT ++APE+
Sbjct: 133 ---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR---RKSLVGTPYWMAPEV 186
Query: 853 AYTCKVSEKSDVFSFGVVLLELVTGRKP 880
+ D++S G++++E+V G P
Sbjct: 187 ISRLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 1e-18
Identities = 62/204 (30%), Positives = 102/204 (50%), Gaps = 17/204 (8%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLK 742
IGSG G V+ L VA+K + +G + F E +++ K+ H +++LY +
Sbjct: 12 IGSGQFGLVW-LGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIH 802
LV E+M +G L L R + GK + + L +G+AYL +IH
Sbjct: 71 RSPICLVFEFMEHGCLSDYL--RAQRGKFSQETL--LGMCLDVCEGMAYLESSN---VIH 123
Query: 803 RDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTH---GYIAPELAYTCKVS 859
RD+ + N L+ E+ K++DFG+ + + Y+ GT + +PE+ K S
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLD----DQYTSSTGTKFPVKWSSPEVFSFSKYS 179
Query: 860 EKSDVFSFGVVLLELVT-GRKPVE 882
KSDV+SFGV++ E+ + G+ P E
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKTPYE 203
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 67/206 (32%), Positives = 100/206 (48%), Gaps = 24/206 (11%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG---VKVFAA-EMEILGKIRHRNILKLYA 738
++G G G V + K VA+K+ + + VK A E+++L ++RH NI+ L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH-HDCS 797
+ G +LV EY+ L + L + G P D R Y L + IAY H H+
Sbjct: 68 AFRRKGRLYLVFEYVER-TLLELL-EASPGGLPP-DAVRSYIWQL--LQAIAYCHSHN-- 120
Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCK 857
IIHRDIK NIL+ E K+ DFG A+ A + S + + T Y APEL
Sbjct: 121 --IIHRDIKPENILVSESGVLKLCDFGFAR-ALRARPASPLTDYVATRWYRAPELL---- 173
Query: 858 VSEKS-----DVFSFGVVLLELVTGR 878
V + + DV++ G ++ EL+ G
Sbjct: 174 VGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 87.5 bits (216), Expect = 1e-18
Identities = 73/212 (34%), Positives = 109/212 (51%), Gaps = 34/212 (16%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL----------WKGDGVKVFAAEMEILGKIRHRNI 733
IG G G VY + VA+K++ W+ D +K E++ L +I+H N
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQ-DIIK----EVKFLQRIKHPNS 87
Query: 734 LKLYACLLKGGSSFLVLEY-MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
++ C L+ +++LV+EY + + + +HK KP L I GA +G+AYL
Sbjct: 88 IEYKGCYLREHTAWLVMEYCLGSASDLLEVHK-----KP-LQEVEIAAITHGALQGLAYL 141
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL 852
H S +IHRDIK+ NILL E + K+ADFG A IA SP S F GT ++APE+
Sbjct: 142 H---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIA--SPANS----FVGTPYWMAPEV 192
Query: 853 AYTCKVSE---KSDVFSFGVVLLELVTGRKPV 881
+ K DV+S G+ +EL + P+
Sbjct: 193 ILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 1e-18
Identities = 66/216 (30%), Positives = 108/216 (50%), Gaps = 29/216 (13%)
Query: 683 LIGSGGTGKVYRLDLKKNAGT---VAVKQL-----------WKGDGVKVFAAEMEILGKI 728
LIGSG G VY L NA + +AVKQ+ K + A E+ +L ++
Sbjct: 7 LIGSGSFGSVY---LGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL 63
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
+H NI++ L + LEY+P G++ L+ + + F R + KG
Sbjct: 64 QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL-----KG 118
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE----NSPKVSDYSCFAGT 844
+ YLH + IIHRDIK +NIL+D KI+DFG++K E ++ G+
Sbjct: 119 LNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGS 175
Query: 845 HGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKP 880
++APE+ + K+D++S G +++E++TG+ P
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 74/211 (35%), Positives = 103/211 (48%), Gaps = 32/211 (15%)
Query: 683 LIGSGGTGKVY--RLD-LKKNAG-TVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKL 736
+G G G V R D L+ N G VAVK+L + ++ F E+EIL ++H NI+K
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 737 YA-CLLKGGSSF-LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHH 794
C G + LV+EY+P G+L L K + LD + A KG+ YL
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQKH----RERLDHRKLLLYASQICKGMEYLG- 125
Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY---------SCFAGTH 845
S +HRD+ + NIL++ + KI DFG+ K+ P+ +Y F
Sbjct: 126 --SKRYVHRDLATRNILVESENRVKIGDFGLTKVL---PQDKEYYKVREPGESPIF---- 176
Query: 846 GYIAPELAYTCKVSEKSDVFSFGVVLLELVT 876
+ APE K S SDV+SFGVVL EL T
Sbjct: 177 -WYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-18
Identities = 61/204 (29%), Positives = 100/204 (49%), Gaps = 15/204 (7%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQ--LWKGDGVKVFAAEMEILGKIRHRNILKLYACLL 741
IG G TG V K VAVK+ L K ++ E+ I+ H N++ +Y L
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 742 KGGSSFLVLEYMPNGNLFQAL-HKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
G ++V+E++ G L + H R+ E + + L + ++YLH + +
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-------TVCLSVLRALSYLH---NQGV 139
Query: 801 IHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSE 860
IHRDIKS +ILL D K++DFG A+ S +V GT ++APE+
Sbjct: 140 IHRDIKSDSILLTSDGRIKLSDFGFC--AQVSKEVPKRKSLVGTPYWMAPEVISRLPYGT 197
Query: 861 KSDVFSFGVVLLELVTGRKPVEEE 884
+ D++S G++++E++ G P E
Sbjct: 198 EVDIWSLGIMVIEMIDGEPPYFNE 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-18
Identities = 75/289 (25%), Positives = 129/289 (44%), Gaps = 48/289 (16%)
Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKI 728
ID + + L+E +G+G G V + + VA+K + +G F E +++ K+
Sbjct: 1 IDPKDLTFLKE---LGTGQFG-VVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKL 56
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
H +++LY K ++V EYM NG L L +E + ++ +G
Sbjct: 57 SHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYL----REHGKRFQPSQLLEMCKDVCEG 112
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTH--- 845
+AYL S IHRD+ + N L+D+ K++DFG+++ + +Y+ G+
Sbjct: 113 MAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD----DEYTSSVGSKFPV 165
Query: 846 GYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHEN 904
+ PE+ K S KSDV++FGV++ E+ + G+ P E NN E
Sbjct: 166 RWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYER---------------FNNSET 210
Query: 905 VLKVLDC------EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVV 947
V KV +ASE K+ I C + RP ++++
Sbjct: 211 VEKVSQGLRLYRPHLASE-------KVYAIMYSCWHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 2e-18
Identities = 81/290 (27%), Positives = 117/290 (40%), Gaps = 54/290 (18%)
Query: 683 LIGSGGTGKVYRLDLKKNAGT---VAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKL 736
+G G G V R + + G VAVK L D + F E I+ + H N+++L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
Y +L +V E P G+L L K + A+ A G+ YL
Sbjct: 62 YGVVLTH-PLMMVTELAPLGSLLDRLRK---DALGHFLISTLCDYAVQIANGMRYLE--- 114
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAK---------IAENSPKVSDYSCFAGTHGY 847
S IHRD+ + NILL D + KI DFG+ + + E KV FA +
Sbjct: 115 SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVP----FA----W 166
Query: 848 IAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVL 906
APE T S SDV+ FGV L E+ T G +P W L+ +L
Sbjct: 167 CAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEP-------------WA--GLSG-SQIL 210
Query: 907 KVLDCE----VASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952
K +D E E+ +D+ ++ C P RP + + L +
Sbjct: 211 KKIDKEGERLERPEACPQDIYNVML---QCWAHNPADRPTFAALREFLPE 257
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-18
Identities = 62/212 (29%), Positives = 105/212 (49%), Gaps = 23/212 (10%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEME---------ILGKIRHRN 732
++G G G VY L +AVKQ+ + D V AAE E +L ++H N
Sbjct: 6 EVLGKGAYGTVY-CGLTNQGQLIAVKQV-ELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN 63
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
I++ L + + +E++P G++ L++ PE F +Y + G+AYL
Sbjct: 64 IVQYLGTCLDDNTISIFMEFVPGGSISSILNRF--GPLPEP-VFCKYTKQI--LDGVAYL 118
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA-KIAENSPKVSDYSCFAGTHG---YI 848
H++C ++HRDIK +N++L + K+ DFG A ++A + + HG ++
Sbjct: 119 HNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM 175
Query: 849 APELAYTCKVSEKSDVFSFGVVLLELVTGRKP 880
APE+ KSD++S G + E+ TG+ P
Sbjct: 176 APEVINESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-18
Identities = 68/212 (32%), Positives = 107/212 (50%), Gaps = 34/212 (16%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL----------WKGDGVKVFAAEMEILGKIRHRNI 733
IG G G VY +N+ VA+K++ W+ D +K E+ L K+RH N
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQ-DIIK----EVRFLQKLRHPNT 77
Query: 734 LKLYACLLKGGSSFLVLEY-MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
++ C L+ +++LV+EY + + + +HK KP L + GA +G+AYL
Sbjct: 78 IQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-----KP-LQEVEIAAVTHGALQGLAYL 131
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL 852
H S +IHRD+K+ NILL E K+ DFG A I ++ + F GT ++APE+
Sbjct: 132 H---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANXFVGTPYWMAPEV 182
Query: 853 AYTCKVSE---KSDVFSFGVVLLELVTGRKPV 881
+ K DV+S G+ +EL + P+
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 3e-18
Identities = 72/214 (33%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILK-L 736
++G G GKV +LK AVK L K D V+ E +L L L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
Y F V+E++ G+L + + K D +R A G+ +LH
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHI-----QDKGRFDLYRATFYAAEIVCGLQFLH--- 113
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTC 856
S II+RD+K N++LD D KIADFG+ K EN + S F GT YIAPE+
Sbjct: 114 SKGIIYRDLKLDNVMLDRDGHIKIADFGMCK--ENVFGDNRASTFCGTPDYIAPEILQGL 171
Query: 857 KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKD 890
K + D +SFGV+L E++ G+ P +GD +D
Sbjct: 172 KYTFSVDWWSFGVLLYEMLIGQSPF---HGDDED 202
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 3e-18
Identities = 72/220 (32%), Positives = 101/220 (45%), Gaps = 28/220 (12%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGT------VAVKQLWKGDGV---KVFAAEMEILGKIRHRN 732
N +GSG G+VY G VAVK L KG K F E ++ H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALH--KRVKEGKPELDWFRRYKIALGAAKGIA 790
I+KL L ++++E M G+L L + + G P L I L AKG
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 791 YLHHDCSPPIIHRDIKSSNILLDE-DYEP----KIADFGVAKIAENSPKVSDYSCFAGTH 845
YL IHRD+ + N L+ E Y+ KI DFG+A+ SDY G
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYK----SDYYRKEGEG 173
Query: 846 ----GYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKP 880
++APE K + +SDV+SFGV++ E++T G++P
Sbjct: 174 LLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 4e-18
Identities = 83/299 (27%), Positives = 136/299 (45%), Gaps = 50/299 (16%)
Query: 668 IDIDAEQICNLEEDNLIGSGGTGKVYRLDLK---KNAGTVAVKQLWKG---DGVKVFAAE 721
ID+ +I EE +IG+G G+V R LK K VA+K L G + F +E
Sbjct: 1 IDVSCVKI---EE--VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSE 55
Query: 722 MEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKI 781
I+G+ H NI+ L + K ++ E+M NG L L R +G + + +
Sbjct: 56 ASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFL--RQNDG--QFTVIQLVGM 111
Query: 782 ALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY-SC 840
G A G+ YL +HRD+ + NIL++ + K++DFG+++ E+ Y S
Sbjct: 112 LRGIAAGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSS 168
Query: 841 FAGTHG--YIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVST 897
G + APE K + SDV+S+G+V+ E+++ G +P YW +
Sbjct: 169 LGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP------------YWDMS 216
Query: 898 H---LNNHENVLKV---LDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950
+ +N E ++ +DC A L ++ + C K N RP ++V L
Sbjct: 217 NQDVINAIEQDYRLPPPMDCPTA----------LHQLMLDCWQKDRNARPKFGQIVSTL 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 5e-18
Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 16/201 (7%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAAEMEILGKIRHRNILKLYACL 740
IG G G+V++ + VA+K + D ++ E+ +L + + K Y
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
LKG ++++EY+ G+ L P D F+ + KG+ YLH S
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLL-----RAGP-FDEFQIATMLKEILKGLDYLH---SEKK 122
Query: 801 IHRDIKSSNILLDEDYEPKIADFGVA-KIAENSPKVSDYSCFAGTHGYIAPELAYTCKVS 859
IHRDIK++N+LL E + K+ADFGVA ++ + K + F GT ++APE+
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK---RNTFVGTPFWMAPEVIQQSAYD 179
Query: 860 EKSDVFSFGVVLLELVTGRKP 880
K+D++S G+ +EL G P
Sbjct: 180 SKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (208), Expect = 7e-18
Identities = 70/217 (32%), Positives = 104/217 (47%), Gaps = 33/217 (15%)
Query: 682 NLIGSGGTGKVYRLDLKK-----NAGTVAVKQLWKGDGVKVFAAEMEILGKI-RHRNILK 735
++IG G G+V + +KK +A +K+ D + FA E+E+L K+ H NI+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHK-RVKEGKP----------ELDWFRRYKIALG 784
L G +L +EY P+GNL L K RV E P L + A
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 785 AAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGT 844
A+G+ YL IHRD+ + NIL+ E+Y KIADFG+++ E K T
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--------KT 169
Query: 845 HG-----YIAPELAYTCKVSEKSDVFSFGVVLLELVT 876
G ++A E + SDV+S+GV+L E+V+
Sbjct: 170 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 9e-18
Identities = 83/286 (29%), Positives = 123/286 (43%), Gaps = 51/286 (17%)
Query: 684 IGSGGTGKV----YRLDLKKNAG-TVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILK 735
+G G G V Y + K VAVK L + G K F E ++ ++ H I++
Sbjct: 3 LGHGNFGSVVKGVYLM--KSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHD 795
L + KG LV+E P G L + L KR E+ ++A A G+AYL
Sbjct: 61 LIG-VCKGEPLMLVMELAPLGPLLKYLKKR-----REIPVSDLKELAHQVAMGMAYLE-- 112
Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHG-----YIAP 850
S +HRD+ + N+LL ++ KI+DFG+++ A + SDY T G + AP
Sbjct: 113 -SKHFVHRDLAARNVLLVNRHQAKISDFGMSR-ALGAG--SDYYRAT-TAGRWPLKWYAP 167
Query: 851 ELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGD--GKDIVYWVSTHLNNHENVLK 907
E K S KSDV+S+GV L E + G KP YG+ G +++ + +
Sbjct: 168 ECINYGKFSSKSDVWSYGVTLWEAFSYGAKP----YGEMKGAEVIAMLE---SGER---- 216
Query: 908 VLDC-EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952
L E + I M+ C P RP E+
Sbjct: 217 -LPRPEECPQEIYSIMLS-------CWKYRPEDRPTFSELESTFRR 254
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 1e-17
Identities = 65/252 (25%), Positives = 109/252 (43%), Gaps = 38/252 (15%)
Query: 721 EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK 780
E+++L + I+ Y G + +E+M G+L Q L K + + L K
Sbjct: 49 ELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILG-----K 103
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSC 840
I++ +G+ YL I+HRD+K SNIL++ E K+ DFGV+ +S S
Sbjct: 104 ISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---- 157
Query: 841 FAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPV--------------EEEYG 886
F GT Y++PE + +SD++S G+ L+E+ GR P+ G
Sbjct: 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEG 217
Query: 887 DGKDIVYWVSTHLNNHEN---VLKVLDCEVASESIK-------EDMIKLLKIAVVCTTKL 936
+ K+ VS H + + ++LD V K ++ + C K
Sbjct: 218 EAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDK---CLKKN 274
Query: 937 PNLRPPMREVVK 948
P R ++E+ K
Sbjct: 275 PKERADLKELTK 286
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-17
Identities = 69/217 (31%), Positives = 106/217 (48%), Gaps = 27/217 (12%)
Query: 684 IGSGGTGKV-----YRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKL 736
+G G GKV Y L +++ VAVK L + K F E E+L ++H +I+K
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKR------VKEGKP--ELDWFRRYKIALGAAKG 788
Y ++G +V EYM +G+L + L + EG EL + IA A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTH--- 845
+ YL S +HRD+ + N L+ E+ KI DFG+++ + +DY G
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYS----TDYYRVGGHTMLP 185
Query: 846 -GYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKP 880
++ PE K + +SDV+S GVVL E+ T G++P
Sbjct: 186 IRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 1e-17
Identities = 70/238 (29%), Positives = 104/238 (43%), Gaps = 33/238 (13%)
Query: 653 EKEVSSKWKLASFHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG 712
K +S WKL+ F E +G+G G+V K A+K L K
Sbjct: 8 TKPDTSSWKLSDF-------------EMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKR 54
Query: 713 DGVKV-----FAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVK 767
+ +K+ A E IL ++ H I+ + + +LE++ G LF L K
Sbjct: 55 EILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRK--- 111
Query: 768 EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
G+ D + Y L A YLH S II+RD+K N+LLD K+ DFG AK
Sbjct: 112 AGRFPNDVAKFYHAELVLA--FEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAK 166
Query: 828 IAENSPKVSDYS-CFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEE 884
KV D + GT Y+APE+ + + D ++ GV+L E + G P ++
Sbjct: 167 ------KVPDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD 218
|
Length = 329 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 64/213 (30%), Positives = 103/213 (48%), Gaps = 21/213 (9%)
Query: 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLW---KGDGVKVFAA-EMEILGKIRH 730
+ E+ N IG G G VYR + VA+K++ + DG+ + + E+ +L +RH
Sbjct: 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRH 65
Query: 731 RNILKLYACLL--KGGSSFLVLEYMPN--GNLFQALHKRVKEGKPELDWFRRYKIALGAA 786
NI++L ++ S FLV+EY +L + E + + + L
Sbjct: 66 PNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKC-------LMLQLL 118
Query: 787 KGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHG 846
+G+ YLH + IIHRD+K SN+LL + KIADFG+A+ K + T
Sbjct: 119 RGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK--PMTPKVVTLW 173
Query: 847 YIAPELAYTCKVSEKS-DVFSFGVVLLELVTGR 878
Y APEL C + D+++ G +L EL+ +
Sbjct: 174 YRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 2e-17
Identities = 77/270 (28%), Positives = 123/270 (45%), Gaps = 34/270 (12%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAAEMEILGKIRHRNILKLYACL 740
IG G G+V++ + VA+K + D ++ E+ +L + + K Y
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
LK ++++EY+ G+ L E P LD + I KG+ YLH S
Sbjct: 72 LKDTKLWIIMEYLGGGSALDLL-----EPGP-LDETQIATILREILKGLDYLH---SEKK 122
Query: 801 IHRDIKSSNILLDEDYEPKIADFGVA-KIAENSPKVSDYSCFAGTHGYIAPELAYTCKVS 859
IHRDIK++N+LL E E K+ADFGVA ++ + K + F GT ++APE+
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK---RNTFVGTPFWMAPEVIKQSAYD 179
Query: 860 EKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESIK 919
K+D++S G+ +EL G P H H + L + +++
Sbjct: 180 SKADIWSLGITAIELAKGEPP-----------------HSELHPMKVLFLIPKNNPPTLE 222
Query: 920 EDMIKLLKIAV-VCTTKLPNLRPPMREVVK 948
+ K LK V C K P+ RP +E++K
Sbjct: 223 GNYSKPLKEFVEACLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 52/166 (31%), Positives = 85/166 (51%), Gaps = 16/166 (9%)
Query: 721 EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPE---LDWFR 777
E +L K++H NI+ G ++V+EY G+L Q + + + PE L WF
Sbjct: 48 EAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWF- 106
Query: 778 RYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSD 837
++ LG + H ++HRDIKS NI L ++ + K+ DFG A++ +
Sbjct: 107 -VQMCLG-------VQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP---GA 155
Query: 838 YSC-FAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVE 882
Y+C + GT Y+ PE+ + KSD++S G +L EL T + P +
Sbjct: 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQ 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 2e-17
Identities = 78/297 (26%), Positives = 133/297 (44%), Gaps = 58/297 (19%)
Query: 678 LEEDNLIGSGGTGKVYRLDL-----KKNAGTVAVKQLWKGDGVKV---FAAEMEILGKIR 729
LEE +G G GKVY+ +L + +A +VA+K L + KV F E E++ ++
Sbjct: 10 LEE---LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQ 66
Query: 730 HRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKR-----------VKEGKPELDWFRR 778
H NI+ L K + ++ EY+ +G+L + L + + K LD
Sbjct: 67 HPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF 126
Query: 779 YKIALGAAKGIAYL--HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVS 836
IA+ A G+ YL HH +HRD+ + N L+ E KI+DFG+++ + +
Sbjct: 127 LHIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIYS----A 177
Query: 837 DYSCFAGTH----GYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDI 891
DY ++ PE K + +SD++SFGVVL E+ + G +P YG
Sbjct: 178 DYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPY---YG----- 229
Query: 892 VYWVSTHLNNHENVLKVLDCEV--ASESIKEDMIKLLKIAVVCTTKLPNLRPPMREV 946
+N E + + ++ E + L+ C ++P RP +++
Sbjct: 230 -------FSNQEVIEMIRSRQLLPCPEDCPARVYALMI---ECWNEIPARRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-17
Identities = 70/218 (32%), Positives = 104/218 (47%), Gaps = 33/218 (15%)
Query: 681 DNLIGSGGTGKVYRLDLKK-----NAGTVAVKQLWKGDGVKVFAAEMEILGKI-RHRNIL 734
+++IG G G+V R +KK NA +K+ + + FA E+E+L K+ H NI+
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQALHK-RVKEGKPE----------LDWFRRYKIAL 783
L G ++ +EY P GNL L K RV E P L + + A
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAG 843
A G+ YL IHRD+ + N+L+ E+ KIADFG+++ E K
Sbjct: 127 DVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVK--------K 175
Query: 844 THG-----YIAPELAYTCKVSEKSDVFSFGVVLLELVT 876
T G ++A E + KSDV+SFGV+L E+V+
Sbjct: 176 TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-17
Identities = 62/210 (29%), Positives = 105/210 (50%), Gaps = 22/210 (10%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVK--QLWKGDGVKVFAAEMEILGKIRHRNILKLYACLL 741
+G G GKVY+ K+ A K + + ++ + E+EIL H I+KL
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEG--KPELDWFRRYKIALGAAKGIAYLHHDCSPP 799
G ++++E+ P G + A+ + G +P++ R + + + YLH S
Sbjct: 80 WDGKLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQVICRQML-----EALQYLH---SMK 130
Query: 800 IIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVS 859
IIHRD+K+ N+LL D + K+ADFGV+ A+N + F GT ++APE+ C+
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVS--AKNVKTLQRRDSFIGTPYWMAPEVV-MCETM 187
Query: 860 E------KSDVFSFGVVLLELVTGRKPVEE 883
+ K+D++S G+ L+E+ P E
Sbjct: 188 KDTPYDYKADIWSLGITLIEMAQIEPPHHE 217
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 3e-17
Identities = 60/216 (27%), Positives = 104/216 (48%), Gaps = 35/216 (16%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA---------EMEILGKIRHRNIL 734
IGSG G V ++ VA+K++ F E++IL +H NI+
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKI-----PHAFDVPTLAKRTLRELKILRHFKHDNII 67
Query: 735 KLYACLLKGGSSF----LVLEYMPNGNLFQALHKRVKEGKPELDWFRR--YKIALGAAKG 788
+ L G+ F +V++ M + +L +H + R Y++ +G
Sbjct: 68 AIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSD---QPLTEEHIRYFLYQLL----RG 119
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY--SCFAGTHG 846
+ Y+H S +IHRD+K SN+L++ED E +I DFG+A+ +SP Y + + T
Sbjct: 120 LKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176
Query: 847 YIAPELAYTC-KVSEKSDVFSFGVVLLELVTGRKPV 881
Y APEL + + + D++S G + E++ GR+ +
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 3e-17
Identities = 61/200 (30%), Positives = 104/200 (52%), Gaps = 15/200 (7%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVK--QLWKGDGVKVFAAEMEILGKIRHRNILKLYACLL 741
IG G TG V K + VAVK L K ++ E+ I+ +H+N++++Y L
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPII 801
G ++++E++ G AL V + + L+ + + + + YLH S +I
Sbjct: 89 VGEELWVLMEFLQGG----ALTDIVSQTR--LNEEQIATVCESVLQALCYLH---SQGVI 139
Query: 802 HRDIKSSNILLDEDYEPKIADFG-VAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSE 860
HRDIKS +ILL D K++DFG A+I+++ PK GT ++APE+
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK---RKSLVGTPYWMAPEVISRTPYGT 196
Query: 861 KSDVFSFGVVLLELVTGRKP 880
+ D++S G++++E+V G P
Sbjct: 197 EVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 3e-17
Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 33/222 (14%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKN-----AGTVAVKQLWKGDGVKVFAAEMEILGKI-RH 730
+++ ++IG G G+V + +KK+ A +K+ D + FA E+E+L K+ H
Sbjct: 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 67
Query: 731 RNILKLYACLLKGGSSFLVLEYMPNGNLFQALHK-RVKEGKPELDWFRRYKIALGA---- 785
NI+ L G +L +EY P+GNL L K RV E P L +
Sbjct: 68 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 127
Query: 786 ------AKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYS 839
A+G+ YL IHRD+ + NIL+ E+Y KIADFG+++ E K
Sbjct: 128 HFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK----- 179
Query: 840 CFAGTHG-----YIAPELAYTCKVSEKSDVFSFGVVLLELVT 876
T G ++A E + SDV+S+GV+L E+V+
Sbjct: 180 ---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 5e-17
Identities = 82/297 (27%), Positives = 127/297 (42%), Gaps = 38/297 (12%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKIR-HRNILKL 736
++G G GKV +LK A+K L K D V E IL H + L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 737 YACLLKGGSSFLVLEYMPNGNL-FQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH-H 794
+ C F V+EY+ G+L FQ R + D R A + +LH H
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRSR------KFDEPRSRFYAAEVTLALMFLHRH 115
Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAY 854
+I+RD+K NILLD + K+ADFG+ K E + F GT YIAPE+
Sbjct: 116 G----VIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEILQ 169
Query: 855 TCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDG-------KDIVY--WVSTHLNN---- 901
+ D ++ GV++ E++ G+ P E + D D++Y W+S +
Sbjct: 170 ELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKA 229
Query: 902 --HENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLP--NLRPPMREVVKMLADAD 954
+N K L C VAS+ ++ + + + L ++PP + +K D +
Sbjct: 230 FMTKNPNKRLGC-VASQGGEDAIKQHPFFKEIDWVLLEQRKIKPPFKPKIKTKRDVN 285
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 6e-17
Identities = 63/204 (30%), Positives = 95/204 (46%), Gaps = 18/204 (8%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKL-Y 737
+G GG G+V +K A K+L K G ++ E +IL K+ R I+ L Y
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDW-FRRYKIALGAAKGIAYLHHDC 796
A K LV+ M G+L ++ + G PE F +I G + +LH
Sbjct: 61 AFETKDDLC-LVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICG----LEHLHQR- 114
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTC 856
I++RD+K N+LLD+ +I+D G+A + K+ AGT GY+APE+
Sbjct: 115 --RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR---AGTPGYMAPEVLQGE 169
Query: 857 KVSEKSDVFSFGVVLLELVTGRKP 880
D F+ G L E++ GR P
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 6e-17
Identities = 66/211 (31%), Positives = 98/211 (46%), Gaps = 16/211 (7%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIR-HRNILKL 736
++G G GKV LK++ AVK L K D V+ E IL R H + +L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
Y C F V+E++ G+L + K + + ++ A + +LH
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFY-----AAEITSALMFLH--- 113
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTC 856
II+RD+K N+LLD + K+ADFG+ K + K + S F GT YIAPE+
Sbjct: 114 DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT--STFCGTPDYIAPEILQEM 171
Query: 857 KVSEKSDVFSFGVVLLELVTGRKPVEEEYGD 887
D ++ GV+L E++ G P E E D
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCGHAPFEAENED 202
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 7e-17
Identities = 76/270 (28%), Positives = 121/270 (44%), Gaps = 34/270 (12%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAAEMEILGKIRHRNILKLYACL 740
IG G G+VY+ + VA+K + D ++ E+ +L + I + Y
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
LKG ++++EY+ G+ L K G E + I KG+ YLH S
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLL----KPGPLEETYIA--TILREILKGLDYLH---SERK 122
Query: 801 IHRDIKSSNILLDEDYEPKIADFGVA-KIAENSPKVSDYSCFAGTHGYIAPELAYTCKVS 859
IHRDIK++N+LL E + K+ADFGVA ++ + K + F GT ++APE+
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK---RNTFVGTPFWMAPEVIKQSAYD 179
Query: 860 EKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESIK 919
K+D++S G+ +EL G P D H + L + + +++
Sbjct: 180 FKADIWSLGITAIELAKGEPP----NSD-------------LHPMRVLFLIPKNSPPTLE 222
Query: 920 EDMIKLLKIAV-VCTTKLPNLRPPMREVVK 948
K K V C K P RP +E++K
Sbjct: 223 GQYSKPFKEFVEACLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 8e-17
Identities = 53/161 (32%), Positives = 86/161 (53%), Gaps = 4/161 (2%)
Query: 720 AEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRY 779
+E+ L H I+K + L++EY G+L + + +R+KE P F+ Y
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLP----FQEY 169
Query: 780 KIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYS 839
++ L + + L S ++HRD+KS+NI L K+ DFG +K +S + S
Sbjct: 170 EVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVAS 229
Query: 840 CFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKP 880
F GT Y+APEL + S+K+D++S GV+L EL+T +P
Sbjct: 230 SFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 8e-17
Identities = 70/208 (33%), Positives = 105/208 (50%), Gaps = 27/208 (12%)
Query: 684 IGSGGTGKVY--RLDLK-KNAGT-VAVKQLWKGDGVKVFA---AEMEILGKIRHRNILKL 736
+G G GKV R D + N G VAVK L G A E+EIL + H NI+K
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 737 YA-CLLKGGSSF-LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHH 794
C GG+ L++E++P+G+L + L + K +++ ++ K A+ KG+ YL
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPR----NKNKINLKQQLKYAVQICKGMDYLG- 126
Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVS------DYSCFAGTHGYI 848
S +HRD+ + N+L++ +++ KI DFG+ K E + D F +
Sbjct: 127 --SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVF-----WY 179
Query: 849 APELAYTCKVSEKSDVFSFGVVLLELVT 876
APE K SDV+SFGV L EL+T
Sbjct: 180 APECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 8e-17
Identities = 70/221 (31%), Positives = 105/221 (47%), Gaps = 32/221 (14%)
Query: 684 IGSGGTGKV-----YRLDLKKNAGTVAVKQLWKGD--GVKVFAAEMEILGKIRHRNILKL 736
+G G GKV Y L K+ VAVK L K F E E+L ++H +I+K
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKR------VKEGKP-----ELDWFRRYKIALGA 785
Y G +V EYM +G+L + L + +G+P EL + IA
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 786 AKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTH 845
A G+ YL S +HRD+ + N L+ + KI DFG+++ + +DY G H
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYS----TDYYRVGG-H 184
Query: 846 G-----YIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKP 880
++ PE K + +SDV+SFGV+L E+ T G++P
Sbjct: 185 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 9e-17
Identities = 66/217 (30%), Positives = 107/217 (49%), Gaps = 25/217 (11%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTV-AVKQLWK---GDGVKVFAAEMEILGKIRH-R 731
+L++ IG G G V ++ L K +GT+ AVK++ K +++++ +
Sbjct: 5 DLKDLGEIGRGAFGTVNKM-LHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCP 63
Query: 732 NILKLYACLLKGGSSFLVLEYMPNG--NLFQALHKRVKEGKPE--LDWFRRYKIALGAAK 787
I+K Y L + G ++ +E M ++ +++ +K PE L KIA+ K
Sbjct: 64 YIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILG-----KIAVATVK 118
Query: 788 GIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS-PKVSDYSCFAGTHG 846
+ YL + IIHRD+K SNILLD + K+ DFG++ +S K D AG
Sbjct: 119 ALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRD----AGCRP 172
Query: 847 YIAPELAYTCKVSE---KSDVFSFGVVLLELVTGRKP 880
Y+APE +SDV+S G+ L E+ TG+ P
Sbjct: 173 YMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 74/290 (25%), Positives = 130/290 (44%), Gaps = 47/290 (16%)
Query: 683 LIGSGGTGKVYRLDLKKNAGT-VAVKQLW------------KGDGVKVFAAEMEILGK-I 728
+GSG G VY++ K N +A+K++ + + +E+ I+ + +
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 729 RHRNILKLYACLLKGGSSFLVLEYM---PNGNLFQALHKRVKEGKPELDWFRRYKIALGA 785
RH NI++ Y L+ ++V++ + P G F +L KE K R + I +
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSL----KEKKQRFTEERIWNIFVQM 122
Query: 786 AKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTH 845
+ YLH + I+HRD+ +NI+L ED + I DFG+AK + K++ GT
Sbjct: 123 VLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSV---VGTI 177
Query: 846 GYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENV 905
Y PE+ EK+DV++FG +L ++ T + P + N ++
Sbjct: 178 LYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF----------------YSTNMLSL 221
Query: 906 -LKVLDCEVASESIKEDMIKLLKIAVV--CTTKLPNLRPPMREVVKMLAD 952
K+++ E + E M V+ C T RP + +V M++D
Sbjct: 222 ATKIVEAVY--EPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 67/213 (31%), Positives = 116/213 (54%), Gaps = 25/213 (11%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILK 735
+L+ + +G+G G+V+ K+ VAVK + G V+ F AE ++ ++H ++K
Sbjct: 7 SLKLEKKLGAGQFGEVWMATYNKHT-KVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVK 65
Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGK----PELDWFRRYKIALGAAKGIAY 791
L+A + K +++ E+M G+L L + EG P+L F + A+G+A+
Sbjct: 66 LHAVVTKE-PIYIITEFMAKGSLLDFL--KSDEGSKQPLPKLIDF-----SAQIAEGMAF 117
Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTH---GYI 848
+ IHRD++++NIL+ KIADFG+A++ E+ ++Y+ G +
Sbjct: 118 IEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED----NEYTAREGAKFPIKWT 170
Query: 849 APELAYTCKVSEKSDVFSFGVVLLELVT-GRKP 880
APE + KSDV+SFG++L+E+VT GR P
Sbjct: 171 APEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-16
Identities = 67/195 (34%), Positives = 101/195 (51%), Gaps = 14/195 (7%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD---GVKV-FAAEMEILGKIRHRNILKLYA 738
L+G G G+V++ LK VAVK K D +K+ F +E IL + H NI+KL
Sbjct: 2 LLGKGNFGEVFKGTLKDKT-PVAVKTC-KEDLPQELKIKFLSEARILKQYDHPNIVKLIG 59
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
+ ++V+E +P G+ L K+ K EL + K AL AA G+AYL S
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFLRKK----KDELKTKQLVKFALDAAAGMAYLE---SK 112
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKV 858
IHRD+ + N L+ E+ KI+DFG+++ E+ S + APE +
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSR-QEDDGIYSSSGLKQIPIKWTAPEALNYGRY 171
Query: 859 SEKSDVFSFGVVLLE 873
S +SDV+S+G++L E
Sbjct: 172 SSESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 2e-16
Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 15/204 (7%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVK--VFAAEMEILGKIRHRNILKLYACLL 741
IG G +G VY VA+KQ+ K + E+ ++ + +H NI+ L
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 742 KGGSSFLVLEYMPNGNLFQALHKR-VKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
G ++V+EY+ G+L + + + EG+ + + + +LH S +
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-------AVCRECLQALEFLH---SNQV 136
Query: 801 IHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSE 860
IHRDIKS NILL D K+ DFG A+ +P+ S S GT ++APE+
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 861 KSDVFSFGVVLLELVTGRKPVEEE 884
K D++S G++ +E+V G P E
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPYLNE 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-16
Identities = 60/200 (30%), Positives = 96/200 (48%), Gaps = 19/200 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRHRNILKLYACL 740
+G G G VY+ +AVK + V++ +E+EIL K I+ Y
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
+ E+M G+L +++++ E L +IA+ KG+ YL S I
Sbjct: 69 FVENRISICTEFMDGGSL--DVYRKIPE--HVLG-----RIAVAVVKGLTYL---WSLKI 116
Query: 801 IHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSE 860
+HRD+K SN+L++ + K+ DFGV+ NS + + GT+ Y+APE +
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKT----YVGTNAYMAPERISGEQYGI 172
Query: 861 KSDVFSFGVVLLELVTGRKP 880
SDV+S G+ +EL GR P
Sbjct: 173 HSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 17/210 (8%)
Query: 677 NLEEDNLIGSGGTGKV-----YRLDLKKNAGTVAVKQL---WKGDGVKVFAAEMEILGKI 728
NL +G+G GKV Y L VAVK L + +E++I+ +
Sbjct: 36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHL 95
Query: 729 -RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAK 787
H NI+ L GG ++ EY G+L L ++ +E L+ + + AK
Sbjct: 96 GNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRK-RESFLTLEDLLSF--SYQVAK 152
Query: 788 GIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK-IAENSPKVSDYSCFAGTHG 846
G+A+L S IHRD+ + N+LL KI DFG+A+ I +S V +
Sbjct: 153 GMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK- 208
Query: 847 YIAPELAYTCKVSEKSDVFSFGVVLLELVT 876
++APE + C + +SDV+S+G++L E+ +
Sbjct: 209 WMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-16
Identities = 66/216 (30%), Positives = 103/216 (47%), Gaps = 20/216 (9%)
Query: 669 DIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLW---KGDGVKVFAAEMEIL 725
D D E+I L G+G G V ++ K + +A K + K E+++L
Sbjct: 4 DDDFERISEL------GAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVL 57
Query: 726 GKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGA 785
+ I+ Y G + +E+M G+L Q L K K E+ K+++
Sbjct: 58 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KEAKRIPEEI----LGKVSIAV 112
Query: 786 AKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTH 845
+G+AYL I+HRD+K SNIL++ E K+ DFGV+ +S S F GT
Sbjct: 113 LRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS----FVGTR 166
Query: 846 GYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPV 881
Y++PE S +SD++S G+ L+EL GR P+
Sbjct: 167 SYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 62/230 (26%), Positives = 98/230 (42%), Gaps = 38/230 (16%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVK-----QLWKGDGVKVFAAEMEILGKIRHRNILKLY 737
L+G G G+V+ + LK A+K ++ K + VK E EIL + H + LY
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
A LV++Y P G LF+ L ++ + E + R Y + A + YLH
Sbjct: 68 ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSE-EVARFYAAEVLLA--LEYLH---L 121
Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYS------------------ 839
I++RD+K NILL E ++DF ++K ++ P +
Sbjct: 122 LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETF 181
Query: 840 ---------CFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKP 880
F GT YIAPE+ D ++ G++L E++ G P
Sbjct: 182 SEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 65/207 (31%), Positives = 106/207 (51%), Gaps = 14/207 (6%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIRHRN 732
N ++ IG G G VY+ K VA+K++ + +GV A E+ +L ++ H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
I+KL + +LV E++ + +L + + G P L + Y L +G+A+
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIP-LPLIKSYLFQL--LQGLAFC 116
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL 852
H S ++HRD+K N+L++ + K+ADFG+A+ A P V Y+ T Y APE+
Sbjct: 117 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVP-VRTYTHEVVTLWYRAPEI 171
Query: 853 AYTCKV-SEKSDVFSFGVVLLELVTGR 878
CK S D++S G + E+VT R
Sbjct: 172 LLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 3e-16
Identities = 69/212 (32%), Positives = 104/212 (49%), Gaps = 18/212 (8%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK-GDGVKVFAAEMEILGKI-RHRNILKLYACLL 741
IG G GKVY++ KK+ AVK L D + AE IL + H N++K Y
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89
Query: 742 K-----GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
K GG +LVLE G++ + + + G+ LD I GA G+ +LH++
Sbjct: 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ-RLDEAMISYILYGALLGLQHLHNN- 147
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL---- 852
IIHRD+K +NILL + K+ DFGV+ ++ + S GT ++APE+
Sbjct: 148 --RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFWMAPEVIACE 203
Query: 853 -AYTCKVSEKSDVFSFGVVLLELVTGRKPVEE 883
Y + DV+S G+ +EL G P+ +
Sbjct: 204 QQYDYSYDARCDVWSLGITAIELGDGDPPLFD 235
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 3e-16
Identities = 65/195 (33%), Positives = 98/195 (50%), Gaps = 30/195 (15%)
Query: 703 TVAVKQLWKGDG----VKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLVLEYMPNGN 757
TVAVK L K D + +EME++ I +H+NI+ L + G ++++EY GN
Sbjct: 46 TVAVKML-KDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGN 104
Query: 758 LFQALHKRVKEG-----------KPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIK 806
L + L R G + +L + A A+G+ YL S IHRD+
Sbjct: 105 LREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLA 161
Query: 807 SSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHG-----YIAPELAYTCKVSEK 861
+ N+L+ ED KIADFG+A+ N DY T+G ++APE + + +
Sbjct: 162 ARNVLVTEDNVMKIADFGLARDVHN----IDYYK-KTTNGRLPVKWMAPEALFDRVYTHQ 216
Query: 862 SDVFSFGVVLLELVT 876
SDV+SFGV+L E+ T
Sbjct: 217 SDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 3e-16
Identities = 69/232 (29%), Positives = 104/232 (44%), Gaps = 40/232 (17%)
Query: 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLW---KGDGVKVFAA-EMEILGKIR 729
++ + E +G G G+VY+ K VA+K++ + DG + A E++IL K++
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK 65
Query: 730 HRNILKLY--------ACLLKGGSSFLVLEYMPNGNLFQALHK-RVKEGKPELDWFRRYK 780
H N++ L K GS ++V YM + +L L VK + ++
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYM-DHDLSGLLENPSVKLTESQIK-----C 119
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSC 840
L +GI YLH I+HRDIK++NIL+D KIADFG+A+ + P
Sbjct: 120 YMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGG 176
Query: 841 FAGTHGYI---------APELA-----YTCKVSEKSDVFSFGVVLLELVTGR 878
GT Y PEL YT V D++ G V E+ T R
Sbjct: 177 GGGTRKYTNLVVTRWYRPPELLLGERRYTTAV----DIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 4e-16
Identities = 60/197 (30%), Positives = 95/197 (48%), Gaps = 20/197 (10%)
Query: 696 DLKKNAGTVAVKQLWKGDGVKV----FAAEMEILGKI-RHRNILKLYACLLKGGSSFLVL 750
D K A TVAVK L K D + +EME++ I +H+NI+ L + G ++++
Sbjct: 42 DKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIV 100
Query: 751 EYMPNGNLFQALHKRVKEG-----------KPELDWFRRYKIALGAAKGIAYLHHDCSPP 799
EY GNL + L R G ++ + A+G+ YL S
Sbjct: 101 EYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQK 157
Query: 800 IIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVS 859
IHRD+ + N+L+ E+ KIADFG+A+ N + ++APE + +
Sbjct: 158 CIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYT 217
Query: 860 EKSDVFSFGVVLLELVT 876
+SDV+SFGV++ E+ T
Sbjct: 218 HQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 4e-16
Identities = 57/185 (30%), Positives = 95/185 (51%), Gaps = 22/185 (11%)
Query: 703 TVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYACLLKGGSS-FLVLEYMPNGN 757
VA+K++ K V A E+++L +RH NI+ L + + V E +
Sbjct: 37 NVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGTD- 95
Query: 758 LFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE 817
LH R+ +P F +Y +G+ Y+H S ++HRD+K SNIL++E+ +
Sbjct: 96 ----LH-RLLTSRPLEKQFIQY-FLYQILRGLKYVH---SAGVVHRDLKPSNILINENCD 146
Query: 818 PKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTC-KVSEKSDVFSFGVVLLELVT 876
KI DFG+A+I + P+++ Y T Y APE+ T K + D++S G + E++
Sbjct: 147 LKICDFGLARIQD--PQMTGY---VSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLE 201
Query: 877 GRKPV 881
G KP+
Sbjct: 202 G-KPL 205
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 5e-16
Identities = 58/215 (26%), Positives = 106/215 (49%), Gaps = 30/215 (13%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG--VKVFAAEMEILGKIRHRNILKLYACL 740
++G G G VY +A+K++ + D V+ E+ + ++HRNI++
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 741 LKGGSSFLVLEYMPNGNLFQALHKR---VKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
+ G + +E +P G+L L + +K+ + + ++ + + +G+ YLH +
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL-----EGLKYLHDN-- 127
Query: 798 PPIIHRDIKSSNILLDEDYEP--KIADFGVAK-IAENSPKVSDYSCFAGTHGYIAPEL-- 852
I+HRDIK N+L++ Y KI+DFG +K +A +P F GT Y+APE+
Sbjct: 128 -QIVHRDIKGDNVLVNT-YSGVVKISDFGTSKRLAGINPCT---ETFTGTLQYMAPEVID 182
Query: 853 ----AYTCKVSEKSDVFSFGVVLLELVTGRKPVEE 883
Y +D++S G ++E+ TG+ P E
Sbjct: 183 KGPRGY----GAPADIWSLGCTIVEMATGKPPFIE 213
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 7e-16
Identities = 70/217 (32%), Positives = 104/217 (47%), Gaps = 31/217 (14%)
Query: 683 LIGSGGTGKVYRLDLKKNAGT-----VAVKQLWKGDGV---KVFA---AEMEILGKIRHR 731
++G GG GKV+++ +K G A+K L K V K A AE IL ++H
Sbjct: 3 VLGKGGYGKVFQV--RKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEG--KPELDWFRRYKIALGAAKGI 789
I+ L GG +L+LEY+ G LF L +EG + F +I+L +
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLE---REGIFMEDTACFYLSEISL----AL 113
Query: 790 AYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK--IAENSPKVSDYSCFAGTHGY 847
+LH II+RD+K NILLD K+ DFG+ K I E + + F GT Y
Sbjct: 114 EHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT----FCGTIEY 166
Query: 848 IAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEE 884
+APE+ + D +S G ++ +++TG P E
Sbjct: 167 MAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAE 203
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 9e-16
Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 16/211 (7%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNIL-KL 736
++G G GKV + K A+K L K D V+ E +L L +L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
++C + V+EY+ G+L + + K +P+ ++ A + G+ +LH
Sbjct: 67 HSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFY-----AAEISVGLFFLHRR- 120
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTC 856
II+RD+K N++LD + KIADFG+ K E+ F GT YIAPE+
Sbjct: 121 --GIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAPEIIAYQ 176
Query: 857 KVSEKSDVFSFGVVLLELVTGRKPVEEEYGD 887
+ D +++GV+L E++ G+ P + E D
Sbjct: 177 PYGKSVDWWAYGVLLYEMLAGQPPFDGEDED 207
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 1e-15
Identities = 58/203 (28%), Positives = 99/203 (48%), Gaps = 13/203 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQ--LWKGDGVKVFAAEMEILGKIRHRNILKLYACLL 741
IG G +G V+ VA+KQ L K ++ E+ ++ ++++ NI+ L
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPII 801
G F+V+EY+ G+L + + +D + + + + +LH + +I
Sbjct: 87 VGDELFVVMEYLAGGSLTDVVTETC------MDEAQIAAVCRECLQALEFLHAN---QVI 137
Query: 802 HRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEK 861
HRDIKS N+LL D K+ DFG A+ +P+ S S GT ++APE+ K
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 195
Query: 862 SDVFSFGVVLLELVTGRKPVEEE 884
D++S G++ +E+V G P E
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLNE 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 61/223 (27%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLW-------KGDGVKVFAAEMEILGKIR 729
N L+G G G+VY +A KQ+ V E+++L ++
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 730 HRNILKLYACLLKGGSSFLV--LEYMPNGNL------FQALHKRVKEGKPELDWFRRYKI 781
H I++ Y CL L +EYMP G++ + AL + V R+Y
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVT---------RKYTR 113
Query: 782 ALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN-SPKVSDYSC 840
+ +G++YLH + I+HRDIK +NIL D K+ DFG +K + +
Sbjct: 114 QI--LEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS 168
Query: 841 FAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEE 883
GT +++PE+ K+DV+S G ++E++T + P E
Sbjct: 169 VTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 59/203 (29%), Positives = 103/203 (50%), Gaps = 15/203 (7%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVK--QLWKGDGVKVFAAEMEILGKIRHRNILKLYACLL 741
+GSG G VY+ AVK +L GD + E+ ++ + +H NI+ + L
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPII 801
++ +EY G+L H + ++ + R + +G+AYLH S +
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLH---SKGKM 128
Query: 802 HRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCK---V 858
HRDIK +NILL ++ + K+ADFGVA A+ + ++ F GT ++APE+A K
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVA--AKITATIAKRKSFIGTPYWMAPEVAAVEKNGGY 186
Query: 859 SEKSDVFSFGVVLLELVTGRKPV 881
++ D+++ G+ +EL + P+
Sbjct: 187 NQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 60/195 (30%), Positives = 89/195 (45%), Gaps = 22/195 (11%)
Query: 704 VAVKQLWKGDGVKV---FAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQ 760
VAVK L F E++IL ++ NI +L +++EYM NG+L Q
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108
Query: 761 ALHKRV------KEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE 814
L K V L + +A A G+ YL S +HRD+ + N L+ +
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGK 165
Query: 815 DYEPKIADFGVAKIAENSPKVSDYSCFAGTH----GYIAPELAYTCKVSEKSDVFSFGVV 870
+Y KIADFG++ + SDY G ++A E K + KSDV++FGV
Sbjct: 166 NYTIKIADFGMS----RNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVT 221
Query: 871 LLELVT--GRKPVEE 883
L E++T +P E
Sbjct: 222 LWEILTLCREQPYEH 236
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 77.1 bits (189), Expect = 2e-15
Identities = 65/213 (30%), Positives = 103/213 (48%), Gaps = 23/213 (10%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQL-WKGDGVKVFAAEMEILGKI-RHRNILKLYACL 740
L+G+G G+VY+ K A+K + GD + E+ +L K HRNI Y
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 741 LKGGSS------FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHH 794
+K +LV+E+ G++ L K K + +W I +G+++LH
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEEWIAY--ICREILRGLSHLHQ 129
Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAY 854
+IHRDIK N+LL E+ E K+ DFGV+ A+ V + F GT ++APE+
Sbjct: 130 H---KVIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFIGTPYWMAPEVI- 183
Query: 855 TCKVSE------KSDVFSFGVVLLELVTGRKPV 881
C + KSD++S G+ +E+ G P+
Sbjct: 184 ACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 65/223 (29%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG-------VKVFAAEMEILGKIR 729
N L+G G G+VY +AVKQ+ V E+++L +R
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 730 HRNILKLYACLLKGGSSFLVL--EYMPNGNL------FQALHKRVKEGKPELDWFRRYKI 781
H I++ Y CL L + EYMP G++ + AL + V RRY
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVT---------RRYTR 113
Query: 782 ALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK-IAENSPKVSDYSC 840
+ +G++YLH S I+HRDIK +NIL D K+ DFG +K I +
Sbjct: 114 QI--LQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS 168
Query: 841 FAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEE 883
GT +++PE+ K+DV+S ++E++T + P E
Sbjct: 169 VTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 2e-15
Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 22/217 (10%)
Query: 669 DIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLW----KGDGVKVFAAEMEI 724
D D E+I L G+G G V+++ K +G + ++L K E+++
Sbjct: 4 DDDFEKISEL------GAGNGGVVFKV-SHKPSGLIMARKLIHLEIKPAIRNQIIRELQV 56
Query: 725 LGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALG 784
L + I+ Y G + +E+M G+L Q L K + + L K+++
Sbjct: 57 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIA 111
Query: 785 AAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGT 844
KG+ YL I+HRD+K SNIL++ E K+ DFGV+ +S S F GT
Sbjct: 112 VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS----FVGT 165
Query: 845 HGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPV 881
Y++PE S +SD++S G+ L+E+ GR P+
Sbjct: 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 3e-15
Identities = 62/204 (30%), Positives = 93/204 (45%), Gaps = 15/204 (7%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYA 738
+G GG G+V ++ A K+L K G + E IL K+ R I+ L A
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59
Query: 739 CLLKGGSSF-LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
+ + LV+ M G+L ++ V E P R G+ +LH
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYN-VDEENPGFPEPRACFYTAQIISGLEHLHQR-- 116
Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVA-KIAENSPKVSDYSCFAGTHGYIAPELAYTC 856
II+RD+K N+LLD D +I+D G+A ++ + K Y AGT G++APEL
Sbjct: 117 -RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY---AGTPGFMAPELLQGE 172
Query: 857 KVSEKSDVFSFGVVLLELVTGRKP 880
+ D F+ GV L E++ R P
Sbjct: 173 EYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 4e-15
Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 38/214 (17%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLY 737
+ +GSG G+V K VA+K+L + + A E+ +L + H N++ L
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLL 80
Query: 738 ACLLKGGSS------FLVLEYMPNGNLFQALHKRVKEGKPELD--WFRRYKIALGAAKGI 789
S +LV M L+ VK K D F Y+I +G+
Sbjct: 81 DVFTPASSLEDFQDVYLVTHLMG-----ADLNNIVKCQKLSDDHIQFLVYQIL----RGL 131
Query: 790 AYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIA 849
Y+H S IIHRD+K SNI ++ED E KI DFG+A+ ++ +++ Y T Y A
Sbjct: 132 KYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD--EMTGY---VATRWYRA 183
Query: 850 PE-----LAYTCKVSEKSDVFSFGVVLLELVTGR 878
PE + Y V D++S G ++ EL+TG+
Sbjct: 184 PEIMLNWMHYNQTV----DIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 4e-15
Identities = 65/211 (30%), Positives = 100/211 (47%), Gaps = 16/211 (7%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNIL-KL 736
++G G GKV + K A+K L K D V+ E +L L +L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
++C + V+EY+ G+L + + + +P ++ A A G+ +LH
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFY-----AAEIAIGLFFLH--- 118
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTC 856
S II+RD+K N++LD + KIADFG+ K EN F GT YIAPE+
Sbjct: 119 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDYIAPEIIAYQ 176
Query: 857 KVSEKSDVFSFGVVLLELVTGRKPVEEEYGD 887
+ D ++FGV+L E++ G+ P E E D
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDED 207
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 4e-15
Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 15/204 (7%)
Query: 684 IGSGGTGKVYR-LDLKKNAGTVAVKQ--LWKGDGVKVFAAEMEILGKIRHRNILKLYACL 740
IG G +G VY +D+ VA+KQ L + ++ E+ ++ + ++ NI+
Sbjct: 27 IGQGASGTVYTAIDIA-TGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
L G ++V+EY+ G+L + + +D + + + + +LH S +
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETC------MDEGQIAAVCRECLQALDFLH---SNQV 136
Query: 801 IHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSE 860
IHRDIKS NILL D K+ DFG A+ +P+ S S GT ++APE+
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 861 KSDVFSFGVVLLELVTGRKPVEEE 884
K D++S G++ +E+V G P E
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPYLNE 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 4e-15
Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 20/213 (9%)
Query: 678 LEEDNLIGSGGTGKVYRLDLKKNAGT----VAVKQLWKGDGVKVFAA---EMEILGKIRH 730
L + L+GSG G V++ + VA+K + G + F M +G + H
Sbjct: 9 LRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDH 68
Query: 731 RNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPE--LDWFRRYKIALGAAKG 788
I++L + G S LV + P G+L + + P+ L+W + AKG
Sbjct: 69 AYIVRLLG-ICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW------CVQIAKG 121
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
+ YL ++HR++ + NILL D +IADFGVA + K YS ++
Sbjct: 122 MYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWM 178
Query: 849 APELAYTCKVSEKSDVFSFGVVLLELVT-GRKP 880
A E + + +SDV+S+GV + E+++ G +P
Sbjct: 179 ALESILFGRYTHQSDVWSYGVTVWEMMSYGAEP 211
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 5e-15
Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 16/208 (7%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKIRHRNIL-KL 736
++G G GKV + K A+K L K D V+ E +L L +L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
++C + V+EY+ G+L + + K +P ++ A A G+ +LH
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFY-----AAEIAIGLFFLH--- 118
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTC 856
S II+RD+K N++LD + KIADFG+ K K + F GT YIAPE+
Sbjct: 119 SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTT--RTFCGTPDYIAPEIIAYQ 176
Query: 857 KVSEKSDVFSFGVVLLELVTGRKPVEEE 884
+ D ++FGV+L E++ G+ P + E
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQPPFDGE 204
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 5e-15
Identities = 66/221 (29%), Positives = 102/221 (46%), Gaps = 37/221 (16%)
Query: 684 IGSGGTGKVYRL-------DLKKNAGTVAVKQLWKGDGVKVFA---AEMEILGKI-RHRN 732
+G G G+V R TVAVK L K A +EME++ I +H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKR-----------VKEGKPELDWFRRYKI 781
I+ L + G ++++EY GNL + L R K + +L +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 782 ALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCF 841
A A+G+ YL S IHRD+ + N+L+ ED KIADFG+A+ V D +
Sbjct: 140 AYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLAR------GVHDIDYY 190
Query: 842 AGTHG------YIAPELAYTCKVSEKSDVFSFGVVLLELVT 876
T ++APE + + +SDV+SFG+++ E+ T
Sbjct: 191 KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 5e-15
Identities = 64/219 (29%), Positives = 107/219 (48%), Gaps = 29/219 (13%)
Query: 684 IGSGGTGKVY-----RLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKL 736
+G G GKV+ L +++ VAVK L + + F E E+L ++H++I++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALH------KRVKEGKP----ELDWFRRYKIALGAA 786
Y +G +V EYM +G+L + L K + G+ +L + IA A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 787 KGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTH- 845
G+ YL S +HRD+ + N L+ + KI DFG+++ + +DY G
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS----TDYYRVGGRTM 185
Query: 846 ---GYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKP 880
++ PE K + +SD++SFGVVL E+ T G++P
Sbjct: 186 LPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 5e-15
Identities = 70/243 (28%), Positives = 121/243 (49%), Gaps = 52/243 (21%)
Query: 684 IGSGGTGKV-YRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLY- 737
+GSG G V LD + A VA+K+L++ ++FA E+ +L ++H N++ L
Sbjct: 23 VGSGAYGTVCSALDRRTGA-KVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLD 81
Query: 738 -----ACLLKGGSSFLVLEYMPN--GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
L + +LV+ +M G L + H+++ E + + F Y++ KG+
Sbjct: 82 VFTPDLSLDRFHDFYLVMPFMGTDLGKLMK--HEKLSEDRIQ---FLVYQML----KGLK 132
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
Y+H + IIHRD+K N+ ++ED E KI DFG+A+ + S+ + + T Y AP
Sbjct: 133 YIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD-----SEMTGYVVTRWYRAP 184
Query: 851 E-----LAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENV 905
E + YT V D++S G ++ E++TG+ + G D HL+ +
Sbjct: 185 EVILNWMHYTQTV----DIWSVGCIMAEMLTGKPLFK-----GHD-------HLDQLMEI 228
Query: 906 LKV 908
+KV
Sbjct: 229 MKV 231
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 7e-15
Identities = 59/211 (27%), Positives = 103/211 (48%), Gaps = 24/211 (11%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL--WKGDGVKVFAAEMEILGKIRHRNILKLYACLL 741
+G G GKVY+ K+ A K + + ++ + E++IL H NI+KL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 742 KGGSSFLVLEYMPNGNL---FQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
+ ++++E+ G + L + + E + + + + + YLH +
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRV-------VCKQTLEALNYLHEN--- 122
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKV 858
IIHRD+K+ NIL D + K+ADFGV+ A+N+ + F GT ++APE+ C+
Sbjct: 123 KIIHRDLKAGNILFTLDGDIKLADFGVS--AKNTRTIQRRDSFIGTPYWMAPEVV-MCET 179
Query: 859 SE------KSDVFSFGVVLLELVTGRKPVEE 883
S+ K+DV+S G+ L+E+ P E
Sbjct: 180 SKDRPYDYKADVWSLGITLIEMAQIEPPHHE 210
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 55/216 (25%), Positives = 98/216 (45%), Gaps = 26/216 (12%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFA-----------AEMEILGKIRHRN 732
IG G VY+ + VA+K+ V++F E+++L ++ H N
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKK------VQIFEMMDAKARQDCLKEIDLLKQLDHPN 63
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
++K A ++ +VLE G+L + + K K+ K + +K + + ++
Sbjct: 64 VIKYLASFIENNELNIVLELADAGDLSR-MIKHFKKQKRLIPERTIWKYFVQLCSALEHM 122
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL 852
H S I+HRDIK +N+ + K+ D G+ + S K + GT Y++PE
Sbjct: 123 H---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSPER 177
Query: 853 AYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDG 888
+ + KSD++S G +L E+ + P YGD
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPF---YGDK 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 73/286 (25%), Positives = 129/286 (45%), Gaps = 36/286 (12%)
Query: 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFA-----AEMEILGKIR 729
+ N + IG G +VYR + VA+K++ D + A E+++L ++
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60
Query: 730 HRNILKLYACLLKGGSSFLVLEYMPNGNLFQALH--KRVKEGKPELD-WFRRYKIALGAA 786
H N++K YA ++ +VLE G+L + + K+ K PE W +Y + L +A
Sbjct: 61 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVW--KYFVQLCSA 118
Query: 787 KGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHG 846
L H S ++HRDIK +N+ + K+ D G+ + S K + GT
Sbjct: 119 -----LEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPY 171
Query: 847 YIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVL 906
Y++PE + + KSD++S G +L E+ + P YGD +N +
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF---YGD----------KMNLYSLCK 218
Query: 907 KVLDCE---VASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949
K+ C+ + S+ E++ +L+ + C P RP + V +
Sbjct: 219 KIEQCDYPPLPSDHYSEELRQLVNM---CINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 56/206 (27%), Positives = 103/206 (50%), Gaps = 21/206 (10%)
Query: 684 IGSGGTGKVYRLDLKKNAGT-----VAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYA 738
IGSG G VY+ +N T + V +L G+ V E+ ++ +H NI+ +
Sbjct: 17 IGSGTYGDVYK---ARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFG 73
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
L+ ++ +E+ G+L H + ++ + R + +G+ YLH S
Sbjct: 74 SYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLH---SK 125
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCK- 857
+HRDIK +NILL ++ K+ADFGV+ A+ + ++ F GT ++APE+A +
Sbjct: 126 GKMHRDIKGANILLTDNGHVKLADFGVS--AQITATIAKRKSFIGTPYWMAPEVAAVERK 183
Query: 858 --VSEKSDVFSFGVVLLELVTGRKPV 881
++ D+++ G+ +EL + P+
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 64/213 (30%), Positives = 103/213 (48%), Gaps = 23/213 (10%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQL-WKGDGVKVFAAEMEILGKI-RHRNILKLYACL 740
++G+G G+VY+ K A+K + D + E+ +L K HRNI Y
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 741 LKGGSS------FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHH 794
+K +LV+E+ G++ L K K + DW I +G+A+LH
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVTD-LVKNTKGNALKEDWIAY--ICREILRGLAHLH- 138
Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAY 854
+ +IHRDIK N+LL E+ E K+ DFGV+ A+ V + F GT ++APE+
Sbjct: 139 --AHKVIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFIGTPYWMAPEVI- 193
Query: 855 TCKVSE------KSDVFSFGVVLLELVTGRKPV 881
C + +SD++S G+ +E+ G P+
Sbjct: 194 ACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-14
Identities = 44/127 (34%), Positives = 61/127 (48%), Gaps = 20/127 (15%)
Query: 462 LILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNI 521
L L N G IP+ + LR L S++L N++ G+IP +G + L+L+ NS +G+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 522 PRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSGSVPLDFLRMGGDGAF 581
P SL L+SL LNL+GN L+G +P L G L F
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL----------------GGRLLHRASFN----F 522
Query: 582 AGNEGLC 588
N GLC
Sbjct: 523 TDNAGLC 529
|
Length = 623 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 1e-14
Identities = 72/242 (29%), Positives = 99/242 (40%), Gaps = 64/242 (26%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTV-AVKQLWKGDGVKV-----FAAEMEILGKIRHRNILKL 736
+IG G G+V L K+ G V A+K L K D +K AE +IL I+KL
Sbjct: 8 VIGRGAFGEV-WLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL 66
Query: 737 YACLLKGGSSF-------LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGI 789
Y SF LV+EYMP G+L L +++ + R Y L A +
Sbjct: 67 YY-------SFQDEEHLYLVMEYMPGGDLMNLL---IRKDVFPEETARFYIAELVLA--L 114
Query: 790 AYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA-KIAENSPKVSD----------- 837
+H IHRDIK NIL+D D K+ADFG+ K+ + +
Sbjct: 115 DSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171
Query: 838 --------------YSCFA-GTHGYIAPE----LAYTCKVSEKSDVFSFGVVLLELVTGR 878
+ GT YIAPE Y + D +S GV+L E++ G
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLEC----DWWSLGVILYEMLYGF 227
Query: 879 KP 880
P
Sbjct: 228 PP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 66/215 (30%), Positives = 105/215 (48%), Gaps = 27/215 (12%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL-WKGDGVKV--FAAEMEILGKIRHRNILKLYACL 740
+G G G VY++ + T+A+K++ + D K E++IL K I+ Y
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVK-EGKPELDWFRRYKIALGAAKGIAYLHHDCSPP 799
G+ ++ +EYM G+L + V EG PE D RR I KG+ +L + +
Sbjct: 69 FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPE-DVLRR--ITYAVVKGLKFLKEEHN-- 123
Query: 800 IIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPE-------- 851
IIHRD+K +N+L++ + + K+ DFGV+ S ++ C Y+APE
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGC----QSYMAPERIKSGGPN 179
Query: 852 --LAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEE 884
YT +SDV+S G+ +LE+ GR P E
Sbjct: 180 QNPTYTV----QSDVWSLGLSILEMALGRYPYPPE 210
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 62/227 (27%), Positives = 102/227 (44%), Gaps = 30/227 (13%)
Query: 677 NLEEDNLIGSGGTGKVYR---LDLKKNAG--TVAVKQLWKGDG---VKVFAAEMEILGKI 728
NL +G G GKV + LK AG TVAVK L + ++ +E +L ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNL--FQALHKRVKEGKPELDWFRRYK------ 780
H +++KLY + G L++EY G+L F ++V D R
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 781 -----------IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829
A ++G+ YL ++HRD+ + N+L+ E + KI+DFG+++
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 830 ENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT 876
S ++A E + + +SDV+SFGV+L E+VT
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 58/230 (25%), Positives = 109/230 (47%), Gaps = 37/230 (16%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGT-VAVKQLWKGDGVKV-----FAAEMEILGKIRH 730
+LE +G+G G+V+ L + + A+K + + +++ E +L ++ H
Sbjct: 2 DLERIKTVGTGTFGRVH-LVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 731 RNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALG---AAK 787
I++L+ ++++EY+P G LF L R+ + G A++
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNS-----------GRFSNSTGLFYASE 109
Query: 788 ---GIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYS-CFAG 843
+ YLH S I++RD+K NILLD++ K+ DFG AK K+ D + G
Sbjct: 110 IVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAK------KLRDRTWTLCG 160
Query: 844 THGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVY 893
T Y+APE+ + ++ D ++ G+++ E++ G P + D +Y
Sbjct: 161 TPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPF---FDDNPFGIY 207
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 74.8 bits (183), Expect = 2e-14
Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 13/203 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQ--LWKGDGVKVFAAEMEILGKIRHRNILKLYACLL 741
IG G +G VY VA++Q L + ++ E+ ++ + ++ NI+ L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPII 801
G ++V+EY+ G+L + + +D + + + + +LH S +I
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETC------MDEGQIAAVCRECLQALEFLH---SNQVI 138
Query: 802 HRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEK 861
HRDIKS NILL D K+ DFG A+ +P+ S S GT ++APE+ K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196
Query: 862 SDVFSFGVVLLELVTGRKPVEEE 884
D++S G++ +E++ G P E
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNE 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-14
Identities = 71/218 (32%), Positives = 96/218 (44%), Gaps = 43/218 (19%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKG 743
IG G G+VY++ K A+K L K K A+ E+ I RNIL L
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSK----KEIVAKKEVAHTIGERNIL---VRTLLD 53
Query: 744 GSSF---------------LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
S F LV +YM G LF L K EG+ D + Y L A
Sbjct: 54 ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQK---EGRFSEDRAKFYIAELVLA-- 108
Query: 789 IAYLH-HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGY 847
+ +LH +D I++RD+K NILLD + DFG++K N + F GT Y
Sbjct: 109 LEHLHKYD----IVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEY 162
Query: 848 IAPEL-----AYTCKVSEKSDVFSFGVVLLELVTGRKP 880
+APE+ YT V D +S GV++ E+ G P
Sbjct: 163 LAPEVLLDEKGYTKHV----DFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 3e-14
Identities = 65/209 (31%), Positives = 96/209 (45%), Gaps = 32/209 (15%)
Query: 684 IGSGGTGKV---YRLDLKKNAGTVAVKQLWKGDGVKVFAA-----EMEILGKIRHRNILK 735
IGSG G V Y +N VA+K+L + V A E+ ++ + H+NI+
Sbjct: 24 IGSGAQGIVCAAYDTVTGQN---VAIKKLSR-PFQNVTHAKRAYRELVLMKLVNHKNIIG 79
Query: 736 LYACLLKGGS------SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGI 789
L S +LV+E M + NL Q + +LD R + GI
Sbjct: 80 LLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQM-------DLDHERMSYLLYQMLCGI 131
Query: 790 AYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIA 849
+LH S IIHRD+K SNI++ D KI DFG+A+ A S ++ Y T Y A
Sbjct: 132 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRA 185
Query: 850 PELAYTCKVSEKSDVFSFGVVLLELVTGR 878
PE+ E D++S G ++ E++ G
Sbjct: 186 PEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 57/215 (26%), Positives = 99/215 (46%), Gaps = 22/215 (10%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGT-----VAVKQLWKGDGVKV---FAAEMEILGKI 728
NL+E +G G G+V+ K V VK L K + F E+++ K+
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQAL---HKRVKEGKPE-LDWFRRYKIALG 784
H+N+++L + +++LEY G+L Q L + ++ KP L ++ +
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 785 AAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGT 844
A G+ +L + +HRD+ + N L+ E K++ ++K NS +Y
Sbjct: 126 IALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNS----EYYKLRNA 178
Query: 845 HG---YIAPELAYTCKVSEKSDVFSFGVVLLELVT 876
++APE S KSDV+SFGV++ E+ T
Sbjct: 179 LIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-14
Identities = 60/204 (29%), Positives = 100/204 (49%), Gaps = 13/204 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV-FAAEMEILGKIRHRNILKLYACLLK 742
+GSG G V L + VA+K + +G + F E +++ K+ H +++LY +
Sbjct: 12 LGSGQFG-VVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIH 802
++V E+M NG L L R ++GK D + +G+ YL + IH
Sbjct: 71 QKPLYIVTEFMENGCLLNYL--RQRQGKLSKDML--LSMCQDVCEGMEYLERN---SFIH 123
Query: 803 RDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAG-THGYIAPELAYTCKVSEK 861
RD+ + N L+ K++DFG+ + + S S A + PE+ K S K
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS--SSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 862 SDVFSFGVVLLELVT-GRKPVEEE 884
SDV+SFGV++ E+ T G+ P E++
Sbjct: 182 SDVWSFGVLMWEVFTEGKMPFEKK 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 3e-14
Identities = 66/229 (28%), Positives = 105/229 (45%), Gaps = 67/229 (29%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA------------EMEILGKIR-H 730
+G G G V++ ++ VA+K K+F A E+ L ++ H
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALK--------KIFDAFRNATDAQRTFREIMFLQELGDH 66
Query: 731 RNILKLYACLLKGGSS---FLVLEYMPN-------GNLFQALHKRVKEGKPELDWFRRYK 780
NI+KL ++K + +LV EYM N+ + +HKR + Y+
Sbjct: 67 PNIVKLLN-VIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKR----------YIMYQ 115
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK------IAENSPK 834
+ K + Y+H S +IHRD+K SNILL+ D K+ADFG+A+ +P
Sbjct: 116 LL----KALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPV 168
Query: 835 VSDYSCFAGTHGYIAPEL-----AYTCKVSEKSDVFSFGVVLLELVTGR 878
++DY T Y APE+ YT V D++S G +L E++ G+
Sbjct: 169 LTDY---VATRWYRAPEILLGSTRYTKGV----DMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 4e-14
Identities = 62/204 (30%), Positives = 97/204 (47%), Gaps = 25/204 (12%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGV--KVFAAEMEILGKIRHRNILKLYAC 739
IG G G V++ ++ VA+K+ + D V K+ E+ +L +++H N++ L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH-HDCSP 798
+ LV EY + + L K + G PE KI + + + H H+C
Sbjct: 69 FRRKRKLHLVFEYCDH-TVLNELEKNPR-GVPEH---LIKKIIWQTLQAVNFCHKHNC-- 121
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL-----A 853
IHRD+K NIL+ + + K+ DFG A+I + DY+ + T Y APEL
Sbjct: 122 --IHRDVKPENILITKQGQIKLCDFGFARIL--TGPGDDYTDYVATRWYRAPELLVGDTQ 177
Query: 854 YTCKVSEKSDVFSFGVVLLELVTG 877
Y V DV++ G V EL+TG
Sbjct: 178 YGPPV----DVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 30/217 (13%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLW-------KGDGVKVFAAEMEILGKIRHRNILK 735
L+G G G+VY +AVKQ+ V E+++L + H I++
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 736 LYACLLKGGSSFL--VLEYMPNGNL------FQALHKRVKEGKPELDWFRRYKIALGAAK 787
Y CL L +E+MP G++ + AL + V R+Y + +
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVT---------RKYTRQI--LE 117
Query: 788 GIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN-SPKVSDYSCFAGTHG 846
G++YLH S I+HRDIK +NIL D K+ DFG +K + + GT
Sbjct: 118 GVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPY 174
Query: 847 YIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEE 883
+++PE+ K+D++S G ++E++T + P E
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 4e-14
Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 36/215 (16%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLY 737
+ IG G G V K VA+K++ + + F E++IL + +H NI+ +
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH-QTFCQRTLREIKILRRFKHENIIGIL 69
Query: 738 ACLLKGGS--SF----LVLEYMPNGNLFQALHKRVKEGKPELD---WFRRYKIALGAAKG 788
+++ S SF +V E M L+K +K D +F Y+I +G
Sbjct: 70 D-IIRPPSFESFNDVYIVQELMETD-----LYKLIKTQHLSNDHIQYFL-YQIL----RG 118
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCF----AGT 844
+ Y+H S ++HRD+K SN+LL+ + + KI DFG+A+IA+ D++ F T
Sbjct: 119 LKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE---HDHTGFLTEYVAT 172
Query: 845 HGYIAPELAYTCKVSEKS-DVFSFGVVLLELVTGR 878
Y APE+ K K+ D++S G +L E+++ R
Sbjct: 173 RWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 6e-14
Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 16/206 (7%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKIRHRNIL-KL 736
+IG G KV + LKKN A+K + K + + E + + L L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
++C FLV+EY+ G+L H + + PE + R Y + A + +LH
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLM--FHMQRQRKLPE-EHARFYAAEICIA--LNFLHER- 115
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTC 856
II+RD+K N+LLD D K+ D+G+ K E S F GT YIAPE+
Sbjct: 116 --GIIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEILRGE 171
Query: 857 KVSEKSDVFSFGVVLLELVTGRKPVE 882
+ D ++ GV++ E++ GR P +
Sbjct: 172 EYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 6e-14
Identities = 63/224 (28%), Positives = 101/224 (45%), Gaps = 40/224 (17%)
Query: 683 LIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGDG-----VKVFAAEMEILGKIRHRNIL 734
++G G G V L ++ G+ VAVK + K D ++ F +E + H N++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTM-KLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 735 KLYACLLKGGSS------FLVLEYMPNGNLFQAL-HKRVKEGKPELDWFRRYKIALGAAK 787
KL + S ++L +M +G+L L + R+ +L K + A
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124
Query: 788 GIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTH-- 845
G+ YL + IHRD+ + N +L ED +ADFG++K K+ +
Sbjct: 125 GMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSK------KIYSGDYYRQGRIA 175
Query: 846 ----GYIAPE-LA---YTCKVSEKSDVFSFGVVLLELVT-GRKP 880
+IA E LA YT KSDV++FGV + E+ T G+ P
Sbjct: 176 KMPVKWIAIESLADRVYT----SKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 7e-14
Identities = 70/236 (29%), Positives = 105/236 (44%), Gaps = 36/236 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
IGSG G V VAVK+L + + A E+ +L + H+NI+ L
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 88
Query: 740 LLKGGS------SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
S +LV+E M + NL Q +H ELD R + GI +LH
Sbjct: 89 FTPQKSLEEFQDVYLVMELM-DANLCQVIHM-------ELDHERMSYLLYQMLCGIKHLH 140
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELA 853
S IIHRD+K SNI++ D KI DFG+A+ A + ++ Y T Y APE+
Sbjct: 141 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV---TRYYRAPEVI 194
Query: 854 YTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVL 909
E D++S G ++ ELV G +++ + H++ V++ L
Sbjct: 195 LGMGYKENVDIWSVGCIMGELVKG------------SVIFQGTDHIDQWNKVIEQL 238
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 9e-14
Identities = 62/204 (30%), Positives = 88/204 (43%), Gaps = 16/204 (7%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVK------VFAAEMEILGKIRHRNILKL 736
+IG G GKV K + AVK L K +K + A +L ++H ++ L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
+ + VL+Y+ G LF L + +P ++ A A I YLH
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFY-----AAEVASAIGYLH--- 113
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTC 856
S II+RD+K NILLD + DFG+ K E S F GT Y+APE+
Sbjct: 114 SLNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKE 171
Query: 857 KVSEKSDVFSFGVVLLELVTGRKP 880
D + G VL E++ G P
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 56/202 (27%), Positives = 100/202 (49%), Gaps = 21/202 (10%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL--WKGDGVKVFAAEME--ILGKIRHRNILKLYAC 739
+G G G+V + + + +K+L + AAE E +L +++H NI+ Y
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV-AYRE 66
Query: 740 LLKGGSS--FLVLEYMPNGNLFQALHKRVKEGKPE---LDWFRRYKIALGAAKGIAYLHH 794
+G ++V+ + G+L+ L ++ + PE ++WF + +AL YLH
Sbjct: 67 SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMAL------QYLHE 120
Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAY 854
I+HRD+K+ N+ L K+ D G+A++ EN ++ S GT Y++PEL
Sbjct: 121 K---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA--STLIGTPYYMSPELFS 175
Query: 855 TCKVSEKSDVFSFGVVLLELVT 876
+ KSDV++ G + E+ T
Sbjct: 176 NKPYNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 1e-13
Identities = 58/206 (28%), Positives = 92/206 (44%), Gaps = 15/206 (7%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYA 738
IG G GKV ++ + A+K + K V AE +L ++ I+ L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
+LVL ++ G LF L + EG+ F + A+ + L +
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQR---EGR-----FDLSRARFYTAELLCALENLHKF 112
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKV 858
+I+RD+K NILLD + DFG+ K+ N + F GT Y+APEL
Sbjct: 113 NVIYRDLKPENILLDYQGHIALCDFGLCKL--NMKDDDKTNTFCGTPEYLAPELLLGHGY 170
Query: 859 SEKSDVFSFGVVLLELVTGRKPVEEE 884
++ D ++ GV+L E++TG P +E
Sbjct: 171 TKAVDWWTLGVLLYEMLTGLPPFYDE 196
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-13
Identities = 64/194 (32%), Positives = 97/194 (50%), Gaps = 30/194 (15%)
Query: 704 VAVKQLWKGDGVKV----FAAEMEILGKI-RHRNILKLYACLLKGGSSFLVLEYMPNGNL 758
VAVK L K D + +EME++ I +H+NI+ L + G ++++EY GNL
Sbjct: 53 VAVKML-KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 111
Query: 759 FQALHKRVKEG---------KPE--LDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKS 807
+ L R G PE L + A A+G+ YL S IHRD+ +
Sbjct: 112 REYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 168
Query: 808 SNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHG-----YIAPELAYTCKVSEKS 862
N+L+ ED KIADFG+A+ + + Y T+G ++APE + + +S
Sbjct: 169 RNVLVTEDNVMKIADFGLAR---DIHHIDYYK--KTTNGRLPVKWMAPEALFDRIYTHQS 223
Query: 863 DVFSFGVVLLELVT 876
DV+SFGV+L E+ T
Sbjct: 224 DVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 42/112 (37%), Positives = 61/112 (54%), Gaps = 19/112 (16%)
Query: 780 KIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS-PKVSDY 838
KIA+ K + YLH S +IHRD+K SN+L++ + + K+ DFG++ +S K D
Sbjct: 107 KIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTID- 163
Query: 839 SCFAGTHGYIAPEL--------AYTCKVSEKSDVFSFGVVLLELVTGRKPVE 882
AG Y+APE Y KSDV+S G+ ++EL TGR P +
Sbjct: 164 ---AGCKPYMAPERINPELNQKGY----DVKSDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 1e-13
Identities = 52/205 (25%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 686 SGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGS 745
G G+V+ V +K KG + E +L + H +++++ L+ G
Sbjct: 76 PGSEGRVFVATKPGQPDPVVLKIGQKGTTL----IEAMLLQNVNHPSVIRMKDTLVSGAI 131
Query: 746 SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDI 805
+ +VL + + +L+ L KR + L + I +G+ YLH + IIHRD+
Sbjct: 132 TCMVLPHY-SSDLYTYLTKRSRP----LPIDQALIIEKQILEGLRYLH---AQRIIHRDV 183
Query: 806 KSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVF 865
K+ NI +++ + I D G A+ +P + AGT APE+ K + K+D++
Sbjct: 184 KTENIFINDVDQVCIGDLGAAQFPVVAP---AFLGLAGTVETNAPEVLARDKYNSKADIW 240
Query: 866 SFGVVLLELVTGRKPVEEEYGDGKD 890
S G+VL E++ + E+ +
Sbjct: 241 SAGIVLFEMLAYPSTIFEDPPSTPE 265
|
Length = 357 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-13
Identities = 48/130 (36%), Positives = 67/130 (51%), Gaps = 9/130 (6%)
Query: 378 PNSYADC---KTIQRLRIS----DNH-LSGKIPDGLWALPNVGMLDFGDNDFTGGISPLI 429
P S ADC T + I DN L G IP+ + L ++ ++ N G I P +
Sbjct: 403 PWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSL 462
Query: 430 GLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGA-LRQLSSLHL 488
G TSL L L N F+G +P LG+LT+L L L N+ SG++P+ALG L +S +
Sbjct: 463 GSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNF 522
Query: 489 EENALTGSIP 498
+NA IP
Sbjct: 523 TDNAGLCGIP 532
|
Length = 623 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 61/211 (28%), Positives = 93/211 (44%), Gaps = 37/211 (17%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAA-EMEILGKIRHRNILKLYA 738
L+G G G V + K+ VA+K+ + VK A E+ +L ++RH N++ L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 739 CLLKGGSSFLVLEYM-----------PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAK 787
+ +LV E++ PNG LD R K +
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPNG----------------LDESRVRKYLFQILR 111
Query: 788 GIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGY 847
GI + H S IIHRDIK NIL+ + K+ DFG A+ +P Y+ + T Y
Sbjct: 112 GIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPG-EVYTDYVATRWY 166
Query: 848 IAPELAY-TCKVSEKSDVFSFGVVLLELVTG 877
APEL K D+++ G ++ E++TG
Sbjct: 167 RAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 60/200 (30%), Positives = 92/200 (46%), Gaps = 24/200 (12%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVK---QLWKGDGVKVFAAEMEILGKIRHRNILKLYACL 740
IG G G+V+ L+ + VAVK + D F E IL + H NI++L
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
+ ++V+E + G+ L EG P L ++ AA G+ YL
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRT---EG-PRLKVKELIQMVENAAAGMEYLESKHC--- 115
Query: 801 IHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHG-------YIAPELA 853
IHRD+ + N L+ E KI+DFG+++ E+ +A T G + APE
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSREEED-------GVYASTGGMKQIPVKWTAPEAL 168
Query: 854 YTCKVSEKSDVFSFGVVLLE 873
+ S +SDV+SFG++L E
Sbjct: 169 NYGRYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 57/188 (30%), Positives = 90/188 (47%), Gaps = 23/188 (12%)
Query: 704 VAVKQLWKGDGVKV----FAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLF 759
VAVK L + D K F E++I+ ++++ NI++L + ++ EYM NG+L
Sbjct: 47 VAVKML-RADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105
Query: 760 QALHKRVKEGK-------PELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILL 812
Q L +R E P + +A+ A G+ YL S +HRD+ + N L+
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLV 162
Query: 813 DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTH----GYIAPELAYTCKVSEKSDVFSFG 868
Y KIADFG+++ + DY G ++A E K + SDV++FG
Sbjct: 163 GNHYTIKIADFGMSR----NLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFG 218
Query: 869 VVLLELVT 876
V L E+ T
Sbjct: 219 VTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 3e-13
Identities = 63/203 (31%), Positives = 87/203 (42%), Gaps = 16/203 (7%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGK-IRHRNILKLY 737
IG G GKV K + AVK L K K AE +L K ++H ++ L+
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
+ VL+Y+ G LF L + +P ++ A A + YLH S
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFY-----AAEIASALGYLH---S 114
Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCK 857
II+RD+K NILLD + DFG+ K E S F GT Y+APE+
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEVLRKQP 172
Query: 858 VSEKSDVFSFGVVLLELVTGRKP 880
D + G VL E++ G P
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 3e-13
Identities = 59/206 (28%), Positives = 93/206 (45%), Gaps = 20/206 (9%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--------DGVKVFAAEMEILGKIRHRNIL 734
+IG G KV ++LKK A+K + K D V+ E H ++
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASN--HPFLV 59
Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHH 794
L++C F V+E++ G+L H + + PE + R Y +A+ L+
Sbjct: 60 GLHSCFQTESRLFFVIEFVSGGDLM--FHMQRQRKLPE-EHARFY-----SAEISLALNF 111
Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAY 854
II+RD+K N+LLD + K+ D+G+ K E S F GT YIAPE+
Sbjct: 112 LHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPEILR 169
Query: 855 TCKVSEKSDVFSFGVVLLELVTGRKP 880
D ++ GV++ E++ GR P
Sbjct: 170 GEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 3e-13
Identities = 67/245 (27%), Positives = 102/245 (41%), Gaps = 28/245 (11%)
Query: 689 TGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL 748
TG +Y + + K + +A + V F E +IL I +L + +L
Sbjct: 25 TGDIYAMKVMKKSVLLAQET------VSFFEEERDILSISNSPWIPQLQYAFQDKDNLYL 78
Query: 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSS 808
V+EY P G+L L++ E + + D + Y L A I +H +HRDIK
Sbjct: 79 VMEYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLA--IHSVH---QMGYVHRDIKPE 131
Query: 809 NILLDEDYEPKIADFG-VAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKS----- 862
N+L+D K+ADFG A++ N S GT YIAPE+ T K
Sbjct: 132 NVLIDRTGHIKLADFGSAARLTANKMVNSKLP--VGTPDYIAPEVLTTMNGDGKGTYGVE 189
Query: 863 -DVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESIKED 921
D +S GV+ E++ GR P E ++ N + LK + S +
Sbjct: 190 CDWWSLGVIAYEMIYGRSPFHE------GTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDL 243
Query: 922 MIKLL 926
+ LL
Sbjct: 244 IQSLL 248
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 3e-13
Identities = 60/203 (29%), Positives = 93/203 (45%), Gaps = 20/203 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAG-TVAVKQ-----LWKGDGVKVFAAEMEILGKIRHRNILKLY 737
+G GG G+V+ L KK+ G VA+K+ L+K + V+ E +IL + ++KL
Sbjct: 9 VGQGGYGQVF-LAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
+L +EY+P G+ F+ L G D R Y + A + LH
Sbjct: 68 YAFQDDEYLYLAMEYVPGGD-FRTL--LNNLGVLSEDHARFYMAEMFEA--VDALHE--- 119
Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCK 857
IHRD+K N L+D K+ DFG++K V+ + G+ Y+APE+
Sbjct: 120 LGYIHRDLKPENFLIDASGHIKLTDFGLSKGI-----VTYANSVVGSPDYMAPEVLRGKG 174
Query: 858 VSEKSDVFSFGVVLLELVTGRKP 880
D +S G +L E + G P
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPP 197
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-13
Identities = 62/206 (30%), Positives = 95/206 (46%), Gaps = 16/206 (7%)
Query: 683 LIGSGGTGKVYRLDLKKN----AGTVAVKQLWKGD-GVKVFAAEMEILGKI-RHRNILKL 736
+IG G KV + LKK A V K+L D + E + + H ++ L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
++C F V+EY+ G+L H + + PE + R Y + A + YLH
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLM--FHMQRQRKLPE-EHARFYSAEISLA--LNYLHER- 115
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTC 856
II+RD+K N+LLD + K+ D+G+ K E S F GT YIAPE+
Sbjct: 116 --GIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGE 171
Query: 857 KVSEKSDVFSFGVVLLELVTGRKPVE 882
D ++ GV++ E++ GR P +
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 5e-13
Identities = 64/203 (31%), Positives = 90/203 (44%), Gaps = 15/203 (7%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKIRHRNILKLY 737
L+G G GKV + K + A+K L K D V E +L RH + L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
V+EY+ G LF L + E D R Y + +A + YLH S
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSR---ERVFSEDRTRFYGAEIVSA--LDYLH---S 113
Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCK 857
I++RD+K N++LD+D KI DFG+ K E + F GT Y+APE+
Sbjct: 114 GKIVYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDND 171
Query: 858 VSEKSDVFSFGVVLLELVTGRKP 880
D + GVV+ E++ GR P
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 5e-13
Identities = 64/217 (29%), Positives = 105/217 (48%), Gaps = 24/217 (11%)
Query: 678 LEEDNLIGSGGTGKVYRLDLKKNAGTV----AVKQLWKGDGVKV---FAAEMEILGKIRH 730
L+ ++GSG G VY+ TV A+K L + G K F E I+ + H
Sbjct: 9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDH 68
Query: 731 RNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPEL--DWFRRYKIALGAAKG 788
++++L L LV + MP+G L +H+ +L +W + AKG
Sbjct: 69 PHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKG 121
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTH--G 846
+ YL ++HRD+ + N+L+ KI DFG+A++ E K +Y+ G
Sbjct: 122 MMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK--EYNADGGKMPIK 176
Query: 847 YIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVE 882
++A E + K + +SDV+S+GV + EL+T G KP +
Sbjct: 177 WMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 6e-13
Identities = 64/212 (30%), Positives = 98/212 (46%), Gaps = 24/212 (11%)
Query: 679 EEDNLIGSGGTGKVYRLDLKK----NAGTVAVKQLWKGDGVK------VFAAEMEILGKI 728
E+ N I + GTG R+ L + VA+K+ K +K VF+ E +IL I
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFS-ERKILNYI 88
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
H + LY +LVLE++ G F L +R K ++ F +I L
Sbjct: 89 NHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL-RRNKRFPNDVGCFYAAQIVLI---- 143
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
YL S I++RD+K N+LLD+D K+ DFG AK+ + GT YI
Sbjct: 144 FEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYT-----LCGTPEYI 195
Query: 849 APELAYTCKVSEKSDVFSFGVVLLELVTGRKP 880
APE+ + +D ++ G+ + E++ G P
Sbjct: 196 APEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 6e-13
Identities = 68/229 (29%), Positives = 103/229 (44%), Gaps = 23/229 (10%)
Query: 677 NLEEDNLIGSGGTGKVY--RLDLKKNAGTV-AVKQLWKGDGVKV------FAAEMEILGK 727
N E ++G+G GKV+ R +AG + A+K L K V+ E ++L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 728 IRHRNIL-KLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAA 786
+R L L+ L+L+Y+ G LF L++R F ++ + A
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREH--------FTESEVRVYIA 112
Query: 787 KGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHG 846
+ + L H II+RDIK NILLD + + DFG++K + YS F GT
Sbjct: 113 EIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS-FCGTIE 171
Query: 847 YIAPELAYTCKVSEKS--DVFSFGVVLLELVTGRKP--VEEEYGDGKDI 891
Y+APE+ D +S GV+ EL+TG P V+ E +I
Sbjct: 172 YMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI 220
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 6e-13
Identities = 65/213 (30%), Positives = 107/213 (50%), Gaps = 30/213 (14%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLW---KGDGVKVFAA-EMEILGKIRHRNILKLY 737
N I G G VYR KK VA+K+L + +G + + E+ IL K++H NI+ +
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVK 70
Query: 738 ACLLKGGSS----FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
++ GS+ ++V+EY+ + L ++ K + L G+A+LH
Sbjct: 71 EVVV--GSNLDKIYMVMEYVEH-----DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH 123
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL- 852
+ I+HRD+K+SN+LL+ KI DFG+A+ + K Y+ T Y APEL
Sbjct: 124 DNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK--PYTQLVVTLWYRAPELL 178
Query: 853 ----AYTCKVSEKSDVFSFGVVLLELVTGRKPV 881
Y+ + D++S G + EL+T +KP+
Sbjct: 179 LGAKEYSTAI----DMWSVGCIFAELLT-KKPL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 7e-13
Identities = 70/279 (25%), Positives = 122/279 (43%), Gaps = 38/279 (13%)
Query: 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLW---------KGDGVKVFAAEMEIL 725
+ N + + IG G +VYR + VA+K++ + D VK E+++L
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVK----EIDLL 56
Query: 726 GKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALH--KRVKEGKPELD-WFRRYKIA 782
++ H N++K ++ +VLE G+L Q + K+ K PE W +Y +
Sbjct: 57 KQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVW--KYFVQ 114
Query: 783 LGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFA 842
L +A + H S ++HRDIK +N+ + K+ D G+ + S K +
Sbjct: 115 LCSA-----VEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLV 167
Query: 843 GTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNH 902
GT Y++PE + + KSD++S G +L E+ + P YGD +N
Sbjct: 168 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF---YGD----------KMNLF 214
Query: 903 ENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRP 941
K+ C+ + KL ++ +C P+ RP
Sbjct: 215 SLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 7e-13
Identities = 63/205 (30%), Positives = 104/205 (50%), Gaps = 19/205 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD---GVKVFAA-EMEILGKIRHRNILKLYAC 739
IG G G V++ ++ VA+K++ D GV A E+ +L +++H+NI++LY
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVK--EGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
L LV EY Q L K G + + + + L KG+A+ H S
Sbjct: 68 LHSDKKLTLVFEYCD-----QDLKKYFDSCNGDIDPEIVKSFMFQL--LKGLAFCH---S 117
Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCK 857
++HRD+K N+L++++ E K+ADFG+A+ A P V YS T Y P++ + K
Sbjct: 118 HNVLHRDLKPQNLLINKNGELKLADFGLAR-AFGIP-VRCYSAEVVTLWYRPPDVLFGAK 175
Query: 858 VSEKS-DVFSFGVVLLELVTGRKPV 881
+ S D++S G + EL +P+
Sbjct: 176 LYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 8e-13
Identities = 74/254 (29%), Positives = 111/254 (43%), Gaps = 32/254 (12%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVK-----VFAAEMEILGKIRHRNILKLY 737
+IG G G+V + K + A+K L K + +K F E +I+ I++L+
Sbjct: 50 VIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLH 109
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
++V+EYMP G+L + PE W R Y + A + +H S
Sbjct: 110 YAFQDDKYLYMVMEYMPGGDLVNLMSNY---DIPE-KWARFYTAEVVLA--LDAIH---S 160
Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVA-KIAENSPKVSDYSCFAGTHGYIAPEL---- 852
IHRD+K N+LLD+ K+ADFG K+ N D + GT YI+PE+
Sbjct: 161 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA--VGTPDYISPEVLKSQ 218
Query: 853 AYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLN--NHENVLKVLD 910
+ D +S GV L E++ G P Y D V T+ +H+N L D
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVGDTPF---YADS-----LVGTYSKIMDHKNSLTFPD 270
Query: 911 CEVASESIKEDMIK 924
S+ K D+I
Sbjct: 271 DIEISKQAK-DLIC 283
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 8e-13
Identities = 61/211 (28%), Positives = 104/211 (49%), Gaps = 35/211 (16%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLY- 737
+GSG G V K+ VA+K+L + ++FA E+ +L ++H N++ L
Sbjct: 22 QVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLD 81
Query: 738 ----ACLLKGGSSF-LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
A F LV+ YM +L + + + E K + + Y++ G+ Y+
Sbjct: 82 VFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHPLSEDKVQ---YLVYQML----CGLKYI 133
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPE- 851
H S IIHRD+K N+ ++ED E KI DFG+A+ A+ ++ + + T Y APE
Sbjct: 134 H---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD-----AEMTGYVVTRWYRAPEV 185
Query: 852 ----LAYTCKVSEKSDVFSFGVVLLELVTGR 878
+ Y V D++S G ++ E++TG+
Sbjct: 186 ILNWMHYNQTV----DIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 8e-13
Identities = 64/203 (31%), Positives = 88/203 (43%), Gaps = 15/203 (7%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLY 737
L+G G GKV + K A+K L K D V E +L RH + L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
V+EY G LF L + E D R Y + +A G YLH S
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALG--YLH---S 113
Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCK 857
+++RD+K N++LD+D KI DFG+ K E + F GT Y+APE+
Sbjct: 114 CDVVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDND 171
Query: 858 VSEKSDVFSFGVVLLELVTGRKP 880
D + GVV+ E++ GR P
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 8e-13
Identities = 60/204 (29%), Positives = 89/204 (43%), Gaps = 16/204 (7%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVK------VFAAEMEILGKIRHRNILKL 736
+IG G GKV K AVK L K +K + + +L ++H ++ L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
+ + VL+Y+ G LF L + +P ++ A A + YLH
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFY-----AAEIASALGYLH--- 113
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTC 856
S I++RD+K NILLD + DFG+ K EN S F GT Y+APE+ +
Sbjct: 114 SLNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQ 171
Query: 857 KVSEKSDVFSFGVVLLELVTGRKP 880
D + G VL E++ G P
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 9e-13
Identities = 62/206 (30%), Positives = 93/206 (45%), Gaps = 31/206 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEI--LGKIR-------HRNIL 734
IG G +V + +K A+K + K F + ++ L +I+ H NIL
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCM-----KKHFKSLEQVNNLREIQALRRLSPHPNIL 61
Query: 735 KLYACLL--KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
+L L K G LV E M + NL++ + R K PE + Y L K + ++
Sbjct: 62 RLIEVLFDRKTGRLALVFELM-DMNLYELIKGR-KRPLPEKR-VKSYMYQL--LKSLDHM 116
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK-IAENSPKVSDYSCFAGTHGYIAPE 851
H + I HRDIK NIL+ D K+ADFG + I P Y+ + T Y APE
Sbjct: 117 HRN---GIFHRDIKPENILIK-DDILKLADFGSCRGIYSKPP----YTEYISTRWYRAPE 168
Query: 852 LAYTCKV-SEKSDVFSFGVVLLELVT 876
T K D+++ G V E+++
Sbjct: 169 CLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 1e-12
Identities = 63/260 (24%), Positives = 104/260 (40%), Gaps = 60/260 (23%)
Query: 684 IGSGGTGKVYRLDLKKNAGT--VAVKQL----WKGDGVKVFAA-EMEILGKIRHRNILKL 736
IG G G+VY+ K A+K+ + G+ A E+ +L +++H N++ L
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 737 YACLL--KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK---IALGAAK---- 787
L S +L+ +Y + +L+Q + + R+ K I K
Sbjct: 68 VEVFLEHADKSVYLLFDYAEH-DLWQIIK-----------FHRQAKRVSIPPSMVKSLLW 115
Query: 788 ----GIAYLHHDCSPPIIHRDIKSSNILL----DEDYEPKIADFGVAKIAENSPKVSDYS 839
G+ YLH S ++HRD+K +NIL+ E KI D G+A++ K
Sbjct: 116 QILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLK----P 168
Query: 840 CFAG-----THGYIAPELA-----YTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGK 889
T Y APEL YT + D+++ G + EL+T + G
Sbjct: 169 LADLDPVVVTIWYRAPELLLGARHYTKAI----DIWAIGCIFAELLTLEPIFK---GREA 221
Query: 890 DIVYWVSTHLNNHENVLKVL 909
I + E + +VL
Sbjct: 222 KIKKSNPFQRDQLERIFEVL 241
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 27/208 (12%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIRHRNILKLYAC 739
IG G G VY+ K VA+K++ + +GV A E+ +L ++ H NI++L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRR------YKIALGAAKGIAYLH 793
+ +LV E+ L L K+ + P Y++ +GIAY H
Sbjct: 67 VHSENKLYLVFEF-----LDLDL-KKYMDSSPLTGLDPPLIKSYLYQLL----QGIAYCH 116
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELA 853
S ++HRD+K N+L+D + K+ADFG+A+ A P V Y+ T Y APE+
Sbjct: 117 ---SHRVLHRDLKPQNLLIDREGALKLADFGLAR-AFGVP-VRTYTHEVVTLWYRAPEIL 171
Query: 854 YTCK-VSEKSDVFSFGVVLLELVTGRKP 880
+ S D++S G + E+V R+P
Sbjct: 172 LGSRQYSTPVDIWSIGCIFAEMVN-RRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-12
Identities = 70/242 (28%), Positives = 119/242 (49%), Gaps = 10/242 (4%)
Query: 331 ENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLN-LLALSNNFSGEVPNSYADCKTIQR 389
ENL L +D++ N+ + + + L L +NN + P ++
Sbjct: 87 ENLLNLLPLPSLDLNLNRLRSNISE--LLELTNLTSLDLDNNNITDIPPLIGLLKSNLKE 144
Query: 390 LRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGEL 449
L +SDN + +P L LPN+ LD ND + + L+ ++L+ L L N+ S +L
Sbjct: 145 LDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSD-LPKLLSNLSNLNNLDLSGNKIS-DL 201
Query: 450 PSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVD 509
P E+ L+ LE L L +NN ++ S+L L+ LS L L N L +P +G+ + +
Sbjct: 202 PPEIELLSALEELDL-SNNSIIELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLET 259
Query: 510 LNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSGSVP 569
L+L+ N +S SL L++L L+LSGN L+ ++P + L L + L+ ++
Sbjct: 260 LDLSNNQIS--SISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKALE 317
Query: 570 LD 571
L
Sbjct: 318 LK 319
|
Length = 394 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 61/209 (29%), Positives = 99/209 (47%), Gaps = 31/209 (14%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIRHRNILKLYAC 739
IG G G VY+ + T+A+K++ + +GV A E+ +L +++H NI++L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 740 LLKGGSSFLVLEY--------MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAY 791
+ +LV EY M + F + +K Y+I +GIAY
Sbjct: 70 VHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKT--------YLYQI----LRGIAY 117
Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEP-KIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
H S ++HRD+K N+L+D K+ADFG+A+ A P V ++ T Y AP
Sbjct: 118 CH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLAR-AFGIP-VRTFTHEVVTLWYRAP 172
Query: 851 E-LAYTCKVSEKSDVFSFGVVLLELVTGR 878
E L + S D++S G + E+V +
Sbjct: 173 EILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 53/165 (32%), Positives = 85/165 (51%), Gaps = 16/165 (9%)
Query: 728 IRHRNILK-LYACLLKGGSSFLVLEYMPNGNLFQALH--KRVKEGKPE-LDWFRRYKIAL 783
+ H+NIL L+ C+ G F++ YM GNL L + + P+ L + +A+
Sbjct: 65 LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAI 124
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAG 843
A G++YLH +IH+DI + N ++DE+ + KI D +++ + P DY C
Sbjct: 125 QIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSR--DLFP--MDYHCLGD 177
Query: 844 THG----YIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEE 883
++A E + S SDV+SFGV+L EL+T G+ P E
Sbjct: 178 NENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE 222
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 2e-12
Identities = 59/203 (29%), Positives = 93/203 (45%), Gaps = 16/203 (7%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNIL-KLYACLLK 742
+ TGK+Y + + + A V K V+ E +L +R L L+
Sbjct: 22 VTGHDTGKLYAMKVLQKAALVQ-----KAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT 76
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIH 802
L+L+Y+ G +F L++R D F ++ + + I L H I++
Sbjct: 77 EAKLHLILDYVSGGEMFTHLYQR--------DNFSEDEVRFYSGEIILALEHLHKLGIVY 128
Query: 803 RDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKS 862
RDIK NILLD + + DFG++K + K YS F GT Y+APE+ K+
Sbjct: 129 RDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-FCGTIEYMAPEIIRGKGGHGKA 187
Query: 863 -DVFSFGVVLLELVTGRKPVEEE 884
D +S G+++ EL+TG P E
Sbjct: 188 VDWWSLGILIFELLTGASPFTLE 210
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 63/203 (31%), Positives = 88/203 (43%), Gaps = 15/203 (7%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKIRHRNILKLY 737
L+G G GKV + K A+K L K D V E +L RH + L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
V+EY G LF L + E + R Y + +A + YLH S
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHLSR---ERVFTEERARFYGAEIVSA--LEYLH---S 113
Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCK 857
+++RDIK N++LD+D KI DFG+ K E + F GT Y+APE+
Sbjct: 114 RDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDND 171
Query: 858 VSEKSDVFSFGVVLLELVTGRKP 880
D + GVV+ E++ GR P
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 3e-12
Identities = 33/91 (36%), Positives = 52/91 (57%)
Query: 435 LSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALT 494
+ L L N G +P+++ +L +L+ + L+ N+ G IP +LG++ L L L N+
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 495 GSIPNEMGDCARIVDLNLARNSLSGNIPRSL 525
GSIP +G + LNL NSLSG +P +L
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 66/213 (30%), Positives = 102/213 (47%), Gaps = 20/213 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK-GDGVKVFAAEMEILGKIR-HRNILKLYACLL 741
IG G GKV+++ KKN AVK L D + AE IL + H N++K Y
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYY 85
Query: 742 K-----GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
K G +LVLE G++ + +K G+ + Y I A G+ +LH +
Sbjct: 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY-ILHEALMGLQHLHVNK 144
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTC 856
+ IHRD+K +NILL + K+ DFGV+ ++ + S GT ++APE+ C
Sbjct: 145 T---IHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFWMAPEVI-AC 198
Query: 857 K------VSEKSDVFSFGVVLLELVTGRKPVEE 883
+ + DV+S G+ +EL G P+ +
Sbjct: 199 EQQLDSTYDARCDVWSLGITAIELGDGDPPLAD 231
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 60/204 (29%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL-----WKGDGVKVFAAEMEILGKIRHRNILKLYA 738
+G GG G+V + +K A K+L K G K+ E EIL K+ I+ L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 739 CLLKGGSSFLVLEYMPNGNL-FQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
LV+ M G+L + + G+ L+ R + GI +LH S
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNV----GERGLEMERVIHYSAQITCGILHLH---S 113
Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVA-KIAENSPKVSDYSCFAGTHGYIAPELAYTC 856
I++RD+K N+LLD+ +++D G+A ++ + AGT+GY+APE+
Sbjct: 114 MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQR----AGTNGYMAPEILKEE 169
Query: 857 KVSEKSDVFSFGVVLLELVTGRKP 880
S D F+ G + E+V GR P
Sbjct: 170 PYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 84/305 (27%), Positives = 139/305 (45%), Gaps = 50/305 (16%)
Query: 669 DIDAEQICNLEEDNLIGSGGTGKVY----RLDLKKNAGT-VAVKQLWKGDGVKV---FAA 720
++ E+I L E +G G G VY R +K A T VAVK + + ++ F
Sbjct: 2 EVSREKITLLRE---LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN 58
Query: 721 EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKE-----GKPELDW 775
E ++ ++++L + KG + +V+E M +G+L L E G+P
Sbjct: 59 EASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 118
Query: 776 FRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK-IAENSPK 834
++A A G+AYL+ + +HRD+ + N ++ D+ KI DFG+ + I E
Sbjct: 119 QEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE---- 171
Query: 835 VSDYSCFAGTH----GYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKD 890
+DY G ++APE + SD++SFGVVL E+ + E+ Y
Sbjct: 172 -TDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---LAEQPY----- 222
Query: 891 IVYWVSTHLNNHENVLK-VLDCEVAS--ESIKEDMIKLLKIAVVCTTKLPNLRPPMREVV 947
L+N E VLK V+D ++ E + L+++ C P +RP E+V
Sbjct: 223 ------QGLSN-EQVLKFVMDGGYLDQPDNCPERVTDLMRM---CWQFNPKMRPTFLEIV 272
Query: 948 KMLAD 952
+L D
Sbjct: 273 NLLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 17/209 (8%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG---VK-VFAAEMEILGKIRHRNILKLYA 738
++G G G V + K+ VA+K+ + VK E+++L ++ NI++L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
+ G +LV EY+ N+ + L + P + R Y L K I + H +
Sbjct: 68 AFRRRGKLYLVFEYVEK-NMLELLEEMPNGVPP--EKVRSYIYQL--IKAIHWCHKN--- 119
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAK-IAENSPKVSDYSCFAGTHGYIAPELAYTCK 857
I+HRDIK N+L+ + K+ DFG A+ ++E S ++Y+ + T Y +PEL
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN--ANYTEYVATRWYRSPELLLGAP 177
Query: 858 VSEKSDVFSFGVVLLELVTGRK--PVEEE 884
+ D++S G +L EL G+ P E E
Sbjct: 178 YGKAVDMWSVGCILGELSDGQPLFPGESE 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 66/223 (29%), Positives = 92/223 (41%), Gaps = 27/223 (12%)
Query: 677 NLEEDNLIGSGGTGKVYR-----LDLKKNAGTVAVKQL---WKGDGVKVFAAEMEILGKI 728
++ +G G G+VY D VAVK L F E I+ K
Sbjct: 7 SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF 66
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQAL-HKRVKEGKP-ELDWFRRYKIALGAA 786
H+NI++L + F++LE M G+L L R + +P L A A
Sbjct: 67 NHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126
Query: 787 KGIAYLHHDCSPPIIHRDIKSSNILLD---EDYEPKIADFGVAK-IAENSPKVSDYSCFA 842
KG YL IHRDI + N LL KIADFG+A+ I + Y
Sbjct: 127 KGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYR-----ASYYRKG 178
Query: 843 GTH----GYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKP 880
G ++ PE + K+DV+SFGV+L E+ + G P
Sbjct: 179 GRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 56/195 (28%), Positives = 88/195 (45%), Gaps = 17/195 (8%)
Query: 689 TGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNIL-KLYACLLKGGSSF 747
+GK+Y + + K A V K + E ++L IR L L+
Sbjct: 27 SGKLYAMKVLKKATIVQ-----KAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81
Query: 748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKS 807
L+L+Y+ G LF L +R + F+ ++ + + + + L H II+RDIK
Sbjct: 82 LILDYINGGELFTHLSQRER--------FKEQEVQIYSGEIVLALEHLHKLGIIYRDIKL 133
Query: 808 SNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKS--DVF 865
NILLD + + DFG++K YS F GT Y+AP++ D +
Sbjct: 134 ENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-FCGTIEYMAPDIVRGGDGGHDKAVDWW 192
Query: 866 SFGVVLLELVTGRKP 880
S GV++ EL+TG P
Sbjct: 193 SMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 5e-12
Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 16/207 (7%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLY 737
++G GG G+V ++ A K+L K G + E +IL K+ R ++ L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLA 66
Query: 738 ACLLKGGSSFLVLEYMPNGNL-FQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
+ LVL M G+L F H G+ + R A G+ LH +
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYHM----GEAGFEEGRAVFYAAEICCGLEDLHQE- 121
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTC 856
I++RD+K NILLD+ +I+D G +A + P+ GT GY+APE+
Sbjct: 122 --RIVYRDLKPENILLDDHGHIRISDLG---LAVHVPEGQTIKGRVGTVGYMAPEVVKNE 176
Query: 857 KVSEKSDVFSFGVVLLELVTGRKPVEE 883
+ + D ++ G +L E++ G+ P ++
Sbjct: 177 RYTFSPDWWALGCLLYEMIAGQSPFQQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 57/199 (28%), Positives = 104/199 (52%), Gaps = 12/199 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQ--LWKGDGVKVFAA-EMEILGKIRHRNILKLYACL 740
+G G VY+ + VA+K+ L +G A E+ ++ +++H NI++L+ +
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
LV EYM + +L + + G + + + + L KGIA+ H + +
Sbjct: 68 HTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQL--LKGIAFCHEN---RV 121
Query: 801 IHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSE 860
+HRD+K N+L+++ E K+ADFG+A+ A P V+ +S T Y AP++ +
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLAR-AFGIP-VNTFSNEVVTLWYRAPDVLLGSRTYS 179
Query: 861 KS-DVFSFGVVLLELVTGR 878
S D++S G ++ E++TGR
Sbjct: 180 TSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 6e-12
Identities = 57/231 (24%), Positives = 91/231 (39%), Gaps = 46/231 (19%)
Query: 681 DNLIGSGGTGKVYRLDLKKNAGTVAVKQL----WKGDGVK------------VFAAEMEI 724
+G G GKV + VA+K++ D K E++I
Sbjct: 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 725 LGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALG 784
+ +I+H NI+ L ++G LV++ M +L K+V + K L + I L
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDL-----KKVVDRKIRLTESQVKCILLQ 127
Query: 785 AAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGT 844
G+ LH +HRD+ +NI ++ KIADFG+A+ P S
Sbjct: 128 ILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLS----K 180
Query: 845 HGYIAPELAYTCKV-------------SEK----SDVFSFGVVLLELVTGR 878
+ T KV +EK D++S G + EL+TG+
Sbjct: 181 DETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 7e-12
Identities = 82/311 (26%), Positives = 127/311 (40%), Gaps = 67/311 (21%)
Query: 677 NLEEDNLIGSGGTGKVYR-----LDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKI 728
N+E IG G G+V++ L + VAVK L + D F E ++ +
Sbjct: 6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 65
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVK-----------------EGKP 771
H NI+KL G L+ EYM G+L + L R
Sbjct: 66 DHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPL 125
Query: 772 ELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831
L + IA A G+AYL +HRD+ + N L+ E+ KIADFG+++
Sbjct: 126 PLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSR---- 178
Query: 832 SPKVSDYSCFAGTHGYI-----APELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEY 885
+ +DY A + I PE + + + +SDV+++GVVL E+ + G +P Y
Sbjct: 179 NIYSADY-YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPY---Y 234
Query: 886 GDGKDIVYWVSTHLNNHENVLK------VLDCEVASESIKEDMIKLLKIAVVCTTKLPNL 939
G HE V+ VL C +L + +C +KLP+
Sbjct: 235 G-------------MAHEEVIYYVRDGNVLSCPDNCPL------ELYNLMRLCWSKLPSD 275
Query: 940 RPPMREVVKML 950
RP + ++L
Sbjct: 276 RPSFASINRIL 286
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 7e-12
Identities = 66/205 (32%), Positives = 97/205 (47%), Gaps = 30/205 (14%)
Query: 684 IGSGGTGKV---YRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKL 736
IGSG G V Y L +N VA+K+L + + A E+ ++ + H+NI+ L
Sbjct: 25 IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81
Query: 737 Y------ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
L + +LV+E M + NL Q + ELD R + GI
Sbjct: 82 LNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQM-------ELDHERMSYLLYQMLCGIK 133
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
+LH S IIHRD+K SNI++ D KI DFG+A+ A S ++ Y T Y AP
Sbjct: 134 HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 187
Query: 851 ELAYTCKVSEKSDVFSFGVVLLELV 875
E+ E D++S G ++ E+V
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 7e-12
Identities = 62/207 (29%), Positives = 106/207 (51%), Gaps = 22/207 (10%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLW---KGDGVKVFAA-EMEILGKIRHRNILKLYAC 739
IG G G VY+ KK VA+K++ + +GV A E+ +L +++H NI+ L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP 799
L++ +L+ E++ + +L + L K + + + Y + +GI + H S
Sbjct: 68 LMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQI--LQGILFCH---SRR 121
Query: 800 IIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL-----AY 854
++HRD+K N+L+D K+ADFG+A+ A P V Y+ T Y APE+ Y
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLAR-AFGIP-VRVYTHEVVTLWYRAPEVLLGSPRY 179
Query: 855 TCKVSEKSDVFSFGVVLLELVTGRKPV 881
+ V D++S G + E+ T +KP+
Sbjct: 180 STPV----DIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 7e-12
Identities = 59/204 (28%), Positives = 97/204 (47%), Gaps = 26/204 (12%)
Query: 684 IGSGGTGKVYRL-DLKKNAGT-------VAVKQLWKGDGVKVFAAEMEILGKIRHRNILK 735
+G G G VY + D K A + V +L + V+ E ++L K+ H I+K
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQA-NQEAQLLSKLDHPAIVK 66
Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGK--PE---LDWFRRYKIALGAAKGIA 790
+A L+ + ++ EY +L L + GK E +WF + + G+
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL------GVH 120
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
Y+H I+HRD+K+ NI L + KI DFGV+++ S ++ + F GT Y++P
Sbjct: 121 YMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLA--TTFTGTPYYMSP 174
Query: 851 ELAYTCKVSEKSDVFSFGVVLLEL 874
E KSD++S G +L E+
Sbjct: 175 EALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 8e-12
Identities = 57/204 (27%), Positives = 88/204 (43%), Gaps = 16/204 (7%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG------DGVKVFAAEMEILGKIRHRNILKL 736
+IG G GKV K + AVK L K + + A +L ++H ++ L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
+ + VL+++ G LF L + +P ++ A A + YLH
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFY-----AAEIASALGYLH--- 113
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTC 856
S I++RD+K NILLD + DFG+ K E + + F GT Y+APE+
Sbjct: 114 SINIVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRKQ 171
Query: 857 KVSEKSDVFSFGVVLLELVTGRKP 880
D + G VL E++ G P
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 9e-12
Identities = 63/208 (30%), Positives = 98/208 (47%), Gaps = 30/208 (14%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
+GSG G V K VAVK+L + + A E+ +L ++H N++ L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 740 LLKGGS------SFLVLEYMPNGNLFQALHKRVKEGKPELD--WFRRYKIALGAAKGIAY 791
S +LV M L+ VK K D F Y+I +G+ Y
Sbjct: 85 FTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQIL----RGLKY 135
Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPE 851
+H S IIHRD+K SN+ ++ED E KI DFG+A+ ++ + + + T Y APE
Sbjct: 136 IH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAPE 187
Query: 852 LAYT-CKVSEKSDVFSFGVVLLELVTGR 878
+ ++ D++S G ++ EL+TGR
Sbjct: 188 IMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-11
Identities = 66/237 (27%), Positives = 101/237 (42%), Gaps = 25/237 (10%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVK-----VFAAEMEILGKIRHRNILKLY 737
+IG G G+V + K A+K L K + +K F E +I+ +++L+
Sbjct: 50 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
++V+EYMP G+L + K W R Y A+ + L S
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----WARFY-----TAEVVLALDAIHS 160
Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYT-- 855
IHRD+K N+LLD+ K+ADFG + N + GT YI+PE+ +
Sbjct: 161 MGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCDTAVGTPDYISPEVLKSQG 219
Query: 856 --CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLD 910
+ D +S GV L E++ G P Y D Y + + NH+N L D
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVGDTPF---YADSLVGTY---SKIMNHKNSLTFPD 270
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-11
Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 40/218 (18%)
Query: 691 KVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL 750
K+ R D KNA + D F E++IL +++ NI++L + ++
Sbjct: 52 KILRPDANKNA---------RND----FLKEVKILSRLKDPNIIRLLGVCVDEDPLCMIT 98
Query: 751 EYMPNGNLFQALHKRVKEGK--------------PELDWFRRYKIALGAAKGIAYLHHDC 796
EYM NG+L Q L + K P + + +AL A G+ YL
Sbjct: 99 EYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---S 155
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTC 856
S +HRD+ + N L+ E+ KIADFG+++ + DY G +A+ C
Sbjct: 156 SLNFVHRDLATRNCLVGENLTIKIADFGMSR----NLYAGDYYRIQGRAVLPIRWMAWEC 211
Query: 857 ----KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKD 890
K + SDV++FGV L E++ K E+ YG+ D
Sbjct: 212 ILMGKFTTASDVWAFGVTLWEILMLCK--EQPYGELTD 247
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-11
Identities = 66/243 (27%), Positives = 98/243 (40%), Gaps = 54/243 (22%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV-----FAAEMEILGKIRHRNILKLYA 738
IG G G+V + A+K L K D + AE +IL + + ++KLY
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
+ + V++Y+P G++ L ++ G E D R Y L A I +H
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLL---IRLGIFEEDLARFYIAELTCA--IESVH---KM 120
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAK--------------------IAENSPKVSDY 838
IHRDIK NIL+D D K+ DFG+ E S + S+
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEI 180
Query: 839 S-----------------CFA----GTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTG 877
C A GT YIAPE+ ++ D +S GV+L E++ G
Sbjct: 181 DRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 240
Query: 878 RKP 880
+ P
Sbjct: 241 QPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-11
Identities = 65/208 (31%), Positives = 98/208 (47%), Gaps = 30/208 (14%)
Query: 684 IGSGGTGKV---YRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKL 736
IGSG G V Y L++N VA+K+L + + A E+ ++ + H+NI+ L
Sbjct: 32 IGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 737 YACLLKGGS------SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
S ++V+E M + NL Q + ELD R + GI
Sbjct: 89 LNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQM-------ELDHERMSYLLYQMLCGIK 140
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
+LH S IIHRD+K SNI++ D KI DFG+A+ A S ++ Y T Y AP
Sbjct: 141 HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAP 194
Query: 851 ELAYTCKVSEKSDVFSFGVVLLELVTGR 878
E+ E D++S G ++ E++ G
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 68/220 (30%), Positives = 106/220 (48%), Gaps = 35/220 (15%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLW---KGDGVKVFAA-EMEILGKIRHRNILKLY 737
IG G G+VY+ K VA+K++ + +G + A E++IL ++ HRNI+ L
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLK 72
Query: 738 ACLL----------KGGSSFLVLEYMPNGNLFQALH-KRVKEGKPELDWFRRYKIALGAA 786
+ G+ +LV EYM + +L L V + + F + +
Sbjct: 73 EIVTDKQDALDFKKDKGAFYLVFEYM-DHDLMGLLESGLVHFSEDHIKSFMKQLL----- 126
Query: 787 KGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHG 846
+G+ Y H +HRDIK SNILL+ + K+ADFG+A++ NS + Y+ T
Sbjct: 127 EGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLY-NSEESRPYTNKVITLW 182
Query: 847 YIAPEL-----AYTCKVSEKSDVFSFGVVLLELVTGRKPV 881
Y PEL Y + DV+S G +L EL T +KP+
Sbjct: 183 YRPPELLLGEERYGPAI----DVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 59/211 (27%), Positives = 92/211 (43%), Gaps = 27/211 (12%)
Query: 684 IGSGGTGKVYRLDLKKNAGT----VAVKQLWKGDGVK---VFAAEMEILGKIRHRNILKL 736
IG+G GKV + + G V VK+L +F E++ ++ H N+L+
Sbjct: 3 IGNGWFGKVLLGEA--HRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHK-RVKE-GKPELDWFRRYKIALGAAKGIAYLHH 794
++ LVLE+ P G+L L R + D +R +A A G+ +LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQR--MACEVASGLLWLHQ 118
Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVA--KIAENSPKVSDYSCFAGTHGYIAPEL 852
IH D+ N L D KI D+G+A + E+ D C A ++APEL
Sbjct: 119 A---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKD--CHAVPLRWLAPEL 173
Query: 853 A-------YTCKVSEKSDVFSFGVVLLELVT 876
++KS+++S GV + EL T
Sbjct: 174 VEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 29/214 (13%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA--EMEILGKIRHRNILKLYACLL 741
+G G G V+ VAVK++ D V A E++I+ ++ H NI+K+Y L
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 742 KGGSS--------------FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAK 787
GS ++V EYM L +++G + R + L +
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETD-----LANVLEQGPLSEEHARLFMYQL--LR 125
Query: 788 GIAYLHHDCSPPIIHRDIKSSNILLD-EDYEPKIADFGVAKIAENSPKVSDY-SCFAGTH 845
G+ Y+H S ++HRD+K +N+ ++ ED KI DFG+A+I + Y S T
Sbjct: 126 GLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182
Query: 846 GYIAPELAYTCKVSEKS-DVFSFGVVLLELVTGR 878
Y +P L + K+ D+++ G + E++TG+
Sbjct: 183 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 4e-11
Identities = 36/104 (34%), Positives = 61/104 (58%), Gaps = 5/104 (4%)
Query: 63 FSGITC--DSVTGR--VTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELS 118
+SG C DS G+ + + DN+ L G I + IS L+ L ++L N + G +P L
Sbjct: 404 WSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG 463
Query: 119 NCSNLKVLNVTGNAMVGSVPD-LSALKNLEIFDLSINYFTGRFP 161
+ ++L+VL+++ N+ GS+P+ L L +L I +L+ N +GR P
Sbjct: 464 SITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 62/209 (29%), Positives = 103/209 (49%), Gaps = 19/209 (9%)
Query: 681 DNLIGSGGTGKVYRLDLK---KNAGTVAVKQLWKGDGVK---VFAAEMEILGKIRHRNIL 734
+ ++G+G G++ R LK K VA+ L G K F AE LG+ H NI+
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69
Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHH 794
+L + +G + +V EYM NG L L K EG +L + + G A G+ YL
Sbjct: 70 RLEGVITRGNTMMIVTEYMSNGALDSFLRKH--EG--QLVAGQLMGMLPGLASGMKYL-- 123
Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHG--YIAPEL 852
+H+ + + +L++ D KI+ F ++ E+ + + Y+ +G + APE
Sbjct: 124 -SEMGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSE-AIYTTMSGKSPVLWAAPEA 179
Query: 853 AYTCKVSEKSDVFSFGVVLLELVT-GRKP 880
S SDV+SFG+V+ E+++ G +P
Sbjct: 180 IQYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (156), Expect = 5e-11
Identities = 52/166 (31%), Positives = 81/166 (48%), Gaps = 29/166 (17%)
Query: 730 HRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGI 789
+ N +KLY + L+++Y+ +G+LF L KEGK + KI + +
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLK---KEGKLSEAEVK--KIIRQLVEAL 122
Query: 790 AYLH-HDCSPPIIHRDIKSSNILLDEDYEPKI--ADFGVAKIAENSPKVSDYSCFAGTHG 846
LH H+ IIH DIK N+L D + +I D+G+ KI +P SC+ GT
Sbjct: 123 NDLHKHN----IIHNDIKLENVLYDR-AKDRIYLCDYGLCKI-IGTP-----SCYDGTLD 171
Query: 847 YIAPELAYTCKVSEKSDVFSF-----GVVLLELVTGRKPVEEEYGD 887
Y +PE K+ + SF GV+ EL+TG+ P +E+ +
Sbjct: 172 YFSPE-----KIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE 212
|
Length = 267 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 6e-11
Identities = 33/104 (31%), Positives = 51/104 (49%), Gaps = 8/104 (7%)
Query: 231 GEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKN 290
G P I KL+ L I L N++ G +P LG++T L+ D+S N G +PE +G L +
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 291 LTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLG 334
L + N+ SG P+ G ++ F+ F +N G
Sbjct: 492 LRILNLNGNSLSGRVPAALG------GRLLHRASFN--FTDNAG 527
|
Length = 623 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 7e-11
Identities = 63/215 (29%), Positives = 98/215 (45%), Gaps = 25/215 (11%)
Query: 679 EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIR---HR 731
EE IG G G VY+ VA+K++ +G+ + E+ +L ++ H
Sbjct: 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHP 61
Query: 732 NILKLY-ACLLKGGSS----FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK-IALGA 785
NI++L C LV E++ + +L L K K G P K +
Sbjct: 62 NIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPP----ETIKDLMRQL 116
Query: 786 AKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTH 845
+G+ +LH S I+HRD+K NIL+ D + KIADFG+A+I ++ S T
Sbjct: 117 LRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALT--SVVV-TL 170
Query: 846 GYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKP 880
Y APE+ + D++S G + EL R+P
Sbjct: 171 WYRAPEVLLQSSYATPVDMWSVGCIFAELFR-RRP 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 7e-11
Identities = 59/177 (33%), Positives = 88/177 (49%), Gaps = 36/177 (20%)
Query: 788 GIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK-----IAENSPKVSDYSCFA 842
G+ Y+H S ++HRD+K N+L++ D E KI DFG+A+ EN+ +++Y
Sbjct: 117 GLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEY---V 170
Query: 843 GTHGYIAPELAYTCKVSEKS-DVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNN 901
T Y APE+ + + K+ DV+S G +L EL+ GRKPV + GKD V LN
Sbjct: 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFK----GKDYVD----QLNQ 221
Query: 902 HENVLKVLDCEVASE--SIK-EDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADP 955
VL D E S S K ++ I+ LPN P + + +A+P
Sbjct: 222 ILQVLGTPDEETLSRIGSPKAQNYIR----------SLPN--IPKKPFESIFPNANP 266
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 7e-11
Identities = 55/204 (26%), Positives = 92/204 (45%), Gaps = 16/204 (7%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLY 737
++G GG G+V ++ A K+L K G + E +IL K+ + ++ L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLA 66
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
+ LVL M G+L ++ G P + R A G+ LH +
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNM---GNPGFEEERALFYAAEILCGLEDLHRE-- 121
Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVA-KIAENSPKVSDYSCFAGTHGYIAPELAYTC 856
++RD+K NILLD+ +I+D G+A KI P+ GT GY+APE+
Sbjct: 122 -NTVYRDLKPENILLDDYGHIRISDLGLAVKI----PEGESIRGRVGTVGYMAPEVLNNQ 176
Query: 857 KVSEKSDVFSFGVVLLELVTGRKP 880
+ + D + G ++ E++ G+ P
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 8e-11
Identities = 62/203 (30%), Positives = 89/203 (43%), Gaps = 14/203 (6%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKIRHRNILKLY 737
L+G G GKV + K A+K L K D V E +L RH + L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
V+EY G LF L + E D R Y + +A + YLH + +
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSA--LDYLHSEKN 116
Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCK 857
+++RD+K N++LD+D KI DFG+ K E + F GT Y+APE+
Sbjct: 117 --VVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDND 172
Query: 858 VSEKSDVFSFGVVLLELVTGRKP 880
D + GVV+ E++ GR P
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 9e-11
Identities = 46/176 (26%), Positives = 85/176 (48%), Gaps = 22/176 (12%)
Query: 715 VKVFAAEMEILGKIRHRNILKLYACLLKGGSSF----LVLEYMPNGNLFQALHKRVKEGK 770
+ + E++ L +I NILK+Y ++ L+LEY G L + L K +
Sbjct: 62 IDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDK-----E 116
Query: 771 PELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830
+L + + +A+ KG+ L+ + P ++++ S + L+ E+Y+ KI G+ KI
Sbjct: 117 KDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILS 174
Query: 831 NSP--KVSDYSCFAGTHGYIAPELAYTC--KVSEKSDVFSFGVVLLELVTGRKPVE 882
+ P V+ Y + ++ + + K D++S GVVL E+ TG+ P E
Sbjct: 175 SPPFKNVNFMV-------YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFE 223
|
Length = 283 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-10
Identities = 64/250 (25%), Positives = 106/250 (42%), Gaps = 54/250 (21%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTV-AVKQLWKGD-----GVKVFAAEMEILGKIRH 730
+ E +IG G G+V RL KK+ G + A+K L K D V AE +IL +
Sbjct: 2 DFESLKVIGRGAFGEV-RLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 731 RNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWF-RRYKIALGAAKGI 789
++K++ + +L++E++P G++ L K+ + ++ +A+ A +
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120
Query: 790 AYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA-------------KIAENSPKVS 836
+ IHRDIK N+LLD K++DFG+ + N P S
Sbjct: 121 GF---------IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPP--S 169
Query: 837 DYS----------------------CFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLEL 874
D+S GT YIAPE+ ++ D +S GV++ E+
Sbjct: 170 DFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229
Query: 875 VTGRKPVEEE 884
+ G P E
Sbjct: 230 LIGYPPFCSE 239
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 58/212 (27%), Positives = 90/212 (42%), Gaps = 26/212 (12%)
Query: 681 DNLIGSGGTGKVYR---LDLKKNAGTVAVKQLWK---GDGVKVFAAEMEILGKIRHRNIL 734
IG G G VY+ + + VAVK + F E I+ + H +I+
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHH 794
KL ++ ++V+E P G L L K LD + + +AYL
Sbjct: 71 KLIG-VITENPVWIVMELAPLGELRSYLQVN----KYSLDLASLILYSYQLSTALAYLE- 124
Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHG-----YIA 849
S +HRDI + N+L+ K+ DFG+ S + D S + + G ++A
Sbjct: 125 --SKRFVHRDIAARNVLVSSPDCVKLGDFGL------SRYLEDESYYKASKGKLPIKWMA 176
Query: 850 PELAYTCKVSEKSDVFSFGVVLLE-LVTGRKP 880
PE + + SDV+ FGV + E L+ G KP
Sbjct: 177 PESINFRRFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 55/187 (29%), Positives = 91/187 (48%), Gaps = 22/187 (11%)
Query: 704 VAVKQLWKGDGVKV----FAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLF 759
VAVK L + D K F E++I+ +++ NI++L A + ++ EYM NG+L
Sbjct: 49 VAVKML-REDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107
Query: 760 QALHKR------VKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD 813
Q L + K + + +A A G+ YL S +HRD+ + N L+
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVG 164
Query: 814 EDYEPKIADFGVAKIAENSPKVSDYSCFAGTH----GYIAPELAYTCKVSEKSDVFSFGV 869
++Y KIADFG+++ + DY G +++ E K + SDV++FGV
Sbjct: 165 KNYTIKIADFGMSR----NLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGV 220
Query: 870 VLLELVT 876
L E++T
Sbjct: 221 TLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 37/218 (16%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLK 742
+IG GG G+VY A+K L D ++ + E L + R +L L +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCL---DKKRIKMKQGETLA-LNERIMLSLVS---T 53
Query: 743 GGSSFLV---------------LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAK 787
G F+V L+ M G+L L + + E+ ++ A +
Sbjct: 54 GDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFY--------ATE 105
Query: 788 GIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA-KIAENSPKVSDYSCFAGTHG 846
I L H + +++RD+K +NILLDE +I+D G+A ++ P S GTHG
Sbjct: 106 IILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHG 160
Query: 847 YIAPELAYTCKVSEKS-DVFSFGVVLLELVTGRKPVEE 883
Y+APE+ + S D FS G +L +L+ G P +
Sbjct: 161 YMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 2e-10
Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 30/216 (13%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYA- 738
IG G G+V++ KK VA+K++ + + F E++IL ++H N++ L
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79
Query: 739 CLLKG-------GSSFLVLEYMPN--GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGI 789
C K GS +LV E+ + L +K VK E+ K+ G+
Sbjct: 80 CRTKATPYNRYKGSFYLVFEFCEHDLAGLLS--NKNVKFTLSEIK-----KVMKMLLNGL 132
Query: 790 AYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAG---THG 846
Y+H I+HRD+K++NIL+ +D K+ADFG+A+ A + K S + + T
Sbjct: 133 YYIH---RNKILHRDMKAANILITKDGILKLADFGLAR-AFSLSKNSKPNRYTNRVVTLW 188
Query: 847 YIAPELAYTCK-VSEKSDVFSFGVVLLELVTGRKPV 881
Y PEL + D++ G ++ E+ T R P+
Sbjct: 189 YRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPI 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 2e-10
Identities = 64/214 (29%), Positives = 99/214 (46%), Gaps = 22/214 (10%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVK-----VFAAEMEILGKIRHRNILKLY 737
+IG G G+V + LK A+K L K + +K F E ++L ++ I L+
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLH 67
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAA-KGIAYLHHDC 796
+ +LV++Y G+L L K ++ PE D R Y + A + LH+
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTLLSK-FEDRLPE-DMARFYLAEMVIAIDSVHQLHY-- 123
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVA-KIAENSPKVSDYSCFAGTHGYIAPELAYT 855
+HRDIK NIL+D + ++ADFG K+ E+ S S GT YI+PE+
Sbjct: 124 ----VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS--SVAVGTPDYISPEILQA 177
Query: 856 C-----KVSEKSDVFSFGVVLLELVTGRKPVEEE 884
K + D +S GV + E++ G P E
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 37/98 (37%), Positives = 54/98 (55%), Gaps = 7/98 (7%)
Query: 785 AAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA-KIAENSPKVSDYSCFAG 843
AA+ I L H + +++RD+K +NILLDE +I+D G+A ++ P S G
Sbjct: 103 AAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VG 157
Query: 844 THGYIAPE-LAYTCKVSEKSDVFSFGVVLLELVTGRKP 880
THGY+APE L +D FS G +L +L+ G P
Sbjct: 158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-10
Identities = 66/234 (28%), Positives = 105/234 (44%), Gaps = 27/234 (11%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVK-----VFAAEMEILGKIRHRNILKLY 737
+IG G G+V + K + A+K L K + +K F E +I+ +++L+
Sbjct: 50 VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
++V+EYMP G+L + PE W + Y A+ + L S
Sbjct: 110 CAFQDDKYLYMVMEYMPGGDLVNLMSNY---DVPE-KWAKFY-----TAEVVLALDAIHS 160
Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVA-KIAENSPKVSDYSCFAGTHGYIAPELAYT- 855
+IHRD+K N+LLD+ K+ADFG K+ E D + GT YI+PE+ +
Sbjct: 161 MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA--VGTPDYISPEVLKSQ 218
Query: 856 ---CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVL 906
+ D +S GV L E++ G P Y D Y + + +H+N L
Sbjct: 219 GGDGYYGRECDWWSVGVFLFEMLVGDTPF---YADSLVGTY---SKIMDHKNSL 266
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 66/215 (30%), Positives = 104/215 (48%), Gaps = 37/215 (17%)
Query: 684 IGSGGTGKVYR--LDLKKNAGTVAVKQLWKGDGVKVFAAEM----EILGKIRHRNILKLY 737
+GSG G V + +KK+ TVAVK L + E+ ++ ++ + I+++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 738 ACLLKGGSSFLVLEYMPNG--NLFQALHKRVKEGK-PELDWFRRYKIALGAAKGIAYLHH 794
+ + S LV+E G N F +K V E EL +++++G + YL
Sbjct: 63 G-ICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITEL----VHQVSMG----MKYLEE 113
Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA---ENSPKVSDYSCFAGTHG----- 846
+HRD+ + N+LL + KI+DFG++K EN K A THG
Sbjct: 114 T---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK-------AKTHGKWPVK 163
Query: 847 YIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKP 880
+ APE K S KSDV+SFGV++ E + G+KP
Sbjct: 164 WYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 37/96 (38%), Positives = 56/96 (58%), Gaps = 7/96 (7%)
Query: 787 KGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHG 846
+G+ Y+H S ++HRD+K SN+LL+ + + KI DFG+A+ S K + + T
Sbjct: 119 RGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLART--TSEKGDFMTEYVVTRW 173
Query: 847 YIAPELAYTCKVSEKS-DVFSFGVVLLELVTGRKPV 881
Y APEL C + DV+S G + EL+ GRKP+
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-10
Identities = 29/82 (35%), Positives = 48/82 (58%)
Query: 205 LRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNL 264
LRG IP IS+LR L ++++ N I G P S+ + L ++L N+ G +P LG L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 265 TLLQEFDISSNQMYGKLPEEIG 286
T L+ +++ N + G++P +G
Sbjct: 490 TSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 3e-10
Identities = 50/214 (23%), Positives = 83/214 (38%), Gaps = 33/214 (15%)
Query: 685 GSGGTGKVYRLDLKKNAGTVAVKQ--LWKGDG--VKVFAAEMEILGKIRHRNILKLYACL 740
+ + K VAVK+ L +K+ E+ +++H NIL
Sbjct: 11 EDLMIVHLAKH--KPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68
Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL---GAAKGIAYLHHDCS 797
+ ++V M G+ L EG PEL IA + Y+H
Sbjct: 69 IVDSELYVVSPLMAYGSCEDLLKTHFPEGLPEL------AIAFILKDVLNALDYIHSK-- 120
Query: 798 PPIIHRDIKSSNILLDEDYEPKIADF----GVAKIAENSPKVSDYSCFAGTH-GYIAPEL 852
IHR +K+S+ILL D + ++ + K + V D+ + + +++PE+
Sbjct: 121 -GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEV 179
Query: 853 ------AYTCKVSEKSDVFSFGVVLLELVTGRKP 880
Y EKSD++S G+ EL G P
Sbjct: 180 LQQNLQGYN----EKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 4e-10
Identities = 66/245 (26%), Positives = 104/245 (42%), Gaps = 61/245 (24%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTV-AVKQLWKGDGVKV-----FAAEMEILGKIRHRNILKL 736
+IG G G+V RL KK+ G + A+K+L K + ++ AE +IL + + ++KL
Sbjct: 8 VIGRGAFGEV-RLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFR----RYKIALGAAKGIAYL 792
Y +L++EY+P G++ L K+ D F R+ IA I +
Sbjct: 67 YYSFQDENYLYLIMEYLPGGDMMTLLMKK--------DTFTEEETRFYIA-ETILAIDSI 117
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK-------------IAENSPKVSD-- 837
H IHRDIK N+LLD K++DFG+ ++ P
Sbjct: 118 H---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDF 174
Query: 838 ----------------------YSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELV 875
YS GT YIAPE+ +++ D +S GV++ E++
Sbjct: 175 ISKPMSSKRKAETWKRNRRALAYST-VGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233
Query: 876 TGRKP 880
G P
Sbjct: 234 VGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 61/208 (29%), Positives = 95/208 (45%), Gaps = 24/208 (11%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKL- 736
++G GG G+V ++ A K+L K G + E +IL K+ R ++ L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 66
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
YA K LVL M G+L ++ G P D R A G+ LH
Sbjct: 67 YAYETKDALC-LVLTLMNGGDLKFHIYNM---GNPGFDEERAVFYAAEITCGLEDLH--- 119
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVA-KIAENSP---KVSDYSCFAGTHGYIAPEL 852
I++RD+K NILLD+ +I+D G+A +I E +V GT GY+APE+
Sbjct: 120 RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV-------GTVGYMAPEV 172
Query: 853 AYTCKVSEKSDVFSFGVVLLELVTGRKP 880
+ + D + G ++ E++ G+ P
Sbjct: 173 VKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 5e-10
Identities = 62/227 (27%), Positives = 111/227 (48%), Gaps = 34/227 (14%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKIRHRNILKLY 737
+IG G G V VA+K++ D ++ E+++L +RH +I+++
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR-EIKLLRLLRHPDIVEIK 65
Query: 738 ACLLKGGSS-----FLVLEYMPNGNLFQALHKRVKEG---KPELDWFRRYKIALGAAKGI 789
+L ++V E M + LH+ +K PE F Y++ + +
Sbjct: 66 HIMLPPSRREFKDIYVVFELMESD-----LHQVIKANDDLTPEHHQFFLYQLL----RAL 116
Query: 790 AYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN-SPKVSDYSCFAGTHGYI 848
Y+H + + HRD+K NIL + D + KI DFG+A++A N +P ++ + T Y
Sbjct: 117 KYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173
Query: 849 APEL--AYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVY 893
APEL ++ K + D++S G + E++TG KP+ GK++V+
Sbjct: 174 APELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFP----GKNVVH 215
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 6e-10
Identities = 61/221 (27%), Positives = 94/221 (42%), Gaps = 42/221 (19%)
Query: 679 EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA---------EMEILGKIR 729
E D IG G G V+ + ++ VA+K++ VF E+++L +
Sbjct: 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKM-----PNVFQNLVSCKRVFRELKMLCFFK 57
Query: 730 HRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRR---YKIALGAA 786
H N+L L Y+ + LHK + +P + Y+I
Sbjct: 58 HDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQIL---- 113
Query: 787 KGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAG--- 843
+G+ YLH S I+HRDIK N+L++ + KI DFG+A++ E D S
Sbjct: 114 RGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEE-----PDESKHMTQEV 165
Query: 844 -THGYIAPELA-----YTCKVSEKSDVFSFGVVLLELVTGR 878
T Y APE+ YT V D++S G + EL+ R
Sbjct: 166 VTQYYRAPEILMGSRHYTSAV----DIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 6e-10
Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 20/203 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
+GSG G V + VAVK+L + + A E+ +L ++H N++ L
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 740 LLKGGSSFLVLEYMPNGNLFQA-LHKRVKEGKPELD--WFRRYKIALGAAKGIAYLHHDC 796
S E NL A L+ VK K + F Y++ +G+ Y+H
Sbjct: 83 FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLL----RGLKYIH--- 135
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYT- 855
S IIHRD+K SN+ ++ED E +I DFG+A+ A++ + + + T Y APE+
Sbjct: 136 SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD-----EMTGYVATRWYRAPEIMLNW 190
Query: 856 CKVSEKSDVFSFGVVLLELVTGR 878
++ D++S G ++ EL+ G+
Sbjct: 191 MHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 23/217 (10%)
Query: 684 IGSGGTGKVYRLDL----KKNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRHRNILKL 736
+G GK+Y+ L +A VA+K L + + F E ++ ++ H NI+ L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQAL-----HKRV-----KEG--KPELDWFRRYKIALG 784
+ + ++ EY+ G+L + L H V ++G K LD IA+
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 785 AAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGT 844
A G+ YL S +H+D+ + NIL+ E KI+D G+++ ++
Sbjct: 133 IAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 845 HGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKP 880
++ PE K S SD++SFGVVL E+ + G +P
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 6e-10
Identities = 70/262 (26%), Positives = 105/262 (40%), Gaps = 75/262 (28%)
Query: 684 IGSGGTGKVYR---LDLKKNAG--TVAVKQLWKG---DGVKVFAAEMEILGKI-RHRNIL 734
+G G GKV + ++K+A TVAVK L +G K E++IL I H N++
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVV 74
Query: 735 KLY-ACLLKGGSSFLVLEYMPNGNLFQAL------------------------------- 762
L AC GG +++EY GNL L
Sbjct: 75 NLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLD 134
Query: 763 ---------------HKRVKEGKPELDWFRRYKIAL----------GAAKGIAYLHHDCS 797
K + + + + + YK L A+G+ +L S
Sbjct: 135 SVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL---AS 191
Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTH---GYIAPELAY 854
IHRD+ + NILL E+ KI DFG+A+ P DY ++APE +
Sbjct: 192 RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP---DYVRKGDARLPLKWMAPESIF 248
Query: 855 TCKVSEKSDVFSFGVVLLELVT 876
+ +SDV+SFGV+L E+ +
Sbjct: 249 DKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 9e-10
Identities = 68/244 (27%), Positives = 105/244 (43%), Gaps = 44/244 (18%)
Query: 683 LIGSGGTGKVY---------RLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNI 733
LIG GG G+VY R+ LKK ++ L K K F E +I + H I
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLK----KRFLREAKIAADLIHPGI 64
Query: 734 LKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGA-------- 785
+ +Y+ G + + Y+ G ++L K V + K L K ++GA
Sbjct: 65 VPVYSICSDGDPVYYTMPYI-EGYTLKSLLKSVWQ-KESLSKELAEKTSVGAFLSIFHKI 122
Query: 786 AKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV---SDY---- 838
I Y+H S ++HRD+K NILL E I D+G A + + D
Sbjct: 123 CATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179
Query: 839 SCFA---------GTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGK 889
C++ GT Y+APE SE +D+++ GV+L +++T P + G+
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK--KGR 237
Query: 890 DIVY 893
I Y
Sbjct: 238 KISY 241
|
Length = 932 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-09
Identities = 35/103 (33%), Positives = 52/103 (50%), Gaps = 2/103 (1%)
Query: 367 LALSNN-FSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGI 425
L L N G +PN + + +Q + +S N + G IP L ++ ++ +LD N F G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 426 SPLIGLSTSLSQLVLQNNRFSGELPSELG-RLTNLERLILTNN 467
+G TSL L L N SG +P+ LG RL + T+N
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 1e-09
Identities = 69/222 (31%), Positives = 103/222 (46%), Gaps = 14/222 (6%)
Query: 75 VTEISFDNKSLSGEISSSISALQS-LTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAM 133
+T + DN +++ +I I L+S L L L N + LP L N NLK L+++ N +
Sbjct: 118 LTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDL 175
Query: 134 VGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLK 193
LS L NL DLS N + P + L+ L L + +N E+ S+ NLK
Sbjct: 176 SDLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNN--SIIELLSSLSNLK 232
Query: 194 NLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNL 253
NL+ L L++ N +PESI L L TLD+ N+IS S+ L L +++L N+L
Sbjct: 233 NLSGLELSN-NKLEDLPESIGNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSL 289
Query: 254 TGELPAE-LGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVF 294
+ LP L L L ++ E+ L
Sbjct: 290 SNALPLIALLLLLLELLLNLLLT----LKALELKLNSILLNN 327
|
Length = 394 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 1e-09
Identities = 65/261 (24%), Positives = 112/261 (42%), Gaps = 37/261 (14%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVK-----VFAAEMEILGKIRHRNILKLY 737
+IG G G+V + +K A+K L K + +K F E ++L R I L+
Sbjct: 8 VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLH 67
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
+ +LV++Y G+L L K ++ F ++ L A + L +
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVL-AIDSVHQLGY--- 123
Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVA-KIAENSPKVSDYSCFAGTHGYIAPELAY-- 854
+HRDIK N+LLD++ ++ADFG ++ + S + GT YI+PE+
Sbjct: 124 ---VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS--NVAVGTPDYISPEILQAM 178
Query: 855 ---TCKVSEKSDVFSFGVVLLELVTGRKP-----VEEEYGDGKDIVYWVSTHLNNHENVL 906
+ + D +S GV + E++ G P + E YG + NH+
Sbjct: 179 EDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK-----------IMNHKEHF 227
Query: 907 KV-LDCEVASESIKEDMIKLL 926
+ D SE K+ + +L+
Sbjct: 228 QFPPDVTDVSEEAKDLIRRLI 248
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 1e-09
Identities = 62/209 (29%), Positives = 104/209 (49%), Gaps = 22/209 (10%)
Query: 684 IGSGGTGKVYRLDLK--KNAGTVAVKQLWKGDGVKVFAA-EMEILGKIRHRNILKLYACL 740
+G G G VY+ K K+ A+KQ+ +G G+ + A E+ +L +++H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQI-EGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 741 LKGGSS--FLVLEYMPNGNLFQAL--HKRVKEGKPELDWFRRYKIAL--GAAKGIAYLHH 794
L +L+ +Y + +L+ + H+ K K + R +L GI YLH
Sbjct: 68 LSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 795 DCSPPIIHRDIKSSNILL----DEDYEPKIADFGVAKIAENSP--KVSDYSCFAGTHGYI 848
+ ++HRD+K +NIL+ E KIAD G A++ NSP ++D T Y
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLF-NSPLKPLADLDPVVVTFWYR 182
Query: 849 APELAYTCKVSEKS-DVFSFGVVLLELVT 876
APEL + K+ D+++ G + EL+T
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 60/200 (30%), Positives = 98/200 (49%), Gaps = 16/200 (8%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQ--LWKGDGVKVFAA-EMEILGKIRHRNILKLYACL 740
+G G V++ K VA+K+ L +G A E+ +L ++H NI+ L+ +
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL-GAAKGIAYLHHDCSPP 799
LV EY+ + +L Q L + L KI + +G++Y H
Sbjct: 73 HTERCLTLVFEYLDS-DLKQYL-----DNCGNLMSMHNVKIFMFQLLRGLSYCHKR---K 123
Query: 800 IIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPE-LAYTCKV 858
I+HRD+K N+L++E E K+ADFG+A+ A++ P YS T Y P+ L + +
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLAR-AKSVP-TKTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 859 SEKSDVFSFGVVLLELVTGR 878
S D++ G +L E+ TGR
Sbjct: 182 STPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 1e-09
Identities = 21/42 (50%), Positives = 27/42 (64%), Gaps = 1/42 (2%)
Query: 29 LNVETQALIQFKSKL-KDPHGVLDSWKESADSPCGFSGITCD 69
LN + AL+ FKS L DP G L SW S+ PC ++G+TCD
Sbjct: 1 LNDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-09
Identities = 51/178 (28%), Positives = 77/178 (43%), Gaps = 14/178 (7%)
Query: 704 VAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALH 763
V VK + G K E++IL I HR I+ L + +V+ +LF +
Sbjct: 122 VIVKAVTGG---KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYV- 176
Query: 764 KRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADF 823
+ L + I + +AYLH IIHRD+K+ NI LDE + DF
Sbjct: 177 ----DRSGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDF 229
Query: 824 GVA-KIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKP 880
G A K+ + Y ++GT +PEL K+D++S G+VL E+
Sbjct: 230 GAACKLDAHPDTPQCYG-WSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 60/218 (27%), Positives = 94/218 (43%), Gaps = 18/218 (8%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVK-----VFAAEMEILGKIRHR 731
+ E +IG G G+V + +K A+K L K + +K F E +L +
Sbjct: 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQ 61
Query: 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAY 791
I L+ +LV++Y G+L L K ++ F ++ L A I
Sbjct: 62 WITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVL-AIHSIHQ 120
Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPE 851
LH+ +HRDIK N+LLD + ++ADFG + + N S GT YI+PE
Sbjct: 121 LHY------VHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPE 173
Query: 852 LAYTC-----KVSEKSDVFSFGVVLLELVTGRKPVEEE 884
+ K + D +S GV + E++ G P E
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE 211
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 56/203 (27%), Positives = 89/203 (43%), Gaps = 14/203 (6%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLY 737
++G GG G+V ++ A K+L K G + E IL K+ R ++ L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLA 66
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
+ LVL M G+L ++ G P D R A G+ L +
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNM---GNPGFDEQRAIFYAAELCCGLEDLQRE-- 121
Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCK 857
I++RD+K NILLD+ +I+D G +A P+ GT GY+APE+ K
Sbjct: 122 -RIVYRDLKPENILLDDRGHIRISDLG---LAVQIPEGETVRGRVGTVGYMAPEVINNEK 177
Query: 858 VSEKSDVFSFGVVLLELVTGRKP 880
+ D + G ++ E++ G+ P
Sbjct: 178 YTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-09
Identities = 69/271 (25%), Positives = 116/271 (42%), Gaps = 68/271 (25%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTV-AVKQLWKGDGVKVFAAEMEILGKIR-HRNIL 734
+ E +IG G G+V RL KK+ G V A+K L K D + E E +G IR R+IL
Sbjct: 2 DFESLKVIGRGAFGEV-RLVQKKDTGHVYAMKILRKADML-----EKEQVGHIRAERDIL 55
Query: 735 ---------KLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWF-RRYKIALG 784
K++ + +L++E++P G++ L K+ + E ++ +A+
Sbjct: 56 VEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAID 115
Query: 785 AAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV--------- 835
+ + + IHRDIK N+LLD K++DFG+ + + +
Sbjct: 116 SIHQLGF---------IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHS 166
Query: 836 --SDYS----------------------CFAGTHGYIAPELAYTCKVSEKSDVFSFGVVL 871
SD++ GT YIAPE+ ++ D +S GV++
Sbjct: 167 LPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226
Query: 872 LELVTGRKPV-----EEEYGDGKDIVYWVST 897
E++ G P +E Y K ++ W T
Sbjct: 227 YEMLIGYPPFCSETPQETY---KKVMNWKET 254
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 62/209 (29%), Positives = 104/209 (49%), Gaps = 22/209 (10%)
Query: 684 IGSGGTGKVYRLDLK--KNAGTVAVKQLWKGDGVKVFAA-EMEILGKIRHRNILKLYACL 740
+G G G VY+ K K+ A+KQ+ +G G+ + A E+ +L +++H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQI-EGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 741 LKGGSS--FLVLEYMPNGNLFQAL--HKRVKEGKPELDWFRRYKIAL--GAAKGIAYLHH 794
L +L+ +Y + +L+ + H+ K K + R +L GI YLH
Sbjct: 68 LSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 126
Query: 795 DCSPPIIHRDIKSSNILL----DEDYEPKIADFGVAKIAENSP--KVSDYSCFAGTHGYI 848
+ ++HRD+K +NIL+ E KIAD G A++ NSP ++D T Y
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLF-NSPLKPLADLDPVVVTFWYR 182
Query: 849 APELAYTCKVSEKS-DVFSFGVVLLELVT 876
APEL + K+ D+++ G + EL+T
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 4e-09
Identities = 68/248 (27%), Positives = 104/248 (41%), Gaps = 60/248 (24%)
Query: 684 IGSGGTGKVYRLDLKKNAGTV-AVKQLWKGD-----GVKVFAAEMEILGKIRHRNILKLY 737
+G G G+V L K + + A+K L K D V AE +IL + + ++KLY
Sbjct: 9 LGIGAFGEVC-LACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLY 67
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
+ + V++Y+P G++ L + E PE+ R+ IA I +H
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLIR--MEVFPEV--LARFYIA-ELTLAIESVH---K 119
Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGV----------------AKIAENSPKVSDY--- 838
IHRDIK NIL+D D K+ DFG+ + I ++S + SD
Sbjct: 120 MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDD 179
Query: 839 ----------------------SCFA----GTHGYIAPELAYTCKVSEKSDVFSFGVVLL 872
C A GT YIAPE+ ++ D +S GV+L
Sbjct: 180 VSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF 239
Query: 873 ELVTGRKP 880
E++ G+ P
Sbjct: 240 EMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 5e-09
Identities = 57/198 (28%), Positives = 101/198 (51%), Gaps = 14/198 (7%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVK--QLWKGDGVKVFAA-EMEILGKIRHRNILKLYACL 740
+G G VY+ K N VA+K +L + +G A E +L ++H NI+ L+ +
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
+ LV EY+ + +L Q + K G + + + L +G++Y+H I
Sbjct: 73 HTKETLTLVFEYV-HTDLCQYMDKH--PGGLHPENVKLFLFQL--LRGLSYIHQRY---I 124
Query: 801 IHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPE-LAYTCKVS 859
+HRD+K N+L+ + E K+ADFG+A+ A++ P + YS T Y P+ L + + S
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHT-YSNEVVTLWYRPPDVLLGSTEYS 182
Query: 860 EKSDVFSFGVVLLELVTG 877
D++ G + +E++ G
Sbjct: 183 TCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 7e-09
Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 678 LEEDNLIGSGGTGKVYR----LDLKKNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRH 730
++ ++GSG G VY+ + +K VA+K+L + K E ++ + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 731 RNILKLYACLLKGGSSFLVLEYMPNGNLFQAL--HKRVKEGKPELDWFRRYKIALGAAKG 788
++ +L L L+ + MP G L + HK + L+W + AKG
Sbjct: 69 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 121
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTH--G 846
+ YL ++HRD+ + N+L+ KI DFG+AK+ K +Y G
Sbjct: 122 MNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEK--EYHAEGGKVPIK 176
Query: 847 YIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKP 880
++A E + +SDV+S+GV + EL+T G KP
Sbjct: 177 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 7e-09
Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 19/210 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQ--LWKGDGVKVFAA-EMEILGKIRHRNILKLYACL 740
+G G VY+ K VA+K+ L +G A E+ +L ++H NI+ L+ +
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
S LV EY L + L + + + ++ +G+ Y H +
Sbjct: 74 HTEKSLTLVFEY-----LDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KV 125
Query: 801 IHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPE-LAYTCKVS 859
+HRD+K N+L++E E K+ADFG+A+ A++ P YS T Y P+ L + S
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR-AKSIP-TKTYSNEVVTLWYRPPDILLGSTDYS 183
Query: 860 EKSDVFSFGVVLLELVTGR-----KPVEEE 884
+ D++ G + E+ TGR VEE+
Sbjct: 184 TQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 7e-09
Identities = 64/255 (25%), Positives = 100/255 (39%), Gaps = 58/255 (22%)
Query: 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----GVKVFAAEMEILGKIRH 730
+ +G G G+V A+K L K D V AE +IL + +
Sbjct: 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADN 60
Query: 731 RNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
+++LY + + V++Y+P G++ L ++ G D R Y L A +
Sbjct: 61 EWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLL---IRMGIFPEDLARFYIAELTCA--VE 115
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGV---------AKIAENSPKVS----D 837
+H IHRDIK NIL+D D K+ DFG+ +K ++ V D
Sbjct: 116 SVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMD 172
Query: 838 YS----------------------------CFA----GTHGYIAPELAYTCKVSEKSDVF 865
+S C A GT YIAPE+ ++ D +
Sbjct: 173 FSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW 232
Query: 866 SFGVVLLELVTGRKP 880
S GV+L E++ G+ P
Sbjct: 233 SVGVILYEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 8e-09
Identities = 33/105 (31%), Positives = 52/105 (49%), Gaps = 6/105 (5%)
Query: 162 RWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGT 221
+W ++ L DN IP I L++L + L+ ++RG IP S+ + L
Sbjct: 417 KWFIDGLGL------DNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEV 470
Query: 222 LDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTL 266
LD+ N +G P S+ +L L + L N+L+G +PA LG L
Sbjct: 471 LDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLL 515
|
Length = 623 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 8e-09
Identities = 44/164 (26%), Positives = 74/164 (45%), Gaps = 21/164 (12%)
Query: 721 EMEILGKIRHRNILKL--------YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPE 772
E+ LG++ H NILK+ ++ F + +M + + +P
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDW-------KDRPL 265
Query: 773 LDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832
L R L A + Y+H +IHRDIK NI L+ D + + DFG A E
Sbjct: 266 LKQTRAIMKQLLCA--VEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKE 320
Query: 833 PKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT 876
+ DY + GT +PE+ E +D++S G++LL++++
Sbjct: 321 REAFDYG-WVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 9e-09
Identities = 48/171 (28%), Positives = 78/171 (45%), Gaps = 11/171 (6%)
Query: 718 FAAEMEILGKIRHRNILKLYACLLKGG------SSFLVLEYMPNGNLFQ-ALHKRVKEGK 770
F +E + + H N+++L L+ S ++L +M +G+L L+ R+ +
Sbjct: 47 FLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCP 106
Query: 771 PELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830
L K A G+ YL S IHRD+ + N +L+E+ +ADFG++K
Sbjct: 107 QYLPTQMLVKFMTDIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIY 163
Query: 831 NSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKP 880
N +IA E + KSDV+SFGV + E+ T G+ P
Sbjct: 164 NGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 1e-08
Identities = 46/169 (27%), Positives = 82/169 (48%), Gaps = 18/169 (10%)
Query: 718 FAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALH--KRVKEGKPEL-- 773
F E ++ + ++++L + +G + +++E M G+L L + E P
Sbjct: 56 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAP 115
Query: 774 -DWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK-IAEN 831
+ ++A A G+AYL+ + +HRD+ + N ++ ED+ KI DFG+ + I E
Sbjct: 116 PSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE- 171
Query: 832 SPKVSDYSCFAGTH----GYIAPELAYTCKVSEKSDVFSFGVVLLELVT 876
+DY G +++PE + SDV+SFGVVL E+ T
Sbjct: 172 ----TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 23/214 (10%)
Query: 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVK--QLWKGDGVKVFAA-EMEILGKI 728
A NLE+ +G G VY+ + N VA+K + +GV A E +L +
Sbjct: 4 ATSYLNLEK---LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGL 60
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL---GA 785
+H NI+ L+ + + V EYM + +L Q + + P Y + L
Sbjct: 61 KHANIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHP-------YNVRLFMFQL 112
Query: 786 AKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTH 845
+G+AY+H I+HRD+K N+L+ E K+ADFG+A+ A++ P + YS T
Sbjct: 113 LRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLAR-AKSIPSQT-YSSEVVTL 167
Query: 846 GYIAPE-LAYTCKVSEKSDVFSFGVVLLELVTGR 878
Y P+ L S D++ G + +E++ G+
Sbjct: 168 WYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 64/227 (28%), Positives = 102/227 (44%), Gaps = 44/227 (19%)
Query: 678 LEEDNLIGSGGTGKVYR----LDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIR-HRN 732
L++ ++GSG G VY+ D + VA+K L + K A EIL +
Sbjct: 9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPK---ANKEILDEAYVMAG 65
Query: 733 ILKLYACLLKG----GSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGA--- 785
+ Y C L G + LV + MP G L LD+ R K +G+
Sbjct: 66 VGSPYVCRLLGICLTSTVQLVTQLMPYGCL--------------LDYVRENKDRIGSQDL 111
Query: 786 -------AKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY 838
AKG++YL ++HRD+ + N+L+ KI DFG+A++ + +Y
Sbjct: 112 LNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET--EY 166
Query: 839 SCFAGTH--GYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVE 882
G ++A E + + +SDV+S+GV + EL+T G KP +
Sbjct: 167 HADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 58/200 (29%), Positives = 99/200 (49%), Gaps = 16/200 (8%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQ--LWKGDGVKVFAA-EMEILGKIRHRNILKLYACL 740
+G G V++ K VA+K+ L +G A E+ +L ++H NI+ L+ +
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL-GAAKGIAYLHHDCSPP 799
S LV EY+ + +L K+ + + KI L +G+AY H
Sbjct: 74 HTDKSLTLVFEYL-DKDL-----KQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---K 124
Query: 800 IIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPE-LAYTCKV 858
++HRD+K N+L++E E K+ADFG+A+ A++ P YS T Y P+ L + +
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR-AKSVP-TKTYSNEVVTLWYRPPDVLLGSSEY 182
Query: 859 SEKSDVFSFGVVLLELVTGR 878
S + D++ G + E+ +GR
Sbjct: 183 STQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 20/214 (9%)
Query: 683 LIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGD-----GVKVFAAEMEILGKIRHRNIL 734
++G G G V LK G+ VAVK L K D ++ F E + + H N++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEFDHPNVI 64
Query: 735 KLYACLLKGGSS------FLVLEYMPNGNLFQ-ALHKRVKEGKPELDWFRRYKIALGAAK 787
KL L+ + ++L +M +G+L L R+ E L + + A
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 788 GIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGY 847
G+ YL S IHRD+ + N +L+E+ +ADFG++K + +
Sbjct: 125 GMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181
Query: 848 IAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKP 880
+A E + SDV++FGV + E++T G+ P
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 3e-08
Identities = 70/314 (22%), Positives = 123/314 (39%), Gaps = 16/314 (5%)
Query: 184 EIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKL 243
+P S+ L +L L + + E++ L L +LD+ N++ + +L L
Sbjct: 61 LLPSSLSRLLSLDLLSPSGISSLD-GSENLLNLLPLPSLDLNLNRLRSNISE-LLELTNL 118
Query: 244 WKIELYANNLTGELPAELGNLTL-LQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFS 302
++L NN+T ++P +G L L+E D+S N+ LP + NL NL N
Sbjct: 119 TSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNK-IESLPSPLRNLPNLKNL-DLSFNDL 175
Query: 303 GEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRK 362
+ P ++ L + GN+ S P + +AL ++D+S N K
Sbjct: 176 SDLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSL--SNLK 232
Query: 363 LLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFT 422
L+ L LSNN ++P S + ++ L +S+N +S L +L N+ LD N +
Sbjct: 233 NLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLS 290
Query: 423 GGISPLIGLSTSLSQL---VLQNNRFSGELPS--ELGRLTNLERLILTNNNFSGKIPSAL 477
+ + L L L +L +L S + + + + L
Sbjct: 291 NALPLIALLLLLLELLLNLLLTLKALELKLNSILLNNNILSNGETSSPEALSILESLNNL 350
Query: 478 GALRQLSSLHLEEN 491
L
Sbjct: 351 WTLDNALDESNLNR 364
|
Length = 394 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 25/215 (11%)
Query: 684 IGSGGTGKVYR--LDLKKNAGTVAVKQLWKGDGVKVFAAEM----EILGKIRHRNILKLY 737
+GSG G V + ++K VA+K L K + K EM EI+ ++ + I+++
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVL-KNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
+ + + LV+E G L+K + K E+ ++ + G+ YL
Sbjct: 62 G-VCEAEALMLVMEMASGG----PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---G 113
Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHG-----YIAPEL 852
+HRD+ + N+LL + KI+DFG++K + D A + G + APE
Sbjct: 114 KNFVHRDLAARNVLLVNQHYAKISDFGLSK----ALGADDSYYKARSAGKWPLKWYAPEC 169
Query: 853 AYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYG 886
K S +SDV+S+G+ + E + G+KP ++ G
Sbjct: 170 INFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG 204
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 7e-08
Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 34/213 (15%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNI--LKLY-- 737
N+IG+G G VY + VA+K++ + K E+ I+ + H NI LK Y
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYK--NRELLIMKNLNHINIIFLKDYYY 129
Query: 738 -ACLLKGGSSF---LVLEYMPNGNLFQALHKRVK---EGKPELDWFRRYKIALGAAKGIA 790
C K + +V+E++P Q +HK +K L F + + +A
Sbjct: 130 TECFKKNEKNIFLNVVMEFIP-----QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALA 184
Query: 791 YLHHDCSPPIIHRDIKSSNILLDED-YEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIA 849
Y+H S I HRD+K N+L+D + + K+ DFG AK + Y C + Y A
Sbjct: 185 YIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYIC---SRFYRA 238
Query: 850 PELA-----YTCKVSEKSDVFSFGVVLLELVTG 877
PEL YT + D++S G ++ E++ G
Sbjct: 239 PELMLGATNYTTHI----DLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 53/143 (37%), Positives = 77/143 (53%), Gaps = 7/143 (4%)
Query: 424 GISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGAL-RQ 482
S + L L L NR SEL LTNL L L NNN + IP +G L
Sbjct: 84 DGSENLLNLLPLPSLDLNLNRLRS-NISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSN 141
Query: 483 LSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLT 542
L L L +N + S+P+ + + + +L+L+ N LS ++P+ LS LS+LN L+LSGNK++
Sbjct: 142 LKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS 199
Query: 543 GSIPDNLMKL-KLSSIDLSENQL 564
+P + L L +DLS N +
Sbjct: 200 -DLPPEIELLSALEELDLSNNSI 221
|
Length = 394 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-07
Identities = 38/108 (35%), Positives = 52/108 (48%), Gaps = 14/108 (12%)
Query: 787 KGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA----KIAENSPKVSDYSCFA 842
+ I YLH + IIHRDIK+ NI ++ + + DFG A I N Y +A
Sbjct: 193 RAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK-----YYGWA 244
Query: 843 GTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKD 890
GT APEL D++S G+VL E+ T + E+ DG D
Sbjct: 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEK--DGLD 290
|
Length = 391 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-07
Identities = 57/176 (32%), Positives = 83/176 (47%), Gaps = 24/176 (13%)
Query: 704 VAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL-EYMPNGNLFQAL 762
V VK W V E +L ++ H +L L + GG + LVL +Y +L+ L
Sbjct: 197 VVVKAGWYASSVH----EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY--RSDLYTYL 250
Query: 763 HKRVKE-GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIA 821
R++ G ++ R L A I Y+H + IIHRDIK+ N+L++ + +
Sbjct: 251 GARLRPLGLAQVTAVARQ--LLSA---IDYIHGE---GIIHRDIKTENVLVNGPEDICLG 302
Query: 822 DFGVAKIAENSPKVSDYSCFAGTHGYIAPE-LA---YTCKVSEKSDVFSFGVVLLE 873
DFG A A S + AGT APE LA YT V D++S G+V+ E
Sbjct: 303 DFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSV----DIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 34/101 (33%), Positives = 52/101 (51%), Gaps = 19/101 (18%)
Query: 787 KGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAG--- 843
+G+ +LH +C I+HRD+K NIL+ + K+ADFG+A+I YSC
Sbjct: 119 RGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARI---------YSCQMALTP 166
Query: 844 ---THGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPV 881
T Y APE+ + D++S G + E+ RKP+
Sbjct: 167 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 1e-07
Identities = 68/275 (24%), Positives = 110/275 (40%), Gaps = 76/275 (27%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTV-AVKQL-----WKGDGVKVFAAEMEILGKIRHRNILKL 736
+IG G G+V RL KK+ G + A+K L +K D + AE ++L + ++ L
Sbjct: 8 VIGKGAFGEV-RLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFR----RYKIA--LGAAKGIA 790
Y +L++E++P G+L L K D F R+ +A + A + +
Sbjct: 67 YYSFQDAQYLYLIMEFLPGGDLMTMLIK--------YDTFSEDVTRFYMAECVLAIEAVH 118
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGV------------------------- 825
L IHRDIK NIL+D K++DFG+
Sbjct: 119 KLG------FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNR 172
Query: 826 -------------------AKIA--ENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDV 864
+IA + + ++ YS GT YIAPE+ ++ D
Sbjct: 173 IDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYST-VGTPDYIAPEIFLQQGYGQECDW 231
Query: 865 FSFGVVLLELVTGRKPV--EEEYGDGKDIVYWVST 897
+S G ++ E + G P E + + I+ W T
Sbjct: 232 WSLGAIMFECLIGWPPFCSENSHETYRKIINWRET 266
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-07
Identities = 52/184 (28%), Positives = 82/184 (44%), Gaps = 31/184 (16%)
Query: 715 VKVFAAEMEILGKIRHRNILKLYACLLKG----GSSFLVLEYMPNGNLFQALHKRVKEGK 770
F E + ++ H NI+ L L G G F V EY+P L + L +G
Sbjct: 22 RARFRRETALCARLYHPNIVAL---LDSGEAPPGLLFAVFEYVPGRTLREVL---AADGA 75
Query: 771 -PELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE-DYEP--KIADFGVA 826
P + R + L +A H+ I+HRD+K NI++ + P K+ DFG+
Sbjct: 76 LPAGETGR---LMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTGVRPHAKVLDFGIG 129
Query: 827 KIAENSPKVSDYSC--------FAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGR 878
+ P V D GT Y APE V+ SD++++G++ LE +TG+
Sbjct: 130 TLL---PGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ 186
Query: 879 KPVE 882
+ V+
Sbjct: 187 RVVQ 190
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 47/180 (26%), Positives = 81/180 (45%), Gaps = 21/180 (11%)
Query: 715 VKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELD 774
+K E+ + RH NI+ + G +++ +M G+ L EG E
Sbjct: 43 LKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEA- 101
Query: 775 WFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIAD----FGVAKIAE 830
I GA +G+ YLH + IHR+IK+S+IL+ D ++ + + + +
Sbjct: 102 --LIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQ 156
Query: 831 NSPKVSDYSCFA-GTHGYIAPEL------AYTCKVSEKSDVFSFGVVLLELVTGRKPVEE 883
+ V D+ F+ +++PEL Y K SD++S G+ EL TGR P ++
Sbjct: 157 KAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVK----SDIYSVGITACELATGRVPFQD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 3e-07
Identities = 33/127 (25%), Positives = 52/127 (40%), Gaps = 25/127 (19%)
Query: 303 GEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRK 362
G P+ +R L + ++ GN G P +LG T+L +D+S N F+GS
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS---------- 481
Query: 363 LLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVG-MLDFGDNDF 421
+P S +++ L ++ N LSG++P L +F DN
Sbjct: 482 --------------IPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAG 527
Query: 422 TGGISPL 428
GI L
Sbjct: 528 LCGIPGL 534
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 3e-07
Identities = 26/78 (33%), Positives = 44/78 (56%), Gaps = 2/78 (2%)
Query: 78 ISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSV 137
I+ S+ G I S+ ++ SL VL L +N +G +P L ++L++LN+ GN++ G V
Sbjct: 447 INLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRV 506
Query: 138 PDLSALKNLEIFDLSINY 155
P +AL + S N+
Sbjct: 507 P--AALGGRLLHRASFNF 522
|
Length = 623 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 3e-07
Identities = 35/99 (35%), Positives = 54/99 (54%), Gaps = 10/99 (10%)
Query: 786 AKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTH 845
AKG+++L S IHRD+ + NILL KI DFG+A+ N S+Y
Sbjct: 224 AKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND---SNYVVKGNAR 277
Query: 846 ---GYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKP 880
++APE + C + +SDV+S+G++L E+ + G P
Sbjct: 278 LPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 3e-07
Identities = 61/219 (27%), Positives = 92/219 (42%), Gaps = 54/219 (24%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQ--LWKGDGVKVFAA-EMEILGKIRHRNILKLYACL 740
+G G VY+ K VA+K+ L +G A E +L ++H NI+ L+ +
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII 72
Query: 741 LKGGSSFLVLEYM-----------PNG----N----LFQALHKRVKEGKPELDWFRRYKI 781
+ LV EY+ G N LFQ L
Sbjct: 73 HTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLL------------------- 113
Query: 782 ALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCF 841
+G+AY H ++HRD+K N+L+ E E K+ADFG+A+ A++ P + YS
Sbjct: 114 -----RGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR-AKSVPSKT-YSNE 163
Query: 842 AGTHGYIAPE--LAYTCKVSEKSDVFSFGVVLLELVTGR 878
T Y P+ L T S D++ G + E+ TGR
Sbjct: 164 VVTLWYRPPDVLLGSTE-YSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 57/225 (25%), Positives = 97/225 (43%), Gaps = 39/225 (17%)
Query: 684 IGSGGTGKVYRLDL-----KKNAGTVAVKQLWKGDGVKV-----FAAEMEILGKIRHRNI 733
+G GKVY+ L + VA+K L D + F E + +++H NI
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL--KDKAEGPLREEFKHEAMMRSRLQHPNI 70
Query: 734 LKLYACLLKGGSSFLVLEYMPNGNLFQAL-----HKRV------KEGKPELDWFRRYKIA 782
+ L + K ++ Y + +L + L H V K K L+ I
Sbjct: 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130
Query: 783 LGAAKGIAYL--HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSC 840
A G+ +L HH ++H+D+ + N+L+ + KI+D G+ + +DY
Sbjct: 131 TQIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDLGLFR----EVYAADYYK 181
Query: 841 FAGTH----GYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKP 880
G +++PE K S SD++S+GVVL E+ + G +P
Sbjct: 182 LMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 3e-07
Identities = 36/118 (30%), Positives = 60/118 (50%), Gaps = 10/118 (8%)
Query: 767 KEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826
E LD + + A+G+ +L S IHRD+ + N+LL + KI DFG+A
Sbjct: 203 TEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLA 259
Query: 827 KIAENSPKVSDYSCFAGTH---GYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKP 880
+ N S+Y ++APE + C + +SDV+S+G++L E+ + G+ P
Sbjct: 260 RDIMND---SNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 4e-07
Identities = 50/151 (33%), Positives = 74/151 (49%), Gaps = 15/151 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTV-AVKQLWKGDG-----VKVFAAEMEILGKIRHRNILKLY 737
I G GKVY L KKN + AVK + K D V AE + L + I+ LY
Sbjct: 12 ISRGAFGKVY-LGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLY 70
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
L + +LV+EY+ G++ LH G + + +Y I+ A + YLH
Sbjct: 71 YSLQSANNVYLVMEYLIGGDVKSLLHIY---GYFDEEMAVKY-IS-EVALALDYLHRH-- 123
Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
IIHRD+K N+L+ + K+ DFG++K+
Sbjct: 124 -GIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 24/211 (11%)
Query: 684 IGSGGTGKVYRL-DLKKNAGTVAVKQL---WKGDGVKVFA----AEMEILGKIRHRNILK 735
IG G GKV++ DLK VA+K++ +G+ + A + L H N+++
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 736 LY-ACLL----KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
L+ C + + LV E++ + +L L K + G P + + L +G+
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPT-ETIKDMMFQL--LRGLD 124
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
+LH S ++HRD+K NIL+ + K+ADFG+A+I ++ T Y AP
Sbjct: 125 FLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV---TLWYRAP 178
Query: 851 ELAYTCKVSEKSDVFSFGVVLLELVTGRKPV 881
E+ + D++S G + E+ RKP+
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 7e-07
Identities = 39/109 (35%), Positives = 58/109 (53%), Gaps = 15/109 (13%)
Query: 786 AKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTH 845
AKG+ +L S IHRD+ + NILL E+ KI DFG+A+ P DY
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP---DYVRKGDAR 242
Query: 846 ---GYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKP-----VEEEY 885
++APE + + +SDV+SFGV+L E+ + G P ++EE+
Sbjct: 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 291
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 8e-07
Identities = 51/177 (28%), Positives = 77/177 (43%), Gaps = 37/177 (20%)
Query: 786 AKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTH 845
A+G+ +L S IHRD+ + NILL E+ KI DFG+A+ P
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240
Query: 846 GYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKP-----VEEEY----GDGKDIVYWV 895
++APE + + +SDV+SFGV+L E+ + G P + EE+ DG
Sbjct: 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDG------- 293
Query: 896 STHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952
T + EN A+ I +I + C P RP +V++L D
Sbjct: 294 -TRMRAPEN---------ATPEIY-------RIMLACWQGDPKERPTFSALVEILGD 333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 58/208 (27%), Positives = 92/208 (44%), Gaps = 22/208 (10%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFA-AEMEILGKIRHRN-ILKLYA 738
IG G GKVY+ K VA+K+ +G+ A E+ +L + I++L
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68
Query: 739 CL---LKGGSS--FLVLEYMPNGNL--FQALHKRVKEGKPELDWFRRYKIALGAAKGIAY 791
K G +LV EY+ + +L F + R + + L KG+A+
Sbjct: 69 VEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL--LKGVAH 125
Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEP-KIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
H ++HRD+K N+L+D+ KIAD G+ + A + P V Y+ T Y AP
Sbjct: 126 CH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR-AFSIP-VKSYTHEIVTLWYRAP 180
Query: 851 E-LAYTCKVSEKSDVFSFGVVLLELVTG 877
E L + S D++S G + E+
Sbjct: 181 EVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 37/163 (22%), Positives = 62/163 (38%), Gaps = 23/163 (14%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNIL--KLYACL 740
L+ G T +VY L K +K + E+ IL + + + K+ A
Sbjct: 5 LLKGGLTNRVYLLGTKD--EDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASG 62
Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKP--ELDWFRRYKIALGAAKGIAYLHHDCSP 798
G S+L++E++ EG+ E+ + IA A+ +A LH
Sbjct: 63 ESDGWSYLLMEWI--------------EGETLDEVSEEEKEDIAEQLAELLAKLHQLPLL 108
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCF 841
+ H D+ NIL+D+ I D+ A P D +
Sbjct: 109 VLCHGDLHPGNILVDDGKILGIIDWEYAGYG---PPAFDLAAA 148
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-06
Identities = 36/100 (36%), Positives = 55/100 (55%), Gaps = 6/100 (6%)
Query: 786 AKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK-IAENSPKVSDYSCFAGT 844
A G+ +L S +HRD+ + N+L+ E KI DFG+A+ I +S +S S F
Sbjct: 249 ANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPL 305
Query: 845 HGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEE 883
++APE + + SDV+SFG++L E+ T G P E
Sbjct: 306 K-WMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPE 344
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 64/231 (27%), Positives = 98/231 (42%), Gaps = 29/231 (12%)
Query: 684 IGSGGTGKVY--RLDLKKNAGTVAVKQLWKGDGVK---VFAAEMEILGKIRHRNILKLYA 738
IG+G GKV ++ V VK+L V+ F E + ++H N+L+
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHK-RVKEG-KPELDWFRRYKIALGAAKGIAYLHHDC 796
+ LV+E+ P G+L L R E P+ +R +A A G+ +LH +
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQR--MACEIALGLLHLHKN- 119
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTH----GYIAPEL 852
IH D+ N LL D KI D+G ++ N K DY +IAPEL
Sbjct: 120 --NFIHSDLALRNCLLTADLTVKIGDYG---LSHNKYK-EDYYVTPDQLWVPLRWIAPEL 173
Query: 853 A-------YTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWV 895
+++S+V+S GV + EL G +P D + + Y V
Sbjct: 174 VDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY-RHLSDEQVLTYTV 223
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 52/206 (25%), Positives = 90/206 (43%), Gaps = 26/206 (12%)
Query: 753 MPNGNLFQALHKRVKEGKPELDWFR-RYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNIL 811
+ + L EG LD Y++A +G+ +L S +HRD+ + N+L
Sbjct: 217 SNDSEVKNLLSDDGSEGLTTLDLLSFTYQVA----RGMEFL---ASKNCVHRDLAARNVL 269
Query: 812 LDEDYEPKIADFGVAK-IAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVV 870
L + KI DFG+A+ I +S VS S F ++APE + + SDV+S+G++
Sbjct: 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVK-WMAPESIFDNLYTTLSDVWSYGIL 328
Query: 871 LLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIA 929
L E+ + G P D ST N ++ ++ + A++ + + M+K
Sbjct: 329 LWEIFSLGGTPYPGMIVD--------STFYNKIKSGYRMAKPDHATQEVYDIMVK----- 375
Query: 930 VVCTTKLPNLRPPMREVVKMLADADP 955
C P RP + ++ P
Sbjct: 376 --CWNSEPEKRPSFLHLSDIVESLLP 399
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 58/225 (25%), Positives = 100/225 (44%), Gaps = 33/225 (14%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGV------KVFAAEMEILGKIRHRNILKL 736
LI +G G VY + K+ A+K++ K + + +VF E +IL + ++ +
Sbjct: 8 LISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFV-ERDILTFAENPFVVSM 66
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
+ +V+EY+ G+ L K + G +D R Y A + YLH
Sbjct: 67 FCSFETKRHLCMVMEYVEGGDC-ATLLKNI--GALPVDMARMYFAETVLA--LEYLH--- 118
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKI--------------AENSPKVSDYSCFA 842
+ I+HRD+K N+L+ K+ DFG++KI +++ + D
Sbjct: 119 NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVC- 177
Query: 843 GTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGD 887
GT YIAPE+ + D ++ G++L E + G P +GD
Sbjct: 178 GTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPF---FGD 219
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 5e-06
Identities = 30/113 (26%), Positives = 52/113 (46%), Gaps = 26/113 (23%)
Query: 126 LNVTGNAMVGSVP-DLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAE 184
L + + G +P D+S L++L+ +LS N G
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRG-------------------------N 457
Query: 185 IPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSI 237
IP S+G++ +L L L++ + G IPES+ +L L L++ N +SG P ++
Sbjct: 458 IPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 5e-06
Identities = 54/250 (21%), Positives = 99/250 (39%), Gaps = 68/250 (27%)
Query: 724 ILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL 783
++ ++ H++++KLY ++ + +V EY+ G L LH+ ++ L W +A
Sbjct: 54 LMSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPLDVFLHR--EKNNVSLHWK--LDVAK 108
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILL-----DEDYEP--KIADFGVAK-IAENSPKV 835
A + YL ++H ++ NIL+ +E Y P K++D G+ + +V
Sbjct: 109 QLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERV 165
Query: 836 SDYSCFAGTHGYIAPELAYTC------KVSEKSDVFSFGVVLLELVT-GRKPV------- 881
P +A C ++ +D +SFG LLE+ + G +P+
Sbjct: 166 ER-----------IPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE 214
Query: 882 -EEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLR 940
E Y D + L + DC + I + C T P R
Sbjct: 215 KERFYQDQ---------------HRLPMPDCAELANLINQ-----------CWTYDPTKR 248
Query: 941 PPMREVVKML 950
P R +++ L
Sbjct: 249 PSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 5e-06
Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 19/154 (12%)
Query: 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHK--RVKEGKPELDWFRRYKIALGAAKGI 789
N++ L+ ++ S FLVL++ G L+ + K + E + W +AL A
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVK-RWAAEMVVALDA---- 100
Query: 790 AYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCF-AGTHGYI 848
LH + I+ RD+ +NILLD+ ++ F +V D A + Y
Sbjct: 101 --LHRE---GIVCRDLNPNNILLDDRGHIQLTYFS------RWSEVEDSCDGEAVENMYC 149
Query: 849 APELAYTCKVSEKSDVFSFGVVLLELVTGRKPVE 882
APE+ + +E D +S G +L EL+TG+ VE
Sbjct: 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVE 183
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 6e-06
Identities = 53/191 (27%), Positives = 89/191 (46%), Gaps = 41/191 (21%)
Query: 721 EMEILGKIRHRNILKLYACLLKGGSS--FLVLEYMPNGNLFQALHKRVKE-GKPE----L 773
E+ ++ +++H+NI++ L + ++++E+ G+L + + K K GK E +
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121
Query: 774 DWFRRYKIALGAAKGIAYLHHDCSPP----IIHRDIKSSNILLDEDYE------------ 817
D R+ AL AY H+ P ++HRD+K NI L
Sbjct: 122 DITRQLLHAL------AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNL 175
Query: 818 -----PKIADFGVAK-IAENSPKVSDYSCFAGTHGYIAPELAY--TCKVSEKSDVFSFGV 869
KI DFG++K I S +SC GT Y +PEL T +KSD+++ G
Sbjct: 176 NGRPIAKIGDFGLSKNIGIESMA---HSC-VGTPYYWSPELLLHETKSYDDKSDMWALGC 231
Query: 870 VLLELVTGRKP 880
++ EL +G+ P
Sbjct: 232 IIYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 9e-06
Identities = 25/81 (30%), Positives = 41/81 (50%), Gaps = 1/81 (1%)
Query: 275 NQ-MYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENL 333
NQ + G +P +I L++L N+ G P G + L + N F+G PE+L
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486
Query: 334 GRYTALTDVDISENQFSGSFP 354
G+ T+L ++++ N SG P
Sbjct: 487 GQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 1e-05
Identities = 66/270 (24%), Positives = 93/270 (34%), Gaps = 46/270 (17%)
Query: 339 LTDVDISENQFSGSFPKYLCEK---RKLLNLLALSNNFSGEVPNSYADC-----KT--IQ 388
L + + N K L + L L LS N +G +P K +Q
Sbjct: 25 LQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQ 84
Query: 389 RLRISDNHLSGKIPDGLWAL---PNVGMLDFGDNDFTGGISPLIG-----LSTSLSQLVL 440
L +SDN L L +L ++ L +N L+ L +L +LVL
Sbjct: 85 ELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVL 144
Query: 441 QNNRFSGE----LPSELGRLTNLERLILTNNNFSG----KIPSALGALRQLSSLHLEENA 492
NR G L L +L+ L L NN + L A L L L N
Sbjct: 145 GRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNG 204
Query: 493 LT--GSIPNEMG--DCARIVDLNLARNSLSGNI-----PRSLSLLSSLNALNLSGNKLT- 542
LT G+ + LNL N+L+ LS SL L+LS N +T
Sbjct: 205 LTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITD 264
Query: 543 -------GSIPDNLMKLKLSSIDLSENQLS 565
+ + L+L DL N+
Sbjct: 265 DGAKDLAEVLAEKESLLEL---DLRGNKFG 291
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 40.2 bits (95), Expect = 1e-04
Identities = 19/60 (31%), Positives = 26/60 (43%)
Query: 458 NLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSL 517
NL+ L L+NN + A L L L L N LT P + L+L+ N+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 66/266 (24%), Positives = 109/266 (40%), Gaps = 59/266 (22%)
Query: 684 IGSGGTGKVYRLDLKKNAGT--VAVKQLWKGDGVK---VFAAEMEILGKIRHRNILKLYA 738
IG+G GKV ++ + G V VK+L K F + + ++H NIL+
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRR-------YKIALGAAKGIAY 791
++ LV EY G+L L + W RR ++A A G+ +
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQE--------QWHRRNSQLLLLQRMACEIAAGVTH 114
Query: 792 LH-HDCSPPIIHRDIKSSNILLDEDYEPKIADFGV--AKIAENSPKVSDYSCFAGTHGYI 848
+H H+ +H D+ N L D K+ D+G+ ++ E+ + D C ++
Sbjct: 115 MHKHN----FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR--WL 168
Query: 849 APELA-------YTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNN 901
APEL T + ++ S+V++ GV L EL + Y +HL+
Sbjct: 169 APELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAA---QPY-----------SHLS- 213
Query: 902 HENVLKVLDCEVASESIKEDMIKLLK 927
D EV + IK+ +KL K
Sbjct: 214 --------DREVLNHVIKDQQVKLFK 231
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.1 bits (87), Expect = 0.002
Identities = 17/60 (28%), Positives = 26/60 (43%)
Query: 194 NLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNL 253
NL L L++ L + L L LD+ N ++ P + L L ++L NNL
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|185285 PRK15387, PRK15387, E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (98), Expect = 0.002
Identities = 77/304 (25%), Positives = 125/304 (41%), Gaps = 89/304 (29%)
Query: 251 NNLTG--ELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSG 308
NNLT LP EL L ++S NQ+ LP L L++F + PSG
Sbjct: 232 NNLTSLPALPPELRTL------EVSGNQL-TSLPVLPPGLLELSIFSNPLTHLPA-LPSG 283
Query: 309 FGDMRKLFAFSIYGNRFSG--PFPENLGRYTALTDVDISENQFSG--SFPKYLCEKRKLL 364
L I+GN+ + P L ++ +S+NQ + + P LC+
Sbjct: 284 ------LCKLWIFGNQLTSLPVLP------PGLQELSVSDNQLASLPALPSELCK----- 326
Query: 365 NLLALSNNFSG--EVPNSYADCKTIQRLRISDNHLSG--KIPDGLWALPNVGMLDFGDND 420
L A +N + +P+ +Q L +SDN L+ +P L+ L
Sbjct: 327 -LWAYNNQLTSLPTLPSG------LQELSVSDNQLASLPTLPSELYKLWA---------- 369
Query: 421 FTGGISPLIGLSTSLSQLVLQNNRFSG--ELPSELGRLTNLERLILTNNNFSGKIPSALG 478
+ ++ L L + L +L++ NR + LPSEL + L+++ N
Sbjct: 370 YNNRLTSLPALPSGLKELIVSGNRLTSLPVLPSEL------KELMVSGN----------- 412
Query: 479 ALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSG 538
+L+SL + + L + L++ RN L+ +P SL LSS +NL G
Sbjct: 413 ---RLTSLPMLPSGL--------------LSLSVYRNQLT-RLPESLIHLSSETTVNLEG 454
Query: 539 NKLT 542
N L+
Sbjct: 455 NPLS 458
|
Length = 788 |
| >gnl|CDD|215633 PLN03210, PLN03210, Resistant to P | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.003
Identities = 51/181 (28%), Positives = 73/181 (40%), Gaps = 24/181 (13%)
Query: 123 LKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDE 182
L+ +++ G+ + +PDLS NLE LS P + L +L L + E
Sbjct: 636 LRNIDLRGSKNLKEIPDLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLE 695
Query: 183 AEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIR---- 238
+P I NLK+L L L+ C+ R + IS + LD+ I EFP ++R
Sbjct: 696 I-LPTGI-NLKSLYRLNLSGCS-RLKSFPDIST--NISWLDLDETAIE-EFPSNLRLENL 749
Query: 239 --------KLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKN 290
K +KLW+ L L L L L S +LP I NL
Sbjct: 750 DELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFL------SDIPSLVELPSSIQNLHK 803
Query: 291 L 291
L
Sbjct: 804 L 804
|
syringae 6; Provisional. Length = 1153 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 973 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.98 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.98 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.98 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.98 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.98 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.98 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.98 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.98 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.98 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.92 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.92 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.91 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.9 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.8 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.8 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.79 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.79 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.79 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.78 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.77 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.77 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.76 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.76 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.75 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.75 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.74 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.73 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.71 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.67 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.65 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.64 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.63 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.62 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.61 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.61 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.61 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.52 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.49 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.48 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.48 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.46 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.44 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.44 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.44 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.37 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.32 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.29 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.28 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.25 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.24 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.22 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.19 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.18 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.17 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.16 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.13 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.11 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.11 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.09 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.09 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.06 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.02 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.01 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 99.0 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.0 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.97 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.91 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.89 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.89 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.87 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.86 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.82 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.78 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.76 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.69 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.67 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.66 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.6 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.59 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.59 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.52 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.5 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 98.47 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.47 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-113 Score=1085.13 Aligned_cols=895 Identities=34% Similarity=0.614 Sum_probs=655.6
Q ss_pred chHHHHHHHHHHHhcCCCcccccCCCCCCCCCCCcceeeeCCCCCceEEEeecCCCCCccccccccCCccCcEeeCCCCc
Q 002061 29 LNVETQALIQFKSKLKDPHGVLDSWKESADSPCGFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNV 108 (973)
Q Consensus 29 ~~~~~~aLl~~k~~~~d~~~~~~~W~~~~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~ 108 (973)
.+.|++||++||+++.||.+.+.+|+.. ++||.|.||+|++ .++|+.|+|++++++|.+++.+..+++|++|+|++|+
T Consensus 27 ~~~~~~~l~~~~~~~~~~~~~~~~w~~~-~~~c~w~gv~c~~-~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~ 104 (968)
T PLN00113 27 HAEELELLLSFKSSINDPLKYLSNWNSS-ADVCLWQGITCNN-SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQ 104 (968)
T ss_pred CHHHHHHHHHHHHhCCCCcccCCCCCCC-CCCCcCcceecCC-CCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCc
Confidence 5689999999999999998889999765 4589999999986 5799999999999999999999999999999999999
Q ss_pred ccCcCChhhh-CCCCCcEEEecCCcccCCCCcccCCCCCCEEeccCccCCCccccccccccccceEEccCCcCCC-----
Q 002061 109 LSGKLPLELS-NCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDE----- 182 (973)
Q Consensus 109 l~~~~p~~l~-~l~~L~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~----- 182 (973)
+++.+|..+. .+++|++|+|++|++++.+|. +.+++|++|+|++|.+++.+|..+.++++|++|++++|.+..
T Consensus 105 ~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~-~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~ 183 (968)
T PLN00113 105 LSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR-GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNS 183 (968)
T ss_pred cCCcCChHHhccCCCCCEEECcCCccccccCc-cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChh
Confidence 9999998765 888888888888887654442 334555555555555555555555555555555555554432
Q ss_pred ------------------CCCcccccCCCCCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCchhhhcccccc
Q 002061 183 ------------------AEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLW 244 (973)
Q Consensus 183 ------------------~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~ 244 (973)
..+|..++++++|++|+|++|++++.+|..++++++|++|+|++|++++.+|..++++++|+
T Consensus 184 ~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~ 263 (968)
T PLN00113 184 LTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQ 263 (968)
T ss_pred hhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCC
Confidence 12344444444444444444444444444555555555555555555545555555555555
Q ss_pred EEEeeccccCCcCCccccccccccEEEeeccccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeeccCCc
Q 002061 245 KIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNR 324 (973)
Q Consensus 245 ~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 324 (973)
+|+|++|.+++.+|..+.++++|++|+|++|.+.+.+|..+.++++|+.|++++|.+.+.+|..++.+++|+.|++++|.
T Consensus 264 ~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~ 343 (968)
T PLN00113 264 YLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNK 343 (968)
T ss_pred EEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCC
Confidence 55555555555555555555555555555555555555555555566666666666655555556666666666666666
Q ss_pred cCCCCCccccccccccccccccccccccCChhhhhhhhHHHHHhhhccCCCCccccccCccccceEeccccccccCCCcc
Q 002061 325 FSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDG 404 (973)
Q Consensus 325 l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 404 (973)
+.+.+|..++.+++|+.|++++|++++.+|..++....+..+...+|++.+.+|..+..+++|+.|+|++|++++.+|..
T Consensus 344 l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~ 423 (968)
T PLN00113 344 FSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSE 423 (968)
T ss_pred CcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChh
Confidence 66666666666666777777777776666766666555555555567777778888888888888899998888888888
Q ss_pred ccCCCCcceEeccCCcCCCCCCCCCCCCCCCCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCccccccccccCC
Q 002061 405 LWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLS 484 (973)
Q Consensus 405 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 484 (973)
|..++.|+.|++++|++++.++..+..+++|+.|+|++|++.+.+|..+ ..++|+.|+|++|++++.+|..+.++++|+
T Consensus 424 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~ 502 (968)
T PLN00113 424 FTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELM 502 (968)
T ss_pred HhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccC
Confidence 8888999999999999988888888888899999999999988888765 458899999999999999999999999999
Q ss_pred EEEcCCcccccCCCccccccccccchhccccccccCCCccccccCCCCeeecCCCccCCCCChhhhccc-CceEEccCCc
Q 002061 485 SLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLK-LSSIDLSENQ 563 (973)
Q Consensus 485 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~-L~~l~ls~N~ 563 (973)
.|+|++|++++.+|..+.++++|+.|+|++|.+++.+|..|..+++|+.|+|++|+++|.+|..+..+. |+.+++++|+
T Consensus 503 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~ 582 (968)
T PLN00113 503 QLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNH 582 (968)
T ss_pred EEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCc
Confidence 999999999999999999999999999999999999999999999999999999999999999999886 9999999999
Q ss_pred cccccCcc--cccCCCCccccCCCCCccCcccccccCCCCCCCccccccCCCCcCchhhhHHHHHHHHHHHHHHHHhhee
Q 002061 564 LSGSVPLD--FLRMGGDGAFAGNEGLCLDQSTKMLMNSKLTACPAIQKQKGGFKDKLVLFCIIAVALAAFLAGLLLVSYK 641 (973)
Q Consensus 564 l~~~~p~~--~~~~~~~~~~~~n~~lc~~~~~~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (973)
+.|.+|.. |..+.. .+|.||+++||.+... ..++|..... ...+..++.+++++++.+++++++++.++
T Consensus 583 l~~~~p~~~~~~~~~~-~~~~~n~~lc~~~~~~-----~~~~c~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (968)
T PLN00113 583 LHGSLPSTGAFLAINA-SAVAGNIDLCGGDTTS-----GLPPCKRVRK---TPSWWFYITCTLGAFLVLALVAFGFVFIR 653 (968)
T ss_pred ceeeCCCcchhcccCh-hhhcCCccccCCcccc-----CCCCCccccc---cceeeeehhHHHHHHHHHHHHHHHHHHHH
Confidence 99999964 444544 7899999999975421 2345542111 11122222222222222222222222222
Q ss_pred cccccccccccccccccccccccccc-----cccCHHHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccccHH
Q 002061 642 NFKLSADMENGEKEVSSKWKLASFHH-----IDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVK 716 (973)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~ 716 (973)
+++. ...+..+.+ ...|....+.. ... ......|...+.||+|+||+||+|++..++..||||++......
T Consensus 654 ~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~- 729 (968)
T PLN00113 654 GRNN-LELKRVENE-DGTWELQFFDSKVSKSITI-NDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI- 729 (968)
T ss_pred hhhc-ccccccccc-cccccccccccccchhhhH-HHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-
Confidence 2211 111111110 11122111111 111 22345678888999999999999999888999999988653322
Q ss_pred HHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcC
Q 002061 717 VFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796 (973)
Q Consensus 717 ~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~ 796 (973)
..+|++.+++++||||+++++++.+++..|+||||+++|+|.++++. ++|..+..++.|+|+|++|+|+.+
T Consensus 730 -~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~--------l~~~~~~~i~~~ia~~L~yLH~~~ 800 (968)
T PLN00113 730 -PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN--------LSWERRRKIAIGIAKALRFLHCRC 800 (968)
T ss_pred -cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc--------CCHHHHHHHHHHHHHHHHHhccCC
Confidence 24578999999999999999999999999999999999999999962 789999999999999999999877
Q ss_pred CCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh
Q 002061 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT 876 (973)
Q Consensus 797 ~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t 876 (973)
+++|+||||||+||+++.++.+++. ||........ ....+++.|+|||++.+..++.++|||||||++|||++
T Consensus 801 ~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~t 873 (968)
T PLN00113 801 SPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLT 873 (968)
T ss_pred CCCeecCCCCHHhEEECCCCceEEE-eccccccccC------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHh
Confidence 7899999999999999999888876 6654332111 12357899999999999999999999999999999999
Q ss_pred CCCCCCcccCCcccHHHHHHHHhccccccchhccccccC--cchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 002061 877 GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVAS--ESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADAD 954 (973)
Q Consensus 877 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 954 (973)
|+.||+...+.......|+....... ....++++.... ....+...++.+++.+||+.||++||+|.||+++|+++.
T Consensus 874 g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 874 GKSPADAEFGVHGSIVEWARYCYSDC-HLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred CCCCCCcccCCCCcHHHHHHHhcCcc-chhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 99999766656666777765443222 123344443322 223455677889999999999999999999999999886
Q ss_pred CCC
Q 002061 955 PCT 957 (973)
Q Consensus 955 ~~~ 957 (973)
...
T Consensus 953 ~~~ 955 (968)
T PLN00113 953 RSS 955 (968)
T ss_pred ccc
Confidence 533
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-57 Score=573.05 Aligned_cols=490 Identities=34% Similarity=0.558 Sum_probs=417.2
Q ss_pred ccCcEeeCCCCcccCcCChhhhCCCCCcEEEecCCcccCCCC-c-ccCCCCCCEEeccCccCCCccccccccccccceEE
Q 002061 97 QSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVP-D-LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLS 174 (973)
Q Consensus 97 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~-~-l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 174 (973)
.+++.|+|++|++++.+|..|..+++|++|+|++|++.+..| . +..+++|++|+|++|.+++.+|. ..+++|++|+
T Consensus 69 ~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~ 146 (968)
T PLN00113 69 SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLD 146 (968)
T ss_pred CcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEE
Confidence 468999999999999999999999999999999999987555 4 45999999999999999988875 5689999999
Q ss_pred ccCCcCCCCCCcccccCCCCCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCchhhhccccccEEEeeccccC
Q 002061 175 IGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLT 254 (973)
Q Consensus 175 l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 254 (973)
|++|.+.. .+|..++++++|++|+|++|.+.+.+|..++++++|++|+|++|++++.+|..++++++|++|+|++|.++
T Consensus 147 Ls~n~~~~-~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~ 225 (968)
T PLN00113 147 LSNNMLSG-EIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLS 225 (968)
T ss_pred CcCCcccc-cCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccC
Confidence 99999863 57899999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcCCccccccccccEEEeeccccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeeccCCccCCCCCcccc
Q 002061 255 GELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLG 334 (973)
Q Consensus 255 ~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~ 334 (973)
+.+|..++++++|++|++++|.+.+.+|..++++++|+.|++++|++.+.+|..+..+++|+.|++++|.+.+.+|..+.
T Consensus 226 ~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~ 305 (968)
T PLN00113 226 GEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVI 305 (968)
T ss_pred CcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccccccccCChhhhhhhhHHHHHhhhccCCCCccccccCccccceEeccccccccCCCccccCCCCcceE
Q 002061 335 RYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGML 414 (973)
Q Consensus 335 ~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 414 (973)
.+++|+.|++++|.+++.+|..+..++.+..+.+.+|++.+.+|..++.+++|+.|+|++|++++.+|..++.+++|+.|
T Consensus 306 ~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L 385 (968)
T PLN00113 306 QLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKL 385 (968)
T ss_pred CCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEE
Confidence 99999999999999999999888887776666556777888888888888888888888888887777777777777777
Q ss_pred eccCCcCCCCCCCCCCCCCCCCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCccccccc---------------
Q 002061 415 DFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGA--------------- 479 (973)
Q Consensus 415 ~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~--------------- 479 (973)
++++|++.+..+..++.+++|+.|+|++|++++..|..|..+++|+.|+|++|++++.+|..+..
T Consensus 386 ~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~ 465 (968)
T PLN00113 386 ILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFF 465 (968)
T ss_pred ECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceee
Confidence 77777666666666666666666666666666555555555555555555555555444433332
Q ss_pred --------cccCCEEEcCCcccccCCCccccccccccchhccccccccCCCccccccCCCCeeecCCCccCCCCChhhhc
Q 002061 480 --------LRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMK 551 (973)
Q Consensus 480 --------l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~ 551 (973)
.++|+.|+|++|++++..|..+.++++|+.|+|++|++++.+|..+..+++|+.|+|++|.++|.+|..+..
T Consensus 466 ~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 545 (968)
T PLN00113 466 GGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSE 545 (968)
T ss_pred eecCcccccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhC
Confidence 356777777888888888888999999999999999999999999999999999999999999999999998
Q ss_pred cc-CceEEccCCccccccCcccccCCC--CccccCCCCCcc
Q 002061 552 LK-LSSIDLSENQLSGSVPLDFLRMGG--DGAFAGNEGLCL 589 (973)
Q Consensus 552 l~-L~~l~ls~N~l~~~~p~~~~~~~~--~~~~~~n~~lc~ 589 (973)
++ |+.|+|++|+++|.+|..+..+.. .-.+.+|+..+.
T Consensus 546 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~ 586 (968)
T PLN00113 546 MPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGS 586 (968)
T ss_pred cccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceee
Confidence 86 999999999999999987655433 234567765543
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-47 Score=414.91 Aligned_cols=287 Identities=46% Similarity=0.739 Sum_probs=245.7
Q ss_pred cccccccccCHHHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecccc--HHHHHHHHHHHHhcCCCceeeEEEE
Q 002061 662 LASFHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG--VKVFAAEMEILGKIRHRNILKLYAC 739 (973)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~ 739 (973)
...|.+.++ ..++++|...+.||+|+||.||+|...+ +..||||++..... .++|.+|++++.+++|||+|+++||
T Consensus 62 ~~~fs~~el-~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 62 LRSFSYDEL-RKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred cceeeHHHH-HHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence 445677777 7889999999999999999999999987 58999998877543 5679999999999999999999999
Q ss_pred EEeCC-eeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCe
Q 002061 740 LLKGG-SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP 818 (973)
Q Consensus 740 ~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~ 818 (973)
|.+++ +.++|||||++|+|.++++.... . .++|.+|++||.++|+||+|||+.+...||||||||+|||+|+++.+
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~--~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a 216 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKG--E-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA 216 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCC--C-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence 99988 59999999999999999986421 1 78999999999999999999999888899999999999999999999
Q ss_pred EEecccCcccccCCCCccccccc-CCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccc-CCcccHHHHHH
Q 002061 819 KIADFGVAKIAENSPKVSDYSCF-AGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEY-GDGKDIVYWVS 896 (973)
Q Consensus 819 kl~Dfgl~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~-~~~~~~~~~~~ 896 (973)
||+|||+|+..+.. ....... .||.+|+|||++..+..+.++|||||||++.|++||+.|.+... .....+..|+.
T Consensus 217 KlsDFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~ 294 (361)
T KOG1187|consen 217 KLSDFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAK 294 (361)
T ss_pred EccCccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHH
Confidence 99999999655431 1111112 79999999999999999999999999999999999999988654 34455888887
Q ss_pred HHhccccccchhcccccc-CcchH-HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCC
Q 002061 897 THLNNHENVLKVLDCEVA-SESIK-EDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPC 956 (973)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~ 956 (973)
...... .+.+++|+... ..... +...++.+++.+|++.+|.+||+|.||+++|+.+...
T Consensus 295 ~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 295 PLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 666666 58899999876 44443 6788899999999999999999999999999665544
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=383.26 Aligned_cols=255 Identities=31% Similarity=0.426 Sum_probs=217.2
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeec---cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCC-eeEEEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK---GDGVKVFAAEMEILGKIRHRNILKLYACLLKGG-SSFLVL 750 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~~lv~ 750 (973)
..+.+..+.||+|..|+|||++++.+++.+|+|++.- +...+++.+|++++++.+||+||++|++|..+. ..+++|
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m 157 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM 157 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence 3456778899999999999999999999999999843 345677899999999999999999999999988 599999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccccc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 830 (973)
|||++|||.+++... +.+++....+++.+|++||.|||+ +++||||||||+|||+...|+|||||||.+....
T Consensus 158 EYMDgGSLd~~~k~~-----g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv 230 (364)
T KOG0581|consen 158 EYMDGGSLDDILKRV-----GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILV 230 (364)
T ss_pred hhcCCCCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhh
Confidence 999999999998753 458999999999999999999995 4899999999999999999999999999998775
Q ss_pred CCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhcc
Q 002061 831 NSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLD 910 (973)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (973)
+. ....++||..|||||.+.+..|+.++||||||++++|+++|+.||........++...........+
T Consensus 231 nS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~pp------- 299 (364)
T KOG0581|consen 231 NS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPP------- 299 (364)
T ss_pred hh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCC-------
Confidence 54 2234789999999999999999999999999999999999999998763334444444443333222
Q ss_pred ccccCcchH-HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 911 CEVASESIK-EDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 911 ~~~~~~~~~-~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
+..+. ...+++.+++..|+++||.+||++.|+++|-.
T Consensus 300 ----P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpf 337 (364)
T KOG0581|consen 300 ----PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPF 337 (364)
T ss_pred ----CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHH
Confidence 11222 36778999999999999999999999998754
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=377.45 Aligned_cols=255 Identities=30% Similarity=0.349 Sum_probs=209.6
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc---------cHHHHHHHHHHHHhcCCCceeeEEEEEEeCC
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD---------GVKVFAAEMEILGKIRHRNILKLYACLLKGG 744 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 744 (973)
..+.|.+.+.||+|+||.|-+|..+.+|+.||||++.+.. ......+|+++|++++|||||+++++|+.++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 4456788899999999999999999999999999997621 1223579999999999999999999999999
Q ss_pred eeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCC---CCeEEe
Q 002061 745 SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDED---YEPKIA 821 (973)
Q Consensus 745 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~---~~~kl~ 821 (973)
+.||||||++||+|.+.+-.+ ..+....-..++.|++.|+.||| ++||+||||||+|||+..+ ..+||+
T Consensus 250 s~YmVlE~v~GGeLfd~vv~n-----k~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKIt 321 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVAN-----KYLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKIT 321 (475)
T ss_pred ceEEEEEEecCccHHHHHHhc-----cccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEec
Confidence 999999999999999998754 23455556789999999999999 8999999999999999876 679999
Q ss_pred cccCcccccCCCCcccccccCCccccccccccccCC--CC-ccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHH
Q 002061 822 DFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCK--VS-EKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTH 898 (973)
Q Consensus 822 Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~-~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~ 898 (973)
|||+|+..+.. .-....+||+.|.|||++.++. +. .++|+||+||+||-+++|.+||.+.+++..-..+...+.
T Consensus 322 DFGlAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~ 398 (475)
T KOG0615|consen 322 DFGLAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGR 398 (475)
T ss_pred ccchhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCc
Confidence 99999977643 3344578999999999997654 33 478999999999999999999988755432211111111
Q ss_pred hccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 899 LNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
. .+.+..+.+..++.++++.+|+..||++||+++|+++|-+
T Consensus 399 y------------~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW 439 (475)
T KOG0615|consen 399 Y------------AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPW 439 (475)
T ss_pred c------------cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChh
Confidence 1 1223456677888999999999999999999999998755
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=389.26 Aligned_cols=253 Identities=37% Similarity=0.516 Sum_probs=208.2
Q ss_pred CcccCcccccCceEEEEEEecCCCcE-EEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCC-eeEEEEE
Q 002061 678 LEEDNLIGSGGTGKVYRLDLKKNAGT-VAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGG-SSFLVLE 751 (973)
Q Consensus 678 ~~~~~~lG~G~~g~V~~a~~~~~~~~-vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~~lv~e 751 (973)
+...+.||+|+||+||+|.++ |+. ||||++... ...++|.+|+.++.+++|||||+++|++.++. ..++|||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE 120 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE 120 (362)
T ss_pred hhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence 345566999999999999999 555 999998762 22568999999999999999999999999887 7999999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCC-eEecCCCCCCeeecCCC-CeEEecccCcccc
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP-IIHRDIKSSNILLDEDY-EPKIADFGVAKIA 829 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~-ivH~Dlkp~Nill~~~~-~~kl~Dfgl~~~~ 829 (973)
|+++|+|.++++.. ....+++..+..+|.|||+||+||| +.+ ||||||||+|||++.++ ++||+|||+++..
T Consensus 121 y~~~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~ 194 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREK 194 (362)
T ss_pred eCCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceee
Confidence 99999999999863 3567999999999999999999999 667 99999999999999998 9999999999866
Q ss_pred cCCCCcccccccCCccccccccccc--cCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccch
Q 002061 830 ENSPKVSDYSCFAGTHGYIAPELAY--TCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLK 907 (973)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
.... ...+...||+.|||||++. ...|+.++||||||+++|||+||+.||..... ......+.
T Consensus 195 ~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--~~~~~~v~----------- 259 (362)
T KOG0192|consen 195 VISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--VQVASAVV----------- 259 (362)
T ss_pred cccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH--HHHHHHHH-----------
Confidence 5432 2333467999999999999 66999999999999999999999999986522 12111111
Q ss_pred hccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 002061 908 VLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADP 955 (973)
Q Consensus 908 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 955 (973)
.....+..+......+..++.+||+.||++||++.+++..|+.+..
T Consensus 260 --~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 260 --VGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred --hcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 1111122222356678889999999999999999999999997643
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-44 Score=368.14 Aligned_cols=201 Identities=32% Similarity=0.512 Sum_probs=181.4
Q ss_pred HHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc----cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 002061 673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL 748 (973)
Q Consensus 673 ~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 748 (973)
....+|+..+.||+|+||+||+|+++.++..||||.+.+.. ..+-+..|+.+|+.++|||||++++++..++..|+
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l 86 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL 86 (429)
T ss_pred cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence 44578999999999999999999999999999999987643 45567889999999999999999999999999999
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCC------CCeEEec
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDED------YEPKIAD 822 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~------~~~kl~D 822 (973)
|||||+||+|.+|++.+ ..+++.....++.|+|.|+++|| +++||||||||+|||++.. -.+||+|
T Consensus 87 VMEyC~gGDLs~yi~~~-----~~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIAD 158 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRRR-----GRLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIAD 158 (429)
T ss_pred EEEeCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecc
Confidence 99999999999999975 36889999999999999999999 8999999999999999865 4589999
Q ss_pred ccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcc
Q 002061 823 FGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEE 884 (973)
Q Consensus 823 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~ 884 (973)
||+|+...+... ....+|++.|||||+++..+|+.|+|+||+|+++|+|++|+.||+..
T Consensus 159 FGfAR~L~~~~~---a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 159 FGFARFLQPGSM---AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred cchhhhCCchhH---HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 999998875432 23468999999999999999999999999999999999999999743
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=384.13 Aligned_cols=248 Identities=27% Similarity=0.399 Sum_probs=212.4
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeec-----cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL 750 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~-----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 750 (973)
.+|+..+.||+|||++||.+++..+|+.||+|++.+ ....+...+|+++.+.++|||||+++++|++.+++|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 689999999999999999999999999999999866 345677889999999999999999999999999999999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccccc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 830 (973)
|+|+.++|..++++ +..+++.+++.+..||+.|+.||| +++|+|||||..|+|++++.++||+|||+|..+.
T Consensus 98 ELC~~~sL~el~Kr-----rk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le 169 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR-----RKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLE 169 (592)
T ss_pred EecCCccHHHHHHh-----cCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeec
Confidence 99999999999984 356899999999999999999999 8899999999999999999999999999999887
Q ss_pred CCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhcc
Q 002061 831 NSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLD 910 (973)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (973)
.... .....+||+.|+|||++....++..+||||+||++|.|++|++||+.. ++..... .+...+
T Consensus 170 ~~~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk-----~vkety~-~Ik~~~------- 234 (592)
T KOG0575|consen 170 YDGE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK-----TVKETYN-KIKLNE------- 234 (592)
T ss_pred Cccc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc-----hHHHHHH-HHHhcC-------
Confidence 5432 333468999999999999999999999999999999999999999754 1212111 111111
Q ss_pred ccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 911 CEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 911 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
+ ..+.....+..++|.++++++|.+|||+++|+.+=
T Consensus 235 --Y--~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~ 270 (592)
T KOG0575|consen 235 --Y--SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHP 270 (592)
T ss_pred --c--ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 1 11223445567899999999999999999999864
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-45 Score=356.68 Aligned_cols=262 Identities=22% Similarity=0.343 Sum_probs=214.6
Q ss_pred HHHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeec----cccHHHHHHHHHHHHhcCCCceeeEEE-EEEeCCe-
Q 002061 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKIRHRNILKLYA-CLLKGGS- 745 (973)
Q Consensus 672 ~~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~-~~~~~~~- 745 (973)
.....+|++.++||+|.||+|||+++..+|..||.|.+.- ....++...|+.+|++++|||||++++ .|.++..
T Consensus 15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ev 94 (375)
T KOG0591|consen 15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEV 94 (375)
T ss_pred cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchh
Confidence 4456688999999999999999999999999999998865 244566788999999999999999998 5555555
Q ss_pred eEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCC-CeEecCCCCCCeeecCCCCeEEeccc
Q 002061 746 SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP-PIIHRDIKSSNILLDEDYEPKIADFG 824 (973)
Q Consensus 746 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~-~ivH~Dlkp~Nill~~~~~~kl~Dfg 824 (973)
.++|||||++|+|...++.. +.....+++..+++++.|++.||.++|....+ -|+||||||.|||++.+|.+|++|||
T Consensus 95 lnivmE~c~~GDLsqmIk~~-K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG 173 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHF-KKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG 173 (375)
T ss_pred hHHHHHhhcccCHHHHHHHH-HhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence 89999999999999999875 45566799999999999999999999953222 38899999999999999999999999
Q ss_pred CcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccc
Q 002061 825 VAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHEN 904 (973)
Q Consensus 825 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 904 (973)
+++.+.... ......+|||.||+||.+.+.+|+.++||||+||++|||+.-+.||.+. .+.+.-.
T Consensus 174 L~r~l~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~~L~~-------- 238 (375)
T KOG0591|consen 174 LGRFLSSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLLSLCK-------- 238 (375)
T ss_pred hHhHhcchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHHHHHH--------
Confidence 999886542 2334578999999999999999999999999999999999999999764 2222211
Q ss_pred cchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 905 VLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
++..+++.+-...-....+.+++..|+..||+.||+...+++.+.
T Consensus 239 --KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 239 --KIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred --HHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 122233322233556778999999999999999998655554443
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=381.47 Aligned_cols=256 Identities=32% Similarity=0.435 Sum_probs=214.7
Q ss_pred CcccCcccccCceEEEEEEecCCCcEEEEEeeec-cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCC
Q 002061 678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK-GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNG 756 (973)
Q Consensus 678 ~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 756 (973)
+..++.||+|.||+||.|.+.. ...||+|.++. ....++|.+|+++|++++|++||++++++..++..|||||||+.|
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 4677899999999999999986 44899999987 445678999999999999999999999999988999999999999
Q ss_pred chHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCcc
Q 002061 757 NLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVS 836 (973)
Q Consensus 757 sL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 836 (973)
+|.+|++.. ....+...+.+.++.|||+||+||+ ++++|||||.++||||+++..+||+|||+|+...+... .
T Consensus 287 sLl~yLr~~---~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y-~ 359 (468)
T KOG0197|consen 287 SLLDYLRTR---EGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY-T 359 (468)
T ss_pred cHHHHhhhc---CCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCCce-e
Confidence 999999862 4556888999999999999999999 88999999999999999999999999999995443332 2
Q ss_pred cccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhccccccC
Q 002061 837 DYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVAS 915 (973)
Q Consensus 837 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
......-+..|.|||++..++++.+||||||||+||||+| |+.||... ...+ . .+.++...+-
T Consensus 360 ~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m--sn~e---v-----------~~~le~GyRl 423 (468)
T KOG0197|consen 360 ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGM--SNEE---V-----------LELLERGYRL 423 (468)
T ss_pred ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCC--CHHH---H-----------HHHHhccCcC
Confidence 2222344678999999999999999999999999999999 99998654 1111 1 1222233333
Q ss_pred cchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCCC
Q 002061 916 ESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPCT 957 (973)
Q Consensus 916 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 957 (973)
..+..++..+++++..||+.+|++|||+..+...++++....
T Consensus 424 p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 424 PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 445567778999999999999999999999999998876543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=358.32 Aligned_cols=250 Identities=29% Similarity=0.373 Sum_probs=207.8
Q ss_pred HHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeE
Q 002061 673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF 747 (973)
Q Consensus 673 ~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 747 (973)
...++|++.++||+|+||+||+++.+++++.+|+|++++. .+.+...+|..++.+++||+||+++..|++++..|
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 4467899999999999999999999999999999999873 35667889999999999999999999999999999
Q ss_pred EEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcc
Q 002061 748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827 (973)
Q Consensus 748 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~ 827 (973)
+|+||+.||.|...+++. ..+++..+.-++.+|+.||.||| +.+|||||+||+|||++.+|+++|+|||+++
T Consensus 102 lVld~~~GGeLf~hL~~e-----g~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k 173 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQRE-----GRFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCK 173 (357)
T ss_pred EEEeccCCccHHHHHHhc-----CCcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccch
Confidence 999999999999999753 46888888899999999999999 8999999999999999999999999999998
Q ss_pred cccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccch
Q 002061 828 IAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLK 907 (973)
Q Consensus 828 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
..-... ......+||+.|||||++.+..|+.++|+||+|+++|||++|.+||... +...+........-
T Consensus 174 ~~~~~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~-----~~~~~~~~I~~~k~---- 242 (357)
T KOG0598|consen 174 EDLKDG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE-----DVKKMYDKILKGKL---- 242 (357)
T ss_pred hcccCC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc-----cHHHHHHHHhcCcC----
Confidence 443322 1223478999999999999999999999999999999999999999654 34444444333320
Q ss_pred hccccccCcchHHHHHHHHHHHHHhcCCCCCCCC----CHHHHHH
Q 002061 908 VLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRP----PMREVVK 948 (973)
Q Consensus 908 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp----t~~evl~ 948 (973)
...+.-...+..+++.+.+..||++|. ++.+|-+
T Consensus 243 -------~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~ 280 (357)
T KOG0598|consen 243 -------PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKR 280 (357)
T ss_pred -------CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence 011111334567788899999999995 4555433
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=346.58 Aligned_cols=262 Identities=23% Similarity=0.326 Sum_probs=205.1
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecccc----HHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG----VKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE 751 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 751 (973)
+.|+...++|+|+||+|||++++++|+.||||++...++ .+-..||++++++++|||+|.++++|......++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 468888899999999999999999999999999876433 3446789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccC
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 831 (973)
||+. ++.+-+.++ ....+...+..+.+|++.|+.|+| ++++|||||||+|||++.+|.+|+||||.|+....
T Consensus 82 ~~dh-TvL~eLe~~----p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 82 YCDH-TVLHELERY----PNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA 153 (396)
T ss_pred ecch-HHHHHHHhc----cCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcC
Confidence 9977 444445443 224678889999999999999999 89999999999999999999999999999998763
Q ss_pred CCCcccccccCCcccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHH-----------h
Q 002061 832 SPKVSDYSCFAGTHGYIAPELAYT-CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTH-----------L 899 (973)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~-----------~ 899 (973)
. ...++..+.|..|+|||.+.+ .+|+.++||||+||++.||++|.+.|.+.. +.+-.+.+... .
T Consensus 154 p--gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~S--DiDQLy~I~ktLG~L~prhq~iF 229 (396)
T KOG0593|consen 154 P--GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRS--DIDQLYLIRKTLGNLIPRHQSIF 229 (396)
T ss_pred C--cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcc--hHHHHHHHHHHHcccCHHHHHHh
Confidence 2 234555788999999999887 689999999999999999999999986542 22222222111 1
Q ss_pred ccccccchhccccc-----cCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 900 NNHENVLKVLDCEV-----ASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 900 ~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
...+....+.-+.. .....+.....+++++..|++.||++|++-+|++.|
T Consensus 230 ~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 230 SSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred ccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 11111111111111 111123334567899999999999999999988754
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-47 Score=387.70 Aligned_cols=475 Identities=27% Similarity=0.391 Sum_probs=400.7
Q ss_pred eEEEeecCCCCCccccccccCCccCcEeeCCCCcccCcCChhhhCCCCCcEEEecCCcccCCCCcccCCCCCCEEeccCc
Q 002061 75 VTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSIN 154 (973)
Q Consensus 75 v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls~n 154 (973)
...+++.++.+. .+.+.+.+|..|.+|++++|+++ .+|.+++.+..++.|+.++|+++..|+.++.+.+|..|+.+.|
T Consensus 47 l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls~lp~~i~s~~~l~~l~~s~n 124 (565)
T KOG0472|consen 47 LQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLSELPEQIGSLISLVKLDCSSN 124 (565)
T ss_pred hhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHhhccHHHhhhhhhhhhhcccc
Confidence 456888888887 67788999999999999999998 7899999999999999999999999999999999999999999
Q ss_pred cCCCccccccccccccceEEccCCcCCCCCCcccccCCCCCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCc
Q 002061 155 YFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFP 234 (973)
Q Consensus 155 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 234 (973)
.+. ..|..++.+-.|+.|+..+|++. .+|+.++++.+|..|++.+|+++...|..+. ++.|++||..+|.++ .+|
T Consensus 125 ~~~-el~~~i~~~~~l~dl~~~~N~i~--slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP 199 (565)
T KOG0472|consen 125 ELK-ELPDSIGRLLDLEDLDATNNQIS--SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLP 199 (565)
T ss_pred cee-ecCchHHHHhhhhhhhccccccc--cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCC
Confidence 998 78889999999999999999997 6799999999999999999999955555444 999999999999998 899
Q ss_pred hhhhccccccEEEeeccccCCcCCccccccccccEEEeeccccccccCCccC-CCCCccEEEcccCCCCCCCCCCcCCcc
Q 002061 235 RSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIG-NLKNLTVFQCFKNNFSGEFPSGFGDMR 313 (973)
Q Consensus 235 ~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~p~~~~~l~ 313 (973)
..++.+.+|..|+|.+|+|. .+| +|.++..|.+|+++.|+++ .+|.+.. ++.+|.+||+.+|+++ +.|+.++.++
T Consensus 200 ~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLr 275 (565)
T KOG0472|consen 200 PELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLR 275 (565)
T ss_pred hhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhh
Confidence 99999999999999999999 677 8999999999999999998 7777765 8999999999999999 8899999999
Q ss_pred cceeeeccCCccCCCCCccccccccccccccccccccccCChhhh--hhhhHHHHHhh-------hccCCC-----C-cc
Q 002061 314 KLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLC--EKRKLLNLLAL-------SNNFSG-----E-VP 378 (973)
Q Consensus 314 ~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~--~~~~ll~ll~l-------~n~~~~-----~-~p 378 (973)
+|++|++++|.|+ ..|..++++ +|+.|-+.+|.+. .+-..+- +....++.+-. ++.-.+ . .+
T Consensus 276 sL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlr-TiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~ 352 (565)
T KOG0472|consen 276 SLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLR-TIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPS 352 (565)
T ss_pred hhhhhcccCCccc-cCCcccccc-eeeehhhcCCchH-HHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCC
Confidence 9999999999999 688899999 9999999999997 3332221 12222333322 111111 1 11
Q ss_pred cc---ccCccccceEeccccccccCCCccccCCCC---cceEeccCCcCCCCCCCCCCCCCCCCEEEcccCCCCCCCChh
Q 002061 379 NS---YADCKTIQRLRISDNHLSGKIPDGLWALPN---VGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSE 452 (973)
Q Consensus 379 ~~---~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~ 452 (973)
.. ...+.+.+.|++++-+++ .+|+..+.-.+ .+..+++.|++...+......-.-.+.+++++|.+. .+|..
T Consensus 353 ~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~elPk~L~~lkelvT~l~lsnn~is-fv~~~ 430 (565)
T KOG0472|consen 353 ESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLCELPKRLVELKELVTDLVLSNNKIS-FVPLE 430 (565)
T ss_pred Ccccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHhhhhhhhHHHHHHHHHHHhhcCccc-cchHH
Confidence 11 223567899999999998 67777776655 889999999998665433222222445677777776 88999
Q ss_pred hhcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCCccccccccccchhccccccccCCCccccccCCCC
Q 002061 453 LGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLN 532 (973)
Q Consensus 453 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 532 (973)
++.+++|..|+|++|.+. .+|..++.+..|+.||+|.|++. ..|...-.+..|+.+-.++|++....|..+.+|.+|.
T Consensus 431 l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~ 508 (565)
T KOG0472|consen 431 LSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLT 508 (565)
T ss_pred HHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcc
Confidence 999999999999999998 78999999999999999999998 7888888888888888888999877777799999999
Q ss_pred eeecCCCccCCCCChhhhccc-CceEEccCCccccccCc
Q 002061 533 ALNLSGNKLTGSIPDNLMKLK-LSSIDLSENQLSGSVPL 570 (973)
Q Consensus 533 ~L~L~~N~l~~~~p~~l~~l~-L~~l~ls~N~l~~~~p~ 570 (973)
+|||.+|.|. .||..++++. ++.|++++||+. .|+
T Consensus 509 tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr--~Pr 544 (565)
T KOG0472|consen 509 TLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR--QPR 544 (565)
T ss_pred eeccCCCchh-hCChhhccccceeEEEecCCccC--CCH
Confidence 9999999998 8888999886 999999999998 554
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=385.55 Aligned_cols=265 Identities=26% Similarity=0.406 Sum_probs=220.7
Q ss_pred cCCcccCcccccCceEEEEEEecC-----CCcEEEEEeeeccc---cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKK-----NAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF 747 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~-----~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 747 (973)
.+.+..+.||+|+||+||+|+... +...||||.++... ..++|+||++++..++|||||+++|+|.+++..+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 455678899999999999998752 34579999998743 4578999999999999999999999999999999
Q ss_pred EEEEccCCCchHHHHHhhhcCC---------CCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCe
Q 002061 748 LVLEYMPNGNLFQALHKRVKEG---------KPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP 818 (973)
Q Consensus 748 lv~e~~~~gsL~~~l~~~~~~~---------~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~ 818 (973)
||+|||..|||.++|..+.... .++++..+.+.||.|||.||+||- ++.+|||||..+|+||.++..|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceEE
Confidence 9999999999999998653211 233788999999999999999999 8899999999999999999999
Q ss_pred EEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHH
Q 002061 819 KIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVST 897 (973)
Q Consensus 819 kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~ 897 (973)
||+|||+++..-..++........-+.+|||||.+..++|+++|||||+||+|||+++ |+.||.+. ..++..+.+..
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~gl--Sn~EVIe~i~~ 720 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGL--SNQEVIECIRA 720 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCccccc--chHHHHHHHHc
Confidence 9999999998766655444434445789999999999999999999999999999999 99999765 22222222221
Q ss_pred HhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCCCCC
Q 002061 898 HLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPCTDK 959 (973)
Q Consensus 898 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~ 959 (973)
. .. -..+..++.++++|+..||+..|.+||+++||-..|+......++
T Consensus 721 g-------------~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~ 768 (774)
T KOG1026|consen 721 G-------------QL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPK 768 (774)
T ss_pred C-------------Cc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCcc
Confidence 1 11 234566778899999999999999999999999999987665543
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=362.02 Aligned_cols=265 Identities=23% Similarity=0.326 Sum_probs=211.6
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-c--cHHHHHHHHHHHHhcC-CCceeeEEEEEEeCC-eeEE
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-D--GVKVFAAEMEILGKIR-HRNILKLYACLLKGG-SSFL 748 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-~--~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~-~~~l 748 (973)
..++|.+.++||.|.||+||+|+...+++.||||++++. . +.-.-.||++.|+++. ||||+++.+++.+.+ ..|+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 467899999999999999999999999999999998763 1 2223468999999998 999999999998887 9999
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccc
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 828 (973)
||||| ..+|++.++.+ +..+++..+..|+.||++||+|+| .+|+.|||+||+|||+.....+||+|||+|+.
T Consensus 88 VfE~M-d~NLYqLmK~R----~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 88 VFEFM-DCNLYQLMKDR----NRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLARE 159 (538)
T ss_pred eHHhh-hhhHHHHHhhc----CCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccc
Confidence 99999 56999999865 567999999999999999999999 89999999999999999999999999999997
Q ss_pred ccCCCCcccccccCCcccccccccc-ccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccc---
Q 002061 829 AENSPKVSDYSCFAGTHGYIAPELA-YTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHEN--- 904 (973)
Q Consensus 829 ~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~--- 904 (973)
+.... .++..+.|..|+|||++ +.+.|+.++||||+|||++|+.+-++.|.+. .+.|-.+.+-..+.....
T Consensus 160 v~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~--sE~Dqi~KIc~VLGtP~~~~~ 234 (538)
T KOG0661|consen 160 VRSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGA--SEIDQIYKICEVLGTPDKDSW 234 (538)
T ss_pred cccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCC--cHHHHHHHHHHHhCCCccccc
Confidence 76543 35567789999999986 5678999999999999999999999998654 222222222111111100
Q ss_pred -----cchhcc---c----cccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 905 -----VLKVLD---C----EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 905 -----~~~~~~---~----~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
+...+. + ............++.+++.+|++|||.+|||+.|++++--
T Consensus 235 ~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pf 293 (538)
T KOG0661|consen 235 PEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPF 293 (538)
T ss_pred hhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcc
Confidence 000000 1 1111122335677889999999999999999999998753
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=362.02 Aligned_cols=253 Identities=30% Similarity=0.406 Sum_probs=210.6
Q ss_pred HHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeec-----cccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCee
Q 002061 673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSS 746 (973)
Q Consensus 673 ~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~-----~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 746 (973)
+...+|.+++.||+|+|++|++|+...+++.||||++.+ +...+-+.+|-.+|.++ .||.|++++..|.++...
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 345678999999999999999999999999999999876 34455678899999999 899999999999999999
Q ss_pred EEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCc
Q 002061 747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826 (973)
Q Consensus 747 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~ 826 (973)
|+|+||+++|+|.+++++. ..+++...+.++.+|+.|++||| ++|||||||||+|||+++||+++|+|||.|
T Consensus 150 YFvLe~A~nGdll~~i~K~-----Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsA 221 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKY-----GSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSA 221 (604)
T ss_pred EEEEEecCCCcHHHHHHHh-----CcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeecccc
Confidence 9999999999999999975 46888888999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCCc-----------ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHH
Q 002061 827 KIAENSPKV-----------SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWV 895 (973)
Q Consensus 827 ~~~~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~ 895 (973)
+.+.+.... .+...++||..|.+||++.....++++|+|+|||++|.|+.|++||... .+...+
T Consensus 222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~----NeyliF- 296 (604)
T KOG0592|consen 222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAA----NEYLIF- 296 (604)
T ss_pred ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccc----cHHHHH-
Confidence 876533221 1124589999999999999999999999999999999999999999754 111111
Q ss_pred HHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 896 STHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
+ ++++..+ ..++...+...+|+.+.+..||.+|+|..+|-+|.
T Consensus 297 q----------kI~~l~y--~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 297 Q----------KIQALDY--EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred H----------HHHHhcc--cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 1 1111111 11122234567888899999999999999998874
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=344.19 Aligned_cols=262 Identities=26% Similarity=0.393 Sum_probs=215.7
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE 751 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 751 (973)
.+.|++..+||.|..++||+|+....++.||||++.-+ .+.+.+.+|++.++.++||||++++.+|..+...|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 35789999999999999999999999999999998653 346788999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccC
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 831 (973)
||.+||+.+.++.....+ +++..+..|..++++||.||| .+|.||||||+.||||+.+|.|||+|||.+..+-.
T Consensus 105 fMa~GS~ldIik~~~~~G---l~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDG---LEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred hhcCCcHHHHHHHHcccc---ccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 999999999998764433 888899999999999999999 88999999999999999999999999998765543
Q ss_pred CCCcc--cccccCCccccccccccc--cCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccch
Q 002061 832 SPKVS--DYSCFAGTHGYIAPELAY--TCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLK 907 (973)
Q Consensus 832 ~~~~~--~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
..... +....+||+.|||||++. ...|+.|+||||||++..|+.+|..||... ...++....+...+....
T Consensus 179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~-----pPmkvLl~tLqn~pp~~~ 253 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKY-----PPMKVLLLTLQNDPPTLL 253 (516)
T ss_pred cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccC-----ChHHHHHHHhcCCCCCcc
Confidence 33211 114568999999999953 446999999999999999999999999754 122333333333332111
Q ss_pred hccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 908 VLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 908 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
-.....+........+.+++..|+++||.+|||+++++++
T Consensus 254 --t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 254 --TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred --cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 1222333444556689999999999999999999999976
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=368.80 Aligned_cols=399 Identities=21% Similarity=0.256 Sum_probs=266.4
Q ss_pred cEEEecCCcccCCCC-cccCC--CCCCEEeccCccCCCccccccccccccceEEccCCcCCCCCCcccccCCCCCCEEEc
Q 002061 124 KVLNVTGNAMVGSVP-DLSAL--KNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFL 200 (973)
Q Consensus 124 ~~L~L~~n~l~~~~~-~l~~l--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ip~~~~~l~~L~~L~L 200 (973)
+.||.+++.+..... .+.++ +.-++||+|+|.++.+.+..|.++++|+++++..|.++ .||...+...+|+.|+|
T Consensus 55 ~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt--~IP~f~~~sghl~~L~L 132 (873)
T KOG4194|consen 55 RLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT--RIPRFGHESGHLEKLDL 132 (873)
T ss_pred eeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh--hcccccccccceeEEee
Confidence 456777777654321 12221 23445777777777666666666666666666666654 34555444555666666
Q ss_pred ccCCCCCCCChhhhccCCCCeeecccccccCCCchhhhccccccEEEeeccccCCcCCccccccccccEEEeeccccccc
Q 002061 201 AHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGK 280 (973)
Q Consensus 201 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ 280 (973)
.+|.|+.+-.+++..++.|+.||||.|.|+...-..|..-.++++|+|++|+|+...-..|.++.+|..|.|+.|++
T Consensus 133 ~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNri--- 209 (873)
T KOG4194|consen 133 RHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRI--- 209 (873)
T ss_pred eccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcc---
Confidence 66666655555555555556666665555533333344444455555555555544444444444444444444444
Q ss_pred cCCccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeeccCCccCCCCCccccccccccccccccccccccCChhhhhh
Q 002061 281 LPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEK 360 (973)
Q Consensus 281 ~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 360 (973)
+...+..|.++++|+.|+|..|+|.-.---.|.++++|+.|.|..|.|..
T Consensus 210 ---------------------ttLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~k--------- 259 (873)
T KOG4194|consen 210 ---------------------TTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISK--------- 259 (873)
T ss_pred ---------------------cccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCccc---------
Confidence 44333444445555555555555543223345555555555555555541
Q ss_pred hhHHHHHhhhccCCCCccccccCccccceEeccccccccCCCccccCCCCcceEeccCCcCCCCCCCCCCCCCCCCEEEc
Q 002061 361 RKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVL 440 (973)
Q Consensus 361 ~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L 440 (973)
.-...|-.+.++++|+|+.|++...-..++++|+.|+.|+||+|.|..+.+..+...++|++|+|
T Consensus 260 ---------------L~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdL 324 (873)
T KOG4194|consen 260 ---------------LDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDL 324 (873)
T ss_pred ---------------ccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEec
Confidence 11234556667777777777777666777777777777777777777777777777888888888
Q ss_pred ccCCCCCCCChhhhcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCCc---cccccccccchhcccccc
Q 002061 441 QNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPN---EMGDCARIVDLNLARNSL 517 (973)
Q Consensus 441 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~---~~~~l~~L~~L~Ls~N~l 517 (973)
++|+|+...+..|..+..|++|+|++|++...--.+|..+++|++|||++|.|...+.+ .|.+|++|+.|+|.+|+|
T Consensus 325 s~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNql 404 (873)
T KOG4194|consen 325 SSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQL 404 (873)
T ss_pred cccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCcee
Confidence 88888888888888888888888888888876677888888888888888888766554 477888999999999999
Q ss_pred ccCCCccccccCCCCeeecCCCccCCCCChhhhcccCceEEccCCccccccCccc
Q 002061 518 SGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSGSVPLDF 572 (973)
Q Consensus 518 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~L~~l~ls~N~l~~~~p~~~ 572 (973)
..+...+|.++..|+.|||.+|.|....|..|..+.|+.|-++.-.+-|+|...|
T Consensus 405 k~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~Lk~Lv~nSssflCDCql~W 459 (873)
T KOG4194|consen 405 KSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPMELKELVMNSSSFLCDCQLKW 459 (873)
T ss_pred eecchhhhccCcccceecCCCCcceeecccccccchhhhhhhcccceEEeccHHH
Confidence 8666688899999999999999998888888888888888888888888888754
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=326.35 Aligned_cols=261 Identities=24% Similarity=0.318 Sum_probs=207.3
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecccc----HHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG----VKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE 751 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 751 (973)
.+|...+++|+|.||.||+|++.++|+.||||+++..+. .....||++.|+.++||||+.++++|...+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 468888999999999999999999999999999976321 2356899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccC
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 831 (973)
||+ .+|+..++.. ...++..++..++.++++|++|+| ++.|+||||||.|+|++.+|.+||+|||+|+.+..
T Consensus 82 fm~-tdLe~vIkd~----~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~ 153 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDK----NIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGS 153 (318)
T ss_pred ecc-ccHHHHhccc----ccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCC
Confidence 995 5999888753 456888899999999999999999 88999999999999999999999999999998876
Q ss_pred CCCcccccccCCccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHh------c----
Q 002061 832 SPKVSDYSCFAGTHGYIAPELAYTC-KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHL------N---- 900 (973)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~------~---- 900 (973)
......+ .+-|..|+|||.++|. .|+..+||||.||++.||+-|.+-|.+. .++.+...-.. .
T Consensus 154 p~~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~----sDidQL~~If~~LGTP~~~~WP 227 (318)
T KOG0659|consen 154 PNRIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGD----SDIDQLSKIFRALGTPTPDQWP 227 (318)
T ss_pred CCccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCC----chHHHHHHHHHHcCCCCcccCc
Confidence 6544433 3679999999998865 6999999999999999999998777543 22222211100 0
Q ss_pred ---cccccchhc--cccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 901 ---NHENVLKVL--DCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 901 ---~~~~~~~~~--~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
.-+.+.++- ................++++..|+..+|.+|.+++|+++|=
T Consensus 228 ~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~ 282 (318)
T KOG0659|consen 228 EMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHP 282 (318)
T ss_pred cccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcch
Confidence 000011110 01111112334456678999999999999999999999763
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=342.65 Aligned_cols=278 Identities=29% Similarity=0.395 Sum_probs=216.2
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHh--cCCCceeeEEEEEEeCC----eeEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGK--IRHRNILKLYACLLKGG----SSFLV 749 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~--l~hpniv~l~~~~~~~~----~~~lv 749 (973)
...+..+.||+|.||.||||+.. ++.||||++. .++.+.|++|.++.+. ++|+||++++++...++ ++++|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp-~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFP-EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc--CceeEEEecC-HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 34466788999999999999998 5899999764 5567788999888775 58999999999887665 78999
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhc------CCCCeEecCCCCCCeeecCCCCeEEecc
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHD------CSPPIIHRDIKSSNILLDEDYEPKIADF 823 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~------~~~~ivH~Dlkp~Nill~~~~~~kl~Df 823 (973)
+||.+.|+|.+||..+ .++|....+|+..+++||+|||++ .+.+|+|||||.+||||..|+++.|+||
T Consensus 287 t~fh~kGsL~dyL~~n------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKAN------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred eeeccCCcHHHHHHhc------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 9999999999999976 689999999999999999999975 3567999999999999999999999999
Q ss_pred cCcccccCCCCcccccccCCccccccccccccCC-C-----CccchHHHHHHHHHHHHhCCC------------CCCccc
Q 002061 824 GVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCK-V-----SEKSDVFSFGVVLLELVTGRK------------PVEEEY 885 (973)
Q Consensus 824 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~-----~~~~DvwslG~~l~el~tg~~------------pf~~~~ 885 (973)
|+|..+.+.....+....+||.+|||||++.+.. + -.+.||||+|.|+|||+++.. ||+..-
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 9999998776666666789999999999987653 2 236899999999999999543 333222
Q ss_pred CCcccHHHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCCCCC-CCCCC
Q 002061 886 GDGKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPCTDK-SPDNS 964 (973)
Q Consensus 886 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~-~~~~~ 964 (973)
+....+.++....+.+.. ...+.+.-.. ...+.-+.+.+..||+.||+.|.|+.=|-+.+.++....+. ..+.+
T Consensus 441 G~hPt~e~mq~~VV~kK~-RP~~p~~W~~----h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~~~~~s~ 515 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVRKKQ-RPKIPDAWRK----HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWEDSSGESS 515 (534)
T ss_pred cCCCCHHHHHHHHHhhcc-CCCChhhhhc----CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCccCCccc
Confidence 333344444433332222 1111111111 13355678899999999999999999999999988765543 44444
Q ss_pred CCC
Q 002061 965 SDK 967 (973)
Q Consensus 965 s~~ 967 (973)
++.
T Consensus 516 ~~~ 518 (534)
T KOG3653|consen 516 SSL 518 (534)
T ss_pred ccc
Confidence 433
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=351.37 Aligned_cols=265 Identities=26% Similarity=0.339 Sum_probs=209.0
Q ss_pred HHHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeC--Ce
Q 002061 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKG--GS 745 (973)
Q Consensus 672 ~~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~ 745 (973)
....+.|+.+++||+|.||.||+|++..+|+.||+|++..+ .......||+.+|++++||||+++.+...+. ..
T Consensus 113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s 192 (560)
T KOG0600|consen 113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS 192 (560)
T ss_pred ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence 34456788889999999999999999999999999998653 2344467999999999999999999988776 68
Q ss_pred eEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccC
Q 002061 746 SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGV 825 (973)
Q Consensus 746 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl 825 (973)
.|||+|||++ +|.-++.. ....++..++..++.|+++||+|+| .++|+|||||.+||||+.+|.+||+|||+
T Consensus 193 iYlVFeYMdh-DL~GLl~~----p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGL 264 (560)
T KOG0600|consen 193 IYLVFEYMDH-DLSGLLSS----PGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGL 264 (560)
T ss_pred EEEEEecccc-hhhhhhcC----CCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccc
Confidence 9999999976 78777653 3567999999999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCCcccccccCCccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccCC-----------cccHHH
Q 002061 826 AKIAENSPKVSDYSCFAGTHGYIAPELAYTC-KVSEKSDVFSFGVVLLELVTGRKPVEEEYGD-----------GKDIVY 893 (973)
Q Consensus 826 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~pf~~~~~~-----------~~~~~~ 893 (973)
|+++..... ..++..+-|..|+|||.+.|. .|++++|+||.|||+.||++|++.|.+...- .....+
T Consensus 265 Ar~y~~~~~-~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~ 343 (560)
T KOG0600|consen 265 ARFYTPSGS-APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDY 343 (560)
T ss_pred eeeccCCCC-cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhc
Confidence 998765433 336667889999999998765 6999999999999999999999999765211 111122
Q ss_pred HHHHHhccccccchhcccc-----ccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 894 WVSTHLNNHENVLKVLDCE-----VASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 894 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
|....+.. ...+.+. ...+.........++|+..++..||++|.|+.++++.
T Consensus 344 W~~~kLP~----~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 344 WPVSKLPH----ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred cccccCCc----ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 22111110 0111111 1111123334567889999999999999999999864
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=354.56 Aligned_cols=248 Identities=27% Similarity=0.385 Sum_probs=214.3
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeec----cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE 751 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 751 (973)
++|.+.+.||+|+||+||||+.+.+.+.||+|.+.+ +++.+.+.+|++++++++||||+.++++|+...+.++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 578888999999999999999999999999998876 3455668899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccC
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 831 (973)
|+.| +|..++.. +..++++.+..++.++..||.||| +.+|+|||+||+||+++..|.+|+||||+|+-+..
T Consensus 82 ~a~g-~L~~il~~-----d~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~ 152 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ-----DGKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST 152 (808)
T ss_pred hhhh-hHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhccc
Confidence 9976 99999975 456899999999999999999999 89999999999999999999999999999987654
Q ss_pred CCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccc
Q 002061 832 SPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDC 911 (973)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (973)
+ ....+...||+-|||||+..++.|+..+|+||+||++||+++|++||... ++.+.++....+...
T Consensus 153 ~--t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-----si~~Lv~~I~~d~v~------- 218 (808)
T KOG0597|consen 153 N--TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-----SITQLVKSILKDPVK------- 218 (808)
T ss_pred C--ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-----HHHHHHHHHhcCCCC-------
Confidence 3 33445578999999999999999999999999999999999999999542 444555544433321
Q ss_pred cccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 912 EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 912 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
.+......+..++...+.+||.+|.+..+++.|--
T Consensus 219 -----~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF 253 (808)
T KOG0597|consen 219 -----PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPF 253 (808)
T ss_pred -----CcccccHHHHHHHHHHhhcChhhcccHHHHhcChH
Confidence 12255667888999999999999999999988754
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=357.88 Aligned_cols=259 Identities=29% Similarity=0.414 Sum_probs=207.2
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeec----cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL 750 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 750 (973)
.+.+.+...||+|.||+||+|++-. .||||++.. ++..+.|++|+.++++-+|.||+-+.||+..+.. .||+
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiT 466 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIIT 466 (678)
T ss_pred HHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeee
Confidence 3455788999999999999999974 799999865 3466789999999999999999999999998877 9999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccccc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 830 (973)
.||+|.+|+.+++.. +..++..+...||.|||+||.||| .++|||||+|..|||+.+++.|||+|||++..-.
T Consensus 467 qwCeGsSLY~hlHv~----etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 467 QWCEGSSLYTHLHVQ----ETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred hhccCchhhhhccch----hhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccceeeee
Confidence 999999999999864 356888899999999999999999 8899999999999999999999999999986432
Q ss_pred CCCCcccccccCCccccccccccccC---CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccch
Q 002061 831 NSPKVSDYSCFAGTHGYIAPELAYTC---KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLK 907 (973)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
.-..........|...|||||+++.. +|++++||||||+|+|||++|..||... ....+..++......
T Consensus 540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~--~~dqIifmVGrG~l~------ 611 (678)
T KOG0193|consen 540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ--NRDQIIFMVGRGYLM------ 611 (678)
T ss_pred eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC--ChhheEEEecccccC------
Confidence 21111222234578899999999743 6899999999999999999999999732 111111111100000
Q ss_pred hccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCC
Q 002061 908 VLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPC 956 (973)
Q Consensus 908 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~ 956 (973)
.| .......+.+++.+|+..||..++++||.+.+|+..|+.+.+.
T Consensus 612 -pd---~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 612 -PD---LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred -cc---chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 00 0112334566888999999999999999999999999988774
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=366.27 Aligned_cols=447 Identities=28% Similarity=0.439 Sum_probs=327.2
Q ss_pred ccCcEeeCCCCcccCcCChhhhCCCCCcEEEecCCcccCCCCcccCCCCCCEEeccCccCCCccccccccccccceEEcc
Q 002061 97 QSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIG 176 (973)
Q Consensus 97 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~ 176 (973)
..|+.|++++|.++ .+-..+.++..|.+|++.+|+++..|++++.+..++.|+.|+|+++ .+|..+..+.+|+.|+.+
T Consensus 45 v~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s 122 (565)
T KOG0472|consen 45 VDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLSQLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCS 122 (565)
T ss_pred cchhhhhhccCchh-hccHhhhcccceeEEEeccchhhhCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcc
Confidence 45677777888776 4555677777788888888888777777777777777787777776 667777777777777777
Q ss_pred CCcCCCCCCcccccCCCCCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCchhhhccccccEEEeeccccCCc
Q 002061 177 DNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGE 256 (973)
Q Consensus 177 ~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~ 256 (973)
.|.+. ++|++++.+..|..|+..+|+++ ..|+++..+.+|..|++.+|+++.. |...-+++.|++|+...|.++ .
T Consensus 123 ~n~~~--el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l-~~~~i~m~~L~~ld~~~N~L~-t 197 (565)
T KOG0472|consen 123 SNELK--ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKAL-PENHIAMKRLKHLDCNSNLLE-T 197 (565)
T ss_pred cccee--ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhC-CHHHHHHHHHHhcccchhhhh-c
Confidence 77664 46667777777777777777776 5666666667777777777777633 333333667777777766666 5
Q ss_pred CCccccccccccEEEeeccccccccCCccCCCCCccEEEcccCCCCCCCCCC-cCCcccceeeeccCCccCCCCCccccc
Q 002061 257 LPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSG-FGDMRKLFAFSIYGNRFSGPFPENLGR 335 (973)
Q Consensus 257 ~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~l~~L~~L~l~~N~l~~~~~~~l~~ 335 (973)
+|+.++.+.+|+.|+|..|++. .+| +|..+..|+.|+++.|.|+ .+|.. ..+++++..|+|.+|++. ..|+.+..
T Consensus 198 lP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~cl 273 (565)
T KOG0472|consen 198 LPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICL 273 (565)
T ss_pred CChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHH
Confidence 6666677777777777777765 455 5666666666666666666 33433 346666666666666666 56666666
Q ss_pred cccccccccccccccccCChhhhhhhhHHHHHhhhccCCCCccccccCccccceEecccccccc----------------
Q 002061 336 YTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSG---------------- 399 (973)
Q Consensus 336 l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~---------------- 399 (973)
+.+|++||+|+|.|+ .+|.+++++ +|+.|-+.+|.+..
T Consensus 274 LrsL~rLDlSNN~is-------------------------~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKy 327 (565)
T KOG0472|consen 274 LRSLERLDLSNNDIS-------------------------SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKY 327 (565)
T ss_pred hhhhhhhcccCCccc-------------------------cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHH
Confidence 666666666666665 566677777 77777777776631
Q ss_pred ---------------------CCCcc----ccCCCCcceEeccCCcCCCCCCCCCCCCC--CCCEEEcccCCCCCCCChh
Q 002061 400 ---------------------KIPDG----LWALPNVGMLDFGDNDFTGGISPLIGLST--SLSQLVLQNNRFSGELPSE 452 (973)
Q Consensus 400 ---------------------~~p~~----~~~l~~L~~L~L~~N~l~~~~~~~~~~~~--~L~~L~L~~N~l~~~~p~~ 452 (973)
..|.+ ...+.+.+.|++++-+++.++.+.|.... -.+..+++.|++. .+|..
T Consensus 328 Lrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~ 406 (565)
T KOG0472|consen 328 LRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKR 406 (565)
T ss_pred HHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHh-hhhhh
Confidence 11111 12345788899999999998888875443 3788999999999 78888
Q ss_pred hhcCCCCCE-EEccCCcCCCCccccccccccCCEEEcCCcccccCCCccccccccccchhccccccccCCCccccccCCC
Q 002061 453 LGRLTNLER-LILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSL 531 (973)
Q Consensus 453 ~~~l~~L~~-L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 531 (973)
+..+..+.+ +.+++|.+. .+|..+..+++|..|+|++|-+. .+|.+++.+..|+.||+|+|++. .+|..+..+..+
T Consensus 407 L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~l 483 (565)
T KOG0472|consen 407 LVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTL 483 (565)
T ss_pred hHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHH
Confidence 887776554 566666665 89999999999999999999998 78999999999999999999998 899988888889
Q ss_pred CeeecCCCccCCCCChhhhccc-CceEEccCCccccccCcccccCCC--CccccCCC
Q 002061 532 NALNLSGNKLTGSIPDNLMKLK-LSSIDLSENQLSGSVPLDFLRMGG--DGAFAGNE 585 (973)
Q Consensus 532 ~~L~L~~N~l~~~~p~~l~~l~-L~~l~ls~N~l~~~~p~~~~~~~~--~~~~~~n~ 585 (973)
+.+-.++|++....|+.+..+. |..|||.+|.+. .||+.+..+.+ +-...|||
T Consensus 484 Etllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNp 539 (565)
T KOG0472|consen 484 ETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNP 539 (565)
T ss_pred HHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCc
Confidence 9999999999966666688886 999999999999 67776666655 23567776
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=348.46 Aligned_cols=261 Identities=28% Similarity=0.386 Sum_probs=207.6
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc--cHHHHHHHHHHHHhcCCCceeeEEEEEEeCC--eeEEEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD--GVKVFAAEMEILGKIRHRNILKLYACLLKGG--SSFLVL 750 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--~~~lv~ 750 (973)
..+|...+.||+|+||+||++...++|...|||.+.... ..+.+.+|++++++++|||||++++...... .+++.|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 346778899999999999999999989999999876531 1556899999999999999999999855444 689999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecC-CCCeEEecccCcccc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE-DYEPKIADFGVAKIA 829 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfgl~~~~ 829 (973)
||+++|+|.+++.+. +. .+++..+..++.||++||+||| ++++|||||||+|||++. ++.+||+|||++...
T Consensus 96 Ey~~~GsL~~~~~~~---g~-~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~ 168 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRY---GG-KLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKL 168 (313)
T ss_pred eccCCCcHHHHHHHc---CC-CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCcccccc
Confidence 999999999999865 22 6899999999999999999999 899999999999999999 799999999999876
Q ss_pred cC-CCCcccccccCCccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccch
Q 002061 830 EN-SPKVSDYSCFAGTHGYIAPELAYTC-KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLK 907 (973)
Q Consensus 830 ~~-~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
.. ...........||+.|||||++..+ ....++||||+||++.||+||+.||... .....++-......
T Consensus 169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~----~~~~~~~~~ig~~~----- 239 (313)
T KOG0198|consen 169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF----FEEAEALLLIGRED----- 239 (313)
T ss_pred ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh----cchHHHHHHHhccC-----
Confidence 54 1122223347899999999999853 3345999999999999999999999753 11111111111111
Q ss_pred hccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCC
Q 002061 908 VLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPC 956 (973)
Q Consensus 908 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~ 956 (973)
..+..+.....+..+++.+|+..||++|||+.++++|..-....
T Consensus 240 -----~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 240 -----SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred -----CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 11122233455678899999999999999999999998765543
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=369.28 Aligned_cols=257 Identities=27% Similarity=0.441 Sum_probs=218.4
Q ss_pred CCcccCcccccCceEEEEEEecCCC---cEEEEEeeec---cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNA---GTVAVKQLWK---GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL 750 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~---~~vavK~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 750 (973)
...+.++||.|.||+|++|+.+..+ ..||||.++. ++...+|..|+.||.+++||||+++.|+......++||+
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 3467799999999999999998554 4699999987 455677999999999999999999999999999999999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccccc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 830 (973)
|||++|+|+.+|+.+ +.++.+.+...+..+||.||+||. +.++|||||.++||||+.+-.+|++|||+++..+
T Consensus 710 EyMENGsLDsFLR~~----DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQN----DGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred hhhhCCcHHHHHhhc----CCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEeccccceeecc
Confidence 999999999999875 567999999999999999999999 8999999999999999999999999999999776
Q ss_pred CCCCcccccccCC--ccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccch
Q 002061 831 NSPKVSDYSCFAG--THGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLK 907 (973)
Q Consensus 831 ~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
++. ...++...| +.+|.|||++..++++.++||||+|++|||.++ |..||.+. ..++...-
T Consensus 783 dd~-~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdm--SNQdVIka------------- 846 (996)
T KOG0196|consen 783 DDP-EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM--SNQDVIKA------------- 846 (996)
T ss_pred cCC-CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccccc--chHHHHHH-------------
Confidence 544 333343334 469999999999999999999999999999988 99999765 22222222
Q ss_pred hccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCCC
Q 002061 908 VLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPCT 957 (973)
Q Consensus 908 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 957 (973)
++..+.-..+.+++..|.+|++.||++|-.+||++.+|+.+|.++.+.+
T Consensus 847 -Ie~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 847 -IEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred -HHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 2233333445577788999999999999999999999999999876544
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=363.78 Aligned_cols=386 Identities=20% Similarity=0.220 Sum_probs=287.3
Q ss_pred cEeeCCCCcccCcCChhhhC-C-CCCcEEEecCCcccCCCC-cccCCCCCCEEeccCccCCCccccccccccccceEEcc
Q 002061 100 TVLSLPFNVLSGKLPLELSN-C-SNLKVLNVTGNAMVGSVP-DLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIG 176 (973)
Q Consensus 100 ~~L~Ls~n~l~~~~p~~l~~-l-~~L~~L~L~~n~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~ 176 (973)
+.||.+.+.+...--..+.. + +.-+.||+++|+++.... .|.++++|+++++..|.++ .+|.......+|+.|+|.
T Consensus 55 ~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~ 133 (873)
T KOG4194|consen 55 RLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLR 133 (873)
T ss_pred eeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeee
Confidence 45778887775321111211 1 234679999999988765 4899999999999999998 789888888899999999
Q ss_pred CCcCCCCCCcccccCCCCCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCchhhhccccccEEEeeccccCCc
Q 002061 177 DNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGE 256 (973)
Q Consensus 177 ~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~ 256 (973)
+|.|+... .+.+..++.|+.||||.|.|+.+.-.+|..=.++++|+|++|+|+......|.++.+|..|.|++|+|+..
T Consensus 134 ~N~I~sv~-se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittL 212 (873)
T KOG4194|consen 134 HNLISSVT-SEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTL 212 (873)
T ss_pred cccccccc-HHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCccccc
Confidence 99998654 46788999999999999999966666788778999999999999988889999999999999999999977
Q ss_pred CCccccccccccEEEeeccccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeeccCCccCCCCCcccccc
Q 002061 257 LPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRY 336 (973)
Q Consensus 257 ~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l 336 (973)
.+..|.++++|+.|+|..|+|.-.---.|..|++|+.|.|..|+|...-...|..|.++++|+|..|+++..-..++-++
T Consensus 213 p~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgL 292 (873)
T KOG4194|consen 213 PQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGL 292 (873)
T ss_pred CHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhccccccc
Confidence 77888999999999999999973335568889999999999999987777778888888888888888887777777778
Q ss_pred ccccccccccccccccCChhhhhhhhHHHHHhhhccCCCCccccccCccccceEeccccccccCCCccccCCCCcceEec
Q 002061 337 TALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDF 416 (973)
Q Consensus 337 ~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 416 (973)
+.|+.|+||+|.|.. .-++++..+++|++|+||+|+|+...+..|..|..|+.|.|
T Consensus 293 t~L~~L~lS~NaI~r------------------------ih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnL 348 (873)
T KOG4194|consen 293 TSLEQLDLSYNAIQR------------------------IHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNL 348 (873)
T ss_pred chhhhhccchhhhhe------------------------eecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcc
Confidence 888888888887762 22344556677777777777777666667766666666666
Q ss_pred cCCcCCCCCCCCCCCCCCCCEEEcccCCCCCCCCh---hhhcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCccc
Q 002061 417 GDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPS---ELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENAL 493 (973)
Q Consensus 417 ~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~---~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 493 (973)
++|++..+....|..+++|+.|||++|.|+..+.+ .|.++++|+.|+|.+|++..+.-.+|.++..|+.|||.+|.|
T Consensus 349 s~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~Nai 428 (873)
T KOG4194|consen 349 SHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAI 428 (873)
T ss_pred cccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcc
Confidence 66666655555566666666666666666543332 344555555555555555533334555555555555555555
Q ss_pred ccCCCccccccccccchhc
Q 002061 494 TGSIPNEMGDCARIVDLNL 512 (973)
Q Consensus 494 ~~~~p~~~~~l~~L~~L~L 512 (973)
..+-|++|..+ +|++|-+
T Consensus 429 aSIq~nAFe~m-~Lk~Lv~ 446 (873)
T KOG4194|consen 429 ASIQPNAFEPM-ELKELVM 446 (873)
T ss_pred eeecccccccc-hhhhhhh
Confidence 55555555554 4544443
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=354.46 Aligned_cols=252 Identities=27% Similarity=0.377 Sum_probs=208.8
Q ss_pred HHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-------ccHHHHHHHHHHHHhcC-CCceeeEEEEEEeCC
Q 002061 673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-------DGVKVFAAEMEILGKIR-HRNILKLYACLLKGG 744 (973)
Q Consensus 673 ~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-------~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~ 744 (973)
...++|.+.+.||+|+||+|+.|++..+++.||||++.+. ...+.+.+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 4567899999999999999999999999999999976553 23456778999999998 999999999999999
Q ss_pred eeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCC-CCeEEecc
Q 002061 745 SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDED-YEPKIADF 823 (973)
Q Consensus 745 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Df 823 (973)
..|+||||+.||+|.+++... ..+.+.....++.|+++|++|+| +++|+||||||+||+++.+ +.+||+||
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~-----g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DF 165 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNK-----GRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDF 165 (370)
T ss_pred eEEEEEEecCCccHHHHHHHc-----CCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEecc
Confidence 999999999999999999863 35777899999999999999999 8999999999999999999 99999999
Q ss_pred cCcccccCCCCcccccccCCccccccccccccCC-CC-ccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcc
Q 002061 824 GVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCK-VS-EKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNN 901 (973)
Q Consensus 824 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 901 (973)
|++.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||++. +...........
T Consensus 166 G~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~-----~~~~l~~ki~~~ 238 (370)
T KOG0583|consen 166 GLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS-----NVPNLYRKIRKG 238 (370)
T ss_pred ccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc-----cHHHHHHHHhcC
Confidence 9998774 1223344578999999999999887 86 7899999999999999999999763 222222222111
Q ss_pred ccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 902 HENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
.-.+...+ . ..++..++.+|+..||.+|+++.|++++-
T Consensus 239 ~~~~p~~~----------~-S~~~~~Li~~mL~~~P~~R~t~~~i~~h~ 276 (370)
T KOG0583|consen 239 EFKIPSYL----------L-SPEARSLIEKMLVPDPSTRITLLEILEHP 276 (370)
T ss_pred CccCCCCc----------C-CHHHHHHHHHHcCCCcccCCCHHHHhhCh
Confidence 11111111 0 55688999999999999999999999543
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=342.24 Aligned_cols=262 Identities=29% Similarity=0.343 Sum_probs=210.9
Q ss_pred CHHHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc----------------cHHHHHHHHHHHHhcCCCcee
Q 002061 671 DAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----------------GVKVFAAEMEILGKIRHRNIL 734 (973)
Q Consensus 671 ~~~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----------------~~~~~~~E~~~l~~l~hpniv 734 (973)
+.++++.|++.+.||+|.||.|-+|++..+++.||||++.+.. ..+...+|+.++++++|||||
T Consensus 92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV 171 (576)
T KOG0585|consen 92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV 171 (576)
T ss_pred cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence 3677899999999999999999999999999999999986521 124678999999999999999
Q ss_pred eEEEEEEe--CCeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeee
Q 002061 735 KLYACLLK--GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILL 812 (973)
Q Consensus 735 ~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill 812 (973)
+++++..+ .+..|||+|||..|.+... ....+.+...+.+.++.++..||+||| .++||||||||.|+|+
T Consensus 172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~-----p~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl 243 (576)
T KOG0585|consen 172 KLIEVLDDPESDKLYLVLEYCSKGEVKWC-----PPDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLL 243 (576)
T ss_pred EEEEeecCcccCceEEEEEeccCCccccC-----CCCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEE
Confidence 99999876 4678999999998876432 122333889999999999999999999 8899999999999999
Q ss_pred cCCCCeEEecccCcccccCCC---CcccccccCCccccccccccccCC----CCccchHHHHHHHHHHHHhCCCCCCccc
Q 002061 813 DEDYEPKIADFGVAKIAENSP---KVSDYSCFAGTHGYIAPELAYTCK----VSEKSDVFSFGVVLLELVTGRKPVEEEY 885 (973)
Q Consensus 813 ~~~~~~kl~Dfgl~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~~l~el~tg~~pf~~~~ 885 (973)
+++|++||+|||.+....... ........+||+.|+|||...++. .+.+.||||+||+||.|+.|+.||-+..
T Consensus 244 ~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~ 323 (576)
T KOG0585|consen 244 SSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF 323 (576)
T ss_pred cCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch
Confidence 999999999999997663221 111223468999999999987632 3468899999999999999999997542
Q ss_pred CCcccHHHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 002061 886 GDGKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADP 955 (973)
Q Consensus 886 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 955 (973)
. ... ..+++...+.....++..+++.+++.+++.+||++|.+..+|..|..-...
T Consensus 324 ~-----~~l----------~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 324 E-----LEL----------FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred H-----HHH----------HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 1 111 122333333333334566778899999999999999999999999987765
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=323.16 Aligned_cols=238 Identities=26% Similarity=0.355 Sum_probs=199.1
Q ss_pred HHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc-----cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeE
Q 002061 673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF 747 (973)
Q Consensus 673 ~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 747 (973)
..+.+|+..+.||.|+||+|.+++.+.+|..+|+|++.+.+ ..+...+|..+|+.+.||+++++++.+.+.+..|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 34568899999999999999999999999999999998753 3456778999999999999999999999999999
Q ss_pred EEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcc
Q 002061 748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827 (973)
Q Consensus 748 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~ 827 (973)
|||||++||.|..++++. ..++....+-+|.||+.|++||| +.+|++||+||+|||+|.+|.+||+|||.|+
T Consensus 121 mvmeyv~GGElFS~Lrk~-----~rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK 192 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKS-----GRFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAK 192 (355)
T ss_pred EEEeccCCccHHHHHHhc-----CCCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceE
Confidence 999999999999999864 35788888899999999999999 8999999999999999999999999999998
Q ss_pred cccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccch
Q 002061 828 IAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLK 907 (973)
Q Consensus 828 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
.+... ....+||+.|+|||+++++.|..++|+|||||++|||+.|.+||..... .... .+
T Consensus 193 ~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-----~~iY----------~K 252 (355)
T KOG0616|consen 193 RVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-----IQIY----------EK 252 (355)
T ss_pred EecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-----HHHH----------HH
Confidence 77532 2346899999999999999999999999999999999999999976421 1221 22
Q ss_pred hccccccCcchHHHHHHHHHHHHHhcCCCCCCC
Q 002061 908 VLDCEVASESIKEDMIKLLKIAVVCTTKLPNLR 940 (973)
Q Consensus 908 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 940 (973)
++...+ ..+.-....+.+++.+.++.|-.+|
T Consensus 253 I~~~~v--~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 253 ILEGKV--KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred HHhCcc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 222222 1122233456667777777787777
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=343.35 Aligned_cols=253 Identities=26% Similarity=0.335 Sum_probs=205.2
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL 748 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 748 (973)
.+++|+.+++||+|+||+||+|+-+.+|..+|+|++++. ..++.+..|-.+|...++|+||+++..|++.+++|+
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 567899999999999999999999999999999999873 456778899999999999999999999999999999
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccc
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 828 (973)
||||++||++..+|.+. ..+++....-++.+++.|++.+| +.|+|||||||+|+|||..|++||+|||++.-
T Consensus 219 iMEylPGGD~mTLL~~~-----~~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRK-----DTLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred EEEecCCccHHHHHHhc-----CcCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccch
Confidence 99999999999999753 46788888889999999999999 89999999999999999999999999999853
Q ss_pred ccC----------------------CCCc----cccc-------------------ccCCccccccccccccCCCCccch
Q 002061 829 AEN----------------------SPKV----SDYS-------------------CFAGTHGYIAPELAYTCKVSEKSD 863 (973)
Q Consensus 829 ~~~----------------------~~~~----~~~~-------------------~~~gt~~y~aPE~~~~~~~~~~~D 863 (973)
... .... .... ..+|||.|||||++.+..|+..+|
T Consensus 291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD 370 (550)
T KOG0605|consen 291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD 370 (550)
T ss_pred hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence 211 0000 0000 246999999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCCCcccCC--cccHHHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCC
Q 002061 864 VFSFGVVLLELVTGRKPVEEEYGD--GKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRP 941 (973)
Q Consensus 864 vwslG~~l~el~tg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp 941 (973)
+||||||+|||+.|.+||..+... .+.+..|........+ .....+..++|.+|+. ||++|.
T Consensus 371 wWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~---------------~~~s~eA~DLI~rll~-d~~~RL 434 (550)
T KOG0605|consen 371 WWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEE---------------VDLSDEAKDLITRLLC-DPENRL 434 (550)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCc---------------CcccHHHHHHHHHHhc-CHHHhc
Confidence 999999999999999999764211 1223333222211111 1122567789999998 999997
Q ss_pred ---CHHHHHHHh
Q 002061 942 ---PMREVVKML 950 (973)
Q Consensus 942 ---t~~evl~~L 950 (973)
.+.||-+|-
T Consensus 435 G~~G~~EIK~HP 446 (550)
T KOG0605|consen 435 GSKGAEEIKKHP 446 (550)
T ss_pred CcccHHHHhcCC
Confidence 477776653
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=351.54 Aligned_cols=249 Identities=25% Similarity=0.364 Sum_probs=210.1
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc--ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM 753 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 753 (973)
..|+.-++||+|+.|.||.|+...+++.||||++... ...+-+.+|+.+|+..+|+|||++++.|..+++.|+|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 4567778999999999999999999999999998653 34455789999999999999999999999999999999999
Q ss_pred CCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCC
Q 002061 754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833 (973)
Q Consensus 754 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 833 (973)
+||+|.|.+... .+++.++..|+.++++||+||| .++|+|||||.+|||++.+|.+||+|||++..+....
T Consensus 353 ~ggsLTDvVt~~------~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 353 EGGSLTDVVTKT------RMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred CCCchhhhhhcc------cccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 999999998754 4889999999999999999999 8999999999999999999999999999998776543
Q ss_pred CcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccc-c
Q 002061 834 KVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDC-E 912 (973)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 912 (973)
. ....-+||+.|||||+.....|++++||||||++++||+-|++||-.+ ..+... .-+.+. .
T Consensus 424 ~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE----~PlrAl-----------yLIa~ng~ 486 (550)
T KOG0578|consen 424 S--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNE----NPLRAL-----------YLIATNGT 486 (550)
T ss_pred C--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCC----ChHHHH-----------HHHhhcCC
Confidence 3 344568999999999999999999999999999999999999999642 111111 111111 1
Q ss_pred ccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 913 VASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 913 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
..-.........+.+|+.+|++.||++||++.|+++|-
T Consensus 487 P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~Hp 524 (550)
T KOG0578|consen 487 PKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHP 524 (550)
T ss_pred CCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcCh
Confidence 11223445567889999999999999999999999874
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=334.67 Aligned_cols=263 Identities=27% Similarity=0.377 Sum_probs=203.1
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhcCCCceeeEEEEEEeCC-----eeEEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGG-----SSFLVL 750 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-----~~~lv~ 750 (973)
-.|+..+++|+|+||.||+|+..++++.||||+.+.+...+ .+|+++|++++|||||++..+|.... ...+||
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k--nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK--NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC--cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence 35777889999999999999999999999999998866554 58999999999999999999886432 335899
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCC-CCeEEecccCcccc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDED-YEPKIADFGVAKIA 829 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfgl~~~~ 829 (973)
|||+. +|+++++.. ......++...+.-+..|+++|++||| +.+|+||||||+|+|+|.+ |.+||||||.|+..
T Consensus 102 eymP~-tL~~~~r~~-~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 102 EYMPE-TLYRVIRHY-TRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HhchH-HHHHHHHHH-hhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 99964 999999864 233456777788889999999999999 8899999999999999975 89999999999988
Q ss_pred cCCCCcccccccCCccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHH--------Hhc
Q 002061 830 ENSPKVSDYSCFAGTHGYIAPELAYTC-KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVST--------HLN 900 (973)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~--------~~~ 900 (973)
..+..... ...|..|+|||.+.|. .|+.+.||||.|||+.||+-|++-|.+..+. .+++..++- ...
T Consensus 177 ~~~epniS---YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~-dQL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 177 VKGEPNIS---YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV-DQLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred ccCCCcee---EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHH-HHHHHHHHHhCCCCHHHHhh
Confidence 76654443 3458899999998865 6999999999999999999999999764221 111111110 000
Q ss_pred cccccchhccccccCc-----chHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 901 NHENVLKVLDCEVASE-----SIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 901 ~~~~~~~~~~~~~~~~-----~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
....+.+...+..... .......+..+++.++++++|.+|.++.|+++|
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 1111111111222111 233445678899999999999999999999876
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=315.84 Aligned_cols=264 Identities=25% Similarity=0.373 Sum_probs=213.4
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeec--cccHHHHHHHHHHHHhcCCCceeeEEEEEEeC-----CeeE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK--GDGVKVFAAEMEILGKIRHRNILKLYACLLKG-----GSSF 747 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~~ 747 (973)
-++|++.+.+|+|||+.||.++.-.+++.+|+|++.. .++.+...+|++..++++|||+++++++...+ .+.|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 4589999999999999999999999999999998865 35667789999999999999999999887443 3589
Q ss_pred EEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcc
Q 002061 748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827 (973)
Q Consensus 748 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~ 827 (973)
++++|...|+|.+.+... ......+++.+.++|+.++++||++||.. ..+++||||||.||++++++.+++.|||.++
T Consensus 100 ll~Pyy~~Gsl~d~i~~~-k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERL-KIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEeehhccccHHHHHHHH-hhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 999999999999999876 44455789999999999999999999943 3459999999999999999999999999987
Q ss_pred cccCCCCc-------ccccccCCccccccccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHH
Q 002061 828 IAENSPKV-------SDYSCFAGTHGYIAPELAY---TCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVST 897 (973)
Q Consensus 828 ~~~~~~~~-------~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~ 897 (973)
..+-.... .+......|..|+|||.+. +...++++|||||||++|+|+.|..||+..++.+.++..-
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLA--- 254 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALA--- 254 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEe---
Confidence 65321111 1122345688999999874 5568899999999999999999999998765544443221
Q ss_pred HhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 898 HLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 898 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
+..+.+.........+.+.+++.+|++.||.+||++.+++..+...
T Consensus 255 ----------v~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 255 ----------VQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred ----------eeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 1111221122223677899999999999999999999999988765
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=341.88 Aligned_cols=247 Identities=31% Similarity=0.450 Sum_probs=208.2
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeec---cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK---GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM 753 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 753 (973)
.|+..+.||+|.||.||+|.+..+++.||+|++.- +.+.+++++|+.++..++++||.++|+.|..+..++++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 56677899999999999999999999999999865 345677899999999999999999999999999999999999
Q ss_pred CCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCC
Q 002061 754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833 (973)
Q Consensus 754 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 833 (973)
.||++.+.++.. ..+++..+..+..++..|+.|+| ..+.+|||||+.||++..+|.+|++|||++.......
T Consensus 94 ~gGsv~~lL~~~-----~~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 94 GGGSVLDLLKSG-----NILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred cCcchhhhhccC-----CCCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechh
Confidence 999999998743 23366666778899999999999 7899999999999999999999999999998776543
Q ss_pred CcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccc
Q 002061 834 KVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEV 913 (973)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (973)
.. ...++||+.|||||++....|+.++||||||++.+||++|.+|+...+. ..+.-.+....
T Consensus 166 ~r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP----------------mrvlflIpk~~ 227 (467)
T KOG0201|consen 166 KR--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP----------------MRVLFLIPKSA 227 (467)
T ss_pred hc--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc----------------ceEEEeccCCC
Confidence 32 2567899999999999988999999999999999999999999976532 00111111222
Q ss_pred cCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 914 ASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 914 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
.+.......+.+.+++..|++++|+.||++.++++|
T Consensus 228 PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 228 PPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred CCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 222233566779999999999999999999999876
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=357.50 Aligned_cols=262 Identities=28% Similarity=0.405 Sum_probs=203.4
Q ss_pred HcCCcccCcccccCceEEEEEEec-----CCCcEEEEEeeecc---ccHHHHHHHHHHHHhc-CCCceeeEEEEEEeC-C
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLK-----KNAGTVAVKQLWKG---DGVKVFAAEMEILGKI-RHRNILKLYACLLKG-G 744 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~-----~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~-~ 744 (973)
.++|++.+.||+|+||.||+|.+. .++..||||++... ...+.+.+|+.+++++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 357899999999999999999852 34568999998653 2345688999999999 899999999988764 4
Q ss_pred eeEEEEEccCCCchHHHHHhhhcC--------------------------------------------------------
Q 002061 745 SSFLVLEYMPNGNLFQALHKRVKE-------------------------------------------------------- 768 (973)
Q Consensus 745 ~~~lv~e~~~~gsL~~~l~~~~~~-------------------------------------------------------- 768 (973)
..++||||+++|+|.+++......
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 689999999999999999753110
Q ss_pred -CCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCcccccccCCcccc
Q 002061 769 -GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGY 847 (973)
Q Consensus 769 -~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y 847 (973)
....+++..+..++.|+++||+||| +++|+||||||+||+++.++.+||+|||+++...............++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 0124778888999999999999999 789999999999999999999999999999765432222222233467889
Q ss_pred ccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhccccccCcchHHHHHHHH
Q 002061 848 IAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLL 926 (973)
Q Consensus 848 ~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 926 (973)
+|||++.+..++.++|||||||++|||++ |..||...... .... ......... ..+......+.
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~-~~~~----~~~~~~~~~----------~~~~~~~~~l~ 307 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN-EEFC----QRLKDGTRM----------RAPENATPEIY 307 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc-HHHH----HHHhcCCCC----------CCCCCCCHHHH
Confidence 99999999999999999999999999997 99999754211 1111 111111100 01112345688
Q ss_pred HHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 002061 927 KIAVVCTTKLPNLRPPMREVVKMLADAD 954 (973)
Q Consensus 927 ~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 954 (973)
+++.+||+.||++||++.|+++.|+++.
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 9999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=311.61 Aligned_cols=253 Identities=28% Similarity=0.355 Sum_probs=211.6
Q ss_pred HHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeE
Q 002061 673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF 747 (973)
Q Consensus 673 ~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 747 (973)
-.+++|++.+.||+|.||.||.|+.++++-.||+|++.+. ....++.+|+++...++||||++++++|.+....|
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riy 98 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIY 98 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeE
Confidence 3567899999999999999999999999999999998773 34567889999999999999999999999999999
Q ss_pred EEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcc
Q 002061 748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827 (973)
Q Consensus 748 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~ 827 (973)
+++||.++|+++..+... ....++......++.|+|.|+.|+| .++|+||||||+|+|++.++..|++|||.+.
T Consensus 99 LilEya~~gel~k~L~~~---~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV 172 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEG---RMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSV 172 (281)
T ss_pred EEEEecCCchHHHHHHhc---ccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCcee
Confidence 999999999999999853 3445777788899999999999999 8999999999999999999999999999997
Q ss_pred cccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccch
Q 002061 828 IAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLK 907 (973)
Q Consensus 828 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
..+. ......+||..|.+||...+..++..+|+|++|++.||++.|..||+... .+..+... ... +
T Consensus 173 ~~p~----~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI-----~k~----~ 238 (281)
T KOG0580|consen 173 HAPS----NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRI-----RKV----D 238 (281)
T ss_pred ecCC----CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHH-----HHc----c
Confidence 6542 23344679999999999999999999999999999999999999997642 11111111 111 1
Q ss_pred hccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 002061 908 VLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952 (973)
Q Consensus 908 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~ 952 (973)
+.++ ........+++.+|+.++|.+|.+..|+++|-.-
T Consensus 239 ~~~p-------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI 276 (281)
T KOG0580|consen 239 LKFP-------STISGGAADLISRLLVKNPIERLALTEVMDHPWI 276 (281)
T ss_pred ccCC-------cccChhHHHHHHHHhccCccccccHHHHhhhHHH
Confidence 1112 2233456788999999999999999999988654
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=377.11 Aligned_cols=260 Identities=30% Similarity=0.413 Sum_probs=214.8
Q ss_pred CCcccCcccccCceEEEEEEecCCCc-----EEEEEeeec---cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAG-----TVAVKQLWK---GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL 748 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~-----~vavK~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 748 (973)
+.+..+.||+|+||.||.|...+... .||||.+.+ .+...+|.+|..+|+.++|||||+++|++.+....++
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i 772 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI 772 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence 45677899999999999999875433 399998876 4567789999999999999999999999999999999
Q ss_pred EEEccCCCchHHHHHhhhcCC--CCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCc
Q 002061 749 VLEYMPNGNLFQALHKRVKEG--KPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~--~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~ 826 (973)
++|||++|+|..||++..... ...+...+...++.|||+|++||+ ++++|||||.++|+|++....|||+|||+|
T Consensus 773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccchh
Confidence 999999999999998642222 345788899999999999999999 889999999999999999999999999999
Q ss_pred ccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhcccccc
Q 002061 827 KIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENV 905 (973)
Q Consensus 827 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 905 (973)
+.....++........-+..|||||.+.++.++.|+|||||||++||++| |..||.... ..++...
T Consensus 850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~--n~~v~~~----------- 916 (1025)
T KOG1095|consen 850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRS--NFEVLLD----------- 916 (1025)
T ss_pred HhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcc--hHHHHHH-----------
Confidence 97666555544444344579999999999999999999999999999999 999997541 1111111
Q ss_pred chhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 002061 906 LKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADP 955 (973)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 955 (973)
+.... +-+.+..++.++++++..||+.+|++||+++.+++.+..+.+
T Consensus 917 --~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~ 963 (1025)
T KOG1095|consen 917 --VLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN 963 (1025)
T ss_pred --HHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence 11111 223445667789999999999999999999999998887654
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=341.00 Aligned_cols=244 Identities=31% Similarity=0.436 Sum_probs=203.7
Q ss_pred cccCcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCCch
Q 002061 679 EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNL 758 (973)
Q Consensus 679 ~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL 758 (973)
...+-||.|+.|.||+|+.. ++.||||+++.-. ..+++-|++++||||+.+.++|.....++||||||..|.|
T Consensus 127 sELeWlGSGaQGAVF~Grl~--netVAVKKV~elk-----ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRLH--NETVAVKKVRELK-----ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhhccCcccceeeeecc--CceehhHHHhhhh-----hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 44577999999999999998 7799999874322 3578899999999999999999999999999999999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCcccc
Q 002061 759 FQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY 838 (973)
Q Consensus 759 ~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~ 838 (973)
+..|+.. ..+.......+..+||.||.||| .+.|||||||.-||||+.+..|||+|||-++..... ...
T Consensus 200 ~~VLka~-----~~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STk 268 (904)
T KOG4721|consen 200 YEVLKAG-----RPITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STK 268 (904)
T ss_pred HHHHhcc-----CccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhh---hhh
Confidence 9999853 45777788899999999999999 889999999999999999999999999998766443 333
Q ss_pred cccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccccCcch
Q 002061 839 SCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESI 918 (973)
Q Consensus 839 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (973)
..+.||..|||||+++..+.++|+||||||||||||+||..||.+-+.. ..+..+-...+.-..+
T Consensus 269 MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss---------------AIIwGVGsNsL~LpvP 333 (904)
T KOG4721|consen 269 MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS---------------AIIWGVGSNSLHLPVP 333 (904)
T ss_pred hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh---------------eeEEeccCCcccccCc
Confidence 4578999999999999999999999999999999999999999764210 0111111122222334
Q ss_pred HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 002061 919 KEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADP 955 (973)
Q Consensus 919 ~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 955 (973)
..+++-|.-+++.||+..|..||++++++.||....+
T Consensus 334 stcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p 370 (904)
T KOG4721|consen 334 STCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASP 370 (904)
T ss_pred ccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence 5566678889999999999999999999999987654
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=319.09 Aligned_cols=267 Identities=24% Similarity=0.232 Sum_probs=205.1
Q ss_pred HHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccccHH----HHHHHHHHHHhcCCCceeeEEEEEEe--CCee
Q 002061 673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVK----VFAAEMEILGKIRHRNILKLYACLLK--GGSS 746 (973)
Q Consensus 673 ~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~----~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~ 746 (973)
..+++|+..+.|++|+||.||+|+++.+++.||+|+++.+.+.. .-.||+.++.+++|||||.+..+... -+.+
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 45678999999999999999999999999999999997654322 34799999999999999999988764 3579
Q ss_pred EEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCc
Q 002061 747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826 (973)
Q Consensus 747 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~ 826 (973)
|||||||++ +|...+... ...+...++.-++.|+++|++||| .+.|+|||+|++|+|++..|.+||+|||+|
T Consensus 153 y~VMe~~Eh-DLksl~d~m----~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLA 224 (419)
T KOG0663|consen 153 YIVMEYVEH-DLKSLMETM----KQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLA 224 (419)
T ss_pred eeeHHHHHh-hHHHHHHhc----cCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchh
Confidence 999999976 899999865 346888889999999999999999 889999999999999999999999999999
Q ss_pred ccccCCCCcccccccCCccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHH---Hhccc
Q 002061 827 KIAENSPKVSDYSCFAGTHGYIAPELAYTC-KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVST---HLNNH 902 (973)
Q Consensus 827 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~---~~~~~ 902 (973)
+.++... ..++..+-|..|+|||.+.+. .|++++||||+|||+.||+++++.|.+...- .++...+.. .....
T Consensus 225 R~ygsp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~-dQl~~If~llGtPte~i 301 (419)
T KOG0663|consen 225 REYGSPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEI-DQLDKIFKLLGTPSEAI 301 (419)
T ss_pred hhhcCCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchH-HHHHHHHHHhCCCcccc
Confidence 9887653 344556779999999998765 5999999999999999999999999754211 111111110 00000
Q ss_pred c----ccc--------hhccccccCcchHH-HHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 903 E----NVL--------KVLDCEVASESIKE-DMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 903 ~----~~~--------~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
. .+. +.....+...+... ..+.-++++...+.+||.+|.|+.|.+++=
T Consensus 302 wpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~ 362 (419)
T KOG0663|consen 302 WPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHE 362 (419)
T ss_pred CCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccc
Confidence 0 000 00000111111110 224456788899999999999999999873
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=345.79 Aligned_cols=253 Identities=27% Similarity=0.350 Sum_probs=212.9
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL 748 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 748 (973)
.++-|+.++.||.|+.|.|-+|++..+|+.+|||++.+. .....+.+|+-+|+-+.|||++++|++|+...++|+
T Consensus 10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lyl 89 (786)
T KOG0588|consen 10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYL 89 (786)
T ss_pred cccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEE
Confidence 345678889999999999999999999999999998764 234567899999999999999999999999999999
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccc
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 828 (973)
|.||+++|.|++|+-.+ +.+++.+..+++.||+.|+.|+| ..+|+|||+||+|++++..+.+||+|||+|..
T Consensus 90 vlEyv~gGELFdylv~k-----G~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsL 161 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLVRK-----GPLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASL 161 (786)
T ss_pred EEEecCCchhHHHHHhh-----CCCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeec
Confidence 99999999999999864 45788889999999999999999 88999999999999999999999999999976
Q ss_pred ccCCCCcccccccCCccccccccccccCCCC-ccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccch
Q 002061 829 AENSPKVSDYSCFAGTHGYIAPELAYTCKVS-EKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLK 907 (973)
Q Consensus 829 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
..++.. ...-+|++.|.|||++.|.+|. .++||||+|||||.++||+.||+++ ++...........-
T Consensus 162 e~~gkl---LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd-----Nir~LLlKV~~G~f---- 229 (786)
T KOG0588|consen 162 EVPGKL---LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD-----NIRVLLLKVQRGVF---- 229 (786)
T ss_pred ccCCcc---ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc-----cHHHHHHHHHcCcc----
Confidence 544422 2235799999999999999986 7899999999999999999999743 44444333322221
Q ss_pred hccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 002061 908 VLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADAD 954 (973)
Q Consensus 908 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 954 (973)
+.+.....+..+++.+|+..||++|.|++||.+|..-..
T Consensus 230 --------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g 268 (786)
T KOG0588|consen 230 --------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSG 268 (786)
T ss_pred --------cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhc
Confidence 122334456778999999999999999999999976443
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=337.40 Aligned_cols=261 Identities=25% Similarity=0.341 Sum_probs=214.8
Q ss_pred CcccCcccccCceEEEEEEecCCCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccC
Q 002061 678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP 754 (973)
Q Consensus 678 ~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 754 (973)
..+.++||+|.||+|.++.... +..||||+++.+ ....+|.+|+++|.+++||||++++++|..++..++|+|||+
T Consensus 540 L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmE 618 (807)
T KOG1094|consen 540 LRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYME 618 (807)
T ss_pred eehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHh
Confidence 4567899999999999999886 689999999874 345789999999999999999999999999999999999999
Q ss_pred CCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCC
Q 002061 755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK 834 (973)
Q Consensus 755 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 834 (973)
+|+|.+++..+... .+......+|+.|||.||+||. +.++||||+.++|+|++.++++||+|||+++-.-..+.
T Consensus 619 nGDLnqFl~aheap---t~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 619 NGDLNQFLSAHELP---TAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred cCcHHHHHHhccCc---ccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCc
Confidence 99999999876322 2455566789999999999999 88999999999999999999999999999987766655
Q ss_pred cccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh--CCCCCCcccCCcccHHHHHHHHhccccccchhcccc
Q 002061 835 VSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT--GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCE 912 (973)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (973)
.......+-+.+|||||.+.-+++++++|||+||+++||+++ ...||.+. .+++.+.-.......+. ..
T Consensus 693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~l--t~e~vven~~~~~~~~~-------~~ 763 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQL--TDEQVVENAGEFFRDQG-------RQ 763 (807)
T ss_pred eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhh--hHHHHHHhhhhhcCCCC-------cc
Confidence 555555667889999999999999999999999999999876 78899764 22222222222222221 11
Q ss_pred ccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 002061 913 VASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADAD 954 (973)
Q Consensus 913 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 954 (973)
.....+..+...+++++.+||+.|-.+||+++++...|.+..
T Consensus 764 ~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 764 VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 223345566778999999999999999999999999987653
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=348.38 Aligned_cols=243 Identities=27% Similarity=0.381 Sum_probs=202.6
Q ss_pred HHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeec-----cccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCee
Q 002061 673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSS 746 (973)
Q Consensus 673 ~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~-----~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 746 (973)
..+.+|...++||+|+||+|++|..+.+++.+|||++++ .++++....|.+++... +||.+++++.+|+..+++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 445788999999999999999999999999999999988 35677788899998877 599999999999999999
Q ss_pred EEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCc
Q 002061 747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826 (973)
Q Consensus 747 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~ 826 (973)
|.||||+.||++..+.+ ...+++.+..-+|..|+.||.||| +++|||||||.+|||+|.+|.+||+|||++
T Consensus 445 ~fvmey~~Ggdm~~~~~------~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlc 515 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHIH------TDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLC 515 (694)
T ss_pred EEEEEecCCCcEEEEEe------cccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccc
Confidence 99999999999655443 346899999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccc
Q 002061 827 KIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVL 906 (973)
Q Consensus 827 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 906 (973)
+.--. .....+.++||+.|||||++.+..|+.++|+|||||+||||+.|+.||.++. ++ ......+....
T Consensus 516 Ke~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd--Ee---e~FdsI~~d~~--- 585 (694)
T KOG0694|consen 516 KEGMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD--EE---EVFDSIVNDEV--- 585 (694)
T ss_pred cccCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC--HH---HHHHHHhcCCC---
Confidence 74321 2224456889999999999999999999999999999999999999997542 11 22222221111
Q ss_pred hhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCH
Q 002061 907 KVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPM 943 (973)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~ 943 (973)
..+.-...+...++.+++..+|++|.-+
T Consensus 586 ---------~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 586 ---------RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ---------CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 1233345567788889999999999855
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=342.19 Aligned_cols=265 Identities=24% Similarity=0.335 Sum_probs=203.7
Q ss_pred cCCcccCcccccCceEEEEEEecC----------------CCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKK----------------NAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKL 736 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~----------------~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l 736 (973)
.+|++.++||+|+||.||+|.+.. ++..||+|++... ....++.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 478889999999999999998643 2447999988653 234568899999999999999999
Q ss_pred EEEEEeCCeeEEEEEccCCCchHHHHHhhhcC--------------CCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEe
Q 002061 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKE--------------GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIH 802 (973)
Q Consensus 737 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH 802 (973)
++++.+.+..++||||+++|+|.+++...... ....+++..+..++.|++.||+||| +.+++|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCccc
Confidence 99999999999999999999999998653211 1234788899999999999999999 789999
Q ss_pred cCCCCCCeeecCCCCeEEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh--CCCC
Q 002061 803 RDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT--GRKP 880 (973)
Q Consensus 803 ~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t--g~~p 880 (973)
|||||+||+++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999976644332222223345789999999988899999999999999999987 5667
Q ss_pred CCcccCCcccHHHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 002061 881 VEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952 (973)
Q Consensus 881 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~ 952 (973)
|... ........+............. ..+......+.+++.+||+.||++|||+.||.+.|++
T Consensus 242 ~~~~--~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGEL--TDEQVIENAGEFFRDQGRQVYL-------FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcC--CHHHHHHHHHHHhhhccccccc-------cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 7643 1222222222111111100000 0111234568899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=324.49 Aligned_cols=255 Identities=25% Similarity=0.325 Sum_probs=210.1
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL 748 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 748 (973)
....|+..+.||+|.-|+||+++...++..+|+|++.++ +...+.+.|.+||+.++||.+..+|+.|+.+...|+
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl 154 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL 154 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence 345678899999999999999999999999999999773 334567789999999999999999999999999999
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccc
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 828 (973)
|||||+||+|....+++ ....++...++-+|.+++.||+||| -.|||+|||||+||||.++|++.|+||.++..
T Consensus 155 ~meyCpGGdL~~LrqkQ---p~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~ 228 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQKQ---PGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLR 228 (459)
T ss_pred EEecCCCccHHHHHhhC---CCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeecccccc
Confidence 99999999999988864 5667899999999999999999999 89999999999999999999999999998753
Q ss_pred ccC---------------------------------CCCc---------------------ccccccCCccccccccccc
Q 002061 829 AEN---------------------------------SPKV---------------------SDYSCFAGTHGYIAPELAY 854 (973)
Q Consensus 829 ~~~---------------------------------~~~~---------------------~~~~~~~gt~~y~aPE~~~ 854 (973)
... .... .....++||-.|.|||++.
T Consensus 229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~ 308 (459)
T KOG0610|consen 229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR 308 (459)
T ss_pred CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence 210 0000 0111357999999999999
Q ss_pred cCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcC
Q 002061 855 TCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTT 934 (973)
Q Consensus 855 ~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~ 934 (973)
|...+.++|+|+|||++|||+.|+.||.+.. ..+. +..++.....-.........+.++|++.+.
T Consensus 309 G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~-~~~T--------------l~NIv~~~l~Fp~~~~vs~~akDLIr~LLv 373 (459)
T KOG0610|consen 309 GEGHGSAVDWWTFGIFLYEMLYGTTPFKGSN-NKET--------------LRNIVGQPLKFPEEPEVSSAAKDLIRKLLV 373 (459)
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCcCCCC-chhh--------------HHHHhcCCCcCCCCCcchhHHHHHHHHHhc
Confidence 9999999999999999999999999998652 1111 222332222222223556678899999999
Q ss_pred CCCCCCCC----HHHHHHH
Q 002061 935 KLPNLRPP----MREVVKM 949 (973)
Q Consensus 935 ~dP~~Rpt----~~evl~~ 949 (973)
+||.+|.. +.||-+|
T Consensus 374 KdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 374 KDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred cChhhhhccccchHHhhcC
Confidence 99999997 8888776
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=352.91 Aligned_cols=261 Identities=27% Similarity=0.392 Sum_probs=204.4
Q ss_pred HcCCcccCcccccCceEEEEEEe-----cCCCcEEEEEeeecc---ccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCe
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDL-----KKNAGTVAVKQLWKG---DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGS 745 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~-----~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 745 (973)
.++|++.+.||+|+||+||+|++ .+++..||||+++.. ...+.+.+|+++++.+ +||||+++++++..++.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 34789999999999999999974 345668999998653 2345678999999999 89999999999999999
Q ss_pred eEEEEEccCCCchHHHHHhhhc----------------------------------------------------------
Q 002061 746 SFLVLEYMPNGNLFQALHKRVK---------------------------------------------------------- 767 (973)
Q Consensus 746 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 767 (973)
.++||||+++|+|.++++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999999975311
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCc
Q 002061 768 ------------EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV 835 (973)
Q Consensus 768 ------------~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 835 (973)
.....+++..+..++.|+++||+||| +++++||||||+||+++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 01124788899999999999999999 789999999999999999999999999999766433221
Q ss_pred ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhcccccc
Q 002061 836 SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVA 914 (973)
Q Consensus 836 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (973)
.......++..|+|||++.+..++.++|||||||++|||++ |..||.....+ ......+.... .
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~-~~~~~~~~~~~---~----------- 335 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-SKFYKMIKEGY---R----------- 335 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-HHHHHHHHhCc---c-----------
Confidence 21222345678999999999999999999999999999998 88998654211 11111111110 0
Q ss_pred CcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 915 SESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 915 ~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
...+.....++.+++.+||+.||++||++.||++.|++.
T Consensus 336 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 336 MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 000111234688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=320.24 Aligned_cols=262 Identities=24% Similarity=0.306 Sum_probs=203.7
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeec----cccHHHHHHHHHHHHhcCCCceeeEEEEEEe-----CCee
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKIRHRNILKLYACLLK-----GGSS 746 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-----~~~~ 746 (973)
..|...+.||+|+||.|++|.++.+|+.||||++.. ....++..||++++++++|+||+.+++.+.. -..+
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 345557899999999999999999999999999874 3456778899999999999999999999865 3468
Q ss_pred EEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCc
Q 002061 747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826 (973)
Q Consensus 747 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~ 826 (973)
|+|+|+| +.+|...++.. +.+......-+++|+++|++|+| +.+|+|||+||.|++++.+...||+|||+|
T Consensus 102 YiV~elM-etDL~~iik~~-----~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 102 YLVFELM-ETDLHQIIKSQ-----QDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred EEehhHH-hhHHHHHHHcC-----ccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccce
Confidence 9999999 67999988753 34788888899999999999999 889999999999999999999999999999
Q ss_pred ccccCCCCcccccccCCccccccccccc-cCCCCccchHHHHHHHHHHHHhCCCCCCcccCCc-------------ccHH
Q 002061 827 KIAENSPKVSDYSCFAGTHGYIAPELAY-TCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDG-------------KDIV 892 (973)
Q Consensus 827 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~-------------~~~~ 892 (973)
+...........+..+.|..|+|||++. ...|+.+.||||.|||+.||++|++-|.+...-. .+..
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l 252 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL 252 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence 9886543344456678899999999874 5679999999999999999999999996542110 0000
Q ss_pred HHH-----HHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 893 YWV-----STHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 893 ~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
..+ ...+...+.... ..+ ....+......++++.+|+..||.+|+|+.|+++|-
T Consensus 253 ~~i~s~~ar~yi~slp~~p~---~~f-~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hP 311 (359)
T KOG0660|consen 253 QKIRSEKARPYIKSLPQIPK---QPF-SSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHP 311 (359)
T ss_pred HHhccHHHHHHHHhCCCCCC---CCH-HHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence 000 001111110000 000 001112334567899999999999999999999873
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=337.63 Aligned_cols=251 Identities=25% Similarity=0.310 Sum_probs=202.1
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE 751 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 751 (973)
.|+..+.||+|+||+||+|.+..+++.||||++... .....+.+|++++++++|++|+++++++.+++..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 367788999999999999999999999999988652 223457789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccC
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 831 (973)
|+++|+|.+++... ....+++..+..++.|++.|++||| +.+++||||||+||++++++.++|+|||++.....
T Consensus 81 ~~~~g~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05631 81 IMNGGDLKFHIYNM---GNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE 154 (285)
T ss_pred ecCCCcHHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence 99999999888643 2335788999999999999999999 88999999999999999999999999999976533
Q ss_pred CCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccc
Q 002061 832 SPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDC 911 (973)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (973)
.. ......||..|+|||++.+..++.++||||+||++|||++|+.||...... .....+........
T Consensus 155 ~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~-------- 221 (285)
T cd05631 155 GE---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER--VKREEVDRRVKEDQ-------- 221 (285)
T ss_pred CC---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcc--hhHHHHHHHhhccc--------
Confidence 22 122346899999999999999999999999999999999999999754211 11111111111100
Q ss_pred cccCcchHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 002061 912 EVASESIKEDMIKLLKIAVVCTTKLPNLRPP-----MREVVKM 949 (973)
Q Consensus 912 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt-----~~evl~~ 949 (973)
..........+.+++.+||+.||.+||+ +++++++
T Consensus 222 ---~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 222 ---EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred ---ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 0111223456788999999999999997 8899886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=347.57 Aligned_cols=258 Identities=29% Similarity=0.409 Sum_probs=206.7
Q ss_pred CCcccCcccccCceEEEEEEecCCCc---E-EEEEeeec-----cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeE
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAG---T-VAVKQLWK-----GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF 747 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~---~-vavK~~~~-----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 747 (973)
+....++||+|+||+||+|+....+. . ||||..+. .....++.+|+++++.++|||||++||+...+...|
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 44566899999999999999985422 3 89998774 345667899999999999999999999999999999
Q ss_pred EEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcc
Q 002061 748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827 (973)
Q Consensus 748 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~ 827 (973)
+|||+|+||+|.+|++.. ...++..++..++.++|+||+||| ++++|||||.++|+|++.++.+||+|||+++
T Consensus 238 ivmEl~~gGsL~~~L~k~----~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKN----KKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred EEEEecCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCcccccc
Confidence 999999999999999874 225899999999999999999999 8899999999999999999999999999987
Q ss_pred cccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccc
Q 002061 828 IAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVL 906 (973)
Q Consensus 828 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 906 (973)
.... .........-+.+|+|||.+....|++++|||||||++||+++ |..||.+.. ..+...++. ...
T Consensus 311 ~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~--~~~v~~kI~---~~~---- 379 (474)
T KOG0194|consen 311 AGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK--NYEVKAKIV---KNG---- 379 (474)
T ss_pred CCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC--HHHHHHHHH---hcC----
Confidence 4431 1111111235689999999999999999999999999999999 888997652 122222221 111
Q ss_pred hhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCCCC
Q 002061 907 KVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPCTD 958 (973)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~ 958 (973)
+....+...+..+..++..||..+|++||+|.++.+.++.+.....
T Consensus 380 ------~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 380 ------YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred ------ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 1111122344556777889999999999999999999998765544
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=351.41 Aligned_cols=261 Identities=26% Similarity=0.396 Sum_probs=203.9
Q ss_pred HcCCcccCcccccCceEEEEEEecC-----CCcEEEEEeeeccc---cHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCe
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKK-----NAGTVAVKQLWKGD---GVKVFAAEMEILGKI-RHRNILKLYACLLKGGS 745 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~-----~~~~vavK~~~~~~---~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 745 (973)
.++|++.+.||+|+||.||+|++.. ++..||||++.... ..+.+.+|+++++.+ +||||+++++++..++.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 3478999999999999999998643 34579999987532 345678899999999 89999999999999999
Q ss_pred eEEEEEccCCCchHHHHHhhhc----------------------------------------------------------
Q 002061 746 SFLVLEYMPNGNLFQALHKRVK---------------------------------------------------------- 767 (973)
Q Consensus 746 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 767 (973)
.++||||+++|+|.+++.....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 9999999999999999865321
Q ss_pred -------CCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCcccccc
Q 002061 768 -------EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSC 840 (973)
Q Consensus 768 -------~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 840 (973)
.....+++..+.+++.|++.||+||| +++++||||||+||+++.++.+||+|||+++.............
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 01124788889999999999999999 78999999999999999999999999999876543322111122
Q ss_pred cCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhccccccCcchH
Q 002061 841 FAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESIK 919 (973)
Q Consensus 841 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (973)
..++..|+|||++.+..++.++|||||||++|||++ |+.||...... .......... . ....+ .
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~-~~~~~~~~~~----~---~~~~~-------~ 338 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN-SKFYKMVKRG----Y---QMSRP-------D 338 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc-HHHHHHHHcc----c---CccCC-------C
Confidence 335678999999998899999999999999999997 99999754221 1111111110 0 00001 1
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 920 EDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 920 ~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
....++.+++.+||+.||++||++.+|++.|+++
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1235688899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=353.84 Aligned_cols=257 Identities=25% Similarity=0.372 Sum_probs=213.6
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeec--cccHHHHHHHHHHHHhcC-CCceeeEEEE-EEe------CCe
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK--GDGVKVFAAEMEILGKIR-HRNILKLYAC-LLK------GGS 745 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~--~~~~~~~~~E~~~l~~l~-hpniv~l~~~-~~~------~~~ 745 (973)
.++++.+.|.+|||+.||.|++...|..||+|++.. +.......+|+++|+.++ |||||.+++. ... ..+
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 356788999999999999999998779999998765 445567889999999997 9999999993 321 246
Q ss_pred eEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccC
Q 002061 746 SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGV 825 (973)
Q Consensus 746 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl 825 (973)
+++.||||+||.|-|++..+.. ..+.+.++++|+.++|+|+++||.. +.+|||||||-+|||++.+|..||||||.
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq---~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQ---TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHh---ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccc
Confidence 8999999999999999987633 2389999999999999999999965 67899999999999999999999999999
Q ss_pred cccccCCCC-ccc------ccccCCcccccccccc---ccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHH
Q 002061 826 AKIAENSPK-VSD------YSCFAGTHGYIAPELA---YTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWV 895 (973)
Q Consensus 826 ~~~~~~~~~-~~~------~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~ 895 (973)
|...-.... ... .-...-|+.|+|||++ .+...++|+|||||||+||.++....||++..
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg---------- 262 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG---------- 262 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc----------
Confidence 864322221 111 0123568999999987 47789999999999999999999999997641
Q ss_pred HHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 002061 896 STHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADP 955 (973)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 955 (973)
-..+++..+.......+...+.+||..||+.||++||++.+|+.++.++..
T Consensus 263 ---------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 263 ---------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred ---------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 134566666555557788899999999999999999999999999988764
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=321.89 Aligned_cols=249 Identities=24% Similarity=0.358 Sum_probs=209.4
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeec-----cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL 748 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~-----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 748 (973)
...+|++.+.||+|.||+|-+|+....|+.||||.+++ +.+.-.+.+|+++|..++||||++++++|+..+...+
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 34688999999999999999999988899999998766 3445568899999999999999999999999999999
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccc
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 828 (973)
||||..+|.|+||+.++ ..+++.+..+++.||.+|+.|+| .++++|||+|.+|||+++++.+||+|||++-.
T Consensus 131 vMEYaS~GeLYDYiSer-----~~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNl 202 (668)
T KOG0611|consen 131 VMEYASGGELYDYISER-----GSLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNL 202 (668)
T ss_pred EEEecCCccHHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhh
Confidence 99999999999999864 46889999999999999999999 89999999999999999999999999999976
Q ss_pred ccCCCCcccccccCCccccccccccccCCCC-ccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccch
Q 002061 829 AENSPKVSDYSCFAGTHGYIAPELAYTCKVS-EKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLK 907 (973)
Q Consensus 829 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
+..... .+.++|++-|.+||++.|.+|. +.+|-|||||+||.++.|..||++. +....++...... +
T Consensus 203 y~~~kf---LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~-----Dhk~lvrQIs~Ga--Y-- 270 (668)
T KOG0611|consen 203 YADKKF---LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR-----DHKRLVRQISRGA--Y-- 270 (668)
T ss_pred hccccH---HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc-----hHHHHHHHhhccc--c--
Confidence 654422 3457899999999999999886 7899999999999999999999754 3333333221111 1
Q ss_pred hccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 908 VLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 908 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
..+. . +....-+|++|+-.+|++|.|+.+|..|-+
T Consensus 271 -rEP~----~----PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 271 -REPE----T----PSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred -cCCC----C----CchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 1111 1 112345788999999999999999998865
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=338.32 Aligned_cols=251 Identities=25% Similarity=0.330 Sum_probs=213.5
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCe-eEEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGS-SFLV 749 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~-~~lv 749 (973)
.++|+.++++|+|+||.++.++++.++..||+|.+.-+ ...+...+|+.++++++|||||.+.+.|.+++. .+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 46789999999999999999999999999999988652 233456789999999999999999999998887 9999
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccc
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 829 (973)
|+|++||++.+.+.+.. ...+++.++..++.|++.|+.||| +..|+|||||+.|||++.++.|+|+|||+|+..
T Consensus 83 m~Y~eGg~l~~~i~~~k---~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l 156 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQK---GVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKIL 156 (426)
T ss_pred EeecCCCCHHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhc
Confidence 99999999999998752 456899999999999999999999 789999999999999999999999999999988
Q ss_pred cCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhc
Q 002061 830 ENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVL 909 (973)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (973)
.+.. ......+||+.||+||++.+.+|..++|||||||++|||++-+++|.... ....+.......
T Consensus 157 ~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~-----m~~Li~ki~~~~------- 222 (426)
T KOG0589|consen 157 NPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN-----MSELILKINRGL------- 222 (426)
T ss_pred CCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc-----hHHHHHHHhhcc-------
Confidence 6653 12334689999999999999999999999999999999999999997652 112211111111
Q ss_pred cccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 910 DCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 910 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
....+..+..++..++..|++.+|+.||++.+++.+
T Consensus 223 ----~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 ----YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ----CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 122344566788899999999999999999999987
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=334.70 Aligned_cols=260 Identities=25% Similarity=0.399 Sum_probs=208.0
Q ss_pred HcCCcccCcccccCceEEEEEEecCCC-----cEEEEEeeeccc---cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCee
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNA-----GTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSS 746 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~-----~~vavK~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 746 (973)
..+|++.+.||+|+||.||+|.....+ ..||+|.+.... ....+.+|++++++++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 357888999999999999999986544 679999886532 345688999999999999999999999998899
Q ss_pred EEEEEccCCCchHHHHHhhhcCCC-----------CCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCC
Q 002061 747 FLVLEYMPNGNLFQALHKRVKEGK-----------PELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDED 815 (973)
Q Consensus 747 ~lv~e~~~~gsL~~~l~~~~~~~~-----------~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~ 815 (973)
+++|||+++|+|.+++........ ..+++..+..++.|++.|++||| +.+++||||||+||+++++
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCC
Confidence 999999999999999976422111 45788899999999999999999 7899999999999999999
Q ss_pred CCeEEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHH
Q 002061 816 YEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYW 894 (973)
Q Consensus 816 ~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~ 894 (973)
+.++|+|||++................++..|+|||++.+..++.++|||||||++|||++ |..||.... ..++...
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~--~~~~~~~ 238 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS--NQEVIEM 238 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHH
Confidence 9999999999876543322222223456788999999988899999999999999999998 999996531 1222222
Q ss_pred HHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 895 VSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 895 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
+.. .. ....+...+.++.+++.+||+.||.+||+++||+++|+.+
T Consensus 239 i~~----~~----------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 239 IRS----RQ----------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHc----CC----------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 111 10 0111223456788999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=339.58 Aligned_cols=263 Identities=24% Similarity=0.347 Sum_probs=205.6
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY 752 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 752 (973)
++|++.+.||+|+||.||+|++..++..||+|++..+ ...+.+.+|++++++++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 5789999999999999999999999999999988653 2345688999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCC
Q 002061 753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832 (973)
Q Consensus 753 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 832 (973)
+++|+|.+++... ..+++..+..++.|++.|++|||+ ..+|+||||||+||+++.++.+||+|||++......
T Consensus 85 ~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 85 MDGGSLDQVLKEA-----KRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred CCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 9999999998753 347888999999999999999994 246999999999999999999999999998755332
Q ss_pred CCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccc--------
Q 002061 833 PKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHEN-------- 904 (973)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~-------- 904 (973)
. .....|+..|+|||++.+..++.++|||||||++|||++|+.||..... ..+...+.........
T Consensus 158 ~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 231 (331)
T cd06649 158 M----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDA--KELEAIFGRPVVDGEEGEPHSISP 231 (331)
T ss_pred c----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHhcccccccccCCccccCc
Confidence 1 2234689999999999999999999999999999999999999964321 1111111000000000
Q ss_pred ------------------------cch-hccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 905 ------------------------VLK-VLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 905 ------------------------~~~-~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
... +...............++.+++.+||++||++|||+.|++++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~ 303 (331)
T cd06649 232 RPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF 303 (331)
T ss_pred ccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChH
Confidence 000 00000000001123457889999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=341.29 Aligned_cols=247 Identities=24% Similarity=0.296 Sum_probs=203.6
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL 748 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 748 (973)
.+.+|++.+.||+|+||+||+|++..+++.||||++... ...+.+.+|++++++++||||+++++++.+++..|+
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 356889999999999999999999999999999998653 234568899999999999999999999999999999
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccc
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 828 (973)
||||+++|+|.+++... ..+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++..
T Consensus 96 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 167 (329)
T PTZ00263 96 LLEFVVGGELFTHLRKA-----GRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKK 167 (329)
T ss_pred EEcCCCCChHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceE
Confidence 99999999999998753 35788888899999999999999 88999999999999999999999999999976
Q ss_pred ccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchh
Q 002061 829 AENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKV 908 (973)
Q Consensus 829 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (973)
..... ....||+.|+|||++.+..++.++|||||||++|||++|+.||... +...............
T Consensus 168 ~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~-----~~~~~~~~i~~~~~~~--- 234 (329)
T PTZ00263 168 VPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD-----TPFRIYEKILAGRLKF--- 234 (329)
T ss_pred cCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCC-----CHHHHHHHHhcCCcCC---
Confidence 54321 1246899999999999999999999999999999999999999643 1111111111111100
Q ss_pred ccccccCcchHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHh
Q 002061 909 LDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPP-----MREVVKML 950 (973)
Q Consensus 909 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt-----~~evl~~L 950 (973)
+.....++.+++.+||+.||.+||+ +.++++|-
T Consensus 235 ---------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp 272 (329)
T PTZ00263 235 ---------PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHP 272 (329)
T ss_pred ---------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCC
Confidence 0112345778999999999999986 78888773
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=337.09 Aligned_cols=246 Identities=22% Similarity=0.273 Sum_probs=202.9
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL 750 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 750 (973)
++|++.+.||+|+||+||+|++..+++.||||++... ...+.+.+|++++++++||||+++++++.++...|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 3688899999999999999999988999999998652 23456788999999999999999999999999999999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccccc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 830 (973)
||+++|+|.+++... ..+++.....++.|++.||+||| +++++||||||+||+++.++.+||+|||++....
T Consensus 81 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~ 152 (291)
T cd05612 81 EYVPGGELFSYLRNS-----GRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR 152 (291)
T ss_pred eCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhcc
Confidence 999999999999753 35788889999999999999999 8899999999999999999999999999987653
Q ss_pred CCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhcc
Q 002061 831 NSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLD 910 (973)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (973)
.. .....|++.|+|||++.+..++.++|||||||++|||++|+.||.... ..............
T Consensus 153 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~-----~~~~~~~i~~~~~~------ 216 (291)
T cd05612 153 DR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN-----PFGIYEKILAGKLE------ 216 (291)
T ss_pred CC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhCCcC------
Confidence 32 122468999999999999889999999999999999999999996531 11111111111110
Q ss_pred ccccCcchHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHhh
Q 002061 911 CEVASESIKEDMIKLLKIAVVCTTKLPNLRPP-----MREVVKMLA 951 (973)
Q Consensus 911 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt-----~~evl~~L~ 951 (973)
.+......+.+++.+|++.||.+||+ +.|+++|-.
T Consensus 217 ------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~ 256 (291)
T cd05612 217 ------FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRW 256 (291)
T ss_pred ------CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCcc
Confidence 01112345788999999999999995 999998853
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=334.61 Aligned_cols=263 Identities=22% Similarity=0.268 Sum_probs=200.9
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE 751 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 751 (973)
+++|++.+.||+|+||+||+|++..+++.||+|++... .....+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 45789999999999999999999999999999988642 234467799999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccC
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 831 (973)
|++ |+|.+++... ...+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++....
T Consensus 84 ~~~-~~l~~~l~~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~ 155 (288)
T cd07871 84 YLD-SDLKQYLDNC----GNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSV 155 (288)
T ss_pred CCC-cCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccC
Confidence 996 5899888643 234688899999999999999999 88999999999999999999999999999875433
Q ss_pred CCCcccccccCCcccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcc---------
Q 002061 832 SPKVSDYSCFAGTHGYIAPELAYT-CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNN--------- 901 (973)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~--------- 901 (973)
... ......+++.|+|||++.+ ..++.++||||+||++|||++|+.||..... ......+......
T Consensus 156 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07871 156 PTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTV--KEELHLIFRLLGTPTEETWPGI 231 (288)
T ss_pred CCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCChHHhhcc
Confidence 221 2223467899999999865 5688999999999999999999999965421 1111111110000
Q ss_pred --ccccchhccccccCcc----hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 902 --HENVLKVLDCEVASES----IKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 902 --~~~~~~~~~~~~~~~~----~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
.........+...... ......+..+++.+|+++||.+|||+.|+++|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 232 TSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred ccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000011111110000 01123457899999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=340.69 Aligned_cols=241 Identities=27% Similarity=0.330 Sum_probs=197.6
Q ss_pred CcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCC
Q 002061 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNG 756 (973)
Q Consensus 682 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 756 (973)
+.||+|+||.||+|++..+++.||||++... .....+.+|++++++++||||+++++++..++..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999999999999999999998753 23456778999999999999999999999999999999999999
Q ss_pred chHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCcc
Q 002061 757 NLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVS 836 (973)
Q Consensus 757 sL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 836 (973)
+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 ~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~ 150 (323)
T cd05571 81 ELFFHLSRE-----RVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--A 150 (323)
T ss_pred cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--C
Confidence 999998753 35788999999999999999999 8899999999999999999999999999987432211 1
Q ss_pred cccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccccCc
Q 002061 837 DYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASE 916 (973)
Q Consensus 837 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (973)
......||+.|+|||++.+..++.++||||+||++|||++|+.||... +............. .
T Consensus 151 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~-----~~~~~~~~~~~~~~------------~ 213 (323)
T cd05571 151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-----DHEKLFELILMEEI------------R 213 (323)
T ss_pred cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCC-----CHHHHHHHHHcCCC------------C
Confidence 223356899999999999999999999999999999999999999643 11111111111111 0
Q ss_pred chHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 002061 917 SIKEDMIKLLKIAVVCTTKLPNLRP-----PMREVVKM 949 (973)
Q Consensus 917 ~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~ 949 (973)
.+......+.+++.+|++.||++|| ++.++++|
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 1122345678899999999999999 89999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=332.29 Aligned_cols=244 Identities=23% Similarity=0.339 Sum_probs=196.4
Q ss_pred CcccccCceEEEEEEecCCCcEEEEEeeeccc--c---HHHHHHHHHHHHhcCCCceeeEEEEEEe----CCeeEEEEEc
Q 002061 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD--G---VKVFAAEMEILGKIRHRNILKLYACLLK----GGSSFLVLEY 752 (973)
Q Consensus 682 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~---~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~~~lv~e~ 752 (973)
..||+|++|.||+|+.. |+.||||++.... . .+.+.+|++++++++||||+++++++.+ ....++||||
T Consensus 26 ~~i~~g~~~~v~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIFN--NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEEC--CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 67999999999999984 8899999986531 1 4667899999999999999999999876 3468999999
Q ss_pred cCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCC
Q 002061 753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832 (973)
Q Consensus 753 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 832 (973)
+++|+|.+++... ..+++.....++.|++.|++|+|+ ..+++||||||+||++++++.+||+|||+++.....
T Consensus 104 ~~~g~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~ 176 (283)
T PHA02988 104 CTRGYLREVLDKE-----KDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP 176 (283)
T ss_pred CCCCcHHHHHhhC-----CCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc
Confidence 9999999999753 357888999999999999999993 248889999999999999999999999998755332
Q ss_pred CCcccccccCCcccccccccccc--CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhcc
Q 002061 833 PKVSDYSCFAGTHGYIAPELAYT--CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLD 910 (973)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (973)
. ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||.... ...............
T Consensus 177 ~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~-----~~~~~~~i~~~~~~~----- 241 (283)
T PHA02988 177 P-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT-----TKEIYDLIINKNNSL----- 241 (283)
T ss_pred c-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHhcCCCC-----
Confidence 1 12457899999999876 678999999999999999999999997541 112222111111100
Q ss_pred ccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 002061 911 CEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADAD 954 (973)
Q Consensus 911 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 954 (973)
..+......+.+++.+||+.||++|||++|+++.|+...
T Consensus 242 -----~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 242 -----KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred -----CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 011123456889999999999999999999999998764
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=341.19 Aligned_cols=253 Identities=21% Similarity=0.247 Sum_probs=204.8
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL 750 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 750 (973)
++|++.+.||+|+||.||+|++..+++.||||++... .....+.+|+++++.++||||+++++++..++..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 3688999999999999999999998999999998753 23456788999999999999999999999999999999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccccc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 830 (973)
||+++|+|.+++... ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++....
T Consensus 81 e~~~g~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~ 152 (333)
T cd05600 81 EYVPGGDFRTLLNNL-----GVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV 152 (333)
T ss_pred eCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCcccc
Confidence 999999999999753 35788899999999999999999 7899999999999999999999999999997554
Q ss_pred CCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhcc
Q 002061 831 NSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLD 910 (973)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (973)
. ......||+.|+|||++.+..++.++||||+||++|||++|+.||.... .............. ..
T Consensus 153 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~-----~~~~~~~i~~~~~~----~~ 218 (333)
T cd05600 153 T-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGST-----PNETWENLKYWKET----LQ 218 (333)
T ss_pred c-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCC-----HHHHHHHHHhcccc----cc
Confidence 3 1223568999999999999999999999999999999999999996531 11111111110000 00
Q ss_pred ccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 911 CEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 911 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
..............+.+++.+|++.+|++||++.+++++-
T Consensus 219 ~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~ 258 (333)
T cd05600 219 RPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHP 258 (333)
T ss_pred CCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCc
Confidence 0000000123355678899999999999999999999873
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=315.40 Aligned_cols=272 Identities=21% Similarity=0.260 Sum_probs=206.4
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc----cHHHHHHHHHHHHhcCCCc-eeeEEEEEEeCC-----
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRN-ILKLYACLLKGG----- 744 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~----- 744 (973)
...|+..++||+|+||+||+|+.+.+|+.||+|++.-+. ......+|+.++++++|+| |+.+++++....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 456778888999999999999999999999999987532 2344689999999999999 999999998776
Q ss_pred -eeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecc
Q 002061 745 -SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADF 823 (973)
Q Consensus 745 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 823 (973)
..++|+||+ .-+|.+|+....... ..++...+..++.|+++|++||| +++|+||||||+||+|+.+|.+||+||
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDF 164 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADF 164 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeecc
Confidence 789999999 569999998753211 34566789999999999999999 899999999999999999999999999
Q ss_pred cCcccccCCCCcccccccCCccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHH-hc-
Q 002061 824 GVAKIAENSPKVSDYSCFAGTHGYIAPELAYTC-KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTH-LN- 900 (973)
Q Consensus 824 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~-~~- 900 (973)
|+|+...-+. ..++..++|..|+|||++.+. .|++.+||||+||+++||++++.-|.+... ..+........ ..
T Consensus 165 GlAra~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se-~~ql~~If~~lGtP~ 241 (323)
T KOG0594|consen 165 GLARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE-IDQLFRIFRLLGTPN 241 (323)
T ss_pred chHHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH-HHHHHHHHHHcCCCC
Confidence 9998554322 235566889999999999877 699999999999999999999999976532 11111111100 00
Q ss_pred -ccc-ccchhccc--ccc----Ccc-h---HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--hhcCC
Q 002061 901 -NHE-NVLKVLDC--EVA----SES-I---KEDMIKLLKIAVVCTTKLPNLRPPMREVVKM--LADAD 954 (973)
Q Consensus 901 -~~~-~~~~~~~~--~~~----~~~-~---~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~--L~~~~ 954 (973)
... ......+- .+. ... . +.......+++.+|++++|.+|.++..+++| +....
T Consensus 242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 000 00000000 000 000 1 1111367789999999999999999999998 55553
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=329.34 Aligned_cols=254 Identities=25% Similarity=0.356 Sum_probs=202.5
Q ss_pred cCCcccCcccccCceEEEEEEec---CCCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLK---KNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV 749 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~---~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 749 (973)
.+|++.+.||+|+||.||+|.+. ..+..||+|.++.. .....+.+|++++++++||||+++++++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46788999999999999999875 34668999988764 2335688999999999999999999999999999999
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccc
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 829 (973)
|||+++|+|.+++... ...+++..+..++.|++.|++||| +.+++||||||+||+++.++.++++|||.+...
T Consensus 85 ~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 85 TEYMSNGALDSFLRKH----EGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEeCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 9999999999999753 235889999999999999999999 789999999999999999999999999987643
Q ss_pred cCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchh
Q 002061 830 ENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKV 908 (973)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (973)
..... .......++..|+|||++.+..++.++|||||||++||+++ |+.||.... ... ...... ....
T Consensus 158 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~--~~~---~~~~~~-~~~~---- 226 (266)
T cd05064 158 KSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS--GQD---VIKAVE-DGFR---- 226 (266)
T ss_pred cccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCC--HHH---HHHHHH-CCCC----
Confidence 22211 11112345678999999999999999999999999999875 999996541 111 111111 1100
Q ss_pred ccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 909 LDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 909 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
...+......+.+++.+||+.+|++||++.++.+.|..+
T Consensus 227 ------~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 227 ------LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ------CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 011122345688899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=305.07 Aligned_cols=254 Identities=24% Similarity=0.313 Sum_probs=207.4
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeec----cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL 750 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 750 (973)
.+.|++.++||+|.|+.||+..+..+|+.+|+|.+.. ..+.+.+.+|+.+-+.++||||+++.+.+.+....|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 4578888999999999999999999999999998754 356788999999999999999999999999999999999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecC---CCCeEEecccCcc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE---DYEPKIADFGVAK 827 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~Dfgl~~ 827 (973)
|+|+|++|..-+-.+ -..++..+-+.+.||++|+.|+| .++|||||+||+|+++.. ...+|++|||+|.
T Consensus 90 e~m~G~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR-----EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred ecccchHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEE
Confidence 999999997766543 23677778899999999999999 899999999999999954 3469999999998
Q ss_pred cccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccch
Q 002061 828 IAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLK 907 (973)
Q Consensus 828 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
....+ .....+.||++|||||+++..+|+..+|||+.||+||-++.|..||.++. ..++.+.+. ...
T Consensus 162 ~l~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~--~~rlye~I~---~g~----- 228 (355)
T KOG0033|consen 162 EVNDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED--QHRLYEQIK---AGA----- 228 (355)
T ss_pred EeCCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc--HHHHHHHHh---ccc-----
Confidence 88633 23345789999999999999999999999999999999999999997641 111111111 100
Q ss_pred hccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 002061 908 VLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952 (973)
Q Consensus 908 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~ 952 (973)
-.+.+..+....+...+++++|+..||.+|.|+.|.+.|-+-
T Consensus 229 ---yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi 270 (355)
T KOG0033|consen 229 ---YDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWI 270 (355)
T ss_pred ---cCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchh
Confidence 011222334445667889999999999999999999987653
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=332.49 Aligned_cols=263 Identities=22% Similarity=0.282 Sum_probs=201.8
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE 751 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 751 (973)
++|++.+.||+|+||+||+|+++.+++.||||++... ...+.+.+|++++++++||||+++++++..++..|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 3688999999999999999999999999999998653 234567889999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccC
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 831 (973)
|++++.+..+... ...+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 152 (287)
T cd07848 81 YVEKNMLELLEEM-----PNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152 (287)
T ss_pred cCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence 9998776554332 235788899999999999999999 78999999999999999999999999999986543
Q ss_pred CCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhc-----------
Q 002061 832 SPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLN----------- 900 (973)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~----------- 900 (973)
... .......|++.|+|||++.+..++.++||||+||++|||++|+.||..... .+....+.....
T Consensus 153 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07848 153 GSN-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESE--IDQLFTIQKVLGPLPAEQMKLFY 229 (287)
T ss_pred ccc-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhhCCCCHHHHHhhh
Confidence 221 122234689999999999988899999999999999999999999975321 111000000000
Q ss_pred cccccchhcccccc------CcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 901 NHENVLKVLDCEVA------SESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 901 ~~~~~~~~~~~~~~------~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
..........+... ..........+.+++.+|+++||++|||++|+++|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 230 SNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred ccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000000000 00011234568999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=344.01 Aligned_cols=263 Identities=25% Similarity=0.363 Sum_probs=205.7
Q ss_pred HcCCcccCcccccCceEEEEEEecCC-----CcEEEEEeeecc---ccHHHHHHHHHHHHhcC-CCceeeEEEEEEeCCe
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKN-----AGTVAVKQLWKG---DGVKVFAAEMEILGKIR-HRNILKLYACLLKGGS 745 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~-----~~~vavK~~~~~---~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~ 745 (973)
..+|++.+.||+|+||.||+|.+... +..||||++... ...+.+.+|+++++++. ||||+++++++.+...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 34778899999999999999987432 346999998653 23456889999999996 9999999999999999
Q ss_pred eEEEEEccCCCchHHHHHhhhcC---------------------------------------------------------
Q 002061 746 SFLVLEYMPNGNLFQALHKRVKE--------------------------------------------------------- 768 (973)
Q Consensus 746 ~~lv~e~~~~gsL~~~l~~~~~~--------------------------------------------------------- 768 (973)
.|+||||+++|+|.+++......
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 99999999999999998753210
Q ss_pred ----------------------------------CCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecC
Q 002061 769 ----------------------------------GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE 814 (973)
Q Consensus 769 ----------------------------------~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~ 814 (973)
....+++..+..++.|+++|++||| +.+++||||||+||+++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEeC
Confidence 0124778888999999999999999 789999999999999999
Q ss_pred CCCeEEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHH
Q 002061 815 DYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVY 893 (973)
Q Consensus 815 ~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~ 893 (973)
++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.....+. ...
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~-~~~- 350 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS-TFY- 350 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH-HHH-
Confidence 99999999999976543322222223456788999999998899999999999999999997 999986532111 111
Q ss_pred HHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 002061 894 WVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADP 955 (973)
Q Consensus 894 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 955 (973)
....... ...........+.+++.+||+.||++||++.+|.++|+++.+
T Consensus 351 ---~~~~~~~----------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 351 ---NKIKSGY----------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred ---HHHhcCC----------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 1111110 001112334568899999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=326.17 Aligned_cols=255 Identities=26% Similarity=0.346 Sum_probs=206.4
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccC
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP 754 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 754 (973)
.+|++.+.||+|+||.||+|.+.++++.||+|++... ...+.+.+|++++++++||||+++++++..++..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 3577889999999999999999988999999988653 345678899999999999999999999999999999999999
Q ss_pred CCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCC
Q 002061 755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK 834 (973)
Q Consensus 755 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 834 (973)
+++|.+++... ....+++..+..++.|+++|++||| +.+++||||||+||++++++.+||+|||++........
T Consensus 86 ~~~L~~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 86 YGNLLDYLREC---NRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCcHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 99999998753 2345789999999999999999999 78999999999999999999999999999876643322
Q ss_pred cccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhccccc
Q 002061 835 VSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEV 913 (973)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (973)
. ......++..|+|||++.+..++.++|||||||++|||++ |..||.... .......... ..
T Consensus 160 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~-----~~~~~~~~~~-~~---------- 222 (263)
T cd05052 160 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYELLEK-GY---------- 222 (263)
T ss_pred e-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHHC-CC----------
Confidence 1 1112234568999999998899999999999999999998 999986431 1111111111 00
Q ss_pred cCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 914 ASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 914 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
....+......+.+++.+|++.+|++||++.+++++|+.+
T Consensus 223 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 223 RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 0011122345688899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=351.01 Aligned_cols=253 Identities=23% Similarity=0.285 Sum_probs=203.9
Q ss_pred CCcccCcccccCceEEEEEEecCC-CcEEEEEeeecc--ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKN-AGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM 753 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 753 (973)
.|.+.+.||+|+||.||+|....+ ++.||+|.+... .....+.+|+++++.++||||+++++++..++..|+||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 488899999999999999998877 778899876442 33456778999999999999999999999999999999999
Q ss_pred CCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCC
Q 002061 754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833 (973)
Q Consensus 754 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 833 (973)
++|+|.+++.... .....+++..+..++.|++.||+|+| +++|+||||||+||+++.++.+||+|||+++......
T Consensus 148 ~gg~L~~~l~~~~-~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 148 SGGDLNKQIKQRL-KEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCHHHHHHHHH-hccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 9999999987542 23445788899999999999999999 7899999999999999999999999999998664432
Q ss_pred CcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccc
Q 002061 834 KVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEV 913 (973)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (973)
.........||+.|+|||++.+..++.++||||+||++|||++|+.||.... .............
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~-----~~~~~~~~~~~~~---------- 288 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS-----QREIMQQVLYGKY---------- 288 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhCCC----------
Confidence 2222334568999999999999999999999999999999999999996431 1111111111110
Q ss_pred cCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 914 ASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 914 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
...+......+.+++.+|++.||++||++.+++++
T Consensus 289 -~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 289 -DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred -CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 00111233568899999999999999999998754
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=313.07 Aligned_cols=252 Identities=23% Similarity=0.345 Sum_probs=215.4
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCC
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNG 756 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 756 (973)
-|.+..+||+|+||.||+|.++++|+.||||++..+.+.+++..|+.++++++.|++|++|+.|......|+|||||..|
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAG 113 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAG 113 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCC
Confidence 36788999999999999999999999999999988999999999999999999999999999999999999999999999
Q ss_pred chHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCcc
Q 002061 757 NLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVS 836 (973)
Q Consensus 757 sL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 836 (973)
+..+.++.+ ...+.+.++..+....+.||+||| ...-||||||+.|||+..+|.+|++|||.|...... -.
T Consensus 114 SiSDI~R~R----~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--MA 184 (502)
T KOG0574|consen 114 SISDIMRAR----RKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--MA 184 (502)
T ss_pred cHHHHHHHh----cCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhhh--HH
Confidence 999999864 567899999999999999999999 677899999999999999999999999998655321 12
Q ss_pred cccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccccCc
Q 002061 837 DYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASE 916 (973)
Q Consensus 837 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (973)
......||+.|||||++..-.|..++||||+|++..||..|++||.+... .+....-...+.....
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHP--------------MRAIFMIPT~PPPTF~ 250 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHP--------------MRAIFMIPTKPPPTFK 250 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccc--------------cceeEeccCCCCCCCC
Confidence 23346899999999999999999999999999999999999999976421 0000111111222233
Q ss_pred chHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 917 SIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 917 ~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
.+.....++-++++.|+-+.|++|.|+-++++|--
T Consensus 251 KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~F 285 (502)
T KOG0574|consen 251 KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTF 285 (502)
T ss_pred ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhh
Confidence 46677888999999999999999999999988743
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=336.39 Aligned_cols=258 Identities=24% Similarity=0.338 Sum_probs=203.6
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcE----EEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGT----VAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF 747 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~----vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 747 (973)
..+|+..+.||+|+||+||+|++..++.. ||||++... ...+++.+|+.+++.++||||+++++++..+ ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 35789999999999999999998655553 899987643 3346788999999999999999999988765 578
Q ss_pred EEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcc
Q 002061 748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827 (973)
Q Consensus 748 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~ 827 (973)
+|+||+++|+|.+++... ...+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||+++
T Consensus 85 ~v~e~~~~g~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 85 LITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred eeeecCCCCCHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccc
Confidence 999999999999999753 235788899999999999999999 8899999999999999999999999999998
Q ss_pred cccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccc
Q 002061 828 IAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVL 906 (973)
Q Consensus 828 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 906 (973)
...............++..|+|||++.+..++.++|||||||++|||++ |+.||.... ...+.... ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~--~~~~~~~~----~~~~~~- 230 (316)
T cd05108 158 LLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSIL----EKGERL- 230 (316)
T ss_pred cccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHH----hCCCCC-
Confidence 7654332222222334678999999999999999999999999999998 999996531 11111111 111100
Q ss_pred hhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCC
Q 002061 907 KVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPC 956 (973)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~ 956 (973)
..+......+.+++.+||+.+|++||++.++++++..+...
T Consensus 231 ---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 231 ---------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred ---------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 00111234578899999999999999999999999976543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=331.91 Aligned_cols=264 Identities=21% Similarity=0.261 Sum_probs=199.2
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY 752 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 752 (973)
++|++.+.||+|+||+||+|+...+++.||||++... .....+.+|+++++.++||||+++++++..+...++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY 84 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence 5789999999999999999999988999999998653 2234567899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCC
Q 002061 753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832 (973)
Q Consensus 753 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 832 (973)
++ ++|.+++... ...++...+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++......
T Consensus 85 ~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 85 VH-TDLCQYMDKH----PGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CC-cCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 95 6888887643 235788889999999999999999 889999999999999999999999999998754322
Q ss_pred CCcccccccCCcccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccc--ccch--
Q 002061 833 PKVSDYSCFAGTHGYIAPELAYT-CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHE--NVLK-- 907 (973)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~-- 907 (973)
. .......+++.|+|||++.+ ..++.++||||+||++|||++|+.||................ ..... ....
T Consensus 157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 233 (303)
T cd07869 157 S--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLV-LGTPNEDTWPGVH 233 (303)
T ss_pred C--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHH-hCCCChhhccchh
Confidence 1 12233567899999999865 457889999999999999999999997542111111111110 00000 0000
Q ss_pred ---hcccc----ccCcchHH------HHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 908 ---VLDCE----VASESIKE------DMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 908 ---~~~~~----~~~~~~~~------~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
..++. .......+ ....+.+++.+|++.||.+|||+.|+++|-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~ 289 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHE 289 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCc
Confidence 00000 00000011 124577899999999999999999999753
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=323.84 Aligned_cols=260 Identities=21% Similarity=0.314 Sum_probs=210.2
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeec-----cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL 750 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~-----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 750 (973)
++|++.+.||+|+||.||+|+...+++.||||.+.. ......+.+|++++++++||||+++++++...+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 578999999999999999999998899999998754 223456788999999999999999999999999999999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccccc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 830 (973)
||+++|+|.+++.... .....+++..+..++.|++.|++||| +++++||||||+||+++.++.++++|||.+....
T Consensus 82 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 82 ELADAGDLSQMIKYFK-KQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCcHHHHHHHhh-hccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence 9999999999987532 22345788899999999999999999 8899999999999999999999999999987654
Q ss_pred CCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhcc
Q 002061 831 NSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLD 910 (973)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (973)
.... ......|++.|+|||++.+..++.++||||+|+++|||++|+.||..... +...+..... ...
T Consensus 158 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~---~~~~~~~~~~-~~~------- 224 (267)
T cd08228 158 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLFSLCQKIE-QCD------- 224 (267)
T ss_pred chhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc---cHHHHHHHHh-cCC-------
Confidence 3221 12234578899999999888899999999999999999999999965322 1122211111 100
Q ss_pred ccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 002061 911 CEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADAD 954 (973)
Q Consensus 911 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 954 (973)
............+.+++.+||+.+|++||++.+|++.+++++
T Consensus 225 --~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 225 --YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred --CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 111112234466889999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=335.20 Aligned_cols=241 Identities=27% Similarity=0.330 Sum_probs=196.5
Q ss_pred CcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCC
Q 002061 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNG 756 (973)
Q Consensus 682 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 756 (973)
+.||+|+||.||+|+...+++.||+|++... .....+.+|++++++++||||+++++++..++..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 3689999999999999999999999998753 23456778999999999999999999999999999999999999
Q ss_pred chHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCcc
Q 002061 757 NLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVS 836 (973)
Q Consensus 757 sL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 836 (973)
+|.+++... ..+++..+..++.|++.||+||| +++++||||||+||+++.++.+||+|||++....... .
T Consensus 81 ~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~ 150 (323)
T cd05595 81 ELFFHLSRE-----RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--A 150 (323)
T ss_pred cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC--C
Confidence 999888643 35788999999999999999999 7899999999999999999999999999986432221 1
Q ss_pred cccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccccCc
Q 002061 837 DYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASE 916 (973)
Q Consensus 837 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (973)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..............
T Consensus 151 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~-----~~~~~~~~~~~~~~------------ 213 (323)
T cd05595 151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HERLFELILMEEIR------------ 213 (323)
T ss_pred ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC-----HHHHHHHHhcCCCC------------
Confidence 2223568999999999999999999999999999999999999996431 11111111111110
Q ss_pred chHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 002061 917 SIKEDMIKLLKIAVVCTTKLPNLRP-----PMREVVKM 949 (973)
Q Consensus 917 ~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~ 949 (973)
.+......+.+++.+|+++||++|| ++.+++++
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 0112345678899999999999998 89988875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=328.28 Aligned_cols=249 Identities=34% Similarity=0.528 Sum_probs=194.2
Q ss_pred ccCcccccCceEEEEEEec----CCCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 002061 680 EDNLIGSGGTGKVYRLDLK----KNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY 752 (973)
Q Consensus 680 ~~~~lG~G~~g~V~~a~~~----~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 752 (973)
..+.||.|.||.||+|.+. ..+..|+||+++.. ...+.+.+|++.+++++||||+++++++...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999998 44678999999653 2357889999999999999999999999988889999999
Q ss_pred cCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCC
Q 002061 753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832 (973)
Q Consensus 753 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 832 (973)
+++|+|.+++... ....+++..+..|+.|+|+||+||| +.+++|+||+++||+++.++.+||+|||++......
T Consensus 83 ~~~g~L~~~L~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 83 CPGGSLDDYLKSK---NKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp -TTEBHHHHHHHT---CTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred ccccccccccccc---ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 9999999999864 3456899999999999999999999 779999999999999999999999999999876333
Q ss_pred CCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhccc
Q 002061 833 PKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDC 911 (973)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (973)
..............|+|||.+.+..++.++||||||+++||+++ |+.||.+. ...++...+ .....
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~--~~~~~~~~~----~~~~~------- 223 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY--DNEEIIEKL----KQGQR------- 223 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS--CHHHHHHHH----HTTEE-------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccc----ccccc-------
Confidence 33222333456789999999998889999999999999999999 78898653 212212121 11110
Q ss_pred cccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 912 EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 912 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
...+......+.+++..||+.||++||++.++++.|
T Consensus 224 ---~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 ---LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ---TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ---ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 011122345688999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=335.54 Aligned_cols=242 Identities=27% Similarity=0.345 Sum_probs=197.8
Q ss_pred CcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCC
Q 002061 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNG 756 (973)
Q Consensus 682 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 756 (973)
+.||+|+||.||+|++..+++.||||++... .....+.+|+++++.++||||+++++++..++..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999999999999999999998753 34456788999999999999999999999999999999999999
Q ss_pred chHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCcc
Q 002061 757 NLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVS 836 (973)
Q Consensus 757 sL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 836 (973)
+|.+++... ..+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 ~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~ 150 (328)
T cd05593 81 ELFFHLSRE-----RVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--A 150 (328)
T ss_pred CHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--c
Confidence 999888642 35789999999999999999999 8899999999999999999999999999987532211 1
Q ss_pred cccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccccCc
Q 002061 837 DYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASE 916 (973)
Q Consensus 837 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (973)
......||+.|+|||++.+..++.++||||+||++|||++|+.||... +............. ..
T Consensus 151 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~-----~~~~~~~~~~~~~~--------~~--- 214 (328)
T cd05593 151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-----DHEKLFELILMEDI--------KF--- 214 (328)
T ss_pred ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCC-----CHHHHHHHhccCCc--------cC---
Confidence 223356899999999999889999999999999999999999999643 11112111111111 01
Q ss_pred chHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHh
Q 002061 917 SIKEDMIKLLKIAVVCTTKLPNLRP-----PMREVVKML 950 (973)
Q Consensus 917 ~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~L 950 (973)
+......+.+++.+|+++||++|| ++.|++++-
T Consensus 215 -p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~ 252 (328)
T cd05593 215 -PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHS 252 (328)
T ss_pred -CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCC
Confidence 112344678899999999999997 899998763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=333.43 Aligned_cols=239 Identities=25% Similarity=0.343 Sum_probs=195.3
Q ss_pred ccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCCch
Q 002061 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNL 758 (973)
Q Consensus 684 lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL 758 (973)
||+|+||+||+|++..+++.||+|++... .....+.+|++++++++||||+++++++..++..|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999999999999999999998652 3345678899999999999999999999999999999999999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCcccc
Q 002061 759 FQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY 838 (973)
Q Consensus 759 ~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~ 838 (973)
.+++... ..+++..+..++.|++.||+||| +++|+||||||+||+++.++.++|+|||+++...... ...
T Consensus 81 ~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~ 150 (312)
T cd05585 81 FHHLQRE-----GRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKT 150 (312)
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccc
Confidence 9998753 35788899999999999999999 8899999999999999999999999999987542221 122
Q ss_pred cccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccccCcch
Q 002061 839 SCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESI 918 (973)
Q Consensus 839 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (973)
....||+.|+|||++.+..++.++||||+||++|||++|+.||... +.............. .+
T Consensus 151 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~-----~~~~~~~~~~~~~~~------------~~ 213 (312)
T cd05585 151 NTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE-----NVNEMYRKILQEPLR------------FP 213 (312)
T ss_pred ccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC-----CHHHHHHHHHcCCCC------------CC
Confidence 3356899999999999999999999999999999999999999653 222222222211110 11
Q ss_pred HHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHH
Q 002061 919 KEDMIKLLKIAVVCTTKLPNLRPP---MREVVKM 949 (973)
Q Consensus 919 ~~~~~~l~~l~~~cl~~dP~~Rpt---~~evl~~ 949 (973)
......+.+++.+||+.||.+||+ +.|+++|
T Consensus 214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 123356788999999999999974 6777665
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=340.23 Aligned_cols=250 Identities=28% Similarity=0.382 Sum_probs=197.0
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE 751 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 751 (973)
..+|+..+.||+|+||+||+|++..+++.||||++... .....+.+|++++++++|+||+++++++..++..|+|||
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 45678889999999999999999988999999998653 234568899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccC
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 831 (973)
|+++|+|.+.. ...+..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 153 ~~~~~~L~~~~---------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~ 220 (353)
T PLN00034 153 FMDGGSLEGTH---------IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220 (353)
T ss_pred cCCCCcccccc---------cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence 99999985432 2456677889999999999999 78999999999999999999999999999976543
Q ss_pred CCCcccccccCCcccccccccccc-----CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccc
Q 002061 832 SPKVSDYSCFAGTHGYIAPELAYT-----CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVL 906 (973)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 906 (973)
... ......||..|+|||++.. ...+.++|||||||++|||++|+.||.... ..+.............
T Consensus 221 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~--~~~~~~~~~~~~~~~~--- 293 (353)
T PLN00034 221 TMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR--QGDWASLMCAICMSQP--- 293 (353)
T ss_pred ccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCC--CccHHHHHHHHhccCC---
Confidence 211 1223568999999998743 234568999999999999999999997321 1122111111111000
Q ss_pred hhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 907 KVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
.........++.+++.+||+.||++||++.|+++|-.
T Consensus 294 --------~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~ 330 (353)
T PLN00034 294 --------PEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPF 330 (353)
T ss_pred --------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 0111233456889999999999999999999999854
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=331.98 Aligned_cols=263 Identities=25% Similarity=0.372 Sum_probs=203.3
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY 752 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 752 (973)
++|++.+.||+|+||.||+|++..++..||+|++... .....+.+|++++++++||||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence 5789999999999999999999998999999987653 2345688999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCC
Q 002061 753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832 (973)
Q Consensus 753 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 832 (973)
+++|+|.+++... ..+++..+..++.|++.|++|||+ ..+++||||||+||+++.++.+||+|||++......
T Consensus 85 ~~~~~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 85 MDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred CCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 9999999999753 347888889999999999999994 247999999999999999999999999998755322
Q ss_pred CCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccc--------
Q 002061 833 PKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHEN-------- 904 (973)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~-------- 904 (973)
. .....|+..|+|||++.+..++.++|||||||++|||++|+.||..... ................
T Consensus 158 ~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 231 (333)
T cd06650 158 M----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDA--KELELMFGCPVEGDPAESETSPRP 231 (333)
T ss_pred c----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcch--hHHHHHhcCcccCCccccccCccc
Confidence 1 1234688999999999988899999999999999999999999975321 1111111000000000
Q ss_pred -------------------cchhcc---ccccCcc-hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 905 -------------------VLKVLD---CEVASES-IKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 905 -------------------~~~~~~---~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
.....+ ....... ......++.+++.+||++||++|||+.|++++-.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~ 301 (333)
T cd06650 232 RPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAF 301 (333)
T ss_pred CCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHH
Confidence 000000 0000000 0012346789999999999999999999987644
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=337.33 Aligned_cols=246 Identities=24% Similarity=0.290 Sum_probs=201.4
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCC-cEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeE
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNA-GTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF 747 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~-~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 747 (973)
..++|++.+.||+|+||.||+|++..++ ..||+|++... ...+.+.+|+++++.++||||+++++++.+++..|
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 4568999999999999999999976544 68999988642 34456788999999999999999999999999999
Q ss_pred EEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcc
Q 002061 748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827 (973)
Q Consensus 748 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~ 827 (973)
+||||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.
T Consensus 108 lv~Ey~~~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~ 179 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRN-----KRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAK 179 (340)
T ss_pred EEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCe
Confidence 999999999999999753 35788899999999999999999 8899999999999999999999999999997
Q ss_pred cccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccch
Q 002061 828 IAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLK 907 (973)
Q Consensus 828 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
..... .....||+.|+|||++.+..++.++||||+||++|||++|+.||.... ...............
T Consensus 180 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-----~~~~~~~i~~~~~~~-- 247 (340)
T PTZ00426 180 VVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE-----PLLIYQKILEGIIYF-- 247 (340)
T ss_pred ecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC-----HHHHHHHHhcCCCCC--
Confidence 65332 123468999999999998889999999999999999999999996531 111111111111100
Q ss_pred hccccccCcchHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 002061 908 VLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRP-----PMREVVKM 949 (973)
Q Consensus 908 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~ 949 (973)
+......+.+++.+|++.||++|+ +++|+++|
T Consensus 248 ----------p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 248 ----------PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ----------CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 111234567899999999999995 89999887
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=322.04 Aligned_cols=248 Identities=26% Similarity=0.346 Sum_probs=197.6
Q ss_pred CcccccCceEEEEEEecCCCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCCch
Q 002061 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNL 758 (973)
Q Consensus 682 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL 758 (973)
+.||+|+||.||+|++..+++.||+|..... +....+.+|++++++++||||+++++++..+...++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 3689999999999999988999999987542 3346688999999999999999999999999999999999999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCcccc
Q 002061 759 FQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY 838 (973)
Q Consensus 759 ~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~ 838 (973)
.+++... ...+++..+..++.|++.||+||| +++++||||||+||+++.++.+|++|||++............
T Consensus 81 ~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 153 (252)
T cd05084 81 LTFLRTE----GPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG 153 (252)
T ss_pred HHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccC
Confidence 9998643 335789999999999999999999 889999999999999999999999999998754432111111
Q ss_pred cccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhccccccCcc
Q 002061 839 SCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASES 917 (973)
Q Consensus 839 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (973)
.....+..|+|||.+.+..++.++|||||||++|||++ |..||..... ......+ .... ....
T Consensus 154 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~--~~~~~~~----~~~~----------~~~~ 217 (252)
T cd05084 154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN--QQTREAI----EQGV----------RLPC 217 (252)
T ss_pred CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH--HHHHHHH----HcCC----------CCCC
Confidence 11223467999999998889999999999999999998 8889864311 1111111 1100 0011
Q ss_pred hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 002061 918 IKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952 (973)
Q Consensus 918 ~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~ 952 (973)
.......+.+++.+|++.+|++||++.++.++|+.
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 11234568889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=339.55 Aligned_cols=261 Identities=23% Similarity=0.276 Sum_probs=200.5
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCC
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPN 755 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 755 (973)
.+|++.+.||+|+||.||+|++..+++.||+|+.. .+.+.+|++++++++||||+++++++..+...++|+|++ +
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~-~ 166 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY-K 166 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC-C
Confidence 57999999999999999999999999999999753 235678999999999999999999999999999999999 4
Q ss_pred CchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCc
Q 002061 756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV 835 (973)
Q Consensus 756 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 835 (973)
++|.+++... ..+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++.......
T Consensus 167 ~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~- 237 (391)
T PHA03212 167 TDLYCYLAAK-----RNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA- 237 (391)
T ss_pred CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc-
Confidence 7898888643 34788999999999999999999 78999999999999999999999999999865432211
Q ss_pred ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCc------ccHHHHHHHHhcccc------
Q 002061 836 SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDG------KDIVYWVSTHLNNHE------ 903 (973)
Q Consensus 836 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~------~~~~~~~~~~~~~~~------ 903 (973)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||....+.. ..+...+.. ....+
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~-~g~~p~~~~~~ 316 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRR-SGTHPNEFPID 316 (391)
T ss_pred cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHH-hcCChhhcCcc
Confidence 12233578999999999998899999999999999999999998875432111 111111110 00000
Q ss_pred ---ccchhc---------ccccc--CcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 904 ---NVLKVL---------DCEVA--SESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 904 ---~~~~~~---------~~~~~--~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
...+.. .+... ..........+.+++.+|++.||++|||+.|++++-.
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~ 378 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAA 378 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChh
Confidence 000000 00000 0111234557889999999999999999999997543
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=320.12 Aligned_cols=250 Identities=23% Similarity=0.328 Sum_probs=215.0
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV 749 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 749 (973)
...-|...+.||+|.|+.|-+|++--+|+.||||++.+. .....+..|++.|+-++|||||++|++.......|+|
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 345688889999999999999999999999999999773 3455678999999999999999999999999999999
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeee-cCCCCeEEecccCccc
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILL-DEDYEPKIADFGVAKI 828 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill-~~~~~~kl~Dfgl~~~ 828 (973)
.|.=++|+|++|+-++ +..+.+....+++.||..|+.|+| +..+||||+||+||.+ ..-|-||++|||++-.
T Consensus 96 LELGD~GDl~DyImKH----e~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNk 168 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKH----EEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNK 168 (864)
T ss_pred EEecCCchHHHHHHhh----hccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeecccccc
Confidence 9999999999999876 334778888899999999999999 7899999999999765 5678999999999988
Q ss_pred ccCCCCcccccccCCccccccccccccCCCC-ccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccch
Q 002061 829 AENSPKVSDYSCFAGTHGYIAPELAYTCKVS-EKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLK 907 (973)
Q Consensus 829 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
+.++.. ....+|+..|-|||++.|..|+ +++||||||||||-+++|+.||+... ..+.+..
T Consensus 169 f~PG~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAN---------------DSETLTm 230 (864)
T KOG4717|consen 169 FQPGKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAN---------------DSETLTM 230 (864)
T ss_pred CCCcch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccccc---------------chhhhhh
Confidence 876644 3346799999999999999987 68999999999999999999998641 1223456
Q ss_pred hccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 908 VLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 908 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
++|+.+. .+.....++.++|..|+..||.+|.+..||+.+-
T Consensus 231 ImDCKYt--vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~ 271 (864)
T KOG4717|consen 231 IMDCKYT--VPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTS 271 (864)
T ss_pred hhccccc--CchhhhHHHHHHHHHHHhcCchhhccHHHHhccc
Confidence 6777763 3456677899999999999999999999997653
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=327.83 Aligned_cols=259 Identities=27% Similarity=0.372 Sum_probs=206.2
Q ss_pred HcCCcccCcccccCceEEEEEEecC-----CCcEEEEEeeeccc---cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCee
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKK-----NAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSS 746 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~-----~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 746 (973)
..+|.+.+.||+|+||.||+|+... +++.||||++.... ..+.+.+|++++++++||||+++++++..+...
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3568888999999999999998753 35789999987632 346789999999999999999999999999999
Q ss_pred EEEEEccCCCchHHHHHhhh---------cCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCC
Q 002061 747 FLVLEYMPNGNLFQALHKRV---------KEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE 817 (973)
Q Consensus 747 ~lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~ 817 (973)
++||||+++|+|.+++.... ......+++..+..++.|++.|++|+| +++++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCe
Confidence 99999999999999997642 122345788899999999999999999 789999999999999999999
Q ss_pred eEEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHH
Q 002061 818 PKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVS 896 (973)
Q Consensus 818 ~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~ 896 (973)
++|+|||++................+++.|+|||++.+..++.++|||||||++|||++ |+.||.... .......
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~--~~~~~~~-- 236 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS--NEEVIEC-- 236 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC--HHHHHHH--
Confidence 99999999875533322111223345788999999999999999999999999999998 999996532 1111111
Q ss_pred HHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 002061 897 THLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952 (973)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~ 952 (973)
...... ..........+.+++.+||+.||++||++.||++.|++
T Consensus 237 -~~~~~~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 237 -ITQGRL-----------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred -HHcCCc-----------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 111000 00111234568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=349.96 Aligned_cols=256 Identities=27% Similarity=0.302 Sum_probs=205.9
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCC-----
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGG----- 744 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----- 744 (973)
...+|++.+.||+|+||+||+|++..+++.||||++... .....+.+|+..+..++|+|++++++.+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 346899999999999999999999999999999998652 33456788999999999999999988775432
Q ss_pred ---eeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEe
Q 002061 745 ---SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIA 821 (973)
Q Consensus 745 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 821 (973)
..++||||+++|+|.+++..+.. ....+++..+..++.|++.||+|+| +++|+||||||+||+++.++.+||+
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~-~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAK-TNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEEE
Confidence 36899999999999999976422 3346888999999999999999999 8899999999999999999999999
Q ss_pred cccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcc
Q 002061 822 DFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNN 901 (973)
Q Consensus 822 Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 901 (973)
|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||... +....+......
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~-----~~~~~~~~~~~~ 260 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE-----NMEEVMHKTLAG 260 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC-----CHHHHHHHHhcC
Confidence 999998664432222233457899999999999999999999999999999999999999643 222222222111
Q ss_pred ccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 902 HENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
.. ...+......+.+++.+||+.||.+||++.+++++
T Consensus 261 ~~-----------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 261 RY-----------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CC-----------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 10 00112234568899999999999999999999876
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=332.51 Aligned_cols=246 Identities=30% Similarity=0.437 Sum_probs=206.6
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeec-----cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE 751 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~-----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 751 (973)
.|.-.+.||+|+||.||-|++..+.+.||||++.. .+...++..|+.+|++++|||++.+.+||-.+...|+|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 35667889999999999999999999999999865 2345678999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccC
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 831 (973)
|| -|+-.|.+.-+ ..++.+..+..|..+.++||+||| +++.||||||+.|||+++.|.||++|||.|....+
T Consensus 107 YC-lGSAsDlleVh----kKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P 178 (948)
T KOG0577|consen 107 YC-LGSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP 178 (948)
T ss_pred HH-hccHHHHHHHH----hccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCc
Confidence 99 67888888765 346888899999999999999999 88999999999999999999999999999976654
Q ss_pred CCCcccccccCCccccccccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchh
Q 002061 832 SPKVSDYSCFAGTHGYIAPELAY---TCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKV 908 (973)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (973)
. ..++|||.|||||++. .+.|+-++||||||++..|+...++|+-.. ...+- ++.+
T Consensus 179 A------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM--NAMSA-------------LYHI 237 (948)
T KOG0577|consen 179 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM--NAMSA-------------LYHI 237 (948)
T ss_pred h------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc--hHHHH-------------HHHH
Confidence 3 2378999999999985 568999999999999999999999998543 11111 1222
Q ss_pred ccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 909 LDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 909 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
...+...-...+....|..|+..|+++-|.+|||..++++|--
T Consensus 238 AQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~f 280 (948)
T KOG0577|consen 238 AQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRF 280 (948)
T ss_pred HhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcch
Confidence 2222222335577788999999999999999999999988754
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=324.25 Aligned_cols=255 Identities=27% Similarity=0.395 Sum_probs=204.9
Q ss_pred cCCcccCcccccCceEEEEEEecCC---CcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKN---AGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV 749 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~---~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 749 (973)
++|++.+.||+|+||+||+|++... ...||||++... .....+.+|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 4688999999999999999998643 457999987653 2345688899999999999999999999999999999
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccc
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 829 (973)
|||+++++|.+++... ...+++..+..++.|++.|++||| +++++||||||+||++++++.++++|||++...
T Consensus 84 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 84 TEYMENGSLDKFLREN----DGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEcCCCCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 9999999999999753 236889999999999999999999 789999999999999999999999999999877
Q ss_pred cCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchh
Q 002061 830 ENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKV 908 (973)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (973)
.............++..|+|||.+.+..++.++||||||+++|||++ |..||.... .......+ ..... .
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~--~~~~~~~~---~~~~~-~--- 227 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS--NQDVIKAV---EDGYR-L--- 227 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC--HHHHHHHH---HcCCC-C---
Confidence 52222111222345678999999998899999999999999999998 999996431 11111111 11000 0
Q ss_pred ccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 909 LDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 909 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
.........+.+++.+|++.+|++||++.|++++|+++
T Consensus 228 -------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 -------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01112345688999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=336.86 Aligned_cols=262 Identities=29% Similarity=0.399 Sum_probs=204.0
Q ss_pred cCCcccCcccccCceEEEEEEecC-----CCcEEEEEeeeccc---cHHHHHHHHHHHHhc-CCCceeeEEEEEEe-CCe
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKK-----NAGTVAVKQLWKGD---GVKVFAAEMEILGKI-RHRNILKLYACLLK-GGS 745 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~-----~~~~vavK~~~~~~---~~~~~~~E~~~l~~l-~hpniv~l~~~~~~-~~~ 745 (973)
++|++.+.||+|+||.||+|.... +++.||+|++.... ..+.+.+|+++++++ +||||+++++++.. +..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 378999999999999999997543 35789999886532 345577899999999 89999999998764 457
Q ss_pred eEEEEEccCCCchHHHHHhhhcC--------------------------------------------------------C
Q 002061 746 SFLVLEYMPNGNLFQALHKRVKE--------------------------------------------------------G 769 (973)
Q Consensus 746 ~~lv~e~~~~gsL~~~l~~~~~~--------------------------------------------------------~ 769 (973)
.+++|||+++|+|.+++...... .
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 88999999999999998643110 0
Q ss_pred CCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCcccccccCCcccccc
Q 002061 770 KPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIA 849 (973)
Q Consensus 770 ~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~a 849 (973)
...+++..+..++.||+.|++||| +.+|+||||||+||+++.++.++|+|||++................++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 125789999999999999999999 78999999999999999999999999999986643322222233456778999
Q ss_pred ccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhccccccCcchHHHHHHHHHH
Q 002061 850 PELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKI 928 (973)
Q Consensus 850 PE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 928 (973)
||++.+..++.++||||+||++|||++ |+.||...... ....... ..... ...+.....++.++
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~-~~~~~~~----~~~~~----------~~~~~~~~~~~~~l 308 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID-EEFCRRL----KEGTR----------MRAPEYATPEIYSI 308 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc-HHHHHHH----hccCC----------CCCCccCCHHHHHH
Confidence 999999999999999999999999998 99999653211 1111111 11110 00111234568899
Q ss_pred HHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 002061 929 AVVCTTKLPNLRPPMREVVKMLADADP 955 (973)
Q Consensus 929 ~~~cl~~dP~~Rpt~~evl~~L~~~~~ 955 (973)
+.+||+.+|++||++.|++++|+++..
T Consensus 309 ~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 309 MLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=330.10 Aligned_cols=254 Identities=26% Similarity=0.364 Sum_probs=216.7
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCC
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPN 755 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 755 (973)
+....++||-|.||.||.|.+++..-.||||.++.+ ...++|..|+.+|+.++|||+|+++++|..+...|||+|||..
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~y 347 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCY 347 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccC
Confidence 456678999999999999999988889999998764 5678999999999999999999999999999999999999999
Q ss_pred CchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCc
Q 002061 756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV 835 (973)
Q Consensus 756 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 835 (973)
|+|.+|+++. .+..++....+.+|.||+.||+||. .+++||||+.++|.||.++..||++|||+++.+....+
T Consensus 348 GNLLdYLRec---nr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY- 420 (1157)
T KOG4278|consen 348 GNLLDYLREC---NRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY- 420 (1157)
T ss_pred ccHHHHHHHh---chhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhhcCCce-
Confidence 9999999875 3445677778899999999999999 88999999999999999999999999999998854422
Q ss_pred ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhcccccc
Q 002061 836 SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVA 914 (973)
Q Consensus 836 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (973)
..+....-++-|.|||-+.-..++.++|||+|||+|||+.| |-.||.+. +..+. ...+...+.
T Consensus 421 TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi-----dlSqV-----------Y~LLEkgyR 484 (1157)
T KOG4278|consen 421 TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DLSQV-----------YGLLEKGYR 484 (1157)
T ss_pred ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc-----cHHHH-----------HHHHhcccc
Confidence 33333344678999999988899999999999999999999 88888543 22222 233444455
Q ss_pred CcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 915 SESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 915 ~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
.+.+..++++++++++.||+|+|.+||+++|+-+.++.+
T Consensus 485 M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 485 MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 556677888999999999999999999999999998854
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=324.95 Aligned_cols=247 Identities=25% Similarity=0.304 Sum_probs=197.8
Q ss_pred ccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCCch
Q 002061 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNL 758 (973)
Q Consensus 684 lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL 758 (973)
||+|+||+||++.+..+++.||||++... ...+.+..|++++++++||||+++.+++..+...|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999999999999999998652 2335567899999999999999999999999999999999999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCcccc
Q 002061 759 FQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY 838 (973)
Q Consensus 759 ~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~ 838 (973)
.+++... ......+++..+..++.|++.||+||| +++|+||||||+||+++.++.++|+|||.+........ ..
T Consensus 81 ~~~~~~~-~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~ 154 (280)
T cd05608 81 RYHIYNV-DEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KT 154 (280)
T ss_pred HHHHHhc-cccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--cc
Confidence 9888643 223456899999999999999999999 78999999999999999999999999999876543322 12
Q ss_pred cccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccccCcch
Q 002061 839 SCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESI 918 (973)
Q Consensus 839 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (973)
....||+.|+|||++.+..++.++||||+||++|||++|+.||....... ..... ........ ...+
T Consensus 155 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~-~~~~~~~~-----------~~~~ 221 (280)
T cd05608 155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKEL-KQRILNDS-----------VTYP 221 (280)
T ss_pred cccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch-hHHHH-HHhhcccC-----------CCCc
Confidence 23468999999999999999999999999999999999999997542111 11111 11110000 0111
Q ss_pred HHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 002061 919 KEDMIKLLKIAVVCTTKLPNLRP-----PMREVVKM 949 (973)
Q Consensus 919 ~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~ 949 (973)
......+.+++.+|++.||++|| ++.++++|
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 222 DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 22345678899999999999999 77888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=326.98 Aligned_cols=260 Identities=22% Similarity=0.317 Sum_probs=203.9
Q ss_pred HHcCCcccCcccccCceEEEEEEecC-----CCcEEEEEeeeccc---cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCe
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKK-----NAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGS 745 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~-----~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 745 (973)
..++|++.+.||+|+||.||+|.+.. ++..||||++.... ...++.+|+.+++.++||||+++++++.++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45678999999999999999998752 35679999876432 34467899999999999999999999999999
Q ss_pred eEEEEEccCCCchHHHHHhhhcC-----CCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEE
Q 002061 746 SFLVLEYMPNGNLFQALHKRVKE-----GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKI 820 (973)
Q Consensus 746 ~~lv~e~~~~gsL~~~l~~~~~~-----~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl 820 (973)
.++||||+++|+|.+++...... .....++..+..++.|++.|++||| +.+++||||||+||++++++.+++
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEE
Confidence 99999999999999999753211 1234578889999999999999999 789999999999999999999999
Q ss_pred ecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHh
Q 002061 821 ADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHL 899 (973)
Q Consensus 821 ~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~ 899 (973)
+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.... .........
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~-----~~~~~~~~~ 235 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS-----NEQVLRFVM 235 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHH
Confidence 99999876543322222222345788999999998899999999999999999999 788986531 111111111
Q ss_pred ccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 002061 900 NNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952 (973)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~ 952 (973)
.... . .........+.+++.+|++.+|++||++.|+++++++
T Consensus 236 ~~~~--~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 236 EGGL--L---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred cCCc--C---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 1110 0 0011234468899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=326.34 Aligned_cols=251 Identities=26% Similarity=0.324 Sum_probs=202.7
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE 751 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 751 (973)
+|++.+.||+|+||+||+|.+..+++.||||++... .....+.+|++++++++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 478889999999999999999988999999988652 223456789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccC
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 831 (973)
|+++|+|.+++... ....+++..+..++.|++.|++||| +.+++||||||+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05605 81 LMNGGDLKFHIYNM---GNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE 154 (285)
T ss_pred ccCCCcHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 99999999888643 2345889999999999999999999 78999999999999999999999999999876543
Q ss_pred CCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccc
Q 002061 832 SPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDC 911 (973)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (973)
... .....|+..|+|||++.+..++.++||||+||++|||++|+.||..... ......+........
T Consensus 155 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~--~~~~~~~~~~~~~~~-------- 221 (285)
T cd05605 155 GET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE--KVKREEVERRVKEDQ-------- 221 (285)
T ss_pred CCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCch--hhHHHHHHHHhhhcc--------
Confidence 221 1234689999999999988899999999999999999999999975421 111111111111110
Q ss_pred cccCcchHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 002061 912 EVASESIKEDMIKLLKIAVVCTTKLPNLRP-----PMREVVKM 949 (973)
Q Consensus 912 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~ 949 (973)
..........+.+++.+||+.||++|| ++.+++++
T Consensus 222 ---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 ---EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ---cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 011123445678899999999999999 88899776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=322.44 Aligned_cols=255 Identities=26% Similarity=0.392 Sum_probs=205.5
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeec-cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK-GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM 753 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 753 (973)
.++|++.++||+|+||.||+|.... +..||+|.+.. ....+.+.+|+.++++++||||+++++++..+...++||||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNN-STKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecC-CceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 4578899999999999999999764 67899998765 334567899999999999999999999999999999999999
Q ss_pred CCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCC
Q 002061 754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833 (973)
Q Consensus 754 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 833 (973)
++|+|.+++... ....+++..+..++.|++.|++||| +.+++||||||+||+++.++.++++|||++.......
T Consensus 84 ~~~~L~~~l~~~---~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 84 AKGSLLDFLKSD---EGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred CCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 999999999753 2345788899999999999999999 7899999999999999999999999999998664332
Q ss_pred CcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhcccc
Q 002061 834 KVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCE 912 (973)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (973)
. .......++..|+|||++.+..++.++|||||||++|+|++ |+.||.... .......+. .... .
T Consensus 158 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~--~~~~~~~~~----~~~~------~- 223 (261)
T cd05072 158 Y-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS--NSDVMSALQ----RGYR------M- 223 (261)
T ss_pred e-eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC--HHHHHHHHH----cCCC------C-
Confidence 1 11122345678999999988889999999999999999998 999996431 111111111 1100 0
Q ss_pred ccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 913 VASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 913 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
........++.+++.+|++.+|++||+++++.+.|+++
T Consensus 224 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 224 ---PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred ---CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 00112335688899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=325.72 Aligned_cols=259 Identities=25% Similarity=0.311 Sum_probs=204.0
Q ss_pred HcCCcccCcccccCceEEEEEEecC-----CCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCee
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKK-----NAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSS 746 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~-----~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 746 (973)
.++|++.+.||+|+||.||+|.+.. .+..||+|..... .....+.+|+.++++++||||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4578899999999999999999986 6788999987542 2345688999999999999999999999998899
Q ss_pred EEEEEccCCCchHHHHHhhhcC--CCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCC---CeEEe
Q 002061 747 FLVLEYMPNGNLFQALHKRVKE--GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY---EPKIA 821 (973)
Q Consensus 747 ~lv~e~~~~gsL~~~l~~~~~~--~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl~ 821 (973)
++||||+++++|.+++...... ....+++..+..++.||+.|++||| +++++||||||+||+++.++ .+|++
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEec
Confidence 9999999999999999764221 1235889999999999999999999 78999999999999998755 59999
Q ss_pred cccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhc
Q 002061 822 DFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLN 900 (973)
Q Consensus 822 Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~ 900 (973)
|||+++................+..|+|||++.+..++.++|||||||++|||++ |+.||.... ....... ...
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~--~~~~~~~---~~~ 236 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT--NQEVMEF---VTG 236 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHH---HHc
Confidence 9999986643322221222234568999999998999999999999999999997 999996531 1111111 111
Q ss_pred cccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 002061 901 NHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952 (973)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~ 952 (973)
... ...+......+.+++.+|++.+|++||++.+|+++|.+
T Consensus 237 ~~~-----------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 237 GGR-----------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred CCc-----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 110 01112234568889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=337.81 Aligned_cols=263 Identities=22% Similarity=0.321 Sum_probs=197.2
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeC-----CeeE
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKG-----GSSF 747 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~~ 747 (973)
+|++.+.||+|+||.||+|++..+++.||||++... .....+.+|++++++++||||+++++++... ...|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 578889999999999999999999999999988642 3345678999999999999999999987543 2479
Q ss_pred EEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcc
Q 002061 748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827 (973)
Q Consensus 748 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~ 827 (973)
+||||++ ++|.+++... ..+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 81 lv~e~~~-~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~ 151 (338)
T cd07859 81 VVFELME-SDLHQVIKAN-----DDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLAR 151 (338)
T ss_pred EEEecCC-CCHHHHHHhc-----ccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccc
Confidence 9999994 6898888642 35789999999999999999999 7899999999999999999999999999997
Q ss_pred cccCCCC-cccccccCCcccccccccccc--CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccc--
Q 002061 828 IAENSPK-VSDYSCFAGTHGYIAPELAYT--CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNH-- 902 (973)
Q Consensus 828 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~-- 902 (973)
....... ........||..|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+.......
T Consensus 152 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~--~~~~~~~~~~~~~~~~ 229 (338)
T cd07859 152 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV--VHQLDLITDLLGTPSP 229 (338)
T ss_pred ccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHHHhCCCCH
Confidence 5432211 112233568999999999865 6789999999999999999999999965321 00000000000000
Q ss_pred -----------cccchhccccccC---cchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 903 -----------ENVLKVLDCEVAS---ESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 903 -----------~~~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
......+...... .........+.+++.+|++.||++||++.|++++-
T Consensus 230 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp 291 (338)
T cd07859 230 ETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADP 291 (338)
T ss_pred HHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCc
Confidence 0000000000000 00011234578899999999999999999999873
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=320.96 Aligned_cols=251 Identities=25% Similarity=0.367 Sum_probs=201.4
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccC
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP 754 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 754 (973)
++|++.+.||+|+||.||+|+.+. +..+|+|.+... ...+.+.+|++++++++||||+++++++..++..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 457888999999999999998875 568999987653 345678899999999999999999999999999999999999
Q ss_pred CCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCC
Q 002061 755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK 834 (973)
Q Consensus 755 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 834 (973)
+|+|.++++.. ...+++..+..++.|++.|++||| +++++||||||+||+++.++.+|++|||.++.......
T Consensus 83 ~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 83 NGCLLNYLRQR----QGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred CCcHHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 99999998753 235789999999999999999999 78999999999999999999999999999876543222
Q ss_pred cccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhccccc
Q 002061 835 VSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEV 913 (973)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (973)
. ......++..|+|||++.+..++.++||||||+++|||++ |+.||.... ....+........ ...+
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~-----~~~~~~~i~~~~~----~~~~-- 223 (256)
T cd05114 156 T-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS-----NYEVVEMISRGFR----LYRP-- 223 (256)
T ss_pred e-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHHCCCC----CCCC--
Confidence 1 1122235668999999988889999999999999999999 899996531 1112221111111 0001
Q ss_pred cCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 914 ASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 914 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
......+.+++.+||+++|++||++.|+++.|.
T Consensus 224 -----~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 224 -----KLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred -----CCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 112346789999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=327.41 Aligned_cols=261 Identities=26% Similarity=0.388 Sum_probs=207.1
Q ss_pred cCCcccCcccccCceEEEEEEec-----CCCcEEEEEeeecc--ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLK-----KNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL 748 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~-----~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 748 (973)
.+|.+.+.||+|+||+||++... .++..||+|.+... ...+.+.+|++++++++||||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 46788999999999999999863 34567999988653 345678999999999999999999999999999999
Q ss_pred EEEccCCCchHHHHHhhhc--------CCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEE
Q 002061 749 VLEYMPNGNLFQALHKRVK--------EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKI 820 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~--------~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl 820 (973)
||||+++++|.+++..... .....+++..+..++.|++.||+||| +++++||||||+||++++++.++|
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEe
Confidence 9999999999999975421 12234899999999999999999999 789999999999999999999999
Q ss_pred ecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHh
Q 002061 821 ADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHL 899 (973)
Q Consensus 821 ~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~ 899 (973)
+|||++................++..|+|||++.+..++.++|||||||++|||++ |..||..... . .......
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~--~---~~~~~i~ 236 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--N---EVIECIT 236 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--H---HHHHHHH
Confidence 99999976543322222223445778999999998899999999999999999998 9999865421 1 1111111
Q ss_pred ccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 002061 900 NNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADP 955 (973)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 955 (973)
.... . .........+.+++.+||+.+|.+||++.|+.+.|+.+..
T Consensus 237 ~~~~--~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 237 QGRV--L---------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred cCCc--C---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 1110 0 0011123468899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=326.24 Aligned_cols=259 Identities=24% Similarity=0.361 Sum_probs=204.3
Q ss_pred HcCCcccCcccccCceEEEEEEec----CCCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLK----KNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF 747 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~----~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 747 (973)
..+|++.+.||+|+||+||+|... ..+..||+|.+... .....+.+|++++++++||||+++++++..+...|
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 356788899999999999999863 34678999988652 23456889999999999999999999999999999
Q ss_pred EEEEccCCCchHHHHHhhhc------------CCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCC
Q 002061 748 LVLEYMPNGNLFQALHKRVK------------EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDED 815 (973)
Q Consensus 748 lv~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~ 815 (973)
+||||+++|+|.+++..... .....+++..+..++.|++.|++||| +++++||||||+||+++++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCC
Confidence 99999999999999864311 01234788899999999999999999 7899999999999999999
Q ss_pred CCeEEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHH
Q 002061 816 YEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYW 894 (973)
Q Consensus 816 ~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~ 894 (973)
+.+|++|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.... ...+...
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~--~~~~~~~ 238 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS--NQEVIEM 238 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC--HHHHHHH
Confidence 9999999999976643332222233445778999999988889999999999999999998 999986431 1111222
Q ss_pred HHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 002061 895 VSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952 (973)
Q Consensus 895 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~ 952 (973)
+. ..... ........++.+++.+|++.||++||++.++.++|+.
T Consensus 239 ~~----~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 239 VR----KRQLL----------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HH----cCCcC----------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11 11100 0111223467889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=326.29 Aligned_cols=261 Identities=21% Similarity=0.259 Sum_probs=194.7
Q ss_pred CCcccCcccccCceEEEEEEecC-CCcEEEEEeeecc----ccHHHHHHHHHHHHhc---CCCceeeEEEEEEe-----C
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKK-NAGTVAVKQLWKG----DGVKVFAAEMEILGKI---RHRNILKLYACLLK-----G 743 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~-~~~~vavK~~~~~----~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~-----~ 743 (973)
+|++.+.||+|+||+||+|++.. .++.||||++... .....+.+|+.+++.+ +||||+++++++.. .
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 68899999999999999999854 4678999988642 2234566788777765 69999999998852 4
Q ss_pred CeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecc
Q 002061 744 GSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADF 823 (973)
Q Consensus 744 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 823 (973)
...++||||++ ++|.+++... ....+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+||
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccc
Confidence 56899999995 6999998753 2345789999999999999999999 789999999999999999999999999
Q ss_pred cCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccc-
Q 002061 824 GVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNH- 902 (973)
Q Consensus 824 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~- 902 (973)
|+++..... .......|++.|+|||++.+..++.++||||+||++|||++|+.||.... ..+....+.......
T Consensus 155 g~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~--~~~~~~~i~~~~~~~~ 229 (290)
T cd07862 155 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS--DVDQLGKILDVIGLPG 229 (290)
T ss_pred cceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCC--HHHHHHHHHHHhCCCC
Confidence 999765433 12233568999999999988899999999999999999999999997542 111111111110000
Q ss_pred -cccc-------hhccccc---cCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 903 -ENVL-------KVLDCEV---ASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 903 -~~~~-------~~~~~~~---~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
.... ..+.... ...........+.+++.+|++.||++|||+.|+++|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 0000 0000000 000011234567789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=324.33 Aligned_cols=258 Identities=26% Similarity=0.360 Sum_probs=201.6
Q ss_pred cCCcccCcccccCceEEEEEEecCCCc----EEEEEeeeccc---cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAG----TVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL 748 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~----~vavK~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 748 (973)
.+|++.+.||+|+||+||+|.+..+++ .|++|.+.... ...++..|+..+++++||||+++++++. +...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 467888999999999999999976665 47777765432 2355677888899999999999999875 456789
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccc
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 828 (973)
++||+++|+|.+++... ...+++..+..++.|++.|++|+| +++++||||||+||+++.++.+||+|||+++.
T Consensus 86 i~e~~~~gsL~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH----RDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADL 158 (279)
T ss_pred EEEeCCCCcHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCcccee
Confidence 99999999999999753 235889999999999999999999 78999999999999999999999999999976
Q ss_pred ccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccch
Q 002061 829 AENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLK 907 (973)
Q Consensus 829 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
..............++..|+|||++.+..++.++|||||||++||+++ |+.||..... ...... .......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--~~~~~~----~~~~~~~-- 230 (279)
T cd05111 159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP--HEVPDL----LEKGERL-- 230 (279)
T ss_pred ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHH----HHCCCcC--
Confidence 643332222333456789999999988899999999999999999998 9999965421 111111 1111110
Q ss_pred hccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCCC
Q 002061 908 VLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPCT 957 (973)
Q Consensus 908 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 957 (973)
..+. .....+.+++.+||..+|++||++.|+++.|..+...+
T Consensus 231 -~~~~-------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 231 -AQPQ-------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred -CCCC-------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 0011 12235678899999999999999999999998866533
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=341.39 Aligned_cols=253 Identities=23% Similarity=0.281 Sum_probs=197.2
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE 751 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 751 (973)
.|+..+.||+|+||+||+|++..+++.||||++... ...+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 578889999999999999999999999999998653 234567899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccC
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 831 (973)
|+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~ 153 (381)
T cd05626 82 YIPGGDMMSLLIRM-----EVFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRW 153 (381)
T ss_pred cCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCccccc
Confidence 99999999998753 34788888899999999999999 78999999999999999999999999999753311
Q ss_pred CCCc---------------------------------------------ccccccCCccccccccccccCCCCccchHHH
Q 002061 832 SPKV---------------------------------------------SDYSCFAGTHGYIAPELAYTCKVSEKSDVFS 866 (973)
Q Consensus 832 ~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws 866 (973)
.... .......||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (381)
T cd05626 154 THNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWS 233 (381)
T ss_pred ccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceee
Confidence 0000 0011246999999999999888999999999
Q ss_pred HHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHH--hcCCCCCCCCCHH
Q 002061 867 FGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVV--CTTKLPNLRPPMR 944 (973)
Q Consensus 867 lG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--cl~~dP~~Rpt~~ 944 (973)
+||++|||++|+.||..... . ............ ... + .......++.+++.+ |+..+|..||++.
T Consensus 234 lG~il~elltG~~Pf~~~~~--~---~~~~~i~~~~~~-~~~--~-----~~~~~s~~~~dli~~ll~~~~~~~~R~~~~ 300 (381)
T cd05626 234 VGVILFEMLVGQPPFLAPTP--T---ETQLKVINWENT-LHI--P-----PQVKLSPEAVDLITKLCCSAEERLGRNGAD 300 (381)
T ss_pred hhhHHHHHHhCCCCCcCCCH--H---HHHHHHHccccc-cCC--C-----CCCCCCHHHHHHHHHHccCcccccCCCCHH
Confidence 99999999999999975421 1 111111100000 000 0 001123445667766 5566777799999
Q ss_pred HHHHHh
Q 002061 945 EVVKML 950 (973)
Q Consensus 945 evl~~L 950 (973)
|+++|-
T Consensus 301 ~~l~hp 306 (381)
T cd05626 301 DIKAHP 306 (381)
T ss_pred HHhcCc
Confidence 999874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=342.26 Aligned_cols=253 Identities=26% Similarity=0.320 Sum_probs=205.0
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL 750 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 750 (973)
++|++.+.||+|+||+||+|++..+++.||||++... .....+.+|++++..++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 3688999999999999999999999999999998753 34456888999999999999999999999999999999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccccc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 830 (973)
||+++|+|.+++... ..+++..+..++.|++.||+||| +++++||||||+||+++.++.+||+|||++....
T Consensus 81 e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 152 (350)
T cd05573 81 EYMPGGDLMNLLIRK-----DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMN 152 (350)
T ss_pred cCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCc
Confidence 999999999999753 35788899999999999999999 7899999999999999999999999999997654
Q ss_pred CCC---------------------------CcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCc
Q 002061 831 NSP---------------------------KVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEE 883 (973)
Q Consensus 831 ~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~ 883 (973)
... .........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~ 232 (350)
T cd05573 153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS 232 (350)
T ss_pred ccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCC
Confidence 332 00112235689999999999999999999999999999999999999975
Q ss_pred ccCCcccHHHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHh
Q 002061 884 EYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPP-MREVVKML 950 (973)
Q Consensus 884 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt-~~evl~~L 950 (973)
.. ............... ..+. .......+.+++.+|++ ||.+||+ +.|++++.
T Consensus 233 ~~-----~~~~~~~i~~~~~~~---~~p~-----~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp 286 (350)
T cd05573 233 DT-----LQETYNKIINWKESL---RFPP-----DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP 286 (350)
T ss_pred CC-----HHHHHHHHhccCCcc---cCCC-----CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence 42 111111111100000 0000 01134567889999997 9999999 99999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=328.24 Aligned_cols=254 Identities=25% Similarity=0.311 Sum_probs=214.0
Q ss_pred HHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcC-CCceeeEEEEEEeCCee
Q 002061 673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIR-HRNILKLYACLLKGGSS 746 (973)
Q Consensus 673 ~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~ 746 (973)
.....|++.+.||+|.||.||+++.+.+|+.+|+|++.+. .....+.+|+++|+++. |||||.+++.|++...+
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 3345788889999999999999999999999999998763 23468899999999998 99999999999999999
Q ss_pred EEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCC----CCeEEec
Q 002061 747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDED----YEPKIAD 822 (973)
Q Consensus 747 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~----~~~kl~D 822 (973)
++|||+++||.|.+.+... .+++.....++.|++.|++|+| +.+|+|||+||+|+|+... +.+|++|
T Consensus 112 ~lvmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~D 182 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLID 182 (382)
T ss_pred EEEEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEee
Confidence 9999999999999999864 2889999999999999999999 8999999999999999643 5799999
Q ss_pred ccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccc
Q 002061 823 FGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNH 902 (973)
Q Consensus 823 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 902 (973)
||++..... .......+||+.|+|||++....|+..+||||+||++|.|++|..||........ .. .....
T Consensus 183 FGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~----~~--~i~~~ 253 (382)
T KOG0032|consen 183 FGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI----FL--AILRG 253 (382)
T ss_pred CCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH----HH--HHHcC
Confidence 999987766 2344557899999999999999999999999999999999999999976521111 11 11111
Q ss_pred cccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 903 ENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
+ ..+..+.+........+++..|+..||.+|+|+.++++|.+
T Consensus 254 ~-------~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 254 D-------FDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred C-------CCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence 1 12333445555677889999999999999999999999854
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=338.07 Aligned_cols=261 Identities=25% Similarity=0.388 Sum_probs=203.7
Q ss_pred HcCCcccCcccccCceEEEEEEec-----CCCcEEEEEeeeccc---cHHHHHHHHHHHHhcC-CCceeeEEEEEEeCCe
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLK-----KNAGTVAVKQLWKGD---GVKVFAAEMEILGKIR-HRNILKLYACLLKGGS 745 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~-----~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~ 745 (973)
.++|.+.+.||+|+||.||+|++. ..++.||||+++... ..+.+.+|++++.++. ||||+++++++..++.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 346788899999999999999964 335689999987532 2346889999999997 9999999999999999
Q ss_pred eEEEEEccCCCchHHHHHhhhc----------------------------------------------------------
Q 002061 746 SFLVLEYMPNGNLFQALHKRVK---------------------------------------------------------- 767 (973)
Q Consensus 746 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 767 (973)
.++||||+++|+|.++++....
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 9999999999999999975321
Q ss_pred -----------------------------------CCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeee
Q 002061 768 -----------------------------------EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILL 812 (973)
Q Consensus 768 -----------------------------------~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill 812 (973)
.....+++..+..++.|++.|++||| +.+++||||||+||++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEEE
Confidence 01124677888999999999999999 7899999999999999
Q ss_pred cCCCCeEEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccH
Q 002061 813 DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDI 891 (973)
Q Consensus 813 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~ 891 (973)
++++.+|++|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||...... .
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~--~- 349 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN--E- 349 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch--H-
Confidence 9999999999999976533222112222356789999999998889999999999999999998 88998653211 1
Q ss_pred HHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 892 VYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 892 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
.......... ....+.....++.+++.+||+.+|++||+++||++.|+++
T Consensus 350 --~~~~~~~~~~----------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 350 --QFYNAIKRGY----------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred --HHHHHHHcCC----------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1111111110 0001112245688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=327.00 Aligned_cols=261 Identities=27% Similarity=0.371 Sum_probs=207.8
Q ss_pred cCCcccCcccccCceEEEEEEecC-----CCcEEEEEeeeccc--cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKK-----NAGTVAVKQLWKGD--GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL 748 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~-----~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 748 (973)
.+|.+.+.||+|+||.||+|+... ++..|++|.+.... ..+.+.+|++++++++||||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 457888999999999999998642 35569999876533 34568899999999999999999999999999999
Q ss_pred EEEccCCCchHHHHHhhhc-----------CCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCC
Q 002061 749 VLEYMPNGNLFQALHKRVK-----------EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE 817 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~-----------~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~ 817 (973)
||||+++++|.+++..+.. .....+++..+..++.|++.|++||| +++++||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCc
Confidence 9999999999999976421 12235789999999999999999999 889999999999999999999
Q ss_pred eEEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHH
Q 002061 818 PKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVS 896 (973)
Q Consensus 818 ~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~ 896 (973)
++|+|||++................++..|+|||++.+..++.++|||||||++|||++ |+.||..... .....
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-----~~~~~ 236 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN-----TEVIE 236 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHH
Confidence 99999999976544322222233456789999999998899999999999999999999 9999865311 11111
Q ss_pred HHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 002061 897 THLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADP 955 (973)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 955 (973)
... ... . .......+..+.+++.+||+.+|++||++.+|+++|+++..
T Consensus 237 ~~~-~~~-~---------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 237 CIT-QGR-V---------LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHh-CCC-C---------CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 111 110 0 00111234568899999999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=339.80 Aligned_cols=254 Identities=23% Similarity=0.288 Sum_probs=202.6
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL 748 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 748 (973)
..++|++.+.||+|+||+||+|++..+++.||+|++.+. ...+.+.+|+.+++.++||||+++++++.++...|+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 356889999999999999999999999999999998652 234457789999999999999999999999999999
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccc
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 828 (973)
||||+++|+|.+++... .++...+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||++..
T Consensus 121 v~Ey~~gg~L~~~l~~~------~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY------DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred EEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 99999999999998643 3677788889999999999999 78999999999999999999999999999976
Q ss_pred ccCCCCcccccccCCccccccccccccC----CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccc
Q 002061 829 AENSPKVSDYSCFAGTHGYIAPELAYTC----KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHEN 904 (973)
Q Consensus 829 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 904 (973)
...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.... ..............
T Consensus 192 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-----~~~~~~~i~~~~~~ 265 (370)
T cd05596 192 MDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-----LVGTYSKIMDHKNS 265 (370)
T ss_pred ccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC-----HHHHHHHHHcCCCc
Confidence 543221 112235689999999998653 47889999999999999999999997531 11111211111110
Q ss_pred cchhccccccCcchHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHHh
Q 002061 905 VLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNL--RPPMREVVKML 950 (973)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rpt~~evl~~L 950 (973)
. . ..........+.+++.+|++.+|.+ ||++.|+++|-
T Consensus 266 ~-~-------~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 266 L-T-------FPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred C-C-------CCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 0 0 0011123456788999999999998 99999998874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=326.18 Aligned_cols=259 Identities=25% Similarity=0.374 Sum_probs=203.9
Q ss_pred CCcccCcccccCceEEEEEEecC-----CCcEEEEEeeeccc---cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKK-----NAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL 748 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~-----~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 748 (973)
+|++.+.||+|+||+||+|+... ....||+|.+.... ..+++.+|+++++.++||||+++++++..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 46788999999999999998753 23578999876532 34568899999999999999999999999999999
Q ss_pred EEEccCCCchHHHHHhhhc-------------------CCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCC
Q 002061 749 VLEYMPNGNLFQALHKRVK-------------------EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSN 809 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~-------------------~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~N 809 (973)
||||+++|+|.+++..... .....+++..+..++.|++.|++||| +.+++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence 9999999999999875311 11234788999999999999999999 7899999999999
Q ss_pred eeecCCCCeEEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCc
Q 002061 810 ILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDG 888 (973)
Q Consensus 810 ill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~ 888 (973)
|++++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.... .
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~ 235 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA--P 235 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC--H
Confidence 9999999999999999876543322222222345678999999988889999999999999999998 999996431 1
Q ss_pred ccHHHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 002061 889 KDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADAD 954 (973)
Q Consensus 889 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 954 (973)
..+..... ... ....+......+.+++.+|++.+|++||++.|+++.|+++.
T Consensus 236 ~~~~~~~~----~~~----------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 236 ERLFNLLK----TGY----------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred HHHHHHHh----CCC----------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 11111111 100 01111223456889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=337.53 Aligned_cols=201 Identities=27% Similarity=0.399 Sum_probs=175.4
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL 750 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 750 (973)
++|++.+.||+|+||+||+|++..+++.||||++.+. .....+.+|+.++.+++||+|+++++++.++...|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 3688999999999999999999999999999998752 23356788999999999999999999999999999999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccccc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 830 (973)
||+++|+|.+++... ..+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++...
T Consensus 81 E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 81 EFLPGGDMMTLLMKK-----DTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred cCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 999999999999753 35788999999999999999999 8899999999999999999999999999987543
Q ss_pred CCCCc---------------------------------ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhC
Q 002061 831 NSPKV---------------------------------SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTG 877 (973)
Q Consensus 831 ~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg 877 (973)
..... .......||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G 232 (363)
T cd05628 153 KAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (363)
T ss_pred ccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhC
Confidence 21100 001134699999999999999999999999999999999999
Q ss_pred CCCCCcc
Q 002061 878 RKPVEEE 884 (973)
Q Consensus 878 ~~pf~~~ 884 (973)
+.||...
T Consensus 233 ~~Pf~~~ 239 (363)
T cd05628 233 YPPFCSE 239 (363)
T ss_pred CCCCCCC
Confidence 9999653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=328.52 Aligned_cols=261 Identities=28% Similarity=0.372 Sum_probs=206.6
Q ss_pred HcCCcccCcccccCceEEEEEEecCC-----CcEEEEEeeecc---ccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCe
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKN-----AGTVAVKQLWKG---DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGS 745 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~-----~~~vavK~~~~~---~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 745 (973)
..+|++.+.||+|+||.||+|..... ...||+|.+... ....++.+|+++++++ +||||+++++++..++.
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 34688889999999999999998643 368999988653 2345678899999999 89999999999999999
Q ss_pred eEEEEEccCCCchHHHHHhhhc-----------CCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecC
Q 002061 746 SFLVLEYMPNGNLFQALHKRVK-----------EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE 814 (973)
Q Consensus 746 ~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~ 814 (973)
.++||||+++|+|.++++.+.. .....+++..+..++.|++.|++||| +++++||||||+||+++.
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVTE 167 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEEcC
Confidence 9999999999999999975321 23446889999999999999999999 789999999999999999
Q ss_pred CCCeEEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHH
Q 002061 815 DYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVY 893 (973)
Q Consensus 815 ~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~ 893 (973)
++.+|++|||+++...............++..|+|||++.+..++.++|||||||++||+++ |..||.... ...
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-----~~~ 242 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-----VEE 242 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC-----HHH
Confidence 99999999999986654332222222345678999999988899999999999999999998 999986431 111
Q ss_pred HHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 002061 894 WVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADAD 954 (973)
Q Consensus 894 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 954 (973)
...... ... ....+......+.+++.+|++++|++|||+.|++++|+.+.
T Consensus 243 ~~~~~~-~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 LFKLLK-EGY----------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHHH-cCC----------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 111111 110 00111223456889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=328.56 Aligned_cols=240 Identities=30% Similarity=0.398 Sum_probs=191.4
Q ss_pred CcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEEEEccCC
Q 002061 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLVLEYMPN 755 (973)
Q Consensus 682 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~ 755 (973)
+.||+|+||+||+|++..+++.||||+++.. ...+.+..|..++... +||||+++++++..++..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3689999999999999999999999998753 2334456677777654 899999999999999999999999999
Q ss_pred CchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCc
Q 002061 756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV 835 (973)
Q Consensus 756 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 835 (973)
|+|.+++... ..+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++.......
T Consensus 81 g~L~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-- 150 (316)
T cd05592 81 GDLMFHIQSS-----GRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-- 150 (316)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--
Confidence 9999988753 35788889999999999999999 7899999999999999999999999999987543222
Q ss_pred ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccccC
Q 002061 836 SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVAS 915 (973)
Q Consensus 836 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..............
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~-----~~~~~~~i~~~~~~----------- 214 (316)
T cd05592 151 GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED-----EDELFDSILNDRPH----------- 214 (316)
T ss_pred CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHcCCCC-----------
Confidence 12233568999999999999899999999999999999999999997531 11222221111111
Q ss_pred cchHHHHHHHHHHHHHhcCCCCCCCCCHH-HHHH
Q 002061 916 ESIKEDMIKLLKIAVVCTTKLPNLRPPMR-EVVK 948 (973)
Q Consensus 916 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~-evl~ 948 (973)
.+.....++.+++.+||+.||++||++. ++++
T Consensus 215 -~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 215 -FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred -CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 1111234567899999999999999875 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=331.06 Aligned_cols=245 Identities=27% Similarity=0.377 Sum_probs=196.0
Q ss_pred CcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHH---HhcCCCceeeEEEEEEeCCeeEEE
Q 002061 678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEIL---GKIRHRNILKLYACLLKGGSSFLV 749 (973)
Q Consensus 678 ~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l---~~l~hpniv~l~~~~~~~~~~~lv 749 (973)
|++.+.||+|+||+||+|.+..+++.||||+++.. ...+.+.+|++++ ++++||||+++++++..++..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 56788999999999999999999999999998753 2334566676655 566899999999999999999999
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccc
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 829 (973)
|||+++|+|..++.. ..+++..+..++.|++.|++||| +.+++||||||+||+++.++.+||+|||++...
T Consensus 81 ~E~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 81 MEYAAGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEG 151 (324)
T ss_pred EcCCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence 999999999888753 25889999999999999999999 889999999999999999999999999998643
Q ss_pred cCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhc
Q 002061 830 ENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVL 909 (973)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (973)
.... .......|++.|+|||++.+..++.++|||||||++|||++|+.||.... ..............
T Consensus 152 ~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~-----~~~~~~~i~~~~~~----- 219 (324)
T cd05589 152 MGFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD-----EEEVFDSIVNDEVR----- 219 (324)
T ss_pred CCCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhCCCC-----
Confidence 2211 12234568999999999999899999999999999999999999996531 11111111111110
Q ss_pred cccccCcchHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHh
Q 002061 910 DCEVASESIKEDMIKLLKIAVVCTTKLPNLRP-----PMREVVKML 950 (973)
Q Consensus 910 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~L 950 (973)
.+......+.+++.+|++.||.+|| ++.+++++-
T Consensus 220 -------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~ 258 (324)
T cd05589 220 -------YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQP 258 (324)
T ss_pred -------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCC
Confidence 1112245577899999999999999 677877753
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=324.96 Aligned_cols=265 Identities=26% Similarity=0.341 Sum_probs=205.6
Q ss_pred cCCcccCcccccCceEEEEEEecCCC----------------cEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNA----------------GTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKL 736 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~----------------~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l 736 (973)
.+|++.+.||+|+||.||+|+....+ ..||+|++... ...+.+.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 57899999999999999999876533 46899988753 245678899999999999999999
Q ss_pred EEEEEeCCeeEEEEEccCCCchHHHHHhhhcC------CCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCe
Q 002061 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKE------GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNI 810 (973)
Q Consensus 737 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Ni 810 (973)
++++..++..++||||+++++|.+++...... ....+++..++.++.|++.|++||| +.+++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhce
Confidence 99999999999999999999999999765321 1236899999999999999999999 78999999999999
Q ss_pred eecCCCCeEEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh--CCCCCCcccCCc
Q 002061 811 LLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT--GRKPVEEEYGDG 888 (973)
Q Consensus 811 ll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t--g~~pf~~~~~~~ 888 (973)
+++.++.++++|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||... ..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~--~~ 239 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL--TD 239 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc--Ch
Confidence 999999999999999876543322222223456788999999988889999999999999999998 67787543 11
Q ss_pred ccHHHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 002061 889 KDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952 (973)
Q Consensus 889 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~ 952 (973)
............... .............++.+++.+|++.||++||++.|+++.|++
T Consensus 240 ~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 240 QQVIENAGHFFRDDG-------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred HHHHHHHHhcccccc-------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 111111111100000 000001112233568999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=342.64 Aligned_cols=365 Identities=24% Similarity=0.358 Sum_probs=261.4
Q ss_pred CccCcEeeCCCCccc-CcCChhhhCCCCCcEEEecCCcccCCCCcccCCCCCCEEeccCccCCCccccccccccccceEE
Q 002061 96 LQSLTVLSLPFNVLS-GKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLS 174 (973)
Q Consensus 96 l~~L~~L~Ls~n~l~-~~~p~~l~~l~~L~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 174 (973)
|+..+-.|+++|.++ +..|.....+++++.|.|...++...|..++.|.+|++|.+++|++. .+-..+..|+.||.+.
T Consensus 6 LpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~ 84 (1255)
T KOG0444|consen 6 LPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLEQVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVI 84 (1255)
T ss_pred cceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhhhChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHh
Confidence 333444444444444 23444455555555555555555444445555555555555555544 2334455566666666
Q ss_pred ccCCcCCCCCCcccccCCCCCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCchhhhccccccEEEeeccccC
Q 002061 175 IGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLT 254 (973)
Q Consensus 175 l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 254 (973)
+..|++...+||..+..|..|+.|+||+|+++ ..|..+..-+++-.|+||+|+|..+....|-++..|-+|+|++|++.
T Consensus 85 ~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe 163 (1255)
T KOG0444|consen 85 VRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE 163 (1255)
T ss_pred hhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh
Confidence 66666666788999999999999999999998 78888888899999999999998433344678889999999999998
Q ss_pred CcCCccccccccccEEEeeccccccccCCccCCCCCccEEEcccCCCC-CCCCCCcCCcccceeeeccCCccCCCCCccc
Q 002061 255 GELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFS-GEFPSGFGDMRKLFAFSIYGNRFSGPFPENL 333 (973)
Q Consensus 255 ~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~-~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l 333 (973)
.+|+.+..+.+|+.|+|++|.+...--..+..+++|++|.+++.+=+ .-+|.++..|.+|..++++.|.+. .+|+.+
T Consensus 164 -~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecl 241 (1255)
T KOG0444|consen 164 -MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECL 241 (1255)
T ss_pred -hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHH
Confidence 67778888999999999999887555556667788888888876543 357788888888888888888887 788888
Q ss_pred cccccccccccccccccccCChhhhhhhhHHHHHhhhccCCCCccccccCccccceEeccccccccCCCccccCCCCcce
Q 002061 334 GRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGM 413 (973)
Q Consensus 334 ~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 413 (973)
-++++|+.|+||+|+|+. +........+|++|+||+|+++ .+|++++.++.|+.
T Consensus 242 y~l~~LrrLNLS~N~ite-------------------------L~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~k 295 (1255)
T KOG0444|consen 242 YKLRNLRRLNLSGNKITE-------------------------LNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTK 295 (1255)
T ss_pred hhhhhhheeccCcCceee-------------------------eeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHH
Confidence 888888888998888872 2223344567888999999998 78888988888888
Q ss_pred EeccCCcCCCC-CCCCCCCCCCCCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcc
Q 002061 414 LDFGDNDFTGG-ISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENA 492 (973)
Q Consensus 414 L~L~~N~l~~~-~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 492 (973)
|.+.+|+++-. +|..++.+.+|+.+..++|.+. ..|+.++.+..|+.|.|+.|++- .+|+++.-++.|+.|||..|.
T Consensus 296 Ly~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNp 373 (1255)
T KOG0444|consen 296 LYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENP 373 (1255)
T ss_pred HHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCc
Confidence 88888886532 4445566666777777777666 66667777777777777777765 566666666777777776664
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=322.03 Aligned_cols=255 Identities=28% Similarity=0.369 Sum_probs=207.5
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc--cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD--GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE 751 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 751 (973)
...+|++.+.||.|+||+||+|++.. ++.||+|++.... ....+.+|+++++.++||||+++++++...+..++|||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 34578899999999999999999988 8899999987643 35678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccC
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 831 (973)
|+++|+|.+++... ....+++..+..++.|++.|++||| +++++||||+|+||+++.++.+||+|||.+.....
T Consensus 83 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 83 LMEKGSLLAFLRSP---EGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred ecccCCHHHHHhcC---CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 99999999999753 2345789999999999999999999 78999999999999999999999999999876543
Q ss_pred CCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhcc
Q 002061 832 SPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLD 910 (973)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (973)
... ......++..|+|||++.+..++.++||||||+++|+|++ |+.||.... .. ...........
T Consensus 157 ~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~--~~---~~~~~~~~~~~------- 222 (261)
T cd05148 157 DVY--LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN--NH---EVYDQITAGYR------- 222 (261)
T ss_pred ccc--cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC--HH---HHHHHHHhCCc-------
Confidence 221 1112345778999999988889999999999999999998 899996532 11 11111111100
Q ss_pred ccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 911 CEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 911 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
..........+.+++.+|++.||++|||++++++.|+.+
T Consensus 223 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 223 ----MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 011123345688999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=318.95 Aligned_cols=255 Identities=29% Similarity=0.371 Sum_probs=204.7
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM 753 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 753 (973)
.++|++.+.||+|++|.||+|.+.. ++.||||.+... ...+.+.+|++++++++||||+++++++..++..|+||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 3468889999999999999999765 578999988653 34567889999999999999999999999999999999999
Q ss_pred CCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCC
Q 002061 754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833 (973)
Q Consensus 754 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 833 (973)
++++|.+++... ....+++..+..++.|++.|++||| +.+++||||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 84 KYGSLLEYLQGG---AGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred cCCcHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 999999999753 2345789999999999999999999 7899999999999999999999999999998665321
Q ss_pred CcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhcccc
Q 002061 834 KVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCE 912 (973)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (973)
. ........+..|+|||++.+..++.++||||||+++|||++ |+.||.... ............. .
T Consensus 158 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----~~~~~~~~~~~~~-~------- 223 (261)
T cd05068 158 Y-EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT-----NAEVLQQVDQGYR-M------- 223 (261)
T ss_pred c-cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHHHcCCC-C-------
Confidence 1 11111223468999999998899999999999999999999 999996531 1111111111100 0
Q ss_pred ccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 913 VASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 913 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
.........+.+++.+|++.+|++||++.++++.|++.
T Consensus 224 ---~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 224 ---PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred ---CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 01112345688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=318.11 Aligned_cols=260 Identities=21% Similarity=0.310 Sum_probs=211.1
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeec-----cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL 750 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~-----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 750 (973)
++|++.+.||+|+||.||+|....+++.||+|.++. ....+.+.+|++++++++|++++++++++..++..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 578899999999999999999998899999998753 223567889999999999999999999999999999999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccccc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 830 (973)
||+++|+|.+++... ......+++..+..++.|++.|++||| +.+++||||+|+||+++.++.++++|||.+....
T Consensus 82 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 82 ELADAGDLSRMIKHF-KKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred ecCCCCCHHHHHHHh-cccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence 999999999998753 223445789999999999999999999 8899999999999999999999999999987554
Q ss_pred CCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhcc
Q 002061 831 NSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLD 910 (973)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (973)
.... ......++..|+|||++.+..++.++||||+||++|+|++|+.||.... .+...........
T Consensus 158 ~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~--------- 223 (267)
T cd08224 158 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLYSLCKKIEKC--------- 223 (267)
T ss_pred CCCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC---ccHHHHHhhhhcC---------
Confidence 3221 1123457889999999998889999999999999999999999996532 1222221111110
Q ss_pred ccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 002061 911 CEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADAD 954 (973)
Q Consensus 911 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 954 (973)
.............+.+++.+||+++|++||++.+|++.++++.
T Consensus 224 -~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 224 -DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred -CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 0111111234456889999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=320.93 Aligned_cols=257 Identities=24% Similarity=0.334 Sum_probs=202.1
Q ss_pred CcccCcccccCceEEEEEEecCC---CcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCe-----
Q 002061 678 LEEDNLIGSGGTGKVYRLDLKKN---AGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGS----- 745 (973)
Q Consensus 678 ~~~~~~lG~G~~g~V~~a~~~~~---~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~----- 745 (973)
|++.+.||+|+||.||+|....+ +..||||+++.+ .....+.+|++.++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 56788999999999999998653 378999988653 234568899999999999999999998866544
Q ss_pred -eEEEEEccCCCchHHHHHhhhc-CCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecc
Q 002061 746 -SFLVLEYMPNGNLFQALHKRVK-EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADF 823 (973)
Q Consensus 746 -~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 823 (973)
.++||||+++|+|.+++..... .....+++..+..++.|++.||+|+| +.+++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence 7999999999999999865422 22346889999999999999999999 789999999999999999999999999
Q ss_pred cCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccc
Q 002061 824 GVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNH 902 (973)
Q Consensus 824 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~ 902 (973)
|+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.... ... .........
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~--~~~---~~~~~~~~~ 232 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE--NHE---IYDYLRHGN 232 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC--HHH---HHHHHHcCC
Confidence 99986654332222222335678999999988889999999999999999999 889986431 111 111111111
Q ss_pred cccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 903 ENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
. ...+......+.+++.+|++.||++||++.|++++|+++
T Consensus 233 ~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 233 R-----------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred C-----------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 011123345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=307.31 Aligned_cols=267 Identities=27% Similarity=0.357 Sum_probs=206.2
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhc--CCCceeeEEEEEEeC----CeeEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKI--RHRNILKLYACLLKG----GSSFLV 749 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l--~hpniv~l~~~~~~~----~~~~lv 749 (973)
.+....+.||+|.||+||+|+++ |+.||||++...+ .+.+.+|.++++.. +|+||+.+++.-..+ ...|+|
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd-E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLv 287 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD-ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLV 287 (513)
T ss_pred heeEEEEEecCccccceeecccc--CCceEEEEecccc-hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEe
Confidence 45677899999999999999999 8899999886544 45567888888764 999999999876543 357999
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhc-----CCCCeEecCCCCCCeeecCCCCeEEeccc
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHD-----CSPPIIHRDIKSSNILLDEDYEPKIADFG 824 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~-----~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 824 (973)
++|.+.|||+|||.+. .++....++++..+|.||+|||.+ .++.|.|||||..||||..++.+.|+|+|
T Consensus 288 TdYHe~GSL~DyL~r~------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 288 TDYHEHGSLYDYLNRN------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred eecccCCcHHHHHhhc------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 9999999999999864 578889999999999999999963 35779999999999999999999999999
Q ss_pred CcccccCCCCc--ccccccCCccccccccccccC----CCC--ccchHHHHHHHHHHHHhC----------CCCCCcccC
Q 002061 825 VAKIAENSPKV--SDYSCFAGTHGYIAPELAYTC----KVS--EKSDVFSFGVVLLELVTG----------RKPVEEEYG 886 (973)
Q Consensus 825 l~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~----~~~--~~~DvwslG~~l~el~tg----------~~pf~~~~~ 886 (973)
+|......... ......+||.+|||||++... .+. ..+||||||.|+||++.+ +.||.+.-.
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 99877654332 223457899999999998532 222 358999999999999873 467765533
Q ss_pred CcccHHHHHHHHhccccccchhccccc-cCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCCC
Q 002061 887 DGKDIVYWVSTHLNNHENVLKVLDCEV-ASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPCT 957 (973)
Q Consensus 887 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 957 (973)
.+.++.++.+-. -.+ -+.+.. ......+....+.++++.||..+|..|-|+--+-+.|.++....
T Consensus 442 ~DPs~eeMrkVV-Cv~-----~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~~ 507 (513)
T KOG2052|consen 442 SDPSFEEMRKVV-CVQ-----KLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNSD 507 (513)
T ss_pred CCCCHHHHhcce-eec-----ccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcCh
Confidence 444444432211 000 011111 11223456778889999999999999999999999999887543
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=320.88 Aligned_cols=246 Identities=27% Similarity=0.322 Sum_probs=194.6
Q ss_pred ccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCCch
Q 002061 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNL 758 (973)
Q Consensus 684 lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL 758 (973)
||+|+||+||+++.+.+|+.||+|++... .....+..|++++++++||||+++++++..+...|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999999999999999988642 1233456799999999999999999999999999999999999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCcccc
Q 002061 759 FQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY 838 (973)
Q Consensus 759 ~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~ 838 (973)
.+++... ....+++..+..++.|++.|++||| +.+++||||||+||+++.++.++|+|||++....... ..
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~ 151 (277)
T cd05607 81 KYHIYNV---GERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TI 151 (277)
T ss_pred HHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---ee
Confidence 9888643 2334788899999999999999999 8899999999999999999999999999987654322 12
Q ss_pred cccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccccCcch
Q 002061 839 SCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESI 918 (973)
Q Consensus 839 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (973)
....|+..|+|||++.+..++.++||||+||++|||++|+.||....... .............. . ...
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~----------~-~~~ 219 (277)
T cd05607 152 TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV-AKEELKRRTLEDEV----------K-FEH 219 (277)
T ss_pred eccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh-hHHHHHHHhhcccc----------c-ccc
Confidence 23468899999999998889999999999999999999999997532111 11111111111110 0 001
Q ss_pred HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 919 KEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 919 ~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
.....++.+++.+|++.||++||+++|+++.+
T Consensus 220 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 220 QNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred ccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 12344678999999999999999996655433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=352.71 Aligned_cols=261 Identities=25% Similarity=0.293 Sum_probs=204.1
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL 750 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 750 (973)
++|++.+.||+|+||+||+|++..+++.||||++... ...+++.+|++++++++||||+++++++.+++..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 5789999999999999999999999999999998652 22456889999999999999999999999999999999
Q ss_pred EccCCCchHHHHHhhhcC------CCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEeccc
Q 002061 751 EYMPNGNLFQALHKRVKE------GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFG 824 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~------~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 824 (973)
||++||+|.+++...... .....++..+..++.|+++||+||| +.+|+||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence 999999999998753211 1223567788899999999999999 7899999999999999999999999999
Q ss_pred CcccccCCCC----------------cccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCc
Q 002061 825 VAKIAENSPK----------------VSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDG 888 (973)
Q Consensus 825 l~~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~ 888 (973)
+++....... ........||+.|+|||++.+..++.++||||+||++|||++|+.||.....
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~-- 236 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG-- 236 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch--
Confidence 9976521110 0011124689999999999999999999999999999999999999975321
Q ss_pred ccHHHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHhhcC
Q 002061 889 KDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRP-PMREVVKMLADA 953 (973)
Q Consensus 889 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-t~~evl~~L~~~ 953 (973)
..... ...... +.. .....+.+..+.+++.+|++.||++|| +++++.+.|+..
T Consensus 237 ~ki~~--~~~i~~---------P~~-~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 237 RKISY--RDVILS---------PIE-VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred hhhhh--hhhccC---------hhh-ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11110 000000 000 000123345678899999999999996 567777777654
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=320.48 Aligned_cols=260 Identities=21% Similarity=0.322 Sum_probs=210.0
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL 750 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 750 (973)
++|++.+.||+|+||.||+|+...+++.||||.+... ...+++.+|+++++.++||||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688899999999999999999888999999987542 23456888999999999999999999999999999999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccccc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 830 (973)
||+++++|.+++.... .....+++..+..++.|++.|++||| +++++|+||||+||+++.++.++++|||.+....
T Consensus 82 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 82 ELADAGDLSRMIKHFK-KQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCHHHHHHHhh-ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence 9999999999987532 23446889999999999999999999 8899999999999999999999999999987654
Q ss_pred CCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhcc
Q 002061 831 NSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLD 910 (973)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (973)
.... ......++..|+|||++.+..++.++||||+|+++|+|++|..||.....+ ..........
T Consensus 158 ~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~---------- 222 (267)
T cd08229 158 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCKKIEQ---------- 222 (267)
T ss_pred cCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch---HHHHhhhhhc----------
Confidence 3321 122345889999999998888999999999999999999999999643211 1111111110
Q ss_pred ccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 002061 911 CEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADAD 954 (973)
Q Consensus 911 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 954 (973)
..............+.+++.+||+.+|++|||+.+|++.++++.
T Consensus 223 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 223 CDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 00111111234557889999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=333.23 Aligned_cols=242 Identities=26% Similarity=0.319 Sum_probs=196.0
Q ss_pred CcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCC
Q 002061 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNG 756 (973)
Q Consensus 682 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 756 (973)
+.||+|+||+||+|++..+++.||+|++... .....+.+|+++++.++||||+++++++..++..|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999999999999999999998753 23456678999999999999999999999999999999999999
Q ss_pred chHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCcc
Q 002061 757 NLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVS 836 (973)
Q Consensus 757 sL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 836 (973)
+|.+++... ..+++..+..++.|++.||+|||+ ..+|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 ~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~ 151 (325)
T cd05594 81 ELFFHLSRE-----RVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--A 151 (325)
T ss_pred cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--c
Confidence 999888643 357899999999999999999993 2699999999999999999999999999987532221 1
Q ss_pred cccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccccCc
Q 002061 837 DYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASE 916 (973)
Q Consensus 837 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (973)
......||+.|+|||++.+..++.++||||+||++|||++|+.||.... .............. .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~-----~~~~~~~i~~~~~~--------~--- 215 (325)
T cd05594 152 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HEKLFELILMEEIR--------F--- 215 (325)
T ss_pred ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC-----HHHHHHHHhcCCCC--------C---
Confidence 1223468999999999999999999999999999999999999996431 11111111111110 0
Q ss_pred chHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 002061 917 SIKEDMIKLLKIAVVCTTKLPNLRP-----PMREVVKM 949 (973)
Q Consensus 917 ~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~ 949 (973)
+......+.+++.+|++.||++|+ ++.++++|
T Consensus 216 -p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 216 -PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred -CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 112234678899999999999996 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=337.48 Aligned_cols=253 Identities=24% Similarity=0.310 Sum_probs=200.6
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL 750 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 750 (973)
++|++.+.||+|+||+||+|++..+++.||||++... .....+.+|+++++.++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 3688999999999999999999999999999998753 23455778999999999999999999999999999999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccccc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 830 (973)
||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++|+|||++....
T Consensus 81 E~~~~g~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 81 EYLPGGDMMTLLMKK-----DTFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK 152 (364)
T ss_pred CCCCCcHHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceecc
Confidence 999999999998753 35889999999999999999999 8899999999999999999999999999986543
Q ss_pred CCCCcc------------------------------------cccccCCccccccccccccCCCCccchHHHHHHHHHHH
Q 002061 831 NSPKVS------------------------------------DYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLEL 874 (973)
Q Consensus 831 ~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el 874 (973)
...... ......||+.|+|||++.+..++.++|||||||++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 232 (364)
T cd05599 153 KSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232 (364)
T ss_pred ccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHh
Confidence 211000 00123589999999999988999999999999999999
Q ss_pred HhCCCCCCcccCCcccHHHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHh
Q 002061 875 VTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPP---MREVVKML 950 (973)
Q Consensus 875 ~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt---~~evl~~L 950 (973)
++|..||.... ............... .. +. .....+.+.+++.+|+. +|.+|++ +.|++++-
T Consensus 233 ~~G~~Pf~~~~-----~~~~~~~i~~~~~~~-~~--~~-----~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~ 297 (364)
T cd05599 233 LVGYPPFCSDN-----PQETYRKIINWKETL-QF--PD-----EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHP 297 (364)
T ss_pred hcCCCCCCCCC-----HHHHHHHHHcCCCcc-CC--CC-----CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCC
Confidence 99999996531 111111111111100 00 00 01123456788888986 9999998 99998863
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=322.78 Aligned_cols=259 Identities=24% Similarity=0.342 Sum_probs=204.4
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCc----EEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAG----TVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF 747 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~----~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 747 (973)
..+|+..+.||+|+||+||+|++..++. .||+|++... .....+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 3567888999999999999999876665 4899987643 2345678899999999999999999988754 578
Q ss_pred EEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcc
Q 002061 748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827 (973)
Q Consensus 748 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~ 827 (973)
++|||+++|+|.+++... ...+++..+..++.|+++|++||| +++++||||||+||++++++.+||+|||+++
T Consensus 85 l~~~~~~~g~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~ 157 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN----KDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (279)
T ss_pred EEEEcCCCCCHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCcee
Confidence 999999999999998753 345889999999999999999999 8899999999999999999999999999998
Q ss_pred cccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccc
Q 002061 828 IAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVL 906 (973)
Q Consensus 828 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 906 (973)
...............++..|+|||+..+..++.++|||||||++|||++ |..||.... ......++.. ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~~~~~~~~~~----~~~~- 230 (279)
T cd05109 158 LLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP--AREIPDLLEK----GERL- 230 (279)
T ss_pred ecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHHC----CCcC-
Confidence 6643322111122335678999999988889999999999999999998 999986531 1122222111 1100
Q ss_pred hhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCCC
Q 002061 907 KVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPCT 957 (973)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 957 (973)
.........+.+++.+||+.||++||++.++++.++++...+
T Consensus 231 ---------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 231 ---------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred ---------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 001123446788999999999999999999999998876544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=329.20 Aligned_cols=241 Identities=30% Similarity=0.402 Sum_probs=194.8
Q ss_pred CcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEEEEccCC
Q 002061 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLVLEYMPN 755 (973)
Q Consensus 682 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~ 755 (973)
+.||+|+||+||+|+++.+++.||||++.+. ...+.+.+|..+++.. +||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 3689999999999999999999999998652 3445667888888876 699999999999999999999999999
Q ss_pred CchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCc
Q 002061 756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV 835 (973)
Q Consensus 756 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 835 (973)
|+|.+++... ..+++..+..++.|++.||+||| +++++||||||+||+++.++.+||+|||++.......
T Consensus 81 g~L~~~i~~~-----~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-- 150 (320)
T cd05590 81 GDLMFHIQKS-----RRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-- 150 (320)
T ss_pred chHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--
Confidence 9999988753 35788899999999999999999 8899999999999999999999999999987542221
Q ss_pred ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccccC
Q 002061 836 SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVAS 915 (973)
Q Consensus 836 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||.... ...............
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~-----~~~~~~~i~~~~~~~---------- 215 (320)
T cd05590 151 KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN-----EDDLFEAILNDEVVY---------- 215 (320)
T ss_pred CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC-----HHHHHHHHhcCCCCC----------
Confidence 12223568999999999998899999999999999999999999996531 122222221111100
Q ss_pred cchHHHHHHHHHHHHHhcCCCCCCCCCH------HHHHHH
Q 002061 916 ESIKEDMIKLLKIAVVCTTKLPNLRPPM------REVVKM 949 (973)
Q Consensus 916 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~------~evl~~ 949 (973)
+......+.+++.+|++.||++||++ .++++|
T Consensus 216 --~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 216 --PTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred --CCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 11123457889999999999999998 667665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=332.57 Aligned_cols=252 Identities=24% Similarity=0.267 Sum_probs=198.7
Q ss_pred CCcccCcccccCceEEEEEEec---CCCcEEEEEeeecc------ccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCee
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLK---KNAGTVAVKQLWKG------DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSS 746 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~---~~~~~vavK~~~~~------~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 746 (973)
+|++.+.||+|+||+||+|+.. .+++.||+|++.+. ...+.+.+|+++++++ +||+|+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4788899999999999998874 46889999998652 2345577899999999 599999999999999999
Q ss_pred EEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCc
Q 002061 747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826 (973)
Q Consensus 747 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~ 826 (973)
++||||+++|+|.+++..+ ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||++
T Consensus 81 ~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~ 152 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR-----DNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLS 152 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCC
Confidence 9999999999999998753 35788899999999999999999 789999999999999999999999999998
Q ss_pred ccccCCCCcccccccCCccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccccc
Q 002061 827 KIAENSPKVSDYSCFAGTHGYIAPELAYTC-KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENV 905 (973)
Q Consensus 827 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 905 (973)
+........ ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ...............
T Consensus 153 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~~~~~~~~~~~-- 228 (332)
T cd05614 153 KEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGER-NTQSEVSRRILKCDP-- 228 (332)
T ss_pred ccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCC-CCHHHHHHHHhcCCC--
Confidence 765332221 12235689999999998765 4788999999999999999999999753211 111111111111111
Q ss_pred chhccccccCcchHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHh
Q 002061 906 LKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRP-----PMREVVKML 950 (973)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~L 950 (973)
.. +......+.+++.+|++.||++|| ++.+++++-
T Consensus 229 ------~~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 268 (332)
T cd05614 229 ------PF----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHP 268 (332)
T ss_pred ------CC----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCC
Confidence 11 112334577899999999999999 788888763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=330.38 Aligned_cols=265 Identities=22% Similarity=0.254 Sum_probs=206.7
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc-cHHHHHHHHHHHHhcC-C-----CceeeEEEEEEeCCeeE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIR-H-----RNILKLYACLLKGGSSF 747 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~-h-----pniv~l~~~~~~~~~~~ 747 (973)
..+|++.+.||+|+||.|.+|.+..+++.||||+++... -..+...|+.+|+.++ | -|+|+++++|....+.|
T Consensus 185 ~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 185 AYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 348999999999999999999999999999999998754 4456678999999996 4 38999999999999999
Q ss_pred EEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCC--CCeEEecccC
Q 002061 748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDED--YEPKIADFGV 825 (973)
Q Consensus 748 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~--~~~kl~Dfgl 825 (973)
||+|.+ .-+|+++++.+ ....++...+..++.||+.||.+|| +.+|||+||||+|||+.+. ..+||+|||.
T Consensus 265 iVfELL-~~NLYellK~n---~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGS 337 (586)
T KOG0667|consen 265 IVFELL-STNLYELLKNN---KFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGS 337 (586)
T ss_pred eeehhh-hhhHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEeccc
Confidence 999999 67999999875 3345889999999999999999999 8899999999999999764 4699999999
Q ss_pred cccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHH----------
Q 002061 826 AKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWV---------- 895 (973)
Q Consensus 826 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~---------- 895 (973)
|+....... ..+.+..|+|||++.|.+|+.+.||||||||++||++|.+.|.++.. ...+...+
T Consensus 338 Sc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne-~DQl~~I~e~lG~Pp~~m 411 (586)
T KOG0667|consen 338 SCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE-YDQLARIIEVLGLPPPKM 411 (586)
T ss_pred ccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH-HHHHHHHHHHhCCCCHHH
Confidence 987754432 24567899999999999999999999999999999999888865411 11111111
Q ss_pred -HHHhccccccc--------------------------------hhccc----cccCcchHHHHHHHHHHHHHhcCCCCC
Q 002061 896 -STHLNNHENVL--------------------------------KVLDC----EVASESIKEDMIKLLKIAVVCTTKLPN 938 (973)
Q Consensus 896 -~~~~~~~~~~~--------------------------------~~~~~----~~~~~~~~~~~~~l~~l~~~cl~~dP~ 938 (973)
........... +...+ .............+.+++.+|+.+||.
T Consensus 412 L~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~ 491 (586)
T KOG0667|consen 412 LDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPA 491 (586)
T ss_pred HHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCch
Confidence 00000000000 00000 000011224456789999999999999
Q ss_pred CCCCHHHHHHHhhc
Q 002061 939 LRPPMREVVKMLAD 952 (973)
Q Consensus 939 ~Rpt~~evl~~L~~ 952 (973)
+|+|+.++++|-.-
T Consensus 492 ~R~tp~qal~Hpfl 505 (586)
T KOG0667|consen 492 ERITPAQALNHPFL 505 (586)
T ss_pred hcCCHHHHhcCccc
Confidence 99999999998653
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=323.25 Aligned_cols=259 Identities=26% Similarity=0.367 Sum_probs=205.8
Q ss_pred HcCCcccCcccccCceEEEEEEecCC-----CcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCee
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKN-----AGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSS 746 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~-----~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 746 (973)
.++|++.+.||+|+||.||+|..... +..||+|.+... .....+.+|+++++.++||||+++++++..+...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 35788899999999999999998643 378999987653 2345678999999999999999999999999999
Q ss_pred EEEEEccCCCchHHHHHhhhcC-----CCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEe
Q 002061 747 FLVLEYMPNGNLFQALHKRVKE-----GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIA 821 (973)
Q Consensus 747 ~lv~e~~~~gsL~~~l~~~~~~-----~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 821 (973)
++||||+++|+|.+++...... ....+++..+..++.|++.|++||| +.+++||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEEC
Confidence 9999999999999999754221 1234788899999999999999999 8899999999999999999999999
Q ss_pred cccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhc
Q 002061 822 DFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLN 900 (973)
Q Consensus 822 Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~ 900 (973)
|||+++...............++..|+|||.+.+..++.++|||||||++||+++ |..||... ..........
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~--~~~~~~~~~~---- 235 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGL--SNEEVLKFVI---- 235 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccC--CHHHHHHHHh----
Confidence 9999876644332222233456789999999988889999999999999999998 99998643 1112221111
Q ss_pred cccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 002061 901 NHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952 (973)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~ 952 (973)
... .. ..+......+.+++.+||+.+|++|||+.++++.|++
T Consensus 236 ~~~-~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 236 DGG-HL---------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred cCC-CC---------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 111 00 0111124568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=325.70 Aligned_cols=258 Identities=26% Similarity=0.385 Sum_probs=203.8
Q ss_pred HcCCcccCcccccCceEEEEEEec-----CCCcEEEEEeeecc---ccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCe
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLK-----KNAGTVAVKQLWKG---DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGS 745 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~-----~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 745 (973)
.++|++.+.||+|+||.||+|... .++..||||++... ...+.+.+|+++++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 357889999999999999999852 34568999988653 2345688999999999 79999999999999999
Q ss_pred eEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccC
Q 002061 746 SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGV 825 (973)
Q Consensus 746 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl 825 (973)
.|+||||+++|+|.++++.. ....+++.++..++.|++.|++||| +++++|+||||+||+++.++.++++|||+
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~---~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRK---RESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCcc
Confidence 99999999999999999753 1233799999999999999999999 78999999999999999999999999999
Q ss_pred cccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccc
Q 002061 826 AKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHEN 904 (973)
Q Consensus 826 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 904 (973)
+................++..|+|||++.+..++.++||||+||++|||++ |+.||...... ......+. ...
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~-~~~~~~~~----~~~- 261 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD-SKFYKLIK----EGY- 261 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch-HHHHHHHH----cCC-
Confidence 876543322111222345778999999999999999999999999999998 99998654211 11111111 100
Q ss_pred cchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 905 VLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
..........++.+++.+|++++|++||++.|+++.|++.
T Consensus 262 ---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 262 ---------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ---------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0000111234688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=328.76 Aligned_cols=246 Identities=27% Similarity=0.345 Sum_probs=197.7
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCC-CceeeEEEEEEeCCeeEEEE
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRH-RNILKLYACLLKGGSSFLVL 750 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~~~~lv~ 750 (973)
+|++.+.||+|+||+||+|++..+++.||||++... ...+.+..|.+++..++| ++|+++++++..++..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 478889999999999999999998999999998752 345567789999999976 56888999999999999999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccccc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 830 (973)
||+++|+|.+++... ..+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++....
T Consensus 81 E~~~~g~L~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05587 81 EYVNGGDLMYHIQQV-----GKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENI 152 (324)
T ss_pred cCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecC
Confidence 999999999988653 34788899999999999999999 7899999999999999999999999999986432
Q ss_pred CCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhcc
Q 002061 831 NSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLD 910 (973)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (973)
... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..............
T Consensus 153 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~-----~~~~~~~i~~~~~~------ 219 (324)
T cd05587 153 FGG--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED-----EDELFQSIMEHNVS------ 219 (324)
T ss_pred CCC--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC-----HHHHHHHHHcCCCC------
Confidence 221 12233568999999999999999999999999999999999999996531 11111111111110
Q ss_pred ccccCcchHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHH
Q 002061 911 CEVASESIKEDMIKLLKIAVVCTTKLPNLRPPM-----REVVKM 949 (973)
Q Consensus 911 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~-----~evl~~ 949 (973)
. +......+.+++.+|++.||.+|++. .++.++
T Consensus 220 --~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 220 --Y----PKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred --C----CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 0 11223467889999999999999976 677655
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=317.41 Aligned_cols=251 Identities=24% Similarity=0.355 Sum_probs=200.8
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccC
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP 754 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 754 (973)
.+|++.+.||+|+||+||+|+... +..||||.+... ...+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 467888999999999999998865 557999987653 345678999999999999999999999998889999999999
Q ss_pred CCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCC
Q 002061 755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK 834 (973)
Q Consensus 755 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 834 (973)
+|+|.+++... ...+++..+..++.|++.|++||| +.+++|+||||+||+++.++.+||+|||.++.......
T Consensus 83 ~~~l~~~i~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 83 NGCLLNYLREH----GKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred CCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 99999998753 225789999999999999999999 88999999999999999999999999999875543221
Q ss_pred cccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhccccc
Q 002061 835 VSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEV 913 (973)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (973)
.......++..|+|||++.+..++.++|||||||++|||++ |+.||.... ....... ...... .
T Consensus 156 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~--~~~~~~~---~~~~~~-~-------- 220 (256)
T cd05113 156 -TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN--NSETVEK---VSQGLR-L-------- 220 (256)
T ss_pred -eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCC--HHHHHHH---HhcCCC-C--------
Confidence 11112335678999999988889999999999999999999 999996431 1111111 111110 0
Q ss_pred cCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 914 ASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 914 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
.........+.+++.+||+++|++||++.++++.++
T Consensus 221 --~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 --YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred --CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 000112456889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=332.96 Aligned_cols=252 Identities=25% Similarity=0.303 Sum_probs=202.3
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL 750 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 750 (973)
++|++.+.||+|+||+||+|+...+++.||||++... ...+.+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 3688899999999999999999999999999998763 23456788999999999999999999999999999999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccccc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 830 (973)
||+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++....
T Consensus 81 e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 153 (330)
T cd05601 81 EYQPGGDLLSLLNRY----EDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLT 153 (330)
T ss_pred CCCCCCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECC
Confidence 999999999999764 235888999999999999999999 8899999999999999999999999999997664
Q ss_pred CCCCcccccccCCccccccccccc------cCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccc
Q 002061 831 NSPKVSDYSCFAGTHGYIAPELAY------TCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHEN 904 (973)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 904 (973)
..... ......||+.|+|||++. +..++.++|||||||++|||++|+.||.... .............
T Consensus 154 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~-----~~~~~~~i~~~~~- 226 (330)
T cd05601 154 ANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT-----SAKTYNNIMNFQR- 226 (330)
T ss_pred CCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC-----HHHHHHHHHcCCC-
Confidence 33221 222346899999999986 4567889999999999999999999996531 1111121111111
Q ss_pred cchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 905 VLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
.... .........+.+++..|++ +|.+||++.++++|
T Consensus 227 ~~~~-------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 227 FLKF-------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred ccCC-------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 0000 0011234557788899997 99999999999976
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=336.83 Aligned_cols=254 Identities=22% Similarity=0.299 Sum_probs=200.3
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL 748 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 748 (973)
...+|++.+.||+|+||.||+|++..+++.||+|++.+. ...+.+.+|+.+++.++||||+++++++..+...|+
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 346799999999999999999999999999999998652 234557889999999999999999999999999999
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccc
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 828 (973)
||||+++|+|.+++... .+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++..
T Consensus 121 v~Ey~~gg~L~~~l~~~------~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 121 VMEYMPGGDLVNLMSNY------DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred EEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEeccccee
Confidence 99999999999998643 3678888899999999999999 88999999999999999999999999999986
Q ss_pred ccCCCCcccccccCCccccccccccccC----CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccc
Q 002061 829 AENSPKVSDYSCFAGTHGYIAPELAYTC----KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHEN 904 (973)
Q Consensus 829 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 904 (973)
...... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||.... ..............
T Consensus 192 ~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~-----~~~~~~~i~~~~~~ 265 (370)
T cd05621 192 MDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS-----LVGTYSKIMDHKNS 265 (370)
T ss_pred cccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC-----HHHHHHHHHhCCcc
Confidence 643221 112345699999999998654 37889999999999999999999996531 11111111111110
Q ss_pred cchhccccccCcchHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHHh
Q 002061 905 VLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNL--RPPMREVVKML 950 (973)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rpt~~evl~~L 950 (973)
............+.+++..|++.+|.+ |+++.|+++|-
T Consensus 266 --------~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp 305 (370)
T cd05621 266 --------LNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHP 305 (370)
T ss_pred --------cCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCc
Confidence 000111123445677888888755544 89999999984
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=329.74 Aligned_cols=247 Identities=23% Similarity=0.356 Sum_probs=195.1
Q ss_pred CcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEEEEccCC
Q 002061 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLVLEYMPN 755 (973)
Q Consensus 682 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~ 755 (973)
+.||+|+||+||+|++..+++.||+|++.+. .....+.+|+.++.++ +||||+++++++..++..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4689999999999999999999999998752 2344577888888776 899999999999999999999999999
Q ss_pred CchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCc
Q 002061 756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV 835 (973)
Q Consensus 756 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 835 (973)
|+|.+++... ..+++..+..++.|++.|++||| +++|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~L~~~~~~~-----~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-- 150 (329)
T cd05618 81 GDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-- 150 (329)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--
Confidence 9999888642 35788999999999999999999 7899999999999999999999999999987432211
Q ss_pred ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCC---cccHHHHHHHHhccccccchhcccc
Q 002061 836 SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGD---GKDIVYWVSTHLNNHENVLKVLDCE 912 (973)
Q Consensus 836 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (973)
.......||..|+|||++.+..++.++|||||||++|||++|+.||...... ......++.........
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-------- 222 (329)
T cd05618 151 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-------- 222 (329)
T ss_pred CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC--------
Confidence 1122356899999999999999999999999999999999999999642111 11112222111111110
Q ss_pred ccCcchHHHHHHHHHHHHHhcCCCCCCCCC------HHHHHHH
Q 002061 913 VASESIKEDMIKLLKIAVVCTTKLPNLRPP------MREVVKM 949 (973)
Q Consensus 913 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt------~~evl~~ 949 (973)
..+.....++.+++.+|++.||++||+ +.++++|
T Consensus 223 ---~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 223 ---RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred ---CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 011123446778999999999999998 4677666
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=317.08 Aligned_cols=252 Identities=25% Similarity=0.358 Sum_probs=202.9
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc-------cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-------GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL 748 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 748 (973)
++|+..+.||+|++|.||+|....+++.||+|.+.... ..+.+.+|++++++++||||+++++++..++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46888999999999999999999889999999876421 23467889999999999999999999999999999
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccc
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 828 (973)
||||+++++|.+++... ..+++..+..++.|++.|++||| +.+++||||+|+||+++.++.++|+|||+++.
T Consensus 82 v~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~ 153 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY-----GALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKR 153 (263)
T ss_pred EEEECCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeccccee
Confidence 99999999999998753 34778888999999999999999 78999999999999999999999999999876
Q ss_pred ccCCCCc-ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccch
Q 002061 829 AENSPKV-SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLK 907 (973)
Q Consensus 829 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
....... .......++..|+|||++.+..++.++||||+|+++|||++|+.||.... .. ..........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~-~~~~~~~~~~----- 223 (263)
T cd06625 154 LQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFE----AM-AAIFKIATQP----- 223 (263)
T ss_pred ccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccc----hH-HHHHHHhccC-----
Confidence 5432211 11123457889999999999889999999999999999999999996431 11 1111111110
Q ss_pred hccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 908 VLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 908 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
.....+......+.+++.+||+.+|++|||+.|++++.
T Consensus 224 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 261 (263)
T cd06625 224 -----TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF 261 (263)
T ss_pred -----CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence 00111223345678899999999999999999999764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=319.80 Aligned_cols=257 Identities=26% Similarity=0.333 Sum_probs=198.9
Q ss_pred CcccCcccccCceEEEEEEecCCCc--EEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeC------Ce
Q 002061 678 LEEDNLIGSGGTGKVYRLDLKKNAG--TVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKG------GS 745 (973)
Q Consensus 678 ~~~~~~lG~G~~g~V~~a~~~~~~~--~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~~ 745 (973)
|.+.+.||+|+||.||+|++..++. .||+|.+... ...+.+.+|++++++++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567889999999999999887665 5899987542 3456788899999999999999999977432 24
Q ss_pred eEEEEEccCCCchHHHHHhhhc-CCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEeccc
Q 002061 746 SFLVLEYMPNGNLFQALHKRVK-EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFG 824 (973)
Q Consensus 746 ~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 824 (973)
.++||||+++|+|.+++..... .....+++.....++.|++.|++||| +++|+||||||+||++++++.++|+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCC
Confidence 6899999999999998853321 22345889999999999999999999 7899999999999999999999999999
Q ss_pred CcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhcccc
Q 002061 825 VAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHE 903 (973)
Q Consensus 825 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 903 (973)
+++...............+++.|+|||+..+..++.++|||||||++|||++ |+.||.... ..... . ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--~~~~~---~-~~~~~~ 231 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE--NSEIY---D-YLRQGN 231 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC--HHHHH---H-HHHcCC
Confidence 9986644332222223346778999999998899999999999999999999 889986431 11111 1 111111
Q ss_pred ccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 904 NVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
.. .........+.+++.+||+.||++||++.+++++|+++
T Consensus 232 ~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 RL----------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00 00112234578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=340.89 Aligned_cols=265 Identities=22% Similarity=0.266 Sum_probs=196.3
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhcCCCceeeEEEEEEeC--------Cee
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKG--------GSS 746 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--------~~~ 746 (973)
..+|++.+.||+|+||+||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++... ...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~--~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 142 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP--QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL 142 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc--chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEE
Confidence 457999999999999999999999889999999885533 2345799999999999999999887432 246
Q ss_pred EEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCC-CeEEecccC
Q 002061 747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY-EPKIADFGV 825 (973)
Q Consensus 747 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfgl 825 (973)
++||||++ +++.+++... ......+++..+..++.|++.||+||| +++|+||||||+||+++.++ .+||+|||+
T Consensus 143 ~lvmE~~~-~~l~~~~~~~-~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DFGl 217 (440)
T PTZ00036 143 NVVMEFIP-QTVHKYMKHY-ARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGS 217 (440)
T ss_pred EEEEecCC-ccHHHHHHHH-hhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeecccc
Confidence 79999996 5787777643 223456889999999999999999999 88999999999999999665 799999999
Q ss_pred cccccCCCCcccccccCCccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccc--
Q 002061 826 AKIAENSPKVSDYSCFAGTHGYIAPELAYTC-KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNH-- 902 (973)
Q Consensus 826 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~-- 902 (973)
++....... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||..... ...+...+. .....
T Consensus 218 a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~-~~~~~~i~~-~~~~p~~ 292 (440)
T PTZ00036 218 AKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSS-VDQLVRIIQ-VLGTPTE 292 (440)
T ss_pred chhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHH-HhCCCCH
Confidence 986643322 2234679999999998654 689999999999999999999999965321 111111111 00000
Q ss_pred -------cccchhccccccCc-----chHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 903 -------ENVLKVLDCEVASE-----SIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 903 -------~~~~~~~~~~~~~~-----~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
+.+..+..+..... .+.....++.+++.+||++||.+|||+.|+++|-.
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~ 353 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPF 353 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChh
Confidence 00000000111000 11122356889999999999999999999997643
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=329.23 Aligned_cols=247 Identities=23% Similarity=0.352 Sum_probs=196.2
Q ss_pred CcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEEEEccCC
Q 002061 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLVLEYMPN 755 (973)
Q Consensus 682 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~ 755 (973)
+.||+|+||+||+|++..+++.||||+++.. ...+.+.+|..+++.+ +||||+++++++..+...|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4689999999999999999999999998752 2345578899999888 799999999999999999999999999
Q ss_pred CchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCc
Q 002061 756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV 835 (973)
Q Consensus 756 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 835 (973)
|+|.+++... ..+++..+..++.|++.||+||| +++++||||||+||+++.++.+||+|||+++......
T Consensus 81 g~L~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-- 150 (329)
T cd05588 81 GDLMFHMQRQ-----RKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-- 150 (329)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCC--
Confidence 9999888642 35889999999999999999999 8899999999999999999999999999986432111
Q ss_pred ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCC---cccHHHHHHHHhccccccchhcccc
Q 002061 836 SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGD---GKDIVYWVSTHLNNHENVLKVLDCE 912 (973)
Q Consensus 836 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (973)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||+..... ......+.......... .
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-------~ 223 (329)
T cd05588 151 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI-------R 223 (329)
T ss_pred CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC-------C
Confidence 1222356899999999999999999999999999999999999999643211 11111121111111110 0
Q ss_pred ccCcchHHHHHHHHHHHHHhcCCCCCCCCC------HHHHHHH
Q 002061 913 VASESIKEDMIKLLKIAVVCTTKLPNLRPP------MREVVKM 949 (973)
Q Consensus 913 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt------~~evl~~ 949 (973)
.+......+.+++.+|++.||.+||+ +.++++|
T Consensus 224 ----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 224 ----IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred ----CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 01122345788999999999999987 6788766
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=322.42 Aligned_cols=266 Identities=27% Similarity=0.341 Sum_probs=200.9
Q ss_pred cccCcccccCceEEEEEEe----cCCCcEEEEEeeeccc---cHHHHHHHHHHHHhcCCCceeeEEEEEEeC--CeeEEE
Q 002061 679 EEDNLIGSGGTGKVYRLDL----KKNAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKG--GSSFLV 749 (973)
Q Consensus 679 ~~~~~lG~G~~g~V~~a~~----~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~lv 749 (973)
+..+.||+|+||+||++.. ..+++.||+|.+.... ..+.+.+|++++++++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 7889999999999987653 3467889999886532 356688999999999999999999987653 468999
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccc
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 829 (973)
|||+++|+|.+++... .+++..+..++.|++.|++||| +++++||||||+||+++.++.++|+|||+++..
T Consensus 87 ~e~~~~~~l~~~~~~~------~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 87 MEYVPLGSLRDYLPKH------KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred ecCCCCCCHHHHHHHc------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 9999999999998743 4899999999999999999999 789999999999999999999999999999866
Q ss_pred cCCCCccc-ccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchh
Q 002061 830 ENSPKVSD-YSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKV 908 (973)
Q Consensus 830 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (973)
........ .....++..|+|||++.+..++.++||||||+++|||++|..||........+........ .......+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 236 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQ-MTVVRLIEL 236 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccc-cchhhhhhh
Confidence 43322111 1123456679999999888899999999999999999999999865421111100000000 000000111
Q ss_pred ccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 002061 909 LDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADAD 954 (973)
Q Consensus 909 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 954 (973)
.+..............+.+++..||+++|++||+++++++.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 1111111112233467889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=324.02 Aligned_cols=240 Identities=29% Similarity=0.398 Sum_probs=192.3
Q ss_pred CcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEEEEccCC
Q 002061 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLVLEYMPN 755 (973)
Q Consensus 682 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~ 755 (973)
+.||+|+||+||+|++..+++.||||++... ...+.+..|..++... +||||+++++++.+++..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4689999999999999999999999998753 3345566788888764 999999999999999999999999999
Q ss_pred CchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCc
Q 002061 756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV 835 (973)
Q Consensus 756 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 835 (973)
|+|.+++... ..+++..+..++.|++.||+||| +++++||||||+||+++.++.+||+|||++.......
T Consensus 81 g~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 150 (316)
T cd05619 81 GDLMFHIQSC-----HKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-- 150 (316)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--
Confidence 9999998753 34788889999999999999999 8899999999999999999999999999987432211
Q ss_pred ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccccC
Q 002061 836 SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVAS 915 (973)
Q Consensus 836 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
.......||..|+|||++.+..++.++||||+||++|||++|+.||.... ............. ..
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~-----~~~~~~~i~~~~~--------~~-- 215 (316)
T cd05619 151 AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD-----EEELFQSIRMDNP--------CY-- 215 (316)
T ss_pred CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhCCC--------CC--
Confidence 11223568999999999999899999999999999999999999996531 1111111111111 00
Q ss_pred cchHHHHHHHHHHHHHhcCCCCCCCCCHH-HHHH
Q 002061 916 ESIKEDMIKLLKIAVVCTTKLPNLRPPMR-EVVK 948 (973)
Q Consensus 916 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~-evl~ 948 (973)
+.....++.+++.+|++.||++||++. ++.+
T Consensus 216 --~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 216 --PRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred --CccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 111234577899999999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=338.57 Aligned_cols=253 Identities=23% Similarity=0.279 Sum_probs=197.9
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL 750 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 750 (973)
++|++.+.||+|+||+||+|+...+++.||||++... ...+.+.+|++++++++||||+++++++.++...|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 3688899999999999999999999999999988652 23456788999999999999999999999999999999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccccc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 830 (973)
||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 81 E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~ 152 (377)
T cd05629 81 EFLPGGDLMTMLIKY-----DTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFH 152 (377)
T ss_pred eCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccccc
Confidence 999999999998753 34788888899999999999999 8899999999999999999999999999986332
Q ss_pred CCCCc------------c---------------------------------cccccCCccccccccccccCCCCccchHH
Q 002061 831 NSPKV------------S---------------------------------DYSCFAGTHGYIAPELAYTCKVSEKSDVF 865 (973)
Q Consensus 831 ~~~~~------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvw 865 (973)
..... . ......||+.|+|||++.+..++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 232 (377)
T cd05629 153 KQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWW 232 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeE
Confidence 10000 0 00124689999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCC---CC
Q 002061 866 SFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLR---PP 942 (973)
Q Consensus 866 slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---pt 942 (973)
|+||++|||++|+.||..... .............. .+ +. .......+.+++.+|+. +|.+| ++
T Consensus 233 SlGvil~elltG~~Pf~~~~~-----~~~~~~i~~~~~~~-~~--p~-----~~~~s~~~~dli~~lL~-~~~~r~~r~~ 298 (377)
T cd05629 233 SLGAIMFECLIGWPPFCSENS-----HETYRKIINWRETL-YF--PD-----DIHLSVEAEDLIRRLIT-NAENRLGRGG 298 (377)
T ss_pred ecchhhhhhhcCCCCCCCCCH-----HHHHHHHHccCCcc-CC--CC-----CCCCCHHHHHHHHHHhc-CHhhcCCCCC
Confidence 999999999999999965321 11111111101000 00 00 01123457788889997 66665 59
Q ss_pred HHHHHHHh
Q 002061 943 MREVVKML 950 (973)
Q Consensus 943 ~~evl~~L 950 (973)
+.|+++|-
T Consensus 299 ~~~~l~hp 306 (377)
T cd05629 299 AHEIKSHP 306 (377)
T ss_pred HHHHhcCC
Confidence 99999874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=328.02 Aligned_cols=242 Identities=26% Similarity=0.348 Sum_probs=194.4
Q ss_pred CcccccCceEEEEEEec---CCCcEEEEEeeecc------ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 002061 682 NLIGSGGTGKVYRLDLK---KNAGTVAVKQLWKG------DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY 752 (973)
Q Consensus 682 ~~lG~G~~g~V~~a~~~---~~~~~vavK~~~~~------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 752 (973)
+.||+|+||+||+|+.. .+++.||||++... .....+.+|+++++.++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 57999999999999874 46889999998652 2234567899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCC
Q 002061 753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832 (973)
Q Consensus 753 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 832 (973)
+++|+|.+++... ..+.+..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (323)
T cd05584 82 LSGGELFMHLERE-----GIFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE 153 (323)
T ss_pred CCCchHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence 9999999998753 34677888889999999999999 789999999999999999999999999998744222
Q ss_pred CCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhcccc
Q 002061 833 PKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCE 912 (973)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (973)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..............
T Consensus 154 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~-----~~~~~~~~~~~~~~-------- 218 (323)
T cd05584 154 GT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN-----RKKTIDKILKGKLN-------- 218 (323)
T ss_pred CC--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC-----HHHHHHHHHcCCCC--------
Confidence 11 1223468999999999998889999999999999999999999996531 11111111111110
Q ss_pred ccCcchHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHh
Q 002061 913 VASESIKEDMIKLLKIAVVCTTKLPNLRP-----PMREVVKML 950 (973)
Q Consensus 913 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~L 950 (973)
.+......+.+++.+|+++||++|| ++.+++++-
T Consensus 219 ----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~ 257 (323)
T cd05584 219 ----LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHP 257 (323)
T ss_pred ----CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCC
Confidence 0112234678999999999999999 888888763
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=321.31 Aligned_cols=265 Identities=24% Similarity=0.335 Sum_probs=202.1
Q ss_pred cCCcccCcccccCceEEEEEEecCC--------------CcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKN--------------AGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYA 738 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~--------------~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~ 738 (973)
.+|++.+.||+|+||.||+|+..+. ...||||++... .....+.+|++++++++|||++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 5789999999999999999987542 235899988653 23456889999999999999999999
Q ss_pred EEEeCCeeEEEEEccCCCchHHHHHhhhcC-------CCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCee
Q 002061 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKE-------GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNIL 811 (973)
Q Consensus 739 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nil 811 (973)
++..+...++||||+++++|.+++...... ....+++..+..++.|++.|++||| +.+++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhEE
Confidence 999999999999999999999999653211 1234688899999999999999999 789999999999999
Q ss_pred ecCCCCeEEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh--CCCCCCcccCCcc
Q 002061 812 LDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT--GRKPVEEEYGDGK 889 (973)
Q Consensus 812 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t--g~~pf~~~~~~~~ 889 (973)
++.++.+|++|||++................++..|+|||+..++.++.++|||||||++|||++ |..||.... ..
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~--~~ 239 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS--DE 239 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC--hH
Confidence 99999999999999876543322222222345778999999988889999999999999999998 667776431 11
Q ss_pred cHHHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 002061 890 DIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952 (973)
Q Consensus 890 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~ 952 (973)
................... .........+.+++.+|++.||++||++.+|++.|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 240 QVIENTGEFFRNQGRQIYL-------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHHHHhhhhccccccC-------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 1111111111100000000 0011123578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=323.36 Aligned_cols=258 Identities=22% Similarity=0.298 Sum_probs=203.1
Q ss_pred cCCcccCcccccCceEEEEEEecC-----CCcEEEEEeeeccc---cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKK-----NAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF 747 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~-----~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 747 (973)
.+|++.+.||+|+||+||+|.+.. .+..||||++.... ..+.+.+|+.+++.++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 457888999999999999998754 35789999987533 2356888999999999999999999999999999
Q ss_pred EEEEccCCCchHHHHHhhhc-----------CCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCC
Q 002061 748 LVLEYMPNGNLFQALHKRVK-----------EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY 816 (973)
Q Consensus 748 lv~e~~~~gsL~~~l~~~~~-----------~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~ 816 (973)
+++||+++++|.+++..... .....+++..+..++.|++.|++|+| +++++||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCC
Confidence 99999999999999863211 11234788889999999999999999 88999999999999999999
Q ss_pred CeEEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHH
Q 002061 817 EPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWV 895 (973)
Q Consensus 817 ~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~ 895 (973)
.+||+|||+++...............+++.|+|||++.+..++.++||||+||++|||++ |..||.... ..+ ..
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~--~~~---~~ 236 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS--NQD---VI 236 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC--HHH---HH
Confidence 999999999876543322222233456789999999988889999999999999999998 888886431 111 11
Q ss_pred HHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 002061 896 STHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952 (973)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~ 952 (973)
......... .........+.+++..||+.+|++||++.+|++.|+.
T Consensus 237 ~~i~~~~~~-----------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 237 EMIRNRQVL-----------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHcCCcC-----------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 111111100 0112234557889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=326.42 Aligned_cols=242 Identities=28% Similarity=0.367 Sum_probs=195.4
Q ss_pred CcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEEEEccCC
Q 002061 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLVLEYMPN 755 (973)
Q Consensus 682 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~ 755 (973)
+.||+|+||+||+|++..+++.||||++... ...+.+..|.++++.+ +||||+++++++..++..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 3689999999999999998999999998752 3345567888888866 799999999999999999999999999
Q ss_pred CchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCc
Q 002061 756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV 835 (973)
Q Consensus 756 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 835 (973)
|+|.+++... ..+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~- 151 (321)
T cd05591 81 GDLMFQIQRS-----RKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV- 151 (321)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc-
Confidence 9999888643 35788889999999999999999 78999999999999999999999999999875432211
Q ss_pred ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccccC
Q 002061 836 SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVAS 915 (973)
Q Consensus 836 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
......||+.|+|||++.+..++.++||||+||++|||++|+.||.... .............. .+
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~-----~~~~~~~i~~~~~~-----~p---- 216 (321)
T cd05591 152 -TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN-----EDDLFESILHDDVL-----YP---- 216 (321)
T ss_pred -cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC-----HHHHHHHHHcCCCC-----CC----
Confidence 1223568999999999998899999999999999999999999997531 11111111111110 01
Q ss_pred cchHHHHHHHHHHHHHhcCCCCCCCC-------CHHHHHHHh
Q 002061 916 ESIKEDMIKLLKIAVVCTTKLPNLRP-------PMREVVKML 950 (973)
Q Consensus 916 ~~~~~~~~~l~~l~~~cl~~dP~~Rp-------t~~evl~~L 950 (973)
......+.+++.+|++.||++|| ++.+++++-
T Consensus 217 ---~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp 255 (321)
T cd05591 217 ---VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHP 255 (321)
T ss_pred ---CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCC
Confidence 11234678899999999999999 888888763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=325.82 Aligned_cols=263 Identities=27% Similarity=0.386 Sum_probs=207.9
Q ss_pred HcCCcccCcccccCceEEEEEEec-------CCCcEEEEEeeecc---ccHHHHHHHHHHHHhc-CCCceeeEEEEEEeC
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLK-------KNAGTVAVKQLWKG---DGVKVFAAEMEILGKI-RHRNILKLYACLLKG 743 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~-------~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 743 (973)
..+|++.+.||+|+||.||+|+.. .++..||+|..... ...+.+.+|+.+++.+ +||||+++++++..+
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 457888999999999999999753 23457999988653 3346788999999999 899999999999999
Q ss_pred CeeEEEEEccCCCchHHHHHhhhcC-----------CCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeee
Q 002061 744 GSSFLVLEYMPNGNLFQALHKRVKE-----------GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILL 812 (973)
Q Consensus 744 ~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill 812 (973)
...|+||||+++|+|.+++...... ....+++..+..++.|+++|++||| +++++||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEEE
Confidence 9999999999999999999764211 1235788899999999999999999 7899999999999999
Q ss_pred cCCCCeEEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccH
Q 002061 813 DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDI 891 (973)
Q Consensus 813 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~ 891 (973)
+.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++||+++ |..||... ..
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-----~~ 245 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-----PV 245 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC-----CH
Confidence 9999999999999986654332222223345678999999998889999999999999999998 78888543 22
Q ss_pred HHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCC
Q 002061 892 VYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPC 956 (973)
Q Consensus 892 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~ 956 (973)
............ ..........+.+++.+||+.+|++||++.|+++.|+++...
T Consensus 246 ~~~~~~~~~~~~-----------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 246 EELFKLLKEGHR-----------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HHHHHHHHcCCc-----------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 222221111110 001123345688899999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=321.43 Aligned_cols=264 Identities=23% Similarity=0.328 Sum_probs=206.2
Q ss_pred HHcCCcccCcccccCceEEEEEEecC-----CCcEEEEEeeeccc---cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCe
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKK-----NAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGS 745 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~-----~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 745 (973)
..++|++.+.||+|+||.||+|..+. .+..||+|.+.... ....+.+|+.++++++||||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 34678999999999999999997652 35579999876532 23457789999999999999999999999999
Q ss_pred eEEEEEccCCCchHHHHHhhhcC-----CCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEE
Q 002061 746 SFLVLEYMPNGNLFQALHKRVKE-----GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKI 820 (973)
Q Consensus 746 ~~lv~e~~~~gsL~~~l~~~~~~-----~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl 820 (973)
.|+||||+++|+|.+++...... ..+...+..+..++.|++.|++||| +++++||||||+||+++.++.+++
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEE
Confidence 99999999999999999764211 1244577788899999999999999 889999999999999999999999
Q ss_pred ecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHh
Q 002061 821 ADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHL 899 (973)
Q Consensus 821 ~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~ 899 (973)
+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.... .........
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~-----~~~~~~~~~ 235 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS-----NEQVLKFVM 235 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHH
Confidence 99999876543322222222345678999999998899999999999999999998 788986531 111111111
Q ss_pred ccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCC
Q 002061 900 NNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPC 956 (973)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~ 956 (973)
. ... ..........+.+++.+|++.||++||++.++++.+++...+
T Consensus 236 ~-~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 281 (288)
T cd05061 236 D-GGY----------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP 281 (288)
T ss_pred c-CCC----------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCC
Confidence 1 100 001112235788999999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=315.16 Aligned_cols=249 Identities=29% Similarity=0.395 Sum_probs=204.8
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeec----cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY 752 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 752 (973)
+|++.+.||+|++|.||+|....+++.|++|.+.. ....+.+.+|++++++++|||++++++++.+++..|+||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 47788899999999999999999999999998764 24456788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCC
Q 002061 753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832 (973)
Q Consensus 753 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 832 (973)
+++++|.+++... ....+++..+..++.|++.|++||| +.+++||||+|+||+++.++.++++|||++......
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 81 AENGDLHKLLKMQ---RGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred CCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence 9999999999753 2346888999999999999999999 789999999999999999999999999998766443
Q ss_pred CCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhcccc
Q 002061 833 PKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCE 912 (973)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (973)
.. ......|++.|+|||+..+..++.++|||||||++|||++|+.||.... ............
T Consensus 155 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~---------- 217 (256)
T cd08529 155 TN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN-----QGALILKIIRGV---------- 217 (256)
T ss_pred cc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHcCC----------
Confidence 22 1223457889999999999889999999999999999999999996542 111111111110
Q ss_pred ccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 913 VASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 913 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
. ..........+.+++.+||+.+|++||++.+++++
T Consensus 218 ~-~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 218 F-PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred C-CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 0 01111334568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=355.69 Aligned_cols=439 Identities=26% Similarity=0.332 Sum_probs=245.6
Q ss_pred eEEEeecCCCCCccccccccCCccCcEeeCCCCcccCcCChhhhCCCCCcEEEecCCcccCCCCcccCCCCCCEEeccCc
Q 002061 75 VTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSIN 154 (973)
Q Consensus 75 v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls~n 154 (973)
..+||++++.++ ..|..|..+.+|+.|.++.|.|. ..|.+.+++.+|++|+|.+|.+...|..+..+++|++||+|+|
T Consensus 47 L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~~lP~~~~~lknl~~LdlS~N 124 (1081)
T KOG0618|consen 47 LKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQSLPASISELKNLQYLDLSFN 124 (1081)
T ss_pred eEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhhcCchhHHhhhcccccccchh
Confidence 556666666665 56667777777777777777776 5667777777777777777777777777777777777777777
Q ss_pred cCCCccccccccccccceEEccCCcCCCCCCcccccCCCCCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCc
Q 002061 155 YFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFP 234 (973)
Q Consensus 155 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 234 (973)
++. .+|..+..++.+.++..++| ... ..++... ++.++|..|.+.+.++..+..+++ .|||+.|.++ -
T Consensus 125 ~f~-~~Pl~i~~lt~~~~~~~s~N-~~~----~~lg~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~ 192 (1081)
T KOG0618|consen 125 HFG-PIPLVIEVLTAEEELAASNN-EKI----QRLGQTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME---V 192 (1081)
T ss_pred ccC-CCchhHHhhhHHHHHhhhcc-hhh----hhhcccc-chhhhhhhhhcccchhcchhhhhe--eeecccchhh---h
Confidence 776 56777777777777777777 110 2223222 666666666666666666666655 5667666665 1
Q ss_pred hhhhccccccEEEeeccccCCcCCccccccccccEEEeeccccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCccc
Q 002061 235 RSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRK 314 (973)
Q Consensus 235 ~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~ 314 (973)
..+..+.+|+.|....|++... --..++|+.|+.++|.+....+.. .-.+|+++++++|++++ +|++++.+.+
T Consensus 193 ~dls~~~~l~~l~c~rn~ls~l----~~~g~~l~~L~a~~n~l~~~~~~p--~p~nl~~~dis~n~l~~-lp~wi~~~~n 265 (1081)
T KOG0618|consen 193 LDLSNLANLEVLHCERNQLSEL----EISGPSLTALYADHNPLTTLDVHP--VPLNLQYLDISHNNLSN-LPEWIGACAN 265 (1081)
T ss_pred hhhhhccchhhhhhhhcccceE----EecCcchheeeeccCcceeecccc--ccccceeeecchhhhhc-chHHHHhccc
Confidence 2344455555555555555411 112234444444444444111111 11244444444444442 2344444444
Q ss_pred ceeeeccCCccCCCCCccccccccccccccccccccccCChhhhhhhhHHHHHhhhccCCCCccccccCccccceEeccc
Q 002061 315 LFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISD 394 (973)
Q Consensus 315 L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~ 394 (973)
|+.+...+|+++ .+|..+...++|+.|++.+|.++ .+|.....++.|++|+|..
T Consensus 266 le~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-------------------------yip~~le~~~sL~tLdL~~ 319 (1081)
T KOG0618|consen 266 LEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-------------------------YIPPFLEGLKSLRTLDLQS 319 (1081)
T ss_pred ceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-------------------------hCCCcccccceeeeeeehh
Confidence 444444444443 34444444444444444444443 4444455566666666666
Q ss_pred cccccCCCccc-cCCC-CcceEeccCCcCCCCCCCCCCCCCCCCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCC
Q 002061 395 NHLSGKIPDGL-WALP-NVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGK 472 (973)
Q Consensus 395 N~l~~~~p~~~-~~l~-~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 472 (973)
|.|. ..|+.+ ..+. .|..|..+.|++...+...-..++.|+.|++.+|.+++..-..+.+.++|+.|+|++|++...
T Consensus 320 N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~f 398 (1081)
T KOG0618|consen 320 NNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSF 398 (1081)
T ss_pred cccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccC
Confidence 6665 333322 2222 255555566655554433333445566666666666655555555666666666666666544
Q ss_pred ccccccccccCCEEEcCCcccccCCCccccccccccchhccccccccCCCccccccCCCCeeecCCCccCC-CCChhhhc
Q 002061 473 IPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTG-SIPDNLMK 551 (973)
Q Consensus 473 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~p~~l~~ 551 (973)
....+.++..|++|+||+|+|+ .+|..+.++..|++|...+|+|. ..| .+..++.|+.+||+.|+|+. .+|.....
T Consensus 399 pas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~ 475 (1081)
T KOG0618|consen 399 PASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPS 475 (1081)
T ss_pred CHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCC
Confidence 4445556666666666666665 45566666666666666666665 455 55666666666666666652 33332222
Q ss_pred ccCceEEccCCcc
Q 002061 552 LKLSSIDLSENQL 564 (973)
Q Consensus 552 l~L~~l~ls~N~l 564 (973)
-+|++|||++|.+
T Consensus 476 p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 476 PNLKYLDLSGNTR 488 (1081)
T ss_pred cccceeeccCCcc
Confidence 3366666666653
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=317.20 Aligned_cols=254 Identities=24% Similarity=0.354 Sum_probs=202.0
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc--ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY 752 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 752 (973)
..+|++.+.||+|+||.||+|++..+++.||+|++... .....+.+|+.++++++||||+++++++..++..|+||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35789999999999999999999988999999988653 3455678899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCC
Q 002061 753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832 (973)
Q Consensus 753 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 832 (973)
+++++|.++++.. ..+++..+..++.|++.|++||| +.+++|||++|+||+++.++.++|+|||++......
T Consensus 88 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06646 88 CGGGSLQDIYHVT-----GPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT 159 (267)
T ss_pred CCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence 9999999988643 35788899999999999999999 789999999999999999999999999999765432
Q ss_pred CCcccccccCCccccccccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhc
Q 002061 833 PKVSDYSCFAGTHGYIAPELAY---TCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVL 909 (973)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (973)
. .......|+..|+|||.+. ...++.++||||+||++|||++|+.||........ ...+ .... ..
T Consensus 160 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~-~~~~-----~~~~----~~ 227 (267)
T cd06646 160 I--AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLM-----SKSN----FQ 227 (267)
T ss_pred c--cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh-heee-----ecCC----CC
Confidence 1 1122346788999999874 34578899999999999999999999864321100 0000 0000 00
Q ss_pred cccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 910 DCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 910 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
.+.. .........+.+++.+||+.+|++||+++++++++
T Consensus 228 ~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 228 PPKL--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCC--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0000 01112345788999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=327.14 Aligned_cols=246 Identities=27% Similarity=0.358 Sum_probs=196.9
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEEE
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLVL 750 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~ 750 (973)
+|++.+.||+|+||+||+|++..+++.||||++.+. .....+..|..++... +||+|+++++++...+..|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 478889999999999999999998999999998753 2234456778888777 6899999999999999999999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccccc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 830 (973)
||+++|+|.+++... ..+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~ 152 (323)
T cd05616 81 EYVNGGDLMYQIQQV-----GRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENM 152 (323)
T ss_pred cCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence 999999999988653 34788899999999999999999 7899999999999999999999999999987543
Q ss_pred CCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhcc
Q 002061 831 NSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLD 910 (973)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (973)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .. ...........
T Consensus 153 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~--~~---~~~~~i~~~~~------- 218 (323)
T cd05616 153 WDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--ED---ELFQSIMEHNV------- 218 (323)
T ss_pred CCC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC--HH---HHHHHHHhCCC-------
Confidence 221 12223568999999999999999999999999999999999999996531 11 11111111111
Q ss_pred ccccCcchHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHH
Q 002061 911 CEVASESIKEDMIKLLKIAVVCTTKLPNLRPPM-----REVVKM 949 (973)
Q Consensus 911 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~-----~evl~~ 949 (973)
..+.....++.+++.+|++.||++|++. .++.++
T Consensus 219 -----~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 219 -----AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred -----CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 0111234567889999999999999974 666654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=324.71 Aligned_cols=240 Identities=28% Similarity=0.377 Sum_probs=192.1
Q ss_pred CcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEEEEccCC
Q 002061 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLVLEYMPN 755 (973)
Q Consensus 682 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~ 755 (973)
+.||+|+||.||+|++..+++.||||++... ........|..++... +||+|+++++++..++..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4689999999999999999999999998753 2345566788887754 899999999999999999999999999
Q ss_pred CchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCc
Q 002061 756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV 835 (973)
Q Consensus 756 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 835 (973)
|+|.+++... ..+++..+..++.|++.||+||| +++|+||||||+||+++.++.++|+|||+++......
T Consensus 81 g~L~~~i~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 150 (316)
T cd05620 81 GDLMFHIQDK-----GRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-- 150 (316)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC--
Confidence 9999988653 35788889999999999999999 8899999999999999999999999999986432211
Q ss_pred ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccccC
Q 002061 836 SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVAS 915 (973)
Q Consensus 836 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||.... .............. .
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~-----~~~~~~~~~~~~~~--------~-- 215 (316)
T cd05620 151 NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD-----EDELFESIRVDTPH--------Y-- 215 (316)
T ss_pred CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhCCCC--------C--
Confidence 12233568999999999999999999999999999999999999996431 11111111111110 1
Q ss_pred cchHHHHHHHHHHHHHhcCCCCCCCCCHH-HHHH
Q 002061 916 ESIKEDMIKLLKIAVVCTTKLPNLRPPMR-EVVK 948 (973)
Q Consensus 916 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~-evl~ 948 (973)
+.....++.+++.+|++.||++||++. ++.+
T Consensus 216 --~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 216 --PRWITKESKDILEKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred --CCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 111234577899999999999999985 5653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=320.17 Aligned_cols=265 Identities=24% Similarity=0.339 Sum_probs=201.9
Q ss_pred cCCcccCcccccCceEEEEEEecC----------------CCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKK----------------NAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKL 736 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~----------------~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l 736 (973)
++|++.+.||+|+||.||+|+... ++..||+|++... ....++.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 468899999999999999986432 3457999988653 234578899999999999999999
Q ss_pred EEEEEeCCeeEEEEEccCCCchHHHHHhhhcCC------CCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCe
Q 002061 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEG------KPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNI 810 (973)
Q Consensus 737 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Ni 810 (973)
++++..++..++||||+++|+|.+++....... ...+++..+..++.|++.|++||| +.+++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChheE
Confidence 999999999999999999999999997642211 124778889999999999999999 78999999999999
Q ss_pred eecCCCCeEEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh--CCCCCCcccCCc
Q 002061 811 LLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT--GRKPVEEEYGDG 888 (973)
Q Consensus 811 ll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t--g~~pf~~~~~~~ 888 (973)
+++.++.++++|||+++...............++..|+|||+..++.++.++|||||||++|||++ |..||.... .
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~--~ 239 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS--D 239 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC--h
Confidence 999999999999999876543322111222344678999999888889999999999999999998 778885431 1
Q ss_pred ccHHHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 002061 889 KDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952 (973)
Q Consensus 889 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~ 952 (973)
................ ... ...+......+.+++.+||+.||++||++.||++.|++
T Consensus 240 ~~~~~~~~~~~~~~~~--~~~-----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 240 EQVIENTGEFFRDQGR--QVY-----LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHHHHHHHhhccc--ccc-----CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1111111111111000 000 00111233568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=339.30 Aligned_cols=251 Identities=23% Similarity=0.274 Sum_probs=197.3
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE 751 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 751 (973)
+|++.+.||+|+||+||+|++..+++.||||++... .....+.+|++++++++||||+++++.+.+++..|+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 688999999999999999999999999999998652 234567899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccC
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 831 (973)
|+++|+|.+++... ..++...+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||++..+..
T Consensus 82 ~~~~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 82 YIPGGDMMSLLIRL-----GIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred CCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 99999999999753 34778888889999999999999 78999999999999999999999999999753210
Q ss_pred CCC-----------------------------------------cccccccCCccccccccccccCCCCccchHHHHHHH
Q 002061 832 SPK-----------------------------------------VSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVV 870 (973)
Q Consensus 832 ~~~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~ 870 (973)
... ........||+.|+|||++.+..++.++||||+||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 000 000112468999999999999999999999999999
Q ss_pred HHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCC---CHHHHH
Q 002061 871 LLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRP---PMREVV 947 (973)
Q Consensus 871 l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp---t~~evl 947 (973)
+|||++|+.||..... ............. ..+ + ........+.+++.+|+ .+|.+|+ ++.|++
T Consensus 234 lyell~G~~Pf~~~~~-----~~~~~~i~~~~~~-~~~--~-----~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell 299 (376)
T cd05598 234 LYEMLVGQPPFLADTP-----AETQLKVINWETT-LHI--P-----SQAKLSREASDLILRLC-CGAEDRLGKNGADEIK 299 (376)
T ss_pred eeehhhCCCCCCCCCH-----HHHHHHHhccCcc-ccC--C-----CCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHh
Confidence 9999999999975421 1111111110000 000 0 01112344566777766 5999999 899999
Q ss_pred HH
Q 002061 948 KM 949 (973)
Q Consensus 948 ~~ 949 (973)
+|
T Consensus 300 ~h 301 (376)
T cd05598 300 AH 301 (376)
T ss_pred CC
Confidence 88
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=314.74 Aligned_cols=250 Identities=27% Similarity=0.405 Sum_probs=202.6
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhcCCCceeeEEEEEE-eCCeeEEEEEcc
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLL-KGGSSFLVLEYM 753 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~~lv~e~~ 753 (973)
..+|++.+.||+|+||.||+|... +..||+|........+.+.+|+.++++++|++++++++++. .+...++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 347888999999999999999876 77899999877666778899999999999999999999764 456789999999
Q ss_pred CCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCC
Q 002061 754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833 (973)
Q Consensus 754 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 833 (973)
++|+|.+++... ....+++..+..++.|++.|++||| +++++||||||+||+++.++.+|++|||++.......
T Consensus 83 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 83 AKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred CCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 999999998753 2345789999999999999999999 7899999999999999999999999999987543221
Q ss_pred CcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhcccc
Q 002061 834 KVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCE 912 (973)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (973)
....++..|+|||++.+..++.++|||||||++|||++ |+.||... ..............
T Consensus 157 -----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~-----~~~~~~~~~~~~~~--------- 217 (256)
T cd05082 157 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-----PLKDVVPRVEKGYK--------- 217 (256)
T ss_pred -----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHhcCCC---------
Confidence 12234568999999998889999999999999999998 99998643 12222221111110
Q ss_pred ccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 913 VASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 913 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
..........+.+++.+|++.+|++|||+.+++++|+++
T Consensus 218 --~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 218 --MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred --CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 011122345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=315.45 Aligned_cols=251 Identities=27% Similarity=0.386 Sum_probs=200.6
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccC
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP 754 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 754 (973)
.+|++.+.||+|+||.||+|+++. +..+|+|++... .....+.+|++++++++||||+++++++...+..|+||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecC-CccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 357888999999999999999864 668999987653 345678899999999999999999999999999999999999
Q ss_pred CCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCC
Q 002061 755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK 834 (973)
Q Consensus 755 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 834 (973)
+++|.+++... ...+++..+..++.|++.|++||| +.+++||||||+||+++.++.+|++|||.++.......
T Consensus 83 ~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 83 NGCLLNYLRER----KGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY 155 (256)
T ss_pred CCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceecccccc
Confidence 99999999753 235789999999999999999999 78999999999999999999999999999876543211
Q ss_pred cccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhccccc
Q 002061 835 VSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEV 913 (973)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (973)
. ......++..|+|||++.+..++.++||||||+++||+++ |+.||.... ..... ... .... ..
T Consensus 156 ~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--~~~~~---~~~-~~~~------~~-- 220 (256)
T cd05059 156 T-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFS--NSEVV---ESV-SAGY------RL-- 220 (256)
T ss_pred c-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCC--HHHHH---HHH-HcCC------cC--
Confidence 1 1111223457999999998899999999999999999999 899996431 11111 111 1110 00
Q ss_pred cCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 914 ASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 914 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
..+.....++.+++.+||+.+|++||++.|+++.|.
T Consensus 221 --~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 221 --YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred --CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 011123456889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=325.55 Aligned_cols=241 Identities=29% Similarity=0.379 Sum_probs=196.1
Q ss_pred CcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEEEEccCC
Q 002061 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLVLEYMPN 755 (973)
Q Consensus 682 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~ 755 (973)
+.||+|+||+||+|++..+++.||||++.+. .....+.+|.++++.+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4689999999999999998999999998753 3345567888898887 799999999999999999999999999
Q ss_pred CchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCc
Q 002061 756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV 835 (973)
Q Consensus 756 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 835 (973)
|+|.+++... ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~L~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 150 (318)
T cd05570 81 GDLMFHIQRS-----GRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-- 150 (318)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC--
Confidence 9999888653 35889999999999999999999 8899999999999999999999999999986432211
Q ss_pred ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccccC
Q 002061 836 SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVAS 915 (973)
Q Consensus 836 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
.......|++.|+|||++.+..++.++||||+||++|||++|+.||.... ..............
T Consensus 151 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~-----~~~~~~~i~~~~~~----------- 214 (318)
T cd05570 151 VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD-----EDELFQSILEDEVR----------- 214 (318)
T ss_pred CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC-----HHHHHHHHHcCCCC-----------
Confidence 11223468999999999999999999999999999999999999996431 11222211111110
Q ss_pred cchHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHH
Q 002061 916 ESIKEDMIKLLKIAVVCTTKLPNLRPPM-----REVVKM 949 (973)
Q Consensus 916 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~-----~evl~~ 949 (973)
.+......+.+++.+||+.||.+||++ .+++++
T Consensus 215 -~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 215 -YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred -CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 011234567899999999999999999 888876
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=330.26 Aligned_cols=264 Identities=28% Similarity=0.285 Sum_probs=199.5
Q ss_pred HHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCC----
Q 002061 673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGG---- 744 (973)
Q Consensus 673 ~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~---- 744 (973)
....+|++.+.||+|+||.||+|++..+++.||||++... .....+.+|+.+++.++||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 4567999999999999999999999999999999998642 34556788999999999999999999986543
Q ss_pred --eeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEec
Q 002061 745 --SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIAD 822 (973)
Q Consensus 745 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 822 (973)
..|+||||+++ ++.+.+.. .+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~D 166 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIHM-------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILD 166 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEec
Confidence 57999999964 66666542 3678888899999999999999 88999999999999999999999999
Q ss_pred ccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHH--------
Q 002061 823 FGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYW-------- 894 (973)
Q Consensus 823 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~-------- 894 (973)
||+++...... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||....... .....
T Consensus 167 fg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~ 242 (359)
T cd07876 167 FGLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID-QWNKVIEQLGTPS 242 (359)
T ss_pred CCCccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCc
Confidence 99987543221 1223468999999999999999999999999999999999999997542100 00000
Q ss_pred ----------HHHHhccccccchh----ccccc----cCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 895 ----------VSTHLNNHENVLKV----LDCEV----ASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 895 ----------~~~~~~~~~~~~~~----~~~~~----~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
+.......+..... ..+.. ...........+.+++.+|++.||++|||+.|+++|-.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 317 (359)
T cd07876 243 AEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPY 317 (359)
T ss_pred HHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCch
Confidence 00000000000000 00000 00001112356789999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=335.72 Aligned_cols=262 Identities=22% Similarity=0.271 Sum_probs=199.4
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCC
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPN 755 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 755 (973)
..|.+.+.||+|+||.||+|.+..+++.||||... ...+.+|++++++++||||+++++++..++..++|||++ .
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~ 243 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-R 243 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-C
Confidence 46899999999999999999999999999999643 234578999999999999999999999999999999999 5
Q ss_pred CchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCc
Q 002061 756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV 835 (973)
Q Consensus 756 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 835 (973)
++|.+++... ...+++..+..++.|+++||+||| +++|+||||||+|||++.++.+||+|||+++........
T Consensus 244 ~~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 244 SDLYTYLGAR----LRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 7898888643 235899999999999999999999 789999999999999999999999999999766433222
Q ss_pred ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccc-CC-----cccHHHHHHHHhccccccchhc
Q 002061 836 SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEY-GD-----GKDIVYWVSTHLNNHENVLKVL 909 (973)
Q Consensus 836 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~-~~-----~~~~~~~~~~~~~~~~~~~~~~ 909 (973)
.......||..|+|||++.+..++.++|||||||++|||++|..|+-... .. ...+...+..............
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 22223568999999999999999999999999999999999876653211 11 1112222221110000000000
Q ss_pred ----------------cccccCcchH---HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 910 ----------------DCEVASESIK---EDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 910 ----------------~~~~~~~~~~---~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
.+........ .....+.+++.+||+.||.+|||+.|++++
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0000000011 122367889999999999999999999987
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=325.71 Aligned_cols=260 Identities=27% Similarity=0.381 Sum_probs=202.9
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcE--EEEEeeecc---ccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeE
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGT--VAVKQLWKG---DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSF 747 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~--vavK~~~~~---~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 747 (973)
..++|++.+.||+|+||.||+|.+..++.. +|+|..... ...+.+.+|++++.++ +||||+++++++..++..|
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~ 84 (303)
T cd05088 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 84 (303)
T ss_pred chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence 456889999999999999999998876654 577766542 2345688899999999 8999999999999999999
Q ss_pred EEEEccCCCchHHHHHhhhc-----------CCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCC
Q 002061 748 LVLEYMPNGNLFQALHKRVK-----------EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY 816 (973)
Q Consensus 748 lv~e~~~~gsL~~~l~~~~~-----------~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~ 816 (973)
+||||+++|+|.++++.... .....+++..+..++.|++.|++||| +++++||||||+||+++.++
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENY 161 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCC
Confidence 99999999999999975421 11235789999999999999999999 88999999999999999999
Q ss_pred CeEEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHH
Q 002061 817 EPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWV 895 (973)
Q Consensus 817 ~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~ 895 (973)
.+||+|||++...... .......++..|+|||++.+..++.++|||||||++|||+| |..||..... . ...
T Consensus 162 ~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~---~~~ 233 (303)
T cd05088 162 VAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--A---ELY 233 (303)
T ss_pred cEEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh--H---HHH
Confidence 9999999998633211 11111234668999999988889999999999999999998 9999964321 1 111
Q ss_pred HHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 002061 896 STHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADP 955 (973)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 955 (973)
... .... ...........+.+++.+|++.+|++||++.+++++++++..
T Consensus 234 ~~~-~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~ 282 (303)
T cd05088 234 EKL-PQGY----------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282 (303)
T ss_pred HHH-hcCC----------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111 1100 000111123457889999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=293.26 Aligned_cols=254 Identities=26% Similarity=0.346 Sum_probs=208.8
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc------cc----HHHHHHHHHHHHhc-CCCceeeEEEEEEe
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG------DG----VKVFAAEMEILGKI-RHRNILKLYACLLK 742 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~------~~----~~~~~~E~~~l~~l-~hpniv~l~~~~~~ 742 (973)
....|+..+.+|.|..++|.++.++.+|+.+|+|++... +. .+.-.+|+.+++++ .||+|+++.++|+.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 345678888999999999999999999999999988541 11 22345699999998 69999999999999
Q ss_pred CCeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEec
Q 002061 743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIAD 822 (973)
Q Consensus 743 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 822 (973)
+...++|+|.|+.|.|+||+.. ...+++....+|+.|+.+|++||| .+.|||||+||+|||++++..+||+|
T Consensus 95 ~sF~FlVFdl~prGELFDyLts-----~VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTS-----KVTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred cchhhhhhhhcccchHHHHhhh-----heeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEec
Confidence 9999999999999999999985 356888999999999999999999 88999999999999999999999999
Q ss_pred ccCcccccCCCCcccccccCCccccccccccc------cCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHH
Q 002061 823 FGVAKIAENSPKVSDYSCFAGTHGYIAPELAY------TCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVS 896 (973)
Q Consensus 823 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~ 896 (973)
||.++..+++.. ....+||++|.|||.+. ...|+..+|+||+||++|.++.|.+||.-. .+++.
T Consensus 167 FGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR-------kQmlM 236 (411)
T KOG0599|consen 167 FGFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR-------KQMLM 236 (411)
T ss_pred cceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH-------HHHHH
Confidence 999998877644 34478999999999984 345788899999999999999999999532 11111
Q ss_pred HHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 897 THLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
.+.-.... -.+..+.+.+......+++.+|++.||.+|.|+.|+++|-.
T Consensus 237 LR~ImeGk------yqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpf 285 (411)
T KOG0599|consen 237 LRMIMEGK------YQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPF 285 (411)
T ss_pred HHHHHhcc------cccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChH
Confidence 11111110 11233445666777889999999999999999999998754
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=321.27 Aligned_cols=259 Identities=27% Similarity=0.363 Sum_probs=204.0
Q ss_pred HcCCcccCcccccCceEEEEEEecC-----CCcEEEEEeeeccc---cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCee
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKK-----NAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSS 746 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~-----~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 746 (973)
.++|++.+.||+|+||.||+|.+.. ++..||+|++.... ..+.+.+|++++++++||||+++++++..+...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 3578999999999999999998753 57789999886532 345688999999999999999999999999999
Q ss_pred EEEEEccCCCchHHHHHhhhc-----------------CCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCC
Q 002061 747 FLVLEYMPNGNLFQALHKRVK-----------------EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSN 809 (973)
Q Consensus 747 ~lv~e~~~~gsL~~~l~~~~~-----------------~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~N 809 (973)
++||||+++|+|.+++..... .....+++..+..++.|++.||+|+| +++++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhh
Confidence 999999999999999975311 12234788899999999999999999 7899999999999
Q ss_pred eeecCCCCeEEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCc
Q 002061 810 ILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDG 888 (973)
Q Consensus 810 ill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~ 888 (973)
|++++++.++++|||++.................+..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~--- 237 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA--- 237 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC---
Confidence 9999999999999999875533322111222234678999999988899999999999999999998 888885431
Q ss_pred ccHHHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 002061 889 KDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952 (973)
Q Consensus 889 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~ 952 (973)
......... ... .. ..+.....++.+++.+|++.||++||++.|+++.|++
T Consensus 238 --~~~~~~~~~-~~~---------~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 238 --HEEVIYYVR-DGN---------VL-SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred --HHHHHHHHh-cCC---------CC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 111111111 111 00 0111234568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=334.71 Aligned_cols=251 Identities=22% Similarity=0.281 Sum_probs=195.2
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE 751 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 751 (973)
+|+..+.||+|+||+||+|+...+++.||||++... ...+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 588899999999999999999999999999998653 234567889999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccC
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 831 (973)
|+++|+|.+++.+. ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~ 153 (382)
T cd05625 82 YIPGGDMMSLLIRM-----GIFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (382)
T ss_pred CCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCccccc
Confidence 99999999998753 34778888899999999999999 78999999999999999999999999999753210
Q ss_pred CCC---------------------------------------------cccccccCCccccccccccccCCCCccchHHH
Q 002061 832 SPK---------------------------------------------VSDYSCFAGTHGYIAPELAYTCKVSEKSDVFS 866 (973)
Q Consensus 832 ~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws 866 (973)
... ........||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (382)
T cd05625 154 THDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 233 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEe
Confidence 000 00011246899999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCC---H
Q 002061 867 FGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPP---M 943 (973)
Q Consensus 867 lG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt---~ 943 (973)
+||++|||++|+.||.... ............... .. + .......+..+++.+++ .+|.+|++ +
T Consensus 234 lGvil~elltG~~Pf~~~~-----~~~~~~~i~~~~~~~-~~--p-----~~~~~s~~~~~li~~l~-~~p~~R~~~~~~ 299 (382)
T cd05625 234 VGVILYEMLVGQPPFLAQT-----PLETQMKVINWQTSL-HI--P-----PQAKLSPEASDLIIKLC-RGPEDRLGKNGA 299 (382)
T ss_pred chHHHHHHHhCCCCCCCCC-----HHHHHHHHHccCCCc-CC--C-----CcccCCHHHHHHHHHHc-cCHhHcCCCCCH
Confidence 9999999999999996531 111111111111000 00 0 01112334566666665 59999987 8
Q ss_pred HHHHHH
Q 002061 944 REVVKM 949 (973)
Q Consensus 944 ~evl~~ 949 (973)
.|+++|
T Consensus 300 ~ei~~h 305 (382)
T cd05625 300 DEIKAH 305 (382)
T ss_pred HHHhcC
Confidence 888876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=314.93 Aligned_cols=253 Identities=28% Similarity=0.406 Sum_probs=202.1
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccC
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP 754 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 754 (973)
.+|++.++||+|+||+||+|++..+ ..||+|++... ...+.+.+|++++++++||||+++++++. +...++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 4689999999999999999998764 56999998763 34567899999999999999999999874 456899999999
Q ss_pred CCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCC
Q 002061 755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK 834 (973)
Q Consensus 755 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 834 (973)
+|+|.+++... ....+++..+..++.|++.||+|+| +.+++||||||+||++++++.++|+|||.++.......
T Consensus 84 ~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 84 KGSLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred CCcHHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 99999999753 2335789999999999999999999 78999999999999999999999999999976643322
Q ss_pred cccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhccccc
Q 002061 835 VSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEV 913 (973)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (973)
. ......++..|+|||+..+..++.++||||||+++|||++ |+.||..... .. .........
T Consensus 158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~--~~---~~~~~~~~~----------- 220 (262)
T cd05071 158 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--RE---VLDQVERGY----------- 220 (262)
T ss_pred c-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh--HH---HHHHHhcCC-----------
Confidence 1 1122346678999999988899999999999999999999 8888865311 11 111110000
Q ss_pred cCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 914 ASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 914 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
......+....+.+++.+|++.+|++||++.++++.|++.
T Consensus 221 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 221 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 0011223456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=339.64 Aligned_cols=366 Identities=27% Similarity=0.416 Sum_probs=263.0
Q ss_pred CCCCCEEeccCccCC-CccccccccccccceEEccCCcCCCCCCcccccCCCCCCEEEcccCCCCCCCChhhhccCCCCe
Q 002061 143 LKNLEIFDLSINYFT-GRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGT 221 (973)
Q Consensus 143 l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 221 (973)
|+-.+-.|+++|.++ +.+|..+.++++++.|.|....+. .+|+.++.+.+|++|.+++|++. .+-..++.|+.|+.
T Consensus 6 LpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~--~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRs 82 (1255)
T KOG0444|consen 6 LPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE--QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRS 82 (1255)
T ss_pred cceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh--hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHH
Confidence 344555677777777 567888888888888888777775 67888888888888888888887 55666777788888
Q ss_pred eecccccccC-CCchhhhccccccEEEeeccccCCcCCccccccccccEEEeeccccccccCCc-cCCCCCccEEEcccC
Q 002061 222 LDICRNKISG-EFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEE-IGNLKNLTVFQCFKN 299 (973)
Q Consensus 222 L~L~~N~l~~-~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~l~~N 299 (973)
+++.+|++.. -+|..+..+..|..|+|++|+++ +.|..+...+++-.|+||+|+|. .+|.. |.+|+.|-+|+|++|
T Consensus 83 v~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~N 160 (1255)
T KOG0444|consen 83 VIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNN 160 (1255)
T ss_pred HhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccc
Confidence 8888887753 35666777777777777777777 66777777777777777777776 34433 556666666777777
Q ss_pred CCCCCCCCCcCCcccceeeeccCCccCCCCCccccccccccccccccccccccCChhhhhhhhHHHHHhhhccCCCCccc
Q 002061 300 NFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPN 379 (973)
Q Consensus 300 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~ll~l~n~~~~~~p~ 379 (973)
++. .+|..+..+..|++|.|++|.+...--..+..+++|+.|.+++.+=+ ...+|.
T Consensus 161 rLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRT-----------------------l~N~Pt 216 (1255)
T KOG0444|consen 161 RLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRT-----------------------LDNIPT 216 (1255)
T ss_pred hhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccch-----------------------hhcCCC
Confidence 666 44555566666666666666655333333444455555555554433 224677
Q ss_pred cccCccccceEeccccccccCCCccccCCCCcceEeccCCcCCCCCCCCCCCCCCCCEEEcccCCCCCCCChhhhcCCCC
Q 002061 380 SYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNL 459 (973)
Q Consensus 380 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L 459 (973)
++..+.+|..+|||.|.+. ++|+.+..+++|..|+||+|+|+.... ..+.-.+|++|+||+|+++ .+|++++.+++|
T Consensus 217 sld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL~~-~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL 293 (1255)
T KOG0444|consen 217 SLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITELNM-TEGEWENLETLNLSRNQLT-VLPDAVCKLTKL 293 (1255)
T ss_pred chhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeeeec-cHHHHhhhhhhccccchhc-cchHHHhhhHHH
Confidence 8888888999999999988 888888888888888888888875432 2244456778888888887 778888888888
Q ss_pred CEEEccCCcCCC-CccccccccccCCEEEcCCcccccCCCccccccccccchhccccccccCCCccccccCCCCeeecCC
Q 002061 460 ERLILTNNNFSG-KIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSG 538 (973)
Q Consensus 460 ~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 538 (973)
+.|++.+|+++- -+|+.++.+.+|+.+..++|.|. ..|..++.|.+|+.|.|++|+|- .+|+.+.-++.|+.|||..
T Consensus 294 ~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlre 371 (1255)
T KOG0444|consen 294 TKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRE 371 (1255)
T ss_pred HHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccC
Confidence 888888887752 36777888888888888888777 67777888888888888888777 6777777778888888877
Q ss_pred CccC
Q 002061 539 NKLT 542 (973)
Q Consensus 539 N~l~ 542 (973)
|+=-
T Consensus 372 NpnL 375 (1255)
T KOG0444|consen 372 NPNL 375 (1255)
T ss_pred CcCc
Confidence 7654
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=324.84 Aligned_cols=262 Identities=27% Similarity=0.370 Sum_probs=205.6
Q ss_pred HcCCcccCcccccCceEEEEEEecC-------CCcEEEEEeeecc---ccHHHHHHHHHHHHhc-CCCceeeEEEEEEeC
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKK-------NAGTVAVKQLWKG---DGVKVFAAEMEILGKI-RHRNILKLYACLLKG 743 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~-------~~~~vavK~~~~~---~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 743 (973)
.++|.+.+.||+|+||.||+|++.. +...||+|.+... .....+.+|+++++++ +||||+++++++..+
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 3578999999999999999998743 2356999988753 3345678899999999 799999999999999
Q ss_pred CeeEEEEEccCCCchHHHHHhhhcC-----------CCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeee
Q 002061 744 GSSFLVLEYMPNGNLFQALHKRVKE-----------GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILL 812 (973)
Q Consensus 744 ~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill 812 (973)
+..|+||||+++|+|.+++..+... ....+++..+..++.|++.|++||| +++++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEE
Confidence 9999999999999999999764211 1235889999999999999999999 7899999999999999
Q ss_pred cCCCCeEEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccH
Q 002061 813 DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDI 891 (973)
Q Consensus 813 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~ 891 (973)
+.++.++|+|||.+................++..|+|||++.+..++.++||||+||++|||++ |..||... ..
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~-----~~ 248 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-----PV 248 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC-----CH
Confidence 9999999999999876543222111222234578999999998889999999999999999998 88888543 11
Q ss_pred HHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 002061 892 VYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADP 955 (973)
Q Consensus 892 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 955 (973)
........ ... ....+......+.+++.+|++.+|++||++.++++.|+++..
T Consensus 249 ~~~~~~~~-~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 249 EELFKLLK-EGH----------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred HHHHHHHH-cCC----------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 11111111 110 011112234567889999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=320.31 Aligned_cols=249 Identities=23% Similarity=0.318 Sum_probs=202.8
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc--ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM 753 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 753 (973)
.+|++.+.||+|+||.||+|++..+++.||+|.+... ...+.+.+|+.+++.++|||++++++++..+.+.|+||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 4788899999999999999999888999999988653 34567889999999999999999999999999999999999
Q ss_pred CCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCC
Q 002061 754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833 (973)
Q Consensus 754 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 833 (973)
++++|.+++... .+++.++..++.|++.|++||| +.+++||||||+||+++.++.++|+|||++.......
T Consensus 100 ~~~~L~~~~~~~------~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 100 AGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred CCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 999999998642 4688899999999999999999 7899999999999999999999999999987553322
Q ss_pred CcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccc
Q 002061 834 KVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEV 913 (973)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (973)
. ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||...... ..+. ....... .
T Consensus 171 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~----~~~~-~~~~~~~--~------- 234 (296)
T cd06654 171 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL----RALY-LIATNGT--P------- 234 (296)
T ss_pred c--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH----HhHH-HHhcCCC--C-------
Confidence 1 122346788999999998888999999999999999999999999654211 1111 1111000 0
Q ss_pred cCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 914 ASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 914 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
...........+.+++.+||.++|++||++.|++++
T Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 001112334567889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=315.41 Aligned_cols=252 Identities=35% Similarity=0.507 Sum_probs=201.7
Q ss_pred CcccCcccccCceEEEEEEecCCCcEEEEEeeeccccHH----HHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 002061 678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVK----VFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM 753 (973)
Q Consensus 678 ~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~----~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 753 (973)
|++.+.||+|+||+||+|+...+++.||+|++....... ...+|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 577889999999999999999999999999998743222 2345999999999999999999999999999999999
Q ss_pred CCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCC
Q 002061 754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833 (973)
Q Consensus 754 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 833 (973)
++++|.+++... ..+++..+..++.|+++||++|| +.+++|+||||+||+++.++.++|+|||.+......
T Consensus 81 ~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~- 151 (260)
T PF00069_consen 81 PGGSLQDYLQKN-----KPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN- 151 (260)
T ss_dssp TTEBHHHHHHHH-----SSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTST-
T ss_pred cccccccccccc-----ccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc-
Confidence 999999999832 35789999999999999999999 789999999999999999999999999998764111
Q ss_pred CcccccccCCccccccccccc-cCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhcccc
Q 002061 834 KVSDYSCFAGTHGYIAPELAY-TCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCE 912 (973)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (973)
........++..|+|||++. +..++.++||||+|+++|+|++|..||... ...+.............. ..
T Consensus 152 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~--~~~~~~~~~~~~~~~~~~------~~ 222 (260)
T PF00069_consen 152 -NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES--NSDDQLEIIEKILKRPLP------SS 222 (260)
T ss_dssp -TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS--SHHHHHHHHHHHHHTHHH------HH
T ss_pred -ccccccccccccccccccccccccccccccccccccccccccccccccccc--cchhhhhhhhhccccccc------cc
Confidence 12333456899999999998 888999999999999999999999999764 111111121111111100 00
Q ss_pred ccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 913 VASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 913 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
. .........+.+++.+|++.||++||++.+++++
T Consensus 223 ~--~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 223 S--QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp T--TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred c--cccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0001112678999999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=318.17 Aligned_cols=249 Identities=26% Similarity=0.370 Sum_probs=199.5
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM 753 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 753 (973)
+|++.+.||+|+||.||+|++..+++.||+|++... ...+.+.+|++++++++||||+++++++..++..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 578889999999999999999988999999988653 23456889999999999999999999999999999999999
Q ss_pred CCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCC
Q 002061 754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833 (973)
Q Consensus 754 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 833 (973)
++++|..+. .+++..+..++.|++.|++||| +.+++|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~- 148 (279)
T cd06619 82 DGGSLDVYR---------KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS- 148 (279)
T ss_pred CCCChHHhh---------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-
Confidence 999986542 3577788899999999999999 889999999999999999999999999998755332
Q ss_pred CcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCccc--HHHHHHHHhccccccchhccc
Q 002061 834 KVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKD--IVYWVSTHLNNHENVLKVLDC 911 (973)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 911 (973)
......|+..|+|||++.+..++.++||||+||++|+|++|+.||......... ............. .
T Consensus 149 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------~ 218 (279)
T cd06619 149 ---IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP-------P 218 (279)
T ss_pred ---cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCC-------C
Confidence 122346899999999999889999999999999999999999999754322111 1111111110100 0
Q ss_pred cccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 912 EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 912 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
.. .......++.+++.+|++.+|++||++.|++++..
T Consensus 219 ~~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~ 255 (279)
T cd06619 219 VL---PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPF 255 (279)
T ss_pred CC---CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcc
Confidence 00 01122346789999999999999999999998744
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=322.97 Aligned_cols=260 Identities=28% Similarity=0.383 Sum_probs=203.2
Q ss_pred cCCcccCcccccCceEEEEEEecCCCc--EEEEEeeec---cccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAG--TVAVKQLWK---GDGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLV 749 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~--~vavK~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv 749 (973)
++|++.+.||+|+||.||+|....++. .+++|.++. ....+.+.+|+++++++ +||||+++++++......|+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 468889999999999999999877654 478887764 23345688999999999 799999999999999999999
Q ss_pred EEccCCCchHHHHHhhhcC-----------CCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCe
Q 002061 750 LEYMPNGNLFQALHKRVKE-----------GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP 818 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~-----------~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~ 818 (973)
|||+++|+|.+++...... ....+++..+..++.|++.|++||| +++++||||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence 9999999999999753211 1134788999999999999999999 7899999999999999999999
Q ss_pred EEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHH
Q 002061 819 KIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVST 897 (973)
Q Consensus 819 kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~ 897 (973)
||+|||++...... ........+..|+|||++.+..++.++|||||||++|||++ |..||.... .......
T Consensus 159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~-----~~~~~~~ 230 (297)
T cd05089 159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT-----CAELYEK 230 (297)
T ss_pred EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHH
Confidence 99999998633211 11111223567999999988889999999999999999997 999996531 1111111
Q ss_pred HhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCCC
Q 002061 898 HLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPCT 957 (973)
Q Consensus 898 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 957 (973)
..... ....+......+.+++.+|++.+|.+||++.++++.|+.+....
T Consensus 231 ~~~~~-----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 231 LPQGY-----------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred HhcCC-----------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 11100 00011123456789999999999999999999999998876544
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=320.05 Aligned_cols=265 Identities=21% Similarity=0.248 Sum_probs=201.1
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE 751 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 751 (973)
+++|++.+.||+|+||+||+|++..+++.||+|++... .....+.+|++++++++||||+++++++..++..++|||
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 35789999999999999999999988999999988642 233457789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccC
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 831 (973)
|++ ++|.+++... ...+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++.....
T Consensus 85 ~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 156 (309)
T cd07872 85 YLD-KDLKQYMDDC----GNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSV 156 (309)
T ss_pred CCC-CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCC
Confidence 996 4888887643 335788889999999999999999 78999999999999999999999999999875433
Q ss_pred CCCcccccccCCcccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccc-------
Q 002061 832 SPKVSDYSCFAGTHGYIAPELAYT-CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHE------- 903 (973)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~------- 903 (973)
... ......++..|+|||++.+ ..++.++||||+||++|||++|+.||..... .+....+........
T Consensus 157 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 232 (309)
T cd07872 157 PTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTV--EDELHLIFRLLGTPTEETWPGI 232 (309)
T ss_pred Ccc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCCHHHHhhh
Confidence 221 1223457899999998865 4688999999999999999999999965421 111111111100000
Q ss_pred ----ccchhccccccC----cchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 904 ----NVLKVLDCEVAS----ESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 904 ----~~~~~~~~~~~~----~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
.....-.+.... ........++.+++.+|++.||.+|||+.|++++-.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 288 (309)
T cd07872 233 SSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAY 288 (309)
T ss_pred cchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChh
Confidence 000000000000 001123456789999999999999999999998543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=320.27 Aligned_cols=267 Identities=27% Similarity=0.360 Sum_probs=199.5
Q ss_pred CCcccCcccccCceEEEEEEe----cCCCcEEEEEeeecc--ccHHHHHHHHHHHHhcCCCceeeEEEEEEe--CCeeEE
Q 002061 677 NLEEDNLIGSGGTGKVYRLDL----KKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLK--GGSSFL 748 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~----~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~l 748 (973)
+|++.+.||+|+||+||+|.. ..+++.||||++... ...+.+.+|++++++++||||+++++++.. ....++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 84 (284)
T cd05081 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL 84 (284)
T ss_pred cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEE
Confidence 678889999999999999984 356889999998653 335578899999999999999999998754 346899
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccc
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 828 (973)
||||+++|+|.+++... ...+++..+..++.|++.||+||| +++++||||||+||+++.++.++|+|||+++.
T Consensus 85 v~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 85 VMEYLPYGSLRDYLQKH----RERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEecCCCCHHHHHHhc----CcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCccccc
Confidence 99999999999999753 235789999999999999999999 78999999999999999999999999999986
Q ss_pred ccCCCCccc-ccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccc---c
Q 002061 829 AENSPKVSD-YSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHE---N 904 (973)
Q Consensus 829 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~---~ 904 (973)
......... .....++..|+|||++.+..++.++|||||||++|||++|..|+...... ............. .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 234 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE---FMRMMGNDKQGQMIVYH 234 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh---hhhhcccccccccchHH
Confidence 643322111 11122345699999999888999999999999999999988776432110 0000000000000 0
Q ss_pred cchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 905 VLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
+.+.+...............+.+++.+||+++|++|||+.|+++.|+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 235 LIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0000111111111122345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=313.68 Aligned_cols=253 Identities=30% Similarity=0.430 Sum_probs=201.5
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccC
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP 754 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 754 (973)
++|++.+.||+|+||.||+|.... +..||+|.+... ...+.+.+|+.++++++||+++++++++. +...+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNG-NTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecC-CceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 468899999999999999998774 668999988753 34567899999999999999999999875 456899999999
Q ss_pred CCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCC
Q 002061 755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK 834 (973)
Q Consensus 755 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 834 (973)
+++|.+++... ....+++..+..++.|++.|++||| +++++||||||+||++++++.++++|||.+........
T Consensus 84 ~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 84 KGSLLDFLKDG---EGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 99999999753 2345789999999999999999999 78999999999999999999999999999976543221
Q ss_pred cccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhccccc
Q 002061 835 VSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEV 913 (973)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (973)
. ......++..|+|||++.+..++.++||||||+++|||++ |..||.... ..+.... ......
T Consensus 158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~--~~~~~~~---~~~~~~---------- 221 (260)
T cd05070 158 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN--NREVLEQ---VERGYR---------- 221 (260)
T ss_pred c-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC--HHHHHHH---HHcCCC----------
Confidence 1 1112235678999999988889999999999999999999 899996531 1111111 111100
Q ss_pred cCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 914 ASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 914 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
..........+.+++.+|++++|++|||+.++.+.|++.
T Consensus 222 -~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 260 (260)
T cd05070 222 -MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLEDY 260 (260)
T ss_pred -CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 011122345688999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=325.92 Aligned_cols=260 Identities=28% Similarity=0.398 Sum_probs=205.6
Q ss_pred cCCcccCcccccCceEEEEEEecC-------CCcEEEEEeeecc---ccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCC
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKK-------NAGTVAVKQLWKG---DGVKVFAAEMEILGKI-RHRNILKLYACLLKGG 744 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~-------~~~~vavK~~~~~---~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 744 (973)
.+|++.+.||+|+||.||+|++.. .+..||+|.+... ...+.+.+|+++++++ +||||+++++++..++
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 368899999999999999998642 1336899987652 3356788999999999 8999999999999999
Q ss_pred eeEEEEEccCCCchHHHHHhhhc-----------CCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeec
Q 002061 745 SSFLVLEYMPNGNLFQALHKRVK-----------EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD 813 (973)
Q Consensus 745 ~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~ 813 (973)
..++||||+++|+|.+++..... .....+++..+..++.|++.|++||| +++++||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEc
Confidence 99999999999999999976421 12345788999999999999999999 78999999999999999
Q ss_pred CCCCeEEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHH
Q 002061 814 EDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIV 892 (973)
Q Consensus 814 ~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~ 892 (973)
.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||... +..
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-----~~~ 243 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI-----PVE 243 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC-----CHH
Confidence 999999999999976644322222222334578999999999999999999999999999998 88888543 122
Q ss_pred HHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 002061 893 YWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADAD 954 (973)
Q Consensus 893 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 954 (973)
........... ...+......+.+++.+|++.+|++||++.|++++|+++.
T Consensus 244 ~~~~~~~~~~~-----------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 244 ELFKLLKEGHR-----------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred HHHHHHHcCCC-----------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 22221111110 0111123456889999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=317.58 Aligned_cols=251 Identities=26% Similarity=0.364 Sum_probs=208.8
Q ss_pred CcccCcccccCceEEEEEEecCC----CcEEEEEeeec---cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 002061 678 LEEDNLIGSGGTGKVYRLDLKKN----AGTVAVKQLWK---GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL 750 (973)
Q Consensus 678 ~~~~~~lG~G~~g~V~~a~~~~~----~~~vavK~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 750 (973)
.+..+.||.|.||.||+|..... .-.||||..+. .++.+.|..|..+++.++||||++++|++.+. ..|+||
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wivm 469 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVM 469 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEE
Confidence 35678899999999999988532 33589998776 35577899999999999999999999998765 689999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccccc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 830 (973)
|.++-|.|..|++.+ ...++......+++||+.||+||| +...|||||.++|||+....-||++|||+++.++
T Consensus 470 EL~~~GELr~yLq~n----k~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e 542 (974)
T KOG4257|consen 470 ELAPLGELREYLQQN----KDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLE 542 (974)
T ss_pred ecccchhHHHHHHhc----cccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhcc
Confidence 999999999999864 456888888999999999999999 8899999999999999999999999999999887
Q ss_pred CCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhc
Q 002061 831 NSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVL 909 (973)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (973)
........ ...-+.-|||||.+.-.+++.++|||-|||.+||++. |..||.+- .+.+.+..+-
T Consensus 543 d~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgv---------------kNsDVI~~iE 606 (974)
T KOG4257|consen 543 DDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGV---------------KNSDVIGHIE 606 (974)
T ss_pred ccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccc---------------cccceEEEec
Confidence 66554333 3344678999999999999999999999999999988 99999764 2222222222
Q ss_pred cccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 910 DCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 910 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
. .-....++.++..++.++.+||++||.+||++.|+...|.++
T Consensus 607 n-GeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv 649 (974)
T KOG4257|consen 607 N-GERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV 649 (974)
T ss_pred C-CCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence 2 222344667788899999999999999999999998888754
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=315.37 Aligned_cols=255 Identities=25% Similarity=0.312 Sum_probs=192.0
Q ss_pred CcccccCceEEEEEEecC--CCcEEEEEeeeccc---cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCC
Q 002061 682 NLIGSGGTGKVYRLDLKK--NAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNG 756 (973)
Q Consensus 682 ~~lG~G~~g~V~~a~~~~--~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 756 (973)
+.||+|+||.||+|.... ++..+|+|.+.... ....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998653 45679999886532 3346888999999999999999999999989999999999999
Q ss_pred chHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCcc
Q 002061 757 NLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVS 836 (973)
Q Consensus 757 sL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 836 (973)
+|.+++...........++..+..++.|++.|++||| +.+++||||||+||+++.++.++++|||.+..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999997643323334677788889999999999999 7899999999999999999999999999987543332222
Q ss_pred cccccCCccccccccccccC-------CCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchh
Q 002061 837 DYSCFAGTHGYIAPELAYTC-------KVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKV 908 (973)
Q Consensus 837 ~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (973)
......++..|+|||++.+. .++.++||||||+++|||++ |+.||..... .+..... .... ....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~--~~~~~~~---~~~~--~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD--EQVLTYT---VREQ--QLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh--HHHHHHH---hhcc--cCCC
Confidence 22234577889999998642 35789999999999999996 9999965321 1111111 0000 0111
Q ss_pred ccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 909 LDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 909 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
.++... ....+.+.+++..|+ .+|++|||+.||++.|+
T Consensus 231 ~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 111111 112334677888998 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=324.18 Aligned_cols=254 Identities=29% Similarity=0.380 Sum_probs=207.4
Q ss_pred CHHHHcCCcccCcccccCceEEEEEEecCC---CcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCC
Q 002061 671 DAEQICNLEEDNLIGSGGTGKVYRLDLKKN---AGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGG 744 (973)
Q Consensus 671 ~~~~~~~~~~~~~lG~G~~g~V~~a~~~~~---~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 744 (973)
.++++ ...++||+|.||.||+|.|... -..||||.+... ....+|.+|+.+|.+++|||++++||+..+ .
T Consensus 108 pee~i---~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-q 183 (1039)
T KOG0199|consen 108 PEEQI---KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-Q 183 (1039)
T ss_pred cHHHH---HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-c
Confidence 34444 4457799999999999999743 335999998763 356789999999999999999999999877 6
Q ss_pred eeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEeccc
Q 002061 745 SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFG 824 (973)
Q Consensus 745 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 824 (973)
..+||||.++.|+|.+.|++ .....+.....+.++.|||.||.||. +++.||||+.++|+++.....|||+|||
T Consensus 184 p~mMV~ELaplGSLldrLrk---a~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFG 257 (1039)
T KOG0199|consen 184 PAMMVFELAPLGSLLDRLRK---AKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFG 257 (1039)
T ss_pred hhhHHhhhcccchHHHHHhh---ccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeeccc
Confidence 78899999999999999986 34567888999999999999999999 8899999999999999999999999999
Q ss_pred CcccccCCCCccccc-ccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccc
Q 002061 825 VAKIAENSPKVSDYS-CFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNH 902 (973)
Q Consensus 825 l~~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~ 902 (973)
+++-.+.+.....+. ...-.+.|+|||.++..+++.++|||+|||++|||+| |+.||.+-. +.+
T Consensus 258 LmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~--g~q------------ 323 (1039)
T KOG0199|consen 258 LMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR--GIQ------------ 323 (1039)
T ss_pred ceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC--HHH------------
Confidence 999876554333222 1234678999999999999999999999999999999 899996541 111
Q ss_pred cccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 903 ENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
+.+.+|..-.-..++.+.+++++++..||...|++|||+..+.+.+
T Consensus 324 --IL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 324 --ILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred --HHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 1222222222334566788999999999999999999999997443
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=318.45 Aligned_cols=258 Identities=25% Similarity=0.365 Sum_probs=202.0
Q ss_pred cCCcccCcccccCceEEEEEEec-----CCCcEEEEEeeecc--ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLK-----KNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL 748 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~-----~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 748 (973)
.+|...++||+|+||.||+|... .++..+|+|.+... .....+.+|++++++++||||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 35678899999999999999753 34668999987652 345678999999999999999999999999999999
Q ss_pred EEEccCCCchHHHHHhhhcC----------CCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCe
Q 002061 749 VLEYMPNGNLFQALHKRVKE----------GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP 818 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~----------~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~ 818 (973)
||||+++|+|.+++...... ....+++..+..++.|++.|++||| +.+++||||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCE
Confidence 99999999999999764211 1135789999999999999999999 8899999999999999999999
Q ss_pred EEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHH
Q 002061 819 KIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVST 897 (973)
Q Consensus 819 kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~ 897 (973)
+|+|||++................+++.|+|||++.+..++.++|||||||++|||++ |+.||.... ..+. ...
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--~~~~---~~~ 236 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS--NTEA---IEC 236 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCC--HHHH---HHH
Confidence 9999999875543222111222345678999999998899999999999999999998 999986431 1111 111
Q ss_pred HhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 002061 898 HLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952 (973)
Q Consensus 898 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~ 952 (973)
...... ...+......+.+++.+||+.||++||++.||.+.|+.
T Consensus 237 ~~~~~~-----------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 237 ITQGRE-----------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHcCcc-----------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 111100 00111223457899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=328.82 Aligned_cols=262 Identities=29% Similarity=0.385 Sum_probs=200.9
Q ss_pred cCCcccCcccccCceEEEEEEec-----CCCcEEEEEeeecc---ccHHHHHHHHHHHHhc-CCCceeeEEEEEEe-CCe
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLK-----KNAGTVAVKQLWKG---DGVKVFAAEMEILGKI-RHRNILKLYACLLK-GGS 745 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~-----~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~-~~~ 745 (973)
++|++.+.||+|+||+||+|.+. .+++.||||++... .....+.+|+.++.++ +||||+++++++.. +..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 47899999999999999999853 45778999998653 2345678899999999 68999999998765 456
Q ss_pred eEEEEEccCCCchHHHHHhhhcC---------------------------------------------------------
Q 002061 746 SFLVLEYMPNGNLFQALHKRVKE--------------------------------------------------------- 768 (973)
Q Consensus 746 ~~lv~e~~~~gsL~~~l~~~~~~--------------------------------------------------------- 768 (973)
.++||||+++|+|.+++......
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 78999999999999998753110
Q ss_pred -----CCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCcccccccCC
Q 002061 769 -----GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAG 843 (973)
Q Consensus 769 -----~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g 843 (973)
....+++..+..++.|++.|++||| +++++||||||+||+++.++.+|++|||++................+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 0123678888999999999999999 88999999999999999999999999999876533222112222345
Q ss_pred ccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhccccccCcchHHHH
Q 002061 844 THGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDM 922 (973)
Q Consensus 844 t~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (973)
+..|+|||++.+..++.++||||||+++|||++ |..||...... ...... ....... ..+ ....
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~~~~~~----~~~~~~~---~~~-------~~~~ 308 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-EEFCRR----LKEGTRM---RAP-------DYTT 308 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc-HHHHHH----HhccCCC---CCC-------CCCC
Confidence 678999999988899999999999999999997 99998653211 111111 1111100 000 0122
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 002061 923 IKLLKIAVVCTTKLPNLRPPMREVVKMLADADP 955 (973)
Q Consensus 923 ~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 955 (973)
.++.+++..||+.+|++||++.|++++|+.+..
T Consensus 309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 457889999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=315.41 Aligned_cols=255 Identities=27% Similarity=0.449 Sum_probs=203.0
Q ss_pred cCCcccCcccccCceEEEEEEecCCCc---EEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAG---TVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV 749 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~---~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 749 (973)
.+|+..+.||+|+||.||+|+...+++ .||+|++... ...+.+.+|++++++++|||++++++++...+..|+|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 467888999999999999999876554 7999987653 2345688999999999999999999999999999999
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccc
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 829 (973)
|||+++++|.+++... ...+++..+..++.|++.|++|+| +.+++||||||+||+++.++.++++|||++...
T Consensus 85 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 85 TEYMENGALDKYLRDH----DGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEcCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceec
Confidence 9999999999998753 245789999999999999999999 789999999999999999999999999998766
Q ss_pred cCCCCcc-cccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccch
Q 002061 830 ENSPKVS-DYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLK 907 (973)
Q Consensus 830 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
....... .......+..|+|||++.+..++.++|||||||++||+++ |+.||.... .......+. .. ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~--~~~~~~~i~---~~-~~~-- 229 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS--NHEVMKAIN---DG-FRL-- 229 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC--HHHHHHHHh---cC-CCC--
Confidence 4322111 1111223467999999988889999999999999999997 999996431 111111111 10 000
Q ss_pred hccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 908 VLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 908 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
....+....+.+++.+||+.+|++||++.+|++.|+++
T Consensus 230 --------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 230 --------PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01112345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=326.21 Aligned_cols=241 Identities=28% Similarity=0.347 Sum_probs=191.2
Q ss_pred CcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHH-HHHhcCCCceeeEEEEEEeCCeeEEEEEccCC
Q 002061 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEME-ILGKIRHRNILKLYACLLKGGSSFLVLEYMPN 755 (973)
Q Consensus 682 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 755 (973)
+.||+|+||+||+|++..+++.||||++... .....+.+|.. +++.++||||+++++++..++..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4689999999999999999999999998653 22234445544 56789999999999999999999999999999
Q ss_pred CchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCc
Q 002061 756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV 835 (973)
Q Consensus 756 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 835 (973)
|+|.+++... ..+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++.......
T Consensus 81 g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-- 150 (323)
T cd05575 81 GELFFHLQRE-----RSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-- 150 (323)
T ss_pred CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--
Confidence 9999988752 35788889999999999999999 7899999999999999999999999999986432211
Q ss_pred ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccccC
Q 002061 836 SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVAS 915 (973)
Q Consensus 836 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||... +.............. .
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~-----~~~~~~~~i~~~~~~--------~-- 215 (323)
T cd05575 151 KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR-----DTAEMYDNILNKPLR--------L-- 215 (323)
T ss_pred CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC-----CHHHHHHHHHcCCCC--------C--
Confidence 1223356899999999999999999999999999999999999999653 122222222111110 0
Q ss_pred cchHHHHHHHHHHHHHhcCCCCCCCCCHH----HHHHH
Q 002061 916 ESIKEDMIKLLKIAVVCTTKLPNLRPPMR----EVVKM 949 (973)
Q Consensus 916 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~----evl~~ 949 (973)
.......+.+++.+|++.||.+||++. |++++
T Consensus 216 --~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~ 251 (323)
T cd05575 216 --KPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNH 251 (323)
T ss_pred --CCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence 112245678899999999999999884 65543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=325.03 Aligned_cols=262 Identities=27% Similarity=0.404 Sum_probs=204.7
Q ss_pred cCCcccCcccccCceEEEEEEec-------CCCcEEEEEeeecc---ccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCC
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLK-------KNAGTVAVKQLWKG---DGVKVFAAEMEILGKI-RHRNILKLYACLLKGG 744 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~-------~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 744 (973)
.+|.+.+.||+|+||.||+|+.. .....||+|++... .....+.+|+++++++ +||||+++++++..+.
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 47788999999999999999863 23457999987653 2345678899999999 6999999999999989
Q ss_pred eeEEEEEccCCCchHHHHHhhhc-----------CCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeec
Q 002061 745 SSFLVLEYMPNGNLFQALHKRVK-----------EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD 813 (973)
Q Consensus 745 ~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~ 813 (973)
..|+||||+++|+|.+++..... .....+++..+..++.|++.|++|+| +++++||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEEc
Confidence 99999999999999999976421 11245889999999999999999999 78999999999999999
Q ss_pred CCCCeEEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHH
Q 002061 814 EDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIV 892 (973)
Q Consensus 814 ~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~ 892 (973)
.++.+||+|||.++...............++..|+|||++.+..++.++|||||||++|||++ |..||.... .....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~--~~~~~ 246 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP--VEELF 246 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC--HHHHH
Confidence 999999999999976643222111222234568999999998899999999999999999999 889985431 11111
Q ss_pred HHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCC
Q 002061 893 YWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPC 956 (973)
Q Consensus 893 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~ 956 (973)
.... .... . ..+.....++.+++.+|++.+|++||++.|+++.|.++...
T Consensus 247 ~~~~----~~~~-~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 247 KLLR----EGHR-M---------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred HHHH----cCCC-C---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 1111 1110 0 01112234677899999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=324.25 Aligned_cols=247 Identities=24% Similarity=0.342 Sum_probs=195.6
Q ss_pred CcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEEEEccCC
Q 002061 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLVLEYMPN 755 (973)
Q Consensus 682 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~ 755 (973)
+.||+|+||+||+|+...+++.||||++... ...+.+.+|+.++.++ +||+|+++++++......|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999998753 2345578899999888 699999999999999999999999999
Q ss_pred CchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCc
Q 002061 756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV 835 (973)
Q Consensus 756 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 835 (973)
|+|.+++... ..+++..+..++.|++.|++||| +++++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~L~~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-- 150 (327)
T cd05617 81 GDLMFHMQRQ-----RKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-- 150 (327)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC--
Confidence 9999888642 35889999999999999999999 7899999999999999999999999999987432211
Q ss_pred ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCC-cccHHHHHHHHhccccccchhcccccc
Q 002061 836 SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGD-GKDIVYWVSTHLNNHENVLKVLDCEVA 914 (973)
Q Consensus 836 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (973)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .................
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---------- 220 (327)
T cd05617 151 DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI---------- 220 (327)
T ss_pred CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC----------
Confidence 1122356899999999999999999999999999999999999999643221 11111111111111110
Q ss_pred CcchHHHHHHHHHHHHHhcCCCCCCCCCH------HHHHHH
Q 002061 915 SESIKEDMIKLLKIAVVCTTKLPNLRPPM------REVVKM 949 (973)
Q Consensus 915 ~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~------~evl~~ 949 (973)
..+......+.+++.+|++.||.+|+++ .++.+|
T Consensus 221 -~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 221 -RIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred -CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 0111223457789999999999999984 577665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=311.56 Aligned_cols=251 Identities=25% Similarity=0.361 Sum_probs=206.7
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCC
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPN 755 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 755 (973)
++|+..+.||+|+||.||+|+...+++.||+|.+......+++.+|++++++++||||+++++++.++...|+++||+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 82 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGA 82 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCC
Confidence 47889999999999999999999888999999987765577899999999999999999999999999999999999999
Q ss_pred CchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCc
Q 002061 756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV 835 (973)
Q Consensus 756 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 835 (973)
++|.+++... ...+++..+..++.|++.|++||| +.+++||||+|+||+++.++.++|+|||++........
T Consensus 83 ~~L~~~l~~~----~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 83 GSVSDIMKIT----NKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CcHHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 9999998643 346899999999999999999999 78999999999999999999999999999876644321
Q ss_pred ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccccC
Q 002061 836 SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVAS 915 (973)
Q Consensus 836 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
......++..|+|||++.+..++.++||||||+++|+|++|+.||...... ... ........ . ..
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~--~~~---~~~~~~~~-------~--~~ 219 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPM--RAI---FMIPNKPP-------P--TL 219 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchh--hhh---hhhccCCC-------C--CC
Confidence 222345788999999999889999999999999999999999999753211 100 00000000 0 01
Q ss_pred cchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 916 ESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 916 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
.........+.+++.+|++.+|++||++.|++++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 1122334568899999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=316.92 Aligned_cols=252 Identities=25% Similarity=0.304 Sum_probs=201.0
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE 751 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 751 (973)
.|+..+.||+|+||+||+|.+..+++.||||.+... .....+.+|+.++++++|++++++++.+..++..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 367778899999999999999999999999987652 123456789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccC
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 831 (973)
|+++|+|.+++... ....+++..+..++.|++.|++||| +.+++||||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~g~~L~~~l~~~---~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05630 81 LMNGGDLKFHIYHM---GEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 154 (285)
T ss_pred ecCCCcHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCC
Confidence 99999999988653 2235788999999999999999999 88999999999999999999999999999875533
Q ss_pred CCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccc
Q 002061 832 SPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDC 911 (973)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (973)
... .....|+..|+|||++.+..++.++||||+||++|||++|+.||....... ............. .
T Consensus 155 ~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~--~~~~~~~~~~~~~-------~ 222 (285)
T cd05630 155 GQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI--KREEVERLVKEVQ-------E 222 (285)
T ss_pred Ccc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc--hHHHHHhhhhhhh-------h
Confidence 221 123468999999999999899999999999999999999999997542111 0001111100000 0
Q ss_pred cccCcchHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHh
Q 002061 912 EVASESIKEDMIKLLKIAVVCTTKLPNLRPP-----MREVVKML 950 (973)
Q Consensus 912 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt-----~~evl~~L 950 (973)
.........+.+++.+||+.||++||+ +.|+++|-
T Consensus 223 ----~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~ 262 (285)
T cd05630 223 ----EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHP 262 (285)
T ss_pred ----hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcCh
Confidence 011122345788999999999999999 88998853
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=312.77 Aligned_cols=249 Identities=22% Similarity=0.332 Sum_probs=202.5
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeec---cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK---GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM 753 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 753 (973)
+|++.+.||+|+||.||++++..+++.||+|.+.. ....+.+.+|+.++++++||||+++++++..++..|+||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 47888999999999999999999999999998754 234567788999999999999999999999999999999999
Q ss_pred CCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCC
Q 002061 754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833 (973)
Q Consensus 754 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 833 (973)
++|+|.+++... ....++......++.|++.|++||| +++++|+||||+||++++++.++++|||.+.......
T Consensus 81 ~~~~l~~~~~~~---~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 81 DGGDLMQKIKLQ---RGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred CCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence 999999988643 2334788889999999999999999 8899999999999999999999999999987654322
Q ss_pred CcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccc
Q 002061 834 KVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEV 913 (973)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (973)
. ......|+..|+|||++.+..++.++||||+|+++|+|++|+.||... +............. .
T Consensus 155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~-----~~~~~~~~~~~~~~--~------- 218 (255)
T cd08219 155 A--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN-----SWKNLILKVCQGSY--K------- 218 (255)
T ss_pred c--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCC-----CHHHHHHHHhcCCC--C-------
Confidence 1 112346888999999999888999999999999999999999999643 11111111111110 0
Q ss_pred cCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 914 ASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 914 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
..+......+.+++.+||+.||++||++.|++..
T Consensus 219 --~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 --PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred --CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0111233457889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=317.48 Aligned_cols=262 Identities=21% Similarity=0.212 Sum_probs=195.5
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhc---CCCceeeEEEEEEe-----CC
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKI---RHRNILKLYACLLK-----GG 744 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~-----~~ 744 (973)
+|++.+.||+|+||+||+|++..+++.||+|.+... .....+.+|+++++++ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 478889999999999999999999999999988642 1223456777777665 79999999998864 34
Q ss_pred eeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEeccc
Q 002061 745 SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFG 824 (973)
Q Consensus 745 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 824 (973)
..++||||++ ++|.+++... ....+++..+..++.|++.||+|+| +.+++||||||+||+++.++.+||+|||
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg 153 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKV---PPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFG 153 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccC
Confidence 5799999996 5898888753 2345889999999999999999999 7899999999999999999999999999
Q ss_pred CcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhc-ccc
Q 002061 825 VAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLN-NHE 903 (973)
Q Consensus 825 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~-~~~ 903 (973)
++....... ......|+..|+|||++.+..++.++||||+||++|||++|+.||..... ............. ...
T Consensus 154 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~-~~~~~~~~~~~~~~~~~ 229 (288)
T cd07863 154 LARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE-ADQLGKIFDLIGLPPED 229 (288)
T ss_pred ccccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCH-HHHHHHHHHHhCCCChh
Confidence 997654322 12234678999999999988999999999999999999999999964311 1111111110000 000
Q ss_pred ccc-------hhccccc---cCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 904 NVL-------KVLDCEV---ASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 904 ~~~-------~~~~~~~---~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
... ....+.. ......+...++.+++.+|+++||++|||+.|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000 0000000 001112234567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=312.50 Aligned_cols=252 Identities=27% Similarity=0.408 Sum_probs=201.6
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeec-cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccC
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK-GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP 754 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 754 (973)
++|++.++||+|+||.||+|.... ++.||+|.+.. ....+++.+|+.++++++||||+++++++. .+..+++|||++
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~-~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYNG-HTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYME 83 (260)
T ss_pred HHceeeeeeccCccceEEeeecCC-CceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCC
Confidence 568889999999999999999765 77899998876 344567899999999999999999999864 557899999999
Q ss_pred CCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCC
Q 002061 755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK 834 (973)
Q Consensus 755 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 834 (973)
+|+|.+++... ....+++..+..++.|++.|++||| +.+++||||||+||+++.++.++++|||++........
T Consensus 84 ~~~L~~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 84 NGSLVDFLKTP---EGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 99999998653 2346889999999999999999999 88999999999999999999999999999876542221
Q ss_pred cccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhccccc
Q 002061 835 VSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEV 913 (973)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (973)
.......++..|+|||++.+..++.++||||||+++||+++ |+.||.... ......... ....
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~~~~~~~~---~~~~---------- 221 (260)
T cd05067 158 -TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT--NPEVIQNLE---RGYR---------- 221 (260)
T ss_pred -ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC--hHHHHHHHH---cCCC----------
Confidence 11122345678999999988889999999999999999999 999996431 111111111 1100
Q ss_pred cCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 002061 914 ASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952 (973)
Q Consensus 914 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~ 952 (973)
.........++.+++.+|++.+|++||+++++.+.|+.
T Consensus 222 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 222 -MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 00111223468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=321.23 Aligned_cols=200 Identities=26% Similarity=0.388 Sum_probs=164.4
Q ss_pred cCcccccCceEEEEEEec--CCCcEEEEEeeeccccHHHHHHHHHHHHhcCCCceeeEEEEEEe--CCeeEEEEEccCCC
Q 002061 681 DNLIGSGGTGKVYRLDLK--KNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLK--GGSSFLVLEYMPNG 756 (973)
Q Consensus 681 ~~~lG~G~~g~V~~a~~~--~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~lv~e~~~~g 756 (973)
.++||+|+||+||+|++. .+++.||+|++........+.+|++++++++||||+++++++.. +...|+||||++ +
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-H 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-C
Confidence 467999999999999975 35788999998766555667899999999999999999998854 456899999995 6
Q ss_pred chHHHHHhhhcC----CCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeee----cCCCCeEEecccCccc
Q 002061 757 NLFQALHKRVKE----GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILL----DEDYEPKIADFGVAKI 828 (973)
Q Consensus 757 sL~~~l~~~~~~----~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill----~~~~~~kl~Dfgl~~~ 828 (973)
+|.+++...... ....+++..+..++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||+++.
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 888887643211 1234788899999999999999999 7899999999999999 4567899999999986
Q ss_pred ccCCCC-cccccccCCccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcc
Q 002061 829 AENSPK-VSDYSCFAGTHGYIAPELAYTC-KVSEKSDVFSFGVVLLELVTGRKPVEEE 884 (973)
Q Consensus 829 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~pf~~~ 884 (973)
...... ........||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 643321 1222345789999999998764 5889999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=316.12 Aligned_cols=255 Identities=26% Similarity=0.441 Sum_probs=203.0
Q ss_pred cCCcccCcccccCceEEEEEEecCCCc---EEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAG---TVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV 749 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~---~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 749 (973)
.+|++.+.||+|+||.||+|....+++ .||||++... ....++.+|++++++++||||+++++++..+...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 457888999999999999999986654 5999988653 2356788999999999999999999999999999999
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccc
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 829 (973)
|||+++|+|.+++... ...+++..+..++.|++.|++||| +.+++||||||+||+++.++.++++|||++...
T Consensus 84 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~ 156 (269)
T cd05065 84 TEFMENGALDSFLRQN----DGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 156 (269)
T ss_pred EecCCCCcHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCcccccc
Confidence 9999999999998753 345789999999999999999999 789999999999999999999999999998765
Q ss_pred cCCCCcccccc-c--CCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhcccccc
Q 002061 830 ENSPKVSDYSC-F--AGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENV 905 (973)
Q Consensus 830 ~~~~~~~~~~~-~--~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 905 (973)
........... . ..+..|+|||++.+..++.++||||+||++||+++ |..||... ...+....+. .... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~--~~~~~~~~i~---~~~~-~ 230 (269)
T cd05065 157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM--SNQDVINAIE---QDYR-L 230 (269)
T ss_pred ccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCC--CHHHHHHHHH---cCCc-C
Confidence 43322111111 1 12457999999998899999999999999999886 99999653 1112222221 1100 0
Q ss_pred chhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 906 LKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
....+.+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 231 ----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 231 ----------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ----------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 01112345578899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=330.23 Aligned_cols=263 Identities=26% Similarity=0.267 Sum_probs=199.3
Q ss_pred HHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeC-----
Q 002061 673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKG----- 743 (973)
Q Consensus 673 ~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~----- 743 (973)
...++|++.+.||+|+||.||+|++..+++.||||++... .....+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 4567999999999999999999999988999999988652 2345677899999999999999999988643
Q ss_pred -CeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEec
Q 002061 744 -GSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIAD 822 (973)
Q Consensus 744 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 822 (973)
...|+||||+++ ++.+++.. .+++..+..++.|+++||+||| +++|+||||||+||+++.++.+||+|
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~D 162 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILD 162 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEee
Confidence 357999999964 67666643 3778888999999999999999 88999999999999999999999999
Q ss_pred ccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHH--------
Q 002061 823 FGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYW-------- 894 (973)
Q Consensus 823 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~-------- 894 (973)
||+++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||...... ......
T Consensus 163 fg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~ 238 (355)
T cd07874 163 FGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQLGTPC 238 (355)
T ss_pred CcccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCC
Confidence 99997554321 122346899999999999989999999999999999999999999653210 000000
Q ss_pred ----------HHHHhccccccchhcccc------c--cCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 895 ----------VSTHLNNHENVLKVLDCE------V--ASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 895 ----------~~~~~~~~~~~~~~~~~~------~--~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
+.......+.......+. . ...........+.+++.+|++.||++|||+.|++++-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp 312 (355)
T cd07874 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHP 312 (355)
T ss_pred HHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCc
Confidence 000000100000000000 0 0001112235678999999999999999999999973
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=316.03 Aligned_cols=252 Identities=27% Similarity=0.367 Sum_probs=199.3
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-ccHHHHHHHHHHHHhc-CCCceeeEEEEEEeC------Cee
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKI-RHRNILKLYACLLKG------GSS 746 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~------~~~ 746 (973)
.+.|++.+.||+|+||+||+|+...+++.||+|++... .....+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 84 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence 45688889999999999999999999999999988653 4456788999999998 799999999998653 468
Q ss_pred EEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCc
Q 002061 747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826 (973)
Q Consensus 747 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~ 826 (973)
|+||||+++|+|.+++... ....+++..+..++.|++.|++||| +++++||||||+||++++++.++|+|||++
T Consensus 85 ~iv~e~~~~~~L~~~l~~~---~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 85 WLVMEFCGAGSVTDLIKNT---KGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred EEEEEcCCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 9999999999999998753 2345789999999999999999999 789999999999999999999999999998
Q ss_pred ccccCCCCcccccccCCccccccccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcc
Q 002061 827 KIAENSPKVSDYSCFAGTHGYIAPELAY-----TCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNN 901 (973)
Q Consensus 827 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 901 (973)
....... .......|+..|+|||++. +..++.++||||+||++|||++|+.||..... .... ......
T Consensus 159 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~----~~~~-~~~~~~ 231 (272)
T cd06637 159 AQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP----MRAL-FLIPRN 231 (272)
T ss_pred eeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH----HHHH-HHHhcC
Confidence 7654321 1223356889999999986 34578899999999999999999999964311 1111 000000
Q ss_pred ccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 902 HENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
. . ... ........+.+++.+||+.+|.+||++.|++++
T Consensus 232 ~--~-----~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 232 P--A-----PRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred C--C-----CCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 0 0 000 111233467899999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=322.86 Aligned_cols=246 Identities=26% Similarity=0.340 Sum_probs=196.1
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcC-CCceeeEEEEEEeCCeeEEEE
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIR-HRNILKLYACLLKGGSSFLVL 750 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~ 750 (973)
+|+..+.||+|+||+||+|++..+++.||||++.+. ...+.+..|..+++.+. |++|+++++++..++..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 467788999999999999999999999999998752 23455678888888885 578888999999999999999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccccc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 830 (973)
||+++|+|.+++... ..+++..+..++.|++.|++||| +++++||||||+||+++.++.+||+|||+++...
T Consensus 81 Ey~~~g~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~ 152 (323)
T cd05615 81 EYVNGGDLMYHIQQV-----GKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHM 152 (323)
T ss_pred cCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccC
Confidence 999999999988653 35889999999999999999999 7899999999999999999999999999987543
Q ss_pred CCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhcc
Q 002061 831 NSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLD 910 (973)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (973)
.... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..............
T Consensus 153 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~-----~~~~~~~i~~~~~~------ 219 (323)
T cd05615 153 VDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED-----EDELFQSIMEHNVS------ 219 (323)
T ss_pred CCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhCCCC------
Confidence 2211 1223468999999999998899999999999999999999999997541 11111111111110
Q ss_pred ccccCcchHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHH
Q 002061 911 CEVASESIKEDMIKLLKIAVVCTTKLPNLRPPM-----REVVKM 949 (973)
Q Consensus 911 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~-----~evl~~ 949 (973)
.+......+.+++.+|++.+|.+|++. .++.+|
T Consensus 220 ------~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05615 220 ------YPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREH 257 (323)
T ss_pred ------CCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence 011223457789999999999999974 455554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=327.88 Aligned_cols=255 Identities=24% Similarity=0.308 Sum_probs=200.6
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL 748 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 748 (973)
..++|++.+.||+|+||.||+|++..+++.||+|++... ...+.+.+|+.+++.++||||+++++++..+...|+
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 120 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 457899999999999999999999999999999998642 234457789999999999999999999999999999
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccc
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 828 (973)
||||+++|+|.+++... .++...+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++..
T Consensus 121 v~Ey~~gg~L~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~ 191 (371)
T cd05622 121 VMEYMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (371)
T ss_pred EEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence 99999999999998643 3677788889999999999999 88999999999999999999999999999976
Q ss_pred ccCCCCcccccccCCccccccccccccC----CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccc
Q 002061 829 AENSPKVSDYSCFAGTHGYIAPELAYTC----KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHEN 904 (973)
Q Consensus 829 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 904 (973)
...... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||... +..............
T Consensus 192 ~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~-----~~~~~~~~i~~~~~~ 265 (371)
T cd05622 192 MNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD-----SLVGTYSKIMNHKNS 265 (371)
T ss_pred cCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC-----CHHHHHHHHHcCCCc
Confidence 543221 112235689999999998654 3788999999999999999999999653 111222222111110
Q ss_pred cchhccccccCcchHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHHhh
Q 002061 905 VLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNL--RPPMREVVKMLA 951 (973)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rpt~~evl~~L~ 951 (973)
..+ .........+.+++..|++..+.+ |+++.|+++|..
T Consensus 266 -~~~-------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~ 306 (371)
T cd05622 266 -LTF-------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 306 (371)
T ss_pred -ccC-------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence 001 111223456778889999844433 789999998753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=311.04 Aligned_cols=250 Identities=31% Similarity=0.458 Sum_probs=204.3
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecccc-HHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG-VKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM 753 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 753 (973)
..+|++.+.||.|+||.||+|... ++.||||.+..... .+++.+|+.++++++|+||+++++++..+...++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 357888999999999999999876 78999999877543 667889999999999999999999999899999999999
Q ss_pred CCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCC
Q 002061 754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833 (973)
Q Consensus 754 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 833 (973)
++++|.+++... ....+++..+..++.|++.|++||| +.+++||||||+||+++.++.++|+|||.++......
T Consensus 83 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 83 AKGSLVDYLRSR---GRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred CCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 999999999753 2235899999999999999999999 8899999999999999999999999999987653221
Q ss_pred CcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhcccc
Q 002061 834 KVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCE 912 (973)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (973)
. ....+..|+|||++.+..++.++||||||+++||+++ |+.||.... ..+....+. ...
T Consensus 157 ~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--~~~~~~~~~----~~~--------- 216 (256)
T cd05039 157 D-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--LKDVVPHVE----KGY--------- 216 (256)
T ss_pred c-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHh----cCC---------
Confidence 1 2234678999999988889999999999999999997 999986431 111111111 110
Q ss_pred ccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 913 VASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 913 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
....+...+..+.+++.+|++.+|++||++.|++++|+.+
T Consensus 217 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 217 -RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred -CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 0011112345688999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=315.83 Aligned_cols=250 Identities=25% Similarity=0.306 Sum_probs=200.0
Q ss_pred CcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 002061 678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY 752 (973)
Q Consensus 678 ~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 752 (973)
|+..+.||+|+||+||+|.+..+++.||+|++... .....+.+|++++++++|++++++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 66778899999999999999999999999988653 2234567899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCC
Q 002061 753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832 (973)
Q Consensus 753 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 832 (973)
+++++|.+++... ....+++..+..++.|++.|+.||| +++|+||||||+||+++.++.++|+|||++......
T Consensus 82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 82 MNGGDLKFHIYNM---GNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred ccCccHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 9999999888643 2345899999999999999999999 889999999999999999999999999998654322
Q ss_pred CCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhcccc
Q 002061 833 PKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCE 912 (973)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (973)
. ......|+..|+|||++.+..++.++|+||+||++|||++|+.||..... ......+......... .
T Consensus 156 ~---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~--~~~~~~~~~~~~~~~~-------~ 223 (285)
T cd05632 156 E---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE--KVKREEVDRRVLETEE-------V 223 (285)
T ss_pred C---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhhhcccc-------c
Confidence 1 12234689999999999988999999999999999999999999975311 1111111111111110 0
Q ss_pred ccCcchHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 002061 913 VASESIKEDMIKLLKIAVVCTTKLPNLRPP-----MREVVKM 949 (973)
Q Consensus 913 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt-----~~evl~~ 949 (973)
........+.+++.+|++.||++||+ +.+++++
T Consensus 224 ----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 224 ----YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ----cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 11122345778999999999999999 7777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=311.12 Aligned_cols=247 Identities=24% Similarity=0.316 Sum_probs=193.9
Q ss_pred cccccCceEEEEEEec--CCCcEEEEEeeeccc---cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCCc
Q 002061 683 LIGSGGTGKVYRLDLK--KNAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGN 757 (973)
Q Consensus 683 ~lG~G~~g~V~~a~~~--~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gs 757 (973)
.||+|+||.||+|.+. ..+..||+|+..... ..+.+.+|+.++++++||||+++++++. ....++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999875 445679999886532 2456889999999999999999999875 457899999999999
Q ss_pred hHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCc-c
Q 002061 758 LFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV-S 836 (973)
Q Consensus 758 L~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~ 836 (973)
|.+++... ...+++..+..++.|++.|++||| +++++||||||+||+++.++.+|++|||++......... .
T Consensus 81 L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 153 (257)
T cd05115 81 LNKFLSGK----KDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK 153 (257)
T ss_pred HHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCcccee
Confidence 99998743 345889999999999999999999 789999999999999999999999999998755432221 1
Q ss_pred cccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhccccccC
Q 002061 837 DYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVAS 915 (973)
Q Consensus 837 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
......++..|+|||++.+..++.++|||||||++||+++ |+.||.... ..+....+. .... .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~~~~~~~~----~~~~----------~ 217 (257)
T cd05115 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK--GPEVMSFIE----QGKR----------L 217 (257)
T ss_pred ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCC--HHHHHHHHH----CCCC----------C
Confidence 1122234578999999988889999999999999999996 999997541 111111111 1110 0
Q ss_pred cchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 916 ESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 916 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
..+.....++.+++.+||+.+|++||++.+|.+.|+.+
T Consensus 218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 11122345688899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=326.87 Aligned_cols=192 Identities=27% Similarity=0.406 Sum_probs=165.8
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccC
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP 754 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 754 (973)
..+|++.+.||+|+||.||+|++..+++.||+|+.... ....|+.++++++||||+++++++..+...++||||+
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~- 139 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY- 139 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc-
Confidence 34799999999999999999999988999999975432 2356999999999999999999999999999999999
Q ss_pred CCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCC
Q 002061 755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK 834 (973)
Q Consensus 755 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 834 (973)
.++|.+++... ...+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++......
T Consensus 140 ~~~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 211 (357)
T PHA03209 140 SSDLYTYLTKR----SRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP- 211 (357)
T ss_pred CCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccCc-
Confidence 56898888643 345889999999999999999999 7899999999999999999999999999987432221
Q ss_pred cccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCC
Q 002061 835 VSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPV 881 (973)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf 881 (973)
......||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 212 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 212 --AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred --ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 122346899999999999999999999999999999999855444
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=310.94 Aligned_cols=252 Identities=29% Similarity=0.418 Sum_probs=200.1
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccC
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP 754 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 754 (973)
++|++.+.||+|++|.||+|.+... ..||+|.+... ...+.+.+|++++++++|||++++++++. ++..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 4578889999999999999998764 47999987653 34467889999999999999999999875 456899999999
Q ss_pred CCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCC
Q 002061 755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK 834 (973)
Q Consensus 755 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 834 (973)
+|+|.+++... ....+++..+..++.|++.|++||| +.+++||||||+||++++++.++|+|||.+........
T Consensus 84 ~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 84 KGSLLDFLKEG---DGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCHHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 99999999753 2335789999999999999999999 78999999999999999999999999999976543321
Q ss_pred cccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhccccc
Q 002061 835 VSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEV 913 (973)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (973)
. ......++..|+|||+..+..++.++||||||+++|||++ |+.||.... ....... ......
T Consensus 158 ~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~~~~~~~---~~~~~~---------- 221 (260)
T cd05069 158 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV--NREVLEQ---VERGYR---------- 221 (260)
T ss_pred c-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHH---HHcCCC----------
Confidence 1 1112345678999999988889999999999999999999 899996531 1111111 111100
Q ss_pred cCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 002061 914 ASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952 (973)
Q Consensus 914 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~ 952 (973)
..........+.+++.+||+++|++||++.++++.|++
T Consensus 222 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 222 -MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 01112334568899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=314.63 Aligned_cols=252 Identities=30% Similarity=0.433 Sum_probs=199.0
Q ss_pred CcccccCceEEEEEEecCCC------cEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 002061 682 NLIGSGGTGKVYRLDLKKNA------GTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY 752 (973)
Q Consensus 682 ~~lG~G~~g~V~~a~~~~~~------~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 752 (973)
+.||+|+||.||+|+..... +.||||.+... .....+.+|+++++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 36899999999999986533 67999987553 3456788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhhcC--CCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCC-----CeEEecccC
Q 002061 753 MPNGNLFQALHKRVKE--GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY-----EPKIADFGV 825 (973)
Q Consensus 753 ~~~gsL~~~l~~~~~~--~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-----~~kl~Dfgl 825 (973)
+++|+|.+++...... ....+++.++..++.|++.|++|+| +.+++|+||||+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999764322 2344788999999999999999999 78999999999999999877 899999999
Q ss_pred cccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccc
Q 002061 826 AKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHEN 904 (973)
Q Consensus 826 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 904 (973)
+................++..|+|||++.+..++.++|||||||++|||++ |+.||.... ..+....+ ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~--~~~~~~~~----~~~~- 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN--NQEVLQHV----TAGG- 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC--HHHHHHHH----hcCC-
Confidence 876543322222222345688999999999999999999999999999998 999996431 11111111 1100
Q ss_pred cchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 002061 905 VLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952 (973)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~ 952 (973)
...........+.+++.+||+.+|++||++.++.+.|++
T Consensus 231 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 ---------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ---------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 001112234567899999999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=346.37 Aligned_cols=258 Identities=21% Similarity=0.330 Sum_probs=201.7
Q ss_pred HHHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeec----cccHHHHHHHHHHHHhcCCCceeeEEEEEEe--CCe
Q 002061 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKIRHRNILKLYACLLK--GGS 745 (973)
Q Consensus 672 ~~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~ 745 (973)
...+.+|++.+.||+|+||+||+|++..++..||+|++.. ......+.+|+.++++++||||++++++|.. ...
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 4566799999999999999999999999999999998864 2345668899999999999999999998854 456
Q ss_pred eEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcC----CCCeEecCCCCCCeeecC-------
Q 002061 746 SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC----SPPIIHRDIKSSNILLDE------- 814 (973)
Q Consensus 746 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~----~~~ivH~Dlkp~Nill~~------- 814 (973)
.|+||||+++|+|.+++.... .....+++..++.|+.||+.||+|||+.. ..+||||||||+|||++.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~-~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCY-KMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 899999999999999997642 22346899999999999999999999421 145999999999999964
Q ss_pred ----------CCCeEEecccCcccccCCCCcccccccCCcccccccccccc--CCCCccchHHHHHHHHHHHHhCCCCCC
Q 002061 815 ----------DYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYT--CKVSEKSDVFSFGVVLLELVTGRKPVE 882 (973)
Q Consensus 815 ----------~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~tg~~pf~ 882 (973)
.+.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~ 244 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244 (1021)
T ss_pred ccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 23489999999976543221 223468999999999854 458899999999999999999999996
Q ss_pred cccCCcccHHHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 883 EEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
.. ......+.... ..+.. ........+.+|+..||+.+|.+||++.|++++
T Consensus 245 ~~----~~~~qli~~lk-~~p~l-----------pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 245 KA----NNFSQLISELK-RGPDL-----------PIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred cC----CcHHHHHHHHh-cCCCC-----------CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 43 12222222211 11100 001123567889999999999999999999953
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=316.92 Aligned_cols=261 Identities=25% Similarity=0.314 Sum_probs=206.0
Q ss_pred HcCCcccCcccccCceEEEEEEecC----CCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEe-CCee
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKK----NAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLK-GGSS 746 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~----~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~ 746 (973)
.++|++.+.||+|+||.||+|.+.. .+..||+|++... ...+.+.+|+.++++++||||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 3578889999999999999999875 2578999987653 335667889999999999999999998765 5778
Q ss_pred EEEEEccCCCchHHHHHhhhcC---CCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecc
Q 002061 747 FLVLEYMPNGNLFQALHKRVKE---GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADF 823 (973)
Q Consensus 747 ~lv~e~~~~gsL~~~l~~~~~~---~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 823 (973)
++++||+++|+|.+++...... ....+++..+..++.|++.|++||| +.+++||||||+||++++++.+|++||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999999764211 1246889999999999999999999 789999999999999999999999999
Q ss_pred cCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccc
Q 002061 824 GVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNH 902 (973)
Q Consensus 824 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~ 902 (973)
|+++.+.............++..|+|||++.+..++.++|||||||++||+++ |+.||... ...++..++.. ..
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~--~~~~~~~~~~~---~~ 236 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI--DPFEMAAYLKD---GY 236 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC--CHHHHHHHHHc---CC
Confidence 99986543322212222345778999999988889999999999999999999 99999653 11122111111 10
Q ss_pred cccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 002061 903 ENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADAD 954 (973)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 954 (973)
. . .........+.+++.+||+.||++||++.++++.|+++.
T Consensus 237 ~-~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 237 R-L----------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred C-C----------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 0 0 011122346789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=311.31 Aligned_cols=246 Identities=26% Similarity=0.319 Sum_probs=194.5
Q ss_pred cccccCceEEEEEEe--cCCCcEEEEEeeeccc----cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCC
Q 002061 683 LIGSGGTGKVYRLDL--KKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNG 756 (973)
Q Consensus 683 ~lG~G~~g~V~~a~~--~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 756 (973)
.||+|+||+||+|.+ ..++..||+|++.... ..+.+.+|+.++++++||||+++++++. ++..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999975 3557899999886532 3456888999999999999999999875 45678999999999
Q ss_pred chHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCcc
Q 002061 757 NLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVS 836 (973)
Q Consensus 757 sL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 836 (973)
+|.+++... ..+++..+..++.|++.|++|+| +++++||||||+||+++.++.+||+|||++..........
T Consensus 81 ~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~ 152 (257)
T cd05116 81 PLNKFLQKN-----KHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY 152 (257)
T ss_pred cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence 999998642 35788999999999999999999 7899999999999999999999999999997664332211
Q ss_pred -cccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhcccccc
Q 002061 837 -DYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVA 914 (973)
Q Consensus 837 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (973)
......++..|+|||.+....++.++|||||||++|||++ |+.||.... .......+. .... .
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~~~~~~~i~----~~~~------~--- 217 (257)
T cd05116 153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK--GNEVTQMIE----SGER------M--- 217 (257)
T ss_pred eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHH----CCCC------C---
Confidence 1122234678999999988889999999999999999998 999997541 122222221 1110 0
Q ss_pred CcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 915 SESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 915 ~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
..+.....++.+++.+||+.||++||++++|.+.|++.
T Consensus 218 -~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 218 -ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred -CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 01112345678999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=313.82 Aligned_cols=255 Identities=27% Similarity=0.426 Sum_probs=202.9
Q ss_pred cCCcccCcccccCceEEEEEEecCCC---cEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNA---GTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV 749 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~---~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 749 (973)
.+|++.+.||+|+||.||+|++..++ ..||+|.+... ...+.+.+|+.++++++||||+++++++..++..|+|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46888999999999999999986443 37999987652 2345788999999999999999999999999999999
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccc
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 829 (973)
|||+++++|.+++... ...+++.++..++.|++.|++||| +.+++||||||+||+++.++.++++|||++...
T Consensus 84 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 84 TEYMENGSLDAFLRKH----DGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEcCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 9999999999999753 235788999999999999999999 889999999999999999999999999999866
Q ss_pred cCCCCcc-cccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccch
Q 002061 830 ENSPKVS-DYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLK 907 (973)
Q Consensus 830 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
....... ......++..|+|||++.+..++.++||||||+++||+++ |+.||.... ..+....+. ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~--~~~~~~~~~---~~~~---- 227 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS--NQDVIKAIE---EGYR---- 227 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCC--HHHHHHHHh---CCCc----
Confidence 4332111 1111223568999999998889999999999999999887 999996531 111111111 1100
Q ss_pred hccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 908 VLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 908 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
..........+.+++.+|++.+|++||++.++++.|+++
T Consensus 228 -------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 -------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 001112345678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=322.62 Aligned_cols=255 Identities=23% Similarity=0.278 Sum_probs=197.5
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL 750 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 750 (973)
++|++.+.||+|+||+||+|+...+++.||||++.+. ...+.+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 3688999999999999999999999999999998652 23455788999999999999999999999999999999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccccc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 830 (973)
||+++|+|.+++... ...+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++....
T Consensus 81 e~~~g~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 153 (331)
T cd05597 81 DYYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLL 153 (331)
T ss_pred ecCCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecC
Confidence 999999999999753 235788889999999999999999 8899999999999999999999999999987654
Q ss_pred CCCCcccccccCCcccccccccccc-----CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccccc
Q 002061 831 NSPKVSDYSCFAGTHGYIAPELAYT-----CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENV 905 (973)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 905 (973)
.... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||... +............. .
T Consensus 154 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~-----~~~~~~~~i~~~~~-~ 226 (331)
T cd05597 154 ADGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE-----SLVETYGKIMNHKE-H 226 (331)
T ss_pred CCCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC-----CHHHHHHHHHcCCC-c
Confidence 3222 11222468999999999863 45788999999999999999999999643 11122111111111 0
Q ss_pred chhccccccCcchHHHHHHHHHHHHHhcCCCC--CCCCCHHHHHHHh
Q 002061 906 LKVLDCEVASESIKEDMIKLLKIAVVCTTKLP--NLRPPMREVVKML 950 (973)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP--~~Rpt~~evl~~L 950 (973)
..+ ..........+.+++.+|+..++ ..||++.++++|-
T Consensus 227 ~~~------~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp 267 (331)
T cd05597 227 FQF------PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHP 267 (331)
T ss_pred ccC------CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCC
Confidence 000 00011133456677777665433 3488999999884
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=324.38 Aligned_cols=239 Identities=26% Similarity=0.306 Sum_probs=188.3
Q ss_pred CcccccCceEEEEEEecCCCcEEEEEeeeccc-----cHHHHHHHH-HHHHhcCCCceeeEEEEEEeCCeeEEEEEccCC
Q 002061 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----GVKVFAAEM-EILGKIRHRNILKLYACLLKGGSSFLVLEYMPN 755 (973)
Q Consensus 682 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-----~~~~~~~E~-~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 755 (973)
+.||+|+||+||+|++..+++.||+|++.... ....+.+|. .+++.++||||+++++++..++..|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36899999999999999989999999986521 223334444 356788999999999999999999999999999
Q ss_pred CchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCc
Q 002061 756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV 835 (973)
Q Consensus 756 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 835 (973)
|+|.+++... ..++......++.|+++||+||| +++|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-- 150 (325)
T cd05602 81 GELFYHLQRE-----RCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-- 150 (325)
T ss_pred CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC--
Confidence 9999998752 34677788889999999999999 8899999999999999999999999999987532221
Q ss_pred ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccccC
Q 002061 836 SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVAS 915 (973)
Q Consensus 836 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||... +.............
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~-----~~~~~~~~i~~~~~------------ 213 (325)
T cd05602 151 GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR-----NTAEMYDNILNKPL------------ 213 (325)
T ss_pred CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCC-----CHHHHHHHHHhCCc------------
Confidence 1223356899999999999999999999999999999999999999643 11122221111110
Q ss_pred cchHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 002061 916 ESIKEDMIKLLKIAVVCTTKLPNLRPPMREVV 947 (973)
Q Consensus 916 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl 947 (973)
.........+.+++.+|++.||.+||++.+.+
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 214 QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 00112344678899999999999999877433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=326.59 Aligned_cols=255 Identities=25% Similarity=0.348 Sum_probs=211.1
Q ss_pred CCcccCcccccCceEEEEEEecCCCc----EEEEEeeec---cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAG----TVAVKQLWK---GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV 749 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~----~vavK~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 749 (973)
.....++||.|+||+||+|.+-..|+ +||+|++.. .+...++.+|+-.|.+++|||++++++++.... +.||
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 34567899999999999999965444 588888765 344677899999999999999999999998776 8899
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccc
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 829 (973)
++||+.|+|.+|++.+ +..+.....+.|..|||+||.||| ++.+|||||.++||||+....+||.|||+++..
T Consensus 776 tq~mP~G~LlDyvr~h----r~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll 848 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREH----RDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLL 848 (1177)
T ss_pred HHhcccchHHHHHHHh----hccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhcc
Confidence 9999999999999875 456788889999999999999999 889999999999999999999999999999887
Q ss_pred cCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchh
Q 002061 830 ENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKV 908 (973)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (973)
.............-.+-|||-|.+....|+.++|||||||++||++| |..|++.... ..+...++..+
T Consensus 849 ~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~------~eI~dlle~ge----- 917 (1177)
T KOG1025|consen 849 APDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA------EEIPDLLEKGE----- 917 (1177)
T ss_pred CcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH------HHhhHHHhccc-----
Confidence 76655444443445678999999999999999999999999999999 9999976521 22222222222
Q ss_pred ccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 002061 909 LDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADP 955 (973)
Q Consensus 909 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 955 (973)
+-..++.+..+++.++.+||..|++.||+++++.+++.++..
T Consensus 918 -----RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 918 -----RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred -----cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 123445566778899999999999999999999999987654
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=317.84 Aligned_cols=262 Identities=25% Similarity=0.370 Sum_probs=202.7
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM 753 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 753 (973)
+|++.+.||+|+||.||+|++..++..||+|.+..+ ....++.+|++++++++||||+++++++..++..++||||+
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~ 81 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHM 81 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeecc
Confidence 688999999999999999999998999999987653 23356788999999999999999999999999999999999
Q ss_pred CCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCC
Q 002061 754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833 (973)
Q Consensus 754 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 833 (973)
++++|.+++... ..+++..+..++.|+++||+|||+ ..+++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 82 DGGSLDQVLKKA-----GRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred CCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 999999999753 357888899999999999999994 2589999999999999999999999999986543221
Q ss_pred CcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccc---------
Q 002061 834 KVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHEN--------- 904 (973)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~--------- 904 (973)
.....|+..|+|||++.+..++.++|||||||++|+|++|+.||.... .................
T Consensus 155 ----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (308)
T cd06615 155 ----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD--AKELEAMFGRPVSEGEAKESHRPVSG 228 (308)
T ss_pred ----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc--hhhHHHhhcCccccccccCCcccccC
Confidence 123467899999999988889999999999999999999999996432 11111111100000000
Q ss_pred ----------cchhccc---cccCcc-hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 905 ----------VLKVLDC---EVASES-IKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 905 ----------~~~~~~~---~~~~~~-~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
..+..+. ...+.. .......+.+++.+|++.+|++||++.|++++..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 289 (308)
T cd06615 229 HPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289 (308)
T ss_pred CCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 0000000 000000 0013346889999999999999999999998854
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=313.15 Aligned_cols=250 Identities=28% Similarity=0.416 Sum_probs=195.5
Q ss_pred CcccccCceEEEEEEecCCCc--EEEEEeeec---cccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEEEEccCC
Q 002061 682 NLIGSGGTGKVYRLDLKKNAG--TVAVKQLWK---GDGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLVLEYMPN 755 (973)
Q Consensus 682 ~~lG~G~~g~V~~a~~~~~~~--~vavK~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~ 755 (973)
+.||+|+||.||+|++.+++. .+|+|..+. ....+.+.+|+++++++ +||||+++++++......|+||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 358999999999999987665 468887764 23445788999999999 899999999999999999999999999
Q ss_pred CchHHHHHhhhc-----------CCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEeccc
Q 002061 756 GNLFQALHKRVK-----------EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFG 824 (973)
Q Consensus 756 gsL~~~l~~~~~-----------~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 824 (973)
|+|.+++..... .....+++..+..++.|++.|++||| +++++||||||+||++++++.+|++|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence 999999975421 11234789999999999999999999 7899999999999999999999999999
Q ss_pred CcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhcccc
Q 002061 825 VAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHE 903 (973)
Q Consensus 825 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 903 (973)
++...... ........+..|+|||++.+..++.++|||||||++|||++ |..||.... ..+ ...... ...
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~--~~~---~~~~~~-~~~ 228 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--CAE---LYEKLP-QGY 228 (270)
T ss_pred Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC--HHH---HHHHHh-CCC
Confidence 98532211 11111233567999999988889999999999999999997 999996431 111 111111 110
Q ss_pred ccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 904 NVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
.. .........+.+++.+|++.+|.+||++.++++.|+++
T Consensus 229 ~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 229 RL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred CC----------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 00 01112234678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=329.81 Aligned_cols=262 Identities=22% Similarity=0.294 Sum_probs=197.9
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCC-----eeE
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGG-----SSF 747 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-----~~~ 747 (973)
+|+..+.||+|+||+||+|.+..+++.||||++... ...+++.+|+++++.++||||+++++++..+. ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478889999999999999999988999999988542 23456789999999999999999999998766 789
Q ss_pred EEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcc
Q 002061 748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827 (973)
Q Consensus 748 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~ 827 (973)
+||||++ ++|.+++.. ...+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||+++
T Consensus 81 lv~e~~~-~~l~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~ 151 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS-----PQPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLAR 151 (372)
T ss_pred EEeeccc-cCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEecccccee
Confidence 9999995 678777753 235889999999999999999999 7899999999999999999999999999997
Q ss_pred cccCCCCcccccccCCccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccc---
Q 002061 828 IAENSPKVSDYSCFAGTHGYIAPELAYTC-KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHE--- 903 (973)
Q Consensus 828 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~--- 903 (973)
....... .......++..|+|||++.+. .++.++||||+||++|||++|+.||..... .+....+........
T Consensus 152 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~i~~~~g~~~~~~ 228 (372)
T cd07853 152 VEEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSP--IQQLDLITDLLGTPSLEA 228 (372)
T ss_pred ecccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCH--HHHHHHHHHHcCCCCHHH
Confidence 6543221 122234678999999998764 478999999999999999999999965321 111111110000000
Q ss_pred ------ccch-hccccccC-------cchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 904 ------NVLK-VLDCEVAS-------ESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 904 ------~~~~-~~~~~~~~-------~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
.... +....... .......+++.+++.+|++.||++|||+.|++++-
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 289 (372)
T cd07853 229 MRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHP 289 (372)
T ss_pred HHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCH
Confidence 0000 00000000 00112245678999999999999999999999873
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=321.86 Aligned_cols=254 Identities=23% Similarity=0.283 Sum_probs=197.8
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL 750 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 750 (973)
++|++.+.||+|+||+||+++...+++.||+|++.+. .....+.+|+.++..++|++|+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 3688899999999999999999999999999998642 23345778999999999999999999999999999999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccccc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 830 (973)
||+++|+|.+++.+. ...+++..+..++.|++.|++||| +++|+||||||+||+++.++.+||+|||++....
T Consensus 81 ey~~~g~L~~~l~~~----~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~ 153 (332)
T cd05623 81 DYYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM 153 (332)
T ss_pred eccCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecc
Confidence 999999999999753 235788889999999999999999 8899999999999999999999999999987543
Q ss_pred CCCCcccccccCCccccccccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccccc
Q 002061 831 NSPKVSDYSCFAGTHGYIAPELAY-----TCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENV 905 (973)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 905 (973)
.... .......||+.|+|||++. ...++.++|||||||++|||++|+.||... +...............
T Consensus 154 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~-----~~~~~~~~i~~~~~~~ 227 (332)
T cd05623 154 EDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE-----SLVETYGKIMNHKERF 227 (332)
T ss_pred cCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC-----CHHHHHHHHhCCCccc
Confidence 2211 1222346899999999986 346789999999999999999999999643 2222222221111100
Q ss_pred chhccccccCcchHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 002061 906 LKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNL--RPPMREVVKM 949 (973)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rpt~~evl~~ 949 (973)
. . +.........+.+++.+|+..+|++ |+++.|+++|
T Consensus 228 -~-----~-p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 228 -Q-----F-PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred -c-----C-CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0 0 0111123455677888877554444 7899999988
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=320.09 Aligned_cols=263 Identities=17% Similarity=0.209 Sum_probs=195.5
Q ss_pred ccCccccc--CceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 002061 680 EDNLIGSG--GTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM 753 (973)
Q Consensus 680 ~~~~lG~G--~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 753 (973)
+.++||+| +||+||+++.+.+|+.||||++... ...+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45679999 7899999999999999999998653 23355778999999999999999999999999999999999
Q ss_pred CCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCC
Q 002061 754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833 (973)
Q Consensus 754 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 833 (973)
++|+|.+++..+. ...+++..+..++.|++.||+||| +.+++||||||+||+++.++.++++||+.+.......
T Consensus 82 ~~~~l~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 82 AYGSAKDLICTHF---MDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred CCCcHHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence 9999999997541 234789999999999999999999 7899999999999999999999999998654332111
Q ss_pred Ccc-----cccccCCcccccccccccc--CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccc----
Q 002061 834 KVS-----DYSCFAGTHGYIAPELAYT--CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNH---- 902 (973)
Q Consensus 834 ~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~---- 902 (973)
... ......++..|+|||++.+ ..++.++||||+||++|||++|+.||....... .............
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~ 234 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ-MLLEKLNGTVPCLLDTT 234 (327)
T ss_pred ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH-HHHHHhcCCcccccccc
Confidence 100 0112346778999999875 458899999999999999999999997532110 0000000000000
Q ss_pred -----------------cccchhc---------cccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 903 -----------------ENVLKVL---------DCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 903 -----------------~~~~~~~---------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
....... ...............+.+++.+|++.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 0000000 0000001122334578899999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=309.62 Aligned_cols=247 Identities=29% Similarity=0.407 Sum_probs=197.3
Q ss_pred CcccccCceEEEEEEecCCC---cEEEEEeeeccc---cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCC
Q 002061 682 NLIGSGGTGKVYRLDLKKNA---GTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPN 755 (973)
Q Consensus 682 ~~lG~G~~g~V~~a~~~~~~---~~vavK~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 755 (973)
+.||+|+||.||+|+....+ ..||+|.+.... ..+++.+|++++++++||||+++++++. ....++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46899999999999876544 789999887643 3567889999999999999999999875 4568999999999
Q ss_pred CchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCc
Q 002061 756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV 835 (973)
Q Consensus 756 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 835 (973)
|+|.+++... ..+++..+..++.|++.|++||| ..+++||||||+||+++.++.+||+|||+++........
T Consensus 80 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~ 151 (257)
T cd05060 80 GPLLKYLKKR-----REIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY 151 (257)
T ss_pred CcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcc
Confidence 9999999753 25789999999999999999999 789999999999999999999999999999866443321
Q ss_pred cc-ccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhccccc
Q 002061 836 SD-YSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEV 913 (973)
Q Consensus 836 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (973)
.. .....++..|+|||.+.+..++.++|||||||++|||++ |+.||... +..+....+... .. .
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~--~~~~~~~~~~~~---~~-~-------- 217 (257)
T cd05060 152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM--KGAEVIAMLESG---ER-L-------- 217 (257)
T ss_pred cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC--CHHHHHHHHHcC---Cc-C--------
Confidence 11 111223568999999998899999999999999999998 99999654 222222222211 10 0
Q ss_pred cCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 914 ASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 914 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
..+......+.+++.+|+..+|++||++.++++.|+++
T Consensus 218 --~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 218 --PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred --CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 01112235688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=331.62 Aligned_cols=252 Identities=24% Similarity=0.301 Sum_probs=197.3
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL 750 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 750 (973)
++|+..+.||+|+||+||+|+...+++.||||++... .....+.+|+.++..++||+|+++++++.+++..|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 3688899999999999999999999999999998652 23456788999999999999999999999999999999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccccc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 830 (973)
||+++|+|.+++... ..+++..+..++.|++.||+||| +++|+||||||+||+++.++.++|+|||++....
T Consensus 81 E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 81 EFLPGGDMMTLLMKK-----DTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred eCCCCccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence 999999999998753 35788899999999999999999 8899999999999999999999999999986543
Q ss_pred CCCCc---------------------------------ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhC
Q 002061 831 NSPKV---------------------------------SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTG 877 (973)
Q Consensus 831 ~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg 877 (973)
..... .......||+.|+|||++.+..++.++||||+||++|||++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG 232 (360)
T cd05627 153 KAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (360)
T ss_pred cccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccC
Confidence 21100 001134689999999999999999999999999999999999
Q ss_pred CCCCCcccCCcccHHHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHH
Q 002061 878 RKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPP---MREVVKM 949 (973)
Q Consensus 878 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt---~~evl~~ 949 (973)
+.||.... ............... ..+. . .....++.+++.+++ .||.+|++ +.|+++|
T Consensus 233 ~~Pf~~~~-----~~~~~~~i~~~~~~~---~~p~---~--~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 233 YPPFCSET-----PQETYRKVMNWKETL---VFPP---E--VPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCCCCC-----HHHHHHHHHcCCCce---ecCC---C--CCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 99996541 111111111111000 0000 0 012345667777766 49999984 7788877
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=316.65 Aligned_cols=251 Identities=24% Similarity=0.308 Sum_probs=203.5
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc--ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY 752 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 752 (973)
..+|++.+.||+|+||.||+|+...+++.||+|.+... ...+.+.+|+.+++.++||||+++++++..+++.|+||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 36889999999999999999999888999999988652 3345678899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCC
Q 002061 753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832 (973)
Q Consensus 753 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 832 (973)
+++++|.+++... .+++..+..++.|++.|+.||| +.+++||||||+||+++.++.++|+|||++......
T Consensus 98 ~~~~~L~~~~~~~------~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 98 LAGGSLTDVVTET------CMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred cCCCCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 9999999998642 4688899999999999999999 789999999999999999999999999998765433
Q ss_pred CCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhcccc
Q 002061 833 PKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCE 912 (973)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (973)
.. ......+++.|+|||.+.+..++.++||||+||++|++++|+.||......... ...... ..
T Consensus 169 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~-----~~~~~~---------~~ 232 (297)
T cd06656 169 QS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-----YLIATN---------GT 232 (297)
T ss_pred cc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe-----eeeccC---------CC
Confidence 21 122346788999999999888999999999999999999999999654211100 000000 00
Q ss_pred ccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 913 VASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 913 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
.....+......+.+++.+||+.+|++||++.+++++-
T Consensus 233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 270 (297)
T cd06656 233 PELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHP 270 (297)
T ss_pred CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 00011223345577899999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=327.18 Aligned_cols=262 Identities=26% Similarity=0.278 Sum_probs=198.8
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeC------
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKG------ 743 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------ 743 (973)
..++|++.+.||+|+||.||+|++..+++.||||++... .....+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 467899999999999999999999988999999998652 3345678899999999999999999987543
Q ss_pred CeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecc
Q 002061 744 GSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADF 823 (973)
Q Consensus 744 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 823 (973)
...|+||||++ ++|.+++.. .+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+||
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Df 170 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDF 170 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeC
Confidence 35799999996 477777643 3678888999999999999999 889999999999999999999999999
Q ss_pred cCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHH--------
Q 002061 824 GVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWV-------- 895 (973)
Q Consensus 824 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~-------- 895 (973)
|+++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||...... ......+
T Consensus 171 G~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~ 246 (364)
T cd07875 171 GLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI-DQWNKVIEQLGTPCP 246 (364)
T ss_pred CCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCH
Confidence 9997654321 122346899999999999999999999999999999999999999643110 0000000
Q ss_pred ----------HHHhccccccchh----ccccc----cCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 896 ----------STHLNNHENVLKV----LDCEV----ASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 896 ----------~~~~~~~~~~~~~----~~~~~----~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
.......+..... ..+.. ...........+.+++.+|++.||.+|||+.|+++|-
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp 319 (364)
T cd07875 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319 (364)
T ss_pred HHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence 0000011100000 00000 0000111234678999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=325.23 Aligned_cols=237 Identities=27% Similarity=0.331 Sum_probs=190.8
Q ss_pred CcccccCceEEEEEEec---CCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccC
Q 002061 682 NLIGSGGTGKVYRLDLK---KNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP 754 (973)
Q Consensus 682 ~~lG~G~~g~V~~a~~~---~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 754 (973)
+.||+|+||+||+++.. .+++.||+|++... .....+.+|++++++++||||+++++++..++..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 57999999999998863 56889999998753 234456789999999999999999999999999999999999
Q ss_pred CCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCC
Q 002061 755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK 834 (973)
Q Consensus 755 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 834 (973)
+|+|.+++... ..+++..+..++.|+++||+||| +.+++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~- 152 (318)
T cd05582 82 GGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE- 152 (318)
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-
Confidence 99999998642 35789999999999999999999 7899999999999999999999999999987553321
Q ss_pred cccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhcccccc
Q 002061 835 VSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVA 914 (973)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (973)
.......|++.|+|||++.+..++.++|||||||++|||++|+.||.... ..............
T Consensus 153 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~-----~~~~~~~i~~~~~~---------- 216 (318)
T cd05582 153 -KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD-----RKETMTMILKAKLG---------- 216 (318)
T ss_pred -CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC-----HHHHHHHHHcCCCC----------
Confidence 11223568999999999998889999999999999999999999996531 11111111111110
Q ss_pred CcchHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 002061 915 SESIKEDMIKLLKIAVVCTTKLPNLRPPMRE 945 (973)
Q Consensus 915 ~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~e 945 (973)
.+......+.+++.+|++.||++||++.+
T Consensus 217 --~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 217 --MPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred --CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 11122345778999999999999999433
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=328.90 Aligned_cols=265 Identities=22% Similarity=0.269 Sum_probs=201.2
Q ss_pred HcCCcccCcccccCceEEEEEEec--CCCcEEEEEeeeccccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLK--KNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY 752 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~--~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 752 (973)
..+|++.+.||+|+||.||+|... ..+..||||.+.... ...+|++++++++||||+++++++..+...|+|||+
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~---~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~ 167 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK---TPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPK 167 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc---cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehh
Confidence 457999999999999999999764 346789999876543 346899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCC
Q 002061 753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832 (973)
Q Consensus 753 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 832 (973)
+. ++|.+++.. ...+++..+..++.|++.||+||| +++|+||||||+||+++.++.++|+|||++......
T Consensus 168 ~~-~~l~~~l~~-----~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 168 YK-CDLFTYVDR-----SGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred cC-CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 95 688888843 245889999999999999999999 789999999999999999999999999999766544
Q ss_pred CCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCc--ccHHHHHHHHhccccccch---
Q 002061 833 PKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDG--KDIVYWVSTHLNNHENVLK--- 907 (973)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~--- 907 (973)
..........||+.|+|||++.+..++.++||||+||++|||++|+.||....... ..+...+.........+..
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 33333334579999999999999999999999999999999999999996543211 1111111110000000000
Q ss_pred ------------hcccccc-Ccc--hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 908 ------------VLDCEVA-SES--IKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 908 ------------~~~~~~~-~~~--~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
...+... +.. .......+.+++.+|++.||++||++.|++.+-.
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~ 377 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPL 377 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCch
Confidence 0000000 000 0112345778999999999999999999998843
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=310.67 Aligned_cols=254 Identities=30% Similarity=0.410 Sum_probs=204.5
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeec-cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK-GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM 753 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 753 (973)
.++|++.+.||+|+||+||+|...+ ++.||||.+.. ....+++.+|+.++++++||||+++++++..+...++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 4578999999999999999999865 57899998875 345677899999999999999999999999888999999999
Q ss_pred CCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCC
Q 002061 754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833 (973)
Q Consensus 754 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 833 (973)
++++|.+++... ....+++..+..++.|++.|++||| +.+++|+||||+||+++.++.++++|||.+.......
T Consensus 84 ~~~~L~~~i~~~---~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 84 SKGSLLDFLKSG---EGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred CCCCHHHHHhcc---ccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 999999999753 2345889999999999999999999 7899999999999999999999999999987664321
Q ss_pred CcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhcccc
Q 002061 834 KVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCE 912 (973)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (973)
. .......++..|+|||.+.+..++.++||||+|+++||+++ |+.||.... .. ...........
T Consensus 158 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~--~~---~~~~~~~~~~~--------- 222 (261)
T cd05034 158 Y-TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT--NR---EVLEQVERGYR--------- 222 (261)
T ss_pred h-hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC--HH---HHHHHHHcCCC---------
Confidence 1 11112234568999999998889999999999999999999 999996431 11 11111111100
Q ss_pred ccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 002061 913 VASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952 (973)
Q Consensus 913 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~ 952 (973)
...+......+.+++.+|++.+|++||++.++.+.|+.
T Consensus 223 --~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 --MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred --CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 00011124468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=319.78 Aligned_cols=264 Identities=22% Similarity=0.265 Sum_probs=200.7
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL 750 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 750 (973)
..++|++.+.||+|+||.||+|++..+++.||+|.+... .....+.+|++++++++||||+++++++..+...++||
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 346789999999999999999999988999999988642 23446778999999999999999999999999999999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccccc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 830 (973)
||++ ++|.+++... ...+++..+..++.|+++||+||| +.+++||||||+||+++.++.++|+|||++....
T Consensus 84 e~~~-~~l~~~l~~~----~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 155 (301)
T cd07873 84 EYLD-KDLKQYLDDC----GNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKS 155 (301)
T ss_pred eccc-cCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence 9996 6898888653 335788899999999999999999 8899999999999999999999999999987543
Q ss_pred CCCCcccccccCCccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccc--ccch
Q 002061 831 NSPKVSDYSCFAGTHGYIAPELAYTC-KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHE--NVLK 907 (973)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~ 907 (973)
.... ......+++.|+|||++.+. .++.++||||+||++|||++|+.||..... ......+........ ....
T Consensus 156 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~~ 231 (301)
T cd07873 156 IPTK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV--EEQLHFIFRILGTPTEETWPG 231 (301)
T ss_pred CCCC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHcCCCChhhchh
Confidence 2211 12234568899999988654 578899999999999999999999975421 111111111100000 0000
Q ss_pred hc---------cccccCc----chHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 908 VL---------DCEVASE----SIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 908 ~~---------~~~~~~~----~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
+. .+..... ........+.+++.+|++.||.+|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 232 ILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred hhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00 0000000 011224467889999999999999999999984
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=324.46 Aligned_cols=236 Identities=27% Similarity=0.342 Sum_probs=188.2
Q ss_pred CcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHH-HHHhcCCCceeeEEEEEEeCCeeEEEEEccCC
Q 002061 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEME-ILGKIRHRNILKLYACLLKGGSSFLVLEYMPN 755 (973)
Q Consensus 682 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 755 (973)
+.||+|+||+||+|++..+|+.||||++... .....+.+|.. +++.++||||+++++++..++..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4689999999999999999999999998653 22334455554 46778999999999999999999999999999
Q ss_pred CchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCc
Q 002061 756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV 835 (973)
Q Consensus 756 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 835 (973)
|+|..++... ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-- 150 (325)
T cd05604 81 GELFFHLQRE-----RSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-- 150 (325)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--
Confidence 9999888642 35788999999999999999999 7899999999999999999999999999986432211
Q ss_pred ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccccC
Q 002061 836 SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVAS 915 (973)
Q Consensus 836 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||... +............. ...
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~-----~~~~~~~~~~~~~~--------~~~- 216 (325)
T cd05604 151 DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR-----DVAEMYDNILHKPL--------VLR- 216 (325)
T ss_pred CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC-----CHHHHHHHHHcCCc--------cCC-
Confidence 1223356899999999999999999999999999999999999999653 12222222211110 000
Q ss_pred cchHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 002061 916 ESIKEDMIKLLKIAVVCTTKLPNLRPPMR 944 (973)
Q Consensus 916 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~ 944 (973)
......+.+++.+|++.+|.+||+++
T Consensus 217 ---~~~~~~~~~ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 217 ---PGASLTAWSILEELLEKDRQRRLGAK 242 (325)
T ss_pred ---CCCCHHHHHHHHHHhccCHHhcCCCC
Confidence 11234577899999999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=309.66 Aligned_cols=251 Identities=29% Similarity=0.421 Sum_probs=203.9
Q ss_pred CcccccCceEEEEEEecCC---CcEEEEEeeecccc---HHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCC
Q 002061 682 NLIGSGGTGKVYRLDLKKN---AGTVAVKQLWKGDG---VKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPN 755 (973)
Q Consensus 682 ~~lG~G~~g~V~~a~~~~~---~~~vavK~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 755 (973)
+.||+|+||.||+|..... +..||+|.+..... .+.+.+|+++++.++|+|++++++++..+...++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 4689999999999999866 88999999876432 56788999999999999999999999999999999999999
Q ss_pred CchHHHHHhhhcC----CCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccC
Q 002061 756 GNLFQALHKRVKE----GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831 (973)
Q Consensus 756 gsL~~~l~~~~~~----~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 831 (973)
++|.+++...... ....+++..+..++.|++.|++||| +++++||||+|+||+++.++.++++|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999763110 1356899999999999999999999 88999999999999999999999999999987754
Q ss_pred CCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhcc
Q 002061 832 SPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLD 910 (973)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (973)
...........++..|+|||.+.+..++.++||||+|+++|||++ |..||... ........+. . ..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--~~~~~~~~~~---~-~~------- 224 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL--SNEEVLEYLR---K-GY------- 224 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC--CHHHHHHHHH---c-CC-------
Confidence 432222333457889999999988889999999999999999999 69999764 1111111111 1 10
Q ss_pred ccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 911 CEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 911 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
..........++.+++.+|++.+|++||++.|++++|+
T Consensus 225 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 ---RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 00111223557889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=321.38 Aligned_cols=247 Identities=25% Similarity=0.369 Sum_probs=201.1
Q ss_pred CcccccCceEEEEEEecCCCcEEEEEeeec--cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCCchH
Q 002061 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWK--GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLF 759 (973)
Q Consensus 682 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~ 759 (973)
-+||+|.||+||.|++..+...+|||-+.. ....+.+..|+...++++|.|||+++|++.++++.-|.||-++||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 479999999999999999999999998755 345566889999999999999999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeec-CCCCeEEecccCcccccCCCCcccc
Q 002061 760 QALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD-EDYEPKIADFGVAKIAENSPKVSDY 838 (973)
Q Consensus 760 ~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~kl~Dfgl~~~~~~~~~~~~~ 838 (973)
+.++..+. .-.-.+...--+..||++||.||| +..|||||||-+||+|. -.|.+||+|||-++...... ...
T Consensus 661 sLLrskWG--PlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~T 733 (1226)
T KOG4279|consen 661 SLLRSKWG--PLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PCT 733 (1226)
T ss_pred HHHHhccC--CCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccCC--ccc
Confidence 99986532 222255666778899999999999 88999999999999996 48999999999988664321 223
Q ss_pred cccCCccccccccccccC--CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccccCc
Q 002061 839 SCFAGTHGYIAPELAYTC--KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASE 916 (973)
Q Consensus 839 ~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (973)
..+.||..|||||++..+ .|+.++|||||||++.||.||++||.+... ..-..+ ++---...+.
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgs--pqAAMF------------kVGmyKvHP~ 799 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGS--PQAAMF------------KVGMYKVHPP 799 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCC--hhHhhh------------hhcceecCCC
Confidence 346799999999999754 589999999999999999999999976421 111111 1111112234
Q ss_pred chHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 917 SIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 917 ~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
.+.+...+...++.+|+.+||.+||++.++++-
T Consensus 800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred CcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 466777888999999999999999999999864
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=322.65 Aligned_cols=236 Identities=28% Similarity=0.347 Sum_probs=187.1
Q ss_pred CcccccCceEEEEEEecCCCcEEEEEeeeccc-----cHHHHHHHHH-HHHhcCCCceeeEEEEEEeCCeeEEEEEccCC
Q 002061 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----GVKVFAAEME-ILGKIRHRNILKLYACLLKGGSSFLVLEYMPN 755 (973)
Q Consensus 682 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-----~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 755 (973)
+.||+|+||+||+|++..+++.||+|++.+.. ....+.+|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999999999999999986531 2233445544 57889999999999999999999999999999
Q ss_pred CchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCc
Q 002061 756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV 835 (973)
Q Consensus 756 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 835 (973)
|+|.+++... ..++...+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-- 150 (321)
T cd05603 81 GELFFHLQRE-----RCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-- 150 (321)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--
Confidence 9998888642 35778888899999999999999 7899999999999999999999999999987432211
Q ss_pred ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccccC
Q 002061 836 SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVAS 915 (973)
Q Consensus 836 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||... +.............
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~-----~~~~~~~~i~~~~~------------ 213 (321)
T cd05603 151 ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR-----DVSQMYDNILHKPL------------ 213 (321)
T ss_pred CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC-----CHHHHHHHHhcCCC------------
Confidence 1223356899999999999889999999999999999999999999653 22222222211110
Q ss_pred cchHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 002061 916 ESIKEDMIKLLKIAVVCTTKLPNLRPPMR 944 (973)
Q Consensus 916 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~ 944 (973)
..+......+.+++.+|++.||.+||++.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 214 QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 01112234578899999999999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=310.93 Aligned_cols=249 Identities=27% Similarity=0.398 Sum_probs=204.2
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY 752 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 752 (973)
..|+..+.||.|+||.||+|.+..+++.||+|++... .....+.+|+++++++.||||+++++++.++...|+||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 3577788999999999999999988999999987653 3346788899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCC
Q 002061 753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832 (973)
Q Consensus 753 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 832 (973)
+++|+|.+++... .+++..+..++.|++.|++|+| +.+++|+||+|+||+++.++.++++|||++......
T Consensus 84 ~~~~~L~~~i~~~------~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06640 84 LGGGSALDLLRAG------PFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred CCCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence 9999999988642 4678888999999999999999 789999999999999999999999999998765433
Q ss_pred CCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhcccc
Q 002061 833 PKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCE 912 (973)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (973)
.. ......++..|+|||++.+..++.++|||||||++|||++|+.||..... . ...... ...
T Consensus 155 ~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~--~---~~~~~~-----------~~~ 216 (277)
T cd06640 155 QI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHP--M---RVLFLI-----------PKN 216 (277)
T ss_pred cc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcCh--H---hHhhhh-----------hcC
Confidence 21 12234578899999999888899999999999999999999999965321 1 111100 001
Q ss_pred ccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 913 VASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 913 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
............+.+++.+||+.+|++||++.+++++-.
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06640 217 NPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKF 255 (277)
T ss_pred CCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChH
Confidence 111223345567889999999999999999999988744
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=321.43 Aligned_cols=254 Identities=24% Similarity=0.278 Sum_probs=198.5
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL 750 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 750 (973)
++|++.+.||+|+||+||+|++..+++.||+|++.+. .....+.+|..++..++|++|+++++++.+++..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 3688999999999999999999999999999988652 23345778999999999999999999999999999999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccccc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 830 (973)
||+++|+|.+++... ...+++..+..++.|++.||+|+| +++|+||||||+||+++.++.+||+|||++....
T Consensus 81 Ey~~gg~L~~~l~~~----~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 153 (331)
T cd05624 81 DYYVGGDLLTLLSKF----EDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMN 153 (331)
T ss_pred eCCCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeecc
Confidence 999999999999753 235788888999999999999999 8899999999999999999999999999987654
Q ss_pred CCCCcccccccCCcccccccccccc-----CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccccc
Q 002061 831 NSPKVSDYSCFAGTHGYIAPELAYT-----CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENV 905 (973)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 905 (973)
.... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.... ...............
T Consensus 154 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~-----~~~~~~~i~~~~~~~ 227 (331)
T cd05624 154 QDGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES-----LVETYGKIMNHEERF 227 (331)
T ss_pred CCCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC-----HHHHHHHHHcCCCcc
Confidence 3222 11223568999999999875 467889999999999999999999996431 111111111111000
Q ss_pred chhccccccCcchHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 002061 906 LKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNL--RPPMREVVKM 949 (973)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rpt~~evl~~ 949 (973)
.. +.........+.+++.+|+..++.+ |+++.++++|
T Consensus 228 ------~~-p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 228 ------QF-PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred ------cC-CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 00 0111123456778888888866554 5688988876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=314.53 Aligned_cols=261 Identities=27% Similarity=0.346 Sum_probs=208.0
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE 751 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 751 (973)
..+|++.+.||+|+||+||+|++..+++.||+|++... ...+.+.+|+++++.++||||+++++++......++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 35788899999999999999999988999999987653 234678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccC
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 831 (973)
|+++++|.+++... ..+++..+..++.+++.|+.|||+ .++++||||+|+||+++.++.++|+|||++.....
T Consensus 84 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 84 FMDCGSLDRIYKKG-----GPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156 (284)
T ss_pred cCCCCCHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence 99999999988652 357889999999999999999994 35899999999999999999999999999865422
Q ss_pred CCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCc------ccHHHHHHHHhcccccc
Q 002061 832 SPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDG------KDIVYWVSTHLNNHENV 905 (973)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~------~~~~~~~~~~~~~~~~~ 905 (973)
.. .....|+..|+|||++.+..++.++||||+||++|++++|+.||....... ......+........
T Consensus 157 ~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 230 (284)
T cd06620 157 SI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP-- 230 (284)
T ss_pred hc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC--
Confidence 21 123468899999999988889999999999999999999999997543211 111112221111110
Q ss_pred chhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCC
Q 002061 906 LKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPC 956 (973)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~ 956 (973)
+. ....+....+.+++.+|++.||++||++.|++++..-.+..
T Consensus 231 -----~~---~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 231 -----PR---LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred -----CC---CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 00 01112345688899999999999999999999986555443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=307.87 Aligned_cols=250 Identities=22% Similarity=0.338 Sum_probs=204.9
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeec----cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY 752 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 752 (973)
+|+..+.||.|+||.||.++...+++.|++|.+.. ......+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 57888999999999999999999999999998754 23445688999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCC
Q 002061 753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832 (973)
Q Consensus 753 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 832 (973)
+++|+|.+++... ....+++..+..++.|++.|++||| +.+++||||+|+||++++++.+||+|||.+......
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 81 ANGGTLYDKIVRQ---KGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE 154 (256)
T ss_pred cCCCcHHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence 9999999999753 2345789999999999999999999 789999999999999999999999999998766433
Q ss_pred CCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhcccc
Q 002061 833 PKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCE 912 (973)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (973)
.. ......+++.|+|||+..+..++.++||||+|+++|||++|+.||... +............
T Consensus 155 ~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~-----~~~~~~~~~~~~~---------- 217 (256)
T cd08221 155 YS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT-----NPLNLVVKIVQGN---------- 217 (256)
T ss_pred cc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC-----CHHHHHHHHHcCC----------
Confidence 21 222346889999999998888899999999999999999999999643 1112221111110
Q ss_pred ccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 913 VASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 913 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
.. ........++.+++.+|++.+|++||++.|+++++
T Consensus 218 ~~-~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 218 YT-PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CC-CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 00 01122345688899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=318.31 Aligned_cols=259 Identities=26% Similarity=0.365 Sum_probs=202.5
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCc----EEEEEeeecccc---HHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAG----TVAVKQLWKGDG---VKVFAAEMEILGKIRHRNILKLYACLLKGGSSF 747 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~----~vavK~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 747 (973)
..+|+..+.||+|+||.||+|.+..+++ .||+|.+..... ...+.+|+.++++++||||+++++++..+ ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 4567888999999999999999876665 478887765322 33678899999999999999999988654 467
Q ss_pred EEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcc
Q 002061 748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827 (973)
Q Consensus 748 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~ 827 (973)
+++||+++|+|.+++... ...+++..+..++.|++.||+||| +++++||||||+||+++.++.+||+|||+++
T Consensus 85 ~v~e~~~~g~l~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~ 157 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEH----KDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (303)
T ss_pred eeehhcCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccc
Confidence 899999999999998753 335788899999999999999999 7899999999999999999999999999998
Q ss_pred cccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccc
Q 002061 828 IAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVL 906 (973)
Q Consensus 828 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 906 (973)
...............++..|+|||++.+..++.++|||||||++||+++ |+.||.... ......++. ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~--~~~~~~~~~----~~~~~~ 231 (303)
T cd05110 158 LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP--TREIPDLLE----KGERLP 231 (303)
T ss_pred cccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHH----CCCCCC
Confidence 6643322112222345678999999998899999999999999999997 999996531 111222211 111000
Q ss_pred hhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCCC
Q 002061 907 KVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPCT 957 (973)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 957 (973)
........+.+++.+||..+|++||++.++++.++++....
T Consensus 232 ----------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 232 ----------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred ----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 01112345788999999999999999999999999875443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=309.31 Aligned_cols=249 Identities=25% Similarity=0.367 Sum_probs=195.8
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-------ccHHHHHHHHHHHHhcCCCceeeEEEEEEe--CCeeE
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-------DGVKVFAAEMEILGKIRHRNILKLYACLLK--GGSSF 747 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~ 747 (973)
+|+..+.||+|+||.||+|.+..++..||+|++... .....+.+|++++++++||||+++++++.. +...+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 688899999999999999999988999999987542 223567889999999999999999998865 46789
Q ss_pred EEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcc
Q 002061 748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827 (973)
Q Consensus 748 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~ 827 (973)
++|||+++++|.+++... ..+++.....++.|++.||+||| +.+++||||+|+||+++.++.++|+|||++.
T Consensus 83 l~~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAY-----GALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 999999999999999753 24788888899999999999999 7899999999999999999999999999987
Q ss_pred cccCCCC-cccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccc
Q 002061 828 IAENSPK-VSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVL 906 (973)
Q Consensus 828 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 906 (973)
....... ........++..|+|||++.+..++.++||||+||++||+++|+.||..... ...+.......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~-----~~~~~~~~~~~---- 225 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA-----MAAIFKIATQP---- 225 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch-----HHHHHHHhcCC----
Confidence 5533211 1112234578899999999988899999999999999999999999964311 11111111000
Q ss_pred hhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 907 KVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
.....+....+.+.+++ .||..+|++||++.||++|
T Consensus 226 ------~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 226 ------TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred ------CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 00111222334455666 6888999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=312.14 Aligned_cols=247 Identities=29% Similarity=0.426 Sum_probs=203.1
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM 753 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 753 (973)
+|++.+.||.|++|.||+|++..+++.||+|++..+ .....+.+|+++++.++|||++++++++.++...|+|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 688889999999999999999988999999988653 23456889999999999999999999999999999999999
Q ss_pred CCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCC
Q 002061 754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833 (973)
Q Consensus 754 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 833 (973)
++++|.+++... .+++..+..++.|++.|+.||| +.+++||||+|+||++++++.++++|||+++......
T Consensus 82 ~~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 82 GGGSCLDLLKPG------KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred CCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 999999998742 5789999999999999999999 7899999999999999999999999999998765432
Q ss_pred CcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccc
Q 002061 834 KVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEV 913 (973)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (973)
.......++..|+|||++.+..++.++||||||+++|+|++|+.||..... ............ +..
T Consensus 153 --~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~-----~~~~~~~~~~~~-------~~~ 218 (274)
T cd06609 153 --SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP-----MRVLFLIPKNNP-------PSL 218 (274)
T ss_pred --cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch-----HHHHHHhhhcCC-------CCC
Confidence 122234678899999999988899999999999999999999999965421 111111111100 011
Q ss_pred cCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 914 ASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 914 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
... .....+.+++.+|+..+|++||++++++++
T Consensus 219 ~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 219 EGN---KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred ccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 000 134467889999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=315.27 Aligned_cols=264 Identities=21% Similarity=0.249 Sum_probs=198.9
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY 752 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 752 (973)
+|++.+.||+|++|+||+|+...+++.||||++... .....+.+|+.++++++||||+++++++.++...|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 478889999999999999999988999999987642 2345678899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCC
Q 002061 753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832 (973)
Q Consensus 753 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 832 (973)
++ ++|.+++... .....+++..+..++.|++.||+||| +.+++||||+|+||+++.++.++|+|||++......
T Consensus 81 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 81 LS-MDLKKYLDSL--PKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP 154 (285)
T ss_pred CC-CCHHHHHhcC--CCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC
Confidence 96 6898888653 12346889999999999999999999 789999999999999999999999999998755332
Q ss_pred CCcccccccCCccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccc---------
Q 002061 833 PKVSDYSCFAGTHGYIAPELAYTC-KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNH--------- 902 (973)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~--------- 902 (973)
. .......+++.|+|||++.+. .++.++||||+||++|+|++|+.||....... .............
T Consensus 155 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 155 V--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID-QLFRIFRILGTPTEDVWPGVTS 231 (285)
T ss_pred c--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCChhhhhcchh
Confidence 1 122234568899999988654 47889999999999999999999997532110 0000000000000
Q ss_pred -cccchhccc---cccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 903 -ENVLKVLDC---EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 903 -~~~~~~~~~---~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
......... ............++.+++.+|++.||++|||+.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000000 00000011234567899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=316.44 Aligned_cols=259 Identities=25% Similarity=0.339 Sum_probs=201.2
Q ss_pred CCcccCcccccCceEEEEEEe----cCCCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeC--CeeE
Q 002061 677 NLEEDNLIGSGGTGKVYRLDL----KKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKG--GSSF 747 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~----~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~ 747 (973)
.|++.+.||+|+||.||.|+. ..++..||+|.+... ...+.+.+|++++++++|||++++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 468889999999999999985 356788999988643 2345788999999999999999999988775 5689
Q ss_pred EEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcc
Q 002061 748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827 (973)
Q Consensus 748 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~ 827 (973)
+||||+++++|.+++... ...+++..+..++.|++.||+|+| +++++||||||+||+++.++.++|+|||+++
T Consensus 85 lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRN----KNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEccCCCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCcccc
Confidence 999999999999998653 235789999999999999999999 8899999999999999999999999999998
Q ss_pred cccCCCCc-ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccC----------CcccHHHHHH
Q 002061 828 IAENSPKV-SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYG----------DGKDIVYWVS 896 (973)
Q Consensus 828 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~----------~~~~~~~~~~ 896 (973)
........ .......++..|+|||++.+..++.++|||||||++|||++++.|+..... ........+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 66433221 112234567789999999888899999999999999999998776543211 0001111111
Q ss_pred HHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 897 THLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
.. .... ...........+.+++.+|++.+|++||++.++++.++++
T Consensus 238 ~~-~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 VL-EEGK----------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HH-HcCc----------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 10 0000 0001122345788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=316.06 Aligned_cols=260 Identities=28% Similarity=0.358 Sum_probs=204.5
Q ss_pred cCCcccCcccccCceEEEEEEecC----CCcEEEEEeeecccc---HHHHHHHHHHHHhcCCCceeeEEEEEEe--CCee
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKK----NAGTVAVKQLWKGDG---VKVFAAEMEILGKIRHRNILKLYACLLK--GGSS 746 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~----~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~ 746 (973)
..|+..+.||+|+||.||+|+... ++..||||++..... .+.+.+|++++++++||||+++++++.. +...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 356778899999999999999753 378899999876433 5678999999999999999999999877 5678
Q ss_pred EEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCc
Q 002061 747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826 (973)
Q Consensus 747 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~ 826 (973)
++||||+++++|.+++... ...+++..+..++.|++.||+||| +.+++||||||+||+++.++.++++|||.+
T Consensus 84 ~lv~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 156 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH----RDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLA 156 (284)
T ss_pred EEEEecCCCCCHHHHHHhC----ccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccc
Confidence 9999999999999999754 235889999999999999999999 789999999999999999999999999999
Q ss_pred ccccCCCCccc-ccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCccc----------HHHHH
Q 002061 827 KIAENSPKVSD-YSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKD----------IVYWV 895 (973)
Q Consensus 827 ~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~----------~~~~~ 895 (973)
........... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+......... ...+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence 86653222111 11223456799999998888999999999999999999999998654221111 11111
Q ss_pred HHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 896 STHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
. ..... ...........++.+++.+|++.+|++||++.||+++|+.+
T Consensus 237 ~-~~~~~----------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 237 E-LLKEG----------ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred H-HHHcC----------CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1 11111 00111122335688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=313.28 Aligned_cols=257 Identities=25% Similarity=0.354 Sum_probs=204.2
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCc----EEEEEeeeccc---cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAG----TVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF 747 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~----~vavK~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 747 (973)
..+|++.+.||+|+||+||+|.+..+++ .||+|+..... ....+.+|++++++++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 3567888999999999999999876554 58999876543 34567889999999999999999999877 7889
Q ss_pred EEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcc
Q 002061 748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827 (973)
Q Consensus 748 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~ 827 (973)
+||||+++|+|.+++... ...+++..+..++.|++.|++||| +.+++||||||+||+++.++.+||+|||.++
T Consensus 85 ~v~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~ 157 (279)
T cd05057 85 LITQLMPLGCLLDYVRNH----KDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (279)
T ss_pred EEEecCCCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccc
Confidence 999999999999998753 334889999999999999999999 7899999999999999999999999999998
Q ss_pred cccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccc
Q 002061 828 IAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVL 906 (973)
Q Consensus 828 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 906 (973)
...............++..|+|||.+....++.++||||||+++||+++ |+.||.... ..++...+. .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~~~~~~~~----~~~~~- 230 (279)
T cd05057 158 LLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP--AVEIPDLLE----KGERL- 230 (279)
T ss_pred cccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC--HHHHHHHHh----CCCCC-
Confidence 6653322222122234568999999988889999999999999999998 999996541 122222211 11100
Q ss_pred hhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 002061 907 KVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADP 955 (973)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 955 (973)
..+......+.+++.+||..+|.+||++.++++.|+++..
T Consensus 231 ---------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 231 ---------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0011122457789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=317.01 Aligned_cols=199 Identities=26% Similarity=0.384 Sum_probs=163.6
Q ss_pred CcccccCceEEEEEEecC--CCcEEEEEeeeccccHHHHHHHHHHHHhcCCCceeeEEEEEEe--CCeeEEEEEccCCCc
Q 002061 682 NLIGSGGTGKVYRLDLKK--NAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLK--GGSSFLVLEYMPNGN 757 (973)
Q Consensus 682 ~~lG~G~~g~V~~a~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~lv~e~~~~gs 757 (973)
.+||+|+||+||+|+... ++..||+|.+........+.+|++++++++||||+++++++.. +...++||||++ ++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~ 85 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-HD 85 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-Cc
Confidence 579999999999999754 5678999998776556678899999999999999999998854 567899999985 58
Q ss_pred hHHHHHhhhc----CCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeee----cCCCCeEEecccCcccc
Q 002061 758 LFQALHKRVK----EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILL----DEDYEPKIADFGVAKIA 829 (973)
Q Consensus 758 L~~~l~~~~~----~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill----~~~~~~kl~Dfgl~~~~ 829 (973)
|.+++..... .....+++..+..++.|++.||+||| +.+++||||||+||++ +.++.+||+|||+++..
T Consensus 86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07867 86 LWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred HHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence 8888754321 11235788899999999999999999 7899999999999999 45678999999999866
Q ss_pred cCCCCc-ccccccCCccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcc
Q 002061 830 ENSPKV-SDYSCFAGTHGYIAPELAYTC-KVSEKSDVFSFGVVLLELVTGRKPVEEE 884 (973)
Q Consensus 830 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~pf~~~ 884 (973)
...... .......||+.|+|||++.+. .++.++||||+||++|||+||+.||...
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred CCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 443221 122345689999999998764 5789999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=309.12 Aligned_cols=255 Identities=25% Similarity=0.339 Sum_probs=189.4
Q ss_pred CcccccCceEEEEEEecC--CCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCC
Q 002061 682 NLIGSGGTGKVYRLDLKK--NAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNG 756 (973)
Q Consensus 682 ~~lG~G~~g~V~~a~~~~--~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 756 (973)
+.||+|+||+||+|.... ....+|+|.+... .....+.+|++.++.++||||+++++++......|+||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 358999999999997543 3457888876543 23456788999999999999999999999999999999999999
Q ss_pred chHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCcc
Q 002061 757 NLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVS 836 (973)
Q Consensus 757 sL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 836 (973)
+|.+++...........++.....++.|++.|++||| +++|+||||||+||+++.++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 9999997653222334567788899999999999999 7899999999999999999999999999986543322212
Q ss_pred cccccCCccccccccccc-------cCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchh
Q 002061 837 DYSCFAGTHGYIAPELAY-------TCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKV 908 (973)
Q Consensus 837 ~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (973)
......++..|+|||+.. ...++.++||||+||++|||++ |..||..... .+ .......... ...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--~~---~~~~~~~~~~--~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD--EQ---VLKQVVREQD--IKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH--HH---HHHHHhhccC--ccC
Confidence 223344677899999874 2356789999999999999999 7888864311 11 1111111111 011
Q ss_pred ccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 909 LDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 909 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
..+.. .......+.+++..|+ .||++||++.||++.+.
T Consensus 231 ~~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 11111 1223445667888888 59999999999998863
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=311.96 Aligned_cols=252 Identities=23% Similarity=0.335 Sum_probs=200.2
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc--ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM 753 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 753 (973)
++|++.+.||+|+||.||+|++..+++.||+|++... .....+.+|+.+++.++||||+++++++..++..|+||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 4788889999999999999999988999999988653 33456788999999999999999999999999999999999
Q ss_pred CCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCC
Q 002061 754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833 (973)
Q Consensus 754 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 833 (973)
++++|.+++... ..+++..+..++.|++.|++||| +.+++|+||||+||+++.++.++|+|||++.......
T Consensus 89 ~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 89 GGGSLQDIYHVT-----GPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI 160 (267)
T ss_pred CCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence 999999998643 35789999999999999999999 7899999999999999999999999999987553221
Q ss_pred CcccccccCCccccccccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhcc
Q 002061 834 KVSDYSCFAGTHGYIAPELAY---TCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLD 910 (973)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (973)
.......|+..|+|||++. ...++.++||||+||++|+|++|+.||...... ... ..........
T Consensus 161 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~-~~~----~~~~~~~~~~----- 228 (267)
T cd06645 161 --AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM-RAL----FLMTKSNFQP----- 228 (267)
T ss_pred --cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch-hhH----HhhhccCCCC-----
Confidence 1223346899999999874 456888999999999999999999998643211 000 0000000000
Q ss_pred ccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 911 CEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 911 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
+.. .........+.+++.+|++.+|++||++.+++++
T Consensus 229 ~~~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 229 PKL--KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred Ccc--cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 000 0001123457889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=310.09 Aligned_cols=249 Identities=27% Similarity=0.357 Sum_probs=200.1
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc-----------cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCe
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----------GVKVFAAEMEILGKIRHRNILKLYACLLKGGS 745 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-----------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 745 (973)
+|.+...||+|++|.||+|.+..+++.||+|.+.... ..+.+.+|++++++++||||+++++++..++.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4677889999999999999998889999999875421 12457889999999999999999999999999
Q ss_pred eEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccC
Q 002061 746 SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGV 825 (973)
Q Consensus 746 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl 825 (973)
.++||||+++++|.+++... ..+++..+..++.|++.|++||| +.+++||||+|+||+++.++.++|+|||.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~ 152 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY-----GAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGI 152 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCC
Confidence 99999999999999999753 34778888999999999999999 78999999999999999999999999999
Q ss_pred cccccCCCCc----ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcc
Q 002061 826 AKIAENSPKV----SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNN 901 (973)
Q Consensus 826 ~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 901 (973)
++........ .......|+..|+|||.+.+..++.++||||+||++|+|++|+.||..... ...+.....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~- 226 (267)
T cd06628 153 SKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ-----LQAIFKIGE- 226 (267)
T ss_pred CcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH-----HHHHHHHhc-
Confidence 8766422111 111224578899999999988899999999999999999999999975311 111111000
Q ss_pred ccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 902 HENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
...+ ..+......+.+++.+||++||.+||++.|++++
T Consensus 227 ------~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 227 ------NASP----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred ------cCCC----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 0001 1112234567889999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=313.07 Aligned_cols=253 Identities=25% Similarity=0.345 Sum_probs=201.5
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc--ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM 753 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 753 (973)
+.|++.+.||+|+||.||+|++..+++.||+|++... ...+.+.+|+++++.++||||+++++++..+...|+||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 4688999999999999999999998999999998653 34567888999999999999999999999999999999999
Q ss_pred CCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCC
Q 002061 754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833 (973)
Q Consensus 754 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 833 (973)
++++|..++.+. ...+++..+..++.|++.|++||| +.+++||||||+||+++.++.++|+|||.+.......
T Consensus 92 ~~~~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 164 (292)
T cd06644 92 PGGAVDAIMLEL----DRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL 164 (292)
T ss_pred CCCcHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceeccccc
Confidence 999998887643 235789999999999999999999 8899999999999999999999999999886543221
Q ss_pred CcccccccCCccccccccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchh
Q 002061 834 KVSDYSCFAGTHGYIAPELAY-----TCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKV 908 (973)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (973)
.......++..|+|||++. ...++.++|||||||++|||++|+.||.... .............
T Consensus 165 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~~----- 232 (292)
T cd06644 165 --QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN-----PMRVLLKIAKSEP----- 232 (292)
T ss_pred --cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc-----HHHHHHHHhcCCC-----
Confidence 1222345788999999984 3456789999999999999999999996531 1111111111110
Q ss_pred ccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 909 LDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 909 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
+.. ........++.+++.+||+.+|++||++.|++++-.
T Consensus 233 --~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 271 (292)
T cd06644 233 --PTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPF 271 (292)
T ss_pred --ccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 000 011223446788999999999999999999987643
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=307.86 Aligned_cols=251 Identities=26% Similarity=0.376 Sum_probs=201.5
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccC
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP 754 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 754 (973)
.+|++.+.||+|+||.||+|.+.. ++.+|+|.+... .....+.+|++++++++||+++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 467888999999999999998865 678999988653 345678999999999999999999999999999999999999
Q ss_pred CCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCC
Q 002061 755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK 834 (973)
Q Consensus 755 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 834 (973)
+++|.+++... ...+++..+..++.|++.|++||| +.+++||||||+||+++.++.++|+|||.+........
T Consensus 83 ~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 83 HGCLSDYLRAQ----RGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred CCcHHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 99999998753 235788999999999999999999 78999999999999999999999999999875543221
Q ss_pred cccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhccccc
Q 002061 835 VSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEV 913 (973)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (973)
.......++.+|+|||++.+..++.++||||+|+++|||++ |+.||.... ............. ...+.
T Consensus 156 -~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-----~~~~~~~~~~~~~----~~~~~- 224 (256)
T cd05112 156 -TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS-----NSEVVETINAGFR----LYKPR- 224 (256)
T ss_pred -cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC-----HHHHHHHHhCCCC----CCCCC-
Confidence 11112235678999999998889999999999999999998 999996531 1222222111100 01111
Q ss_pred cCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 914 ASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 914 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
.....+.+++.+||+.+|++||++.|++++|.
T Consensus 225 ------~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 225 ------LASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ------CCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 12356889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=312.70 Aligned_cols=251 Identities=23% Similarity=0.316 Sum_probs=200.5
Q ss_pred CcccCcccccCceEEEEEEecCCCcEEEEEeeecc--ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCC
Q 002061 678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPN 755 (973)
Q Consensus 678 ~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 755 (973)
|++.+.||+|+||.||+|++..++..+|+|.+... ...+.+.+|+++++.++|||++++++++..+...|+||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 67788999999999999999998999999988653 3456788899999999999999999999999999999999999
Q ss_pred CchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCc
Q 002061 756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV 835 (973)
Q Consensus 756 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 835 (973)
++|..++... ...+++..+..++.|+++||+||| +.+++||||||+||+++.++.++++|||++.......
T Consensus 87 ~~l~~~~~~~----~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-- 157 (282)
T cd06643 87 GAVDAVMLEL----ERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-- 157 (282)
T ss_pred CcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEccccccccccccc--
Confidence 9998887642 235889999999999999999999 7899999999999999999999999999986543221
Q ss_pred ccccccCCccccccccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhcc
Q 002061 836 SDYSCFAGTHGYIAPELAY-----TCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLD 910 (973)
Q Consensus 836 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (973)
.......++..|+|||++. +..++.++||||+||++|||++|+.||.... ....+......... ...
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-----~~~~~~~~~~~~~~--~~~- 229 (282)
T cd06643 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN-----PMRVLLKIAKSEPP--TLA- 229 (282)
T ss_pred cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC-----HHHHHHHHhhcCCC--CCC-
Confidence 1122346889999999973 4457789999999999999999999996531 11111111111110 000
Q ss_pred ccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 911 CEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 911 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
.+......+.+++.+||+.+|++||++.+++++-.
T Consensus 230 ------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 264 (282)
T cd06643 230 ------QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF 264 (282)
T ss_pred ------CccccCHHHHHHHHHHccCChhhCcCHHHHhcCCC
Confidence 11123456889999999999999999999987754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=313.58 Aligned_cols=258 Identities=26% Similarity=0.302 Sum_probs=201.8
Q ss_pred HHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-ccHHHHHHHHHHHHhc-CCCceeeEEEEEE-----eCCe
Q 002061 673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKI-RHRNILKLYACLL-----KGGS 745 (973)
Q Consensus 673 ~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~~~-----~~~~ 745 (973)
...++|++.+.||+|+||+||+|++..+++.||+|++... .....+.+|+.+++++ +||||+++++++. .++.
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 94 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQ 94 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCe
Confidence 4567899999999999999999999998999999987653 2345678899999999 6999999999874 3457
Q ss_pred eEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccC
Q 002061 746 SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGV 825 (973)
Q Consensus 746 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl 825 (973)
.++||||+++++|.+++... ......+++..+..++.|+++|+.||| +.+++||||||+||+++.++.++++|||.
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~kl~dfg~ 170 (286)
T cd06638 95 LWLVLELCNGGSVTDLVKGF-LKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGV 170 (286)
T ss_pred EEEEEeecCCCCHHHHHHHh-hccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCEEEccCCc
Confidence 89999999999999988753 223346788899999999999999999 78999999999999999999999999999
Q ss_pred cccccCCCCcccccccCCccccccccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhc
Q 002061 826 AKIAENSPKVSDYSCFAGTHGYIAPELAY-----TCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLN 900 (973)
Q Consensus 826 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 900 (973)
++....... ......|++.|+|||++. +..++.++||||+||++|||++|+.||..... .... .....
T Consensus 171 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~----~~~~-~~~~~ 243 (286)
T cd06638 171 SAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP----MRAL-FKIPR 243 (286)
T ss_pred eeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch----hHHH-hhccc
Confidence 876543221 122346889999999875 34578899999999999999999999965311 1111 11000
Q ss_pred cccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 901 NHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
... ....++ ......+.+++.+||+.||++||++.|++++.
T Consensus 244 ~~~--~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 244 NPP--PTLHQP-------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred cCC--CcccCC-------CCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 000 001111 11234588899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=333.34 Aligned_cols=263 Identities=17% Similarity=0.185 Sum_probs=194.2
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-ccHHHHHHHHHHHHhcCC------CceeeEEEEEEeC-Ce
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRH------RNILKLYACLLKG-GS 745 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~h------pniv~l~~~~~~~-~~ 745 (973)
...+|++.+.||+|+||+||+|.+..+++.||||++... .....+..|++++++++| ++++++++++..+ .+
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~ 206 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGH 206 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCce
Confidence 346899999999999999999999988999999998652 333456678888877754 4588999988764 57
Q ss_pred eEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCC---------
Q 002061 746 SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY--------- 816 (973)
Q Consensus 746 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~--------- 816 (973)
.++|||++ +++|.+++..+ ..+++..+..++.||+.||+|||+ ..+||||||||+|||++.++
T Consensus 207 ~~iv~~~~-g~~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~~~~ 278 (467)
T PTZ00284 207 MCIVMPKY-GPCLLDWIMKH-----GPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTNR 278 (467)
T ss_pred EEEEEecc-CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCccccccccc
Confidence 89999998 78898888653 358889999999999999999993 25999999999999998765
Q ss_pred -------CeEEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcc
Q 002061 817 -------EPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGK 889 (973)
Q Consensus 817 -------~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~ 889 (973)
.+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..
T Consensus 279 ~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~--~~ 351 (467)
T PTZ00284 279 ALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD--NL 351 (467)
T ss_pred ccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--hH
Confidence 499999998753322 1234578999999999999999999999999999999999999997532 11
Q ss_pred cHHHHHHHHhcccc----------ccchhcc------ccccC-----------cchHHHHHHHHHHHHHhcCCCCCCCCC
Q 002061 890 DIVYWVSTHLNNHE----------NVLKVLD------CEVAS-----------ESIKEDMIKLLKIAVVCTTKLPNLRPP 942 (973)
Q Consensus 890 ~~~~~~~~~~~~~~----------~~~~~~~------~~~~~-----------~~~~~~~~~l~~l~~~cl~~dP~~Rpt 942 (973)
+....+.......+ ....+.+ +.... .........+.+|+.+||++||++|||
T Consensus 352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t 431 (467)
T PTZ00284 352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN 431 (467)
T ss_pred HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence 11111111100000 0000000 00000 000011345779999999999999999
Q ss_pred HHHHHHHhh
Q 002061 943 MREVVKMLA 951 (973)
Q Consensus 943 ~~evl~~L~ 951 (973)
+.|+++|-.
T Consensus 432 a~e~L~Hp~ 440 (467)
T PTZ00284 432 ARQMTTHPY 440 (467)
T ss_pred HHHHhcCcc
Confidence 999998644
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=305.93 Aligned_cols=245 Identities=30% Similarity=0.415 Sum_probs=194.8
Q ss_pred CcccccCceEEEEEEecCCCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCCch
Q 002061 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNL 758 (973)
Q Consensus 682 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL 758 (973)
+.||+|+||.||+|... ++..||+|++... .....+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 36899999999999876 4789999987653 2234688999999999999999999999999999999999999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCcccc
Q 002061 759 FQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY 838 (973)
Q Consensus 759 ~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~ 838 (973)
.+++... ...+++..+..++.|++.|+.|+| +++++||||||+||+++.++.++++|||++........ ...
T Consensus 80 ~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~ 151 (250)
T cd05085 80 LSFLRKK----KDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSS 151 (250)
T ss_pred HHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceecccccc-ccC
Confidence 9998643 235789999999999999999999 88999999999999999999999999999875433211 111
Q ss_pred cccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhccccccCcc
Q 002061 839 SCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASES 917 (973)
Q Consensus 839 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (973)
....++..|+|||++.+..++.++||||||+++|++++ |..||.... ... ... ........ ..
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~--~~~---~~~-~~~~~~~~----------~~ 215 (250)
T cd05085 152 GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMT--NQQ---ARE-QVEKGYRM----------SC 215 (250)
T ss_pred CCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCC--HHH---HHH-HHHcCCCC----------CC
Confidence 12234678999999998889999999999999999998 999996531 111 111 11111100 01
Q ss_pred hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 918 IKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 918 ~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
.......+.+++.+|++.+|++||++.|++++|.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 216 PQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 1123456889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=314.84 Aligned_cols=251 Identities=23% Similarity=0.336 Sum_probs=203.5
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc--ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM 753 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 753 (973)
.+|++.+.||.|+||+||+|.+..+++.||+|.+... ...+.+.+|+.+++.++|||++++++++..++..|+||||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688899999999999999999988999999988652 34567889999999999999999999999999999999999
Q ss_pred CCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCC
Q 002061 754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833 (973)
Q Consensus 754 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 833 (973)
++++|.+++... .+++.++..++.|++.|++||| +.+++||||+|+||+++.++.++|+|||++.......
T Consensus 99 ~~~~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 99 AGGSLTDVVTET------CMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred CCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 999999988642 4789999999999999999999 8899999999999999999999999999987554332
Q ss_pred CcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccc
Q 002061 834 KVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEV 913 (973)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (973)
. ......++..|+|||.+.+..++.++|||||||++|+|++|+.||..... ............. .
T Consensus 170 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~-----~~~~~~~~~~~~~--~------ 234 (296)
T cd06655 170 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP-----LRALYLIATNGTP--E------ 234 (296)
T ss_pred c--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhcCCc--c------
Confidence 1 12234578899999999988899999999999999999999999965421 1111111100000 0
Q ss_pred cCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 914 ASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 914 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
...+......+.+++.+||..||++||++.+++++=.
T Consensus 235 -~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~ 271 (296)
T cd06655 235 -LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPF 271 (296)
T ss_pred -cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence 0011223446788999999999999999999987643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=304.65 Aligned_cols=249 Identities=23% Similarity=0.356 Sum_probs=201.2
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEe-CCeeEEEEE
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLK-GGSSFLVLE 751 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~~lv~e 751 (973)
+|++.+.||+|++|.||+|++..+++.||+|++... ...+.+.+|++++++++|||++++++.+.. +...|+|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 478899999999999999999988999999998652 234567889999999999999999998764 446899999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccC
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 831 (973)
|+++++|.+++... ....+++.++..++.|++.|++++| +.+++||||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~~l~~~l~~~---~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 81 FCEGGDLYHKLKEQ---KGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred ccCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 99999999999753 2345789999999999999999999 78999999999999999999999999999876643
Q ss_pred CCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccc
Q 002061 832 SPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDC 911 (973)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (973)
... ......+++.|+|||++.+..++.++||||+|+++|+|++|+.||... +............ .
T Consensus 155 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~-----~~~~~~~~~~~~~--~------ 219 (257)
T cd08223 155 QCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK-----DMNSLVYRIIEGK--L------ 219 (257)
T ss_pred cCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC-----CHHHHHHHHHhcC--C------
Confidence 221 122345788999999999999999999999999999999999999643 1112211111110 0
Q ss_pred cccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 912 EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 912 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
..........+.+++.+|++.+|++||++.+++++
T Consensus 220 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 220 ---PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ---CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 01112334568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=309.51 Aligned_cols=252 Identities=31% Similarity=0.421 Sum_probs=205.9
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM 753 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 753 (973)
+|+..+.||+|+||.||+|.+..+++.||+|++... ...+++.+|++++++++||||+++++++..+...++|+||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 578889999999999999999988999999988653 34456889999999999999999999999999999999999
Q ss_pred CCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCC-CCeEecCCCCCCeeecCCCCeEEecccCcccccCC
Q 002061 754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS-PPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832 (973)
Q Consensus 754 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~-~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 832 (973)
++++|.+++... ...++...+..++.|++.|++|+| + .+++|+||+|+||+++.++.++|+|||.+......
T Consensus 82 ~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 82 DGGSLDKILKEV----QGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred CCCcHHHHHHHc----cCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 999999998753 146788899999999999999999 6 89999999999999999999999999998755322
Q ss_pred CCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhcccc
Q 002061 833 PKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCE 912 (973)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (973)
.. ....++..|+|||++.+..++.++||||+|+++|+|++|+.||...................... +.
T Consensus 155 ~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------~~ 223 (265)
T cd06605 155 LA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP-------PR 223 (265)
T ss_pred Hh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC-------CC
Confidence 11 11567889999999999899999999999999999999999997653322333333322222111 00
Q ss_pred ccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 913 VASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 913 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
. ........+.+++.+||..+|++||++.+++++
T Consensus 224 ~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 224 L---PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred C---ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 0 011145568899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=307.81 Aligned_cols=253 Identities=27% Similarity=0.429 Sum_probs=202.0
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc-cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM 753 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 753 (973)
.++|++.+.||+|+||.||+|.... +..||+|.+.... ..+.+.+|++++++++|+||+++++++.. ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecC-CccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 3578899999999999999998764 5679999876533 45678899999999999999999999877 7789999999
Q ss_pred CCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCC
Q 002061 754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833 (973)
Q Consensus 754 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 833 (973)
++|+|.+++... .....++..+..++.|++.|++||| +.+++||||+|+||+++.++.++++|||.+.......
T Consensus 83 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 83 AKGSLLDFLKSD---EGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred CCCcHHHHHHhC---CccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 999999999753 2345788899999999999999999 7899999999999999999999999999987654322
Q ss_pred CcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhcccc
Q 002061 834 KVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCE 912 (973)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (973)
. .......++..|+|||++.+..++.++|||||||++|++++ |+.||.... ..+....+. .....
T Consensus 157 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~--~~~~~~~~~----~~~~~------- 222 (260)
T cd05073 157 Y-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS--NPEVIRALE----RGYRM------- 222 (260)
T ss_pred c-ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHh----CCCCC-------
Confidence 1 11122345678999999998889999999999999999999 999996531 111111111 11000
Q ss_pred ccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 002061 913 VASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952 (973)
Q Consensus 913 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~ 952 (973)
.........+.+++.+|++.+|++||++.++.+.|+.
T Consensus 223 ---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 ---PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ---CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0112234568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=308.34 Aligned_cols=255 Identities=25% Similarity=0.406 Sum_probs=201.8
Q ss_pred CCcccCcccccCceEEEEEEecC-CCcEEEEEeeecc------------ccHHHHHHHHHHHHh-cCCCceeeEEEEEEe
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKK-NAGTVAVKQLWKG------------DGVKVFAAEMEILGK-IRHRNILKLYACLLK 742 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~-~~~~vavK~~~~~------------~~~~~~~~E~~~l~~-l~hpniv~l~~~~~~ 742 (973)
.|++.+.||+|+||.||+|.+.. .++.+|||.+... ....++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999987 6789999987531 123446678888765 799999999999999
Q ss_pred CCeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEec
Q 002061 743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIAD 822 (973)
Q Consensus 743 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 822 (973)
++..++||||+++++|.+++... ......+++..++.++.|++.|+.|||+ ..+++||||+|+||+++.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSL-KEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHH-HhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999999998653 2234468889999999999999999994 36899999999999999999999999
Q ss_pred ccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccc
Q 002061 823 FGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNH 902 (973)
Q Consensus 823 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 902 (973)
||.+....... ......|+..|+|||++.+..++.++||||||+++|||++|+.||... +............
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~-----~~~~~~~~~~~~~ 229 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST-----NMLSLATKIVEAV 229 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc-----CHHHHHHHHhhcc
Confidence 99987654332 223356889999999999888999999999999999999999999643 1111111111110
Q ss_pred cccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 002061 903 ENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952 (973)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~ 952 (973)
. ...........+.+++.+||+.||++||++.|+.+++++
T Consensus 230 ~----------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 230 Y----------EPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred C----------CcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 0 000011223568889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=304.77 Aligned_cols=246 Identities=28% Similarity=0.388 Sum_probs=196.8
Q ss_pred CcccccCceEEEEEEecCCCcEEEEEeeeccc---cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCCch
Q 002061 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNL 758 (973)
Q Consensus 682 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL 758 (973)
++||+|+||.||+|.+.. ++.||+|++.... ....+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 468999999999999988 8999999876532 346788999999999999999999999999999999999999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCcccc
Q 002061 759 FQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY 838 (973)
Q Consensus 759 ~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~ 838 (973)
.+++... ...+++..+..++.+++.|++||| +++++||||+|+||+++.++.++|+|||.+............
T Consensus 80 ~~~l~~~----~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (251)
T cd05041 80 LTFLRKK----KNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD 152 (251)
T ss_pred HHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence 9998653 235788899999999999999999 789999999999999999999999999998755422221111
Q ss_pred cccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhccccccCcc
Q 002061 839 SCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASES 917 (973)
Q Consensus 839 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (973)
....++..|+|||++.+..++.++|||||||++|||++ |..||.... .......+.. ... ...
T Consensus 153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~--~~~~~~~~~~----~~~----------~~~ 216 (251)
T cd05041 153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMS--NQQTRERIES----GYR----------MPA 216 (251)
T ss_pred ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCC--HHHHHHHHhc----CCC----------CCC
Confidence 12234567999999988889999999999999999999 888886542 1111111111 000 001
Q ss_pred hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 918 IKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 918 ~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
+......+.+++.+|++.+|++||++.|+++.|.
T Consensus 217 ~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 217 PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 1123456888999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=322.10 Aligned_cols=259 Identities=22% Similarity=0.315 Sum_probs=196.0
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeC------C
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKG------G 744 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~ 744 (973)
.++|++.+.||+|+||+||+|.+..+++.||||++... ...+.+.+|++++++++||||+++++++... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 46799999999999999999999988999999998653 2345577899999999999999999987543 3
Q ss_pred eeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEeccc
Q 002061 745 SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFG 824 (973)
Q Consensus 745 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 824 (973)
..|+++|++ +++|.+++.. ..+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||
T Consensus 94 ~~~~~~~~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 94 EVYLVTNLM-GADLNNIVKC------QKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cEEEEeecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCc
Confidence 568999998 7899887753 24889999999999999999999 7899999999999999999999999999
Q ss_pred CcccccCCCCcccccccCCcccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccc
Q 002061 825 VAKIAENSPKVSDYSCFAGTHGYIAPELAYT-CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHE 903 (973)
Q Consensus 825 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 903 (973)
+++..... .....||..|+|||++.+ ..++.++||||+||++|+|++|+.||.... ..+....+........
T Consensus 164 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--~~~~~~~~~~~~~~~~ 236 (343)
T cd07878 164 LARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGND--YIDQLKRIMEVVGTPS 236 (343)
T ss_pred cceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCC--HHHHHHHHHHHhCCCC
Confidence 99765432 223468999999999876 568899999999999999999999996431 1111111100000000
Q ss_pred -ccc---------hhcc--ccccCcc----hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 904 -NVL---------KVLD--CEVASES----IKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 904 -~~~---------~~~~--~~~~~~~----~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
... .... +...... .....+.+.+++.+|++.||++|||+.|+++|-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp 299 (343)
T cd07878 237 PEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHP 299 (343)
T ss_pred HHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 000 0000 0000000 001123467899999999999999999999873
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=310.45 Aligned_cols=262 Identities=24% Similarity=0.332 Sum_probs=200.8
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc----cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE 751 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 751 (973)
++|+..+.||+|+||.||+|++..+++.||+|++.... ..+.+.+|++++++++|||++++++++..+...++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 36888999999999999999999889999999876422 23567889999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccC
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 831 (973)
|++++.|..+... ...+++..+..++.|++.||+||| +.+++||||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07847 81 YCDHTVLNELEKN-----PRGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTG 152 (286)
T ss_pred ccCccHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCC
Confidence 9999888776643 235889999999999999999999 78999999999999999999999999999976644
Q ss_pred CCCcccccccCCcccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcc---------
Q 002061 832 SPKVSDYSCFAGTHGYIAPELAYT-CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNN--------- 901 (973)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~--------- 901 (973)
... ......++..|+|||++.+ ..++.++||||+|+++|||++|+.||...... +...........
T Consensus 153 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07847 153 PGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDV--DQLYLIRKTLGDLIPRHQQIF 228 (286)
T ss_pred Ccc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCChHHhhhc
Confidence 321 1223457889999999876 45788999999999999999999999754211 111111111000
Q ss_pred --ccccchhccccccC-----cchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 902 --HENVLKVLDCEVAS-----ESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 902 --~~~~~~~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
.........+.... .........+.+++.+||+.+|++||++.|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 229 STNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00000000000000 0011224568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=308.03 Aligned_cols=254 Identities=23% Similarity=0.326 Sum_probs=197.8
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc--ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY 752 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 752 (973)
...+.....||+|+||.||+|++..++..||+|.+... ...+.+.+|++++++++||||+++++++..++..++||||
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 86 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQ 86 (268)
T ss_pred cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEec
Confidence 34445557899999999999999988999999987653 3456788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecC-CCCeEEecccCcccccC
Q 002061 753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE-DYEPKIADFGVAKIAEN 831 (973)
Q Consensus 753 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfgl~~~~~~ 831 (973)
+++++|.+++.... .....++..+..++.|++.|++||| +.+++||||||+||+++. ++.++|+|||.+.....
T Consensus 87 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 87 VPGGSLSALLRSKW--GPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred CCCCCHHHHHHHhc--ccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 99999999997531 1112267788889999999999999 789999999999999986 67999999999875533
Q ss_pred CCCcccccccCCccccccccccccCC--CCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhc
Q 002061 832 SPKVSDYSCFAGTHGYIAPELAYTCK--VSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVL 909 (973)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (973)
... ......|+..|+|||++.+.. ++.++||||+|+++|+|++|+.||..... .....+........+
T Consensus 162 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~------ 231 (268)
T cd06624 162 INP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE--PQAAMFKVGMFKIHP------ 231 (268)
T ss_pred CCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccC--hhhhHhhhhhhccCC------
Confidence 211 122345789999999986543 78899999999999999999999965311 111111110001110
Q ss_pred cccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 910 DCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 910 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
..+.....++.+++.+||+.+|++||++.|++++
T Consensus 232 ------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 232 ------EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ------CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 1112234567889999999999999999999876
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=312.69 Aligned_cols=247 Identities=27% Similarity=0.422 Sum_probs=200.8
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM 753 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 753 (973)
.|+..+.||+|+||.||+|.+..+++.||+|.+... ...+.+.+|++++++++||||+++++++..+...|+||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 466778899999999999999988999999987642 33456889999999999999999999999999999999999
Q ss_pred CCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCC
Q 002061 754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833 (973)
Q Consensus 754 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 833 (973)
++++|.+++.. ..+++..+..++.|+++|+.||| +++++|+||+|+||+++.++.++++|||++.......
T Consensus 85 ~~~~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 85 GGGSALDLLKP------GPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence 99999998853 24788899999999999999999 7899999999999999999999999999987654321
Q ss_pred CcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccc
Q 002061 834 KVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEV 913 (973)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (973)
. ......++..|+|||++.+..++.++|||||||++|||++|+.||..... ...... .... .
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~--~~~~~~----~~~~----------~ 217 (277)
T cd06642 156 I--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHP--MRVLFL----IPKN----------S 217 (277)
T ss_pred h--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccch--hhHHhh----hhcC----------C
Confidence 1 12224578899999999988899999999999999999999999864321 111111 0000 0
Q ss_pred cCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 914 ASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 914 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
...........+.+++.+|++.+|++||++.+++++-
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06642 218 PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHK 254 (277)
T ss_pred CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhH
Confidence 0111123345678999999999999999999999864
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=303.82 Aligned_cols=253 Identities=27% Similarity=0.373 Sum_probs=204.2
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc--ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM 753 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 753 (973)
++|++.+.||.|+||.||+|+...+++.+|+|++... ...+.+.+|++++++++||||+++++++..+...|++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 4688899999999999999999988899999988753 34567899999999999999999999999999999999999
Q ss_pred CCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCC
Q 002061 754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833 (973)
Q Consensus 754 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 833 (973)
++++|.+++... ...+++..+..++.|++.|++||| +.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 83 ~~~~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 83 GGGSLQDIYQVT----RGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI 155 (262)
T ss_pred CCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence 999999988753 235788999999999999999999 7899999999999999999999999999987654321
Q ss_pred CcccccccCCccccccccccccC---CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhcc
Q 002061 834 KVSDYSCFAGTHGYIAPELAYTC---KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLD 910 (973)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (973)
. ......++..|+|||.+.+. .++.++||||+|+++|||++|+.||..... ........... ..
T Consensus 156 ~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~-----~~~~~~~~~~~------~~ 222 (262)
T cd06613 156 A--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP-----MRALFLISKSN------FP 222 (262)
T ss_pred h--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhcc------CC
Confidence 1 12234678899999998776 788999999999999999999999965321 11111110000 00
Q ss_pred ccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 911 CEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 911 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
... ..........+.+++.+||+.+|.+||++.+++++
T Consensus 223 ~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 223 PPK-LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred Ccc-ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 11123345678899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=304.96 Aligned_cols=249 Identities=21% Similarity=0.347 Sum_probs=203.9
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY 752 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 752 (973)
+|++.+.||+|+||.||+++...+++.||+|++... ...+++.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 478889999999999999999988999999988642 3345788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCC
Q 002061 753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832 (973)
Q Consensus 753 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 832 (973)
+++++|.+++... ....+++..+..++.|++.|++||| +.+++|+||+|+||+++.++.++++|||.+......
T Consensus 81 ~~~~~l~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~ 154 (256)
T cd08218 81 CEGGDLYKKINAQ---RGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST 154 (256)
T ss_pred CCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence 9999999988753 2235788899999999999999999 789999999999999999999999999998765432
Q ss_pred CCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhcccc
Q 002061 833 PKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCE 912 (973)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (973)
.. ......|+..|+|||+..+..++.++|||||||++|+|++|+.||... +....+........
T Consensus 155 ~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~-----~~~~~~~~~~~~~~--------- 218 (256)
T cd08218 155 VE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG-----NMKNLVLKIIRGSY--------- 218 (256)
T ss_pred hh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC-----CHHHHHHHHhcCCC---------
Confidence 21 112245788999999999888999999999999999999999999643 22222222211111
Q ss_pred ccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 913 VASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 913 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
..........+.+++.+|++.+|++||++.||+++
T Consensus 219 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 219 --PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred --CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 01112334568899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=307.16 Aligned_cols=248 Identities=27% Similarity=0.437 Sum_probs=199.6
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccC
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP 754 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 754 (973)
..+|++.+.||+|+||.||+|.. +++.||+|++......+.+.+|+.++++++|||++++++++..+ ..++||||++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 35688999999999999999975 47789999987766667889999999999999999999988654 4799999999
Q ss_pred CCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCC
Q 002061 755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK 834 (973)
Q Consensus 755 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 834 (973)
+++|.+++... ....+++..+..++.|++.|++|+| +.+++||||||+||+++.++.++|+|||.+.......
T Consensus 82 ~~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~- 154 (254)
T cd05083 82 KGNLVNFLRTR---GRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV- 154 (254)
T ss_pred CCCHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence 99999999753 2335788899999999999999999 7899999999999999999999999999987543211
Q ss_pred cccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhccccc
Q 002061 835 VSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEV 913 (973)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (973)
.....+..|+|||++.+..++.++|||||||++|||++ |+.||.... ......... ...
T Consensus 155 ----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-----~~~~~~~~~-~~~---------- 214 (254)
T cd05083 155 ----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS-----LKEVKECVE-KGY---------- 214 (254)
T ss_pred ----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC-----HHHHHHHHh-CCC----------
Confidence 11234568999999988889999999999999999998 999996531 111111111 110
Q ss_pred cCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 002061 914 ASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952 (973)
Q Consensus 914 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~ 952 (973)
...........+.+++.+||+.+|++||+++++++.|++
T Consensus 215 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 215 RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 001111234567899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=311.32 Aligned_cols=253 Identities=25% Similarity=0.384 Sum_probs=201.4
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM 753 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 753 (973)
+|++.+.||+|+||+||+|++..++..||+|.+... .....+.+|++++++++||||+++++++..++..|+||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 678899999999999999999988999999988653 23467889999999999999999999999999999999999
Q ss_pred CCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCC
Q 002061 754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833 (973)
Q Consensus 754 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 833 (973)
++++|.+++... .....+++..+..++.|++.|+.|||+ +.+++||||||+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~l~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 82 DAGSLDKLYAGG--VATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred CCCCHHHHHHhc--cccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 999999888752 123358999999999999999999994 3589999999999999999999999999987553221
Q ss_pred CcccccccCCccccccccccccCC------CCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccch
Q 002061 834 KVSDYSCFAGTHGYIAPELAYTCK------VSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLK 907 (973)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
.....++..|+|||++.+.. ++.++||||+||++|+|++|+.||.... ...............
T Consensus 158 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~----- 226 (286)
T cd06622 158 ----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET--YANIFAQLSAIVDGD----- 226 (286)
T ss_pred ----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc--hhhHHHHHHHHhhcC-----
Confidence 12245788999999985543 4789999999999999999999996531 111111111111100
Q ss_pred hccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 908 VLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 908 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
....+......+.+++.+|++.+|++||++.+++++-
T Consensus 227 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~ 263 (286)
T cd06622 227 ------PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHP 263 (286)
T ss_pred ------CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcCh
Confidence 0111223456678899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=307.20 Aligned_cols=254 Identities=24% Similarity=0.380 Sum_probs=204.9
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEe--CCeeEEEE
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLK--GGSSFLVL 750 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~lv~ 750 (973)
+|++.+.||.|+||.||+|.+..+++.||+|++... ...+++.+|++++++++||||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 478889999999999999999999999999988642 334567889999999999999999998754 45689999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcC--CCCeEecCCCCCCeeecCCCCeEEecccCccc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC--SPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~--~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 828 (973)
||+++++|.+++... ......+++..+..++.|++.|++|+|..+ +.+++|+||+|+||+++.++.+|++|||++..
T Consensus 81 e~~~~~~L~~~l~~~-~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 81 EYCEGGDLAQLIQKC-KKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred hhccCCCHHHHHHHH-hhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999999764 233456899999999999999999999543 56899999999999999999999999999986
Q ss_pred ccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchh
Q 002061 829 AENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKV 908 (973)
Q Consensus 829 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (973)
....... .....++..|+|||++.+..++.++||||||+++|+|++|+.||.... .. ...... ....
T Consensus 160 ~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~---~~~~~~-~~~~----- 226 (265)
T cd08217 160 LGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN--QL---QLASKI-KEGK----- 226 (265)
T ss_pred ccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC--HH---HHHHHH-hcCC-----
Confidence 6543221 123468899999999998889999999999999999999999997542 11 111111 1110
Q ss_pred ccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 909 LDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 909 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
...........+.+++.+|++.+|++||++.+|+++
T Consensus 227 -----~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 227 -----FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -----CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 111222345678899999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=308.15 Aligned_cols=262 Identities=30% Similarity=0.328 Sum_probs=205.1
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEe--CCeeEEEEE
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLK--GGSSFLVLE 751 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~lv~e 751 (973)
+|+..+.||.|++|.||+|.+..+++.||+|.+... ....++.+|++++++++||||+++++++.. +...|+|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 81 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME 81 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence 678889999999999999999988999999988753 234668899999999999999999998865 347899999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccC
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 831 (973)
|+++++|.+++.... .....++...+..++.|+++|++||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~~~~~L~~~l~~~~-~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 82 YCEGGSLDSIYKKVK-KRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred ecCCCCHHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999887542 23445788899999999999999999 78999999999999999999999999999865432
Q ss_pred CCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccc
Q 002061 832 SPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDC 911 (973)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (973)
... ....++..|+|||.+.+..++.++||||+||++|+|++|+.||...................... ....+.
T Consensus 158 ~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 231 (287)
T cd06621 158 SLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPN--PELKDE 231 (287)
T ss_pred ccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCc--hhhccC
Confidence 211 12456889999999998899999999999999999999999997653211222222222211111 000000
Q ss_pred cccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 912 EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 912 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
. .......+.+.+++.+||+++|++|||+.|++++-.
T Consensus 232 -~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~ 268 (287)
T cd06621 232 -P--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPW 268 (287)
T ss_pred -C--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcc
Confidence 0 001123456889999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=304.82 Aligned_cols=239 Identities=22% Similarity=0.329 Sum_probs=186.0
Q ss_pred CcccccCceEEEEEEecCC------------CcEEEEEeeecc--ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeE
Q 002061 682 NLIGSGGTGKVYRLDLKKN------------AGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF 747 (973)
Q Consensus 682 ~~lG~G~~g~V~~a~~~~~------------~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 747 (973)
+.||+|+||.||+|+.... ...||+|++... .....+.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 3689999999999986421 335889987553 33456788999999999999999999999988999
Q ss_pred EEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCC-------eEE
Q 002061 748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE-------PKI 820 (973)
Q Consensus 748 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~-------~kl 820 (973)
+||||+++|+|..++... ...+++..+..++.|+++|++||| +++++||||||+||+++.++. +++
T Consensus 81 lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK----SDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred EEEecccCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEe
Confidence 999999999998888643 235788899999999999999999 889999999999999987664 899
Q ss_pred ecccCcccccCCCCcccccccCCccccccccccc-cCCCCccchHHHHHHHHHHHH-hCCCCCCcccCCcccHHHHHHHH
Q 002061 821 ADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAY-TCKVSEKSDVFSFGVVLLELV-TGRKPVEEEYGDGKDIVYWVSTH 898 (973)
Q Consensus 821 ~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~el~-tg~~pf~~~~~~~~~~~~~~~~~ 898 (973)
+|||++...... ....++..|+|||++. +..++.++|||||||++|||+ +|+.||...... .... .
T Consensus 154 ~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--~~~~----~ 221 (262)
T cd05077 154 SDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA--EKER----F 221 (262)
T ss_pred CCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh--HHHH----H
Confidence 999988654321 1235788999999886 566889999999999999998 588888643111 1000 0
Q ss_pred hccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 899 LNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
..... ... ......+.+++.+||+.||++||++.+++++++
T Consensus 222 ~~~~~--------~~~----~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 222 YEGQC--------MLV----TPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred HhcCc--------cCC----CCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 00000 000 011345788999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=286.24 Aligned_cols=253 Identities=26% Similarity=0.358 Sum_probs=196.9
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc---ccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLVLE 751 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e 751 (973)
++.+.+..||.|..|.||+++.+.+|...|||.+... ++-+++.+.++++..- ++|+||+.+|||..+..+++.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 4556677899999999999999999999999998774 3445666777776554 58999999999999999999999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccC
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 831 (973)
.| ..-....+++. ..++++.-.-++...+..||.||-+ .++|+|||+||+|||+|+.|.+|+||||.+..+-.
T Consensus 172 lM-s~C~ekLlkri----k~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd 244 (391)
T KOG0983|consen 172 LM-STCAEKLLKRI----KGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD 244 (391)
T ss_pred HH-HHHHHHHHHHh----cCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeec
Confidence 98 34555555543 3457888888899999999999986 78999999999999999999999999999876543
Q ss_pred CCCcccccccCCccccccccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchh
Q 002061 832 SPKVSDYSCFAGTHGYIAPELAY---TCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKV 908 (973)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (973)
. ..++...|-+.|||||.+. ...|+-++||||||++++|+.||+.||..-. .++... -....+.+
T Consensus 245 S---kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~---tdFe~l-tkvln~eP----- 312 (391)
T KOG0983|consen 245 S---KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK---TDFEVL-TKVLNEEP----- 312 (391)
T ss_pred c---cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC---ccHHHH-HHHHhcCC-----
Confidence 2 3344456889999999985 3468899999999999999999999997532 122111 11111111
Q ss_pred ccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 909 LDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 909 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
+.+..+ ......+.+++..|+++|+.+||...++++|--
T Consensus 313 --P~L~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~F 351 (391)
T KOG0983|consen 313 --PLLPGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPF 351 (391)
T ss_pred --CCCCcc--cCcCHHHHHHHHHHhhcCcccCcchHHHhcCcc
Confidence 111111 114567889999999999999999999987643
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=305.42 Aligned_cols=257 Identities=30% Similarity=0.432 Sum_probs=206.3
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY 752 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 752 (973)
++|++.+.||.|+||+||+|....++..||+|++... ...+.+.+|++.++.++|||++++++.+..+...|+||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 3688999999999999999999888999999988653 2456788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCC
Q 002061 753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832 (973)
Q Consensus 753 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 832 (973)
+++++|.+++.... ....+++..+..++.|++.|++||| +.+++||||+|+||++++++.++++|||++......
T Consensus 81 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 81 LSGGSLLDIMKSSY--PRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred cCCCcHHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 99999999997531 1246889999999999999999999 889999999999999999999999999998766543
Q ss_pred CCcc--cccccCCccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhc
Q 002061 833 PKVS--DYSCFAGTHGYIAPELAYTC-KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVL 909 (973)
Q Consensus 833 ~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (973)
.... ......|+..|+|||++... .++.++|||||||++|+|++|+.||..... .............
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~----- 225 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP-----MKVLMLTLQNDPP----- 225 (267)
T ss_pred ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccCh-----hhhHHHHhcCCCC-----
Confidence 2221 12234688999999998776 788999999999999999999999965421 1111111111110
Q ss_pred cccccCc-chHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 910 DCEVASE-SIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 910 ~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
..... ........+.+++.+|++.||++||++.+++++
T Consensus 226 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 226 --SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred --CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 01000 012344668899999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=311.90 Aligned_cols=253 Identities=25% Similarity=0.360 Sum_probs=198.0
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeec----cccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLV 749 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~----~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv 749 (973)
-..|++.++||+||.++||++...+ .+.||+|++.. .....-|.+|+..|.++ .|.+|+++++|...++..|||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 4578999999999999999999876 45777776543 23455689999999999 499999999999999999999
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccc
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 829 (973)
|||= ..+|.++|+... .....| .+..++.|++.|+.++| .+||||.||||.|+++-. |.+||.|||.|.-+
T Consensus 439 mE~G-d~DL~kiL~k~~---~~~~~~-~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKK---SIDPDW-FLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLVK-GRLKLIDFGIANAI 509 (677)
T ss_pred eecc-cccHHHHHHhcc---CCCchH-HHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEEe-eeEEeeeechhccc
Confidence 9975 669999998652 222334 67789999999999999 789999999999998865 68999999999888
Q ss_pred cCCCCcccccccCCccccccccccccC-----------CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHH
Q 002061 830 ENSPKVSDYSCFAGTHGYIAPELAYTC-----------KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTH 898 (973)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~ 898 (973)
............+||+.||+||++... +.++++||||+|||||+|+.|+.||+.. ...+..
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~-------~n~~aK- 581 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI-------INQIAK- 581 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH-------HHHHHH-
Confidence 766655556678999999999998432 3667899999999999999999999743 111111
Q ss_pred hccccccchhccccccCcchHH-HHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 899 LNNHENVLKVLDCEVASESIKE-DMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
+..+.+++..-+++.- ...++.+++..|+++||.+||+..|++++--
T Consensus 582 ------l~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpF 629 (677)
T KOG0596|consen 582 ------LHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPF 629 (677)
T ss_pred ------HHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcc
Confidence 2233444332111110 0112889999999999999999999998743
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=308.66 Aligned_cols=254 Identities=28% Similarity=0.383 Sum_probs=200.0
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----c-------cHHHHHHHHHHHHhcCCCceeeEEEEEEeCC
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----D-------GVKVFAAEMEILGKIRHRNILKLYACLLKGG 744 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~-------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 744 (973)
+|...+.||.|+||.||+|....+++.||||.+... . ..+.+.+|++++++++|||++++++++..++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 467788999999999999999888999999987531 0 1245778999999999999999999999999
Q ss_pred eeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEeccc
Q 002061 745 SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFG 824 (973)
Q Consensus 745 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 824 (973)
..++||||+++|+|.+++... ..+++..+..++.|++.|+.||| +.+++||||+|+||+++.++.++++|||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~ 153 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-----GRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFG 153 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecc
Confidence 999999999999999998753 35788889999999999999999 7899999999999999999999999999
Q ss_pred CcccccCCCCcccccccCCccccccccccccCC--CCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccc
Q 002061 825 VAKIAENSPKVSDYSCFAGTHGYIAPELAYTCK--VSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNH 902 (973)
Q Consensus 825 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 902 (973)
++................|+..|+|||++.... ++.++||||+|+++||+++|..||.... .............
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~----~~~~~~~~~~~~~ 229 (272)
T cd06629 154 ISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE----AIAAMFKLGNKRS 229 (272)
T ss_pred ccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc----hHHHHHHhhcccc
Confidence 987554322111222345788999999987654 7899999999999999999999996431 1111111110000
Q ss_pred cccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 903 ENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
..........+....+.+++.+|++++|++||++.+|+++
T Consensus 230 -------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 230 -------APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred -------CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 0011111112345678889999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=306.11 Aligned_cols=250 Identities=25% Similarity=0.332 Sum_probs=197.9
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-------ccHHHHHHHHHHHHhcCCCceeeEEEEEEeC--Cee
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-------DGVKVFAAEMEILGKIRHRNILKLYACLLKG--GSS 746 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~ 746 (973)
.+|++.+.||+|+||.||+|++..+++.||||++... ...+.+.+|++++++++||||+++++++.++ ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4688899999999999999999999999999987531 2245678899999999999999999988763 467
Q ss_pred EEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCc
Q 002061 747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826 (973)
Q Consensus 747 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~ 826 (973)
++||||+++++|.+++... ..+++.....++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++
T Consensus 82 ~~v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~ 153 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY-----GALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGAS 153 (265)
T ss_pred EEEEEecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccc
Confidence 8999999999999998753 24678888899999999999999 789999999999999999999999999998
Q ss_pred ccccCCCC-cccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccccc
Q 002061 827 KIAENSPK-VSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENV 905 (973)
Q Consensus 827 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 905 (973)
........ ........|+..|+|||++.+..++.++|||||||++|||++|+.||.... ... .+.......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~----~~~-~~~~~~~~~--- 225 (265)
T cd06652 154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE----AMA-AIFKIATQP--- 225 (265)
T ss_pred cccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc----hHH-HHHHHhcCC---
Confidence 75543211 112223458889999999988889999999999999999999999996431 111 111111000
Q ss_pred chhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 906 LKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
.....+......+.+++.+|+. +|.+||+++|++++
T Consensus 226 -------~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 226 -------TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred -------CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 0111233445567788889984 99999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=306.17 Aligned_cols=248 Identities=27% Similarity=0.367 Sum_probs=197.4
Q ss_pred CcccccCceEEEEEEecC-CC--cEEEEEeeeccc---cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCC
Q 002061 682 NLIGSGGTGKVYRLDLKK-NA--GTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPN 755 (973)
Q Consensus 682 ~~lG~G~~g~V~~a~~~~-~~--~~vavK~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 755 (973)
+.||+|++|.||+|.+.. .+ ..||||.+.... ..+.+.+|++++++++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999865 23 369999887643 35678899999999999999999999888 889999999999
Q ss_pred CchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCc
Q 002061 756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV 835 (973)
Q Consensus 756 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 835 (973)
|+|.+++..... ..+++..+..++.|++.||+||| +++++||||+|+||+++.++.+||+|||++.........
T Consensus 80 ~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 80 GSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred CcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccc
Confidence 999999976421 45799999999999999999999 889999999999999999999999999999876543221
Q ss_pred c-cccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhccccc
Q 002061 836 S-DYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEV 913 (973)
Q Consensus 836 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (973)
. ......++..|+|||++.+..++.++|||||||++|||++ |+.||... ................
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-----~~~~~~~~~~~~~~~~-------- 220 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL-----SGSQILKKIDKEGERL-------- 220 (257)
T ss_pred eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHHhcCCcC--------
Confidence 1 1112456789999999998899999999999999999999 99999643 1111211111111100
Q ss_pred cCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 914 ASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 914 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
......+..+.+++.+|++.+|++||++.|+++.|.
T Consensus 221 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 --ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred --CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 011123456888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=313.52 Aligned_cols=262 Identities=23% Similarity=0.290 Sum_probs=197.7
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY 752 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 752 (973)
+|++.+.||+|+||+||+|++..+|+.||+|++... .....+.+|++++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 478889999999999999999999999999988642 2234577899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCC
Q 002061 753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832 (973)
Q Consensus 753 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 832 (973)
++ ++|.+++... ...+++..+..++.||++||+||| +.+++||||||+||+++.++.++|+|||+++.....
T Consensus 81 ~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 152 (284)
T cd07839 81 CD-QDLKKYFDSC----NGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 152 (284)
T ss_pred CC-CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCC
Confidence 96 5888877643 245889999999999999999999 789999999999999999999999999998755432
Q ss_pred CCcccccccCCccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccc-----ccc
Q 002061 833 PKVSDYSCFAGTHGYIAPELAYTC-KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHE-----NVL 906 (973)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~-----~~~ 906 (973)
.. ......++..|+|||++.+. .++.++||||+||++|||++|..||............... ...... ...
T Consensus 153 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 229 (284)
T cd07839 153 VR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR-LLGTPTEESWPGVS 229 (284)
T ss_pred CC--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHH-HhCCCChHHhHHhh
Confidence 21 12234578899999998765 4689999999999999999999987432211111111000 000000 000
Q ss_pred hhcc----cccc-----CcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 907 KVLD----CEVA-----SESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 907 ~~~~----~~~~-----~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
...+ +... .........++.+++.+|++.||.+|||+.|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 230 KLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred hcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0000 0000 00112234577899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=305.94 Aligned_cols=247 Identities=27% Similarity=0.366 Sum_probs=200.5
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc-------cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-------GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV 749 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 749 (973)
+|+..+.||+|+||+||+|....+++.||+|.+.... ..+.+.+|++++++++||||+++++++..+...++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677889999999999999999889999999876532 446788999999999999999999999999999999
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccc
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 829 (973)
|||+++++|.+++... ..+++..+..++.|++.|++||| +.+++|+||+|+||+++.++.+||+|||.+...
T Consensus 81 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~ 152 (258)
T cd06632 81 LELVPGGSLAKLLKKY-----GSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQV 152 (258)
T ss_pred EEecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceec
Confidence 9999999999999753 34788899999999999999999 789999999999999999999999999998765
Q ss_pred cCCCCcccccccCCccccccccccccCC-CCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchh
Q 002061 830 ENSPKVSDYSCFAGTHGYIAPELAYTCK-VSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKV 908 (973)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (973)
.... ......|+..|+|||.+.... ++.++|+||+|+++|+|++|+.||.... .......... ....
T Consensus 153 ~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~-----~~~~~~~~~~-~~~~--- 220 (258)
T cd06632 153 VEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE-----GVAAVFKIGR-SKEL--- 220 (258)
T ss_pred cccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc-----HHHHHHHHHh-cccC---
Confidence 4332 122356788999999987766 8899999999999999999999996542 1111111110 0000
Q ss_pred ccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 909 LDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 909 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
...+......+.+++.+||+.+|++||++.+++++
T Consensus 221 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 221 ------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred ------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 01111234567789999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=303.44 Aligned_cols=248 Identities=27% Similarity=0.375 Sum_probs=201.8
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY 752 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 752 (973)
+|+..+.||+|+||.||+|....+++.||||.+... .....+.+|++++++++|||++++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 578889999999999999999989999999988653 3456788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCC-CeEEecccCcccccC
Q 002061 753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY-EPKIADFGVAKIAEN 831 (973)
Q Consensus 753 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfgl~~~~~~ 831 (973)
+++++|.+++... ....+++..+..++.|++.|++|+| +++++||||+|+||++++++ .++++|||.+.....
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 81 APGGTLAEYIQKR---CNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred CCCCCHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 9999999999753 2345788999999999999999999 78999999999999998654 589999999986643
Q ss_pred CCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccc
Q 002061 832 SPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDC 911 (973)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (973)
... .....++..|+|||.+.+..++.++||||+|+++|+|++|+.||.... ....+........ .
T Consensus 155 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~-----~~~~~~~~~~~~~--~----- 219 (256)
T cd08220 155 KSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN-----LPALVLKIMSGTF--A----- 219 (256)
T ss_pred Ccc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc-----hHHHHHHHHhcCC--C-----
Confidence 321 122457889999999998889999999999999999999999996531 1112111111110 0
Q ss_pred cccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 912 EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 912 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
.........+.+++.+||+++|++|||+.|++++
T Consensus 220 ----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 220 ----PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ----CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 0011234567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=308.76 Aligned_cols=253 Identities=26% Similarity=0.357 Sum_probs=202.5
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc--ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM 753 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 753 (973)
++|++.+.||+|+||+||+|.+..++..||+|++... ...+.+.+|++++++++||||+++++++..+...|+||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 4688999999999999999999888999999988653 34567889999999999999999999999999999999999
Q ss_pred CCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCC
Q 002061 754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833 (973)
Q Consensus 754 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 833 (973)
++++|.+++... ...+++..+..++.|++.|+.||| +.+++||||+|+||+++.++.++|+|||.+.......
T Consensus 85 ~~~~L~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 85 DGGALDSIMLEL----ERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred CCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 999999998753 235889999999999999999999 7899999999999999999999999999886543321
Q ss_pred CcccccccCCccccccccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchh
Q 002061 834 KVSDYSCFAGTHGYIAPELAY-----TCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKV 908 (973)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (973)
. ......++..|+|||++. +..++.++||||+|+++|||++|+.||.... .............
T Consensus 158 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~----- 225 (280)
T cd06611 158 Q--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN-----PMRVLLKILKSEP----- 225 (280)
T ss_pred c--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC-----HHHHHHHHhcCCC-----
Confidence 1 222346889999999874 3457789999999999999999999996541 1111111111110
Q ss_pred ccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 909 LDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 909 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
+.. ..+......+.+++.+||+.+|++||++.+++++-.
T Consensus 226 --~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 264 (280)
T cd06611 226 --PTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPF 264 (280)
T ss_pred --CCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChh
Confidence 000 011123346788999999999999999999998743
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=306.29 Aligned_cols=250 Identities=30% Similarity=0.380 Sum_probs=191.2
Q ss_pred CcccccCceEEEEEEecC---CCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEE-eCCeeEEEEEccC
Q 002061 682 NLIGSGGTGKVYRLDLKK---NAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLL-KGGSSFLVLEYMP 754 (973)
Q Consensus 682 ~~lG~G~~g~V~~a~~~~---~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~~lv~e~~~ 754 (973)
+.||+|+||.||+|.+.. .+..||+|++... ...+.+.+|+.+++.++||||+++++++. .++..++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999999753 3457999987542 23567888999999999999999999765 4566899999999
Q ss_pred CCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCC
Q 002061 755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK 834 (973)
Q Consensus 755 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 834 (973)
+|+|.+++... ....++..+..++.|++.|++||| +.+++||||||+||++++++.+||+|||+++.......
T Consensus 81 ~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 81 HGDLRNFIRSE----THNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY 153 (262)
T ss_pred CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence 99999999753 223567788899999999999999 78999999999999999999999999999875533211
Q ss_pred c--ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhC-CCCCCcccCCcccHHHHHHHHhccccccchhccc
Q 002061 835 V--SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTG-RKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDC 911 (973)
Q Consensus 835 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (973)
. .......++..|+|||++.+..++.++|||||||++|||++| ..||... . ............. .
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~--~---~~~~~~~~~~~~~-------~ 221 (262)
T cd05058 154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV--D---SFDITVYLLQGRR-------L 221 (262)
T ss_pred eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC--C---HHHHHHHHhcCCC-------C
Confidence 1 111123456789999999888899999999999999999995 5566432 1 1111111111110 0
Q ss_pred cccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 002061 912 EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADAD 954 (973)
Q Consensus 912 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 954 (973)
......+..+.+++.+||+.+|++||++.|+++.++++.
T Consensus 222 ----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 222 ----LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred ----CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 001112346889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=305.21 Aligned_cols=254 Identities=26% Similarity=0.293 Sum_probs=205.8
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeec-----cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL 748 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~-----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 748 (973)
..+.|..-++||+|+||+||-++.+.+|+-+|.|++.+ ........+|.+++++++.+.||.+-..|+..+..++
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 34567777889999999999999999999999997754 3455667889999999999999999999999999999
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccc
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 828 (973)
|+..|.||+|.-++.+. +.+.+++.++.-+|.+|+.||++|| ..+||+||+||+|||+|+.|+++|+|+|+|..
T Consensus 263 VLtlMNGGDLkfHiyn~---g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAve 336 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNH---GNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVE 336 (591)
T ss_pred EEEeecCCceeEEeecc---CCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEe
Confidence 99999999998888765 4467999999999999999999999 78999999999999999999999999999998
Q ss_pred ccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchh
Q 002061 829 AENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKV 908 (973)
Q Consensus 829 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (973)
+..+.. ....+||.+|||||++....|+..+|+||+||++|||+.|+.||...... .-...+..+....+
T Consensus 337 i~~g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK--vk~eEvdrr~~~~~----- 406 (591)
T KOG0986|consen 337 IPEGKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK--VKREEVDRRTLEDP----- 406 (591)
T ss_pred cCCCCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh--hhHHHHHHHHhcch-----
Confidence 765533 33358999999999999999999999999999999999999999754211 10111111111111
Q ss_pred ccccccCcchHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 002061 909 LDCEVASESIKEDMIKLLKIAVVCTTKLPNLRP-----PMREVVKM 949 (973)
Q Consensus 909 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~ 949 (973)
.+.+....++..++-...+++||.+|. .+++|-+|
T Consensus 407 ------~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H 446 (591)
T KOG0986|consen 407 ------EEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH 446 (591)
T ss_pred ------hhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence 112233445566677778899999996 55666654
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=315.39 Aligned_cols=252 Identities=27% Similarity=0.340 Sum_probs=202.8
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc-----cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE 751 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 751 (973)
+|+..+.||+|+||+||+|....+++.||+|.+.... ..+.+.+|+++++.++||||+++++++..++..|+|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 6888899999999999999999889999999887632 34568889999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccC
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 831 (973)
|+++++|.+++... ....+++..+..++.|++.||+||| +.+++||||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~~~~L~~~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 82 YCPGGELFRLLQRQ---PGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred ecCCCCHHHHHHhC---CCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 99999999998743 2346888999999999999999999 88999999999999999999999999999865432
Q ss_pred CCCcc---------------------------cccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcc
Q 002061 832 SPKVS---------------------------DYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEE 884 (973)
Q Consensus 832 ~~~~~---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~ 884 (973)
..... ......|+..|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 21100 011236788999999999888999999999999999999999999654
Q ss_pred cCCcccHHHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCC----HHHHHHH
Q 002061 885 YGDGKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPP----MREVVKM 949 (973)
Q Consensus 885 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt----~~evl~~ 949 (973)
.. ............ ...........+.+++.+|++.||++||+ +.|++++
T Consensus 236 ~~-----~~~~~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 236 NR-----DETFSNILKKEV----------TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred ch-----HHHHHHHhcCCc----------cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 21 111111111110 00111114567889999999999999999 7777775
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=310.10 Aligned_cols=252 Identities=25% Similarity=0.344 Sum_probs=195.5
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc---cHHHHHHHHHH-HHhcCCCceeeEEEEEEeCCeeEEEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD---GVKVFAAEMEI-LGKIRHRNILKLYACLLKGGSSFLVLE 751 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~E~~~-l~~l~hpniv~l~~~~~~~~~~~lv~e 751 (973)
++|++.+.||+|+||.||+|++..+|+.||+|++.... ....+..|+.. ++..+||||+++++++..+...|+|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36888999999999999999999999999999886532 23445556665 566799999999999999999999999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCC-CeEecCCCCCCeeecCCCCeEEecccCccccc
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP-PIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~-~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 830 (973)
|++ |+|.+++.... .....+++..+..++.|++.|++||| ++ +++||||||+||+++.++.+||+|||++....
T Consensus 81 ~~~-~~l~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 81 VMD-TSLDKFYKKVY-DKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhc-ccHHHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 995 78988887542 23356899999999999999999999 55 89999999999999999999999999987553
Q ss_pred CCCCcccccccCCcccccccccccc----CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccc
Q 002061 831 NSPKVSDYSCFAGTHGYIAPELAYT----CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVL 906 (973)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 906 (973)
.. .......++..|+|||++.+ ..++.++|+||+||++|||++|+.||...... .... ........
T Consensus 156 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~-~~~~~~~~--- 225 (283)
T cd06617 156 DS---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP---FQQL-KQVVEEPS--- 225 (283)
T ss_pred cc---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC---HHHH-HHHHhcCC---
Confidence 22 11222457889999998864 45688999999999999999999999643211 1111 11111000
Q ss_pred hhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 907 KVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
... ........+.+++.+|++.+|++||++.+++++
T Consensus 226 ----~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 226 ----PQL---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred ----CCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 011234568899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=289.68 Aligned_cols=208 Identities=27% Similarity=0.376 Sum_probs=177.6
Q ss_pred HHHcCCcccCcccccCceEEEEEEecCCC----cEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEe-C
Q 002061 673 EQICNLEEDNLIGSGGTGKVYRLDLKKNA----GTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLK-G 743 (973)
Q Consensus 673 ~~~~~~~~~~~lG~G~~g~V~~a~~~~~~----~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 743 (973)
+....|+.+..||+|.||.||+|...++. +.+|+|+++.+ ......-||+..++.++|||++.+..+|.. +
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 34567899999999999999999766443 26899998765 334567899999999999999999999877 8
Q ss_pred CeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCC----CCeE
Q 002061 744 GSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDED----YEPK 819 (973)
Q Consensus 744 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~----~~~k 819 (973)
..+++++||.+. +|++.++-+.......++...+..|..||+.|+.||| ++=|+|||+||.||||..+ |.||
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeE
Confidence 899999999976 9999998765555567999999999999999999999 7779999999999999888 8999
Q ss_pred EecccCcccccCCCCcc-cccccCCccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcc
Q 002061 820 IADFGVAKIAENSPKVS-DYSCFAGTHGYIAPELAYTC-KVSEKSDVFSFGVVLLELVTGRKPVEEE 884 (973)
Q Consensus 820 l~Dfgl~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~pf~~~ 884 (973)
|+|||+++.+.+.-... .....+-|..|+|||.+.|. .|+.+.||||.|||+.||+|-++.|.+.
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 99999999887654433 33446679999999998765 6899999999999999999998888654
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=320.64 Aligned_cols=240 Identities=25% Similarity=0.303 Sum_probs=188.1
Q ss_pred ccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhc---CCCceeeEEEEEEeCCeeEEEEEccCC
Q 002061 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKI---RHRNILKLYACLLKGGSSFLVLEYMPN 755 (973)
Q Consensus 684 lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~~~~~~lv~e~~~~ 755 (973)
||+|+||+||+|++..+++.||||++... ........|..++.+. +||+|+++++++..+...|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 69999999999999999999999998652 2233345566776655 699999999999999999999999999
Q ss_pred CchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCc
Q 002061 756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV 835 (973)
Q Consensus 756 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 835 (973)
|+|.+++... ..+++..+..++.||++||+||| +++|+||||||+||+++.++.++|+|||++.......
T Consensus 81 g~L~~~l~~~-----~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-- 150 (330)
T cd05586 81 GELFWHLQKE-----GRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-- 150 (330)
T ss_pred ChHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--
Confidence 9999888642 35788999999999999999999 7899999999999999999999999999986532221
Q ss_pred ccccccCCccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhcccccc
Q 002061 836 SDYSCFAGTHGYIAPELAYTC-KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVA 914 (973)
Q Consensus 836 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (973)
.......||..|+|||++.+. .++.++||||+||++|||++|+.||... +.............. ..
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~-----~~~~~~~~i~~~~~~--------~~ 217 (330)
T cd05586 151 KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE-----DTQQMYRNIAFGKVR--------FP 217 (330)
T ss_pred CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCC-----CHHHHHHHHHcCCCC--------CC
Confidence 112235689999999998754 4789999999999999999999999653 122222211111110 00
Q ss_pred CcchHHHHHHHHHHHHHhcCCCCCCCC----CHHHHHHH
Q 002061 915 SESIKEDMIKLLKIAVVCTTKLPNLRP----PMREVVKM 949 (973)
Q Consensus 915 ~~~~~~~~~~l~~l~~~cl~~dP~~Rp----t~~evl~~ 949 (973)
. ......+.+++.+|++.||.+|| ++.++++|
T Consensus 218 ~---~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 218 K---NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred C---ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 0 11234567899999999999998 57777765
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=319.83 Aligned_cols=271 Identities=27% Similarity=0.305 Sum_probs=208.1
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeec---cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCC------ee
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK---GDGVKVFAAEMEILGKIRHRNILKLYACLLKGG------SS 746 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------~~ 746 (973)
..|...+.||+|+||.||+|+++.+|+.||||.+.. ....++..+|++++++++|||||+++++-++.. ..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 345667889999999999999999999999999877 456677889999999999999999999876543 56
Q ss_pred EEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeec--CCCC--eEEec
Q 002061 747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD--EDYE--PKIAD 822 (973)
Q Consensus 747 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~--~~~~--~kl~D 822 (973)
.+|||||.+|||+..+.+ .+....+++.+.+.+...++.||.||| +++||||||||.||++- .+|+ .||+|
T Consensus 93 vlvmEyC~gGsL~~~L~~--PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtD 167 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNS--PENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTD 167 (732)
T ss_pred eEEEeecCCCcHHHHhcC--cccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeec
Confidence 899999999999999975 344456899999999999999999999 88999999999999974 4454 79999
Q ss_pred ccCcccccCCCCcccccccCCccccccccccc-cCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcc
Q 002061 823 FGVAKIAENSPKVSDYSCFAGTHGYIAPELAY-TCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNN 901 (973)
Q Consensus 823 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 901 (973)
||.|+..+.+. .....+||..|.+||+.. .+.|+..+|.|||||++|+++||..||....+.......+.....+.
T Consensus 168 fG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkk 244 (732)
T KOG4250|consen 168 FGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKK 244 (732)
T ss_pred ccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccC
Confidence 99999776654 455689999999999998 48899999999999999999999999987655433322222222222
Q ss_pred ccccchhccc------------cccCcchHHHHHHHHHHHHHhcCCCCCCCC--CHHHHHHHhhcCC
Q 002061 902 HENVLKVLDC------------EVASESIKEDMIKLLKIAVVCTTKLPNLRP--PMREVVKMLADAD 954 (973)
Q Consensus 902 ~~~~~~~~~~------------~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp--t~~evl~~L~~~~ 954 (973)
.....-.... .......+.....+...+..++..+|.+|. .+.+..+.+.++.
T Consensus 245 p~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL 311 (732)
T KOG4250|consen 245 PSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL 311 (732)
T ss_pred CCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence 1111111111 111112334445566667778889999998 6666666655543
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=309.68 Aligned_cols=253 Identities=26% Similarity=0.347 Sum_probs=198.9
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-ccHHHHHHHHHHHHhc-CCCceeeEEEEEEe------CCe
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKI-RHRNILKLYACLLK------GGS 745 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~------~~~ 745 (973)
..+.|++.+.||+|+||.||+|++..+++.||+|+.... ....++.+|+.+++++ +||||+++++++.. +..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 93 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQ 93 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCE
Confidence 346889999999999999999999988999999987653 3445678899999998 79999999999853 457
Q ss_pred eEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccC
Q 002061 746 SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGV 825 (973)
Q Consensus 746 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl 825 (973)
.|++|||+++|+|.+++... ....+++..+..++.|++.|++||| +.+++||||+|+||++++++.++|+|||+
T Consensus 94 ~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~l~dfg~ 167 (282)
T cd06636 94 LWLVMEFCGAGSVTDLVKNT---KGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGV 167 (282)
T ss_pred EEEEEEeCCCCcHHHHHHHc---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCcc
Confidence 89999999999999998753 2334778888899999999999999 78999999999999999999999999999
Q ss_pred cccccCCCCcccccccCCccccccccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhc
Q 002061 826 AKIAENSPKVSDYSCFAGTHGYIAPELAY-----TCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLN 900 (973)
Q Consensus 826 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 900 (973)
+....... .......|+..|+|||++. +..++.++|||||||++|||++|+.||...... ... ... .
T Consensus 168 ~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~----~~~-~~~-~ 239 (282)
T cd06636 168 SAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM----RAL-FLI-P 239 (282)
T ss_pred hhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH----hhh-hhH-h
Confidence 87553221 1122346889999999875 346788999999999999999999999643110 000 000 0
Q ss_pred cccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 901 NHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
... .. ..........+.+++.+||+.||.+||++.|++++
T Consensus 240 ~~~------~~---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 240 RNP------PP---KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred hCC------CC---CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 000 00 01112234568899999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=310.80 Aligned_cols=264 Identities=22% Similarity=0.272 Sum_probs=197.8
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc---cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE 751 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 751 (973)
+++|++.+.||+|++|+||+|+.+.+++.||||.+.... ....+.+|++++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 467899999999999999999999889999999886532 23456789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccC
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 831 (973)
|++ ++|.+++... ...+++..+..++.|+++||+||| +.+++||||||+||+++.++.+||+|||+++....
T Consensus 84 ~~~-~~L~~~~~~~----~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 155 (291)
T cd07844 84 YLD-TDLKQYMDDC----GGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSV 155 (291)
T ss_pred cCC-CCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCC
Confidence 997 5999988753 235788999999999999999999 78999999999999999999999999999865432
Q ss_pred CCCcccccccCCcccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccc-ccc----
Q 002061 832 SPKVSDYSCFAGTHGYIAPELAYT-CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNH-ENV---- 905 (973)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~---- 905 (973)
... ......++..|+|||++.+ ..++.++||||+|+++|+|++|+.||.............. ...... +..
T Consensus 156 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 232 (291)
T cd07844 156 PSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIF-RVLGTPTEETWPGV 232 (291)
T ss_pred CCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHH-HhcCCCChhhhhhh
Confidence 211 1122346789999999875 4578999999999999999999999965421111111110 000000 000
Q ss_pred ---chhcc---ccccCcc----hHHH--HHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 906 ---LKVLD---CEVASES----IKED--MIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 906 ---~~~~~---~~~~~~~----~~~~--~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
..... ....... .... ...+.+++.+|++++|++||++.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred hhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 00000 0000000 0011 2567789999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=308.91 Aligned_cols=262 Identities=26% Similarity=0.331 Sum_probs=202.2
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc----cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY 752 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 752 (973)
+|++.+.||+|+||.||+|++..+++.||||++.... ..+.+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788899999999999999999889999999886532 346788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCC
Q 002061 753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832 (973)
Q Consensus 753 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 832 (973)
+ +++|.+++... ...+++..+..++.|+++|++||| +.+++|+||||+||+++.++.++++|||.+......
T Consensus 81 ~-~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 81 M-PSDLSEVLRDE----ERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred c-CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 9 99999998753 245889999999999999999999 789999999999999999999999999998766443
Q ss_pred CCcccccccCCccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccc--------
Q 002061 833 PKVSDYSCFAGTHGYIAPELAYTC-KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHE-------- 903 (973)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~-------- 903 (973)
.. .......++..|+|||++.+. .++.++||||+|+++|||++|+.||.... +.... ..+........
T Consensus 153 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07832 153 EP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEN-DIEQL-AIVFRTLGTPNEETWPGLT 229 (286)
T ss_pred CC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCC-HHHHH-HHHHHHcCCCChHHHhhcc
Confidence 21 122335688999999998654 46889999999999999999988875431 11111 11111110000
Q ss_pred ---ccchhccccccC----cchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 904 ---NVLKVLDCEVAS----ESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 904 ---~~~~~~~~~~~~----~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
............ ....+....+.+++.+|++++|++||+++++++|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 230 SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred CcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000000 0011234678899999999999999999999976
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=307.69 Aligned_cols=258 Identities=26% Similarity=0.356 Sum_probs=202.2
Q ss_pred cCCcccCcccccCceEEEEEEecC-----CCcEEEEEeeeccc---cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKK-----NAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF 747 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~-----~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 747 (973)
++|+..+.||+|+||+||+|+.+. +.+.||+|.+.... ..+.+.+|++++++++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 467888999999999999999753 35679999876533 2467899999999999999999999999989999
Q ss_pred EEEEccCCCchHHHHHhhhcCC----CCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecc
Q 002061 748 LVLEYMPNGNLFQALHKRVKEG----KPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADF 823 (973)
Q Consensus 748 lv~e~~~~gsL~~~l~~~~~~~----~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 823 (973)
+||||+++|+|.+++....... ...+++..+..++.|++.|++||| +.+++||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999997542111 125899999999999999999999 789999999999999999999999999
Q ss_pred cCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccc
Q 002061 824 GVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNH 902 (973)
Q Consensus 824 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~ 902 (973)
|++....... ........++..|+|||.+.+..++.++||||||+++|++++ |..||.... ....... .. ..
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~--~~~~~~~---~~-~~ 234 (275)
T cd05046 162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS--DEEVLNR---LQ-AG 234 (275)
T ss_pred ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccc--hHHHHHH---HH-cC
Confidence 9986443221 112223356778999999988888999999999999999999 888986431 1111111 11 00
Q ss_pred cccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 002061 903 ENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952 (973)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~ 952 (973)
. .. . .........+.+++.+|++.+|++||++.|++++|.+
T Consensus 235 ~-~~-~-------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 235 K-LE-L-------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred C-cC-C-------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 0 00 0 0011223468889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=305.44 Aligned_cols=250 Identities=22% Similarity=0.324 Sum_probs=197.9
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeecc--------ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--------DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL 748 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 748 (973)
+|+..+.||+|+||+||+|... +++.+|||.+... .....+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 4788899999999999999875 5889999987642 123557889999999999999999999999999999
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccc
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 828 (973)
||||+++++|.+++.+. ..+++..+..++.|++.|++|+| +.+++|+||+|+||+++.++.++|+|||.+..
T Consensus 80 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 151 (265)
T cd06631 80 FMEFVPGGSISSILNRF-----GPLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARR 151 (265)
T ss_pred EEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHh
Confidence 99999999999999753 24688888999999999999999 78999999999999999999999999999875
Q ss_pred ccCCCC----cccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccc
Q 002061 829 AENSPK----VSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHEN 904 (973)
Q Consensus 829 ~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 904 (973)
...... ........|+..|+|||++.+..++.++||||+||++|+|++|+.||..... .... .........
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~----~~~~-~~~~~~~~~ 226 (265)
T cd06631 152 LAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR----LAAM-FYIGAHRGL 226 (265)
T ss_pred hhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh----HHHH-HHhhhccCC
Confidence 432111 1112234588999999999988899999999999999999999999964311 1110 000000000
Q ss_pred cchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 905 VLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
. +. ........+.+++.+|++.+|++||++.|++++
T Consensus 227 ~-----~~----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 227 M-----PR----LPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred C-----CC----CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0 11 111234567889999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=306.19 Aligned_cols=253 Identities=24% Similarity=0.354 Sum_probs=202.3
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc--------cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD--------GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL 748 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 748 (973)
+|+..+.||+|+||.||+|....+++.||+|++.... ..+.+.+|++++++++||||+++++++.+++..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4778899999999999999999889999999886522 34568899999999999999999999999999999
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCC-CeEEecccCcc
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY-EPKIADFGVAK 827 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfgl~~ 827 (973)
||||+++++|.+++... ..+++..+..++.|++.|++||| +.+++|+||+|+||+++.++ .++|+|||.+.
T Consensus 81 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~ 152 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY-----GAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAA 152 (268)
T ss_pred EEeccCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccc
Confidence 99999999999998753 35788899999999999999999 78999999999999998776 59999999987
Q ss_pred cccCCCCc--ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccccc
Q 002061 828 IAENSPKV--SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENV 905 (973)
Q Consensus 828 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 905 (973)
........ .......++..|+|||++.+..++.++||||+|+++|++++|+.||..... ...........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~------ 224 (268)
T cd06630 153 RLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH--SNHLALIFKIA------ 224 (268)
T ss_pred ccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC--cchHHHHHHHh------
Confidence 66433111 111234578899999999888899999999999999999999999964321 11111111100
Q ss_pred chhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 906 LKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
........+......+.+++.+|++.+|++||++.|++++
T Consensus 225 ----~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 225 ----SATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred ----ccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 0001112223345678889999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=308.85 Aligned_cols=239 Identities=21% Similarity=0.332 Sum_probs=187.2
Q ss_pred CcccccCceEEEEEEecCCCc-------EEEEEeeecc--ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 002061 682 NLIGSGGTGKVYRLDLKKNAG-------TVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY 752 (973)
Q Consensus 682 ~~lG~G~~g~V~~a~~~~~~~-------~vavK~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 752 (973)
+.||+|+||.||+|.....+. .||+|.+... ...+.+.+|+.+++.++|||++++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 368999999999999865443 4888877543 2345678899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCC--------eEEeccc
Q 002061 753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE--------PKIADFG 824 (973)
Q Consensus 753 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~--------~kl~Dfg 824 (973)
+++|+|.+++... ...+++..+..++.|++.|++||| +.+++||||||+||+++.++. ++++|||
T Consensus 81 ~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 81 VKFGSLDTYLKKN----KNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred CCCCcHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccc
Confidence 9999999999753 235788999999999999999999 889999999999999987765 6999999
Q ss_pred CcccccCCCCcccccccCCccccccccccccC-CCCccchHHHHHHHHHHHHhCC-CCCCcccCCcccHHHHHHHHhccc
Q 002061 825 VAKIAENSPKVSDYSCFAGTHGYIAPELAYTC-KVSEKSDVFSFGVVLLELVTGR-KPVEEEYGDGKDIVYWVSTHLNNH 902 (973)
Q Consensus 825 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~-~pf~~~~~~~~~~~~~~~~~~~~~ 902 (973)
.+...... ....++..|+|||++.+. .++.++|||||||++|||++|. .||.... ...... .....
T Consensus 154 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~-----~~~~~~-~~~~~ 221 (258)
T cd05078 154 ISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD-----SQKKLQ-FYEDR 221 (258)
T ss_pred cccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc-----HHHHHH-HHHcc
Confidence 88654322 224578899999999764 5789999999999999999985 5554321 111110 00011
Q ss_pred cccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 903 ENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
. .. +.....++.+++.+||+.||++|||++++++.|+
T Consensus 222 ~--------~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 H--------QL----PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred c--------cC----CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 00 1112246789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=303.51 Aligned_cols=238 Identities=22% Similarity=0.366 Sum_probs=190.2
Q ss_pred CcccccCceEEEEEEecCCC----------cEEEEEeeecccc-HHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 002061 682 NLIGSGGTGKVYRLDLKKNA----------GTVAVKQLWKGDG-VKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL 750 (973)
Q Consensus 682 ~~lG~G~~g~V~~a~~~~~~----------~~vavK~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 750 (973)
+.||+|+||.||+|.+..++ ..|++|.+..... ...+.+|+.++++++||||+++++++.. ...++||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 46899999999999998765 3588887765433 6788999999999999999999999887 7789999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCC-------CeEEecc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY-------EPKIADF 823 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-------~~kl~Df 823 (973)
||+++|+|.+++... ...+++..+..++.|++.||+||| +++++||||||+||+++.++ .++++||
T Consensus 80 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 80 EYVKFGPLDVFLHRE----KNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EcCCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCC
Confidence 999999999999764 225788899999999999999999 88999999999999999887 7999999
Q ss_pred cCcccccCCCCcccccccCCccccccccccccC--CCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhc
Q 002061 824 GVAKIAENSPKVSDYSCFAGTHGYIAPELAYTC--KVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLN 900 (973)
Q Consensus 824 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~ 900 (973)
|++...... ....++..|+|||++.+. .++.++|||||||++||+++ |..||..... .....+..
T Consensus 153 g~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~--~~~~~~~~---- 220 (259)
T cd05037 153 GIPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS--SEKERFYQ---- 220 (259)
T ss_pred Ccccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc--hhHHHHHh----
Confidence 998765431 123467789999998776 78899999999999999999 5777765421 11111111
Q ss_pred cccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 901 NHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
..... .. .....+.+++.+||+.+|++||++.|+++.|+
T Consensus 221 ~~~~~---------~~---~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 DQHRL---------PM---PDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred cCCCC---------CC---CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00000 00 00157889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=307.02 Aligned_cols=255 Identities=26% Similarity=0.334 Sum_probs=200.7
Q ss_pred cCCcccCcccccCceEEEEEEecCC---CcEEEEEeeeccc---cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKN---AGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV 749 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~---~~~vavK~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 749 (973)
.+|.+.+.||+|+||.||+|.+... ...||||...... ..+.+.+|++++++++||||+++++++.+ ...|+|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 4578889999999999999987643 3469999876532 34578899999999999999999998865 457899
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccc
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 829 (973)
|||+++|+|.+++... ...+++..+..++.|++.|++|+| +.+++||||||+||+++.++.++++|||++...
T Consensus 85 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 85 MELAPLGELRSYLQVN----KYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEcCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeec
Confidence 9999999999999753 235789999999999999999999 789999999999999999999999999998765
Q ss_pred cCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchh
Q 002061 830 ENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKV 908 (973)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (973)
..... .......++..|+|||.+.+..++.++||||||+++||+++ |+.||..... ......+ ......
T Consensus 158 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~--~~~~~~~----~~~~~~--- 227 (270)
T cd05056 158 EDESY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN--NDVIGRI----ENGERL--- 227 (270)
T ss_pred ccccc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHH----HcCCcC---
Confidence 43321 11112234568999999988889999999999999999986 9999965421 1111111 111100
Q ss_pred ccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 002061 909 LDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADP 955 (973)
Q Consensus 909 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 955 (973)
..+......+.+++.+|+.++|++|||+.++++.|+++..
T Consensus 228 -------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 228 -------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred -------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0111234568889999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=307.25 Aligned_cols=256 Identities=29% Similarity=0.373 Sum_probs=202.2
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-ccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCC------e
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKI-RHRNILKLYACLLKGG------S 745 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~------~ 745 (973)
..++|++.+.||+|++|+||+|.+..+++.||+|++... ...+.+.+|+++++++ +||||+++++++.... .
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ 83 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence 457899999999999999999999988999999988763 3456788999999999 7999999999997644 4
Q ss_pred eEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccC
Q 002061 746 SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGV 825 (973)
Q Consensus 746 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl 825 (973)
.++||||+++++|.+++.... .....+++..+..++.|++.|++||| +.+++|+||+|+||++++++.++++|||.
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 84 LWLVMELCGGGSVTDLVKGLR-KKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEcCCCCcHHHHHHHHh-hcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 899999999999999987542 12346889999999999999999999 88999999999999999999999999999
Q ss_pred cccccCCCCcccccccCCcccccccccccc-----CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhc
Q 002061 826 AKIAENSPKVSDYSCFAGTHGYIAPELAYT-----CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLN 900 (973)
Q Consensus 826 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 900 (973)
+....... .......|+..|+|||++.. ..++.++||||+||++|+|++|+.||..... .. .......
T Consensus 160 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~----~~~~~~~ 232 (275)
T cd06608 160 SAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP-MR----ALFKIPR 232 (275)
T ss_pred ceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch-HH----HHHHhhc
Confidence 87554322 12223458889999998753 3467889999999999999999999964311 11 1111110
Q ss_pred cccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 901 NHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
.. . ... .........+.+++.+|++.||++|||+.|++++
T Consensus 233 ~~--~-----~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 233 NP--P-----PTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred cC--C-----CCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 00 0 000 1112245678899999999999999999999875
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=291.16 Aligned_cols=251 Identities=25% Similarity=0.304 Sum_probs=204.0
Q ss_pred HHHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCee
Q 002061 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSS 746 (973)
Q Consensus 672 ~~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 746 (973)
...+++|+..++||+|.||+|.+++.+.+++.+|+|+++++ +.++.-..|-++++..+||.+..+...|+..++.
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drl 243 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRL 243 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceE
Confidence 34677899999999999999999999999999999998874 3455567799999999999999999999999999
Q ss_pred EEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCc
Q 002061 747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826 (973)
Q Consensus 747 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~ 826 (973)
+.||||..||.|+-++.+. ..+++....-+-..|..||.||| +++||+||+|.+|.|++.||++||+|||++
T Consensus 244 CFVMeyanGGeLf~HLsre-----r~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLC 315 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRE-----RVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLC 315 (516)
T ss_pred EEEEEEccCceEeeehhhh-----hcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccc
Confidence 9999999999998888652 35777777788899999999999 889999999999999999999999999998
Q ss_pred ccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccc
Q 002061 827 KIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVL 906 (973)
Q Consensus 827 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 906 (973)
+.- .........++||+.|+|||++....|+.++|+|.+||++|||++|+.||...+. ..+... ..
T Consensus 316 KE~--I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh--~kLFeL---Il------- 381 (516)
T KOG0690|consen 316 KEE--IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH--EKLFEL---IL------- 381 (516)
T ss_pred hhc--ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch--hHHHHH---HH-------
Confidence 732 2222334568899999999999999999999999999999999999999975421 111111 10
Q ss_pred hhccccccCcchHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 002061 907 KVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRP-----PMREVVKM 949 (973)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~ 949 (973)
-.+. .++....++...++...+.+||.+|. .+.||.++
T Consensus 382 ---~ed~--kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 382 ---MEDL--KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred ---hhhc--cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 0000 12233444566777788899999996 56666654
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=302.79 Aligned_cols=250 Identities=30% Similarity=0.414 Sum_probs=201.3
Q ss_pred CcccCcccccCceEEEEEEecCCC----cEEEEEeeeccc---cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 002061 678 LEEDNLIGSGGTGKVYRLDLKKNA----GTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL 750 (973)
Q Consensus 678 ~~~~~~lG~G~~g~V~~a~~~~~~----~~vavK~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 750 (973)
+++.+.||+|+||.||+|++...+ ..||+|++.... ..+.+.+|++++++++||||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 356788999999999999998766 889999987643 4667889999999999999999999999999999999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccccc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 830 (973)
||+++++|.+++.... ...+++..+..++.|++.|++||| +.+++||||+|+||+++.++.++++|||.+....
T Consensus 81 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 81 EYMEGGDLLDYLRKNR---PKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY 154 (258)
T ss_pred eccCCCCHHHHHHhhh---hccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceecc
Confidence 9999999999997531 112799999999999999999999 8899999999999999999999999999997665
Q ss_pred CCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhc
Q 002061 831 NSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVL 909 (973)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (973)
........ ...++..|+|||.+.+..++.++||||+|+++|+|++ |+.||... +.............
T Consensus 155 ~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~-----~~~~~~~~~~~~~~------ 222 (258)
T smart00219 155 DDDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM-----SNEEVLEYLKKGYR------ 222 (258)
T ss_pred cccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHhcCCC------
Confidence 44221111 2236789999999988889999999999999999998 78888642 11111111111110
Q ss_pred cccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 910 DCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 910 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
.........++.+++.+|+..+|++|||+.|+++.|
T Consensus 223 -----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 -----LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -----CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 001112355688899999999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=305.01 Aligned_cols=238 Identities=23% Similarity=0.338 Sum_probs=184.7
Q ss_pred cccccCceEEEEEEecCC------------------------CcEEEEEeeecc--ccHHHHHHHHHHHHhcCCCceeeE
Q 002061 683 LIGSGGTGKVYRLDLKKN------------------------AGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKL 736 (973)
Q Consensus 683 ~lG~G~~g~V~~a~~~~~------------------------~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hpniv~l 736 (973)
.||+|+||.||+|....+ ...||+|++... .....+.+|+++++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 589999999999985321 235889987653 234567889999999999999999
Q ss_pred EEEEEeCCeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCC
Q 002061 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY 816 (973)
Q Consensus 737 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~ 816 (973)
++++..+...++||||+++|+|..++... ...+++..+..++.|+++||+||| +++++||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE----KGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLG 154 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccC
Confidence 99999999999999999999999888642 345788899999999999999999 78999999999999997643
Q ss_pred -------CeEEecccCcccccCCCCcccccccCCcccccccccccc-CCCCccchHHHHHHHHHHHH-hCCCCCCcccCC
Q 002061 817 -------EPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYT-CKVSEKSDVFSFGVVLLELV-TGRKPVEEEYGD 887 (973)
Q Consensus 817 -------~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~-tg~~pf~~~~~~ 887 (973)
.++++|||.+...... ....++..|+|||.+.+ ..++.++|||||||++||++ +|+.||.....
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~- 227 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP- 227 (274)
T ss_pred cccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh-
Confidence 3899999987543221 12346788999998865 56889999999999999995 69999965321
Q ss_pred cccHHHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 888 GKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 888 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
........ .... .. ......+.+++.+||+.+|++||++.++++.|.
T Consensus 228 -~~~~~~~~----~~~~--------~~----~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 228 -SEKERFYE----KKHR--------LP----EPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred -HHHHHHHH----hccC--------CC----CCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 11111111 0000 00 011235788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=313.44 Aligned_cols=269 Identities=21% Similarity=0.283 Sum_probs=201.2
Q ss_pred CCcccCcccccCceEEEEEEecC--CCcEEEEEeeec-----cccHHHHHHHHHHHHhcCCCceeeEEEEEEeC--CeeE
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKK--NAGTVAVKQLWK-----GDGVKVFAAEMEILGKIRHRNILKLYACLLKG--GSSF 747 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~--~~~~vavK~~~~-----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~ 747 (973)
+|++.+.||+|+||.||+|.... +++.||+|.+.. ....+.+.+|++++++++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47788899999999999999988 789999999876 33346678899999999999999999999887 8899
Q ss_pred EEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecC----CCCeEEecc
Q 002061 748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE----DYEPKIADF 823 (973)
Q Consensus 748 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~----~~~~kl~Df 823 (973)
+||||++ +++.+++..........++...+..++.|++.|++||| +.+++||||||+||+++. ++.+|++||
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 9999996 47777776543333346888999999999999999999 789999999999999999 899999999
Q ss_pred cCcccccCCCC-cccccccCCccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccCCcc--------cHHH
Q 002061 824 GVAKIAENSPK-VSDYSCFAGTHGYIAPELAYTC-KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGK--------DIVY 893 (973)
Q Consensus 824 gl~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~--------~~~~ 893 (973)
|++........ ........++..|+|||++.+. .++.++|||||||++|+|++|+.||.....+.. ....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99886643322 1122234578899999988664 578999999999999999999999976533220 0000
Q ss_pred HHHHHh----------ccccccchh---cc-ccccCcchH-------HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 894 WVSTHL----------NNHENVLKV---LD-CEVASESIK-------EDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 894 ~~~~~~----------~~~~~~~~~---~~-~~~~~~~~~-------~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
.+.... ...+..... .. ......... ....++.+++.+|+++||++|||+.|++++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000000 000000000 00 000000000 233568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=313.95 Aligned_cols=252 Identities=24% Similarity=0.328 Sum_probs=208.3
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeec--cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccC
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK--GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP 754 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 754 (973)
-|+++..||.|+||.||+|..++++...|-|++.. ++..+++.-|+++|..++||+||++++.|..++..+|..|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 46778889999999999999998888888888754 4567788999999999999999999999999999999999999
Q ss_pred CCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCC
Q 002061 755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK 834 (973)
Q Consensus 755 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 834 (973)
||-+...+-.. ...+...++.-+++|++.||.||| +..|||||+|+.|||++-+|.++++|||.+..... .
T Consensus 113 GGAVDaimlEL----~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t 183 (1187)
T KOG0579|consen 113 GGAVDAIMLEL----GRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--T 183 (1187)
T ss_pred CchHhHHHHHh----ccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchh--H
Confidence 99988877543 346888999999999999999999 88999999999999999999999999998864322 2
Q ss_pred cccccccCCcccccccccc-----ccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhc
Q 002061 835 VSDYSCFAGTHGYIAPELA-----YTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVL 909 (973)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (973)
......+.||+.|||||+. ...+|+.++||||||++|.||..+.+|..+. ++...+-......++ ..
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel-----npMRVllKiaKSePP--TL- 255 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL-----NPMRVLLKIAKSEPP--TL- 255 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc-----chHHHHHHHhhcCCC--cc-
Confidence 2334468899999999986 4678999999999999999999999997643 333333333333221 11
Q ss_pred cccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 910 DCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 910 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
..+......+.+++.+|+.++|..||+++++++|-.
T Consensus 256 ------lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpf 291 (1187)
T KOG0579|consen 256 ------LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPF 291 (1187)
T ss_pred ------cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcc
Confidence 234556677899999999999999999999998754
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=308.10 Aligned_cols=256 Identities=29% Similarity=0.344 Sum_probs=200.8
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-ccHHHHHHHHHHHHhc-CCCceeeEEEEEEeC-----Cee
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKI-RHRNILKLYACLLKG-----GSS 746 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~-----~~~ 746 (973)
..++|++.+.||+|+||.||+|....+++.+|+|++... .....+.+|+.+++++ +|||++++++++... +..
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~ 99 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL 99 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence 467899999999999999999999988999999988653 3345678899999999 899999999998653 358
Q ss_pred EEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCc
Q 002061 747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826 (973)
Q Consensus 747 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~ 826 (973)
|+||||+++|+|.++++... .....+++..+..++.|++.|++||| +.+++||||||+||+++.++.++|+|||++
T Consensus 100 ~lv~ey~~~~sL~~~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~kl~dfg~~ 175 (291)
T cd06639 100 WLVLELCNGGSVTELVKGLL-ICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVS 175 (291)
T ss_pred EEEEEECCCCcHHHHHHHhh-hcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEeecccc
Confidence 99999999999999987532 22345789999999999999999999 789999999999999999999999999998
Q ss_pred ccccCCCCcccccccCCccccccccccccC-----CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcc
Q 002061 827 KIAENSPKVSDYSCFAGTHGYIAPELAYTC-----KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNN 901 (973)
Q Consensus 827 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 901 (973)
........ ......|+..|+|||++... .++.++||||+||++|||++|+.||..... ...+......
T Consensus 176 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~-----~~~~~~~~~~ 248 (291)
T cd06639 176 AQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP-----VKTLFKIPRN 248 (291)
T ss_pred hhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH-----HHHHHHHhcC
Confidence 76543221 11224578899999987543 367899999999999999999999965311 1111111111
Q ss_pred ccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 902 HENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
.. ....+ ..+....+.+++.+|++.+|++||++.|++++
T Consensus 249 ~~--~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 249 PP--PTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CC--CCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 00 01111 11233468899999999999999999999876
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=306.04 Aligned_cols=248 Identities=27% Similarity=0.384 Sum_probs=200.2
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeec---cccHHHHHHHHHHHHhcC---CCceeeEEEEEEeCCeeEEEE
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK---GDGVKVFAAEMEILGKIR---HRNILKLYACLLKGGSSFLVL 750 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~---~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~lv~ 750 (973)
.|+..+.||+|+||.||+|.+..+++.||+|.+.. ....+++.+|++++++++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 47778899999999999999998899999998764 234567889999999996 999999999999999999999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccccc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 830 (973)
||+++++|.+++... .+++..+..++.|++.|++||| +.+++||||+|+||+++.++.++++|||++....
T Consensus 82 e~~~~~~L~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06917 82 EYAEGGSVRTLMKAG------PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLN 152 (277)
T ss_pred ecCCCCcHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence 999999999988642 5789999999999999999999 7899999999999999999999999999998665
Q ss_pred CCCCcccccccCCccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhc
Q 002061 831 NSPKVSDYSCFAGTHGYIAPELAYTC-KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVL 909 (973)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (973)
... .......|+..|+|||++.++ .++.++|||||||++|+|++|+.||.... ............
T Consensus 153 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~-----~~~~~~~~~~~~------- 218 (277)
T cd06917 153 QNS--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVD-----AFRAMMLIPKSK------- 218 (277)
T ss_pred CCc--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCC-----hhhhhhccccCC-------
Confidence 433 122334688999999998654 46889999999999999999999996542 111111110000
Q ss_pred cccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 910 DCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 910 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
.+.... ......+.+++.+|++.||++||++.|++++-
T Consensus 219 ~~~~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~ 256 (277)
T cd06917 219 PPRLED---NGYSKLLREFVAACLDEEPKERLSAEELLKSK 256 (277)
T ss_pred CCCCCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhhCh
Confidence 011111 01345688899999999999999999998753
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=312.26 Aligned_cols=262 Identities=26% Similarity=0.370 Sum_probs=199.8
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc----cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE 751 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 751 (973)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ..+.+.+|++++++++||||+++++++..++..|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36888999999999999999999889999999875522 24567889999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccC
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 831 (973)
|+++++|.++... ...+++..+..++.|+++|++||| +.+++|||++|+||++++++.++++|||++.....
T Consensus 81 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 81 FVDHTVLDDLEKY-----PNGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred cCCccHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 9999988876653 234789999999999999999999 78999999999999999999999999999876543
Q ss_pred CCCcccccccCCcccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhc----------
Q 002061 832 SPKVSDYSCFAGTHGYIAPELAYT-CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLN---------- 900 (973)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~---------- 900 (973)
.. .......++..|+|||++.+ ..++.++||||||+++|||++|+.||..... .+....+.....
T Consensus 153 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07846 153 PG--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD--IDQLYHIIKCLGNLIPRHQEIF 228 (286)
T ss_pred Cc--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch--HHHHHHHHHHhCCCchhhHHHh
Confidence 32 12233457889999999865 4577899999999999999999999964321 110000000000
Q ss_pred -cccccchhccccccC-----cchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 901 -NHENVLKVLDCEVAS-----ESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 901 -~~~~~~~~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
..........+.... .........+.+++.+||+.+|++||++.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred ccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 000000000000000 0011234668899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=306.03 Aligned_cols=257 Identities=23% Similarity=0.348 Sum_probs=198.5
Q ss_pred CcccCcccccCceEEEEEEecC---CCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCC------
Q 002061 678 LEEDNLIGSGGTGKVYRLDLKK---NAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGG------ 744 (973)
Q Consensus 678 ~~~~~~lG~G~~g~V~~a~~~~---~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------ 744 (973)
|++.+.||+|+||+||+|.+.. +++.||||++..+ ...+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 5677889999999999998753 4688999988653 33556889999999999999999999886532
Q ss_pred eeEEEEEccCCCchHHHHHhhhc-CCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecc
Q 002061 745 SSFLVLEYMPNGNLFQALHKRVK-EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADF 823 (973)
Q Consensus 745 ~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 823 (973)
..++++||+++|+|.+++..... .....+++.....++.|++.|++||| +.+++||||||+||+++.++.+|++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence 24789999999999988754321 12234788899999999999999999 789999999999999999999999999
Q ss_pred cCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccc
Q 002061 824 GVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNH 902 (973)
Q Consensus 824 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~ 902 (973)
|+++...............++..|++||.+.+..++.++|||||||++|||++ |+.||.... .......+. ..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~--~~~~~~~~~----~~ 231 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE--NSEIYNYLI----KG 231 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC--HHHHHHHHH----cC
Confidence 99886643322222222345678999999988889999999999999999999 889986431 111111111 11
Q ss_pred cccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 903 ENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
.... ........+.+++.+|++.+|++||++.|+++.|+++
T Consensus 232 ~~~~----------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 NRLK----------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CcCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1000 0112335788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=304.80 Aligned_cols=246 Identities=28% Similarity=0.411 Sum_probs=200.6
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM 753 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 753 (973)
-|+..+.||+|+||.||+|.+..+++.||||..... ...+.+.+|++++++++||||+++++++..+...|+||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 367788999999999999999888999999987543 23456888999999999999999999999999999999999
Q ss_pred CCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCC
Q 002061 754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833 (973)
Q Consensus 754 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 833 (973)
++++|.+++.. ..+++..+..++.|++.|++||| +.+++|+||+|+||+++.++.++++|||++.......
T Consensus 85 ~~~~l~~~i~~------~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06641 85 GGGSALDLLEP------GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence 99999998863 24789999999999999999999 8899999999999999999999999999987554321
Q ss_pred CcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccc
Q 002061 834 KVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEV 913 (973)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (973)
.......++..|+|||.+.+..++.++||||+||++|+|++|..||.... .............
T Consensus 156 --~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~-----~~~~~~~~~~~~~---------- 218 (277)
T cd06641 156 --IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH-----PMKVLFLIPKNNP---------- 218 (277)
T ss_pred --hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc-----hHHHHHHHhcCCC----------
Confidence 11223457889999999988888999999999999999999999996431 1111111111100
Q ss_pred cCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 914 ASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 914 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
..........+.+++.+|++.+|++||++.+++++
T Consensus 219 -~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 219 -PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred -CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 01112234567889999999999999999999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=307.71 Aligned_cols=250 Identities=24% Similarity=0.326 Sum_probs=202.9
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeec--cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK--GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY 752 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 752 (973)
..+|++.+.||+|+||.||+|....+++.||+|.+.. ....+.+.+|+.++++++|||++++++++..++..|+|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 3688999999999999999999988889999998754 23456688999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCC
Q 002061 753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832 (973)
Q Consensus 753 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 832 (973)
+++++|.+++.+. .+++..+..++.|++.|++||| +++++||||+|+||+++.++.++|+|||++......
T Consensus 98 ~~~~~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~ 168 (293)
T cd06647 98 LAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (293)
T ss_pred CCCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence 9999999998642 4678889999999999999999 889999999999999999999999999988755433
Q ss_pred CCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhcccc
Q 002061 833 PKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCE 912 (973)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (973)
.. ......+++.|+|||.+.+..++.++|||||||++|++++|+.||........ +...... ..
T Consensus 169 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~-----~~~~~~~---------~~ 232 (293)
T cd06647 169 QS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-----LYLIATN---------GT 232 (293)
T ss_pred cc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh-----eeehhcC---------CC
Confidence 22 22234688899999999888899999999999999999999999965321100 0000000 00
Q ss_pred ccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 913 VASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 913 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
............+.+++.+||+.+|++||++.+++.|
T Consensus 233 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 233 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0001112234567889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=309.07 Aligned_cols=247 Identities=30% Similarity=0.408 Sum_probs=198.1
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL 750 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 750 (973)
..|+..+.||+|+||+||+|+...+++.||+|++... ...+++.+|+++++.++||||+++++++..++..|+||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 4588889999999999999999988999999988642 23356889999999999999999999999999999999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccccc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 830 (973)
||++ |++.+++... ...+++..+..++.|++.|+.||| +.+++||||+|+||+++.++.++|+|||++....
T Consensus 95 e~~~-g~l~~~~~~~----~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 95 EYCL-GSASDILEVH----KKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred HhhC-CCHHHHHHHc----ccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 9996 6777776543 235789999999999999999999 7899999999999999999999999999986543
Q ss_pred CCCCcccccccCCccccccccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccch
Q 002061 831 NSPKVSDYSCFAGTHGYIAPELAY---TCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLK 907 (973)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
.. ....++..|+|||++. ...++.++||||||+++|||++|+.||.... .............
T Consensus 167 ~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~-----~~~~~~~~~~~~~---- 231 (307)
T cd06607 167 PA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----AMSALYHIAQNDS---- 231 (307)
T ss_pred CC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc-----HHHHHHHHhcCCC----
Confidence 22 1245788999999874 4568899999999999999999999996431 1111111111100
Q ss_pred hccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 908 VLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 908 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
+. .........+.+++.+||+.+|++||++.+++++..
T Consensus 232 ---~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 269 (307)
T cd06607 232 ---PT---LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRF 269 (307)
T ss_pred ---CC---CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 00 111234557889999999999999999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=307.78 Aligned_cols=256 Identities=25% Similarity=0.351 Sum_probs=197.4
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeecc---ccHHHHHHHHHHHHhcC-CCceeeEEEEEEeCCeeEEEEEc
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIR-HRNILKLYACLLKGGSSFLVLEY 752 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~ 752 (973)
+|+..+.||+|+||+||++.+..+++.||+|++... .....+.+|+.++.++. ||||+++++++..+...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 566778899999999999999999999999988653 33456788999999996 99999999999999999999999
Q ss_pred cCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCC
Q 002061 753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832 (973)
Q Consensus 753 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 832 (973)
++ +++.++...........+++..+..++.|++.|++|||+ +.+++||||||+||+++.++.++|+|||++......
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 85 466554432212223568899999999999999999994 358999999999999999999999999998765432
Q ss_pred CCcccccccCCccccccccccccC---CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhc
Q 002061 833 PKVSDYSCFAGTHGYIAPELAYTC---KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVL 909 (973)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (973)
.. .....|+..|+|||++.+. .++.++||||+||++|||++|+.||.... .....+........
T Consensus 162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~~~~~~~~~~------ 228 (288)
T cd06616 162 IA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN----SVFDQLTQVVKGDP------ 228 (288)
T ss_pred Cc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc----hHHHHHhhhcCCCC------
Confidence 11 1223578899999998766 68899999999999999999999996532 11111111111110
Q ss_pred cccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 910 DCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 910 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
+............++.+++.+|++++|++||++.+|+++
T Consensus 229 -~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 229 -PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred -CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111112345578899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=314.17 Aligned_cols=245 Identities=25% Similarity=0.373 Sum_probs=197.8
Q ss_pred cccCcccccCceEEEEEEecCCCcEEEE---E---eeeccccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCe--eEEEE
Q 002061 679 EEDNLIGSGGTGKVYRLDLKKNAGTVAV---K---QLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGS--SFLVL 750 (973)
Q Consensus 679 ~~~~~lG~G~~g~V~~a~~~~~~~~vav---K---~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~--~~lv~ 750 (973)
+...+||+|+|-+||||.+..+|..||= | +.+.+...++|..|+.+|+.++||||++++++|.+... ..+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 3456799999999999999999988873 3 22335566889999999999999999999999987654 78899
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecC-CCCeEEecccCcccc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE-DYEPKIADFGVAKIA 829 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfgl~~~~ 829 (973)
|.|..|+|..|.+++ ...+...+..|+.||++||.|||++ .++|||||||-+||||+. .|.|||+|+|+|+..
T Consensus 123 EL~TSGtLr~Y~kk~-----~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~ 196 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKH-----RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL 196 (632)
T ss_pred ecccCCcHHHHHHHh-----ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHh
Confidence 999999999999876 2467778899999999999999987 789999999999999986 689999999999877
Q ss_pred cCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhc
Q 002061 830 ENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVL 909 (973)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (973)
..... ...+|||.|||||+.. ..|.+.+||||||++++||+|+.+||.+ ....++..+......++ .-+
T Consensus 197 r~s~a----ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE----C~n~AQIYKKV~SGiKP--~sl 265 (632)
T KOG0584|consen 197 RKSHA----KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE----CTNPAQIYKKVTSGIKP--AAL 265 (632)
T ss_pred hcccc----ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh----hCCHHHHHHHHHcCCCH--HHh
Confidence 54322 2368999999999875 7899999999999999999999999963 33444444433322221 000
Q ss_pred cccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 910 DCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 910 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
..-.-+++.+||.+|+.. ...||++.|++++
T Consensus 266 --------~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 266 --------SKVKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred --------hccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 111123577899999999 9999999999975
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=343.42 Aligned_cols=252 Identities=27% Similarity=0.397 Sum_probs=204.5
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeec----cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY 752 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 752 (973)
++.....||.|.||.||-|...++|+..|||-+.- ....+...+|+.++..++|||+|+++++-.+.+.++|.|||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence 56778899999999999999999999999997654 23455678999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCC
Q 002061 753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832 (973)
Q Consensus 753 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 832 (973)
|++|+|.+.+... ...++.....+..|++.|++||| ++|||||||||.||+++.+|.+|.+|||.|+.+.+.
T Consensus 1316 C~~GsLa~ll~~g-----ri~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHG-----RIEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred hccCcHHHHHHhc-----chhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 9999999998753 23455566678899999999999 889999999999999999999999999999988765
Q ss_pred CCc--ccccccCCccccccccccccC---CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccch
Q 002061 833 PKV--SDYSCFAGTHGYIAPELAYTC---KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLK 907 (973)
Q Consensus 833 ~~~--~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
... .......||+.|||||++.+. ...-+.||||+|||+.||+||+.||...+.+ -.+.+.|..
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-~aIMy~V~~---------- 1456 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-WAIMYHVAA---------- 1456 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-hHHHhHHhc----------
Confidence 322 223356899999999999653 4667899999999999999999999865321 111221111
Q ss_pred hccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 908 VLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 908 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
...+..+.....+=.+++..|+..||.+|.++.|++++--
T Consensus 1457 ----gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f 1496 (1509)
T KOG4645|consen 1457 ----GHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAF 1496 (1509)
T ss_pred ----cCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhc
Confidence 1112233445566678899999999999999999887643
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=305.53 Aligned_cols=265 Identities=20% Similarity=0.242 Sum_probs=196.8
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE 751 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 751 (973)
.++|.+.+.||+|+||.||+|....+++.||+|++... .....+.+|+++++.++|+||+++++++..++..|+|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 46789999999999999999999988999999988653 223357789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccC
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 831 (973)
|++ +++.+++... ...+.+..+..++.|++.||+||| +.+++||||||+||+++.++.++|+|||+++....
T Consensus 84 ~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 84 YMH-TDLAQYMIQH----PGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred ccc-CCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 995 6777776542 234677888899999999999999 78999999999999999999999999999875433
Q ss_pred CCCcccccccCCccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHH----------hc
Q 002061 832 SPKVSDYSCFAGTHGYIAPELAYTC-KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTH----------LN 900 (973)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~----------~~ 900 (973)
... ......++..|+|||++.+. .++.++||||+||++|||++|+.||.........+...+... ..
T Consensus 156 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 156 PSQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CCC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence 221 12223568899999998754 578899999999999999999999975422111111110000 00
Q ss_pred cccccchhccccccCcchH------HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 901 NHENVLKVLDCEVASESIK------EDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~------~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
..+................ .....+.+++.+|++.||.+|||+.|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 0000000000000000000 113467789999999999999999999865
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=307.32 Aligned_cols=261 Identities=23% Similarity=0.292 Sum_probs=199.2
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc-------cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-------GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV 749 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 749 (973)
+|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+|++++++++||||+++++++.++...++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778889999999999999999889999999986532 123467899999999999999999999999999999
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccc
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 829 (973)
|||+ +|+|.+++... ...+++..+..++.|+++||+||| +.+++||||+|+||+++.++.++|+|||++...
T Consensus 81 ~e~~-~~~L~~~i~~~----~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~ 152 (298)
T cd07841 81 FEFM-ETDLEKVIKDK----SIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSF 152 (298)
T ss_pred Eccc-CCCHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeec
Confidence 9999 89999999753 135899999999999999999999 789999999999999999999999999999866
Q ss_pred cCCCCcccccccCCcccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccc-----
Q 002061 830 ENSPKVSDYSCFAGTHGYIAPELAYT-CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHE----- 903 (973)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~----- 903 (973)
..... ......++..|+|||.+.+ ..++.++|||||||++|||++|..||..... ......... ......
T Consensus 153 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~ 228 (298)
T cd07841 153 GSPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD-IDQLGKIFE-ALGTPTEENWP 228 (298)
T ss_pred cCCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc-HHHHHHHHH-HcCCCchhhhh
Confidence 54321 1222356788999998864 4578899999999999999999887764321 111111100 000000
Q ss_pred ---ccchhccccc-----cCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 904 ---NVLKVLDCEV-----ASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 904 ---~~~~~~~~~~-----~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
.......... ...........+.+++.+|+++||++||++.|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 229 GVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000000 000112234678899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=306.21 Aligned_cols=245 Identities=26% Similarity=0.329 Sum_probs=201.9
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL 750 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 750 (973)
++|++.+.||+|+||.||+|++..+++.||+|++... ...+.+.+|++++++++||||+++++++.++...|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 3688899999999999999999988999999988652 23456888999999999999999999999999999999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccccc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 830 (973)
||+++++|.+++... ..++...+..++.|++.||+||| +.+++||||+|+||+++.++.+||+|||++....
T Consensus 81 e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 152 (290)
T cd05580 81 EYVPGGELFSHLRKS-----GRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK 152 (290)
T ss_pred ecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccC
Confidence 999999999998753 35788899999999999999999 7899999999999999999999999999987654
Q ss_pred CCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhcc
Q 002061 831 NSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLD 910 (973)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (973)
.. .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||.... ..............
T Consensus 153 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~------ 216 (290)
T cd05580 153 GR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN-----PIQIYEKILEGKVR------ 216 (290)
T ss_pred CC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHhcCCcc------
Confidence 33 223457899999999988888999999999999999999999996532 11111111111110
Q ss_pred ccccCcchHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHh
Q 002061 911 CEVASESIKEDMIKLLKIAVVCTTKLPNLRP-----PMREVVKML 950 (973)
Q Consensus 911 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~L 950 (973)
.+......+.+++.+||+.+|.+|+ ++.|++++-
T Consensus 217 ------~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~ 255 (290)
T cd05580 217 ------FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHP 255 (290)
T ss_pred ------CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCc
Confidence 0111245678899999999999999 788887654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=301.40 Aligned_cols=253 Identities=21% Similarity=0.302 Sum_probs=187.2
Q ss_pred cccccCceEEEEEEecCC--CcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCCc
Q 002061 683 LIGSGGTGKVYRLDLKKN--AGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGN 757 (973)
Q Consensus 683 ~lG~G~~g~V~~a~~~~~--~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gs 757 (973)
.||+|+||+||+|+.... ...+++|.+... ...+.+.+|+.+++.++||||+++++++......|+||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999976532 234667765542 345678899999999999999999999999999999999999999
Q ss_pred hHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCccc
Q 002061 758 LFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSD 837 (973)
Q Consensus 758 L~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 837 (973)
|.++++.... .....++..+..++.|+++||+||| +.+++||||||+||+++.++.++|+|||++...........
T Consensus 82 L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 82 LKSYLSQEQW-HRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred HHHHHHhhhc-ccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 9999976422 2334667778899999999999999 78999999999999999999999999999764322221122
Q ss_pred ccccCCcccccccccccc-------CCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhc
Q 002061 838 YSCFAGTHGYIAPELAYT-------CKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVL 909 (973)
Q Consensus 838 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (973)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||... .. ............ ....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~--~~---~~~~~~~~~~~~--~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL--SD---REVLNHVIKDQQ--VKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC--CH---HHHHHHHHhhcc--cccC
Confidence 223467889999998743 245789999999999999997 56787542 11 111111111111 1112
Q ss_pred cccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 910 DCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 910 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
++.... .....+.+++..|| .+|++||++++|++.|.
T Consensus 231 ~~~~~~----~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLEL----PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCC----CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 222211 12345777888999 67999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=299.60 Aligned_cols=250 Identities=30% Similarity=0.414 Sum_probs=206.9
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc---cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM 753 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 753 (973)
+|++.+.||+|++|.||+|++..+++.||||++.... ..+.+.+|++++++++|||++++++++..+...++||||+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 6788899999999999999999999999999887643 4677899999999999999999999999999999999999
Q ss_pred CCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCC-CCeEecCCCCCCeeecCCCCeEEecccCcccccCC
Q 002061 754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS-PPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832 (973)
Q Consensus 754 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~-~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 832 (973)
++++|.+++... ..++...+..++.|+++|++|+| + .+++||||+|+||+++.++.++|+|||.+......
T Consensus 82 ~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 82 DGGSLADLLKKV-----GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred CCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 999999999753 45789999999999999999999 7 89999999999999999999999999998766433
Q ss_pred CCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhcccc
Q 002061 833 PKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCE 912 (973)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (973)
... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ............... .
T Consensus 154 ~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~~~-------~- 221 (264)
T cd06623 154 LDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ--PSFFELMQAICDGPP-------P- 221 (264)
T ss_pred CCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc--cCHHHHHHHHhcCCC-------C-
Confidence 221 1234578899999999988899999999999999999999999976421 122222222211111 0
Q ss_pred ccCcchHH-HHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 913 VASESIKE-DMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 913 ~~~~~~~~-~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
..... ....+.+++.+|++.+|++||++.|++++
T Consensus 222 ---~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 222 ---SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ---CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11111 45678899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=307.81 Aligned_cols=253 Identities=21% Similarity=0.247 Sum_probs=197.9
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE 751 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 751 (973)
+|++.+.||+|+||.||+|.+..+++.||+|.+... ...+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 688899999999999999999999999999988653 234567789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccC
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 831 (973)
|+++++|.+++... ..+++..+..++.|++.|++|+| +.+++||||||+||+++.++.++++|||+++....
T Consensus 82 ~~~g~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 82 YVEGGDCATLLKNI-----GALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred cCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 99999999999653 34788889999999999999999 78999999999999999999999999998863211
Q ss_pred CCC-------------cccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHH
Q 002061 832 SPK-------------VSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTH 898 (973)
Q Consensus 832 ~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~ 898 (973)
... ........++..|+|||.+.+..++.++|+|||||++|||++|+.||... .........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~-----~~~~~~~~~ 228 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD-----TPEELFGQV 228 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHH
Confidence 100 00111235788999999998888999999999999999999999999643 111221111
Q ss_pred hccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 899 LNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
...... .+. ........+.+++.+||+.||++||++.++.+.++
T Consensus 229 ~~~~~~-----~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 229 ISDDIE-----WPE----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred HhcccC-----CCC----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 111100 000 00123445789999999999999998544444444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=306.06 Aligned_cols=262 Identities=26% Similarity=0.330 Sum_probs=200.9
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY 752 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 752 (973)
+|++.+.||+|+||.||+|.+.++++.||||++... ...+.+.+|++++++++||||+++++++..++..++||||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 688899999999999999999988999999987642 2346788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCC
Q 002061 753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832 (973)
Q Consensus 753 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 832 (973)
++++.+..+... ...+++..+..++.|++.|++||| +.+++|||++|+||++++++.++|+|||.+......
T Consensus 82 ~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 82 VERTLLELLEAS-----PGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred CCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 988776655442 234788999999999999999999 789999999999999999999999999998766543
Q ss_pred CCcccccccCCccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcc----------
Q 002061 833 PKVSDYSCFAGTHGYIAPELAYTC-KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNN---------- 901 (973)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~---------- 901 (973)
.. .......++..|+|||++.+. .++.++||||+|+++|+|++|+.||.... ..+...........
T Consensus 154 ~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07833 154 PA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDS--DIDQLYLIQKCLGPLPPSHQELFS 230 (288)
T ss_pred cc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhCCCCHHHhhhcc
Confidence 22 122334678899999999888 78899999999999999999999996431 11111111110000
Q ss_pred -ccccc--hhcccccc----CcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 902 -HENVL--KVLDCEVA----SESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 902 -~~~~~--~~~~~~~~----~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
..... +..+.... .........++.+++.+||+.+|++||++++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00000 00000000 00011225678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=331.44 Aligned_cols=254 Identities=24% Similarity=0.400 Sum_probs=191.3
Q ss_pred HHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeC------
Q 002061 673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKG------ 743 (973)
Q Consensus 673 ~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------ 743 (973)
+...+|+..+.||+||||.|||++.+-+|+.||||++.-. .....+.+|+..+.+++|||||+++..|.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 4566788999999999999999999999999999998653 3455678999999999999999998432100
Q ss_pred --------------------------------------------------------------------------------
Q 002061 744 -------------------------------------------------------------------------------- 743 (973)
Q Consensus 744 -------------------------------------------------------------------------------- 743 (973)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ---------------------------------CeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHh
Q 002061 744 ---------------------------------GSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790 (973)
Q Consensus 744 ---------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~ 790 (973)
...||-||||+...+.+++++..... .....++++.+|++|++
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~----~~d~~wrLFreIlEGLa 711 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS----QRDEAWRLFREILEGLA 711 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch----hhHHHHHHHHHHHHHHH
Confidence 11379999999988888887642111 45678899999999999
Q ss_pred hhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccccc----------------CCCCcccccccCCccccccccccc
Q 002061 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE----------------NSPKVSDYSCFAGTHGYIAPELAY 854 (973)
Q Consensus 791 ~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~ 854 (973)
|+| +.|+|||||||.|||+++++.|||+|||+|+... .+......+..+||.-|+|||++.
T Consensus 712 YIH---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~ 788 (1351)
T KOG1035|consen 712 YIH---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS 788 (1351)
T ss_pred HHH---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence 999 8899999999999999999999999999998621 112223455678999999999987
Q ss_pred cC---CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHH
Q 002061 855 TC---KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVV 931 (973)
Q Consensus 855 ~~---~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 931 (973)
+. +|+.|+||||+|||++||+. ||.... +-+..+ ..++... +... . .........=.+++.+
T Consensus 789 ~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM----ERa~iL-~~LR~g~-iP~~--~----~f~~~~~~~e~slI~~ 853 (1351)
T KOG1035|consen 789 DTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM----ERASIL-TNLRKGS-IPEP--A----DFFDPEHPEEASLIRW 853 (1351)
T ss_pred ccccccccchhhhHHHHHHHHHHhc---cCCchH----HHHHHH-HhcccCC-CCCC--c----ccccccchHHHHHHHH
Confidence 54 49999999999999999995 565431 111111 1122111 1111 1 1122223334578999
Q ss_pred hcCCCCCCCCCHHHHHH
Q 002061 932 CTTKLPNLRPPMREVVK 948 (973)
Q Consensus 932 cl~~dP~~Rpt~~evl~ 948 (973)
+++.||.+|||+.|++.
T Consensus 854 Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 854 LLSHDPSKRPTATELLN 870 (1351)
T ss_pred HhcCCCccCCCHHHHhh
Confidence 99999999999999985
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=308.67 Aligned_cols=247 Identities=25% Similarity=0.388 Sum_probs=197.6
Q ss_pred CcccCcccccCceEEEEEEecCCCcEEEEEeeec--cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCC
Q 002061 678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK--GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPN 755 (973)
Q Consensus 678 ~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 755 (973)
|.....||+|+||.||+|....++..||||++.. ....+.+.+|+.+++.++||||+++++++..++..|+||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 3445679999999999999988899999998754 23455688999999999999999999999999999999999999
Q ss_pred CchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCc
Q 002061 756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV 835 (973)
Q Consensus 756 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 835 (973)
++|.+++.. ..+++..+..++.|++.|++||| +++++||||||+||+++.++.++|+|||++........
T Consensus 104 ~~L~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~- 173 (292)
T cd06658 104 GALTDIVTH------TRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP- 173 (292)
T ss_pred CcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-
Confidence 999998753 24788899999999999999999 78999999999999999999999999999875532211
Q ss_pred ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccccC
Q 002061 836 SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVAS 915 (973)
Q Consensus 836 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
......|+..|+|||+..+..++.++||||+|+++|||++|+.||.... .......+.. . ......
T Consensus 174 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~--~~~~~~~~~~---~-------~~~~~~- 239 (292)
T cd06658 174 -KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP--PLQAMRRIRD---N-------LPPRVK- 239 (292)
T ss_pred -cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHh---c-------CCCccc-
Confidence 1223457899999999988889999999999999999999999996431 1111111110 0 001100
Q ss_pred cchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 916 ESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 916 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
........+.+++.+|+..||.+|||+.|++++
T Consensus 240 -~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 240 -DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred -cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 011223457788999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=308.39 Aligned_cols=248 Identities=24% Similarity=0.348 Sum_probs=198.3
Q ss_pred cccCcccccCceEEEEEEecCCCcEEEEEeeec--cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCC
Q 002061 679 EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK--GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNG 756 (973)
Q Consensus 679 ~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 756 (973)
+....||+|+||.||+|....+++.||+|++.. ....+.+.+|+.+++.++|||++++++++..++..|+||||++++
T Consensus 24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~ 103 (297)
T cd06659 24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG 103 (297)
T ss_pred HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence 344579999999999999988899999999864 234456789999999999999999999999999999999999999
Q ss_pred chHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCcc
Q 002061 757 NLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVS 836 (973)
Q Consensus 757 sL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 836 (973)
+|.+++.. ..+++..+..++.|++.|++||| +.+++||||+|+||+++.++.++|+|||++........
T Consensus 104 ~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-- 172 (297)
T cd06659 104 ALTDIVSQ------TRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-- 172 (297)
T ss_pred CHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--
Confidence 99987753 24788999999999999999999 88999999999999999999999999999865433211
Q ss_pred cccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccccCc
Q 002061 837 DYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASE 916 (973)
Q Consensus 837 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (973)
......|+..|+|||++.+..++.++||||+||++|||++|+.||.... .. ............ . ..
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~--~~---~~~~~~~~~~~~--~-------~~ 238 (297)
T cd06659 173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS--PV---QAMKRLRDSPPP--K-------LK 238 (297)
T ss_pred cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HH---HHHHHHhccCCC--C-------cc
Confidence 1223468899999999998889999999999999999999999996431 11 111111111000 0 00
Q ss_pred chHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 917 SIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 917 ~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
........+.+++.+|++.+|++||++.+++++-.
T Consensus 239 ~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~ 273 (297)
T cd06659 239 NAHKISPVLRDFLERMLTREPQERATAQELLDHPF 273 (297)
T ss_pred ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChh
Confidence 01122345788999999999999999999999643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=300.82 Aligned_cols=249 Identities=25% Similarity=0.371 Sum_probs=202.4
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY 752 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 752 (973)
+|++.+.||+|+||.||+|..+.++..||+|.+... ...+.+.+|++++++++||||+++++++..+...++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 477889999999999999999999999999988653 3456778999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCC-eEEecccCcccccC
Q 002061 753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE-PKIADFGVAKIAEN 831 (973)
Q Consensus 753 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~-~kl~Dfgl~~~~~~ 831 (973)
+++++|.+++... ....+++..+..++.|+++|++||| +.+++|+||+|+||++++++. ++++|||.+.....
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (257)
T cd08225 81 CDGGDLMKRINRQ---RGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154 (257)
T ss_pred CCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence 9999999999753 2335789999999999999999999 789999999999999998864 69999999876643
Q ss_pred CCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccc
Q 002061 832 SPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDC 911 (973)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (973)
... ......|++.|+|||+..+..++.++||||||+++|||++|+.||... +...++........ .
T Consensus 155 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-----~~~~~~~~~~~~~~--~----- 220 (257)
T cd08225 155 SME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN-----NLHQLVLKICQGYF--A----- 220 (257)
T ss_pred Ccc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc-----cHHHHHHHHhcccC--C-----
Confidence 321 112245788999999998888999999999999999999999999643 22222222211110 0
Q ss_pred cccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 912 EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 912 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
.........+.+++.+|++.+|++||++.|++++
T Consensus 221 ----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 221 ----PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ----CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0111223468889999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=307.32 Aligned_cols=262 Identities=23% Similarity=0.300 Sum_probs=198.6
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY 752 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 752 (973)
+|+..+.||.|++|.||+|++..+++.||||++... .....+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 478889999999999999999988999999988642 2335688999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCC
Q 002061 753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832 (973)
Q Consensus 753 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 832 (973)
++ ++|.+++... ....+++..+..++.|++.|++||| +.+++||||+|+||+++.++.++++|||++......
T Consensus 81 ~~-~~l~~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~ 153 (284)
T cd07860 81 LH-QDLKKFMDAS---PLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 153 (284)
T ss_pred cc-cCHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 95 6898888643 2346889999999999999999999 789999999999999999999999999998755432
Q ss_pred CCcccccccCCccccccccccccCC-CCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccc--------
Q 002061 833 PKVSDYSCFAGTHGYIAPELAYTCK-VSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHE-------- 903 (973)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~-------- 903 (973)
.. ......++..|+|||++.+.. ++.++|||||||++|||+||+.||..... ................
T Consensus 154 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07860 154 VR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTS 230 (284)
T ss_pred cc--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHHhCCCChhhhhhhhH
Confidence 21 122335688999999887654 58899999999999999999999965321 1111111111000000
Q ss_pred ------ccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 904 ------NVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 904 ------~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
.......... ..........+.+++.+|++.||++||++.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 231 LPDYKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHHHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0000000000 00011223457789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=306.52 Aligned_cols=250 Identities=30% Similarity=0.423 Sum_probs=199.3
Q ss_pred CcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 002061 678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY 752 (973)
Q Consensus 678 ~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 752 (973)
|+..+.||+|+||.||+|++..++..||+|++... +....+.+|++++++++|||++++++++.++...++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 77788999999999999999988999999988642 2345688899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCC
Q 002061 753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832 (973)
Q Consensus 753 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 832 (973)
++ |++.+.+... ...+++..+..++.|++.|+.||| +.+++||||+|+||+++.++.++|+|||++......
T Consensus 107 ~~-g~l~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (317)
T cd06635 107 CL-GSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178 (317)
T ss_pred CC-CCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence 96 5787777543 335889999999999999999999 789999999999999999999999999988654322
Q ss_pred CCcccccccCCccccccccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhc
Q 002061 833 PKVSDYSCFAGTHGYIAPELAY---TCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVL 909 (973)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (973)
....|+..|+|||++. +..++.++|||||||++|||++|+.||.... ............
T Consensus 179 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-----~~~~~~~~~~~~------- 240 (317)
T cd06635 179 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----AMSALYHIAQNE------- 240 (317)
T ss_pred ------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHHhcc-------
Confidence 2245788999999974 4568899999999999999999999986531 111111111110
Q ss_pred cccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCC
Q 002061 910 DCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPC 956 (973)
Q Consensus 910 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~ 956 (973)
............+.+++.+|++.+|.+||++.+++++.......
T Consensus 241 ---~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 241 ---SPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred ---CCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 00011122344678899999999999999999999987765443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=305.44 Aligned_cols=263 Identities=26% Similarity=0.260 Sum_probs=199.0
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc----cHHHHHHHHHHHHhcCCCceeeEEEEEEeC--CeeEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYACLLKG--GSSFL 748 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~l 748 (973)
.++|++.+.||+|+||.||+|++..+++.||+|.++... ....+.+|++++++++||||+++++++..+ ...|+
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 457899999999999999999999889999999886532 233567899999999999999999998877 88999
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccc
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 828 (973)
||||++ ++|.+++... ...+++..+..++.|++.||+||| +.+++||||||+||+++.++.++|+|||++..
T Consensus 84 v~e~~~-~~L~~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~ 155 (293)
T cd07843 84 VMEYVE-HDLKSLMETM----KQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLARE 155 (293)
T ss_pred EehhcC-cCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceee
Confidence 999996 5999888753 235899999999999999999999 78999999999999999999999999999886
Q ss_pred ccCCCCcccccccCCccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcc------
Q 002061 829 AENSPKVSDYSCFAGTHGYIAPELAYTC-KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNN------ 901 (973)
Q Consensus 829 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~------ 901 (973)
...... ......++..|+|||++.+. .++.++|+||+|+++|||++|+.||..... ......+......
T Consensus 156 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~--~~~~~~~~~~~~~~~~~~~ 231 (293)
T cd07843 156 YGSPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSE--IDQLNKIFKLLGTPTEKIW 231 (293)
T ss_pred ccCCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCchHHH
Confidence 654321 22234578899999998754 468899999999999999999999975421 1100000000000
Q ss_pred -----cc-----ccchhccccccCcchHH-HHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 902 -----HE-----NVLKVLDCEVASESIKE-DMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 902 -----~~-----~~~~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
.+ ................. ....+.+++.+|++.+|++|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 232 PGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred HHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00 00000000000001111 25567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=343.41 Aligned_cols=472 Identities=26% Similarity=0.324 Sum_probs=309.8
Q ss_pred cccccccCCccCcEeeCCCCcccCcCChhhhCCCCCcEEEecCCcccCCCCcccCCCCCCEEeccCccCCCccccccccc
Q 002061 88 EISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNL 167 (973)
Q Consensus 88 ~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l 167 (973)
.||..+..-..++.|+++.|.+-..--+.+.+.-+|+.|||++|++...|..+..+.+|+.|.++.|.|. ..|....++
T Consensus 12 ~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~ 90 (1081)
T KOG0618|consen 12 LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQISSFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNM 90 (1081)
T ss_pred ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccccCCchhhhHHHHhhcccchhhHh-hCchhhhhh
Confidence 4555555555566666666655421122334444566666666666666666666666666666666666 455666666
Q ss_pred cccceEEccCCcCCCCCCcccccCCCCCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCchhhhccccccEEE
Q 002061 168 TQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIE 247 (973)
Q Consensus 168 ~~L~~L~l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~ 247 (973)
.+|++|.|.+|.+. .+|.++..+++|++|+++.|++. .+|..+..++.++.+..++|..... ++... ++.++
T Consensus 91 ~~l~~lnL~~n~l~--~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~----lg~~~-ik~~~ 162 (1081)
T KOG0618|consen 91 RNLQYLNLKNNRLQ--SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQR----LGQTS-IKKLD 162 (1081)
T ss_pred hcchhheeccchhh--cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhh----hcccc-chhhh
Confidence 66666666666664 45666666777777777777766 5666666666666666666622111 22222 56666
Q ss_pred eeccccCCcCCccccccccccEEEeeccccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeeccCCccCC
Q 002061 248 LYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSG 327 (973)
Q Consensus 248 L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 327 (973)
|..|.+.+.++..+..++. .|||++|.+. -..+.++.+|+.+.+..|+++... -.-++|+.|+.++|.++.
T Consensus 163 l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l~----~~g~~l~~L~a~~n~l~~ 233 (1081)
T KOG0618|consen 163 LRLNVLGGSFLIDIYNLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSELE----ISGPSLTALYADHNPLTT 233 (1081)
T ss_pred hhhhhcccchhcchhhhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceEE----ecCcchheeeeccCccee
Confidence 6666666666666665555 5677777664 233455666666666666665321 123556666666666652
Q ss_pred CCCccccccccccccccccccccccCChhhhhhhhHHHHHhhhccCCCCccccccCccccceEeccccccccCCCccccC
Q 002061 328 PFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWA 407 (973)
Q Consensus 328 ~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 407 (973)
..+ -..-.+|+++|+++|+++ .+|.|++...++.. +..++|....+|..+...++|+.|...+|.++ .+|....+
T Consensus 234 ~~~--~p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~-l~~n~N~l~~lp~ri~~~~~L~~l~~~~nel~-yip~~le~ 308 (1081)
T KOG0618|consen 234 LDV--HPVPLNLQYLDISHNNLS-NLPEWIGACANLEA-LNANHNRLVALPLRISRITSLVSLSAAYNELE-YIPPFLEG 308 (1081)
T ss_pred ecc--ccccccceeeecchhhhh-cchHHHHhcccceE-ecccchhHHhhHHHHhhhhhHHHHHhhhhhhh-hCCCcccc
Confidence 222 122345666666666666 34455544443222 22222222456666666777888888888887 67777777
Q ss_pred CCCcceEeccCCcCCCCCCCCCCCCCC-CCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCccccccccccCCEE
Q 002061 408 LPNVGMLDFGDNDFTGGISPLIGLSTS-LSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSL 486 (973)
Q Consensus 408 l~~L~~L~L~~N~l~~~~~~~~~~~~~-L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 486 (973)
+..|+.|+|..|+|...+...+..... |..|..+.|++....-..=...+.|+.|++.+|.++...-..+.+...|+.|
T Consensus 309 ~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVL 388 (1081)
T KOG0618|consen 309 LKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVL 388 (1081)
T ss_pred cceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeee
Confidence 888888888888887666655444433 6777777777763322222234678999999999998776788999999999
Q ss_pred EcCCcccccCCCccccccccccchhccccccccCCCccccccCCCCeeecCCCccCCCCChhhhccc-CceEEccCCccc
Q 002061 487 HLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLK-LSSIDLSENQLS 565 (973)
Q Consensus 487 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~-L~~l~ls~N~l~ 565 (973)
+|++|+|...+...+.++..|++|+||+|+|+ .+|..+.+++.|++|...+|+|. ..| .+..++ |+.+|+|.|+|+
T Consensus 389 hLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~ 465 (1081)
T KOG0618|consen 389 HLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLS 465 (1081)
T ss_pred eecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhh
Confidence 99999999776777899999999999999999 88899999999999999999999 777 677776 999999999997
Q ss_pred cc-cCccc--ccCCCCccccCCCC
Q 002061 566 GS-VPLDF--LRMGGDGAFAGNEG 586 (973)
Q Consensus 566 ~~-~p~~~--~~~~~~~~~~~n~~ 586 (973)
-. +|... .... .-.+.||.+
T Consensus 466 ~~~l~~~~p~p~Lk-yLdlSGN~~ 488 (1081)
T KOG0618|consen 466 EVTLPEALPSPNLK-YLDLSGNTR 488 (1081)
T ss_pred hhhhhhhCCCcccc-eeeccCCcc
Confidence 44 33221 1111 135677775
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=312.61 Aligned_cols=263 Identities=25% Similarity=0.286 Sum_probs=199.5
Q ss_pred HHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeC-----
Q 002061 673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKG----- 743 (973)
Q Consensus 673 ~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~----- 743 (973)
....+|+..+.||+|+||.||+|++..+++.||||++... .....+.+|+.++++++||||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 4467899999999999999999999999999999987542 3345677899999999999999999988643
Q ss_pred -CeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEec
Q 002061 744 -GSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIAD 822 (973)
Q Consensus 744 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 822 (973)
...|+||||++ ++|.+++... ++...+..++.|++.||+||| +.+++||||||+||+++.++.+||+|
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~~-------l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~D 161 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQMD-------LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILD 161 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhhc-------CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEcc
Confidence 35799999995 5888877532 778888999999999999999 78999999999999999999999999
Q ss_pred ccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHH--------
Q 002061 823 FGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYW-------- 894 (973)
Q Consensus 823 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~-------- 894 (973)
||.++....... .....++..|+|||++.+..++.++||||+||++|+|++|+.||...... ......
T Consensus 162 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~ 237 (353)
T cd07850 162 FGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI-DQWNKIIEQLGTPS 237 (353)
T ss_pred CccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhcCCCC
Confidence 999976543221 22245788999999999999999999999999999999999999643210 000000
Q ss_pred ----------HHHHhccccc-----cchhccccc----cCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 895 ----------VSTHLNNHEN-----VLKVLDCEV----ASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 895 ----------~~~~~~~~~~-----~~~~~~~~~----~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
.......... ..+...... ...........+.+++.+|++.||++||++.|++++-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~ 312 (353)
T cd07850 238 DEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHP 312 (353)
T ss_pred HHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcCh
Confidence 0000000000 000000000 0000112345678999999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=331.03 Aligned_cols=272 Identities=24% Similarity=0.286 Sum_probs=211.5
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeec-----cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV 749 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~-----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 749 (973)
.++|++.++||+|+||.|..++++.+++.||+|++.+ ..+..-|..|-.+|..-+.+-|++++..|.++.+.|+|
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV 153 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV 153 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence 3578999999999999999999999999999999977 34556789999999999999999999999999999999
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccc
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 829 (973)
||||+||+|-..+.+. + .+++..+.-++..|.-||.-+| +.|+|||||||+|||++..|++|++|||.+..+
T Consensus 154 MdY~pGGDlltLlSk~----~-~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsClkm 225 (1317)
T KOG0612|consen 154 MDYMPGGDLLTLLSKF----D-RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKM 225 (1317)
T ss_pred EecccCchHHHHHhhc----C-CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHHhc
Confidence 9999999999999865 2 5777777788999999999999 899999999999999999999999999999888
Q ss_pred cCCCCcccccccCCccccccccccc----c-CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccc
Q 002061 830 ENSPKVSDYSCFAGTHGYIAPELAY----T-CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHEN 904 (973)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 904 (973)
...+. ......+|||.|++||+++ + +.|++.+|+||+||++|||+.|..||..+ .++..........+
T Consensus 226 ~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad-----slveTY~KIm~hk~- 298 (1317)
T KOG0612|consen 226 DADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD-----SLVETYGKIMNHKE- 298 (1317)
T ss_pred CCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH-----HHHHHHHHHhchhh-
Confidence 65543 3344578999999999985 3 57999999999999999999999999643 22222222222111
Q ss_pred cchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHh----------hcCCCCCCCCCCCCCCCCC
Q 002061 905 VLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPP---MREVVKML----------ADADPCTDKSPDNSSDKSG 969 (973)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt---~~evl~~L----------~~~~~~~~~~~~~~s~~~~ 969 (973)
...+.+ ..+.++...++|.+.+ -+|+.|.. +.++-.|. ++..++.-|+..+.+|+|.
T Consensus 299 ~l~FP~-------~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevssd~DTsn 368 (1317)
T KOG0612|consen 299 SLSFPD-------ETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSSDDDTSN 368 (1317)
T ss_pred hcCCCc-------ccccCHHHHHHHHHHh-cChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCCCCCcccc
Confidence 111111 1123334455555433 57888877 88887764 3444444455555555543
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=299.16 Aligned_cols=252 Identities=30% Similarity=0.447 Sum_probs=201.1
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc----cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY 752 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 752 (973)
+|+..+.||+|+||.||+|....+++.||+|.+.... ..+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5788899999999999999998889999999987532 456788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCC
Q 002061 753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832 (973)
Q Consensus 753 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 832 (973)
+++++|.+++... ..+++..+..++.|+++|++||| +.+++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~ 152 (264)
T cd06626 81 CSGGTLEELLEHG-----RILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN 152 (264)
T ss_pred CCCCcHHHHHhhc-----CCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence 9999999998752 24678888999999999999999 789999999999999999999999999998766443
Q ss_pred CCccc--ccccCCccccccccccccCC---CCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccch
Q 002061 833 PKVSD--YSCFAGTHGYIAPELAYTCK---VSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLK 907 (973)
Q Consensus 833 ~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
..... .....++..|+|||++.+.. ++.++||||||+++||+++|+.||..... .......+.. ....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~-~~~~~~~~~~--~~~~---- 225 (264)
T cd06626 153 TTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN-EFQIMFHVGA--GHKP---- 225 (264)
T ss_pred CCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc-hHHHHHHHhc--CCCC----
Confidence 22111 11245788999999998766 88999999999999999999999964321 1111111110 0000
Q ss_pred hccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 908 VLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 908 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
... ........+.+++.+|++.+|++||++.|++++
T Consensus 226 ----~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 226 ----PIP--DSLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred ----CCC--cccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000 011224557789999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=305.46 Aligned_cols=266 Identities=21% Similarity=0.209 Sum_probs=197.7
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc----cHHHHHHHHHHHHhcC-CCceeeEEEEEEeCCe-----
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIR-HRNILKLYACLLKGGS----- 745 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~----- 745 (973)
++|++.+.||+|+||.||+|.+..+++.||||+..... ....+.+|+.+++.++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36888999999999999999999999999999876432 2356788999999995 6999999999877665
Q ss_pred eEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecC-CCCeEEeccc
Q 002061 746 SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE-DYEPKIADFG 824 (973)
Q Consensus 746 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg 824 (973)
.|+||||+++ +|.+++..........+++..+..++.||+.||+||| +++++||||+|+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999975 8989887543222346899999999999999999999 789999999999999998 8899999999
Q ss_pred CcccccCCCCcccccccCCcccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccc
Q 002061 825 VAKIAENSPKVSDYSCFAGTHGYIAPELAYT-CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHE 903 (973)
Q Consensus 825 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 903 (973)
.+....... .......+++.|+|||++.+ ..++.++||||||+++|+|++|..||..... .......... .....
T Consensus 157 ~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~-~~~~~~~~~~-~~~~~ 232 (295)
T cd07837 157 LGRAFSIPV--KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE-LQQLLHIFKL-LGTPT 232 (295)
T ss_pred cceecCCCc--cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHHH-hCCCC
Confidence 987553321 11223356788999998865 4578999999999999999999999964311 0011111100 00000
Q ss_pred c-----cchhc----cccccC----cchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 904 N-----VLKVL----DCEVAS----ESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 904 ~-----~~~~~----~~~~~~----~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
. ..... .+.... ........++.+++.+|+++||.+||++.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0 00000 000000 0012234668899999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=300.40 Aligned_cols=247 Identities=24% Similarity=0.285 Sum_probs=202.6
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE 751 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 751 (973)
+|++.+.||.|+||.||+|++..+++.||+|++... ...+.+.+|++++++++||||+++++++.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 478889999999999999999988999999988652 345678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccC
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 831 (973)
|+++++|.+++... ..+++..+..++.|+++|++||| +.+++|+||+|+||++++++.++++|||.+.....
T Consensus 81 ~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 152 (258)
T cd05578 81 LLLGGDLRYHLSQK-----VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP 152 (258)
T ss_pred CCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCC
Confidence 99999999998753 35788899999999999999999 78999999999999999999999999999876544
Q ss_pred CCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccc
Q 002061 832 SPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDC 911 (973)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (973)
.. ......|+..|+|||++.+..++.++|+||+|+++|+|++|+.||...... ..............
T Consensus 153 ~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~-------- 219 (258)
T cd05578 153 DT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQIRAKQETADV-------- 219 (258)
T ss_pred Cc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHHHHHhccccc--------
Confidence 32 122345788999999998888999999999999999999999999764321 11111111111111
Q ss_pred cccCcchHHHHHHHHHHHHHhcCCCCCCCCCH--HHHHH
Q 002061 912 EVASESIKEDMIKLLKIAVVCTTKLPNLRPPM--REVVK 948 (973)
Q Consensus 912 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~--~evl~ 948 (973)
..+......+.+++.+||+.||.+||++ +|+++
T Consensus 220 ----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 220 ----LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred ----cCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 1112234678899999999999999999 77654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=296.80 Aligned_cols=251 Identities=27% Similarity=0.361 Sum_probs=205.7
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc----cHHHHHHHHHHHHhcCCCceeeEEEEEEeC--CeeEEEE
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYACLLKG--GSSFLVL 750 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~lv~ 750 (973)
+|+..+.||+|++|.||+|....+++.|++|++.... ..+.+.+|++++++++||||+++++++... ...++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677889999999999999999889999999886643 367788999999999999999999999888 8899999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccccc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 830 (973)
||+++++|.+++... ..+++..+..++.|+++|++||| +.+++|+||+|+||+++.++.++|+|||.+....
T Consensus 81 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 152 (260)
T cd06606 81 EYVSGGSLSSLLKKF-----GKLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLG 152 (260)
T ss_pred EecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence 999999999999753 26899999999999999999999 7899999999999999999999999999988765
Q ss_pred CCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhcc
Q 002061 831 NSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLD 910 (973)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (973)
............++..|+|||.+.+...+.++||||||+++|+|++|..||.... +......... ...
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~-~~~------- 220 (260)
T cd06606 153 DIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG----NPMAALYKIG-SSG------- 220 (260)
T ss_pred cccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----chHHHHHhcc-ccC-------
Confidence 5432111233567889999999988889999999999999999999999997653 1111111111 000
Q ss_pred ccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 911 CEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 911 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
.....+......+.+++.+|++.+|++||++.|++++
T Consensus 221 --~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 221 --EPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred --CCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 0111122225678899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=298.67 Aligned_cols=249 Identities=27% Similarity=0.358 Sum_probs=204.9
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY 752 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 752 (973)
+|++.+.||+|+||.||+|++..+++.+|+|.+... .....+.+|++++++++||||+++++++..+...|+||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 478889999999999999999988999999988652 3345677899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCC
Q 002061 753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832 (973)
Q Consensus 753 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 832 (973)
+++++|.+++.... .....+++..+..++.|+++|++||| +.+++|+||+|+||+++.++.+|++|||++......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 81 APFGDLSKAISKRK-KKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred cCCCCHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 99999999987642 23456889999999999999999999 889999999999999999999999999999766543
Q ss_pred CCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhcccc
Q 002061 833 PKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCE 912 (973)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (973)
. .....++..|+|||.+.+..++.++|+||+|+++|||++|+.||.... ......... ..
T Consensus 157 ~----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~-----~~~~~~~~~-~~---------- 216 (256)
T cd08530 157 M----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS-----MQDLRYKVQ-RG---------- 216 (256)
T ss_pred C----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHh-cC----------
Confidence 1 122457889999999999889999999999999999999999996542 111111111 00
Q ss_pred ccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 913 VASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 913 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
............+.+++.+|++.+|++||++.|++++
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 217 KYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0011122445668899999999999999999999876
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=301.33 Aligned_cols=264 Identities=21% Similarity=0.299 Sum_probs=199.9
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM 753 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 753 (973)
+|++.+.||.|++|.||+|++..+++.||||++... ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 478899999999999999999988999999988653 23456778999999999999999999999999999999999
Q ss_pred CCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCC
Q 002061 754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833 (973)
Q Consensus 754 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 833 (973)
+ ++|.+++.... ....+++..+..++.|+++|++||| +.+++||||+|+||++++++.++++|||++.......
T Consensus 81 ~-~~l~~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 81 D-KDLKKYMDTHG--VRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred C-ccHHHHHHhcC--CCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 7 58988887542 2345899999999999999999999 7899999999999999999999999999987553321
Q ss_pred CcccccccCCccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHH----------hccc
Q 002061 834 KVSDYSCFAGTHGYIAPELAYTC-KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTH----------LNNH 902 (973)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~----------~~~~ 902 (973)
. ......++..|+|||++.+. .++.++||||+||++|+|++|+.||...... .......... ....
T Consensus 155 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07836 155 N--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE-DQLLKIFRIMGTPTESTWPGISQL 231 (284)
T ss_pred c--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCChhhHHHHhcC
Confidence 1 12224568899999988654 5688999999999999999999999754211 1111110000 0000
Q ss_pred cccchhccc---cccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 903 ENVLKVLDC---EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 903 ~~~~~~~~~---~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
+........ .............+.+++.+|++.||.+||++.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000000000 00000112234567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=301.14 Aligned_cols=258 Identities=25% Similarity=0.365 Sum_probs=207.3
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc-cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY 752 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 752 (973)
....|+..+.||+|++|.||+|.+..++..||+|++.... ..+.+.+|++++++++|+|++++++++..+...|+|+||
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 96 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY 96 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence 4456888899999999999999999889999999987643 366788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCC
Q 002061 753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832 (973)
Q Consensus 753 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 832 (973)
+++++|.+++.... ..+++..+..++.|++.|++||| +.+++|+||+|+||+++.++.++|+|||.+......
T Consensus 97 ~~~~~L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 97 MDGGSLTDIITQNF----VRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred cCCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 99999999998641 36889999999999999999999 789999999999999999999999999988655332
Q ss_pred CCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhcccc
Q 002061 833 PKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCE 912 (973)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (973)
.. ......++..|+|||++.+..++.++|||||||++|+|++|+.||.... ............. ..
T Consensus 170 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~-----~~~~~~~~~~~~~--~~----- 235 (286)
T cd06614 170 KS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREP-----PLRALFLITTKGI--PP----- 235 (286)
T ss_pred hh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhcCC--CC-----
Confidence 11 1223457889999999988889999999999999999999999996431 1111111111000 00
Q ss_pred ccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 002061 913 VASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADAD 954 (973)
Q Consensus 913 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 954 (973)
..........+.+++.+|++.+|.+||++.+++++-.-..
T Consensus 236 --~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 236 --LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred --CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence 0111123456888999999999999999999987544333
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=305.39 Aligned_cols=263 Identities=21% Similarity=0.268 Sum_probs=193.9
Q ss_pred Cccccc--CceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCC
Q 002061 682 NLIGSG--GTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPN 755 (973)
Q Consensus 682 ~~lG~G--~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 755 (973)
..||+| +||+||+|++..+++.||||+.... ...+.+.+|+.+++.++||||+++++++..++..++||||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 9999999999989999999987642 2346688899999999999999999999999999999999999
Q ss_pred CchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCc
Q 002061 756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV 835 (973)
Q Consensus 756 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 835 (973)
|++.+++.... ...+++..+..++.|++.||+||| +.+++||||||+||+++.++.++++||+.+.........
T Consensus 84 ~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~ 157 (328)
T cd08226 84 GSANSLLKTYF---PEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK 157 (328)
T ss_pred CCHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence 99999987642 234788889999999999999999 789999999999999999999999999865433211110
Q ss_pred cc-----ccccCCccccccccccccC--CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHh---------
Q 002061 836 SD-----YSCFAGTHGYIAPELAYTC--KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHL--------- 899 (973)
Q Consensus 836 ~~-----~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~--------- 899 (973)
.. .....++..|+|||++.+. .++.++||||+||++|||++|+.||...... ...........
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 236 (328)
T cd08226 158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT-QMLLQKLKGPPYSPLDITTF 236 (328)
T ss_pred ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH-HHHHHHhcCCCCCCcccccc
Confidence 00 0112345679999998763 4789999999999999999999999754211 00000000000
Q ss_pred -------c-ccccc--------------chhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 900 -------N-NHENV--------------LKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 900 -------~-~~~~~--------------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
. ..... ....+..............+.+++.+|++.||++|||+.|++++-.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~ 310 (328)
T cd08226 237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAF 310 (328)
T ss_pred chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHH
Confidence 0 00000 0000011111223345677899999999999999999999987643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=294.51 Aligned_cols=249 Identities=29% Similarity=0.407 Sum_probs=204.3
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc--cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccC
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD--GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP 754 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 754 (973)
+|+..+.||+|++|.||+|.+..+++.|++|++.... ..+.+.+|++++++++||+++++++++..+...++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4778899999999999999999889999999987654 56788999999999999999999999999999999999999
Q ss_pred CCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCC
Q 002061 755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK 834 (973)
Q Consensus 755 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 834 (973)
+++|.+++... ...+++..+..++.|+++|+++|| ..+++||||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 81 GGSLKDLLKST----NQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred CCcHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence 99999998753 246899999999999999999999 78999999999999999999999999999876654321
Q ss_pred cccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhcccccc
Q 002061 835 VSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVA 914 (973)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (973)
.....++..|+|||++.+..++.++||||+|+++|+|++|+.||.... .......... .. .....
T Consensus 154 ---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~-~~-~~~~~----- 218 (253)
T cd05122 154 ---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELP-----PMKALFKIAT-NG-PPGLR----- 218 (253)
T ss_pred ---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCc-----hHHHHHHHHh-cC-CCCcC-----
Confidence 223467889999999988889999999999999999999999996531 1111111110 00 00000
Q ss_pred CcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 915 SESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 915 ~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
........+.+++.+|++.||++|||+.|++++
T Consensus 219 --~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 219 --NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred --cccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 011124568899999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=299.42 Aligned_cols=244 Identities=27% Similarity=0.323 Sum_probs=194.5
Q ss_pred ccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCCch
Q 002061 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNL 758 (973)
Q Consensus 684 lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL 758 (973)
||+|+||+||+|....+++.||+|.+... .....+.+|++++++++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999988999999988642 2344567899999999999999999999999999999999999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCcccc
Q 002061 759 FQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY 838 (973)
Q Consensus 759 ~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~ 838 (973)
.+++... ....+++..+..++.|++.|+.||| +.+++||||+|+||+++.++.++++|||.+...... ...
T Consensus 81 ~~~l~~~---~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~ 151 (277)
T cd05577 81 KYHIYNV---GEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKI 151 (277)
T ss_pred HHHHHHc---CcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC---Ccc
Confidence 9999754 2245889999999999999999999 789999999999999999999999999998755432 112
Q ss_pred cccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccccCcch
Q 002061 839 SCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESI 918 (973)
Q Consensus 839 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (973)
....++..|+|||++.+..++.++||||+||++|+|++|+.||...... .............. ....
T Consensus 152 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~------------~~~~ 218 (277)
T cd05577 152 KGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK-VEKEELKRRTLEMA------------VEYP 218 (277)
T ss_pred ccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc-ccHHHHHhcccccc------------ccCC
Confidence 2345788999999998888999999999999999999999999654221 11111111000000 0111
Q ss_pred HHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 002061 919 KEDMIKLLKIAVVCTTKLPNLRP-----PMREVVKM 949 (973)
Q Consensus 919 ~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~ 949 (973)
......+.+++.+||+.+|++|| ++.+++++
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 219 DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred ccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 12345678999999999999999 77777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=299.57 Aligned_cols=247 Identities=25% Similarity=0.381 Sum_probs=199.0
Q ss_pred CcccCcccccCceEEEEEEecCCCcEEEEEeeecc--ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCC
Q 002061 678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPN 755 (973)
Q Consensus 678 ~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 755 (973)
|...+.||+|++|.||+|....+++.||+|++... ...+.+.+|+.+++.++|||++++++++..+++.++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44457899999999999999888999999987542 3345678999999999999999999999999999999999999
Q ss_pred CchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCc
Q 002061 756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV 835 (973)
Q Consensus 756 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 835 (973)
++|.+++.. ..+++..+..++.|++.|++||| +++++||||+|+||+++.++.++++|||.+........
T Consensus 101 ~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~- 170 (285)
T cd06648 101 GALTDIVTH------TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP- 170 (285)
T ss_pred CCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-
Confidence 999998864 24788899999999999999999 88999999999999999999999999998765433211
Q ss_pred ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccccC
Q 002061 836 SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVAS 915 (973)
Q Consensus 836 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
......|+..|+|||+..+..++.++||||+||++|||++|+.||... +............. +..
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~-----~~~~~~~~~~~~~~-------~~~-- 235 (285)
T cd06648 171 -RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE-----PPLQAMKRIRDNLP-------PKL-- 235 (285)
T ss_pred -ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCC-----CHHHHHHHHHhcCC-------CCC--
Confidence 122345889999999998888999999999999999999999999643 11122221111110 000
Q ss_pred cchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 916 ESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 916 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
.........+.+++.+||+++|++||++.+++++
T Consensus 236 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 236 KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred cccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 0011233568899999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=295.85 Aligned_cols=245 Identities=25% Similarity=0.321 Sum_probs=192.6
Q ss_pred HcCCcccCcc--cccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEEEE
Q 002061 675 ICNLEEDNLI--GSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLVLE 751 (973)
Q Consensus 675 ~~~~~~~~~l--G~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e 751 (973)
.++|++.+.+ |+|+||.||++..+.+++.+|+|.+....... .|+.....+ +|||++++++++..++..|+|||
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e 89 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMD 89 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEE
Confidence 3466666666 99999999999999999999999876532111 123222222 79999999999999999999999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCC-CeEEecccCccccc
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY-EPKIADFGVAKIAE 830 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfgl~~~~~ 830 (973)
|+++|+|.+++... ..+++..+..++.|+++|++|+| +.+++||||||+||+++.++ .++++|||.+....
T Consensus 90 ~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 161 (267)
T PHA03390 90 YIKDGDLFDLLKKE-----GKLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161 (267)
T ss_pred cCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence 99999999999753 26899999999999999999999 78999999999999999988 99999999987554
Q ss_pred CCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhcc
Q 002061 831 NSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLD 910 (973)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (973)
.. ....++..|+|||++.+..++.++||||+|+++|||++|+.||........+...+.... ....
T Consensus 162 ~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~------- 227 (267)
T PHA03390 162 TP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKL------- 227 (267)
T ss_pred CC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccC-------
Confidence 22 123578999999999988999999999999999999999999975432222222222211 1100
Q ss_pred ccccCcchHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHH
Q 002061 911 CEVASESIKEDMIKLLKIAVVCTTKLPNLRPP-MREVVKM 949 (973)
Q Consensus 911 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt-~~evl~~ 949 (973)
.........+.+++.+|++.+|.+||+ ++|++++
T Consensus 228 -----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 228 -----PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred -----CcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 111234556889999999999999996 6998864
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=300.16 Aligned_cols=258 Identities=23% Similarity=0.263 Sum_probs=194.6
Q ss_pred CcccCcccccCceEEEEEEecCCCcEEEEEeeecc---ccHHHHHHHHHHHHhcC-CCceeeEEEEEEeC--CeeEEEEE
Q 002061 678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIR-HRNILKLYACLLKG--GSSFLVLE 751 (973)
Q Consensus 678 ~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~--~~~~lv~e 751 (973)
|++.+.||+|+||.||+|....+++.||+|++... .......+|+.+++++. |||++++++++.++ +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 56788999999999999999988999999988652 22233457888898885 99999999999887 88999999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccC
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 831 (973)
|++ |++.+++... ...+++..+..++.|++.||+||| +.+++||||+|+||+++. +.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 81 LMD-MNLYELIKGR----KRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYS 151 (282)
T ss_pred cCC-ccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence 996 5888887643 245899999999999999999999 789999999999999999 9999999999976543
Q ss_pred CCCcccccccCCccccccccccc-cCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccc------
Q 002061 832 SPKVSDYSCFAGTHGYIAPELAY-TCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHEN------ 904 (973)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~------ 904 (973)
... .....++..|+|||++. +..++.++||||+||++|||++|+.||.... ..+..............
T Consensus 152 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 226 (282)
T cd07831 152 KPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN--ELDQIAKIHDVLGTPDAEVLKKF 226 (282)
T ss_pred CCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC--HHHHHHHHHHHcCCCCHHHHHhh
Confidence 321 12245788999999764 4557889999999999999999999996532 11111111111110000
Q ss_pred ----cchhcccccc----CcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 905 ----VLKVLDCEVA----SESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 905 ----~~~~~~~~~~----~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
......+... ..........+.+++.+|++++|++||++.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 227 RKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0000000000 00112345778999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=299.90 Aligned_cols=242 Identities=24% Similarity=0.266 Sum_probs=188.8
Q ss_pred cccccCceEEEEEEecCCCcEEEEEeeeccc-----cHHHHHHHHHHHHh---cCCCceeeEEEEEEeCCeeEEEEEccC
Q 002061 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----GVKVFAAEMEILGK---IRHRNILKLYACLLKGGSSFLVLEYMP 754 (973)
Q Consensus 683 ~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~---l~hpniv~l~~~~~~~~~~~lv~e~~~ 754 (973)
.||+|+||.||+|....+++.||+|.+.... ....+.+|..+++. .+||+|+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999999889999999886521 12234445444443 479999999999999999999999999
Q ss_pred CCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCC
Q 002061 755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK 834 (973)
Q Consensus 755 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 834 (973)
+|+|.+++... ..+++..+..++.|++.|++||| +.+++||||||+||+++.++.++++|||++.......
T Consensus 81 ~~~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~- 151 (279)
T cd05633 81 GGDLHYHLSQH-----GVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 151 (279)
T ss_pred CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-
Confidence 99999988753 35899999999999999999999 7899999999999999999999999999987553321
Q ss_pred cccccccCCccccccccccc-cCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccc
Q 002061 835 VSDYSCFAGTHGYIAPELAY-TCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEV 913 (973)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (973)
.....|+..|+|||.+. +..++.++||||+||++|||++|+.||...... .............
T Consensus 152 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~----------- 215 (279)
T cd05633 152 ---PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--DKHEIDRMTLTVN----------- 215 (279)
T ss_pred ---ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCc--CHHHHHHHhhcCC-----------
Confidence 12245899999999986 456889999999999999999999999754221 1111111110000
Q ss_pred cCcchHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHh
Q 002061 914 ASESIKEDMIKLLKIAVVCTTKLPNLRP-----PMREVVKML 950 (973)
Q Consensus 914 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~L 950 (973)
...+.....++.+++.+|++.||.+|| +++|+++|.
T Consensus 216 -~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~ 256 (279)
T cd05633 216 -VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV 256 (279)
T ss_pred -cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence 111222345688899999999999999 699999973
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=304.83 Aligned_cols=268 Identities=25% Similarity=0.272 Sum_probs=200.5
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc----cHHHHHHHHHHHHhcCCCceeeEEEEEEeC--CeeE
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYACLLKG--GSSF 747 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~ 747 (973)
...+|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+|+.++++++|||++++++++... +..+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 3568999999999999999999999999999999886432 123456899999999999999999998754 5689
Q ss_pred EEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcc
Q 002061 748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827 (973)
Q Consensus 748 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~ 827 (973)
+||||++ ++|.+++... ...+++..+..++.|++.|++||| +.+++||||||+||+++.++.+||+|||.+.
T Consensus 85 lv~e~~~-~~l~~~l~~~----~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~ 156 (309)
T cd07845 85 LVMEYCE-QDLASLLDNM----PTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLAR 156 (309)
T ss_pred EEEecCC-CCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceee
Confidence 9999996 5888888653 245889999999999999999999 7899999999999999999999999999998
Q ss_pred cccCCCCcccccccCCcccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccc-c
Q 002061 828 IAENSPKVSDYSCFAGTHGYIAPELAYT-CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHEN-V 905 (973)
Q Consensus 828 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~-~ 905 (973)
....... ......++..|+|||++.+ ..++.++||||+||++|||++|+.||.... .......+......... .
T Consensus 157 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~--~~~~~~~~~~~~~~~~~~~ 232 (309)
T cd07845 157 TYGLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS--EIEQLDLIIQLLGTPNESI 232 (309)
T ss_pred ecCCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHhcCCCChhh
Confidence 6654321 1222345788999999865 457899999999999999999999996431 11111111111100000 0
Q ss_pred ----------chhc--ccccc--CcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 906 ----------LKVL--DCEVA--SESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 906 ----------~~~~--~~~~~--~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
.... ..... ........+.+.+++.+|+++||++|||+.|++++-.=.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~ 294 (309)
T cd07845 233 WPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK 294 (309)
T ss_pred chhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence 0000 00000 000111355678899999999999999999999875543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=297.72 Aligned_cols=242 Identities=28% Similarity=0.373 Sum_probs=196.8
Q ss_pred ccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCCch
Q 002061 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNL 758 (973)
Q Consensus 684 lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL 758 (973)
||.|+||.||+|++..+++.||+|++... ...+.+.+|++++++++||||+++++++.++...|+||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999988999999988652 2346688999999999999999999999999999999999999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCcccc
Q 002061 759 FQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY 838 (973)
Q Consensus 759 ~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~ 838 (973)
.+++.+. ..+++..+..++.|++.|++|+| +.+++|+||+|+||+++.++.++++|||.+....... ..
T Consensus 81 ~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~ 149 (262)
T cd05572 81 WTILRDR-----GLFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KT 149 (262)
T ss_pred HHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cc
Confidence 9999753 24788899999999999999999 7899999999999999999999999999987664432 12
Q ss_pred cccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccccCcch
Q 002061 839 SCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESI 918 (973)
Q Consensus 839 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (973)
....++..|+|||.+.+..++.++|+||+|+++|+|++|+.||..... +............. ....+
T Consensus 150 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~----------~~~~~ 216 (262)
T cd05572 150 WTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE---DPMEIYNDILKGNG----------KLEFP 216 (262)
T ss_pred ccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC---CHHHHHHHHhccCC----------CCCCC
Confidence 224678899999999888899999999999999999999999976532 11222222111000 00111
Q ss_pred HHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 002061 919 KEDMIKLLKIAVVCTTKLPNLRPP-----MREVVKM 949 (973)
Q Consensus 919 ~~~~~~l~~l~~~cl~~dP~~Rpt-----~~evl~~ 949 (973)
......+.+++.+||+.+|++||+ +.|++++
T Consensus 217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH 252 (262)
T ss_pred cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence 122456889999999999999999 7887764
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=310.31 Aligned_cols=267 Identities=22% Similarity=0.319 Sum_probs=199.0
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeec---cccHHHHHHHHHHHHhcCCCceeeEEEEEEeC-----CeeE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK---GDGVKVFAAEMEILGKIRHRNILKLYACLLKG-----GSSF 747 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~~ 747 (973)
++|++.+.||+|+||.||+|++..+++.||||++.. ......+.+|+.++++++||||+++++++... ...|
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 84 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY 84 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence 578999999999999999999999999999998864 23345678899999999999999999887543 3579
Q ss_pred EEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcc
Q 002061 748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827 (973)
Q Consensus 748 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~ 827 (973)
+|+||++ +++.+++.. ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.++|+|||++.
T Consensus 85 lv~e~~~-~~l~~~~~~------~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 85 IVQELME-TDLYKLIKT------QHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEehhcc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECccccee
Confidence 9999996 588777753 25888999999999999999999 8899999999999999999999999999987
Q ss_pred cccCCCCc-ccccccCCcccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccc--c
Q 002061 828 IAENSPKV-SDYSCFAGTHGYIAPELAYT-CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNH--E 903 (973)
Q Consensus 828 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~--~ 903 (973)
........ .......|+..|+|||++.+ ..++.++||||+||++|+|++|+.||.... ............... +
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~--~~~~~~~~~~~~~~~~~~ 232 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKD--YLHQLNLILGVLGTPSQE 232 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHcCCCCHH
Confidence 65432211 11223467899999998754 568899999999999999999999996431 111111110000000 0
Q ss_pred ccchhcc-----------cccc-C--cchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--hhcCC
Q 002061 904 NVLKVLD-----------CEVA-S--ESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM--LADAD 954 (973)
Q Consensus 904 ~~~~~~~-----------~~~~-~--~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~--L~~~~ 954 (973)
....+.+ .... . ........++.+++.+||+.||++|||+.|++++ ++...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 0000000 0000 0 0011234568899999999999999999999998 55543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=299.95 Aligned_cols=246 Identities=24% Similarity=0.336 Sum_probs=202.7
Q ss_pred ccCcccccCceEEEEEEecCCCcEEEEEeeec----cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCC
Q 002061 680 EDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPN 755 (973)
Q Consensus 680 ~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 755 (973)
..++||.|.||+||-|+++++|+.||||++.+ .+...+..+|+.+|+.++||.||.+...|+..+.+++|||.+ +
T Consensus 568 ~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~ 646 (888)
T KOG4236|consen 568 ADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-H 646 (888)
T ss_pred hHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-c
Confidence 35789999999999999999999999999876 345677899999999999999999999999999999999999 6
Q ss_pred CchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCC---CCeEEecccCcccccCC
Q 002061 756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDED---YEPKIADFGVAKIAENS 832 (973)
Q Consensus 756 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~---~~~kl~Dfgl~~~~~~~ 832 (973)
|+..+.+-.. +...+++....-++.||+.||.||| -++|+|+|+||+|||+... .++||||||.|+..+..
T Consensus 647 GDMLEMILSs---EkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk 720 (888)
T KOG4236|consen 647 GDMLEMILSS---EKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK 720 (888)
T ss_pred chHHHHHHHh---hcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence 6777766543 4556888777888999999999999 7899999999999999754 37999999999988765
Q ss_pred CCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhcccc
Q 002061 833 PKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCE 912 (973)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (973)
.. ....+||+.|+|||+++.+.|...-||||.||++|.-++|..||.++ +++.. .+++.. ++
T Consensus 721 sF---RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd----EdInd----QIQNAa----FM--- 782 (888)
T KOG4236|consen 721 SF---RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED----EDIND----QIQNAA----FM--- 782 (888)
T ss_pred hh---hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc----cchhH----Hhhccc----cc---
Confidence 33 33478999999999999999999999999999999999999999754 22222 222222 11
Q ss_pred ccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 913 VASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 913 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
+....+.+......++|...++..-.+|-+....+.|.
T Consensus 783 yPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~ 820 (888)
T KOG4236|consen 783 YPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHP 820 (888)
T ss_pred cCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccch
Confidence 22344566666778888888888888998888776543
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=301.08 Aligned_cols=264 Identities=21% Similarity=0.242 Sum_probs=196.6
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE 751 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 751 (973)
++|++.+.||+|++|+||+|++..+++.||+|++... ...+.+.+|++++++++||||+++++++..+...|+|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 5788999999999999999999988999999987542 233567889999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecC-CCCeEEecccCccccc
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE-DYEPKIADFGVAKIAE 830 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfgl~~~~~ 830 (973)
|++ ++|.+++... .....++..+..++.|++.||+||| +++++||||+|+||+++. ++.+|++|||++....
T Consensus 82 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 82 YLD-LDLKKHMDSS---PDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred ccc-ccHHHHHHhC---CCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 995 5888877543 2233577888899999999999999 789999999999999985 5679999999997554
Q ss_pred CCCCcccccccCCccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccccc----
Q 002061 831 NSPKVSDYSCFAGTHGYIAPELAYTC-KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENV---- 905 (973)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~---- 905 (973)
... .......+++.|+|||++.+. .++.++||||+||++|+|++|+.||...... .................
T Consensus 155 ~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 231 (294)
T PLN00009 155 IPV--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI-DELFKIFRILGTPNEETWPGV 231 (294)
T ss_pred CCc--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChhhcccc
Confidence 321 112234578899999988664 5789999999999999999999999653211 11111111000000000
Q ss_pred ---chh--ccccccC----cchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 906 ---LKV--LDCEVAS----ESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 906 ---~~~--~~~~~~~----~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
... ..+.... ........++.+++.+|++.+|++||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0000000 0111234567889999999999999999999875
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=324.80 Aligned_cols=274 Identities=21% Similarity=0.274 Sum_probs=191.6
Q ss_pred HHHHcCCcccCcccccCceEEEEEEecCCCc-EEEEE------------------eeec-cccHHHHHHHHHHHHhcCCC
Q 002061 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAG-TVAVK------------------QLWK-GDGVKVFAAEMEILGKIRHR 731 (973)
Q Consensus 672 ~~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~-~vavK------------------~~~~-~~~~~~~~~E~~~l~~l~hp 731 (973)
.....+|++.+.||+|+||+||++..+.... .+++| .... ......+.+|++++++++||
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence 4556789999999999999999987653221 12211 1111 12345678999999999999
Q ss_pred ceeeEEEEEEeCCeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCee
Q 002061 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNIL 811 (973)
Q Consensus 732 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nil 811 (973)
||+++++++..++..|+|+|++ ++++.+++..................++.|++.||+||| +++||||||||+|||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NIL 299 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIF 299 (501)
T ss_pred CcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEE
Confidence 9999999999999999999999 567888776432222223345667789999999999999 889999999999999
Q ss_pred ecCCCCeEEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCC-CCcccCC-cc
Q 002061 812 LDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKP-VEEEYGD-GK 889 (973)
Q Consensus 812 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p-f~~~~~~-~~ 889 (973)
++.++.+||+|||+++......... .....||..|+|||++.+..++.++|||||||++|||++|..+ |...... ..
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~ 378 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKEREAF-DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378 (501)
T ss_pred ECCCCCEEEEeCCCceecCcccccc-cccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence 9999999999999998665432211 2235689999999999999999999999999999999998754 4322111 11
Q ss_pred cHHHHHHHHhccccc-------cchhccccc---cCcchH------HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 890 DIVYWVSTHLNNHEN-------VLKVLDCEV---ASESIK------EDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 890 ~~~~~~~~~~~~~~~-------~~~~~~~~~---~~~~~~------~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
.+...+......... +...++... ...... .....+.+++.+|+++||.+||++.|++++-
T Consensus 379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp 455 (501)
T PHA03210 379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALP 455 (501)
T ss_pred HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhCh
Confidence 111111110000000 000000000 000000 1123466788899999999999999999863
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=302.51 Aligned_cols=262 Identities=23% Similarity=0.268 Sum_probs=197.7
Q ss_pred CcccCcccccCceEEEEEEecCCCcEEEEEeeeccc----cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 002061 678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM 753 (973)
Q Consensus 678 ~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 753 (973)
|++.+.||.|++|+||+|.+..+|..||+|++.... ..+.+.+|++++++++|||++++++++.+++..|+||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567889999999999999999889999999886532 2356788999999999999999999999999999999999
Q ss_pred CCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCC
Q 002061 754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833 (973)
Q Consensus 754 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 833 (973)
+ ++|.+++... ....+++..+..++.|+++||+||| +++++||||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~-~~l~~~~~~~---~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~ 153 (283)
T cd07835 81 D-LDLKKYMDSS---PLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV 153 (283)
T ss_pred C-cCHHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence 4 6899988753 2245899999999999999999999 7899999999999999999999999999987553321
Q ss_pred CcccccccCCccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccc----------
Q 002061 834 KVSDYSCFAGTHGYIAPELAYTC-KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNH---------- 902 (973)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~---------- 902 (973)
. ......++..|+|||++.+. .++.++||||+|+++|+|++|+.||...... ..............
T Consensus 154 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07835 154 R--TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI-DQLFRIFRTLGTPDEDVWPGVTSL 230 (283)
T ss_pred c--ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChHHhhhhhhc
Confidence 1 12223568899999987654 5788999999999999999999999653111 01111111000000
Q ss_pred cccch-hcc--ccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 903 ENVLK-VLD--CEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 903 ~~~~~-~~~--~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
+.... ... ..............+.+++.+|++.||++||++.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000 000 000000111223568899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=306.57 Aligned_cols=265 Identities=24% Similarity=0.328 Sum_probs=198.8
Q ss_pred HHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeec----cccHHHHHHHHHHHHhc-CCCceeeEEEEEEeC--Ce
Q 002061 673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKI-RHRNILKLYACLLKG--GS 745 (973)
Q Consensus 673 ~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~----~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~--~~ 745 (973)
....+|++.+.||+|+||.||+|.+..+++.||||++.. ......+.+|+.+++++ +||||+++++++... ..
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 445788999999999999999999998899999998754 23345577899999999 999999999988653 46
Q ss_pred eEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccC
Q 002061 746 SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGV 825 (973)
Q Consensus 746 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl 825 (973)
.|+||||++ ++|..++... .+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~ 153 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRAN------ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGL 153 (337)
T ss_pred EEEEecccc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccc
Confidence 899999996 5998887642 5788888999999999999999 78999999999999999999999999999
Q ss_pred cccccCCCCc---ccccccCCcccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcc
Q 002061 826 AKIAENSPKV---SDYSCFAGTHGYIAPELAYT-CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNN 901 (973)
Q Consensus 826 ~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 901 (973)
+......... .......|+..|+|||++.+ ..++.++||||||+++|+|++|+.||..... .+....+......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~--~~~~~~~~~~~~~ 231 (337)
T cd07852 154 ARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTST--LNQLEKIIEVIGP 231 (337)
T ss_pred hhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCC
Confidence 9766433221 12233468899999998754 4578899999999999999999999964321 1111110000000
Q ss_pred c----------cccchhcc----ccc--cCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 902 H----------ENVLKVLD----CEV--ASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 902 ~----------~~~~~~~~----~~~--~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
. .....+++ ... ...........+.+++.+||+.||++||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 232 PSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred CCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0 00000000 000 000111234578899999999999999999999987
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=301.62 Aligned_cols=266 Identities=22% Similarity=0.275 Sum_probs=195.9
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc----cHHHHHHHHHHHHhcCCCceeeEEEEEEeCC-----
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYACLLKGG----- 744 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----- 744 (973)
..++|++.+.||+|+||.||+|+...+++.||||++.... ....+.+|++++++++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 4568999999999999999999999999999999876422 2334568999999999999999999886543
Q ss_pred ---eeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEe
Q 002061 745 ---SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIA 821 (973)
Q Consensus 745 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 821 (973)
..++||||++ +++.+++... ...+++..+..++.|++.|++||| +++++|+||||+||+++.++.+||+
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~ 161 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSNK----NVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLA 161 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEEC
Confidence 4599999995 5888877642 235889999999999999999999 7899999999999999999999999
Q ss_pred cccCcccccCCCCc--ccccccCCccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHH
Q 002061 822 DFGVAKIAENSPKV--SDYSCFAGTHGYIAPELAYTC-KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTH 898 (973)
Q Consensus 822 Dfgl~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~ 898 (973)
|||++......... .......++..|+|||++.+. .++.++||||+|+++|||++|+.||..... ......+...
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~--~~~~~~~~~~ 239 (310)
T cd07865 162 DFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE--QHQLTLISQL 239 (310)
T ss_pred cCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHH
Confidence 99999765432211 112234578899999987654 478899999999999999999999965321 1111111111
Q ss_pred hccccc-c-c-----hhcc----ccccCcchH------HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 899 LNNHEN-V-L-----KVLD----CEVASESIK------EDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 899 ~~~~~~-~-~-----~~~~----~~~~~~~~~------~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
....+. . . ...+ +........ .....+.+++.+|++.||++|||++|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 240 CGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 100000 0 0 0000 000000000 012456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=294.59 Aligned_cols=250 Identities=24% Similarity=0.320 Sum_probs=197.9
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-------ccHHHHHHHHHHHHhcCCCceeeEEEEEEeC--Cee
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-------DGVKVFAAEMEILGKIRHRNILKLYACLLKG--GSS 746 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~ 746 (973)
.+|++.+.||+|+||.||+|++..++..||+|.+... .....+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 3688899999999999999999999999999987431 2345688899999999999999999998664 468
Q ss_pred EEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCc
Q 002061 747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826 (973)
Q Consensus 747 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~ 826 (973)
++||||+++++|.+++... ..+++.....++.|++.|++||| +.+++|+||||+||+++.++.++|+|||++
T Consensus 82 ~~v~e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~ 153 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY-----GALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGAS 153 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccc
Confidence 8999999999999998743 24678888999999999999999 789999999999999999999999999999
Q ss_pred ccccCCCC-cccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccccc
Q 002061 827 KIAENSPK-VSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENV 905 (973)
Q Consensus 827 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 905 (973)
+....... ........++..|+|||++.+..++.++|||||||++||+++|+.||.... .. ..+.......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~-~~~~~~~~~~--- 225 (264)
T cd06653 154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE----AM-AAIFKIATQP--- 225 (264)
T ss_pred cccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC----HH-HHHHHHHcCC---
Confidence 76532211 111223458899999999988889999999999999999999999996531 11 1111111100
Q ss_pred chhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 906 LKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
.....+....+.+.+++.+|++ +|.+||++.+++.|
T Consensus 226 -------~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 226 -------TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred -------CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 0111223344568889999999 57999999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=292.54 Aligned_cols=251 Identities=28% Similarity=0.381 Sum_probs=205.9
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY 752 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 752 (973)
+|++.+.||+|+||.||+|.+..++..||+|++... ...+.+.+|+++++.++|||++++++.+..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 478889999999999999999988999999998653 3456688999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCC
Q 002061 753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832 (973)
Q Consensus 753 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 832 (973)
+++++|.+++.... .....+++..+..++.+++.|++||| +.+++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 81 ADGGDLSQKIKKQK-KEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred cCCCcHHHHHHHhh-ccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 99999999998642 12356899999999999999999999 789999999999999999999999999998766443
Q ss_pred CCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhcccc
Q 002061 833 PKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCE 912 (973)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (973)
.. ......|++.|+|||...+..++.++||||+|+++|+|++|+.||.... ............. .
T Consensus 157 ~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~~~~~~~~~~~~~-------~- 221 (258)
T cd08215 157 VD--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-----LLELALKILKGQY-------P- 221 (258)
T ss_pred cc--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-----HHHHHHHHhcCCC-------C-
Confidence 21 1223467889999999988889999999999999999999999996431 2222222111110 0
Q ss_pred ccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 913 VASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 913 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
..+......+.+++.+|+..+|++||++.|++++
T Consensus 222 ---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 222 ---PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0111234567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=277.03 Aligned_cols=258 Identities=23% Similarity=0.279 Sum_probs=204.8
Q ss_pred cCCccc-CcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhc-CCCceeeEEEEEEe----CCeeEEE
Q 002061 676 CNLEED-NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKI-RHRNILKLYACLLK----GGSSFLV 749 (973)
Q Consensus 676 ~~~~~~-~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~----~~~~~lv 749 (973)
++|.+. ++||-|-.|.|-.+.++.+++.+|+|++.. .+...+|++..=.. .|||||.++++|+. .....+|
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D---s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiV 137 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD---SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIV 137 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhc---CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEee
Confidence 344442 679999999999999999999999999854 33456888875444 69999999999864 4567899
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecC---CCCeEEecccCc
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE---DYEPKIADFGVA 826 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~Dfgl~ 826 (973)
||.|+||.|++.++++ +...+.+.++..|+.||+.|+.||| +.+|.||||||+|+|.+. +..+|++|||+|
T Consensus 138 mE~meGGeLfsriq~~---g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 138 MECMEGGELFSRIQDR---GDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred eecccchHHHHHHHHc---ccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEecccccc
Confidence 9999999999999875 5667899999999999999999999 899999999999999975 557999999999
Q ss_pred ccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccc
Q 002061 827 KIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVL 906 (973)
Q Consensus 827 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 906 (973)
+..... ......+-|+.|.|||++...+|+...|+||+||++|-|++|.+||....+..-+.. .+.++....
T Consensus 212 K~t~~~---~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispg--Mk~rI~~gq--- 283 (400)
T KOG0604|consen 212 KETQEP---GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG--MKRRIRTGQ--- 283 (400)
T ss_pred cccCCC---ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChh--HHhHhhccC---
Confidence 865432 233345679999999999999999999999999999999999999976544222111 111111111
Q ss_pred hhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 002061 907 KVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADAD 954 (973)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 954 (973)
-.+..+.+....+...++++..+..+|.+|.|+.|++.+-.-.+
T Consensus 284 ----y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~ 327 (400)
T KOG0604|consen 284 ----YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQ 327 (400)
T ss_pred ----ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcc
Confidence 12234456677788889999999999999999999998866443
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=302.43 Aligned_cols=252 Identities=27% Similarity=0.333 Sum_probs=206.4
Q ss_pred HHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 002061 673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL 748 (973)
Q Consensus 673 ~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 748 (973)
..+..|.+.+.||+|.|++|.+|++..++..||||.+.+. ...+.+.+|+++++.++|||||+++.+.+.+..+|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 4456789999999999999999999999999999998773 233457899999999999999999999999999999
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccc
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 828 (973)
||||+.+|.+++|+..+. .........++.|+.+|++|+| ++.|||||||++||+++.+..+||+|||++..
T Consensus 133 V~eya~~ge~~~yl~~~g-----r~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~ 204 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHG-----RMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTF 204 (596)
T ss_pred EEEeccCchhHHHHHhcc-----cchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeecccccee
Confidence 999999999999998752 2344677789999999999999 88999999999999999999999999999998
Q ss_pred ccCCCCcccccccCCccccccccccccCCCC-ccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccch
Q 002061 829 AENSPKVSDYSCFAGTHGYIAPELAYTCKVS-EKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLK 907 (973)
Q Consensus 829 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
+..... ...++|++.|.|||++.+.+|. +.+|+||+|+++|.++.|..||++..- .... .+
T Consensus 205 ~~~~~~---lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l-----k~Lr----------~r 266 (596)
T KOG0586|consen 205 FDYGLM---LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL-----KELR----------PR 266 (596)
T ss_pred eccccc---ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc-----cccc----------ch
Confidence 865433 3346799999999999988875 789999999999999999999975311 0000 01
Q ss_pred hccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 002061 908 VLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952 (973)
Q Consensus 908 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~ 952 (973)
.+-..+. .+.-...++.+++++++-.+|.+|++.+++.++-+.
T Consensus 267 vl~gk~r--Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~ 309 (596)
T KOG0586|consen 267 VLRGKYR--IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWR 309 (596)
T ss_pred heeeeec--ccceeechhHHHHHHhhccCccccCCHHHhhhhccc
Confidence 1111110 011223456788889999999999999999887654
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=298.25 Aligned_cols=258 Identities=21% Similarity=0.207 Sum_probs=185.7
Q ss_pred cCCcccCcccccCceEEEEEEecCC---CcEEEEEeeeccccH-------------HHHHHHHHHHHhcCCCceeeEEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKN---AGTVAVKQLWKGDGV-------------KVFAAEMEILGKIRHRNILKLYAC 739 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~---~~~vavK~~~~~~~~-------------~~~~~E~~~l~~l~hpniv~l~~~ 739 (973)
.+|++.+.||+|+||+||+|++..+ +..+|+|+....... .....+...+..++|+++++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 5799999999999999999999876 567777754322110 011223344556789999999997
Q ss_pred EEeCC----eeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCC
Q 002061 740 LLKGG----SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDED 815 (973)
Q Consensus 740 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~ 815 (973)
+.... ..++++|++. .++.+.+... ...++..+..++.|++.|++||| +.+++||||||+||+++.+
T Consensus 92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRI-----KCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGN 162 (294)
T ss_pred eeEecCCceEEEEEEehhc-cCHHHHHHhh-----ccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCC
Confidence 65543 4478888873 4666665532 12467778899999999999999 7899999999999999999
Q ss_pred CCeEEecccCcccccCCCCc-----ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCccc
Q 002061 816 YEPKIADFGVAKIAENSPKV-----SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKD 890 (973)
Q Consensus 816 ~~~kl~Dfgl~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~ 890 (973)
+.++|+|||+++........ .......||+.|+|||++.+..++.++||||+||++|||++|+.||.........
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~ 242 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL 242 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence 99999999999866432211 1112246899999999999999999999999999999999999999765222221
Q ss_pred HHHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 891 IVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 891 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
........... +..... ......+.+.+++..|++.+|++||++.++.+.++
T Consensus 243 ~~~~~~~~~~~------~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 243 IHAAKCDFIKR------LHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHhHHHHHHH------hhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 11111111000 000100 01122456889999999999999999999998763
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=284.24 Aligned_cols=255 Identities=25% Similarity=0.342 Sum_probs=196.7
Q ss_pred cccCcccccCceEEEEEEecCCCcEEEEEeeecc---ccHHHHHHHHHHHHh-cCCCceeeEEEEEEeCCeeEEEEEccC
Q 002061 679 EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGK-IRHRNILKLYACLLKGGSSFLVLEYMP 754 (973)
Q Consensus 679 ~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~-l~hpniv~l~~~~~~~~~~~lv~e~~~ 754 (973)
+-...||.|+||+|+|-.++..|+..|||++... .+.+++..|.+...+ -+.||||+++|....++..|+.||.|
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM- 145 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM- 145 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-
Confidence 4456799999999999999999999999999763 456678888886544 47999999999999999999999999
Q ss_pred CCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCC
Q 002061 755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK 834 (973)
Q Consensus 755 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 834 (973)
..|+..+-..-..-....+++.-.-+|......||.||-+ ...|||||+||+|||++..|.+|+||||.+......
T Consensus 146 d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S-- 221 (361)
T KOG1006|consen 146 DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS-- 221 (361)
T ss_pred hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHH--
Confidence 5677665543323344568888888888889999999987 578999999999999999999999999998765433
Q ss_pred cccccccCCccccccccccc--cCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhcccc
Q 002061 835 VSDYSCFAGTHGYIAPELAY--TCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCE 912 (973)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (973)
...+.-.|-..|||||.+. +..|+-++||||||++|||+.||..||..... ....+.......++. +..
T Consensus 222 -iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s----vfeql~~Vv~gdpp~---l~~- 292 (361)
T KOG1006|consen 222 -IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS----VFEQLCQVVIGDPPI---LLF- 292 (361)
T ss_pred -HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH----HHHHHHHHHcCCCCe---ecC-
Confidence 2333456788899999985 44589999999999999999999999976422 222222222222111 111
Q ss_pred ccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 913 VASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 913 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
.....+....+..++..|+.+|-..||...++.++
T Consensus 293 --~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 293 --DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred --cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 11123456678899999999999999999998764
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=298.60 Aligned_cols=244 Identities=25% Similarity=0.378 Sum_probs=195.9
Q ss_pred cCcccccCceEEEEEEecCCCcEEEEEeeec--cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCCch
Q 002061 681 DNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK--GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNL 758 (973)
Q Consensus 681 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL 758 (973)
...||+|+||.||+|....+++.||||++.. ......+.+|+.+++.++|||++++++++..++..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 4679999999999999998899999998754 23445688899999999999999999999999999999999999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCcccc
Q 002061 759 FQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY 838 (973)
Q Consensus 759 ~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~ 838 (973)
.+++... .+++..+..++.|++.|++||| +.+++||||+|+||+++.++.++++|||.+....... ...
T Consensus 105 ~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~ 173 (292)
T cd06657 105 TDIVTHT------RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRR 173 (292)
T ss_pred HHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceeccccc--ccc
Confidence 9887532 4688899999999999999999 7899999999999999999999999999886554322 122
Q ss_pred cccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccccCcch
Q 002061 839 SCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESI 918 (973)
Q Consensus 839 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (973)
....|+..|+|||++.+..++.++||||+|+++|+|++|+.||.... .......+.... + ... ...
T Consensus 174 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~--~~~~~~~~~~~~---~-------~~~--~~~ 239 (292)
T cd06657 174 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKMIRDNL---P-------PKL--KNL 239 (292)
T ss_pred cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhhC---C-------ccc--CCc
Confidence 33457899999999988888999999999999999999999996431 111111111111 0 000 001
Q ss_pred HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 919 KEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 919 ~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
......+.+++.+|++.+|.+||++.+++++
T Consensus 240 ~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 240 HKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred ccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 1223457788999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=300.09 Aligned_cols=267 Identities=25% Similarity=0.273 Sum_probs=199.6
Q ss_pred HHHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCC---
Q 002061 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGG--- 744 (973)
Q Consensus 672 ~~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--- 744 (973)
....++|++.+.||+|+||.||+|.+..+++.||||++... .....+.+|++++++++|||++++++++.+..
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 45677899999999999999999999988999999998653 23345678999999999999999999887654
Q ss_pred -------eeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCC
Q 002061 745 -------SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE 817 (973)
Q Consensus 745 -------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~ 817 (973)
..++|+||+++ ++.+++... ...+++..+..++.|++.||+||| +.+++||||+|+||++++++.
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~ 154 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESG----LVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQ 154 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCc
Confidence 78999999975 777776542 335899999999999999999999 789999999999999999999
Q ss_pred eEEecccCcccccCCCCcccccccCCcccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHH
Q 002061 818 PKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYT-CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVS 896 (973)
Q Consensus 818 ~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~ 896 (973)
+||+|||.+........ .......++..|+|||.+.+ ..++.++||||+||++|||++|+.||.... .......+.
T Consensus 155 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~--~~~~~~~~~ 231 (302)
T cd07864 155 IKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ--ELAQLELIS 231 (302)
T ss_pred EEeCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHH
Confidence 99999999876643321 11222345778999998764 357889999999999999999999996431 111111111
Q ss_pred HHhccccc--cchhc--------cccc-----cCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 897 THLNNHEN--VLKVL--------DCEV-----ASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 897 ~~~~~~~~--~~~~~--------~~~~-----~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
........ ...+. +... ...........+.+++.+|++.||.+||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 232 RLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred HHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11111000 00000 0000 000011124568899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=296.56 Aligned_cols=260 Identities=24% Similarity=0.312 Sum_probs=200.9
Q ss_pred CcccCcccccCceEEEEEEecCCCcEEEEEeeeccc----cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 002061 678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM 753 (973)
Q Consensus 678 ~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 753 (973)
|++.+.||+|++|.||+|+...+++.+|+|++.... ....+.+|++++++++||||+++++++..++..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567788999999999999999889999999876532 3456788999999999999999999999999999999999
Q ss_pred CCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCC
Q 002061 754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833 (973)
Q Consensus 754 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 833 (973)
+ +++.+++... ...+++..+..++.|++.|++||| +.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~-~~l~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~ 152 (283)
T cd05118 81 D-TDLYKLIKDR----QRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV 152 (283)
T ss_pred C-CCHHHHHHhh----cccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence 6 4888888653 246889999999999999999999 7899999999999999999999999999987665433
Q ss_pred CcccccccCCccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccc-cc-cc----
Q 002061 834 KVSDYSCFAGTHGYIAPELAYTC-KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNH-EN-VL---- 906 (973)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~-~~-~~---- 906 (973)
.......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||..... .+....+....... +. ..
T Consensus 153 --~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd05118 153 --RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE--IDQLFKIFRTLGTPDPEVWPKFTS 228 (283)
T ss_pred --ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHcCCCchHhcccchh
Confidence 122334578899999998776 788999999999999999999999964321 11111111110000 00 00
Q ss_pred -------hhcccc--ccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 907 -------KVLDCE--VASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 907 -------~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
...... ...........++.+++.+||++||.+||++.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000000 0011123456788999999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=299.11 Aligned_cols=243 Identities=30% Similarity=0.423 Sum_probs=193.3
Q ss_pred CcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 002061 678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY 752 (973)
Q Consensus 678 ~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 752 (973)
|...+.||+|+||+||+|++..+++.||+|++... ...+.+.+|++++++++|||++++++++.++...|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 56667899999999999999988999999988642 2335678899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCC
Q 002061 753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832 (973)
Q Consensus 753 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 832 (973)
+. |++.+++... ...+++..+..++.|++.|++||| +.+++||||+|+||+++.++.++|+|||++.....
T Consensus 103 ~~-~~l~~~l~~~----~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~- 173 (313)
T cd06633 103 CL-GSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP- 173 (313)
T ss_pred CC-CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCC-
Confidence 95 6787877643 235789999999999999999999 78999999999999999999999999998864321
Q ss_pred CCcccccccCCccccccccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhc
Q 002061 833 PKVSDYSCFAGTHGYIAPELAY---TCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVL 909 (973)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (973)
.....|+..|+|||++. +..++.++|||||||++|||++|+.||.... . ............
T Consensus 174 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~--~---~~~~~~~~~~~~------ 237 (313)
T cd06633 174 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--A---MSALYHIAQNDS------ 237 (313)
T ss_pred -----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--h---HHHHHHHHhcCC------
Confidence 12346788999999974 4568889999999999999999999986531 1 111111111100
Q ss_pred cccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 910 DCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 910 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
+. .........+.+++.+|++++|.+||++.+++++
T Consensus 238 -~~---~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 238 -PT---LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -CC---CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 0111223457889999999999999999999976
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=295.50 Aligned_cols=261 Identities=28% Similarity=0.326 Sum_probs=198.0
Q ss_pred CcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeC--CeeEEEEE
Q 002061 678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKG--GSSFLVLE 751 (973)
Q Consensus 678 ~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~lv~e 751 (973)
|++.+.||+|+||.||+|....+++.||+|++... .....+.+|++++++++|||++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 56788999999999999999988999999998764 2345678899999999999999999999887 88999999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccC
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 831 (973)
|++ ++|.+++... ...+++..+..++.|+++|++||| +.+++|+||+|+||++++++.++++|||.+.....
T Consensus 81 ~~~-~~l~~~~~~~----~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~ 152 (287)
T cd07840 81 YMD-HDLTGLLDSP----EVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTK 152 (287)
T ss_pred ccc-ccHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence 996 5888887642 246889999999999999999999 78999999999999999999999999999986654
Q ss_pred CCCcccccccCCcccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccc-----cc
Q 002061 832 SPKVSDYSCFAGTHGYIAPELAYT-CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHE-----NV 905 (973)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~-----~~ 905 (973)
... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... ......+........ ..
T Consensus 153 ~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07840 153 RNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE--LEQLEKIFELCGSPTDENWPGV 229 (287)
T ss_pred CCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCchhhcccc
Confidence 321 12223456788999998765 4578999999999999999999999965421 111111111000000 00
Q ss_pred ch-----hccccc-----cCcchHH-HHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 906 LK-----VLDCEV-----ASESIKE-DMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 906 ~~-----~~~~~~-----~~~~~~~-~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
.. ...... ....... +...+.+++.+|++.+|++||++.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred ccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00 000000 0000111 25678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=300.22 Aligned_cols=249 Identities=29% Similarity=0.417 Sum_probs=197.6
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE 751 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 751 (973)
.|+..+.||+|+||.||+|+...+++.||+|.+... ....++.+|+++++.++|||++++++++..+...++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 467778999999999999999988999999987531 234567789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccC
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 831 (973)
|+. |++.+++... ...+++..+..++.|++.|++||| +.+++||||+|+||+++.++.++++|||++.....
T Consensus 96 ~~~-~~l~~~~~~~----~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 96 YCL-GSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred ccC-CCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 996 6887777543 234788899999999999999999 78999999999999999999999999999875533
Q ss_pred CCCcccccccCCccccccccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchh
Q 002061 832 SPKVSDYSCFAGTHGYIAPELAY---TCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKV 908 (973)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (973)
. ....++..|+|||++. ...++.++|||||||++|+|++|+.||..... ...... .. ...
T Consensus 168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~---~~-~~~----- 230 (308)
T cd06634 168 A------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSALYH---IA-QNE----- 230 (308)
T ss_pred c------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH--HHHHHH---Hh-hcC-----
Confidence 2 1245788999999974 35678899999999999999999999865311 111110 00 000
Q ss_pred ccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 002061 909 LDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADAD 954 (973)
Q Consensus 909 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 954 (973)
............+.+++.+||+.+|++||++.+++++.....
T Consensus 231 ----~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 231 ----SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred ----CCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 000111223456788999999999999999999998866554
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=251.71 Aligned_cols=262 Identities=23% Similarity=0.307 Sum_probs=197.5
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY 752 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 752 (973)
+|...++||+|.||+||+|+..++++.||+|++.-+ .......+|+-+++.++|.|||+++++...+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 466678899999999999999999999999988652 2345678999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCC
Q 002061 753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832 (973)
Q Consensus 753 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 832 (973)
| ..+|..|.... ...++.+....++.|+++|+.|+| ++++.|||+||+|.++..+|+.|++|||+++-++-+
T Consensus 83 c-dqdlkkyfdsl----ng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgip 154 (292)
T KOG0662|consen 83 C-DQDLKKYFDSL----NGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP 154 (292)
T ss_pred h-hHHHHHHHHhc----CCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence 9 55888887653 456888899999999999999999 889999999999999999999999999999876543
Q ss_pred CCcccccccCCccccccccccccCC-CCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHH--H-Hhccc-cccc
Q 002061 833 PKVSDYSCFAGTHGYIAPELAYTCK-VSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVS--T-HLNNH-ENVL 906 (973)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~--~-~~~~~-~~~~ 906 (973)
...++..+-|..|++|.++++.+ |+++.|+||-||++.|+.. |++.|.+.+.+++ +...+. + ..+.. +.+.
T Consensus 155 --vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddq-lkrif~~lg~p~ed~wps~t 231 (292)
T KOG0662|consen 155 --VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ-LKRIFRLLGTPTEDQWPSMT 231 (292)
T ss_pred --eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHH-HHHHHHHhCCCccccCCccc
Confidence 23445567799999999998765 7899999999999999988 6666654422221 111111 1 01111 1111
Q ss_pred hhccccccCc-----chHHHHHHH----HHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 907 KVLDCEVASE-----SIKEDMIKL----LKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 907 ~~~~~~~~~~-----~~~~~~~~l----~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
+..|-...+. ...+..+++ .+++.+.+.-+|.+|.++.+.+++
T Consensus 232 ~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 232 KLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred cCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 1111111111 122333332 456667777889999999988875
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-32 Score=288.01 Aligned_cols=247 Identities=31% Similarity=0.440 Sum_probs=202.9
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY 752 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 752 (973)
+|++.+.||+|++|.||+|+...+++.||+|.+... ...+.+.+|++++++++|||++++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 478889999999999999999988999999998764 3456788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCC
Q 002061 753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832 (973)
Q Consensus 753 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 832 (973)
+++++|.+++... ..+++..+..++.|++.|+.||| +.+++||||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (254)
T cd06627 81 AENGSLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDV 152 (254)
T ss_pred CCCCcHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence 9999999998753 45889999999999999999999 889999999999999999999999999999866543
Q ss_pred CCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhcccc
Q 002061 833 PKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCE 912 (973)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (973)
... .....++..|+|||...+..++.++||||+|+++|+|++|+.||.... ..............
T Consensus 153 ~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~----~~~~~~~~~~~~~~--------- 217 (254)
T cd06627 153 SKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN----PMAALFRIVQDDHP--------- 217 (254)
T ss_pred ccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc----HHHHHHHHhccCCC---------
Confidence 221 223457889999999988888999999999999999999999996532 11111111111110
Q ss_pred ccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 913 VASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 913 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
.........+.+++.+|++.+|++||++.+++.+
T Consensus 218 ---~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 218 ---PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred ---CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 0111224567889999999999999999999854
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-32 Score=298.93 Aligned_cols=257 Identities=19% Similarity=0.214 Sum_probs=190.0
Q ss_pred CceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCCchHHHHH
Q 002061 688 GTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALH 763 (973)
Q Consensus 688 ~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~ 763 (973)
++|.||.++...+++.||||++... ...+.+.+|++++++++||||+++++++..++..+++|||+++|+|.+++.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~ 91 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK 91 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence 4566666666667999999998653 345678999999999999999999999999999999999999999999998
Q ss_pred hhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCc-----ccc
Q 002061 764 KRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV-----SDY 838 (973)
Q Consensus 764 ~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~-----~~~ 838 (973)
.. ....+++.....++.|++.||+||| +++|+||||||+||+++.++.++++|||.+......... ...
T Consensus 92 ~~---~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~ 165 (314)
T cd08216 92 TH---FPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFP 165 (314)
T ss_pred Hh---cccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccccc
Confidence 64 2234788888999999999999999 789999999999999999999999999988655322111 111
Q ss_pred cccCCcccccccccccc--CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcc---ccc-------cc
Q 002061 839 SCFAGTHGYIAPELAYT--CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNN---HEN-------VL 906 (973)
Q Consensus 839 ~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~---~~~-------~~ 906 (973)
....++..|+|||++.+ ..++.++||||+||++|||++|+.||...... ............. ... ..
T Consensus 166 ~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (314)
T cd08216 166 KSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT-QMLLEKVRGTVPCLLDKSTYPLYEDSMS 244 (314)
T ss_pred ccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccCccccccCchhhhcCCcC
Confidence 22356778999999865 35889999999999999999999999753211 1111111100000 000 00
Q ss_pred h----hcc----ccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 907 K----VLD----CEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 907 ~----~~~----~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
. ..+ .............++.+++.+||++||++|||+.+++++-.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~ 297 (314)
T cd08216 245 QSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF 297 (314)
T ss_pred cccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCch
Confidence 0 000 00011112334467889999999999999999999998754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=323.62 Aligned_cols=257 Identities=27% Similarity=0.390 Sum_probs=205.7
Q ss_pred cccCcccccCceEEEEEEecC-------CCcEEEEEeeecc---ccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeE
Q 002061 679 EEDNLIGSGGTGKVYRLDLKK-------NAGTVAVKQLWKG---DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSF 747 (973)
Q Consensus 679 ~~~~~lG~G~~g~V~~a~~~~-------~~~~vavK~~~~~---~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 747 (973)
.+.+.+|+|+||.||+|.... ....||||.++.. .+.+.+..|+++++.+ +||||+.+++++..++..+
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~ 378 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY 378 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence 555689999999999998651 1457999998763 3467789999999998 6999999999999999999
Q ss_pred EEEEccCCCchHHHHHhhh---------cCCC--CCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCC
Q 002061 748 LVLEYMPNGNLFQALHKRV---------KEGK--PELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY 816 (973)
Q Consensus 748 lv~e~~~~gsL~~~l~~~~---------~~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~ 816 (973)
+|+||++.|+|.++++... .... ..+...+.+.++.|||.|++||+ +.++||||+.++|||++.+.
T Consensus 379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVLi~~~~ 455 (609)
T KOG0200|consen 379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVLITKNK 455 (609)
T ss_pred EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEEecCCC
Confidence 9999999999999998764 1111 23888999999999999999999 88999999999999999999
Q ss_pred CeEEecccCcccccCCCCcccc-cccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHH
Q 002061 817 EPKIADFGVAKIAENSPKVSDY-SCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYW 894 (973)
Q Consensus 817 ~~kl~Dfgl~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~ 894 (973)
.+||+|||+++...+....... +...-+..|||||.+....|+.++|||||||+|||++| |..||.+.. ...++..
T Consensus 456 ~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~-~~~~l~~- 533 (609)
T KOG0200|consen 456 VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP-PTEELLE- 533 (609)
T ss_pred EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC-cHHHHHH-
Confidence 9999999999976554443321 11113457999999999999999999999999999999 899996521 0112211
Q ss_pred HHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 895 VSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 895 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
.++. ....+.+..+..++++++..||+.+|++||++.++++.++..
T Consensus 534 ---~l~~----------G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 534 ---FLKE----------GNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred ---HHhc----------CCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 1111 112233344566789999999999999999999999999883
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=305.34 Aligned_cols=266 Identities=21% Similarity=0.285 Sum_probs=199.9
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeec----cccHHHHHHHHHHHHhcCCCceeeEEEEEEeC-----Cee
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKIRHRNILKLYACLLKG-----GSS 746 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~ 746 (973)
.+|.+.+.||+|+||+||+|++..+++.||||++.. ......+.+|+.+++.++||||+++++++... ...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 478889999999999999999999999999998764 22345677899999999999999999987643 357
Q ss_pred EEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCc
Q 002061 747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826 (973)
Q Consensus 747 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~ 826 (973)
|+||||+. ++|.+++... ..+++..+..++.|++.||+||| +++++||||||+||+++.++.+||+|||++
T Consensus 85 ~lv~e~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 85 YIVYELMD-TDLHQIIRSS-----QTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEeCCC-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 99999995 7888888642 35889999999999999999999 789999999999999999999999999999
Q ss_pred ccccCCCCcccccccCCcccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccc---
Q 002061 827 KIAENSPKVSDYSCFAGTHGYIAPELAYT-CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNH--- 902 (973)
Q Consensus 827 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~--- 902 (973)
....... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||..... ..............
T Consensus 156 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~ 231 (337)
T cd07858 156 RTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY--VHQLKLITELLGSPSEE 231 (337)
T ss_pred cccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHHHhCCCChH
Confidence 7654332 11223457889999998764 4688999999999999999999999965421 11111000000000
Q ss_pred -------cccchhccc--ccc----CcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--hhcCC
Q 002061 903 -------ENVLKVLDC--EVA----SESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM--LADAD 954 (973)
Q Consensus 903 -------~~~~~~~~~--~~~----~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~--L~~~~ 954 (973)
....+.... ... .........++.+++.+|++.+|++||++.|++++ ++.+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 232 DLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred HhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 000000000 000 00112345668899999999999999999999998 55543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=302.49 Aligned_cols=267 Identities=24% Similarity=0.298 Sum_probs=200.2
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEe----CCeeE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLK----GGSSF 747 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~~~ 747 (973)
.+|++.+.||+|+||.||+|....+++.||+|++... .....+.+|+.++++++||||+++++++.. ....|
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 5788999999999999999999999999999988653 234567789999999999999999988753 35689
Q ss_pred EEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcc
Q 002061 748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827 (973)
Q Consensus 748 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~ 827 (973)
+||||++ |+|.+++... ..+++..+..++.|++.||+||| +++++||||||+||+++.++.+||+|||++.
T Consensus 85 lv~e~~~-~~l~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 85 VVMDLME-SDLHHIIHSD-----QPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEehhh-hhHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccce
Confidence 9999995 6888887532 34889999999999999999999 7899999999999999999999999999987
Q ss_pred cccCCCCc--ccccccCCcccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccc-
Q 002061 828 IAENSPKV--SDYSCFAGTHGYIAPELAYT-CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHE- 903 (973)
Q Consensus 828 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~- 903 (973)
........ .......|+..|+|||++.+ ..++.++||||+||++|||++|+.||..... ......+.......+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~--~~~~~~~~~~~g~~~~ 233 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNY--VHQLKLILSVLGSPSE 233 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCCh--HHHHHHHHHHhCCChh
Confidence 65432211 11123468889999998765 4588999999999999999999999965421 111111111000000
Q ss_pred ---------ccchhcc--cccc----CcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 904 ---------NVLKVLD--CEVA----SESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 904 ---------~~~~~~~--~~~~----~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
...+..+ +... .........++.+++.+|++.+|++||++.+++++-.-.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~ 298 (334)
T cd07855 234 EVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLA 298 (334)
T ss_pred HhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhh
Confidence 0000000 0000 001122356789999999999999999999999875543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-31 Score=291.86 Aligned_cols=261 Identities=25% Similarity=0.239 Sum_probs=196.6
Q ss_pred CcccCcccccCceEEEEEEecCCCcEEEEEeeeccc----cHHHHHHHHHHHHhc---CCCceeeEEEEEEeCCe-----
Q 002061 678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKI---RHRNILKLYACLLKGGS----- 745 (973)
Q Consensus 678 ~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l---~hpniv~l~~~~~~~~~----- 745 (973)
|++.+.||+|+||.||+|+++.+++.||+|++.... ....+.+|+.+++++ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567889999999999999999889999999986421 233466788877666 59999999999988766
Q ss_pred eEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccC
Q 002061 746 SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGV 825 (973)
Q Consensus 746 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl 825 (973)
.+++|||++ ++|.+++... ....+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||.
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~---~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~ 153 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKC---PKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGL 153 (287)
T ss_pred eEEEehhcc-cCHHHHHHHc---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCc
Confidence 899999996 5898888753 2235899999999999999999999 78999999999999999999999999999
Q ss_pred cccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccc-c
Q 002061 826 AKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHE-N 904 (973)
Q Consensus 826 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~-~ 904 (973)
+........ .....++..|+|||++.+..++.++||||+||++|||++|+.||..... ................ .
T Consensus 154 ~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07838 154 ARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE-ADQLDKIFDVIGLPSEEE 229 (287)
T ss_pred ceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh-HHHHHHHHHHcCCCChHh
Confidence 876643321 1223468899999999988999999999999999999999999875321 1111111111000000 0
Q ss_pred -c------chhcccc---ccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 905 -V------LKVLDCE---VASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 905 -~------~~~~~~~---~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
. ....... .......+....+.+++.+||+.||++||++.|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0 0000000 0011122345677899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-32 Score=292.81 Aligned_cols=242 Identities=24% Similarity=0.262 Sum_probs=188.2
Q ss_pred cccccCceEEEEEEecCCCcEEEEEeeeccc-----cHHHHHHHHH---HHHhcCCCceeeEEEEEEeCCeeEEEEEccC
Q 002061 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----GVKVFAAEME---ILGKIRHRNILKLYACLLKGGSSFLVLEYMP 754 (973)
Q Consensus 683 ~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-----~~~~~~~E~~---~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 754 (973)
.||+|+||.||+|+...+++.||+|.+.... ....+..|.. .++...||+|+++++++..++..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999999889999999876521 1122334443 3444579999999999999999999999999
Q ss_pred CCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCC
Q 002061 755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK 834 (973)
Q Consensus 755 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 834 (973)
+|+|.+++... ..+++..+..++.|++.|++||| +.+++||||||+||+++.++.++|+|||++.......
T Consensus 81 g~~L~~~l~~~-----~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~- 151 (278)
T cd05606 81 GGDLHYHLSQH-----GVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 151 (278)
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC-
Confidence 99999888642 35899999999999999999999 7899999999999999999999999999987553221
Q ss_pred cccccccCCccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccc
Q 002061 835 VSDYSCFAGTHGYIAPELAYTC-KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEV 913 (973)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (973)
.....|+..|+|||++.++ .++.++||||+||++|||++|+.||...... ............. ..
T Consensus 152 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~--------~~- 217 (278)
T cd05606 152 ---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--DKHEIDRMTLTMA--------VE- 217 (278)
T ss_pred ---CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCcc--chHHHHHHhhccC--------CC-
Confidence 1224689999999998754 6889999999999999999999999764221 1111111110000 11
Q ss_pred cCcchHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHh
Q 002061 914 ASESIKEDMIKLLKIAVVCTTKLPNLRP-----PMREVVKML 950 (973)
Q Consensus 914 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~L 950 (973)
.+......+.+++.+|+..+|.+|| ++.+++++-
T Consensus 218 ---~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~ 256 (278)
T cd05606 218 ---LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHP 256 (278)
T ss_pred ---CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCc
Confidence 1112245688899999999999999 999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-32 Score=300.27 Aligned_cols=270 Identities=24% Similarity=0.301 Sum_probs=205.1
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCC-----eeE
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGG-----SSF 747 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-----~~~ 747 (973)
+|++.+.||.|++|.||+|+...+++.||||++... ...+.+.+|+.+++.++||||+++++++.... ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 578889999999999999999988999999988653 34567889999999999999999999987765 789
Q ss_pred EEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcc
Q 002061 748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827 (973)
Q Consensus 748 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~ 827 (973)
+||||++ ++|.+++... ..+++..+..++.|++.||+||| +++++||||||+||+++.++.++|+|||.+.
T Consensus 81 lv~e~~~-~~l~~~l~~~-----~~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~ 151 (330)
T cd07834 81 IVTELME-TDLHKVIKSP-----QPLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLAR 151 (330)
T ss_pred EEecchh-hhHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceE
Confidence 9999996 5888888642 26889999999999999999999 7899999999999999999999999999998
Q ss_pred cccCCCCc-ccccccCCccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccc--
Q 002061 828 IAENSPKV-SDYSCFAGTHGYIAPELAYTC-KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHE-- 903 (973)
Q Consensus 828 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~-- 903 (973)
........ .......++..|+|||++.+. .++.++||||+|+++|+|++|+.||..... ......+........
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~--~~~~~~i~~~~~~~~~~ 229 (330)
T cd07834 152 GVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY--IDQLNLIVEVLGTPSEE 229 (330)
T ss_pred eecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH--HHHHHHHHHhcCCCChh
Confidence 66543210 112234578899999999887 789999999999999999999999965421 111111111000000
Q ss_pred --------ccchhccc--cc----cCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--hhcCCCCC
Q 002061 904 --------NVLKVLDC--EV----ASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM--LADADPCT 957 (973)
Q Consensus 904 --------~~~~~~~~--~~----~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~--L~~~~~~~ 957 (973)
.....+.. .. ...........+.+++.+||+++|++||++.+++++ +++....+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~ 299 (330)
T cd07834 230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPE 299 (330)
T ss_pred HhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccc
Confidence 00000000 00 000011234568899999999999999999999996 55555433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=295.52 Aligned_cols=249 Identities=29% Similarity=0.388 Sum_probs=203.1
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeec-----cccHHHHHHHHHHHHhcC-CCceeeEEEEEEeCCeeEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKIR-HRNILKLYACLLKGGSSFLV 749 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~-----~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv 749 (973)
++|++.+.||+|+||.||+|+...+++.||+|++.. ....+.+.+|++++++++ ||||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 368889999999999999999998899999998865 233456788999999998 99999999999999999999
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccc
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 829 (973)
|||+++++|.+++... ..+++..+..++.|++.|++||| +.+++|+||+|+||+++.++.++++|||++...
T Consensus 81 ~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~ 152 (280)
T cd05581 81 LEYAPNGELLQYIRKY-----GSLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVL 152 (280)
T ss_pred EcCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCcccccc
Confidence 9999999999999753 25899999999999999999999 789999999999999999999999999998765
Q ss_pred cCCCCc------------------ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccH
Q 002061 830 ENSPKV------------------SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDI 891 (973)
Q Consensus 830 ~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~ 891 (973)
...... .......++..|+|||+..+..++.++||||+|+++|++++|+.||.... .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~ 227 (280)
T cd05581 153 DPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN-----E 227 (280)
T ss_pred CCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc-----H
Confidence 433211 12223467889999999988889999999999999999999999997542 1
Q ss_pred HHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCH----HHHHHH
Q 002061 892 VYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPM----REVVKM 949 (973)
Q Consensus 892 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~----~evl~~ 949 (973)
............ ..+....+.+.+++.+|++.+|++||++ .+++++
T Consensus 228 ~~~~~~~~~~~~------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 228 YLTFQKILKLEY------------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HHHHHHHHhcCC------------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 111111111100 0111224567899999999999999999 888765
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=277.83 Aligned_cols=257 Identities=21% Similarity=0.277 Sum_probs=198.1
Q ss_pred CcccccCceEEEEEEecCCCcEEEEEeeecc--ccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEEEEccCCCch
Q 002061 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLVLEYMPNGNL 758 (973)
Q Consensus 682 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~gsL 758 (973)
+.||+|+|+.|--+....+|..||||++.+. ....++.+|++++... .|+||++++++|++++..|+|||.|.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 5699999999999999999999999999773 4456788999999998 599999999999999999999999999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCC---eEEecccCcccccC----
Q 002061 759 FQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE---PKIADFGVAKIAEN---- 831 (973)
Q Consensus 759 ~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~---~kl~Dfgl~~~~~~---- 831 (973)
...++++ ..+.+.+..++..+||.||.||| .+||.|||+||+|||...... +|||||.+..-...
T Consensus 164 LshI~~~-----~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~ 235 (463)
T KOG0607|consen 164 LSHIQKR-----KHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC 235 (463)
T ss_pred HHHHHHh-----hhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence 9999865 35888899999999999999999 899999999999999976554 89999988753321
Q ss_pred -CCCcccccccCCccccccccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcc-----cHHHH-HHH-H
Q 002061 832 -SPKVSDYSCFAGTHGYIAPELAY-----TCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGK-----DIVYW-VST-H 898 (973)
Q Consensus 832 -~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~-----~~~~~-~~~-~ 898 (973)
...+......+|+..|||||+.. ...|+.+.|.||||||+|-|++|..||.+..+.+- ..... ... .
T Consensus 236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LF 315 (463)
T KOG0607|consen 236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLF 315 (463)
T ss_pred CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHH
Confidence 11222333567999999999863 34588899999999999999999999976533211 11111 010 0
Q ss_pred hccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 899 LNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
..-++...++ ....+.....+..+++...+-.||..|.++.+++.+-.
T Consensus 316 esIQEGkYeF-----PdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw 363 (463)
T KOG0607|consen 316 ESIQEGKYEF-----PDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPW 363 (463)
T ss_pred HHHhccCCcC-----ChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcc
Confidence 0011111222 22234445556677777888899999999999988543
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=294.21 Aligned_cols=245 Identities=27% Similarity=0.352 Sum_probs=195.2
Q ss_pred ccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCCch
Q 002061 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNL 758 (973)
Q Consensus 684 lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL 758 (973)
||.|+||.||+|++..+++.||+|++... ...+.+.+|++++++++||||+++++.+..+...|+||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999988999999988653 2345688899999999999999999999999999999999999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCC----
Q 002061 759 FQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK---- 834 (973)
Q Consensus 759 ~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~---- 834 (973)
.+++.+. ..+++..+..++.|+++||+||| +.+++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 152 (265)
T cd05579 81 ASLLENV-----GSLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN 152 (265)
T ss_pred HHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccc
Confidence 9999753 25789999999999999999999 78999999999999999999999999999875433211
Q ss_pred --cccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhcccc
Q 002061 835 --VSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCE 912 (973)
Q Consensus 835 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (973)
........++..|+|||+..+..++.++||||||+++|++++|+.||.... .............
T Consensus 153 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~~~~~~~~~~~~~--------- 218 (265)
T cd05579 153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET-----PEEIFQNILNGKI--------- 218 (265)
T ss_pred cccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHhcCCc---------
Confidence 112233457889999999988888999999999999999999999996542 1111111111010
Q ss_pred ccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 913 VASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 913 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
...........+.+++.+|++.+|++|||+.++.+.++
T Consensus 219 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 219 -EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred -CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 00000112456789999999999999999955554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-32 Score=295.07 Aligned_cols=260 Identities=25% Similarity=0.336 Sum_probs=197.0
Q ss_pred CcccCcccccCceEEEEEEecCCCcEEEEEeeeccc---cHHHHHHHHHHHHhcC-CCceeeEEEEEEeCCeeEEEEEcc
Q 002061 678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD---GVKVFAAEMEILGKIR-HRNILKLYACLLKGGSSFLVLEYM 753 (973)
Q Consensus 678 ~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~ 753 (973)
|++.+.||+|++|+||+|+...+++.||||++.... ......+|+..+++++ |||++++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567889999999999999999889999999876532 2234567999999998 999999999999999999999999
Q ss_pred CCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCC
Q 002061 754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833 (973)
Q Consensus 754 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 833 (973)
+|+|.+++... ....+++..+..++.|++.|++||| +.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 -~~~l~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (283)
T cd07830 81 -EGNLYQLMKDR---KGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP 153 (283)
T ss_pred -CCCHHHHHHhc---ccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC
Confidence 88999988754 1346799999999999999999999 7899999999999999999999999999987654322
Q ss_pred CcccccccCCccccccccccc-cCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcc-----------
Q 002061 834 KVSDYSCFAGTHGYIAPELAY-TCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNN----------- 901 (973)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~----------- 901 (973)
. .....++..|+|||++. +..++.++|+||||+++|||++|+.||..... .+..+........
T Consensus 154 ~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd07830 154 P---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSE--IDQLYKICSVLGTPTKQDWPEGYK 228 (283)
T ss_pred C---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCCh--HHHHHHHHHhcCCCChhhhhhHhh
Confidence 1 22345788999999875 44578999999999999999999999965421 1111111000000
Q ss_pred -ccccchhccccc---cCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 902 -HENVLKVLDCEV---ASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 902 -~~~~~~~~~~~~---~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
............ ...........+.+++.+|++.+|++||++.|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 229 LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred hhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000000000 000011124568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=297.14 Aligned_cols=254 Identities=27% Similarity=0.385 Sum_probs=195.3
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc---ccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLVL 750 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~ 750 (973)
.++|++.+.||+|+||+||+|++..+++.||||++... .....+.+|+.++.+. .||||+++++++.++...|+||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 46788999999999999999999988999999998653 2334566677766666 4999999999999999999999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccccc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 830 (973)
||++ +++.++.... ...+++..+..++.|++.|++|||+ ..+++||||+|+||+++.++.++|+|||.+....
T Consensus 94 e~~~-~~l~~l~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 94 ELMS-TCLDKLLKRI----QGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eccC-cCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 9984 5777766542 2368889999999999999999994 2589999999999999999999999999987553
Q ss_pred CCCCcccccccCCccccccccccccCC----CCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccc
Q 002061 831 NSPKVSDYSCFAGTHGYIAPELAYTCK----VSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVL 906 (973)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 906 (973)
.... .....++..|+|||++.+.. ++.++||||||+++|||++|+.||.....+ .............
T Consensus 167 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~~~~~-- 237 (296)
T cd06618 167 DSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE----FEVLTKILQEEPP-- 237 (296)
T ss_pred CCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH----HHHHHHHhcCCCC--
Confidence 3221 12235778999999987554 788999999999999999999999642111 1111111111110
Q ss_pred hhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 907 KVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
. .. .......++.+++.+|++.||++||++.+++++..
T Consensus 238 ~-----~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 238 S-----LP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred C-----CC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 0 00 00123456889999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-32 Score=301.12 Aligned_cols=265 Identities=23% Similarity=0.238 Sum_probs=197.1
Q ss_pred cCCcc-cCcccccCceEEEEEEecCCCcEEEEEeeeccccH----------------HHHHHHHHHHHhcCCCceeeEEE
Q 002061 676 CNLEE-DNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGV----------------KVFAAEMEILGKIRHRNILKLYA 738 (973)
Q Consensus 676 ~~~~~-~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~----------------~~~~~E~~~l~~l~hpniv~l~~ 738 (973)
.+|.. .+.||+|+||+||+|.+..+++.||||++...... ..+.+|++++++++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45553 46799999999999999988999999988653211 14678999999999999999999
Q ss_pred EEEeCCeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCe
Q 002061 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP 818 (973)
Q Consensus 739 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~ 818 (973)
++..++..++||||++ |+|.+++... ..+++.....++.|++.|++||| +.+++||||+|+||+++.++.+
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK-----IRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGIC 158 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCE
Confidence 9999999999999996 6898888642 34788899999999999999999 7899999999999999999999
Q ss_pred EEecccCcccccCCCC------------cccccccCCccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCccc
Q 002061 819 KIADFGVAKIAENSPK------------VSDYSCFAGTHGYIAPELAYTC-KVSEKSDVFSFGVVLLELVTGRKPVEEEY 885 (973)
Q Consensus 819 kl~Dfgl~~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~pf~~~~ 885 (973)
+++|||.+........ ........++..|+|||++.+. .++.++||||+||++|||++|+.||....
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999876542110 1111223467889999998764 46889999999999999999999997542
Q ss_pred CCcccHHHHHHHHhccccc--cchh--------cccccc---CcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 886 GDGKDIVYWVSTHLNNHEN--VLKV--------LDCEVA---SESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 886 ~~~~~~~~~~~~~~~~~~~--~~~~--------~~~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
. .+....+......... .... ...... .........++.+++.+|++.+|++||++.|++.+-.
T Consensus 239 ~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~ 315 (335)
T PTZ00024 239 E--IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEY 315 (335)
T ss_pred H--HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcc
Confidence 1 1111111111100000 0000 000000 0001122456889999999999999999999998654
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.4e-32 Score=289.14 Aligned_cols=240 Identities=25% Similarity=0.291 Sum_probs=186.3
Q ss_pred CcccccCceEEEEEEecCCCcEEEEEeeeccc-----cHHHHHHHHHHH-HhcCCCceeeEEEEEEeCCeeEEEEEccCC
Q 002061 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----GVKVFAAEMEIL-GKIRHRNILKLYACLLKGGSSFLVLEYMPN 755 (973)
Q Consensus 682 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l-~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 755 (973)
+.||+|+||.||+|....+++.||||++.... ....+..|..++ ...+|||++++++++..++..|+||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56899999999999999889999999886532 122334454443 445899999999999999999999999999
Q ss_pred CchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCc
Q 002061 756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV 835 (973)
Q Consensus 756 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 835 (973)
++|.+++... ..+++..+..++.|++.||.|+| +.+++||||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---- 149 (260)
T cd05611 82 GDCASLIKTL-----GGLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---- 149 (260)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc----
Confidence 9999998753 24788889999999999999999 78999999999999999999999999998875432
Q ss_pred ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccccC
Q 002061 836 SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVAS 915 (973)
Q Consensus 836 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
.....++..|+|||.+.+..++.++||||+|+++|||++|..||.... .............. ...
T Consensus 150 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~--------~~~ 214 (260)
T cd05611 150 --NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET-----PDAVFDNILSRRIN--------WPE 214 (260)
T ss_pred --cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHhcccC--------CCC
Confidence 122357889999999988888999999999999999999999996431 11111111111100 000
Q ss_pred cchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 002061 916 ESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVK 948 (973)
Q Consensus 916 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~ 948 (973)
.........+.+++.+|++.+|++||++.++.+
T Consensus 215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~ 247 (260)
T cd05611 215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQE 247 (260)
T ss_pred cccccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence 111123456889999999999999997754443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-32 Score=299.80 Aligned_cols=266 Identities=24% Similarity=0.305 Sum_probs=195.6
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc----cHHHHHHHHHHHHhcCCCceeeEEEEEEeC------
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYACLLKG------ 743 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------ 743 (973)
.+++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+|++++++++||||+++++++.+.
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 3678999999999999999999999889999999875421 234567899999999999999999987543
Q ss_pred --CeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEe
Q 002061 744 --GSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIA 821 (973)
Q Consensus 744 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 821 (973)
...++||||++ +++...+... ...+++..+..++.|+++||+||| +.+++||||||+||++++++.++++
T Consensus 86 ~~~~~~lv~~~~~-~~l~~~~~~~----~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~ 157 (311)
T cd07866 86 KRGSVYMVTPYMD-HDLSGLLENP----SVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIA 157 (311)
T ss_pred cCceEEEEEecCC-cCHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEC
Confidence 34699999996 4676666532 346899999999999999999999 7899999999999999999999999
Q ss_pred cccCcccccCCCCc---------ccccccCCccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccH
Q 002061 822 DFGVAKIAENSPKV---------SDYSCFAGTHGYIAPELAYTC-KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDI 891 (973)
Q Consensus 822 Dfgl~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~ 891 (973)
|||++......... .......+++.|+|||++.+. .++.++||||+||++|||++|+.||..... ...
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~--~~~ 235 (311)
T cd07866 158 DFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD--IDQ 235 (311)
T ss_pred cCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH--HHH
Confidence 99999765432211 112234568889999987654 578999999999999999999999964311 111
Q ss_pred HHHHHHHhccc--------cccch----hccccccCc---chHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 892 VYWVSTHLNNH--------ENVLK----VLDCEVASE---SIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 892 ~~~~~~~~~~~--------~~~~~----~~~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
...+....... ..... ......... ......+.+.+++.+|++.||++|||+.|++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 236 LHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 11100000000 00000 000000000 011223568899999999999999999999865
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.7e-32 Score=300.71 Aligned_cols=265 Identities=21% Similarity=0.281 Sum_probs=196.6
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeC------Ce
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKG------GS 745 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~~ 745 (973)
.+|...+.||+|+||.||+|++..+++.||||++... .....+.+|++++++++||||+++++++... ..
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 5788899999999999999999988999999988652 2234578899999999999999999998654 24
Q ss_pred eEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccC
Q 002061 746 SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGV 825 (973)
Q Consensus 746 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl 825 (973)
.++|+||+. .++.++.. ..+++..+..++.|++.|++||| +.+++||||||+||+++.++.++++|||+
T Consensus 95 ~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 95 FYLVMPYMQ-TDLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred EEEEecccc-cCHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 699999995 46665542 24788899999999999999999 78999999999999999999999999999
Q ss_pred cccccCCCCcccccccCCcccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccc
Q 002061 826 AKIAENSPKVSDYSCFAGTHGYIAPELAYT-CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHEN 904 (973)
Q Consensus 826 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 904 (973)
++..... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||..... ...........-...+.
T Consensus 164 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~ 237 (342)
T cd07879 164 ARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY-LDQLTQILKVTGVPGPE 237 (342)
T ss_pred CcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCCHH
Confidence 8754321 123456889999999876 4688999999999999999999999975311 00111100000000000
Q ss_pred c---------chhcc--ccccCcc----hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--hhcCCCCC
Q 002061 905 V---------LKVLD--CEVASES----IKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM--LADADPCT 957 (973)
Q Consensus 905 ~---------~~~~~--~~~~~~~----~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~--L~~~~~~~ 957 (973)
. ..... +...... ......++.+++.+|++.||++||++.|++++ ++...+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~ 307 (342)
T cd07879 238 FVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDAD 307 (342)
T ss_pred HHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccc
Confidence 0 00000 0000000 11223467899999999999999999999977 77776543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=288.45 Aligned_cols=250 Identities=25% Similarity=0.331 Sum_probs=198.2
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeec-------cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK-------GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV 749 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~-------~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 749 (973)
+|.+.+.||+|+||.||+|++...+..+++|+.+. .....++.+|+.++++++||||+++++++.++...++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 57888999999999999999987766677776543 12334567899999999999999999999998999999
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccc
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 829 (973)
|||+++++|.+++.... .....+++..+..++.|+++|++||| +.+++|+||+|+||+++. +.++++|||.+...
T Consensus 81 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~ 155 (260)
T cd08222 81 TEYCEGRDLDCKLEELK-HTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLL 155 (260)
T ss_pred EEeCCCCCHHHHHHHHh-hcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeec
Confidence 99999999999987542 23456899999999999999999999 789999999999999975 57999999998765
Q ss_pred cCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhc
Q 002061 830 ENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVL 909 (973)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (973)
..... ......|+..|+|||...+..++.++|+||+|+++|+|++|..||... +.............
T Consensus 156 ~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~-----~~~~~~~~~~~~~~------ 222 (260)
T cd08222 156 MGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ-----NFLSVVLRIVEGPT------ 222 (260)
T ss_pred CCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc-----cHHHHHHHHHcCCC------
Confidence 43221 122345788999999998888899999999999999999999999642 12222221111110
Q ss_pred cccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 910 DCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 910 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
..........+.+++.+|++.+|++||++.|++++
T Consensus 223 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 223 -----PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred -----CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 01122344578889999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=299.72 Aligned_cols=263 Identities=22% Similarity=0.287 Sum_probs=192.5
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc--ccHHHHHHHHHHHHhcCCCceeeEEEEEEeC----------
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKG---------- 743 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~---------- 743 (973)
.+|++.+.||+|+||+||+|....+++.||+|++... ...+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 5789999999999999999999999999999987653 3456688999999999999999999876543
Q ss_pred ----CeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecC-CCCe
Q 002061 744 ----GSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE-DYEP 818 (973)
Q Consensus 744 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~ 818 (973)
...|+||||++ ++|.+++.. ..+++..+..++.|++.|++||| +.+++||||||+||+++. ++.+
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ------GPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceE
Confidence 35799999996 588887753 24788899999999999999999 789999999999999974 5678
Q ss_pred EEecccCcccccCCCCcc-cccccCCcccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHH
Q 002061 819 KIADFGVAKIAENSPKVS-DYSCFAGTHGYIAPELAYT-CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVS 896 (973)
Q Consensus 819 kl~Dfgl~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~ 896 (973)
+++|||.+.......... ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||...... ........
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~-~~~~~~~~ 233 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHEL-EQMQLILE 233 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH
Confidence 999999987653321111 1122357889999998654 56788999999999999999999999643110 00000000
Q ss_pred HHhcccc--------ccchhcc--ccccC----cchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 897 THLNNHE--------NVLKVLD--CEVAS----ESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 897 ~~~~~~~--------~~~~~~~--~~~~~----~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
....... ....... ..... ........++.+++.+|+++||++||++.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 0000000 0000000 00000 0011234567899999999999999999999965
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=297.54 Aligned_cols=259 Identities=21% Similarity=0.316 Sum_probs=195.1
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCC-----
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGG----- 744 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----- 744 (973)
..++|++.+.||+|+||.||+|....++..||||++... .....+.+|++++++++||||+++++++..+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 346799999999999999999999989999999988542 22345778999999999999999999987543
Q ss_pred -eeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecc
Q 002061 745 -SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADF 823 (973)
Q Consensus 745 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 823 (973)
..++||||+ +++|.+++.. ..+++..+..++.|++.|++||| +.+++||||||+||+++.++.++++||
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeec
Confidence 458999999 7799888753 24789999999999999999999 789999999999999999999999999
Q ss_pred cCcccccCCCCcccccccCCcccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHH-----
Q 002061 824 GVAKIAENSPKVSDYSCFAGTHGYIAPELAYT-CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVST----- 897 (973)
Q Consensus 824 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~----- 897 (973)
|++...... .....+++.|+|||++.+ ..++.++||||+|+++|++++|+.||...... .........
T Consensus 163 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~ 236 (343)
T cd07880 163 GLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL-DQLMEIMKVTGTPS 236 (343)
T ss_pred ccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCC
Confidence 998755332 122356889999999875 45788999999999999999999999753210 000000000
Q ss_pred -----Hhccccccchhcc--ccccC----cchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 898 -----HLNNHENVLKVLD--CEVAS----ESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 898 -----~~~~~~~~~~~~~--~~~~~----~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
...... ...... +.... .........+.+++.+|++.||++|||+.+++++
T Consensus 237 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 237 KEFVQKLQSED-AKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred HHHHHhhcchh-HHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 000000 00000 0011234467899999999999999999999954
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-31 Score=290.76 Aligned_cols=251 Identities=25% Similarity=0.301 Sum_probs=196.3
Q ss_pred CCcccCcccccCceEEEEEEec---CCCcEEEEEeeecc------ccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCee
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLK---KNAGTVAVKQLWKG------DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSS 746 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~---~~~~~vavK~~~~~------~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 746 (973)
+|++.+.||+|+||.||+|+.. .+|..||+|++... ...+.+.+|+++++++ +||+|+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4778899999999999999875 46889999988652 2345678899999999 599999999999999999
Q ss_pred EEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCc
Q 002061 747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826 (973)
Q Consensus 747 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~ 826 (973)
|+||||+++++|.+++... ..+++..+..++.|++.||+||| +.+++||||+|+||+++.++.++|+|||++
T Consensus 81 ~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 152 (290)
T cd05613 81 HLILDYINGGELFTHLSQR-----ERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLS 152 (290)
T ss_pred EEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccc
Confidence 9999999999999998753 34778888899999999999999 789999999999999999999999999998
Q ss_pred ccccCCCCcccccccCCccccccccccccC--CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccc
Q 002061 827 KIAENSPKVSDYSCFAGTHGYIAPELAYTC--KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHEN 904 (973)
Q Consensus 827 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 904 (973)
........ .......|+..|+|||++.+. .++.++||||+|+++|+|++|+.||.... ..................
T Consensus 153 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~-~~~~~~~~~~~~~~~~~~ 230 (290)
T cd05613 153 KEFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDG-EKNSQAEISRRILKSEPP 230 (290)
T ss_pred eecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCC-ccccHHHHHHHhhccCCC
Confidence 76533221 122234588999999998653 46789999999999999999999996431 111222222221111111
Q ss_pred cchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 002061 905 VLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRP-----PMREVVKM 949 (973)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~ 949 (973)
.+......+.+++.+|++.||++|| ++.+++++
T Consensus 231 ------------~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 231 ------------YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred ------------CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 1112334678899999999999997 77777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=297.57 Aligned_cols=262 Identities=23% Similarity=0.284 Sum_probs=195.5
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeC------
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKG------ 743 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------ 743 (973)
..++|++.+.||+|+||.||+|.+..+++.||+|++... ...+.+.+|++++++++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 346899999999999999999999888999999988653 2245677899999999999999999988643
Q ss_pred CeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecc
Q 002061 744 GSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADF 823 (973)
Q Consensus 744 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 823 (973)
...|++++++ +++|.+++.. ..+++..+..++.|+++|++||| +.+++||||||+||++++++.+||+||
T Consensus 95 ~~~~lv~~~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~df 164 (345)
T cd07877 95 NDVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDF 164 (345)
T ss_pred ccEEEEehhc-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEEEecc
Confidence 3468888887 7899887753 24789999999999999999999 789999999999999999999999999
Q ss_pred cCcccccCCCCcccccccCCcccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccc
Q 002061 824 GVAKIAENSPKVSDYSCFAGTHGYIAPELAYT-CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNH 902 (973)
Q Consensus 824 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 902 (973)
|++...... .....++..|+|||++.+ ..++.++||||+||++|||++|+.||..... ...............
T Consensus 165 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~-~~~~~~~~~~~~~~~ 238 (345)
T cd07877 165 GLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-IDQLKLILRLVGTPG 238 (345)
T ss_pred ccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCC
Confidence 998754322 123457889999998866 4678899999999999999999999964311 011111111000000
Q ss_pred cccchhccc-----------cccCc----chHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 903 ENVLKVLDC-----------EVASE----SIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 903 ~~~~~~~~~-----------~~~~~----~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
+.....+.. ..... ........+.+++.+|++.||++||++.+++++-.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 302 (345)
T cd07877 239 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 302 (345)
T ss_pred HHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChh
Confidence 000000000 00000 00012346789999999999999999999998753
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-31 Score=293.05 Aligned_cols=259 Identities=24% Similarity=0.336 Sum_probs=196.4
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeec----cccHHHHHHHHHHHHhcCCCceeeEEEEEEe-CCeeEE
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKIRHRNILKLYACLLK-GGSSFL 748 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~~l 748 (973)
..++|++.+.||+|+||.||+|++..+++.||||++.. ....+.+.+|++++++++||||+++.+++.. +...|+
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 45689999999999999999999999999999998754 2334667889999999999999999998865 567899
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccc
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 828 (973)
||||+ +++|.+++... .+++.....++.|+++|++||| +.+++||||+|+||+++.++.++++|||.+..
T Consensus 88 v~e~~-~~~L~~~~~~~------~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 88 VTELL-GTDLHRLLTSR------PLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred Eeehh-ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCccccccc
Confidence 99998 67888887632 4677788889999999999999 78999999999999999999999999999875
Q ss_pred ccCCCCcccccccCCcccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccc----
Q 002061 829 AENSPKVSDYSCFAGTHGYIAPELAYT-CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHE---- 903 (973)
Q Consensus 829 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~---- 903 (973)
.... .....++..|+|||++.+ ..++.++||||+||++|+|++|+.||..... ......+........
T Consensus 158 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~--~~~~~~~~~~~~~~~~~~~ 230 (328)
T cd07856 158 QDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH--VNQFSIITDLLGTPPDDVI 230 (328)
T ss_pred cCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCCHHHH
Confidence 4322 122356889999998765 5688999999999999999999999964311 111000010000000
Q ss_pred ------ccchhcc-ccccC-----cchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 904 ------NVLKVLD-CEVAS-----ESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 904 ------~~~~~~~-~~~~~-----~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
...+... ..... .........+.+++.+|++.+|++||++.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 231 NTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 00000 0011224578899999999999999999999988
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=291.34 Aligned_cols=254 Identities=24% Similarity=0.267 Sum_probs=197.3
Q ss_pred CCcccCcccccCceEEEEEEec---CCCcEEEEEeeecc------ccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCee
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLK---KNAGTVAVKQLWKG------DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSS 746 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~---~~~~~vavK~~~~~------~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 746 (973)
+|++.+.||+|+||.||+|+.. .++..||||++... ...+.+.+|+++++++ +||+|+++++++..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4678889999999999999864 35778999988642 2345678899999999 599999999999999999
Q ss_pred EEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCc
Q 002061 747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826 (973)
Q Consensus 747 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~ 826 (973)
++||||+++|+|.+++... ..+++..+..++.|+++||+||| +.+++||||+|+||+++.++.++++|||++
T Consensus 81 ~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~ 152 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR-----EHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLS 152 (288)
T ss_pred EEEEecCCCCcHHHHHhhc-----CCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccc
Confidence 9999999999999998642 34788889999999999999999 789999999999999999999999999998
Q ss_pred ccccCCCCcccccccCCccccccccccccCC--CCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccc
Q 002061 827 KIAENSPKVSDYSCFAGTHGYIAPELAYTCK--VSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHEN 904 (973)
Q Consensus 827 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 904 (973)
......... ......|+..|+|||...+.. .+.++||||+|+++|||++|+.||..... ................
T Consensus 153 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~- 229 (288)
T cd05583 153 KEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE-QNSQSEISRRILKSKP- 229 (288)
T ss_pred ccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcc-cchHHHHHHHHHccCC-
Confidence 765433211 112245788999999987655 77899999999999999999999964311 1111111111111111
Q ss_pred cchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 002061 905 VLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952 (973)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~ 952 (973)
..+......+.+++.+|++.||++|||+.++.+.|+.
T Consensus 230 -----------~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 230 -----------PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred -----------CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 0111223457789999999999999998888766654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=290.77 Aligned_cols=260 Identities=26% Similarity=0.325 Sum_probs=199.1
Q ss_pred CcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 002061 678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM 753 (973)
Q Consensus 678 ~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 753 (973)
|+..+.||+|++|.||+|+...+++.||+|++... ...+.+.+|++++++++|||++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 56678899999999999999999999999988753 23456778999999999999999999999999999999999
Q ss_pred CCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCC
Q 002061 754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833 (973)
Q Consensus 754 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 833 (973)
+ ++|.+++... ...+++..+..++.|++.|++||| +.+++||||+|+||++++++.++|+|||.+.......
T Consensus 81 ~-~~l~~~i~~~----~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 152 (282)
T cd07829 81 D-MDLKKYLDKR----PGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL 152 (282)
T ss_pred C-cCHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCc
Confidence 7 5899999764 145889999999999999999999 7899999999999999999999999999987664332
Q ss_pred CcccccccCCccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccc--------
Q 002061 834 KVSDYSCFAGTHGYIAPELAYTC-KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHEN-------- 904 (973)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~-------- 904 (973)
. ......++..|+|||++.+. .++.++||||+||++||+++|+.||..... ......+.........
T Consensus 153 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07829 153 R--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE--IDQLFKIFQILGTPTEESWPGVTK 228 (282)
T ss_pred c--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccH--HHHHHHHHHHhCCCcHHHHHhhcc
Confidence 2 22233457789999998766 788999999999999999999999965321 1110111100000000
Q ss_pred c--chhccccc----cCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 905 V--LKVLDCEV----ASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 905 ~--~~~~~~~~----~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
. .+..-+.. ...........+.+++.+|++.+|++||++.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 229 LPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0 00000000 001111224578999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-32 Score=300.54 Aligned_cols=259 Identities=24% Similarity=0.312 Sum_probs=197.0
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCe-----
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGS----- 745 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~----- 745 (973)
.++|++.+.||+|++|.||+|++..+++.||||++... ...+.+.+|+.++++++|||++++.+++..++.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 45789999999999999999999988999999987642 234557789999999999999999988766554
Q ss_pred -eEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEeccc
Q 002061 746 -SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFG 824 (973)
Q Consensus 746 -~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 824 (973)
.++|+||+ +++|.+++.. ..+++..+..++.|++.|++||| +.+++||||+|+||+++.++.++|+|||
T Consensus 94 ~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred cEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEcccc
Confidence 89999999 6799988864 35889999999999999999999 7899999999999999999999999999
Q ss_pred CcccccCCCCcccccccCCcccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccc
Q 002061 825 VAKIAENSPKVSDYSCFAGTHGYIAPELAYT-CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHE 903 (973)
Q Consensus 825 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 903 (973)
++...... .....++..|+|||.+.+ ..++.++||||+||++||+++|+.||..... ......+........
T Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~--~~~~~~i~~~~~~~~ 236 (343)
T cd07851 164 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH--IDQLKRIMNLVGTPD 236 (343)
T ss_pred cccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCC
Confidence 98765332 222457889999998865 3678899999999999999999999964321 111111100000000
Q ss_pred -c---------cchhcc---ccccC---cchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 904 -N---------VLKVLD---CEVAS---ESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 904 -~---------~~~~~~---~~~~~---~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
. ....+. ..... ........++.+++.+|++.||++|||+.||+++-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~ 299 (343)
T cd07851 237 EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHP 299 (343)
T ss_pred HHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCC
Confidence 0 000000 00000 00112256788999999999999999999998863
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=295.85 Aligned_cols=263 Identities=24% Similarity=0.271 Sum_probs=193.1
Q ss_pred CCcccCcccccCceEEEEEEecCC--CcEEEEEeeecc----ccHHHHHHHHHHHHhc-CCCceeeEEEEEEeC----Ce
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKN--AGTVAVKQLWKG----DGVKVFAAEMEILGKI-RHRNILKLYACLLKG----GS 745 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~--~~~vavK~~~~~----~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~----~~ 745 (973)
+|++.+.||+|+||.||+|+...+ +..||||++... ...+.+.+|+++++++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 477888999999999999999887 889999987642 2245678899999999 599999999875432 45
Q ss_pred eEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccC
Q 002061 746 SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGV 825 (973)
Q Consensus 746 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl 825 (973)
.|+++||++ ++|.+++.. ...+++..+..++.|++.||+||| +.+++||||||+||+++.++.++|+|||+
T Consensus 81 ~~~~~e~~~-~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~ 151 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS-----GQPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGL 151 (332)
T ss_pred EEEEEeccc-CCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCC
Confidence 789999985 689888863 235789999999999999999999 78999999999999999999999999999
Q ss_pred cccccCCCCc--ccccccCCcccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccc
Q 002061 826 AKIAENSPKV--SDYSCFAGTHGYIAPELAYT-CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNH 902 (973)
Q Consensus 826 ~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 902 (973)
+......... .......|+..|+|||+..+ ..++.++||||+||++|+|++|+.||..... ..............
T Consensus 152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~ 229 (332)
T cd07857 152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY--VDQLNQILQVLGTP 229 (332)
T ss_pred ceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH--HHHHHHHHHHhCCC
Confidence 9765432211 11223468899999998765 4688999999999999999999999965321 11100000000000
Q ss_pred -----------c--ccchhcccccc---CcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 903 -----------E--NVLKVLDCEVA---SESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 903 -----------~--~~~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
. ........... ..........+.+++.+|++.||.+|||+.|++++=
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~ 293 (332)
T cd07857 230 DEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHP 293 (332)
T ss_pred CHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 0 00000000000 000011235688999999999999999999998763
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=278.54 Aligned_cols=153 Identities=22% Similarity=0.330 Sum_probs=132.3
Q ss_pred ccccccccccccccccCHHHH-cCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccccH-HHHHHHHHHHHhcC---
Q 002061 655 EVSSKWKLASFHHIDIDAEQI-CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGV-KVFAAEMEILGKIR--- 729 (973)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~-~~~~~E~~~l~~l~--- 729 (973)
+-...|....+|++.|+.... .+|.+.++||.|.|++||+|.+....+.||+|+.+..+.+ +....|+++|++++
T Consensus 56 E~~~dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~D 135 (590)
T KOG1290|consen 56 EDPEDYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGD 135 (590)
T ss_pred cChhhhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcC
Confidence 344556788899999998888 8999999999999999999999999999999999886544 34578999999983
Q ss_pred --C---CceeeEEEEEEe----CCeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCe
Q 002061 730 --H---RNILKLYACLLK----GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800 (973)
Q Consensus 730 --h---pniv~l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~i 800 (973)
| .+||+++++|.. +.+++||+|++ |.+|..++.... -..++...+..|+.||+.||.|||++| +|
T Consensus 136 p~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~---YrGlpl~~VK~I~~qvL~GLdYLH~ec--gI 209 (590)
T KOG1290|consen 136 PNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSN---YRGLPLSCVKEICRQVLTGLDYLHREC--GI 209 (590)
T ss_pred CCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhC---CCCCcHHHHHHHHHHHHHHHHHHHHhc--Cc
Confidence 2 479999999974 56899999999 779999998653 345888999999999999999999976 99
Q ss_pred EecCCCCCCeeec
Q 002061 801 IHRDIKSSNILLD 813 (973)
Q Consensus 801 vH~Dlkp~Nill~ 813 (973)
||.||||+|||+.
T Consensus 210 IHTDlKPENvLl~ 222 (590)
T KOG1290|consen 210 IHTDLKPENVLLC 222 (590)
T ss_pred cccCCCcceeeee
Confidence 9999999999984
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=316.73 Aligned_cols=145 Identities=33% Similarity=0.413 Sum_probs=131.5
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc-----cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV 749 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 749 (973)
+++|++.+.||+|+||+||+|++..+++.||||++.... ....+.+|+.+++.++||||+++++++......|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 468899999999999999999999889999999986532 235688899999999999999999999999999999
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcc
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~ 827 (973)
|||+++++|.+++... ..+++..+..++.||+.||+||| ..+|+||||||+|||++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~-----~~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIY-----GYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999999753 24778888999999999999999 7899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=280.58 Aligned_cols=238 Identities=32% Similarity=0.369 Sum_probs=193.9
Q ss_pred ccccCceEEEEEEecCCCcEEEEEeeeccc-----cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCCch
Q 002061 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNL 758 (973)
Q Consensus 684 lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL 758 (973)
||+|+||.||++....+++.||+|++.... ..+.+.+|++++++++|||++++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999999889999999886532 345788999999999999999999999999999999999999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCcccc
Q 002061 759 FQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY 838 (973)
Q Consensus 759 ~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~ 838 (973)
.+++... ..+++..+..++.|++.|+.|+| +.+++|+||+|+||+++.++.++++|||.+....... ...
T Consensus 81 ~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~ 150 (250)
T cd05123 81 FSHLSKE-----GRFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRT 150 (250)
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--Ccc
Confidence 9999753 25789999999999999999999 7899999999999999999999999999987654331 112
Q ss_pred cccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccccCcch
Q 002061 839 SCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESI 918 (973)
Q Consensus 839 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (973)
....++..|+|||...+...+.++|+||||+++|++++|+.||..... ............. .+
T Consensus 151 ~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~------------~~ 213 (250)
T cd05123 151 NTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-----KEIYEKILKDPLR------------FP 213 (250)
T ss_pred cCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHhcCCCC------------CC
Confidence 234578899999999888889999999999999999999999964311 1222221111110 11
Q ss_pred HHHHHHHHHHHHHhcCCCCCCCCCH---HHHHH
Q 002061 919 KEDMIKLLKIAVVCTTKLPNLRPPM---REVVK 948 (973)
Q Consensus 919 ~~~~~~l~~l~~~cl~~dP~~Rpt~---~evl~ 948 (973)
......+.+++.+||..||++||++ .++.+
T Consensus 214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 214 EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKA 246 (250)
T ss_pred CCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence 1114567889999999999999999 55554
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-32 Score=279.48 Aligned_cols=243 Identities=28% Similarity=0.363 Sum_probs=191.2
Q ss_pred HHHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCe
Q 002061 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGS 745 (973)
Q Consensus 672 ~~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 745 (973)
.....+|....+||+|+||+|-+|..+.+.+.+|||+++++ ++.+--..|-++|..- +-|.++++..+|+.-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 34456889999999999999999999999999999998873 3333345566676655 57899999999999999
Q ss_pred eEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccC
Q 002061 746 SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGV 825 (973)
Q Consensus 746 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl 825 (973)
.|.||||+.||+|--.+++. ..+.+..+.-+|.+||-||-||| +++||+||+|.+|||++.+|++||+|||+
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~-----GkFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGm 496 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQV-----GKFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGM 496 (683)
T ss_pred eeeEEEEecCchhhhHHHHh-----cccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeeccc
Confidence 99999999999998888764 34566667778999999999999 89999999999999999999999999999
Q ss_pred cccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccccc
Q 002061 826 AKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENV 905 (973)
Q Consensus 826 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 905 (973)
++.---. ......+.||+.|+|||++...+|+.++|+||+||+||||+.|+.||+++ ++..+.+-+..+ .-
T Consensus 497 cKEni~~--~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe--DE~elF~aI~eh---nv-- 567 (683)
T KOG0696|consen 497 CKENIFD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE--DEDELFQAIMEH---NV-- 567 (683)
T ss_pred ccccccC--CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHHHc---cC--
Confidence 8632222 22334578999999999999999999999999999999999999999865 222222222111 11
Q ss_pred chhccccccCcchHHHHHHHHHHHHHhcCCCCCCCC
Q 002061 906 LKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRP 941 (973)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp 941 (973)
..+.-...+...+....+.+.|.+|.
T Consensus 568 ----------syPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 568 ----------SYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred ----------cCcccccHHHHHHHHHHhhcCCcccc
Confidence 11222334455566667788999885
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-32 Score=278.50 Aligned_cols=265 Identities=22% Similarity=0.244 Sum_probs=202.7
Q ss_pred HHHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccccH-HHHHHHHHHHHhcC-C-C----ceeeEEEEEEeCC
Q 002061 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGV-KVFAAEMEILGKIR-H-R----NILKLYACLLKGG 744 (973)
Q Consensus 672 ~~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~-~~~~~E~~~l~~l~-h-p----niv~l~~~~~~~~ 744 (973)
.....+|++...+|+|.||.|-++.+.+++..||||+++.-..+ +...-|+++++++. + | -+|++.++|.-.+
T Consensus 85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 44578999999999999999999999999999999998774333 34456999999993 2 3 4788889999999
Q ss_pred eeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecC----------
Q 002061 745 SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE---------- 814 (973)
Q Consensus 745 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~---------- 814 (973)
+.++|+|.+ |-|+++++..+ ...+++...+..|+.|++++++||| +.+++|-|+||+||++.+
T Consensus 165 hiCivfell-G~S~~dFlk~N---~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k 237 (415)
T KOG0671|consen 165 HICIVFELL-GLSTFDFLKEN---NYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPK 237 (415)
T ss_pred ceEEEEecc-ChhHHHHhccC---CccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccC
Confidence 999999998 77999999864 4556888999999999999999999 899999999999999832
Q ss_pred ----------CCCeEEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcc
Q 002061 815 ----------DYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEE 884 (973)
Q Consensus 815 ----------~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~ 884 (973)
+..+++.|||.|+...... +..+.|..|+|||++.+-.++.++||||+||||+|+.+|...|+.-
T Consensus 238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtH 312 (415)
T KOG0671|consen 238 KKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTH 312 (415)
T ss_pred CccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccC
Confidence 2358999999998654432 4467899999999999999999999999999999999999999753
Q ss_pred cCCcccHHHHHHHHhcccc----------------cc-----------chhccccc----cCcchHHHHHHHHHHHHHhc
Q 002061 885 YGDGKDIVYWVSTHLNNHE----------------NV-----------LKVLDCEV----ASESIKEDMIKLLKIAVVCT 933 (973)
Q Consensus 885 ~~~~~~~~~~~~~~~~~~~----------------~~-----------~~~~~~~~----~~~~~~~~~~~l~~l~~~cl 933 (973)
. +-+.+ .+....+...+ .+ ..+.+... .......+..+|++++.+|+
T Consensus 313 e-n~EHL-aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL 390 (415)
T KOG0671|consen 313 E-NLEHL-AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRML 390 (415)
T ss_pred C-cHHHH-HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHH
Confidence 2 11111 11111000000 00 00000000 00012344567999999999
Q ss_pred CCCCCCCCCHHHHHHHh
Q 002061 934 TKLPNLRPPMREVVKML 950 (973)
Q Consensus 934 ~~dP~~Rpt~~evl~~L 950 (973)
..||.+|+|++|++.|-
T Consensus 391 ~fDP~~RiTl~EAL~Hp 407 (415)
T KOG0671|consen 391 EFDPARRITLREALSHP 407 (415)
T ss_pred ccCccccccHHHHhcCH
Confidence 99999999999999763
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=272.48 Aligned_cols=261 Identities=22% Similarity=0.251 Sum_probs=209.2
Q ss_pred HcCCcccCcccccCceEEEEEEecCC-----CcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEe-CCe
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKN-----AGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLK-GGS 745 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~-----~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~ 745 (973)
-++++....+-+|.||+||.|.+++. .+.|-||.++.. -....+..|.-.+..+.|||+.++.+++.+ .+.
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~ 362 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYAT 362 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCc
Confidence 34677778899999999999988743 334666766542 234557788889999999999999998765 567
Q ss_pred eEEEEEccCCCchHHHHHhhhc---CCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEec
Q 002061 746 SFLVLEYMPNGNLFQALHKRVK---EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIAD 822 (973)
Q Consensus 746 ~~lv~e~~~~gsL~~~l~~~~~---~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 822 (973)
++.+|.++.-|+|..++..... .....+...+...++.|++.|++||| ++++||.||.++|.+|++.-++|++|
T Consensus 363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~LqVkltD 439 (563)
T KOG1024|consen 363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQLQVKLTD 439 (563)
T ss_pred ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhheeEEecc
Confidence 8999999999999999984421 12334667788899999999999999 89999999999999999999999999
Q ss_pred ccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhcc
Q 002061 823 FGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNN 901 (973)
Q Consensus 823 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~ 901 (973)
=.+++..-+.++..-......+..||+||.+....|+.++|||||||++|||+| |+.||.+.+ ..++ .
T Consensus 440 saLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeID-----PfEm-~----- 508 (563)
T KOG1024|consen 440 SALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEID-----PFEM-E----- 508 (563)
T ss_pred chhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccC-----HHHH-H-----
Confidence 999998877665544444566889999999999999999999999999999999 999997642 1111 1
Q ss_pred ccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 002061 902 HENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADAD 954 (973)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 954 (973)
..+...++-.++.+++.+++.++.-||+.+|++||++++++.-|.+..
T Consensus 509 -----~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 509 -----HYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred -----HHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 112222223345567778999999999999999999999999988754
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=278.63 Aligned_cols=220 Identities=24% Similarity=0.217 Sum_probs=177.4
Q ss_pred cCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCCchHHHHHhhh
Q 002061 687 GGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRV 766 (973)
Q Consensus 687 G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~ 766 (973)
|.+|+||+|++..+++.||+|++.... .+.+|...+....||||+++++++..++..++||||+++|+|.+++...
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~---~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~- 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS---EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF- 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh---hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh-
Confidence 899999999999999999999986643 2344555556667999999999999999999999999999999998753
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCcccccccCCccc
Q 002061 767 KEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHG 846 (973)
Q Consensus 767 ~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~ 846 (973)
..+++..+..++.|++.|++|+| +++++||||||+||+++.++.++++|||.+....... ....++..
T Consensus 80 ----~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~ 147 (237)
T cd05576 80 ----LNIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENM 147 (237)
T ss_pred ----cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcc
Confidence 24789999999999999999999 7899999999999999999999999999876554321 12345678
Q ss_pred cccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccccCcchHHHHHHHH
Q 002061 847 YIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLL 926 (973)
Q Consensus 847 y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 926 (973)
|+|||+..+..++.++||||+|+++|||++|+.|+...... ..... .. ..+......+.
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----------~~~~~------~~----~~~~~~~~~~~ 206 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----------INTHT------TL----NIPEWVSEEAR 206 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----------ccccc------cc----CCcccCCHHHH
Confidence 99999998888999999999999999999999887532100 00000 00 01112235678
Q ss_pred HHHHHhcCCCCCCCCCH
Q 002061 927 KIAVVCTTKLPNLRPPM 943 (973)
Q Consensus 927 ~l~~~cl~~dP~~Rpt~ 943 (973)
+++.+|++.||++||++
T Consensus 207 ~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 207 SLLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHHccCCHHHhcCC
Confidence 89999999999999996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=294.99 Aligned_cols=254 Identities=27% Similarity=0.366 Sum_probs=209.3
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-ccHHHHHHHHHHHHhc-CCCceeeEEEEEEe-----CCeeE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKI-RHRNILKLYACLLK-----GGSSF 747 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~-----~~~~~ 747 (973)
...|++.+.||.|.+|.||+++..++++.+|||+.... +..+++..|+.+++.. .|||++.++++|.. ++..|
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLW 97 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLW 97 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEE
Confidence 35678899999999999999999999999999987663 4455678899999888 69999999999863 57899
Q ss_pred EEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcc
Q 002061 748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827 (973)
Q Consensus 748 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~ 827 (973)
+|||||.+||..|+++.-. ...+.|..+.-|...++.|+.+|| .+.++|||||-.||+++.++.||++|||++.
T Consensus 98 LVMEfC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLvDFGvSa 171 (953)
T KOG0587|consen 98 LVMEFCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLVDFGVSA 171 (953)
T ss_pred EEeeccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEeeeeeee
Confidence 9999999999999998753 556899999999999999999999 8899999999999999999999999999998
Q ss_pred cccCCCCcccccccCCccccccccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccc
Q 002061 828 IAENSPKVSDYSCFAGTHGYIAPELAY-----TCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNH 902 (973)
Q Consensus 828 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 902 (973)
..... .......+||+.|||||++. ...|+..+|+||||++..||.-|.+|+.+... +.....
T Consensus 172 QldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP-------mraLF~--- 239 (953)
T KOG0587|consen 172 QLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP-------MRALFL--- 239 (953)
T ss_pred eeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch-------hhhhcc---
Confidence 66433 22334568999999999985 34578899999999999999999999976521 001000
Q ss_pred cccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 903 ENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
-.-.+...-..+....+++-+++..|+.+|.++||++.++++|-
T Consensus 240 ----IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hp 283 (953)
T KOG0587|consen 240 ----IPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHP 283 (953)
T ss_pred ----CCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCC
Confidence 01112222234667788999999999999999999999998764
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=292.06 Aligned_cols=244 Identities=24% Similarity=0.256 Sum_probs=197.8
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEEEEcc
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLVLEYM 753 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~ 753 (973)
...|+....+|.|+|+.|-.+.+..+++..+||++.+. ..+..+|+.++... +||||+++.+.+.++.+.|+|||.+
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~--~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l 398 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR--ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELL 398 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccc--ccccccccchhhhhcCCCcceeecceecCCceeeeeehhc
Confidence 45677777899999999999999999999999998765 33446788777666 7999999999999999999999999
Q ss_pred CCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeee-cCCCCeEEecccCcccccCC
Q 002061 754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILL-DEDYEPKIADFGVAKIAENS 832 (973)
Q Consensus 754 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill-~~~~~~kl~Dfgl~~~~~~~ 832 (973)
.|+-+.+.+... +... ..+..|+.+|+.|+.||| ++|+||||+||+|||+ +++++++|+|||.++.....
T Consensus 399 ~g~ell~ri~~~-----~~~~-~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 399 DGGELLRRIRSK-----PEFC-SEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred cccHHHHHHHhc-----chhH-HHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 999888877643 1222 566679999999999999 8899999999999999 68999999999999866544
Q ss_pred CCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhcccc
Q 002061 833 PKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCE 912 (973)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (973)
.....-|..|.|||+.....|++++|+||||++||+|++|+.||..-..+ ..+...+...+
T Consensus 470 -----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-----~ei~~~i~~~~--------- 530 (612)
T KOG0603|consen 470 -----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-----IEIHTRIQMPK--------- 530 (612)
T ss_pred -----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-----HHHHHhhcCCc---------
Confidence 11123578999999999999999999999999999999999999764322 11111221111
Q ss_pred ccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 002061 913 VASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952 (973)
Q Consensus 913 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~ 952 (973)
..........+++.+|++.||.+||++.++.++-.-
T Consensus 531 ----~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 531 ----FSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ----cccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 113345567889999999999999999999988776
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-32 Score=279.26 Aligned_cols=257 Identities=29% Similarity=0.320 Sum_probs=197.6
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc---------ccHHHHHHHHHHHHhcCCCceeeEEEEEEe-CC
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---------DGVKVFAAEMEILGKIRHRNILKLYACLLK-GG 744 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~ 744 (973)
.++|-..+.||+|||++||+|.+....+.||||+-.-. .-.+...+|.++-+.++||.||++|++|.- .+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 45788889999999999999999988999999975321 123456789999999999999999999975 45
Q ss_pred eeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeec---CCCCeEEe
Q 002061 745 SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD---EDYEPKIA 821 (973)
Q Consensus 745 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~---~~~~~kl~ 821 (973)
..+-|+|||+|.+|.-|++.+ ..+++.+...|+.||+.||.||... +.+|||-|+||.|||+- .-|.+||+
T Consensus 542 sFCTVLEYceGNDLDFYLKQh-----klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQH-----KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred cceeeeeecCCCchhHHHHhh-----hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEee
Confidence 678999999999999999875 3578889999999999999999865 78999999999999984 35789999
Q ss_pred cccCcccccCCCCccc-----ccccCCcccccccccccc----CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHH
Q 002061 822 DFGVAKIAENSPKVSD-----YSCFAGTHGYIAPELAYT----CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIV 892 (973)
Q Consensus 822 Dfgl~~~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~ 892 (973)
|||+++.++....... .+-..||.+|++||.+-- .+.+.++||||+||++|.++.|+.||.-... -.++
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs-QQdI- 693 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS-QQDI- 693 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh-HHHH-
Confidence 9999998876544322 223579999999998753 3578899999999999999999999975411 1111
Q ss_pred HHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 002061 893 YWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVK 948 (973)
Q Consensus 893 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~ 948 (973)
+.... +..-....+ ..-+....+...+|++|+++.-++|.++.++..
T Consensus 694 ------LqeNT-IlkAtEVqF--P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 694 ------LQENT-ILKATEVQF--PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred ------Hhhhc-hhcceeccC--CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 11111 100000111 111233445677899999999999988887754
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=265.64 Aligned_cols=268 Identities=22% Similarity=0.311 Sum_probs=198.9
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEe-------
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLK------- 742 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~------- 742 (973)
....|+...+||+|.||+||+|+.+.+++.||+|+..-+ .-.....+|++++..++|+|++.+++.|..
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 345678888999999999999999999999999976432 223346799999999999999999887743
Q ss_pred -CCeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEe
Q 002061 743 -GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIA 821 (973)
Q Consensus 743 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 821 (973)
....|+||++|+. +|.-.+... ...++...+.+++.++..||.|+| +..|+|||+||.|++|+.+|.+||+
T Consensus 95 ~r~t~ylVf~~ceh-DLaGlLsn~----~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklA 166 (376)
T KOG0669|consen 95 DRATFYLVFDFCEH-DLAGLLSNR----KVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLA 166 (376)
T ss_pred ccceeeeeHHHhhh-hHHHHhcCc----cccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEee
Confidence 2347999999975 787777643 456888999999999999999999 7899999999999999999999999
Q ss_pred cccCcccccCC--CCcccccccCCccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHH
Q 002061 822 DFGVAKIAENS--PKVSDYSCFAGTHGYIAPELAYTC-KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTH 898 (973)
Q Consensus 822 Dfgl~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~ 898 (973)
|||+++.+... ....+++..+-|..|++||.+.|. .|+++.|||+-||++.||++|.+-+++.. +..-...+...
T Consensus 167 DFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnt--eqqql~~Is~L 244 (376)
T KOG0669|consen 167 DFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNT--EQQQLHLISQL 244 (376)
T ss_pred ccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCCh--HHHHHHHHHHH
Confidence 99999765432 223345667779999999988754 69999999999999999999998887542 11111111111
Q ss_pred hcccc--------c--cchhcccc-ccCcc---hHHHH------HHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 899 LNNHE--------N--VLKVLDCE-VASES---IKEDM------IKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 899 ~~~~~--------~--~~~~~~~~-~~~~~---~~~~~------~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
..... . +.+.+..+ ..... .++.. .+..+++..++..||.+|+++++++.|-.
T Consensus 245 cGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~ 317 (376)
T KOG0669|consen 245 CGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDF 317 (376)
T ss_pred hccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhh
Confidence 11100 0 11111000 10000 11111 14567888999999999999999987754
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-31 Score=261.88 Aligned_cols=201 Identities=26% Similarity=0.420 Sum_probs=176.1
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeec-----cccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeE
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSF 747 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~-----~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 747 (973)
.+.+|+..++||+|+|++|.+++++++.+.+|+|++++ +++.+-.+.|-.+.... +||.+|.+..+|..+...+
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 35688999999999999999999999999999999876 34555667788877766 7999999999999999999
Q ss_pred EEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcc
Q 002061 748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827 (973)
Q Consensus 748 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~ 827 (973)
.|.||++||+|--.++++ ..++++...-+...|+-||.||| ++|||+||+|.+||+++..|++|++|+|+++
T Consensus 328 fvieyv~ggdlmfhmqrq-----rklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmck 399 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK 399 (593)
T ss_pred EEEEEecCcceeeehhhh-----hcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhh
Confidence 999999999997777653 35788888888999999999999 8999999999999999999999999999986
Q ss_pred cccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcc
Q 002061 828 IAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEE 884 (973)
Q Consensus 828 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~ 884 (973)
.--. .....+.++||+.|.|||++++..|..++|+|++||+++||+.|+.||+--
T Consensus 400 e~l~--~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdiv 454 (593)
T KOG0695|consen 400 EGLG--PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIV 454 (593)
T ss_pred cCCC--CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCccee
Confidence 3221 122344578999999999999999999999999999999999999999743
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=245.51 Aligned_cols=201 Identities=27% Similarity=0.391 Sum_probs=168.3
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeec---cccHHHHHHHHHHHHh-cCCCceeeEEEEEEeCCeeEEEEEc
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK---GDGVKVFAAEMEILGK-IRHRNILKLYACLLKGGSSFLVLEY 752 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~---~~~~~~~~~E~~~l~~-l~hpniv~l~~~~~~~~~~~lv~e~ 752 (973)
....+..||+|+||.|=+.++..+|...|+|.+.. .+..++..+|+.+..+ ..+|.+|.+|+.+..+..+++.||.
T Consensus 47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~ 126 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL 126 (282)
T ss_pred hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence 44566789999999999999999999999999876 3445566778887655 4799999999999999999999999
Q ss_pred cCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCC
Q 002061 753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832 (973)
Q Consensus 753 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 832 (973)
| ..||..+-+.- ......+++...-+||..+.+||.|||+ ...+||||+||+|||++.+|++|+||||.+....+.
T Consensus 127 M-~tSldkfy~~v-~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS 202 (282)
T KOG0984|consen 127 M-DTSLDKFYRKV-LKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS 202 (282)
T ss_pred h-hhhHHHHHHHH-HhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence 9 56887766543 3345678999999999999999999997 678999999999999999999999999998766543
Q ss_pred CCcccccccCCccccccccccc----cCCCCccchHHHHHHHHHHHHhCCCCCCcc
Q 002061 833 PKVSDYSCFAGTHGYIAPELAY----TCKVSEKSDVFSFGVVLLELVTGRKPVEEE 884 (973)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~DvwslG~~l~el~tg~~pf~~~ 884 (973)
- ..+...|-..|||||.+. .+.|+.++||||||+++.||.+++.||+..
T Consensus 203 i---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 203 I---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred h---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 1 222235678899999874 347899999999999999999999999754
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-30 Score=275.70 Aligned_cols=203 Identities=26% Similarity=0.380 Sum_probs=174.7
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL 750 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 750 (973)
.-|..++.||-|+||+|.+++-.++...||+|.+.+. ..+..++.|-+||..-+.+-||++|..|.+++.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 3477789999999999999999999999999988763 34566788999999999999999999999999999999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccc-
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA- 829 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~- 829 (973)
+|++||++-.+|-+. ..+.+...+-++.++++|+++.| ..|+|||||||+|||||.+|++||+|||+++-+
T Consensus 709 dYIPGGDmMSLLIrm-----gIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRM-----GIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred eccCCccHHHHHHHh-----ccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccce
Confidence 999999999998764 35777777788899999999999 899999999999999999999999999998532
Q ss_pred --------cCCCCcc-------------------------------cccccCCccccccccccccCCCCccchHHHHHHH
Q 002061 830 --------ENSPKVS-------------------------------DYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVV 870 (973)
Q Consensus 830 --------~~~~~~~-------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~ 870 (973)
+.++... .....+||..|+|||++....|+..+|+||.|||
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI 860 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence 1111100 0012469999999999999999999999999999
Q ss_pred HHHHHhCCCCCCcccC
Q 002061 871 LLELVTGRKPVEEEYG 886 (973)
Q Consensus 871 l~el~tg~~pf~~~~~ 886 (973)
||||+.|+.||.....
T Consensus 861 l~em~~g~~pf~~~tp 876 (1034)
T KOG0608|consen 861 LYEMLVGQPPFLADTP 876 (1034)
T ss_pred HHHHhhCCCCccCCCC
Confidence 9999999999976543
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=300.00 Aligned_cols=266 Identities=18% Similarity=0.175 Sum_probs=172.4
Q ss_pred HHcCCcccCcccccCceEEEEEEecCC----CcEEEEEeeeccccHHHHHHHHHHHHhcCCCceeeEEEE------EEeC
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKN----AGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYAC------LLKG 743 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~----~~~vavK~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~------~~~~ 743 (973)
..++|++.+.||+|+||+||+|++..+ +..||||++......+....| .+++..+.++..++.. ...+
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~ 207 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKE 207 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHH--HHHhhchhhHHHHHHhhhcccccccC
Confidence 456899999999999999999999988 899999987653322222221 1122222222222211 2356
Q ss_pred CeeEEEEEccCCCchHHHHHhhhcC---------------CCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCC
Q 002061 744 GSSFLVLEYMPNGNLFQALHKRVKE---------------GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSS 808 (973)
Q Consensus 744 ~~~~lv~e~~~~gsL~~~l~~~~~~---------------~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~ 808 (973)
...++||||+++++|.+++...... .........+..++.|++.||+||| +++|+||||||+
T Consensus 208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLKP~ 284 (566)
T PLN03225 208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVKPQ 284 (566)
T ss_pred CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCCHH
Confidence 6789999999999999998753100 0001122345679999999999999 789999999999
Q ss_pred CeeecC-CCCeEEecccCcccccCCCCcccccccCCccccccccccccC----------------------CCCccchHH
Q 002061 809 NILLDE-DYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTC----------------------KVSEKSDVF 865 (973)
Q Consensus 809 Nill~~-~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~Dvw 865 (973)
|||++. ++.+||+|||+++....... .......+++.|+|||.+... .++.++|||
T Consensus 285 NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw 363 (566)
T PLN03225 285 NIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 363 (566)
T ss_pred HEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence 999986 57999999999976543322 122345689999999965322 234466999
Q ss_pred HHHHHHHHHHhCCCCCCcccC--------CcccHHHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCC
Q 002061 866 SFGVVLLELVTGRKPVEEEYG--------DGKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLP 937 (973)
Q Consensus 866 slG~~l~el~tg~~pf~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP 937 (973)
|+||++|||+++..|++.... .+.+...|......... .+ ....+ +..........+++.+|++.||
T Consensus 364 SlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~--~~-~~~~~--~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 364 SAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRAS--PD-LRRGF--EVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred HHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccc--hh-hhhhh--hhccccchHHHHHHHHHccCCc
Confidence 999999999998776543200 01111111111100000 00 00000 0000112235589999999999
Q ss_pred CCCCCHHHHHHHh
Q 002061 938 NLRPPMREVVKML 950 (973)
Q Consensus 938 ~~Rpt~~evl~~L 950 (973)
++|||+.|+++|-
T Consensus 439 ~kR~ta~e~L~Hp 451 (566)
T PLN03225 439 RQRISAKAALAHP 451 (566)
T ss_pred ccCCCHHHHhCCc
Confidence 9999999999973
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-31 Score=293.31 Aligned_cols=247 Identities=25% Similarity=0.384 Sum_probs=188.9
Q ss_pred cccCcccccCceE-EEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEEEEccCCC
Q 002061 679 EEDNLIGSGGTGK-VYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLVLEYMPNG 756 (973)
Q Consensus 679 ~~~~~lG~G~~g~-V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~g 756 (973)
.-.+.+|+|+.|+ ||+|... |+.||||++-.+ -.+...+|++.++.- +|||||++++...++...|+..|.| ..
T Consensus 512 ~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e-~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~ 587 (903)
T KOG1027|consen 512 SPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEE-FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-AC 587 (903)
T ss_pred ccHHHcccCCCCcEEEEEeeC--CceehHHHHhhH-hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hh
Confidence 3346789999987 8999988 789999987543 244568999999888 6999999999999999999999999 57
Q ss_pred chHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecC---C--CCeEEecccCcccccC
Q 002061 757 NLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE---D--YEPKIADFGVAKIAEN 831 (973)
Q Consensus 757 sL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~--~~~kl~Dfgl~~~~~~ 831 (973)
+|.+++... ..............+..|++.|+++|| +.+||||||||+||||+. + .+++|+|||++++...
T Consensus 588 sL~dlie~~-~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 588 SLQDLIESS-GLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred hHHHHHhcc-ccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 999999863 111111111345678899999999999 889999999999999976 3 4699999999998875
Q ss_pred CCCc-ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhc
Q 002061 832 SPKV-SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVL 909 (973)
Q Consensus 832 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (973)
+... .......||-+|+|||++....-+.++||+|+||++|+.++ |.+||++......++. .....+...
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl-------~~~~~L~~L- 735 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANIL-------TGNYTLVHL- 735 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhh-------cCccceeee-
Confidence 5433 22445679999999999998888889999999999999999 5999987632211111 111111100
Q ss_pred cccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 910 DCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 910 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
....++ ...++|.+|+++||..||++.+|+.|
T Consensus 736 ------~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 736 ------EPLPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred ------ccCchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 001111 56789999999999999999999865
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-31 Score=279.05 Aligned_cols=253 Identities=25% Similarity=0.330 Sum_probs=206.0
Q ss_pred HHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeE
Q 002061 673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF 747 (973)
Q Consensus 673 ~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 747 (973)
..+.+++.+..||-|+||.|=+++.......+|+|++++. ...+.+..|-.+|...+.|.||++|-.|.+..++|
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY 496 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY 496 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence 4456778888999999999999999876666899988763 34456778999999999999999999999999999
Q ss_pred EEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcc
Q 002061 748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827 (973)
Q Consensus 748 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~ 827 (973)
|.||-|-||.++..++++ ..++.....-++..+.+|++||| +++||+||+||+|.+++.+|-+||.|||.|+
T Consensus 497 mLmEaClGGElWTiLrdR-----g~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAK 568 (732)
T KOG0614|consen 497 MLMEACLGGELWTILRDR-----GSFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAK 568 (732)
T ss_pred hhHHhhcCchhhhhhhhc-----CCcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHH
Confidence 999999999999999865 35666677778899999999999 8999999999999999999999999999999
Q ss_pred cccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccch
Q 002061 828 IAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLK 907 (973)
Q Consensus 828 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
....+.. ...++||+.|.|||++..+..+.++|.||||+++||+++|.+||... +........++.-+
T Consensus 569 ki~~g~K---TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~-----dpmktYn~ILkGid---- 636 (732)
T KOG0614|consen 569 KIGSGRK---TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGV-----DPMKTYNLILKGID---- 636 (732)
T ss_pred HhccCCc---eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCC-----chHHHHHHHHhhhh----
Confidence 8876643 33478999999999999999999999999999999999999999764 22222222211111
Q ss_pred hccccccCcchHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHhh
Q 002061 908 VLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPP-----MREVVKMLA 951 (973)
Q Consensus 908 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt-----~~evl~~L~ 951 (973)
..+.+....+...+++++.....|.+|.- +.||-+|-+
T Consensus 637 ------~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~W 679 (732)
T KOG0614|consen 637 ------KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRW 679 (732)
T ss_pred ------hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhh
Confidence 11223334445667788888899999974 778877654
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=264.96 Aligned_cols=238 Identities=32% Similarity=0.419 Sum_probs=192.5
Q ss_pred CceEEEEEEecCCCcEEEEEeeecccc---HHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCCchHHHHHh
Q 002061 688 GTGKVYRLDLKKNAGTVAVKQLWKGDG---VKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHK 764 (973)
Q Consensus 688 ~~g~V~~a~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 764 (973)
+||.||+|+...+++.||+|++..... .+.+.+|++.+++++|+|++++++++..+...+++|||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999998899999999876433 67889999999999999999999999999999999999999999999875
Q ss_pred hhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCcccccccCCc
Q 002061 765 RVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGT 844 (973)
Q Consensus 765 ~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt 844 (973)
. ..+++..+..++.+++.+++||| +.+++|+||+|+||+++.++.++++|||.+....... ......++
T Consensus 81 ~-----~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~ 149 (244)
T smart00220 81 R-----GRLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGT 149 (244)
T ss_pred c-----cCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCC
Confidence 3 12788999999999999999999 7899999999999999999999999999998665432 22234578
Q ss_pred cccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccccCcchHHHHHH
Q 002061 845 HGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIK 924 (973)
Q Consensus 845 ~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 924 (973)
..|++||...+..++.++||||+|+++|++++|..||.... +......... ...... .........+
T Consensus 150 ~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~----~~~~~~~~~~-~~~~~~--------~~~~~~~~~~ 216 (244)
T smart00220 150 PEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD----QLLELFKKIG-KPKPPF--------PPPEWKISPE 216 (244)
T ss_pred cCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----cHHHHHHHHh-ccCCCC--------ccccccCCHH
Confidence 89999999988889999999999999999999999996531 1111111111 111000 0000003457
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 925 LLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 925 l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
+.+++.+|+..+|++||++.+++++
T Consensus 217 ~~~~i~~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 217 AKDLIRKLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred HHHHHHHHccCCchhccCHHHHhhC
Confidence 8899999999999999999999873
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-31 Score=256.93 Aligned_cols=265 Identities=21% Similarity=0.262 Sum_probs=190.2
Q ss_pred CcccCcccccCceEEEEEEecCCCcEEEEEeeec----cccHHHHHHHHHHHHhcCCCceeeEEEEEEeC-----CeeEE
Q 002061 678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKIRHRNILKLYACLLKG-----GSSFL 748 (973)
Q Consensus 678 ~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~~l 748 (973)
.+-.+.||.|+||.||.+.+..+|+.||.|++.. -...+++-+|.+++..++|.|++..++..... .+.|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 3566889999999999999999999999998755 23557788999999999999999998877653 24688
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccc
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 828 (973)
|+|.|. .+|...+- +...++...+.-+.+||++||+||| +.+|.||||||.|.++..+...||||||+++.
T Consensus 135 ~TELmQ-SDLHKIIV-----SPQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 135 LTELMQ-SDLHKIIV-----SPQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLART 205 (449)
T ss_pred HHHHHH-hhhhheec-----cCCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccc
Confidence 889884 46665553 2445777778889999999999999 88999999999999999999999999999986
Q ss_pred ccCCCCcccccccCCccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccCCc-----------ccHHHH--
Q 002061 829 AENSPKVSDYSCFAGTHGYIAPELAYTC-KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDG-----------KDIVYW-- 894 (973)
Q Consensus 829 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~-----------~~~~~~-- 894 (973)
.+..+. ...+..+-|..|+|||++.|. .|+.++||||.||++.|++..+..|+....-. .....+
T Consensus 206 ee~d~~-~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ 284 (449)
T KOG0664|consen 206 WDQRDR-LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKY 284 (449)
T ss_pred cchhhh-hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHH
Confidence 654322 223334568899999999865 68999999999999999999888886321100 000000
Q ss_pred ----HHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 002061 895 ----VSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952 (973)
Q Consensus 895 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~ 952 (973)
.+.++.+.....-.+..-+.-......-.+-..+...++..||++|.+..+.+.++-.
T Consensus 285 ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~ 346 (449)
T KOG0664|consen 285 ACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL 346 (449)
T ss_pred HhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence 1111111110000000000000011112234566778899999999999999887653
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=280.33 Aligned_cols=262 Identities=19% Similarity=0.174 Sum_probs=181.1
Q ss_pred HHcCCcccCcccccCceEEEEEEec----------------CCCcEEEEEeeeccc--cHH--------------HHHHH
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLK----------------KNAGTVAVKQLWKGD--GVK--------------VFAAE 721 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~----------------~~~~~vavK~~~~~~--~~~--------------~~~~E 721 (973)
..++|++.++||+|+||+||+|... ..++.||||++.... ..+ ....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 3568999999999999999999752 235679999986421 111 23346
Q ss_pred HHHHHhcCCCce-----eeEEEEEEe--------CCeeEEEEEccCCCchHHHHHhhhcC-------------------C
Q 002061 722 MEILGKIRHRNI-----LKLYACLLK--------GGSSFLVLEYMPNGNLFQALHKRVKE-------------------G 769 (973)
Q Consensus 722 ~~~l~~l~hpni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~ 769 (973)
+.++.+++|.++ ++++++|.. ++..++||||+++|+|.++++..... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766554 667777643 35689999999999999998742110 1
Q ss_pred CCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCcccccccCCcccccc
Q 002061 770 KPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIA 849 (973)
Q Consensus 770 ~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~a 849 (973)
....++..+..++.|+++|++|+| +.+|+||||||+||+++.++.+||+|||++........ .......+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence 123567788899999999999999 78999999999999999999999999999975543221 11122345789999
Q ss_pred ccccccCC--------------------C--CccchHHHHHHHHHHHHhCCC-CCCcccCC-------cccHHHHHHHHh
Q 002061 850 PELAYTCK--------------------V--SEKSDVFSFGVVLLELVTGRK-PVEEEYGD-------GKDIVYWVSTHL 899 (973)
Q Consensus 850 PE~~~~~~--------------------~--~~~~DvwslG~~l~el~tg~~-pf~~~~~~-------~~~~~~~~~~~~ 899 (973)
||++.... + ..+.||||+||++|+|++|.. ||...... ..+...|.....
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 99875322 1 134799999999999999875 77532111 111111111100
Q ss_pred ccccccchhccccccCcchHHHHHHHHHHHHHhcCCCC---CCCCCHHHHHHHh
Q 002061 900 NNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLP---NLRPPMREVVKML 950 (973)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP---~~Rpt~~evl~~L 950 (973)
................+++.+++..+| .+|+|++|+++|-
T Consensus 459 -----------~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp 501 (507)
T PLN03224 459 -----------QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHR 501 (507)
T ss_pred -----------cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCC
Confidence 001011122234567788889998766 6899999999874
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=239.62 Aligned_cols=263 Identities=19% Similarity=0.238 Sum_probs=197.8
Q ss_pred HHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhcC-CCceeeEEEEEEeC--CeeEEE
Q 002061 673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIR-HRNILKLYACLLKG--GSSFLV 749 (973)
Q Consensus 673 ~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~--~~~~lv 749 (973)
-..++|++.+++|+|.|++||.|....+.+.++||++++ ...+.+.+|+++++.+. ||||+++++...++ ..+.+|
T Consensus 35 g~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 35 GNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 355789999999999999999999988899999998864 44567899999999997 99999999998764 457899
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCC-CCeEEecccCccc
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDED-YEPKIADFGVAKI 828 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfgl~~~ 828 (973)
+||+++.+...... .++...+.-.+.+++.||.|+| +.||+|||+||.|++++.. -..++.|+|+|.+
T Consensus 114 FE~v~n~Dfk~ly~--------tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEF 182 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYP--------TLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
T ss_pred hhhhccccHHHHhh--------hhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhh
Confidence 99999877655443 3566777889999999999999 8999999999999999864 5699999999998
Q ss_pred ccCCCCcccccccCCccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHH------------
Q 002061 829 AENSPKVSDYSCFAGTHGYIAPELAYTC-KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWV------------ 895 (973)
Q Consensus 829 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~------------ 895 (973)
+.++. .+...+.+..|.-||.+... .|+.+-|+|||||++..|+..+.||---.....+++..+
T Consensus 183 YHp~~---eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl 259 (338)
T KOG0668|consen 183 YHPGK---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYL 259 (338)
T ss_pred cCCCc---eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHH
Confidence 76553 34456778889999998654 478899999999999999999999954322222222221
Q ss_pred -HHHhccccccchhcccc-------ccCcchHH-HHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 896 -STHLNNHENVLKVLDCE-------VASESIKE-DMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 896 -~~~~~~~~~~~~~~~~~-------~~~~~~~~-~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
+-.+.-.+.+..++..- +....... ..++..+++.+.+.+|-++|+|++|.++|-
T Consensus 260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~Hp 323 (338)
T KOG0668|consen 260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHP 323 (338)
T ss_pred HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCc
Confidence 11111111111111100 00000111 124567888899999999999999998763
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-29 Score=265.19 Aligned_cols=199 Identities=30% Similarity=0.436 Sum_probs=174.1
Q ss_pred HHHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc-----cH-----HHHHHHHHHHHhcC---CCceeeEEE
Q 002061 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----GV-----KVFAAEMEILGKIR---HRNILKLYA 738 (973)
Q Consensus 672 ~~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-----~~-----~~~~~E~~~l~~l~---hpniv~l~~ 738 (973)
...+.+|...+++|+|+||.|+.|.++++...|+||.+.++. +. ..+-.|+++|.+++ |+||+++++
T Consensus 557 ~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLd 636 (772)
T KOG1152|consen 557 YKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLD 636 (772)
T ss_pred ecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhh
Confidence 455678999999999999999999999999999999987742 11 22456999999997 999999999
Q ss_pred EEEeCCeeEEEEEccCCC-chHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCC
Q 002061 739 CLLKGGSSFLVLEYMPNG-NLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE 817 (973)
Q Consensus 739 ~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~ 817 (973)
+|++++.+|++||-...| +|++++.. .+.+++.....|+.||+.|+++|| +.+|||||||-+||.++.+|-
T Consensus 637 fFEddd~yyl~te~hg~gIDLFd~IE~-----kp~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~ 708 (772)
T KOG1152|consen 637 FFEDDDYYYLETEVHGEGIDLFDFIEF-----KPRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGF 708 (772)
T ss_pred eeecCCeeEEEecCCCCCcchhhhhhc-----cCccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCe
Confidence 999999999999986544 89999975 356888999999999999999999 889999999999999999999
Q ss_pred eEEecccCcccccCCCCcccccccCCccccccccccccCCCC-ccchHHHHHHHHHHHHhCCCCCC
Q 002061 818 PKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVS-EKSDVFSFGVVLLELVTGRKPVE 882 (973)
Q Consensus 818 ~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~tg~~pf~ 882 (973)
+|+.|||.+....++ ....++||.+|.|||++.|.+|- ..-|||++|++||.++....||.
T Consensus 709 ~klidfgsaa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 709 VKLIDFGSAAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred EEEeeccchhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999999999766543 34567899999999999988875 56899999999999999988884
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=246.29 Aligned_cols=256 Identities=27% Similarity=0.308 Sum_probs=198.3
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCC------e
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGG------S 745 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------~ 745 (973)
.+|.-...+|.|.- .|..|.+.-.++.||+|+...+ ...++..+|...+..+.|+||++++.+|.... +
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 46777788999999 7878888888999999987553 34567789999999999999999999997543 5
Q ss_pred eEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccC
Q 002061 746 SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGV 825 (973)
Q Consensus 746 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl 825 (973)
.|+|||+| .++|...+.. .++-..+..+.+|+++|++|+| +.+|+|||+||+||++..++.+||.|||+
T Consensus 96 ~y~v~e~m-~~nl~~vi~~-------elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVILM-------ELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGL 164 (369)
T ss_pred HHHHHHhh-hhHHHHHHHH-------hcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchh
Confidence 69999999 5689888873 3677788899999999999999 89999999999999999999999999999
Q ss_pred cccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHH----------
Q 002061 826 AKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWV---------- 895 (973)
Q Consensus 826 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~---------- 895 (973)
|+..+.. ...+..+.|..|+|||++-+..+.+.+||||+||++.||++|+.-|.+.. .+.+|.
T Consensus 165 ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d----~idQ~~ki~~~lgtpd 237 (369)
T KOG0665|consen 165 ARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD----HIDQWNKIIEQLGTPD 237 (369)
T ss_pred hcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch----HHHHHHHHHHHhcCCC
Confidence 9866543 33445678899999999998889999999999999999999999886431 122221
Q ss_pred -----------HHHhccccccch------hccccccC--cchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 896 -----------STHLNNHENVLK------VLDCEVAS--ESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 896 -----------~~~~~~~~~~~~------~~~~~~~~--~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
+......+.+.. +-|..+.. +..+-......+++.+|+-.+|++|-+++++++|-
T Consensus 238 ~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HP 311 (369)
T KOG0665|consen 238 PSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHP 311 (369)
T ss_pred HHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCC
Confidence 111111111111 11111111 11122334567788999999999999999999984
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-28 Score=256.26 Aligned_cols=279 Identities=21% Similarity=0.219 Sum_probs=213.4
Q ss_pred cccccccccCHHHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-ccHHHHHHHHHHHHhcC------CCcee
Q 002061 662 LASFHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIR------HRNIL 734 (973)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~------hpniv 734 (973)
...++.+.+++..-.+|.+....|+|-|++|..|.+...|..||||++... ...+.=.+|+++|+++. --|++
T Consensus 418 aEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hcl 497 (752)
T KOG0670|consen 418 AEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCL 497 (752)
T ss_pred ccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHH
Confidence 456777888888888999999999999999999999988999999999774 34455678999999995 34899
Q ss_pred eEEEEEEeCCeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecC
Q 002061 735 KLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE 814 (973)
Q Consensus 735 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~ 814 (973)
+++-.|....++|||+|-+ .-+|.+.++..+. ...+....+..++.|+.-||..|- .-+|+|.||||+||||.+
T Consensus 498 rl~r~F~hknHLClVFE~L-slNLRevLKKyG~--nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE 571 (752)
T KOG0670|consen 498 RLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGR--NVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNE 571 (752)
T ss_pred HHHHHhhhcceeEEEehhh-hchHHHHHHHhCc--ccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEecc
Confidence 9999999999999999988 5699999987643 345677788999999999999999 779999999999999987
Q ss_pred C-CCeEEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCc-----
Q 002061 815 D-YEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDG----- 888 (973)
Q Consensus 815 ~-~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~----- 888 (973)
. ..+||||||.|.......-+. ..-+..|.|||++.|..|+...|+||.||+|||+.||+..|.+.....
T Consensus 572 ~k~iLKLCDfGSA~~~~eneitP----YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~ 647 (752)
T KOG0670|consen 572 SKNILKLCDFGSASFASENEITP----YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLF 647 (752)
T ss_pred CcceeeeccCccccccccccccH----HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHH
Confidence 5 468999999998765443211 223568999999999999999999999999999999999996542110
Q ss_pred -----ccHHHHHHH------Hhccc-ccc---------------c-----------hhccccccCcchHHHHHHHHHHHH
Q 002061 889 -----KDIVYWVST------HLNNH-ENV---------------L-----------KVLDCEVASESIKEDMIKLLKIAV 930 (973)
Q Consensus 889 -----~~~~~~~~~------~~~~~-~~~---------------~-----------~~~~~~~~~~~~~~~~~~l~~l~~ 930 (973)
.-...++.. +.... ..+ . .++.....+.........|.+|+.
T Consensus 648 me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLd 727 (752)
T KOG0670|consen 648 MELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLD 727 (752)
T ss_pred HHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHH
Confidence 000011100 00000 000 0 000011112223445667889999
Q ss_pred HhcCCCCCCCCCHHHHHHHh
Q 002061 931 VCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 931 ~cl~~dP~~Rpt~~evl~~L 950 (973)
.|+..||++|.|..++++|-
T Consensus 728 kml~LdP~KRit~nqAL~Hp 747 (752)
T KOG0670|consen 728 KMLILDPEKRITVNQALKHP 747 (752)
T ss_pred HHhccChhhcCCHHHHhcCC
Confidence 99999999999999999874
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-26 Score=238.02 Aligned_cols=210 Identities=38% Similarity=0.575 Sum_probs=184.7
Q ss_pred ccccCceEEEEEEecCCCcEEEEEeeecccc---HHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCCchHH
Q 002061 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG---VKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQ 760 (973)
Q Consensus 684 lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~ 760 (973)
||+|.+|.||++....+++.+++|++..... .+.+.+|++.++.++|++++++++++......+++|||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999998899999999877544 4788999999999999999999999999999999999999999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecC-CCCeEEecccCcccccCCCCccccc
Q 002061 761 ALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE-DYEPKIADFGVAKIAENSPKVSDYS 839 (973)
Q Consensus 761 ~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfgl~~~~~~~~~~~~~~ 839 (973)
++... ...+++..+..++.+++++++++| +.+++|+||+|.||+++. ++.++++|||.+........ ...
T Consensus 81 ~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~ 151 (215)
T cd00180 81 LLKEN----EGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLK 151 (215)
T ss_pred HHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhh
Confidence 98753 135788999999999999999999 789999999999999999 89999999999976644321 122
Q ss_pred ccCCccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccccCcch
Q 002061 840 CFAGTHGYIAPELAYTC-KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESI 918 (973)
Q Consensus 840 ~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (973)
...+...|++||..... .++.++|+|++|++++++
T Consensus 152 ~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------- 187 (215)
T cd00180 152 TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------- 187 (215)
T ss_pred cccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------------
Confidence 34577899999998877 788999999999999998
Q ss_pred HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 919 KEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 919 ~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
..+.+++.+|++.+|++||++.++++++
T Consensus 188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ----PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ----HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 4577899999999999999999998764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-27 Score=233.06 Aligned_cols=251 Identities=21% Similarity=0.298 Sum_probs=192.0
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-ccHHHHHHHHHHHHhc-CCCceeeEEEE-EEeCCeeEEEEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKI-RHRNILKLYAC-LLKGGSSFLVLE 751 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~-~~~~~~~~lv~e 751 (973)
.+.|.+.+.+|+|.||.+-+++++.+...+|+|-+..+ ...++|.+|...--.+ .|.||+.-|++ |+..+.++.++|
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 45789999999999999999999999999999988765 4567788888765555 58999988774 566778889999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecC--CCCeEEecccCcccc
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE--DYEPKIADFGVAKIA 829 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~--~~~~kl~Dfgl~~~~ 829 (973)
|++.|+|.+-+.. ..+-+....+++.|+++|+.|+| +.++||||||.+||||-. ..++|+||||..+..
T Consensus 103 ~aP~gdL~snv~~------~GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 103 FAPRGDLRSNVEA------AGIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred cCccchhhhhcCc------ccccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeeccccccc
Confidence 9999999887653 24667777899999999999999 889999999999999943 447999999998765
Q ss_pred cCCCCcccccccCCccccccccccccC-----CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccc
Q 002061 830 ENSPKVSDYSCFAGTHGYIAPELAYTC-----KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHEN 904 (973)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 904 (973)
+..-. ...-+..|.|||+.... ...+.+|||.||+++|.++||..||+.....+.....|.++..+....
T Consensus 174 g~tV~-----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~ 248 (378)
T KOG1345|consen 174 GTTVK-----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPA 248 (378)
T ss_pred Cceeh-----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCcc
Confidence 43221 12235679999986432 356789999999999999999999986555555666665555444432
Q ss_pred cchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 002061 905 VLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVK 948 (973)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~ 948 (973)
.. .......++..++.++-+.++|++|=...++.+
T Consensus 249 ~P---------~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 249 LP---------KKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred Cc---------hhhcccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence 22 222334456777788889999999944444433
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6e-27 Score=244.55 Aligned_cols=265 Identities=25% Similarity=0.352 Sum_probs=201.6
Q ss_pred HcCCcccCcccccCceEEEEEEecC---CCcEEEEEeeeccccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKK---NAGTVAVKQLWKGDGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLVL 750 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~---~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~ 750 (973)
...|..+++||+|.|++||+|.+.. .++.||+|.+.......++.+|++++.++ -+.||+++.+++..++.+.+|+
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivl 114 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVL 114 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEe
Confidence 4568889999999999999999987 68899999998888888999999999999 5999999999999999999999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecC-CCCeEEecccCcccc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE-DYEPKIADFGVAKIA 829 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfgl~~~~ 829 (973)
||+++.+-.++... ++...+..++..+..||+++| ..|||||||||.|++.+. .+.-.|.|||+|...
T Consensus 115 p~~~H~~f~~l~~~--------l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~ 183 (418)
T KOG1167|consen 115 PYFEHDRFRDLYRS--------LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY 183 (418)
T ss_pred cccCccCHHHHHhc--------CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHHHH
Confidence 99999988887763 567888899999999999999 899999999999999985 567899999998722
Q ss_pred cCCC-------------C---------------------cc--------cccccCCccccccccccccC-CCCccchHHH
Q 002061 830 ENSP-------------K---------------------VS--------DYSCFAGTHGYIAPELAYTC-KVSEKSDVFS 866 (973)
Q Consensus 830 ~~~~-------------~---------------------~~--------~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws 866 (973)
+... . .. ......||++|+|||++... ..++++||||
T Consensus 184 d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws 263 (418)
T KOG1167|consen 184 DGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWS 263 (418)
T ss_pred HhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceee
Confidence 1100 0 00 00124599999999998754 4688999999
Q ss_pred HHHHHHHHHhCCCCCCcccCCcccHHHHH-----------HHHhcc-----ccc---cch------hcc-----c----c
Q 002061 867 FGVVLLELVTGRKPVEEEYGDGKDIVYWV-----------STHLNN-----HEN---VLK------VLD-----C----E 912 (973)
Q Consensus 867 lG~~l~el~tg~~pf~~~~~~~~~~~~~~-----------~~~~~~-----~~~---~~~------~~~-----~----~ 912 (973)
.||++.-+++++.||-....+-..+.+.+ +..... ... ..+ -++ + .
T Consensus 264 ~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n 343 (418)
T KOG1167|consen 264 AGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPN 343 (418)
T ss_pred ccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccc
Confidence 99999999999999976544433222221 000000 000 000 000 0 0
Q ss_pred ccCcchHHHH-HHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 913 VASESIKEDM-IKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 913 ~~~~~~~~~~-~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
.......+.. ..+++++.+|+..+|.+|-|+.|.++|-
T Consensus 344 ~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHp 382 (418)
T KOG1167|consen 344 TEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHP 382 (418)
T ss_pred eeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCc
Confidence 1111112222 2678999999999999999999999864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.8e-28 Score=262.54 Aligned_cols=252 Identities=26% Similarity=0.362 Sum_probs=201.5
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeec--cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK--GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM 753 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 753 (973)
.+|+...++|.|.||.||||++..+++..|||+++- ..+.+..+.|+-+++..+||||+.+++.+...+..++.||||
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc 94 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC 94 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence 478889999999999999999999999999998865 467778899999999999999999999999999999999999
Q ss_pred CCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCC
Q 002061 754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833 (973)
Q Consensus 754 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 833 (973)
.+|+|.+.-+ ....+++.++..+.....+|++|+| +.+-+|||||-.||++++.|.+|++|||.+..+...
T Consensus 95 gggslQdiy~-----~TgplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqitat- 165 (829)
T KOG0576|consen 95 GGGSLQDIYH-----VTGPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT- 165 (829)
T ss_pred CCCcccceee-----ecccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhhh-
Confidence 9999988654 3456788888888999999999999 889999999999999999999999999998755422
Q ss_pred CcccccccCCcccccccccc---ccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhcc
Q 002061 834 KVSDYSCFAGTHGYIAPELA---YTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLD 910 (973)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (973)
......+.||+.|||||+. +.+.|...+|||++|+...|+-.-+.|..+. ..+....+-... .++
T Consensus 166 -i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdl-------hpmr~l~LmTkS----~~q 233 (829)
T KOG0576|consen 166 -IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDL-------HPMRALFLMTKS----GFQ 233 (829)
T ss_pred -hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccccc-------chHHHHHHhhcc----CCC
Confidence 2334457899999999986 4567889999999999999998877775432 111111110000 011
Q ss_pred ccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 911 CEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 911 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
+.. .+......+.+.++++.|+.++|.+||++..+++|
T Consensus 234 pp~-lkDk~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 234 PPT-LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred CCc-ccCCccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 111 11223445568889999999999999999877653
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.8e-28 Score=246.52 Aligned_cols=426 Identities=20% Similarity=0.242 Sum_probs=304.7
Q ss_pred CCCCCcce-----eeeCCC---------CCceEEEeecCCCCCccccccccCCccCcEeeCCCCcccCcCChhhhCCCCC
Q 002061 58 DSPCGFSG-----ITCDSV---------TGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNL 123 (973)
Q Consensus 58 ~~~c~w~g-----v~C~~~---------~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L 123 (973)
+.+|...+ |+|+.. +...++|+|..|+|+..-+.+++.+++|++||||+|+|+..-|.+|..+.+|
T Consensus 38 P~pC~Cs~~~g~~VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l 117 (498)
T KOG4237|consen 38 PAPCTCSDVEGGIVDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASL 117 (498)
T ss_pred CCCcccCCCCCceEEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhh
Confidence 33455544 788642 3568999999999997667789999999999999999999999999999999
Q ss_pred cEEEecC-CcccCCCCc-ccCCCCCCEEeccCccCCCccccccccccccceEEccCCcCCCCCCcc-cccCCCCCCEEEc
Q 002061 124 KVLNVTG-NAMVGSVPD-LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPE-SIGNLKNLTYLFL 200 (973)
Q Consensus 124 ~~L~L~~-n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ip~-~~~~l~~L~~L~L 200 (973)
..|-+-+ |+|+.++.. |++|..|+.|.+.-|++.-.....|..+++|..|.+.+|.+.. ++. .+..+..++.+.+
T Consensus 118 ~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~--i~~~tf~~l~~i~tlhl 195 (498)
T KOG4237|consen 118 LSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQS--ICKGTFQGLAAIKTLHL 195 (498)
T ss_pred hHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhh--hccccccchhccchHhh
Confidence 8887777 999998875 9999999999999999998899999999999999999998863 455 6888999999999
Q ss_pred ccCCCC------------CCCChhhhccCCCCeeecccccccCCCchhhhc-cccccEEEeeccccCCcCC-cccccccc
Q 002061 201 AHCNLR------------GRIPESISELRELGTLDICRNKISGEFPRSIRK-LQKLWKIELYANNLTGELP-AELGNLTL 266 (973)
Q Consensus 201 ~~n~l~------------~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~-l~~L~~L~L~~N~l~~~~~-~~l~~l~~ 266 (973)
..|.+- ...|..++..+-..-..+.++++....+..|.. +..+..=..+.+...+..| ..|..+++
T Consensus 196 A~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~ 275 (498)
T KOG4237|consen 196 AQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPN 275 (498)
T ss_pred hcCccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhccc
Confidence 998832 234455566666666667777776555555442 2333322233333443444 56899999
Q ss_pred ccEEEeeccccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeeccCCccCCCCCcccccccccccccccc
Q 002061 267 LQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISE 346 (973)
Q Consensus 267 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~ 346 (973)
|+.|+|++|+++++-+.+|..+..++.|+|..|+|...-...|.++..|+.|+|++|+|+...|..|..+..|.+|+|-.
T Consensus 276 L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~ 355 (498)
T KOG4237|consen 276 LRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLS 355 (498)
T ss_pred ceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehcc
Confidence 99999999999999999999999999999999999977777899999999999999999999999999999999999999
Q ss_pred ccccccCChhhhhhhhHHHHHhhhccCCCCccccccCccccceEeccccccccC---CCccccCCCCcceEeccCCcCCC
Q 002061 347 NQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGK---IPDGLWALPNVGMLDFGDNDFTG 423 (973)
Q Consensus 347 N~l~~~~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~L~L~~N~l~~ 423 (973)
|.+.- -|.+.-+.+.+-- +...|..|- ++...++.+.++++.+... .|+.....+ .+
T Consensus 356 Np~~C-----nC~l~wl~~Wlr~-~~~~~~~~C--q~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~------------s~ 415 (498)
T KOG4237|consen 356 NPFNC-----NCRLAWLGEWLRK-KSVVGNPRC--QSPGFVRQIPISDVAFGDFRCGGPEELGCLT------------SS 415 (498)
T ss_pred CcccC-----ccchHHHHHHHhh-CCCCCCCCC--CCCchhccccchhccccccccCCccccCCCC------------CC
Confidence 98861 1222222222222 222232221 2334577777777766521 222211100 00
Q ss_pred CCCCCCCCCCCCCE-EEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCCcccc
Q 002061 424 GISPLIGLSTSLSQ-LVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMG 502 (973)
Q Consensus 424 ~~~~~~~~~~~L~~-L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 502 (973)
.-|+ ..+-+.+ ..-|++.++ .+|..+. ..-.+|++.+|.++ .+|.. .+++| .+|||+|++.......|.
T Consensus 416 ~cP~---~c~c~~tVvRcSnk~lk-~lp~~iP--~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~ 485 (498)
T KOG4237|consen 416 PCPP---PCTCLDTVVRCSNKLLK-LLPRGIP--VDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFS 485 (498)
T ss_pred CCCC---CcchhhhhHhhcccchh-hcCCCCC--chhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhccccc
Confidence 0111 1112222 223444443 4443321 24567778888887 55655 56667 788888888766677788
Q ss_pred ccccccchhcccc
Q 002061 503 DCARIVDLNLARN 515 (973)
Q Consensus 503 ~l~~L~~L~Ls~N 515 (973)
++++|.+|-||.|
T Consensus 486 n~tql~tlilsyn 498 (498)
T KOG4237|consen 486 NMTQLSTLILSYN 498 (498)
T ss_pred chhhhheeEEecC
Confidence 8888888877765
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.3e-25 Score=229.93 Aligned_cols=198 Identities=36% Similarity=0.486 Sum_probs=171.4
Q ss_pred CcccCcccccCceEEEEEEecCCCcEEEEEeeeccc---cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccC
Q 002061 678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP 754 (973)
Q Consensus 678 ~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 754 (973)
|++.+.||.|++|+||+|....+++.+|+|.+.... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 566788999999999999999888999999987643 46788899999999999999999999999999999999999
Q ss_pred CCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCC
Q 002061 755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK 834 (973)
Q Consensus 755 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 834 (973)
+++|.+++.... ..+++..+..++.+++.++.++| +.+++|+|++|.||+++.++.++++|||.+........
T Consensus 81 ~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~ 153 (225)
T smart00221 81 GGDLFDYLRKKG----GKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA 153 (225)
T ss_pred CCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence 999999987541 11788899999999999999999 77999999999999999999999999999876654321
Q ss_pred cccccccCCcccccccccc-ccCCCCccchHHHHHHHHHHHHhCCCCCCc
Q 002061 835 VSDYSCFAGTHGYIAPELA-YTCKVSEKSDVFSFGVVLLELVTGRKPVEE 883 (973)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~~l~el~tg~~pf~~ 883 (973)
.......++..|++||.. ....++.++|||++|+++|||++|+.||..
T Consensus 154 -~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 154 -ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred -ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 112234567889999998 666788899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-23 Score=267.71 Aligned_cols=363 Identities=18% Similarity=0.222 Sum_probs=181.6
Q ss_pred CCceEEEeecCCCCCcc-c-cccccCCccCcEeeCCCCc------ccCcCChhhhCCC-CCcEEEecCCcccCCCCcccC
Q 002061 72 TGRVTEISFDNKSLSGE-I-SSSISALQSLTVLSLPFNV------LSGKLPLELSNCS-NLKVLNVTGNAMVGSVPDLSA 142 (973)
Q Consensus 72 ~~~v~~l~l~~~~l~~~-~-~~~l~~l~~L~~L~Ls~n~------l~~~~p~~l~~l~-~L~~L~L~~n~l~~~~~~l~~ 142 (973)
+.+|..+.+.-..+... + +..+..+++|+.|.+..+. +...+|..|..++ +|+.|++.++.+...|..+ .
T Consensus 531 ~~~v~~i~l~~~~~~~~~i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~~lP~~f-~ 609 (1153)
T PLN03210 531 TKKVLGITLDIDEIDELHIHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLRCMPSNF-R 609 (1153)
T ss_pred cceeeEEEeccCccceeeecHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCCCCCCcC-C
Confidence 34666666654444321 1 2346667777777665442 2234555555553 4666666666666555554 3
Q ss_pred CCCCCEEeccCccCCCccccccccccccceEEccCCcCCCCCCcccccCCCCCCEEEcccCCCCCCCChhhhccCCCCee
Q 002061 143 LKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTL 222 (973)
Q Consensus 143 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 222 (973)
..+|++|++++|.+. .+ |..+..+++|+.|+|++|...+.+|. ++.+++|++|
T Consensus 610 ~~~L~~L~L~~s~l~-~L-------------------------~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L 662 (1153)
T PLN03210 610 PENLVKLQMQGSKLE-KL-------------------------WDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETL 662 (1153)
T ss_pred ccCCcEEECcCcccc-cc-------------------------ccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEE
Confidence 455666666665554 23 34444445555555554433333332 4445555555
Q ss_pred ecccccccCCCchhhhccccccEEEeeccccCCcCCccccccccccEEEeeccccccccCCccCCCCCccEEEcccCCCC
Q 002061 223 DICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFS 302 (973)
Q Consensus 223 ~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 302 (973)
+|++|.....+|..+.++++|+.|++++|..-..+|..+ ++++|+.|++++|.....+|.. .++|+.|++++|.+.
T Consensus 663 ~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~ 738 (1153)
T PLN03210 663 KLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE 738 (1153)
T ss_pred EecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc
Confidence 555544333445555555555555555433222344333 4555555555555433333322 234444455544443
Q ss_pred CCCCCCcCCcccceeeeccCCccCCCCCccccccccccccccccccccccCChhhhhhhhHHHHHhhhccCCCCcccccc
Q 002061 303 GEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYA 382 (973)
Q Consensus 303 ~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~ 382 (973)
.+|..+ .+++|+.|.+. ++... .++. .+....+..+.
T Consensus 739 -~lP~~~-~l~~L~~L~l~------------------------~~~~~-~l~~----------------~~~~l~~~~~~ 775 (1153)
T PLN03210 739 -EFPSNL-RLENLDELILC------------------------EMKSE-KLWE----------------RVQPLTPLMTM 775 (1153)
T ss_pred -cccccc-ccccccccccc------------------------ccchh-hccc----------------cccccchhhhh
Confidence 223222 23333333332 22111 0000 00000111112
Q ss_pred CccccceEeccccccccCCCccccCCCCcceEeccCCcCCCCCCCCCCCCCCCCEEEcccCCCCCCCChhhhcCCCCCEE
Q 002061 383 DCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERL 462 (973)
Q Consensus 383 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 462 (973)
.+++|+.|+|++|...+.+|..+.++++|+.|++++|...+.+|..+ .+++|+.|+|++|..-..+|.. .++|+.|
T Consensus 776 ~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L 851 (1153)
T PLN03210 776 LSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDL 851 (1153)
T ss_pred ccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEe
Confidence 23456666666665555566666666666666666654333333332 4566666776665443344432 2467777
Q ss_pred EccCCcCCCCccccccccccCCEEEcCCc-ccccCCCccccccccccchhcccc
Q 002061 463 ILTNNNFSGKIPSALGALRQLSSLHLEEN-ALTGSIPNEMGDCARIVDLNLARN 515 (973)
Q Consensus 463 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N 515 (973)
+|++|.++ .+|..+..+++|+.|+|++| +++ .+|..+..+++|+.|+++++
T Consensus 852 ~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C 903 (1153)
T PLN03210 852 NLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDC 903 (1153)
T ss_pred ECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCC
Confidence 77777776 56666777777777777763 454 45556666777777776665
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.92 E-value=6e-24 Score=270.20 Aligned_cols=346 Identities=24% Similarity=0.369 Sum_probs=201.4
Q ss_pred ccccccccccceEEccCCcCCC-----CCCcccccCCC-CCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCc
Q 002061 161 PRWVVNLTQLVSLSIGDNVYDE-----AEIPESIGNLK-NLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFP 234 (973)
Q Consensus 161 ~~~~~~l~~L~~L~l~~n~l~~-----~~ip~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 234 (973)
+.+|.++++|+.|.+..+.... ..+|+.+..++ +|+.|.+.++.++ .+|..+ ...+|++|+|++|++. .++
T Consensus 551 ~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~ 627 (1153)
T PLN03210 551 ENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLW 627 (1153)
T ss_pred HHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccc
Confidence 3445556666666665443211 23455555543 4666666666665 455555 3466666666666665 455
Q ss_pred hhhhccccccEEEeeccccCCcCCccccccccccEEEeeccccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCccc
Q 002061 235 RSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRK 314 (973)
Q Consensus 235 ~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~ 314 (973)
..+..+++|+.|+|++|.....+| .+..+++|+.|+|++|.....+|..+.++++|+.|++++|.....+|..+ ++++
T Consensus 628 ~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~s 705 (1153)
T PLN03210 628 DGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKS 705 (1153)
T ss_pred cccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCC
Confidence 556666666666666554333444 35666666666666665444666666666666666666654433445433 4555
Q ss_pred ceeeeccCCccCCCCCccccccccccccccccccccccCChhhhhhhhHHHHHhhhccCCCCccccccCccccceEeccc
Q 002061 315 LFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISD 394 (973)
Q Consensus 315 L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~ 394 (973)
|+.|++++|.....+|.. ..+|+.|+|++|.++ .+| ..+ .+++|++|++.+
T Consensus 706 L~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP------------------------~~~-~l~~L~~L~l~~ 756 (1153)
T PLN03210 706 LYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFP------------------------SNL-RLENLDELILCE 756 (1153)
T ss_pred CCEEeCCCCCCccccccc---cCCcCeeecCCCccc-ccc------------------------ccc-cccccccccccc
Confidence 666666555433333322 234455555555543 122 111 234444444444
Q ss_pred cccccCCCccccCCCCcceEeccCCcCCCCCCCCCCCCCCCCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCcc
Q 002061 395 NHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIP 474 (973)
Q Consensus 395 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 474 (973)
+... .+.. .+....+..+..+++|+.|+|++|...+.+|..++++++|+.|+|++|...+.+|
T Consensus 757 ~~~~-~l~~----------------~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP 819 (1153)
T PLN03210 757 MKSE-KLWE----------------RVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLP 819 (1153)
T ss_pred cchh-hccc----------------cccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeC
Confidence 3221 1111 1111111222345678888888877666778888888888888888765444666
Q ss_pred ccccccccCCEEEcCCcccccCCCccccccccccchhccccccccCCCccccccCCCCeeecCC-CccCCCCChhhhccc
Q 002061 475 SALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSG-NKLTGSIPDNLMKLK 553 (973)
Q Consensus 475 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~l~~l~ 553 (973)
..+ ++++|+.|+|++|.....+|.. ..+|+.|+|++|.|+ .+|.++..+++|+.|+|++ |+|. .+|..+..++
T Consensus 820 ~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~ 893 (1153)
T PLN03210 820 TGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLK 893 (1153)
T ss_pred CCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCccccccc
Confidence 655 6778888888877544444443 356777888888887 6777788888888888877 5555 5666666665
Q ss_pred -CceEEccCCc
Q 002061 554 -LSSIDLSENQ 563 (973)
Q Consensus 554 -L~~l~ls~N~ 563 (973)
|+.++++++.
T Consensus 894 ~L~~L~l~~C~ 904 (1153)
T PLN03210 894 HLETVDFSDCG 904 (1153)
T ss_pred CCCeeecCCCc
Confidence 7777777653
|
syringae 6; Provisional |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.7e-26 Score=233.60 Aligned_cols=288 Identities=17% Similarity=0.242 Sum_probs=149.3
Q ss_pred CCCcccCcCChhhhCCCCCcEEEecCCcccCCCCc-ccCCCCCCEEeccCccCCCccccccccccccceEEccC-CcCCC
Q 002061 105 PFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD-LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGD-NVYDE 182 (973)
Q Consensus 105 s~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~-n~l~~ 182 (973)
+.-+++ ++|..+. ..-..++|..|+|+.+|+. |+.+++|+.||||.|+|+.+-|.+|.++.+|.+|-+.+ |+|++
T Consensus 54 r~~GL~-eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~ 130 (498)
T KOG4237|consen 54 RGKGLT-EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITD 130 (498)
T ss_pred cCCCcc-cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhh
Confidence 333444 4554432 3446677777777777763 77777777777777777777777777776666655544 66652
Q ss_pred CCCcc-cccCCCCCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCchhhhccccccEEEeeccccC-------
Q 002061 183 AEIPE-SIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLT------- 254 (973)
Q Consensus 183 ~~ip~-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~------- 254 (973)
+|. .|++|..|+.|.+.-|++.-...+.|..|++|..|.+.+|.+...--..|..+..++.+++..|.+-
T Consensus 131 --l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~w 208 (498)
T KOG4237|consen 131 --LPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPW 208 (498)
T ss_pred --hhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccch
Confidence 333 4566666666666666666555566666666666666666665222225666666666666665522
Q ss_pred -----CcCCccccccccccEEEeeccccccccCCccCC-CCCccEEEcccCCCCCCCC-CCcCCcccceeeeccCCccCC
Q 002061 255 -----GELPAELGNLTLLQEFDISSNQMYGKLPEEIGN-LKNLTVFQCFKNNFSGEFP-SGFGDMRKLFAFSIYGNRFSG 327 (973)
Q Consensus 255 -----~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~ 327 (973)
-..|-.++...-..-..+.++++....+..|.. +..+..=..+.+...++.| ..|..+++|+.|+|++|+|++
T Consensus 209 la~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~ 288 (498)
T KOG4237|consen 209 LADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITR 288 (498)
T ss_pred hhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccch
Confidence 011111222222222222222222222221111 1111111112222222223 234455555555555555554
Q ss_pred CCCccccccccccccccccccccccCChhhhhhhhHHHHHhhhccCCCCccccccCccccceEeccccccccCCCccccC
Q 002061 328 PFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWA 407 (973)
Q Consensus 328 ~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 407 (973)
+-+.+|..+..++.|.|..|+|. ..-...|.++..|+.|+|.+|+|+..-|.+|..
T Consensus 289 i~~~aFe~~a~l~eL~L~~N~l~------------------------~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~ 344 (498)
T KOG4237|consen 289 IEDGAFEGAAELQELYLTRNKLE------------------------FVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQT 344 (498)
T ss_pred hhhhhhcchhhhhhhhcCcchHH------------------------HHHHHhhhccccceeeeecCCeeEEEecccccc
Confidence 44445555555555555555543 112234556666666777777776666666666
Q ss_pred CCCcceEeccCCcC
Q 002061 408 LPNVGMLDFGDNDF 421 (973)
Q Consensus 408 l~~L~~L~L~~N~l 421 (973)
+..|..|.|-.|.+
T Consensus 345 ~~~l~~l~l~~Np~ 358 (498)
T KOG4237|consen 345 LFSLSTLNLLSNPF 358 (498)
T ss_pred cceeeeeehccCcc
Confidence 66666666666654
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=246.08 Aligned_cols=267 Identities=27% Similarity=0.412 Sum_probs=149.1
Q ss_pred CCCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCchhhhccccccEEEeeccccCCcCCccccccccccEEEe
Q 002061 193 KNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDI 272 (973)
Q Consensus 193 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L 272 (973)
.+-..|+|++|+++ .+|..+. ++|+.|++++|+|+ .+|.. .++|++|+|++|+|+ .+|.. .++|+.|++
T Consensus 201 ~~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~L 269 (788)
T PRK15387 201 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT-SLPVL---PPGLLELSI 269 (788)
T ss_pred CCCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccC-cccCc---ccccceeec
Confidence 34567788888887 5666554 36777777777777 34432 356666666666666 34432 345666666
Q ss_pred eccccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeeccCCccCCCCCcccccccccccccccccccccc
Q 002061 273 SSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGS 352 (973)
Q Consensus 273 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ 352 (973)
++|.++ .+|..+ ++|+.|++++|+++. +|. .+ ++|+.|+|++|+|++
T Consensus 270 s~N~L~-~Lp~lp---~~L~~L~Ls~N~Lt~-LP~---~p------------------------~~L~~LdLS~N~L~~- 316 (788)
T PRK15387 270 FSNPLT-HLPALP---SGLCKLWIFGNQLTS-LPV---LP------------------------PGLQELSVSDNQLAS- 316 (788)
T ss_pred cCCchh-hhhhch---hhcCEEECcCCcccc-ccc---cc------------------------cccceeECCCCcccc-
Confidence 666665 333322 344555555555542 222 12 334444454444441
Q ss_pred CChhhhhhhhHHHHHhhhccCCCCccccccCccccceEeccccccccCCCccccCCCCcceEeccCCcCCCCCCCCCCCC
Q 002061 353 FPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLS 432 (973)
Q Consensus 353 ~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~ 432 (973)
+|. + ..+|+.|++++|+|++ +|.. ..+|+.|+|++|+|++.+. ..
T Consensus 317 Lp~---------------------l------p~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~LP~----lp 361 (788)
T PRK15387 317 LPA---------------------L------PSELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLASLPT----LP 361 (788)
T ss_pred CCC---------------------C------cccccccccccCcccc-cccc---ccccceEecCCCccCCCCC----CC
Confidence 111 0 0124444555555542 3321 1244555555555554321 12
Q ss_pred CCCCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCCccccccccccchhc
Q 002061 433 TSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNL 512 (973)
Q Consensus 433 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 512 (973)
.+|+.|++++|+|.. +|.. ..+|+.|+|++|+|++ +|.. .++|+.|++++|+|++ +|..+ .+|+.|+|
T Consensus 362 ~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l~---~~L~~L~L 429 (788)
T PRK15387 362 SELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPMLP---SGLLSLSV 429 (788)
T ss_pred cccceehhhcccccc-Cccc---ccccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcch---hhhhhhhh
Confidence 456666666666663 4432 2457777777777763 4432 2467777777777774 44432 35667777
Q ss_pred cccccccCCCccccccCCCCeeecCCCccCCCCChhhhc
Q 002061 513 ARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMK 551 (973)
Q Consensus 513 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~ 551 (973)
++|+|+ .+|..+.++++|+.|+|++|+|+|.+|..+..
T Consensus 430 s~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~ 467 (788)
T PRK15387 430 YRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALRE 467 (788)
T ss_pred ccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHHH
Confidence 777777 56777777777777777777777776666533
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-24 Score=267.35 Aligned_cols=199 Identities=20% Similarity=0.188 Sum_probs=140.3
Q ss_pred hcCC-CceeeEEEEEE-------eCCeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCC
Q 002061 727 KIRH-RNILKLYACLL-------KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798 (973)
Q Consensus 727 ~l~h-pniv~l~~~~~-------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~ 798 (973)
.++| +||++++++|. ..+..+.++||+ +++|.+++... ...+++..+..++.||++||+||| ++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH---~~ 99 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP----DRSVDAFECFHVFRQIVEIVNAAH---SQ 99 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc----cccccHHHHHHHHHHHHHHHHHHH---hC
Confidence 4455 57778888772 234567889988 67999999742 345889999999999999999999 88
Q ss_pred CeEecCCCCCCeeecCC-------------------CCeEEecccCcccccCCCC--------------cccccccCCcc
Q 002061 799 PIIHRDIKSSNILLDED-------------------YEPKIADFGVAKIAENSPK--------------VSDYSCFAGTH 845 (973)
Q Consensus 799 ~ivH~Dlkp~Nill~~~-------------------~~~kl~Dfgl~~~~~~~~~--------------~~~~~~~~gt~ 845 (973)
+|+||||||+|||++.. +.+|++|||+++....... ........||+
T Consensus 100 gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 179 (793)
T PLN00181 100 GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMS 179 (793)
T ss_pred CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCc
Confidence 99999999999999653 4566666666653211000 00011235788
Q ss_pred ccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccccCcchHHHHHHH
Q 002061 846 GYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKL 925 (973)
Q Consensus 846 ~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 925 (973)
.|||||++.+..++.++|||||||++|||++|..|+..... ....... . ...+ .......+.
T Consensus 180 ~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---~~~~~~~-~---------~~~~-----~~~~~~~~~ 241 (793)
T PLN00181 180 WYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR---TMSSLRH-R---------VLPP-----QILLNWPKE 241 (793)
T ss_pred ceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH---HHHHHHH-h---------hcCh-----hhhhcCHHH
Confidence 99999999999999999999999999999999888753210 0000000 0 0000 001112334
Q ss_pred HHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 926 LKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 926 ~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
..++.+||+++|.+||++.|++++-.
T Consensus 242 ~~~~~~~L~~~P~~Rps~~eil~h~~ 267 (793)
T PLN00181 242 ASFCLWLLHPEPSCRPSMSELLQSEF 267 (793)
T ss_pred HHHHHHhCCCChhhCcChHHHhhchh
Confidence 57788999999999999999998754
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=4e-23 Score=207.36 Aligned_cols=167 Identities=20% Similarity=0.226 Sum_probs=126.4
Q ss_pred CchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCc
Q 002061 756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV 835 (973)
Q Consensus 756 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 835 (973)
|+|.++++.+ ...+++..+..++.|++.||+||| +.+ ||+||+++.++.+++ ||.+.......
T Consensus 1 GsL~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-- 63 (176)
T smart00750 1 VSLADILEVR----GRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ-- 63 (176)
T ss_pred CcHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeecccc--
Confidence 6899999753 335899999999999999999999 444 999999999999999 99987654321
Q ss_pred ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccccC
Q 002061 836 SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVAS 915 (973)
Q Consensus 836 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
..||+.|+|||++.+..++.++|||||||++|||++|+.||..................... +.. .
T Consensus 64 -----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~-~ 129 (176)
T smart00750 64 -----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD--------PRD-R 129 (176)
T ss_pred -----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCC--------ccc-c
Confidence 25789999999999999999999999999999999999999654222222222211111110 000 0
Q ss_pred cchHHHHH--HHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 916 ESIKEDMI--KLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 916 ~~~~~~~~--~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
........ .+.+++.+|++.+|++||++.|+++++...
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 11122222 689999999999999999999999998765
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.3e-23 Score=242.52 Aligned_cols=265 Identities=25% Similarity=0.409 Sum_probs=171.2
Q ss_pred cccceEEccCCcCCCCCCcccccCCCCCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCchhhhccccccEEE
Q 002061 168 TQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIE 247 (973)
Q Consensus 168 ~~L~~L~l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~ 247 (973)
..-..|++++|.++ .+|..+. ++|+.|++++|+++ .+|. ..++|++|+|++|+|+ .+|.. .++|+.|+
T Consensus 201 ~~~~~LdLs~~~Lt--sLP~~l~--~~L~~L~L~~N~Lt-~LP~---lp~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~ 268 (788)
T PRK15387 201 NGNAVLNVGESGLT--TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPVL---PPGLLELS 268 (788)
T ss_pred CCCcEEEcCCCCCC--cCCcchh--cCCCEEEccCCcCC-CCCC---CCCCCcEEEecCCccC-cccCc---ccccceee
Confidence 44678999999997 5788776 48999999999999 4664 3589999999999999 55643 46899999
Q ss_pred eeccccCCcCCccccccccccEEEeeccccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeeccCCccCC
Q 002061 248 LYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSG 327 (973)
Q Consensus 248 L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 327 (973)
|++|.|+ .+|.. .++|+.|++++|+++ .+|.. +++|+.|++++|+|++ +|... .+|+.|++++|++++
T Consensus 269 Ls~N~L~-~Lp~l---p~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~-Lp~lp---~~L~~L~Ls~N~L~~ 336 (788)
T PRK15387 269 IFSNPLT-HLPAL---PSGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPALP---SELCKLWAYNNQLTS 336 (788)
T ss_pred ccCCchh-hhhhc---hhhcCEEECcCCccc-ccccc---ccccceeECCCCcccc-CCCCc---ccccccccccCcccc
Confidence 9999998 55553 357889999999998 55653 4789999999999985 34322 345566666666653
Q ss_pred CCCccccccccccccccccccccccCChhhhhhhhHHHHHhhhccCCCCccccccCccccceEeccccccccCCCccccC
Q 002061 328 PFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWA 407 (973)
Q Consensus 328 ~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 407 (973)
+|.. ..+|+.|+|++|+|++ +|. . ..+|+.|++++|+|++ +|..
T Consensus 337 -LP~l---p~~Lq~LdLS~N~Ls~-LP~------------------------l---p~~L~~L~Ls~N~L~~-LP~l--- 380 (788)
T PRK15387 337 -LPTL---PSGLQELSVSDNQLAS-LPT------------------------L---PSELYKLWAYNNRLTS-LPAL--- 380 (788)
T ss_pred -cccc---ccccceEecCCCccCC-CCC------------------------C---Ccccceehhhcccccc-Cccc---
Confidence 3321 1345556666665551 221 0 1234445555555552 3321
Q ss_pred CCCcceEeccCCcCCCCCCCCCCCCCCCCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCccccccccccCCEEE
Q 002061 408 LPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLH 487 (973)
Q Consensus 408 l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 487 (973)
+.+|+.|+|++|+|++ +|.. .++|+.|++++|+|++ +|... .+|+.|+
T Consensus 381 ------------------------~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l~---~~L~~L~ 428 (788)
T PRK15387 381 ------------------------PSGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPMLP---SGLLSLS 428 (788)
T ss_pred ------------------------ccccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcch---hhhhhhh
Confidence 2345555555555552 3322 2356666666666653 44322 3455666
Q ss_pred cCCcccccCCCccccccccccchhccccccccCCCccc
Q 002061 488 LEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSL 525 (973)
Q Consensus 488 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 525 (973)
|++|+|+ .+|..+.++++|+.|+|++|+|++..+..+
T Consensus 429 Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L 465 (788)
T PRK15387 429 VYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL 465 (788)
T ss_pred hccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHH
Confidence 6666666 456666666666666666666666555544
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.8e-24 Score=209.06 Aligned_cols=249 Identities=22% Similarity=0.300 Sum_probs=188.1
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeec----cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE 751 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 751 (973)
.......+|.+...|+.|+|++.. ..+++|++.. ....++|..|.-.++.+.||||+.+++.|..+....+|..
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwqg--ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq 267 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQG--NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQ 267 (448)
T ss_pred hhhhhhhhhccCCCcccccccccC--cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeee
Confidence 344667789999999999999984 4677777654 2345678999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEe--cccCcccc
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIA--DFGVAKIA 829 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~--Dfgl~~~~ 829 (973)
||+.|+|+..++.. ....++-.+..+++.++|+|++|||+- ++-|-.--+..+.|+++++.+++|. |--++-
T Consensus 268 ~mp~gslynvlhe~---t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsf-- 341 (448)
T KOG0195|consen 268 YMPFGSLYNVLHEQ---TSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSF-- 341 (448)
T ss_pred eccchHHHHHHhcC---ccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeee--
Confidence 99999999999864 445577888999999999999999964 3333344688999999999887765 322221
Q ss_pred cCCCCcccccccCCccccccccccccCCCC---ccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccc
Q 002061 830 ENSPKVSDYSCFAGTHGYIAPELAYTCKVS---EKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVL 906 (973)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 906 (973)
+.. ...-.+.||+||.++.++.+ .++|+|||++++||+.|...||.+...-+- . .
T Consensus 342 qe~-------gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec--g-------------m 399 (448)
T KOG0195|consen 342 QEV-------GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC--G-------------M 399 (448)
T ss_pred ecc-------ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh--h-------------h
Confidence 111 12236899999999877644 579999999999999999999976421000 0 1
Q ss_pred hhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 002061 907 KVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADAD 954 (973)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 954 (973)
++.-..+....++.....+.+++.-|++.||.+||.++.|+-.|+++.
T Consensus 400 kialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 400 KIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred hhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 111112222233344556778888999999999999999999888764
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-22 Score=238.52 Aligned_cols=305 Identities=19% Similarity=0.289 Sum_probs=153.2
Q ss_pred HHHHHHHHhcCCCCCCchHHHHHHHHHHHhcCCCcccccC----CCCCCCCCCCcce----------------eeeCCCC
Q 002061 13 ALLCFILVSVFPPSLSLNVETQALIQFKSKLKDPHGVLDS----WKESADSPCGFSG----------------ITCDSVT 72 (973)
Q Consensus 13 ~~~~~~~~~~~~~~~~~~~~~~aLl~~k~~~~d~~~~~~~----W~~~~~~~c~w~g----------------v~C~~~~ 72 (973)
++=|+.-++ .|++-....|.+++++..+.+.-|. .+++ |++.++ +|-=.. |.|. .
T Consensus 46 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~p~-~~~~~~~~~~~~~~-fc~~~~~~~~~l~~~~~~~~~tv~~~--~ 120 (754)
T PRK15370 46 AQNCIAYLC-HPPETASPEEIKSKFECLRMLAFPA-YADNIQYSRGGADQ-YCILSENSQEILSIVFNTEGYTVEGG--G 120 (754)
T ss_pred HHHHHHHHh-CCCCCCCHHHHHHHHHHHHHhcCCc-hhhccccccCCCCc-ccccCCcchhhheeeecCCceEEecC--C
Confidence 344666664 4555566889999999999997774 3455 987765 785443 6664 3
Q ss_pred CceEEEeecCCCCCcccc--ccccCCccCcEeeCCCCcccCcCC---hhh-----hCCCCCcEEEecCCcccCCCCcccC
Q 002061 73 GRVTEISFDNKSLSGEIS--SSISALQSLTVLSLPFNVLSGKLP---LEL-----SNCSNLKVLNVTGNAMVGSVPDLSA 142 (973)
Q Consensus 73 ~~v~~l~l~~~~l~~~~~--~~l~~l~~L~~L~Ls~n~l~~~~p---~~l-----~~l~~L~~L~L~~n~l~~~~~~l~~ 142 (973)
+.|+.+...+........ ....+....-. +=..+.-.++.+ .++ +-..+.+.|+++++.++..|..+.
T Consensus 121 ~~vt~l~~~g~~~~~~~~~~~~~~~~~~~w~-~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~LtsLP~~Ip- 198 (754)
T PRK15370 121 KSVTYTRVTESEQASSASGSKDAVNYELIWS-EWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLTTIPACIP- 198 (754)
T ss_pred CcccccccccccccccCCCCCChhhHHHHHH-HHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcCcCCcccc-
Confidence 456666555432221110 00000000000 000000000000 001 111234555555555555444332
Q ss_pred CCCCCEEeccCccCCCccccccccccccceEEccCCcCCCCCCcccccCCCCCCEEEcccCCCCCCCChhhhccCCCCee
Q 002061 143 LKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTL 222 (973)
Q Consensus 143 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 222 (973)
++|+.|+|++|.++ .+|..+. ++|++|++++|.++ .+|..+. .+|+.|+|++|+++ .+|..+. ++|+.|
T Consensus 199 -~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt--sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L 267 (754)
T PRK15370 199 -EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT--SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSL 267 (754)
T ss_pred -cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc--cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEE
Confidence 34555555555555 2333332 35555555555554 3444332 34566666666665 4454443 356666
Q ss_pred ecccccccCCCchhhhccccccEEEeeccccCCcCCccccccccccEEEeeccccccccCCccCCCCCccEEEcccCCCC
Q 002061 223 DICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFS 302 (973)
Q Consensus 223 ~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 302 (973)
+|++|+|+ .+|..+. ++|++|+|++|+|+ .+|..+. ++|+.|++++|+++ .+|..+. ++|+.|++++|.++
T Consensus 268 ~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~Lt 338 (754)
T PRK15370 268 DLFHNKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLT-ALPETLP--PGLKTLEAGENALT 338 (754)
T ss_pred ECcCCccC-ccccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHhcCCccc-cCCcccc--ccceeccccCCccc
Confidence 66666665 3454443 35666666666666 3343332 35666666666665 3343332 45666666666665
Q ss_pred CCCCCCcCCcccceeeeccCCccCCCCCcccccccccccccccccccc
Q 002061 303 GEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFS 350 (973)
Q Consensus 303 ~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~ 350 (973)
+ +|..+. ++|+.|++++|+|+ .+|..+. +.|+.|+|++|+|+
T Consensus 339 ~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt 380 (754)
T PRK15370 339 S-LPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT 380 (754)
T ss_pred c-CChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC
Confidence 3 444332 46666666666665 3444332 45666777777666
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5e-22 Score=200.24 Aligned_cols=205 Identities=21% Similarity=0.251 Sum_probs=179.9
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEEEEccCC
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLVLEYMPN 755 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~ 755 (973)
.|.+.++||+|.||+++.|+..-+++.||||.-....+..++..|+...+.+ ..++|-.++.+..++.+-.+|+|.+ |
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-G 107 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-G 107 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-C
Confidence 6899999999999999999999999999999877777888999999999998 5799999999888888889999999 8
Q ss_pred CchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCC-----CeEEecccCccccc
Q 002061 756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY-----EPKIADFGVAKIAE 830 (973)
Q Consensus 756 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-----~~kl~Dfgl~~~~~ 830 (973)
-||+|+..-+ ...++...+..+|.|++.-++|+| ++.+|+|||||+|+||...+ .+.+.|||+|+.+.
T Consensus 108 PSLEDLFD~C----gR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 108 PSLEDLFDLC----GRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred cCHHHHHHHh----cCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 8999988754 446899999999999999999999 88999999999999998654 48999999998775
Q ss_pred CCCC-----cccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcc
Q 002061 831 NSPK-----VSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGK 889 (973)
Q Consensus 831 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~ 889 (973)
.... ........||.+||+--...|++.+.+.|+-|+|-++.+.+-|..||++..++..
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tn 244 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTN 244 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcch
Confidence 4432 2233456799999999999999999999999999999999999999998755433
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=3e-22 Score=218.50 Aligned_cols=165 Identities=18% Similarity=0.150 Sum_probs=129.0
Q ss_pred HHHcCCcccCcccccCceEEEEEEecC-CCcEEEEEeeecc-------ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCC
Q 002061 673 EQICNLEEDNLIGSGGTGKVYRLDLKK-NAGTVAVKQLWKG-------DGVKVFAAEMEILGKIRHRNILKLYACLLKGG 744 (973)
Q Consensus 673 ~~~~~~~~~~~lG~G~~g~V~~a~~~~-~~~~vavK~~~~~-------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 744 (973)
....+|++.+.||+|+||+||+|++.. +++.||||+.... .....+.+|++++++++|+|+++.+.. .+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~ 91 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG 91 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence 345679999999999999999999875 6778899986432 124568999999999999999853332 24
Q ss_pred eeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCC-CCCCeeecCCCCeEEecc
Q 002061 745 SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDI-KSSNILLDEDYEPKIADF 823 (973)
Q Consensus 745 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dl-kp~Nill~~~~~~kl~Df 823 (973)
..|+||||++|++|.. ... . . ...++.|+++||+|+| +++|+|||| ||+||+++.++.+||+||
T Consensus 92 ~~~LVmE~~~G~~L~~-~~~-----~---~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDF 156 (365)
T PRK09188 92 KDGLVRGWTEGVPLHL-ARP-----H---G---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDF 156 (365)
T ss_pred CcEEEEEccCCCCHHH-hCc-----c---c---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEEC
Confidence 5799999999999962 110 0 1 1357889999999999 889999999 999999999999999999
Q ss_pred cCcccccCCCCccc------ccccCCcccccccccccc
Q 002061 824 GVAKIAENSPKVSD------YSCFAGTHGYIAPELAYT 855 (973)
Q Consensus 824 gl~~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~ 855 (973)
|+++.......... .....+++.|+|||++..
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 99987754332111 234568889999999853
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.9e-22 Score=193.16 Aligned_cols=206 Identities=20% Similarity=0.189 Sum_probs=176.3
Q ss_pred HHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhcCC-CceeeEEEEEEeCCeeEEEEE
Q 002061 673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRH-RNILKLYACLLKGGSSFLVLE 751 (973)
Q Consensus 673 ~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~~~~lv~e 751 (973)
.....|.++++||.|+||.+|.|....+|+.||||+-.......++..|.++.+.+++ ..|-.+..+..++.+-.+||+
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 3457899999999999999999999999999999998888888889999999999975 677777888888888999999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCC---CCeEEecccCccc
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDED---YEPKIADFGVAKI 828 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~---~~~kl~Dfgl~~~ 828 (973)
.+ |.+|.+.+.-. ...++-..++..|-|++.-++|+| .+++|||||||+|+++.-+ ..+.+.|||+|+.
T Consensus 92 LL-GPsLEdLfnfC----~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFC----SRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred cc-CccHHHHHHHH----hhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhh
Confidence 99 88999988754 335788899999999999999999 7899999999999999754 4589999999987
Q ss_pred ccCCCC-----cccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccC
Q 002061 829 AENSPK-----VSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYG 886 (973)
Q Consensus 829 ~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~ 886 (973)
+..... ........||.+|.+--+..+.+.+.+.|+-|+|.++.+.--|..||++..+
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka 226 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA 226 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence 754322 1223356799999998888888888999999999999999999999987643
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.6e-21 Score=210.36 Aligned_cols=260 Identities=22% Similarity=0.229 Sum_probs=193.9
Q ss_pred CCcccCcccccCceEEEEEEecCCC-cEEEEEeeecccc--HHHHHHHHHHHHhcCC----CceeeEEEEE-EeCCeeEE
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNA-GTVAVKQLWKGDG--VKVFAAEMEILGKIRH----RNILKLYACL-LKGGSSFL 748 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~-~~vavK~~~~~~~--~~~~~~E~~~l~~l~h----pniv~l~~~~-~~~~~~~l 748 (973)
+|.+.+.||+|+||.||+|.+..++ ..+|+|....... ...+..|..++..+.. +++..+++.. ..+...|+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 7999999999999999999998764 5789997765322 2267889999988863 6888999988 57788999
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCC-----CCeEEecc
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDED-----YEPKIADF 823 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-----~~~kl~Df 823 (973)
||+.+ |.+|.++.... ....++.....+++.|++.+|+++| +.|++||||||.|+++... ..+.+.||
T Consensus 99 VM~l~-G~sL~dl~~~~---~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRN---PPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred EEecc-CccHHHHHHhC---CCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 99988 88999987654 2567899999999999999999999 8999999999999999865 35999999
Q ss_pred cCccccc--CCCC----cc-c-ccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHH
Q 002061 824 GVAKIAE--NSPK----VS-D-YSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWV 895 (973)
Q Consensus 824 gl~~~~~--~~~~----~~-~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~ 895 (973)
|+++... .... .. . .....||..|.++.+..+...+.+.|+||++.++.|+..|..||........ ...+
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~--~~~~ 249 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL--KSKF 249 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch--HHHH
Confidence 9998332 1111 11 1 1235699999999999999999999999999999999999999965422111 1111
Q ss_pred HHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 002061 896 STHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADP 955 (973)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 955 (973)
........ ... . .... ...+.++...+-..+...+|....+.+.+++...
T Consensus 250 ~~~~~~~~-----~~~-~-~~~~---~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~ 299 (322)
T KOG1164|consen 250 EKDPRKLL-----TDR-F-GDLK---PEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD 299 (322)
T ss_pred HHHhhhhc-----ccc-c-cCCC---hHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence 11100000 000 0 1111 2234444444556899999999999998876644
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=3e-21 Score=228.97 Aligned_cols=246 Identities=25% Similarity=0.443 Sum_probs=123.3
Q ss_pred CCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCchhhhccccccEEEeeccccCCcCCccccccccccEEEee
Q 002061 194 NLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDIS 273 (973)
Q Consensus 194 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls 273 (973)
+.+.|++++++++ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|++|++++|+|+ .+|..+. .+|+.|+|+
T Consensus 179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls 249 (754)
T PRK15370 179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELS 249 (754)
T ss_pred CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECc
Confidence 3445555555555 3343332 34555555555555 3343332 35555555555555 3343332 245555555
Q ss_pred ccccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeeccCCccCCCCCccccccccccccccccccccccC
Q 002061 274 SNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSF 353 (973)
Q Consensus 274 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~ 353 (973)
+|.+. .+|..+. ++|+.|++++|+++ .+|..+. ++|+.|++++|+|++ +|..+. ++|+.|++++|+++. +
T Consensus 250 ~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~-L 319 (754)
T PRK15370 250 INRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTA-L 319 (754)
T ss_pred CCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCcccc-C
Confidence 55555 3444432 34555555555555 2343332 245555555555552 333221 345666666666652 2
Q ss_pred ChhhhhhhhHHHHHhhhccCCCCccccccCccccceEeccccccccCCCccccCCCCcceEeccCCcCCCCCCCCCCCCC
Q 002061 354 PKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLST 433 (973)
Q Consensus 354 p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ 433 (973)
| ..+ .++|+.|++++|.+++ +|..+. ++|+.|++++|+|+..+. .+ .+
T Consensus 320 P------------------------~~l--~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~~LP~-~l--p~ 367 (754)
T PRK15370 320 P------------------------ETL--PPGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQITVLPE-TL--PP 367 (754)
T ss_pred C------------------------ccc--cccceeccccCCcccc-CChhhc--CcccEEECCCCCCCcCCh-hh--cC
Confidence 2 111 1456677777777763 454432 456666666666653322 11 24
Q ss_pred CCCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCcccc----ccccccCCEEEcCCcccc
Q 002061 434 SLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSA----LGALRQLSSLHLEENALT 494 (973)
Q Consensus 434 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~----~~~l~~L~~L~Ls~N~l~ 494 (973)
+|+.|+|++|+|+ .+|..+. ..|+.|++++|+++ .+|.. +..++.+..|+|.+|.+.
T Consensus 368 ~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 368 TITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred CcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence 5666666666666 3444443 24666666666665 33332 233455666666666655
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.5e-22 Score=231.13 Aligned_cols=254 Identities=20% Similarity=0.241 Sum_probs=190.4
Q ss_pred cccCcccccCceEEEEEEecCCCcEEEEEeee----ccccH----HHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 002061 679 EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLW----KGDGV----KVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL 750 (973)
Q Consensus 679 ~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~----~~~~~----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 750 (973)
...+.+|.|++|.|+.+.........+.|... ..... ..+..|+.+-..++|||++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 34577999999988888877666555655432 21111 12556777788889999988887777666666669
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccccc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 830 (973)
|||++ +|+..+... ..+...++.-++.|+..|++|+| +.|+.|||+|++|++++.+|.+||+|||.+....
T Consensus 401 E~~~~-Dlf~~~~~~-----~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN-----GKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred hcccH-HHHHHHhcc-----cccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeec
Confidence 99999 999988752 34677788889999999999999 8999999999999999999999999999987665
Q ss_pred CCCCc--ccccccCCccccccccccccCCCCc-cchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccch
Q 002061 831 NSPKV--SDYSCFAGTHGYIAPELAYTCKVSE-KSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLK 907 (973)
Q Consensus 831 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
.+... ......+|+..|+|||++.+..|++ .+||||.|+++..|.+|+.||......+....+... ..+
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~--------~~~ 543 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNY--------SDQ 543 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcc--------ccc
Confidence 44333 3344578999999999999999986 589999999999999999999876443333200000 001
Q ss_pred hccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 908 VLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 908 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
.-............+.+...++.+|++.||.+|.|+.+|++.
T Consensus 544 ~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 544 RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 111111122344556677889999999999999999999863
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.3e-19 Score=200.25 Aligned_cols=258 Identities=32% Similarity=0.390 Sum_probs=195.2
Q ss_pred CcccCcccccCceEEEEEEecCCCcEEEEEeeeccc-----cHHHHHHHHHHHHhcCCC-ceeeEEEEEEeCCeeEEEEE
Q 002061 678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----GVKVFAAEMEILGKIRHR-NILKLYACLLKGGSSFLVLE 751 (973)
Q Consensus 678 ~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~hp-niv~l~~~~~~~~~~~lv~e 751 (973)
|+..+.||.|+||.||++.+. ..+|+|.+.... ....+.+|+.+++.+.|+ +++++.+++......++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 667788999999999999988 688999886632 356789999999999988 79999999977777899999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCC-CeEEecccCccccc
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY-EPKIADFGVAKIAE 830 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfgl~~~~~ 830 (973)
|+.++++.+++...... ..+.......++.|++.+++|+| +.+++|||+||+||+++..+ .++++|||.+....
T Consensus 79 ~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~ 153 (384)
T COG0515 79 YVDGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP 153 (384)
T ss_pred cCCCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence 99999999766643111 35788899999999999999999 78899999999999999988 79999999997554
Q ss_pred CCCCcc----cccccCCcccccccccccc---CCCCccchHHHHHHHHHHHHhCCCCCCcccCC--cccHHHHHHHHhcc
Q 002061 831 NSPKVS----DYSCFAGTHGYIAPELAYT---CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGD--GKDIVYWVSTHLNN 901 (973)
Q Consensus 831 ~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~--~~~~~~~~~~~~~~ 901 (973)
...... ......|+..|+|||.+.+ ..+....|+||+|++++++++|..||...... .......+......
T Consensus 154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP 233 (384)
T ss_pred CCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc
Confidence 433221 2345679999999999987 57888999999999999999999997654321 11111111111100
Q ss_pred ccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 902 HENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
.................+.+++..|+..+|..|.+..+....
T Consensus 234 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 ------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ------ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000002223457788889999999999999987765
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.9e-20 Score=215.37 Aligned_cols=248 Identities=24% Similarity=0.310 Sum_probs=181.0
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc---c---HHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD---G---VKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL 750 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 750 (973)
++...+.+|.+.|=+|.+|++.+ | .|+||++-+.. . ..+..+|++ ...++|||++++.-+...+...|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 56778899999999999999986 5 59999986632 2 233334444 55569999999988877788889999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccccc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 830 (973)
+|+.+ +|+|.+.. ++-+...+...|+.|++.|+..+| ..||+|||||.+||||+.=.-+.|+||..-+..-
T Consensus 101 qyvkh-nLyDRlST-----RPFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtY 171 (1431)
T KOG1240|consen 101 QYVKH-NLYDRLST-----RPFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTY 171 (1431)
T ss_pred HHHhh-hhhhhhcc-----chHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCcc
Confidence 99955 88888864 456778888999999999999999 8899999999999999999999999998765331
Q ss_pred -CCCCcccccccC----CccccccccccccC----------C-CCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHH
Q 002061 831 -NSPKVSDYSCFA----GTHGYIAPELAYTC----------K-VSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVY 893 (973)
Q Consensus 831 -~~~~~~~~~~~~----gt~~y~aPE~~~~~----------~-~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~ 893 (973)
+.+...++..+. .-.+|.|||.+... . .+++-||||+||++.|+++ |++||.-. +
T Consensus 172 LPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS--------Q 243 (1431)
T KOG1240|consen 172 LPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS--------Q 243 (1431)
T ss_pred CCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH--------H
Confidence 223333333222 23579999987431 1 6678899999999999998 89998532 2
Q ss_pred HHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 002061 894 WVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952 (973)
Q Consensus 894 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~ 952 (973)
..+-+..........+. .. + -..+..++..|++.||++|.++.+.++.-++
T Consensus 244 L~aYr~~~~~~~e~~Le-~I-----e--d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 244 LLAYRSGNADDPEQLLE-KI-----E--DVSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred HHhHhccCccCHHHHHH-hC-----c--CccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 21111111110000000 00 0 1146788999999999999999999988553
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.7e-19 Score=188.06 Aligned_cols=233 Identities=21% Similarity=0.282 Sum_probs=149.3
Q ss_pred CcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcC----------CCceeeEEEEEE-
Q 002061 678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIR----------HRNILKLYACLL- 741 (973)
Q Consensus 678 ~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~----------hpniv~l~~~~~- 741 (973)
+...+.||.|+++.||.+.+.++++.+|||+.... ...+.+.+|.-....+. |-.++-.++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 35567899999999999999999999999987542 34556666665544432 222333333221
Q ss_pred --------eC--C------eeEEEEEccCCCchHHHHHhhhcCC--CCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEec
Q 002061 742 --------KG--G------SSFLVLEYMPNGNLFQALHKRVKEG--KPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHR 803 (973)
Q Consensus 742 --------~~--~------~~~lv~e~~~~gsL~~~l~~~~~~~--~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~ 803 (973)
.. . ..+++|+-+ .++|.+.+....... ........+..+..|+.+.+++|| ..|++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEec
Confidence 11 1 226788887 679988865321111 122445566777899999999999 7899999
Q ss_pred CCCCCCeeecCCCCeEEecccCcccccCCCCcccccccCCcccccccccccc--------CCCCccchHHHHHHHHHHHH
Q 002061 804 DIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYT--------CKVSEKSDVFSFGVVLLELV 875 (973)
Q Consensus 804 Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~~l~el~ 875 (973)
||+|+|++++++|.++|+||+.....+... .....+..|.+||.... ..++.+.|.|++|+++|.++
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~-----~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRY-----RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEE-----EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCcee-----eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 999999999999999999999776543321 11234578999997643 24788999999999999999
Q ss_pred hCCCCCCcccCCcccHHHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCC
Q 002061 876 TGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLR 940 (973)
Q Consensus 876 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 940 (973)
+|..||+......... ..+-.+ . +.++.+..+|..+++++|++|
T Consensus 245 C~~lPf~~~~~~~~~~--------------~~f~~C------~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPE--------------WDFSRC------R-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTSG--------------GGGTTS------S----HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCcccccc--------------ccchhc------C-CcCHHHHHHHHHHccCCcccC
Confidence 9999998642211110 011111 1 456678889999999999988
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=4e-19 Score=178.70 Aligned_cols=138 Identities=21% Similarity=0.205 Sum_probs=107.2
Q ss_pred cCcccccCceEEEEEEecCCCcEEEEEeeeccc----c-------HHH-----------------HHHHHHHHHhcCCCc
Q 002061 681 DNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----G-------VKV-----------------FAAEMEILGKIRHRN 732 (973)
Q Consensus 681 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~-------~~~-----------------~~~E~~~l~~l~hpn 732 (973)
...||+|+||.||+|.+. +|+.||||+++... . ... ..+|++.+.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 357999999999999997 79999999986531 1 112 234999999998877
Q ss_pred eeeEEEEEEeCCeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhh-hhcCCCCeEecCCCCCCee
Q 002061 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL-HHDCSPPIIHRDIKSSNIL 811 (973)
Q Consensus 733 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~L-H~~~~~~ivH~Dlkp~Nil 811 (973)
+.....+... ..++||||++++++...... ...++......++.|++.+++++ | +.+|+||||||+||+
T Consensus 81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIl 150 (190)
T cd05147 81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLK-----DAPLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLL 150 (190)
T ss_pred CCCCcEEEec--CCEEEEEEeCCCCCcchhhh-----cCCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEE
Confidence 6443333222 23899999988877554321 23578888999999999999999 6 679999999999999
Q ss_pred ecCCCCeEEecccCccccc
Q 002061 812 LDEDYEPKIADFGVAKIAE 830 (973)
Q Consensus 812 l~~~~~~kl~Dfgl~~~~~ 830 (973)
++ ++.++++|||+|....
T Consensus 151 i~-~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 151 YH-DGKLYIIDVSQSVEHD 168 (190)
T ss_pred EE-CCcEEEEEccccccCC
Confidence 98 4789999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.4e-19 Score=181.45 Aligned_cols=169 Identities=14% Similarity=0.178 Sum_probs=130.1
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc-----cHHH------HHHHHHHHHhcCCCceeeEEEEEEe
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----GVKV------FAAEMEILGKIRHRNILKLYACLLK 742 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-----~~~~------~~~E~~~l~~l~hpniv~l~~~~~~ 742 (973)
.-++|+..+.+|.|+||.||.+.. ++..+|||++..+. .... +.+|++.+.++.||+|..+.+++..
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 346899999999999999999766 36689999986521 1112 5789999999999999999988664
Q ss_pred C--------CeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecC
Q 002061 743 G--------GSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE 814 (973)
Q Consensus 743 ~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~ 814 (973)
. ...++||||++|.+|.++.. ++. ....+++.++..+| ..|++|||++|.||+++.
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~ 170 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSK 170 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeC
Confidence 3 35799999999999977632 222 24558999999999 889999999999999999
Q ss_pred CCCeEEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHH
Q 002061 815 DYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELV 875 (973)
Q Consensus 815 ~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~ 875 (973)
+| ++++|||.......... . ..+.....+..++|+|+||+++....
T Consensus 171 ~g-i~liDfg~~~~~~e~~a-~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 171 NG-LRIIDLSGKRCTAQRKA-K-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CC-EEEEECCCcccccchhh-H-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 88 99999998764421110 0 11333445667899999999877654
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.1e-21 Score=176.36 Aligned_cols=166 Identities=29% Similarity=0.466 Sum_probs=84.9
Q ss_pred ccCCccCcEeeCCCCcccCcCChhhhCCCCCcEEEecCCcccCCCCcccCCCCCCEEeccCccCCCccccccccccccce
Q 002061 93 ISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVS 172 (973)
Q Consensus 93 l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~ 172 (973)
+..+.+++.|.||+|+++ .+|..++.+.+|++|++++|++...|++++.+++|+.|+++-|.+. +.|..|+.++.|+.
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~lev 106 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEV 106 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhh-cCccccCCCchhhh
Confidence 344455555555555555 4445555555555555555555555555555555555555555544 44444444444444
Q ss_pred EEccCCcCCCCCCcccccCCCCCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCchhhhccccccEEEeeccc
Q 002061 173 LSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANN 252 (973)
Q Consensus 173 L~l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~ 252 (973)
|||.+|.+++..+ |..|..++.|+-|+|++|.+. .+|..++++++|+.|.+..|.
T Consensus 107 ldltynnl~e~~l------------------------pgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdnd 161 (264)
T KOG0617|consen 107 LDLTYNNLNENSL------------------------PGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDND 161 (264)
T ss_pred hhccccccccccC------------------------CcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCc
Confidence 4444444444444 444444455555555555554 445555555555555555555
Q ss_pred cCCcCCccccccccccEEEeeccccccccCCccCC
Q 002061 253 LTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGN 287 (973)
Q Consensus 253 l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 287 (973)
+- .+|..++.++.|++|.+.+|+++ .+|..+++
T Consensus 162 ll-~lpkeig~lt~lrelhiqgnrl~-vlppel~~ 194 (264)
T KOG0617|consen 162 LL-SLPKEIGDLTRLRELHIQGNRLT-VLPPELAN 194 (264)
T ss_pred hh-hCcHHHHHHHHHHHHhcccceee-ecChhhhh
Confidence 54 45555555555555555555555 44444444
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=5.9e-19 Score=181.99 Aligned_cols=250 Identities=22% Similarity=0.294 Sum_probs=165.5
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCc-----------------------------------EEEEEeeec---cccH
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAG-----------------------------------TVAVKQLWK---GDGV 715 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~-----------------------------------~vavK~~~~---~~~~ 715 (973)
.+++|++...||+|+...||.|+...+|. +.|||.++. ....
T Consensus 155 tiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~ 234 (598)
T KOG4158|consen 155 TIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGD 234 (598)
T ss_pred chhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCch
Confidence 35679999999999999999988764211 245665543 1111
Q ss_pred HHHHH----------------HHHH--HHh--------cCCCceeeEEEEEEe---------------------------
Q 002061 716 KVFAA----------------EMEI--LGK--------IRHRNILKLYACLLK--------------------------- 742 (973)
Q Consensus 716 ~~~~~----------------E~~~--l~~--------l~hpniv~l~~~~~~--------------------------- 742 (973)
..+.+ |..+ .+. -+|||||+++++|.+
T Consensus 235 ~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~ 314 (598)
T KOG4158|consen 235 AHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGE 314 (598)
T ss_pred HHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCC
Confidence 22211 1111 111 259999999987743
Q ss_pred CCeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeec--CCC--Ce
Q 002061 743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD--EDY--EP 818 (973)
Q Consensus 743 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~--~~~--~~ 818 (973)
+...|+||...+ .+|..|+..+ ..+......+..|+++|+.||| .+||.|||+|.+||++. +|+ ..
T Consensus 315 ~~tlylvMkrY~-~tLr~yl~~~------~~s~r~~~~~laQlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~L 384 (598)
T KOG4158|consen 315 PKTLYLVMKRYR-QTLREYLWTR------HRSYRTGRVILAQLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQL 384 (598)
T ss_pred CceEEEehhcch-hhHHHHHhcC------CCchHHHHHHHHHHHHHHHHHH---HccchhhcccccceEEEecCCCCcEE
Confidence 224599999884 5999999753 3445566678999999999999 88999999999999984 333 47
Q ss_pred EEecccCcccccCCCC----cccccccCCccccccccccccCC------CCccchHHHHHHHHHHHHhCCCCCCcccCCc
Q 002061 819 KIADFGVAKIAENSPK----VSDYSCFAGTHGYIAPELAYTCK------VSEKSDVFSFGVVLLELVTGRKPVEEEYGDG 888 (973)
Q Consensus 819 kl~Dfgl~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~~l~el~tg~~pf~~~~~~~ 888 (973)
.++|||.+--.+...- ....-...|....||||+....+ -..++|.|+.|.+.||+++...||.....-.
T Consensus 385 VvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~ 464 (598)
T KOG4158|consen 385 VVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML 464 (598)
T ss_pred EEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe
Confidence 8999998743332211 11122345778899999985432 2358999999999999999999997531111
Q ss_pred ccHHHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 002061 889 KDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVK 948 (973)
Q Consensus 889 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~ 948 (973)
-+...+....+ +..+......+.+++...++.||.+|+++.=...
T Consensus 465 L~~r~Yqe~qL---------------Palp~~vpp~~rqlV~~lL~r~pskRvsp~iAAN 509 (598)
T KOG4158|consen 465 LDTRTYQESQL---------------PALPSRVPPVARQLVFDLLKRDPSKRVSPNIAAN 509 (598)
T ss_pred echhhhhhhhC---------------CCCcccCChHHHHHHHHHhcCCccccCCccHHHh
Confidence 11111111111 1112333445678888899999999998654433
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.2e-18 Score=173.11 Aligned_cols=138 Identities=20% Similarity=0.226 Sum_probs=109.2
Q ss_pred cCcccccCceEEEEEEecCCCcEEEEEeeecccc----------------------------HHHHHHHHHHHHhcCCCc
Q 002061 681 DNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG----------------------------VKVFAAEMEILGKIRHRN 732 (973)
Q Consensus 681 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~----------------------------~~~~~~E~~~l~~l~hpn 732 (973)
...||+|++|.||+|.+. +|+.||||++..... ...+.+|.+.+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 467999999999999987 799999998875310 112357899999999998
Q ss_pred eeeEEEEEEeCCeeEEEEEccCCCchHHH-HHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCC-CCeEecCCCCCCe
Q 002061 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQA-LHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS-PPIIHRDIKSSNI 810 (973)
Q Consensus 733 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~-~~ivH~Dlkp~Ni 810 (973)
+.....+... ..++||||++++++... +.. ..++......++.|++.++.++| . .+|+||||||+||
T Consensus 81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~------~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NI 149 (190)
T cd05145 81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLKD------VPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNI 149 (190)
T ss_pred CCCceEEEec--CCEEEEEEecCCCchhhhhhh------ccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhE
Confidence 7555444333 24899999988855433 322 24567788899999999999999 5 8999999999999
Q ss_pred eecCCCCeEEecccCcccccC
Q 002061 811 LLDEDYEPKIADFGVAKIAEN 831 (973)
Q Consensus 811 ll~~~~~~kl~Dfgl~~~~~~ 831 (973)
+++ ++.++++|||++.....
T Consensus 150 ll~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 150 LYH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred EEE-CCCEEEEEcccceecCC
Confidence 999 88999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.4e-18 Score=168.76 Aligned_cols=185 Identities=17% Similarity=0.159 Sum_probs=137.3
Q ss_pred cccCcccccCceEEEEEEecCCCcEEEEEeeecccc------HHHHHHHHHHHHhcC-CCceeeEEEEEEeCCeeEEEEE
Q 002061 679 EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG------VKVFAAEMEILGKIR-HRNILKLYACLLKGGSSFLVLE 751 (973)
Q Consensus 679 ~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~------~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e 751 (973)
.+...|++|+||+||.+.. .+..++.+.+..... ...+.+|+++++++. |+++.+++++ ...+++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 3457899999999997776 377888776654322 125789999999995 5888888886 34699999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCC-CCCCeeecCCCCeEEecccCccccc
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDI-KSSNILLDEDYEPKIADFGVAKIAE 830 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dl-kp~Nill~~~~~~kl~Dfgl~~~~~ 830 (973)
|++|.+|.+.... ....++.|++++++++| +.||+|||| ||.||+++.++.++|+|||++....
T Consensus 79 yI~G~~L~~~~~~------------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~ 143 (218)
T PRK12274 79 YLAGAAMYQRPPR------------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGN 143 (218)
T ss_pred eecCccHHhhhhh------------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecC
Confidence 9999988654321 01246789999999999 889999999 7999999999999999999998655
Q ss_pred CCCCc------ccc-----cccCCccccccccccccC-CCC-ccchHHHHHHHHHHHHhCCCCCCcc
Q 002061 831 NSPKV------SDY-----SCFAGTHGYIAPELAYTC-KVS-EKSDVFSFGVVLLELVTGRKPVEEE 884 (973)
Q Consensus 831 ~~~~~------~~~-----~~~~gt~~y~aPE~~~~~-~~~-~~~DvwslG~~l~el~tg~~pf~~~ 884 (973)
..... .+. .-...++.|++|+...-- ..+ .+.+.++.|.-+|.++|+..|+-.+
T Consensus 144 ~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 144 PRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred CcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 43321 110 012356777888754321 223 5679999999999999998887543
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.5e-20 Score=171.98 Aligned_cols=167 Identities=29% Similarity=0.489 Sum_probs=141.8
Q ss_pred hhhCCCCCcEEEecCCcccCCCCcccCCCCCCEEeccCccCCCccccccccccccceEEccCCcCCCCCCcccccCCCCC
Q 002061 116 ELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNL 195 (973)
Q Consensus 116 ~l~~l~~L~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ip~~~~~l~~L 195 (973)
.+..+++.+.|.||+|+++..+|.++.|.+|+.|++++|+++ ++|.+++.+++|
T Consensus 28 gLf~~s~ITrLtLSHNKl~~vppnia~l~nlevln~~nnqie--------------------------~lp~~issl~kl 81 (264)
T KOG0617|consen 28 GLFNMSNITRLTLSHNKLTVVPPNIAELKNLEVLNLSNNQIE--------------------------ELPTSISSLPKL 81 (264)
T ss_pred cccchhhhhhhhcccCceeecCCcHHHhhhhhhhhcccchhh--------------------------hcChhhhhchhh
Confidence 345667788888999999888888888888888888888886 456677777777
Q ss_pred CEEEcccCCCCCCCChhhhccCCCCeeeccccccc-CCCchhhhccccccEEEeeccccCCcCCccccccccccEEEeec
Q 002061 196 TYLFLAHCNLRGRIPESISELRELGTLDICRNKIS-GEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISS 274 (973)
Q Consensus 196 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~ 274 (973)
++|++.-|++. ..|..|+.++.|+.|||+.|++. ..+|..|..+..|+.|+|+.|.+. .+|..++++++||.|.+..
T Consensus 82 r~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrd 159 (264)
T KOG0617|consen 82 RILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRD 159 (264)
T ss_pred hheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeecc
Confidence 77777777776 77888888888888888888775 358999999999999999999999 8999999999999999999
Q ss_pred cccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCc
Q 002061 275 NQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDM 312 (973)
Q Consensus 275 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l 312 (973)
|.+- .+|..++.++.|+.|.+.+|+++ .+|..++++
T Consensus 160 ndll-~lpkeig~lt~lrelhiqgnrl~-vlppel~~l 195 (264)
T KOG0617|consen 160 NDLL-SLPKEIGDLTRLRELHIQGNRLT-VLPPELANL 195 (264)
T ss_pred Cchh-hCcHHHHHHHHHHHHhcccceee-ecChhhhhh
Confidence 9998 89999999999999999999999 566555544
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.9e-20 Score=204.19 Aligned_cols=273 Identities=21% Similarity=0.273 Sum_probs=185.7
Q ss_pred EEeecCCCCC-ccccccccCCccCcEeeCCCCcccCc----CChhhhCCCCCcEEEecCCcccCCC-------CcccCCC
Q 002061 77 EISFDNKSLS-GEISSSISALQSLTVLSLPFNVLSGK----LPLELSNCSNLKVLNVTGNAMVGSV-------PDLSALK 144 (973)
Q Consensus 77 ~l~l~~~~l~-~~~~~~l~~l~~L~~L~Ls~n~l~~~----~p~~l~~l~~L~~L~L~~n~l~~~~-------~~l~~l~ 144 (973)
.|+|.++.++ +.....+..++.|+.|+++++.+++. ++..+...++|++|+++++.+.+.+ ..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 4677777887 34455567778899999999888543 5666777888999999888876311 2356678
Q ss_pred CCCEEeccCccCCCccccccccccc---cceEEccCCcCCCCCC---cccccCC-CCCCEEEcccCCCCCC----CChhh
Q 002061 145 NLEIFDLSINYFTGRFPRWVVNLTQ---LVSLSIGDNVYDEAEI---PESIGNL-KNLTYLFLAHCNLRGR----IPESI 213 (973)
Q Consensus 145 ~L~~L~Ls~n~l~~~~~~~~~~l~~---L~~L~l~~n~l~~~~i---p~~~~~l-~~L~~L~L~~n~l~~~----~~~~~ 213 (973)
+|+.|++++|.+.+..+..+..+.+ |++|++++|.++.... ...+..+ ++|+.|++++|.+++. ++..+
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~ 161 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKAL 161 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHH
Confidence 8999999988887766777766666 8888888888764222 2345566 7888888888888843 33456
Q ss_pred hccCCCCeeecccccccCC----CchhhhccccccEEEeeccccCCcC----CccccccccccEEEeeccccccccCCcc
Q 002061 214 SELRELGTLDICRNKISGE----FPRSIRKLQKLWKIELYANNLTGEL----PAELGNLTLLQEFDISSNQMYGKLPEEI 285 (973)
Q Consensus 214 ~~l~~L~~L~L~~N~l~~~----~~~~l~~l~~L~~L~L~~N~l~~~~----~~~l~~l~~L~~L~Ls~N~l~~~~p~~~ 285 (973)
..+++|++|++++|.+++. ++..+..+++|++|+|++|.+++.. ...+..+++|++|++++|.+++.....+
T Consensus 162 ~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l 241 (319)
T cd00116 162 RANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAAL 241 (319)
T ss_pred HhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHH
Confidence 6667888888888888743 2334455568888888888876432 3345567788888888888775333332
Q ss_pred C-----CCCCccEEEcccCCCCC----CCCCCcCCcccceeeeccCCccCCC----CCcccccc-ccccccccccccc
Q 002061 286 G-----NLKNLTVFQCFKNNFSG----EFPSGFGDMRKLFAFSIYGNRFSGP----FPENLGRY-TALTDVDISENQF 349 (973)
Q Consensus 286 ~-----~l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~----~~~~l~~l-~~L~~L~Ls~N~l 349 (973)
. ..++|+.|++++|.++. .+...+..+++|+.+++++|.++.. ....+... +.|++||+.+|.+
T Consensus 242 ~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 242 ASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred HHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 2 23678888888887762 2223445556777777777777744 33333334 5677777777653
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.8e-19 Score=197.13 Aligned_cols=224 Identities=27% Similarity=0.313 Sum_probs=174.5
Q ss_pred cccccCceEEEEEEe---cCCCcEEEEEeeeccc----cHHHHHHHHHHHHhcC-CCceeeEEEEEEeCCeeEEEEEccC
Q 002061 683 LIGSGGTGKVYRLDL---KKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIR-HRNILKLYACLLKGGSSFLVLEYMP 754 (973)
Q Consensus 683 ~lG~G~~g~V~~a~~---~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~~ 754 (973)
.+|+|+||.|++++- .+.+.-+|+|++++.. .......|..++...+ ||.++++...++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999997543 3447779999887631 2224566888999886 9999999999999999999999999
Q ss_pred CCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCC
Q 002061 755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK 834 (973)
Q Consensus 755 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 834 (973)
+|++...+.. ...+.......+...++-|++++| +.+++|||+|++||+++.+|.+++.|||+++..-....
T Consensus 81 gg~lft~l~~-----~~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~ 152 (612)
T KOG0603|consen 81 GGDLFTRLSK-----EVMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI 152 (612)
T ss_pred cchhhhcccc-----CCchHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhh
Confidence 9999887764 334666777778888999999999 89999999999999999999999999999875533211
Q ss_pred cccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhcccccc
Q 002061 835 VSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVA 914 (973)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (973)
.+||..|||||++. ....++|.||+|++++||+||..||..+ .. .... .. .
T Consensus 153 ------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~------~~---~~Il-~~-----------~ 203 (612)
T KOG0603|consen 153 ------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD------TM---KRIL-KA-----------E 203 (612)
T ss_pred ------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH------HH---HHHh-hh-----------c
Confidence 26899999999987 5688999999999999999999999751 11 1111 10 1
Q ss_pred CcchHHHHHHHHHHHHHhcCCCCCCCCCH
Q 002061 915 SESIKEDMIKLLKIAVVCTTKLPNLRPPM 943 (973)
Q Consensus 915 ~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~ 943 (973)
...+.+......+++..++..+|..|.-.
T Consensus 204 ~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 204 LEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 12344555566677777788888888644
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.3e-20 Score=206.83 Aligned_cols=107 Identities=18% Similarity=0.203 Sum_probs=54.7
Q ss_pred EEeccCccCC-CccccccccccccceEEccCCcCCCC---CCcccccCCCCCCEEEcccCCCCC------CCChhhhccC
Q 002061 148 IFDLSINYFT-GRFPRWVVNLTQLVSLSIGDNVYDEA---EIPESIGNLKNLTYLFLAHCNLRG------RIPESISELR 217 (973)
Q Consensus 148 ~L~Ls~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~---~ip~~~~~l~~L~~L~L~~n~l~~------~~~~~~~~l~ 217 (973)
.|+|+.+.++ +.....+..+++|++|+++++.++.. .++..+...++|++|+++++.+.+ .++..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 4667777766 33444555566666666666665331 234444555566666666665542 1223344445
Q ss_pred CCCeeecccccccCCCchhhhcccc---ccEEEeeccccC
Q 002061 218 ELGTLDICRNKISGEFPRSIRKLQK---LWKIELYANNLT 254 (973)
Q Consensus 218 ~L~~L~L~~N~l~~~~~~~l~~l~~---L~~L~L~~N~l~ 254 (973)
+|+.|+|++|.+.+..+..+..+.+ |++|++++|+++
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~ 121 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLG 121 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccc
Confidence 5555555555554444444433333 444444444444
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=6.3e-18 Score=187.34 Aligned_cols=218 Identities=25% Similarity=0.413 Sum_probs=165.1
Q ss_pred HHhcCCCceeeEEEEEEeCCeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecC
Q 002061 725 LGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRD 804 (973)
Q Consensus 725 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~D 804 (973)
|+.+.|.|+.++++.+..+...+.|.+||..|+|.|.+.. ....++|.....++.+++.||+|+|. +....|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~----~~~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN----EDIKLDYFFILSFIRDISKGLAYLHN--SPIGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc----cccCccHHHHHHHHHHHHHHHHHHhc--Ccceeeee
Confidence 3567899999999999999999999999999999999976 35578999999999999999999995 33348999
Q ss_pred CCCCCeeecCCCCeEEecccCcccccCCCCcccccccCCccccccccccccCC-------CCccchHHHHHHHHHHHHhC
Q 002061 805 IKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCK-------VSEKSDVFSFGVVLLELVTG 877 (973)
Q Consensus 805 lkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwslG~~l~el~tg 877 (973)
+++.|.+++....+|++|||+.................-..-|.|||.+++.. .+.+.||||+|++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 99999999999999999999987654311112222222346799999987531 45679999999999999999
Q ss_pred CCCCCcccCCcc--cHHHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 002061 878 RKPVEEEYGDGK--DIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADP 955 (973)
Q Consensus 878 ~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 955 (973)
+.||+....... .+...++. ... ..+.+...... +..+.+..++..||..+|++||++.+|-..++.+..
T Consensus 155 ~~~~~~~~~~~~~~eii~~~~~---~~~---~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRVKK---GGS---NPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cCccccccccCChHHHHHHHHh---cCC---CCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 999987543333 33333333 011 11122221111 333468899999999999999999999888887654
Q ss_pred C
Q 002061 956 C 956 (973)
Q Consensus 956 ~ 956 (973)
.
T Consensus 227 ~ 227 (484)
T KOG1023|consen 227 G 227 (484)
T ss_pred c
Confidence 3
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.4e-17 Score=197.16 Aligned_cols=196 Identities=20% Similarity=0.244 Sum_probs=157.6
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhcC---CCceeeEEEEEEeCCeeEEEE
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIR---HRNILKLYACLLKGGSSFLVL 750 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~lv~ 750 (973)
....|.+.+.||+|+||+||+|...+ |+.||+|+-+...-.+ |.=-.+++.|++ -+.|+.+..++.-.+.-++|+
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE-fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ 773 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE-FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVS 773 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee-eeehHHHHHhhchhhhcchHHHHHHHccCCcceeee
Confidence 34578889999999999999999988 9999999876543221 222234445555 234455555555667778999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecC-------CCCeEEecc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE-------DYEPKIADF 823 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~-------~~~~kl~Df 823 (973)
||.+.|+|.+++. ....++|.-+..++.|+++.+++|| ..+|||+||||+|.++.. ...++|+||
T Consensus 774 ey~~~Gtlld~~N-----~~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 774 EYSPYGTLLDLIN-----TNKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred eccccccHHHhhc-----cCCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEec
Confidence 9999999999997 3456899999999999999999999 889999999999999952 345899999
Q ss_pred cCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCC
Q 002061 824 GVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRK 879 (973)
Q Consensus 824 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~ 879 (973)
|.+..+.--.........++|-.+-.+|+..|+.++.++|-|.++.+++.|++|++
T Consensus 846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 99976643333345666788999999999999999999999999999999999954
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=9.7e-17 Score=162.56 Aligned_cols=134 Identities=18% Similarity=0.269 Sum_probs=104.5
Q ss_pred cccCcccccCceEEEEEEecCCCcEEEEEeeecc--ccHHHHHHHHHHHHhc-----CCCceeeEEEEEEeCC---eeE-
Q 002061 679 EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKI-----RHRNILKLYACLLKGG---SSF- 747 (973)
Q Consensus 679 ~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l-----~hpniv~l~~~~~~~~---~~~- 747 (973)
.-.+.||+|+||.||. ++.++.. +||++... ...+.+.+|+++++.+ +||||++++++++++. .++
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 4457899999999995 6665555 69987642 3456789999999999 5799999999998763 434
Q ss_pred EEEEc--cCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH-hhhhhcCCCCeEecCCCCCCeeecC----CCCeEE
Q 002061 748 LVLEY--MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGI-AYLHHDCSPPIIHRDIKSSNILLDE----DYEPKI 820 (973)
Q Consensus 748 lv~e~--~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l-~~LH~~~~~~ivH~Dlkp~Nill~~----~~~~kl 820 (973)
+|+|| +++|+|.+++.+. .+++. ..++.|++.++ +||| +++|+||||||+||+++. ++.++|
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~------~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~L 150 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC------RYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVV 150 (210)
T ss_pred EEecCCCCcchhHHHHHHcc------cccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEE
Confidence 78999 5579999999642 24443 35577778777 9999 889999999999999974 337999
Q ss_pred ecccCc
Q 002061 821 ADFGVA 826 (973)
Q Consensus 821 ~Dfgl~ 826 (973)
+||+.+
T Consensus 151 iDg~G~ 156 (210)
T PRK10345 151 CDNIGE 156 (210)
T ss_pred EECCCC
Confidence 995433
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.1e-16 Score=164.48 Aligned_cols=141 Identities=19% Similarity=0.180 Sum_probs=108.9
Q ss_pred CcccCcccccCceEEEEEE-ecCCCcEEEEEeeecccc--------------------------HHHHHHHHHHHHhcCC
Q 002061 678 LEEDNLIGSGGTGKVYRLD-LKKNAGTVAVKQLWKGDG--------------------------VKVFAAEMEILGKIRH 730 (973)
Q Consensus 678 ~~~~~~lG~G~~g~V~~a~-~~~~~~~vavK~~~~~~~--------------------------~~~~~~E~~~l~~l~h 730 (973)
|++.+.||+|+||.||+|. +..+|+.||||++..... ...+.+|++.++++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 6778899999999999998 666799999998864210 1235679999999975
Q ss_pred Cc--eeeEEEEEEeCCeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCC-eEecCCCC
Q 002061 731 RN--ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP-IIHRDIKS 807 (973)
Q Consensus 731 pn--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~-ivH~Dlkp 807 (973)
.. +.+++++ ...++||||++++++..+... ...........++.|++.+++++| ..+ ++||||||
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp 177 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK-----DVEPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSE 177 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCcccccccc-----cCCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCCh
Confidence 33 3344432 235899999999888665422 123455566789999999999999 788 99999999
Q ss_pred CCeeecCCCCeEEecccCcccccC
Q 002061 808 SNILLDEDYEPKIADFGVAKIAEN 831 (973)
Q Consensus 808 ~Nill~~~~~~kl~Dfgl~~~~~~ 831 (973)
+||+++ ++.++++|||.+...+.
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhccCC
Confidence 999999 88999999999875443
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.65 E-value=6e-17 Score=175.42 Aligned_cols=177 Identities=24% Similarity=0.328 Sum_probs=131.5
Q ss_pred CeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecc
Q 002061 744 GSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADF 823 (973)
Q Consensus 744 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 823 (973)
.+.|+.|++|+..+|.+|+.++ ......++.....++.|++.|++| ++.+|||+||.||+...+.++||+||
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr--~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDF 400 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRR--RTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDF 400 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCC--CcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhh
Confidence 3578999999999999999754 233446778888999999999999 47899999999999999999999999
Q ss_pred cCcccccCCC----CcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHH
Q 002061 824 GVAKIAENSP----KVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTH 898 (973)
Q Consensus 824 gl~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~ 898 (973)
|+........ ....++...||..||+||.+.+..|+.++||||||++++|++. =..+|+.. +.
T Consensus 401 gl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~-----------~t- 468 (516)
T KOG1033|consen 401 GLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI-----------AT- 468 (516)
T ss_pred hheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH-----------Hh-
Confidence 9988765443 2234556789999999999999999999999999999999997 22232211 00
Q ss_pred hccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 002061 899 LNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVV 947 (973)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl 947 (973)
...+-|..+.+....+. +.=..++.+++.+.|.+||++.++.
T Consensus 469 ------~~d~r~g~ip~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~~ 510 (516)
T KOG1033|consen 469 ------LTDIRDGIIPPEFLQDY-PEEYTLLQQLLSPSPEERPSAIEVA 510 (516)
T ss_pred ------hhhhhcCCCChHHhhcC-cHHHHHHHHhcCCCcccCchHHHHh
Confidence 11111122221222222 2234678899999999999555443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.1e-16 Score=182.77 Aligned_cols=211 Identities=23% Similarity=0.257 Sum_probs=141.4
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCC
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPN 755 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 755 (973)
.+|+.++.|..|+||.||.++++.+.+.+|+| +.+.....+ + ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lilR--n---ilt~a~npfvv--------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLILR--N---ILTFAGNPFVV--------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-ccccchhhh--c---cccccCCccee---------------------
Confidence 47888999999999999999999999999995 443322111 1 23333444444
Q ss_pred CchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCC-
Q 002061 756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK- 834 (973)
Q Consensus 756 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~- 834 (973)
|+=...++. .+.++. +++.+++|+| +.+|+|||+||+|.+|+.-|++|++|||+++.......
T Consensus 136 gDc~tllk~-----~g~lPv--------dmvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 GDCATLLKN-----IGPLPV--------DMVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred chhhhhccc-----CCCCcc--------hhhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 222222322 112232 2277899999 89999999999999999999999999999864321100
Q ss_pred ------------cccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccc
Q 002061 835 ------------VSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNH 902 (973)
Q Consensus 835 ------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 902 (973)
.......+||+.|+|||++....|+..+|+|++|+++||.+.|+.||.++. ....+...+...
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdt-----peelfg~visd~ 274 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT-----PEELFGQVISDD 274 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCC-----HHHHHhhhhhhh
Confidence 001112479999999999999999999999999999999999999997642 112222221111
Q ss_pred cccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCH
Q 002061 903 ENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPM 943 (973)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~ 943 (973)
.... +.......+..+++...++.+|..|--.
T Consensus 275 i~wp---------E~dea~p~Ea~dli~~LL~qnp~~Rlgt 306 (1205)
T KOG0606|consen 275 IEWP---------EEDEALPPEAQDLIEQLLRQNPLCRLGT 306 (1205)
T ss_pred cccc---------ccCcCCCHHHHHHHHHHHHhChHhhccc
Confidence 1111 1112223345667777888999999533
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.2e-15 Score=155.87 Aligned_cols=132 Identities=20% Similarity=0.303 Sum_probs=111.4
Q ss_pred CcccccCceEEEEEEecCCCcEEEEEeeeccc----------cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 002061 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----------GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE 751 (973)
Q Consensus 682 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 751 (973)
+.||+|++|.||+|... +..|+||+..... ....+.+|++++..+.|+++.....++......++|||
T Consensus 2 ~~l~~G~~~~vy~~~~~--~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFL--GIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEeeC--CCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 57899999999999873 6789999754311 12356789999999999998887777777788899999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccc
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 828 (973)
|++|++|.+++... .+ .+..++.+++.++.++| +.+++|||++|.||+++ ++.++++|||.+..
T Consensus 80 ~~~G~~L~~~~~~~--------~~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSN--------GM-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhc--------cH-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999988642 12 77889999999999999 78999999999999999 78999999998763
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.6e-15 Score=153.71 Aligned_cols=128 Identities=20% Similarity=0.287 Sum_probs=104.9
Q ss_pred cccccCceEEEEEEecCCCcEEEEEeeecc----c------cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 002061 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----D------GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY 752 (973)
Q Consensus 683 ~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 752 (973)
.||+|+||+||+|... +..|++|+.... . ...++.+|+++++.++|+++.....++......++||||
T Consensus 1 ~ig~G~~~~vy~~~~~--~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL--GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeecC--CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 3799999999999854 678999975431 0 124567899999999988766555556666778999999
Q ss_pred cCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccc
Q 002061 753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828 (973)
Q Consensus 753 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 828 (973)
++|++|.+++.... . .++.+++.+++++| +.+++|||++|.||+++ ++.+++.|||.+..
T Consensus 79 ~~g~~l~~~~~~~~------~------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGN------D------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcH------H------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999998875420 0 78899999999999 88999999999999999 88999999998864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.61 E-value=5.5e-15 Score=174.13 Aligned_cols=135 Identities=21% Similarity=0.286 Sum_probs=110.4
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeee-c---c------ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCC
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLW-K---G------DGVKVFAAEMEILGKIRHRNILKLYACLLKGG 744 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~-~---~------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 744 (973)
...|...+.||+|+||+||+|.+... .+++|+.. + . ...+++.+|+++++.++|++++....++..+.
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 34556788999999999999988743 34444321 1 1 12345788999999999999998888777777
Q ss_pred eeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEeccc
Q 002061 745 SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFG 824 (973)
Q Consensus 745 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 824 (973)
..++||||+++++|.+++. ....++.+++++++++| +.+++|||+||+||++ .++.++++|||
T Consensus 410 ~~~lv~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFG 472 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFG 472 (535)
T ss_pred CCEEEEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCc
Confidence 8899999999999988875 23568899999999999 7899999999999999 67899999999
Q ss_pred Cccc
Q 002061 825 VAKI 828 (973)
Q Consensus 825 l~~~ 828 (973)
+++.
T Consensus 473 la~~ 476 (535)
T PRK09605 473 LGKY 476 (535)
T ss_pred cccc
Confidence 9864
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.1e-15 Score=177.83 Aligned_cols=148 Identities=30% Similarity=0.464 Sum_probs=123.0
Q ss_pred chHHHHHHHHHHHhcCCCcccccCCCCCCCC---CCCcceeeeCC--CC--CceEEEeecCCCCCccccccccCCccCcE
Q 002061 29 LNVETQALIQFKSKLKDPHGVLDSWKESADS---PCGFSGITCDS--VT--GRVTEISFDNKSLSGEISSSISALQSLTV 101 (973)
Q Consensus 29 ~~~~~~aLl~~k~~~~d~~~~~~~W~~~~~~---~c~w~gv~C~~--~~--~~v~~l~l~~~~l~~~~~~~l~~l~~L~~ 101 (973)
.+.|.+||++||+++.+|.. .+|+.+ +| +|.|.||.|+. .. .+|+.|+|++++++|.+|+.++.+++|+.
T Consensus 370 ~~~~~~aL~~~k~~~~~~~~--~~W~g~-~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L~~ 446 (623)
T PLN03150 370 LLEEVSALQTLKSSLGLPLR--FGWNGD-PCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQS 446 (623)
T ss_pred CchHHHHHHHHHHhcCCccc--CCCCCC-CCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCCCE
Confidence 46799999999999987753 589753 22 12799999953 22 35999999999999999999999999999
Q ss_pred eeCCCCcccCcCChhhhCCCCCcEEEecCCcccCCCCc-ccCCCCCCEEeccCccCCCccccccccc-cccceEEccCCc
Q 002061 102 LSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD-LSALKNLEIFDLSINYFTGRFPRWVVNL-TQLVSLSIGDNV 179 (973)
Q Consensus 102 L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~~~~l-~~L~~L~l~~n~ 179 (973)
|+|++|.++|.+|..++.+++|+.|+|++|++++.+|. ++++++|++|+|++|.++|.+|..+..+ .++..+++.+|.
T Consensus 447 L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~ 526 (623)
T PLN03150 447 INLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNA 526 (623)
T ss_pred EECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCCc
Confidence 99999999999999999999999999999999987664 8999999999999999999888777653 345566666553
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.3e-15 Score=152.54 Aligned_cols=134 Identities=22% Similarity=0.188 Sum_probs=105.3
Q ss_pred CcccCcccccCceEEEEEEecCCCcEEEEEeeeccc------------------------cHHHHHHHHHHHHhcCCCc-
Q 002061 678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD------------------------GVKVFAAEMEILGKIRHRN- 732 (973)
Q Consensus 678 ~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~------------------------~~~~~~~E~~~l~~l~hpn- 732 (973)
|.+.+.||+|+||.||+|... +|+.||||++.... ......+|+.++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 677789999999999999886 58999999865421 0113567888898888774
Q ss_pred -eeeEEEEEEeCCeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCee
Q 002061 733 -ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNIL 811 (973)
Q Consensus 733 -iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nil 811 (973)
+.+.++ ....++||||+++++|.+.... .....++.+++.++.++| ..+++||||+|.||+
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~Nil 157 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEFNIL 157 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCcccEE
Confidence 444443 2456899999999988654320 234568889999999999 789999999999999
Q ss_pred ecCCCCeEEecccCccccc
Q 002061 812 LDEDYEPKIADFGVAKIAE 830 (973)
Q Consensus 812 l~~~~~~kl~Dfgl~~~~~ 830 (973)
+++++.++|+|||.+....
T Consensus 158 l~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 158 VDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred EcCCCcEEEEECCccccCC
Confidence 9999999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.52 E-value=8.1e-14 Score=135.82 Aligned_cols=135 Identities=24% Similarity=0.212 Sum_probs=112.4
Q ss_pred ccCcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhcCC--CceeeEEEEEEeCCeeEEEEEccCCCc
Q 002061 680 EDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRH--RNILKLYACLLKGGSSFLVLEYMPNGN 757 (973)
Q Consensus 680 ~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~~~~lv~e~~~~gs 757 (973)
+.+.||+|.++.||++...+ ..++||..........+.+|+..++.++| +++.+++++...++..+++|||+++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 34679999999999999864 68999987664445678899999999976 588899988888888999999998876
Q ss_pred hHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccc
Q 002061 758 LFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828 (973)
Q Consensus 758 L~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 828 (973)
+..+ +......++.+++++++++|.....+++|+|++|.||+++.++.+++.|||.++.
T Consensus 80 ~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 80 LDEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 6432 4456667889999999999953335799999999999999989999999998863
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.2e-13 Score=139.80 Aligned_cols=134 Identities=22% Similarity=0.210 Sum_probs=95.9
Q ss_pred cCcccccCceEEEEEEecCCCcEEEEEeeecccc----HHH----------------------HHHHHHHHHhcCCCc--
Q 002061 681 DNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG----VKV----------------------FAAEMEILGKIRHRN-- 732 (973)
Q Consensus 681 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~----~~~----------------------~~~E~~~l~~l~hpn-- 732 (973)
.+.||+|+||+||+|.+. +++.||||++..... ... ...|.+.+.++.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999987 688999998765211 111 134555666654432
Q ss_pred eeeEEEEEEeCCeeEEEEEccCCCchHH-HHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCC-CCeEecCCCCCCe
Q 002061 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQ-ALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS-PPIIHRDIKSSNI 810 (973)
Q Consensus 733 iv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~-~~ivH~Dlkp~Ni 810 (973)
+.+.+++ ...++||||++++.+.. .+... . .. .....++.+++.++.++| . .+++||||||+||
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~-----~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Ni 146 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-R-----LL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNI 146 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhh-h-----hc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhE
Confidence 3344433 24589999999854421 12211 0 01 456788999999999999 6 8999999999999
Q ss_pred eecCCCCeEEecccCccccc
Q 002061 811 LLDEDYEPKIADFGVAKIAE 830 (973)
Q Consensus 811 ll~~~~~~kl~Dfgl~~~~~ 830 (973)
+++ ++.++++|||.+....
T Consensus 147 li~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 147 LVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred EEE-CCcEEEEECccccccc
Confidence 999 8999999999986443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.3e-13 Score=142.07 Aligned_cols=133 Identities=20% Similarity=0.276 Sum_probs=103.4
Q ss_pred cCccc-ccCceEEEEEEecCCCcEEEEEeeecc---------------ccHHHHHHHHHHHHhcCCCce--eeEEEEEEe
Q 002061 681 DNLIG-SGGTGKVYRLDLKKNAGTVAVKQLWKG---------------DGVKVFAAEMEILGKIRHRNI--LKLYACLLK 742 (973)
Q Consensus 681 ~~~lG-~G~~g~V~~a~~~~~~~~vavK~~~~~---------------~~~~~~~~E~~~l~~l~hpni--v~l~~~~~~ 742 (973)
...|| .|+.|+||.++.. +..+|||.+... .....+.+|++++.+++|+++ .+.+++...
T Consensus 36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 35687 8999999999886 678999977431 122457889999999998775 666766443
Q ss_pred C-C---eeEEEEEccCC-CchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCC
Q 002061 743 G-G---SSFLVLEYMPN-GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE 817 (973)
Q Consensus 743 ~-~---~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~ 817 (973)
+ . ..++||||++| .+|.+++... .++.. .+.+++.+++++| +.||+||||||.|||++.++.
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~------~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~ 180 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQEA------PLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGK 180 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhcC------CCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCC
Confidence 2 2 23599999997 6898887532 23332 3578999999999 889999999999999999999
Q ss_pred eEEecccCccc
Q 002061 818 PKIADFGVAKI 828 (973)
Q Consensus 818 ~kl~Dfgl~~~ 828 (973)
++++|||.+..
T Consensus 181 v~LIDfg~~~~ 191 (239)
T PRK01723 181 FWLIDFDRGEL 191 (239)
T ss_pred EEEEECCCccc
Confidence 99999998763
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.3e-15 Score=175.93 Aligned_cols=256 Identities=24% Similarity=0.259 Sum_probs=190.8
Q ss_pred cCCcccCcccccCceEEEEEEecC-CCcEEEEEeeecc----ccHHHHHHHHHHHHhcC-CCceeeEEEEEEeCCeeEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKK-NAGTVAVKQLWKG----DGVKVFAAEMEILGKIR-HRNILKLYACLLKGGSSFLV 749 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~-~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv 749 (973)
..|...+.||+|+|+.|-.+.... ....+|+|.+... ....+...|..+-+.+. |+|++.+++.....+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 467778889999999998877743 3456777765442 22334455777777776 99999999999999999999
Q ss_pred EEccCCCchHHHH-HhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCC-CeEEecccCcc
Q 002061 750 LEYMPNGNLFQAL-HKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY-EPKIADFGVAK 827 (973)
Q Consensus 750 ~e~~~~gsL~~~l-~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfgl~~ 827 (973)
+||.++|++.+-+ +.. ....+....-.+..|+..++.|+|. ..++.|||+||+|.+++..+ ..++.|||+|.
T Consensus 100 ~~~s~g~~~f~~i~~~~----~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPD----STGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred cCcccccccccccccCC----ccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhc
Confidence 9999999998877 321 1133444556788999999999996 46899999999999999999 99999999998
Q ss_pred cccC-CCCcccccccCC-ccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccc
Q 002061 828 IAEN-SPKVSDYSCFAG-THGYIAPELAYTC-KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHEN 904 (973)
Q Consensus 828 ~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 904 (973)
.+.. ...........| ++.|+|||...+. ...+..|+||.|+++..+++|..|++.......+...|......
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~---- 249 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGR---- 249 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccc----
Confidence 8776 444444455677 9999999998875 44678999999999999999999998764444333333222100
Q ss_pred cchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 905 VLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
..............++..+++..+|..|.+.+++...
T Consensus 250 --------~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 250 --------FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred --------cccCccccCChhhhhcccccccCCchhcccccccccc
Confidence 0011122233345667778888999999999887554
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.3e-13 Score=157.26 Aligned_cols=198 Identities=29% Similarity=0.511 Sum_probs=100.4
Q ss_pred EEEecCCcccCCCCcccCCCCCCEEeccCccCCCcccccccccc-ccceEEccCCcCCCCCCcccccCCCCCCEEEcccC
Q 002061 125 VLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLT-QLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHC 203 (973)
Q Consensus 125 ~L~L~~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~-~L~~L~l~~n~l~~~~ip~~~~~l~~L~~L~L~~n 203 (973)
.|+++.|.+...+..+..++.++.|++.+|.++ .++.....+. +|+.|++++|.+
T Consensus 97 ~l~~~~~~~~~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i----------------------- 152 (394)
T COG4886 97 SLDLNLNRLRSNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKI----------------------- 152 (394)
T ss_pred eeeccccccccCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccch-----------------------
Confidence 566666666555555555566666666666665 3344444442 555555555544
Q ss_pred CCCCCCChhhhccCCCCeeecccccccCCCchhhhccccccEEEeeccccCCcCCccccccccccEEEeeccccccccCC
Q 002061 204 NLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPE 283 (973)
Q Consensus 204 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~ 283 (973)
. .+|..+..+++|+.|++++|+++ .+|...+.+++|+.|++++|+++ .+|.....+..|++|++++|.+. ..+.
T Consensus 153 --~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~ 226 (394)
T COG4886 153 --E-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLS 226 (394)
T ss_pred --h-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecch
Confidence 4 33334444444444444444444 33333334444555555555554 34443334444555555555322 3444
Q ss_pred ccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeeccCCccCCCCCccccccccccccccccccccccCCh
Q 002061 284 EIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPK 355 (973)
Q Consensus 284 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~ 355 (973)
.+.++.++..+.+.+|++.. .+..++.+++++.|++++|+++...+ ++.+.+|+.|++++|.+....|.
T Consensus 227 ~~~~~~~l~~l~l~~n~~~~-~~~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 227 SLSNLKNLSGLELSNNKLED-LPESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred hhhhcccccccccCCceeee-ccchhccccccceecccccccccccc--ccccCccCEEeccCccccccchh
Confidence 44555555555555555442 24445555555555555555553322 55566666666666666544443
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.44 E-value=5.3e-15 Score=160.06 Aligned_cols=183 Identities=28% Similarity=0.450 Sum_probs=115.4
Q ss_pred cCCCCCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCchhhhccccccEEEeeccccCCcCCccccccccccE
Q 002061 190 GNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQE 269 (973)
Q Consensus 190 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~ 269 (973)
-.+..-...+|+.|++. .+|..+..+..|+.|.|.+|.|. .+|..++++..|.+|+|+.|+++ .+|..++.|+ |+.
T Consensus 72 ~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkv 147 (722)
T KOG0532|consen 72 YDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKV 147 (722)
T ss_pred ccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-cee
Confidence 34455556677777776 66666776777777777777776 66667777777777777777776 5666666665 667
Q ss_pred EEeeccccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeeccCCccCCCCCccccccccccccccccccc
Q 002061 270 FDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQF 349 (973)
Q Consensus 270 L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l 349 (973)
|-+++|+++ .+|..++.+..|..|+.+.|++. .+|..++++.+|+.|.+..|++. .+|+.+..+ .|..||+|.|++
T Consensus 148 li~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNki 223 (722)
T KOG0532|consen 148 LIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKI 223 (722)
T ss_pred EEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCce
Confidence 777777766 66666666666666666666666 45555666666666666666665 344444422 355666666666
Q ss_pred cccCChhhhhhhhHHHHHhhhccCCCCccccccCccccceEeccccccccCCCcccc
Q 002061 350 SGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLW 406 (973)
Q Consensus 350 ~~~~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 406 (973)
+ .+|..|.+|+.|++|-|.+|.|. ..|..++
T Consensus 224 s-------------------------~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC 254 (722)
T KOG0532|consen 224 S-------------------------YLPVDFRKMRHLQVLQLENNPLQ-SPPAQIC 254 (722)
T ss_pred e-------------------------ecchhhhhhhhheeeeeccCCCC-CChHHHH
Confidence 5 34455555666666666666665 4554443
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.8e-13 Score=162.85 Aligned_cols=93 Identities=40% Similarity=0.676 Sum_probs=65.6
Q ss_pred CCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCCccccccccccchhccccccccCCCccccccCCCCeeecCC
Q 002061 459 LERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSG 538 (973)
Q Consensus 459 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 538 (973)
++.|+|++|.++|.+|..+..+++|+.|+|++|++.|.+|..++.+++|+.|+|++|+++|.+|..++.+++|+.|+|++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 56666777777666666666777777777777777666776677777777777777777777777777777777777777
Q ss_pred CccCCCCChhhhc
Q 002061 539 NKLTGSIPDNLMK 551 (973)
Q Consensus 539 N~l~~~~p~~l~~ 551 (973)
|+++|.+|..+..
T Consensus 500 N~l~g~iP~~l~~ 512 (623)
T PLN03150 500 NSLSGRVPAALGG 512 (623)
T ss_pred CcccccCChHHhh
Confidence 7777777776544
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.6e-14 Score=156.32 Aligned_cols=179 Identities=31% Similarity=0.550 Sum_probs=127.6
Q ss_pred ccccccccccccccCChhhhhhhhHHHHHhhhccCCCCccccccCccccceEeccccccccCCCccccCCCCcceEeccC
Q 002061 339 LTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGD 418 (973)
Q Consensus 339 L~~L~Ls~N~l~~~~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 418 (973)
-...||+.|++. .+|..+|.+-.+ +.+.++.|.+..+|..+.++..|++|||+.|+++ ..|..++.+
T Consensus 77 t~~aDlsrNR~~-elp~~~~~f~~L-e~liLy~n~~r~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~l---------- 143 (722)
T KOG0532|consen 77 TVFADLSRNRFS-ELPEEACAFVSL-ESLILYHNCIRTIPEAICNLEALTFLDLSSNQLS-HLPDGLCDL---------- 143 (722)
T ss_pred hhhhhccccccc-cCchHHHHHHHH-HHHHHHhccceecchhhhhhhHHHHhhhccchhh-cCChhhhcC----------
Confidence 456778888887 566655554432 2222222222344444455555555555555554 344443332
Q ss_pred CcCCCCCCCCCCCCCCCCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCC
Q 002061 419 NDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIP 498 (973)
Q Consensus 419 N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 498 (973)
-|+.|.+++|+++ .+|..++.++.|..||.+.|.+. .+|..++++.+|+.|.+..|++. .+|
T Consensus 144 ---------------pLkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp 205 (722)
T KOG0532|consen 144 ---------------PLKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLP 205 (722)
T ss_pred ---------------cceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCC
Confidence 3788888888888 78888888888999999999997 67788888999999999999988 466
Q ss_pred ccccccccccchhccccccccCCCccccccCCCCeeecCCCccCCCCChhhhc
Q 002061 499 NEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMK 551 (973)
Q Consensus 499 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~ 551 (973)
.++. .-.|..||+|.|+++ .+|-.|.+|+.|++|-|.+|+|+ .+|..+..
T Consensus 206 ~El~-~LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~ 255 (722)
T KOG0532|consen 206 EELC-SLPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICE 255 (722)
T ss_pred HHHh-CCceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHHh
Confidence 6666 447889999999998 89999999999999999999998 67776644
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.37 E-value=5.1e-13 Score=152.36 Aligned_cols=199 Identities=33% Similarity=0.459 Sum_probs=157.6
Q ss_pred EeeCCCCcccCcCChhhhCCCCCcEEEecCCcccCCCCcccCCC-CCCEEeccCccCCCccccccccccccceEEccCCc
Q 002061 101 VLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALK-NLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNV 179 (973)
Q Consensus 101 ~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~l~~l~-~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~ 179 (973)
.|+++.|.+. .-+..+..++.++.|++.+|.++..++....++ +|+.|++++|++. .+|..+..+++|+.|+++.|.
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~ 174 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFND 174 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCcccccCccccccchhhcccccccccchh-hhhhhhhccccccccccCCch
Confidence 6888888874 234567777999999999999999999888885 9999999999998 566788899999999999998
Q ss_pred CCCCCCcccccCCCCCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCchhhhccccccEEEeeccccCCcCCc
Q 002061 180 YDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPA 259 (973)
Q Consensus 180 l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~ 259 (973)
+. .+|...+.+++|+.|++++|+++ .+|........|++|++++|.+. ..+..+.++.++..|.+.+|++. ..+.
T Consensus 175 l~--~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~ 249 (394)
T COG4886 175 LS--DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPE 249 (394)
T ss_pred hh--hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccc
Confidence 86 46677668889999999999998 67776667777888888888644 56667778888888888888877 3466
Q ss_pred cccccccccEEEeeccccccccCCccCCCCCccEEEcccCCCCCCCCCC
Q 002061 260 ELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSG 308 (973)
Q Consensus 260 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~ 308 (973)
.++.+++++.|++++|+++. ++. ++.+.+|+.|+++.|.+....+..
T Consensus 250 ~~~~l~~l~~L~~s~n~i~~-i~~-~~~~~~l~~L~~s~n~~~~~~~~~ 296 (394)
T COG4886 250 SIGNLSNLETLDLSNNQISS-ISS-LGSLTNLRELDLSGNSLSNALPLI 296 (394)
T ss_pred hhccccccceeccccccccc-ccc-ccccCccCEEeccCccccccchhh
Confidence 77777778888888888773 333 777777777777777777555543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.6e-11 Score=137.39 Aligned_cols=169 Identities=18% Similarity=0.222 Sum_probs=132.2
Q ss_pred EEEecCCCcEEEEEeeecccc--HHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCCchHHHHHhhhcCCCC
Q 002061 694 RLDLKKNAGTVAVKQLWKGDG--VKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKP 771 (973)
Q Consensus 694 ~a~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~ 771 (973)
.|..+.++.+|.|+..+.... .+...+-++.++.++||||+++++.++.++..|+|+|.+. .|..++.+.
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l------ 101 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL------ 101 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh------
Confidence 566777788999998776544 5567788999999999999999999999999999999984 688888754
Q ss_pred CCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCcccccccCCcccccccc
Q 002061 772 ELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPE 851 (973)
Q Consensus 772 ~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE 851 (973)
....+...+.||+.||.|||+ +.+++|++|....|+|+..|+.||++|.++........ .....+--..|..|+
T Consensus 102 --~~~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~ 175 (690)
T KOG1243|consen 102 --GKEEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPE 175 (690)
T ss_pred --HHHHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChh
Confidence 255667789999999999997 45899999999999999999999999998865543221 111112223466777
Q ss_pred ccccCCCCccchHHHHHHHHHHHHhCC
Q 002061 852 LAYTCKVSEKSDVFSFGVVLLELVTGR 878 (973)
Q Consensus 852 ~~~~~~~~~~~DvwslG~~l~el~tg~ 878 (973)
.+.... -..|.|-|||++||++.|.
T Consensus 176 ~~~~s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 176 EIDPSE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred hcCccc--cchhhhhHHHHHHHHhCcc
Confidence 543222 3469999999999999993
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.4e-11 Score=139.97 Aligned_cols=143 Identities=19% Similarity=0.208 Sum_probs=99.3
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc------cH----------------------------------
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD------GV---------------------------------- 715 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~------~~---------------------------------- 715 (973)
..|+ .+.||.|++|.||+|+... |+.||||+.++.. +.
T Consensus 118 ~~fd-~~plasaSigQVh~A~l~~-G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~ 195 (437)
T TIGR01982 118 AEFE-EKPLAAASIAQVHRARLVD-GKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLR 195 (437)
T ss_pred hhCC-CcceeeeehhheEEEEecC-CCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHH
Confidence 3444 3689999999999999874 8999999875421 00
Q ss_pred --HHHHHHHHHHHhc----C-CCceeeEEEEEEeCCeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHH-
Q 002061 716 --KVFAAEMEILGKI----R-HRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAK- 787 (973)
Q Consensus 716 --~~~~~E~~~l~~l----~-hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~- 787 (973)
-++.+|++.+.++ + ++++.-..-+....+..++||||++|++|.++..... . ..+ +..++.+++.
T Consensus 196 ~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~-~---~~~---~~~ia~~~~~~ 268 (437)
T TIGR01982 196 RELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE-A---GLD---RKALAENLARS 268 (437)
T ss_pred HHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh-c---CCC---HHHHHHHHHHH
Confidence 0134455555554 2 3443322222233456799999999999988765321 1 112 3346666665
Q ss_pred HHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccccc
Q 002061 788 GIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830 (973)
Q Consensus 788 ~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 830 (973)
.+..+| ..|++|+|++|.||+++.++++++.|||++....
T Consensus 269 ~l~ql~---~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 269 FLNQVL---RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHHH---hCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 467888 7899999999999999999999999999987664
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.28 E-value=5e-12 Score=140.59 Aligned_cols=248 Identities=22% Similarity=0.197 Sum_probs=179.9
Q ss_pred cCCcccCcccc--cCceEEEEEEe--cCCCcEEEEEeeec----cccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCee
Q 002061 676 CNLEEDNLIGS--GGTGKVYRLDL--KKNAGTVAVKQLWK----GDGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSS 746 (973)
Q Consensus 676 ~~~~~~~~lG~--G~~g~V~~a~~--~~~~~~vavK~~~~----~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 746 (973)
..+.....+|. |.+|.||.+.. .+++..+|+|+-+. +....+-.+|+...+++ .|++.++.+..++..+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34567788999 99999999999 88899999998543 23344446777777777 599999999999999999
Q ss_pred EEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHH----HHhhhhhcCCCCeEecCCCCCCeeecCC-CCeEEe
Q 002061 747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAK----GIAYLHHDCSPPIIHRDIKSSNILLDED-YEPKIA 821 (973)
Q Consensus 747 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~----~l~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~ 821 (973)
|+-+|++ +.+|.++.+.. ...++....+....+..+ |+.++| +.+++|-|+||.||+...+ ...+++
T Consensus 194 fiqtE~~-~~sl~~~~~~~----~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~ 265 (524)
T KOG0601|consen 194 FIQTELC-GESLQSYCHTP----CNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLT 265 (524)
T ss_pred eeeeccc-cchhHHhhhcc----cccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecC
Confidence 9999998 57888877643 223455566677777777 999999 8899999999999999999 889999
Q ss_pred cccCcccccCCCCccccc---ccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHH
Q 002061 822 DFGVAKIAENSPKVSDYS---CFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTH 898 (973)
Q Consensus 822 Dfgl~~~~~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~ 898 (973)
|||+...+.......... ...|...|++||... +.++.+.|+|++|.+..+..++..+....+. ..|...
T Consensus 266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~-----~~W~~~- 338 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKN-----SSWSQL- 338 (524)
T ss_pred CcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCC-----CCcccc-
Confidence 999998776554322222 124677899999875 4578899999999999999998766543210 011000
Q ss_pred hccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 002061 899 LNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVK 948 (973)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~ 948 (973)
.. ... ..+.......++...+..|++.+|..|++.+.+..
T Consensus 339 ---r~----~~i---p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 339 ---RQ----GYI---PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ---cc----ccC---chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 00 000 00111111233444777899999999999887654
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.25 E-value=9.7e-12 Score=126.44 Aligned_cols=209 Identities=23% Similarity=0.271 Sum_probs=141.3
Q ss_pred HHhcCCCceeeEEEEEEeC-----CeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCC
Q 002061 725 LGKIRHRNILKLYACLLKG-----GSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP 799 (973)
Q Consensus 725 l~~l~hpniv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ 799 (973)
+-.+.|-|+|++..|+.+. .+..+++|||.-|++..+|++..+. ...+......++..||..||.|||+. +..
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~-~~a~~~~~wkkw~tqIlsal~yLhs~-~Pp 198 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKN-QKALFQKAWKKWCTQILSALSYLHSC-DPP 198 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHh-hhhhhHHHHHHHHHHHHhhhhhhhcc-CCc
Confidence 4445799999999998653 3468899999999999999876433 33456666778999999999999974 889
Q ss_pred eEecCCCCCCeeecCCCCeEEecccCccccc--CCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhC
Q 002061 800 IIHRDIKSSNILLDEDYEPKIADFGVAKIAE--NSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTG 877 (973)
Q Consensus 800 ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~--~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg 877 (973)
|+|+++.-+-|++..+|-+|++--.-..... ............+-++|.|||.=.....+.++|||+||....||..+
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 9999999999999999988876322111110 01111112234567899999987666777899999999999999887
Q ss_pred CCCCCcccCCcccHHHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 002061 878 RKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADAD 954 (973)
Q Consensus 878 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 954 (973)
..--..... .-..+. . +...+.. .... .=..++.+|++..|..||+|++++.|.-.+.
T Consensus 279 Eiq~tnseS--~~~~ee---~------ia~~i~~-len~-------lqr~~i~kcl~~eP~~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 279 EIQSTNSES--KVEVEE---N------IANVIIG-LENG-------LQRGSITKCLEGEPNGRPDARLLLFHPLLFE 336 (458)
T ss_pred eeccCCCcc--eeehhh---h------hhhheee-ccCc-------cccCcCcccccCCCCCCcchhhhhcCceeee
Confidence 543211100 000000 0 0000000 0000 0124677899999999999999998876543
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.24 E-value=2e-12 Score=129.27 Aligned_cols=129 Identities=22% Similarity=0.335 Sum_probs=70.3
Q ss_pred CCCCeeecccccccCCCchhhhccccccEEEeeccccCCcCCccccccccccEEEeeccccccccCCccCCCCCccEEEc
Q 002061 217 RELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQC 296 (973)
Q Consensus 217 ~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 296 (973)
+.|++||||+|.|+ .+..+..-+++++.|++++|.|.. + ..+..+++|+.||||+|.++ .+..+-.+|.+.+.|.|
T Consensus 284 q~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~-v-~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~L 359 (490)
T KOG1259|consen 284 QELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRT-V-QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKL 359 (490)
T ss_pred hhhhhccccccchh-hhhhhhhhccceeEEeccccceee-e-hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeeh
Confidence 44555555555555 444444445555555555555552 2 12555555556666655555 33444444555555666
Q ss_pred ccCCCCCCCCCCcCCcccceeeeccCCccCCC-CCccccccccccccccccccccc
Q 002061 297 FKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGP-FPENLGRYTALTDVDISENQFSG 351 (973)
Q Consensus 297 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~-~~~~l~~l~~L~~L~Ls~N~l~~ 351 (973)
+.|.|.. -++++.+-+|..|++.+|+|... -...+++++.|+.+.|.+|.+.+
T Consensus 360 a~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~ 413 (490)
T KOG1259|consen 360 AQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG 413 (490)
T ss_pred hhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence 6655542 23455555666666666666532 22356667777777777777763
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.22 E-value=1e-11 Score=142.23 Aligned_cols=147 Identities=18% Similarity=0.135 Sum_probs=96.7
Q ss_pred HHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecccc------------------------------------HH
Q 002061 673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG------------------------------------VK 716 (973)
Q Consensus 673 ~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~------------------------------------~~ 716 (973)
.....|+. +.||+|++|.||+|+.+++|+.||||+..+... .+
T Consensus 117 ~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~ 195 (537)
T PRK04750 117 EWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEK 195 (537)
T ss_pred HHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHH
Confidence 34566777 799999999999999998899999999864210 01
Q ss_pred ------HHHHHHHHHHhc----CCCceeeEEEEEEe-CCeeEEEEEccCCCchHHHHHhhhcCC--CCCCCHHHHHHHHH
Q 002061 717 ------VFAAEMEILGKI----RHRNILKLYACLLK-GGSSFLVLEYMPNGNLFQALHKRVKEG--KPELDWFRRYKIAL 783 (973)
Q Consensus 717 ------~~~~E~~~l~~l----~hpniv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~--~~~~~~~~~~~i~~ 783 (973)
++.+|+..+.++ .+...+.+-.++.+ ....++||||++|+.+.+.-.-. ..+ ...+....+..++.
T Consensus 196 ~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~-~~g~d~~~la~~~v~~~~~ 274 (537)
T PRK04750 196 TLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALR-AAGTDMKLLAERGVEVFFT 274 (537)
T ss_pred HHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHH-hcCCCHHHHHHHHHHHHHH
Confidence 133344444444 24444444444432 55678999999999998753211 011 01122222223333
Q ss_pred HHHHHHhhhhhcCCCCeEecCCCCCCeeecCCC----CeEEecccCcccccC
Q 002061 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY----EPKIADFGVAKIAEN 831 (973)
Q Consensus 784 ~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~----~~kl~Dfgl~~~~~~ 831 (973)
|+ . ..|++|+|++|.||+++.++ ++++.|||++.....
T Consensus 275 Qi-------f---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 275 QV-------F---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HH-------H---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 33 3 46999999999999999988 999999999876643
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.19 E-value=3.9e-12 Score=134.31 Aligned_cols=227 Identities=21% Similarity=0.202 Sum_probs=148.7
Q ss_pred EeeCCCCcccCc----CChhhhCCCCCcEEEecCCcccCCCC--cccCCCCCCEEeccCccCCCcc--ccccccccccce
Q 002061 101 VLSLPFNVLSGK----LPLELSNCSNLKVLNVTGNAMVGSVP--DLSALKNLEIFDLSINYFTGRF--PRWVVNLTQLVS 172 (973)
Q Consensus 101 ~L~Ls~n~l~~~----~p~~l~~l~~L~~L~L~~n~l~~~~~--~l~~l~~L~~L~Ls~n~l~~~~--~~~~~~l~~L~~ 172 (973)
.+.+++-.++.. +..-=.++.+|+...|.+..+..... ....|++++.||||.|-|.... -....+|++|+.
T Consensus 97 ~~si~nK~vE~iGfDki~akQsn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~ 176 (505)
T KOG3207|consen 97 VLSISNKQVEFIGFDKIAAKQSNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLEN 176 (505)
T ss_pred HhhhcCceeEEecHHHHHHHhhhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchh
Confidence 344444444432 23333567788888888888765543 5778889999999988877543 345567888888
Q ss_pred EEccCCcCCCCCCcccccCCCCCCEEEcccCCCCCC-CChhhhccCCCCeeecccccccCCCchhhhccccccEEEeecc
Q 002061 173 LSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGR-IPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYAN 251 (973)
Q Consensus 173 L~l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N 251 (973)
|+|+.|++....-...-..++.|+.|.|+.|+++.. +...+..+++|+.|+|..|..-........-++.|+.|+|++|
T Consensus 177 LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N 256 (505)
T KOG3207|consen 177 LNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNN 256 (505)
T ss_pred cccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCC
Confidence 888888875321111223567888888888888732 2233456788888888888533244444555778888888888
Q ss_pred ccCCcC-CccccccccccEEEeecccccccc-CCc-----cCCCCCccEEEcccCCCCCC-CCCCcCCcccceeeeccCC
Q 002061 252 NLTGEL-PAELGNLTLLQEFDISSNQMYGKL-PEE-----IGNLKNLTVFQCFKNNFSGE-FPSGFGDMRKLFAFSIYGN 323 (973)
Q Consensus 252 ~l~~~~-~~~l~~l~~L~~L~Ls~N~l~~~~-p~~-----~~~l~~L~~L~l~~N~l~~~-~p~~~~~l~~L~~L~l~~N 323 (973)
++-... -...+.++.|+.|+++.+.+...- |+. ...+++|++|++..|+|..- .-..+..+++|+.|.+..|
T Consensus 257 ~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n 336 (505)
T KOG3207|consen 257 NLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLN 336 (505)
T ss_pred cccccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccc
Confidence 876332 134677888888888888876432 222 24467888888888888532 1134555667777777777
Q ss_pred ccCC
Q 002061 324 RFSG 327 (973)
Q Consensus 324 ~l~~ 327 (973)
.+..
T Consensus 337 ~ln~ 340 (505)
T KOG3207|consen 337 YLNK 340 (505)
T ss_pred cccc
Confidence 7763
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.18 E-value=3.6e-12 Score=127.56 Aligned_cols=112 Identities=26% Similarity=0.368 Sum_probs=80.1
Q ss_pred CCCCCCCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCCccccccccccc
Q 002061 430 GLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVD 509 (973)
Q Consensus 430 ~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 509 (973)
...+.++.|++|+|.|.. + ..+..+++|+.||||+|.++ .+-.+-..+.++++|.|++|.|... ..++++-+|..
T Consensus 304 KL~Pkir~L~lS~N~i~~-v-~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE~L--SGL~KLYSLvn 378 (490)
T KOG1259|consen 304 KLAPKLRRLILSQNRIRT-V-QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQNKIETL--SGLRKLYSLVN 378 (490)
T ss_pred hhccceeEEeccccceee-e-hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhhhHhhh--hhhHhhhhhee
Confidence 445666666777776662 2 22667777788888888776 4445555677788888888877632 45667777888
Q ss_pred hhccccccccCC-CccccccCCCCeeecCCCccCCCCCh
Q 002061 510 LNLARNSLSGNI-PRSLSLLSSLNALNLSGNKLTGSIPD 547 (973)
Q Consensus 510 L~Ls~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~p~ 547 (973)
||+++|+|.... ...++++|-|+.+.|.+|+|++ +|+
T Consensus 379 LDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~-~vd 416 (490)
T KOG1259|consen 379 LDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG-SVD 416 (490)
T ss_pred ccccccchhhHHHhcccccccHHHHHhhcCCCccc-cch
Confidence 888888887432 3568899999999999999995 444
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.17 E-value=8.5e-11 Score=116.92 Aligned_cols=125 Identities=25% Similarity=0.231 Sum_probs=94.1
Q ss_pred CcccccCceEEEEEEecCCCcEEEEEeeeccc-cHHHHHHHHHHHHhcCCCcee-eEEEEEEeCCeeEEEEEccCCCchH
Q 002061 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNIL-KLYACLLKGGSSFLVLEYMPNGNLF 759 (973)
Q Consensus 682 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~hpniv-~l~~~~~~~~~~~lv~e~~~~gsL~ 759 (973)
+.++.|.++.||+++.. ++.|++|+..... ....+.+|+++++.+.+.+++ +++.+. .+..++||||++|.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 56899999999999876 7789999875543 234567899999998665554 344332 33458999999998775
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCC-----eEecCCCCCCeeecCCCCeEEecccCcc
Q 002061 760 QALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP-----IIHRDIKSSNILLDEDYEPKIADFGVAK 827 (973)
Q Consensus 760 ~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~-----ivH~Dlkp~Nill~~~~~~kl~Dfgl~~ 827 (973)
+. . . ....++.+++++++.|| ..+ ++|+|++|.||+++ ++.+++.|||.+.
T Consensus 80 ~~--~-------~----~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 80 TE--D-------F----SDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cc--c-------c----cCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 32 0 0 11245678999999999 555 59999999999999 6789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.16 E-value=5.8e-12 Score=143.67 Aligned_cols=250 Identities=28% Similarity=0.319 Sum_probs=192.7
Q ss_pred cCCccCcEeeCCCCcccCcCChhhhCCCCCcEEEecCCcccCCCCcccCCCCCCEEeccCccCCCccccccccccccceE
Q 002061 94 SALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSL 173 (973)
Q Consensus 94 ~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 173 (973)
..+..++.+.++.|.+.. +-..+..+.+|+.|++.+|+|......+..+++|++||+++|.|+.. ..+..++.|+.|
T Consensus 69 ~~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L 145 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKIENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKEL 145 (414)
T ss_pred HHhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhcccchhhhhcchheeccccccccc--cchhhccchhhh
Confidence 467778888899998873 44568889999999999999988666688999999999999999854 456677889999
Q ss_pred EccCCcCCCCCCcccccCCCCCCEEEcccCCCCCCCC-hhhhccCCCCeeecccccccCCCchhhhccccccEEEeeccc
Q 002061 174 SIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIP-ESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANN 252 (973)
Q Consensus 174 ~l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~ 252 (973)
++++|.+... ..+..+++|+.+++++|+++..-+ . ...+.+|+.+++.+|.+.. ...+..+..+..+++..|.
T Consensus 146 ~l~~N~i~~~---~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~--i~~~~~~~~l~~~~l~~n~ 219 (414)
T KOG0531|consen 146 NLSGNLISDI---SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE--IEGLDLLKKLVLLSLLDNK 219 (414)
T ss_pred eeccCcchhc---cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc--ccchHHHHHHHHhhccccc
Confidence 9999998643 566779999999999999985433 2 5888999999999999963 3445555666667899999
Q ss_pred cCCcCCcccccccc--ccEEEeeccccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeeccCCccCC---
Q 002061 253 LTGELPAELGNLTL--LQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSG--- 327 (973)
Q Consensus 253 l~~~~~~~l~~l~~--L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~--- 327 (973)
++..-+ +..+.. |+.+++++|++. ..+..+..+.++..|++.+|++... ..+.....+..+....|.+..
T Consensus 220 i~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 294 (414)
T KOG0531|consen 220 ISKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSEA 294 (414)
T ss_pred ceeccC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccc--ccccccchHHHhccCcchhcchhh
Confidence 883322 233333 899999999997 5557788889999999999998753 335566777788888888762
Q ss_pred CCCcc-ccccccccccccccccccccCChhh
Q 002061 328 PFPEN-LGRYTALTDVDISENQFSGSFPKYL 357 (973)
Q Consensus 328 ~~~~~-l~~l~~L~~L~Ls~N~l~~~~p~~~ 357 (973)
..... ....+.++.+.+..|.+....+...
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (414)
T KOG0531|consen 295 ISQEYITSAAPTLVTLTLELNPIRKISSLDL 325 (414)
T ss_pred hhccccccccccccccccccCcccccccccH
Confidence 22222 5677889999999999886555443
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=4.2e-12 Score=130.68 Aligned_cols=240 Identities=18% Similarity=0.221 Sum_probs=154.8
Q ss_pred cccccCCccCcEeeCCCCcccC----cCChhhhCCCCCcEEEecCCccc----CCCCc-------ccCCCCCCEEeccCc
Q 002061 90 SSSISALQSLTVLSLPFNVLSG----KLPLELSNCSNLKVLNVTGNAMV----GSVPD-------LSALKNLEIFDLSIN 154 (973)
Q Consensus 90 ~~~l~~l~~L~~L~Ls~n~l~~----~~p~~l~~l~~L~~L~L~~n~l~----~~~~~-------l~~l~~L~~L~Ls~n 154 (973)
-+.+..+..++.|+||+|.|.- .+...+.+.++|+.-++|+--.. ..|+. +...++|++||||+|
T Consensus 23 ~~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDN 102 (382)
T KOG1909|consen 23 EEELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDN 102 (382)
T ss_pred HHHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeecccc
Confidence 3456678888899999998853 35556777888888888764321 11221 234456777777777
Q ss_pred cCCCccccccccccccceEEccCCcCCCCCCcccccCCCCCCEEEcccCCCCCCCChh-------------hhccCCCCe
Q 002061 155 YFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPES-------------ISELRELGT 221 (973)
Q Consensus 155 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~-------------~~~l~~L~~ 221 (973)
.|....+..|.. -+..+..|++|.|.+|.+...-... ...-++|++
T Consensus 103 A~G~~g~~~l~~---------------------ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv 161 (382)
T KOG1909|consen 103 AFGPKGIRGLEE---------------------LLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRV 161 (382)
T ss_pred ccCccchHHHHH---------------------HHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEE
Confidence 765444433321 2334455555555555554211111 122356788
Q ss_pred eecccccccCCC----chhhhccccccEEEeeccccCCc----CCccccccccccEEEeeccccccc----cCCccCCCC
Q 002061 222 LDICRNKISGEF----PRSIRKLQKLWKIELYANNLTGE----LPAELGNLTLLQEFDISSNQMYGK----LPEEIGNLK 289 (973)
Q Consensus 222 L~L~~N~l~~~~----~~~l~~l~~L~~L~L~~N~l~~~----~~~~l~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~ 289 (973)
+...+|++.... ...|...+.|+.+.++.|.|... +...|..+++|+.|||..|.++.. +...+..++
T Consensus 162 ~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~ 241 (382)
T KOG1909|consen 162 FICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWP 241 (382)
T ss_pred EEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccc
Confidence 888888876432 23455667888888888887622 224567788888888888887632 345566778
Q ss_pred CccEEEcccCCCCCCCCCCc-----CCcccceeeeccCCccCC----CCCcccccccccccccccccccc
Q 002061 290 NLTVFQCFKNNFSGEFPSGF-----GDMRKLFAFSIYGNRFSG----PFPENLGRYTALTDVDISENQFS 350 (973)
Q Consensus 290 ~L~~L~l~~N~l~~~~p~~~-----~~l~~L~~L~l~~N~l~~----~~~~~l~~l~~L~~L~Ls~N~l~ 350 (973)
+|+.|++++|.+......+| ...++|+.|.+.+|.|+. .+...+...+.|..|+|++|.+.
T Consensus 242 ~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 242 HLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred hheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 88888888888887655443 236788999999998873 22334556788999999999983
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.11 E-value=9.6e-12 Score=131.37 Aligned_cols=209 Identities=20% Similarity=0.202 Sum_probs=157.2
Q ss_pred cCCccCcEeeCCCCcccCcCC--hhhhCCCCCcEEEecCCcccCCCC---cccCCCCCCEEeccCccCCCccc-cccccc
Q 002061 94 SALQSLTVLSLPFNVLSGKLP--LELSNCSNLKVLNVTGNAMVGSVP---DLSALKNLEIFDLSINYFTGRFP-RWVVNL 167 (973)
Q Consensus 94 ~~l~~L~~L~Ls~n~l~~~~p--~~l~~l~~L~~L~L~~n~l~~~~~---~l~~l~~L~~L~Ls~n~l~~~~~-~~~~~l 167 (973)
+++.+|+...|.+..+.. .+ .....|++++.||||+|-+..--+ -...|++|+.|+||.|.+.-... ..-..+
T Consensus 118 sn~kkL~~IsLdn~~V~~-~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l 196 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVED-AGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL 196 (505)
T ss_pred hhHHhhhheeecCccccc-cchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence 468889999999888763 23 357789999999999998865433 24688999999999998763222 222367
Q ss_pred cccceEEccCCcCCCCCCcccccCCCCCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCc--hhhhccccccE
Q 002061 168 TQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFP--RSIRKLQKLWK 245 (973)
Q Consensus 168 ~~L~~L~l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--~~l~~l~~L~~ 245 (973)
++|+.|.|+.+.++...+-..+..+++|+.|+|..|.....-.....-+..|++|||++|++- ..+ ...+.++.|+.
T Consensus 197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~ 275 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLNQ 275 (505)
T ss_pred hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccchhh
Confidence 899999999998886666556678899999999999644344455667788999999999886 344 45788999999
Q ss_pred EEeeccccCCc-CCcc-----ccccccccEEEeeccccccc-cCCccCCCCCccEEEcccCCCCCC
Q 002061 246 IELYANNLTGE-LPAE-----LGNLTLLQEFDISSNQMYGK-LPEEIGNLKNLTVFQCFKNNFSGE 304 (973)
Q Consensus 246 L~L~~N~l~~~-~~~~-----l~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~ 304 (973)
|+++.+.++.. .|+. ...+++|++|+++.|++... .-..+..+.+|+.|.+..|.++.+
T Consensus 276 Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~e 341 (505)
T KOG3207|consen 276 LNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNKE 341 (505)
T ss_pred hhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhccccccccc
Confidence 99999998843 2332 35678999999999998522 223456678889999889988754
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.11 E-value=6.8e-11 Score=115.10 Aligned_cols=108 Identities=25% Similarity=0.260 Sum_probs=25.2
Q ss_pred CccCcEeeCCCCcccCcCChhhh-CCCCCcEEEecCCcccCCCCcccCCCCCCEEeccCccCCCccccccccccccceEE
Q 002061 96 LQSLTVLSLPFNVLSGKLPLELS-NCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLS 174 (973)
Q Consensus 96 l~~L~~L~Ls~n~l~~~~p~~l~-~l~~L~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 174 (973)
...+++|+|++|.|+. | +.++ .+.+|+.|+|++|.|+.. +.+..+++|++|++++|.|+...+.....+++|++|+
T Consensus 18 ~~~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~~l-~~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~ 94 (175)
T PF14580_consen 18 PVKLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQITKL-EGLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELY 94 (175)
T ss_dssp --------------------S--TT-TT--EEE-TTS--S---TT----TT--EEE--SS---S-CHHHHHH-TT--EEE
T ss_pred cccccccccccccccc-c-cchhhhhcCCCEEECCCCCCccc-cCccChhhhhhcccCCCCCCccccchHHhCCcCCEEE
Confidence 3345666666666652 2 2343 355666666666666543 3455556666666666666532221112345555555
Q ss_pred ccCCcCCCCCCcccccCCCCCCEEEcccCCCC
Q 002061 175 IGDNVYDEAEIPESIGNLKNLTYLFLAHCNLR 206 (973)
Q Consensus 175 l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~ 206 (973)
+++|++....--..+..+++|++|+|.+|.++
T Consensus 95 L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 95 LSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp -TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred CcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 55555443222233334444444444444443
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.3e-11 Score=140.93 Aligned_cols=126 Identities=21% Similarity=0.279 Sum_probs=62.1
Q ss_pred CCCeeecccccccCCCchhhhccccccEEEeeccccCCcCCccccccccccEEEeeccccccccCCccCCCCCccEEEcc
Q 002061 218 ELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCF 297 (973)
Q Consensus 218 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 297 (973)
.++.++..++.+...--. ...+..++.+.+..|.+.. +-..+..+++|+.|++.+|+|.. +...+..+++|++|+++
T Consensus 50 ~~~~~~~~~~~~~~~~~~-~~~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls 126 (414)
T KOG0531|consen 50 DLEEIDLIFNLDGSDEDL-VESLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLS 126 (414)
T ss_pred hhhhhcchhccccchhhh-HHHhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhh-cccchhhhhcchheecc
Confidence 444555555544322111 1345555666666666662 33345566666666666666652 22225556666666666
Q ss_pred cCCCCCCCCCCcCCcccceeeeccCCccCCCCCcccccccccccccccccccc
Q 002061 298 KNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFS 350 (973)
Q Consensus 298 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~ 350 (973)
+|+|+... .+..++.|+.|++.+|.|+. ...+..+..|+.+++++|++.
T Consensus 127 ~N~I~~i~--~l~~l~~L~~L~l~~N~i~~--~~~~~~l~~L~~l~l~~n~i~ 175 (414)
T KOG0531|consen 127 FNKITKLE--GLSTLTLLKELNLSGNLISD--ISGLESLKSLKLLDLSYNRIV 175 (414)
T ss_pred cccccccc--chhhccchhhheeccCcchh--ccCCccchhhhcccCCcchhh
Confidence 66665432 23334444455555555441 122333444444444444443
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=3.7e-12 Score=131.06 Aligned_cols=233 Identities=18% Similarity=0.261 Sum_probs=137.3
Q ss_pred CceEEEeecCCCCCcc----ccccccCCccCcEeeCCCC---cccCcCChh-------hhCCCCCcEEEecCCcccC-CC
Q 002061 73 GRVTEISFDNKSLSGE----ISSSISALQSLTVLSLPFN---VLSGKLPLE-------LSNCSNLKVLNVTGNAMVG-SV 137 (973)
Q Consensus 73 ~~v~~l~l~~~~l~~~----~~~~l~~l~~L~~L~Ls~n---~l~~~~p~~-------l~~l~~L~~L~L~~n~l~~-~~ 137 (973)
..++.|+|++|.+.-+ +.+.|.+.++|+..++|+- ++..++|.. +-.+++|++||||.|-+.. .+
T Consensus 30 ~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g~ 109 (382)
T KOG1909|consen 30 DSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKGI 109 (382)
T ss_pred CceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccch
Confidence 5689999999998754 4556788899999999863 344456654 4556799999999999832 23
Q ss_pred Cc----ccCCCCCCEEeccCccCCCcccc-------------ccccccccceEEccCCcCCCCC---CcccccCCCCCCE
Q 002061 138 PD----LSALKNLEIFDLSINYFTGRFPR-------------WVVNLTQLVSLSIGDNVYDEAE---IPESIGNLKNLTY 197 (973)
Q Consensus 138 ~~----l~~l~~L~~L~Ls~n~l~~~~~~-------------~~~~l~~L~~L~l~~n~l~~~~---ip~~~~~l~~L~~ 197 (973)
+. +.++..|++|.|.+|.+.-.-.. -...-++||++..++|++...+ +...+...+.|+.
T Consensus 110 ~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~lee 189 (382)
T KOG1909|consen 110 RGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHPTLEE 189 (382)
T ss_pred HHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhccccce
Confidence 32 67899999999999998632222 2233456667777777665432 2223445566666
Q ss_pred EEcccCCCCCC----CChhhhccCCCCeeecccccccCCC----chhhhccccccEEEeeccccCCcCCccccccccccE
Q 002061 198 LFLAHCNLRGR----IPESISELRELGTLDICRNKISGEF----PRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQE 269 (973)
Q Consensus 198 L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~----~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~ 269 (973)
+.++.|.|... +...+..+++|+.|||.+|.++... ...++.+++|+.|+++.|.+.......|.+
T Consensus 190 vr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~------ 263 (382)
T KOG1909|consen 190 VRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVD------ 263 (382)
T ss_pred EEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHH------
Confidence 66666666522 1234555566666666666555322 223334444555555555544332222211
Q ss_pred EEeeccccccccCCcc-CCCCCccEEEcccCCCCCC----CCCCcCCcccceeeeccCCcc
Q 002061 270 FDISSNQMYGKLPEEI-GNLKNLTVFQCFKNNFSGE----FPSGFGDMRKLFAFSIYGNRF 325 (973)
Q Consensus 270 L~Ls~N~l~~~~p~~~-~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l 325 (973)
.+ ...++|++|.+.+|.|+.. +...+...+.|..|+|++|++
T Consensus 264 --------------al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 264 --------------ALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred --------------HHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 00 1134555555555555431 122344466677777777776
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.06 E-value=2.1e-09 Score=106.93 Aligned_cols=135 Identities=16% Similarity=0.157 Sum_probs=95.9
Q ss_pred CcccccCceEEEEEEecC------CCcEEEEEeeecc------------cc------------HHHH----HHHHHHHHh
Q 002061 682 NLIGSGGTGKVYRLDLKK------NAGTVAVKQLWKG------------DG------------VKVF----AAEMEILGK 727 (973)
Q Consensus 682 ~~lG~G~~g~V~~a~~~~------~~~~vavK~~~~~------------~~------------~~~~----~~E~~~l~~ 727 (973)
..||.|.-+.||.|.... .+..+|||+.+.. .+ .+.+ .+|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998653 3579999976430 00 1122 379999988
Q ss_pred cCC--CceeeEEEEEEeCCeeEEEEEccCCCchHH-HHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhh-hhcCCCCeEec
Q 002061 728 IRH--RNILKLYACLLKGGSSFLVLEYMPNGNLFQ-ALHKRVKEGKPELDWFRRYKIALGAAKGIAYL-HHDCSPPIIHR 803 (973)
Q Consensus 728 l~h--pniv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~L-H~~~~~~ivH~ 803 (973)
+.. -++-+++++ ...++||||+.++.+.. .+++ ..++..+...+..+++.++..+ | ..++|||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd------~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHG 149 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD------AKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHA 149 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc------cccCHHHHHHHHHHHHHHHHHHHH---hCCeecC
Confidence 853 344455543 45689999997654321 2221 1234445567788999999999 7 7799999
Q ss_pred CCCCCCeeecCCCCeEEecccCccccc
Q 002061 804 DIKSSNILLDEDYEPKIADFGVAKIAE 830 (973)
Q Consensus 804 Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 830 (973)
|+++.||+++ ++.+.++|||.+....
T Consensus 150 DLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 150 DLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 9999999997 4689999999887554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.2e-10 Score=111.54 Aligned_cols=65 Identities=28% Similarity=0.328 Sum_probs=16.6
Q ss_pred ccCCCCCCEEEcccCCCCCCCChhh-hccCCCCeeecccccccCCC-chhhhccccccEEEeeccccC
Q 002061 189 IGNLKNLTYLFLAHCNLRGRIPESI-SELRELGTLDICRNKISGEF-PRSIRKLQKLWKIELYANNLT 254 (973)
Q Consensus 189 ~~~l~~L~~L~L~~n~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~-~~~l~~l~~L~~L~L~~N~l~ 254 (973)
+..+++|+.|++++|+|+. +.+.+ ..+++|++|+|++|+|.... -..++.+++|+.|+|.+|.++
T Consensus 60 l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 60 LPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp ----TT--EEE--SS---S--CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred ccChhhhhhcccCCCCCCc-cccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 3344555555555555542 22222 23455555555555554211 122333444444444444443
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.01 E-value=2.2e-10 Score=127.67 Aligned_cols=250 Identities=19% Similarity=0.204 Sum_probs=175.3
Q ss_pred HHHHcCCcccCcccccCceEEEEEEec-CCCcEEEEEeeecc--ccHHH--HHHHHHHHHhc-CCCceeeEEEEEEeCCe
Q 002061 672 AEQICNLEEDNLIGSGGTGKVYRLDLK-KNAGTVAVKQLWKG--DGVKV--FAAEMEILGKI-RHRNILKLYACLLKGGS 745 (973)
Q Consensus 672 ~~~~~~~~~~~~lG~G~~g~V~~a~~~-~~~~~vavK~~~~~--~~~~~--~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 745 (973)
.....+|..+..||.|.|+.|++...+ .++..|++|..... ....+ -..|+.+...+ .|.+++..+..|...+.
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 344567888999999999999987766 67889999976542 11111 23566666666 58999998888888888
Q ss_pred eEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCC-CCeEEeccc
Q 002061 746 SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDED-YEPKIADFG 824 (973)
Q Consensus 746 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg 824 (973)
.|+--||+++++....... ...++...++++..|++.++.++| ++.++|+|+||+||++..+ +..+++|||
T Consensus 341 ~~ip~e~~~~~s~~l~~~~-----~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~ 412 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVT-----SQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFG 412 (524)
T ss_pred ccCchhhhcCcchhhhhHH-----HHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhccccc
Confidence 8899999999988766532 224666778889999999999999 8899999999999999986 788999999
Q ss_pred CcccccCCCCcccccccCCccccc--cccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccc
Q 002061 825 VAKIAENSPKVSDYSCFAGTHGYI--APELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNH 902 (973)
Q Consensus 825 l~~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 902 (973)
.+..+.-.. .......+++ +|+......+..+.|++|||..+.|.+++..--... . .|
T Consensus 413 ~~t~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~----~---~~-------- 472 (524)
T KOG0601|consen 413 CWTRLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG----V---QS-------- 472 (524)
T ss_pred cccccceec-----ccccccccccccchhhccccccccccccccccccccccccCcccCccc----c---cc--------
Confidence 886422111 1112233344 555556677889999999999999999985432111 0 00
Q ss_pred cccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 002061 903 ENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADAD 954 (973)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 954 (973)
..+...... ........+..+...+..+++..||.+.++..+.+-..
T Consensus 473 ---~~i~~~~~p--~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 473 ---LTIRSGDTP--NLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred ---eeeeccccc--CCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 001111010 01111245666777888999999999998877665443
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=99.00 E-value=3.2e-10 Score=82.80 Aligned_cols=40 Identities=55% Similarity=1.107 Sum_probs=31.2
Q ss_pred hHHHHHHHHHHHhcC-CCcccccCCCCCC-CCCCCcceeeeC
Q 002061 30 NVETQALIQFKSKLK-DPHGVLDSWKESA-DSPCGFSGITCD 69 (973)
Q Consensus 30 ~~~~~aLl~~k~~~~-d~~~~~~~W~~~~-~~~c~w~gv~C~ 69 (973)
++|++||++||+++. ||.+++.+|+.+. .+||.|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 579999999999998 5778999999874 578999999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.00 E-value=9.8e-11 Score=136.55 Aligned_cols=250 Identities=21% Similarity=0.201 Sum_probs=172.0
Q ss_pred HHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeec-----cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeE
Q 002061 673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF 747 (973)
Q Consensus 673 ~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~-----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 747 (973)
...+.+.+.+.+-.|.++.++.++-...|...++|+... ..+++...++-.+.-..++|.++.....+......+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 345677888899999999999988777776666665433 123333444444554556788887776666677889
Q ss_pred EEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcc
Q 002061 748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827 (973)
Q Consensus 748 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~ 827 (973)
++++|..+++|...++.-. ..+..........+.++.++|| ...+.|||++|.|.+...++..+++|||...
T Consensus 881 L~~~~~~~~~~~Skl~~~~-----~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~ 952 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSG-----CLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLS 952 (1205)
T ss_pred hhhHHhccCCchhhhhcCC-----CcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCcccccc
Confidence 9999999999999988642 2233333445566778899999 6678999999999999999999999998433
Q ss_pred cccCC-------------------------CC----cccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCC
Q 002061 828 IAENS-------------------------PK----VSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGR 878 (973)
Q Consensus 828 ~~~~~-------------------------~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~ 878 (973)
..+-. .. ........||+.|.+||...+.....++|+|+.|++++|.++|.
T Consensus 953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~ 1032 (1205)
T KOG0606|consen 953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGI 1032 (1205)
T ss_pred ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCC
Confidence 22100 00 01122356899999999999999999999999999999999999
Q ss_pred CCCCcccCCcccHHHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 002061 879 KPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMR 944 (973)
Q Consensus 879 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~ 944 (973)
.||..... .+.+........ -....+.+......+++...+..+|.+|-.+.
T Consensus 1033 pp~na~tp-----q~~f~ni~~~~~---------~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1033 PPFNAETP-----QQIFENILNRDI---------PWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCCcch-----hhhhhccccCCC---------CCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 99976521 111111111110 00112223334455666777788899987666
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=1.5e-09 Score=131.82 Aligned_cols=272 Identities=21% Similarity=0.176 Sum_probs=125.5
Q ss_pred CCCEEeccCcc--CCCccccccccccccceEEccCCcCCCCCCcccccCCCCCCEEEcccCCCCCCCChhhhccCCCCee
Q 002061 145 NLEIFDLSINY--FTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTL 222 (973)
Q Consensus 145 ~L~~L~Ls~n~--l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 222 (973)
+|++|-+..|. +.......|..++.|+.|||++|. +..++|..++.|-+|++|+|++..+. .+|..+++|+.|.+|
T Consensus 546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~-~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~L 623 (889)
T KOG4658|consen 546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNS-SLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYL 623 (889)
T ss_pred ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCC-ccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhhee
Confidence 34444444443 222233334445555555554432 12356666666666666666666666 566666666666666
Q ss_pred ecccccccCCCchhhhccccccEEEeeccccC--CcCCccccccccccEEEeeccccccccCCccCCCCCcc----EEEc
Q 002061 223 DICRNKISGEFPRSIRKLQKLWKIELYANNLT--GELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLT----VFQC 296 (973)
Q Consensus 223 ~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~--~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~----~L~l 296 (973)
++..+.-...+|.....+.+|++|.+...... ...-..+.++.+|+.+....... .+-..+..++.|. .+.+
T Consensus 624 nl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~--~~~e~l~~~~~L~~~~~~l~~ 701 (889)
T KOG4658|consen 624 NLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSV--LLLEDLLGMTRLRSLLQSLSI 701 (889)
T ss_pred ccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchh--HhHhhhhhhHHHHHHhHhhhh
Confidence 66666544444555566667776666554322 22223334444455444432221 1111112222222 1111
Q ss_pred ccCCCCCCCCCCcCCcccceeeeccCCccCCCCCccccccccccccccccccccccCChhhhhhhhHHHHHhhhccCCCC
Q 002061 297 FKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGE 376 (973)
Q Consensus 297 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~ll~l~n~~~~~ 376 (973)
..+... ..+..+..+.+|+.|.+.++.+............. ++ ..+.+..... .+...-.
T Consensus 702 ~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~---~~---------------~f~~l~~~~~-~~~~~~r 761 (889)
T KOG4658|consen 702 EGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIV---LL---------------CFPNLSKVSI-LNCHMLR 761 (889)
T ss_pred cccccc-eeecccccccCcceEEEEcCCCchhhcccccccch---hh---------------hHHHHHHHHh-hcccccc
Confidence 111111 23334455555555555555554222211111110 00 0111111111 1111112
Q ss_pred ccccccCccccceEeccccccccCCCccccCCCCcceEeccCCcCCCC-CCCCCCCCCCCCEEEc
Q 002061 377 VPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGG-ISPLIGLSTSLSQLVL 440 (973)
Q Consensus 377 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~~~~L~~L~L 440 (973)
.+...--.++|+.|++..+.....+......+..++.+.+..+.+.+. .....+.++++..+.+
T Consensus 762 ~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l~~~~~l~~l~~i~~~~l 826 (889)
T KOG4658|consen 762 DLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGLRMLCSLGGLPQLYWLPL 826 (889)
T ss_pred ccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEecccccccceeeecCCCCceeEeccc
Confidence 222223447888888888877766666666666666666666666654 2333334444444333
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.2e-08 Score=97.27 Aligned_cols=128 Identities=25% Similarity=0.333 Sum_probs=98.9
Q ss_pred CcccccCceEEEEEEecCCCcEEEEEe-eeccc---------cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 002061 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQ-LWKGD---------GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE 751 (973)
Q Consensus 682 ~~lG~G~~g~V~~a~~~~~~~~vavK~-~~~~~---------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 751 (973)
..+++|+-+.+|.+.+. |..+++|. +.+.. ...+-.+|+.++.+++--.|--..-+..+.+...|+||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 45889999999999775 55677774 22211 12345679999999876666666666778888899999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcc
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~ 827 (973)
|++|..|.+++... ...++..+-+-+.-|| ..+|||+|+.++||.+..+. +.+.|||++.
T Consensus 80 ~I~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~ 139 (204)
T COG3642 80 YIEGELLKDALEEA------------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGE 139 (204)
T ss_pred EeCChhHHHHHHhc------------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCccc
Confidence 99998888888742 1345566667778899 88999999999999998875 9999999986
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.89 E-value=5.6e-08 Score=102.89 Aligned_cols=265 Identities=15% Similarity=0.154 Sum_probs=160.4
Q ss_pred cccCcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhc-CCCceeeEEEEE-------EeCCeeEEEE
Q 002061 679 EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKI-RHRNILKLYACL-------LKGGSSFLVL 750 (973)
Q Consensus 679 ~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~-------~~~~~~~lv~ 750 (973)
...+.||+|+-+.+|-.-.- + ..+-|++..+--..+ ...+..|... .||-+-.-+.+= ..+....+.|
T Consensus 14 ~~gr~LgqGgea~ly~l~e~--~-d~VAKIYh~Pppa~~-aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV--R-DQVAKIYHAPPPAAQ-AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCCccccCCccceeeecchh--h-chhheeecCCCchHH-HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 45688999999999964322 2 345566655322221 2233344333 566443311111 1122356778
Q ss_pred EccCCC-chHHHHH-hhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccc
Q 002061 751 EYMPNG-NLFQALH-KRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828 (973)
Q Consensus 751 e~~~~g-sL~~~l~-~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 828 (973)
+.+++. ....+.. ....+.-+..+|....+.+..+|.+.+.|| ..|.+-+|++++|+|+++++.+.+.|-..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccceee
Confidence 877664 1222221 112345667899999999999999999999 78999999999999999999999998664332
Q ss_pred ccCCCCcccccccCCccccccccccc-----cCCCCccchHHHHHHHHHHHHhC-CCCCCcccCC--cc-cHH-HHHHHH
Q 002061 829 AENSPKVSDYSCFAGTHGYIAPELAY-----TCKVSEKSDVFSFGVVLLELVTG-RKPVEEEYGD--GK-DIV-YWVSTH 898 (973)
Q Consensus 829 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~tg-~~pf~~~~~~--~~-~~~-~~~~~~ 898 (973)
. .....+.+.+|...|.+||.-. +..-+...|-|.+|+++++++.| ++||.+.+.. .. -.. ......
T Consensus 167 ~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~ 243 (637)
T COG4248 167 N---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR 243 (637)
T ss_pred c---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence 2 3345667889999999999743 34456779999999999999885 9999865321 11 111 111111
Q ss_pred hccccccchhccccccCcchHHHHHHHHHHHHHhcCCC--CCCCCCHHHHHHHhhcC
Q 002061 899 LNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKL--PNLRPPMREVVKMLADA 953 (973)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~d--P~~Rpt~~evl~~L~~~ 953 (973)
.-....-..-..+.............+.-+...|+... |.-||+++..+..|...
T Consensus 244 f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al 300 (637)
T COG4248 244 FAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL 300 (637)
T ss_pred eeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence 11110000000011111112223344555566777543 56899999888777653
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.89 E-value=2.2e-09 Score=130.39 Aligned_cols=128 Identities=24% Similarity=0.319 Sum_probs=71.7
Q ss_pred cccceEEccCCcCCCCCCcccccCCCCCCEEEcccCC--CCCCCChhhhccCCCCeeecccccccCCCchhhhccccccE
Q 002061 168 TQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCN--LRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWK 245 (973)
Q Consensus 168 ~~L~~L~l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~--l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~ 245 (973)
...+...+-+|.+.. ++... ..++|+.|-+..|. +.....+.|..++.|++|||++|.=-+.+|..+++|-+|++
T Consensus 523 ~~~rr~s~~~~~~~~--~~~~~-~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~Lry 599 (889)
T KOG4658|consen 523 NSVRRMSLMNNKIEH--IAGSS-ENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRY 599 (889)
T ss_pred hheeEEEEeccchhh--ccCCC-CCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhc
Confidence 445555555554432 22222 22356666666664 44333344566666666666666544566666666666666
Q ss_pred EEeeccccCCcCCccccccccccEEEeeccccccccCCccCCCCCccEEEcccC
Q 002061 246 IELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKN 299 (973)
Q Consensus 246 L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N 299 (973)
|+|+...++ .+|..+.++..|.+||+..+.-...+|.....|++|++|.+...
T Consensus 600 L~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s 652 (889)
T KOG4658|consen 600 LDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRS 652 (889)
T ss_pred ccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeecc
Confidence 666666666 56666666666666666665544344455555666666655443
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.87 E-value=9.4e-09 Score=107.19 Aligned_cols=139 Identities=22% Similarity=0.296 Sum_probs=102.3
Q ss_pred CcccccCceEEEEEEecCCCcEEEEEeeeccc---cHHHHHHHHHHHHhcCCC--ceeeEEEEEEeC---CeeEEEEEcc
Q 002061 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHR--NILKLYACLLKG---GSSFLVLEYM 753 (973)
Q Consensus 682 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~hp--niv~l~~~~~~~---~~~~lv~e~~ 753 (973)
+.|+.|.++.||++...+ |+.+++|+..... ....+.+|+++++.+++. .+.+++.+.... +..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 568999999999998864 6789999876533 356788999999999753 456667766553 3568999999
Q ss_pred CCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhc--------------------------------------
Q 002061 754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHD-------------------------------------- 795 (973)
Q Consensus 754 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~-------------------------------------- 795 (973)
+|+++.+.+.. ..++..+...++.+++++++.||+-
T Consensus 83 ~G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (223)
T cd05154 83 DGRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA 156 (223)
T ss_pred CCEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence 99887654320 1245555556666666666666631
Q ss_pred ---------------CCCCeEecCCCCCCeeecC--CCCeEEecccCcc
Q 002061 796 ---------------CSPPIIHRDIKSSNILLDE--DYEPKIADFGVAK 827 (973)
Q Consensus 796 ---------------~~~~ivH~Dlkp~Nill~~--~~~~kl~Dfgl~~ 827 (973)
....++|+|+.|.||+++. ++.+.+.||+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 1246799999999999998 6678999999775
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.86 E-value=2.6e-08 Score=94.22 Aligned_cols=140 Identities=24% Similarity=0.277 Sum_probs=104.0
Q ss_pred ccCcccccCceEEEEEEecCCCcEEEEEeee-ccc---------cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 002061 680 EDNLIGSGGTGKVYRLDLKKNAGTVAVKQLW-KGD---------GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV 749 (973)
Q Consensus 680 ~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~-~~~---------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 749 (973)
....+-+|+-+.|+++.+. |+.+.||.-. +.. ..++-.+|++.+.+++--.|.-..-++.+...-.++
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 4567899999999999987 7788888432 211 233456799999988765666555566676677899
Q ss_pred EEccCC-CchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCC---CeEEecccC
Q 002061 750 LEYMPN-GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY---EPKIADFGV 825 (973)
Q Consensus 750 ~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl~Dfgl 825 (973)
|||++| .++.+++..... ..........++.+|-+.+.-|| ..++||+|+..+||++..++ .+.+.|||+
T Consensus 89 ME~~~g~~~vk~~i~~~~~---~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgl 162 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTME---DESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGL 162 (229)
T ss_pred EEeccchhHHHHHHHHHcc---CcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecc
Confidence 999966 388888876421 12222233577888889999999 88999999999999997655 358999999
Q ss_pred cc
Q 002061 826 AK 827 (973)
Q Consensus 826 ~~ 827 (973)
+.
T Consensus 163 s~ 164 (229)
T KOG3087|consen 163 SS 164 (229)
T ss_pred hh
Confidence 75
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.82 E-value=1.9e-09 Score=86.24 Aligned_cols=60 Identities=35% Similarity=0.505 Sum_probs=34.4
Q ss_pred cCCEEEcCCcccccCCCccccccccccchhccccccccCCCccccccCCCCeeecCCCcc
Q 002061 482 QLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKL 541 (973)
Q Consensus 482 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l 541 (973)
+|++|++++|+|+...+..|.++++|+.|++++|+|+...|..|.++++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 455555555555555555555555555555555555555555556666666666666553
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.78 E-value=2.6e-09 Score=85.43 Aligned_cols=59 Identities=37% Similarity=0.523 Sum_probs=28.5
Q ss_pred CCCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcc
Q 002061 434 SLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENA 492 (973)
Q Consensus 434 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 492 (973)
+|++|++++|+|+...+..|.++++|++|++++|+++...|.+|.++++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 34455555555544444444444555555555555544444444444444444444444
|
... |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.76 E-value=3e-10 Score=126.72 Aligned_cols=108 Identities=32% Similarity=0.358 Sum_probs=57.9
Q ss_pred CCCCCCCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCCccccccccccc
Q 002061 430 GLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVD 509 (973)
Q Consensus 430 ~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 509 (973)
..++.|+.|+|++|+++.. +.+..+++|+.|||+.|.++.+.--...++. |+.|.|++|.++.. ..+.++.+|+.
T Consensus 184 qll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN~l~tL--~gie~LksL~~ 258 (1096)
T KOG1859|consen 184 QLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNNALTTL--RGIENLKSLYG 258 (1096)
T ss_pred HHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhhh-heeeeecccHHHhh--hhHHhhhhhhc
Confidence 3345556666666666532 2555666666666666666632222233333 66666666666532 23455666666
Q ss_pred hhccccccccCCC-ccccccCCCCeeecCCCccC
Q 002061 510 LNLARNSLSGNIP-RSLSLLSSLNALNLSGNKLT 542 (973)
Q Consensus 510 L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~ 542 (973)
|||++|-|.+.-. ..+..+..|+.|+|.||++-
T Consensus 259 LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 259 LDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred cchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 6666666554221 12344555666666666664
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.69 E-value=3.2e-07 Score=96.93 Aligned_cols=136 Identities=15% Similarity=0.084 Sum_probs=96.0
Q ss_pred ccccCceEEEEEEecCCCcEEEEEeeecccc---H----------HHHHHHHHHHHhcCCCc--eeeEEEEEEe-----C
Q 002061 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG---V----------KVFAAEMEILGKIRHRN--ILKLYACLLK-----G 743 (973)
Q Consensus 684 lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~---~----------~~~~~E~~~l~~l~hpn--iv~l~~~~~~-----~ 743 (973)
+-+.....|++.... |+.|.||+...... . ..+.+|...+.++..-+ +.+++++.+. .
T Consensus 30 v~~~~~rrvvr~~~~--g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 30 FRELEGRRTLRFELA--GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EecCCCceEEEEEEC--CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 333333446676554 67899997643221 1 13778999988884322 3344555543 2
Q ss_pred CeeEEEEEccCCC-chHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecC-------C
Q 002061 744 GSSFLVLEYMPNG-NLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE-------D 815 (973)
Q Consensus 744 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~-------~ 815 (973)
...++|||++++. +|.+++.... ....+...+..++.+++..+.-|| ..||+|+|++++|||++. +
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~---~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWA---TNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCC
Confidence 3568999999876 8988886421 123455667789999999999999 889999999999999975 4
Q ss_pred CCeEEecccCcc
Q 002061 816 YEPKIADFGVAK 827 (973)
Q Consensus 816 ~~~kl~Dfgl~~ 827 (973)
+.+.++||+.+.
T Consensus 182 ~~~~LIDl~r~~ 193 (268)
T PRK15123 182 LKLSVIDLHRAQ 193 (268)
T ss_pred ceEEEEECCccc
Confidence 679999999875
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.67 E-value=4.4e-07 Score=98.97 Aligned_cols=170 Identities=17% Similarity=0.265 Sum_probs=128.9
Q ss_pred CceEEEEEEecCCCcEEEEEeeeccc--cHHHHHHHHHHHHhcCCCceeeEEEEEEe----CCeeEEEEEccCCC-chHH
Q 002061 688 GTGKVYRLDLKKNAGTVAVKQLWKGD--GVKVFAAEMEILGKIRHRNILKLYACLLK----GGSSFLVLEYMPNG-NLFQ 760 (973)
Q Consensus 688 ~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~~~lv~e~~~~g-sL~~ 760 (973)
...+.||+....+|..|++|++.... .......-+++++++.|+|+|++.++|.. +...++||+|.++. +|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 44689999999999999999994322 11122345889999999999999998863 45679999999864 7766
Q ss_pred HHHhhh----------cCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccccc
Q 002061 761 ALHKRV----------KEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830 (973)
Q Consensus 761 ~l~~~~----------~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 830 (973)
+--... .......++...+.++.|++.||.++| +.|...+-+.|.+|+++.+.+++|+..|......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 543221 122345678899999999999999999 7899999999999999999999999888776554
Q ss_pred CCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCC
Q 002061 831 NSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRK 879 (973)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~ 879 (973)
+... |-+.+ -.+-|.=.||.+++.+.||..
T Consensus 445 ~d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 445 EDPT----------------EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCCC----------------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 4320 11111 225688899999999999854
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.8e-09 Score=96.38 Aligned_cols=139 Identities=20% Similarity=0.266 Sum_probs=106.9
Q ss_pred CCCEEEcccCCCCCCCChhhh---cCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCCccccccccccch
Q 002061 434 SLSQLVLQNNRFSGELPSELG---RLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDL 510 (973)
Q Consensus 434 ~L~~L~L~~N~l~~~~p~~~~---~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 510 (973)
.+..++|++++|. .+++... ....|+..+|++|.+....+..-...+-++.|+|++|+|+ .+|.++..++.|+.|
T Consensus 28 E~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l 105 (177)
T KOG4579|consen 28 ELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL 105 (177)
T ss_pred Hhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence 4566788888776 4555544 4456777799999998444443344568899999999998 577779999999999
Q ss_pred hccccccccCCCccccccCCCCeeecCCCccCCCCChhhhccc-CceEEccCCccccccCcccccCC
Q 002061 511 NLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLK-LSSIDLSENQLSGSVPLDFLRMG 576 (973)
Q Consensus 511 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~-L~~l~ls~N~l~~~~p~~~~~~~ 576 (973)
+++.|.+. ..|..+..+.+|..|+..+|.+- .||..+.... ....++.+|+|.+.++...+.+.
T Consensus 106 Nl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~klqa~k 170 (177)
T KOG4579|consen 106 NLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKKLQALK 170 (177)
T ss_pred ccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCcccccccC
Confidence 99999998 77888888999999999999998 7776654333 55667899999999998655443
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.60 E-value=1e-08 Score=115.84 Aligned_cols=151 Identities=23% Similarity=0.338 Sum_probs=102.6
Q ss_pred HHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCcc--cc-----cccCCcccccccccccc
Q 002061 783 LGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVS--DY-----SCFAGTHGYIAPELAYT 855 (973)
Q Consensus 783 ~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~--~~-----~~~~gt~~y~aPE~~~~ 855 (973)
.+++.|+.|+|. +.++||++|.|++|.++..+..|++.|+.+....++.... .+ ........|.|||++.+
T Consensus 106 ~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 445599999997 6789999999999999999999999999886554422110 01 11234567999999999
Q ss_pred CCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcC
Q 002061 856 CKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTT 934 (973)
Q Consensus 856 ~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~ 934 (973)
...+.++|+||+||++|.+.. |+.-+... +..+.+-......... ........+.++.+=+.+++.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~---~~~~~~~~~~~~~~~~----------~~~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAAN---GGLLSYSFSRNLLNAG----------AFGYSNNLPSELRESLKKLLN 250 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhcc---CCcchhhhhhcccccc----------cccccccCcHHHHHHHHHHhc
Confidence 888999999999999999994 55554322 1111111111111111 011113344556666778889
Q ss_pred CCCCCCCCHHHHHH
Q 002061 935 KLPNLRPPMREVVK 948 (973)
Q Consensus 935 ~dP~~Rpt~~evl~ 948 (973)
.++..||++.++..
T Consensus 251 ~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 251 GDSAVRPTLDLLLS 264 (700)
T ss_pred CCcccCcchhhhhc
Confidence 99999998877754
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.59 E-value=2.7e-07 Score=93.56 Aligned_cols=133 Identities=25% Similarity=0.216 Sum_probs=92.1
Q ss_pred cccCcccccCceEEEEEEecCCCcEEEEEeeecc------------------------ccHHHHHHHHHHHHhcCCC--c
Q 002061 679 EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG------------------------DGVKVFAAEMEILGKIRHR--N 732 (973)
Q Consensus 679 ~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~------------------------~~~~~~~~E~~~l~~l~hp--n 732 (973)
.+...||-|.-|.||.|..++ |..+|||.-.-. ......++|.++|.++.-. .
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~-g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPK-GRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred hhccccccCccceEEEEECCC-CCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 456889999999999999986 889999943210 0122357899999988644 4
Q ss_pred eeeEEEEEEeCCeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeee
Q 002061 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILL 812 (973)
Q Consensus 733 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill 812 (973)
+-+.+++ +...+||||++|-.|...- ++....-.+...|++-+.-+- ..|+||+|+.+-||++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV 235 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILV 235 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEE
Confidence 4444443 3567999999886664321 112222233444444444444 4689999999999999
Q ss_pred cCCCCeEEecccCcccc
Q 002061 813 DEDYEPKIADFGVAKIA 829 (973)
Q Consensus 813 ~~~~~~kl~Dfgl~~~~ 829 (973)
++||.+.+.||--+...
T Consensus 236 ~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 236 TEDGDIVVIDWPQAVPI 252 (304)
T ss_pred ecCCCEEEEeCcccccC
Confidence 99999999999977644
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.59 E-value=4.5e-07 Score=90.06 Aligned_cols=124 Identities=25% Similarity=0.244 Sum_probs=78.9
Q ss_pred EEEEEEecCCCcEEEEEeeecc--------------c--------------cHHHHHHHHHHHHhcCCCc--eeeEEEEE
Q 002061 691 KVYRLDLKKNAGTVAVKQLWKG--------------D--------------GVKVFAAEMEILGKIRHRN--ILKLYACL 740 (973)
Q Consensus 691 ~V~~a~~~~~~~~vavK~~~~~--------------~--------------~~~~~~~E~~~l~~l~hpn--iv~l~~~~ 740 (973)
.||.|...+ |..||||..+.. . ......+|++.|.++..-+ +-+++++.
T Consensus 1 ~Vy~~~~~~-~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDPD-GEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEECT-TEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECCC-CCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 389998865 779999976330 0 0123567999999997653 44555432
Q ss_pred EeCCeeEEEEEccC--CCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhh-hhhcCCCCeEecCCCCCCeeecCCCC
Q 002061 741 LKGGSSFLVLEYMP--NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAY-LHHDCSPPIIHRDIKSSNILLDEDYE 817 (973)
Q Consensus 741 ~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~-LH~~~~~~ivH~Dlkp~Nill~~~~~ 817 (973)
...+||||++ |..+..+.... +.......++.+++..+.. +| ..|++|+|+.+.||+++++ .
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~~-------~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~ 144 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDVD-------LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-K 144 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHCG-------GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-C
T ss_pred ----CCEEEEEecCCCccchhhHHhcc-------ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-e
Confidence 3479999998 65555443321 1122334566677775555 46 7899999999999999988 9
Q ss_pred eEEecccCccccc
Q 002061 818 PKIADFGVAKIAE 830 (973)
Q Consensus 818 ~kl~Dfgl~~~~~ 830 (973)
+.+.|||.+....
T Consensus 145 ~~iIDf~qav~~~ 157 (188)
T PF01163_consen 145 VYIIDFGQAVDSS 157 (188)
T ss_dssp EEE--GTTEEETT
T ss_pred EEEEecCcceecC
Confidence 9999999887543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.52 E-value=6e-09 Score=116.58 Aligned_cols=127 Identities=24% Similarity=0.278 Sum_probs=92.1
Q ss_pred cccceEeccccccccCCCccccCCCCcceEeccCCcCCCCCCCCCCCCCCCCEEEcccCCCCCCCCh-hhhcCCCCCEEE
Q 002061 385 KTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPS-ELGRLTNLERLI 463 (973)
Q Consensus 385 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~ 463 (973)
..|...+.++|.+. ..-..+.-++.|+.|+|++|+++... .+..++.|++|||++|+++ .+|. ...++ .|+.|.
T Consensus 164 n~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~~L~ 238 (1096)
T KOG1859|consen 164 NKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KLQLLN 238 (1096)
T ss_pred hhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhh-hheeee
Confidence 45667777888876 45556666778888888888887654 5567788888888888888 3443 22333 388899
Q ss_pred ccCCcCCCCccccccccccCCEEEcCCcccccCCC-ccccccccccchhccccccc
Q 002061 464 LTNNNFSGKIPSALGALRQLSSLHLEENALTGSIP-NEMGDCARIVDLNLARNSLS 518 (973)
Q Consensus 464 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~ 518 (973)
|++|.++.. ..+.+|++|+.|||++|-|.+--. ..++.+..|+.|+|.+|.+-
T Consensus 239 lrnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 239 LRNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred ecccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 999988732 357788888999999998875432 22466778889999999885
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.8e-08 Score=101.58 Aligned_cols=20 Identities=30% Similarity=0.438 Sum_probs=12.6
Q ss_pred cccCccccceEecccccccc
Q 002061 380 SYADCKTIQRLRISDNHLSG 399 (973)
Q Consensus 380 ~~~~l~~L~~L~Ls~N~l~~ 399 (973)
.+..+++|..|.+++|+|.+
T Consensus 244 ~Ln~f~~l~dlRv~~~Pl~d 263 (418)
T KOG2982|consen 244 ALNGFPQLVDLRVSENPLSD 263 (418)
T ss_pred HHcCCchhheeeccCCcccc
Confidence 45556666667777776653
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.47 E-value=2.4e-08 Score=99.38 Aligned_cols=236 Identities=19% Similarity=0.176 Sum_probs=139.8
Q ss_pred ccCCccCcEeeCCCCcccCc----CChhhhCCCCCcEEEecCCcccCC-----------CCcccCCCCCCEEeccCccCC
Q 002061 93 ISALQSLTVLSLPFNVLSGK----LPLELSNCSNLKVLNVTGNAMVGS-----------VPDLSALKNLEIFDLSINYFT 157 (973)
Q Consensus 93 l~~l~~L~~L~Ls~n~l~~~----~p~~l~~l~~L~~L~L~~n~l~~~-----------~~~l~~l~~L~~L~Ls~n~l~ 157 (973)
+..+..+..++||+|-|..+ +...|++-.+|+..+++.-..... .+.+.++++|+..+||.|.|.
T Consensus 26 l~~~d~~~evdLSGNtigtEA~e~l~~~ia~~~~L~vvnfsd~ftgr~kde~~~~L~~Ll~aLlkcp~l~~v~LSDNAfg 105 (388)
T COG5238 26 LEMMDELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAFTGRDKDELYSNLVMLLKALLKCPRLQKVDLSDNAFG 105 (388)
T ss_pred HHhhcceeEEeccCCcccHHHHHHHHHHHhhhcceeEeehhhhhhcccHHHHHHHHHHHHHHHhcCCcceeeeccccccC
Confidence 34466777777777777543 334455566777777766432111 123456677777777777766
Q ss_pred CccccccccccccceEEccCCcCCCCCCcccccCCCCCCEEEcccCCCCCCCChhhh-------------ccCCCCeeec
Q 002061 158 GRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESIS-------------ELRELGTLDI 224 (973)
Q Consensus 158 ~~~~~~~~~l~~L~~L~l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~-------------~l~~L~~L~L 224 (973)
...|..+ -+.++.-+.|++|.|++|.+...-..-++ .-+.|++...
T Consensus 106 ~~~~e~L---------------------~d~is~~t~l~HL~l~NnGlGp~aG~rigkal~~la~nKKaa~kp~Le~vic 164 (388)
T COG5238 106 SEFPEEL---------------------GDLISSSTDLVHLKLNNNGLGPIAGGRIGKALFHLAYNKKAADKPKLEVVIC 164 (388)
T ss_pred cccchHH---------------------HHHHhcCCCceeEEeecCCCCccchhHHHHHHHHHHHHhhhccCCCceEEEe
Confidence 5444322 23345556777777777776522211121 2366888888
Q ss_pred ccccccCCCchh-----hhccccccEEEeeccccCCcCC-----ccccccccccEEEeeccccccc----cCCccCCCCC
Q 002061 225 CRNKISGEFPRS-----IRKLQKLWKIELYANNLTGELP-----AELGNLTLLQEFDISSNQMYGK----LPEEIGNLKN 290 (973)
Q Consensus 225 ~~N~l~~~~~~~-----l~~l~~L~~L~L~~N~l~~~~~-----~~l~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~ 290 (973)
..|++. ..+.. +..-..|+.+.+..|.|.-..- ..+..+++|+.|||..|.++.. +...++..+.
T Consensus 165 grNRle-ngs~~~~a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La~al~~W~~ 243 (388)
T COG5238 165 GRNRLE-NGSKELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLADALCEWNL 243 (388)
T ss_pred ccchhc-cCcHHHHHHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHHHHhcccch
Confidence 888886 33322 2222478888888888772211 1234578888888888887633 2334555677
Q ss_pred ccEEEcccCCCCCCCCCCc----C--CcccceeeeccCCccCCCCCcc-------cccccccccccccccccc
Q 002061 291 LTVFQCFKNNFSGEFPSGF----G--DMRKLFAFSIYGNRFSGPFPEN-------LGRYTALTDVDISENQFS 350 (973)
Q Consensus 291 L~~L~l~~N~l~~~~p~~~----~--~l~~L~~L~l~~N~l~~~~~~~-------l~~l~~L~~L~Ls~N~l~ 350 (973)
|+.|.+.+|-++.....++ . ..++|..|-...|.+.+.+-.. -..++-|..|.+.+|+|.
T Consensus 244 lrEL~lnDClls~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~~~~i~~~~l~~~e~~~~p~L~~le~ngNr~~ 316 (388)
T COG5238 244 LRELRLNDCLLSNEGVKSVLRRFNEKFVPNLMPLPGDYNERRGGIILDISLNEFEQDAVPLLVDLERNGNRIK 316 (388)
T ss_pred hhhccccchhhccccHHHHHHHhhhhcCCCccccccchhhhcCceeeeechhhhhhcccHHHHHHHHccCcch
Confidence 8888888888876544332 1 2467777777777766433222 134556666667777765
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.47 E-value=2.2e-08 Score=101.00 Aligned_cols=80 Identities=13% Similarity=0.140 Sum_probs=39.5
Q ss_pred cccEEEeecccccccc-CCccCCCCCccEEEcccCCCCCCC-CCCcCCcccceeeeccCCccCCCCCc------cccccc
Q 002061 266 LLQEFDISSNQMYGKL-PEEIGNLKNLTVFQCFKNNFSGEF-PSGFGDMRKLFAFSIYGNRFSGPFPE------NLGRYT 337 (973)
Q Consensus 266 ~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~~~------~l~~l~ 337 (973)
++..+-+..|.+...- -..+..++.+..|+|+.|+|..-- -+.+..+++|..|.+.+|.+.+.+-. .+++++
T Consensus 200 nv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d~l~~~err~llIaRL~ 279 (418)
T KOG2982|consen 200 NVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSDPLRGGERRFLLIARLT 279 (418)
T ss_pred cchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcccccccCCcceEEEEeecc
Confidence 3444444444443211 122333444555555555554311 13455566666666666665532221 256777
Q ss_pred cccccccc
Q 002061 338 ALTDVDIS 345 (973)
Q Consensus 338 ~L~~L~Ls 345 (973)
+++.|+=+
T Consensus 280 ~v~vLNGs 287 (418)
T KOG2982|consen 280 KVQVLNGS 287 (418)
T ss_pred ceEEecCc
Confidence 77777655
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 973 | ||||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 1e-48 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 1e-34 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 6e-48 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 1e-34 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-47 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-46 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-33 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-33 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 7e-33 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-31 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-29 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-29 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-29 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-29 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-25 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-25 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-22 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-22 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-22 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 7e-22 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-21 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-20 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-20 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-20 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-20 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-20 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-20 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-20 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-20 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-20 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-20 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-20 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-20 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-20 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-20 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-20 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 7e-20 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 7e-20 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-20 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-20 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-20 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 8e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 8e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 8e-20 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 8e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 8e-20 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 8e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 8e-20 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 9e-20 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 9e-20 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-19 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-19 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-19 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-19 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-19 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-19 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-19 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-19 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 8e-19 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-18 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-18 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-18 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-18 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 8e-18 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 1e-13 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 1e-12 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-18 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-18 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-18 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-18 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-18 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-18 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-18 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-18 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-18 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-18 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 7e-18 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 9e-18 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-17 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-17 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-17 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-17 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-17 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-17 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 7e-17 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-17 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 8e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-17 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 9e-17 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 9e-17 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 9e-17 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-16 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-16 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-16 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-16 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-16 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-16 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-16 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-16 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-16 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-16 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-16 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-16 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-16 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-16 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-16 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-16 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-16 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-16 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-16 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-16 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-16 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-16 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-16 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-16 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-16 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-16 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-16 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-16 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-16 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-16 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-16 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-16 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-16 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 7e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-16 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 8e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-16 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 8e-16 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 8e-16 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-16 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 9e-16 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-15 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-15 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-15 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-15 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-15 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-15 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-15 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-15 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-15 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-15 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-15 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-15 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-15 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-15 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-15 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-15 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-15 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-15 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-15 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-15 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-15 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-15 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-15 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-15 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-15 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-15 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-15 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-15 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-15 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-15 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-15 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-15 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-15 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-15 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-15 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-15 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-15 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-15 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-15 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-15 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-15 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-15 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-15 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-15 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-15 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-15 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-15 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-15 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-15 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-15 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-15 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-15 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-15 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-15 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-15 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-15 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-15 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-15 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 8e-15 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-15 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 8e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 8e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-15 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-15 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-15 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 9e-15 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 9e-15 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-14 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-14 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-14 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-14 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-14 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-14 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-14 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-14 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-14 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-14 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-14 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-14 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-14 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-14 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-14 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-14 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-14 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-14 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-14 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-14 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-14 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-14 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-14 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-14 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-14 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-14 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-14 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-14 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 7e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-14 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 7e-14 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 8e-14 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 8e-14 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 8e-14 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 8e-14 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 8e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 8e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 8e-14 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 8e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 8e-14 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 9e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-13 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-13 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-13 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-13 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-13 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-13 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-13 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-13 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-13 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-13 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-13 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-13 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-13 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-13 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-13 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-13 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-13 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-13 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-13 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-13 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-13 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-13 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-13 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-13 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 8e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 8e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 9e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 9e-13 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-13 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 9e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-12 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-12 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-12 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-12 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-12 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-12 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-12 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-12 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-12 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-12 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-12 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-12 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-12 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-12 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-12 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-12 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-12 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-12 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 5e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-12 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-12 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-12 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-12 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-12 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 7e-12 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-12 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 7e-12 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 8e-12 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 8e-12 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 8e-12 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 8e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-12 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 8e-12 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 8e-12 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 9e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-12 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-11 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-11 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-11 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-11 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-11 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-11 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-11 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-11 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-11 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-11 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-11 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-11 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-11 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-11 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-11 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-11 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-11 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-11 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-11 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-11 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-11 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-11 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-11 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-11 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-11 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-11 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-11 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-11 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-11 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-11 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-11 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-11 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-11 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-11 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-11 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-11 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-11 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-11 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-11 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-11 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-11 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-11 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-11 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-11 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-11 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-11 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-11 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-11 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-11 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-11 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-11 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-11 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-11 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-11 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 6e-11 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-11 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-11 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-11 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-11 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 6e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-11 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 6e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-11 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 7e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-11 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 7e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 7e-11 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 7e-11 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 3e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 7e-11 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 7e-11 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 8e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 8e-11 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-11 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-11 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 8e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 8e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 8e-11 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 9e-11 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 9e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-11 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 9e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-10 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-10 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-10 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 1e-10 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 3e-05 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-10 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-10 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-10 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-10 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-10 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-10 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 1e-10 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 2e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-10 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-10 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-10 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-10 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-10 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-10 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-10 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-10 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-10 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-10 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-10 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-10 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-10 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 5e-10 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 7e-05 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-10 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-10 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 6e-10 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 2e-04 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 7e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 7e-10 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 7e-10 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 1e-04 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 7e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 7e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 8e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 8e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 8e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 8e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 8e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 8e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 8e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 9e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 9e-10 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 1e-09 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 8e-05 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-09 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-09 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-09 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-09 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-09 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-09 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-09 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 8e-09 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 8e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 9e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-08 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-08 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-08 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-08 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-08 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-08 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-08 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-08 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-08 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-08 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-08 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-08 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-08 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-08 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-08 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-08 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-08 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-08 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-08 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-08 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-08 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 4e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-08 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-08 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 6e-08 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 7e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 7e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 7e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-07 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-07 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-07 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-07 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-07 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-07 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-07 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-07 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-07 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-07 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-07 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 4e-07 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-07 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 4e-07 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-07 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 4e-07 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 4e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-07 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 4e-07 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 4e-07 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-07 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-07 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-07 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-07 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-07 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-07 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-07 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-07 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-07 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 5e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 5e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-07 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 5e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-07 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 5e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 5e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 5e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 6e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 6e-07 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 6e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 6e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 6e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 6e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 7e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 7e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 7e-07 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 7e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 7e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 7e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 7e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 8e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 8e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 8e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 8e-07 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 8e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-07 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 9e-07 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 9e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-06 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-06 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-06 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-06 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-06 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 |
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 440 bits (1133), Expect = e-141
Identities = 175/618 (28%), Positives = 260/618 (42%), Gaps = 79/618 (12%)
Query: 23 FPPSLSLNVETQALIQFKSKLKDPHGVLDSWKESADSPCGFSGITCDSVTGRVTEISFDN 82
PS SL E LI FK L D +L W + + PC F G+TC +VT I +
Sbjct: 4 ASPSQSLYREIHQLISFKDVLPDK-NLLPDWSSNKN-PCTFDGVTCRD--DKVTSIDLSS 59
Query: 83 K--------------------------------------------------SLSGEISS- 91
K SLSG +++
Sbjct: 60 KPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTL 119
Query: 92 -SISALQSLTVLSLPFNVLSGKLPLE-LSNCSNLKVLNVTGNAMVGSVPD----LSALKN 145
S+ + L L++ N L + ++L+VL+++ N++ G+
Sbjct: 120 TSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGE 179
Query: 146 LEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNL 205
L+ +S N +G V L L + N IP +G+ L +L ++ L
Sbjct: 180 LKHLAISGNKISGDVD--VSRCVNLEFLDVSSN-NFSTGIP-FLGDCSALQHLDISGNKL 235
Query: 206 RGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAEL-GNL 264
G +IS EL L+I N+ G P L+ L + L N TGE+P L G
Sbjct: 236 SGDFSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGAC 293
Query: 265 TLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFP-SGFGDMRKLFAFSIYGN 323
L D+S N YG +P G+ L NNFSGE P MR L + N
Sbjct: 294 DTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFN 353
Query: 324 RFSGPFPENLGRYTA-LTDVDISENQFSGSFPKYLCEKRKL-LNLLALSNN-FSGEVPNS 380
FSG PE+L +A L +D+S N FSG LC+ K L L L NN F+G++P +
Sbjct: 354 EFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPT 413
Query: 381 YADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVL 440
++C + L +S N+LSG IP L +L + L N G I + +L L+L
Sbjct: 414 LSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLIL 473
Query: 441 QNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNE 500
N +GE+PS L TNL + L+NN +G+IP +G L L+ L L N+ +G+IP E
Sbjct: 474 DFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAE 533
Query: 501 MGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPD---NLMKLKLSSI 557
+GDC ++ L+L N +G IP ++ S ++ N + G N K
Sbjct: 534 LGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAANFIAGKRYVYIKNDGMKKECHG 589
Query: 558 DLSENQLSGSVPLDFLRM 575
+ + G R+
Sbjct: 590 AGNLLEFQGIRSEQLNRL 607
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 412 bits (1061), Expect = e-131
Identities = 137/541 (25%), Positives = 233/541 (43%), Gaps = 53/541 (9%)
Query: 76 TEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVG 135
+ LSG+ S +IS L +L++ N G +P +L+ L++ N G
Sbjct: 226 QHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTG 283
Query: 136 SVPD--LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIP-ESIGNL 192
+PD A L DLS N+F G P + + + L SL++ N E+P +++ +
Sbjct: 284 EIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSN-NFSGELPMDTLLKM 342
Query: 193 KNLTYLFLAHCNLRGRIPESISELR-ELGTLDICRNKISGEFPRSI--RKLQKLWKIELY 249
+ L L L+ G +PES++ L L TLD+ N SG ++ L ++ L
Sbjct: 343 RGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQ 402
Query: 250 ANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGF 309
N TG++P L N + L +S N + G +P +G+L L + + N GE P
Sbjct: 403 NNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQEL 462
Query: 310 GDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLAL 369
++ L + N +G P L T L + +S N+ +G PK++ L L
Sbjct: 463 MYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLS 522
Query: 370 SNNFSGEVPNSYADCKTIQRLRISDNHLSGKI--------------------PDGLWALP 409
+N+FSG +P DC+++ L ++ N +G I +
Sbjct: 523 NNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDG 582
Query: 410 NVGMLDFGDND--FTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNN 467
N F G S + ++ + + + + G ++ L ++ N
Sbjct: 583 MKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYN 642
Query: 468 NFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSL 527
SG IP +G++ L L+L N ++GSIP+E+GD + L+L+ N L G IP+++S
Sbjct: 643 MLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSA 702
Query: 528 LSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSGSVPLDFLRMGGDGAFAGNEGL 587
L+ L ++LS N L+G IP+ + + + F N GL
Sbjct: 703 LTMLTEIDLSNNNLSGPIPEM---GQFETFPPA-------------------KFLNNPGL 740
Query: 588 C 588
C
Sbjct: 741 C 741
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 1e-20
Identities = 38/127 (29%), Positives = 61/127 (48%), Gaps = 5/127 (3%)
Query: 454 GRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLA 513
++T+++ N + S+L +L L SL L + + GS+ A + L+L+
Sbjct: 50 DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLS 108
Query: 514 RNSLSGNIP--RSLSLLSSLNALNLSGNKLTGSIPD-NLMKL-KLSSIDLSENQLSGSVP 569
RNSLSG + SL S L LN+S N L +KL L +DLS N +SG+
Sbjct: 109 RNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANV 168
Query: 570 LDFLRMG 576
+ ++
Sbjct: 169 VGWVLSD 175
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-18
Identities = 38/139 (27%), Positives = 61/139 (43%), Gaps = 26/139 (18%)
Query: 75 VTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMV 134
+ ++ G S + S+ L + +N+LSG +P E+ + L +LN+ N +
Sbjct: 610 RNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDIS 669
Query: 135 GSVPD-LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLK 193
GS+PD + L+ L I DLS N G IP+++ L
Sbjct: 670 GSIPDEVGDLRGLNILDLSSNKLDG-------------------------RIPQAMSALT 704
Query: 194 NLTYLFLAHCNLRGRIPES 212
LT + L++ NL G IPE
Sbjct: 705 MLTEIDLSNNNLSGPIPEM 723
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 325 bits (836), Expect = e-104
Identities = 112/285 (39%), Positives = 168/285 (58%), Gaps = 20/285 (7%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL--WKGDGVKV-FAAEMEILGKIRHRNI 733
N N++G GG GKVY+ L + VAVK+L + G ++ F E+E++ HRN+
Sbjct: 31 NFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 89
Query: 734 LKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
L+L + LV YM NG++ L +R E +P LDW +R +IALG+A+G+AYLH
Sbjct: 90 LRLRGFCMTPTERLLVYPYMANGSVASCLRER-PESQPPLDWPKRQRIALGSARGLAYLH 148
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN-----SPKVSDYSCFAGTHGYI 848
C P IIHRD+K++NILLDE++E + DFG+AK+ + + V GT G+I
Sbjct: 149 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV------RGTIGHI 202
Query: 849 APELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVY---WVSTHLNNHENV 905
APE T K SEK+DVF +GV+LLEL+TG++ + D V WV L + +
Sbjct: 203 APEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE-KKL 261
Query: 906 LKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950
++D ++ E++ +L+++A++CT P RP M EVV+ML
Sbjct: 262 EALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 319 bits (819), Expect = 2e-97
Identities = 85/617 (13%), Positives = 193/617 (31%), Gaps = 79/617 (12%)
Query: 21 SVFPPSLSLNVETQALIQFKSKLKDPHGVLDSWKESADSP-CGFS--------------- 64
+V +L+ + + ++ + L ++ +
Sbjct: 6 TVKDNALTDDAIVPIKLSRTAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKE 65
Query: 65 --------GITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSG----K 112
G++ +S GRVT +S + SG + +I L L VL+L +
Sbjct: 66 LDMWGAQPGVSLNS-NGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLF 124
Query: 113 LPLELSNCSNLKVLNVTGNAMVGSVPDLSA---LKNLEIFDLSINYFTGRFPRWVVNLTQ 169
P +S + + + D +L ++ + + +
Sbjct: 125 GPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLK 184
Query: 170 LVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKI 229
+ N + + +++ L L ++ + E +
Sbjct: 185 DTQIGQLSN--NITFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEY-----AQQ 237
Query: 230 SGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQM--------YGKL 281
L+ L +E+Y +LP L L +Q +++ N+ +
Sbjct: 238 YKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQA 297
Query: 282 PEEIGNLKNLTVFQCFKNNF-SGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALT 340
+ + + + NN + + M+KL N+ G P G L
Sbjct: 298 LADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLA 356
Query: 341 DVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYA--DCKTIQRLRISDNHLS 398
++++ NQ + P C + + L+ ++N +PN + + + S N +
Sbjct: 357 SLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIG 415
Query: 399 G-------KIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSG---- 447
+ + NV ++ +N + L + LS + L N +
Sbjct: 416 SVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKN 475
Query: 448 ---ELPSELGRLTNLERLILTNNNFSGKIPSALGA--LRQLSSLHLEENALTGSIPNEMG 502
+ L + L N + + A L L + L N+ + P +
Sbjct: 476 SLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPL 533
Query: 503 DCARIVDL------NLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSS 556
+ + + + N P ++L SL L + N + + + + +S
Sbjct: 534 NSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKITP-NISV 591
Query: 557 IDLSENQLSGSVPLDFL 573
+D+ +N S+ L ++
Sbjct: 592 LDIKDNPNI-SIDLSYV 607
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 237 bits (606), Expect = 2e-67
Identities = 72/489 (14%), Positives = 162/489 (33%), Gaps = 51/489 (10%)
Query: 74 RVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAM 133
+ + ++ I S T + N ++ + + + L+ + +
Sbjct: 160 DLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPF 218
Query: 134 VGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLK 193
V + E + NL L + + + + ++P + L
Sbjct: 219 VAENI----CEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNC-PNLTKLPTFLKALP 273
Query: 194 NLTYLFLAHCNLR--------GRIPESISELRELGTLDICRNKI-SGEFPRSIRKLQKLW 244
+ + +A + ++ + I N + + S++K++KL
Sbjct: 274 EMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLG 333
Query: 245 KIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEI-GNLKNLTVFQCFKNNFSG 303
+E N L G+LP G+ L +++ NQ+ ++P G + + N
Sbjct: 334 MLECLYNQLEGKLP-AFGSEIKLASLNLAYNQI-TEIPANFCGFTEQVENLSFAHNKLK- 390
Query: 304 EFPSGF--GDMRKLFAFSIYGNRFSG-------PFPENLGRYTALTDVDISENQFSGSFP 354
P+ F + + A N P + ++ +++S NQ S FP
Sbjct: 391 YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISK-FP 449
Query: 355 KYLCEKRKLLNLLALSNN--------FSGEVPNSYADCKTIQRLRISDNHLSGKIPD--G 404
K L L+ + L N + ++ + + + + N L+ + D
Sbjct: 450 KELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFR 508
Query: 405 LWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQN------NRFSGELPSELGRLTN 458
LP + +D N F+ S++L ++N NR E P + +
Sbjct: 509 ATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPS 567
Query: 459 LERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLS 518
L +L + +N+ + + +S L +++N + + L +
Sbjct: 568 LTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624
Query: 519 GNIPRSLSL 527
+I +L
Sbjct: 625 -DIRGCDAL 632
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-25
Identities = 23/154 (14%), Positives = 52/154 (33%), Gaps = 8/154 (5%)
Query: 429 IGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSG----KIPSALGALRQLS 484
+ + ++ L L+ SG +P +G+LT LE L L ++ P + A
Sbjct: 77 LNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDE 136
Query: 485 SLHLEENALTGSIPNEMG--DCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLT 542
+ + D + ++ + + +I +S + + N +T
Sbjct: 137 QKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT 196
Query: 543 GSIPDNLMKL-KLSSIDLSENQLSGSVPLDFLRM 575
+ +M+L KL + + +
Sbjct: 197 -FVSKAVMRLTKLRQFYMGNSPFVAENICEAWEN 229
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 297 bits (763), Expect = 2e-93
Identities = 96/283 (33%), Positives = 149/283 (52%), Gaps = 20/283 (7%)
Query: 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD------GVKVFAAEMEILGKIR 729
N +G GG G VY+ + N TVAVK+L + F E++++ K +
Sbjct: 31 PISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ 88
Query: 730 HRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGI 789
H N+++L G LV YMPNG+L L +G P L W R KIA GAA GI
Sbjct: 89 HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL--DGTPPLSWHMRCKIAQGAANGI 146
Query: 790 AYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK--VSDYSCFAGTHGY 847
+LH + IHRDIKS+NILLDE + KI+DFG+A+ +E + ++ S GT Y
Sbjct: 147 NFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMT--SRIVGTTAY 201
Query: 848 IAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLK 907
+APE A +++ KSD++SFGVVLLE++TG V+E + ++ + + +
Sbjct: 202 MAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP-QLLLDIKEEIEDEEKTIED 259
Query: 908 VLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950
+D ++ + + +A C + N RP +++V ++L
Sbjct: 260 YIDKKMNDADSTS-VEAMYSVASQCLHEKKNKRPDIKKVQQLL 301
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 292 bits (749), Expect = 3e-91
Identities = 97/282 (34%), Positives = 145/282 (51%), Gaps = 13/282 (4%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD--GVKVFAAEMEILGKIRHRNIL 734
N + LIG G GKVY+ L+ A VA+K+ G++ F E+E L RH +++
Sbjct: 40 NFDHKFLIGHGVFGKVYKGVLRDGA-KVALKRRTPESSQGIEEFETEIETLSFCRHPHLV 98
Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHH 794
L + L+ +YM NGNL + L+ + W +R +I +GAA+G+ YLH
Sbjct: 99 SLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMS-MSWEQRLEICIGAARGLHYLHT 157
Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA--ENSPKVSDYSCFAGTHGYIAPEL 852
IIHRD+KS NILLDE++ PKI DFG++K + +S + GT GYI PE
Sbjct: 158 RA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS--TVVKGTLGYIDPEY 212
Query: 853 AYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKD-IVYWVSTHLNNHENVLKVLDC 911
+++EKSDV+SFGVVL E++ R + + + W NN + +++D
Sbjct: 213 FIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN-GQLEQIVDP 271
Query: 912 EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953
+A + E + K AV C RP M +V+ L A
Sbjct: 272 NLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 276 bits (708), Expect = 8e-82
Identities = 94/540 (17%), Positives = 185/540 (34%), Gaps = 44/540 (8%)
Query: 75 VTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMV 134
+ L S S + L VL L + + S+L L +TGN +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 135 GSVPD-LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLK 193
S L +L+ + +L L L++ N+ ++PE NL
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 194 NLTYLFLAHCNLRGRIPESISELRELG----TLDICRNKISGEFPRSIRKLQKLWKIELY 249
NL +L L+ ++ + L ++ +LD+ N ++ P + +++ +L K+ L
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLR 208
Query: 250 ANNLTGELPAE-LGNLTLLQEFDISSNQM--YGKLPE-EIGNLKNLTVFQCFKNNFS--- 302
N + + + L L+ + + G L + + L+ L + +
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD 268
Query: 303 ---GEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCE 359
+ F + + +FS+ ++ +++ +F L
Sbjct: 269 YYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQFPTLKLKS 326
Query: 360 KRKL------------------LNLLALSNN---FSGEVPNSYADCKTIQRLRISDNHLS 398
++L L L LS N F G S +++ L +S N +
Sbjct: 327 LKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI 386
Query: 399 GKIPDGLWALPNVGMLDFGDNDFTGGISP-LIGLSTSLSQLVLQNNRFSGELPSELGRLT 457
+ L + LDF ++ + +L L + + L+
Sbjct: 387 T-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS 445
Query: 458 NLERLILTNNNFSGKI-PSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNS 516
+LE L + N+F P LR L+ L L + L P + + LN++ N+
Sbjct: 446 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNN 505
Query: 517 LSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL--KLSSIDLSENQLSGSVPLDFLR 574
L+SL L+ S N + S L L+ ++L++N + +
Sbjct: 506 FFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFL 565
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 259 bits (664), Expect = 1e-75
Identities = 98/520 (18%), Positives = 173/520 (33%), Gaps = 55/520 (10%)
Query: 98 SLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD-LSALKNLEIFDLSINYF 156
S L L FN L + L+VL+++ + +L +L L+ N
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88
Query: 157 TGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRG-RIPESISE 215
L+ L L + + IG+LK L L +AH ++ ++PE S
Sbjct: 89 QSLALGAFSGLSSLQKLVAVET-NLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 216 LRELGTLDICRNKISGEFPRSIRKLQKL----WKIELYANNLTGELPAELGNLTLLQEFD 271
L L LD+ NKI + +R L ++ ++L N + P + L +
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLT 206
Query: 272 ISSNQMYGKLPEE-IGNLKNLTVFQCFKNNFSG--------------------------- 303
+ +N + + I L L V + F
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266
Query: 304 ------EFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYL 357
+ F + + +FS+ ++ +++ +F FP
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQ-FPTLK 323
Query: 358 CEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLS--GKIPDGLWALPNVGMLD 415
+ K L + G S D +++ L +S N LS G + ++ LD
Sbjct: 324 LKSLKRLTF----TSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLD 379
Query: 416 FGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELP-SELGRLTNLERLILTNNNFSGKIP 474
N +S L L Q++ S L NL L +++ +
Sbjct: 380 LSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN 438
Query: 475 SALGALRQLSSLHLEENALTGSI-PNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNA 533
L L L + N+ + P+ + + L+L++ L P + + LSSL
Sbjct: 439 GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV 498
Query: 534 LNLSGNKLTGSIPDNLMKLK-LSSIDLSENQLSGSVPLDF 572
LN+S N L L +D S N + S +
Sbjct: 499 LNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQEL 538
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 7e-65
Identities = 93/510 (18%), Positives = 175/510 (34%), Gaps = 37/510 (7%)
Query: 76 TEISFDNKSLSGEISSSISALQSLTVLSLPFNVL-SGKLPLELSNCSNLKVLNVTGNAMV 134
++ +L+ + I L++L L++ N++ S KLP SN +NL+ L+++ N +
Sbjct: 103 QKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162
Query: 135 GSVP-DLSALKNLEIF----DLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESI 189
DL L + + DLS+N +L L++ +N + I
Sbjct: 163 SIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCI 221
Query: 190 GNLKNLTYLFLAHCNLRGRI---PESISELRELGTLDICRNKIS------GEFPRSIRKL 240
L L L R S L L L I +++ + L
Sbjct: 222 QGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCL 281
Query: 241 QKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNN 300
+ L + + Q ++ + + ++ +LK LT +
Sbjct: 282 TNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTF-----TS 334
Query: 301 FSGEFPSGFGDMRKLFAFSIYGNR--FSGPFPENLGRYTALTDVDISENQFSGSFPKYLC 358
G D+ L + N F G ++ T+L +D+S N +L
Sbjct: 335 NKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFL- 393
Query: 359 EKRKLLNLLAL---SNNFSGEVPNSY-ADCKTIQRLRISDNHLSGKIPDGLWALPNVGML 414
L L L +N S + + L IS H L ++ +L
Sbjct: 394 ---GLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL 450
Query: 415 DFGDNDFTGGISP-LIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKI 473
N F P + +L+ L L + P+ L++L+ L +++NNF
Sbjct: 451 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLD 510
Query: 474 PSALGALRQLSSLHLEENALTGSIPNEMGDCAR-IVDLNLARNSLSGNIPRS--LSLLSS 530
L L L N + S E+ + LNL +N + L +
Sbjct: 511 TFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKD 570
Query: 531 LNALNLSGNKLTGSIPDNLMKLKLSSIDLS 560
L + ++ + P + + + S++++
Sbjct: 571 QRQLLVEVERMECATPSDKQGMPVLSLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 9e-50
Identities = 81/414 (19%), Positives = 139/414 (33%), Gaps = 39/414 (9%)
Query: 184 EIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKL 243
+IP+++ + L L+ LR S EL LD+ R +I + + L L
Sbjct: 21 KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 244 WKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNF-S 302
+ L N + L+ LQ+ + IG+LK L N S
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
Query: 303 GEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDV----DISENQFSGSFPKYLC 358
+ P F ++ L + N+ + +L + + D+S N + P
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF- 197
Query: 359 EKRKLLNLLAL---SNNFSGEVPNSYADCKTIQRLRISD---------NHLSGKIPDGLW 406
K + L L +N S V + + + L + +L L
Sbjct: 198 ---KEIRLHKLTLRNNFDSLNVMKT--CIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALE 252
Query: 407 ALPNVGMLDFGDN---DFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLI 463
L N+ + +F + I L T++S L + + L
Sbjct: 253 GLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLE 310
Query: 464 LTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLS--GNI 521
L N F L +L++L+ G D + L+L+RN LS G
Sbjct: 311 LVNCKFGQFPTLKLKSLKRLTFTS-----NKGGNAFSEVDLPSLEFLDLSRNGLSFKGCC 365
Query: 522 PRSLSLLSSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLSENQLSGSVPLDFLR 574
+S +SL L+LS N + + N + L +L +D + L
Sbjct: 366 SQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 418
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 5e-32
Identities = 53/202 (26%), Positives = 72/202 (35%), Gaps = 17/202 (8%)
Query: 377 VPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLS 436
VPN C + + KIPD L + LD N S L
Sbjct: 7 VPNITYQC--------MELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQ 55
Query: 437 QLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGS 496
L L L++L LILT N A L L L E L
Sbjct: 56 VLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASL 115
Query: 497 IPNEMGDCARIVDLNLARNSL-SGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLK-- 553
+G + +LN+A N + S +P S L++L L+LS NK+ +L L
Sbjct: 116 ENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQM 175
Query: 554 ---LSSIDLSENQLSGSVPLDF 572
S+DLS N ++ P F
Sbjct: 176 PLLNLSLDLSLNPMNFIQPGAF 197
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 21/121 (17%), Positives = 43/121 (35%), Gaps = 7/121 (5%)
Query: 61 CGFSGITCDSVTG--RVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELS 118
C ++ + + ++ + + + L SL VL N + EL
Sbjct: 480 CQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQ 539
Query: 119 NC-SNLKVLNVTGNAMVGSVPD---LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLS 174
+ S+L LN+T N + L +K+ + + P + ++SL+
Sbjct: 540 HFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGM-PVLSLN 598
Query: 175 I 175
I
Sbjct: 599 I 599
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 265 bits (680), Expect = 9e-76
Identities = 89/598 (14%), Positives = 179/598 (29%), Gaps = 74/598 (12%)
Query: 38 QFKSKLKDPHGVLDSWKESA--DSPCGFSGITCDSVTGRVTEISFDNKSLSGEISSSISA 95
++ S + +W + D G+ D+ GRVT +S G + +I
Sbjct: 287 RYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRVTGLSLAGFGAKGRVPDAIGQ 345
Query: 96 LQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD--LSALKNLEIFDLSI 153
L L VLS + + L + + + L + L + DL
Sbjct: 346 LTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQ 405
Query: 154 NYFTGR---FPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHC------- 203
+ P + L IG+ I ++I L L ++ A+
Sbjct: 406 DAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNI 465
Query: 204 ------------NLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYAN 251
S S L++L +++ + P + L +L + + N
Sbjct: 466 AVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACN 525
Query: 252 NLTG---------ELPAELGNLTLLQEFDISSNQMYGKLPEE--IGNLKNLTVFQCFKNN 300
L + +Q F + N + P + + L + C N
Sbjct: 526 RGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEE-FPASASLQKMVKLGLLDCVHNK 584
Query: 301 FSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYT-ALTDVDISENQFSGSFPKYLCE 359
+ FG KL + N+ PE+ +T + + S N+ P
Sbjct: 585 VR-HLEA-FGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLK-YIPNIF-N 639
Query: 360 KRKLLNLLAL---SNNFSGEVPN-----SYADCKTIQRLRISDNHLSGKIPDGLWALPNV 411
+ + + ++ N E N + +S N + + +
Sbjct: 640 AKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPI 699
Query: 412 GMLDFGDNDFT-------GGISPLIGLSTSLSQLVLQNNRFSGELPSEL--GRLTNLERL 462
+ +N T + L+ + L+ N+ + L + L L +
Sbjct: 700 STIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNM 758
Query: 463 ILTNNNFSGKIPSALGALRQLSSLHLEE------NALTGSIPNEMGDCARIVDLNLARNS 516
++ N FS P+ QL + + N + P + C ++ L + N
Sbjct: 759 DVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSND 817
Query: 517 LSGNIPRSLSLLSSLNALNLSGNKLT-GSIPDNLMKLKLSSIDLSENQLSGSVPLDFL 573
+ + L L L+++ N + ++ L ++ D L
Sbjct: 818 IR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDAL 872
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 4e-51
Identities = 80/503 (15%), Positives = 155/503 (30%), Gaps = 47/503 (9%)
Query: 90 SSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNL-EI 148
S L++ +V F V+ KL + + + + D ALK + E
Sbjct: 228 GIKRSELETQSVRGESFTVIDNKLTKD-------ANVPIQLKETAEYIKDYKALKAIWEA 280
Query: 149 FDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGR 208
D + ++ D D+ + + N +T L LA +GR
Sbjct: 281 LDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGV--DLDNNGRVTGLSLAGFGAKGR 338
Query: 209 IPESISELRELGTLDICRNKISGEFP-------RSIRKLQKLWKIELYANNLTGELPAEL 261
+P++I +L EL L + + ++ +I ++ + + L
Sbjct: 339 VPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRL 398
Query: 262 GNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIY 321
LLQ+ + +M + +LK+ + N + KL
Sbjct: 399 NLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNL--TNRITFISKAIQRLTKLQIIYFA 456
Query: 322 GNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSY 381
+ F+ D + + + + L ++ + ++P+
Sbjct: 457 NSPFTYDNIA-----VDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFL 511
Query: 382 ADCKTIQRLRISDNHLSG---------KIPDGLWALPNVGMLDFGDNDFTG-GISPLIGL 431
D +Q L I+ N ++ D P + + G N+ S +
Sbjct: 512 YDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQK 571
Query: 432 STSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGA-LRQLSSLHLEE 490
L L +N+ G L L L N IP A Q+ L
Sbjct: 572 MVKLGLLDCVHNKVRH--LEAFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSH 628
Query: 491 NALTGSIPN--EMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNA-----LNLSGNKLTG 543
N L IPN + ++ + N + + + LS N++
Sbjct: 629 NKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQK 687
Query: 544 SIPDNLMKL-KLSSIDLSENQLS 565
+ +S+I LS N ++
Sbjct: 688 FPTELFATGSPISTIILSNNLMT 710
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 165 bits (418), Expect = 6e-42
Identities = 43/360 (11%), Positives = 100/360 (27%), Gaps = 39/360 (10%)
Query: 227 NKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIG 286
+ + + ++ + L G +P +G LT L+ ++
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368
Query: 287 NLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISE 346
+ + K+ + F D + L + L I+
Sbjct: 369 EELTPDMSEERKHRIRMHYKKMFLDY-----------------DQRL-NLSDLLQDAINR 410
Query: 347 NQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLW 406
N K K + L+N + + + +Q + +++ + W
Sbjct: 411 NPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDW 469
Query: 407 ALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTN 466
+ L+ + L N +LP L L L+ L +
Sbjct: 470 ED-----ANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIAC 524
Query: 467 NNFSG---------KIPSALGALRQLSSLHLEENALTG-SIPNEMGDCARIVDLNLARNS 516
N ++ ++ ++ N L + ++ L+ N
Sbjct: 525 NRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNK 584
Query: 517 LSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL--KLSSIDLSENQLSGSVPLDFLR 574
+ + L L L N++ IP++ ++ + S N+L + +
Sbjct: 585 VR--HLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAK 641
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 248 bits (636), Expect = 4e-75
Identities = 72/300 (24%), Positives = 116/300 (38%), Gaps = 33/300 (11%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEI--LGKIRHRNIL 734
L+ + G G V++ L VAVK D + + E E+ L ++H NIL
Sbjct: 25 PLQLLEVKARGRFGCVWKAQLLNE--YVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENIL 81
Query: 735 KLYACLLKGGSS----FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
+ +G S +L+ + G+L L V + W IA A+G+A
Sbjct: 82 QFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV------VSWNELCHIAETMARGLA 135
Query: 791 YLHHD-------CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAG 843
YLH D P I HRDIKS N+LL + IADFG+A E D G
Sbjct: 136 YLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVG 195
Query: 844 THGYIAPELA-----YTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTH 898
T Y+APE+ + + D+++ G+VL EL + + +
Sbjct: 196 TRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ 255
Query: 899 LNNHENVLKVLDCEVASESIKED------MIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952
+ E++ +V+ + +++ M L + C R V + +
Sbjct: 256 HPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ 315
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 259 bits (663), Expect = 7e-75
Identities = 100/507 (19%), Positives = 175/507 (34%), Gaps = 32/507 (6%)
Query: 75 VTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMV 134
+T ++ + L +++ + LT L + FN +S P LKVLN+ N +
Sbjct: 27 ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 86
Query: 135 GSVPD-LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLK 193
+ NL L N V L++L + N + L+
Sbjct: 87 QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSST-KLGTQVQLE 145
Query: 194 NLTYLFLAHCNLRGRIPESIS--ELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYAN 251
NL L L++ ++ E + L L++ N+I P + +L+ + L
Sbjct: 146 NLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNV 205
Query: 252 NLTGELPAELG---NLTLLQEFDISSNQMYGKLPEEIGNLK--NLTVFQCFKNNFSGEFP 306
L L +L T ++ +S++Q+ LK NLT+ NN +
Sbjct: 206 QLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGN 265
Query: 307 SGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNL 366
F + +L F + N F +L + +++ + S
Sbjct: 266 DSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSIS------------ 313
Query: 367 LALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGIS 426
+ S+ K ++ L + DN + G + L N+ L ++ +
Sbjct: 314 ---LASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTL 370
Query: 427 PLIGLS----TSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIP-SALGALR 481
+ L L L N+ S L +LE L L N ++ L
Sbjct: 371 TNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLE 430
Query: 482 QLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSG--NIPRSLSLLSSLNALNLSGN 539
+ ++L N N + L L R +L + P L +L L+LS N
Sbjct: 431 NIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNN 490
Query: 540 KLTGSIPDNLMKL-KLSSIDLSENQLS 565
+ D L L KL +DL N L+
Sbjct: 491 NIANINDDMLEGLEKLEILDLQHNNLA 517
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 259 bits (663), Expect = 8e-75
Identities = 95/526 (18%), Positives = 174/526 (33%), Gaps = 35/526 (6%)
Query: 76 TEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVG 135
TE+ + S+ ++ ++L L L N LS NL+ L ++ N +
Sbjct: 100 TELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQA 159
Query: 136 SVPD---LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIG-- 190
+ + A +L+ +LS N P + +L L + + + E +
Sbjct: 160 LKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNV-QLGPSLTEKLCLE 218
Query: 191 -NLKNLTYLFLAHCNLRGRIPESISELR--ELGTLDICRNKISGEFPRSIRKLQKLWKIE 247
++ L L++ L + L+ L LD+ N ++ S L +L
Sbjct: 219 LANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFF 278
Query: 248 LYANNLTGELPAELGNLTLLQEFDISSNQMYGKL---------PEEIGNLKNLTVFQCFK 298
L NN+ L L ++ ++ + + LK L
Sbjct: 279 LEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMED 338
Query: 299 NNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLG----RYTALTDVDISENQFSGSFP 354
N+ G + F + L S+ + S N ++ L +++++N+ S
Sbjct: 339 NDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIES 398
Query: 355 KYLCEKRKLLNLLALSNNFSGEVP-NSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGM 413
L L N E+ + + I + +S N + +P++
Sbjct: 399 DAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQR 458
Query: 414 LDFGDNDFTG--GISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFS- 470
L +L+ L L NN + L L LE L L +NN +
Sbjct: 459 LMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLAR 518
Query: 471 -------GKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPR 523
G L L L L+LE N D + ++L N+L+
Sbjct: 519 LWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPAS 578
Query: 524 SLSLLSSLNALNLSGNKLTGSIPDNLMKL--KLSSIDLSENQLSGS 567
+ SL +LNL N +T L+ +D+ N +
Sbjct: 579 VFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCT 624
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 2e-60
Identities = 88/524 (16%), Positives = 169/524 (32%), Gaps = 38/524 (7%)
Query: 74 RVTEISFDNKSLSGEISSSISALQ--SLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGN 131
+ E+ N + S + SL L L N + P L L +
Sbjct: 146 NLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNV 205
Query: 132 AMVGSVPD----LSALKNLEIFDLSINYFTGRFPRWVVNL--TQLVSLSIGDNVYDEAEI 185
+ S+ + A ++ LS + + + L T L L + N
Sbjct: 206 QLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYN-NLNVVG 264
Query: 186 PESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRN---------KISGEFPRS 236
+S L L Y FL + N++ S+ L + L++ R+ + S
Sbjct: 265 NDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFS 324
Query: 237 IRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIG----NLKNLT 292
+ L+ L + + N++ G L L+ +S++ + L
Sbjct: 325 FQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLH 384
Query: 293 VFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPEN-LGRYTALTDVDISENQFSG 351
+ KN S F + L + N + ++ +S N++
Sbjct: 385 ILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQ 444
Query: 352 SFPKYLCEKRKLLNLLALSNNFSG--EVPNSYADCKTIQRLRISDNHLSGKIPDGLWALP 409
L L+ P+ + + + L +S+N+++ D L L
Sbjct: 445 LTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLE 504
Query: 410 NVGMLDFGDN--------DFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLER 461
+ +LD N GG + + L L L++N F L L+
Sbjct: 505 KLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKI 564
Query: 462 LILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCAR-IVDLNLARNSLSGN 520
+ L NN + S L SL+L++N +T G R + +L++ N
Sbjct: 565 IDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCT 624
Query: 521 IPRSLSLLSSLNALNLSGNKLTGSI----PDNLMKLKLSSIDLS 560
++ +N + + +L+ P + + D S
Sbjct: 625 CESIAWFVNWINETHTNIPELSSHYLCNTPPHYHGFPVRLFDTS 668
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 2e-59
Identities = 84/412 (20%), Positives = 141/412 (34%), Gaps = 23/412 (5%)
Query: 184 EIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKL 243
++P+ + N+T L L H LR + + +L +LD+ N IS P +KL L
Sbjct: 18 QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPML 75
Query: 244 WKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSG 303
+ L N L+ T L E + SN + KNL N S
Sbjct: 76 KVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSS 135
Query: 304 EFPSGFGDMRKLFAFSIYGNRFSGPFPENLG--RYTALTDVDISENQFSGSFPKYLCEKR 361
+ L + N+ E L ++L +++S NQ P
Sbjct: 136 TKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIG 195
Query: 362 KLLNLLALSNNFSGEVPNS---YADCKTIQRLRISDNHLSGKIPDGLWALPNVG--MLDF 416
+L L + + +I+ L +S++ LS L MLD
Sbjct: 196 RLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDL 255
Query: 417 GDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNN--------- 467
N+ + L L+ N L L N+ L L +
Sbjct: 256 SYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLA 315
Query: 468 NFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSL 527
+ + L+ L L++E+N + G N + L+L+ + S + +
Sbjct: 316 SLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETF 375
Query: 528 ----LSSLNALNLSGNKLTGSIPDNLMKLK-LSSIDLSENQLSGSVPLDFLR 574
S L+ LNL+ NK++ D L L +DL N++ + R
Sbjct: 376 VSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWR 427
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 2e-55
Identities = 66/405 (16%), Positives = 140/405 (34%), Gaps = 26/405 (6%)
Query: 194 NLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNL 253
+ +H L ++P+ + + L++ N++ + + +L +++ N +
Sbjct: 5 SHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 254 TGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMR 313
+ P L +L+ ++ N++ + NLT N+ + F +
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121
Query: 314 KLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLAL---S 370
L + N S + L ++ +S N+ + +L L S
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQA-LKSEELDIFANSSLKKLELSS 180
Query: 371 NNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGL---WALPNVGMLDFGDNDFTGGISP 427
N P + + L +++ L + + L A ++ L ++ + +
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT 240
Query: 428 LIGL--STSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSS 485
T+L+ L L N + L LE L NN +L L +
Sbjct: 241 TFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRY 300
Query: 486 LHLEEN---------ALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNL 536
L+L+ + +L + LN+ N + G + L +L L+L
Sbjct: 301 LNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSL 360
Query: 537 SGNK-----LTGSIPDNLMKLKLSSIDLSENQLSGSVPLDFLRMG 576
S + LT +L L ++L++N++S F +G
Sbjct: 361 SNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLG 405
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 232 bits (595), Expect = 2e-69
Identities = 76/273 (27%), Positives = 126/273 (46%), Gaps = 10/273 (3%)
Query: 323 NRFSGPFPENLGRYTALTDVDISENQFSGSF--PKYLCEKRKLLNL-LALSNNFSGEVPN 379
+ G + + + ++D+S + P L L L + NN G +P
Sbjct: 36 RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPP 95
Query: 380 SYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLV 439
+ A + L I+ ++SG IPD L + + LDF N +G + P I +L +
Sbjct: 96 AIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT 155
Query: 440 LQNNRFSGELPSELGRLTNLER-LILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIP 498
NR SG +P G + L + ++ N +GKIP L L+ + L N L G
Sbjct: 156 FDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDAS 214
Query: 499 NEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLK-LSSI 557
G ++LA+NSL+ ++ + L +LN L+L N++ G++P L +LK L S+
Sbjct: 215 VLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSL 273
Query: 558 DLSENQLSGSVP--LDFLRMGGDGAFAGNEGLC 588
++S N L G +P + R A+A N+ LC
Sbjct: 274 NVSFNNLCGEIPQGGNLQRFDVS-AYANNKCLC 305
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 3e-68
Identities = 94/401 (23%), Positives = 143/401 (35%), Gaps = 102/401 (25%)
Query: 32 ETQALIQFKSKLKDPHGVLDSWKESAD-SPCGFSGITCDSVT--GRVTEISFDNKSLSGE 88
+ QAL+Q K L +P L SW + D + G+ CD+ T RV + +L
Sbjct: 7 DKQALLQIKKDLGNP-TTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK- 64
Query: 89 ISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEI 148
+P L+N L L + G
Sbjct: 65 ---------------------PYPIPSSLANLPYLNFLYIGGI----------------- 86
Query: 149 FDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGR 208
N G IP +I L L YL++ H N+ G
Sbjct: 87 -----NNLVG-------------------------PIPPAIAKLTQLHYLYITHTNVSGA 116
Query: 209 IPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLT-LL 267
IP+ +S+++ L TLD N +SG P SI L L I N ++G +P G+ + L
Sbjct: 117 IPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLF 176
Query: 268 QEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSG 327
IS N++ GK+P NL NL +N G+ FG + + N +
Sbjct: 177 TSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAF 235
Query: 328 PFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTI 387
+ +G L +D+ N+ G+ P+ L K +
Sbjct: 236 DLGK-VGLSKNLNGLDLRNNRIYGTLPQGL------------------------TQLKFL 270
Query: 388 QRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPL 428
L +S N+L G+IP G L + + +N G SPL
Sbjct: 271 HSLNVSFNNLCGEIPQGG-NLQRFDVSAYANNKCLCG-SPL 309
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 1e-65
Identities = 71/324 (21%), Positives = 115/324 (35%), Gaps = 54/324 (16%)
Query: 251 NNLTGELPAELGNLTLLQEFDISSNQMYG--KLPEEIGNLKNLTVFQCFK-NNFSGEFPS 307
G L + D+S + +P + NL L NN G P
Sbjct: 36 RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPP 95
Query: 308 GFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLL 367
+ +L I SG P+ L +
Sbjct: 96 AIAKLTQLHYLYITHTNVSGAIPDFLSQ-------------------------------- 123
Query: 368 ALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISP 427
KT+ L S N LSG +P + +LPN+ + F N +G I
Sbjct: 124 ----------------IKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167
Query: 428 LIGLSTSLSQ-LVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSL 486
G + L + + NR +G++P L NL + L+ N G G+ + +
Sbjct: 168 SYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKI 226
Query: 487 HLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIP 546
HL +N+L + ++G + L+L N + G +P+ L+ L L++LN+S N L G IP
Sbjct: 227 HLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285
Query: 547 DNLMKLKLSSIDLSENQLSGSVPL 570
+ + N+ PL
Sbjct: 286 QGGNLQRFDVSAYANNKCLCGSPL 309
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 6e-53
Identities = 54/184 (29%), Positives = 82/184 (44%), Gaps = 4/184 (2%)
Query: 393 SDNHLSGKIPDGLWALPNVGMLDFGDNDFTG--GISPLIGLSTSLSQLVLQN-NRFSGEL 449
+ G + D V LD + I + L+ L + N G +
Sbjct: 34 CNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPI 93
Query: 450 PSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVD 509
P + +LT L L +T+ N SG IP L ++ L +L NAL+G++P + +V
Sbjct: 94 PPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVG 153
Query: 510 LNLARNSLSGNIPRSLSLLSSL-NALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSGSV 568
+ N +SG IP S S L ++ +S N+LTG IP L L+ +DLS N L G
Sbjct: 154 ITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDA 213
Query: 569 PLDF 572
+ F
Sbjct: 214 SVLF 217
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 2e-68
Identities = 86/288 (29%), Positives = 133/288 (46%), Gaps = 31/288 (10%)
Query: 664 SFHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEME 723
S H ID +E + ++G G G V + + VA+KQ+ K F E+
Sbjct: 1 SLHMIDYK-----EIEVEEVVGRGAFGVVCKAKWRAK--DVAIKQIESESERKAFIVELR 53
Query: 724 ILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL 783
L ++ H NI+KLY L LV+EY G+L+ LH E P L
Sbjct: 54 QLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHG--AEPLPYYTAAHAMSWCL 109
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE-PKIADFGVAKIAENSPKVSDYSCFA 842
++G+AYLH +IHRD+K N+LL KI DFG A + +
Sbjct: 110 QCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----MTNNK 164
Query: 843 GTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNH 902
G+ ++APE+ SEK DVFS+G++L E++T RKP +E G I++ V
Sbjct: 165 GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR-- 222
Query: 903 ENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950
+ +++ + + L+ C +K P+ RP M E+VK++
Sbjct: 223 ---PPL------IKNLPKPIESLMT---RCWSKDPSQRPSMEEIVKIM 258
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 4e-67
Identities = 89/289 (30%), Positives = 148/289 (51%), Gaps = 35/289 (12%)
Query: 669 DIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGT-VAVKQLWKGD----GVKVFAAEME 723
DI L IG+G G V+R + G+ VAVK L + D V F E+
Sbjct: 33 DIPWCD---LNIKEKIGAGSFGTVHRAEWH---GSDVAVKILMEQDFHAERVNEFLREVA 86
Query: 724 ILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL 783
I+ ++RH NI+ + + + +V EY+ G+L++ LHK + +LD RR +A
Sbjct: 87 IMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK--SGAREQLDERRRLSMAY 144
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAG 843
AKG+ YLH+ +PPI+HR++KS N+L+D+ Y K+ DFG++++ ++ S AG
Sbjct: 145 DVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS--KSAAG 201
Query: 844 THGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGD--GKDIVYWVSTHLNN 901
T ++APE+ +EKSDV+SFGV+L EL T ++P +G+ +V V
Sbjct: 202 TPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP----WGNLNPAQVVAAV---GFK 254
Query: 902 HENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950
+ L+ ++ + +++ C T P RP ++ +L
Sbjct: 255 CKR----LEI---PRNLNPQVAAIIE---GCWTNEPWKRPSFATIMDLL 293
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 1e-64
Identities = 91/539 (16%), Positives = 168/539 (31%), Gaps = 43/539 (7%)
Query: 75 VTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMV 134
+ F L +++ S L +LT L L + + L L +T N ++
Sbjct: 35 TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLI 94
Query: 135 GSVPD-LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLK 193
LS K L+ + + N L SL +G N +
Sbjct: 95 FMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSI-KLPKGFPTE 153
Query: 194 NLTYLFLAHCNLRGRIPESISELRELG--TLDICRNKISGEFPRSIRKLQKLWKIELYAN 251
L L + + E +S L++ +L++ N I+ +
Sbjct: 154 KLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA-GIEPGAFDSAVFQSLNFGGT 212
Query: 252 NLTGELPAELGNLTL----------------------------LQEFDISSNQMYGKLPE 283
+ L N T+ ++ ++ + +
Sbjct: 213 QNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSN 272
Query: 284 EIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVD 343
L + S E PSG + L + N+F + + +LT +
Sbjct: 273 TFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLS 331
Query: 344 ISENQFSGSFPKYLCEKRKLLNLLALSNN---FSGEVPNSYADCKTIQRLRISDNHLSGK 400
I N E + L L LS++ S + +Q L +S N
Sbjct: 332 IKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSL 391
Query: 401 IPDGLWALPNVGMLDFGDNDFTGGISP-LIGLSTSLSQLVLQNNRFSGELPSELGRLTNL 459
+ P + +LD + L L L ++ L L
Sbjct: 392 KTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPAL 451
Query: 460 ERLILTNNNFSGKI---PSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNS 516
+ L L N+F ++L L +L L L L+ + + ++L+ N
Sbjct: 452 QHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNR 511
Query: 517 LSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLK-LSSIDLSENQLSGSVPLDFLR 574
L+ + +LS L + LNL+ N ++ +P L L +I+L +N L + +
Sbjct: 512 LTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNIYFL 569
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 5e-63
Identities = 104/532 (19%), Positives = 171/532 (32%), Gaps = 29/532 (5%)
Query: 56 SADSPCGFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPL 115
S+D C V + +N L+ EI ++ S L FNVL
Sbjct: 3 SSDQKC-----IEKEVN---KTYNCENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNT 51
Query: 116 ELSNCSNLKVLNVTGNAMVGSVPD-LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLS 174
S NL L++T + D + L+ L+ N + L L
Sbjct: 52 TFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLF 111
Query: 175 IGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFP 234
+ + N K L L+L ++ +L LD N I
Sbjct: 112 FIQT-GISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSK 170
Query: 235 RSIRKLQKLWKIELY-ANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGN--LKNL 291
+ LQ+ + L N + + + Q + Q + + + N +++L
Sbjct: 171 EDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSL 230
Query: 292 TVFQCFKNNFSGEFPSGFGDMRK--LFAFSIYGNRFSGPFPENLGRYTALTDVDISENQF 349
+ + P+ F + + + + ++ + F ++ L ++D++
Sbjct: 231 WLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHL 290
Query: 350 SGSFPKYLCEKRKLLNLLALSNN-FSGEVPNSYADCKTIQRLRISDNHLSGKIPDG-LWA 407
S P L L L LS N F S ++ ++ L I N ++ G L
Sbjct: 291 S-ELPSGLVGLST-LKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLEN 348
Query: 408 LPNVGMLDFGDNDFTGGISPLIGLS--TSLSQLVLQNNRFSGELPSELGRLTNLERLILT 465
L N+ LD +D + L + L L L N LE L L
Sbjct: 349 LENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLA 408
Query: 466 NNNFSGKIP-SALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNI--- 521
K S L L L+L + L S + LNL N
Sbjct: 409 FTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQK 468
Query: 522 PRSLSLLSSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLSENQLSGSVPLDF 572
SL L L L LS L+ L ++ +DLS N+L+ S
Sbjct: 469 TNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEAL 520
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 6e-50
Identities = 71/401 (17%), Positives = 131/401 (32%), Gaps = 14/401 (3%)
Query: 184 EIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKL 243
EIP ++ + L + L + S L L LD+ R +I + + +L
Sbjct: 26 EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRL 83
Query: 244 WKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSG 303
+ L AN L L L+ + + N K L N+ S
Sbjct: 84 DTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISS 143
Query: 304 EFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALT--DVDISENQFSGSFPKYLCEKR 361
KL N E++ T ++++ N + +
Sbjct: 144 IKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA-GIEPGAFDSA 202
Query: 362 KLLNLLALSNNFSGEVPNSYADCK--TIQRLRISDNHLSGKIPDGLWALP--NVGMLDFG 417
+L + + ++ D P L +V ++
Sbjct: 203 VFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQ 262
Query: 418 DNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSAL 477
+ F S + L +L L S ELPS L L+ L++L+L+ N F +
Sbjct: 263 KHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISA 321
Query: 478 GALRQLSSLHLEENALTGSIPNEM-GDCARIVDLNLARNSL--SGNIPRSLSLLSSLNAL 534
L+ L ++ N + + + +L+L+ + + S L LS L +L
Sbjct: 322 SNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSL 381
Query: 535 NLSGNKLTGSIPDNLMKL-KLSSIDLSENQLSGSVPLDFLR 574
NLS N+ + + +L +DL+ +L +
Sbjct: 382 NLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQ 422
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 4e-45
Identities = 75/439 (17%), Positives = 141/439 (32%), Gaps = 14/439 (3%)
Query: 74 RVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKV--LNVTGN 131
+ + + +S + L VL N + ++S+ LN+ GN
Sbjct: 130 TLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGN 189
Query: 132 AMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVN--LTQLVSLSIGDN-VYDEAEIPES 188
+ G P + + + + N + L + D D +
Sbjct: 190 DIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFE 249
Query: 189 IGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIEL 248
++ + L + L LD+ +S E P + L L K+ L
Sbjct: 250 GLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVL 308
Query: 249 YANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEE-IGNLKNLTVFQCFKNN--FSGEF 305
AN N L I N +L + NL+NL ++ S
Sbjct: 309 SANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCC 368
Query: 306 PSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLN 365
++ L + ++ N E L +D++ + + + LL
Sbjct: 369 NLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLK 428
Query: 366 LLALSNN-FSGEVPNSYADCKTIQRLRISDNHLSGKI---PDGLWALPNVGMLDFGDNDF 421
+L LS++ + +Q L + NH + L L + +L D
Sbjct: 429 VLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDL 488
Query: 422 TGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALR 481
+ ++ + L +NR + L L + L L +N+ S +PS L L
Sbjct: 489 SSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILS 547
Query: 482 QLSSLHLEENALTGSIPNE 500
Q +++L +N L + N
Sbjct: 548 QQRTINLRQNPLDCTCSNI 566
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 2e-64
Identities = 78/299 (26%), Positives = 133/299 (44%), Gaps = 48/299 (16%)
Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG---------VKVFAA 720
+ + +E + IG GG G V++ L K+ VA+K L GD + F
Sbjct: 16 LADNE---IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQR 72
Query: 721 EMEILGKIRHRNILKLY-ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRY 779
E+ I+ + H NI+KLY +V+E++P G+L+ L + + W +
Sbjct: 73 EVFIMSNLNHPNIVKLYGLMH---NPPRMVMEFVPCGDLYHRLLDK----AHPIKWSVKL 125
Query: 780 KIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE-----PKIADFGVAKIAENSPK 834
++ L A GI Y+ + +PPI+HRD++S NI L E K+ADFG+++
Sbjct: 126 RLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----S 179
Query: 835 VSDYSCFAGTHGYIAPEL--AYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIV 892
V S G ++APE A +EK+D +SF ++L ++TG P +E +
Sbjct: 180 VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI 239
Query: 893 YWVSTHLNNHENV-LKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950
+ E + + E + ++++ C + P RP +VK L
Sbjct: 240 NMIR-----EEGLRPTI------PEDCPPRLRNVIEL---CWSGDPKKRPHFSYIVKEL 284
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 3e-64
Identities = 88/299 (29%), Positives = 133/299 (44%), Gaps = 50/299 (16%)
Query: 669 DIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGT-VAVKQLWKG------DGVKVFAAE 721
+ID + L + +IG GG GKVYR G VAVK ++ E
Sbjct: 3 EIDFAE---LTLEEIIGIGGFGKVYRAFWI---GDEVAVKAARHDPDEDISQTIENVRQE 56
Query: 722 MEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKI 781
++ ++H NI+ L LK + LV+E+ G L + L + +
Sbjct: 57 AKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK------RIPPDILVNW 110
Query: 782 ALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP--------KIADFGVAKIAENSP 833
A+ A+G+ YLH + PIIHRD+KSSNIL+ + E KI DFG+A+ +
Sbjct: 111 AVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT 170
Query: 834 KVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGD--GKDI 891
K+S AG + ++APE+ S+ SDV+S+GV+L EL+TG P + G +
Sbjct: 171 KMS----AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP----FRGIDGLAV 222
Query: 892 VYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950
Y V N L + E KL++ C P+ RP ++ L
Sbjct: 223 AYGV---AMNKLA----LPI---PSTCPEPFAKLME---DCWNPDPHSRPSFTNILDQL 268
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 2e-63
Identities = 82/314 (26%), Positives = 138/314 (43%), Gaps = 54/314 (17%)
Query: 651 NGEKEVSSKWKLASFHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLW 710
+G ++ + W +I Q + IGSG G VY+ G VAVK L
Sbjct: 10 HGSRDAADDW--------EIPDGQ---ITVGQRIGSGSFGTVYKGKWH---GDVAVKMLN 55
Query: 711 KGD----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRV 766
++ F E+ +L K RH NIL + +V ++ +L+ LH
Sbjct: 56 VTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLA-IVTQWCEGSSLYHHLHAS- 113
Query: 767 KEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826
+ + + + IA A+G+ YLH + IIHRD+KS+NI L ED KI DFG+A
Sbjct: 114 ---ETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLA 167
Query: 827 KIAENSPKVSDYSCFAGTHGYIAPEL---AYTCKVSEKSDVFSFGVVLLELVTGRKPVEE 883
+ +G+ ++APE+ + S +SDV++FG+VL EL+TG+ P
Sbjct: 168 TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP--- 224
Query: 884 EYGDGKDIVYWVSTHLNNHENVLKVL-------DCEVASESIKEDMIKLLKIAVVCTTKL 936
Y + +NN + +++++ D + + M +L+ C K
Sbjct: 225 -YSN-----------INNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMA---ECLKKK 269
Query: 937 PNLRPPMREVVKML 950
+ RP ++ +
Sbjct: 270 RDERPSFPRILAEI 283
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 7e-63
Identities = 68/296 (22%), Positives = 118/296 (39%), Gaps = 46/296 (15%)
Query: 667 HIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL----WKGDGVKVFAAEM 722
H ID +Q L + +G++++ + N + VK L W + F E
Sbjct: 4 HSGIDFKQ---LNFLTKLNENHSGELWKGRWQGN--DIVVKVLKVRDWSTRKSRDFNEEC 58
Query: 723 EILGKIRHRNILKLYACLLKGGSSFL--VLEYMPNGNLFQALHKRVKEGKPELDWFRRYK 780
L H N+L + + + +MP G+L+ LH+ +D + K
Sbjct: 59 PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEG---TNFVVDQSQAVK 115
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSC 840
AL A+G+A+LH P I + S ++++DED +I+ V ++ ++
Sbjct: 116 FALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRM----- 169
Query: 841 FAGTHGYIAPEL---AYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGD--GKDIVYWV 895
++APE +D++SF V+L ELVT P + D +I V
Sbjct: 170 --YAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVP----FADLSNMEIGMKV 223
Query: 896 STHLNNHENV-LKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950
+ E + + I + KL+KI C + P RP +V +L
Sbjct: 224 A-----LEGLRPTI------PPGISPHVSKLMKI---CMNEDPAKRPKFDMIVPIL 265
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 1e-61
Identities = 99/519 (19%), Positives = 172/519 (33%), Gaps = 29/519 (5%)
Query: 75 VTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMV 134
I L S S S L L L + +L L +TGN +
Sbjct: 34 TKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ 93
Query: 135 GSVPD-LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLK 193
P S L +LE + L L L++ N ++P NL
Sbjct: 94 SFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLT 153
Query: 194 NLTYLFLAHCNLRGRIPESISELRELG----TLDICRNKISGEFPRSIRKLQKLWKIELY 249
NL ++ L++ ++ + LRE +LD+ N I + KL ++ L
Sbjct: 154 NLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLR 212
Query: 250 ANNLTGELPAE-LGNLTLLQEFDISSNQMYGKLPEEI------GNLKNLTV--FQCFKNN 300
N + + L NL L + + + EI L ++T+ F+ N
Sbjct: 213 GNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTN 272
Query: 301 FSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEK 360
+ F + + A S+ G + E++ ++ + I Q L
Sbjct: 273 DFSDDIVKFHCLANVSAMSLAGVSIK--YLEDVPKHFKWQSLSIIRCQLKQFPTLDL--- 327
Query: 361 RKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLW--ALPNVGMLDFGD 418
L L L+ N G + ++ L +S N LS ++ LD
Sbjct: 328 -PFLKSLTLTMN-KGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSF 385
Query: 419 NDFTGGISPLIGLSTSLSQLVLQNNRFSGELP-SELGRLTNLERLILTNNNFSGKIPSAL 477
N +S L L Q++ S L L L ++ N
Sbjct: 386 NGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIF 444
Query: 478 GALRQLSSLHLEENALTGSIPNEM-GDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNL 536
L L++L + N+ + + + + + L+L++ L L L LN+
Sbjct: 445 LGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNM 504
Query: 537 SGNKLTGSIPDNLMKLK-LSSIDLSENQLSGSVPLDFLR 574
S N L + +L LS++D S N++ +
Sbjct: 505 SHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQH 542
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 2e-52
Identities = 82/506 (16%), Positives = 159/506 (31%), Gaps = 48/506 (9%)
Query: 84 SLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD-LSA 142
+ + L L+ L L N + P S ++L+ L + +
Sbjct: 67 EIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQ 126
Query: 143 LKNLEIFDLSINYFTG-RFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLT----Y 197
L L+ +++ N+ + P + NLT LV + + N + L+
Sbjct: 127 LITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQT-ITVNDLQFLRENPQVNLS 185
Query: 198 LFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPR-SIRKLQKLWKIELYANNLTGE 256
L ++ + I + + +L L + N S + ++ L L L E
Sbjct: 186 LDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDE 244
Query: 257 LPAELGNLTLLQ--------EFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSG 308
E+ ++++ EF ++ + + L N++ +
Sbjct: 245 RNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVP 304
Query: 309 FGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNL-- 366
K + SI + +L L + ++ N+ S SF K L+L
Sbjct: 305 K--HFKWQSLSIIRCQLKQFPTLDL---PFLKSLTLTMNKGSISFKKVALPSLSYLDLSR 359
Query: 367 ---------------------LALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGL 405
L LS N + + ++ + +Q L + L
Sbjct: 360 NALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSA 419
Query: 406 WA-LPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSE-LGRLTNLERLI 463
+ L + LD + + TSL+ L + N F S TNL L
Sbjct: 420 FLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLD 479
Query: 464 LTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPR 523
L+ L +L L++ N L + + L+ + N + +
Sbjct: 480 LSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGI 539
Query: 524 SLSLLSSLNALNLSGNKLTGSIPDNL 549
SL NL+ N + I ++
Sbjct: 540 LQHFPKSLAFFNLTNNSVA-CICEHQ 564
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-27
Identities = 36/194 (18%), Positives = 65/194 (33%), Gaps = 5/194 (2%)
Query: 386 TIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRF 445
+ + + +S N L + LD + LS L+L N
Sbjct: 33 STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPI 92
Query: 446 SGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTG-SIPNEMGDC 504
P LT+LE L+ + +G L L L++ N + +P +
Sbjct: 93 QSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNL 152
Query: 505 ARIVDLNLARNSLSGNIPRSLSLLSSLNA----LNLSGNKLTGSIPDNLMKLKLSSIDLS 560
+V ++L+ N + L L L++S N + +KL + L
Sbjct: 153 TNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLR 212
Query: 561 ENQLSGSVPLDFLR 574
N S ++ L+
Sbjct: 213 GNFNSSNIMKTCLQ 226
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-23
Identities = 29/145 (20%), Positives = 48/145 (33%), Gaps = 2/145 (1%)
Query: 430 GLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLE 489
+ +S + L N + L+ L L+ A L LS+L L
Sbjct: 29 DIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILT 88
Query: 490 ENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTG-SIPDN 548
N + P + +L L+ + L +L LN++ N + +P
Sbjct: 89 GNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAY 148
Query: 549 LMKL-KLSSIDLSENQLSGSVPLDF 572
L L +DLS N + D
Sbjct: 149 FSNLTNLVHVDLSYNYIQTITVNDL 173
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 20/105 (19%), Positives = 36/105 (34%), Gaps = 6/105 (5%)
Query: 74 RVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAM 133
+T + L L L +L++ N L + +L L+ + N +
Sbjct: 474 NLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRI 533
Query: 134 VGSVPD-LSALKNLEIFDLSINYFT-----GRFPRWVVNLTQLVS 172
S K+L F+L+ N +F +WV Q +
Sbjct: 534 ETSKGILQHFPKSLAFFNLTNNSVACICEHQKFLQWVKEQKQFLV 578
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 3e-60
Identities = 67/299 (22%), Positives = 116/299 (38%), Gaps = 47/299 (15%)
Query: 669 DIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEI 724
DI EQ LE LIG G G+VY G VA++ + +K F E+
Sbjct: 29 DIPFEQ---LEIGELIGKGRFGQVYHGRWH---GEVAIRLIDIERDNEDQLKAFKREVMA 82
Query: 725 LGKIRHRNILKLY-ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL 783
+ RH N++ AC+ ++ L+ + K LD + +IA
Sbjct: 83 YRQTRHENVVLFMGACM-SPPHLAIITSLCKGRTLYSVVRDA----KIVLDVNKTRQIAQ 137
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI---AENSPKVSDYSC 840
KG+ YLH + I+H+D+KS N+ D + I DFG+ I + +
Sbjct: 138 EIVKGMGYLH---AKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRI 193
Query: 841 FAGTHGYIAPEL---------AYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDI 891
G ++APE+ S+ SDVF+ G + EL P + + + I
Sbjct: 194 QNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ--PAEAI 251
Query: 892 VYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950
++ + + ++ + +++ +L C RP +++ ML
Sbjct: 252 IWQM------GTGMKP----NLSQIGMGKEISDILL---FCWAFEQEERPTFTKLMDML 297
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 5e-60
Identities = 71/307 (23%), Positives = 119/307 (38%), Gaps = 50/307 (16%)
Query: 664 SFHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG--VKVFAAE 721
S H + E ++G G G+ ++ ++ + +K+L + D + F E
Sbjct: 1 SMPHRIFRPSDL-IHGE--VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKE 57
Query: 722 MEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKI 781
++++ + H N+LK L K + EY+ G L + + W +R
Sbjct: 58 VKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSM----DSQYPWSQRVSF 113
Query: 782 ALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSC- 840
A A G+AYLH S IIHRD+ S N L+ E+ +ADFG+A++ + +
Sbjct: 114 AKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRS 170
Query: 841 -----------FAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGK 889
G ++APE+ EK DVFSFG+VL E++
Sbjct: 171 LKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADP------- 223
Query: 890 DIVYWVSTHLNNHENVLKVL------DCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPM 943
++ ++ NV L +C + I V C P RP
Sbjct: 224 ---DYLPRTMDFGLNVRGFLDRYCPPNCPPS----------FFPITVRCCDLDPEKRPSF 270
Query: 944 REVVKML 950
++ L
Sbjct: 271 VKLEHWL 277
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 2e-58
Identities = 70/326 (21%), Positives = 120/326 (36%), Gaps = 46/326 (14%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEI--LGKIRHRNIL 734
NL+ LIG G G VY+ L + VAVK + + F E I + + H NI
Sbjct: 14 NLKLLELIGRGRYGAVYKGSLDER--PVAVKVFSFANR-QNFINEKNIYRVPLMEHDNIA 70
Query: 735 KLYACLLKGGSS-----FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGI 789
+ + + LV+EY PNG+L + L DW ++A +G+
Sbjct: 71 RFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT------SDWVSSCRLAHSVTRGL 124
Query: 790 AYLHHD------CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSC--- 840
AYLH + P I HRD+ S N+L+ D I+DFG++ + V
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184
Query: 841 ---FAGTHGYIAPE-------LAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKD 890
GT Y+APE L ++ D+++ G++ E+ R +
Sbjct: 185 AISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM-RCTDLFPGESVPE 243
Query: 891 IV---YWVSTHLNNHENVLKVLDCEVASESIKED-------MIKLLKIAVVCTTKLPNLR 940
+ E++ ++ E E + L + C + R
Sbjct: 244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEAR 303
Query: 941 PPMREVVKMLADADPCTDKSPDNSSD 966
+ + +A+ +++ S
Sbjct: 304 LTAQXAEERMAELMMIWERNKSVSPT 329
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 7e-58
Identities = 77/313 (24%), Positives = 120/313 (38%), Gaps = 46/313 (14%)
Query: 669 DIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEI--LG 726
A+QI + IG G G+V+ + VAVK + + + E EI
Sbjct: 33 RTIAKQI---QMVKQIGKGRYGEVWMGKWRGE--KVAVKVFFTTE-EASWFRETEIYQTV 86
Query: 727 KIRHRNILKLYACLLKGGSS----FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIA 782
+RH NIL A +KG S +L+ +Y NG+L+ L LD K+A
Sbjct: 87 LMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT------LDAKSMLKLA 140
Query: 783 LGAAKGIAYLH-----HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSD 837
+ G+ +LH P I HRD+KS NIL+ ++ IAD G+A + D
Sbjct: 141 YSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVD 200
Query: 838 YSC--FAGTHGYIAPEL------AYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGK 889
GT Y+ PE+ + +D++SFG++L E+ +
Sbjct: 201 IPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGI--VEEY 258
Query: 890 DIVYWVSTHLNNHENVLKVLDCE----------VASESIKEDMIKLLKIAVVCTTKLPNL 939
+ Y + ++ + C +S+ M KL+ C P
Sbjct: 259 QLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMT---ECWAHNPAS 315
Query: 940 RPPMREVVKMLAD 952
R V K LA
Sbjct: 316 RLTALRVKKTLAK 328
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 1e-57
Identities = 78/308 (25%), Positives = 121/308 (39%), Gaps = 42/308 (13%)
Query: 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEI--LGKIR 729
A I LE +G G G+V+R + VAVK D K + E E+ +R
Sbjct: 7 ARDITLLE---CVGKGRYGEVWRGSWQGE--NVAVKIFSSRD-EKSWFRETELYNTVMLR 60
Query: 730 HRNILKLYACLLKGGSS----FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGA 785
H NIL A + S +L+ Y G+L+ L LD +I L
Sbjct: 61 HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT------LDTVSCLRIVLSI 114
Query: 786 AKGIAYLHHD-----CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSC 840
A G+A+LH + P I HRD+KS NIL+ ++ + IAD G+A + S D
Sbjct: 115 ASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGN 174
Query: 841 --FAGTHGYIAPEL------AYTCKVSEKSDVFSFGVVLLELVTGRKPVEEE------YG 886
GT Y+APE+ ++ D+++FG+VL E+ +
Sbjct: 175 NPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234
Query: 887 D--GKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMR 944
D D + + + + S+ + KL+K C + P+ R
Sbjct: 235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMK---ECWYQNPSARLTAL 291
Query: 945 EVVKMLAD 952
+ K L
Sbjct: 292 RIKKTLTK 299
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 3e-55
Identities = 77/314 (24%), Positives = 126/314 (40%), Gaps = 50/314 (15%)
Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEI--LGK 727
A I E IG G G+V+R + VAVK + + + E EI
Sbjct: 39 TIARTIVLQE---SIGKGRFGEVWRGKWRGE--EVAVKIFSSRE-ERSWFREAEIYQTVM 92
Query: 728 IRHRNILKLYACLLKGGSS----FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL 783
+RH NIL A K + +LV +Y +G+LF L++ + K+AL
Sbjct: 93 LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT------VTVEGMIKLAL 146
Query: 784 GAAKGIAYLHHD-----CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY 838
A G+A+LH + P I HRD+KS NIL+ ++ IAD G+A +++ D
Sbjct: 147 STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDI 206
Query: 839 SC--FAGTHGYIAPEL------AYTCKVSEKSDVFSFGVVLLELVTGRKPVE--EEYGDG 888
+ GT Y+APE+ + +++D+++ G+V E+ E+Y
Sbjct: 207 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY--- 263
Query: 889 KDIVY--WVSTHLNNHENVLKV--------LDCEVASESIKEDMIKLLKIAVVCTTKLPN 938
+ Y V + + E V + S M K+++ C
Sbjct: 264 -QLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR---ECWYANGA 319
Query: 939 LRPPMREVVKMLAD 952
R + K L+
Sbjct: 320 ARLTALRIKKTLSQ 333
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 2e-51
Identities = 98/442 (22%), Positives = 171/442 (38%), Gaps = 34/442 (7%)
Query: 123 LKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDE 182
L +T + + + +AL L T +L Q+ +L
Sbjct: 3 LGSATITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRL---G 57
Query: 183 AEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQK 242
+ + + L NLT + ++ L P + L +L + + N+I+ P + L
Sbjct: 58 IKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTN 113
Query: 243 LWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFS 302
L + L+ N +T P L NLT L ++SSN + + L +L F N +
Sbjct: 114 LTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTI--SDISALSGLTSLQQLS-FGNQVT 168
Query: 303 GEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRK 362
++ L I N+ S L + T L + + NQ S P +
Sbjct: 169 D--LKPLANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITPLGILTN-- 222
Query: 363 LLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFT 422
L+ L+L+ N + + A + L +++N +S P L L + L G N +
Sbjct: 223 -LDELSLNGN-QLKDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQIS 278
Query: 423 GGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQ 482
ISPL GL T+L+ L L N+ S + L NL L L NN S P + +L +
Sbjct: 279 N-ISPLAGL-TALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISP--VSSLTK 332
Query: 483 LSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLT 542
L L N ++ + + + I L+ N +S P L+ L+ + L L+ T
Sbjct: 333 LQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWT 388
Query: 543 GSIPDNLMKLKLSSIDLSENQL 564
+ + + + + +
Sbjct: 389 NAPVNYKANVSIPNTVKNVTGA 410
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 3e-49
Identities = 93/491 (18%), Positives = 182/491 (37%), Gaps = 36/491 (7%)
Query: 59 SPCGFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELS 118
+ I D+ + +++ +S + L +T L + +
Sbjct: 10 QDTPINQIFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVE 65
Query: 119 NCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDN 178
+NL +N + N + + L L L ++ N P + NLT L L++ +N
Sbjct: 66 YLNNLTQINFSNN-QLTDITPLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNN 122
Query: 179 VYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIR 238
+ + + NL NL L L+ + ++S L L L N+++ P +
Sbjct: 123 ---QITDIDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTDLKP--LA 174
Query: 239 KLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFK 298
L L ++++ +N ++ + L LT L+ ++NQ+ +G L NL
Sbjct: 175 NLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISD--ITPLGILTNLDELSLNG 230
Query: 299 NNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLC 358
N + L + N+ S L T LT++ + NQ S P L
Sbjct: 231 NQLKD--IGTLASLTNLTDLDLANNQISNL--APLSGLTKLTELKLGANQISNISP--LA 284
Query: 359 EKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGD 418
L NL N + ++ K + L + N++S P + +L + L F +
Sbjct: 285 GLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYN 340
Query: 419 NDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALG 478
N + +S L L T+++ L +N+ S + L LT + +L L + ++ +
Sbjct: 341 NKVSD-VSSLANL-TNINWLSAGHNQISD--LTPLANLTRITQLGLNDQAWTNAPVNYKA 396
Query: 479 ALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSG 538
+ +++ AL P + D + ++ N S S +
Sbjct: 397 NVSIPNTVKNVTGALI--APATISDGGSYTEPDITWNLPSYT-NEVSYTFSQPVTIGKGT 453
Query: 539 NKLTGSIPDNL 549
+G++ L
Sbjct: 454 TTFSGTVTQPL 464
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 4e-42
Identities = 97/387 (25%), Positives = 146/387 (37%), Gaps = 52/387 (13%)
Query: 187 ESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKI 246
+ L L N+ + ++L ++ TL R I + L L +I
Sbjct: 18 FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQI 73
Query: 247 ELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFP 306
N LT P L NLT L + +++NQ+ + NL NLT F N +
Sbjct: 74 NFSNNQLTDITP--LKNLTKLVDILMNNNQI--ADITPLANLTNLTGLTLFNNQITD--- 126
Query: 307 SGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNL 366
+ L T L +++S N S L L
Sbjct: 127 -----------------------IDPLKNLTNLNRLELSSNTISD--ISALSGLTSL-QQ 160
Query: 367 LALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGIS 426
L+ N + P + T++RL IS N +S L L N+ L +N + I+
Sbjct: 161 LSFGNQVTDLKPLAN--LTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISD-IT 215
Query: 427 PLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSL 486
PL L T+L +L L N+ L LTNL L L NN S P L L +L+ L
Sbjct: 216 PLGIL-TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTEL 270
Query: 487 HLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIP 546
L N ++ P + + +L L N L P +S L +L L L N ++ P
Sbjct: 271 KLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP 326
Query: 547 DNLMKLKLSSIDLSENQLSGSVPLDFL 573
+ + KL + N++S L L
Sbjct: 327 VSSLT-KLQRLFFYNNKVSDVSSLANL 352
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 5e-33
Identities = 91/357 (25%), Positives = 142/357 (39%), Gaps = 51/357 (14%)
Query: 219 LGTLDICR-NKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQM 277
LG+ I + I+ F L + K L N+T + +L +
Sbjct: 3 LGSATITQDTPINQIFT--DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLG- 57
Query: 278 YGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYT 337
K + + L NLT N + + ++ KL + N+ + L T
Sbjct: 58 -IKSIDGVEYLNNLTQINFSNNQLTD--ITPLKNLTKLVDILMNNNQIADI--TPLANLT 112
Query: 338 ALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHL 397
LT + + NQ + ++ L N + RL +S N +
Sbjct: 113 NLTGLTLFNNQIT--------------DIDPLKN------------LTNLNRLELSSNTI 146
Query: 398 SGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLT 457
S L L ++ L FG+ + PL L T+L +L + +N+ S S L +LT
Sbjct: 147 SD--ISALSGLTSLQQLSFGNQVT--DLKPLANL-TTLERLDISSNKVSD--ISVLAKLT 199
Query: 458 NLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSL 517
NLE LI TNN S P LG L L L L N L + + DL+LA N +
Sbjct: 200 NLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQI 255
Query: 518 SGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSGSVPLDFLR 574
S P LS L+ L L L N+++ P + L++++L+ENQL P+ L+
Sbjct: 256 SNLAP--LSGLTKLTELKLGANQISNISPLAGLT-ALTNLELNENQLEDISPISNLK 309
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 3e-49
Identities = 90/485 (18%), Positives = 170/485 (35%), Gaps = 73/485 (15%)
Query: 88 EISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLE 147
E+ ++S T ++ P + V + +
Sbjct: 25 EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDC----------LDRQAH 74
Query: 148 IFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRG 207
+L+ + P L SL N E+PE +LK+L L
Sbjct: 75 ELELNNLGLS-SLPE---LPPHLESLVASCN--SLTELPELPQSLKSLLVDNNNLKAL-- 126
Query: 208 RIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLL 267
+ L L + N++ + P ++ L I++ N+L +LP +L +
Sbjct: 127 --SDLPPLLEY---LGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK-KLPDLPPSLEFI 178
Query: 268 QEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSG 327
+NQ+ +LP E+ NL LT N+ + P + + N
Sbjct: 179 ---AAGNNQL-EELP-ELQNLPFLTAIYADNNSLK-KLPDLPLSLESI---VAGNNILE- 228
Query: 328 PFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTI 387
L LT + N + P L L + +N+ ++P +++
Sbjct: 229 -ELPELQNLPFLTTIYADNNLLK-TLPDLPPS----LEALNVRDNYLTDLPEL---PQSL 279
Query: 388 QRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSG 447
L +S+N S + + PN+ L+ N+ I L L SL +L + NN+
Sbjct: 280 TFLDVSENIFS-GLSEL---PPNLYYLNASSNE----IRSLCDLPPSLEELNVSNNKLI- 330
Query: 448 ELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARI 507
ELP+ LERLI + N+ + ++P L+ LH+E N L P+
Sbjct: 331 ELPALPP---RLERLIASFNHLA-EVPELPQNLK---QLHVEYNPLR-EFPDIPE----- 377
Query: 508 VDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSGS 567
++ ++ ++ L +L L++ N L PD ++ + ++ ++
Sbjct: 378 ---SVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPESVE--DLRMNSERVVDP 431
Query: 568 VPLDF 572
Sbjct: 432 YEFAH 436
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 5e-43
Identities = 88/477 (18%), Positives = 166/477 (34%), Gaps = 70/477 (14%)
Query: 76 TEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCS---------NLKVL 126
TE + + V L + LEL+N +L+ L
Sbjct: 37 TEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLPELPPHLESL 96
Query: 127 NVTGNAMVGSVPD-LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEI 185
+ N++ +P+ +LK+L + + ++ + L L + +N ++
Sbjct: 97 VASCNSLT-ELPELPQSLKSLLVDNNNLKALSD-------LPPLLEYLGVSNN--QLEKL 146
Query: 186 PESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWK 245
PE + N L + + + +L+ ++P+ L + N++ E P ++ L L
Sbjct: 147 PE-LQNSSFLKIIDVDNNSLK-KLPDLPPSLEFI---AAGNNQLE-ELP-ELQNLPFLTA 199
Query: 246 IELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEF 305
I N+L +LP +L + +N + + E+ NL LT N
Sbjct: 200 IYADNNSLK-KLPDLPLSLESI---VAGNNIL--EELPELQNLPFLTTIYADNNLLK-TL 252
Query: 306 PSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLN 365
P + L + N + PE LT +D+SEN FS + L
Sbjct: 253 PDLPPSLEALN---VRDNYLTD-LPELPQS---LTFLDVSENIFS-GLSELPPN----LY 300
Query: 366 LLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGI 425
L S+N + + +++ L +S+N L ++P P + L N +
Sbjct: 301 YLNASSNEIRSLCDL---PPSLEELNVSNNKLI-ELPA---LPPRLERLIASFNHLAE-V 352
Query: 426 SPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSS 485
L +L QL ++ N E P + +L N+ ++P L+
Sbjct: 353 PELPQ---NLKQLHVEYNPLR-EFPDIPESVEDL-----RMNSHLAEVPELPQNLK---Q 400
Query: 486 LHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLT 542
LH+E N L P+ + DL + + + L +
Sbjct: 401 LHVETNPLR-EFPDIPE---SVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-38
Identities = 82/422 (19%), Positives = 153/422 (36%), Gaps = 59/422 (13%)
Query: 73 GRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNA 132
+ + SL+ E+ +L+SL V + LS L+ L V+ N
Sbjct: 91 PHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALS-------DLPPLLEYLGVSNNQ 142
Query: 133 MVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNL 192
+ +P+L L+I D+ N + P L ++ G+N +E +PE + NL
Sbjct: 143 LE-KLPELQNSSFLKIIDVDNNSLK-KLPDL---PPSLEFIAAGNNQLEE--LPE-LQNL 194
Query: 193 KNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANN 252
LT ++ + +L+ ++P+ L + N + ++ L L I N
Sbjct: 195 PFLTAIYADNNSLK-KLPDLPLSLESI---VAGNNILE--ELPELQNLPFLTTIYADNNL 248
Query: 253 LTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDM 312
L LP +L L ++ N + LPE +L L V + + S P+
Sbjct: 249 LK-TLPDLPPSLEAL---NVRDNYL-TDLPELPQSLTFLDVSENIFSGLSELPPN----- 298
Query: 313 RKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNN 372
L+ + N + L ++++S N+ P L L S N
Sbjct: 299 --LYYLNASSNEIRS-LCDLPPS---LEELNVSNNKLI-ELPALPPR----LERLIASFN 347
Query: 373 FSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLS 432
EVP + +++L + N L + PD ++ + L + ++ + L
Sbjct: 348 HLAEVPEL---PQNLKQLHVEYNPLR-EFPDIPESVED---LRMNSH-----LAEVPELP 395
Query: 433 TSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENA 492
+L QL ++ N E P + +L + + A +L E +
Sbjct: 396 QNLKQLHVETNPLR-EFPDIPESVEDLR---MNSERVVDPYEFAHETTDKLEDDVFEHHH 451
Query: 493 LT 494
Sbjct: 452 HH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-19
Identities = 43/208 (20%), Positives = 73/208 (35%), Gaps = 29/208 (13%)
Query: 358 CEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFG 417
L L S+N + E+P + K+ + + P G + +
Sbjct: 8 VSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLR 66
Query: 418 DNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSAL 477
D L +L L N S LP +LE L+ + N+ + ++P
Sbjct: 67 DC-----------LDRQAHELELNNLGLS-SLPELPP---HLESLVASCNSLT-ELPELP 110
Query: 478 GALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLS 537
+L+ L + AL+ P + L ++ N L +P L S L +++
Sbjct: 111 QSLKSLLVDNNNLKALSDLPPL-------LEYLGVSNNQLE-KLP-ELQNSSFLKIIDVD 161
Query: 538 GNKLTGSIPDNLMKLKLSSIDLSENQLS 565
N L +PD L+ I NQL
Sbjct: 162 NNSLK-KLPDLPPSLE--FIAAGNNQLE 186
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 4e-15
Identities = 34/171 (19%), Positives = 57/171 (33%), Gaps = 37/171 (21%)
Query: 425 ISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALR--- 481
I+P +T L + + ++ + E+P E + + + + P G R
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 482 ----------QLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSL 531
Q L L L+ S+P + L + NSL+ +P L SL
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLS-SLPELPPH---LESLVASCNSLT-ELPELPQSLKSL 116
Query: 532 NALNLSGNKLTGSIPDNLMKLKLS-----------------SIDLSENQLS 565
N + L+ +P L L +S ID+ N L
Sbjct: 117 LVDNNNLKALS-DLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK 166
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 1e-47
Identities = 97/523 (18%), Positives = 188/523 (35%), Gaps = 34/523 (6%)
Query: 75 VTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMV 134
+ L S S + L VL L + + S+L L +TGN +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 135 GSVPD-LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLK 193
S L +L+ + +L L L++ N+ ++PE NL
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 194 NLTYLFLAHCNLRGRIPESISELREL----GTLDICRNKISGEFPRSIRKLQKLWKIELY 249
NL +L L+ ++ + L ++ +LD+ N ++ K +L K+ L
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLR 208
Query: 250 ANNLTGELPAE-LGNLTLLQEFDI------SSNQMYGKLPEEIGNLKNLTVFQ---CFKN 299
N + + + L L+ + + + + L NLT+ + + +
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD 268
Query: 300 NFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCE 359
+ + F + + +FS+ ++ +++ +F L
Sbjct: 269 YYLDDIIDLFNCLTNVSSFSLVSVTIERV--KDFSYNFGWQHLELVNCKFGQFPTLKLKS 326
Query: 360 KRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLS--GKIPDGLWALPNVGMLDFG 417
L L ++N G + D +++ L +S N LS G + ++ LD
Sbjct: 327 ----LKRLTFTSNKGGNAFSE-VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLS 381
Query: 418 DNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSE--LGRLTNLERLILTNNNFSGKIPS 475
N +S L L Q++ ++ L NL L +++ +
Sbjct: 382 FNGVIT-MSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNG 439
Query: 476 ALGALRQLSSLHLEENALTGSIPNEM-GDCARIVDLNLARNSLSGNIPRSLSLLSSLNAL 534
L L L + N+ + ++ + + L+L++ L P + + LSSL L
Sbjct: 440 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 499
Query: 535 NLSGNKLTGSIPDNLMKL--KLSSIDLSENQLSGSVP-LDFLR 574
N++ N+L S+PD + L I L N S P +D+L
Sbjct: 500 NMASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLS 541
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 3e-40
Identities = 79/460 (17%), Positives = 154/460 (33%), Gaps = 44/460 (9%)
Query: 145 NLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCN 204
+ + DLS N + +L L + E + +L +L+ L L
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIE-DGAYQSLSHLSTLILTGNP 87
Query: 205 LRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLT-GELPAELGN 263
++ + S L L L ++ I L+ L ++ + N + +LP N
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 264 LTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQC---FKNNFSGEFPSGFGDMRKLFAFSI 320
LT L+ D+SSN++ ++ L + + N G +L ++
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTL 207
Query: 321 YGNRFSGPFPENLGRY-TALTDVDISENQFSG---------SFPKYLCEKRKLLNLLALS 370
N S + + L + +F S + LC LA
Sbjct: 208 RNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 267
Query: 371 NNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDG--LWALPNVGMLDFGDNDFT------ 422
+ + ++ + + + + + ++ D + ++ +++ F
Sbjct: 268 DYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNCKFGQFPTLKLKS 326
Query: 423 -----------GGISPLIGLSTSLSQLVLQNNR--FSGELPSELGRLTNLERLILTNNNF 469
G + L SL L L N F G T+L+ L L+ N
Sbjct: 327 LKRLTFTSNKGGNAFSEVDL-PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGV 385
Query: 470 SGKIPSALGALRQLSSLHLEENALTGSIPNE--MGDCARIVDLNLARNSLSGNIPRSLSL 527
+ S L QL L + + L + ++ L+++ +
Sbjct: 386 I-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG 443
Query: 528 LSSLNALNLSGNKLTGSIPDN-LMKL-KLSSIDLSENQLS 565
LSSL L ++GN + + +L L+ +DLS+ QL
Sbjct: 444 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 483
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 3e-19
Identities = 30/145 (20%), Positives = 49/145 (33%), Gaps = 2/145 (1%)
Query: 430 GLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLE 489
L S L L N L+ L L+ A +L LS+L L
Sbjct: 25 NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILT 84
Query: 490 ENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLT-GSIPDN 548
N + + + L +L+ + L +L LN++ N + +P+
Sbjct: 85 GNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144
Query: 549 LMKL-KLSSIDLSENQLSGSVPLDF 572
L L +DLS N++ D
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDL 169
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 4e-46
Identities = 94/488 (19%), Positives = 185/488 (37%), Gaps = 31/488 (6%)
Query: 98 SLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD-LSALKNLEIFDLSINYF 156
++ L L FN ++ +L C+NL+VL + + + D +L +LE DLS N+
Sbjct: 27 AMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHL 86
Query: 157 TGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPE-SISE 215
+ W L+ L L++ N Y + NL NL L + + I +
Sbjct: 87 SSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAG 146
Query: 216 LRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSN 275
L L L+I + +S++ ++ + + L+ + L L+ ++ ++
Sbjct: 147 LTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDT 206
Query: 276 QMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGR 335
+ + + + + S F ++ KL + + + F +
Sbjct: 207 NLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVE--FDDC--T 262
Query: 336 YTALTDVDISENQFSGSFPKYLCEKRKLLNLLALS---NNFSGEVPNSYADCKTIQRLRI 392
L D + SE+ K + + + L ++ Y+ + ++R+ +
Sbjct: 263 LNGLGDFNPSESDVVSELGKV-----ETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITV 317
Query: 393 SDNHLSGKIPDGLWA-LPNVGMLDFGDNDFTGGI---SPLIGLSTSLSQLVLQNNRFS-- 446
++ + +P L ++ LD +N S G SL LVL N
Sbjct: 318 ENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSM 376
Query: 447 GELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCAR 506
+ L L NL L ++ N F +P + ++ L+L + + +
Sbjct: 377 QKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQ--T 432
Query: 507 IVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSG 566
+ L+++ N+L + L L L +S NKL ++PD + L + +S NQL
Sbjct: 433 LEVLDVSNNNLD-SFSLF---LPRLQELYISRNKLK-TLPDASLFPVLLVMKISRNQLK- 486
Query: 567 SVPLDFLR 574
SVP
Sbjct: 487 SVPDGIFD 494
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-35
Identities = 66/418 (15%), Positives = 137/418 (32%), Gaps = 32/418 (7%)
Query: 184 EIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKL 243
IP + + L L+ + + L L + ++I+ + L L
Sbjct: 19 SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSL 76
Query: 244 WKIELYANNLTGELPAELGNLTLLQEFDISSNQMYG-KLPEEIGNLKNLTVFQCFKNNFS 302
++L N+L+ + G L+ L+ ++ N + NL NL +
Sbjct: 77 EHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETF 136
Query: 303 GEFPSG-FGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKR 361
E F + L I ++L + + + ++ + + +
Sbjct: 137 SEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADIL 195
Query: 362 KLLNLLALSNN---------FSGEVPNSYADCKTIQRLRISDNHLSG--KIPDGLWALPN 410
+ L L + + +S + ++D + K+ + L
Sbjct: 196 SSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSE 255
Query: 411 VGMLDFGDNDFT-------GGISPLIGLST-SLSQLVLQNNRFSGELPSELGRLTNLERL 462
V D N +S L + T ++ +L + +L + L ++R+
Sbjct: 256 VEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRI 315
Query: 463 ILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEM---GDCARIVDLNLARNSLS- 518
+ N+ S L+ L L L EN + G + L L++N L
Sbjct: 316 TVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRS 375
Query: 519 -GNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLSENQLSGSVPLDFLR 574
L L +L +L++S N +PD+ K+ ++LS + V +
Sbjct: 376 MQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQ 431
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 6e-35
Identities = 82/455 (18%), Positives = 150/455 (32%), Gaps = 27/455 (5%)
Query: 96 LQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGN--AMVGSVPDLSALKNLEIFDLSI 153
L SL L L N LS S+LK LN+ GN +G L NL+ +
Sbjct: 73 LGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGN 132
Query: 154 NYFTGRFPRWV-VNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPES 212
R LT L L I + +S+ +++++ +L L +
Sbjct: 133 VETFSEIRRIDFAGLTSLNELEIKALSLRNYQ-SQSLKSIRDIHHLTLHLSESAFLLEIF 191
Query: 213 ISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDI 272
L + L++ ++ + + ++ A + L L + +
Sbjct: 192 ADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYIL 251
Query: 273 SSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPEN 332
++ + + L L F +++ E + + I
Sbjct: 252 ELSE----VEFDDCTLNGLGDFNPSESDVVSELG--KVETVTIRRLHIPQFYLFYDLSTV 305
Query: 333 LGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEV----PNSYADCKTIQ 388
+ + + ++ P + K L L LS N E ++Q
Sbjct: 306 YSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQ 364
Query: 389 RLRISDNHLS--GKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFS 446
L +S NHL K + L L N+ LD N F + + L L +
Sbjct: 365 TLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHP-MPDSCQWPEKMRFLNLSSTGIR 423
Query: 447 GELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCAR 506
+ + + LE L ++NNN L L+ L++ N L ++P+
Sbjct: 424 -VVKTCI--PQTLEVLDVSNNNLD-SFSLFLPRLQ---ELYISRNKLK-TLPDASL-FPV 474
Query: 507 IVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKL 541
++ + ++RN L L+SL + L N
Sbjct: 475 LLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-29
Identities = 70/428 (16%), Positives = 141/428 (32%), Gaps = 37/428 (8%)
Query: 90 SSSISALQSLTVLSLPFNVLSG-KLPLELSNCSNLKVLNVTGNAMVGSVP--DLSALKNL 146
SS L SL L+L N + N +NL+ L + + D + L +L
Sbjct: 91 SSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSL 150
Query: 147 EIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLR 206
++ + + ++ + L++ + L ++ YL L NL
Sbjct: 151 NELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLL-EIFADILSSVRYLELRDTNLA 209
Query: 207 GRIPESISELRELGTLDICRNKIS-------GEFPRSIRKLQKLWKIELYANNLTG---- 255
+ + + S E + +R + +L ++E L G
Sbjct: 210 RFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDF 269
Query: 256 -----ELPAELGNLTL--LQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSG 308
++ +ELG + ++ I ++ L L+ + + S
Sbjct: 270 NPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSF 329
Query: 309 FGDMRKLFAFSIYGNRFSGPFPEN---LGRYTALTDVDISENQFSGSFPKYLCEKRKLLN 365
++ L + N + +N G + +L + +S+N S K L N
Sbjct: 330 SQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKTGEILLTLKN 388
Query: 366 L--LALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTG 423
L L +S N +P+S + ++ L +S + + + + +LD +N+
Sbjct: 389 LTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLDS 445
Query: 424 GISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQL 483
L L +L + N+ LP L + ++ N L L
Sbjct: 446 FSLFL----PRLQELYISRNKLK-TLPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSL 499
Query: 484 SSLHLEEN 491
+ L N
Sbjct: 500 QKIWLHTN 507
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-23
Identities = 70/412 (16%), Positives = 141/412 (34%), Gaps = 57/412 (13%)
Query: 81 DNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMV----GS 136
+ ++ S + L SL L + L L + ++ L + +
Sbjct: 132 NVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIF 191
Query: 137 VPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDE---AEIPESIGNLK 193
LS+++ LE+ D ++ F + + L+ +V + E+ + + +
Sbjct: 192 ADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYIL 251
Query: 194 NLTYLFLAHCNLRG------RIPESISELRELGT-----LDICRNKISGEFPRSIRKLQK 242
L+ + C L G + +SEL ++ T L I + + + L+K
Sbjct: 252 ELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEK 311
Query: 243 LWKIELYANNLTGELPAELGNLTLLQEFDISSNQM---YGKLPEEIGNLKNLTVFQCFKN 299
+ +I + + + + +L L+ D+S N M Y K G +L +N
Sbjct: 312 VKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQN 371
Query: 300 NFS--GEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYL 357
+ + ++ L + I N F P P++ + +++S +
Sbjct: 372 HLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI 429
Query: 358 CEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFG 417
+ L +L +SNN +Q L IS N L +PD
Sbjct: 430 PQT---LEVLDVSNNNLDSFSLFL---PRLQELYISRNKLK-TLPDA------------- 469
Query: 418 DNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNF 469
L L + + N+ RLT+L+++ L N +
Sbjct: 470 ------------SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-44
Identities = 78/399 (19%), Positives = 149/399 (37%), Gaps = 57/399 (14%)
Query: 170 LVSLSIGDNVYDEAEIP--ESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRN 227
+L+ I +L L ++ + EL + L +
Sbjct: 2 AATLATLPA-----PINQIFPDADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGE 54
Query: 228 KISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGN 287
K++ + I L L + L N +T P L NL L I +N++ + N
Sbjct: 55 KVAS--IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQN 108
Query: 288 LKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISEN 347
L NL ++N S S ++ K+++ ++ N L T L + ++E+
Sbjct: 109 LTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTES 165
Query: 348 QFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWA 407
+ ++ ++N + L ++ N + P L +
Sbjct: 166 KVK--------------DVTPIAN------------LTDLYSLSLNYNQIEDISP--LAS 197
Query: 408 LPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNN 467
L ++ N T I+P+ + T L+ L + NN+ + S L L+ L L + N
Sbjct: 198 LTSLHYFTAYVNQITD-ITPVANM-TRLNSLKIGNNKITD--LSPLANLSQLTWLEIGTN 253
Query: 468 NFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSL 527
S +A+ L +L L++ N ++ I + + +++ L L N L +
Sbjct: 254 QISD--INAVKDLTKLKMLNVGSNQIS-DISV-LNNLSQLNSLFLNNNQLGNEDMEVIGG 309
Query: 528 LSSLNALNLSGNKLTGSIP-DNLMKLKLSSIDLSENQLS 565
L++L L LS N +T P +L K+ S D + +
Sbjct: 310 LTNLTTLFLSQNHITDIRPLASLSKMD--SADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 6e-43
Identities = 76/420 (18%), Positives = 144/420 (34%), Gaps = 75/420 (17%)
Query: 123 LKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDE 182
L + + + L L T L + L + +
Sbjct: 2 AATLATLPAP-INQIFPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGE---K 55
Query: 183 AEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQK 242
+ I L NL YL L + P +S L +L L I NKI+ +++ L
Sbjct: 56 VASIQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD--ISALQNLTN 111
Query: 243 LWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFS 302
L ++ L +N++ + L NLT + ++ +N + N+ L ++
Sbjct: 112 LRELYLNEDNISD--ISPLANLTKMYSLNLGANHN-LSDLSPLSNMTGLNYLTVTESKVK 168
Query: 303 GEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRK 362
+ ++ L++ S+ N+ L T+L NQ +
Sbjct: 169 D--VTPIANLTDLYSLSLNYNQIEDI--SPLASLTSLHYFTAYVNQIT------------ 212
Query: 363 LLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFT 422
++ ++N + L+I +N ++ L L + L+ G N +
Sbjct: 213 --DITPVAN------------MTRLNSLKIGNNKITD--LSPLANLSQLTWLEIGTNQIS 256
Query: 423 GGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQ 482
I+ + L T L L + +N+ S S L L+ L L L NN + +G L
Sbjct: 257 D-INAVKDL-TKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTN 312
Query: 483 LSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLT 542
L++L L +N +T P L+ LS +++ + + +
Sbjct: 313 LTTLFLSQNHITDIRP--------------------------LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-42
Identities = 80/356 (22%), Positives = 147/356 (41%), Gaps = 26/356 (7%)
Query: 219 LGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMY 278
TL I+ FP L + + L ++T + L + + ++ ++
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKV- 56
Query: 279 GKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTA 338
+ I L NL N + S ++ KL I N+ + L T
Sbjct: 57 -ASIQGIEYLTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKITDI--SALQNLTN 111
Query: 339 LTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLS 398
L ++ ++E+ S P L K+ +L L N + + ++ + L ++++ +
Sbjct: 112 LRELYLNEDNISDISP--LANLTKMYSL-NLGANHNLSDLSPLSNMTGLNYLTVTESKVK 168
Query: 399 GKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTN 458
P + L ++ L N ISPL L TSL N+ + + + +T
Sbjct: 169 DVTP--IANLTDLYSLSLNYNQIED-ISPLASL-TSLHYFTAYVNQITD--ITPVANMTR 222
Query: 459 LERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLS 518
L L + NN + S L L QL+ L + N ++ N + D ++ LN+ N +S
Sbjct: 223 LNSLKIGNNKITD--LSPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQIS 278
Query: 519 GNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLSENQLSGSVPLDFL 573
+I L+ LS LN+L L+ N+L + + L L+++ LS+N ++ PL L
Sbjct: 279 -DIS-VLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLASL 332
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 6e-39
Identities = 75/388 (19%), Positives = 136/388 (35%), Gaps = 49/388 (12%)
Query: 59 SPCGFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELS 118
P + I D+ S++ ++ L+S+T L + ++ + +
Sbjct: 8 LPAPINQIFPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SIQ-GIE 63
Query: 119 NCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDN 178
+NL+ LN+ GN + + LS L L + N T + NLT L L + ++
Sbjct: 64 YLTNLEYLNLNGNQ-ITDISPLSNLVKLTNLYIGTNKITD--ISALQNLTNLRELYLNED 120
Query: 179 VYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIR 238
+ NL + L L + +S + L L + +K+ P I
Sbjct: 121 ---NISDISPLANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKDVTP--IA 174
Query: 239 KLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFK 298
L L+ + L N + P L +LT L F NQ+ + N+ L +
Sbjct: 175 NLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD--ITPVANMTRLNSLKIGN 230
Query: 299 NNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLC 358
N + S ++ +L I N+ S + T L +++ NQ S
Sbjct: 231 NKITD--LSPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQIS-------- 278
Query: 359 EKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGD 418
++ L+N + L +++N L + + + L N+ L
Sbjct: 279 ------DISVLNN------------LSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQ 320
Query: 419 NDFTGGISPLIGLSTSLSQLVLQNNRFS 446
N T I PL L + + N
Sbjct: 321 NHIT-DIRPLASL-SKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 8e-19
Identities = 40/188 (21%), Positives = 78/188 (41%), Gaps = 14/188 (7%)
Query: 388 QRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSG 447
L ++ PD L T + L S+++LV+ + +
Sbjct: 3 ATLATLPAPINQIFPDA--DLAEGIRAVLQKASVTD-VVTQEEL-ESITKLVVAGEKVAS 58
Query: 448 ELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARI 507
+ LTNLE L L N + P L L +L++L++ N +T + + + +
Sbjct: 59 --IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNL 112
Query: 508 VDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLSENQLSG 566
+L L +++S P L+ L+ + +LNL N S L + L+ + ++E+++
Sbjct: 113 RELYLNEDNISDISP--LANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKD 169
Query: 567 SVPLDFLR 574
P+ L
Sbjct: 170 VTPIANLT 177
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 46.0 bits (110), Expect = 4e-05
Identities = 21/94 (22%), Positives = 40/94 (42%), Gaps = 9/94 (9%)
Query: 483 LSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLT 542
++L + P+ D A + L + S++ + L S+ L ++G K+
Sbjct: 2 AATLATLPAPINQIFPDA--DLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 543 GSIPD--NLMKLKLSSIDLSENQLSGSVPLDFLR 574
SI L L+ ++L+ NQ++ PL L
Sbjct: 58 -SIQGIEYLTNLE--YLNLNGNQITDISPLSNLV 88
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 3e-43
Identities = 73/298 (24%), Positives = 120/298 (40%), Gaps = 52/298 (17%)
Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILG 726
++ E + E+ IG G G+V+ L+ + VAVK + D F E IL
Sbjct: 111 LNHEDLVLGEQ---IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILK 167
Query: 727 KIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAA 786
+ H NI++L + ++V+E + G+ L L ++ AA
Sbjct: 168 QYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE----GARLRVKTLLQMVGDAA 223
Query: 787 KGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHG 846
G+ YL S IHRD+ + N L+ E KI+DFG+++ + Y+ G
Sbjct: 224 AGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD----GVYAASGGL-R 275
Query: 847 YI-----APELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLN 900
+ APE + S +SDV+SFG++L E + G P Y +L+
Sbjct: 276 QVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASP------------YP---NLS 320
Query: 901 NHENVLKV-----LDC-EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952
N + V L C E+ +++ M + C P RP + + L
Sbjct: 321 NQQTREFVEKGGRLPCPELCPDAVFRLMEQ-------CWAYEPGQRPSFSTIYQELQS 371
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 4e-43
Identities = 48/370 (12%), Positives = 99/370 (26%), Gaps = 54/370 (14%)
Query: 183 AEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQK 242
+ L+ + +S+ + D R +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNN 57
Query: 243 LWKIELYANNLTGELPAELGNLTL--LQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNN 300
L L + T ++ S + + P++ L +L
Sbjct: 58 PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPL-PQFPDQAFRLSHLQHMTIDAAG 115
Query: 301 FSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEK 360
E P L ++ N P ++ L ++ I P+ L
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLAST 173
Query: 361 RKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDND 420
L N +Q LR+ + +P + L
Sbjct: 174 DASGEHQGLVN---------------LQSLRLEWTGIR-SLPASIANL------------ 205
Query: 421 FTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGAL 480
+L L ++N+ S L + L LE L L P G
Sbjct: 206 ------------QNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGR 252
Query: 481 RQLSSLHLEE-NALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGN 539
L L L++ + L ++P ++ ++ L+L +P ++ L + + + +
Sbjct: 253 APLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH 311
Query: 540 KLTGSIPDNL 549
+ +
Sbjct: 312 LQA-QLDQHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-35
Identities = 54/329 (16%), Positives = 104/329 (31%), Gaps = 29/329 (8%)
Query: 96 LQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINY 155
L + LS + + + N +I +
Sbjct: 11 SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSN---NPQIETRTGRA 67
Query: 156 FTGRFPRWVVNLTQ--LVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESI 213
+ + TQ V+L + + P+ L +L ++ + L +P+++
Sbjct: 68 LK-ATADLLEDATQPGRVALELRSV--PLPQFPDQAFRLSHLQHMTIDAAGLM-ELPDTM 123
Query: 214 SELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTL------- 266
+ L TL + RN + P SI L +L ++ + A ELP L +
Sbjct: 124 QQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGL 182
Query: 267 --LQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNR 324
LQ + + LP I NL+NL + + S + KL + G
Sbjct: 183 VNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCT 240
Query: 325 FSGPFPENLGRYTALTDVDISE-NQFSGSFPKYLCEKRKLLNL--LALSNNFS-GEVPNS 380
+P G L + + + + + P + +L L L L + +P+
Sbjct: 241 ALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIH---RLTQLEKLDLRGCVNLSRLPSL 296
Query: 381 YADCKTIQRLRISDNHLSGKIPDGLWALP 409
A + + + + A P
Sbjct: 297 IAQLPANCIILVPPHLQAQLDQHRPVARP 325
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 43/216 (19%), Positives = 74/216 (34%), Gaps = 38/216 (17%)
Query: 88 EISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD-------- 139
E+ ++ L L+L N L LP +++ + L+ L++ + +P+
Sbjct: 118 ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDAS 176
Query: 140 --LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTY 197
L NL+ L P + NL L SL I ++ + + +I +L L
Sbjct: 177 GEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPL--SALGPAIHHLPKLEE 233
Query: 198 LFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGEL 257
L L C P L L + +NL L
Sbjct: 234 LDLRGCTALRNYPPIFGGRAPLKRLILKDC-----------------------SNLL-TL 269
Query: 258 PAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTV 293
P ++ LT L++ D+ +LP I L +
Sbjct: 270 PLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCI 305
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 38/184 (20%), Positives = 66/184 (35%), Gaps = 14/184 (7%)
Query: 88 EISSSISALQSLTVL---------SLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVP 138
+ +SI++L L L LP + S E NL+ L + + S+P
Sbjct: 141 ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLP 199
Query: 139 D-LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTY 197
++ L+NL+ + + + + +L +L L + P G L
Sbjct: 200 ASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALR-NYPPIFGGRAPLKR 257
Query: 198 LFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGEL 257
L L C+ +P I L +L LD+ P I +L I + +L +L
Sbjct: 258 LILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVP-PHLQAQL 316
Query: 258 PAEL 261
Sbjct: 317 DQHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 1e-05
Identities = 14/81 (17%), Positives = 29/81 (35%), Gaps = 3/81 (3%)
Query: 76 TEISFDNKSLSGEISSSISALQSLTVLSLP-FNVLSGKLPLELSNCSNLKVLNVTGNAMV 134
E+ + L L L + L LPL++ + L+ L++ G +
Sbjct: 232 EELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNL 290
Query: 135 GSVPD-LSALKNLEIFDLSIN 154
+P ++ L I + +
Sbjct: 291 SRLPSLIAQLPANCIILVPPH 311
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 3e-40
Identities = 73/278 (26%), Positives = 115/278 (41%), Gaps = 42/278 (15%)
Query: 681 DNLIGSGGTGKVYR-LDLKKNAGTVAVKQL----WKGDGVKVFAAEMEILGKIRHRNILK 735
D IG G VY+ LD + VA +L + F E E+L ++H NI++
Sbjct: 31 DIEIGRGSFKTVYKGLDTETTV-EVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 736 LYACLLKGGSS----FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRY--KIALGAAKGI 789
Y LV E M +G L L + ++ R + +I KG+
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQIL----KGL 142
Query: 790 AYLHHDCSPPIIHRDIKSSNILLD-EDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
+LH +PPIIHRD+K NI + KI D G+A + S + GT ++
Sbjct: 143 QFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPEFM 197
Query: 849 APELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKV 908
APE+ Y K E DV++FG+ +LE+ T P Y + N + +
Sbjct: 198 APEM-YEEKYDESVDVYAFGMCMLEMATSEYP----YSE-----------CQNAAQIYRR 241
Query: 909 LDCEVASESIKEDMIKLLK-IAVVCTTKLPNLRPPMRE 945
+ V S + I +K I C + + R +++
Sbjct: 242 VTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKD 279
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-39
Identities = 60/233 (25%), Positives = 105/233 (45%), Gaps = 33/233 (14%)
Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIR 729
+D + +E LIGSGG G+V++ + + T +K++ + + E++ L K+
Sbjct: 5 VDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--EKAEREVKALAKLD 62
Query: 730 HRNILKLYAC----------------LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPE- 772
H NI+ C K F+ +E+ G L Q + KR E +
Sbjct: 63 HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122
Query: 773 --LDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830
L+ F + KG+ Y+H S +I+RD+K SNI L + + KI DFG+ +
Sbjct: 123 LALELFEQ------ITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLK 173
Query: 831 NSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEE 883
N + GT Y++PE + ++ D+++ G++L EL+ E
Sbjct: 174 ND---GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE 223
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-39
Identities = 72/293 (24%), Positives = 125/293 (42%), Gaps = 44/293 (15%)
Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV--FAAEMEILGK 727
++ I + +G G G+VY KK + TVAVK L K D ++V F E ++ +
Sbjct: 217 MERTDITMKHK---LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKE 272
Query: 728 IRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAK 787
I+H N+++L + +++ E+M GNL L + + E+ +A +
Sbjct: 273 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISS 329
Query: 788 GIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP-KVSDYSCFAGTHG 846
+ YL IHR++ + N L+ E++ K+ADFG++++ + F
Sbjct: 330 AMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-- 384
Query: 847 YIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENV 905
+ APE K S KSDV++FGV+L E+ T G P Y ++ +
Sbjct: 385 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP------------YP---GIDLSQVY 429
Query: 906 LKV-----LDC-EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952
+ ++ E E + E M C P+ RP E+ +
Sbjct: 430 ELLEKDYRMERPEGCPEKVYELMRA-------CWQWNPSDRPSFAEIHQAFET 475
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-39
Identities = 73/295 (24%), Positives = 125/295 (42%), Gaps = 54/295 (18%)
Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIR 729
++ +++ L+ IG G G V D + N VAVK + + F AE ++ ++R
Sbjct: 190 LNMKELKLLQT---IGKGEFGDVMLGDYRGN--KVAVKCIKNDATAQAFLAEASVMTQLR 244
Query: 730 HRNILKLYA-CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
H N+++L + + G ++V EYM G+L L R G+ L K +L +
Sbjct: 245 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEA 301
Query: 789 IAYL-HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGY 847
+ YL ++ +HRD+ + N+L+ ED K++DFG+ K S
Sbjct: 302 MEYLEGNNF----VHRDLAARNVLVSEDNVAKVSDFGLTK--------EASSTQDTGKLP 349
Query: 848 I---APELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHE 903
+ APE K S KSDV+SFG++L E+ + GR P Y + +
Sbjct: 350 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP------------YP---RIPLKD 394
Query: 904 NVLKV-----LDC-EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952
V +V +D + ++ + M C RP ++ + L
Sbjct: 395 VVPRVEKGYKMDAPDGCPPAVYDVMKN-------CWHLDAATRPTFLQLREQLEH 442
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-39
Identities = 54/234 (23%), Positives = 100/234 (42%), Gaps = 32/234 (13%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD--GVKVFAAEMEILGKIRHRNIL 734
+ +G GG V ++ + A+K++ + + E ++ H NIL
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 735 KLYACLLKGGSS----FLVLEYMPNGNLFQALHKRVKEGK--PE---LDWFRRYKIALGA 785
+L A L+ + +L+L + G L+ + + +G E L G
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLL------GI 143
Query: 786 AKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK-------VSDY 838
+G+ +H + HRD+K +NILL ++ +P + D G A + + D+
Sbjct: 144 CRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDW 200
Query: 839 SCFAGTHGYIAPEL----AYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDG 888
+ T Y APEL ++ C + E++DV+S G VL ++ G P + + G
Sbjct: 201 AAQRCTISYRAPELFSVQSH-CVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG 253
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-39
Identities = 74/297 (24%), Positives = 125/297 (42%), Gaps = 52/297 (17%)
Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV--FAAEMEILGK 727
++ I + +G G G+VY KK + TVAVK L K D ++V F E ++ +
Sbjct: 10 MERTDITMKHK---LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKE 65
Query: 728 IRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAK 787
I+H N+++L + +++ E+M GNL L + + E+ +A +
Sbjct: 66 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISS 122
Query: 788 GIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGY 847
+ YL IHRD+ + N L+ E++ K+ADFG++++ Y+ A
Sbjct: 123 AMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG----DTYT--AHAGAK 173
Query: 848 I-----APELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNN 901
APE K S KSDV++FGV+L E+ T G P Y ++
Sbjct: 174 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP------------YP---GIDL 218
Query: 902 HENVLKV-----LDC-EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952
+ + ++ E E + E M C P+ RP E+ +
Sbjct: 219 SQVYELLEKDYRMERPEGCPEKVYELMRA-------CWQWNPSDRPSFAEIHQAFET 268
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 4e-39
Identities = 98/517 (18%), Positives = 169/517 (32%), Gaps = 49/517 (9%)
Query: 94 SALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD--LSALKNLEIFDL 151
L + L L FN + L++L + ++ L NL I DL
Sbjct: 21 QVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDL 80
Query: 152 SINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESI-GNLKNLTYLFLAHCNLRG-RI 209
+ P L L L + +A + + NLK LT L L+ +R +
Sbjct: 81 GSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYL 140
Query: 210 PESISELRELGTLDICRNKISGEFPRSIRKLQ--KLWKIELYANNLTGELPAELGNL--- 264
S +L L ++D N+I + LQ L L AN+L + + G
Sbjct: 141 HPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNP 200
Query: 265 ---TLLQEFDISSNQMYGKLPEEIGN------------LKNLTVFQCFKNNFSGEFPSGF 309
+L+ D+S N + N ++ +N + F
Sbjct: 201 FRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTF 260
Query: 310 GDMRK--LFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLL 367
+ + + + L ++++ N+ + + L +L
Sbjct: 261 AGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDN-LQVL 319
Query: 368 ALSNNFSGEVP-NSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGIS 426
LS N GE+ +++ + + + NH++ L + LD DN T
Sbjct: 320 NLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT--- 376
Query: 427 PLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSG-KIPSALGALRQLSS 485
I S+ + L N+ LP + L+ N I L + L
Sbjct: 377 --IHFIPSIPDIFLSGNKLV-TLPKI---NLTANLIHLSENRLENLDILYFLLRVPHLQI 430
Query: 486 LHLEENALTGSIPNEM--GDCARIVDLNLARNSLSGNIPRSLSL-----LSSLNALNLSG 538
L L +N + S + + + L L N L L LS L L L+
Sbjct: 431 LILNQNRFS-SCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNH 489
Query: 539 NKLTGSIPDNLMK--LKLSSIDLSENQLSGSVPLDFL 573
N L S+P + L + L+ N+L+ D
Sbjct: 490 NYLN-SLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP 525
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 6e-33
Identities = 112/621 (18%), Positives = 191/621 (30%), Gaps = 91/621 (14%)
Query: 76 TEISFDNKSLSGEI-SSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMV 134
+ ++ I + L +L +L L + + P +L L + +
Sbjct: 51 QLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLS 110
Query: 135 GSVPD---LSALKNLEIFDLSINYFTGRFPRWV-VNLTQLVSLSIGDNVYDEAEIPESIG 190
+V LK L DLS N + L L S+ N +
Sbjct: 111 DAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVC-EHELE 169
Query: 191 NL--KNLTYLFLAHCNLRGRIPESISELRE------LGTLDICRNKIS----GEFPRSIR 238
L K L++ LA +L R+ + L LD+ N + G F +I
Sbjct: 170 PLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAIS 229
Query: 239 KLQ--------KLWKIELYANNLTGELPAELGNLTL--LQEFDISSNQMYGKLPEEIGNL 288
K Q + +N+ L ++ D+S ++ L
Sbjct: 230 KSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETL 289
Query: 289 KNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQ 348
K+L V N + F + L ++ N + N + +D+ +N
Sbjct: 290 KDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNH 349
Query: 349 FSGSFPKYLCEKRKLLNLLALSNNFSGEVPN---------SYADCKTI-------QRLRI 392
+ + + L L L +N + S T+ + +
Sbjct: 350 IA-IIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHL 408
Query: 393 SDNHLSG-KIPDGLWALPNVGMLDFGDNDFTGGISP-LIGLSTSLSQLVLQNNRFSGELP 450
S+N L I L +P++ +L N F+ + SL QL L N
Sbjct: 409 SENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWE 468
Query: 451 SELGR-----LTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCA 505
+EL L++L+ L L +N + P L L L L N LT + +
Sbjct: 469 TELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHN----- 522
Query: 506 RIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLS 565
L ++L L++S N+L PD + L +D++ N+
Sbjct: 523 --------------------DLPANLEILDISRNQLLAPNPDVFVSLS--VLDITHNKFI 560
Query: 566 GSVPLDFLRMGGDGAFAGNEGL--------CLDQSTKMLMNSKLTACPAIQKQKGGFKDK 617
L + G S L + C + K
Sbjct: 561 CECELSTFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLK--- 617
Query: 618 LVLFCIIAVALAAFLAGLLLV 638
LF + V L FL +L V
Sbjct: 618 FSLFIVCTVTLTLFLMTILTV 638
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 9e-33
Identities = 98/466 (21%), Positives = 156/466 (33%), Gaps = 56/466 (12%)
Query: 116 ELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSI 175
++ N+T VP + L E LS NY L QL L +
Sbjct: 7 RIAFYRFC---NLT------QVPQV--LNTTERLLLSFNYIRTVTASSFPFLEQLQLLEL 55
Query: 176 GDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEF-- 233
G E+ NL NL L L + P++ L L L + +S
Sbjct: 56 GSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLK 115
Query: 234 PRSIRKLQKLWKIELYANNLTG-ELPAELGNLTLLQEFDISSNQMYGKLPEEIGNL--KN 290
R L+ L +++L N + L G L L+ D SSNQ++ E+ L K
Sbjct: 116 DGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKT 175
Query: 291 LTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFS 350
L+ F N+ +G F R L +D+S N ++
Sbjct: 176 LSFFSLAANSLYSRVSVDWGKCMNPF------------------RNMVLEILDVSGNGWT 217
Query: 351 GSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPN 410
SN S S I +++ + L
Sbjct: 218 VDITG------------NFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLAR 265
Query: 411 VGM--LDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNN 468
+ LD S + L L L N+ + L NL+ L L+ N
Sbjct: 266 SSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNL 325
Query: 469 FSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLL 528
S L +++ + L++N + ++ L+L N+L+ ++ +
Sbjct: 326 LGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFI 380
Query: 529 SSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSGSVPLDFLR 574
S+ + LSGNKL ++P + I LSEN+L L FL
Sbjct: 381 PSIPDIFLSGNKLV-TLPKINLTAN--LIHLSENRLENLDILYFLL 423
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 5e-16
Identities = 57/309 (18%), Positives = 107/309 (34%), Gaps = 25/309 (8%)
Query: 75 VTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMV 134
V + + + S L+ L VL+L +N ++ NL+VLN++ N ++
Sbjct: 268 VRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYN-LL 326
Query: 135 GSVPD--LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNL 192
G + L + DL N+ + L +L +L + DN + +I +
Sbjct: 327 GELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDN-----AL-TTIHFI 380
Query: 193 KNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSI-RKLQKLWKIELYAN 251
++ +FL+ L +++ + + N++ ++ L + L N
Sbjct: 381 PSIPDIFLSGNKLVTLPKINLT----ANLIHLSENRLENLDILYFLLRVPHLQILILNQN 436
Query: 252 NLTG-ELPAELGNLTLLQEFDISSNQMYGKLPEEI-----GNLKNLTVFQCFKNNFSGEF 305
+ L++ + N + E+ L +L V N +
Sbjct: 437 RFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLP 496
Query: 306 PSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLN 365
P F + L S+ NR + +L L +DIS NQ P L
Sbjct: 497 PGVFSHLTALRGLSLNSNRLTVLSHNDL--PANLEILDISRNQLLAPNPDVF---VSLSV 551
Query: 366 LLALSNNFS 374
L N F
Sbjct: 552 LDITHNKFI 560
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 5e-39
Identities = 78/309 (25%), Positives = 127/309 (41%), Gaps = 60/309 (19%)
Query: 667 HIDIDAEQICNLEEDNLIGSGGTGKVYR---LDLKKNAGTVAVKQLWKGDGVKV---FAA 720
+ I E++ D +IG G G VY +D +N A+K L + ++ F
Sbjct: 13 DVLIPHERV-VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLR 71
Query: 721 EMEILGKIRHRNILKLYA-CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRY 779
E ++ + H N+L L L G ++L YM +G+L Q + + +
Sbjct: 72 EGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI----RSPQRNPTVKDLI 127
Query: 780 KIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYS 839
L A+G+ YL +HRD+ + N +LDE + K+ADFG+A+ + YS
Sbjct: 128 SFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR---EYYS 181
Query: 840 CFAGTHGYI-----APELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVY 893
H + A E T + + KSDV+SFGV+L EL+T G P Y
Sbjct: 182 VQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP------------Y 229
Query: 894 WVSTHLNNHENVLKVL----------DCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPM 943
H++ + + L C +S+ + M + C P +RP
Sbjct: 230 R---HIDPFD-LTHFLAQGRRLPQPEYC---PDSLYQVMQQ-------CWEADPAVRPTF 275
Query: 944 REVVKMLAD 952
R +V +
Sbjct: 276 RVLVGEVEQ 284
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 5e-39
Identities = 65/276 (23%), Positives = 122/276 (44%), Gaps = 38/276 (13%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYA 738
IG G GK + ++ +K++ + E+ +L ++H NI++
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPE---LDWFRRYKIALGAAKGIAYLHHD 795
+ GS ++V++Y G+LF+ ++ + E LDWF +I L + ++H
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWF--VQICLA----LKHVH-- 142
Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYT 855
I+HRDIKS NI L +D ++ DFG+A++ ++ +++ GT Y++PE+
Sbjct: 143 -DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA--RACIGTPYYLSPEICEN 199
Query: 856 CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVA- 914
+ KSD+++ G VL EL T + E + VLK++
Sbjct: 200 KPYNNKSDIWALGCVLYELCTLKHAFEAG---------------SMKNLVLKIISGSFPP 244
Query: 915 -SESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949
S D+ L+ + P RP + +++
Sbjct: 245 VSLHYSYDLRSLVSQ---LFKRNPRDRPSVNSILEK 277
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 5e-39
Identities = 84/307 (27%), Positives = 119/307 (38%), Gaps = 64/307 (20%)
Query: 668 IDIDAEQICNLEEDNLIGSGGTGKVYR---LDLKKNAGTVAVKQLWKGDGVKV---FAAE 721
I + + E IG G G VY LD AVK L + + F E
Sbjct: 20 IGPSSLIVHFNEV---IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 76
Query: 722 MEILGKIRHRNILKLYA-CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK 780
I+ H N+L L CL GS +VL YM +G+L +
Sbjct: 77 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE----THNPTVKDLIG 132
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK-IAENSPKVSDYS 839
L AKG+ YL S +HRD+ + N +LDE + K+ADFG+A+ + + YS
Sbjct: 133 FGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY----YS 185
Query: 840 CFAGTHGYI-----APELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVY 893
T + A E T K + KSDV+SFGV+L EL+T G P Y
Sbjct: 186 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP------------Y 233
Query: 894 WVSTHLNNHENVLKVL----------DCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPM 943
+N + + L C + + E M+K C +RP
Sbjct: 234 P---DVNTFD-ITVYLLQGRRLLQPEYC---PDPLYEVMLK-------CWHPKAEMRPSF 279
Query: 944 REVVKML 950
E+V +
Sbjct: 280 SELVSRI 286
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 7e-39
Identities = 73/303 (24%), Positives = 122/303 (40%), Gaps = 52/303 (17%)
Query: 677 NLEEDNLIGSGGTGKVYR----LDLKKNAGTVAVKQLWKGDGVKV---FAAEMEILGKIR 729
L+ +G G GKV + VAVK L G E+EIL +
Sbjct: 22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY 81
Query: 730 HRNILKLYACLLKGGSS--FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAK 787
H NI+K + G + L++E++P+G+L + L K K +++ ++ K A+ K
Sbjct: 82 HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN----KNKINLKQQLKYAVQICK 137
Query: 788 GIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGY 847
G+ YL S +HRD+ + N+L++ +++ KI DFG+ K E + Y+
Sbjct: 138 GMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY--YT--VKDDRD 190
Query: 848 I-----APELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIV--YWVSTHL 899
APE K SDV+SFGV L EL+T K I + +
Sbjct: 191 SPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHG---QM 247
Query: 900 NNHENVLKVL----------DCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949
++ L +C + + + M K C P+ R + +++
Sbjct: 248 TVTR-LVNTLKEGKRLPCPPNC---PDEVYQLMRK-------CWEFQPSNRTSFQNLIEG 296
Query: 950 LAD 952
Sbjct: 297 FEA 299
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-38
Identities = 81/308 (26%), Positives = 116/308 (37%), Gaps = 52/308 (16%)
Query: 670 IDAEQICNLEEDNLIGSGGTGKVYR---LDLKKNAGT-VAVKQLWKGDGVKV---FAAEM 722
+ + + + +G G G V L N G VAVKQL + G F E+
Sbjct: 20 FEERHLKYISQ---LGKGNFGSVELCRYDPLGDNTGALVAVKQL-QHSGPDQQRDFQREI 75
Query: 723 EILGKIRHRNILKLYACLLKGGSS--FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK 780
+IL + I+K G LV+EY+P+G L L + + LD R
Sbjct: 76 QILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH----RARLDASRLLL 131
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSC 840
+ KG+ YL S +HRD+ + NIL++ + KIADFG+AK+ DY
Sbjct: 132 YSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD---KDYYV 185
Query: 841 FAGTHGYI-----APELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYW 894
G APE S +SDV+SFGVVL EL T K + +
Sbjct: 186 -VREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCE 244
Query: 895 VSTHLNNHENVLKVL----------DCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMR 944
+ +L++L C + E M C P RP
Sbjct: 245 RDVPALSR--LLELLEEGQRLPAPPAC---PAEVHELMKL-------CWAPSPQDRPSFS 292
Query: 945 EVVKMLAD 952
+ L
Sbjct: 293 ALGPQLDM 300
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-38
Identities = 80/294 (27%), Positives = 130/294 (44%), Gaps = 48/294 (16%)
Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKI 728
+ E+I L+E +GSG G V K VAVK + +G F E + + K+
Sbjct: 5 LKREEITLLKE---LGSGQFGVVKLGKWKGQY-DVAVKMIKEGSMSEDEFFQEAQTMMKL 60
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
H ++K Y K ++V EY+ NG L L L+ + ++ +G
Sbjct: 61 SHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSH----GKGLEPSQLLEMCYDVCEG 116
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
+A+L S IHRD+ + N L+D D K++DFG+ + + Y GT +
Sbjct: 117 MAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD----DQYVSSVGTKFPV 169
Query: 849 ---APELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHEN 904
APE+ + K S KSDV++FG+++ E+ + G+ P Y N E
Sbjct: 170 KWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP------------YD---LYTNSEV 214
Query: 905 VLKV-----LDC-EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952
VLKV L +AS++I + M C +LP RP ++++ +
Sbjct: 215 VLKVSQGHRLYRPHLASDTIYQIMYS-------CWHELPEKRPTFQQLLSSIEP 261
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 2e-38
Identities = 74/294 (25%), Positives = 124/294 (42%), Gaps = 52/294 (17%)
Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIR 729
++ +++ L+ IG G G V D + N VAVK + + F AE ++ ++R
Sbjct: 18 LNMKELKLLQT---IGKGEFGDVMLGDYRGN--KVAVKCIKNDATAQAFLAEASVMTQLR 72
Query: 730 HRNILKLYA-CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
H N+++L + + G ++V EYM G+L L R G+ L K +L +
Sbjct: 73 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEA 129
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
+ YL +HRD+ + N+L+ ED K++DFG+ K S +
Sbjct: 130 MEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK--------EASSTQDTGKLPV 178
Query: 849 ---APELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHEN 904
APE K S KSDV+SFG++L E+ + GR P Y + +
Sbjct: 179 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP------------YP---RIPLKDV 223
Query: 905 VLKV-----LDC-EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952
V +V +D + ++ E M C +RP ++ + L
Sbjct: 224 VPRVEKGYKMDAPDGCPPAVYEVMKN-------CWHLDAAMRPSFLQLREQLEH 270
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-38
Identities = 65/296 (21%), Positives = 126/296 (42%), Gaps = 40/296 (13%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFA-----AEMEILGKIRHRNILKLY 737
IG G +VYR + VA+K++ D + A E+++L ++ H N++K Y
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGK--PE---LDWFRRYKIALGAAKGIAYL 792
A ++ +VLE G+L + + K+ + PE +F ++ + ++
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFV--QLCSA----LEHM 152
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL 852
H S ++HRDIK +N+ + K+ D G+ + + K + GT Y++PE
Sbjct: 153 H---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPER 207
Query: 853 AYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCE 912
+ + KSD++S G +L E+ + P + + + K+ C+
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK-------------KIEQCD 254
Query: 913 VA---SESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPCTDKSPDNSS 965
S+ E++ +L+ +C P RP + V + CT S ++
Sbjct: 255 YPPLPSDHYSEELRQLVN---MCINPDPEKRPDVTYVYDVAKRMHACTASSLEHHH 307
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-38
Identities = 75/296 (25%), Positives = 130/296 (43%), Gaps = 52/296 (17%)
Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKI 728
ID ++ ++E IGSG G V+ VA+K + +G + F E E++ K+
Sbjct: 5 IDPSELTFVQE---IGSGQFGLVHLGYWLNK-DKVAIKTIREGAMSEEDFIEEAEVMMKL 60
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
H +++LY L+ LV E+M +G L L + + + L +G
Sbjct: 61 SHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYL----RTQRGLFAAETLLGMCLDVCEG 116
Query: 789 IAYL--HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHG 846
+AYL +IHRD+ + N L+ E+ K++DFG+ + + Y+ GT
Sbjct: 117 MAYLEEAC-----VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD----DQYTSSTGTKF 167
Query: 847 YI---APELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNH 902
+ +PE+ + S KSDV+SFGV++ E+ + G+ P Y + +N
Sbjct: 168 PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP------------YE---NRSNS 212
Query: 903 ENVLKV-----LDC-EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952
E V + L +AS + + M C + P RP +++ LA+
Sbjct: 213 EVVEDISTGFRLYKPRLASTHVYQIMNH-------CWRERPEDRPAFSRLLRQLAE 261
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 6e-38
Identities = 79/310 (25%), Positives = 124/310 (40%), Gaps = 55/310 (17%)
Query: 670 IDAEQICNLEEDNLIGSGGTGKVYR---LDLKKNAGT-VAVKQLWKG--DGVKVFAAEME 723
+ + L++ +G G G V L+ N G VAVK+L + ++ F E+E
Sbjct: 7 FEERHLKFLQQ---LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 63
Query: 724 ILGKIRHRNILKLYACLLKGGSS--FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKI 781
IL ++H NI+K G L++EY+P G+L L K K +D + +
Sbjct: 64 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQY 119
Query: 782 ALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCF 841
KG+ YL + IHRD+ + NIL++ + KI DFG+ K+ ++
Sbjct: 120 TSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD---KEFFK- 172
Query: 842 AGTHGYI-----APELAYTCKVSEKSDVFSFGVVLLELVT----GRKPVEEEYGDGKDIV 892
G APE K S SDV+SFGVVL EL T + P E +
Sbjct: 173 VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK 232
Query: 893 YWVSTHLNNHENVLKVL----------DCEVASESIKEDMIKLLKIAVVCTTKLPNLRPP 942
+ ++++L C + I M + C N RP
Sbjct: 233 QG---QMIVFH-LIELLKNNGRLPRPDGC---PDEIYMIMTE-------CWNNNVNQRPS 278
Query: 943 MREVVKMLAD 952
R++ +
Sbjct: 279 FRDLALRVDQ 288
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 6e-38
Identities = 65/296 (21%), Positives = 124/296 (41%), Gaps = 52/296 (17%)
Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKI 728
ID + + L+E +G+G G V + VA+K + +G F E +++ +
Sbjct: 21 IDPKDLTFLKE---LGTGQFGVVKYGKWRGQY-DVAIKMIKEGSMSEDEFIEEAKVMMNL 76
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
H +++LY K F++ EYM NG L L +E + + ++ +
Sbjct: 77 SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL----REMRHRFQTQQLLEMCKDVCEA 132
Query: 789 IAYL--HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHG 846
+ YL +HRD+ + N L+++ K++DFG+++ + +Y+ G+
Sbjct: 133 MEYLESKQ-----FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD----DEYTSSVGSKF 183
Query: 847 YI---APELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNH 902
+ PE+ K S KSD+++FGV++ E+ + G+ P Y N
Sbjct: 184 PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP------------YE---RFTNS 228
Query: 903 ENVLKV-----LDC-EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952
E + L +ASE + M C + + RP + ++ + D
Sbjct: 229 ETAEHIAQGLRLYRPHLASEKVYTIMYS-------CWHEKADERPTFKILLSNILD 277
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 6e-38
Identities = 77/301 (25%), Positives = 131/301 (43%), Gaps = 54/301 (17%)
Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAG---TVAVKQLWKG---DGVKVFAAEME 723
I+A +I + IGSG +G+V L+ VA+K L G + F +E
Sbjct: 46 IEASRIHIEKI---IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEAS 102
Query: 724 ILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL 783
I+G+ H NI++L + +G + +V EYM NG+L L + + + +
Sbjct: 103 IMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL----RTHDGQFTIMQLVGMLR 158
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAG 843
G G+ YL +HRD+ + N+L+D + K++DFG++++ E+ + +
Sbjct: 159 GVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED----DPDAAYTT 211
Query: 844 THGYI-----APELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVST 897
T G I APE S SDV+SFGVV+ E++ G +P YW
Sbjct: 212 TGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP------------YW--- 256
Query: 898 HLNNHENVLKV-----LDC-EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951
++ N + + V L ++ + M+ C K RP ++V +L
Sbjct: 257 NMTNRDVISSVEEGYRLPAPMGCPHALHQLMLD-------CWHKDRAQRPRFSQIVSVLD 309
Query: 952 D 952
Sbjct: 310 A 310
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-37
Identities = 80/310 (25%), Positives = 124/310 (40%), Gaps = 55/310 (17%)
Query: 670 IDAEQICNLEEDNLIGSGGTGKVYR---LDLKKNAGT-VAVKQLWKG--DGVKVFAAEME 723
+ + L++ +G G G V L+ N G VAVK+L + ++ F E+E
Sbjct: 38 FEERHLKFLQQ---LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 94
Query: 724 ILGKIRHRNILKLYACLLKGGSS--FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKI 781
IL ++H NI+K G L++EY+P G+L L K K +D + +
Sbjct: 95 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQY 150
Query: 782 ALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCF 841
KG+ YL + IHRD+ + NIL++ + KI DFG+ K+ +Y
Sbjct: 151 TSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD---KEYYK- 203
Query: 842 AGTHGYI-----APELAYTCKVSEKSDVFSFGVVLLELVT----GRKPVEEEYGDGKDIV 892
G APE K S SDV+SFGVVL EL T + P E +
Sbjct: 204 VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK 263
Query: 893 YWVSTHLNNHENVLKVL----------DCEVASESIKEDMIKLLKIAVVCTTKLPNLRPP 942
+ ++++L C + I M + C N RP
Sbjct: 264 QG---QMIVFH-LIELLKNNGRLPRPDGC---PDEIYMIMTE-------CWNNNVNQRPS 309
Query: 943 MREVVKMLAD 952
R++ +
Sbjct: 310 FRDLALRVDQ 319
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-37
Identities = 62/282 (21%), Positives = 120/282 (42%), Gaps = 41/282 (14%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFA-AEMEILGKIRHRNILKLYA 738
IG+G G+ ++ K + + K+L G + K +E+ +L +++H NI++ Y
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 739 CLL--KGGSSFLVLEYMPNGNLFQALHKRVKEGK--PE---LDWFRRYKIALGAAKGIAY 791
++ + ++V+EY G+L + K KE + E L ++ L +
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM--TQLTLA----LKE 126
Query: 792 LH--HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIA 849
H D ++HRD+K +N+ LD K+ DFG+A+I + + F GT Y++
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA--KTFVGTPYYMS 184
Query: 850 PELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVL 909
PE +EKSD++S G +L EL P + E K+
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF---------------SQKELAGKIR 229
Query: 910 DCEVA--SESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949
+ + +++ +++ RP + E+++
Sbjct: 230 EGKFRRIPYRYSDELNEIITR---MLNLKDYHRPSVEEILEN 268
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-37
Identities = 75/310 (24%), Positives = 114/310 (36%), Gaps = 57/310 (18%)
Query: 670 IDAEQICNLEEDNLIGSGGTGKVYR---LDLKKNAGT-VAVKQLWKGDGVKV---FAAEM 722
+ + + +G G GKV G VAVK L G + + E+
Sbjct: 28 FHKRYLKKIRD---LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEI 84
Query: 723 EILGKIRHRNILKLYACLLKGGSS--FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK 780
+IL + H +I+K C G++ LV+EY+P G+L L + + +
Sbjct: 85 DILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH------SIGLAQLLL 138
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSC 840
A +G+AYLH + IHRD+ + N+LLD D KI DFG+AK +Y
Sbjct: 139 FAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG---HEYYR 192
Query: 841 FAGTHGYI-----APELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIV-- 892
G APE K SDV+SFGV L EL+T + I
Sbjct: 193 -VREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIA 251
Query: 893 YWVSTHLNNHENVLKVL----------DCEVASESIKEDMIKLLKIAVVCTTKLPNLRPP 942
+ + ++L C + M C + RP
Sbjct: 252 QGQ---MTVLR-LTELLERGERLPRPDKC---PAEVYHLMKN-------CWETEASFRPT 297
Query: 943 MREVVKMLAD 952
++ +L
Sbjct: 298 FENLIPILKT 307
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-37
Identities = 63/298 (21%), Positives = 116/298 (38%), Gaps = 60/298 (20%)
Query: 677 NLEEDNLIGSGGTGKVYR----LDLKKNAGTVAVKQLWKGDGVKV---FAAEMEILGKIR 729
++ ++GSG G VY+ + +K VA+K+L + K E ++ +
Sbjct: 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 730 HRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGI 789
+ ++ +L L + L+ + MP G L + + K + + AKG+
Sbjct: 76 NPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGM 130
Query: 790 AYL--HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGY 847
YL ++HRD+ + N+L+ KI DFG+AK+ + + G
Sbjct: 131 NYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA-----EEKEYHAEGGK 180
Query: 848 I-----APELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNN 901
+ A E + +SDV+S+GV + EL+T G KP Y +
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP------------YD---GIPA 225
Query: 902 HENVLKVLDC-------EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952
E + +L+ + + + M K C + RP RE++ +
Sbjct: 226 SE-ISSILEKGERLPQPPICTIDVYMIMRK-------CWMIDADSRPKFRELIIEFSK 275
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 3e-37
Identities = 66/482 (13%), Positives = 150/482 (31%), Gaps = 26/482 (5%)
Query: 74 RVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAM 133
R + SL ++S + ++ L L N LS +L+ + L++LN++ N +
Sbjct: 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70
Query: 134 VGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPE-SIGNL 192
DL +L L DL+ NY ++ + +L +N I S
Sbjct: 71 Y-ETLDLESLSTLRTLDLNNNYVQE-----LLVGPSIETLHAANN-----NISRVSCSRG 119
Query: 193 KNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISG-EFPRSIRKLQKLWKIELYAN 251
+ ++LA+ + + LD+ N+I F L + L N
Sbjct: 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179
Query: 252 NLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGD 311
+ ++ ++ L+ D+SSN++ + E + +T N
Sbjct: 180 FIY-DVKGQV-VFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV-LIEKALRF 235
Query: 312 MRKLFAFSIYGNRFS-GPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALS 370
+ L F + GN F G + + + V + E+ + L
Sbjct: 236 SQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK---KLTGQNEEECTVPTLGHYG 292
Query: 371 NNFSGEVPNSYAD-CKTIQRLRISDNHLSG----KIPDGLWALPNVGMLDFGDNDFTGGI 425
++P +AD ++R + G ++ +D + I
Sbjct: 293 AYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVI 352
Query: 426 SPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSS 485
+ + L + ++ + L+ + +
Sbjct: 353 DQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLL 412
Query: 486 LHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSI 545
+ + + + I D ++ ++ + + L +L+ ++
Sbjct: 413 RAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQLAEENARLKKLNGEADLALASANATL 472
Query: 546 PD 547
+
Sbjct: 473 QE 474
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 8e-37
Identities = 58/398 (14%), Positives = 121/398 (30%), Gaps = 23/398 (5%)
Query: 185 IPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLW 244
I E N + +L+ + + LD+ N +S + KL
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 245 KIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGE 304
+ L +N L E +L +L+ L+ D+++N + +E+ ++ NN S
Sbjct: 62 LLNLSSNVLY-ETL-DLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISRV 114
Query: 305 FPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLL 364
S + + + N+ + + G + + +D+ N+ L L
Sbjct: 115 SCSRGQGKKNI---YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 365 NLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGG 424
L L NF +V ++ L +S N L+ + + V + +N
Sbjct: 172 EHLNLQYNFIYDVKGQ-VVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-L 228
Query: 425 ISPLIGLSTSLSQLVLQNNRFS-GELPSELGRLTNLERLILTNNNFSGKIPSALGALRQL 483
I + S +L L+ N F G L + ++ +
Sbjct: 229 IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQT--VAKQTVKKLTGQNEEECTVP 286
Query: 484 SSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSL----LSSLNALNLSGN 539
+ H + A S G+ L + ++
Sbjct: 287 TLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKE 346
Query: 540 KLTGSIPDNLMKLK--LSSIDLSENQLSGSVPLDFLRM 575
+ ++ D + K +++ + L V
Sbjct: 347 QYR-TVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAH 383
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 3e-17
Identities = 26/152 (17%), Positives = 56/152 (36%), Gaps = 9/152 (5%)
Query: 424 GISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQL 483
I + + ++ L S N++ L L+ N S + L +L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 484 SSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTG 543
L+L N L ++ + + L+L N + L + S+ L+ + N ++
Sbjct: 61 ELLNLSSNVLY-ETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112
Query: 544 SIPDNLMKLKLSSIDLSENQLSGSVPLDFLRM 575
+ + + +I L+ N+++ LD
Sbjct: 113 RVSCSRGQ-GKKNIYLANNKITMLRDLDEGCR 143
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 4e-37
Identities = 83/307 (27%), Positives = 119/307 (38%), Gaps = 64/307 (20%)
Query: 668 IDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAG---TVAVKQLWKGDGVKV---FAAE 721
I + + E IG G G VY L N G AVK L + + F E
Sbjct: 84 IGPSSLIVHFNEV---IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 140
Query: 722 MEILGKIRHRNILKLYA-CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK 780
I+ H N+L L CL GS +VL YM +G+L +
Sbjct: 141 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE----THNPTVKDLIG 196
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK-IAENSPKVSDYS 839
L AKG+ +L S +HRD+ + N +LDE + K+ADFG+A+ + + S
Sbjct: 197 FGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF----DS 249
Query: 840 CFAGTHGYI-----APELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVY 893
T + A E T K + KSDV+SFGV+L EL+T G P Y
Sbjct: 250 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP------------Y 297
Query: 894 WVSTHLNNHENVLKVL----------DCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPM 943
+N + + L C + + E M+K C +RP
Sbjct: 298 P---DVNTFD-ITVYLLQGRRLLQPEYC---PDPLYEVMLK-------CWHPKAEMRPSF 343
Query: 944 REVVKML 950
E+V +
Sbjct: 344 SELVSRI 350
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 6e-37
Identities = 85/320 (26%), Positives = 145/320 (45%), Gaps = 59/320 (18%)
Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAG----TVAVKQLWKGDGVKV---FAAEM 722
I + + IG+G G+VY+ LK ++G VA+K L G K F E
Sbjct: 41 IHPSCVTRQKV---IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 97
Query: 723 EILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIA 782
I+G+ H NI++L + K ++ EYM NG L + L +E E + +
Sbjct: 98 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFL----REKDGEFSVLQLVGML 153
Query: 783 LGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFA 842
G A G+ YL + +HRD+ + NIL++ + K++DFG++++ E+ P + +
Sbjct: 154 RGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP----EATYT 206
Query: 843 GTHGYI-----APELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVS 896
+ G I APE K + SDV+SFG+V+ E++T G +P YW
Sbjct: 207 TSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP------------YW-- 252
Query: 897 THLNNHENVLKVLDC-------EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949
L+NHE V+K ++ +I + M++ C + RP ++V +
Sbjct: 253 -ELSNHE-VMKAINDGFRLPTPMDCPSAIYQLMMQ-------CWQQERARRPKFADIVSI 303
Query: 950 LAD--ADPCTDKSPDNSSDK 967
L P + K+ + +
Sbjct: 304 LDKLIRAPDSLKTLADFDPR 323
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 8e-37
Identities = 77/294 (26%), Positives = 136/294 (46%), Gaps = 48/294 (16%)
Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKI 728
+ E + +E +G+G G+V+ + VAVK L +G F AE ++ ++
Sbjct: 10 VPRETLKLVER---LGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSPDAFLAEANLMKQL 65
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
+H+ +++LYA + + +++ EYM NG+L L +L + +A A+G
Sbjct: 66 QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEG 121
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
+A++ IHRD++++NIL+ + KIADFG+A++ E+ ++Y+ G I
Sbjct: 122 MAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED----NEYTAREGAKFPI 174
Query: 849 ---APELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHEN 904
APE + KSDV+SFG++L E+VT GR P Y + N E
Sbjct: 175 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP------------YP---GMTNPEV 219
Query: 905 VLKV-----LDC-EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952
+ + + + E + + M C + P RP + +L D
Sbjct: 220 IQNLERGYRMVRPDNCPEELYQLMRL-------CWKERPEDRPTFDYLRSVLED 266
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 8e-37
Identities = 76/325 (23%), Positives = 124/325 (38%), Gaps = 75/325 (23%)
Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAG---TVAVKQLWKGDG-----VKVFAAE 721
ID + + +G G G V +LK+ G VAVK + K D ++ F +E
Sbjct: 31 IDRNLLILGKI---LGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSE 86
Query: 722 MEILGKIRHRNILKLYACLLKGGSS-----FLVLEYMPNGNLFQAL-HKRVKEGKPELDW 775
+ H N+++L ++ S ++L +M G+L L + R++ G +
Sbjct: 87 AACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPL 146
Query: 776 FRRYKIALGAAKGIAYL--HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833
K + A G+ YL + +HRD+ + N +L +D +ADFG++K +
Sbjct: 147 QTLLKFMVDIALGMEYLSNRN-----FLHRDLAARNCMLRDDMTVCVADFGLSKKIYS-- 199
Query: 834 KVSDYSCFAGTHGYI-----APELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGD 887
DY G + A E + KSDV++FGV + E+ T G P
Sbjct: 200 --GDYYR-QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP------- 249
Query: 888 GKDIVYWVSTHLNNHENVLKVL----------DCEVASESIKEDMIKLLKIAVVCTTKLP 937
Y + NHE + L DC + + E M C P
Sbjct: 250 -----YP---GVQNHE-MYDYLLHGHRLKQPEDC---LDELYEIMYS-------CWRTDP 290
Query: 938 NLRPPMREVVKMLADADPCTDKSPD 962
RP + L + + PD
Sbjct: 291 LDRPTFSVLRLQL---EKLLESLPD 312
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 69/317 (21%), Positives = 124/317 (39%), Gaps = 70/317 (22%)
Query: 670 IDAEQICNLEEDNLIGSGGTGKVYR-----LDLKKNAGTVAVKQLWKGDGVKV---FAAE 721
I + +EE +G GKVY+ + VA+K L + F E
Sbjct: 6 ISLSAVRFMEE---LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHE 62
Query: 722 MEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKR-----------VKEGK 770
+ +++H N++ L + K ++ Y +G+L + L R + K
Sbjct: 63 AMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122
Query: 771 PELDWFRRYKIALGAAKGIAYL--HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
L+ + A G+ YL HH ++H+D+ + N+L+ + KI+D G+ +
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFRE 177
Query: 829 AENSPKVSDYSCFAGTHGYI-----APELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVE 882
+DY + + APE K S SD++S+GVVL E+ + G +P
Sbjct: 178 VYA----ADY-YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP-- 230
Query: 883 EEYGDGKDIVYWVSTHLNNHENVLK------VLDC-EVASESIKEDMIKLLKIAVVCTTK 935
Y +N + V++ VL C + + MI+ C +
Sbjct: 231 ----------YC---GYSNQD-VVEMIRNRQVLPCPDDCPAWVYALMIE-------CWNE 269
Query: 936 LPNLRPPMREVVKMLAD 952
P+ RP +++ L
Sbjct: 270 FPSRRPRFKDIHSRLRA 286
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 59/236 (25%), Positives = 102/236 (43%), Gaps = 38/236 (16%)
Query: 679 EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG-VKVFAAEMEILGKIRHRNILKLY 737
EE ++G G G+V + ++ A+K++ + + +E+ +L + H+ +++ Y
Sbjct: 9 EEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYY 68
Query: 738 ACLLKGGSS-------------FLVLEYMPNGNLFQALHKRVKEGKPE--LDWFRRYKIA 782
A L+ + F+ +EY NG L+ +H + + FR +I
Sbjct: 69 AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR--QIL 126
Query: 783 LGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSC-- 840
++Y+H S IIHRD+K NI +DE KI DFG+AK S +
Sbjct: 127 EA----LSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 841 ----------FAGTHGYIAPE-LAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEY 885
GT Y+A E L T +EK D++S G++ E++ E
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERV 235
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-36
Identities = 76/294 (25%), Positives = 134/294 (45%), Gaps = 48/294 (16%)
Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKI 728
I E + ++ +G+G G+V+ K+ VAVK + G V+ F AE ++ +
Sbjct: 185 IPRESLKLEKK---LGAGQFGEVWMATYNKH-TKVAVKTMKPGSMSVEAFLAEANVMKTL 240
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
+H ++KL+A + K +++ E+M G+L L + + + A+G
Sbjct: 241 QHDKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSD---EGSKQPLPKLIDFSAQIAEG 296
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
+A++ IHRD++++NIL+ KIADFG+A++ E+ ++Y+ G I
Sbjct: 297 MAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIED----NEYTAREGAKFPI 349
Query: 849 ---APELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHEN 904
APE + KSDV+SFG++L+E+VT GR P Y ++N E
Sbjct: 350 KWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP------------YP---GMSNPEV 394
Query: 905 VLKV-----LDC-EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952
+ + + E E + M++ C P RP + +L D
Sbjct: 395 IRALERGYRMPRPENCPEELYNIMMR-------CWKNRPEERPTFEYIQSVLDD 441
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-36
Identities = 76/316 (24%), Positives = 122/316 (38%), Gaps = 66/316 (20%)
Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGT---VAVKQLWKG-----DGVKVFAAE 721
I + + LE+ +G G G V R + +G VAVK L + + F E
Sbjct: 15 IGEKDLRLLEK---LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 71
Query: 722 MEILGKIRHRNILKLYA-CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK 780
+ + + HRN+++LY L +V E P G+L R+++ + +
Sbjct: 72 VNAMHSLDHRNLIRLYGVVL--TPPMKMVTELAPLGSL----LDRLRKHQGHFLLGTLSR 125
Query: 781 IALGAAKGIAYL--HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY 838
A+ A+G+ YL IHRD+ + N+LL KI DFG+ + + Y
Sbjct: 126 YAVQVAEGMGYLESKR-----FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH--Y 178
Query: 839 SCFAGTHGYI-----APELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIV 892
H + APE T S SD + FGV L E+ T G++P
Sbjct: 179 V--MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP------------ 224
Query: 893 YWVSTHLNNHENVLKVLDC--------EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMR 944
+ LN + +L +D E + I M++ C P RP
Sbjct: 225 WI---GLNGSQ-ILHKIDKEGERLPRPEDCPQDIYNVMVQ-------CWAHKPEDRPTFV 273
Query: 945 EVVKMLADADPCTDKS 960
+ L +A P ++
Sbjct: 274 ALRDFLLEAQPTDMRA 289
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-36
Identities = 82/322 (25%), Positives = 141/322 (43%), Gaps = 62/322 (19%)
Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLK---KNAGTVAVKQLWKGDGVKV---FAAEME 723
+DA I + +G+G G+V LK K +VA+K L G K F E
Sbjct: 42 LDATNISIDKV---VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEAS 98
Query: 724 ILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL 783
I+G+ H NI++L + K +V EYM NG+L L K + + +
Sbjct: 99 IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH----DAQFTVIQLVGMLR 154
Query: 784 GAAKGIAYL--HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCF 841
G A G+ YL +HRD+ + NIL++ + K++DFG+ ++ E+ P + +
Sbjct: 155 GIASGMKYLSDMG-----YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP----EAAY 205
Query: 842 AGTHGYI-----APELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWV 895
G I +PE K + SDV+S+G+VL E+++ G +P YW
Sbjct: 206 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP------------YW- 252
Query: 896 STHLNNHENVLKVLDC-------EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVK 948
++N + V+K +D ++ + M+ C K N RP ++V
Sbjct: 253 --EMSNQD-VIKAVDEGYRLPPPMDCPAALYQLMLD-------CWQKDRNNRPKFEQIVS 302
Query: 949 MLAD--ADPCTDKSPDNSSDKS 968
+L +P + K +++ +
Sbjct: 303 ILDKLIRNPGSLKIITSAAARP 324
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-36
Identities = 86/326 (26%), Positives = 137/326 (42%), Gaps = 74/326 (22%)
Query: 670 IDAEQICNLEEDNLIGSGGTGKVYR-----LDLKKNAGTVAVKQLWKGDGVKV---FAAE 721
I I E +G G GKV+ L K+ VAVK L K + F E
Sbjct: 12 IKRRDIVLKRE---LGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPTLAARKDFQRE 67
Query: 722 MEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKR-----------VKEGK 770
E+L ++H +I+K Y G +V EYM +G+L + L ++ K
Sbjct: 68 AELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAK 127
Query: 771 PELDWFRRYKIALGAAKGIAYL--HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
EL + IA A G+ YL H +HRD+ + N L+ + KI DFG+++
Sbjct: 128 GELGLSQMLHIASQIASGMVYLASQH-----FVHRDLATRNCLVGANLLVKIGDFGMSRD 182
Query: 829 AENSPKVSDYSCFAGTHGYI-----APELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVE 882
+ +DY G H + PE K + +SDV+SFGV+L E+ T G++P
Sbjct: 183 VYS----TDY-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP-- 235
Query: 883 EEYGDGKDIVYWVSTHLNNHENVLK------VLDC-EVASESIKEDMIKLLKIAVVCTTK 935
++ L+N E V++ VL+ V + + + M+ C +
Sbjct: 236 ----------WF---QLSNTE-VIECITQGRVLERPRVCPKEVYDVMLG-------CWQR 274
Query: 936 LPNLRPPMREVVKMLADADPCTDKSP 961
P R ++E+ K+L +P
Sbjct: 275 EPQQRLNIKEIYKIL---HALGKATP 297
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 5e-36
Identities = 83/310 (26%), Positives = 133/310 (42%), Gaps = 72/310 (23%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAG--TVAVKQLWKG---DGVKVFAAEMEILGKI-RH 730
+++ ++IG G G+V + +KK+ A+K++ + D + FA E+E+L K+ H
Sbjct: 26 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 85
Query: 731 RNILKLYACLLKGGSSFLVLEYMPNGNLFQALHK-RVKEGKPELDWFRRY---------- 779
NI+ L G +L +EY P+GNL L K RV E P
Sbjct: 86 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145
Query: 780 KIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYS 839
A A+G+ YL IHRD+ + NIL+ E+Y KIADFG+++ E Y
Sbjct: 146 HFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV------YV 196
Query: 840 CFAGTHGYI-----APE-LAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIV 892
T G + A E L Y+ + SDV+S+GV+L E+V+ G P
Sbjct: 197 --KKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTP------------ 241
Query: 893 YWVSTHLNNHENVLKVL----------DCEVASESIKEDMIKLLKIAVVCTTKLPNLRPP 942
Y + E + + L +C + + + M + C + P RP
Sbjct: 242 YC---GMTCAE-LYEKLPQGYRLEKPLNC---DDEVYDLMRQ-------CWREKPYERPS 287
Query: 943 MREVVKMLAD 952
+++ L
Sbjct: 288 FAQILVSLNR 297
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 8e-36
Identities = 69/322 (21%), Positives = 131/322 (40%), Gaps = 22/322 (6%)
Query: 648 DMENGEKEVSSKWKLASFHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVK 707
+++ +++ + ++ + + E +G+G G V+++ K + +A K
Sbjct: 8 ELDEQQRKRLEAFLTQKQKVGELKDDDFEKISE---LGAGNGGVVFKVSHKPSGLVMARK 64
Query: 708 QLW---KGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHK 764
+ K E+++L + I+ Y G + +E+M G+L Q L K
Sbjct: 65 LIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK 124
Query: 765 RVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFG 824
+ + L K+++ KG+ YL I+HRD+K SNIL++ E K+ DFG
Sbjct: 125 AGRIPEQILG-----KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFG 177
Query: 825 VAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEE 884
V+ +S S F GT Y++PE S +SD++S G+ L+E+ GR P+
Sbjct: 178 VSGQLIDSMANS----FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233
Query: 885 YGDGKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMR 944
++++ + E + D + I + + N PP
Sbjct: 234 DAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFEL-LDYIVNEPPPKL 292
Query: 945 EVVKMLADA----DPCTDKSPD 962
+ + C K+P
Sbjct: 293 PSGVFSLEFQDFVNKCLIKNPA 314
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 9e-36
Identities = 69/210 (32%), Positives = 98/210 (46%), Gaps = 21/210 (10%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVK-----QLWKGDGVKVFAAEMEILGKIRHRNILKL 736
+G G G VY K++ +A+K QL K E+EI +RH NIL+L
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQAL--HKRVKEGKPELDWFRRYKIALGAAKGIAYLHH 794
Y +L+LEY P G +++ L + E + Y L A ++Y H
Sbjct: 75 YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT-----ATYITEL--ANALSYCH- 126
Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAY 854
S +IHRDIK N+LL E KIADFG + A +S + C GT Y+ PE+
Sbjct: 127 --SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--TDLC--GTLDYLPPEMIE 180
Query: 855 TCKVSEKSDVFSFGVVLLELVTGRKPVEEE 884
EK D++S GV+ E + G+ P E
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 210
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 1e-35
Identities = 75/369 (20%), Positives = 130/369 (35%), Gaps = 49/369 (13%)
Query: 167 LTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICR 226
L++G++ +P+ + ++T L + NL +P ELR TL++
Sbjct: 39 NNGNAVLNVGES--GLTTLPDCLP--AHITTLVIPDNNLT-SLPALPPELR---TLEVSG 90
Query: 227 NKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIG 286
N+++ P L +L LPA L L I NQ+ LP
Sbjct: 91 NQLT-SLPVLPPGLLELSIFSNPLT----HLPALPSGLCKL---WIFGNQL-TSLPVLPP 141
Query: 287 NLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISE 346
L+ L+V +N P+ ++ KL Y N+ + P L ++ +S+
Sbjct: 142 GLQELSVS----DNQLASLPALPSELCKL---WAYNNQLTS-LPMLPS---GLQELSVSD 190
Query: 347 NQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLW 406
NQ + S P +L L A +N + +P ++ L +S N L+ +P
Sbjct: 191 NQLA-SLPTLPS---ELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTS-LPVLPS 241
Query: 407 ALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTN 466
L L N T + L L L + N+ + LP L L++ + L
Sbjct: 242 ELKE---LMVSGNRLTS-LPMLPS---GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEG 293
Query: 467 NNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDL-NLARNSLSGNIPRSL 525
N S + ALR+++S + L A + L
Sbjct: 294 NPLSERTLQ---ALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEP 350
Query: 526 SLLSSLNAL 534
+ +
Sbjct: 351 APADRWHMF 359
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-35
Identities = 82/420 (19%), Positives = 137/420 (32%), Gaps = 49/420 (11%)
Query: 115 LELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLS 174
+ + VLNV + + ++PD ++ + N T P +L +L
Sbjct: 34 MRACLNNGNAVLNVGESGL-TTLPD-CLPAHITTLVIPDNNLT-SLPA---LPPELRTLE 87
Query: 175 IGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFP 234
+ N +P L L+ +L P S L + L I N+++ P
Sbjct: 88 VSGN--QLTSLPVLPPGLLELSIFSNPLTHL----PALPSGLCK---LWIFGNQLT-SLP 137
Query: 235 RSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVF 294
LQ+L + N L LPA L L +NQ+ LP L+ L+V
Sbjct: 138 VLPPGLQELS---VSDNQLA-SLPALPSELCKL---WAYNNQL-TSLPMLPSGLQELSVS 189
Query: 295 QCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFP 354
+N P+ ++ KL Y NR + P L ++ +S N+ + S P
Sbjct: 190 ----DNQLASLPTLPSELYKL---WAYNNRLT-SLPALPS---GLKELIVSGNRLT-SLP 237
Query: 355 KYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGML 414
E L L +S N +P + L + N L+ ++P+ L L + +
Sbjct: 238 VLPSE----LKELMVSGNRLTSLPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTV 289
Query: 415 DFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIP 474
+ N + + TS RF S L +
Sbjct: 290 NLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAA--ADWLVPARE 347
Query: 475 SALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNAL 534
+ E+NA S D + + I L+ L+ AL
Sbjct: 348 GEPAPADRWHMFGQEDNADAFS---LFLDRLSETENFIKDAGFKAQISSWLAQLAEDEAL 404
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-34
Identities = 80/386 (20%), Positives = 132/386 (34%), Gaps = 96/386 (24%)
Query: 181 DEAEIPESIGN--LKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIR 238
A + + + L + L +P+ + + TL I N ++ P
Sbjct: 26 GRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPALPP 81
Query: 239 KLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFK 298
+L+ L E+ N LT LP L L F LP L L +F
Sbjct: 82 ELRTL---EVSGNQLT-SLPVLPPGLLELSIFSNPLTH----LPALPSGLCKLWIF---- 129
Query: 299 NNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLC 358
N P +++L +S+NQ + S P
Sbjct: 130 GNQLTSLPVLPPGLQEL---------------------------SVSDNQLA-SLPALPS 161
Query: 359 EKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGD 418
+L L A +N + +P +Q L +SDN L+ +P
Sbjct: 162 ---ELCKLWAYNNQLT-SLPML---PSGLQELSVSDNQLA-SLPTLP------------- 200
Query: 419 NDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALG 478
+ L +L NNR + LP+ L+ LI++ N + +P
Sbjct: 201 --------------SELYKLWAYNNRLT-SLPALPS---GLKELIVSGNRLTS-LPVLPS 241
Query: 479 ALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSG 538
L+ L + N LT S+P L++ RN L+ +P SL LSS +NL G
Sbjct: 242 ELK---ELMVSGNRLT-SLPMLPSGLLS---LSVYRNQLT-RLPESLIHLSSETTVNLEG 293
Query: 539 NKLTGSIPDNLMKLKLSSIDLSENQL 564
N L+ ++ +++S +
Sbjct: 294 NPLS-ERTLQALR-EITSAPGYSGPI 317
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-31
Identities = 65/303 (21%), Positives = 122/303 (40%), Gaps = 45/303 (14%)
Query: 264 LTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGN 323
++ + + LP+ + ++T NN + P+ ++R L + GN
Sbjct: 39 NNGNAVLNVGESGL-TTLPDCLP--AHITTLVIPDNNLT-SLPALPPELRTL---EVSGN 91
Query: 324 RFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYAD 383
+ + P L+ + P LC+ L + N +P
Sbjct: 92 QLTS-LPVLPPGLLELSIFSNPLTHLP-ALPSGLCK-------LWIFGNQLTSLPVL--- 139
Query: 384 CKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNN 443
+Q L +SDN L+ +P L L +N T + L L +L + +N
Sbjct: 140 PPGLQELSVSDNQLA-SLPALPSELCK---LWAYNNQLTS-LPMLPS---GLQELSVSDN 191
Query: 444 RFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGD 503
+ + LP+ L L NN + +P+ L+ L + N LT S+P
Sbjct: 192 QLA-SLPTLPSELYKLW---AYNNRLT-SLPALPSGLK---ELIVSGNRLT-SLPVLPS- 241
Query: 504 CARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLSEN 562
+ +L ++ N L+ ++P L S L +L++ N+LT +P++L+ L ++++L N
Sbjct: 242 --ELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGN 294
Query: 563 QLS 565
LS
Sbjct: 295 PLS 297
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 1e-30
Identities = 84/418 (20%), Positives = 135/418 (32%), Gaps = 70/418 (16%)
Query: 69 DSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNV 128
D + +T + + +L+ + + L L + N L+ LP+ L + +
Sbjct: 57 DCLPAHITTLVIPDNNLT-SLPALPP---ELRTLEVSGNQLT-SLPVLPPGLLELSIFSN 111
Query: 129 TGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPES 188
+P L L + N T P L LS+ DN A +P
Sbjct: 112 PLT----HLPAL--PSGLCKLWIFGNQLT-SLPV---LPPGLQELSVSDN--QLASLPAL 159
Query: 189 IGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIEL 248
L L + L +P S L+E L + N+++ P +L KLW
Sbjct: 160 PSELCKLW---AYNNQLT-SLPMLPSGLQE---LSVSDNQLA-SLPTLPSELYKLW---A 208
Query: 249 YANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSG 308
Y N LT LPA L L +S N++ LP LK L V N P
Sbjct: 209 YNNRLT-SLPALPSGLKEL---IVSGNRL-TSLPVLPSELKELMV----SGNRLTSLPML 259
Query: 309 FGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLA 368
+ L S+Y N+ + PE+L ++ T V++ N S R++ +
Sbjct: 260 PSGLLSL---SVYRNQLTR-LPESLIHLSSETTVNLEGNPLS-ERTLQAL--REITSAPG 312
Query: 369 LSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPL 428
S I + P AL
Sbjct: 313 YSGP------------------IIRFDMAGASAPRETRALHLAAADWLVPAREG-----E 349
Query: 429 IGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSL 486
+ ++N + L RL+ E + + F +I S L L + +L
Sbjct: 350 PAPADRWHMFGQEDN--ADAFSLFLDRLSETENF-IKDAGFKAQISSWLAQLAEDEAL 404
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 71/305 (23%), Positives = 122/305 (40%), Gaps = 65/305 (21%)
Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGT---VAVKQLWKG---DGVKVFAAEME 723
I E + +G G G+VY + G VAVK K D + F +E
Sbjct: 9 IAREDVVLNRI---LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAV 65
Query: 724 ILGKIRHRNILKLYA-CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIA 782
I+ + H +I+KL +++++E P G L L + K L +
Sbjct: 66 IMKNLDHPHIVKLIGIIE--EEPTWIIMELYPYGELGHYL----ERNKNSLKVLTLVLYS 119
Query: 783 LGAAKGIAYL--HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSC 840
L K +AYL + +HRDI NIL+ K+ DFG+++ E+ DY
Sbjct: 120 LQICKAMAYLESIN-----CVHRDIAVRNILVASPECVKLGDFGLSRYIED----EDY-- 168
Query: 841 FAGTHGYI-----APELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYW 894
+ + + +PE + + SDV+ F V + E+++ G++P ++
Sbjct: 169 YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP------------FF 216
Query: 895 VSTHLNNHENVLKVLDC-------EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVV 947
L N + V+ VL+ ++ + M + C P+ RP E+V
Sbjct: 217 ---WLENKD-VIGVLEKGDRLPKPDLCPPVLYTLMTR-------CWDYDPSDRPRFTELV 265
Query: 948 KMLAD 952
L+D
Sbjct: 266 CSLSD 270
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-35
Identities = 68/318 (21%), Positives = 113/318 (35%), Gaps = 62/318 (19%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD--GVKVFAAEMEILGKIR-HRNI 733
L ++ GG VY + A+K+L + + E+ + K+ H NI
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88
Query: 734 LKLYACLLKGGSS-------FLVLEYMPNGNLFQALHKRVKEGK-PE---LDWFRRYKIA 782
++ + G FL+L + G L + L K G L F
Sbjct: 89 VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFY----- 143
Query: 783 LGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFA 842
+ + ++H PPIIHRD+K N+LL K+ DFG A + P S +
Sbjct: 144 -QTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRR 201
Query: 843 ----------GTHGYIAPEL--AYTCK-VSEKSDVFSFGVVLLELVTGRKPVEEEYGDGK 889
T Y PE+ Y+ + EK D+++ G +L L + P E+
Sbjct: 202 ALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED------ 255
Query: 890 DIVYWVSTHLNNHENVLKVLDCEV---ASESIKEDMIKLLKIAVVCTTKLPNLRPPMREV 946
L++++ + ++ L++ P R + EV
Sbjct: 256 -------------GAKLRIVNGKYSIPPHDTQYTVFHSLIRA---MLQVNPEERLSIAEV 299
Query: 947 VK---MLADADPCTDKSP 961
V +A A KSP
Sbjct: 300 VHQLQEIAAARNVNPKSP 317
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-35
Identities = 72/313 (23%), Positives = 117/313 (37%), Gaps = 67/313 (21%)
Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAG---TVAVKQLWKG----DGVKVFAAEM 722
I +Q +G G G V LK+ G VAVK L ++ F E
Sbjct: 20 IPEQQFTLGRM---LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREA 76
Query: 723 EILGKIRHRNILKLYACLLKGGSS------FLVLEYMPNGNLFQAL-HKRVKEGKPELDW 775
+ + H ++ KL L+ + ++L +M +G+L L R+ E L
Sbjct: 77 ACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPL 136
Query: 776 FRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV 835
+ + A G+ YL S IHRD+ + N +L ED +ADFG+++ +
Sbjct: 137 QTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYS---- 189
Query: 836 SDYSCFAGTHGYI-----APELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGK 889
DY G + A E + SDV++FGV + E++T G+ P
Sbjct: 190 GDYYR-QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP--------- 239
Query: 890 DIVYWVSTHLNNHENVLKVL----------DCEVASESIKEDMIKLLKIAVVCTTKLPNL 939
Y + N E + L +C E + + M + C + P
Sbjct: 240 ---YA---GIENAE-IYNYLIGGNRLKQPPEC---MEEVYDLMYQ-------CWSADPKQ 282
Query: 940 RPPMREVVKMLAD 952
RP + L +
Sbjct: 283 RPSFTCLRMELEN 295
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 61/225 (27%), Positives = 94/225 (41%), Gaps = 19/225 (8%)
Query: 667 HIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVK-----QLWKGDGVKVFAAE 721
+ +D +G GG K + + A K L K + + E
Sbjct: 6 EVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSME 65
Query: 722 MEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQAL--HKRVKEGKPELDWFRRY 779
+ I + H++++ + F+VLE +L + K + E PE R Y
Sbjct: 66 ISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTE--PEA---RYY 120
Query: 780 KIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYS 839
+ G YLH + +IHRD+K N+ L+ED E KI DFG+A E +
Sbjct: 121 LRQI--VLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL 175
Query: 840 CFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEE 884
C GT YIAPE+ S + DV+S G ++ L+ G+ P E
Sbjct: 176 C--GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 218
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 69/309 (22%), Positives = 126/309 (40%), Gaps = 60/309 (19%)
Query: 670 IDAEQICNLEEDNLIGSGGTGKVYR-----LDLKKNAGTVAVKQLWKGDGVKV---FAAE 721
+ E+I E +G G G VY + + VA+K + + ++ F E
Sbjct: 22 VAREKITMSRE---LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 78
Query: 722 MEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKE-----GKPELDWF 776
++ + ++++L + +G + +++E M G+L L
Sbjct: 79 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 138
Query: 777 RRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVS 836
+ ++A A G+AYL+ + +HRD+ + N ++ ED+ KI DFG+ + +
Sbjct: 139 KMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE----T 191
Query: 837 DYSCFAGTHGYI-----APELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKD 890
DY G G + +PE + SDV+SFGVVL E+ T +P
Sbjct: 192 DY-YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP---------- 240
Query: 891 IVYWVSTHLNNHENVLK------VLDC-EVASESIKEDMIKLLKIAVVCTTKLPNLRPPM 943
Y L+N + VL+ +LD + + + E M C P +RP
Sbjct: 241 --YQ---GLSNEQ-VLRFVMEGGLLDKPDNCPDMLFELMRM-------CWQYNPKMRPSF 287
Query: 944 REVVKMLAD 952
E++ + +
Sbjct: 288 LEIISSIKE 296
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-35
Identities = 64/303 (21%), Positives = 117/303 (38%), Gaps = 59/303 (19%)
Query: 670 IDAEQICNLEEDNLIGSGGTGKVYR----LDLKKNAGTVAVKQLWKGDGVKV---FAAEM 722
++ L+ +GSG G V++ + + V +K + G + M
Sbjct: 10 FKETELRKLKV---LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHM 66
Query: 723 EILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIA 782
+G + H +I++L S LV +Y+P G+L + + + L
Sbjct: 67 LAIGSLDHAHIVRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQH----RGALGPQLLLNWG 121
Query: 783 LGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFA 842
+ AKG+ YL ++HR++ + N+LL + ++ADFGVA +
Sbjct: 122 VQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD---DKQL--L 173
Query: 843 GTHGYI-----APELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVS 896
+ A E + K + +SDV+S+GV + EL+T G +P Y
Sbjct: 174 YSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP------------YA-- 219
Query: 897 THLNNHENVLKVLDC-------EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949
L E V +L+ ++ + + M+K C N+RP +E+
Sbjct: 220 -GLRLAE-VPDLLEKGERLAQPQICTIDVYMVMVK-------CWMIDENIRPTFKELANE 270
Query: 950 LAD 952
Sbjct: 271 FTR 273
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-35
Identities = 63/296 (21%), Positives = 117/296 (39%), Gaps = 56/296 (18%)
Query: 677 NLEEDNLIGSGGTGKVYR----LDLKKNAGTVAVKQLWKGDGVKV---FAAEMEILGKIR 729
++ ++GSG G VY+ + +K VA+K+L + K E ++ +
Sbjct: 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 730 HRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGI 789
+ ++ +L L + L+ + MP G L + + K + + AKG+
Sbjct: 76 NPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGM 130
Query: 790 AYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI- 848
YL ++HRD+ + N+L+ KI DFG+AK+ + + G +
Sbjct: 131 NYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA-----EEKEYHAEGGKVP 182
Query: 849 ----APELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHE 903
A E + +SDV+S+GV + EL+T G KP Y + E
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP------------YD---GIPASE 227
Query: 904 NVLKVLDC-------EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952
+ +L+ + + + M+K C + RP RE++ +
Sbjct: 228 -ISSILEKGERLPQPPICTIDVYMIMVK-------CWMIDADSRPKFRELIIEFSK 275
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-35
Identities = 67/208 (32%), Positives = 101/208 (48%), Gaps = 16/208 (7%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVK-----QLWKGDGVKVFAAEMEILGKIRHRNILKLY 737
L+G G VYR + VA+K ++K V+ E++I +++H +IL+LY
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGK-PELDWFRRYKIALGAAKGIAYLHHDC 796
+LVLE NG + + L RVK E R + + G+ YLH
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEA---RHFMHQI--ITGMLYLH--- 129
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTC 856
S I+HRD+ SN+LL + KIADFG+A + + C GT YI+PE+A
Sbjct: 130 SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC--GTPNYISPEIATRS 187
Query: 857 KVSEKSDVFSFGVVLLELVTGRKPVEEE 884
+SDV+S G + L+ GR P + +
Sbjct: 188 AHGLESDVWSLGCMFYTLLIGRPPFDTD 215
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-35
Identities = 77/327 (23%), Positives = 126/327 (38%), Gaps = 75/327 (22%)
Query: 670 IDAEQICNLEEDNLIGSGGTGKVYR-----LDLKKNAGTVAVKQLWKG--DGVKVFAAEM 722
I I E +G G GKV+ L +++ VAVK L + + F E
Sbjct: 38 IKRRDIVLKWE---LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREA 94
Query: 723 EILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKR----------VKEGKPE 772
E+L ++H++I++ + +G +V EYM +G+L + L
Sbjct: 95 ELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP 154
Query: 773 LDWFRRYKIALGAAKGIAYL--HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK-IA 829
L + +A A G+ YL H +HRD+ + N L+ + KI DFG+++ I
Sbjct: 155 LGLGQLLAVASQVAAGMVYLAGLH-----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIY 209
Query: 830 ENSPKVSDYSCFAGTHGYI-----APE-LAYTCKVSEKSDVFSFGVVLLELVT-GRKPVE 882
DY G + PE + Y K + +SDV+SFGVVL E+ T G++P
Sbjct: 210 ST-----DY-YRVGGRTMLPIRWMPPESILYR-KFTTESDVWSFGVVLWEIFTYGKQP-- 260
Query: 883 EEYGDGKDIVYWVSTHLNNHENVLK------VLDC-EVASESIKEDMIKLLKIAVVCTTK 935
++ L+N E + L+ + M C +
Sbjct: 261 ----------WY---QLSNTE-AIDCITQGRELERPRACPPEVYAIMRG-------CWQR 299
Query: 936 LPNLRPPMREVVKMLADADPCTDKSPD 962
P R +++V L P
Sbjct: 300 EPQQRHSIKDVHARL---QALAQAPPV 323
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 5e-35
Identities = 83/302 (27%), Positives = 135/302 (44%), Gaps = 48/302 (15%)
Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKI 728
I E + + +G G G+V+ VA+K L G + F E +++ K+
Sbjct: 181 IPRESLRLEVK---LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKL 236
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
RH +++LYA + + ++V EYM G+L L L + +A A G
Sbjct: 237 RHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASG 292
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
+AY+ +HRD++++NIL+ E+ K+ADFG+A++ E+ ++Y+ G I
Sbjct: 293 MAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED----NEYTARQGAKFPI 345
Query: 849 ---APELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHEN 904
APE A + + KSDV+SFG++L EL T GR P Y + N E
Sbjct: 346 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP------------YP---GMVNREV 390
Query: 905 VLKV-----LDC-EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPCTD 958
+ +V + C ES+ + M + C K P RP + L D T+
Sbjct: 391 LDQVERGYRMPCPPECPESLHDLMCQ-------CWRKEPEERPTFEYLQAFLEDYFTSTE 443
Query: 959 KS 960
Sbjct: 444 PQ 445
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 7e-35
Identities = 60/209 (28%), Positives = 91/209 (43%), Gaps = 19/209 (9%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVK-----QLWKGDGVKVFAAEMEILGKIRHRNILKLY 737
+G GG K + + A K L K + + E+ I + H++++ +
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQAL--HKRVKEGKPELDWFRRYKIALGAAKGIAYLHHD 795
F+VLE +L + K + E PE R Y + G YLH +
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTE--PEA---RYYLRQI--VLGCQYLHRN 160
Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYT 855
+IHRD+K N+ L+ED E KI DFG+A E + C GT YIAPE+
Sbjct: 161 R---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTPNYIAPEVLSK 215
Query: 856 CKVSEKSDVFSFGVVLLELVTGRKPVEEE 884
S + DV+S G ++ L+ G+ P E
Sbjct: 216 KGHSFEVDVWSIGCIMYTLLVGKPPFETS 244
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 8e-35
Identities = 65/304 (21%), Positives = 114/304 (37%), Gaps = 63/304 (20%)
Query: 670 IDAEQICNLEEDNLIGSGGTGKVYR--LDLKKNAGT-VAVKQLWKG---DGVKVFAAEME 723
I E+I IG G G V++ +N VA+K + F E
Sbjct: 12 IQRERIELGRC---IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 68
Query: 724 ILGKIRHRNILKLYA-CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIA 782
+ + H +I+KL ++++E G L ++ K LD A
Sbjct: 69 TMRQFDHPHIVKLIGVIT--ENPVWIIMELCTLGEL----RSFLQVRKYSLDLASLILYA 122
Query: 783 LGAAKGIAYL-HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCF 841
+ +AYL +HRDI + N+L+ + K+ DFG+++ E+ S Y +
Sbjct: 123 YQLSTALAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMED----STY--Y 172
Query: 842 AGTHGYI-----APELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWV 895
+ G + APE + + SDV+ FGV + E++ G KP +
Sbjct: 173 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP------------FQ- 219
Query: 896 STHLNNHENVLKVLDC-------EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVK 948
+ N++ V+ ++ ++ M K C P+ RP E+
Sbjct: 220 --GVKNND-VIGRIENGERLPMPPNCPPTLYSLMTK-------CWAYDPSRRPRFTELKA 269
Query: 949 MLAD 952
L+
Sbjct: 270 QLST 273
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 52/217 (23%), Positives = 93/217 (42%), Gaps = 30/217 (13%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKIRHRN--ILK 735
IGSGG+ KV+++ L + A+K + + + E+ L K++ + I++
Sbjct: 34 KQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 92
Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH-H 794
LY + ++V+E N +L L K+ + + Y + + + +H H
Sbjct: 93 LYDYEITDQYIYMVMECG-NIDLNSWLKKK---KSIDPWERKSYWKNM--LEAVHTIHQH 146
Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL-- 852
I+H D+K +N L+ + K+ DFG+A + GT Y+ PE
Sbjct: 147 G----IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 201
Query: 853 ---------AYTCKVSEKSDVFSFGVVLLELVTGRKP 880
K+S KSDV+S G +L + G+ P
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 59/222 (26%), Positives = 93/222 (41%), Gaps = 35/222 (15%)
Query: 681 DNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK---GDGVKVFAAEMEILGKIRHRNILKLY 737
+++G G T V+R KK A+K V V E E+L K+ H+NI+KL+
Sbjct: 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 738 ACLLKGGSS--FLVLEYMPNGNLFQALHKRVKEGK-PELDWFRRYKIALGAAKGIAYLHH 794
A + + L++E+ P G+L+ L + PE + F + G+ +L
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESE-FLIVLRDV--VGGMNHLR- 129
Query: 795 DCSPPIIHRDIKSSNILL----DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
I+HR+IK NI+ D K+ DFG A+ E+ + GT Y+ P
Sbjct: 130 --ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS---LYGTEEYLHP 184
Query: 851 EL------------AYTCKVSEKSDVFSFGVVLLELVTGRKP 880
++ Y V D++S GV TG P
Sbjct: 185 DMYERAVLRKDHQKKYGATV----DLWSIGVTFYHAATGSLP 222
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 75/305 (24%), Positives = 117/305 (38%), Gaps = 63/305 (20%)
Query: 670 IDAEQICNLEEDNLIGSGGTGKVYR--LDLKKNAGTVAVKQLWKG----DGVKVFAAEME 723
+D + + ED +GSG G V + +KK TVAVK L AE
Sbjct: 13 LDRKLL--TLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEAN 70
Query: 724 ILGKIRHRNILKLYA-CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIA 782
++ ++ + I+++ C S LV+E G L + L + + ++
Sbjct: 71 VMQQLDNPYIVRMIGICE--AESWMLVMEMAELGPLNKYLQQNRHVKDKNI-----IELV 123
Query: 783 LGAAKGIAYL--HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSC 840
+ G+ YL + +HRD+ + N+LL + KI+DFG++K Y
Sbjct: 124 HQVSMGMKYLEESN-----FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY--YK- 175
Query: 841 FAGTHGYI-----APELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYW 894
A THG APE K S KSDV+SFGV++ E + G+KP Y
Sbjct: 176 -AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP------------YR 222
Query: 895 VSTHLNNHENVLKVLDC-------EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVV 947
+ E V +L+ + + M C T RP V
Sbjct: 223 ---GMKGSE-VTAMLEKGERMGCPAGCPREMYDLMNL-------CWTYDVENRPGFAAVE 271
Query: 948 KMLAD 952
L +
Sbjct: 272 LRLRN 276
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-34
Identities = 48/212 (22%), Positives = 89/212 (41%), Gaps = 27/212 (12%)
Query: 683 LIGSGGTGKVYR-LDLKKNAGTVAVKQL-WKGD--GVKVFAAEMEILGKIRHRNILKLY- 737
I GG G +Y LD N V +K L GD + AE + L ++ H +I++++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 738 ----ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
++V+EY+ +L ++ ++ L L ++YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-------LPVAEAIAYLLEILPALSYLH 199
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELA 853
S +++ D+K NI+L E+ + K+ D G +++ + GT G+ APE+
Sbjct: 200 ---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS------RINSFGYLYGTPGFQAPEIV 249
Query: 854 YTCKVSEKSDVFSFGVVLLELVTGRKPVEEEY 885
+ +D+++ G L L Y
Sbjct: 250 -RTGPTVATDIYTVGRTLAALTLDLPTRNGRY 280
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 2e-34
Identities = 82/304 (26%), Positives = 134/304 (44%), Gaps = 52/304 (17%)
Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKI 728
I E + + +G G G+V+ VA+K L G + F E +++ K+
Sbjct: 264 IPRESLRLEVK---LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKL 319
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
RH +++LYA + + ++V EYM G+L L L + +A A G
Sbjct: 320 RHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASG 375
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
+AY+ +HRD++++NIL+ E+ K+ADFG+A++ E+ ++Y+ A
Sbjct: 376 MAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED----NEYT--ARQGAKF 426
Query: 849 -----APELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNH 902
APE A + + KSDV+SFG++L EL T GR P Y + N
Sbjct: 427 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP------------YP---GMVNR 471
Query: 903 ENVLKV-----LDC-EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPC 956
E + +V + C ES+ + M + C K P RP + L D
Sbjct: 472 EVLDQVERGYRMPCPPECPESLHDLMCQ-------CWRKEPEERPTFEYLQAFLEDYFTS 524
Query: 957 TDKS 960
T+
Sbjct: 525 TEPQ 528
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 64/207 (30%), Positives = 94/207 (45%), Gaps = 17/207 (8%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVK-----QLWKGDGVKVFAAEMEILGKIRHRNILKLY 737
+G G G VY K+N +A+K QL K E+EI +RH NIL++Y
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
+L+LE+ P G L++ L K G+ + + L A + Y H
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFMEEL--ADALHYCH---E 132
Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCK 857
+IHRDIK N+L+ E KIADFG + A + + C GT Y+ PE+
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR--RTMC--GTLDYLPPEMIEGKT 188
Query: 858 VSEKSDVFSFGVVLLELVTGRKPVEEE 884
EK D++ GV+ E + G P +
Sbjct: 189 HDEKVDLWCAGVLCYEFLVGMPPFDSP 215
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 3e-34
Identities = 52/217 (23%), Positives = 93/217 (42%), Gaps = 30/217 (13%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRH--RNILK 735
IGSGG+ KV+++ L + A+K + + + + E+ L K++ I++
Sbjct: 15 KQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 73
Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH-H 794
LY + ++V+E N +L L K+ + + Y + + + +H H
Sbjct: 74 LYDYEITDQYIYMVMEC-GNIDLNSWLKKK---KSIDPWERKSYWKNM--LEAVHTIHQH 127
Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL-- 852
I+H D+K +N L+ + K+ DFG+A + GT Y+ PE
Sbjct: 128 G----IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 182
Query: 853 ---------AYTCKVSEKSDVFSFGVVLLELVTGRKP 880
K+S KSDV+S G +L + G+ P
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-34
Identities = 72/311 (23%), Positives = 113/311 (36%), Gaps = 68/311 (21%)
Query: 670 IDAEQICNLEEDNLIGSGGTGKVYR-----LDLKKNAGTVAVKQLWKGDGVKV---FAAE 721
+ + I + +G G G+VY + + VAVK L + + F E
Sbjct: 27 VPRKNITLIRG---LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLME 83
Query: 722 MEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQAL--HKRVKEGKPELDWFRRY 779
I+ K H+NI++ L+ F+++E M G+L L + L
Sbjct: 84 ALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLL 143
Query: 780 KIALGAAKGIAYL--HHDCSPPIIHRDIKSSNILLD---EDYEPKIADFGVAK-IAENSP 833
+A A G YL +H IHRDI + N LL KI DFG+A+ I
Sbjct: 144 HVARDIACGCQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-- 196
Query: 834 KVSDYSCFAGTHGYI-----APE-LAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYG 886
Y G + PE + K+D +SFGV+L E+ + G P
Sbjct: 197 ---SY-YRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMP------ 245
Query: 887 DGKDIVYWVSTHLNNHENVLK------VLDC-EVASESIKEDMIKLLKIAVVCTTKLPNL 939
Y +N E VL+ +D + + M + C P
Sbjct: 246 ------YP---SKSNQE-VLEFVTSGGRMDPPKNCPGPVYRIMTQ-------CWQHQPED 288
Query: 940 RPPMREVVKML 950
RP +++ +
Sbjct: 289 RPNFAIILERI 299
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 3e-34
Identities = 63/290 (21%), Positives = 109/290 (37%), Gaps = 59/290 (20%)
Query: 684 IGSGGTGKVYRLDLKKNAGT--VAVKQLWKGDGVKV---FAAEMEILGKIRHRNILKLYA 738
+G G G V + + VA+K L +G E +I+ ++ + I++L
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 739 -CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL--HHD 795
C + LV+E G L HK + + E+ ++ + G+ YL +
Sbjct: 78 VCQ--AEALMLVMEMAGGGPL----HKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN- 130
Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI-----AP 850
+HRD+ + N+LL + KI+DFG++K Y+ A + G AP
Sbjct: 131 ----FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY--YT--ARSAGKWPLKWYAP 182
Query: 851 ELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVL 909
E K S +SDV+S+GV + E ++ G+KP Y + E V+ +
Sbjct: 183 ECINFRKFSSRSDVWSYGVTMWEALSYGQKP------------YK---KMKGPE-VMAFI 226
Query: 910 DC-------EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952
+ + M C RP V + +
Sbjct: 227 EQGKRMECPPECPPELYALMSD-------CWIYKWEDRPDFLTVEQRMRA 269
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-34
Identities = 53/227 (23%), Positives = 95/227 (41%), Gaps = 38/227 (16%)
Query: 679 EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRHRNILK 735
E +G GG G V+ K + A+K++ + E++ L K+ H I++
Sbjct: 8 EPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVR 67
Query: 736 LYACLLKGGSS------------FLVLEYMPNGNLFQALHKRVKEGKPE----LDWFRRY 779
+ L+ ++ ++ ++ NL ++ R + E L F
Sbjct: 68 YFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL-- 125
Query: 780 KIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS------- 832
+IA + +LH S ++HRD+K SNI D K+ DFG+ +
Sbjct: 126 QIAEA----VEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 833 ---PKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT 876
P + ++ GT Y++PE + S K D+FS G++L EL+
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 5e-34
Identities = 42/229 (18%), Positives = 83/229 (36%), Gaps = 38/229 (16%)
Query: 684 IGSGGTGKVYRLDLKKNAGT-VAVKQLWKGDGVKVFAA-------------------EME 723
+ G K+ L + A+K+ K K E++
Sbjct: 39 LNQGKFNKII---LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQ 95
Query: 724 ILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWF-----RR 778
I+ I++ L + +++ EYM N ++ + K + +
Sbjct: 96 IITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC 155
Query: 779 YKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY 838
+Y+H++ + I HRD+K SNIL+D++ K++DFG ++ +
Sbjct: 156 I--IKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVD----KKI 207
Query: 839 SCFAGTHGYIAPELAYTCKV--SEKSDVFSFGVVLLELVTGRKPVEEEY 885
GT+ ++ PE K D++S G+ L + P +
Sbjct: 208 KGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 7e-34
Identities = 51/217 (23%), Positives = 92/217 (42%), Gaps = 30/217 (13%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRH--RNILK 735
IGSGG+ KV+++ L + A+K + + + + E+ L K++ I++
Sbjct: 62 KQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 120
Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH-H 794
LY + ++V+E N +L L K+ + + Y + + + +H H
Sbjct: 121 LYDYEITDQYIYMVMEC-GNIDLNSWLKKK---KSIDPWERKSYWKNM--LEAVHTIHQH 174
Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL-- 852
I+H D+K +N L+ + K+ DFG+A + G Y+ PE
Sbjct: 175 G----IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIK 229
Query: 853 ---------AYTCKVSEKSDVFSFGVVLLELVTGRKP 880
K+S KSDV+S G +L + G+ P
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 8e-34
Identities = 56/227 (24%), Positives = 106/227 (46%), Gaps = 30/227 (13%)
Query: 668 IDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAAEMEI 724
+++ A+ + + E +G G G V ++ + +AVK++ K +++I
Sbjct: 2 MEVKADDLEPIME---LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDI 58
Query: 725 LGK-IRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGK--PELDWFRRYKI 781
+ + + Y L + G ++ +E M + +L + + + +G+ PE D KI
Sbjct: 59 SMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPE-DILG--KI 114
Query: 782 ALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCF 841
A+ K + +LH S +IHRD+K SN+L++ + K+ DFG++ +
Sbjct: 115 AVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDD---VAKDID 169
Query: 842 AGTHGYIAPE--------LAYTCKVSEKSDVFSFGVVLLELVTGRKP 880
AG Y+APE Y+ KSD++S G+ ++EL R P
Sbjct: 170 AGCKPYMAPERINPELNQKGYSV----KSDIWSLGITMIELAILRFP 212
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 8e-34
Identities = 73/308 (23%), Positives = 120/308 (38%), Gaps = 63/308 (20%)
Query: 677 NLEEDNLIGSGGTGKVYR-----LDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKI 728
NL+ +G+G GKV L + VAVK L D + +E++I+ +
Sbjct: 47 NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL 106
Query: 729 -RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKR---------VKEGKPELDWFRR 778
+H NI+ L GG ++ EY G+L L ++
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDL 166
Query: 779 YKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA-KIAENSPKVSD 837
+ A+G+A+L S IHRD+ + N+LL + KI DFG+A I + S+
Sbjct: 167 LHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND----SN 219
Query: 838 YSCFAGTHGYI-----APELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDI 891
Y + + APE + C + +SDV+S+G++L E+ + G P
Sbjct: 220 YI--VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP----------- 266
Query: 892 VYWVSTHLNNHENVLK------VLDC-EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMR 944
Y L N + K + A ++I M C P RP +
Sbjct: 267 -YP--GILVNSK-FYKLVKDGYQMAQPAFAPKNIYSIMQA-------CWALEPTHRPTFQ 315
Query: 945 EVVKMLAD 952
++ L +
Sbjct: 316 QICSFLQE 323
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 72/312 (23%), Positives = 114/312 (36%), Gaps = 67/312 (21%)
Query: 677 NLEEDNLIGSGGTGKVYR-----LDLKKNAGTVAVKQLWKGDGVKV---FAAEMEILGKI 728
L +G+G GKV L A TVAVK L + +E+++L +
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83
Query: 729 -RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK------- 780
H NI+ L GG + ++ EY G+L L ++ +
Sbjct: 84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 781 ------IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA-KIAENSP 833
+ AKG+A+L S IHRD+ + NILL KI DFG+A I +
Sbjct: 144 LEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKND-- 198
Query: 834 KVSDYSCFAGTHGYI-----APELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGD 887
+ + APE + C + +SDV+S+G+ L EL + G P Y
Sbjct: 199 ---SN-YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP----YPG 250
Query: 888 GKDIVYWVSTHLNNHENVLK------VLDC-EVASESIKEDMIKLLKIAVVCTTKLPNLR 940
+ K + E A + + M C P R
Sbjct: 251 -----------MPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKT-------CWDADPLKR 292
Query: 941 PPMREVVKMLAD 952
P +++V+++
Sbjct: 293 PTFKQIVQLIEK 304
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-33
Identities = 75/299 (25%), Positives = 125/299 (41%), Gaps = 42/299 (14%)
Query: 662 LASFHHIDIDAEQICNLEEDNL-----IGSGGTGKVYRLDLKKNAGTVAVKQL---WKGD 713
+ S + I EQ + ++L IG G G V ++ K + +AVK++
Sbjct: 3 IESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK 62
Query: 714 GVKVFAAEMEILGK-IRHRNILKLYACLLKGGSSFLVLEYMPNG--NLFQALHKRVKEGK 770
K +++++ + I++ Y L + G ++ +E M ++ ++ + +
Sbjct: 63 EQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVI 122
Query: 771 PELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830
PE + KI L K + +L + IIHRDIK SNILLD K+ DFG++
Sbjct: 123 PE-EILG--KITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177
Query: 831 NSPKVSDYSCFAGTHGYIAPE--------LAYTCKVSEKSDVFSFGVVLLELVTGRKPVE 882
+S + AG Y+APE Y +SDV+S G+ L EL TGR P
Sbjct: 178 DS---IAKTRDAGCRPYMAPERIDPSASRQGYDV----RSDVWSLGITLYELATGRFP-- 228
Query: 883 EEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRP 941
Y + ++ + L + S S + + L C TK + RP
Sbjct: 229 --YPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFI-NFVNL------CLTKDESKRP 278
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-33
Identities = 73/310 (23%), Positives = 113/310 (36%), Gaps = 66/310 (21%)
Query: 670 IDAEQICNLEEDNLIGSGGTGKVYR-----LDLKKNAGTVAVKQLWKGDGVKV---FAAE 721
+ + I + +G G G+VY + + VAVK L + + F E
Sbjct: 68 VPRKNITLIRG---LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLME 124
Query: 722 MEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQAL--HKRVKEGKPELDWFRRY 779
I+ K H+NI++ L+ F++LE M G+L L + L
Sbjct: 125 ALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLL 184
Query: 780 KIALGAAKGIAYL--HHDCSPPIIHRDIKSSNILLD---EDYEPKIADFGVAK-IAENSP 833
+A A G YL +H IHRDI + N LL KI DFG+A+ I
Sbjct: 185 HVARDIACGCQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-- 237
Query: 834 KVSDYSCFAGTHGYI-----APELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGD 887
Y G + PE + K+D +SFGV+L E+ + G P
Sbjct: 238 ---GY-YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP------- 286
Query: 888 GKDIVYWVSTHLNNHENVLK------VLDC-EVASESIKEDMIKLLKIAVVCTTKLPNLR 940
Y +N E VL+ +D + + M + C P R
Sbjct: 287 -----YP---SKSNQE-VLEFVTSGGRMDPPKNCPGPVYRIMTQ-------CWQHQPEDR 330
Query: 941 PPMREVVKML 950
P +++ +
Sbjct: 331 PNFAIILERI 340
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-33
Identities = 77/311 (24%), Positives = 127/311 (40%), Gaps = 66/311 (21%)
Query: 677 NLEEDNLIGSGGTGKVYR-------LDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILG 726
L +G G G+V D K A TVAVK L + +EME++
Sbjct: 82 KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 141
Query: 727 KI-RHRNILKLYACLLKGGSSFLVLEYMPNGNL-----------FQALHKRVKEGKPELD 774
I +H+NI+ L + G ++++EY GNL + + + + ++
Sbjct: 142 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 201
Query: 775 WFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK 834
+ A+G+ YL S IHRD+ + N+L+ E+ KIADFG+A+ N
Sbjct: 202 FKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINN--- 255
Query: 835 VSDYSCFAGTHGYI-----APELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDG 888
DY T+G + APE + + +SDV+SFGV++ E+ T G P
Sbjct: 256 -IDY-YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP-------- 305
Query: 889 KDIVYWVSTHLNNHENVLK------VLDC-EVASESIKEDMIKLLKIAVVCTTKLPNLRP 941
Y + E + K +D + + M C +P+ RP
Sbjct: 306 ----YP---GIPVEE-LFKLLKEGHRMDKPANCTNELYMMMRD-------CWHAVPSQRP 350
Query: 942 PMREVVKMLAD 952
+++V+ L
Sbjct: 351 TFKQLVEDLDR 361
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 1e-33
Identities = 59/222 (26%), Positives = 93/222 (41%), Gaps = 35/222 (15%)
Query: 681 DNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK---GDGVKVFAAEMEILGKIRHRNILKLY 737
+++G G T V+R KK A+K V V E E+L K+ H+NI+KL+
Sbjct: 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 738 ACLLKGGSS--FLVLEYMPNGNLFQALHKRVKEGK-PELDWFRRYKIALGAAKGIAYLHH 794
A + + L++E+ P G+L+ L + PE + F + G+ +L
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESE-FLIVLRDV--VGGMNHLR- 129
Query: 795 DCSPPIIHRDIKSSNILL----DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
I+HR+IK NI+ D K+ DFG A+ E+ + GT Y+ P
Sbjct: 130 --ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS---LYGTEEYLHP 184
Query: 851 EL------------AYTCKVSEKSDVFSFGVVLLELVTGRKP 880
++ Y V D++S GV TG P
Sbjct: 185 DMYERAVLRKDHQKKYGATV----DLWSIGVTFYHAATGSLP 222
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-33
Identities = 77/311 (24%), Positives = 127/311 (40%), Gaps = 66/311 (21%)
Query: 677 NLEEDNLIGSGGTGKVYR-------LDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILG 726
L +G G G+V D K A TVAVK L + +EME++
Sbjct: 36 KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 95
Query: 727 KI-RHRNILKLYACLLKGGSSFLVLEYMPNGNL-----------FQALHKRVKEGKPELD 774
I +H+NI+ L + G ++++EY GNL + + + + ++
Sbjct: 96 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 775 WFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK 834
+ A+G+ YL S IHRD+ + N+L+ E+ KIADFG+A+ N
Sbjct: 156 FKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINN--- 209
Query: 835 VSDYSCFAGTHGYI-----APELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDG 888
DY T+G + APE + + +SDV+SFGV++ E+ T G P
Sbjct: 210 -IDY-YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP-------- 259
Query: 889 KDIVYWVSTHLNNHENVLK------VLDC-EVASESIKEDMIKLLKIAVVCTTKLPNLRP 941
Y + E + K +D + + M C +P+ RP
Sbjct: 260 ----YP---GIPVEE-LFKLLKEGHRMDKPANCTNELYMMMRD-------CWHAVPSQRP 304
Query: 942 PMREVVKMLAD 952
+++V+ L
Sbjct: 305 TFKQLVEDLDR 315
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-33
Identities = 95/511 (18%), Positives = 164/511 (32%), Gaps = 62/511 (12%)
Query: 82 NKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD-- 139
L + +S T+L++ N +S ++ + S L++L ++ N + +
Sbjct: 9 KNGLI-HVPKDLSQ--KTTILNISQNYISELWTSDILSLSKLRILIISHNRI-QYLDISV 64
Query: 140 LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLF 199
+ LE DLS N L L + N +D I + GN+ L +L
Sbjct: 65 FKFNQELEYLDLSHNKLVKISCHP---TVNLKHLDLSFNAFDALPICKEFGNMSQLKFLG 121
Query: 200 LAHCNLRGRIPESISELRELG-TLDICRNKISGEFPRSIRKL--QKLWKIELYANNLTGE 256
L+ +L I+ L L + E P ++ + L +
Sbjct: 122 LSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFI 181
Query: 257 LPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLF 316
L + + L+ +I K + L L N L
Sbjct: 182 LDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNL-------------TLN 228
Query: 317 AFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGE 376
N F L +T + IS + G S
Sbjct: 229 NIETTWNSFIRIL--QLVWHTTVWYFSISNVKLQGQLD---------FRDFDYSGT---- 273
Query: 377 VPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLS 436
K + ++ + N+ + +F + +
Sbjct: 274 ------SLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFL 327
Query: 437 QLVLQNNRFSGELPSELGRLTNLERLILTNNNFS--GKIPSALGALRQLSSLHLEENALT 494
L NN + + G LT LE LIL N KI ++ L L + +N+++
Sbjct: 328 HLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVS 387
Query: 495 GSIPNEMGDC-ARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL- 552
++ LN++ N L+ I R L + L+L NK+ SIP ++KL
Sbjct: 388 YDEKKGDCSWTKSLLSLNMSSNILTDTIFR--CLPPRIKVLDLHSNKIK-SIPKQVVKLE 444
Query: 553 KLSSIDLSENQLSGSVPLDFLRMGGDGAFAG 583
L ++++ NQL SVP DG F
Sbjct: 445 ALQELNVASNQLK-SVP--------DGIFDR 466
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 83.8 bits (207), Expect = 8e-17
Identities = 64/403 (15%), Positives = 127/403 (31%), Gaps = 51/403 (12%)
Query: 89 ISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEI 148
I + L L L L L +++ + KVL V G D L++
Sbjct: 107 ICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYG-EKEDPEGLQDFNT 165
Query: 149 FDLSINYFTGRFPRWVVN----------LTQLVSLSIGDNVYDEAEIPESIGNLKNLTYL 198
L I + T + ++++ L+ + + + I + L+ L
Sbjct: 166 ESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNL 225
Query: 199 FLAHCNLRGRIPESISEL---RELGTLDICRNKISG-----EFPRSIRKLQKLWKIELYA 250
L + I +L + I K+ G +F S L+ L ++ +
Sbjct: 226 TLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVS 285
Query: 251 NNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFG 310
+ + + + + + + N + G
Sbjct: 286 DVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCG 345
Query: 311 DMRKLFAFSIYGNRFS--GPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLA 368
+ +L + N+ E + +L +DIS+N S K C K L L
Sbjct: 346 HLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLN 405
Query: 369 LSNNFSGEVPNSYADC--KTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGIS 426
+S+N + ++ C I+ L + N + IP + L
Sbjct: 406 MSSN---ILTDTIFRCLPPRIKVLDLHSNKIK-SIPKQVVKL------------------ 443
Query: 427 PLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNF 469
+L +L + +N+ RLT+L+++ L N +
Sbjct: 444 ------EALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 6e-13
Identities = 40/231 (17%), Positives = 84/231 (36%), Gaps = 32/231 (13%)
Query: 75 VTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMV 134
++ + S ++ + + + L S S L+ + N +
Sbjct: 278 LSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLT 337
Query: 135 GSVPD-LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLK 193
+V + L LE L +N QL LS + +K
Sbjct: 338 DTVFENCGHLTELETLILQMN--------------QLKELSKIAEMTT---------QMK 374
Query: 194 NLTYLFLAHCNLRGRIPESI-SELRELGTLDICRNKI-SGEFPRSIRKLQKLWKIELYAN 251
+L L ++ ++ + S + L +L++ N + F +++ L L++N
Sbjct: 375 SLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLD---LHSN 431
Query: 252 NLTGELPAELGNLTLLQEFDISSNQMYGKLPEEI-GNLKNLTVFQCFKNNF 301
+ +P ++ L LQE +++SNQ+ +P+ I L +L N +
Sbjct: 432 KIK-SIPKQVVKLEALQELNVASNQL-KSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 38/210 (18%), Positives = 64/210 (30%), Gaps = 48/210 (22%)
Query: 66 ITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKV 125
+ C S + F N L+ + + L L L L N L
Sbjct: 317 MLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK--------------- 361
Query: 126 LNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEI 185
+ ++ E+ + L L I N E
Sbjct: 362 ----------ELSKIA-----EMTT---------------QMKSLQQLDISQNSVSYDEK 391
Query: 186 PESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWK 245
K+L L ++ L I + + LD+ NKI P+ + KL+ L +
Sbjct: 392 KGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQE 448
Query: 246 IELYANNLTGELPAELGNLTLLQEFDISSN 275
+ + +N L LT LQ+ + +N
Sbjct: 449 LNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-33
Identities = 60/217 (27%), Positives = 93/217 (42%), Gaps = 22/217 (10%)
Query: 681 DNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK---GDGVKVFAAEMEILGKIRHRNILKLY 737
+G+GG G V R + VA+KQ + + + E++I+ K+ H N++
Sbjct: 19 KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78
Query: 738 AC------LLKGGSSFLVLEYMPNGNLFQALHKRVKEGK-PELDWFRRYKIALGAAKGIA 790
L L +EY G+L + L++ E R + +A +
Sbjct: 79 EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGP-IRTLLSDISSA--LR 135
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEP---KIADFGVAKIAENSPKVSDYSCFAGTHGY 847
YLH IIHRD+K NI+L + KI D G AK + ++ F GT Y
Sbjct: 136 YLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE---FVGTLQY 189
Query: 848 IAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEE 884
+APEL K + D +SFG + E +TG +P
Sbjct: 190 LAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN 226
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 57/320 (17%), Positives = 116/320 (36%), Gaps = 89/320 (27%)
Query: 670 IDAEQICNLEEDNLIGSGGTGKVYR-------LDLKKNAGTVAVKQLWKG--DGVKVFAA 720
I E + E +G G K+++ + + V +K L K + + F
Sbjct: 5 IRNEDLIFNES---LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE 61
Query: 721 EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK 780
++ K+ H++++ Y + G + LV E++ G+L L K+ K ++ + +
Sbjct: 62 AASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL----KKNKNCINILWKLE 117
Query: 781 IALGAAKGIAYL--HHDCSPPIIHRDIKSSNILLDEDYEP--------KIADFGVAKIAE 830
+A A + +L + +IH ++ + NILL + + K++D G++
Sbjct: 118 VAKQLAAAMHFLEENT-----LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL 172
Query: 831 NSPKVSDYSCFAGTHGY------IAPE-LAYTCKVSEKSDVFSFGVVLLELVT-GRKPVE 882
D + PE + ++ +D +SFG L E+ + G KP
Sbjct: 173 P----KDI--------LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP-- 218
Query: 883 EEYGDGKDIVYWVSTHLNNHENVLKVLD----------CEVASESIKEDMIKLLKIAVVC 932
L++ L+ + E+A + C
Sbjct: 219 ----------LS---ALDSQR-KLQFYEDRHQLPAPKAAELA-----NLINN-------C 252
Query: 933 TTKLPNLRPPMREVVKMLAD 952
P+ RP R +++ L
Sbjct: 253 MDYEPDHRPSFRAIIRDLNS 272
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 3e-33
Identities = 70/305 (22%), Positives = 119/305 (39%), Gaps = 65/305 (21%)
Query: 670 IDAEQICNLEEDNLIGSGGTGKVYR---LDLKKNAGTVAVKQLWKGDGVKV---FAAEME 723
I E+I IG G G V++ + + A VA+K V F E
Sbjct: 387 IQRERIELGRC---IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 443
Query: 724 ILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL 783
+ + H +I+KL + + ++++E G L L R K LD A
Sbjct: 444 TMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVR----KFSLDLASLILYAY 498
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAG 843
+ +AYL S +HRDI + N+L+ + K+ DFG+++ E+ S Y +
Sbjct: 499 QLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED----STY--YKA 549
Query: 844 THGYI-----APELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVST 897
+ G + APE + + SDV+ FGV + E++ G KP +
Sbjct: 550 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP------------FQ--- 594
Query: 898 HLNNHENVLKVL----------DCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVV 947
+ N++ V+ + +C ++ M K C P+ RP E+
Sbjct: 595 GVKNND-VIGRIENGERLPMPPNC---PPTLYSLMTK-------CWAYDPSRRPRFTELK 643
Query: 948 KMLAD 952
L+
Sbjct: 644 AQLST 648
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-33
Identities = 56/205 (27%), Positives = 99/205 (48%), Gaps = 21/205 (10%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLL 741
+G G G VY+ K+ VA+KQ+ ++ E+ I+ + +++K Y
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 742 KGGSSFLVLEYMPNG---NLFQALHKRVKEGKPELDWFRRYKIAL---GAAKGIAYLHHD 795
K ++V+EY G ++ + +K + E +IA KG+ YLH
Sbjct: 95 KNTDLWIVMEYCGAGSVSDIIRLRNKTLTED----------EIATILQSTLKGLEYLH-- 142
Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYT 855
IHRDIK+ NILL+ + K+ADFGVA + + ++ + GT ++APE+
Sbjct: 143 -FMRKIHRDIKAGNILLNTEGHAKLADFGVA--GQLTDTMAKRNTVIGTPFWMAPEVIQE 199
Query: 856 CKVSEKSDVFSFGVVLLELVTGRKP 880
+ +D++S G+ +E+ G+ P
Sbjct: 200 IGYNCVADIWSLGITAIEMAEGKPP 224
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 6e-33
Identities = 29/301 (9%), Positives = 66/301 (21%), Gaps = 52/301 (17%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVK-----QLWKGDGVKVFAAEMEILGKIRHRNILKLY 737
+ G V+ + + A+K ++ ++ + +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 738 ACL--------------------------LKGGSSFLVLEYMP--NGNLFQALHKRVKEG 769
+ L++ LF L
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 770 KPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829
E + + A L ++H N+ + D + D
Sbjct: 189 GDEGILALHI-LTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244
Query: 830 ENSPKVSDYSCFAGTHGYIAPEL--AYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGD 887
+ Y E A T + + + G+ + + P
Sbjct: 245 GTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPG 299
Query: 888 GKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVV 947
K S + ++ L C + +K + + L R E +
Sbjct: 300 IKGSWKRPSLRVPGTDS-LAFGSCTPLPDFVKTLIGRFL-------NFDRRRRLLPLEAM 351
Query: 948 K 948
+
Sbjct: 352 E 352
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 6e-33
Identities = 50/207 (24%), Positives = 90/207 (43%), Gaps = 23/207 (11%)
Query: 682 NLIGSGGTGKVYR-LDLKKNAGTVAVKQLWKGDGVKVFAA---EMEILGKIRHRNILKLY 737
+G G G+V+R D K+ AVK+ V++ E+ + I+ LY
Sbjct: 64 PRVGRGSFGEVHRMKD-KQTGFQCAVKK------VRLEVFRVEELVACAGLSSPRIVPLY 116
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
+ +G + +E + G+L Q + + + ++ AL +G+ YLH
Sbjct: 117 GAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQ--AL---EGLEYLHTRR- 170
Query: 798 PPIIHRDIKSSNILLDED-YEPKIADFGVAK-IAENSPKVSDYSC--FAGTHGYIAPELA 853
I+H D+K+ N+LL D + DFG A + + S + GT ++APE+
Sbjct: 171 --ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 228
Query: 854 YTCKVSEKSDVFSFGVVLLELVTGRKP 880
K D++S ++L ++ G P
Sbjct: 229 MGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 6e-33
Identities = 61/223 (27%), Positives = 103/223 (46%), Gaps = 22/223 (9%)
Query: 667 HIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAAEME 723
+ + NL E +GSG G+V+++ +K +AVKQ+ + K +++
Sbjct: 19 RYQAEINDLENLGE---MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLD 75
Query: 724 ILGK-IRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIA 782
++ K I++ + + F+ +E M G + L KR++ PE K+
Sbjct: 76 VVLKSHDCPYIVQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPE-RILG--KMT 130
Query: 783 LGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFA 842
+ K + YL +IHRD+K SNILLDE + K+ DFG++ + A
Sbjct: 131 VAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDD---KAKDRSA 185
Query: 843 GTHGYIAPE-----LAYTCKVSEKSDVFSFGVVLLELVTGRKP 880
G Y+APE ++DV+S G+ L+EL TG+ P
Sbjct: 186 GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 8e-33
Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 16/204 (7%)
Query: 683 LIGSGGTGKVYR-LDLKKNAGTVAVKQL---WKGDG--VKVFAAEMEILGKIRHRNILKL 736
+G GG VY D N VA+K + + +K F E+ ++ H+NI+ +
Sbjct: 18 KLGGGGMSTVYLAEDTILNI-KVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
+ +LV+EY+ L + + L GI + H
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYIESHGP-----LSVDTAINFTNQILDGIKHAHDM- 130
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTC 856
I+HRDIK NIL+D + KI DFG+AK A + ++ + GT Y +PE A
Sbjct: 131 --RIVHRDIKPQNILIDSNKTLKIFDFGIAK-ALSETSLTQTNHVLGTVQYFSPEQAKGE 187
Query: 857 KVSEKSDVFSFGVVLLELVTGRKP 880
E +D++S G+VL E++ G P
Sbjct: 188 ATDECTDIYSIGIVLYEMLVGEPP 211
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 8e-33
Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 18/206 (8%)
Query: 683 LIGSGGTGKVYR-LDLKKNAGTVAVKQ--LWKGDGVKVFAAEMEILGKIRHRNILKLYAC 739
++G G G VY DL N +A+K+ + E+ + ++H+NI++
Sbjct: 29 VLGKGTYGIVYAGRDLS-NQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRY-KIALGAAKGIAYLHHDCSP 798
+ G + +E +P G+L L + K Y K L +G+ YLH +
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL---EGLKYLHDNQ-- 142
Query: 799 PIIHRDIKSSNILLD-EDYEPKIADFGVAK-IAENSPKVSDYSCFAGTHGYIAPE--LAY 854
I+HRDIK N+L++ KI+DFG +K +A +P F GT Y+APE
Sbjct: 143 -IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET---FTGTLQYMAPEIIDKG 198
Query: 855 TCKVSEKSDVFSFGVVLLELVTGRKP 880
+ +D++S G ++E+ TG+ P
Sbjct: 199 PRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 59/235 (25%), Positives = 109/235 (46%), Gaps = 32/235 (13%)
Query: 661 KLASFHHI--DIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQ--LWKGDGVK 716
K + H+ D+D ++ + +G G GKVY+ K+ A K + ++
Sbjct: 4 KSREYEHVRRDLDPNEVWEIVG--ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE 61
Query: 717 VFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNG---NLFQALHKRVKEGKPEL 773
+ E+EIL H I+KL G ++++E+ P G + L + + E +
Sbjct: 62 DYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ--- 118
Query: 774 DWFRRYKIAL---GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830
I + + + +LH S IIHRD+K+ N+L+ + + ++ADFGV+ A+
Sbjct: 119 -------IQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVS--AK 166
Query: 831 NSPKVSDYSCFAGTHGYIAPELAYTCKVSE-----KSDVFSFGVVLLELVTGRKP 880
N + F GT ++APE+ + + K+D++S G+ L+E+ P
Sbjct: 167 NLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-32
Identities = 80/330 (24%), Positives = 123/330 (37%), Gaps = 83/330 (25%)
Query: 677 NLEEDNLIGSGGTGKVYR---LDLKKNAG--TVAVKQLWKGDGVKV---FAAEMEILGKI 728
N+E IG G G+V++ L VAVK L + + F E ++ +
Sbjct: 48 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 107
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRY--------- 779
+ NI+KL G L+ EYM G+L + L L
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167
Query: 780 ----------KIALGAAKGIAYL--HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA- 826
IA A G+AYL +HRD+ + N L+ E+ KIADFG++
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLVGENMVVKIADFGLSR 222
Query: 827 KIAENSPKVSDYSCFAGTHGYI-----APE-LAYTCKVSEKSDVFSFGVVLLELVT-GRK 879
I DY A + I PE + Y + + +SDV+++GVVL E+ + G +
Sbjct: 223 NIYSA-----DY-YKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQ 275
Query: 880 PVEEEYGDGKDIVYWVSTHLNNHENVLK------VLDC-EVASESIKEDMIKLLKIAVVC 932
P Y+ + + E V+ +L C E + M C
Sbjct: 276 P------------YY---GMAHEE-VIYYVRDGNILACPENCPLELYNLMRL-------C 312
Query: 933 TTKLPNLRPPMREVV----KMLADADPCTD 958
+KLP RP + +M A+
Sbjct: 313 WSKLPADRPSFCSIHRILQRMCERAEGTVG 342
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 19/202 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQ--LWKGDGVKVFAAEMEILGKIRHRNILKLYACLL 741
IG G +G VY VA++Q L + ++ E+ ++ + ++ NI+ L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL---GAAKGIAYLHHDCSP 798
G ++V+EY+ G+L + + +IA + + +LH S
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETC---------MDEGQIAAVCRECLQALEFLH---SN 135
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKV 858
+IHRDIKS NILL D K+ DFG A+ +P+ S S GT ++APE+
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPEVVTRKAY 193
Query: 859 SEKSDVFSFGVVLLELVTGRKP 880
K D++S G++ +E++ G P
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPP 215
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-32
Identities = 74/317 (23%), Positives = 120/317 (37%), Gaps = 72/317 (22%)
Query: 677 NLEEDNLIGSGGTGKVYR-----LDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKI 728
NLE ++GSG GKV + + VAVK L + + +E++++ ++
Sbjct: 46 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 105
Query: 729 -RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQAL-HKRVKEGKPELDWFRRY------- 779
H NI+ L G +L+ EY G+L L KR K + E+++ +
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 780 ----------KIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA-KI 828
A AKG+ +L +HRD+ + N+L+ KI DFG+A I
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDI 222
Query: 829 AENSPKVSDYSCFAGTHGYI-----APELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVE 882
+ S+Y + + APE + + KSDV+S+G++L E+ + G P
Sbjct: 223 MSD----SNYV--VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP-- 274
Query: 883 EEYGDGKDIVYWVSTHLNNHENVLK------VLDC-EVASESIKEDMIKLLKIAVVCTTK 935
Y + N K +D A+E I M C
Sbjct: 275 ----------YP---GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQS-------CWAF 314
Query: 936 LPNLRPPMREVVKMLAD 952
RP + L
Sbjct: 315 DSRKRPSFPNLTSFLGC 331
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 63/225 (28%), Positives = 99/225 (44%), Gaps = 24/225 (10%)
Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAAEMEILG 726
I+ + E IGSG T V VA+K++ + E++ +
Sbjct: 12 INRDDYELQEV---IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMS 68
Query: 727 KIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL--- 783
+ H NI+ Y + +LV++ + G++ + V +G+ + IA
Sbjct: 69 QCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILR 128
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGV-AKIAENSPKVSDYS--C 840
+G+ YLH IHRD+K+ NILL ED +IADFGV A +A +
Sbjct: 129 EVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT 185
Query: 841 FAGTHGYIAPEL-----AYTCKVSEKSDVFSFGVVLLELVTGRKP 880
F GT ++APE+ Y K D++SFG+ +EL TG P
Sbjct: 186 FVGTPCWMAPEVMEQVRGYDFKA----DIWSFGITAIELATGAAP 226
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 3e-32
Identities = 77/310 (24%), Positives = 122/310 (39%), Gaps = 64/310 (20%)
Query: 677 NLEEDNLIGSGGTGKVYR-----LDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKI 728
L+ +G G G+V +D TVAVK L +G + +E++IL I
Sbjct: 28 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 87
Query: 729 -RHRNILKLY-ACLLKGGSSFLVLEYMPNGNLFQAL-HKRVKEGKPELDWFRRYK----- 780
H N++ L AC GG +++E+ GNL L KR + ++ YK
Sbjct: 88 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 147
Query: 781 -----IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV 835
+ AKG+ +L S IHRD+ + NILL E KI DFG+A+
Sbjct: 148 EHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK---- 200
Query: 836 SDYSCFAGTHGYI-----APELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGK 889
+ APE + + +SDV+SFGV+L E+ + G P
Sbjct: 201 DPD-YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP--------- 250
Query: 890 DIVYWVSTHLNNHENVLK------VLDC-EVASESIKEDMIKLLKIAVVCTTKLPNLRPP 942
Y + E + + + + + + M+ C P+ RP
Sbjct: 251 ---YP---GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD-------CWHGEPSQRPT 297
Query: 943 MREVVKMLAD 952
E+V+ L +
Sbjct: 298 FSELVEHLGN 307
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 3e-32
Identities = 78/317 (24%), Positives = 127/317 (40%), Gaps = 73/317 (23%)
Query: 677 NLEEDNLIGSGGTGKVYR---LDLKKNAG--TVAVKQLWKG---DGVKVFAAEMEILGKI 728
NL +G G GKV + LK AG TVAVK L + ++ +E +L ++
Sbjct: 24 NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV 83
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRY--------- 779
H +++KLY + G L++EY G+L L + K G L
Sbjct: 84 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 780 ----------KIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA-KI 828
A ++G+ YL ++HRD+ + NIL+ E + KI+DFG++ +
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDV 200
Query: 829 AENSPKVSDYSCFAGTHGYI-----APELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVE 882
E D + G I A E + + +SDV+SFGV+L E+VT G P
Sbjct: 201 YEE-----DS-YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP-- 252
Query: 883 EEYGDGKDIVYWVSTHLNNHENVLK------VLDC-EVASESIKEDMIKLLKIAVVCTTK 935
Y + + ++ + SE + M++ C +
Sbjct: 253 ----------YP---GIPPER-LFNLLKTGHRMERPDNCSEEMYRLMLQ-------CWKQ 291
Query: 936 LPNLRPPMREVVKMLAD 952
P+ RP ++ K L
Sbjct: 292 EPDKRPVFADISKDLEK 308
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-32
Identities = 62/209 (29%), Positives = 102/209 (48%), Gaps = 21/209 (10%)
Query: 678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQ--LWKGDGVKVFAAEMEILGKIRHRNILK 735
L+ IG G TG V K + VAVK L K ++ E+ I+ +H N+++
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQAL-HKRVKEGKPELDWFRRYKIAL---GAAKGIAY 791
+Y L G ++++E++ G L + R+ E + IA + +AY
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQ----------IATVCEAVLQALAY 156
Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPE 851
LH + +IHRDIKS +ILL D K++DFG A+ S V GT ++APE
Sbjct: 157 LH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFC--AQISKDVPKRKSLVGTPYWMAPE 211
Query: 852 LAYTCKVSEKSDVFSFGVVLLELVTGRKP 880
+ + + D++S G++++E+V G P
Sbjct: 212 VISRSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-32
Identities = 50/204 (24%), Positives = 84/204 (41%), Gaps = 16/204 (7%)
Query: 683 LIGSGGTGKVYR-LDLKKNAGTVAVKQL---WKGDGVKV--FAAEMEILGKIRHRNILKL 736
L+G GG G VY D + VA+K + D V E G+++ +++ +
Sbjct: 41 LVGRGGMGDVYEAEDTVRER-IVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
+ G ++ + + +L L ++ G L R I + H
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAMLRRQ---GP--LAPPRAVAIVRQIGSALDAAHAA- 153
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTC 856
HRD+K NIL+ D + DFG+A A K++ GT Y+APE
Sbjct: 154 --GATHRDVKPENILVSADDFAYLVDFGIAS-ATTDEKLTQLGNTVGTLYYMAPERFSES 210
Query: 857 KVSEKSDVFSFGVVLLELVTGRKP 880
+ ++D+++ VL E +TG P
Sbjct: 211 HATYRADIYALTCVLYECLTGSPP 234
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-32
Identities = 77/311 (24%), Positives = 123/311 (39%), Gaps = 66/311 (21%)
Query: 677 NLEEDNLIGSGGTGKVYR-------LDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILG 726
L +G G G+V D VAVK L + +EME++
Sbjct: 70 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 129
Query: 727 KI-RHRNILKLYACLLKGGSSFLVLEYMPNGNL-----------FQALHKRVKEGKPELD 774
I +H+NI+ L + G ++++EY GNL + + + +L
Sbjct: 130 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 189
Query: 775 WFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK 834
A A+G+ YL S IHRD+ + N+L+ ED KIADFG+A+ +
Sbjct: 190 SKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH--- 243
Query: 835 VSDYSCFAGTHGYI-----APELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDG 888
DY T+G + APE + + +SDV+SFGV+L E+ T G P
Sbjct: 244 -IDY-YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP-------- 293
Query: 889 KDIVYWVSTHLNNHENVLK------VLDC-EVASESIKEDMIKLLKIAVVCTTKLPNLRP 941
Y + E + K +D + + M C +P+ RP
Sbjct: 294 ----YP---GVPVEE-LFKLLKEGHRMDKPSNCTNELYMMMRD-------CWHAVPSQRP 338
Query: 942 PMREVVKMLAD 952
+++V+ L
Sbjct: 339 TFKQLVEDLDR 349
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-32
Identities = 50/213 (23%), Positives = 86/213 (40%), Gaps = 29/213 (13%)
Query: 679 EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV----FAAEMEILGKI-RHRNI 733
+ + +G G G+V+++ K++ AVK+ AE+ K+ +H
Sbjct: 60 QRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCC 119
Query: 734 LKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPE---LDWFRRYKIALGAAKGIA 790
++L +GG +L E +L Q + PE + R +A
Sbjct: 120 VRLEQAWEEGGILYLQTELC-GPSLQQHC-EAWGASLPEAQVWGYLRD------TLLALA 171
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
+LH S ++H D+K +NI L K+ DFG+ + G Y+AP
Sbjct: 172 HLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV---QEGDPRYMAP 225
Query: 851 EL---AYTCKVSEKSDVFSFGVVLLELVTGRKP 880
EL +Y +DVFS G+ +LE+ +
Sbjct: 226 ELLQGSYGT----AADVFSLGLTILEVACNMEL 254
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 6e-32
Identities = 66/425 (15%), Positives = 125/425 (29%), Gaps = 70/425 (16%)
Query: 166 NLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDIC 225
+ I D E I L N + + +R + R++ L++
Sbjct: 19 YDCVFYDVHIDMQTQDVYFGFEDI-TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLN 77
Query: 226 RNKISGEFPRSIRKLQKLWKIELYANNLTGELPAE-LGNLTLLQEFDISSNQMYGKLPEE 284
+I + + K+ + N + LP N+ LL + N + LP
Sbjct: 78 DLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL-SSLPRG 135
Query: 285 I-GNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVD 343
I N LT NN F L + NR +
Sbjct: 136 IFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT----------------H 179
Query: 344 ISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPD 403
+ + L +S N + A ++ L S N ++ +
Sbjct: 180 VDLSLIPS------------LFHANVSYNLLSTLAIPIA----VEELDASHNSIN-VVRG 222
Query: 404 GLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLI 463
+ + L+ L LQ+N + + L L +
Sbjct: 223 PV--------------------------NVELTILKLQHNNLT-DTAW-LLNYPGLVEVD 254
Query: 464 LTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPR 523
L+ N + +++L L++ N L ++ + L+L+ N L ++ R
Sbjct: 255 LSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVER 312
Query: 524 SLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSGSVPLDFLRMGGDGAFAG 583
+ L L L N + ++ + L ++ LS N + R A
Sbjct: 313 NQPQFDRLENLYLDHNSIV-TLKLSTHH-TLKNLTLSHNDWDCNSLRALFRNVARPAVDD 370
Query: 584 NEGLC 588
+ C
Sbjct: 371 ADQHC 375
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-24
Identities = 65/387 (16%), Positives = 129/387 (33%), Gaps = 52/387 (13%)
Query: 96 LQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD--LSALKNLEIFDLSI 153
L + +++ + + L + +++LN+ + + + ++ +
Sbjct: 44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGF 102
Query: 154 NYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESI-GNLKNLTYLFLAHCNLRGRIPES 212
N P N+ L L + N + +P I N LT L +++ NL RI +
Sbjct: 103 NAIRYLPPHVFQNVPLLTVLVLERNDL--SSLPRGIFHNTPKLTTLSMSNNNLE-RIEDD 159
Query: 213 I-SELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFD 271
L L + N+++ S+ + L+ + N L+ L ++E D
Sbjct: 160 TFQATTSLQNLQLSSNRLT-HVDLSL--IPSLFHANVSYNLLS-----TLAIPIAVEELD 211
Query: 272 ISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPE 331
S N + + + LT+ + NN + + +
Sbjct: 212 ASHNSI-NVVRGPV--NVELTILKLQHNNLTD--TAWLLNY------------------- 247
Query: 332 NLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLR 391
L +VD+S N+ + K + L L +SNN + T++ L
Sbjct: 248 -----PGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLD 301
Query: 392 ISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPS 451
+S NHL + + L N + +L L L +N +
Sbjct: 302 LSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKL--STHHTLKNLTLSHNDWDCNSLR 357
Query: 452 ELGRLTNLERLILTNNNFSGKIPSALG 478
L N+ R + + + KI L
Sbjct: 358 AL--FRNVARPAVDDADQHCKIDYQLE 382
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 4e-20
Identities = 50/291 (17%), Positives = 96/291 (32%), Gaps = 35/291 (12%)
Query: 90 SSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD--LSALKNLE 147
+ + + ++ L + FN + P N L VL + N + S+P L
Sbjct: 86 TYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLT 144
Query: 148 IFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPE-SIGNLKNLTYLFLAHCNLR 206
+S N T L +L + N + + + +L + +++ L
Sbjct: 145 TLSMSNNNLERIEDDTFQATTSLQNLQLSSN-----RLTHVDLSLIPSLFHANVSYNLL- 198
Query: 207 GRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTL 266
+++ + LD N I+ + +L ++L NNLT + L N
Sbjct: 199 ----STLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTAW-LLNYPG 249
Query: 267 LQEFDISSNQMYGKLPEEI-GNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRF 325
L E D+S N++ K+ ++ L N + L + N
Sbjct: 250 LVEVDLSYNEL-EKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHL 307
Query: 326 SGPFPENLGRYTALTDVDISENQFS----GSFPKYLCEKRKLLNLLALSNN 372
N ++ L ++ + N + L L LS+N
Sbjct: 308 LH-VERNQPQFDRLENLYLDHNSIVTLKLSTHHT--------LKNLTLSHN 349
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 6e-20
Identities = 50/242 (20%), Positives = 89/242 (36%), Gaps = 22/242 (9%)
Query: 330 PENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNL--LALSNNFSGEVP-NSYADCKT 386
NL DV I F E L N + N+ ++P +
Sbjct: 14 DSNLQYDCVFYDVHIDMQTQDVYFGF---EDITLNNQKIVTFKNSTMRKLPAALLDSFRQ 70
Query: 387 IQRLRISDNHLSGKIPDG-LWALPNVGMLDFGDNDFTGGISPLIGLS-TSLSQLVLQNNR 444
++ L ++D + +I + L G N + P + + L+ LVL+ N
Sbjct: 71 VELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERND 128
Query: 445 FSGELPSEL-GRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGD 503
S LP + L L ++NNN A L +L L N LT + +
Sbjct: 129 LS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSL 184
Query: 504 CARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQ 563
+ N++ N LS +L++ ++ L+ S N + + + +L+ + L N
Sbjct: 185 IPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPVNV-ELTILKLQHNN 237
Query: 564 LS 565
L+
Sbjct: 238 LT 239
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 1e-16
Identities = 37/187 (19%), Positives = 74/187 (39%), Gaps = 17/187 (9%)
Query: 92 SISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDL 151
+S + SL ++ +N+LS L+ ++ L+ + N++ V L I L
Sbjct: 181 DLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRG-PVNVELTILKL 233
Query: 152 SINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESI-GNLKNLTYLFLAHCNLRGRIP 210
N T W++N LV + + N + +I ++ L L++++ L +
Sbjct: 234 QHNNLTD--TAWLLNYPGLVEVDLSYN--ELEKIMYHPFVKMQRLERLYISNNRLV-ALN 288
Query: 211 ESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEF 270
+ L LD+ N + R+ + +L + L N++ L L L+
Sbjct: 289 LYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNL 344
Query: 271 DISSNQM 277
+S N
Sbjct: 345 TLSHNDW 351
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 20/142 (14%), Positives = 45/142 (31%), Gaps = 14/142 (9%)
Query: 449 LPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEM-GDCARI 507
+ S L + + L + + + + +P + ++
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 71
Query: 508 VDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL--KLSSIDLSENQLS 565
LNL + + + ++ L + N + +P ++ + L+ + L N LS
Sbjct: 72 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS 130
Query: 566 GSVPLDFLRMGGDGAFAGNEGL 587
S+P G F L
Sbjct: 131 -SLP--------RGIFHNTPKL 143
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 22/226 (9%)
Query: 661 KLASFHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKV 717
L ++ D E++ E IG G G+V++ + VA+K + D ++
Sbjct: 9 GLPGMQNLKADPEELFTKLE--KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIED 66
Query: 718 FAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFR 777
E+ +L + + K Y LK ++++EY+ G+ L
Sbjct: 67 IQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP---------LD 117
Query: 778 RYKIAL---GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK 834
+IA KG+ YLH S IHRDIK++N+LL E E K+ADFGVA + +
Sbjct: 118 ETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDT 172
Query: 835 VSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKP 880
+ F GT ++APE+ K+D++S G+ +EL G P
Sbjct: 173 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-31
Identities = 76/482 (15%), Positives = 143/482 (29%), Gaps = 76/482 (15%)
Query: 94 SALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSI 153
S + + + L L+ ++ + + + L L +
Sbjct: 18 DNFASEVAAAFEMQATD---TISEEQLATLTSLDCHNSS-ITDMTGIEKLTGLTKLICTS 73
Query: 154 NYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPE-SIGNLKNLTYLFLAHCNLRGRIPES 212
N T + T L L+ N ++ + L LTYL L
Sbjct: 74 NNITT-LD--LSQNTNLTYLACDSN-----KLTNLDVTPLTKLTYLNCDTNKLT---KLD 122
Query: 213 ISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDI 272
+S+ L L+ RN ++ E + +L +++ + N +L + T L D
Sbjct: 123 VSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDC 177
Query: 273 SSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPEN 332
S N++ ++ K L C NN + + +L N+
Sbjct: 178 SFNKITE---LDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNK-------- 223
Query: 333 LGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRI 392
LT++D++ L S N E+ S + L
Sbjct: 224 ------LTEIDVTPL--------------TQLTYFDCSVNPLTELDVS--TLSKLTTLHC 261
Query: 393 SDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSE 452
L +I L + + +T L L Q + EL
Sbjct: 262 IQTDLL-EID--LTHNTQLIYFQAEGCRKI--KELDVTHNTQLYLLDCQAAGIT-ELD-- 313
Query: 453 LGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNL 512
L + L L L N + ++ + +L SL + +G + +
Sbjct: 314 LSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFE 368
Query: 513 ARNSLSGNIP-----RSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSGS 567
A SL++ S + L+ GN + P + ++ ++ LS
Sbjct: 369 AEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMN-IEPGDGGVYDQATNTITWENLSTD 427
Query: 568 VP 569
P
Sbjct: 428 NP 429
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 3e-20
Identities = 64/366 (17%), Positives = 120/366 (32%), Gaps = 42/366 (11%)
Query: 92 SISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDL 151
++ L LT L+ N L+ L++S L LN N + + D+S L D
Sbjct: 101 DVTPLTKLTYLNCDTNKLT---KLDVSQNPLLTYLNCARNTL--TEIDVSHNTQLTELDC 155
Query: 152 SINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPE-SIGNLKNLTYLFLAHCNLRGRIP 210
+N + V TQL +L N +I E + K L L N+ ++
Sbjct: 156 HLNKKITKLD--VTPQTQLTTLDCSFN-----KITELDVSQNKLLNRLNCDTNNIT-KLD 207
Query: 211 ESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEF 270
+++ +L LD NK++ E + L +L + N LT EL + L+ L
Sbjct: 208 --LNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTL 259
Query: 271 DISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFP 330
+ ++ + + L FQ E +L+ +
Sbjct: 260 HCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT---E 311
Query: 331 ENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRL 390
+L + L + ++ + + K L L+ N + + +
Sbjct: 312 LDLSQNPKLVYLYLNNTELT-ELDVSHNTK---LKSLSCVNAHIQDFSSV-GKIPALNNN 366
Query: 391 RISDNHLSGKIPDG-----LWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRF 445
++ + L + +LD N I P G + +
Sbjct: 367 FEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMN--IEPGDGGVYDQATNTITWENL 424
Query: 446 SGELPS 451
S + P+
Sbjct: 425 STDNPA 430
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 5e-10
Identities = 32/141 (22%), Positives = 62/141 (43%), Gaps = 13/141 (9%)
Query: 433 TSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENA 492
+L+ L N+ + ++ + +LT L +LI T+NN + + L L+ L + N
Sbjct: 42 ATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLACDSNK 96
Query: 493 LTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL 552
LT ++ + ++ LN N L+ + +S L LN + N LT I +
Sbjct: 97 LT-NLD--VTPLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARNTLT-EIDVSHNT- 148
Query: 553 KLSSIDLSENQLSGSVPLDFL 573
+L+ +D N+ + +
Sbjct: 149 QLTELDCHLNKKITKLDVTPQ 169
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 62/209 (29%), Positives = 101/209 (48%), Gaps = 20/209 (9%)
Query: 683 LIGSGGTGKVYR-LDLKKNAGTVAVKQL---WKGDG--VKVFAAEMEILGKIRHRNILKL 736
++G GG +V+ DL+ + VAVK L D F E + + H I+ +
Sbjct: 19 ILGFGGMSEVHLARDLRDHR-DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 737 Y----ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
Y A G ++V+EY+ L +H G + R ++ A + + +
Sbjct: 78 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE---GP--MTPKRAIEVIADACQALNFS 132
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK-IAENSPKVSDYSCFAGTHGYIAPE 851
H + IIHRD+K +NI++ K+ DFG+A+ IA++ V+ + GT Y++PE
Sbjct: 133 HQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 852 LAYTCKVSEKSDVFSFGVVLLELVTGRKP 880
A V +SDV+S G VL E++TG P
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 52/381 (13%), Positives = 109/381 (28%), Gaps = 66/381 (17%)
Query: 185 IPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLW 244
I E N + +L+ + + LD+ N +S + KL
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 245 KIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGE 304
+ L +N L E +L +L+ L+ D+++N + +E+ ++ NN S
Sbjct: 62 LLNLSSNVLY-ETL-DLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISRV 114
Query: 305 FPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLL 364
S + ++ + N+ + + G + + +D+ N+
Sbjct: 115 SCSRGQGKKNIY---LANNKITMLRDLDEGCRSRVQYLDLKLNEID-------------- 157
Query: 365 NLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGG 424
+ A T++ L + N +
Sbjct: 158 ---------TVNFAELAASSDTLEHLNLQYNFIY-------------------------D 183
Query: 425 ISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLS 484
+ + L L L +N+ + + E + + L NN I AL + L
Sbjct: 184 VKGQVVF-AKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLE 240
Query: 485 SLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGS 544
L N +A+ ++ + ++ L G
Sbjct: 241 HFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVK-KLTGQNEEECTVPTLGHYGA-YCCE 297
Query: 545 IPDNLMKLKLSSIDLSENQLS 565
+L I L +
Sbjct: 298 DLPAPFADRL--IALGHHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 56/327 (17%), Positives = 115/327 (35%), Gaps = 23/327 (7%)
Query: 74 RVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAM 133
R + SL ++S + ++ L L N LS +L+ + L++LN++ N +
Sbjct: 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70
Query: 134 VGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLK 193
DL +L L DL+ NY ++ + +L +N + + S +
Sbjct: 71 Y-ETLDLESLSTLRTLDLNNNYVQE-----LLVGPSIETLHAANNNI--SRVSCSR--GQ 120
Query: 194 NLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISG-EFPRSIRKLQKLWKIELYANN 252
++LA+ + + LD+ N+I F L + L N
Sbjct: 121 GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF 180
Query: 253 LTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDM 312
+ ++ ++ L+ D+SSN++ + E + +T N
Sbjct: 181 IY-DVKGQV-VFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFS 236
Query: 313 RKLFAFSIYGNRFS-GPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSN 371
+ L F + GN F G + + + V + + C + L
Sbjct: 237 QNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEEC---TVPTLGHYGA 293
Query: 372 NFSGEVPNSYADCKTIQRLRISDNHLS 398
++P +AD + + + +H
Sbjct: 294 YCCEDLPAPFAD----RLIALGHHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-31
Identities = 51/313 (16%), Positives = 98/313 (31%), Gaps = 19/313 (6%)
Query: 281 LPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALT 340
+ E N + + ++ S + + GN S +L +T L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 341 DVDISENQFSGSFPKYLCEKRKLLNL--LALSNNFSGEVPNSYADCKTIQRLRISDNHLS 398
+++S N + L L L L+NN+ E+ +I+ L ++N++S
Sbjct: 62 LLNLSSNVLYE-----TLDLESLSTLRTLDLNNNYVQELLV----GPSIETLHAANNNIS 112
Query: 399 GKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSG-ELPSELGRLT 457
++ + +N T G + + L L+ N
Sbjct: 113 -RVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169
Query: 458 NLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSL 517
LE L L N + + +L +L L N L + E A + ++L N L
Sbjct: 170 TLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL 226
Query: 518 SGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSGSVPLDFLRMGG 577
I ++L +L +L GN + +++ + +
Sbjct: 227 V-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTV 285
Query: 578 DGAFAGNEGLCLD 590
C D
Sbjct: 286 PTLGHYGAYCCED 298
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 42/293 (14%), Positives = 97/293 (33%), Gaps = 19/293 (6%)
Query: 89 ISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD-LSALKNLE 147
I + + + L L + N+K L+++GN + L+ LE
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 148 IFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRG 207
+ +LS N + +L+ L +L + +N + + + ++ L A+ N+
Sbjct: 62 LLNLSSNVLYETLD--LESLSTLRTLDLNNN-----YV-QELLVGPSIETLHAANNNIS- 112
Query: 208 RIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTG-ELPAELGNLTL 266
R+ S + + + NKI+ ++ ++L N + +
Sbjct: 113 RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 267 LQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFS 326
L+ ++ N +Y + ++ L N + F + S+ N+
Sbjct: 171 LEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227
Query: 327 GPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPN 379
+ L L D+ N F + K + ++ ++
Sbjct: 228 L-IEKALRFSQNLEHFDLRGNGFHCGTLRDF--FSKNQRVQTVAKQTVKKLTG 277
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 26/149 (17%), Positives = 56/149 (37%), Gaps = 9/149 (6%)
Query: 424 GISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQL 483
I + + ++ L S N++ L L+ N S + L +L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 484 SSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTG 543
L+L N L ++ + + L+L N + L + S+ L+ + N ++
Sbjct: 61 ELLNLSSNVLY-ETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112
Query: 544 SIPDNLMKLKLSSIDLSENQLSGSVPLDF 572
+ + + +I L+ N+++ LD
Sbjct: 113 RVSCSRGQ-GKKNIYLANNKITMLRDLDE 140
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-31
Identities = 69/335 (20%), Positives = 125/335 (37%), Gaps = 62/335 (18%)
Query: 639 SYKNFKLSADMENGEKEVSSKWKLA-SFHHIDIDAEQICNLEEDNLIGSGGTGKVYR--L 695
K + D E S +L + D I ++E +G G G V +
Sbjct: 302 PDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIE----LGCGNFGSVRQGVY 357
Query: 696 DLKKNAGTVAVKQLWKGDGVKV---FAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY 752
++K VA+K L +G E +I+ ++ + I++L + + + LV+E
Sbjct: 358 RMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG-VCQAEALMLVMEM 416
Query: 753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL--HHDCSPPIIHRDIKSSNI 810
G L + L + + E+ ++ + G+ YL + +HR++ + N+
Sbjct: 417 AGGGPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEEKN-----FVHRNLAARNV 467
Query: 811 LLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI-----APELAYTCKVSEKSDVF 865
LL + KI+DFG++K Y+ A + G APE K S +SDV+
Sbjct: 468 LLVNRHYAKISDFGLSKALGADDSY--YT--ARSAGKWPLKWYAPECINFRKFSSRSDVW 523
Query: 866 SFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDC-------EVASES 917
S+GV + E ++ G+KP Y + E V+ ++
Sbjct: 524 SYGVTMWEALSYGQKP------------YK---KMKGPE-VMAFIEQGKRMECPPECPPE 567
Query: 918 IKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952
+ M C RP V + +
Sbjct: 568 LYALMSD-------CWIYKWEDRPDFLTVEQRMRA 595
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 5e-31
Identities = 49/275 (17%), Positives = 90/275 (32%), Gaps = 29/275 (10%)
Query: 679 EEDNLIGSGGTGKVYR-----LDLKKNAGTVAVKQLWKGDG--VKVFAAEMEILGKIRHR 731
+L+G G +VY L+ KN +K + + ME L
Sbjct: 68 YVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQH 127
Query: 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAY 791
+K Y+ L S LV E G L A++ + + A+ I
Sbjct: 128 MFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQ 187
Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEP-----------KIADFGVAKIAENSPKVSDYSC 840
+H IIH DIK N +L + + D G + + PK + ++
Sbjct: 188 VH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTA 244
Query: 841 FAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIV-----YWV 895
T G+ E+ + + D F + ++ G + G
Sbjct: 245 KCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPH 304
Query: 896 STHLNNH-ENVLKVLDCEV--ASESIKEDMIKLLK 927
N +L + DC + + +++ + K+ +
Sbjct: 305 LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 8e-31
Identities = 45/217 (20%), Positives = 79/217 (36%), Gaps = 33/217 (15%)
Query: 684 IGSG--GTGKVYRLDLKKNAGTVAVKQL----WKGDGVKVFAAEMEILGKIRHRNILKLY 737
IG G V K V V+++ + V E+ + H NI+
Sbjct: 33 IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL---GAAKGIAYLHH 794
A + ++V +M G+ + +G EL IA G K + Y+HH
Sbjct: 93 ATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNEL------AIAYILQGVLKALDYIHH 146
Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGV-AKIAENSPK----VSDYSCFAGTHGYIA 849
+HR +K+S+IL+ D + ++ + + + +++
Sbjct: 147 M---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLS 203
Query: 850 PEL------AYTCKVSEKSDVFSFGVVLLELVTGRKP 880
PE+ Y KSD++S G+ EL G P
Sbjct: 204 PEVLQQNLQGYD----AKSDIYSVGITACELANGHVP 236
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-30
Identities = 66/210 (31%), Positives = 103/210 (49%), Gaps = 32/210 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL-----WKGDGVKVFAAEMEILGKIRHRNILKLYA 738
IG G G VY +N+ VA+K++ + + E+ L K+RH N ++
Sbjct: 62 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 739 CLLKGGSSFLVLEYMPNG--NLFQALHKRVKEGKPELDWFRRYKIAL---GAAKGIAYLH 793
C L+ +++LV+EY +L + K ++E + IA GA +G+AYLH
Sbjct: 122 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVE----------IAAVTHGALQGLAYLH 171
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELA 853
S +IHRD+K+ NILL E K+ DFG A + +P S F GT ++APE+
Sbjct: 172 ---SHNMIHRDVKAGNILLSEPGLVKLGDFGSA--SIMAPANS----FVGTPYWMAPEVI 222
Query: 854 YTCKVSE---KSDVFSFGVVLLELVTGRKP 880
+ K DV+S G+ +EL + P
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 6e-30
Identities = 57/281 (20%), Positives = 108/281 (38%), Gaps = 35/281 (12%)
Query: 679 EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKI-RHRNILKLY 737
+++G G G + + N VAVK++ + E+++L + H N+++ +
Sbjct: 27 CPKDVLGHGAEGTIVYRGMFDN-RDVAVKRILP-ECFSFADREVQLLRESDEHPNVIRYF 84
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
++ +E L + + ++ L+ + G+A+LH S
Sbjct: 85 CTEKDRQFQYIAIELCA-ATLQEYVEQK-DFAHLGLE---PITLLQQTTSGLAHLH---S 136
Query: 798 PPIIHRDIKSSNILLDEDYE-----PKIADFGVAKIAE-NSPKVSDYSCFAGTHGYIAPE 851
I+HRD+K NIL+ I+DFG+ K S S GT G+IAPE
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196
Query: 852 L---AYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLK 907
+ + D+FS G V +++ G P + +I L ++
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI-------LLGACSLDC 249
Query: 908 VLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVK 948
+ + + ++I+ P RP + V+K
Sbjct: 250 LHPEKHEDVIAR-ELIEK------MIAMDPQKRPSAKHVLK 283
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 7e-30
Identities = 69/402 (17%), Positives = 124/402 (30%), Gaps = 53/402 (13%)
Query: 166 NLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDIC 225
+ I D E I L N + + +R + R++ L++
Sbjct: 25 YDCVFYDVHIDMQTQDVYFGFEDI-TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLN 83
Query: 226 RNKISGEFPRSIRKLQKLWKIELYANNLTGELPAE-LGNLTLLQEFDISSNQMYGKLPEE 284
+I + + K+ + N + LP N+ LL + N + LP
Sbjct: 84 DLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL-SSLPRG 141
Query: 285 I-GNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVD 343
I N LT NN F L + NR +
Sbjct: 142 IFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT----------------H 185
Query: 344 ISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPD 403
+ + L +S N + A ++ L S N ++ +
Sbjct: 186 VDLSLIPS------------LFHANVSYNLLSTLAIPIA----VEELDASHNSIN-VVRG 228
Query: 404 GLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSE-LGRLTNLERL 462
+ +L N+ T + L+ L ++ L N ++ ++ LERL
Sbjct: 229 P--VNVELTILKLQHNNLT-DTAWLLNY-PGLVEVDLSYNELE-KIMYHPFVKMQRLERL 283
Query: 463 ILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIP 522
++NN + + L L L N L + R+ +L L NS+ +
Sbjct: 284 YISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK 340
Query: 523 RSLSLLSSLNALNLSGNKLTGS----IPDNLMKLKLSSIDLS 560
LS +L L LS N + + N+ + + D
Sbjct: 341 --LSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQH 380
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 8e-29
Identities = 76/474 (16%), Positives = 151/474 (31%), Gaps = 38/474 (8%)
Query: 88 EISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD--LSALKN 145
I S++ + + E +N K++ + M +P L + +
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQ 76
Query: 146 LEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESI-GNLKNLTYLFLAHCN 204
+E+ +L+ + L +G N +P + N+ LT L L +
Sbjct: 77 VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAI--RYLPPHVFQNVPLLTVLVLERND 134
Query: 205 LRGRIPESI-SELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGN 263
L +P I +L TL + N + + + L ++L +N LT + L
Sbjct: 135 LS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSL 190
Query: 264 LTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGN 323
+ L ++S N + + + N+ + ++ L + N
Sbjct: 191 IPSLFHANVSYNLL-----STLAIPIAVEELDASHNSINVVRGPVNVELTIL---KLQHN 242
Query: 324 RFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYAD 383
+ L Y L +VD+S N+ + K + L L +SNN +
Sbjct: 243 NLTD--TAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLVALNLYGQP 299
Query: 384 CKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNN 443
T++ L +S NHL + + L N + +L L L +N
Sbjct: 300 IPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKL--STHHTLKNLTLSHN 355
Query: 444 RFSGELPSELGRLTNLERLILTNNNFSGKIPSALGA----------LRQLSSLHLEENAL 493
+ S N+ R + + + KI L ++ ++
Sbjct: 356 DWDCN--SLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSV 413
Query: 494 TGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPD 547
+ G C+ +N ++ + L L N+L +
Sbjct: 414 VEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQ 467
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 93.1 bits (231), Expect = 1e-19
Identities = 81/479 (16%), Positives = 144/479 (30%), Gaps = 55/479 (11%)
Query: 96 LQSLTVLSLPFNVLSGKLPLEL-SNCSNLKVLNVTGNAMVGSVPD--LSALKNLEIFDLS 152
+ LTVL L N LS LP + N L L+++ N + + D A +L+ LS
Sbjct: 122 VPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLS 179
Query: 153 INYFT----GRFPR------------WVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLT 196
N T P + + L N + + LT
Sbjct: 180 SNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHN--SINVVRGPV--NVELT 235
Query: 197 YLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGE 256
L L H NL + L +D+ N++ K+Q+L ++ + N L
Sbjct: 236 ILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-A 292
Query: 257 LPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLF 316
L + L+ D+S N + + L N+ L
Sbjct: 293 LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLK 348
Query: 317 AFSIYGNRFSG----PFPENLGRYTALTDVDISENQFSGSFPKYLCEKR------KLLNL 366
++ N + N+ R A+ D D C++ +LL
Sbjct: 349 NLTLSHNDWDCNSLRALFRNVAR-PAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQY 407
Query: 367 LALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGIS 426
+AL+ + +V + C + + G L L+ N+ +
Sbjct: 408 IALT-SVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEV- 465
Query: 427 PLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSL 486
L+ +Q + L +E+ TNL R L + + + L
Sbjct: 466 ------QQLTNEQIQQEQLLQGLHAEI--DTNLRRYRLPKDGLARSSDNLNKVFTHLKER 517
Query: 487 HLEENALTGSIPNEMGDCARIV-DLNLARNSLSGNI-PRSLSLLSSLNALNLSGNKLTG 543
+ T + E + DL +L + + +L K+
Sbjct: 518 QAFKLRETQARRTEADAKQKETEDLEQENIALEKQLDNKRAKQAELRQETSLKRQKVKQ 576
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 70.0 bits (171), Expect = 2e-12
Identities = 26/136 (19%), Positives = 48/136 (35%), Gaps = 5/136 (3%)
Query: 433 TSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENA 492
+ + E L N + + N+ + L + RQ+ L+L +
Sbjct: 27 CVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQ 86
Query: 493 LTGSIPNEM-GDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNL-M 550
+ I I L + N++ P + L L L N L+ S+P +
Sbjct: 87 IE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFH 144
Query: 551 KL-KLSSIDLSENQLS 565
KL+++ +S N L
Sbjct: 145 NTPKLTTLSMSNNNLE 160
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 1e-07
Identities = 21/160 (13%), Positives = 47/160 (29%), Gaps = 14/160 (8%)
Query: 431 LSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEE 490
+ V + S L + + L + +
Sbjct: 1 VGGQQRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKN 60
Query: 491 NALTGSIPNEM-GDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNL 549
+ + +P + ++ LNL + + + ++ L + N + +P ++
Sbjct: 61 STMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHV 118
Query: 550 MK--LKLSSIDLSENQLSGSVPLDFLRMGGDGAFAGNEGL 587
+ L+ + L N LS S+P G F L
Sbjct: 119 FQNVPLLTVLVLERNDLS-SLP--------RGIFHNTPKL 149
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-29
Identities = 64/213 (30%), Positives = 101/213 (47%), Gaps = 27/213 (12%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL-WKGDGVKVFAAEMEILGKI-RHRNILKLYACLL 741
+G+G G+VY+ K A+K + GD + E+ +L K HRNI Y +
Sbjct: 32 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 91
Query: 742 KGGSSF------LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL---GAAKGIAYL 792
K LV+E+ G++ L K K + +W IA +G+++L
Sbjct: 92 KKNPPGMDDQLWLVMEFCGAGSV-TDLIKNTKGNTLKEEW-----IAYICREILRGLSHL 145
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL 852
H +IHRDIK N+LL E+ E K+ DFGV+ A+ V + F GT ++APE+
Sbjct: 146 H---QHKVIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFIGTPYWMAPEV 200
Query: 853 AYTCKVSE-----KSDVFSFGVVLLELVTGRKP 880
+ + KSD++S G+ +E+ G P
Sbjct: 201 IACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 65/215 (30%), Positives = 96/215 (44%), Gaps = 30/215 (13%)
Query: 683 LIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGDGVKVFAA---EMEILGKIRHRNILKL 736
+G G G+V L N T VAVK + V E+ I + H N++K
Sbjct: 14 TLGEGAYGEVQ---LAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 70
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRY---KIALGAAKGIAYLH 793
Y +G +L LEY G LF + + +R+ +A G+ YLH
Sbjct: 71 YGHRREGNIQYLFLEYCSGGELF---DRIEPDIGMPEPDAQRFFHQLMA-----GVVYLH 122
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL- 852
I HRDIK N+LLDE KI+DFG+A + + + + GT Y+APEL
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 853 ---AYTCKVSEKSDVFSFGVVLLELVTGRKPVEEE 884
+ +E DV+S G+VL ++ G P ++
Sbjct: 180 KRREFH---AEPVDVWSCGIVLTAMLAGELPWDQP 211
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 120 bits (301), Expect = 4e-29
Identities = 30/242 (12%), Positives = 69/242 (28%), Gaps = 44/242 (18%)
Query: 678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAE---MEILGKIR 729
L ++G ++ + V + + +K E + +L I+
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 730 HRNILKLYACLLK------------------GGSSFLVLEY---MP-----NGNLFQALH 763
++ K++ + VL P + L
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 764 KRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADF 823
K + R + L + +A LHH ++H ++ +I+LD+ + F
Sbjct: 200 SHSSTHKSLVHHARLQ-LTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGF 255
Query: 824 GVAKIAENSPKVSDYSCFAGTHGYIAPELAY-----TCKVSEKSDVFSFGVVLLELVTGR 878
+ + VS A + ++ D ++ G+ + +
Sbjct: 256 EHLV-RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
Query: 879 KP 880
P
Sbjct: 315 LP 316
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 62/222 (27%), Positives = 96/222 (43%), Gaps = 37/222 (16%)
Query: 683 LIGSGGTGKVYRLDLKKNAGT---VAVKQLWK------GDGVKVFAAEMEILGKIRHRNI 733
L+G G GKV ++ T AVK L K +G E+++L ++RH+N+
Sbjct: 12 LLGEGSYGKVK---EVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNV 68
Query: 734 LKLYACLLKGGSS--FLVLEYMPNGN--LFQAL-HKRVKEGKPELDWFRRYKIALGAAKG 788
++L L ++V+EY G + ++ KR + Y L G
Sbjct: 69 IQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQA-----HGYFCQL--IDG 121
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY----SCFAGT 844
+ YLH I+H+DIK N+LL KI+ GVA+ P +D S G+
Sbjct: 122 LEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALH--PFAADDTCRTSQ--GS 174
Query: 845 HGYIAPELAYTCKVSE--KSDVFSFGVVLLELVTGRKPVEEE 884
+ PE+A K D++S GV L + TG P E +
Sbjct: 175 PAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD 216
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-29
Identities = 51/257 (19%), Positives = 90/257 (35%), Gaps = 29/257 (11%)
Query: 641 KNFKLSADMENGEKEVSSKWKLASFHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKN 700
K +L EK + LA H I LE +++ D +
Sbjct: 37 KRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTD 96
Query: 701 AGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQ 760
+ + ++ + +N + ++ ++ NL
Sbjct: 97 WPLSSPSPMDAPSV------KIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKD 150
Query: 761 ALHKRVKEGKPE----LDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY 816
+++R E L F +IA + +LH S ++HRD+K SNI D
Sbjct: 151 WMNRRCSLEDREHGVCLHIFI--QIAEA----VEFLH---SKGLMHRDLKPSNIFFTMDD 201
Query: 817 EPKIADFGVAKIAENS----------PKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFS 866
K+ DFG+ + P + ++ GT Y++PE + S K D+FS
Sbjct: 202 VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFS 261
Query: 867 FGVVLLELVTGRKPVEE 883
G++L EL+ E
Sbjct: 262 LGLILFELLYSFSTQME 278
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 65/215 (30%), Positives = 96/215 (44%), Gaps = 30/215 (13%)
Query: 683 LIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGDGVKVFAA---EMEILGKIRHRNILKL 736
+G G G+V L N T VAVK + V E+ I + H N++K
Sbjct: 14 TLGEGAYGEVQ---LAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 70
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRY---KIALGAAKGIAYLH 793
Y +G +L LEY G LF + + +R+ +A G+ YLH
Sbjct: 71 YGHRREGNIQYLFLEYCSGGELF---DRIEPDIGMPEPDAQRFFHQLMA-----GVVYLH 122
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL- 852
I HRDIK N+LLDE KI+DFG+A + + + + GT Y+APEL
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 853 ---AYTCKVSEKSDVFSFGVVLLELVTGRKPVEEE 884
+ +E DV+S G+VL ++ G P ++
Sbjct: 180 KRREFH---AEPVDVWSCGIVLTAMLAGELPWDQP 211
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-28
Identities = 70/215 (32%), Positives = 102/215 (47%), Gaps = 34/215 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGT---VAVK-----QLWKGDGVKVFAAEMEILGKIRHRNILK 735
IG G KV L ++ T VA+K QL K+F E+ I+ + H NI+K
Sbjct: 23 IGKGNFAKVK---LARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVK 78
Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQAL--HKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
L+ + + +L++EY G +F L H R+KE + R + +A + Y H
Sbjct: 79 LFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEA-----RSKFRQIVSA--VQYCH 131
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL- 852
I+HRD+K+ N+LLD D KIADFG + K+ C G Y APEL
Sbjct: 132 QKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD-AFC--GAPPYAAPELF 185
Query: 853 ---AYTCKVSEKSDVFSFGVVLLELVTGRKPVEEE 884
Y + DV+S GV+L LV+G P + +
Sbjct: 186 QGKKYDGP---EVDVWSLGVILYTLVSGSLPFDGQ 217
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-28
Identities = 65/294 (22%), Positives = 115/294 (39%), Gaps = 48/294 (16%)
Query: 681 DNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKI-RHRNILKLYAC 739
+ ++G G +G V + VAVK++ + E+++L + H N+++ Y
Sbjct: 20 EKILGYGSSGTVVFQGSFQGR-PVAVKRMLIDF-CDIALMEIKLLTESDDHPNVIRYYCS 77
Query: 740 LLKGGSSFLVLEYMPNGNLFQAL--HKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
++ LE N NL + E + + A G+A+LH S
Sbjct: 78 ETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---S 133
Query: 798 PPIIHRDIKSSNILLD-------------EDYEPKIADFGVAKI--AENSPKVSDYSCFA 842
IIHRD+K NIL+ E+ I+DFG+ K + S ++ + +
Sbjct: 134 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS 193
Query: 843 GTHGYIAPEL-------AYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYW 894
GT G+ APEL +++ D+FS G V +++ G+ P ++Y +I
Sbjct: 194 GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNI--- 250
Query: 895 VSTHLNNHENV--LKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREV 946
+ ++ +K L D+I P RP +V
Sbjct: 251 ----IRGIFSLDEMKCLHDRSLIAEAT-DLISQ------MIDHDPLKRPTAMKV 293
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 68/244 (27%), Positives = 96/244 (39%), Gaps = 62/244 (25%)
Query: 683 LIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGDGVKVFAA------------------- 720
IG G G V L N A+K L K ++
Sbjct: 20 EIGKGSYGVVK---LAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQP 76
Query: 721 ---------EMEILGKIRHRNILKLYACLLKGGSS--FLVLEYMPNGNLFQ-ALHKRVKE 768
E+ IL K+ H N++KL L ++V E + G + + K + E
Sbjct: 77 RGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSE 136
Query: 769 GKPELDWFRRY--KIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826
D R Y + G I YLH IIHRDIK SN+L+ ED KIADFGV+
Sbjct: 137 -----DQARFYFQDLIKG----IEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVS 184
Query: 827 KIAENSPKVSDYSCFAGTHGYIAPEL------AYTCKVSEKSDVFSFGVVLLELVTGRKP 880
+ S + + GT ++APE ++ K DV++ GV L V G+ P
Sbjct: 185 NEFKGSDALLSNTV--GTPAFMAPESLSETRKIFSGK---ALDVWAMGVTLYCFVFGQCP 239
Query: 881 VEEE 884
+E
Sbjct: 240 FMDE 243
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 6e-28
Identities = 60/244 (24%), Positives = 101/244 (41%), Gaps = 31/244 (12%)
Query: 648 DMENGEKEVSSKWKLASFHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVK 707
+++ +WK + + + ++G GG G+V ++ A K
Sbjct: 161 YLDSIYFNRFLQWKWLERQPVTKN-----TFRQYRVLGKGGFGEVCACQVRATGKMYACK 215
Query: 708 QLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQAL 762
+L K G + E +IL K+ R ++ L + LVL M G+L +
Sbjct: 216 KLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHI 275
Query: 763 HKRVKEGKPELDWFRRY--KIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKI 820
+ + G PE Y +I G + LH I++RD+K NILLD+ +I
Sbjct: 276 YHMGQAGFPE-ARAVFYAAEICCG----LEDLH---RERIVYRDLKPENILLDDHGHIRI 327
Query: 821 ADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL----AYTCKVSEKSDVFSFGVVLLELVT 876
+D G+A + GT GY+APE+ YT D ++ G +L E++
Sbjct: 328 SDLGLAV--HVPEGQTIKG-RVGTVGYMAPEVVKNERYTFSP----DWWALGCLLYEMIA 380
Query: 877 GRKP 880
G+ P
Sbjct: 381 GQSP 384
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-27
Identities = 63/234 (26%), Positives = 100/234 (42%), Gaps = 30/234 (12%)
Query: 659 KWKLASFHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----D 713
+WK + D + ++G GG G+V+ +K A K+L K
Sbjct: 173 QWKWLEAQPMGED-----WFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRK 227
Query: 714 GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVK-EGKPE 772
G + E +IL K+ R I+ L LV+ M G++ ++ + +
Sbjct: 228 GYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ 287
Query: 773 LDWFRRY--KIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830
Y +I G + +LH II+RD+K N+LLD+D +I+D G+A E
Sbjct: 288 EPRAIFYTAQIVSG----LEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAV--E 338
Query: 831 NSPKVSDYSCFAGTHGYIAPEL----AYTCKVSEKSDVFSFGVVLLELVTGRKP 880
+ +AGT G++APEL Y V D F+ GV L E++ R P
Sbjct: 339 LKAGQTKTKGYAGTPGFMAPELLLGEEYDFSV----DYFALGVTLYEMIAARGP 388
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 1e-27
Identities = 30/312 (9%), Positives = 81/312 (25%), Gaps = 78/312 (25%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV------------------------- 717
++G ++ + V + +
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 718 -----FAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM----PNGNLFQALHKRVKE 768
F +++ + + ++++ Y + L
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 769 GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828
K + R + L + +A LHH ++H ++ +I+LD+ + F
Sbjct: 200 HKSLVHHARLQ-LTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV- 254
Query: 829 AENSPKVSDYSCFAGTHGYIAPEL-----------AYTCKVSEKSDVFSFGVVLLELVTG 877
+ + + G+ PEL ++ D ++ G+V+ +
Sbjct: 255 -----RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309
Query: 878 RKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMI-KLLKIAVVCTTKL 936
P L E + + C+ + ++ ++ L
Sbjct: 310 DLP------------ITKDAALGGSEWIFR--SCKNIPQPVR-ALLEGFL-------RYP 347
Query: 937 PNLRPPMREVVK 948
R + ++
Sbjct: 348 KEDRLLPLQAME 359
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-27
Identities = 66/358 (18%), Positives = 121/358 (33%), Gaps = 59/358 (16%)
Query: 225 CRNK----ISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGK 280
C K + P R L L N + E + L+E +++ N +
Sbjct: 18 CHRKRFVAVPEGIPTETRLLD------LGKNRIKTLNQDEFASFPHLEELELNENIV-SA 70
Query: 281 LPEEI-GNLKNLTVFQCFKNNFSGEFPSG-FGDMRKLFAFSIYGNRFSGPFPENLGRYTA 338
+ NL NL N P G F + L I N+
Sbjct: 71 VEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYN 129
Query: 339 LTDVDISENQFS----GSFPKYLCEKRKLLNL--LALSNNFSGEVP-NSYADCKTIQRLR 391
L +++ +N +F L +L L L +P + + + LR
Sbjct: 130 LKSLEVGDNDLVYISHRAF-------SGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLR 182
Query: 392 ISDNHLSGKIPDGLWA-LPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELP 450
+ +++ I D + L + +L+ + ++P +L+ L + + + +P
Sbjct: 183 LRHLNIN-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVP 240
Query: 451 SE-LGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVD 509
+ L L L L+ N S S L L +L + L L
Sbjct: 241 YLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA--------------- 285
Query: 510 LNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMK--LKLSSIDLSENQLS 565
+ + G L+ L LN+SGN+LT ++ +++ L ++ L N L+
Sbjct: 286 -VVEPYAFRG--------LNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-22
Identities = 63/303 (20%), Positives = 108/303 (35%), Gaps = 9/303 (2%)
Query: 74 RVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAM 133
+ + ++ L L L N++S P +N NL+ L + N +
Sbjct: 33 ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRL 92
Query: 134 VGSVPD--LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESI-G 190
+P + L NL D+S N +L L SL +GDN D I
Sbjct: 93 K-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDN--DLVYISHRAFS 149
Query: 191 NLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYA 250
L +L L L CNL E++S L L L + I+ S ++L +L +E+
Sbjct: 150 GLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISH 209
Query: 251 NNLTGELPAELGNLTLLQEFDISSNQMYGKLPEE-IGNLKNLTVFQCFKNNFSGEFPSGF 309
+ L I+ + +P + +L L N S S
Sbjct: 210 WPYLDTMTPNCLYGLNLTSLSITHCNL-TAVPYLAVRHLVYLRFLNLSYNPISTIEGSML 268
Query: 310 GDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLAL 369
++ +L + G + + P L +++S NQ + + + + L L L
Sbjct: 269 HELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLIL 327
Query: 370 SNN 372
+N
Sbjct: 328 DSN 330
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 2e-20
Identities = 53/270 (19%), Positives = 96/270 (35%), Gaps = 32/270 (11%)
Query: 329 FPENLGRYTALTDVDISENQFS----GSFPKYLCEKRKLLNLLALSNNFSGEV-PNSYAD 383
PE + T +D+ +N+ F + L L L+ N V P ++ +
Sbjct: 26 VPEGIPTET--RLLDLGKNRIKTLNQDEFASF-----PHLEELELNENIVSAVEPGAFNN 78
Query: 384 CKTIQRLRISDNHLSGKIPDG-LWALPNVGMLDFGDNDFTGGISPLI--GLSTSLSQLVL 440
++ L + N L IP G L N+ LD +N + + L +L L +
Sbjct: 79 LFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVI-LLDYMFQDL-YNLKSLEV 135
Query: 441 QNNRFSGELPSE-LGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPN 499
+N + L +LE+L L N + AL L L L L +
Sbjct: 136 GDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDY 194
Query: 500 EMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDN-LMKLK-LSSI 557
R+ L ++ + + +L +L+++ LT ++P + L L +
Sbjct: 195 SFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFL 253
Query: 558 DLSENQLSGSVPLDFLRMGGDGAFAGNEGL 587
+LS N +S ++ L
Sbjct: 254 NLSYNPIS-TIE--------GSMLHELLRL 274
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 55/245 (22%), Positives = 85/245 (34%), Gaps = 51/245 (20%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK-------GDGVKVFAAEMEILGKIRHRNILKL 736
IG G G V + A+K + K V+ E+ ++ K+ H NI +L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALG------------ 784
Y LV+E G+L L+ + + +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 785 ----------------AAK-------GIAYLHHDCSPPIIHRDIKSSNILL--DEDYEPK 819
+ + YLH + I HRDIK N L ++ +E K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIK 210
Query: 820 IADFGVAKIAENSPKVSDYSC--FAGTHGYIAPEL--AYTCKVSEKSDVFSFGVVLLELV 875
+ DFG++K Y AGT ++APE+ K D +S GV+L L+
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270
Query: 876 TGRKP 880
G P
Sbjct: 271 MGAVP 275
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-27
Identities = 64/232 (27%), Positives = 91/232 (39%), Gaps = 52/232 (22%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK----------GDGVKVFAAEMEILGKIRHRNI 733
+GSG G+V +K VA++ + K D E+EIL K+ H I
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 734 LKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGK-PELDWFRRYKIALGAAK----- 787
+K+ ++VLE M G LF + V + E
Sbjct: 203 IKIKN-FFDAEDYYIVLELMEGGELFDKV---VGNKRLKEAT----------CKLYFYQM 248
Query: 788 --GIAYLHHDCSPPIIHRDIKSSNILL---DEDYEPKIADFGVAKIAENSPKVSDYSCFA 842
+ YLH IIHRD+K N+LL +ED KI DFG +KI + +
Sbjct: 249 LLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT---LC 302
Query: 843 GTHGYIAPEL-------AYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGD 887
GT Y+APE+ Y V D +S GV+L ++G P E
Sbjct: 303 GTPTYLAPEVLVSVGTAGYNRAV----DCWSLGVILFICLSGYPPFSEHRTQ 350
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-27
Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 20/206 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK---GDGVKVFAAEMEILGKIRHRNILKLYACL 740
+GSG G V+ ++ + + +K + K ++ AE+E+L + H NI+K++
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKP--ELDWFRRYKIALGAAKGIAYLHHDCSP 798
+ ++V+E G L + + GK E K + A +AY H S
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA---LAYFH---SQ 143
Query: 799 PIIHRDIKSSNILL---DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPE-LAY 854
++H+D+K NIL KI DFG+A++ ++ ++ AGT Y+APE
Sbjct: 144 HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN---AAGTALYMAPEVFKR 200
Query: 855 TCKVSEKSDVFSFGVVLLELVTGRKP 880
V+ K D++S GVV+ L+TG P
Sbjct: 201 --DVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 45/236 (19%), Positives = 85/236 (36%), Gaps = 53/236 (22%)
Query: 679 EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKI-RHRNI 733
E IGSG G V++ + + A+K+ K V E+ + +H ++
Sbjct: 14 HELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHV 73
Query: 734 LKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGK--PE---LDWFRRYKIALGAAKG 788
++ ++ + + EY G+L A+ + + E D + +G
Sbjct: 74 VRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQ------VGRG 127
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEP-------------------KIADFGVAKIA 829
+ Y+H S ++H DIK SNI + P KI D G
Sbjct: 128 LRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184
Query: 830 ENSPKVSDYSCFAGTHGYIAPEL-----AYTCKVSEKSDVFSFGVVLLELVTGRKP 880
+SP+V G ++A E+ + K+D+F+ + ++
Sbjct: 185 -SSPQV-----EEGDSRFLANEVLQENYTHL----PKADIFALALTVVCAAGAEPL 230
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 6e-27
Identities = 64/215 (29%), Positives = 96/215 (44%), Gaps = 33/215 (15%)
Query: 683 LIGSGGTGKVYRLDLKKNAGT---VAVKQLWKGDGV--KVFAAEMEILGKIRHRNILKLY 737
IGSG G L ++ T VAVK + +G + V E+ +RH NI++
Sbjct: 27 DIGSGNFGVAR---LMRDKLTKELVAVKYIERGAAIDENV-QREIINHRSLRHPNIVRFK 82
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQ--ALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHD 795
+L +++EY G L++ R E E +F + ++ G++Y H
Sbjct: 83 EVILTPTHLAIIMEYASGGELYERICNAGRFSE--DEARFFFQQLLS-----GVSYCHSM 135
Query: 796 CSPPIIHRDIKSSNILLDEDYEP--KIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL- 852
I HRD+K N LLD P KI DFG +K + + + GT YIAPE+
Sbjct: 136 Q---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TV--GTPAYIAPEVL 189
Query: 853 ---AYTCKVSEKSDVFSFGVVLLELVTGRKPVEEE 884
Y K +DV+S GV L ++ G P E+
Sbjct: 190 LRQEYDGK---IADVWSCGVTLYVMLVGAYPFEDP 221
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 65/217 (29%), Positives = 103/217 (47%), Gaps = 35/217 (16%)
Query: 683 LIGSGGTGKVYRLDLKKNAGT---VAVKQLWK------GDGVKVFAAEMEILGKIRHRNI 733
+G G GKV + ++ T VAVK L + K+ E++ L RH +I
Sbjct: 18 TLGVGTFGKVK---IGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR-EIQNLKLFRHPHI 73
Query: 734 LKLYACLLKGGSSFLVLEYMPNGNLFQAL--HKRVKEGKPELDWFRRYKIALGAAKGIAY 791
+KLY + F+V+EY+ G LF + H RV+E E + ++ + Y
Sbjct: 74 IKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEE--MEARRLFQQILS-----AVDY 126
Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPE 851
H ++HRD+K N+LLD KIADFG++ + + + SC G+ Y APE
Sbjct: 127 CHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL-RTSC--GSPNYAAPE 180
Query: 852 L----AYTCKVSEKSDVFSFGVVLLELVTGRKPVEEE 884
+ Y + D++S GV+L L+ G P ++E
Sbjct: 181 VISGRLYA---GPEVDIWSCGVILYALLCGTLPFDDE 214
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-27
Identities = 68/433 (15%), Positives = 133/433 (30%), Gaps = 42/433 (9%)
Query: 89 ISSSISALQSLTVLSLPFNVLSGKLPLELSNC-SNLKVLNVTGN--AMVGSVPDLSALKN 145
I I+ SL+ S +N +S + + + + G S+ +
Sbjct: 3 IMLPINNNFSLSQNSF-YNTIS-GTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQ 60
Query: 146 LEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNL 205
L+ + P + Q+ L I N +PE +L+ L L
Sbjct: 61 FSELQLNRLNLS-SLPDNL--PPQITVLEITQNALIS--LPELPASLEYLD---ACDNRL 112
Query: 206 RGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLT 265
+PE + L+ LD+ N+++ P L+ + N LT LP +L
Sbjct: 113 S-TLPELPASLKH---LDVDNNQLT-MLPELPALLEYIN---ADNNQLT-MLPELPTSLE 163
Query: 266 LLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKL----FAFSIY 321
+L + +NQ+ LPE +L+ L V N P+ F
Sbjct: 164 VL---SVRNNQL-TFLPELPESLEALDV----STNLLESLPAVPVRNHHSEETEIFFRCR 215
Query: 322 GNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSY 381
NR + PEN+ + + +N S S + ++ +
Sbjct: 216 ENRITH-IPENILSLDPTCTIILEDNPLS-SRIRESLSQQTAQPDYHGPRIYFSMSDGQQ 273
Query: 382 ADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQ 441
++ + + + + N F+ + L + S
Sbjct: 274 NTLHRPLADAVTAW-FPENKQSDVSQIWHAFEHEEHANTFSAFLDRL-SDTVSARNTSGF 331
Query: 442 NNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEM 501
+ + + L +L+ L + + + L+ +L + L +
Sbjct: 332 REQ----VAAWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLLVHQASEGL 387
Query: 502 GDCARIVDLNLAR 514
D L+L R
Sbjct: 388 FDNDTGALLSLGR 400
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 1e-26
Identities = 56/347 (16%), Positives = 112/347 (32%), Gaps = 53/347 (15%)
Query: 185 IPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDIC---RNKISGEFPRSIRKLQ 241
I I N +L+ + + G + S + + RN+ + +
Sbjct: 3 IMLPINNNFSLS-QNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--IN 59
Query: 242 KLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNF 301
+ +++L NL+ LP L + +I+ N + LPE +L+ L +N
Sbjct: 60 QFSELQLNRLNLS-SLPDNLP--PQITVLEITQNAL-ISLPELPASLEYLDA----CDNR 111
Query: 302 SGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKR 361
P ++ L + N+ + PE L ++ NQ + P+
Sbjct: 112 LSTLPELPASLKHL---DVDNNQLTM-LPELPAL---LEYINADNNQLT-MLPELPTS-- 161
Query: 362 KLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDF 421
L +L++ NN +P ++++ L +S N L +P +
Sbjct: 162 --LEVLSVRNNQLTFLPEL---PESLEALDVSTNLLES-LPAVPVRNHH----------- 204
Query: 422 TGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALR 481
+ + NR + +P + L +IL +N S +I +L
Sbjct: 205 ---------SEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQT 254
Query: 482 QLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLL 528
H + S + + D N +S +
Sbjct: 255 AQPDYHGPRIYFSMSDGQQNTLHRPLAD--AVTAWFPENKQSDVSQI 299
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 3e-22
Identities = 56/286 (19%), Positives = 101/286 (35%), Gaps = 33/286 (11%)
Query: 285 IGNLKNLTV--FQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDV 342
I N +L+ F + ++ S + K N E L +++
Sbjct: 7 INNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSEL 64
Query: 343 DISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIP 402
++ S S P L + +L ++ N +P A ++ L DN LS +P
Sbjct: 65 QLNRLNLS-SLPDNLP---PQITVLEITQNALISLPELPAS---LEYLDACDNRLS-TLP 116
Query: 403 DGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERL 462
+ +L + LD +N T + L L + NN+ + LP T+LE L
Sbjct: 117 ELPASLKH---LDVDNNQLTM-LPELPA---LLEYINADNNQLT-MLPELP---TSLEVL 165
Query: 463 ILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCAR----IVDLNLARNSLS 518
+ NN + +P +L L + N L S+P + N ++
Sbjct: 166 SVRNNQLT-FLPELPESLEAL---DVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT 220
Query: 519 GNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQL 564
+IP ++ L + L N L+ I ++L +
Sbjct: 221 -HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIY 265
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 99.7 bits (248), Expect = 9e-22
Identities = 57/345 (16%), Positives = 97/345 (28%), Gaps = 72/345 (20%)
Query: 227 NKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIG 286
+ ++ + K +K N L L + E ++ + LP+ +
Sbjct: 23 SGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSELQLNRLNL-SSLPDNLP 79
Query: 287 NLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISE 346
+TV + +N P + L NR S PE L +D+
Sbjct: 80 --PQITVLEITQNALI-SLPELPASLEYL---DACDNRLST-LPELPAS---LKHLDVDN 129
Query: 347 NQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLW 406
NQ + P+ LL + NN +P +++ L + +N L+ +P+
Sbjct: 130 NQLT-MLPELPA----LLEYINADNNQLTMLPEL---PTSLEVLSVRNNQLT-FLPELP- 179
Query: 407 ALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTN 466
SL L + N LP+ R + E
Sbjct: 180 --------------------------ESLEALDVSTNLLE-SLPAVPVRNHHSEET---- 208
Query: 467 NNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLS 526
EN +T IP + + L N LS I SLS
Sbjct: 209 ----------------EIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLS 251
Query: 527 LLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSGSVPLD 571
++ + + S L D + D
Sbjct: 252 QQTAQPDYHGPRIYFSMSDG-QQNTLHRPLADAVTAWFPENKQSD 295
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 9e-27
Identities = 67/205 (32%), Positives = 96/205 (46%), Gaps = 21/205 (10%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKIRHRNILKLYAC 739
+GSG G+V K A+K + K E+ +L + H NI+KLY
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGK-PELDWFRRYKIALGAAKGIAYLHHDCSP 798
+ +LV+E G LF + + K E+D K L + YLH
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEI---IHRMKFNEVDAAVIIKQVLSG---VTYLH---KH 155
Query: 799 PIIHRDIKSSNILL---DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYT 855
I+HRD+K N+LL ++D KI DFG++ + EN K+ + GT YIAPE+
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKE---RLGTAYYIAPEV-LR 211
Query: 856 CKVSEKSDVFSFGVVLLELVTGRKP 880
K EK DV+S GV+L L+ G P
Sbjct: 212 KKYDEKCDVWSIGVILFILLAGYPP 236
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-26
Identities = 66/214 (30%), Positives = 96/214 (44%), Gaps = 40/214 (18%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA------EMEILGKIRHRNILKLY 737
IG+G G VY+ L + VA+K KV E++I+ K+ H NI++L
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIK--------KVLQDKRFKNRELQIMRKLDHCNIVRLR 113
Query: 738 ACLLKGGSSF------LVLEYMPNGNLFQALHKRVKEGKP-ELDWFRRYKIALGAAKGIA 790
G LVL+Y+P +++ + + + + + Y L + +A
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQL--FRSLA 170
Query: 791 YLHHDCSPPIIHRDIKSSNILLDED-YEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIA 849
Y+H S I HRDIK N+LLD D K+ DFG AK Y C + Y A
Sbjct: 171 YIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC---SRYYRA 224
Query: 850 PEL-----AYTCKVSEKSDVFSFGVVLLELVTGR 878
PEL YT + DV+S G VL EL+ G+
Sbjct: 225 PELIFGATDYTSSI----DVWSAGCVLAELLLGQ 254
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 59/205 (28%), Positives = 91/205 (44%), Gaps = 17/205 (8%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV-----FAAEMEILGKIRHRNILKLY 737
++G G V + A+K L K +K E +++ ++ H +KLY
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 96
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRY--KIALGAAKGIAYLHHD 795
+ L Y NG L + + K G + R Y +I + YLH
Sbjct: 97 FTFQDDEKLYFGLSYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSA----LEYLH-- 147
Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYT 855
IIHRD+K NILL+ED +I DFG AK+ K + + F GT Y++PEL
Sbjct: 148 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 206
Query: 856 CKVSEKSDVFSFGVVLLELVTGRKP 880
+ SD+++ G ++ +LV G P
Sbjct: 207 KSACKSSDLWALGCIIYQLVAGLPP 231
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 67/208 (32%), Positives = 98/208 (47%), Gaps = 27/208 (12%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKIRHRNILKLYAC 739
+G G G+V + + AVK + K E+E+L K+ H NI+KL+
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGK-PELDWFRRYKIALGAAKGIAYLHHDCSP 798
L S ++V E G LF + +K + E D R K I Y+H
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEI---IKRKRFSEHDAARIIKQVFSG---ITYMH---KH 140
Query: 799 PIIHRDIKSSNILL---DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL--- 852
I+HRD+K NILL ++D + KI DFG++ + + K+ D GT YIAPE+
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD---RIGTAYYIAPEVLRG 197
Query: 853 AYTCKVSEKSDVFSFGVVLLELVTGRKP 880
Y K DV+S GV+L L++G P
Sbjct: 198 TYDEKC----DVWSAGVILYILLSGTPP 221
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-26
Identities = 66/206 (32%), Positives = 96/206 (46%), Gaps = 22/206 (10%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKIRHRNILKLYA 738
+G G G+V K AVK + K + E+++L ++ H NI+KLY
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGK-PELDWFRRYKIALGAAKGIAYLHHDCS 797
G +LV E G LF + + + E+D R + L I Y+H
Sbjct: 94 FFEDKGYFYLVGEVYTGGELFDEI---ISRKRFSEVDAARIIRQVLSG---ITYMH---K 144
Query: 798 PPIIHRDIKSSNILL---DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAY 854
I+HRD+K N+LL +D +I DFG++ E S K+ D GT YIAPE+
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD---KIGTAYYIAPEV-L 200
Query: 855 TCKVSEKSDVFSFGVVLLELVTGRKP 880
EK DV+S GV+L L++G P
Sbjct: 201 HGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 59/206 (28%), Positives = 89/206 (43%), Gaps = 25/206 (12%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLL 741
IG G G+V K A K++ K + V F E+EI+ + H NI++LY
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGK-PELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
+LV+E G LF+ + V + E D R K L A +AY H +
Sbjct: 77 DNTDIYLVMELCTGGELFERV---VHKRVFRESDAARIMKDVLSA---VAYCH---KLNV 127
Query: 801 IHRDIKSSNILL---DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL---AY 854
HRD+K N L D K+ DFG+A + + GT Y++P++ Y
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT---KVGTPYYVSPQVLEGLY 184
Query: 855 TCKVSEKSDVFSFGVVLLELVTGRKP 880
+ D +S GV++ L+ G P
Sbjct: 185 GPEC----DEWSAGVMMYVLLCGYPP 206
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 5e-26
Identities = 56/220 (25%), Positives = 85/220 (38%), Gaps = 46/220 (20%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFA---------AEMEILGKIRHRNIL 734
G G G V K +VA+K KV M+ L + H NI+
Sbjct: 31 AGQGTFGTVQLGKEKSTGMSVAIK--------KVIQDPRFRNRELQIMQDLAVLHHPNIV 82
Query: 735 KLYACLLKGGSS-------FLVLEYMPNGNLFQALHKRVKEGKPELDWFRR---YKIALG 784
+L + G +V+EY+P+ L + + + +++
Sbjct: 83 QLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLI-- 139
Query: 785 AAKGIAYLHHDCSPPIIHRDIKSSNILLD-EDYEPKIADFGVAKIAENSPKVSDYSCFAG 843
+ I LH S + HRDIK N+L++ D K+ DFG AK S Y C
Sbjct: 140 --RSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYIC--- 193
Query: 844 THGYIAPEL-----AYTCKVSEKSDVFSFGVVLLELVTGR 878
+ Y APEL YT V D++S G + E++ G
Sbjct: 194 SRYYRAPELIFGNQHYTTAV----DIWSVGCIFAEMMLGE 229
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 8e-26
Identities = 67/205 (32%), Positives = 98/205 (47%), Gaps = 21/205 (10%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKIRHRNILKLYAC 739
+G G G+V + + AVK + K E+E+L K+ H NI+KL+
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGK-PELDWFRRYKIALGAAKGIAYLHHDCSP 798
L S ++V E G LF + +K + E D R K I Y+H
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEI---IKRKRFSEHDAARIIKQVFSG---ITYMHKHN-- 141
Query: 799 PIIHRDIKSSNILL---DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYT 855
I+HRD+K NILL ++D + KI DFG++ + + K+ D GT YIAPE+
Sbjct: 142 -IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD---RIGTAYYIAPEV-LR 196
Query: 856 CKVSEKSDVFSFGVVLLELVTGRKP 880
EK DV+S GV+L L++G P
Sbjct: 197 GTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 8e-26
Identities = 73/416 (17%), Positives = 132/416 (31%), Gaps = 46/416 (11%)
Query: 136 SVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNL 195
VP+L A ++ DLS+N L L L + + L +L
Sbjct: 24 QVPELPA--HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSL 81
Query: 196 TYLFLAHCNLRGRIPESI-SELRELGTLDICRNKISGEF--PRSIRKLQKLWKIELYANN 252
L L + ++ + L L L + + + G + L L + L NN
Sbjct: 82 IILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNN 140
Query: 253 LTGELPAEL-GNLTLLQEFDISSNQMYGKLPEEI---GNLKNLTVFQCFKNNFSGEFPSG 308
+ PA N+ D++ N++ + EE K+ T+ +
Sbjct: 141 IKKIQPASFFLNMRRFHVLDLTFNKV-KSICEEDLLNFQGKHFTLLRLSSITLQ------ 193
Query: 309 FGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLA 368
+ N + T++T +D+S N F S K +
Sbjct: 194 ----------DMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFF---DAIAGTK 240
Query: 369 LSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPL 428
+ + N + + G G+ D + +
Sbjct: 241 IQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVK------TCDLSKSKIFA-LLKS 293
Query: 429 I--GLSTSLSQLVLQNNRFSGELPSE-LGRLTNLERLILTNNNFSGKIPSALGALRQLSS 485
+ T L QL L N + ++ LT+L +L L+ N L +L
Sbjct: 294 VFSHF-TDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEV 351
Query: 486 LHLEENALTGSIPNEMGD-CARIVDLNLARNSLSGNIPRS-LSLLSSLNALNLSGN 539
L L N + ++ ++ + +L L N L ++P L+SL + L N
Sbjct: 352 LDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-22
Identities = 74/412 (17%), Positives = 120/412 (29%), Gaps = 55/412 (13%)
Query: 98 SLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD--LSALKNLEIFDLSINY 155
+ + L N ++ S +L+ L V + + L +L I L N
Sbjct: 31 HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90
Query: 156 FTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESI-GNLKNLTYLFLAHCNLRGRIPESI- 213
F L L L++ D A + + L +L L L N++ P S
Sbjct: 91 FLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFF 150
Query: 214 SELRELGTLDICRNKISGEFPRSIRKLQKLWKIELY----------ANNLTGELPAELGN 263
+R LD+ NK+ + Q L L E
Sbjct: 151 LNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFK 210
Query: 264 LTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGN 323
T + D+S N + + + T Q + S S FG
Sbjct: 211 NTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFG-----------HT 259
Query: 324 RFSGPFPENLGR--YTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVP-NS 380
F P + + D+S+++ + K + L L L+ N ++ N+
Sbjct: 260 NFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNA 318
Query: 381 YADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVL 440
+ + +L +S N L I + F L L L
Sbjct: 319 FWGLTHLLKLNLSQNFLG-SIDSRM---------------FEN--------LDKLEVLDL 354
Query: 441 QNNRFSGELPSEL-GRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEEN 491
N L + L NL+ L L N L L + L N
Sbjct: 355 SYNHIR-ALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 8e-14
Identities = 31/155 (20%), Positives = 54/155 (34%), Gaps = 11/155 (7%)
Query: 431 LSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPS-ALGALRQLSSLHLE 489
L ++ + L N + + RL +L+ L + I + L L L L+
Sbjct: 28 LPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLD 87
Query: 490 ENALTGSIPNEM-GDCARIVDLNLARNSL-SGNIPR-SLSLLSSLNALNLSGNKLT---- 542
N + A + L L + +L + L+SL L L N +
Sbjct: 88 YNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQP 146
Query: 543 GSIPDNLMKLKLSSIDLSENQLSGSVPLDFLRMGG 577
S N+ + +DL+ N++ D L G
Sbjct: 147 ASFFLNMRRFH--VLDLTFNKVKSICEEDLLNFQG 179
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 70/216 (32%), Positives = 99/216 (45%), Gaps = 30/216 (13%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLK 742
+G G T VYR K A+K L K K+ E+ +L ++ H NI+KL
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFET 119
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGK-PELDWFRRYKIALGAAK-------GIAYLHH 794
LVLE + G LF + V++G E D AA +AYLH
Sbjct: 120 PTEISLVLELVTGGELFDRI---VEKGYYSERD----------AADAVKQILEAVAYLH- 165
Query: 795 DCSPPIIHRDIKSSNILL---DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPE 851
I+HRD+K N+L D KIADFG++KI E+ + GT GY APE
Sbjct: 166 --ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT---VCGTPGYCAPE 220
Query: 852 LAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGD 887
+ C + D++S G++ L+ G +P +E GD
Sbjct: 221 ILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD 256
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 64/228 (28%), Positives = 90/228 (39%), Gaps = 44/228 (19%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK----------GDGVKVFAAEMEILGKIRHRNI 733
+GSG G+V +K VA+K + K D E+EIL K+ H I
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 734 LKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGK-PELDWFRRYKIALGAAK----- 787
+K+ ++VLE M G LF + V + E
Sbjct: 78 IKIKN-FFDAEDYYIVLELMEGGELFDKV---VGNKRLKEAT----------CKLYFYQM 123
Query: 788 --GIAYLHHDCSPPIIHRDIKSSNILL---DEDYEPKIADFGVAKIAENSPKVSDYSCFA 842
+ YLH IIHRD+K N+LL +ED KI DFG +KI + +
Sbjct: 124 LLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT---LC 177
Query: 843 GTHGYIAPE-LAYTCKV--SEKSDVFSFGVVLLELVTGRKPVEEEYGD 887
GT Y+APE L + D +S GV+L ++G P E
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ 225
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-25
Identities = 65/214 (30%), Positives = 97/214 (45%), Gaps = 41/214 (19%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA------EMEILGKIRHRNILKLY 737
IG+G G V++ L ++ VA+K KV E++I+ ++H N++ L
Sbjct: 48 IGNGSFGVVFQAKLVES-DEVAIK--------KVLQDKRFKNRELQIMRIVKHPNVVDLK 98
Query: 738 ACLLKGGSS------FLVLEYMPNGNLFQALHKRVKEGKP-ELDWFRRYKIALGAAKGIA 790
A G LVLEY+P +++A K + + + Y L + +A
Sbjct: 99 AFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQL--LRSLA 155
Query: 791 YLHHDCSPPIIHRDIKSSNILLDED-YEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIA 849
Y+H S I HRDIK N+LLD K+ DFG AKI Y C + Y A
Sbjct: 156 YIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC---SRYYRA 209
Query: 850 PEL-----AYTCKVSEKSDVFSFGVVLLELVTGR 878
PEL YT + D++S G V+ EL+ G+
Sbjct: 210 PELIFGATNYTTNI----DIWSTGCVMAELMQGQ 239
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-25
Identities = 63/260 (24%), Positives = 108/260 (41%), Gaps = 44/260 (16%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLY 737
IG G GKV + A+K + K + V+ E++I+ + H ++ L+
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRY--KIALGAAKGIAYLHHD 795
F+V++ + G+L L + + + + + ++ + + YL
Sbjct: 82 YSFQDEEDMFMVVDLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMA----LDYLQ-- 132
Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL--- 852
+ IIHRD+K NILLDE I DF +A + + AGT Y+APE+
Sbjct: 133 -NQRIIHRDMKPDNILLDEHGHVHITDFNIAA--MLPRETQITT-MAGTKPYMAPEMFSS 188
Query: 853 ----AYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKV 908
Y+ V D +S GV EL+ GR+P Y + + ++ E V
Sbjct: 189 RKGAGYSFAV----DWWSLGVTAYELLRGRRP------------YHIRSSTSSKEIVHTF 232
Query: 909 LDCEVA-SESIKEDMIKLLK 927
V + ++M+ LLK
Sbjct: 233 ETTVVTYPSAWSQEMVSLLK 252
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 5e-25
Identities = 65/219 (29%), Positives = 103/219 (47%), Gaps = 39/219 (17%)
Query: 683 LIGSGGTGKVYRLDLKKNAGT---VAVK-----QLWKGDGVKVFAAEMEILGKIRHRNIL 734
+G G GKV + K+ T VAVK ++ D V E++ L RH +I+
Sbjct: 23 TLGVGTFGKVK---VGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHII 79
Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQAL--HKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
KLY + F+V+EY+ G LF + + R+ E E + ++ G+ Y
Sbjct: 80 KLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDE--KESRRLFQQILS-----GVDYC 132
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY---SCFAGTHGYIA 849
H ++HRD+K N+LLD KIADFG++ N ++ SC G+ Y A
Sbjct: 133 HRHM---VVHRDLKPENVLLDAHMNAKIADFGLS----NMMSDGEFLRTSC--GSPNYAA 183
Query: 850 PEL----AYTCKVSEKSDVFSFGVVLLELVTGRKPVEEE 884
PE+ Y + D++S GV+L L+ G P +++
Sbjct: 184 PEVISGRLYA---GPEVDIWSSGVILYALLCGTLPFDDD 219
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 8e-25
Identities = 68/217 (31%), Positives = 103/217 (47%), Gaps = 36/217 (16%)
Query: 683 LIGSGGTGKVYRLDLKKNAGT---VAVKQLWK------GDGVKVFAAEMEILGKIRHRNI 733
+G G GKV L + T VA+K + + ++V E+ L +RH +I
Sbjct: 16 TLGEGSFGKVK---LATHYKTQQKVALKFISRQLLKKSDMHMRVER-EISYLKLLRHPHI 71
Query: 734 LKLYACLLKGGSSFLVLEYMPNGNLFQAL--HKRVKEGKPELDWFRRYKIALGAAKGIAY 791
+KLY + +V+EY G LF + KR+ E E F + I I Y
Sbjct: 72 IKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTE--DEGRRFFQQIIC-----AIEY 123
Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPE 851
H I+HRD+K N+LLD++ KIADFG++ I + + SC G+ Y APE
Sbjct: 124 CHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT-SC--GSPNYAAPE 177
Query: 852 L----AYTCKVSEKSDVFSFGVVLLELVTGRKPVEEE 884
+ Y + DV+S G+VL ++ GR P ++E
Sbjct: 178 VINGKLYA---GPEVDVWSCGIVLYVMLVGRLPFDDE 211
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 8e-25
Identities = 65/223 (29%), Positives = 93/223 (41%), Gaps = 29/223 (13%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLY 737
L+G G GKV + K A+K L K D V E +L RH + L
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK--IALGAAKGIAYLHHD 795
V+EY G LF L + E D R Y I + YLH +
Sbjct: 215 YSFQTHDRLCFVMEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSA----LDYLHSE 267
Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL--- 852
+ +++RD+K N++LD+D KI DFG+ K E + F GT Y+APE+
Sbjct: 268 KN--VVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLED 323
Query: 853 -AYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYW 894
Y V D + GVV+ E++ GR P Y + ++
Sbjct: 324 NDYGRAV----DWWGLGVVMYEMMCGRLPF---YNQDHEKLFE 359
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 56/207 (27%), Positives = 88/207 (42%), Gaps = 42/207 (20%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKIRHRNILKLYAC 739
+G G V R K A K + + E I K++H NI++L+
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGK-PELDWFRRYKIALGAAK-------GIAY 791
+ + +LV + + G LF+ + V E D A+ IAY
Sbjct: 74 IQEESFHYLVFDLVTGGELFEDI---VAREFYSEAD----------ASHCIQQILESIAY 120
Query: 792 LHHDCSPPIIHRDIKSSNILL---DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
H S I+HR++K N+LL + K+ADFG+A +S FAGT GY+
Sbjct: 121 CH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG---FAGTPGYL 174
Query: 849 APEL----AYTCKVSEKSDVFSFGVVL 871
+PE+ Y+ V D+++ GV+L
Sbjct: 175 SPEVLKKDPYSKPV----DIWACGVIL 197
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-25
Identities = 66/218 (30%), Positives = 91/218 (41%), Gaps = 32/218 (14%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWK---------------GDGVKVFAAEMEILG 726
+GSG G+V K A+K + K + E+ +L
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 727 KIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGK-PELDWFRRYKIALGA 785
+ H NI+KL+ +LV E+ G LF+ + + K E D K L
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI---INRHKFDECDAANIMKQILSG 158
Query: 786 AKGIAYLHHDCSPPIIHRDIKSSNILL---DEDYEPKIADFGVAKIAENSPKVSDYSCFA 842
I YLH I+HRDIK NILL + KI DFG++ K+ D
Sbjct: 159 ---ICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD---RL 209
Query: 843 GTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKP 880
GT YIAPE K +EK DV+S GV++ L+ G P
Sbjct: 210 GTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 9e-25
Identities = 63/227 (27%), Positives = 98/227 (43%), Gaps = 35/227 (15%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTV-AVKQLWKG-----DGVKVFAAEMEILGKI---RHRNI 733
+IG GG G+VY K + G + A+K L K G + E +L + I
Sbjct: 196 IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254
Query: 734 LKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRY--KIALGAAKGIAY 791
+ + +L+ M G+L L + G R Y +I LG + +
Sbjct: 255 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILG----LEH 307
Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPE 851
+H + +++RD+K +NILLDE +I+D G+A + S K GTHGY+APE
Sbjct: 308 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLAC--DFSKKKP--HASVGTHGYMAPE 360
Query: 852 L-----AYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVY 893
+ AY D FS G +L +L+ G P + K +
Sbjct: 361 VLQKGVAYDSSA----DWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 403
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 68/240 (28%), Positives = 93/240 (38%), Gaps = 48/240 (20%)
Query: 684 IGSGGTGKVYRLDLKKNAGT---VAVKQLWK-----------GDGVKVFAAEMEILGKIR 729
+GSG G V+ + V VK + K KV E+ IL ++
Sbjct: 32 LGSGAFGFVW---TAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTL-EIAILSRVE 87
Query: 730 HRNILKLYACLLKGGSSFLVLEYMPNGN-LFQ--ALHKRVKEGKPELDWFRRY--KIALG 784
H NI+K+ G LV+E +G LF H R+ E P ++
Sbjct: 88 HANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDE--PLA---SYIFRQLVSA 142
Query: 785 AAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGT 844
+ YL IIHRDIK NI++ ED+ K+ DFG A E C GT
Sbjct: 143 ----VGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLF-YTFC--GT 192
Query: 845 HGYIAPEL----AYTCKVSEKSDVFSFGVVLLELVTGRKPVEE--EYGDGK-DIVYWVST 897
Y APE+ Y + +++S GV L LV P E E + Y VS
Sbjct: 193 IEYCAPEVLMGNPYRGP---ELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSK 249
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-24
Identities = 71/258 (27%), Positives = 107/258 (41%), Gaps = 33/258 (12%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV-----FAAEMEILGKIRHRNILKLY 737
+IG G G+V + K A+K L K + +K F E +I+ +++L+
Sbjct: 76 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
++V+EYMP G+L + PE W R Y + A + +H S
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDLVNLMSNY---DVPE-KWARFYTAEVVLA--LDAIH---S 186
Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL----- 852
IHRD+K N+LLD+ K+ADFG V + GT YI+PE+
Sbjct: 187 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVLKSQG 245
Query: 853 ---AYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVL 909
Y + D +S GV L E++ G P Y D Y + + NH+N L
Sbjct: 246 GDGYYGREC----DWWSVGVFLYEMLVGDTPF---YADSLVGTY---SKIMNHKNSLTFP 295
Query: 910 DCEVASESIKEDMIKLLK 927
D S+ K + L
Sbjct: 296 DDNDISKEAKNLICAFLT 313
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 2e-24
Identities = 87/530 (16%), Positives = 170/530 (32%), Gaps = 72/530 (13%)
Query: 65 GITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLK 124
G + + + N++L+ + + LSL N +S ++S S L+
Sbjct: 23 GSMTPFSNELESMVDYSNRNLT-HVPKDLPP--RTKALSLSQNSISELRMPDISFLSELR 79
Query: 125 VLNVTGNAMVGSVPD--LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDE 182
VL ++ N + S+ ++LE D+S N + L L + N +D
Sbjct: 80 VLRLSHN-RIRSLDFHVFLFNQDLEYLDVSHNRLQNISCCP---MASLRHLDLSFNDFDV 135
Query: 183 AEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELG-TLDICRNKISGEFPRSIRKLQ 241
+ + GNL LT+L L+ R ++ L LD+ I G S++
Sbjct: 136 LPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPN 195
Query: 242 KLWKIELYANNLTGELPAELGNLTL----LQEFDISSNQMYGKLPEEIGNLKNLTVFQCF 297
++ N + + L L ++ + + T+
Sbjct: 196 TTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVT 255
Query: 298 KNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYL 357
+ + + + + ++I + +
Sbjct: 256 LQHIETTWKCSVKLFQFFW-------------------PRPVEYLNIYNLTITERIDREE 296
Query: 358 CEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFG 417
+ K++ + + + +
Sbjct: 297 FTYSETAL-------------------KSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLS 337
Query: 418 DNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSAL 477
+D +S + L N F+ + L L+ LIL N
Sbjct: 338 ISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVA 396
Query: 478 GALRQLSSLHLEENALTGSIPNEMGDC-----ARIVDLNLARNSLSGNIPRSLSLLSSLN 532
+ +SSL + +L S+ + D I+ LNL+ N L+G++ R L +
Sbjct: 397 LMTKNMSSLETLDVSLN-SLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVK 453
Query: 533 ALNLSGNKLTGSIPDNLMKL-KLSSIDLSENQLSGSVPLDFLRMGGDGAF 581
L+L N++ SIP ++ L L ++++ NQL SVP DG F
Sbjct: 454 VLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVP--------DGVF 493
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 2e-14
Identities = 61/403 (15%), Positives = 130/403 (32%), Gaps = 34/403 (8%)
Query: 92 SISALQSLTVLSLPFNVL-SGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFD 150
S + SL L L FN + E N + L L ++ DL + +L +
Sbjct: 116 SCCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL--DLLPVAHLHLSC 173
Query: 151 LSINYFT-----GRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFL----A 201
+ ++ + G + T ++ L N ++ S+ L +L +
Sbjct: 174 ILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDE 233
Query: 202 HCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIE---LYANNLTG--- 255
+C ++ L + + + + + + + +E +Y +T
Sbjct: 234 NCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERID 293
Query: 256 --ELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMR 313
E L L + + + + ++
Sbjct: 294 REEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPS 353
Query: 314 KLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNF 373
+ N F+ + L + + N +F K + + +L L +
Sbjct: 354 SFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSL 412
Query: 374 ----SGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFT---GGIS 426
S + A ++I L +S N L+G + L P V +LD +N ++
Sbjct: 413 NSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIMSIPKDVT 470
Query: 427 PLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNF 469
L +L +L + +N+ RLT+L+ + L +N +
Sbjct: 471 HL----QALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPW 509
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 55/195 (28%), Positives = 91/195 (46%), Gaps = 19/195 (9%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWK--GDGVKVFAAEMEILGKIRHRNILKLYACL 740
++GSG +V+ + + A+K + K E+ +L KI+H NI+ L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGK-PELDWFRRYKIALGAAKGIAYLHHDCSPP 799
+LV++ + G LF + ++ G E D + L A + YLH
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRI---LERGVYTEKDASLVIQQVLSA---VKYLH---ENG 126
Query: 800 IIHRDIKSSNILL---DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTC 856
I+HRD+K N+L +E+ + I DFG++K+ +N S GT GY+APE+
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI----MSTACGTPGYVAPEVLAQK 182
Query: 857 KVSEKSDVFSFGVVL 871
S+ D +S GV+
Sbjct: 183 PYSKAVDCWSIGVIT 197
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 56/215 (26%), Positives = 86/215 (40%), Gaps = 47/215 (21%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK-----------GDGVKVFAAEMEILGKI-RHR 731
+G G + V R K AVK + + + E++IL K+ H
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVK--EGKPELDWFRRYKIALGAAK-- 787
NI++L FLV + M G LF L ++V E + K
Sbjct: 85 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKE--------------TRKIM 130
Query: 788 -----GIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFA 842
I LH I+HRD+K NILLD+D K+ DFG + + K+ +
Sbjct: 131 RALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE---VC 184
Query: 843 GTHGYIAPE-LAYTCKVSEKS-----DVFSFGVVL 871
GT Y+APE + + + D++S GV++
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 58/226 (25%), Positives = 99/226 (43%), Gaps = 47/226 (20%)
Query: 683 LIGSGGTGKVYRLDLKKNAGT---VAVKQLWK---------GDGVKVFAAEMEILGKIRH 730
L+GSGG G VY VA+K + K +G +V E+ +L K+
Sbjct: 50 LLGSGGFGSVY---SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKVSS 105
Query: 731 R--NILKLYACLLKGGSSFLVLEY-MPNGNLFQ--ALHKRVKEGKPELDWFRRY--KIAL 783
+++L + S L+LE P +LF ++E R + ++
Sbjct: 106 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA-----RSFFWQVL- 159
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY-EPKIADFGVAKIAENSPKVSDYSCFA 842
+ + + H+ ++HRDIK NIL+D + E K+ DFG + +++ Y+ F
Sbjct: 160 ---EAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFD 209
Query: 843 GTHGYIAPEL----AYTCKVSEKSDVFSFGVVLLELVTGRKPVEEE 884
GT Y PE Y + + V+S G++L ++V G P E +
Sbjct: 210 GTRVYSPPEWIRYHRYHGR---SAAVWSLGILLYDMVCGDIPFEHD 252
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 27/287 (9%), Positives = 72/287 (25%), Gaps = 58/287 (20%)
Query: 683 LIGSGGTGKVYR-LDLKKNAGTVAVKQLWKGDG-----VKVFAAEMEILGKIRHRNILKL 736
G + ++ LD + VA+ + ++ + L +I + ++
Sbjct: 38 FHGGVPPLQFWQALDTALDR-QVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC 796
+ +V E++ G+L + + A H
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVADTS-------PSPVGAIRAMQSLAAAADAAHRA- 148
Query: 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTC 856
+ S + + D + +A +
Sbjct: 149 --GVALSIDHPSRVRVSIDGDVVLAYP----------------------ATMPD------ 178
Query: 857 KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASE 916
+ + D+ G L L+ R P+ E + + +D ++ +
Sbjct: 179 -ANPQDDIRGIGASLYALLVNRWPLPEA--GVRSGLAPAERDTAGQPIEPADIDRDIPFQ 235
Query: 917 SIKEDMIKLLKIAVVCTTKLPNLRPP--MREVVKMLADADPCTDKSP 961
+ +A +R + +++ T+
Sbjct: 236 --------ISAVAARSVQGDGGIRSASTLLNLMQQATAVADRTEVLG 274
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-24
Identities = 58/223 (26%), Positives = 93/223 (41%), Gaps = 25/223 (11%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV-----FAAEMEILGKIRHRNILKLY 737
+IG G G+V + LK A+K L K + +K F E ++L + I L+
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH 140
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRY--KIALGAAKGIAYLHHD 795
+ +LV++Y G+L L K E + + R Y ++ + I +H
Sbjct: 141 YAFQDDNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIA----IDSVH-- 192
Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYT 855
+HRDIK NIL+D + ++ADFG V GT YI+PE+
Sbjct: 193 -QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV-AVGTPDYISPEILQA 250
Query: 856 CKVSEKS-----DVFSFGVVLLELVTGRKPVEEEYGDGKDIVY 893
+ + D +S GV + E++ G P Y + Y
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGETPF---YAESLVETY 290
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-24
Identities = 54/218 (24%), Positives = 96/218 (44%), Gaps = 34/218 (15%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK--GDGVKVFAAEMEILGKIRHRNIL 734
+ + ++G G G+V++ + +A K + + E+ ++ ++ H N++
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKP--ELDWFRRYKIALGAAK----- 787
+LY LV+EY+ G LF + + E ELD
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRI---IDESYNLTELD----------TILFMKQI 196
Query: 788 --GIAYLHHDCSPPIIHRDIKSSNILL--DEDYEPKIADFGVAKIAENSPKVSDYSCFAG 843
GI ++H I+H D+K NIL + + KI DFG+A+ + K+ G
Sbjct: 197 CEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV---NFG 250
Query: 844 THGYIAPE-LAYTCKVSEKSDVFSFGVVLLELVTGRKP 880
T ++APE + Y VS +D++S GV+ L++G P
Sbjct: 251 TPEFLAPEVVNYDF-VSFPTDMWSVGVIAYMLLSGLSP 287
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 6e-24
Identities = 52/213 (24%), Positives = 87/213 (40%), Gaps = 44/213 (20%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK----------GDGVKVFAAEMEILGKIR-HRN 732
IG G + V R + AVK + + + E IL ++ H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGK-PELDWFRRYKIALGAAK---- 787
I+ L FLV + M G LF L ++ E +
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGELFDYL---TEKVALSEKE----------TRSIMRS 208
Query: 788 ---GIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGT 844
+++LH + I+HRD+K NILLD++ + +++DFG + E K+ + GT
Sbjct: 209 LLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE---LCGT 262
Query: 845 HGYIAPE-LAYTCKVSEKS-----DVFSFGVVL 871
GY+APE L + + D+++ GV+L
Sbjct: 263 PGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 6e-24
Identities = 66/223 (29%), Positives = 92/223 (41%), Gaps = 30/223 (13%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLY 737
L+G G GKV + K A+K L K D V E +L RH + L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK--IALGAAKGIAYLHHD 795
V+EY G LF L + E + R Y I + YLH
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLSR---ERVFTEERARFYGAEIVSA----LEYLH-- 122
Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL--- 852
S +++RDIK N++LD+D KI DFG+ K E + F GT Y+APE+
Sbjct: 123 -SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLED 179
Query: 853 -AYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYW 894
Y V D + GVV+ E++ GR P Y + ++
Sbjct: 180 NDYGRAV----DWWGLGVVMYEMMCGRLPF---YNQDHERLFE 215
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 8e-24
Identities = 54/211 (25%), Positives = 86/211 (40%), Gaps = 24/211 (11%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK-------GDGVKVFAAEMEILGKIRHRNILKL 736
IG G V R ++ AVK + G + E I ++H +I++L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKP--ELDWFRRYKIALGAAKGIAYLH- 793
G ++V E+M +L + KR G E + L A + Y H
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA---LRYCHD 148
Query: 794 HDCSPPIIHRDIKSSNILL---DEDYEPKIADFGVAK-IAENSPKVSDYSCFAGTHGYIA 849
++ IIHRD+K +LL + K+ FGVA + E+ GT ++A
Sbjct: 149 NN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG---RVGTPHFMA 201
Query: 850 PELAYTCKVSEKSDVFSFGVVLLELVTGRKP 880
PE+ + DV+ GV+L L++G P
Sbjct: 202 PEVVKREPYGKPVDVWGCGVILFILLSGCLP 232
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-24
Identities = 51/213 (23%), Positives = 85/213 (39%), Gaps = 33/213 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKIRHR-NILKLYA 738
+G G V + K A K L K D E+ +L + ++ L+
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAK-------GIAY 791
L+LEY G +F + E E D + G+ Y
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVSEND----------VIRLIKQILEGVYY 146
Query: 792 LHHDCSPPIIHRDIKSSNILL---DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
LH I+H D+K NILL + KI DFG+++ ++ ++ + GT Y+
Sbjct: 147 LH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE---IMGTPEYL 200
Query: 849 APE-LAYTCKVSEKSDVFSFGVVLLELVTGRKP 880
APE L Y ++ +D+++ G++ L+T P
Sbjct: 201 APEILNYDP-ITTATDMWNIGIIAYMLLTHTSP 232
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-23
Identities = 51/240 (21%), Positives = 92/240 (38%), Gaps = 19/240 (7%)
Query: 648 DMENGEKEVSSKWKLASFHHIDIDAEQICNL-EEDNLIGSGGTGKVYRLDLKKNAGTVAV 706
+ + +K WK +++ + + + +GSG G V+R K
Sbjct: 22 KINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVA 81
Query: 707 KQLWK--GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHK 764
K + E+ I+ ++ H ++ L+ L+LE++ G LF +
Sbjct: 82 KFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI-- 139
Query: 765 RVKEGKP--ELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILL--DEDYEPKI 820
E E + + A G+ ++H I+H DIK NI+ + KI
Sbjct: 140 -AAEDYKMSEAEVINYMRQACE---GLKHMH---EHSIVHLDIKPENIMCETKKASSVKI 192
Query: 821 ADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKP 880
DFG+A V T + APE+ V +D+++ GV+ L++G P
Sbjct: 193 IDFGLATKLNPDEIVKV---TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 56/200 (28%), Positives = 89/200 (44%), Gaps = 28/200 (14%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKIRHRNILKLYAC 739
+G G V R K A K + + E I K++H NI++L+
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGK-PELDWFRRYKIALGAAKGIAYLHHDCSP 798
+ + +LV + + G LF+ + V E D + L + IAY H S
Sbjct: 97 IQEESFHYLVFDLVTGGELFEDI---VAREFYSEADASHCIQQILES---IAYCH---SN 147
Query: 799 PIIHRDIKSSNILL---DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL--- 852
I+HR++K N+LL + K+ADFG+A +S FAGT GY++PE+
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG---FAGTPGYLSPEVLKK 204
Query: 853 -AYTCKVSEKSDVFSFGVVL 871
Y+ V D+++ GV+L
Sbjct: 205 DPYSKPV----DIWACGVIL 220
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 69/226 (30%), Positives = 110/226 (48%), Gaps = 34/226 (15%)
Query: 683 LIGSGGTGKVY--RLDLKKNAGTV-AVKQLWKG-----DGVKVFAAEMEILGKIRHRNIL 734
++G G GKV+ + +A + A+K L K D V+ E +IL ++ H I+
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ERDILVEVNHPFIV 89
Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRY--KIALGAAKGIAYL 792
KL+ G +L+L+++ G+LF L K E + + Y ++AL + +L
Sbjct: 90 KLHYAFQTEGKLYLILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALA----LDHL 142
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL 852
H S II+RD+K NILLDE+ K+ DFG++K E+ F GT Y+APE+
Sbjct: 143 H---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEV 197
Query: 853 ----AYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYW 894
+T D +SFGV++ E++TG P G +
Sbjct: 198 VNRRGHTQSA----DWWSFGVLMFEMLTGTLPF---QGKDRKETMT 236
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 66/226 (29%), Positives = 103/226 (45%), Gaps = 34/226 (15%)
Query: 683 LIGSGGTGKVY--RLDLKKNAGTV-AVKQLWK------GDGVKVFAAEMEILGKIRHRNI 733
++G GG GKV+ R N G + A+K L K AE IL +++H I
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 734 LKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRY--KIALGAAKGIAY 791
+ L GG +L+LEY+ G LF L + EG D Y +I++ + +
Sbjct: 84 VDLIYAFQTGGKLYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMA----LGH 136
Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPE 851
LH II+RD+K NI+L+ K+ DFG+ K E+ + F GT Y+APE
Sbjct: 137 LH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHTFCGTIEYMAPE 191
Query: 852 L----AYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVY 893
+ + V D +S G ++ +++TG P G+ +
Sbjct: 192 ILMRSGHNRAV----DWWSLGALMYDMLTGAPPF---TGENRKKTI 230
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 50/213 (23%), Positives = 85/213 (39%), Gaps = 35/213 (16%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKI-RHRNILKLYA--- 738
++G G GKV ++ A+K L+ E++ + +I+ +
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYD---SPKARQEVDHHWQASGGPHIVCILDVYE 92
Query: 739 -CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAK-------GIA 790
+++E M G LF + +R + E + AA+ I
Sbjct: 93 NMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTERE----------AAEIMRDIGTAIQ 142
Query: 791 YLHHDCSPPIIHRDIKSSNILL---DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGY 847
+LH S I HRD+K N+L ++D K+ DFG AK + T Y
Sbjct: 143 FLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA----LQTPCYTPYY 195
Query: 848 IAPELAYTCKVSEKSDVFSFGVVLLELVTGRKP 880
+APE+ K + D++S GV++ L+ G P
Sbjct: 196 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 54/217 (24%), Positives = 90/217 (41%), Gaps = 39/217 (17%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK--------GDGVKVFAAEMEILGKIRHRNILK 735
+GSG V + K A K + K G + E+ IL ++ H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGK-PELDWFRRYKIALGAAK------- 787
L+ L+LE + G LF L ++ E + A
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEE----------ATSFIKQILD 126
Query: 788 GIAYLHHDCSPPIIHRDIKSSNILLDEDYEP----KIADFGVAKIAENSPKVSDYSCFAG 843
G+ YLH + I H D+K NI+L + P K+ DFG+A E+ + + G
Sbjct: 127 GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFG 180
Query: 844 THGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKP 880
T ++APE+ + ++D++S GV+ L++G P
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-23
Identities = 58/229 (25%), Positives = 89/229 (38%), Gaps = 35/229 (15%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLY 737
+IG G +V + +K+ A+K + K V F E ++L R I +L+
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRY--KIALGAAKGIAYLHHD 795
+LV+EY G+L L K + + R Y +I + I +H
Sbjct: 128 FAFQDENYLYLVMEYYVGGDLLTLLSK--FGERIPAEMARFYLAEIVMA----IDSVH-- 179
Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL--- 852
+HRDIK NILLD ++ADFG V GT Y++PE+
Sbjct: 180 -RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV-AVGTPDYLSPEILQA 237
Query: 853 --------AYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVY 893
+Y + D ++ GV E+ G+ P Y D Y
Sbjct: 238 VGGGPGTGSYGPEC----DWWALGVFAYEMFYGQTPF---YADSTAETY 279
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-23
Identities = 59/205 (28%), Positives = 93/205 (45%), Gaps = 24/205 (11%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
IGSG G V VA+K+L + + A E+ ++ + H+NI+ L
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 92
Query: 740 LLKGGSS------FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
S ++V+E M NL Q + + + + Y++ GI +LH
Sbjct: 93 FTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMS---YLLYQML----CGIKHLH 144
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELA 853
S IIHRD+K SNI++ D KI DFG+A+ A S ++ Y T Y APE+
Sbjct: 145 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRAPEVI 198
Query: 854 YTCKVSEKSDVFSFGVVLLELVTGR 878
E D++S G ++ E++ G
Sbjct: 199 LGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 72/390 (18%), Positives = 130/390 (33%), Gaps = 116/390 (29%)
Query: 184 EIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKL 243
++P+ + + L L + + L+ L TL + NKIS P + L KL
Sbjct: 45 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 102
Query: 244 WKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSG 303
++ L N L ELP ++ LQE + N++ K+ + +
Sbjct: 103 ERLYLSKNQLK-ELPEKM--PKTLQELRVHENEIT-KVRKSV------------------ 140
Query: 304 EFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKL 363
F + ++ + N L I F G +
Sbjct: 141 -----FNGLNQMIVVELGTNP--------------LKSSGIENGAFQG-----------M 170
Query: 364 LNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTG 423
L +RI+D +++ IP GL
Sbjct: 171 KKL---------------------SYIRIADTNIT-TIPQGL----------P------- 191
Query: 424 GISPLIGLSTSLSQLVLQNNRFSGELPSE-LGRLTNLERLILTNNNFSGKIPSALGALRQ 482
SL++L L N+ + ++ + L L NL +L L+ N+ S +L
Sbjct: 192 ---------PSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPH 241
Query: 483 LSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRS-------LSLLSSLNALN 535
L LHL N L +P + D I + L N++S I + + +S + ++
Sbjct: 242 LRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVS 299
Query: 536 LSGNKLT-GSIPDNLMK--LKLSSIDLSEN 562
L N + I + + +++ L
Sbjct: 300 LFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 3e-21
Identities = 71/312 (22%), Positives = 118/312 (37%), Gaps = 51/312 (16%)
Query: 290 NLTVFQCFKNNFSGEFPSG-FGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQ 348
+L V QC + P D L + N+ + + L + + N+
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLPPDTALL---DLQNNKITEIKDGDFKNLKNLHTLILINNK 87
Query: 349 FS----GSFPKYLCEKRKLLNL--LALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIP 402
S G+F L+ L L LS N E+P KT+Q LR+ +N ++ K+
Sbjct: 88 ISKISPGAF-------APLVKLERLYLSKNQLKELPEKMP--KTLQELRVHENEIT-KVR 137
Query: 403 DGLWA-LPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLER 461
++ L + +++ G N L ++N F G + L
Sbjct: 138 KSVFNGLNQMIVVELGTN--------------PLKSSGIENGAFQG--------MKKLSY 175
Query: 462 LILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEM-GDCARIVDLNLARNSLSGN 520
+ + + N + IP G L+ LHL+ N +T + + L L+ NS+S
Sbjct: 176 IRIADTNIT-TIPQ--GLPPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAV 231
Query: 521 IPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLK-LSSIDLSENQLSGSVPLDFLRMGGDG 579
SL+ L L+L+ NKL +P L K + + L N +S DF G +
Sbjct: 232 DNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNT 290
Query: 580 AFAGNEGLCLDQ 591
A G+ L
Sbjct: 291 KKASYSGVSLFS 302
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 9e-16
Identities = 58/322 (18%), Positives = 108/322 (33%), Gaps = 61/322 (18%)
Query: 81 DNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD- 139
+ L ++ + +L L N ++ + N NL L + N + +
Sbjct: 39 SDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KISPG 94
Query: 140 -LSALKNLEIFDLSINYFT----GRF-----------------PRWVVNLTQLVSLSIGD 177
+ L LE LS N L Q++ + +G
Sbjct: 95 AFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGT 154
Query: 178 NVYDEAEIPESI-GNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRS 236
N + I +K L+Y+ +A N+ IP+ + L L + NKI+ S
Sbjct: 155 NPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAAS 211
Query: 237 IRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQC 296
++ L L K+ L N+++ L N L+E +++N++ K+P + + K + V
Sbjct: 212 LKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYL 270
Query: 297 FKNNFS----GEF--PSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFS 350
NN S +F P S++ N + +I + F
Sbjct: 271 HNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNP--------------VQYWEIQPSTFR 316
Query: 351 GSFPKYLCEKRKLLNLLALSNN 372
+ + L N
Sbjct: 317 CV---------YVRAAVQLGNY 329
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-23
Identities = 55/218 (25%), Positives = 89/218 (40%), Gaps = 41/218 (18%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK--------GDGVKVFAAEMEILGKIRHRNILK 735
+GSG V + K A K + K G + E+ IL ++ H NI+
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGK-PELDWFRRYKIALGAAK------- 787
L+ L+LE + G LF L ++ E + A
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEE----------ATSFIKQILD 126
Query: 788 GIAYLHHDCSPPIIHRDIKSSNILL----DEDYEPKIADFGVAKIAENSPKVSDYSCFAG 843
G+ YLH + I H D+K NI+L K+ DFG+A E+ + + G
Sbjct: 127 GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFG 180
Query: 844 THGYIAPE-LAYTCKVSEKSDVFSFGVVLLELVTGRKP 880
T ++APE + Y + ++D++S GV+ L++G P
Sbjct: 181 TPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASP 217
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 6e-23
Identities = 58/218 (26%), Positives = 91/218 (41%), Gaps = 41/218 (18%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK--------GDGVKVFAAEMEILGKIRHRNILK 735
+GSG V + K A K + K G + E+ IL +IRH NI+
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGK-PELDWFRRYKIALGAAK------- 787
L+ L+LE + G LF L ++ E + A +
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDE----------ATQFLKQILD 119
Query: 788 GIAYLHHDCSPPIIHRDIKSSNILL----DEDYEPKIADFGVAKIAENSPKVSDYSCFAG 843
G+ YLH S I H D+K NI+L + K+ DFG+A E + + G
Sbjct: 120 GVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN---IFG 173
Query: 844 THGYIAPE-LAYTCKVSEKSDVFSFGVVLLELVTGRKP 880
T ++APE + Y + ++D++S GV+ L++G P
Sbjct: 174 TPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASP 210
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 7e-23
Identities = 59/205 (28%), Positives = 93/205 (45%), Gaps = 24/205 (11%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
IGSG G V VA+K+L + + A E+ ++ + H+NI+ L
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 129
Query: 740 LLKGGSS------FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
+ +LV+E M NL Q + + + + Y++ GI +LH
Sbjct: 130 FTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMS---YLLYQML----CGIKHLH 181
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELA 853
S IIHRD+K SNI++ D KI DFG+A+ A S ++ Y T Y APE+
Sbjct: 182 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRAPEVI 235
Query: 854 YTCKVSEKSDVFSFGVVLLELVTGR 878
E D++S G ++ E+V +
Sbjct: 236 LGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 66/295 (22%), Positives = 107/295 (36%), Gaps = 40/295 (13%)
Query: 290 NLTVFQCFKNNFSGEFPSG-FGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQ 348
+L V QC P D L + N S ++ L + + N+
Sbjct: 34 HLRVVQCSDLGLK-AVPKEISPDTTLL---DLQNNDISELRKDDFKGLQHLYALVLVNNK 89
Query: 349 FS----GSFPKYLCEKRKLLNL--LALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIP 402
S +F L L L +S N E+P + ++ LRI DN + K+P
Sbjct: 90 ISKIHEKAF-------SPLRKLQKLYISKNHLVEIPPNLP--SSLVELRIHDNRIR-KVP 139
Query: 403 DGLWA-LPNVGMLDFGDNDFT-GGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLE 460
G+++ L N+ ++ G N G P L+ L + + + +P +L L
Sbjct: 140 KGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLN 196
Query: 461 RLILTNNNFSGKIPS-ALGALRQLSSLHLEENALTGSIPNEM-GDCARIVDLNLARNSLS 518
L L +N I L +L L L N + I N + +L+L N LS
Sbjct: 197 ELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS 254
Query: 519 GNIPRSLSLLSSLNALNLSGNKLTGSIPDN--------LMKLKLSSIDLSENQLS 565
+P L L L + L N +T + N + + + I L N +
Sbjct: 255 -RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVP 307
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 6e-21
Identities = 69/375 (18%), Positives = 117/375 (31%), Gaps = 82/375 (21%)
Query: 194 NLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNL 253
+L + + L+ +P+ IS + LD+ N IS + LQ L+ + L N +
Sbjct: 34 HLRVVQCSDLGLK-AVPKEISP--DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 254 TGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMR 313
+ L LQ+ IS N + ++P + +L + N F +R
Sbjct: 91 SKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLR 147
Query: 314 KLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNF 373
+ + GN L + F G L L
Sbjct: 148 NMNCIEMGGNP--------------LENSGFEPGAFDG------------LKL------- 174
Query: 374 SGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISP--LIGL 431
LRIS+ L+ IP L + L N I L+
Sbjct: 175 --------------NYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQA-IELEDLLRY 216
Query: 432 STSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEEN 491
+ L +L L +N+ L L L L L NN S ++P+ L L+ L ++L N
Sbjct: 217 -SKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTN 274
Query: 492 ALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLT-GSIPDNLM 550
+T + N + N ++L N + +
Sbjct: 275 NIT----------------KVGVNDFCP--VGFGVKRAYYNGISLFNNPVPYWEVQPATF 316
Query: 551 K--LKLSSIDLSENQ 563
+ +I +
Sbjct: 317 RCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 1e-16
Identities = 51/291 (17%), Positives = 95/291 (32%), Gaps = 39/291 (13%)
Query: 90 SSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIF 149
LQ L L L N +S S L+ L ++ N +V +P + +L
Sbjct: 71 KDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPP-NLPSSLVEL 128
Query: 150 DLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRI 209
+ N L + + +G N + + + L YL ++ L I
Sbjct: 129 RIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GI 187
Query: 210 PESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQE 269
P+ + L L + NKI + + KL+++ L N + L L L+E
Sbjct: 188 PKDL--PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRE 245
Query: 270 FDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPF 329
+ +N++ ++P + +LK L V NN + + N F
Sbjct: 246 LHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT----------------KVGVNDFCPVG 288
Query: 330 PENLGRYTALTDVDISENQFS------GSFPKYLCEKRKLLNL--LALSNN 372
+ + + N +F R + + + N
Sbjct: 289 FGV--KRAYYNGISLFNNPVPYWEVQPATF-------RCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 42/147 (28%), Positives = 67/147 (45%), Gaps = 6/147 (4%)
Query: 430 GLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLE 489
+S + L LQNN S + L +L L+L NN S A LR+L L++
Sbjct: 51 EISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110
Query: 490 ENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSI--PD 547
+N L IP + + +V+L + N + S L ++N + + GN L S P
Sbjct: 111 KNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPG 167
Query: 548 NLMKLKLSSIDLSENQLSGSVPLDFLR 574
LKL+ + +SE +L+ +P D
Sbjct: 168 AFDGLKLNYLRISEAKLT-GIPKDLPE 193
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 1e-22
Identities = 60/247 (24%), Positives = 105/247 (42%), Gaps = 35/247 (14%)
Query: 645 LSADMENGEKEVSSKWKLASFHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTV 704
+ + +++ KW+ S + +D + +G+G G+V + K++
Sbjct: 15 VKEFLAKAKEDFLKKWETPSQNTAQLD-----QFDRIKTLGTGSFGRVMLVKHKESGNHY 69
Query: 705 AVKQLWKGDGVKV-----FAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLF 759
A+K L K VK+ E IL + ++KL + ++V+EY+ G +F
Sbjct: 70 AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 129
Query: 760 QALHKRVKEGKPELDWFRRY--KIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE 817
L + G+ R Y +I L YLH S +I+RD+K N+L+D+
Sbjct: 130 SHLRR---IGRFSEPHARFYAAQIVLT----FEYLH---SLDLIYRDLKPENLLIDQQGY 179
Query: 818 PKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL----AYTCKVSEKSDVFSFGVVLLE 873
++ DFG AK + GT +APE+ Y V D ++ GV++ E
Sbjct: 180 IQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSKGYNKAV----DWWALGVLIYE 230
Query: 874 LVTGRKP 880
+ G P
Sbjct: 231 MAAGYPP 237
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 1e-22
Identities = 47/210 (22%), Positives = 78/210 (37%), Gaps = 33/210 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK-GDGVKVFAAEMEILGKIRHRNILKLYACLLK 742
+G G G V+R + T K + G + E+ IL RHRNIL L+
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES 72
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGKP--ELDWFRRYKIALGAAK-------GIAYLH 793
++ E++ ++F+ + E + + +LH
Sbjct: 73 MEELVMIFEFISGLDIFERI---NTSAFELNERE----------IVSYVHQVCEALQFLH 119
Query: 794 HDCSPPIIHRDIKSSNILL--DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPE 851
S I H DI+ NI+ KI +FG A+ + Y APE
Sbjct: 120 ---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPE 173
Query: 852 -LAYTCKVSEKSDVFSFGVVLLELVTGRKP 880
+ VS +D++S G ++ L++G P
Sbjct: 174 VHQHDV-VSTATDMWSLGTLVYVLLSGINP 202
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 60/246 (24%), Positives = 96/246 (39%), Gaps = 56/246 (22%)
Query: 683 LIGSGGTGKVYRLDLKKNAGT---VAVKQLWK---------GDGVKVFAAEMEILGKIR- 729
L+G GG G V+ VA+K + + D V E+ +L K+
Sbjct: 38 LLGKGGFGTVF---AGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL-EVALLWKVGA 93
Query: 730 ---HRNILKLYACLLKGGSSFLVLEY-MPNGNLFQ--ALHKRVKEGKPELDWFRRY--KI 781
H +++L LVLE +P +LF + EG R + ++
Sbjct: 94 GGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPS-----RCFFGQV 148
Query: 782 ALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY-EPKIADFGVAKIAENSPKVSDYSC 840
I + H ++HRDIK NIL+D K+ DFG + + P Y+
Sbjct: 149 VAA----IQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP----YTD 197
Query: 841 FAGTHGYIAPEL----AYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIV---Y 893
F GT Y PE Y + V+S G++L ++V G P E + ++I+
Sbjct: 198 FDGTRVYSPPEWISRHQYHAL---PATVWSLGILLYDMVCGDIPFERD----QEILEAEL 250
Query: 894 WVSTHL 899
H+
Sbjct: 251 HFPAHV 256
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 56/218 (25%), Positives = 90/218 (41%), Gaps = 41/218 (18%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK--------GDGVKVFAAEMEILGKIRHRNILK 735
+GSG V + K A K + K G + E+ IL +I+H N++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGK-PELDWFRRYKIALGAAK------- 787
L+ L+LE + G LF L ++ E + A +
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEE----------ATEFLKQILN 125
Query: 788 GIAYLHHDCSPPIIHRDIKSSNILL----DEDYEPKIADFGVAKIAENSPKVSDYSCFAG 843
G+ YLH S I H D+K NI+L KI DFG+A + + + G
Sbjct: 126 GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFG 179
Query: 844 THGYIAPE-LAYTCKVSEKSDVFSFGVVLLELVTGRKP 880
T ++APE + Y + ++D++S GV+ L++G P
Sbjct: 180 TPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASP 216
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 2e-22
Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 23/206 (11%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIRHRNILKLYAC 739
IG G G V++ ++ VA+K++ +GV A E+ +L +++H+NI++L+
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP 799
L LV E+ Q L K +LD KG+ + H
Sbjct: 70 LHSDKKLTLVFEFCD-----QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--- 121
Query: 800 IIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL-----AY 854
++HRD+K N+L++ + E K+A+FG+A+ A P V YS T Y P++ Y
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLAR-AFGIP-VRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 855 TCKVSEKSDVFSFGVVLLELVTGRKP 880
+ + D++S G + EL +P
Sbjct: 180 STSI----DMWSAGCIFAELANAGRP 201
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-22
Identities = 44/201 (21%), Positives = 82/201 (40%), Gaps = 14/201 (6%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK--GDGVKVFAAEMEILGKIRHRNILKLYACLL 741
+G+G G V+R+ + A K + + E++ + +RH ++ L+
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPII 801
++ E+M G LF+ + E + + KG+ ++H +
Sbjct: 225 DDNEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVC---KGLCHMH---ENNYV 277
Query: 802 HRDIKSSNILLDEDYEP--KIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVS 859
H D+K NI+ K+ DFG+ + V GT + APE+A V
Sbjct: 278 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEFAAPEVAEGKPVG 334
Query: 860 EKSDVFSFGVVLLELVTGRKP 880
+D++S GV+ L++G P
Sbjct: 335 YYTDMWSVGVLSYILLSGLSP 355
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 102 bits (254), Expect = 3e-22
Identities = 66/224 (29%), Positives = 104/224 (46%), Gaps = 31/224 (13%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKI-RHRNILKL 736
++G G GKV + K AVK L K D V+ E +L + + +L
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK--IALGAAKGIAYLHH 794
++C + V+EY+ G+L + + G+ + Y IA+G + +L
Sbjct: 408 HSCFQTMDRLYFVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIG----LFFLQ- 459
Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL-- 852
S II+RD+K N++LD + KIADFG+ K EN F GT YIAPE+
Sbjct: 460 --SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGTPDYIAPEIIA 515
Query: 853 --AYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYW 894
Y V D ++FGV+L E++ G+ P G+ +D ++
Sbjct: 516 YQPYGKSV----DWWAFGVLLYEMLAGQAPF---EGEDEDELFQ 552
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 3e-22
Identities = 49/200 (24%), Positives = 85/200 (42%), Gaps = 27/200 (13%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKIRHRNILKLYAC 739
+G G V R A + + E I ++H NI++L+
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGK-PELDWFRRYKIALGAAKGIAYLHHDCSP 798
+ + G +L+ + + G LF+ + V E D + L A + + H
Sbjct: 79 ISEEGHHYLIFDLVTGGELFEDI---VAREYYSEADASHCIQQILEA---VLHCH---QM 129
Query: 799 PIIHRDIKSSNILL---DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL--- 852
++HR++K N+LL + K+ADFG+A E + + FAGT GY++PE+
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA--WFGFAGTPGYLSPEVLRK 187
Query: 853 -AYTCKVSEKSDVFSFGVVL 871
Y V D+++ GV+L
Sbjct: 188 DPYGKPV----DLWACGVIL 203
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 5e-22
Identities = 63/231 (27%), Positives = 103/231 (44%), Gaps = 34/231 (14%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKI-RHRNILKL 736
+IG G KV + LKK A+K + K + + E + + H ++ L
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK--IALGAAKGIAYLHH 794
++C F V+EY+ G+L + + + K + R Y I+L + YLH
Sbjct: 76 HSCFQTESRLFFVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLA----LNYLH- 127
Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL-- 852
II+RD+K N+LLD + K+ D+G+ K E S F GT YIAPE+
Sbjct: 128 --ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILR 183
Query: 853 --AYTCKVSEKSDVFSFGVVLLELVTGRKP------VEEEYGDGKDIVYWV 895
Y V D ++ GV++ E++ GR P + + +D ++ V
Sbjct: 184 GEDYGFSV----DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 230
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 6e-22
Identities = 64/224 (28%), Positives = 98/224 (43%), Gaps = 31/224 (13%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKI-RHRNILKL 736
++G G GKV +K+ AVK L K D V+ E IL H + +L
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 89
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK--IALGAAKGIAYLHH 794
+ C F V+E++ G+L + K + + R Y I + +LH
Sbjct: 90 FCCFQTPDRLFFVMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISA----LMFLH- 141
Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL-- 852
II+RD+K N+LLD + K+ADFG+ K E + F GT YIAPE+
Sbjct: 142 --DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYIAPEILQ 197
Query: 853 --AYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYW 894
Y V D ++ GV+L E++ G P + +D ++
Sbjct: 198 EMLYGPAV----DWWAMGVLLYEMLCGHAPF---EAENEDDLFE 234
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 7e-22
Identities = 66/224 (29%), Positives = 104/224 (46%), Gaps = 31/224 (13%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKI-RHRNILKL 736
++G G GKV + K AVK L K D V+ E +L + + +L
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK--IALGAAKGIAYLHH 794
++C + V+EY+ G+L + + G+ + Y IA+G + +L
Sbjct: 87 HSCFQTMDRLYFVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIG----LFFLQ- 138
Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL-- 852
S II+RD+K N++LD + KIADFG+ K EN F GT YIAPE+
Sbjct: 139 --SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGTPDYIAPEIIA 194
Query: 853 --AYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYW 894
Y V D ++FGV+L E++ G+ P G+ +D ++
Sbjct: 195 YQPYGKSV----DWWAFGVLLYEMLAGQAPF---EGEDEDELFQ 231
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 8e-22
Identities = 70/224 (31%), Positives = 106/224 (47%), Gaps = 31/224 (13%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGK-IRHRNILKL 736
++G G GKV+ + KK A+K L K D V+ E +L H + +
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 83
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK--IALGAAKGIAYLHH 794
+ + F V+EY+ G+L + K +L Y I LG + +LH
Sbjct: 84 FCTFQTKENLFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILG----LQFLH- 135
Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL-- 852
S I++RD+K NILLD+D KIADFG+ K EN + + F GT YIAPE+
Sbjct: 136 --SKGIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNTFCGTPDYIAPEILL 191
Query: 853 --AYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYW 894
Y V D +SFGV+L E++ G+ P +G ++ ++
Sbjct: 192 GQKYNHSV----DWWSFGVLLYEMLIGQSPF---HGQDEEELFH 228
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 9e-22
Identities = 52/211 (24%), Positives = 85/211 (40%), Gaps = 36/211 (17%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWK--GDGVKVFAAEMEILGKIR-HRNILKLYAC 739
++G G +V + AVK + K G E+E+L + + HRN+L+L
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRY------KIALGAAKGIAYLH 793
+ +LV E M G++ +HKR R + + A + +LH
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHIHKR-----------RHFNELEASVVVQDVASALDFLH 128
Query: 794 HDCSPPIIHRDIKSSNILL---DEDYEPKIADFGVAKIAENSPKVSDYSC-----FAGTH 845
+ I HRD+K NIL ++ KI DF + + + S S G+
Sbjct: 129 ---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185
Query: 846 GYIAPELAYTCKVSEKS-----DVFSFGVVL 871
Y+APE+ D++S GV+L
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 9e-22
Identities = 62/231 (26%), Positives = 103/231 (44%), Gaps = 34/231 (14%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKI-RHRNILKL 736
+IG G KV + LKK A++ + K + + E + + H ++ L
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118
Query: 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK--IALGAAKGIAYLHH 794
++C F V+EY+ G+L + + + K + R Y I+L + YLH
Sbjct: 119 HSCFQTESRLFFVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLA----LNYLH- 170
Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL-- 852
II+RD+K N+LLD + K+ D+G+ K E S F GT YIAPE+
Sbjct: 171 --ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILR 226
Query: 853 --AYTCKVSEKSDVFSFGVVLLELVTGRKP------VEEEYGDGKDIVYWV 895
Y V D ++ GV++ E++ GR P + + +D ++ V
Sbjct: 227 GEDYGFSV----DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 273
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-21
Identities = 52/207 (25%), Positives = 88/207 (42%), Gaps = 27/207 (13%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIR-HRNILKLYACLLK 742
+G G + KK+ AVK + K E+ L H NI+KL+
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK-EITALKLCEGHPNIVKLHEVFHD 77
Query: 743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRY------KIALGAAKGIAYLHHDC 796
+FLV+E + G LF+ + K+ + + I ++++H
Sbjct: 78 QLHTFLVMELLNGGELFERIKKK-----------KHFSETEASYIMRKLVSAVSHMH--- 123
Query: 797 SPPIIHRDIKSSNILL---DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELA 853
++HRD+K N+L +++ E KI DFG A++ + T Y APEL
Sbjct: 124 DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP--LKTPCFTLHYAAPELL 181
Query: 854 YTCKVSEKSDVFSFGVVLLELVTGRKP 880
E D++S GV+L +++G+ P
Sbjct: 182 NQNGYDESCDLWSLGVILYTMLSGQVP 208
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 2e-21
Identities = 54/210 (25%), Positives = 97/210 (46%), Gaps = 22/210 (10%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQ--LWKGDGVKVFAA-EMEILGKIRHRNI 733
+ + +G G VY+ K VA+K+ L +G A E+ +L ++H NI
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 62
Query: 734 LKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
+ L+ + S LV EY+ + L + + + ++ +G+AY H
Sbjct: 63 VTLHDIIHTEKSLTLVFEYLD-----KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH 117
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL- 852
++HRD+K N+L++E E K+ADFG+A+ A++ P Y T Y P++
Sbjct: 118 RQK---VLHRDLKPQNLLINERGELKLADFGLAR-AKSIP-TKTYDNEVVTLWYRPPDIL 172
Query: 853 ----AYTCKVSEKSDVFSFGVVLLELVTGR 878
Y+ ++ D++ G + E+ TGR
Sbjct: 173 LGSTDYSTQI----DMWGVGCIFYEMATGR 198
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 2e-21
Identities = 52/205 (25%), Positives = 87/205 (42%), Gaps = 20/205 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKI-RHRNILKLYA---- 738
+G G GKV ++ K+ A+K L + E+E+ + + +I+++
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR---REVELHWRASQCPHIVRIVDVYEN 126
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
+V+E + G LF + R + E + K A I YLH S
Sbjct: 127 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA---IQYLH---SI 180
Query: 799 PIIHRDIKSSNILL---DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYT 855
I HRD+K N+L + K+ DFG AK + ++ T Y+APE+
Sbjct: 181 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT---PCYTPYYVAPEVLGP 237
Query: 856 CKVSEKSDVFSFGVVLLELVTGRKP 880
K + D++S GV++ L+ G P
Sbjct: 238 EKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 3e-21
Identities = 70/225 (31%), Positives = 95/225 (42%), Gaps = 33/225 (14%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTV-AVKQLWKG-----DGVKVFAAEMEILGK-IRHRNILK 735
+IG G GKV L K AVK L K K +E +L K ++H ++
Sbjct: 45 VIGKGSFGKVL-LARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103
Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRY--KIALGAAKGIAYLH 793
L+ + VL+Y+ G LF L + E R Y +IA + YLH
Sbjct: 104 LHFSFQTADKLYFVLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASA----LGYLH 156
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL- 852
S I++RD+K NILLD + DFG+ K EN S S F GT Y+APE+
Sbjct: 157 ---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPEYLAPEVL 211
Query: 853 ---AYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYW 894
Y V D + G VL E++ G P Y +Y
Sbjct: 212 HKQPYDRTV----DWWCLGAVLYEMLYGLPPF---YSRNTAEMYD 249
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 4e-21
Identities = 49/285 (17%), Positives = 96/285 (33%), Gaps = 40/285 (14%)
Query: 290 NLTVFQCFKNNFSGEFPSG-FGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQ 348
+ T +C + P+G +L + N+ + T LT + +S N
Sbjct: 8 SGTEIRCNSKGLT-SVPTGIPSSATRL---ELESNKLQSLPHGVFDKLTQLTKLSLSSNG 63
Query: 349 FSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWAL 408
S C + +L + L +S N + + L
Sbjct: 64 LSFKG----CCSQSDFGTTSL------------------KYLDLSFNGVI-TMSSNFLGL 100
Query: 409 PNVGMLDFGDNDFT--GGISPLIGLSTSLSQLVLQNNRFSGELPSE-LGRLTNLERLILT 465
+ LDF ++ S + L +L L + + + L++LE L +
Sbjct: 101 EQLEHLDFQHSNLKQMSEFSVFLSL-RNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMA 158
Query: 466 NNNFSGKIPS-ALGALRQLSSLHLEENALTGSIPNEMGDC-ARIVDLNLARNSLSGNIPR 523
N+F LR L+ L L + L + + + + LN++ N+
Sbjct: 159 GNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTF 217
Query: 524 SLSLLSSLNALNLSGNKLTGSIPDNL---MKLKLSSIDLSENQLS 565
L+SL L+ S N + + L+ ++L++N +
Sbjct: 218 PYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 5e-17
Identities = 56/259 (21%), Positives = 93/259 (35%), Gaps = 15/259 (5%)
Query: 76 TEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVG 135
TEI ++K L+ + + I + S T L L N L + L L+++ N +
Sbjct: 10 TEIRCNSKGLT-SVPTGIPS--SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF 66
Query: 136 ---SVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNL 192
+L+ DLS N + L QL L + + +L
Sbjct: 67 KGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL 125
Query: 193 KNLTYLFLAHCNLRGRIPESI-SELRELGTLDICRNKISGEFPRSI-RKLQKLWKIELYA 250
+NL YL ++H + R I + L L L + N F I +L+ L ++L
Sbjct: 126 RNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 184
Query: 251 NNLTGELPAE-LGNLTLLQEFDISSNQMYGKLPEEI-GNLKNLTVFQCFKNNFSGEFPSG 308
L +L +L+ LQ ++S N L L +L V N+
Sbjct: 185 CQLE-QLSPTAFNSLSSLQVLNMSHNNF-FSLDTFPYKCLNSLQVLDYSLNHIMTSKKQE 242
Query: 309 FGDM-RKLFAFSIYGNRFS 326
L ++ N F+
Sbjct: 243 LQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 9e-16
Identities = 28/150 (18%), Positives = 58/150 (38%), Gaps = 7/150 (4%)
Query: 430 GLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGK--IPSALGALRQLSSLH 487
G+ +S ++L L++N+ +LT L +L L++N S K + L L
Sbjct: 25 GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLD 84
Query: 488 LEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSL-SLLSSLNALNLSGNKLTGSIP 546
L N + ++ + ++ L+ ++L S+ L +L L++S
Sbjct: 85 LSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAF 142
Query: 547 DN-LMKL-KLSSIDLSENQLSGSVPLDFLR 574
+ L L + ++ N + D
Sbjct: 143 NGIFNGLSSLEVLKMAGNSFQENFLPDIFT 172
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 7e-15
Identities = 47/269 (17%), Positives = 92/269 (34%), Gaps = 34/269 (12%)
Query: 184 EIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEF--PRSIRKLQ 241
+P I + T L L L+ +L +L L + N +S + +S
Sbjct: 21 SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78
Query: 242 KLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNF 301
L ++L N + + + L L+ D + + + +VF
Sbjct: 79 SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSN--------LKQMSEFSVFL------ 123
Query: 302 SGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKR 361
+R L I F ++L + ++ N F +F + +
Sbjct: 124 ---------SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTEL 174
Query: 362 KLLNLLALSNNFSGEVP-NSYADCKTIQRLRISDNHLSGKIPDG-LWALPNVGMLDFGDN 419
+ L L LS ++ ++ ++Q L +S N+ + L ++ +LD+ N
Sbjct: 175 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLN 233
Query: 420 DFTGGISP--LIGLSTSLSQLVLQNNRFS 446
L +SL+ L L N F+
Sbjct: 234 HIM-TSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 54/315 (17%), Positives = 85/315 (26%), Gaps = 86/315 (27%)
Query: 233 FPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGK--LPEEIGNLKN 290
P S +L+ L +N L LT L + +SSN + K + +
Sbjct: 26 IPSSATRLE------LESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTS 79
Query: 291 LTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFS 350
L N S F + +L + + +
Sbjct: 80 LKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSN-------------------LKQMSEF 119
Query: 351 GSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDG-LWALP 409
F L NL L IS H +G L
Sbjct: 120 SVF-------LSLRNL---------------------IYLDISHTHTR-VAFNGIFNGLS 150
Query: 410 NVGMLDFGDNDFTGGISP--LIGLSTSLSQLVLQNNRFSGELPSE-LGRLTNLERLILTN 466
++ +L N F P L +L+ L L + +L L++L+ L +++
Sbjct: 151 SLEVLKMAGNSFQENFLPDIFTEL-RNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSH 208
Query: 467 NNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLS 526
NNF L L L N + + +
Sbjct: 209 NNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQ----------------------H 245
Query: 527 LLSSLNALNLSGNKL 541
SSL LNL+ N
Sbjct: 246 FPSSLAFLNLTQNDF 260
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 5e-21
Identities = 58/248 (23%), Positives = 95/248 (38%), Gaps = 76/248 (30%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA------EMEILGKIRHRNILKLY 737
+G+G G V + ++ A+K KV E++I+ + H NI+KL
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALK--------KVLQDPRYKNRELDIMKVLDHVNIIKLV 66
Query: 738 ACLLKGGSSF--------------------------------------LVLEYMPNGNLF 759
G +++EY+P+ L
Sbjct: 67 DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLH 125
Query: 760 QALHKRVKEGKP---ELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD-ED 815
+ L ++ G+ L Y++ + + ++H S I HRDIK N+L++ +D
Sbjct: 126 KVLKSFIRSGRSIPMNLISIYIYQLF----RAVGFIH---SLGICHRDIKPQNLLVNSKD 178
Query: 816 YEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL-----AYTCKVSEKSDVFSFGVV 870
K+ DFG AK S Y C + Y APEL YT + D++S G V
Sbjct: 179 NTLKLCDFGSAKKLIPSEPSVAYIC---SRFYRAPELMLGATEYTPSI----DLWSIGCV 231
Query: 871 LLELVTGR 878
EL+ G+
Sbjct: 232 FGELILGK 239
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 6e-21
Identities = 56/204 (27%), Positives = 103/204 (50%), Gaps = 19/204 (9%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQ--LWKGDGVKVFAA-EMEILGKIRHRNILKLYACL 740
+G+G VY+ K VA+K+ L +G A E+ ++ +++H NI++LY +
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72
Query: 741 LKGGSSFLVLEYMPNGNLFQAL-HKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP 799
LV E+M N +L + + + V L+ +G+A+ H +
Sbjct: 73 HTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--- 128
Query: 800 IIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL-----AY 854
I+HRD+K N+L+++ + K+ DFG+A+ A P V+ +S T Y AP++ Y
Sbjct: 129 ILHRDLKPQNLLINKRGQLKLGDFGLAR-AFGIP-VNTFSSEVVTLWYRAPDVLMGSRTY 186
Query: 855 TCKVSEKSDVFSFGVVLLELVTGR 878
+ + D++S G +L E++TG+
Sbjct: 187 STSI----DIWSCGCILAEMITGK 206
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 7e-21
Identities = 64/249 (25%), Positives = 106/249 (42%), Gaps = 30/249 (12%)
Query: 646 SADMENGEKEVSSKWKLASFHHIDIDAEQICNLEEDNLIGSGGTGKVY--RLDLKKNAGT 703
+ + E+ + + I+ N E ++G+G GKV+ R + G
Sbjct: 29 GEQLLTVKHELRTANLTGHAEKVGIE-----NFELLKVLGTGAYGKVFLVRKISGHDTGK 83
Query: 704 V-AVKQLWK------GDGVKVFAAEMEILGKIRHRN-ILKLYACLLKGGSSFLVLEYMPN 755
+ A+K L K + E ++L IR ++ L+ L+L+Y+
Sbjct: 84 LYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYING 143
Query: 756 GNLFQALHKRVKEGKPELDWFRRY--KIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD 813
G LF L + + + Y +I L + +LH II+RDIK NILLD
Sbjct: 144 GELFTHLSQ---RERFTEHEVQIYVGEIVLA----LEHLH---KLGIIYRDIKLENILLD 193
Query: 814 EDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPE-LAYTCKVSEKS-DVFSFGVVL 871
+ + DFG++K Y F GT Y+AP+ + +K+ D +S GV++
Sbjct: 194 SNGHVVLTDFGLSKEFVADETERAYD-FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLM 252
Query: 872 LELVTGRKP 880
EL+TG P
Sbjct: 253 YELLTGASP 261
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 7e-21
Identities = 59/219 (26%), Positives = 98/219 (44%), Gaps = 38/219 (17%)
Query: 684 IGSGGTGKVY--RLDLKKNAGTVAVKQLWKGDGVKVFAA-EMEILGKIRHRNILKLYACL 740
+G G G VY + K+ A+KQ+ +G G+ + A E+ +L +++H N++ L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQI-EGTGISMSACREIALLRELKHPNVISLQKVF 87
Query: 741 LKGGSS--FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAK--------GIA 790
L +L+ +Y L +K + + ++ G K GI
Sbjct: 88 LSHADRKVWLLFDYAE-----HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 142
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEP----KIADFGVAKIAENSP--KVSDYSCFAGT 844
YLH + ++HRD+K +NIL+ + KIAD G A+ NSP ++D T
Sbjct: 143 YLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR-LFNSPLKPLADLDPVVVT 198
Query: 845 HGYIAPEL-----AYTCKVSEKSDVFSFGVVLLELVTGR 878
Y APEL YT + D+++ G + EL+T
Sbjct: 199 FWYRAPELLLGARHYTKAI----DIWAIGCIFAELLTSE 233
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 9e-21
Identities = 56/214 (26%), Positives = 85/214 (39%), Gaps = 41/214 (19%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGK-IRHRNILKLYACL 740
IG G R K AVK + K D + E+EIL + +H NI+ L
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EIEILLRYGQHPNIITLKDVY 85
Query: 741 LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRY------KIALGAAKGIAYLHH 794
G ++V E M G L + ++ + + K + YLH
Sbjct: 86 DDGKYVYVVTELMKGGELLDKILRQKF-----------FSEREASAVLFTITKTVEYLH- 133
Query: 795 DCSPPIIHRDIKSSNILL---DEDYEP-KIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
+ ++HRD+K SNIL + E +I DFG AK + T ++AP
Sbjct: 134 --AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL--LMTPCYTANFVAP 189
Query: 851 EL----AYTCKVSEKSDVFSFGVVLLELVTGRKP 880
E+ Y D++S GV+L ++TG P
Sbjct: 190 EVLERQGYDAAC----DIWSLGVLLYTMLTGYTP 219
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 1e-20
Identities = 49/277 (17%), Positives = 93/277 (33%), Gaps = 22/277 (7%)
Query: 309 FGDMRKLFAFSIYGNRFSGPFP-ENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLL 367
+G R L + + ++ + +L + + + + L
Sbjct: 39 YGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQ 98
Query: 368 ALS---NNFSGEVPNSYADC--KTIQRLRISDNHLSGKIPD----GLWALPNVGMLDFGD 418
L+ +G P + + L + + + + W P + +L
Sbjct: 99 ELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQ 158
Query: 419 NDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSE----LGRLTNLERLILTNNNF---SG 471
+ + +LS L L +N GE + L+ L L N SG
Sbjct: 159 AHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSG 218
Query: 472 KIPSALGALRQLSSLHLEENALTGSIPNEMGD-CARIVDLNLARNSLSGNIPRSLSLLSS 530
+ A QL L L N+L + D +++ LNL+ L +P+ L +
Sbjct: 219 VCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGLP--AK 275
Query: 531 LNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSGS 567
L+ L+LS N+L P ++ ++ L N S
Sbjct: 276 LSVLDLSYNRLD-RNPSPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 9e-20
Identities = 59/301 (19%), Positives = 104/301 (34%), Gaps = 24/301 (7%)
Query: 263 NLTLLQEFDISSNQMYGKLPEEI-GNLKNLTVFQCFKNNFSGEFP-SGFGDMRKLFAFSI 320
N + + S+ G E+ G ++L + + + L ++
Sbjct: 16 NFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTV 75
Query: 321 YGNRFSGPFPENLGR---YTALTDVDISENQFSGSFPKYLCEKRKL-LNLLALSNNFSGE 376
R R + L ++ + + +G+ P L E LN+L L N
Sbjct: 76 RAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT 135
Query: 377 VPNSYADC-----KTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGL 431
A+ ++ L I+ H + + P + LD DN G + L
Sbjct: 136 RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISAL 195
Query: 432 S----TSLSQLVLQNNRF---SGELPSELGRLTNLERLILTNNNFSGKIPSALGA-LRQL 483
+L L L+N SG + L+ L L++N+ + QL
Sbjct: 196 CPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQL 255
Query: 484 SSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTG 543
+SL+L L +P + A++ L+L+ N L P L + L+L GN
Sbjct: 256 NSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDR-NPSPDEL-PQVGNLSLKGNPFLD 310
Query: 544 S 544
S
Sbjct: 311 S 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 5e-18
Identities = 50/265 (18%), Positives = 94/265 (35%), Gaps = 30/265 (11%)
Query: 324 RFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYAD 383
FS P P+ +A + ++ + G + L K ++ A F+ + +
Sbjct: 16 NFSDPKPD---WSSAFNCLGAADVELYGG-GRSLEYLLKRVDTEADLGQFTDIIKSL--- 68
Query: 384 CKTIQRLRISDNHLSGKIPDG---LWALPNVGMLDFGDNDFTGGISPLIG--LSTSLSQL 438
+++RL + + +I G + + + L + + TG P + L+ L
Sbjct: 69 --SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNIL 126
Query: 439 VLQNNRFSGELPSELGRL-----TNLERLILTNNNFSGKIPSALGALRQLSSLHLEENAL 493
L+N ++ + L L L+ L + + + LS+L L +N
Sbjct: 127 NLRNVSWAT-RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPE 185
Query: 494 TGSIPNEMGDCAR----IVDLNLARN---SLSGNIPRSLSLLSSLNALNLSGNKLTGSIP 546
G C + L L + SG + L L+LS N L +
Sbjct: 186 LGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG 245
Query: 547 DNLMKL--KLSSIDLSENQLSGSVP 569
+L+S++LS L VP
Sbjct: 246 APSCDWPSQLNSLNLSFTGLK-QVP 269
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 74.2 bits (182), Expect = 3e-14
Identities = 47/290 (16%), Positives = 81/290 (27%), Gaps = 30/290 (10%)
Query: 143 LKNLEIFDLSINYFTGRFP-RWVVNLTQLVSLSIGDNVYDEAEIPE--SIGNLKNLTYLF 199
++LE ++ ++ L L++ + + + L L
Sbjct: 42 GRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELT 101
Query: 200 LAHCNLRGRIPESISELRELG--TLDICRNKISGEFPRSIR----KLQKLWKIELYANNL 253
L + + G P + E L++ + L + + +
Sbjct: 102 LENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHS 161
Query: 254 TGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMR 313
++ L D+S N G+ S P F ++
Sbjct: 162 LNFSCEQVRVFPALSTLDLSDNPELGERGL-----------------ISALCPLKFPTLQ 204
Query: 314 KLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNF 373
L + SG L +D+S N + C+ LN L LS
Sbjct: 205 VLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTG 264
Query: 374 SGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTG 423
+VP + L +S N L P LP VG L N F
Sbjct: 265 LKQVPKGLP--AKLSVLDLSYNRLDR-NPS-PDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 6e-13
Identities = 40/244 (16%), Positives = 67/244 (27%), Gaps = 46/244 (18%)
Query: 74 RVTEISFDNKSLSGEISSSISALQS---LTVLSLPFNVLSGKLP-------------LEL 117
+ ++ + I + L L+L ++G P L L
Sbjct: 69 SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNL 128
Query: 118 SNCS-----------------NLKVLNVTGNAM-VGSVPDLSALKNLEIFDLSINYFTGR 159
N S LKVL++ S + L DLS N G
Sbjct: 129 RNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGE 188
Query: 160 FPRW----VVNLTQLVSLSIGDNVYD--EAEIPESIGNLKNLTYLFLAHCNLRGRIPESI 213
+ L L++ + + L L L+H +LR
Sbjct: 189 RGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPS 248
Query: 214 -SELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDI 272
+L +L++ + KL L +L N L P+ L + +
Sbjct: 249 CDWPSQLNSLNLSFTGLKQVPKGLPAKLSVL---DLSYNRLD-RNPSPDE-LPQVGNLSL 303
Query: 273 SSNQ 276
N
Sbjct: 304 KGNP 307
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 33/193 (17%), Positives = 66/193 (34%), Gaps = 17/193 (8%)
Query: 75 VTEISFDNKSLSGEISS----SISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTG 130
+ ++ N S + + L VLS+ ++ L L+++
Sbjct: 123 LNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSD 182
Query: 131 NAMVGSVP--------DLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDE 182
N +G L+ L + + + +G QL L + N +
Sbjct: 183 NPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRD 242
Query: 183 AEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQK 242
A S L L L+ L+ ++P+ + +L LD+ N++ P S +L +
Sbjct: 243 AAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLD-RNP-SPDELPQ 297
Query: 243 LWKIELYANNLTG 255
+ + L N
Sbjct: 298 VGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 8e-10
Identities = 31/154 (20%), Positives = 59/154 (38%), Gaps = 11/154 (7%)
Query: 428 LIGLSTSLSQLVLQNNRFSGELP-SELGRLTNLERLILTNNNFSGKIPS---ALGALRQL 483
L G SL L+ + + + +++ + +L+RL + +I + + L
Sbjct: 38 LYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGL 97
Query: 484 SSLHLEENALTGSIPNEMGDCA--RIVDLNLARNSLSGNIPRSLSL----LSSLNALNLS 537
L LE +TG+ P + + + LNL S + L L L+++
Sbjct: 98 QELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIA 157
Query: 538 GNKLTGSIPDNLMKLK-LSSIDLSENQLSGSVPL 570
+ + LS++DLS+N G L
Sbjct: 158 QAHSLNFSCEQVRVFPALSTLDLSDNPELGERGL 191
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 2e-20
Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 30/209 (14%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV-----FAAEMEILGKIRHRNILKLY 737
+G+G G+V+ + + N A+K L K V++ E +L + H I++++
Sbjct: 13 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 72
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRY--KIALGAAKGIAYLHHD 795
F++++Y+ G LF L K + + Y ++ L + YLH
Sbjct: 73 GTFQDAQQIFMIMDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLA----LEYLH-- 123
Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL--- 852
S II+RD+K NILLD++ KI DFG AK + Y+ GT YIAPE+
Sbjct: 124 -SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYT-LCGTPDYIAPEVVST 177
Query: 853 -AYTCKVSEKSDVFSFGVVLLELVTGRKP 880
Y + D +SFG+++ E++ G P
Sbjct: 178 KPYNKSI----DWWSFGILIYEMLAGYTP 202
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 2e-20
Identities = 54/204 (26%), Positives = 86/204 (42%), Gaps = 23/204 (11%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAA-EMEILGKIRHRNILKLYAC 739
IG G G V++ + VA+K+ + +K A E+ +L +++H N++ L
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP 799
+ LV EY + + L R + G PE + + + + H
Sbjct: 71 FRRKRRLHLVFEYCDH-TVLHEL-DRYQRGVPEHL-VKSITWQT--LQAVNFCHKHN--- 122
Query: 800 IIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL-----AY 854
IHRD+K NIL+ + K+ DFG A+ P Y T Y +PEL Y
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFAR-LLTGP-SDYYDDEVATRWYRSPELLVGDTQY 180
Query: 855 TCKVSEKSDVFSFGVVLLELVTGR 878
V DV++ G V EL++G
Sbjct: 181 GPPV----DVWAIGCVFAELLSGV 200
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 50/209 (23%), Positives = 79/209 (37%), Gaps = 21/209 (10%)
Query: 386 TIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISP--LIGLSTSLSQLVLQNN 443
QR+ + N +S A N+ +L N I GL L QL L +N
Sbjct: 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLAR-IDAAAFTGL-ALLEQLDLSDN 90
Query: 444 RFSGELPSE-LGRLTNLERLILTNNNFSGKIPS-ALGALRQLSSLHLEENALTGSIPNEM 501
+ L L L L ++ L L L+L++NAL ++P++
Sbjct: 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDT 148
Query: 502 -GDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDN-LMKL-KLSSID 558
D + L L N +S R+ L SL+ L L N++ + + L +L ++
Sbjct: 149 FRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLY 207
Query: 559 LSENQLSGSVPLDFLRMGGDGAFAGNEGL 587
L N LS ++P A A L
Sbjct: 208 LFANNLS-ALP--------TEALAPLRAL 227
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 43/162 (26%), Positives = 66/162 (40%), Gaps = 15/162 (9%)
Query: 430 GLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLE 489
G+ + ++ L NR S + NL L L +N + +A L L L L
Sbjct: 29 GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS 88
Query: 490 ENALTGSIPNEM-GDCARIVDLNLARNSLSGNIP-RSLSLLSSLNALNLSGNKLTGSIPD 547
+NA S+ R+ L+L R L + L++L L L N L ++PD
Sbjct: 89 DNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPD 146
Query: 548 N-LMKL-KLSSIDLSENQLSGSVPLDFLRMGGDGAFAGNEGL 587
+ L L+ + L N++S SVP + AF G L
Sbjct: 147 DTFRDLGNLTHLFLHGNRIS-SVP--------ERAFRGLHSL 179
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 50/207 (24%), Positives = 78/207 (37%), Gaps = 15/207 (7%)
Query: 367 LALSNNFSGEVP-NSYADCKTIQRLRISDNHLSGKIPDG-LWALPNVGMLDFGDNDFTGG 424
+ L N VP S+ C+ + L + N L+ +I L + LD DN
Sbjct: 37 IFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQLRS 95
Query: 425 ISP--LIGLSTSLSQLVLQNNRFSGELPSE-LGRLTNLERLILTNNNFSGKIPS-ALGAL 480
+ P GL L L L EL L L+ L L +N +P L
Sbjct: 96 VDPATFHGL-GRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDL 152
Query: 481 RQLSSLHLEENALTGSIPNEM-GDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGN 539
L+ L L N ++ S+P + L L +N ++ P + L L L L N
Sbjct: 153 GNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211
Query: 540 KLTGSIPDNLMKL--KLSSIDLSENQL 564
L+ ++P + L + L++N
Sbjct: 212 NLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 51/228 (22%), Positives = 86/228 (37%), Gaps = 16/228 (7%)
Query: 81 DNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD- 139
+ L + I A + + L N +S C NL +L + N + +
Sbjct: 19 PQQGLQ-AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNV-LARIDAA 74
Query: 140 -LSALKNLEIFDLSINY-FTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESI-GNLKNLT 196
+ L LE DLS N P L +L +L + E+ + L L
Sbjct: 75 AFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRC--GLQELGPGLFRGLAALQ 132
Query: 197 YLFLAHCNLRGRIPESI-SELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTG 255
YL+L L+ +P+ +L L L + N+IS R+ R L L ++ L+ N +
Sbjct: 133 YLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA- 190
Query: 256 ELPAE-LGNLTLLQEFDISSNQMYGKLPEEI-GNLKNLTVFQCFKNNF 301
+ +L L + +N + LP E L+ L + N +
Sbjct: 191 HVHPHAFRDLGRLMTLYLFANNL-SALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 56/257 (21%), Positives = 94/257 (36%), Gaps = 52/257 (20%)
Query: 296 CFKNNFSGEFPSGF-GDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFS---- 350
C + P G +++F ++GNR S + LT + + N +
Sbjct: 18 CPQQGLQ-AVPVGIPAASQRIF---LHGNRISHVPAASFRACRNLTILWLHSNVLARIDA 73
Query: 351 GSFPKYLCEKRKLLNL--LALSNNFSGEV--PNSYADCKTIQRLRISDNHLSGKIPDGLW 406
+F L L L LS+N P ++ + L + L ++ GL+
Sbjct: 74 AAF-------TGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLF 125
Query: 407 A-LPNVGMLDFGDNDFTGGISP--LIGLSTSLSQLVLQNNRFSGELPSE-LGRLTNLERL 462
L + L DN + L +L+ L L NR S +P L +L+RL
Sbjct: 126 RGLAALQYLYLQDNALQA-LPDDTFRDL-GNLTHLFLHGNRIS-SVPERAFRGLHSLDRL 182
Query: 463 ILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIP 522
+L N + P A L +L +L+L N L+ ++P
Sbjct: 183 LLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALP-----------------------T 218
Query: 523 RSLSLLSSLNALNLSGN 539
+L+ L +L L L+ N
Sbjct: 219 EALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 4e-12
Identities = 62/296 (20%), Positives = 91/296 (30%), Gaps = 81/296 (27%)
Query: 203 CNLRG--RIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAE 260
C +G +P I + + N+IS S R + L + L++N L A
Sbjct: 18 CPQQGLQAVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA 75
Query: 261 LGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSI 320
L LL++ D+S N + P+ F + +L +
Sbjct: 76 FTGLALLEQLDLSDNAQLRSVD-----------------------PATFHGLGRLHTLHL 112
Query: 321 YGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNS 380
++ F G L L
Sbjct: 113 DRCGLQ----------------ELGPGLFRG-----------LAAL-------------- 131
Query: 381 YADCKTIQRLRISDNHLSGKIPDGLWA-LPNVGMLDFGDNDFTGGISP--LIGLSTSLSQ 437
Q L + DN L +PD + L N+ L N + + GL SL +
Sbjct: 132 -------QYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISS-VPERAFRGL-HSLDR 181
Query: 438 LVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENAL 493
L+L NR + P L L L L NN S AL LR L L L +N
Sbjct: 182 LLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 40/216 (18%), Positives = 71/216 (32%), Gaps = 9/216 (4%)
Query: 184 EIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKL 243
+P I +FL + S R L L + N ++ + L L
Sbjct: 25 AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 244 WKIELYANNLTGELPAE-LGNLTLLQEFDISSNQMYGKLPEEI-GNLKNLTVFQCFKNNF 301
+++L N + L L + + +L + L L N
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL-QELGPGLFRGLAALQYLYLQDNAL 141
Query: 302 SGEFPSG-FGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEK 360
P F D+ L ++GNR S +L + + +N+ + +
Sbjct: 142 Q-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRD 199
Query: 361 RKLLNLLALSNNFSGEVP-NSYADCKTIQRLRISDN 395
L L L N +P + A + +Q LR++DN
Sbjct: 200 LGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 3e-20
Identities = 61/225 (27%), Positives = 97/225 (43%), Gaps = 52/225 (23%)
Query: 679 EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQL------WKGDGVKVFAA-EMEILGKIRHR 731
E+ + +G G VY+ K VA+K++ DG+ A E+++L ++ H
Sbjct: 13 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 72
Query: 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELD---WFRRYKIALGAA-- 786
NI+ L + LV ++M E D + + L +
Sbjct: 73 NIIGLLDAFGHKSNISLVFDFM------------------ETDLEVIIKDNSLVLTPSHI 114
Query: 787 --------KGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDY 838
+G+ YLH I+HRD+K +N+LLDE+ K+ADFG+AK + SP Y
Sbjct: 115 KAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK-SFGSP-NRAY 169
Query: 839 SCFAGTHGYIAPEL-----AYTCKVSEKSDVFSFGVVLLELVTGR 878
+ T Y APEL Y V D+++ G +L EL+
Sbjct: 170 THQVVTRWYRAPELLFGARMYGVGV----DMWAVGCILAELLLRV 210
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 4e-20
Identities = 59/242 (24%), Positives = 98/242 (40%), Gaps = 26/242 (10%)
Query: 350 SGSFPKYLCEKRKLLNL----------LALSNNFSGEVP-NSYADCKTIQRLRISDNHLS 398
S F K +C +R L + L L N + +++ ++ L++ N +
Sbjct: 53 SNQFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR 112
Query: 399 GKIPDG-LWALPNVGMLDFGDNDFTGGISP--LIGLSTSLSQLVLQNNRFSGELPSE-LG 454
+I G L ++ L+ DN T I L + L +L L+NN +PS
Sbjct: 113 -QIEVGAFNGLASLNTLELFDNWLTV-IPSGAFEYL-SKLRELWLRNNPIE-SIPSYAFN 168
Query: 455 RLTNLERLILTNNNFSGKIPS-ALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLA 513
R+ +L RL L I A L L L+L + +P + + +L ++
Sbjct: 169 RVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMS 226
Query: 514 RNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDN-LMKL-KLSSIDLSENQLSGSVPLD 571
N P S LSSL L + ++++ I N L L ++L+ N LS S+P D
Sbjct: 227 GNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLS-SLPHD 284
Query: 572 FL 573
Sbjct: 285 LF 286
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 2e-18
Identities = 60/288 (20%), Positives = 103/288 (35%), Gaps = 53/288 (18%)
Query: 290 NLTVFQCFKNNFSGEFPSG-FGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQ 348
+ C + S E P G + R L + N + L + + N
Sbjct: 55 QFSKVVCTRRGLS-EVPQGIPSNTRYLN---LMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 349 FS----GSFPKYLCEKRKLLNL--LALSNNFSGEVP-NSYADCKTIQRLRISDNHLSGKI 401
G+F L +L L L +N+ +P ++ ++ L + +N + I
Sbjct: 111 IRQIEVGAF-------NGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SI 162
Query: 402 PDGLWA-LPNVGMLDFGDNDFTGGISP--LIGLSTSLSQLVLQNNRFSGELPSELGRLTN 458
P + +P++ LD G+ IS GL +L L L ++P+ L L
Sbjct: 163 PSYAFNRVPSLMRLDLGELKKLEYISEGAFEGL-FNLKYLNLGMCNIK-DMPN-LTPLVG 219
Query: 459 LERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLS 518
LE L ++ N+F P + L L L + + ++ I
Sbjct: 220 LEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIE-------------------- 258
Query: 519 GNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL--KLSSIDLSENQL 564
+ L+SL LNL+ N L+ S+P +L L + L N
Sbjct: 259 ---RNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 3e-16
Identities = 45/211 (21%), Positives = 78/211 (36%), Gaps = 7/211 (3%)
Query: 94 SALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD--LSALKNLEIFDL 151
L L VL L N + + ++L L + N + +P L L L
Sbjct: 96 RHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWL 154
Query: 152 SINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPE 211
N + L+ L +G+ E + L NL YL L CN++ +P
Sbjct: 155 RNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP- 212
Query: 212 SISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFD 271
+++ L L L++ N P S L L K+ + + ++ L L E +
Sbjct: 213 NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELN 272
Query: 272 ISSNQMYGKLPEEI-GNLKNLTVFQCFKNNF 301
++ N + LP ++ L+ L N +
Sbjct: 273 LAHNNL-SSLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 3e-15
Identities = 45/231 (19%), Positives = 85/231 (36%), Gaps = 11/231 (4%)
Query: 98 SLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD--LSALKNLEIFDLSINY 155
+ L+L N + + +L+VL + N + + + L +L +L N+
Sbjct: 76 NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRN-SIRQIEVGAFNGLASLNTLELFDNW 134
Query: 156 FTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESI-GNLKNLTYLFLAHCNLRGRIPESI- 213
T L++L L + +N IP + +L L L I E
Sbjct: 135 LTVIPSGAFEYLSKLRELWLRNN--PIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAF 192
Query: 214 SELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAE-LGNLTLLQEFDI 272
L L L++ I + P ++ L L ++E+ N+ E+ L+ L++ +
Sbjct: 193 EGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWV 249
Query: 273 SSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGN 323
++Q+ L +L NN S F +R L ++ N
Sbjct: 250 MNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 4e-14
Identities = 55/301 (18%), Positives = 94/301 (31%), Gaps = 67/301 (22%)
Query: 202 HCNLRG--RIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPA 259
C RG +P+ I L++ N I + R L L ++L N++ ++
Sbjct: 60 VCTRRGLSEVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEV 116
Query: 260 E-LGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAF 318
L L ++ N L + F + KL
Sbjct: 117 GAFNGLASLNTLELFDNW-----------LTVIP-------------SGAFEYLSKLREL 152
Query: 319 SIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLAL----SNNFS 374
+ N I F+ + +L+ L
Sbjct: 153 WLRNNPIE----------------SIPSYAFNR-----------VPSLMRLDLGELKKLE 185
Query: 375 GEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISP--LIGLS 432
++ ++ L + ++ +P+ L L + L+ N F I P GL
Sbjct: 186 YISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPE-IRPGSFHGL- 241
Query: 433 TSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENA 492
+SL +L + N++ S + L +L L L +NN S LR L LHL N
Sbjct: 242 SSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNP 301
Query: 493 L 493
Sbjct: 302 W 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 8e-14
Identities = 54/247 (21%), Positives = 96/247 (38%), Gaps = 25/247 (10%)
Query: 184 EIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKL 243
E+P+ I N YL L N++ ++ L L L + RN I + L L
Sbjct: 68 EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASL 125
Query: 244 WKIELYANNLTGELPAE-LGNLTLLQEFDISSNQMYGKLPEEI-GNLKNLTVFQCFKNNF 301
+EL+ N LT +P+ L+ L+E + +N + +P + +L +
Sbjct: 126 NTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPI-ESIPSYAFNRVPSLMRLDLGELKK 183
Query: 302 SGEFPSG-FGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFS----GSFPKY 356
G F + L ++ NL L ++++S N F GSF
Sbjct: 184 LEYISEGAFEGLFNLKYLNLGMCNIK--DMPNLTPLVGLEELEMSGNHFPEIRPGSF--- 238
Query: 357 LCEKRKLLNL--LALSNNFSGEV-PNSYADCKTIQRLRISDNHLSGKIPDGLWA-LPNVG 412
L +L L + N+ + N++ ++ L ++ N+LS +P L+ L +
Sbjct: 239 ----HGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLV 293
Query: 413 MLDFGDN 419
L N
Sbjct: 294 ELHLHHN 300
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 5e-20
Identities = 57/206 (27%), Positives = 87/206 (42%), Gaps = 23/206 (11%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAA-EMEILGKIRHRNILKLY 737
L+G G G V + K VA+K+ + VK A E+++L ++RH N++ L
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
K +LV E++ + ++ LD+ K GI + H
Sbjct: 91 EVCKKKKRWYLVFEFVD-----HTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN- 144
Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL----- 852
IIHRDIK NIL+ + K+ DFG A+ + Y T Y APEL
Sbjct: 145 --IIHRDIKPENILVSQSGVVKLCDFGFAR--TLAAPGEVYDDEVATRWYRAPELLVGDV 200
Query: 853 AYTCKVSEKSDVFSFGVVLLELVTGR 878
Y V DV++ G ++ E+ G
Sbjct: 201 KYGKAV----DVWAIGCLVTEMFMGE 222
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 9e-20
Identities = 52/227 (22%), Positives = 96/227 (42%), Gaps = 57/227 (25%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIRHRNILKLY-- 737
IG G G+V++ +K VA+K++ + +G + A E++IL ++H N++ L
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 738 ------ACLLKGGSSFLVLEYM----------PNGNLFQALHKRVKEGKPELDWFRRYKI 781
GS +LV ++ + K ++
Sbjct: 85 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK---------------RV 129
Query: 782 ALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCF 841
G+ Y+H + I+HRD+K++N+L+ D K+ADFG+A+ A + K S + +
Sbjct: 130 MQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLAR-AFSLAKNSQPNRY 185
Query: 842 AGTHG-----YIAPEL-----AYTCKVSEKSDVFSFGVVLLELVTGR 878
T+ Y PEL Y + D++ G ++ E+ T
Sbjct: 186 --TNRVVTLWYRPPELLLGERDYGPPI----DLWGAGCIMAEMWTRS 226
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 1e-19
Identities = 65/242 (26%), Positives = 101/242 (41%), Gaps = 26/242 (10%)
Query: 350 SGSFPKYLCEKRKLLNL----------LALSNNFSGEVP-NSYADCKTIQRLRISDNHLS 398
S F K +C ++ L + L L N + NS+ + ++ L++S NH+
Sbjct: 42 SNQFSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR 101
Query: 399 GKIPDG-LWALPNVGMLDFGDNDFTGGISP--LIGLSTSLSQLVLQNNRFSGELPSEL-G 454
I G L N+ L+ DN T I + L + L +L L+NN +PS
Sbjct: 102 -TIEIGAFNGLANLNTLELFDNRLTT-IPNGAFVYL-SKLKELWLRNNPIE-SIPSYAFN 157
Query: 455 RLTNLERLILTNNNFSGKIPS-ALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLA 513
R+ +L RL L I A L L L+L L IP + ++ +L+L+
Sbjct: 158 RIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLS 215
Query: 514 RNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDN-LMKL-KLSSIDLSENQLSGSVPLD 571
N LS P S L L L + +++ I N L L I+L+ N L+ +P D
Sbjct: 216 GNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLT-LLPHD 273
Query: 572 FL 573
Sbjct: 274 LF 275
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-17
Identities = 63/288 (21%), Positives = 104/288 (36%), Gaps = 53/288 (18%)
Query: 290 NLTVFQCFKNNFSGEFPSG-FGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQ 348
+ C + N E P G + R L ++ N+ + L + +S N
Sbjct: 44 QFSKVICVRKNLR-EVPDGISTNTRLLN---LHENQIQIIKVNSFKHLRHLEILQLSRNH 99
Query: 349 FS----GSFPKYLCEKRKLLNL--LALSNNFSGEVP-NSYADCKTIQRLRISDNHLSGKI 401
G+F L NL L L +N +P ++ ++ L + +N + I
Sbjct: 100 IRTIEIGAF-------NGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SI 151
Query: 402 PDGLWA-LPNVGMLDFGDNDFTGGISP--LIGLSTSLSQLVLQNNRFSGELPSELGRLTN 458
P + +P++ LD G+ IS GL ++L L L E+P+ L L
Sbjct: 152 PSYAFNRIPSLRRLDLGELKRLSYISEGAFEGL-SNLRYLNLAMCNLR-EIPN-LTPLIK 208
Query: 459 LERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLS 518
L+ L L+ N+ S P + L L L + ++ + I
Sbjct: 209 LDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIE-------------------- 247
Query: 519 GNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL--KLSSIDLSENQL 564
+ L SL +NL+ N LT +P +L L I L N
Sbjct: 248 ---RNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 2e-16
Identities = 53/262 (20%), Positives = 102/262 (38%), Gaps = 17/262 (6%)
Query: 67 TCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVL 126
+C + +++ K+L E+ IS + +L+L N + + +L++L
Sbjct: 40 SCS---NQFSKVICVRKNLR-EVPDGIST--NTRLLNLHENQIQIIKVNSFKHLRHLEIL 93
Query: 127 NVTGNAMVGSVPD--LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAE 184
++ N + ++ + L NL +L N T V L++L L + +N
Sbjct: 94 QLSRN-HIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNN--PIES 150
Query: 185 IPESI-GNLKNLTYLFLAHCNLRGRIPESI-SELRELGTLDICRNKISGEFPRSIRKLQK 242
IP + +L L L I E L L L++ + E P ++ L K
Sbjct: 151 IPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIK 208
Query: 243 LWKIELYANNLTGELPAE-LGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNF 301
L +++L N+L+ + L LQ+ + +Q+ NL++L NN
Sbjct: 209 LDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNL 267
Query: 302 SGEFPSGFGDMRKLFAFSIYGN 323
+ F + L ++ N
Sbjct: 268 TLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 1e-14
Identities = 46/173 (26%), Positives = 76/173 (43%), Gaps = 23/173 (13%)
Query: 430 GLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLE 489
G+ST+ L L N+ + L +LE L L+ N+ A L L++L L
Sbjct: 61 GISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF 120
Query: 490 ENALTGSIPNEM-GDCARIVDLNLARNSLSGNIP-RSLSLLSSLNALNLSG-NKLTGSIP 546
+N LT +IPN +++ +L L N + +IP + + + SL L+L +L+ I
Sbjct: 121 DNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLS-YIS 177
Query: 547 DN-LMKL-KLSSIDLSENQLSGSVP-------LDFLRMGG-------DGAFAG 583
+ L L ++L+ L +P LD L + G G+F G
Sbjct: 178 EGAFEGLSNLRYLNLAMCNLR-EIPNLTPLIKLDELDLSGNHLSAIRPGSFQG 229
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 1e-13
Identities = 51/247 (20%), Positives = 97/247 (39%), Gaps = 25/247 (10%)
Query: 184 EIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKL 243
E+P+ I N L L ++ S LR L L + RN I + L L
Sbjct: 57 EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANL 114
Query: 244 WKIELYANNLTGELPAE-LGNLTLLQEFDISSNQMYGKLPEEI-GNLKNLTVFQCFKNNF 301
+EL+ N LT +P L+ L+E + +N + +P + +L +
Sbjct: 115 NTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPI-ESIPSYAFNRIPSLRRLDLGELKR 172
Query: 302 SGEFPSG-FGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFS----GSFPKY 356
G F + L ++ NL L ++D+S N S GSF
Sbjct: 173 LSYISEGAFEGLSNLRYLNLAMCNLR--EIPNLTPLIKLDELDLSGNHLSAIRPGSF--- 227
Query: 357 LCEKRKLLNL--LALSNNFSGEVP-NSYADCKTIQRLRISDNHLSGKIPDGLWA-LPNVG 412
+ L++L L + + + N++ + +++ + ++ N+L+ +P L+ L ++
Sbjct: 228 ----QGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLE 282
Query: 413 MLDFGDN 419
+ N
Sbjct: 283 RIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 1e-13
Identities = 59/298 (19%), Positives = 97/298 (32%), Gaps = 61/298 (20%)
Query: 202 HCNLRG--RIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPA 259
C + +P+ IS L++ N+I S + L+ L ++L N++
Sbjct: 49 ICVRKNLREVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIG 106
Query: 260 ELGNLTLLQEFDISSNQMYGKLPEEI-GNLKNLTVFQCFKNNFSGEFPSG-FGDMRKLFA 317
L L ++ N++ +P L L N PS F + L
Sbjct: 107 AFNGLANLNTLELFDNRL-TTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRR 164
Query: 318 FSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEV 377
+LG L+ ISE F G L NL
Sbjct: 165 L-------------DLGELKRLSY--ISEGAFEG-----------LSNL----------- 187
Query: 378 PNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISP--LIGLSTSL 435
+ L ++ +L +IP+ L L + LD N + I P GL L
Sbjct: 188 ----------RYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSA-IRPGSFQGL-MHL 233
Query: 436 SQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENAL 493
+L + ++ + L +L + L +NN + L L +HL N
Sbjct: 234 QKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 30/167 (17%), Positives = 60/167 (35%), Gaps = 15/167 (8%)
Query: 94 SALQSLTVLSLPFNVLSGKLPLEL-SNCSNLKVLNVTGNAMVGSVPD--LSALKNLEIFD 150
L L L L N + +P + +L+ L++ + + + L NL +
Sbjct: 133 VYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLN 191
Query: 151 LSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEI----PESIGNLKNLTYLFLAHCNLR 206
L++ P L +L L + N + P S L +L L++ ++
Sbjct: 192 LAMCNLR-EIPNLT-PLIKLDELDLSGN-----HLSAIRPGSFQGLMHLQKLWMIQSQIQ 244
Query: 207 GRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNL 253
+ L+ L +++ N ++ L L +I L+ N
Sbjct: 245 VIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 1e-19
Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 24/204 (11%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIRHRNILKLYAC 739
IG G G VY+ T A+K++ + +G+ E+ IL +++H NI+KLY
Sbjct: 10 IGEGTYGVVYKAQNNYGE-TFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP 799
+ LV E++ Q L K + + L+ L GIAY H
Sbjct: 69 IHTKKRLVLVFEHLD-----QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--- 120
Query: 800 IIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL-----AY 854
++HRD+K N+L++ + E KIADFG+A+ A P V Y+ T Y AP++ Y
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLAR-AFGIP-VRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 855 TCKVSEKSDVFSFGVVLLELVTGR 878
+ + D++S G + E+V G
Sbjct: 179 STTI----DIWSVGCIFAEMVNGT 198
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-19
Identities = 49/221 (22%), Positives = 81/221 (36%), Gaps = 45/221 (20%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA-------------EMEILGKIRH 730
I SG G V + VA+K+++ E+ +L H
Sbjct: 30 ISSGSYGAVCAGVDSEGI-PVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 731 RNILKLYACLL-KGGSSF----LVLEYMPNGNLFQALHKRVKEGKPEL-DWFRRYKI--A 782
NIL L + + LV E M L + + + + + +Y +
Sbjct: 89 PNILGLRDIFVHFEEPAMHKLYLVTELMRTD-----LAQVIHDQRIVISPQHIQYFMYHI 143
Query: 783 LGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFA 842
L G+ LH ++HRD+ NILL ++ + I DF +A+ + Y
Sbjct: 144 L---LGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHY---V 194
Query: 843 GTHGYIAPEL-----AYTCKVSEKSDVFSFGVVLLELVTGR 878
Y APEL +T V D++S G V+ E+ +
Sbjct: 195 THRWYRAPELVMQFKGFTKLV----DMWSAGCVMAEMFNRK 231
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 1e-19
Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 26/205 (12%)
Query: 684 IGSGGTGKVYR-LDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIRHRNILKLYA 738
+G G G VY+ D VA+K++ + +G+ A E+ +L ++ H NI+ L
Sbjct: 29 VGEGTYGVVYKAKD--SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
+ LV E+M + L K + E K L + +G+A+ H
Sbjct: 87 VIHSERCLTLVFEFME-----KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR-- 139
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL-----A 853
I+HRD+K N+L++ D K+ADFG+A+ A P V Y+ T Y AP++
Sbjct: 140 -ILHRDLKPQNLLINSDGALKLADFGLAR-AFGIP-VRSYTHEVVTLWYRAPDVLMGSKK 196
Query: 854 YTCKVSEKSDVFSFGVVLLELVTGR 878
Y+ V D++S G + E++TG+
Sbjct: 197 YSTSV----DIWSIGCIFAEMITGK 217
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-19
Identities = 51/209 (24%), Positives = 90/209 (43%), Gaps = 29/209 (13%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIRHRNILKLYAC 739
+G G G+VY+ TVA+K++ + +GV A E+ +L +++HRNI++L +
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP 799
+ L+ EY L K+ + P++ G+ + H
Sbjct: 102 IHHNHRLHLIFEYAE-----NDL-KKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR--- 152
Query: 800 IIHRDIKSSNILLDEDYEP-----KIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL-- 852
+HRD+K N+LL KI DFG+A+ A P + ++ T Y PE+
Sbjct: 153 CLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR-AFGIP-IRQFTHEIITLWYRPPEILL 210
Query: 853 ---AYTCKVSEKSDVFSFGVVLLELVTGR 878
Y+ V D++S + E++
Sbjct: 211 GSRHYSTSV----DIWSIACIWAEMLMKT 235
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-19
Identities = 30/181 (16%), Positives = 71/181 (39%), Gaps = 7/181 (3%)
Query: 363 LLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFT 422
L S + A ++ + +++ +++ + G+ N+ L + T
Sbjct: 22 FKAYLNGLLGQSSTANITEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHAT 79
Query: 423 GGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQ 482
+P+ GL ++L +L + + + L LT+L L ++++ I + + L +
Sbjct: 80 N-YNPISGL-SNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPK 137
Query: 483 LSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLT 542
++S+ L N I + + LN+ + + + R + LN L +
Sbjct: 138 VNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVH-DY-RGIEDFPKLNQLYAFSQTIG 194
Query: 543 G 543
G
Sbjct: 195 G 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 5e-18
Identities = 31/166 (18%), Positives = 60/166 (36%), Gaps = 11/166 (6%)
Query: 139 DLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYL 198
+++L + + ++++ TG + + L+I + A I L NL L
Sbjct: 42 QMNSLTYITLANINVTDLTG-----IEYAHNIKDLTINNI---HATNYNPISGLSNLERL 93
Query: 199 FLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELP 258
+ ++ ++S L L LDI + I L K+ I+L N ++
Sbjct: 94 RIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM 153
Query: 259 AELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGE 304
L L L+ +I + + I + L F G+
Sbjct: 154 P-LKTLPELKSLNIQFDGV-HDY-RGIEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-16
Identities = 34/165 (20%), Positives = 68/165 (41%), Gaps = 7/165 (4%)
Query: 92 SISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDL 151
+ + + SLT ++L ++ L + N+K L + + +S L NLE +
Sbjct: 39 TEAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIH-ATNYNPISGLSNLERLRI 95
Query: 152 SINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPE 211
T + LT L L I + +D++ + I L + + L++ I
Sbjct: 96 MGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSIL-TKINTLPKVNSIDLSYNGAITDI-M 153
Query: 212 SISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGE 256
+ L EL +L+I + + R I KL ++ ++ + G+
Sbjct: 154 PLKTLPELKSLNIQFDGVHD--YRGIEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 9e-16
Identities = 30/159 (18%), Positives = 64/159 (40%), Gaps = 9/159 (5%)
Query: 75 VTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMV 134
+T I+ N +++ +++ I ++ L++ + P +S SNL+ L + G +
Sbjct: 46 LTYITLANINVT-DLTG-IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVT 101
Query: 135 GS-VPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLK 193
+P+LS L +L + D+S + + L ++ S+ + N + L
Sbjct: 102 SDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYN--GAITDIMPLKTLP 159
Query: 194 NLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGE 232
L L + + I + +L L I G+
Sbjct: 160 ELKSLNIQFDGVHD--YRGIEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 4e-13
Identities = 24/142 (16%), Positives = 60/142 (42%), Gaps = 6/142 (4%)
Query: 433 TSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENA 492
SL+ + L N + +L + + N++ L + N + + + + L L L +
Sbjct: 44 NSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKD 99
Query: 493 LTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL 552
+T + + L+++ ++ +I ++ L +N+++LS N I L L
Sbjct: 100 VTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTL 158
Query: 553 K-LSSIDLSENQLSGSVPLDFL 573
L S+++ + + ++
Sbjct: 159 PELKSLNIQFDGVHDYRGIEDF 180
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 5e-10
Identities = 26/133 (19%), Positives = 54/133 (40%), Gaps = 5/133 (3%)
Query: 433 TSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENA 492
++ + S ++ +L + L N N + + + + + L +
Sbjct: 20 STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIH 77
Query: 493 LTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL 552
T P + + + L + ++ + +LS L+SL L++S + SI + L
Sbjct: 78 ATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTL 135
Query: 553 -KLSSIDLSENQL 564
K++SIDLS N
Sbjct: 136 PKVNSIDLSYNGA 148
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 24/210 (11%), Positives = 60/210 (28%), Gaps = 34/210 (16%)
Query: 214 SELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDIS 273
S + + ++ + + ++ L I L N+T +L + +++ I+
Sbjct: 20 STFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTIN 74
Query: 274 SNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENL 333
+ I L NL + + + + + L I + +
Sbjct: 75 NIHA--TNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI 132
Query: 334 GRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRIS 393
+ +D+S N + +++ L ++ L I
Sbjct: 133 NTLPKVNSIDLSYNG-------------AITDIMPLKTL------------PELKSLNIQ 167
Query: 394 DNHLSGKIPDGLWALPNVGMLDFGDNDFTG 423
+ + G+ P + L G
Sbjct: 168 FDGVH-DY-RGIEDFPKLNQLYAFSQTIGG 195
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-19
Identities = 57/206 (27%), Positives = 106/206 (51%), Gaps = 27/206 (13%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
+GSG G V K++ VA+K+L + ++FA E+ +L ++H N++ L
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 740 LLKGGSS------FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
S +LV+ +M +L + + + E K + + Y++ KG+ Y+H
Sbjct: 92 FTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQ---YLVYQML----KGLKYIH 143
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELA 853
S ++HRD+K N+ ++ED E KI DFG+A+ A +++ Y T Y APE+
Sbjct: 144 ---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHA--DAEMTGY---VVTRWYRAPEVI 195
Query: 854 YTCKV-SEKSDVFSFGVVLLELVTGR 878
+ ++ D++S G ++ E++TG+
Sbjct: 196 LSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 4e-19
Identities = 42/237 (17%), Positives = 86/237 (36%), Gaps = 18/237 (7%)
Query: 66 ITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKV 125
I D +I+ +++ + + L +T LS ++ + + +NL
Sbjct: 12 IFPDPALANAIKIAAGKSNVTDT--VTQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIG 67
Query: 126 LNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEI 185
L + N + + L L + +LS N + L + +L + +
Sbjct: 68 LELKDNQ-ITDLAPLKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQITD--- 121
Query: 186 PESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWK 245
+ L NL L+L + ++ L L L I ++S P + L KL
Sbjct: 122 VTPLAGLSNLQVLYLDLNQITN--ISPLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTT 177
Query: 246 IELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFS 302
++ N ++ ++ L +L L E + +NQ+ + N NL + +
Sbjct: 178 LKADDNKIS-DISP-LASLPNLIEVHLKNNQISDV--SPLANTSNLFIVTLTNQTIT 230
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 3e-18
Identities = 50/256 (19%), Positives = 90/256 (35%), Gaps = 19/256 (7%)
Query: 117 LSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIG 176
+N + + V + L + T V L L+ L +
Sbjct: 15 DPALANAIKIAAGKSN-VTDTVTQADLDGITTLSAFGTGVTTIEG--VQYLNNLIGLELK 71
Query: 177 DNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRS 236
DN + + NL +T L L+ L + +I+ L+ + TLD+ +I+ P
Sbjct: 72 DN---QITDLAPLKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITDVTP-- 124
Query: 237 IRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQC 296
+ L L + L N +T + L LT LQ I + Q+ + NL LT +
Sbjct: 125 LAGLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQV--SDLTPLANLSKLTTLKA 180
Query: 297 FKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKY 356
N S S + L + N+ S L + L V ++ + + P +
Sbjct: 181 DDNKISDI--SPLASLPNLIEVHLKNNQISD--VSPLANTSNLFIVTLTNQTIT-NQPVF 235
Query: 357 LCEKRKLLNLLALSNN 372
+ N++ +
Sbjct: 236 YNNNLVVPNVVKGPSG 251
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 8e-17
Identities = 52/319 (16%), Positives = 107/319 (33%), Gaps = 49/319 (15%)
Query: 211 ESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEF 270
L + ++ ++ + L + + + +T + + L L
Sbjct: 13 FPDPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGL 68
Query: 271 DISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFP 330
++ NQ+ + NL +T + N S ++ + + + +
Sbjct: 69 ELKDNQI--TDLAPLKNLTKITELELSGNPLKN--VSAIAGLQSIKTLDLTSTQITDV-- 122
Query: 331 ENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRL 390
L + L + + NQ + N+ L+ +Q L
Sbjct: 123 TPLAGLSNLQVLYLDLNQIT--------------NISPLAG------------LTNLQYL 156
Query: 391 RISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELP 450
I + +S + L L + L DN + ISPL L +L ++ L+NN+ S
Sbjct: 157 SIGNAQVS-DL-TPLANLSKLTTLKADDNKISD-ISPLASL-PNLIEVHLKNNQISDV-- 210
Query: 451 SELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDL 510
S L +NL + LTN + + L + + A P + D +
Sbjct: 211 SPLANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPI--APATISD-----NG 263
Query: 511 NLARNSLSGNIPRSLSLLS 529
A +L+ N+ ++ +S
Sbjct: 264 TYASPNLTWNLTSFINNVS 282
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 47/210 (22%), Positives = 87/210 (41%), Gaps = 17/210 (8%)
Query: 91 SSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFD 150
+ L +L L L N ++ L L N + + L ++GN + +V ++ L++++ D
Sbjct: 57 EGVQYLNNLIGLELKDNQIT-DLA-PLKNLTKITELELSGNP-LKNVSAIAGLQSIKTLD 113
Query: 151 LSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIP 210
L+ T P + L+ L L + N + + L NL YL + + +
Sbjct: 114 LTSTQITDVTP--LAGLSNLQVLYLDLN---QITNISPLAGLTNLQYLSIGNAQVSD--L 166
Query: 211 ESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEF 270
++ L +L TL NKIS P + L L ++ L N ++ P L N + L
Sbjct: 167 TPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIV 222
Query: 271 DISSNQMYGKLPEEIGNLKNLTVFQCFKNN 300
+++ + + + NL V K
Sbjct: 223 TLTNQTITN---QPVFYNNNLVVPNVVKGP 249
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 3e-15
Identities = 57/287 (19%), Positives = 110/287 (38%), Gaps = 43/287 (14%)
Query: 287 NLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISE 346
L N K+N + D+ + S +G + E + L +++ +
Sbjct: 17 ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 347 NQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLW 406
NQ + L L L+ I L +S N L K +
Sbjct: 73 NQIT-----------DLAPLKNLTK---------------ITELELSGNPL--KNVSAIA 104
Query: 407 ALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTN 466
L ++ LD T ++PL GL ++L L L N+ + + S L LTNL+ L + N
Sbjct: 105 GLQSIKTLDLTSTQITD-VTPLAGL-SNLQVLYLDLNQIT-NI-SPLAGLTNLQYLSIGN 160
Query: 467 NNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLS 526
S + + L L +L++L ++N ++ I + +++++L N +S ++ L+
Sbjct: 161 AQVS-DL-TPLANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQIS-DVS-PLA 214
Query: 527 LLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSGSVPLDFL 573
S+L + L+ +T + P + + + P
Sbjct: 215 NTSNLFIVTLTNQTIT-NQPVFYNNNLVVPNVVKGPSGAPIAPATIS 260
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 50/315 (15%), Positives = 109/315 (34%), Gaps = 50/315 (15%)
Query: 166 NLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDIC 225
L + ++ G + + + +L +T L + I E + L L L++
Sbjct: 17 ALANAIKIAAGKSNVTD---TVTQADLDGITTLSAFGTGVT-TI-EGVQYLNNLIGLELK 71
Query: 226 RNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEI 285
N+I+ P ++ L K+ ++EL N L + A + L ++ D++S Q+ +
Sbjct: 72 DNQITDLAP--LKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITD--VTPL 125
Query: 286 GNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDIS 345
L NL V N + S + L SI + S L + LT +
Sbjct: 126 AGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSD--LTPLANLSKLTTLKAD 181
Query: 346 ENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGL 405
+N+ S ++ L++ + + + +N +S P L
Sbjct: 182 DNKIS--------------DISPLASL------------PNLIEVHLKNNQISDVSP--L 213
Query: 406 WALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILT 465
N+ ++ + T + + +V + + + T +
Sbjct: 214 ANTSNLFIVTLTNQTIT-NQPVFYNNNLVVPNVVKGPS------GAPIAPATISDNGTYA 266
Query: 466 NNNFSGKIPSALGAL 480
+ N + + S + +
Sbjct: 267 SPNLTWNLTSFINNV 281
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 47/246 (19%), Positives = 81/246 (32%), Gaps = 20/246 (8%)
Query: 127 NVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIP 186
++T + + AL N + T +L + +LS
Sbjct: 2 SITQPTAINVIFPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGT---GVTTI 56
Query: 187 ESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKI 246
E + L NL L L + + L ++ L++ N + I LQ + +
Sbjct: 57 EGVQYLNNLIGLELKDNQITD--LAPLKNLTKITELELSGNPLKNVSA--IAGLQSIKTL 112
Query: 247 ELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFP 306
+L + +T P L L+ LQ + NQ+ + L NL S
Sbjct: 113 DLTSTQITDVTP--LAGLSNLQVLYLDLNQI--TNISPLAGLTNLQYLSIGNAQVSDL-- 166
Query: 307 SGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNL 366
+ ++ KL N+ S L L +V + NQ S P L +
Sbjct: 167 TPLANLSKLTTLKADDNKISD--ISPLASLPNLIEVHLKNNQISDVSP---LANTSNLFI 221
Query: 367 LALSNN 372
+ L+N
Sbjct: 222 VTLTNQ 227
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-18
Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 30/208 (14%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
+GSG G V K VAVK+L + + A E+ +L ++H N++ L
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 740 LLKGGSS------FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKI--ALGAAKGIAY 791
S +LV M L+ + + + D ++ I L +G+ Y
Sbjct: 97 FTPARSLEEFNDVYLVTHLMGAD-----LN-NIVKCQKLTDDHVQFLIYQIL---RGLKY 147
Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPE 851
+H S IIHRD+K SN+ ++ED E KI DFG+A+ + +++ Y T Y APE
Sbjct: 148 IH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT--ADEMTGY---VATRWYRAPE 199
Query: 852 LAYTCKV-SEKSDVFSFGVVLLELVTGR 878
+ ++ D++S G ++ EL+TGR
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-18
Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 30/208 (14%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
+GSG G V + VA+K+L++ ++FA E+ +L +RH N++ L
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 740 LLKGGSS------FLVLEYMPNGNLFQALHKRVKEGKPELDWFRR--YKIALGAAKGIAY 791
+ +LV+ +M L K +K K D + Y++ KG+ Y
Sbjct: 93 FTPDETLDDFTDFYLVMPFMGTD-----LGKLMKHEKLGEDRIQFLVYQML----KGLRY 143
Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPE 851
+H + IIHRD+K N+ ++ED E KI DFG+A+ A +++ Y T Y APE
Sbjct: 144 IH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA--DSEMTGY---VVTRWYRAPE 195
Query: 852 LAYTCKV-SEKSDVFSFGVVLLELVTGR 878
+ ++ D++S G ++ E++TG+
Sbjct: 196 VILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 86.9 bits (215), Expect = 3e-18
Identities = 59/278 (21%), Positives = 97/278 (34%), Gaps = 79/278 (28%)
Query: 677 NLEEDNLIGSGGTGKVYR-----LDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKI 728
L+ +G G G+V +D TVAVK L +G + +E++IL I
Sbjct: 23 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 82
Query: 729 -RHRNILKLY-ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK------ 780
H N++ L AC GG +++E+ GNL L + E P R++
Sbjct: 83 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYV 142
Query: 781 ----------------------IALGAAKGIAYLHHDCSPPIIHRDIKSSNILL------ 812
K ++ + + +P +++D + L+
Sbjct: 143 GAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQV 202
Query: 813 ------------------------DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
E KI DFG+A+ DY +
Sbjct: 203 AKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD---PDYV--RKGDARL 257
Query: 849 -----APELAYTCKVSEKSDVFSFGVVLLELVT-GRKP 880
APE + + +SDV+SFGV+L E+ + G P
Sbjct: 258 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 9e-18
Identities = 52/221 (23%), Positives = 91/221 (41%), Gaps = 39/221 (17%)
Query: 679 EEDNLIGSGGTGKVYR-LDLKKNAGTVAVKQL---WKGDGVKVFAA-EMEILGKIR---H 730
E IG G GKV++ DLK VA+K++ +G+ + E+ +L + H
Sbjct: 14 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 73
Query: 731 RNILKLY-----ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGA 785
N+++L+ + + LV E++ Q L LD +
Sbjct: 74 PNVVRLFDVCTVSRTDRETKLTLVFEHVD-----QDL-TTY------LDKVPEPGVPTET 121
Query: 786 AK--------GIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSD 837
K G+ +LH ++HRD+K NIL+ + K+ADFG+A+ +
Sbjct: 122 IKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR-IYSFQM--A 175
Query: 838 YSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGR 878
+ T Y APE+ + D++S G + E+ +
Sbjct: 176 LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 1e-17
Identities = 55/280 (19%), Positives = 94/280 (33%), Gaps = 45/280 (16%)
Query: 319 SIYGNRFSGPFPENLGRYTALTDVDISENQFS----GSFPKYLCEKRKLLNL--LALSNN 372
+ NR + +L R L + ++ N + SF L +L L LS N
Sbjct: 58 DLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSF-------SSLGSLEHLDLSYN 110
Query: 373 FSGEVPNS-YADCKTIQRLRISDNHLSGKIPDGLWA-LPNVGMLDFGDNDFTGGISP--L 428
+ + +S + ++ L + N L++ L + +L G+ D I
Sbjct: 111 YLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDF 170
Query: 429 IGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHL 488
GL T L +L + + P L + N+ LIL + + + L L
Sbjct: 171 AGL-TFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLEL 229
Query: 489 EENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDN 548
+ L + LS SL + + ++ L +
Sbjct: 230 RDTDLD----------------TFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKL 272
Query: 549 LMKL-KLSSIDLSENQLSGSVPLDFLRMGGDGAFAGNEGL 587
L ++ L ++ S NQL SVP DG F L
Sbjct: 273 LNQISGLLELEFSRNQLK-SVP--------DGIFDRLTSL 303
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 2e-17
Identities = 45/291 (15%), Positives = 91/291 (31%), Gaps = 25/291 (8%)
Query: 183 AEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQK 242
IP + + + L L++ + + L L + N I+ S L
Sbjct: 44 NSIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGS 101
Query: 243 LWKIELYANNLTGELPAEL-GNLTLLQEFDISSNQMYGKLPEEI--GNLKNLTVFQCFKN 299
L ++L N L+ L + L+ L ++ N Y L E +L L + +
Sbjct: 102 LEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNP-YKTLGETSLFSHLTKLQILRVGNM 159
Query: 300 NFSGEFPSG-FGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLC 358
+ + F + L I + P++L ++ + + Q +
Sbjct: 160 DTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFV 218
Query: 359 EKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGD 418
+ + L L + + LS + L + D
Sbjct: 219 DVTSSVECLELRDT---------------DLDTFHFSELSTGETNSLIKKFTFRNVKITD 263
Query: 419 NDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNF 469
+ L + + L +L N+ RLT+L+++ L N +
Sbjct: 264 ESLFQVMKLLNQI-SGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 1e-16
Identities = 57/311 (18%), Positives = 117/311 (37%), Gaps = 25/311 (8%)
Query: 82 NKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD-- 139
+ SL+ I S ++ ++ L L N ++ +L C NL+ L +T N + ++ +
Sbjct: 40 SGSLN-SIPSGLTE--AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDS 95
Query: 140 LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESI--GNLKNLTY 197
S+L +LE DLS NY + W L+ L L++ N Y + E+ +L L
Sbjct: 96 FSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKT--LGETSLFSHLTKLQI 153
Query: 198 LFLAHCNLRGRIPESI-SELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGE 256
L + + + +I + L L L+I + + P+S++ +Q + + L+
Sbjct: 154 LRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILL 213
Query: 257 LPAELGNLTLLQEFDISSNQMYGKLPEEI-----GNLKNLTVFQ--CFKNNFSGEFPSGF 309
L + + ++ ++ + E+ +L F+ + +
Sbjct: 214 LEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLL 273
Query: 310 GDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLAL 369
+ L N+ R T+L + + N + C ++ L
Sbjct: 274 NQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWD-------CSCPRIDYLSRW 326
Query: 370 SNNFSGEVPNS 380
N S + S
Sbjct: 327 LNKNSQKEQGS 337
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 9e-15
Identities = 47/309 (15%), Positives = 96/309 (31%), Gaps = 51/309 (16%)
Query: 202 HCNLRGR----IPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGEL 257
C IP ++E + +LD+ N+I+ +++ L + L +N + +
Sbjct: 35 ICKGSSGSLNSIPSGLTE--AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TI 91
Query: 258 PAEL-GNLTLLQEFDISSNQMYGKLPEEI-GNLKNLTVFQCFKNNFSGEFPSG-FGDMRK 314
+ +L L+ D+S N + L L +LT N + + F + K
Sbjct: 92 EEDSFSSLGSLEHLDLSYNYL-SNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTK 150
Query: 315 LFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLAL---SN 371
L + T I F+G L L L ++
Sbjct: 151 LQILRVGNMD-------------TFTK--IQRKDFAG-----------LTFLEELEIDAS 184
Query: 372 NFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWA-LPNVGMLDFGDND--------FT 422
+ P S + + L + + + +V L+ D D +
Sbjct: 185 DLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELS 243
Query: 423 GGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQ 482
G + + + + + + ++ L +++ L L + N L
Sbjct: 244 TGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTS 302
Query: 483 LSSLHLEEN 491
L + L N
Sbjct: 303 LQKIWLHTN 311
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 2e-17
Identities = 53/242 (21%), Positives = 91/242 (37%), Gaps = 51/242 (21%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
IG G G VY K VA+K++ + + E+ IL +++ I++LY
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDL 93
Query: 740 LL-KGGSSF----LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKI--ALGAAKGIAYL 792
++ F +VLE + L K K + + + L G ++
Sbjct: 94 IIPDDLLKFDELYIVLEIADSD-----LKKLFKTPIFLTEEHIKTILYNLL---LGENFI 145
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHG------ 846
H IIHRD+K +N LL++D K+ DFG+A+ + + +
Sbjct: 146 H---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNK 202
Query: 847 --------------YIAPEL-----AYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGD 887
Y APEL YT + D++S G + EL+ + + +
Sbjct: 203 NLKKQLTSHVVTRWYRAPELILLQENYTKSI----DIWSTGCIFAELLNMLQSHINDPTN 258
Query: 888 GK 889
Sbjct: 259 RF 260
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 5e-17
Identities = 58/220 (26%), Positives = 98/220 (44%), Gaps = 50/220 (22%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA---------EMEILGKIRHRNIL 734
IG G G V N VA+K+ + F E++IL + RH NI+
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKK------ISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 735 KLYACLL-KGGSSF----LVLEYMPNGNLFQALHKRVKEGKPELDWFR--RYKIALGAAK 787
+ + +V + M L+K +K D Y+I +
Sbjct: 89 GINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQIL----R 139
Query: 788 GIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE----NSPKVSDYSCFAG 843
G+ Y+H S ++HRD+K SN+LL+ + KI DFG+A++A+ ++ +++Y
Sbjct: 140 GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY---VA 193
Query: 844 THGYIAPEL-----AYTCKVSEKSDVFSFGVVLLELVTGR 878
T Y APE+ YT + D++S G +L E+++ R
Sbjct: 194 TRWYRAPEIMLNSKGYTKSI----DIWSVGCILAEMLSNR 229
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 84.4 bits (208), Expect = 7e-17
Identities = 41/282 (14%), Positives = 90/282 (31%), Gaps = 42/282 (14%)
Query: 117 LSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIG 176
+ N+ + V + L +++ + + ++ +
Sbjct: 17 DDAFAETIKDNLKKKS-VTDAVTQNELNSIDQIIANNS-----------DIKSV------ 58
Query: 177 DNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRS 236
+ I L N+T LFL L I + ++ L+ LG L + NKI + S
Sbjct: 59 ----------QGIQYLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDENKIK-DLS-S 104
Query: 237 IRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQC 296
++ L+KL + L N ++ ++ L +L L+ + +N++ + L L
Sbjct: 105 LKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSL 160
Query: 297 FKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKY 356
N S + KL + N S L L +++ + +
Sbjct: 161 EDNQISDI--VPLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFSQECLNKPINH 216
Query: 357 LCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLS 398
+ + P +D ++ + +
Sbjct: 217 QSNLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWHLPE 256
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 81.7 bits (201), Expect = 4e-16
Identities = 61/287 (21%), Positives = 105/287 (36%), Gaps = 18/287 (6%)
Query: 75 VTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMV 134
+ +I +N + + I L ++T L L N L+ P L+N NL L + N +
Sbjct: 45 IDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENK-I 99
Query: 135 GSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKN 194
+ L LK L+ L N + +V+L QL SL +G+N + + L
Sbjct: 100 KDLSSLKDLKKLKSLSLEHNGISDING--LVHLPQLESLYLGNN---KITDITVLSRLTK 154
Query: 195 LTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLT 254
L L L + I ++ L +L L + +N IS R++ L+ L +EL++
Sbjct: 155 LDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFSQECL 210
Query: 255 GELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRK 314
+ NL + + + PE I + + K + +
Sbjct: 211 NKPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKPN-VKWHLPEFTNEVSFIFYQ 267
Query: 315 LFAFSIYGNRFSGPFPENLGR-YTALTDVDISENQFSGSFPKYLCEK 360
RF G + L YT DVD + + +
Sbjct: 268 PVTIGKAKARFHGRVTQPLKEVYTVSYDVDGTVIKTKVEAGTRITAP 314
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 81.7 bits (201), Expect = 5e-16
Identities = 43/185 (23%), Positives = 83/185 (44%), Gaps = 15/185 (8%)
Query: 382 ADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQ 441
+ + ++ + L ++ + ++D + + L ++++L L
Sbjct: 18 DAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQGIQYL-PNVTKLFLN 73
Query: 442 NNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEM 501
N+ + L L NL L L N + S+L L++L SL LE N ++ I +
Sbjct: 74 GNKLTDI--KPLTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNGIS-DING-L 127
Query: 502 GDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLS 560
++ L L N ++ +I LS L+ L+ L+L N+++ I L L KL ++ LS
Sbjct: 128 VHLPQLESLYLGNNKIT-DIT-VLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLS 183
Query: 561 ENQLS 565
+N +S
Sbjct: 184 KNHIS 188
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 77.1 bits (189), Expect = 1e-14
Identities = 47/235 (20%), Positives = 99/235 (42%), Gaps = 17/235 (7%)
Query: 331 ENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRL 390
+ ++ + + + + ++ + +N+ V + +L
Sbjct: 15 FPDDAFAETIKDNLKKKSVTDAVTQNELNS---IDQIIANNSDIKSVQG-IQYLPNVTKL 70
Query: 391 RISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELP 450
++ N L+ I L L N+G L +N +S L L L L L++N S ++
Sbjct: 71 FLNGNKLT-DIK-PLTNLKNLGWLFLDENKIKD-LSSLKDL-KKLKSLSLEHNGIS-DIN 125
Query: 451 SELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDL 510
L L LE L L NN + + L L +L +L LE+N ++ I + ++ +L
Sbjct: 126 G-LVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNL 180
Query: 511 NLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLK-LSSIDLSENQL 564
L++N +S ++ +L+ L +L+ L L + ++ L +++ ++ L
Sbjct: 181 YLSKNHIS-DLR-ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 233
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 70.5 bits (172), Expect = 2e-12
Identities = 53/321 (16%), Positives = 100/321 (31%), Gaps = 44/321 (13%)
Query: 219 LGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMY 278
+G I FP + K L ++T + L + + +++ +
Sbjct: 1 MGETITVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI- 55
Query: 279 GKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTA 338
+ + I L N+T N + P +++ L + N+ +L
Sbjct: 56 KSV-QGIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKDL--SSLKDLKK 110
Query: 339 LTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLS 398
L + + N S ++ L + ++ L + +N ++
Sbjct: 111 LKSLSLEHNGIS--------------DINGLVH------------LPQLESLYLGNNKIT 144
Query: 399 GKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTN 458
L L + L DN + I PL GL T L L L N S +L L L N
Sbjct: 145 --DITVLSRLTKLDTLSLEDNQISD-IVPLAGL-TKLQNLYLSKNHIS-DL-RALAGLKN 198
Query: 459 LERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLS 518
L+ L L + K + L +++ + +L P + D N+ +
Sbjct: 199 LDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV--TPEIISDDGDYEKPNVKWHLPE 256
Query: 519 GNIPRSLSLLSSLNALNLSGN 539
S +
Sbjct: 257 FTNEVSFIFYQPVTIGKAKAR 277
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 69.8 bits (170), Expect = 2e-12
Identities = 45/168 (26%), Positives = 73/168 (43%), Gaps = 13/168 (7%)
Query: 407 ALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTN 466
A + T L S+ Q++ N+ + + L N+ +L L
Sbjct: 19 AFAETIKDNLKKKSVTD-AVTQNEL-NSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNG 74
Query: 467 NNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLS 526
N + I L L+ L L L+EN + + + + D ++ L+L N +S +I L
Sbjct: 75 NKLT-DI-KPLTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS-DIN-GLV 128
Query: 527 LLSSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLSENQLSGSVPLDFL 573
L L +L L NK+T L +L KL ++ L +NQ+S VPL L
Sbjct: 129 HLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQISDIVPLAGL 174
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 9e-17
Identities = 50/212 (23%), Positives = 89/212 (41%), Gaps = 40/212 (18%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA-----EMEILGKIR-HRNILKLY 737
+G G +V+ N V VK L K E++IL +R NI+ L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKIL------KPVKKKKIKREIKILENLRGGPNIITLA 97
Query: 738 ACLLKGGSSF---LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHH 794
++K S LV E++ N + + + F Y+I K + Y H
Sbjct: 98 -DIVKDPVSRTPALVFEHVNNTDF----KQLYQTLTDYDIRFYMYEIL----KALDYCH- 147
Query: 795 DCSPPIIHRDIKSSNILLD-EDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL- 852
S I+HRD+K N+++D E + ++ D+G+A+ +Y+ + + PEL
Sbjct: 148 --SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELL 202
Query: 853 ----AYTCKVSEKSDVFSFGVVLLELVTGRKP 880
Y + D++S G +L ++ ++P
Sbjct: 203 VDYQMYDYSL----DMWSLGCMLASMIFRKEP 230
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 1e-16
Identities = 53/247 (21%), Positives = 92/247 (37%), Gaps = 56/247 (22%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLYAC 739
IG+G G V K VA+K++ + + E+ IL ++ H +++K+
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDI 120
Query: 740 LL-KGGSSF----LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKI--ALGAAKGIAYL 792
++ K F +VLE K + + + + L G+ Y+
Sbjct: 121 VIPKDVEKFDELYVVLEIAD-----SDFKKLFRTPVYLTELHIKTLLYNLL---VGVKYV 172
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHG------ 846
H S I+HRD+K +N L+++D K+ DFG+A+ + + +
Sbjct: 173 H---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVT 229
Query: 847 -------------------YIAPEL-----AYTCKVSEKSDVFSFGVVLLELVTGRKPVE 882
Y APEL YT + DV+S G + EL+ K
Sbjct: 230 FPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAI----DVWSIGCIFAELLNMIKENV 285
Query: 883 EEYGDGK 889
+ D
Sbjct: 286 AYHADRG 292
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 51/215 (23%), Positives = 86/215 (40%), Gaps = 25/215 (11%)
Query: 679 EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVF--AAEMEI-----LGKI 728
E IG G G VY+ + VA+K + G + E+ L
Sbjct: 12 EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAF 71
Query: 729 RHRNILKLY-----ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIAL 783
H N+++L + + LV E++ +L L K G P + +
Sbjct: 72 EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPA-ETIKDLMRQF 129
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAG 843
+G+ +LH +C I+HRD+K NIL+ K+ADFG+A+ + +
Sbjct: 130 --LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR-IYSYQM--ALTPVVV 181
Query: 844 THGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGR 878
T Y APE+ + D++S G + E+ +
Sbjct: 182 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-16
Identities = 39/200 (19%), Positives = 79/200 (39%), Gaps = 16/200 (8%)
Query: 386 TIQRLRISDNHLSGKIPDG-LWALPNVGMLDFGDNDFTGGISP--LIGLSTSLSQLVLQN 442
+ Q L++ + HL IP LPN+ + + + L + ++ + ++N
Sbjct: 32 STQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNL-SKVTHIEIRN 89
Query: 443 NRFSGELPSE-LGRLTNLERLILTNNNFSGKIP--SALGALRQLSSLHLEENALTGSIPN 499
R + + L L L+ L + N P + + + L + +N SIP
Sbjct: 90 TRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPV 148
Query: 500 EM--GDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNL---MKLKL 554
G C + L L N + ++ + L+A+ L+ NK I + +
Sbjct: 149 NAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGP 207
Query: 555 SSIDLSENQLSGSVPLDFLR 574
S +D+S+ ++ ++P L
Sbjct: 208 SLLDVSQTSVT-ALPSKGLE 226
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 5e-13
Identities = 26/161 (16%), Positives = 51/161 (31%), Gaps = 17/161 (10%)
Query: 430 GLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPS-ALGALRQLSSLHL 488
L S L L L N+ R+ ++ + ++ S + L +++ + +
Sbjct: 28 SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEI 87
Query: 489 EENALTGSIPNEM-GDCARIVDLNLARNSLSGNIP--RSLSLLSSLNALNLSGNKLTGSI 545
I + + + L + L P + L ++ N SI
Sbjct: 88 RNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSI 146
Query: 546 PDNL---MKLKLSSIDLSENQLSGSVPLDFLRMGGDGAFAG 583
P N + + ++ L N + SV AF G
Sbjct: 147 PVNAFQGLCNETLTLKLYNNGFT-SVQ--------GYAFNG 178
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 37/207 (17%), Positives = 77/207 (37%), Gaps = 18/207 (8%)
Query: 364 LNLLALSNNFSGEVP-NSYADCKTIQRLRISDNHLSGKIPDGL-WALPNVGMLDFGDNDF 421
L L +P +++++ I R+ +S + ++ + L V ++ +
Sbjct: 33 TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRN 92
Query: 422 TGGISP--LIGLSTSLSQLVLQNNRFSGELPSE--LGRLTNLERLILTNNNFSGKIPSAL 477
I P L L L L + N P + L +T+N + IP
Sbjct: 93 LTYIDPDALKEL-PLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNA 150
Query: 478 --GALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSL--SLLSSLNA 533
G + +L L N T S+ + ++ + L +N I + + S +
Sbjct: 151 FQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSL 209
Query: 534 LNLSGNKLTGSIP----DNLMKLKLSS 556
L++S +T ++P ++L +L +
Sbjct: 210 LDVSQTSVT-ALPSKGLEHLKELIARN 235
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 36/219 (16%), Positives = 64/219 (29%), Gaps = 18/219 (8%)
Query: 94 SALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD--LSALKNLEIFDL 151
S S L L L SN N+ + V+ + + + L + ++
Sbjct: 28 SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEI 87
Query: 152 SINYFTGRFPRWV-VNLTQLVSLSIGDNVYDEAEIPE--SIGNLKNLTYLFLAHCNLRGR 208
L L L I + P+ + + L +
Sbjct: 88 RNTRNLTYIDPDALKELPLLKFLGIFNT--GLKMFPDLTKVYSTDIFFILEITDNPYMTS 145
Query: 209 IPE-SISELR-ELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAEL--GNL 264
IP + L E TL + N + KL + L N + + G
Sbjct: 146 IPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVY 204
Query: 265 TLLQEFDISSNQMYGKLPEEI-GNLKNLTVFQCFKNNFS 302
+ D+S + LP + +LK L +N ++
Sbjct: 205 SGPSLLDVSQTSV-TALPSKGLEHLKELI----ARNTWT 238
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 50/217 (23%), Positives = 85/217 (39%), Gaps = 34/217 (15%)
Query: 386 TIQRLRISDNHLSGKIPDGLWA-LPNVGMLDFGDNDFT----GGISPLIGLSTSLSQLVL 440
+ + L +S N L + + P + +LD + G L + LS L+L
Sbjct: 29 STKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSL----SHLSTLIL 83
Query: 441 QNNRFSGELPSEL-GRLTNLERLILTNNNFSGKIPS-ALGALRQLSSLHLEENALTGSIP 498
N L L++L++L+ N + + + +G L+ L L++ N + S
Sbjct: 84 TGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ-SFK 140
Query: 499 NEMGDCARIV---DLNLARN---SLSGNIPRSLSLLSSLNA-LNLSGNKLTGSIPDNL-M 550
+ + L+L+ N S+ R L + LN L+LS N + I
Sbjct: 141 -LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFK 198
Query: 551 KLKLSSIDLSENQLSGSVPLDFLRMGGDGAFAGNEGL 587
+++L + L NQL SVP DG F L
Sbjct: 199 EIRLKELALDTNQLK-SVP--------DGIFDRLTSL 226
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 35/184 (19%), Positives = 59/184 (32%), Gaps = 21/184 (11%)
Query: 430 GLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPS-ALGALRQLSSLHL 488
L S L L N L+ L L+ I A +L LS+L L
Sbjct: 25 NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLIL 83
Query: 489 EENALTGSIPNEM-GDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIP- 546
N + S+ + + L +L+ + L +L LN++ N + S
Sbjct: 84 TGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKL 141
Query: 547 ----DNLMKLKLSSIDLSENQLSGSVPLDFLRMGGDGAFAGNEGLCLDQSTKMLMNSKLT 602
NL L+ +DLS N++ S+ + L + L + +
Sbjct: 142 PEYFSNLTNLE--HLDLSSNKIQ-SIY--------CTDLRVLHQMPLLNLSLDLSLNPMN 190
Query: 603 ACPA 606
Sbjct: 191 FIQP 194
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 3e-10
Identities = 47/218 (21%), Positives = 84/218 (38%), Gaps = 46/218 (21%)
Query: 335 RYTALTDVDISENQFS----GSFPKYLCEKRKLLNL--LALSNNFSGEVP-NSYADCKTI 387
+ L +D+S + G++ + L +L L L+ N + +++ ++
Sbjct: 50 SFPELQVLDLSRCEIQTIEDGAY-------QSLSHLSTLILTGNPIQSLALGAFSGLSSL 102
Query: 388 QRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRF-S 446
Q+L + +L+ + + G L +L +L + +N S
Sbjct: 103 QKLVAVETNLA-SLENFP----------IG------------HL-KTLKELNVAHNLIQS 138
Query: 447 GELPSELGRLTNLERLILTNNNFSGKIPSALGALRQL----SSLHLEENALTGSIPNEMG 502
+LP LTNLE L L++N + L L Q+ SL L N + I
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAF 197
Query: 503 DCARIVDLNLARNSLSGNIPR-SLSLLSSLNALNLSGN 539
R+ +L L N L ++P L+SL + L N
Sbjct: 198 KEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 43/195 (22%), Positives = 77/195 (39%), Gaps = 14/195 (7%)
Query: 90 SSSISALQSLTVLSLPFNVLSGKLPLEL-SNCSNLKVLNVTGNAMVGSVPD--LSALKNL 146
S S + L VL L + + + S+L L +TGN + S+ S L +L
Sbjct: 45 SYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGN-PIQSLALGAFSGLSSL 102
Query: 147 EIFDLSINYFTGRFPRWV-VNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNL 205
+ + +L L L++ N+ ++PE NL NL +L L+ +
Sbjct: 103 QKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 161
Query: 206 RGRIPESI-SELREL----GTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAE 260
+ I + L ++ +LD+ N ++ K +L ++ L N L
Sbjct: 162 Q-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGI 219
Query: 261 LGNLTLLQEFDISSN 275
LT LQ+ + +N
Sbjct: 220 FDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 4e-07
Identities = 40/255 (15%), Positives = 76/255 (29%), Gaps = 53/255 (20%)
Query: 240 LQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEI-GNLKNLTVFQCFK 298
+ L L N L + LQ D+S ++ + + +L +L+
Sbjct: 30 TKNLD---LSFNPLRHLGSYSFFSFPELQVLDLSRCEI-QTIEDGAYQSLSHLSTLILTG 85
Query: 299 NNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLC 358
N S+ FSG ++L + E + S +
Sbjct: 86 NPIQ----------------SLALGAFSGL--------SSLQKLVAVETNLA-SLENFPI 120
Query: 359 EKRKLLNLLALSNNF--SGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDF 416
K L L +++N S ++P +++ ++ L +S N + ++
Sbjct: 121 GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNK--------IQSIYC------ 166
Query: 417 GDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSA 476
D L + L L N + + + L+ L L N
Sbjct: 167 --TDLRV----LHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGI 219
Query: 477 LGALRQLSSLHLEEN 491
L L + L N
Sbjct: 220 FDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 4e-06
Identities = 48/247 (19%), Positives = 83/247 (33%), Gaps = 38/247 (15%)
Query: 183 AEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQK 242
+IP+++ + L L+ LR S EL LD+ R +I + + L
Sbjct: 20 YKIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSH 77
Query: 243 LWKIELYANNLTGELPAEL-GNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNF 301
L + L N + L L+ LQ+ L +L
Sbjct: 78 LSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETN-----------LASL---------- 115
Query: 302 SGEFPSG-FGDMRKLFAFSIYGNRF-SGPFPENLGRYTALTDVDISENQFS----GSFPK 355
+ G ++ L ++ N S PE T L +D+S N+
Sbjct: 116 ----ENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRV 171
Query: 356 YLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWA-LPNVGML 414
L + L L LS N + ++ L + N L +PDG++ L ++ +
Sbjct: 172 -LHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKI 229
Query: 415 DFGDNDF 421
N +
Sbjct: 230 WLHTNPW 236
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 53/224 (23%), Positives = 93/224 (41%), Gaps = 51/224 (22%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA---------EMEILGKIRHRNIL 734
+G G G V K VA+K+ ++ F E++IL +H NI+
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKK------IEPFDKPLFALRTLREIKILKHFKHENII 72
Query: 735 KLYACLL-KGGSSF----LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKI--ALGAAK 787
++ +F ++ E M LH+ + + D +Y I L +
Sbjct: 73 TIFNIQRPDSFENFNEVYIIQELMQTD-----LHRVIS-TQMLSDDHIQYFIYQTL---R 123
Query: 788 GIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTH-- 845
+ LH +IHRD+K SN+L++ + + K+ DFG+A+I + S + +
Sbjct: 124 AVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180
Query: 846 GYI------APEL-----AYTCKVSEKSDVFSFGVVLLELVTGR 878
++ APE+ Y+ + DV+S G +L EL R
Sbjct: 181 EFVATRWYRAPEVMLTSAKYSRAM----DVWSCGCILAELFLRR 220
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 5e-16
Identities = 53/225 (23%), Positives = 100/225 (44%), Gaps = 51/225 (22%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHRNILKLY-- 737
+G GG G V+ VA+K++ D E++I+ ++ H NI+K++
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVFEI 76
Query: 738 --------ACLLKGGSSF----LVLEYMPNGNLFQALHKRVKEGKPELDWFRR--YKIAL 783
+ + +V EYM L +++G + R Y++
Sbjct: 77 LGPSGSQLTDDVGSLTELNSVYIVQEYMETD-----LANVLEQGPLLEEHARLFMYQLL- 130
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLD-EDYEPKIADFGVAKIAE----NSPKVSDY 838
+G+ Y+H S ++HRD+K +N+ ++ ED KI DFG+A+I + + +S+
Sbjct: 131 ---RGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184
Query: 839 SCFAGTHGYIAPEL-----AYTCKVSEKSDVFSFGVVLLELVTGR 878
T Y +P L YT + D+++ G + E++TG+
Sbjct: 185 ---LVTKWYRSPRLLLSPNNYTKAI----DMWAAGCIFAEMLTGK 222
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 7e-16
Identities = 84/466 (18%), Positives = 150/466 (32%), Gaps = 91/466 (19%)
Query: 165 VNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGR----IPESISELRELG 220
++L + SL I +A E + L+ + L C L I ++ L
Sbjct: 1 MSLD-IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALA 59
Query: 221 TLDICRNKISGEFPRSI--------RKLQKLWKIELYANNLTGE----LPAELGNLTLLQ 268
L++ N++ + K+QKL L LTG L + L L LQ
Sbjct: 60 ELNLRSNELGDVGVHCVLQGLQTPSCKIQKLS---LQNCCLTGAGCGVLSSTLRTLPTLQ 116
Query: 269 EFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFS-- 326
E +S N +G+ + + + +L + S
Sbjct: 117 ELHLSDNL--------LGDAGLQLLCEGLLDPQC-----------RLEKLQLEYCSLSAA 157
Query: 327 --GPFPENLGRYTALTDVDISENQFSGSFPKYLCE-----KRKLLNLLALSNNFSGEVPN 379
P L ++ +S N + + + LC+ +L L S + +
Sbjct: 158 SCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCR 217
Query: 380 SYAD----CKTIQRLRISDNHLSGKIPDGLWAL--------PNVGMLDFGDNDFT----G 423
+++ L + N L G+ L + L + T G
Sbjct: 218 DLCGIVASKASLRELALGSNKLGD---VGMAELCPGLLHPSSRLRTLWIWECGITAKGCG 274
Query: 424 GISPLIGLSTSLSQLVLQNNRFSGELPSELGRL-----TNLERLILTNNNFSGK----IP 474
+ ++ SL +L L N E L LE L + + +F+
Sbjct: 275 DLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFS 334
Query: 475 SALGALRQLSSLHLEENALTGSIPNEMGD-----CARIVDLNLARNSLS----GNIPRSL 525
S L R L L + N L + E+ + + L LA +S ++ +L
Sbjct: 335 SVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATL 394
Query: 526 SLLSSLNALNLSGNKLTGS----IPDNLM--KLKLSSIDLSENQLS 565
SL L+LS N L + + +++ L + L + S
Sbjct: 395 LANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 440
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-10
Identities = 82/475 (17%), Positives = 158/475 (33%), Gaps = 94/475 (19%)
Query: 75 VTEISFDNKSLSGE-ISSSISALQSLTVLSLPFNVLSGK----LPLELSNCSNLKVLNVT 129
+ + + LS + + LQ V+ L L+ + L L LN+
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64
Query: 130 GNAMVGS-VPDLS-ALKN----LEIFDLSINYFTGR----FPRWVVNLTQLVSLSIGDNV 179
N + V + L+ ++ L TG + L L L + DN+
Sbjct: 65 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL 124
Query: 180 YDEAEIPESIGNLKN----LTYLFLAHCNLRGRIPESISEL----RELGTLDICRNKISG 231
+A + L + L L L +C+L E ++ + + L + N I+
Sbjct: 125 LGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINE 184
Query: 232 E--------FPRSIRKLQKLWKIELYANNLTGE----LPAELGNLTLLQEFDISSNQMYG 279
S +L+ L L + +T + L + + L+E + SN+
Sbjct: 185 AGVRVLCQGLKDSPCQLEALK---LESCGVTSDNCRDLCGIVASKASLRELALGSNK--- 238
Query: 280 KLPEEIGN--LKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRY- 336
+G+ + L + +L I+ + +L R
Sbjct: 239 -----LGDVGMAELCPGLLHPS-------------SRLRTLWIWECGITAKGCGDLCRVL 280
Query: 337 ---TALTDVDISENQFSGSFPKYLCEKRKLLNL----LALSNNFSGE-----VPNSYADC 384
+L ++ ++ N+ + LCE L + + + A
Sbjct: 281 RAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQN 340
Query: 385 KTIQRLRISDNHLSGKIPDGLWAL------PNVGM--LDFGDNDFT----GGISPLIGLS 432
+ + L+IS+N L G+ L P + L D D + ++ + +
Sbjct: 341 RFLLELQISNNRLED---AGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLAN 397
Query: 433 TSLSQLVLQNNRFSGELPSELGRL-----TNLERLILTNNNFSGKIPSALGALRQ 482
SL +L L NN +L LE+L+L + +S ++ L AL +
Sbjct: 398 HSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEK 452
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 1e-09
Identities = 59/334 (17%), Positives = 102/334 (30%), Gaps = 72/334 (21%)
Query: 267 LQEFDISSNQMYGK-LPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRF 325
+Q DI ++ E + L+ V + +
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSA------------- 51
Query: 326 SGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCK 385
L AL ++++ N+ + + L
Sbjct: 52 -------LRVNPALAELNLRSNELGDVGVHCVLQ--------GLQTP-----------SC 85
Query: 386 TIQRLRISDNHLSGK----IPDGLWALPNVGMLDFGDNDFT-GGISPLIGL----STSLS 436
IQ+L + + L+G + L LP + L DN G+ L L
Sbjct: 86 KIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLE 145
Query: 437 QLVLQNNRFSGE----LPSELGRLTNLERLILTNNNFSGKIPSALG-ALR----QLSSLH 487
+L L+ S L S L + + L ++NN+ + L L+ QL +L
Sbjct: 146 KLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALK 205
Query: 488 LEENALT----GSIPNEMGDCARIVDLNLARNSLSGN-----IPRSLSLLSSLNALNLSG 538
LE +T + + A + +L L N L P L S L L +
Sbjct: 206 LESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWE 265
Query: 539 NKLT----GSIPDNLMKLK-LSSIDLSENQLSGS 567
+T G + L + L + L+ N+L
Sbjct: 266 CGITAKGCGDLCRVLRAKESLKELSLAGNELGDE 299
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 4e-04
Identities = 30/147 (20%), Positives = 49/147 (33%), Gaps = 29/147 (19%)
Query: 431 LSTSLSQLVLQNNRFSGELPSELGR-LTNLERLILTNNNFSGK----IPSALGALRQLSS 485
+S + L +Q S +EL L + + L + + I SAL L+
Sbjct: 1 MSLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 60
Query: 486 LHLEENALTGSIPNEMGDC-----ARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNK 540
L+L N L + + +I L+L L+ +LSS L
Sbjct: 61 LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT---GAGCGVLSST----LRTLP 113
Query: 541 LTGSIPDNLMKLKLSSIDLSENQLSGS 567
L + LS+N L +
Sbjct: 114 ------------TLQELHLSDNLLGDA 128
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 8e-16
Identities = 38/159 (23%), Positives = 64/159 (40%), Gaps = 31/159 (19%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKI-RHRNILKLYA---- 738
+G G GKV ++ K+ A+K L + E+E+ + + +I+++
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR---REVELHWRASQCPHIVRIVDVYEN 82
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAA-------KGIAY 791
+V+E + G LF + R + E + A+ + I Y
Sbjct: 83 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE----------ASEIMKSIGEAIQY 132
Query: 792 LHHDCSPPIIHRDIKSSNILL---DEDYEPKIADFGVAK 827
LH S I HRD+K N+L + K+ DFG AK
Sbjct: 133 LH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 46/181 (25%), Positives = 74/181 (40%), Gaps = 11/181 (6%)
Query: 386 TIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRF 445
L +S+N L L + L+ + T + L L L L +N+
Sbjct: 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVDGTL-PVLGTLDLSHNQL 89
Query: 446 SGELPSELGRLTNLERLILTNNNFSGKIPS-ALGALRQLSSLHLEENALTGSIPNEMGDC 504
LP L L L ++ N + +P AL L +L L+L+ N L ++P +
Sbjct: 90 Q-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTP 146
Query: 505 -ARIVDLNLARNSLSGNIPRSL-SLLSSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLSE 561
++ L+LA N+L+ +P L + L +L+ L L N L +IP L L
Sbjct: 147 TPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHG 204
Query: 562 N 562
N
Sbjct: 205 N 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 39/159 (24%), Positives = 61/159 (38%), Gaps = 21/159 (13%)
Query: 430 GLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLE 489
L + L L N + L T L +L L + K+ G L L +L L
Sbjct: 28 DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLS 85
Query: 490 ENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSL-SLLSSLNALNLSGNKLTGSIP-- 546
N L S+P + L+++ N L+ ++P L L L L GN+L ++P
Sbjct: 86 HNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPG 142
Query: 547 --DNLMKLKLSSIDLSENQLSGSVPLDFLRMGGDGAFAG 583
KL+ + L+ N L+ +P G G
Sbjct: 143 LLTPTPKLE--KLSLANNNLT-ELP--------AGLLNG 170
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 51/226 (22%), Positives = 79/226 (34%), Gaps = 35/226 (15%)
Query: 76 TEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVG 135
E++ D ++L+ + + T+L L N+L L + L LN+
Sbjct: 13 LEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE--- 66
Query: 136 SVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNL 195
L L++ L L +L + N +P L L
Sbjct: 67 -------LTKLQVDG---------------TLPVLGTLDLSHN--QLQSLPLLGQTLPAL 102
Query: 196 TYLFLAHCNLRGRIPESI-SELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLT 254
T L ++ L +P L EL L + N++ P + KL K+ L NNLT
Sbjct: 103 TVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT 161
Query: 255 GELPAEL-GNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKN 299
ELPA L L L + N +Y +P+ L N
Sbjct: 162 -ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 42/180 (23%), Positives = 73/180 (40%), Gaps = 28/180 (15%)
Query: 432 STSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEEN 491
S ++ + LP +L + L L+ N + L +L+ L+L+
Sbjct: 9 VASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65
Query: 492 ALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIP----D 547
LT + G + L+L+ N L ++P L +L L++S N+LT S+P
Sbjct: 66 ELT-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALR 121
Query: 548 NLMKLKLSSIDLSENQLSGSVPLDFLRMGGDGAFAGNEGLCLDQSTKM-LMNSKLTACPA 606
L +L+ + L N+L ++P G + K+ L N+ LT PA
Sbjct: 122 GLGELQ--ELYLKGNELK-TLP--------PGLLTP-----TPKLEKLSLANNNLTELPA 165
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 53/233 (22%), Positives = 77/233 (33%), Gaps = 39/233 (16%)
Query: 287 NLKNLTVFQCFKNNFSGEFPSG-FGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDIS 345
+ + C K N + P D L + N L YT LT +++
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDLPKDTTILH---LSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 346 ENQFSGSFPKYLCEKRKLLNL--LALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPD 403
+ + L L L L LS+N +P + L +S N L+ +P
Sbjct: 64 RAELT-----KLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLT-SLPL 117
Query: 404 GLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSEL-GRLTNLERL 462
G G L +L L+ N LP L LE+L
Sbjct: 118 GA---------------LRG--------LGELQELYLKGNELK-TLPPGLLTPTPKLEKL 153
Query: 463 ILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARN 515
L NNN + L L L +L L+EN+L +IP + L N
Sbjct: 154 SLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 38/203 (18%), Positives = 63/203 (31%), Gaps = 22/203 (10%)
Query: 225 CRNKISGEFPRSI-RKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPE 283
C + P + + L L N L A L T L + ++ ++ KL
Sbjct: 17 CDKRNLTALPPDLPKDTTILH---LSENLLYTFSLATLMPYTRLTQLNLDRAEL-TKLQV 72
Query: 284 EIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVD 343
+ G L L N P + L + NR + L L ++
Sbjct: 73 D-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELY 130
Query: 344 ISENQFS----GSFPKYLCEKRKLLNL--LALSNNFSGEVP-NSYADCKTIQRLRISDNH 396
+ N+ G L L+L+NN E+P + + L + +N
Sbjct: 131 LKGNELKTLPPGLL-------TPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENS 183
Query: 397 LSGKIPDGLWALPNVGMLDFGDN 419
L IP G + + N
Sbjct: 184 LYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 50/202 (24%), Positives = 82/202 (40%), Gaps = 14/202 (6%)
Query: 91 SSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFD 150
I L ++T L L N L+ P L+N NL L + N V + L LK L+
Sbjct: 62 QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDEN-KVKDLSSLKDLKKLKSLS 118
Query: 151 LSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIP 210
L N + +V+L QL SL +G+N + + L L L L + I
Sbjct: 119 LEHNGISDING--LVHLPQLESLYLGNN---KITDITVLSRLTKLDTLSLEDNQIS-DI- 171
Query: 211 ESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEF 270
++ L +L L + +N IS R++ L+ L +EL++ + NL +
Sbjct: 172 VPLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTV 229
Query: 271 DISSNQMYGKLPEEIGNLKNLT 292
+ + PE I + +
Sbjct: 230 KNTDGSL--VTPEIISDDGDYE 249
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 5e-14
Identities = 43/185 (23%), Positives = 85/185 (45%), Gaps = 15/185 (8%)
Query: 382 ADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQ 441
+ + ++ + L ++ + ++D + + L ++++L L
Sbjct: 21 DAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQGIQYL-PNVTKLFLN 76
Query: 442 NNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEM 501
N+ + ++ L L NL L L N + S+L L++L SL LE N ++ I +
Sbjct: 77 GNKLT-DI-KPLANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGIS-DING-L 130
Query: 502 GDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLS 560
++ L L N ++ +I LS L+ L+ L+L N+++ I L L KL ++ LS
Sbjct: 131 VHLPQLESLYLGNNKIT-DIT-VLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLS 186
Query: 561 ENQLS 565
+N +S
Sbjct: 187 KNHIS 191
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 39/279 (13%), Positives = 88/279 (31%), Gaps = 42/279 (15%)
Query: 117 LSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIG 176
+ N+ + V + L +++ + + ++ +
Sbjct: 20 DDAFAETIKDNLKKKS-VTDAVTQNELNSIDQIIANNS-----------DIKSV------ 61
Query: 177 DNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRS 236
+ I L N+T LFL L I + ++ L+ LG L + NK+
Sbjct: 62 ----------QGIQYLPNVTKLFLNGNKLT-DI-KPLANLKNLGWLFLDENKVKDLSS-- 107
Query: 237 IRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQC 296
++ L+KL + L N ++ ++ L +L L+ + +N++ + L L
Sbjct: 108 LKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSL 163
Query: 297 FKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKY 356
N S + KL + N S L L +++ + +
Sbjct: 164 EDNQISDI--VPLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFSQECLNKPINH 219
Query: 357 LCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDN 395
+ + P +D ++ + +
Sbjct: 220 QSNLVVPNTVKNTDGSLV--TPEIISDDGDYEKPNVKWH 256
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 49/235 (20%), Positives = 102/235 (43%), Gaps = 17/235 (7%)
Query: 331 ENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRL 390
+ + ++ + + + + ++ + +N+ V + +L
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVTQNELNS---IDQIIANNSDIKSVQG-IQYLPNVTKL 73
Query: 391 RISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELP 450
++ N L+ I L L N+G L +N +S L L L L L++N S ++
Sbjct: 74 FLNGNKLT-DIK-PLANLKNLGWLFLDENKVKD-LSSLKDL-KKLKSLSLEHNGIS-DIN 128
Query: 451 SELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDL 510
L L LE L L NN + I + L L +L +L LE+N ++ I + ++ +L
Sbjct: 129 G-LVHLPQLESLYLGNNKIT-DI-TVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNL 183
Query: 511 NLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLK-LSSIDLSENQL 564
L++N +S ++ R+L+ L +L+ L L + ++ L +++ ++ L
Sbjct: 184 YLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 9e-11
Identities = 46/171 (26%), Positives = 74/171 (43%), Gaps = 13/171 (7%)
Query: 404 GLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLI 463
A + T L S+ Q++ N+ + + L N+ +L
Sbjct: 19 SDDAFAETIKDNLKKKSVTD-AVTQNEL-NSIDQIIANNSDIK-SV-QGIQYLPNVTKLF 74
Query: 464 LTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPR 523
L N + I L L+ L L L+EN + + + + D ++ L+L N +S +I
Sbjct: 75 LNGNKLT-DI-KPLANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS-DIN- 128
Query: 524 SLSLLSSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLSENQLSGSVPLDFL 573
L L L +L L NK+T I L +L KL ++ L +NQ+S VPL L
Sbjct: 129 GLVHLPQLESLYLGNNKIT-DI-TVLSRLTKLDTLSLEDNQISDIVPLAGL 177
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 35/185 (18%), Positives = 73/185 (39%), Gaps = 12/185 (6%)
Query: 91 SSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFD 150
++ L++L L L N + L L + LK L++ N + + L L LE
Sbjct: 84 KPLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNG-ISDINGLVHLPQLESLY 140
Query: 151 LSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIP 210
L N T + LT+L +LS+ DN + + L L L+L+ ++
Sbjct: 141 LGNNKITDITV--LSRLTKLDTLSLEDN---QISDIVPLAGLTKLQNLYLSKNHISD--L 193
Query: 211 ESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEF 270
+++ L+ L L++ + + L ++ +L P + + ++
Sbjct: 194 RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKP 251
Query: 271 DISSN 275
++ +
Sbjct: 252 NVKWH 256
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 6e-10
Identities = 52/294 (17%), Positives = 96/294 (32%), Gaps = 44/294 (14%)
Query: 227 NKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIG 286
I F + K L ++T + L + + +++ + K + I
Sbjct: 12 TPIKQIFS--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI--KSVQGIQ 65
Query: 287 NLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISE 346
L N+T N + P +++ L + N+ +L L + +
Sbjct: 66 YLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDL--SSLKDLKKLKSLSLEH 121
Query: 347 NQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLW 406
N S ++ L + ++ L + +N ++ I L
Sbjct: 122 NGIS--------------DINGLVH------------LPQLESLYLGNNKIT-DI-TVLS 153
Query: 407 ALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTN 466
L + L DN + I PL GL T L L L N S +L L L NL+ L L +
Sbjct: 154 RLTKLDTLSLEDNQISD-IVPLAGL-TKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFS 209
Query: 467 NNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGN 520
K + L +++ + +L P + D N+ +
Sbjct: 210 QECLNKPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVKWHLPEFT 261
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-13
Identities = 60/222 (27%), Positives = 93/222 (41%), Gaps = 41/222 (18%)
Query: 683 LIGSGGTGKVYR-LDLKKNAGTVAVKQLWKGDGVKVFAAEMEI--LGKIR---------- 729
+G G V+ D+ N VA+K + +GD V AAE EI L ++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNT-HVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 730 -HRNILKLYAC-LLKGGSS---FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALG 784
+ILKL KG + +V E + NL + K G P L + ++ L
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIP-LIYVKQISKQL- 140
Query: 785 AAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP------KIADFGVAKIAENSPKVSDY 838
G+ Y+H C IIH DIK N+L++ P KIAD G A + ++
Sbjct: 141 -LLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE--HYTNS 195
Query: 839 --SCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGR 878
+ Y +PE+ +D++S ++ EL+TG
Sbjct: 196 IQTRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 59/235 (25%), Positives = 101/235 (42%), Gaps = 63/235 (26%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIR-HRNILKLYA 738
+G G G V++ ++ VAVK+++ A E+ IL ++ H NI+ L
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 739 CLLKGGSSF----LVLEYMP-------NGNLFQALHKRVKEGKPELDWFRRYKIALGAAK 787
L + LV +YM N+ + +HK+ + Y++ K
Sbjct: 77 VLR--ADNDRDVYLVFDYMETDLHAVIRANILEPVHKQ----------YVVYQLI----K 120
Query: 788 GIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHG- 846
I YLH S ++HRD+K SNILL+ + K+ADFG+++ N +V++ +
Sbjct: 121 VIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 847 ------------------YIAPEL-----AYTCKVSEKSDVFSFGVVLLELVTGR 878
Y APE+ YT + D++S G +L E++ G+
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGI----DMWSLGCILGEILCGK 228
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 71.8 bits (175), Expect = 7e-13
Identities = 108/709 (15%), Positives = 187/709 (26%), Gaps = 248/709 (34%)
Query: 269 EFDISSNQM-YGKLPEEIGNLKNLTVF-QCFKNNF--------------SGEF------P 306
+F+ +Q Y + L+VF F +NF E
Sbjct: 8 DFETGEHQYQYKDI---------LSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSK 58
Query: 307 SGFGDMRKLF-AFSIYGNRFSGPFPENLGR--YTALTD-VDISENQFSGSFPKYLCEKRK 362
+LF F E + R Y L + + Q S Y+ ++ +
Sbjct: 59 DAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDR 118
Query: 363 LLNLLALSNN-FS-GEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNV---GMLDFG 417
L N N F+ V + +LR L P NV G+L G
Sbjct: 119 LYN----DNQVFAKYNVSRL----QPYLKLR---QALLELRPA-----KNVLIDGVLGSG 162
Query: 418 DNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSE-----LGRLTNLERLILTNNNFSGK 472
T ++ V + + ++ + L + E ++
Sbjct: 163 --------------KTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKL--- 205
Query: 473 IPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLL---- 528
L Q+ + + +I + + L R S L +L
Sbjct: 206 -------LYQIDPNWTSRSDHSSNIKLRIHS----IQAELRRLLKSKPYENCLLVLLNVQ 254
Query: 529 --SSLNALNL-------SGNKLTGSIPDNLMKLKLSSIDLSENQLSGSVPLDFLRMGGDG 579
+ NA NL + K + D L + I L + ++
Sbjct: 255 NAKAWNAFNLSCKILLTTRFK---QVTDFLSAATTTHISLDHHSMT------LTPDEVKS 305
Query: 580 AFAGNEGLCLDQSTKMLMNSKLTACPAIQKQKGGFKDKLVLFCIIAVALAAFLAGLLLVS 639
LD + L LT P L IIA ++ LA +
Sbjct: 306 LLL----KYLDCRPQDLPREVLTTNP------------RRL-SIIAESIRDGLA-----T 343
Query: 640 YKNFKLSADMENGEKEVSSKWKLASFHHIDIDAEQICNLEEDNLIGSGGTGK-------V 692
+ N+K + KL + ++ LE + V
Sbjct: 344 WDNWKHV-----------NCDKLTTIIESSLN-----VLEPAEY-------RKMFDRLSV 380
Query: 693 YRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF----- 747
+ +++ +W + + M ++ K L Y+ + K
Sbjct: 381 FPPSAHIPTILLSL--IWFD---VIKSDVMVVVNK------LHKYSLVEKQPKESTISIP 429
Query: 748 -LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPII----- 801
+ LE ALH+ + + Y I + D PP +
Sbjct: 430 SIYLELKVKLENEYALHRSIVD---------HYNIPK------TFDSDDLIPPYLDQYFY 474
Query: 802 -----H--------RDIKSSNILLDEDY-EPKIADFGVAK-------------------I 828
H R + LD + E KI A I
Sbjct: 475 SHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYI 534
Query: 829 AENSPK----VSDYSCF---AGTHGYIAPELAYTCKV-----SEKSDVF 865
+N PK V+ F + + YT + +E +F
Sbjct: 535 CDNDPKYERLVNAILDFLPKIEENLICSK---YTDLLRIALMAEDEAIF 580
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 65.3 bits (158), Expect = 8e-11
Identities = 62/473 (13%), Positives = 147/473 (31%), Gaps = 140/473 (29%)
Query: 7 LCFHLLALLCFILVSVFPPSLSLNVETQALIQFKSKLKDPHG--VLDS-W-KESADSPCG 62
L + + L ++ L + + VL + ++ ++
Sbjct: 205 LLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNA--- 261
Query: 63 FSGITC--------DSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLP 114
F ++C VT ++ + + SL S +++ + ++L + LP
Sbjct: 262 F-NLSCKILLTTRFKQVTDFLSAATTTHISLD-HHSMTLTPDEVKSLLLKYLDCRPQDLP 319
Query: 115 LELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRW----VVNLTQL 170
E+ + ++ +++ ++++ + W LT +
Sbjct: 320 REVLTTNPRRL------SIIA-----ESIRD----------GLATWDNWKHVNCDKLTTI 358
Query: 171 VSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRI-PESISELRELGTLDICRNKI 229
+ S+ NV + AE + + + L+ + P S I
Sbjct: 359 IESSL--NVLEPAE-------YRKM-FDRLS-------VFPPSA--------------HI 387
Query: 230 SGEFPRSIRKLQKLWKIELYANNLTGELP----AELGNLTLLQ----EFDISSNQMYGKL 281
P + L +W ++ +L +L++ E IS +Y +L
Sbjct: 388 ----PTIL--LSLIW------FDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLEL 435
Query: 282 PEEIGNLKNL--------TVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENL 333
++ N L + + F ++ + + D Y F ++
Sbjct: 436 KVKLENEYALHRSIVDHYNIPKTFDSD---DLIPPYLDQ--------Y-------FYSHI 477
Query: 334 GRYTALTDVDISENQFSGSFPKYLCE----KRKLLNLLALSNNFSGEVPNSYADCKTIQR 389
G + L +++ E F + ++K+ + + + N SG + N+ K +
Sbjct: 478 GHH--LKNIEHPER--MTLFRMVFLDFRFLEQKIRH-DSTAWNASGSILNTLQQLKFYKP 532
Query: 390 LRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQN 442
I DN + L + D + + T L ++ L
Sbjct: 533 -YICDND---PKYERL-------VNAILDFLPKIEENLICSKYTDLLRIALMA 574
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 59.5 bits (143), Expect = 5e-09
Identities = 93/557 (16%), Positives = 170/557 (30%), Gaps = 163/557 (29%)
Query: 38 QFKSKLKDPHGVLDSWKESADSPCG----FSGITCDSVTGRVTEISFDNKSLSGEISSSI 93
K++ + P + + E D F+ +V+ R+ L
Sbjct: 97 PIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAK---YNVS-RLQPY----LKL-------R 141
Query: 94 SALQSLTVLSLPFNVL-----SGKLPLELSNCSNLKVLNVTGNAM----VGSV--PD--L 140
AL L ++ SGK + L C + KV + + + P+ L
Sbjct: 142 QALLELR--PAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVL 199
Query: 141 SALKNLEIFDLSINYFTG---------RFPRWVVNLTQLV-------SLSIGDNVYDEAE 184
L+ L ++ + N+ + R L +L+ L + NV + A+
Sbjct: 200 EMLQKL-LYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQN-AK 257
Query: 185 IPESIGNLKNLTYLFLAHCN--LRGRIPESISELRELGTLDICRNKISGEF-PRSIRKLQ 241
+ F C L R + L T I + S P ++ L
Sbjct: 258 AWNA----------FNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLL 307
Query: 242 KLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKL----PEEIGNLKNL------ 291
+ + +LP E+ + +S + + N K++
Sbjct: 308 LKY-----LDCRPQDLPREVLTTNPRR---LS---IIAESIRDGLATWDNWKHVNCDKLT 356
Query: 292 TVFQCFKNNFSGEFPSGFGDMRKLF-AFSIYGNRFSGPFPEN-------LGRY---TALT 340
T+ + N P+ + RK+F S+ FP + L +
Sbjct: 357 TIIESSLNVLE---PA---EYRKMFDRLSV--------FPPSAHIPTILLSLIWFDVIKS 402
Query: 341 DVDISENQFSGSF-----PK---------YLCEKRKLLNLLALSNNF--SGEVPNSYADC 384
DV + N+ PK YL K KL N AL + +P ++ D
Sbjct: 403 DVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTF-DS 461
Query: 385 KTIQRLRISDN--------HLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLS 436
+ + D HL L + LDF F + ST+ +
Sbjct: 462 DDLIPPYL-DQYFYSHIGHHLKNIEHPERMTLFRMVFLDF---RFLE--QKIRHDSTAWN 515
Query: 437 QLVLQNNRFSGELPSELGRLTNLERLILTNNN-FSGKIPSALGALRQLSSLHLEENALTG 495
SG + + L +L + I N+ + + + L L + +EEN +
Sbjct: 516 A--------SGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPK-----IEENLI-- 560
Query: 496 SIPNEMGDCARIVDLNL 512
++ + L
Sbjct: 561 -----CSKYTDLLRIAL 572
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.8 bits (123), Expect = 1e-06
Identities = 108/646 (16%), Positives = 190/646 (29%), Gaps = 202/646 (31%)
Query: 137 VPDL--SALKNLEIFDL--SINYFTG-RFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGN 191
V D+ S L EI + S + +G W + LS + + + +
Sbjct: 38 VQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTL-------LSKQEEMVQKF-----VEE 85
Query: 192 LKNLTYLFLAH-CNLRGRIPESISELRELGTLDICRNKISGE---F-PRSIRKLQKLWKI 246
+ + Y FL R P ++ + R+++ + F ++ +LQ K+
Sbjct: 86 VLRINYKFLMSPIKTEQRQPSMMTRMYIE-----QRDRLYNDNQVFAKYNVSRLQPYLKL 140
Query: 247 ELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKN-LTVFQCFKNNFSGEF 305
L PA+ N+ + + + G G K + + C +
Sbjct: 141 RQALLELR---PAK--NVLI--------DGVLG-----SG--KTWVALDVCLSYKVQCKM 180
Query: 306 PSGFGDMRKLFAFSIY----GNRFS-GPFPENLGRYTALTDVDISENQFSGSFPKYLCE- 359
F I+ N S E L + D + + S K
Sbjct: 181 D-----------FKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHS 229
Query: 360 ----KRKLLN-------LLALSNNFSGEVPNSYA-DCKTIQRLRISDNHLSGKIPDGLWA 407
R+LL LL L N + + N++ CK + R
Sbjct: 230 IQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTR---------------- 273
Query: 408 LPNVGMLDFGDNDFTGGIS---PLIGLSTSLS-QLVLQ--NNRFSGELPSE--------- 452
+ DF T IS + L+ L+L+ + R +LP E
Sbjct: 274 --FKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQ-DLPREVLTTNPRRL 330
Query: 453 --LGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDL 510
+ + + T +N+ L + + S LE P E L
Sbjct: 331 SIIAES--IRDGLATWDNWKHVNCDKLTTIIESSLNVLE--------PAEYRKMFD--RL 378
Query: 511 NLARNSLSGNIPRS-LSLL------------------SSLNALNLSGNKLTGSIPDNLMK 551
++ S +IP LSL+ SL + + T SIP ++
Sbjct: 379 SVFPPSA--HIPTILLSLIWFDVIKSDVMVVVNKLHKYSL--VEKQPKESTISIPSIYLE 434
Query: 552 LKLSSIDLSE---------NQLSGSVPLDFLRMGGDGAFAGNEG---LCLDQSTKMLMNS 599
LK+ + N D + D F + G ++ +M +
Sbjct: 435 LKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFR 494
Query: 600 KLTACPAIQKQKGGFKD------KLVLFCIIAVALAAFLAGLL-LVSYKNF--------- 643
+ F D K+ A + L L L YK +
Sbjct: 495 MV------------FLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYE 542
Query: 644 KLSADMEN-----GEKEVSSKWKLASFHHIDIDAEQICNLEEDNLI 684
+L + + E + SK + D+ +I + ED I
Sbjct: 543 RLVNAILDFLPKIEENLICSK-------YTDL--LRIALMAEDEAI 579
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.5 bits (99), Expect = 7e-04
Identities = 44/319 (13%), Positives = 90/319 (28%), Gaps = 99/319 (31%)
Query: 666 HHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFA-AEMEI 724
HH+D + + + +++ V+ N V+ + K + + E++
Sbjct: 5 HHMDFETGEH-QYQYKDIL------SVFEDAFVDNFDCKDVQDMPKS----ILSKEEIDH 53
Query: 725 LGKIRHR--NILKLYACLLKGGSS----FLVLEYMPNGN-LFQALHKRVKEGKPELDWFR 777
+ + L+L+ LL F+ N L + ++ P + R
Sbjct: 54 IIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQ--PSMM-TR 110
Query: 778 RYKIALGAAKGIAY---LHHDCSPPIIHRDI-------KSSNILLDEDYEPKIADFGVA- 826
Y I L++D + ++ K LL+ + GV
Sbjct: 111 MY---------IEQRDRLYND-NQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLG 160
Query: 827 --KIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGV--------------- 869
K + A C + F +
Sbjct: 161 SGK-----------TWVA----------LDVCLSYKVQCKMDFKIFWLNLKNCNSPETVL 199
Query: 870 -VLLELVTGRKPVEEEYGDG----KDIVYWVSTHLNN------HENVLKVLDCEVASESI 918
+L +L+ P D K ++ + L +EN L VL V +
Sbjct: 200 EMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLL-NVQNAKA 258
Query: 919 KEDMIKLLKIA--VVCTTK 935
++ ++ TT+
Sbjct: 259 ----WNAFNLSCKILLTTR 273
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 70.9 bits (173), Expect = 1e-12
Identities = 44/228 (19%), Positives = 72/228 (31%), Gaps = 13/228 (5%)
Query: 329 FPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQ 388
+ + L ++S + + E L L + + +
Sbjct: 341 WCRDSATDEQLFRCELSVEKST----VLQSELESCKELQELEPENKWCLLTIILLMRALD 396
Query: 389 RLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGE 448
L L LD + F S L + L L + +
Sbjct: 397 PLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-- 454
Query: 449 LPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIV 508
+ L +L + L L++N +P AL ALR L L +NAL ++ + + R+
Sbjct: 455 VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQ 511
Query: 509 DLNLARNSLSGNIP--RSLSLLSSLNALNLSGNKLTGSIPDNLMKLKL 554
+L L N L + L L LNL GN L +L
Sbjct: 512 ELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAE 557
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 70.6 bits (172), Expect = 1e-12
Identities = 42/276 (15%), Positives = 78/276 (28%), Gaps = 30/276 (10%)
Query: 222 LDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKL 281
+++ R I K + + + L ++S + L
Sbjct: 306 AASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST-VL 364
Query: 282 PEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTD 341
E+ + K L E + E L ++ L
Sbjct: 365 QSELESCKELQ-----------ELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKA 413
Query: 342 VDISENQFSGSFPKYLCEKRKLLN-------LLALSNNFSGEVPNSYADCKTIQRLRISD 394
VD + + +L +L L++ + + + L +S
Sbjct: 414 VDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVLCH-LEQLLLVTHLDLSH 472
Query: 395 NHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSG-ELPSEL 453
N L +P L AL + +L DN + + L L +L+L NNR L
Sbjct: 473 NRLR-ALPPALAALRCLEVLQASDNALEN-VDGVANL-PRLQELLLCNNRLQQSAAIQPL 529
Query: 454 GRLTNLERLILTNN------NFSGKIPSALGALRQL 483
L L L N ++ L ++ +
Sbjct: 530 VSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 565
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 68.2 bits (166), Expect = 6e-12
Identities = 39/206 (18%), Positives = 72/206 (34%), Gaps = 14/206 (6%)
Query: 364 LNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTG 423
L LS S + + CK +Q L + I + + + L +
Sbjct: 351 LFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTI---ILLMRALDPLLYEKETLQY 407
Query: 424 GISPLIGL-STSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQ 482
S L + + L ++F E ++ L L + + + + L L
Sbjct: 408 -FSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCH-LEQLLL 464
Query: 483 LSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLT 542
++ L L N L ++P + + L + N+L N+ ++ L L L L N+L
Sbjct: 465 VTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQ 521
Query: 543 GSIPD--NLMKLK-LSSIDLSENQLS 565
L+ L ++L N L
Sbjct: 522 -QSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 65.5 bits (159), Expect = 4e-11
Identities = 40/306 (13%), Positives = 82/306 (26%), Gaps = 55/306 (17%)
Query: 83 KSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSA 142
++ G S L L SL + + + + K + + D +
Sbjct: 288 RTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSAT 347
Query: 143 LKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEI------------PESIG 190
+ L +LS+ T + + +L L + I E++
Sbjct: 348 DEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQ 406
Query: 191 NLKNLTYL--------FLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQK 242
L + E ++ L + ++ + +L
Sbjct: 407 YFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTV--LCHLEQLLL 464
Query: 243 LWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFS 302
+ ++L N L LP L L L+ S N + + + + NL L
Sbjct: 465 VTHLDLSHNRLR-ALPPALAALRCLEVLQASDNAL--ENVDGVANLPRLQE--------- 512
Query: 303 GEFPSGFGDMRKLFAFSIYGNRFSG-PFPENLGRYTALTDVDISENQFSGSFPKYLCEKR 361
+ NR + L L +++ N +
Sbjct: 513 ---------------LLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGI---QE 553
Query: 362 KLLNLL 367
+L +L
Sbjct: 554 RLAEML 559
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 60.2 bits (145), Expect = 2e-09
Identities = 29/159 (18%), Positives = 55/159 (34%), Gaps = 14/159 (8%)
Query: 425 ISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLS 484
+ P L+++ L + L+ + + + S +
Sbjct: 377 LEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVL 436
Query: 485 --------SLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNL 536
LHL LT + + + + L+L+ N L +P +L+ L L L
Sbjct: 437 KMEYADVRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQA 493
Query: 537 SGNKLTGSIPDNLMKL-KLSSIDLSENQLSGSVPLDFLR 574
S N L ++ + L +L + L N+L S + L
Sbjct: 494 SDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLV 530
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 53.6 bits (128), Expect = 2e-07
Identities = 30/140 (21%), Positives = 54/140 (38%), Gaps = 10/140 (7%)
Query: 88 EISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLE 147
E S + VL L L+ L L + L+++ N + P L+AL+ LE
Sbjct: 432 ENSVLKMEYADVRVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLRALPPALAALRCLE 489
Query: 148 IFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAH----- 202
+ S N V NL +L L + +N ++ + + + L L L
Sbjct: 490 VLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 547
Query: 203 -CNLRGRIPESISELRELGT 221
++ R+ E + + + T
Sbjct: 548 EEGIQERLAEMLPSVSSILT 567
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 44.7 bits (105), Expect = 1e-04
Identities = 33/188 (17%), Positives = 55/188 (29%), Gaps = 5/188 (2%)
Query: 378 PNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQ 437
++ L +W + D L +
Sbjct: 294 NRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFR 353
Query: 438 LVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSI 497
L + S L SEL L+ L N I + +R L L E+ L
Sbjct: 354 CELSVEK-STVLQSELESCKELQELEPENKWCLLTI---ILLMRALDPLLYEKETLQYFS 409
Query: 498 PNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSI 557
+ D R L+ R+ + + L+L+ LT + L ++ +
Sbjct: 410 TLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCHLEQLLLVTHL 468
Query: 558 DLSENQLS 565
DLS N+L
Sbjct: 469 DLSHNRLR 476
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 43/178 (24%), Positives = 72/178 (40%), Gaps = 23/178 (12%)
Query: 401 IPDGLWALPNVGMLDFGDNDFTGGISP---LIGLSTSLSQLVLQNNRFSGELPSE-LGRL 456
+P L +LD N+ + + L T+L L+L +N + + SE +
Sbjct: 33 VPQSL--PSYTALLDLSHNNLSR-LRAEWTPTRL-TNLHSLLLSHNHLN-FISSEAFVPV 87
Query: 457 TNLERLILTNNNFSGKIPS-ALGALRQLSSLHLEENALTGSIPNEM-GDCARIVDLNLAR 514
NL L L++N+ + L+ L L L N + + D A++ L L++
Sbjct: 88 PNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQ 145
Query: 515 NSLSGNIP----RSLSLLSSLNALNLSGNKLTGSIP----DNLMKLKLSSIDLSENQL 564
N +S P + + L L L+LS NKL +P L + + L N L
Sbjct: 146 NQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK-KLPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 37/165 (22%), Positives = 61/165 (36%), Gaps = 45/165 (27%)
Query: 430 GLSTSLSQLVLQNNRFSGELPSE--LGRLTNLERLILTNNNFSGKIPS-ALGALRQLSSL 486
L + + L L +N S L +E RLTNL L+L++N+ + I S A + L L
Sbjct: 36 SLPSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYL 93
Query: 487 HLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIP 546
L N L ++ + S L +L L L N + +
Sbjct: 94 DLSSNHLH-TLDEFL-----------------------FSDLQALEVLLLYNNHIV-VVD 128
Query: 547 ----DNLMKLKLSSIDLSENQLSGSVPLDFLRMGGDGAFAGNEGL 587
+++ +L+ + LS+NQ+S P L
Sbjct: 129 RNAFEDMAQLQ--KLYLSQNQIS-RFP--------VELIKDGNKL 162
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 29/138 (21%), Positives = 50/138 (36%), Gaps = 11/138 (7%)
Query: 191 NLKNLTYLFLAHCNLRGRIPESI-SELRELGTLDICRNKISGEFPRSI-RKLQKLWKIEL 248
L NL L L+H +L I + L LD+ N + + LQ L + L
Sbjct: 62 RLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLL 119
Query: 249 YANNLTGELPAE-LGNLTLLQEFDISSNQMYGKLPEEI----GNLKNLTVFQCFKNNFSG 303
Y N++ + ++ LQ+ +S NQ+ + P E+ L L + N
Sbjct: 120 YNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKK 177
Query: 304 EFPSGFGDMRKLFAFSIY 321
+ + +Y
Sbjct: 178 LPLTDLQKLPAWVKNGLY 195
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 39/175 (22%), Positives = 68/175 (38%), Gaps = 16/175 (9%)
Query: 330 PENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVP-NSYADCKTIQ 388
P++L YT +D+S N S ++ + L+ L LS+N + ++ ++
Sbjct: 34 PQSLPSYT--ALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLR 91
Query: 389 RLRISDNHLSGKIPDG-LWALPNVGMLDFGDNDFTGGISP--LIGLSTSLSQLVLQNNRF 445
L +S NHL + + L + +L +N + + L +L L N+
Sbjct: 92 YLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVV-VDRNAFEDM-AQLQKLYLSQNQI 148
Query: 446 SGELPSE----LGRLTNLERLILTNNNFSGKIPSALGALRQLS--SLHLEENALT 494
S P E +L L L L++N + L L L+L N L
Sbjct: 149 S-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 41/192 (21%), Positives = 75/192 (39%), Gaps = 14/192 (7%)
Query: 364 LNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTG 423
L ++ + + +Q ++++ + G+ N+ L N +
Sbjct: 21 AVKQNLGKQSVTDLVS-QKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHLSHNQISD 77
Query: 424 GISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQL 483
+SPL L T L +L + NR L RL L NN +L L+ L
Sbjct: 78 -LSPLKDL-TKLEELSVNRNRLKNLNGIPS---ACLSRLFLDNNELRD--TDSLIHLKNL 130
Query: 484 SSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTG 543
L + N L SI +G +++ L+L N ++ N L+ L +N ++L+G K
Sbjct: 131 EILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEIT-NTG-GLTRLKKVNWIDLTGQKCVN 186
Query: 544 SIPDNLMKLKLS 555
+L ++
Sbjct: 187 EPVKYQPELYIT 198
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 44/167 (26%), Positives = 68/167 (40%), Gaps = 14/167 (8%)
Query: 408 LPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNN 467
L N + G T + L + + N+ + + TNL+ L L++N
Sbjct: 18 LANAVKQNLGKQSVTD-LVSQKEL-SGVQNFNGDNSNIQS--LAGMQFFTNLKELHLSHN 73
Query: 468 NFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSL 527
S + S L L +L L + N L ++ A + L L N L SL
Sbjct: 74 QIS-DL-SPLKDLTKLEELSVNRNRLK-NLNG--IPSACLSRLFLDNNELRD--TDSLIH 126
Query: 528 LSSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLSENQLSGSVPLDFL 573
L +L L++ NKL SI L L KL +DL N+++ + L L
Sbjct: 127 LKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNEITNTGGLTRL 171
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 37/232 (15%), Positives = 73/232 (31%), Gaps = 39/232 (16%)
Query: 117 LSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIG 176
+N N+ + V + L ++ F+ + N+ L
Sbjct: 15 DPGLANAVKQNLGKQS-VTDLVSQKELSGVQNFNGDNS-----------NIQSL------ 56
Query: 177 DNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRS 236
+ NL L L+H + + + +L +L L + RN++
Sbjct: 57 ----------AGMQFFTNLKELHLSHNQIS-DL-SPLKDLTKLEELSVNRNRLKNLNGIP 104
Query: 237 IRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQC 296
L +L+ L N L L +L L+ I +N++ K +G L L V
Sbjct: 105 SACLSRLF---LDNNELRD--TDSLIHLKNLEILSIRNNKL--KSIVMLGFLSKLEVLDL 157
Query: 297 FKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQ 348
N + G ++K+ + G + + V + +
Sbjct: 158 HGNEITN--TGGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGR 207
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 34/152 (22%), Positives = 63/152 (41%), Gaps = 17/152 (11%)
Query: 425 ISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLS 484
+ P GL + + L + L+ ++ N+N + + + L
Sbjct: 12 VFPDPGL-ANAVKQNLGKQSVTDL--VSQKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLK 66
Query: 485 SLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLN--ALNLSGNKLT 542
LHL N ++ + + D ++ +L++ RN L +L+ + S L L N+L
Sbjct: 67 ELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLK-----NLNGIPSACLSRLFLDNNELR 119
Query: 543 GSIPDNLMKLK-LSSIDLSENQLSGSVPLDFL 573
D+L+ LK L + + N+L V L FL
Sbjct: 120 D--TDSLIHLKNLEILSIRNNKLKSIVMLGFL 149
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 5e-09
Identities = 23/137 (16%), Positives = 60/137 (43%), Gaps = 10/137 (7%)
Query: 437 QLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGS 496
+ + + + ++ L N + L + + + + L + + + + + + S
Sbjct: 1 ESIQRPTPIN-QV-FPDPGLANAVKQNLGKQSVT-DL-VSQKELSGVQNFNGDNSNIQ-S 55
Query: 497 IPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSS 556
+ M + +L+L+ N +S ++ L L+ L L+++ N+L ++ + + LS
Sbjct: 56 LAG-MQFFTNLKELHLSHNQIS-DLS-PLKDLTKLEELSVNRNRLK-NL-NGIPSACLSR 110
Query: 557 IDLSENQLSGSVPLDFL 573
+ L N+L + L L
Sbjct: 111 LFLDNNELRDTDSLIHL 127
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 35/189 (18%), Positives = 60/189 (31%), Gaps = 39/189 (20%)
Query: 91 SSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFD 150
S + L L LS+ N L L + L L + N + L LKNLEI
Sbjct: 79 SPLKDLTKLEELSVNRNRLKN---LNGIPSACLSRLFLDNN-ELRDTDSLIHLKNLEILS 134
Query: 151 LSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIP 210
+ N +L S+ +G L L L L +
Sbjct: 135 IRNN--------------KLKSIV-------------MLGFLSKLEVLDLHGNEITN--T 165
Query: 211 ESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGEL--PAELGNLTLLQ 268
++ L+++ +D+ K E ++ +L+ I + G P + N
Sbjct: 166 GGLTRLKKVNWIDLTGQKCVNE---PVKYQPELY-ITNTVKDPDGRWISPYYISNGGSYV 221
Query: 269 EFDISSNQM 277
+ +
Sbjct: 222 DGCVLWELP 230
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 31/188 (16%), Positives = 66/188 (35%), Gaps = 20/188 (10%)
Query: 187 ESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKI 246
L N L ++ S EL + + + I ++ L ++
Sbjct: 13 FPDPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQSLAG--MQFFTNLKEL 68
Query: 247 ELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLK--NLTVFQCFKNNFSGE 304
L N ++ +L L +LT L+E ++ N++ + + + L+ N
Sbjct: 69 HLSHNQIS-DLSP-LKDLTKLEELSVNRNRL-----KNLNGIPSACLSRLFLDNNELRD- 120
Query: 305 FPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLL 364
++ L SI N+ LG + L +D+ N+ + + + K +
Sbjct: 121 -TDSLIHLKNLEILSIRNNKLKS--IVMLGFLSKLEVLDLHGNEITNTGG---LTRLKKV 174
Query: 365 NLLALSNN 372
N + L+
Sbjct: 175 NWIDLTGQ 182
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 44/268 (16%), Positives = 79/268 (29%), Gaps = 65/268 (24%)
Query: 227 NKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIG 286
I+ FP L K L ++T + L+ +Q F+ ++ + + +
Sbjct: 7 TPINQVFP--DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNI--QSLAGMQ 60
Query: 287 NLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISE 346
NL N S + L T L ++ ++
Sbjct: 61 FFTNLKELHLSHNQIS----------------DL----------SPLKDLTKLEELSVNR 94
Query: 347 NQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLW 406
N +L NL + + + RL + +N L D L
Sbjct: 95 N--------------RLKNLNGIPS-------------ACLSRLFLDNNELRD--TDSLI 125
Query: 407 ALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTN 466
L N+ +L +N I L L + L L L N + L RL + + LT
Sbjct: 126 HLKNLEILSIRNNKLKS-IVMLGFL-SKLEVLDLHGNEITN--TGGLTRLKKVNWIDLTG 181
Query: 467 NNFSGKIPSALGALRQLSSLHLEENALT 494
+ L +++ +
Sbjct: 182 QKCVNEPVKYQPELYITNTVKDPDGRWI 209
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 56/291 (19%), Positives = 100/291 (34%), Gaps = 19/291 (6%)
Query: 121 SNLKVLNVTGNAMVGSVP--DLSALKNLEIFDLSINYFTGRFPRWV-VNLTQLVSLSIGD 177
N L + + S +LE ++S N V NL +L + I +
Sbjct: 30 RNAIELRFVLT-KLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI-E 87
Query: 178 NVYDEAEIPESI-GNLKNLTYLFLAHCNLRGRIPESI-SELRELGTLDICRN-KISGEFP 234
+ I NL NL YL +++ ++ +P+ + LDI N I
Sbjct: 88 KANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIER 146
Query: 235 RSIRKLQKLWK-IELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEI-GNLKNLT 292
S L + L N + E+ N T L E ++S N +LP ++
Sbjct: 147 NSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPV 205
Query: 293 VFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGS 352
+ + G +++KL A S Y + E L AL + ++ +
Sbjct: 206 ILDISRTRIHSLPSYGLENLKKLRARSTYNLKKLPTL-EKL---VALMEASLTYPSHCCA 261
Query: 353 FPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPD 403
F + R++ L + N Y QR +++++ S
Sbjct: 262 FANWR---RQISELHPICNKSILRQEVDYMTQARGQRSSLAEDNESSYSRG 309
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 3e-10
Identities = 24/161 (14%), Positives = 57/161 (35%), Gaps = 18/161 (11%)
Query: 430 GLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPS-ALGALRQLSSLHL 488
L + +L + +LE++ ++ N+ I + L +L + +
Sbjct: 27 DLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI 86
Query: 489 EE-NALTGSIPNEM-GDCARIVDLNLARNSLSGNIPRSLSL-LSSLNALNLSGNKLTGSI 545
E+ N L I E + + L ++ + ++P + L++ N +I
Sbjct: 87 EKANNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTI 144
Query: 546 PDNL---MKLKLSSIDLSENQLSGSVPLDFLRMGGDGAFAG 583
N + + + L++N + + + AF G
Sbjct: 145 ERNSFVGLSFESVILWLNKNGIQ-EIH--------NSAFNG 176
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 48/289 (16%), Positives = 77/289 (26%), Gaps = 60/289 (20%)
Query: 184 EIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSI-RKLQK 242
EIP + +N L LR + S +L ++I +N + + L K
Sbjct: 23 EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80
Query: 243 LWKIELYANNLTGELPAE-LGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNF 301
L +I + N + E NL LQ IS+ +
Sbjct: 81 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTG--------------IKHLP------ 120
Query: 302 SGEFPSGFGDMRKLFAFSIYGNRFSGPFPENL--GRYTALTDVDISENQFSGSFPKYLCE 359
+ I N N G + +++N
Sbjct: 121 ----DVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFN 175
Query: 360 KRKLLNLLALSNNFSGEVP-NSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGD 418
+L L NN E+P + + L IS + +P
Sbjct: 176 GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLE----------- 223
Query: 419 NDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNN 467
L L N + +LP+ L +L L LT
Sbjct: 224 -----------NL-KKLRARSTYNLK---KLPT-LEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 51/320 (15%), Positives = 95/320 (29%), Gaps = 56/320 (17%)
Query: 290 NLTVFQCFKNNFSGEFPSG-FGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQ 348
+ VF C ++ + E PS + +L + + L ++IS+N
Sbjct: 10 SNRVFLCQESKVT-EIPSDLPRNAIEL---RFVLTKLRVIQKGAFSGFGDLEKIEISQND 65
Query: 349 F-----SGSFPKYLCEKRKLLNLLAL----SNNFSGEVPNSYADCKTIQRLRISDNHLSG 399
+ F L L + +NN P ++ + +Q L IS+ +
Sbjct: 66 VLEVIEADVF-------SNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK- 117
Query: 400 KIPDGLWA-LPNVGMLDFGDNDFTGGISP--LIGLSTSLSQLVLQNNR--------FSG- 447
+PD +LD DN I +GLS L L N F+G
Sbjct: 118 HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGT 177
Query: 448 --------------ELPSE-LGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENA 492
ELP++ + L ++ L L++L +
Sbjct: 178 QLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 237
Query: 493 LTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL 552
++ +++ +L S + + ++ L+ NK + M
Sbjct: 238 KLPTLEK----LVALMEASLTYPS---HCCAFANWRRQISELHPICNKSILRQEVDYMTQ 290
Query: 553 KLSSIDLSENQLSGSVPLDF 572
S F
Sbjct: 291 ARGQRSSLAEDNESSYSRGF 310
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 34/184 (18%), Positives = 55/184 (29%), Gaps = 34/184 (18%)
Query: 96 LQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD--LSAL-KNLEIFDLS 152
L +L L + + + + +L++ N + ++ L I L+
Sbjct: 103 LPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLN 162
Query: 153 INYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPES 212
N EI S N L L L+ N +P
Sbjct: 163 KNGIQ--------------------------EIHNSAFNGTQLDELNLSDNNNLEELPND 196
Query: 213 I-SELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFD 271
+ LDI R +I + L+KL NL +LP L L L E
Sbjct: 197 VFHGASGPVILDISRTRIHSLPSYGLENLKKLR--ARSTYNLK-KLPT-LEKLVALMEAS 252
Query: 272 ISSN 275
++
Sbjct: 253 LTYP 256
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 3e-11
Identities = 32/142 (22%), Positives = 61/142 (42%), Gaps = 12/142 (8%)
Query: 430 GLSTSLSQLVLQNNRFSGELPSE--LGRLTNLERLILTNNNFSGKIPSALGALRQLSSLH 487
+ ++L L NN F+ L + +L L ++ +NN + A ++ +
Sbjct: 29 HIPQYTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEIL 87
Query: 488 LEENALTGSIPNEMGD-CARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIP 546
L N L ++ ++M + L L N ++ S LSS+ L+L N++T ++
Sbjct: 88 LTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVA 145
Query: 547 ----DNLMKLKLSSIDLSENQL 564
D L LS+++L N
Sbjct: 146 PGAFDTLH--SLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 7e-07
Identities = 20/133 (15%), Positives = 48/133 (36%), Gaps = 8/133 (6%)
Query: 173 LSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESI-SELRELGTLDICRNKISG 231
L + +N + E L L + ++ + I E + + + N++
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLE- 94
Query: 232 EFPRSI-RKLQKLWKIELYANNLTGELPAEL-GNLTLLQEFDISSNQMYGKLPEEI-GNL 288
+ + L+ L + L +N +T + + L+ ++ + NQ+ + L
Sbjct: 95 NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQI-TTVAPGAFDTL 152
Query: 289 KNLTVFQCFKNNF 301
+L+ N F
Sbjct: 153 HSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 34/166 (20%), Positives = 70/166 (42%), Gaps = 29/166 (17%)
Query: 330 PENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVP-NSYADCKTIQ 388
PE++ +YT ++ ++ N+F+ + +K L + SNN ++ ++ +
Sbjct: 27 PEHIPQYT--AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVN 84
Query: 389 RLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGE 448
+ ++ N L + + M GL SL L+L++NR +
Sbjct: 85 EILLTSNRLE--------NVQH-KMFK--------------GL-ESLKTLMLRSNRIT-C 119
Query: 449 LPSEL-GRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENAL 493
+ ++ L+++ L L +N + P A L LS+L+L N
Sbjct: 120 VGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPF 165
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 7e-11
Identities = 52/163 (31%), Positives = 69/163 (42%), Gaps = 26/163 (15%)
Query: 427 PLIGLSTSLSQLVLQNNRFSGELPSELG---RLTNLERLILTNNNFSGKIPSALGALRQL 483
I ++ L L N+ ++ LTNL LILT N L L
Sbjct: 57 QGIQYLPNVRYLALGGNKLH-----DISALKELTNLTYLILTGNQLQSLPNGVFDKLTNL 111
Query: 484 SSLHLEENALTGSIPNEMGDC-ARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLT 542
L L EN L S+P+ + D + LNLA N L L++L L+LS N+L
Sbjct: 112 KELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ 170
Query: 543 GSIP----DNLMKLKLSSIDLSENQLSGSVPLDFLRMGGDGAF 581
S+P D L +LK + L +NQL SVP DG F
Sbjct: 171 -SLPEGVFDKLTQLK--DLRLYQNQLK-SVP--------DGVF 201
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 55/211 (26%), Positives = 91/211 (43%), Gaps = 33/211 (15%)
Query: 683 LIGSGGTGKVYR-LDLKKNAGTVAVKQLWKGDGVKVFAA----EMEILGKIRHR------ 731
+IG G G+V + D K + VA+K + K F E+ IL +R +
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQ-HVALKMVRN---EKRFHRQAAEEIRILEHLRKQDKDNTM 159
Query: 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAY 791
N++ + + E + + NL++ + K +G L R++ ++ + +
Sbjct: 160 NVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFS-LPLVRKFAHSI--LQCLDA 215
Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEP--KIADFGVAKIAENSPKVSDY--SCFAGTHGY 847
LH IIH D+K NILL + K+ DFG + +V Y S F Y
Sbjct: 216 LH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ--RVYTYIQSRF-----Y 265
Query: 848 IAPELAYTCKVSEKSDVFSFGVVLLELVTGR 878
APE+ + D++S G +L EL+TG
Sbjct: 266 RAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 36/139 (25%), Positives = 63/139 (45%), Gaps = 11/139 (7%)
Query: 430 GLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLE 489
L +++++ L+ N P L R+ L+NN S P A LR L+SL L
Sbjct: 29 NLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLY 88
Query: 490 ENALTGSIPNEMGDC-ARIVDLNLARNSLSGNIPR-SLSLLSSLNALNLSGNKLTGSIP- 546
N +T +P + + + L L N ++ + + L +LN L+L NKL +I
Sbjct: 89 GNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ-TIAK 145
Query: 547 ---DNLMKLKLSSIDLSEN 562
L ++ ++ L++N
Sbjct: 146 GTFSPLRAIQ--TMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 37/137 (27%), Positives = 57/137 (41%), Gaps = 14/137 (10%)
Query: 386 TIQRLRISDNHLSGKIPDG-LWALPNVGMLDFGDNDFT----GGISPLIGLSTSLSQLVL 440
TI +R+ N + IP G + +D +N + L SL+ LVL
Sbjct: 33 TITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGL----RSLNSLVL 87
Query: 441 QNNRFSGELPSEL-GRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPN 499
N+ + ELP L L +L+ L+L N + A L L+ L L +N L +I
Sbjct: 88 YGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAK 145
Query: 500 EMGD-CARIVDLNLARN 515
I ++LA+N
Sbjct: 146 GTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 4e-07
Identities = 32/143 (22%), Positives = 52/143 (36%), Gaps = 10/143 (6%)
Query: 401 IPDGLWALPNVGMLDFGDNDFTGGISP--LIGLSTSLSQLVLQNNRFSGELPSEL-GRLT 457
IP L + + N I P L ++ L NN+ S EL + L
Sbjct: 26 IPTNL--PETITEIRLEQNTIKV-IPPGAFSPY-KKLRRIDLSNNQIS-ELAPDAFQGLR 80
Query: 458 NLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDC-ARIVDLNLARNS 516
+L L+L N + S L L L L N + + + + L+L N
Sbjct: 81 SLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNK 139
Query: 517 LSGNIPRSLSLLSSLNALNLSGN 539
L + S L ++ ++L+ N
Sbjct: 140 LQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 8e-06
Identities = 30/126 (23%), Positives = 54/126 (42%), Gaps = 8/126 (6%)
Query: 370 SNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGL-WALPNVGMLDFGDNDFTGGISPL 428
N P +++ K ++R+ +S+N +S ++ L ++ L N T +
Sbjct: 41 QNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITE-LPKS 98
Query: 429 I--GLSTSLSQLVLQNNRFSGELPSEL-GRLTNLERLILTNNNFSGKIPSALGALRQLSS 485
+ GL SL L+L N+ + L + L NL L L +N LR + +
Sbjct: 99 LFEGL-FSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQT 156
Query: 486 LHLEEN 491
+HL +N
Sbjct: 157 MHLAQN 162
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 62.1 bits (150), Expect = 3e-10
Identities = 25/130 (19%), Positives = 40/130 (30%), Gaps = 25/130 (19%)
Query: 436 SQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPS-ALGALRQLSSLHLEENALT 494
S + + + L NL L + N + L L +L +L + ++ L
Sbjct: 10 SSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR 69
Query: 495 GSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKL 554
+ P + L+ LNLS N L + L L
Sbjct: 70 -FVA-----------------------PDAFHFTPRLSRLNLSFNALESLSWKTVQGLSL 105
Query: 555 SSIDLSENQL 564
+ LS N L
Sbjct: 106 QELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 52.0 bits (124), Expect = 5e-07
Identities = 22/86 (25%), Positives = 37/86 (43%), Gaps = 2/86 (2%)
Query: 433 TSLSQLVLQNNRFSGELPSE-LGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEEN 491
+L++L ++N + L L L L L + + P A +LS L+L N
Sbjct: 31 ENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90
Query: 492 ALTGSIPNEMGDCARIVDLNLARNSL 517
AL S+ + + +L L+ N L
Sbjct: 91 ALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 4e-10
Identities = 55/359 (15%), Positives = 111/359 (30%), Gaps = 84/359 (23%)
Query: 243 LWKIELYANNLTGE----LPAELGNLTLLQEFDISSNQMYGK-----LPEEIGNLKNLTV 293
+ L + +T E + A L ++E +S N + G L E I + K+L +
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTI-GTEAARWLSENIASKKDLEI 64
Query: 294 FQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSF 353
+ F + F+G + +L ++ L V +S+N F +
Sbjct: 65 AE-FSDIFTGRVKDEIPEALRLLLQALLKC-------------PKLHTVRLSDNAFGPTA 110
Query: 354 PKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGM 413
+ L + LS + ++ L + +N L
Sbjct: 111 QEPLID--------FLSKH------------TPLEHLYLHNNGLG-----------PQAG 139
Query: 414 LDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGE----LPSELGRLTNLERLILTNNNF 469
++ + L ++ NR L + + N
Sbjct: 140 AKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGI 199
Query: 470 SGK-----IPSALGALRQLSSLHLEENALTG----SIPNEMGDCARIVDLNLARNSLSGN 520
+ + L ++L L L++N T ++ + + +L L LS
Sbjct: 200 RPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSAR 259
Query: 521 ----IPRSLSLLS--SLNALNLSGNKLTG--------SIPDNLMKLKLSSIDLSENQLS 565
+ + S L L L L N++ I + + L ++L+ N+ S
Sbjct: 260 GAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLL--FLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 21/145 (14%), Positives = 53/145 (36%), Gaps = 27/145 (18%)
Query: 434 SLSQLVLQNNRFSGE----LPSELGRLTNLERLILTNNNFSGK----IPSALGALRQLSS 485
S+ L+ + + E + + L +++ ++L+ N + + + + + L
Sbjct: 5 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64
Query: 486 LHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSI 545
+ TG + +E+ + R+ + ++L L+ + LS N +
Sbjct: 65 AEFSDI-FTGRVKDEIPEALRL-------------LLQALLKCPKLHTVRLSDNAFGPTA 110
Query: 546 PDNLMKL-----KLSSIDLSENQLS 565
+ L+ L + L N L
Sbjct: 111 QEPLIDFLSKHTPLEHLYLHNNGLG 135
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 3e-05
Identities = 40/254 (15%), Positives = 81/254 (31%), Gaps = 52/254 (20%)
Query: 75 VTEISFDNKSLSGE----ISSSISALQSLTVLSLPFNVLSGKLPLE----------LSNC 120
V EI ++ E +S +I++ + L + L C
Sbjct: 34 VKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKC 93
Query: 121 SNLKVLNVTGNA-----MVGSVPDLSALKNLEIFDLSINYFT-------------GRFPR 162
L + ++ NA + LS LE L N +
Sbjct: 94 PKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNK 153
Query: 163 WVVNLTQLVSLSIGDNVYDEA---EIPESIGNLKNLTYLFLAHCNLRGR-----IPESIS 214
N L S+ G N + E ++ + + L + + +R + E ++
Sbjct: 154 KAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLA 213
Query: 215 ELRELGTLDICRNKISGE----FPRSIRKLQKLWKIELYANNLT-------GELPAELGN 263
+EL LD+ N + +++ L ++ L L+ + ++L N
Sbjct: 214 YCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLEN 273
Query: 264 LTLLQEFDISSNQM 277
+ LQ + N++
Sbjct: 274 IG-LQTLRLQYNEI 286
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 4e-10
Identities = 54/211 (25%), Positives = 80/211 (37%), Gaps = 50/211 (23%)
Query: 386 TIQRLRISDNHLSGKIPDGLWA-LPNVGMLDFGDNDFTGGISPLI--GLSTSLSQLVLQN 442
++L + N LS +P + L + +L DN + I L +L L + +
Sbjct: 38 DTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKEL-KNLETLWVTD 94
Query: 443 NRFSGELPSEL-GRLTNLERLILTNNNFSGKIPS-ALGALRQLSSLHLEENALTGSIPNE 500
N+ LP + +L NL L L N +P +L +L+ L L N L S+P
Sbjct: 95 NKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLP-- 149
Query: 501 MGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIP----DNLMKLKLSS 556
L+SL L L N+L +P D L +LK +
Sbjct: 150 ---------------------KGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELK--T 185
Query: 557 IDLSENQLSGSVPLDFLRMGGDGAFAGNEGL 587
+ L NQL VP +GAF E L
Sbjct: 186 LKLDNNQLK-RVP--------EGAFDSLEKL 207
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 46/177 (25%), Positives = 68/177 (38%), Gaps = 14/177 (7%)
Query: 370 SNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWA-LPNVGMLDFGDNDFTGGISPL 428
SN S ++ ++ L ++DN L +P G++ L N+ L DN +
Sbjct: 46 SNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQA-LPIG 103
Query: 429 I--GLSTSLSQLVLQNNRFSGELPSEL-GRLTNLERLILTNNNFSGKIPS-ALGALRQLS 484
+ L +L++L L N+ LP + LT L L L N +P L L
Sbjct: 104 VFDQL-VNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLK 160
Query: 485 SLHLEENALTGSIPNEMGDC-ARIVDLNLARNSLSGNIPR-SLSLLSSLNALNLSGN 539
L L N L +P D + L L N L +P + L L L L N
Sbjct: 161 ELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 49/202 (24%), Positives = 81/202 (40%), Gaps = 19/202 (9%)
Query: 82 NKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD-- 139
+K L+ I S+I A L L N LS + L++L + N + ++P
Sbjct: 25 SKKLT-AIPSNIPA--DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGI 80
Query: 140 LSALKNLEIFDLSINYFT----GRFPRWVVNLTQLVSLSIGDNVYDEAEIPESI-GNLKN 194
LKNLE ++ N G F L L L + N +P + +L
Sbjct: 81 FKELKNLETLWVTDNKLQALPIGVF----DQLVNLAELRLDRN--QLKSLPPRVFDSLTK 134
Query: 195 LTYLFLAHCNLRGRIPESI-SELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNL 253
LTYL L + L+ +P+ + +L L L + N++ + KL +L ++L N L
Sbjct: 135 LTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQL 193
Query: 254 TGELPAELGNLTLLQEFDISSN 275
+L L+ + N
Sbjct: 194 KRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 6e-07
Identities = 44/176 (25%), Positives = 77/176 (43%), Gaps = 10/176 (5%)
Query: 321 YGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVP-N 379
N+ S + R T L + +++N+ + P + ++ K L L +++N +P
Sbjct: 45 QSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPIG 103
Query: 380 SYADCKTIQRLRISDNHLSGKIPDGLWA-LPNVGMLDFGDNDFTGGISPLI--GLSTSLS 436
+ + LR+ N L +P ++ L + L G N+ + + L TSL
Sbjct: 104 VFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQS-LPKGVFDKL-TSLK 160
Query: 437 QLVLQNNRFSGELPSEL-GRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEEN 491
+L L NN+ +P +LT L+ L L NN A +L +L L L+EN
Sbjct: 161 ELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 6e-10
Identities = 52/212 (24%), Positives = 84/212 (39%), Gaps = 31/212 (14%)
Query: 682 NLIGSGGTGKVYR-LDLKKNAGTVAVKQLWKGDGVKVFAA---EMEILGKIRHR------ 731
+LIG G G+V + D + VA+K + E+ +L +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQE-WVAIKIIKNKK--AFLNQAQIEVRLLELMNKHDTEMKY 116
Query: 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAY 791
I+ L + LV E + + NL+ L G L+ R++ + + +
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVS-LNLTRKFAQQM--CTALLF 172
Query: 792 LH-HDCSPPIIHRDIKSSNILLDEDYEP--KIADFGVAKIAENSPKVSDY--SCFAGTHG 846
L + S IIH D+K NILL KI DFG + ++ Y S F
Sbjct: 173 LATPELS--IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ--RIYQYIQSRF----- 223
Query: 847 YIAPELAYTCKVSEKSDVFSFGVVLLELVTGR 878
Y +PE+ D++S G +L+E+ TG
Sbjct: 224 YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 48/220 (21%), Positives = 84/220 (38%), Gaps = 35/220 (15%)
Query: 683 LIGSGGTGKVYR-LDLKKNAGTVAVKQLWKGDGVKVF--AA--EMEILGKIRHR------ 731
+G G GKV LD + VA+K + V + AA E+ +L KI+ +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKII---RNVGKYREAARLEINVLKKIKEKDKENKF 82
Query: 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAY 791
+ + G + E + N F+ L + + P L R L A + +
Sbjct: 83 LCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYP-LPHVRHMAYQLCHA--LRF 138
Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP----KVSDY--SCFAGTH 845
LH + + H D+K NIL + + + ++ +V+D+ + F H
Sbjct: 139 LH-ENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH 195
Query: 846 --GYI------APELAYTCKVSEKSDVFSFGVVLLELVTG 877
+ PE+ ++ DV+S G +L E G
Sbjct: 196 HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 4e-09
Identities = 46/224 (20%), Positives = 84/224 (37%), Gaps = 43/224 (19%)
Query: 683 LIGSGGTGKVYR-LDLKKNAGTVAVKQLWKGDGVKVF--AA--EMEILGKIRHR------ 731
+G G GKV +D K VAVK + V + AA E+++L +
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIV---KNVDRYCEAARSEIQVLEHLNTTDPNSTF 77
Query: 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAY 791
+++ G +V E + + + + + LD R+ + + + +
Sbjct: 78 RCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFR-LDHIRKMAYQICKS--VNF 133
Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP----KVSDY--SCFAGTH 845
LH + H D+K NIL + + + + + KV D+ + + H
Sbjct: 134 LH-SNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH 190
Query: 846 --GYI------APE----LAYTCKVSEKSDVFSFGVVLLELVTG 877
+ APE L + S+ DV+S G +L+E G
Sbjct: 191 HSTLVSTRHYRAPEVILALGW----SQPCDVWSIGCILIEYYLG 230
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 36/136 (26%), Positives = 56/136 (41%), Gaps = 18/136 (13%)
Query: 437 QLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGS 496
+L ++ + L L + L L+ NN KI S+L + L L L N +
Sbjct: 29 ELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-K 84
Query: 497 IPNEMGDCARIVDLNLARN---SLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLK 553
I N + +L ++ N SLSG + L +L L +S NK+T + KL
Sbjct: 85 IENLDAVADTLEELWISYNQIASLSG-----IEKLVNLRVLYMSNNKITN--WGEIDKLA 137
Query: 554 ----LSSIDLSENQLS 565
L + L+ N L
Sbjct: 138 ALDKLEDLLLAGNPLY 153
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 5e-07
Identities = 27/126 (21%), Positives = 54/126 (42%), Gaps = 9/126 (7%)
Query: 452 ELGRLTNLERLILTNNNFSG--KIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVD 509
+ T E++ L + K+ + L L+ L L N + I + + +
Sbjct: 18 KSVVATEAEKVEL-HGMIPPIEKMDATLSTLKACKHLALSTNNIE-KISS-LSGMENLRI 74
Query: 510 LNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLSENQLSGSV 568
L+L RN + I ++ +L L +S N++ S+ + KL L + +S N+++
Sbjct: 75 LSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWG 131
Query: 569 PLDFLR 574
+D L
Sbjct: 132 EIDKLA 137
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 27/120 (22%), Positives = 52/120 (43%), Gaps = 14/120 (11%)
Query: 88 EISSSISALQSLTVLSLPFNVLSGKLPLE-LSNCSNLKVLNVTGNAMVGSVPDLSAL-KN 145
++ +++S L++ L+L N + + LS NL++L++ N ++ + +L A+
Sbjct: 39 KMDATLSTLKACKHLALSTNNIEK---ISSLSGMENLRILSLGRN-LIKKIENLDAVADT 94
Query: 146 LEIFDLSINYFT---GRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAH 202
LE +S N G + L L L + +N + + L L L LA
Sbjct: 95 LEELWISYNQIASLSG-----IEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAG 149
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 32/137 (23%), Positives = 50/137 (36%), Gaps = 9/137 (6%)
Query: 414 LDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKI 473
L + L L + L L N ++ S L + NL L L N KI
Sbjct: 30 LHGMIPPIEKMDATLSTL-KACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-KI 85
Query: 474 PSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLS--GNIPRSLSLLSSL 531
+ L L + N + S+ + + L ++ N ++ G I L+ L L
Sbjct: 86 ENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITNWGEI-DKLAALDKL 142
Query: 532 NALNLSGNKLTGSIPDN 548
L L+GN L +N
Sbjct: 143 EDLLLAGNPLYNDYKEN 159
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 31/144 (21%), Positives = 54/144 (37%), Gaps = 27/144 (18%)
Query: 166 NLTQLVSLSIGDNVYDEAEIP--ESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLD 223
L L++ N I S+ ++NL L L ++ +I + L L
Sbjct: 46 TLKACKHLALSTN-----NIEKISSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELW 99
Query: 224 ICRNKISGEFPRSIRKLQKLWKIE-LY-ANNLTGELP--AELGNLTLLQEFDISSNQMYG 279
I N+I+ S+ ++KL + LY +NN +L L L++ ++ N +Y
Sbjct: 100 ISYNQIA-----SLSGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN 154
Query: 280 KLPEE----------IGNLKNLTV 293
E + L NL
Sbjct: 155 DYKENNATSEYRIEVVKRLPNLKK 178
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 46/157 (29%), Positives = 63/157 (40%), Gaps = 18/157 (11%)
Query: 430 GLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLE 489
G+ +L LQ+ + + LT L L L N L +L +L L
Sbjct: 32 GIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA 91
Query: 490 ENALTGSIPNEMGDC-ARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIP-- 546
N L S+P + D ++ L L N L L+ L L L+ N+L SIP
Sbjct: 92 NNQLA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAG 149
Query: 547 --DNLMKLKLSSIDLSENQLSGSVPLDFLRMGGDGAF 581
D L L+ ++ LS NQL SVP GAF
Sbjct: 150 AFDKLTNLQ--TLSLSTNQLQ-SVP--------HGAF 175
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 53/222 (23%), Positives = 76/222 (34%), Gaps = 46/222 (20%)
Query: 67 TCDSVTG-----RVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCS 121
TC++VTG E+ KSL + S I A L L L+ +
Sbjct: 3 TCETVTGCTCNEGKKEVDCQGKSLDS-VPSGIPA--DTEKLDLQSTGLATLSDATFRGLT 59
Query: 122 NLKVLNVTGNAMVGSVPD--LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNV 179
L LN+ N + ++ L L L+ N QL SL +G V
Sbjct: 60 KLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANN--------------QLASLPLG--V 102
Query: 180 YDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESI-SELRELGTLDICRNKIS----GEFP 234
+D +L L L+L N +P + L +L L + N++ G F
Sbjct: 103 FD---------HLTQLDKLYL-GGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAF- 151
Query: 235 RSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQ 276
KL L + L N L L LQ + NQ
Sbjct: 152 ---DKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQ 190
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 55.3 bits (132), Expect = 4e-08
Identities = 38/246 (15%), Positives = 64/246 (26%), Gaps = 72/246 (29%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVK----------QLWKGDGVKVFAAEMEILGKI----- 728
IG G G+V++ VA+K + E+ I ++
Sbjct: 28 IGEGVFGEVFQTIADH--TPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85
Query: 729 ----RHRNILKLYAC------------------------------LLKGGSSFLVLEYMP 754
R + L + K F+VLE+
Sbjct: 86 EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145
Query: 755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE 814
G + + ++ I +A HRD+ N+LL +
Sbjct: 146 GGIDLEQMRTKL------SSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNVLLKK 197
Query: 815 DYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSD--VFSFGVVLL 872
K+ K S + G + YT E+ VF +
Sbjct: 198 TSLKKLHYTLNGK-----------SSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDE 246
Query: 873 ELVTGR 878
+L TG
Sbjct: 247 DLFTGD 252
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 5e-08
Identities = 30/111 (27%), Positives = 51/111 (45%), Gaps = 4/111 (3%)
Query: 434 SLSQLVLQNNRFS-GELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENA 492
+ +LVL N+R + G+L LE L N + I + L L +L L L +N
Sbjct: 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNR 75
Query: 493 LTGSIPNEMGDCARIVDLNLARNSLSG-NIPRSLSLLSSLNALNLSGNKLT 542
++G + C + LNL+ N + + L L +L +L+L ++T
Sbjct: 76 VSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 1e-07
Identities = 26/115 (22%), Positives = 46/115 (40%), Gaps = 3/115 (2%)
Query: 89 ISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEI 148
+ + S ++ L + + N GKL L+ L+ + S+ +L L L+
Sbjct: 12 RNRTPSDVKELVLDNSRSN--EGKLEGLTDEFEELEFLSTINV-GLTSIANLPKLNKLKK 68
Query: 149 FDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHC 203
+LS N +G L L++ N + E + L+NL L L +C
Sbjct: 69 LELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 1e-07
Identities = 33/111 (29%), Positives = 53/111 (47%), Gaps = 5/111 (4%)
Query: 455 RLTNLERLILTNNNFS-GKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLA 513
++++ L+L N+ + GK+ +L L LT SI N + ++ L L+
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELS 72
Query: 514 RNSLSGNIPRSLSLLSSLNALNLSGNKLTG-SIPDNLMKLK-LSSIDLSEN 562
N +SG + +L LNLSGNK+ S + L KL+ L S+DL
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 1e-06
Identities = 26/116 (22%), Positives = 43/116 (37%), Gaps = 8/116 (6%)
Query: 383 DCKTIQRLRISDNHLS-GKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLS--TSLSQLV 439
++ L + ++ + GK+ + L + G++ + L L +L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINV----GLTSIANLPKLNKLKKLE 70
Query: 440 LQNNRFSGELPSELGRLTNLERLILTNNNFSG-KIPSALGALRQLSSLHLEENALT 494
L +NR SG L + NL L L+ N L L L SL L +T
Sbjct: 71 LSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 1e-06
Identities = 20/112 (17%), Positives = 45/112 (40%), Gaps = 5/112 (4%)
Query: 166 NLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDIC 225
+ + L + ++ +E ++ + L +L + L I ++ +L +L L++
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72
Query: 226 RNKISGEFPRSIRKLQKLWKIELYANNLT--GELPAELGNLTLLQEFDISSN 275
N++SG K L + L N + + L L L+ D+ +
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTI-EPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 3e-06
Identities = 24/112 (21%), Positives = 42/112 (37%), Gaps = 15/112 (13%)
Query: 191 NLKNLTYLFLAHC-NLRGRIPESISELRELGTLDICRNKIS--GEFPRSIRKLQKLWKIE 247
++ L L + + G++ E EL L ++ P KL KL K+E
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLP----KLNKLKKLE 70
Query: 248 LYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKN 299
L N ++G L L ++S N+ I +L + + +N
Sbjct: 71 LSDNRVSGGLEVLAEKCPNLTHLNLSGNK--------IKDLSTIEPLKKLEN 114
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 9e-08
Identities = 56/229 (24%), Positives = 91/229 (39%), Gaps = 49/229 (21%)
Query: 683 LIGSGGTGKVYR-LDLKKNAGTVAVKQLWKGDGVKVF--AA--EMEILGKIRHR-----N 732
+G G G+V + AVK + +K + +A E +IL KI++ N
Sbjct: 42 KMGDGTFGRVLLCQHIDNKK-YYAVKVV---RNIKKYTRSAKIEADILKKIQNDDINNNN 97
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
I+K + + L+ E + +L++ + + G ++ + Y I + K + YL
Sbjct: 98 IVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFH-IEDIKLYCIEI--LKALNYL 153
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP----------KVSDY--SC 840
S + H D+K NILLD+ Y K K+ D+ +
Sbjct: 154 R-KMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCAT 210
Query: 841 FAGTH--GYI------APE----LAYTCKVSEKSDVFSFGVVLLELVTG 877
F + I APE L + SD++SFG VL EL TG
Sbjct: 211 FKSDYHGSIINTRQYRAPEVILNLGW----DVSSDMWSFGCVLAELYTG 255
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 37/127 (29%), Positives = 57/127 (44%), Gaps = 13/127 (10%)
Query: 457 TNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDC-ARIVDLNLARN 515
TN + L L +N + P +L L L+L N L ++P + D ++ L+L N
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTN 98
Query: 516 SLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLSENQLSGSVPLDFLR 574
L+ L L L + NKLT +P + +L L+ + L +NQL S+P
Sbjct: 99 QLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK-SIP----- 151
Query: 575 MGGDGAF 581
GAF
Sbjct: 152 ---HGAF 155
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 42/140 (30%), Positives = 64/140 (45%), Gaps = 12/140 (8%)
Query: 430 GLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSAL-GALRQLSSLHL 488
G+ T+ L L +N+ + P L NL+ L L +N +P + +L QL+ L L
Sbjct: 37 GIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDL 95
Query: 489 EENALTGSIPNEMGDC-ARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIP- 546
N LT +P+ + D + +L + N L+ +PR + L+ L L L N+L SIP
Sbjct: 96 GTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK-SIPH 152
Query: 547 ---DNLMKLKLSSIDLSENQ 563
D L L L N
Sbjct: 153 GAFDRLSSLT--HAYLFGNP 170
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 6e-05
Identities = 30/110 (27%), Positives = 47/110 (42%), Gaps = 3/110 (2%)
Query: 191 NLKNLTYLFLAHCNLRGRIPESI-SELRELGTLDICRNKISGEFPRSIRKLQKLWKIELY 249
+L NL L+L L +P + L +L LD+ N+++ +L L ++ +
Sbjct: 62 SLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMC 120
Query: 250 ANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKN 299
N LT ELP + LT L + NQ+ L +LT F N
Sbjct: 121 CNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 39/130 (30%), Positives = 54/130 (41%), Gaps = 18/130 (13%)
Query: 457 TNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDC-ARIVDLNLARN 515
L L N+ L L+ L+L N L S+PN + + + LNL+ N
Sbjct: 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTN 86
Query: 516 SLSGNIPRSLSLLSSLNALNLSGNKLTGSIP----DNLMKLKLSSIDLSENQLSGSVPLD 571
L L+ L L L+ N+L S+P D L +LK + L +NQL SVP
Sbjct: 87 QLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLK--DLRLYQNQLK-SVP-- 140
Query: 572 FLRMGGDGAF 581
DG F
Sbjct: 141 ------DGVF 144
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 16/115 (13%), Positives = 42/115 (36%), Gaps = 4/115 (3%)
Query: 90 SSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIF 149
++ + L L + + + ++ + N + + L+ L+
Sbjct: 12 AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDGFPLLRRLKTL 69
Query: 150 DLSINYFTGRFPRWVVNLTQLVSLSIGDN-VYDEAEIPESIGNLKNLTYLFLAHC 203
++ N L L L + +N + + ++ + + +LK+LTYL +
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 1e-06
Identities = 30/118 (25%), Positives = 46/118 (38%), Gaps = 8/118 (6%)
Query: 380 SYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLS--TSLSQ 437
Y + + L + + I + L +DF DN+ I L G L
Sbjct: 14 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNE----IRKLDGFPLLRRLKT 68
Query: 438 LVLQNNRFSGELPSELGRLTNLERLILTNNNFSG-KIPSALGALRQLSSLHLEENALT 494
L++ NNR L +L LILTNN+ L +L+ L+ L + N +T
Sbjct: 69 LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 26/110 (23%), Positives = 39/110 (35%), Gaps = 7/110 (6%)
Query: 362 KLLNL--LALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDN 419
+ L L + N A + SDN + K+ DG L + L +N
Sbjct: 17 NAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNNN 74
Query: 420 DFTGGISPLIGLSTSLSQLVLQNNRFS--GELPSELGRLTNLERLILTNN 467
L L++L+L NN G+L L L +L L + N
Sbjct: 75 RICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 19/116 (16%), Positives = 36/116 (31%), Gaps = 17/116 (14%)
Query: 187 ESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIR---KLQKL 243
N L L + I + L + +D N+I R + L++L
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI-----RKLDGFPLLRRL 66
Query: 244 WKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKN 299
+ + N + L L E +++N + L +L K+
Sbjct: 67 KTLLVNNNRICRIGEGLDQALPDLTELILTNNS--------LVELGDLDPLASLKS 114
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 5e-06
Identities = 22/115 (19%), Positives = 38/115 (33%), Gaps = 7/115 (6%)
Query: 451 SELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDL 510
++ L L I + L Q ++ +N + + R+ L
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTL 69
Query: 511 NLARNSLSGNIPRSLSLLSSLNALNLSGNKLT--GSIPDNLMKLK-LSSIDLSEN 562
+ N + L L L L+ N L G + D L LK L+ + + N
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 22/111 (19%), Positives = 41/111 (36%), Gaps = 4/111 (3%)
Query: 433 TSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENA 492
+L L+ + + + L + + ++N K+ LR+L +L + N
Sbjct: 19 VRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNNNR 75
Query: 493 LTGSIPNEMGDCARIVDLNLARNSLSG-NIPRSLSLLSSLNALNLSGNKLT 542
+ + +L L NSL L+ L SL L + N +T
Sbjct: 76 ICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 21/115 (18%), Positives = 38/115 (33%), Gaps = 12/115 (10%)
Query: 464 LTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLS--GNI 521
LT + + L L + I N + ++ + N +
Sbjct: 4 LTAELIE-QAAQ-YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGF 60
Query: 522 PRSLSLLSSLNALNLSGNKLTGSIPDNLMKL--KLSSIDLSENQLSGSVPLDFLR 574
P L L L ++ N++ I + L + L+ + L+ N L LD L
Sbjct: 61 PL----LRRLKTLLVNNNRIC-RIGEGLDQALPDLTELILTNNSLVELGDLDPLA 110
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 5e-07
Identities = 41/216 (18%), Positives = 72/216 (33%), Gaps = 35/216 (16%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRH-RNILKLYACLLK 742
IG G G ++ N VA+K + E + I +Y +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE 77
Query: 743 GGSSFLVLEYM-PN-GNLFQALHKRVKEGKPELDWFRRY---KIALGAAKGIAYLHHDCS 797
G + LV++ + P+ +L ++ F A + +H
Sbjct: 78 GLHNVLVIDLLGPSLEDLLDLCGRK----------FSVKTVAMAAKQMLARVQSIH---E 124
Query: 798 PPIIHRDIKSSNILLDEDYEPK-----IADFGVAKIAENS------PKVSDYSCFAGTHG 846
+++RDIK N L+ + DFG+ K + P + +GT
Sbjct: 125 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKN-LSGTAR 183
Query: 847 Y--IAPELAYTCKVSEKSDVFSFGVVLLELVTGRKP 880
Y I L S + D+ + G V + + G P
Sbjct: 184 YMSINTHLGREQ--SRRDDLEALGHVFMYFLRGSLP 217
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 51.5 bits (122), Expect = 8e-07
Identities = 26/162 (16%), Positives = 52/162 (32%), Gaps = 22/162 (13%)
Query: 423 GGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGA--L 480
+SP++ L+ L + + + L NL+ L + + + + L
Sbjct: 162 VDLSPVLDAMPLLNNLKI---KGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDL 218
Query: 481 RQLSSLHLEENALTGSIPNEMGDCARIVD---------LNLARNSLSGNIPRSLS---LL 528
L L L +M + L + + +L
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278
Query: 529 SSLNALNLSGNKLTGS----IPDNLMKL-KLSSIDLSENQLS 565
L +++S LT + D++ K+ L I++ N LS
Sbjct: 279 PQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 50.0 bits (118), Expect = 2e-06
Identities = 32/300 (10%), Positives = 85/300 (28%), Gaps = 22/300 (7%)
Query: 282 PEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTD 341
E + + K + +M+ + + +
Sbjct: 46 AGEAEKAAGKLIAEKTKKGYVETLEEVAKEMKVEAKKYALSYDEAEEGVNLMDKILKDKK 105
Query: 342 VDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKI 401
+ + G + + + + + + + + IS
Sbjct: 106 LPSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQV--- 162
Query: 402 PDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELG--RLTNL 459
D L + +L+ T +S +L L + + + ++ L NL
Sbjct: 163 -DLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNL 221
Query: 460 ERLIL---TNNNFSGKIPSAL------GALRQLSSLHLEENALTGSIPNEMGDC---ARI 507
E+L+L + + L L + + + + ++
Sbjct: 222 EKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQL 281
Query: 508 VDLNLARNSLSGN----IPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQ 563
++++ L+ + + + L +N+ N L+ + L K ID+S++Q
Sbjct: 282 ETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKIDVSDSQ 341
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 8e-07
Identities = 39/227 (17%), Positives = 75/227 (33%), Gaps = 39/227 (17%)
Query: 684 IGSGGTGKVY--------RLDLKKNAGTVAVK------------QLWKGDGVKVFAAEME 723
G +Y D ++K ++ + + +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 724 ILGKIRHRNILKLYACLLKGGS-SFLVLEYM-PN-GNLFQALHKRVKEGKPELDWFRRYK 780
L I + FLVL + + + K V + L +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVL------Q 163
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKI--ADFGVAKIAENSPKVSDY 838
+A + +LH + +H ++ + NI +D + + ++ A +G A S K Y
Sbjct: 164 VACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAY 220
Query: 839 -----SCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKP 880
S G +I+ +L C S +SD+ S G +L+ + G P
Sbjct: 221 VEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 33/151 (21%), Positives = 45/151 (29%), Gaps = 56/151 (37%)
Query: 787 KGIAYLHHDCSPPIIHRDIKSSNILL---------------------------------- 812
+G+ YLH C IIH DIK NILL
Sbjct: 157 QGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAP 214
Query: 813 ---------------DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCK 857
E + KIAD G A + T Y + E+
Sbjct: 215 ATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-----TEDIQTRQYRSLEVLIGSG 269
Query: 858 VSEKSDVFSFGVVLLELVTGRKPVEEEYGDG 888
+ +D++S + EL TG E G+
Sbjct: 270 YNTPADIWSTACMAFELATGDYLFEPHSGEE 300
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 36/139 (25%), Positives = 58/139 (41%), Gaps = 32/139 (23%)
Query: 430 GLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLE 489
G+ +++L L N+F+ +P EL +L + L+NN S + + QL +L L
Sbjct: 28 GIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILS 86
Query: 490 ENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIP--- 546
N L IP PR+ L SL L+L GN ++ +P
Sbjct: 87 YNRLR-CIP-----------------------PRTFDGLKSLRLLSLHGNDIS-VVPEGA 121
Query: 547 -DNLMKLKLSSIDLSENQL 564
++L LS + + N L
Sbjct: 122 FNDLS--ALSHLAIGANPL 138
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 26/110 (23%), Positives = 45/110 (40%), Gaps = 2/110 (1%)
Query: 95 ALQSLTVLSLPFNVLS-GKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSI 153
++ L L + GK+ + NL+ L++ ++ SV +L L L+ +LS
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSNLPKLPKLKKLELSE 80
Query: 154 NYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHC 203
N G L L L++ N + E + L+ L L L +C
Sbjct: 81 NRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 2e-06
Identities = 34/114 (29%), Positives = 51/114 (44%), Gaps = 5/114 (4%)
Query: 455 RLTNLERLILTNNNFS-GKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLA 513
+ L+L N + GKI L L L L S+ N + ++ L L+
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELS 79
Query: 514 RNSLSGNIPRSLSLLSSLNALNLSGNKLTG-SIPDNLMKLK-LSSIDLSENQLS 565
N + G + L +L LNLSGNKL S + L KL+ L S+DL +++
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 6e-06
Identities = 28/119 (23%), Positives = 41/119 (34%), Gaps = 8/119 (6%)
Query: 380 SYADCKTIQRLRISDNHLS-GKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLS--TSLS 436
++ L + + + GKI N+ L + G+ + L L
Sbjct: 19 RNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINV----GLISVSNLPKLPKLK 74
Query: 437 QLVLQNNRFSGELPSELGRLTNLERLILTNNNFSG-KIPSALGALRQLSSLHLEENALT 494
+L L NR G L +L NL L L+ N L L L SL L +T
Sbjct: 75 KLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 6e-06
Identities = 24/113 (21%), Positives = 42/113 (37%), Gaps = 17/113 (15%)
Query: 191 NLKNLTYLFLAHC-NLRGRIPESISELRELGTLDICRNKISGEFPRSI---RKLQKLWKI 246
+ L L +C + G+I +E L L + + S+ KL KL K+
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-----SVSNLPKLPKLKKL 76
Query: 247 ELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKN 299
EL N + G L L L ++S N+ + ++ L + +
Sbjct: 77 ELSENRIFGGLDMLAEKLPNLTHLNLSGNK--------LKDISTLEPLKKLEC 121
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 49/216 (22%), Positives = 78/216 (36%), Gaps = 35/216 (16%)
Query: 684 IGSGGTGKVYR-LDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRH-RNILKLYACLL 741
IG G G++ +L N VA+K E ++ I ++Y
Sbjct: 17 IGCGNFGELRLGKNLYTNE-YVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGP 75
Query: 742 KGGSSFLVLEYM-PN-GNLFQALHKRVKEGKPELDWFRRY---KIALGAAKGIAYLHHDC 796
G + +VLE + P+ +LF + F IA+ + Y+H
Sbjct: 76 CGKYNAMVLELLGPSLEDLFDLCDRT----------FSLKTVLMIAIQLISRMEYVH--- 122
Query: 797 SPPIIHRDIKSSNILLDEDYEPK-----IADFGVAK--IAENSPKVSDYSC---FAGTHG 846
S +I+RD+K N L+ I DF +AK I + K Y GT
Sbjct: 123 SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTAR 182
Query: 847 Y--IAPELAYTCKVSEKSDVFSFGVVLLELVTGRKP 880
Y I L S + D+ + G + + + G P
Sbjct: 183 YMSINTHLGKEQ--SRRDDLEALGHMFMYFLRGSLP 216
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 47/214 (21%), Positives = 81/214 (37%), Gaps = 33/214 (15%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIR-HRNILKLYACLLK 742
IGSG G++Y + VA+K E +I ++ I + ++
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVE 74
Query: 743 GGSSFLVLEYM-PN-GNLFQALHKRVKEGKPELDWFRRY---KIALGAAKGIAYLHHDCS 797
G + LV++ + P+ +LF ++ +A + ++H S
Sbjct: 75 GDYNVLVMDLLGPSLEDLFNFCSRK----------LSLKTVLMLADQMINRVEFVH---S 121
Query: 798 PPIIHRDIKSSNILLDEDYEPK---IADFGVAKIAENS------PKVSDYSCFAGTHGY- 847
+HRDIK N L+ I DFG+AK ++ P + + GT Y
Sbjct: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN-LTGTARYA 180
Query: 848 -IAPELAYTCKVSEKSDVFSFGVVLLELVTGRKP 880
+ L S + D+ S G VL+ + G P
Sbjct: 181 SVNTHLGIEQ--SRRDDLESLGYVLMYFLRGSLP 212
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 5e-06
Identities = 53/210 (25%), Positives = 79/210 (37%), Gaps = 25/210 (11%)
Query: 684 IGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRH-RNILKLYACLLK 742
IGSG G +Y VA+K E +I ++ I + C +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE 76
Query: 743 GGSSFLVLEYM-PN-GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800
G + +V+E + P+ +LF ++ K L +A I Y+H S
Sbjct: 77 GDYNVMVMELLGPSLEDLFNFCSRKFSL-KTVLL------LADQMISRIEYIH---SKNF 126
Query: 801 IHRDIKSSNILLDEDYEPK---IADFGVAK--IAENSPKVSDYSC---FAGTHGY--IAP 850
IHRD+K N L+ + I DFG+AK + + Y GT Y I
Sbjct: 127 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 186
Query: 851 ELAYTCKVSEKSDVFSFGVVLLELVTGRKP 880
L S + D+ S G VL+ G P
Sbjct: 187 HLGIEQ--SRRDDLESLGYVLMYFNLGSLP 214
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 5e-06
Identities = 36/249 (14%), Positives = 67/249 (26%), Gaps = 47/249 (18%)
Query: 337 TALTDVDISENQFSGSFPKYLCEKRKLLNL----LALSNNFSGEVPNSY------ADCKT 386
+T +D+ N FS + L L L N G + A
Sbjct: 109 FTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPAN 168
Query: 387 IQRLRISDNHLSGKIPDGLWAL--------PNVGMLDFGDNDFT-GGISPLI----GLST 433
+ L + N+L+ L +V LD N + L +
Sbjct: 169 VNSLNLRGNNLA---SKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPN 225
Query: 434 SLSQLVLQNNRFSGE----LPSELGRLTNLERLILTNNNFSGK-------IPSALGALRQ 482
+ L L N G L L +L+ + L + + +A +++
Sbjct: 226 HVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQK 285
Query: 483 LSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNI----------PRSLSLLSSLN 532
+ + + S + + R + SL L++ L
Sbjct: 286 IILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELR 345
Query: 533 ALNLSGNKL 541
+ L
Sbjct: 346 ESIQTCKPL 354
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 59/295 (20%), Positives = 102/295 (34%), Gaps = 62/295 (21%)
Query: 337 TALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNH 396
+T +D+S N L + A +N + ++ L +S N
Sbjct: 22 HGVTSLDLSLNNLYSISTVELIQ--------AFANTPA-----------SVTSLNLSGNS 62
Query: 397 LSGK----IPDGLWALP-NVGMLDFGDNDFTGG-----ISPLIGLSTSLSQLVLQNNRFS 446
L K + L A+P NV L+ N + + L + +++ L L N FS
Sbjct: 63 LGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFS 122
Query: 447 GELPSELGRL-----TNLERLILTNNNFSGKIPSALG-ALR----QLSSLHLEENALTGS 496
+ SE + ++ L L N+ K L L ++SL+L N L
Sbjct: 123 SKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASK 182
Query: 497 IPNEMGD-----CARIVDLNLARNSLSGNIPRSLSLL-----SSLNALNLSGNKLTGSIP 546
E+ A + L+L+ N L L+ + + + +LNL N L G
Sbjct: 183 NCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSL 242
Query: 547 DNLMKL-----KLSSIDLSENQLSGSVPLDFLRMGGDGAFAGNEGLCLDQSTKML 596
+NL L L ++ L + + M + A Q ++
Sbjct: 243 ENLKLLKDSLKHLQTVYLDYDIVK--------NMSKEQCKALGAAFPNIQKIILV 289
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 37/233 (15%), Positives = 85/233 (36%), Gaps = 11/233 (4%)
Query: 53 WKESADSPCGFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGK 112
W+ + + + +S + + + + + L +V+
Sbjct: 49 WQTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVS 108
Query: 113 -LPLELSNCSNLKVLNVTGNAMV-GSVPDLSALKNLEIFDLSI-NYFTGRFPRWVV-NLT 168
L LS CS L+ L++ G + V L+ NL +LS + F+ + ++ + +
Sbjct: 109 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 168
Query: 169 QLVSLSIGD--NVYDEAEIPESIGNLKNLTYLFLAHC--NLRGRIPESISE-LRELGTLD 223
+L L++ + ++ + +T L L+ NL+ ++ L LD
Sbjct: 169 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 228
Query: 224 ICR-NKISGEFPRSIRKLQKLWKIEL-YANNLTGELPAELGNLTLLQEFDISS 274
+ + + + +L L + L ++ E ELG + L+ +
Sbjct: 229 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFG 281
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 28/102 (27%), Positives = 42/102 (41%), Gaps = 17/102 (16%)
Query: 485 SLHLEENALTGSIPNEMGDC-ARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTG 543
L L +N L + + +V L L RN L+G P + S + L L NK+
Sbjct: 33 ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK- 91
Query: 544 SIP----DNLMKLKLSSIDLSENQLSGSVPLDFLRMGGDGAF 581
I L +LK ++L +NQ+S V G+F
Sbjct: 92 EISNKMFLGLHQLKT--LNLYDNQIS-CVM--------PGSF 122
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 8e-05
Identities = 70/506 (13%), Positives = 139/506 (27%), Gaps = 82/506 (16%)
Query: 84 SLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSAL 143
L G+ + L + + S+ + L+ + L
Sbjct: 72 ELKGKPHFADFNLVPDGWGGYVYPWIE----AMSSSYTWLEEIR---------------L 112
Query: 144 KNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHC 203
K + + D + F N L LS + + + +NL L L
Sbjct: 113 KRMVVTDDCLELIAKSFK----NFKVL-VLSSCEGFSTDG-LAAIAATCRNLKELDLRES 166
Query: 204 NLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGE-LPAELG 262
++ +S P + L L I A+ ++ L +
Sbjct: 167 DVDDVSGHWLSHF-----------------PDTYTSLVSL-NISCLASEVSFSALERLVT 208
Query: 263 NLTLLQEFDISSNQMYGKLPEEIGNLKNLTVF--QCFKNNFSGEFPSGFGDM----RKLF 316
L+ ++ KL + L + + SG ++L
Sbjct: 209 RCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELR 268
Query: 317 AFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGE 376
S + + P + LT +++S L + L L + +
Sbjct: 269 CLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDA 328
Query: 377 VPNSYAD-CKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSL 435
A CK ++ LR+ + + G+ + L
Sbjct: 329 GLEVLASTCKDLRELRVF----------PSEPFVMEPNVALTEQ----GLVSVSMGCPKL 374
Query: 436 SQLVLQNNRFSGELPSELGR-LTNLERLILTNNNFSGKIP-------SALGAL----RQL 483
++ + + + R N+ R L GA+ + L
Sbjct: 375 ESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDL 434
Query: 484 SSLHLEENALTGSIPNEMGD-CARIVDLNLARNSLSGNIPRSLSL-LSSLNALNLSGNKL 541
L L LT + +G ++ L++A S + SL L +
Sbjct: 435 RRLSL-SGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPF 493
Query: 542 TG-SIPDNLMKL-KLSSIDLSENQLS 565
++ N KL + S+ +S +S
Sbjct: 494 GDKALLANASKLETMRSLWMSSCSVS 519
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 40/234 (17%), Positives = 80/234 (34%), Gaps = 54/234 (23%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAV--------------------KQLWKGDGVKVFAAEM 722
IGSGG G +Y A +++ K D +K +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 723 EILGKIRHRNILKLYAC----LLKGGSSFLVLEYM-PN-GNLFQALHKRVKEGKPELDWF 776
++ + I Y F+V+E + + + F
Sbjct: 104 ----QLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGT-----------F 148
Query: 777 RR---YKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKI--ADFGVAKIAEN 831
++ ++ + + Y+H + +H DIK++N+LL ++ AD+G++
Sbjct: 149 KKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCP 205
Query: 832 SPKVSDY-----SCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKP 880
+ Y GT + + + +S +SDV G +L + G+ P
Sbjct: 206 NGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 44/232 (18%), Positives = 87/232 (37%), Gaps = 47/232 (20%)
Query: 683 LIGSGGTGKVYRLDLKKN-----AGTVAVKQLWKGDG-----VKVF--------AAEMEI 724
IG GG G +Y D+ + VK +G +K + +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 725 LGKIRHRNILKLYACLLKGGSS----FLVLEYM-PN-GNLFQALHKRVKEGKPELDWFRR 778
K+++ + K + L + F++++ + +++A KR F R
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKR----------FSR 151
Query: 779 ---YKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKI--ADFGVAKIAENSP 833
+++L + Y+H +H DIK+SN+LL+ ++ D+G+A
Sbjct: 152 KTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208
Query: 834 KVSDY-----SCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKP 880
Y C GT + + + S + D+ G +++ +TG P
Sbjct: 209 VHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 24/188 (12%), Positives = 57/188 (30%), Gaps = 15/188 (7%)
Query: 89 ISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEI 148
+ + L+ SL ++ + + L L L ++ +
Sbjct: 238 FFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRK 297
Query: 149 FDLS-INYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRG 207
DL T + L L + + D + K L L +
Sbjct: 298 LDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRG-LEVLAQYCKQLKRLRIERGADEQ 356
Query: 208 RIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELG-NLTL 266
+ + + + G + + + ++L+ + +Y +++T E +G L
Sbjct: 357 GMEDEEGLVSQRGLIALAQG---------CQELEYM---AVYVSDITNESLESIGTYLKN 404
Query: 267 LQEFDISS 274
L +F +
Sbjct: 405 LCDFRLVL 412
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 973 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.98 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.98 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.98 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.98 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.97 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.94 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.94 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.93 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.93 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.93 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.92 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.92 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.91 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.9 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.9 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.9 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.89 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.89 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.88 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.88 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.88 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.88 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.88 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.87 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.87 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.87 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.85 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.85 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.84 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.84 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.83 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.83 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.83 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.83 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.83 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.83 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.81 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.81 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.81 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.81 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.81 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.81 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.8 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.79 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.79 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.76 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.76 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.76 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.75 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.75 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.75 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.75 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.73 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.73 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.71 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.71 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.71 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.7 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.68 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.67 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.66 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.65 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.64 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.64 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.63 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.6 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.59 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.55 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.55 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.54 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.54 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.53 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.52 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.5 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.48 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.48 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.46 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.46 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.38 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.32 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.3 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.3 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.27 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.26 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 99.17 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.1 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.03 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.99 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.97 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.9 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.9 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.82 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.79 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.56 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.51 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.37 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.33 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.27 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.27 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.08 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.9 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.87 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.81 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.74 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.72 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.68 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.32 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.28 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.07 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.05 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.0 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.95 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.8 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.7 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.64 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.64 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.35 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.35 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.3 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.11 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.94 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.66 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 94.95 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.08 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 92.25 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 86.59 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-78 Score=744.28 Aligned_cols=561 Identities=35% Similarity=0.531 Sum_probs=440.6
Q ss_pred CCCchHHHHHHHHHHHhcCCCcccccCCCCCCCCCCCcceeeeCCCCCceEEEeecCCCCCcc---cc------------
Q 002061 26 SLSLNVETQALIQFKSKLKDPHGVLDSWKESADSPCGFSGITCDSVTGRVTEISFDNKSLSGE---IS------------ 90 (973)
Q Consensus 26 ~~~~~~~~~aLl~~k~~~~d~~~~~~~W~~~~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~---~~------------ 90 (973)
+.+.++|++|||+||+++.||. .+++|+.++ +||.|.||+|+ ++||++|+|++.+++|. ++
T Consensus 7 ~~~~~~~~~all~~k~~~~~~~-~l~~W~~~~-~~C~w~gv~C~--~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l 82 (768)
T 3rgz_A 7 SQSLYREIHQLISFKDVLPDKN-LLPDWSSNK-NPCTFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESL 82 (768)
T ss_dssp -CCHHHHHHHHHHHHTTCSCTT-SSTTCCTTS-CGGGSTTEEEE--TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEE
T ss_pred ccCCHHHHHHHHHHHhhCCCcc-cccCCCCCC-CCcCCcceEEC--CCcEEEEECCCCCcCCccCccChhHhccCccccc
Confidence 4457899999999999999998 899998554 58999999998 68999999999999987 44
Q ss_pred -----------ccccCCccCcEeeCCCCcccCcCCh--hhhCCCCCcEEEecCCcccCCCCc-c-cCCCCCCEEeccCcc
Q 002061 91 -----------SSISALQSLTVLSLPFNVLSGKLPL--ELSNCSNLKVLNVTGNAMVGSVPD-L-SALKNLEIFDLSINY 155 (973)
Q Consensus 91 -----------~~l~~l~~L~~L~Ls~n~l~~~~p~--~l~~l~~L~~L~L~~n~l~~~~~~-l-~~l~~L~~L~Ls~n~ 155 (973)
+.++.+++|++|+|++|.++|.+|. .++++++|++|+|++|.+.+..+. + .++++|++|||++|.
T Consensus 83 ~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~ 162 (768)
T 3rgz_A 83 FLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANS 162 (768)
T ss_dssp ECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSC
T ss_pred CCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCc
Confidence 4678889999999999999998888 899999999999999988766553 2 556666666666665
Q ss_pred CCCccccc---c----------------------ccccccceEEccCCcCCCCCCcccccCCCCCCEEEcccCCCCCCCC
Q 002061 156 FTGRFPRW---V----------------------VNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIP 210 (973)
Q Consensus 156 l~~~~~~~---~----------------------~~l~~L~~L~l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~~ 210 (973)
+++..|.. + ..+++|++|++++|.+.. .+|. ++++++|++|+|++|++++.+|
T Consensus 163 l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~-~~~~-l~~l~~L~~L~Ls~n~l~~~~~ 240 (768)
T 3rgz_A 163 ISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFST-GIPF-LGDCSALQHLDISGNKLSGDFS 240 (768)
T ss_dssp CEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCS-CCCB-CTTCCSCCEEECCSSCCCSCHH
T ss_pred cCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCC-CCcc-cccCCCCCEEECcCCcCCCccc
Confidence 55443332 1 334455555555555542 2233 5555555555555555555555
Q ss_pred hhhhccCCCCeeeccccccc----------------------CCCchhhhcc-ccccEEEeeccccCCcCCccccccccc
Q 002061 211 ESISELRELGTLDICRNKIS----------------------GEFPRSIRKL-QKLWKIELYANNLTGELPAELGNLTLL 267 (973)
Q Consensus 211 ~~~~~l~~L~~L~L~~N~l~----------------------~~~~~~l~~l-~~L~~L~L~~N~l~~~~~~~l~~l~~L 267 (973)
..++.+++|++|+|++|+++ +.+|..+..+ ++|++|+|++|.+++.+|..|+++++|
T Consensus 241 ~~l~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L 320 (768)
T 3rgz_A 241 RAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLL 320 (768)
T ss_dssp HHTTTCSSCCEEECCSSCCEESCCCCCCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTC
T ss_pred HHHhcCCCCCEEECCCCcccCccCccccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCc
Confidence 55544444444444444333 3444444443 666666666666666666666666666
Q ss_pred cEEEeeccccccccCCc-cCCCCCccEEEcccCCCCCCCCC-------------------------CcCC--cccceeee
Q 002061 268 QEFDISSNQMYGKLPEE-IGNLKNLTVFQCFKNNFSGEFPS-------------------------GFGD--MRKLFAFS 319 (973)
Q Consensus 268 ~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~l~~N~l~~~~p~-------------------------~~~~--l~~L~~L~ 319 (973)
++|+|++|++.+.+|.. +.++++|++|++++|++++.+|. .+.. +++|+.|+
T Consensus 321 ~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~ 400 (768)
T 3rgz_A 321 ESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELY 400 (768)
T ss_dssp CEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEE
T ss_pred cEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEE
Confidence 66666666665555544 55555555555555555544444 4333 56677777
Q ss_pred ccCCccCCCCCccccccccccccccccccccccCChhhhhhhhHHHHHhhhccCCCCccccccCccccceEecccccccc
Q 002061 320 IYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSG 399 (973)
Q Consensus 320 l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~ 399 (973)
+++|.+++.+|..+..+++|++|+|++|++++.+|..+..+.++..+....|.+.+.+|..+..+++|++|+|++|++++
T Consensus 401 L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 480 (768)
T 3rgz_A 401 LQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTG 480 (768)
T ss_dssp CCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCS
T ss_pred CCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccC
Confidence 77777777888889999999999999999999999998888876666666788888999999999999999999999999
Q ss_pred CCCccccCCCCcceEeccCCcCCCCCCCCCCCCCCCCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCccccc--
Q 002061 400 KIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSAL-- 477 (973)
Q Consensus 400 ~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-- 477 (973)
.+|..+..+++|++|+|++|++++.+|..++.+++|++|+|++|++++.+|..++.+++|++|+|++|+++|.+|..+
T Consensus 481 ~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~ 560 (768)
T 3rgz_A 481 EIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFK 560 (768)
T ss_dssp CCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGT
T ss_pred cCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhc
Confidence 999999999999999999999999999999999999999999999999999999999999999999999987777543
Q ss_pred --------------------------------------------------------------------cccccCCEEEcC
Q 002061 478 --------------------------------------------------------------------GALRQLSSLHLE 489 (973)
Q Consensus 478 --------------------------------------------------------------------~~l~~L~~L~Ls 489 (973)
+.+++|++|||+
T Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs 640 (768)
T 3rgz_A 561 QSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMS 640 (768)
T ss_dssp TTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECC
T ss_pred ccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECc
Confidence 335789999999
Q ss_pred CcccccCCCccccccccccchhccccccccCCCccccccCCCCeeecCCCccCCCCChhhhccc-CceEEccCCcccccc
Q 002061 490 ENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLK-LSSIDLSENQLSGSV 568 (973)
Q Consensus 490 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~-L~~l~ls~N~l~~~~ 568 (973)
+|+++|.+|.+++++++|+.|+|++|+++|.+|..|+++++|+.|||++|+|+|.+|..+..++ |+.|||++|+++|.|
T Consensus 641 ~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~i 720 (768)
T 3rgz_A 641 YNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPI 720 (768)
T ss_dssp SSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEEC
T ss_pred CCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccC
Confidence 9999999999999999999999999999999999999999999999999999999999999997 999999999999999
Q ss_pred Ccc--cccCCCCccccCCCCCccCccc
Q 002061 569 PLD--FLRMGGDGAFAGNEGLCLDQST 593 (973)
Q Consensus 569 p~~--~~~~~~~~~~~~n~~lc~~~~~ 593 (973)
|.. |..+.. .+|.|||++||.|+.
T Consensus 721 P~~~~~~~~~~-~~~~gN~~Lcg~~l~ 746 (768)
T 3rgz_A 721 PEMGQFETFPP-AKFLNNPGLCGYPLP 746 (768)
T ss_dssp CSSSSGGGSCG-GGGCSCTEEESTTSC
T ss_pred CCchhhccCCH-HHhcCCchhcCCCCc
Confidence 974 666665 789999999999873
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-61 Score=593.25 Aligned_cols=496 Identities=30% Similarity=0.472 Sum_probs=409.4
Q ss_pred ceEEEeecCCCCCccccccc-cCCccCcEeeCCCCcccCcCChh-------------------------hhCCCCCcEEE
Q 002061 74 RVTEISFDNKSLSGEISSSI-SALQSLTVLSLPFNVLSGKLPLE-------------------------LSNCSNLKVLN 127 (973)
Q Consensus 74 ~v~~l~l~~~~l~~~~~~~l-~~l~~L~~L~Ls~n~l~~~~p~~-------------------------l~~l~~L~~L~ 127 (973)
+.+.|+|+++.+++.+|..+ ..+++|++|+|++|.+++..|.. ++.+++|++|+
T Consensus 127 ~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~ 206 (768)
T 3rgz_A 127 GLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLD 206 (768)
T ss_dssp TCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEE
T ss_pred CCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEE
Confidence 45555555555555555443 44455555555555444433332 25667777777
Q ss_pred ecCCcccCCCCcccCCCCCCEEeccCccCCCccccccccccccceEEccCCcCCCC---------------------CCc
Q 002061 128 VTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEA---------------------EIP 186 (973)
Q Consensus 128 L~~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---------------------~ip 186 (973)
|++|.+.+.++.++++++|++|+|++|.+++.+|..+.++++|++|++++|.+... .+|
T Consensus 207 Ls~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~L~~n~l~~~ip 286 (768)
T 3rgz_A 207 VSSNNFSTGIPFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIP 286 (768)
T ss_dssp CCSSCCCSCCCBCTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCCCCTTCCEEECCSSEEEESCC
T ss_pred CcCCcCCCCCcccccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCccccCCCCEEECcCCccCCccC
Confidence 77777777666677888888888888888877888888888888887777766421 345
Q ss_pred ccccCC-CCCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCchh-hhccccccEEEeeccccCCcCCcccccc
Q 002061 187 ESIGNL-KNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRS-IRKLQKLWKIELYANNLTGELPAELGNL 264 (973)
Q Consensus 187 ~~~~~l-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-l~~l~~L~~L~L~~N~l~~~~~~~l~~l 264 (973)
..+..+ ++|++|+|++|++++.+|..|+.+++|++|+|++|++++.+|.. +.++++|++|+|++|.+++.+|..+.++
T Consensus 287 ~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l 366 (768)
T 3rgz_A 287 DFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNL 366 (768)
T ss_dssp CCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHH
T ss_pred HHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhh
Confidence 555553 77777777777777777777777788888888888777677765 7777888888888888877777777777
Q ss_pred c-cccEEEeeccccccccCCccCC--CCCccEEEcccCCCCCCCCCCcCCcccceeeeccCCccCCCCCccccccccccc
Q 002061 265 T-LLQEFDISSNQMYGKLPEEIGN--LKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTD 341 (973)
Q Consensus 265 ~-~L~~L~Ls~N~l~~~~p~~~~~--l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~ 341 (973)
+ +|++|++++|++++.+|..+.. +++|++|++++|++++.+|..++.+++|+.|++++|++++.+|..++.+++|+.
T Consensus 367 ~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~ 446 (768)
T 3rgz_A 367 SASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRD 446 (768)
T ss_dssp TTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCE
T ss_pred hcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCE
Confidence 6 7888888888888777877776 788999999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccCChhhhhhhhHHHHHhhhccCCCCccccccCccccceEeccccccccCCCccccCCCCcceEeccCCcC
Q 002061 342 VDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDF 421 (973)
Q Consensus 342 L~Ls~N~l~~~~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 421 (973)
|++++|++++.+|..+.....+..+...+|++.+.+|..+.++++|++|+|++|++++.+|.++..+++|++|+|++|++
T Consensus 447 L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 526 (768)
T 3rgz_A 447 LKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSF 526 (768)
T ss_dssp EECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCC
T ss_pred EECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcc
Confidence 99999999999999998888776666667888889999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCCCEEEcccCCCCCCCChhhh-----------------------------------------------
Q 002061 422 TGGISPLIGLSTSLSQLVLQNNRFSGELPSELG----------------------------------------------- 454 (973)
Q Consensus 422 ~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~----------------------------------------------- 454 (973)
++.+|..++.+++|+.|+|++|+++|.+|..+.
T Consensus 527 ~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 606 (768)
T 3rgz_A 527 SGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNR 606 (768)
T ss_dssp EEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGG
T ss_pred cCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhc
Confidence 999999999999999999999999988886553
Q ss_pred -----------------------cCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCCccccccccccchh
Q 002061 455 -----------------------RLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLN 511 (973)
Q Consensus 455 -----------------------~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 511 (973)
.+++|+.|+|++|+++|.+|..++++++|+.|+|++|+++|.+|..|+++++|+.||
T Consensus 607 l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~Ld 686 (768)
T 3rgz_A 607 LSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILD 686 (768)
T ss_dssp GGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEE
T ss_pred cccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEE
Confidence 346799999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCccccccCCCCeeecCCCccCCCCChhhhcccCceEEccCCccccccC
Q 002061 512 LARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSGSVP 569 (973)
Q Consensus 512 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~L~~l~ls~N~l~~~~p 569 (973)
|++|+++|.+|..+..+++|++|+|++|+|+|.||..-.-..+....+.+|+.-|-.|
T Consensus 687 Ls~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~ 744 (768)
T 3rgz_A 687 LSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP 744 (768)
T ss_dssp CCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTT
T ss_pred CCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCC
Confidence 9999999999999999999999999999999999986322235566778887554333
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-57 Score=549.40 Aligned_cols=505 Identities=18% Similarity=0.187 Sum_probs=406.6
Q ss_pred cceeeeCCC---------CCceEEEeecCCCCCccccccccCCccCcEeeCCCCcccCcCChhhhCCCCCcEEEecCCcc
Q 002061 63 FSGITCDSV---------TGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAM 133 (973)
Q Consensus 63 w~gv~C~~~---------~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l 133 (973)
+..|.|... ...++.|+|+++.+++..|..++.+++|++|+|++|.+++..|..|+.+++|++|+|++|++
T Consensus 14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l 93 (606)
T 3t6q_A 14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93 (606)
T ss_dssp TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcc
Confidence 556888642 25799999999999998899999999999999999999988899999999999999999999
Q ss_pred cCCCC-cccCCCCCCEEeccCccCCCccccccccccccceEEccCCcCCCCCCcccccCCCCCCEEEcccCCCCCCCChh
Q 002061 134 VGSVP-DLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPES 212 (973)
Q Consensus 134 ~~~~~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~ 212 (973)
++.++ .|+++++|++|+|++|.+++..+..+.++++|++|++++|.+....+|..++ +++|++|++++|++++..|..
T Consensus 94 ~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L~L~~n~l~~~~~~~ 172 (606)
T 3t6q_A 94 IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFP-TEKLKVLDFQNNAIHYLSKED 172 (606)
T ss_dssp SEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCC-CTTCCEEECCSSCCCEECHHH
T ss_pred cccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccC-CcccCEEEcccCcccccChhh
Confidence 88765 6999999999999999999888899999999999999999998766666655 999999999999999888999
Q ss_pred hhccCCCC--eeecccccccCCCchhhhccccccEEEeeccccC--------------------------CcCCcccccc
Q 002061 213 ISELRELG--TLDICRNKISGEFPRSIRKLQKLWKIELYANNLT--------------------------GELPAELGNL 264 (973)
Q Consensus 213 ~~~l~~L~--~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~--------------------------~~~~~~l~~l 264 (973)
++.+++|+ +|++++|++++..|..+.. .+|++|++++|... ...+..+..+
T Consensus 173 ~~~l~~L~~l~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l 251 (606)
T 3t6q_A 173 MSSLQQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251 (606)
T ss_dssp HHTTTTCCSEEEECTTCCCCEECTTTTTT-CEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGG
T ss_pred hhhhcccceeEEecCCCccCccChhHhhh-ccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchh
Confidence 99999999 8999999999777766543 45555555544300 0011112222
Q ss_pred c--cccEEEeeccccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeeccCCccCCCCCcccccccccccc
Q 002061 265 T--LLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDV 342 (973)
Q Consensus 265 ~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L 342 (973)
. +|+.|++++|.+++..+..|.++++|++|++++|+++ .+|..+..+++|++|++++|++++..|..+..+++|++|
T Consensus 252 ~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 330 (606)
T 3t6q_A 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHL 330 (606)
T ss_dssp GGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEE
T ss_pred hcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEE
Confidence 1 4566666666666555555666666666666666665 455556666666666666666665555556666666666
Q ss_pred ccccccccccCChh-hhhhhhHHHHHhhhccCCCCc--cccccCccccceEeccccccccCCCccccCCCCcceEeccCC
Q 002061 343 DISENQFSGSFPKY-LCEKRKLLNLLALSNNFSGEV--PNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDN 419 (973)
Q Consensus 343 ~Ls~N~l~~~~p~~-~~~~~~ll~ll~l~n~~~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 419 (973)
++++|.+.+.+|.. +..+..+..+....|.+.+.. +..+..+++|++|++++|++.+..|..|..+++|+.|++++|
T Consensus 331 ~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 410 (606)
T 3t6q_A 331 SIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFT 410 (606)
T ss_dssp ECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTC
T ss_pred ECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCC
Confidence 66666665544443 333333222222233333333 667899999999999999999999999999999999999999
Q ss_pred cCCCCCCCC-CCCCCCCCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCC---ccccccccccCCEEEcCCccccc
Q 002061 420 DFTGGISPL-IGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGK---IPSALGALRQLSSLHLEENALTG 495 (973)
Q Consensus 420 ~l~~~~~~~-~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~L~Ls~N~l~~ 495 (973)
++++..+.. +..+++|++|++++|.+.+..|..+..+++|++|+|++|++++. .+..+..+++|++|+|++|++++
T Consensus 411 ~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~ 490 (606)
T 3t6q_A 411 RLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSS 490 (606)
T ss_dssp CEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCE
T ss_pred cCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCc
Confidence 999876654 88999999999999999999999999999999999999999863 34679999999999999999999
Q ss_pred CCCccccccccccchhccccccccCCCccccccCCCCeeecCCCccCCCCChhhhccc-CceEEccCCccccccCcc
Q 002061 496 SIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLK-LSSIDLSENQLSGSVPLD 571 (973)
Q Consensus 496 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~-L~~l~ls~N~l~~~~p~~ 571 (973)
..|..|+++++|+.|+|++|++++..|..|..+++| .|+|++|++++.+|..+..++ |+.+++++|+|.|.|+..
T Consensus 491 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~~ 566 (606)
T 3t6q_A 491 IDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNI 566 (606)
T ss_dssp ECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGGGH
T ss_pred cChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCCcH
Confidence 999999999999999999999999999999999999 999999999998888888875 999999999999999953
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-59 Score=560.78 Aligned_cols=490 Identities=20% Similarity=0.279 Sum_probs=355.1
Q ss_pred chHHHHHHHHHHHhcCCCc-c-------cccCCCCCCCCCCCc---ceeeeCCCCCceEEEeecCCCCCccccccccCCc
Q 002061 29 LNVETQALIQFKSKLKDPH-G-------VLDSWKESADSPCGF---SGITCDSVTGRVTEISFDNKSLSGEISSSISALQ 97 (973)
Q Consensus 29 ~~~~~~aLl~~k~~~~d~~-~-------~~~~W~~~~~~~c~w---~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~ 97 (973)
...|++||.+||+++.++. . ..++|+.+ .+||.| .||+|+.. +||++|+|++++++|.+|+++++|+
T Consensus 28 ~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~-~~~c~w~~~~GV~C~~~-~~V~~L~L~~~~l~g~lp~~l~~L~ 105 (636)
T 4eco_A 28 YIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFN-KELDMWGAQPGVSLNSN-GRVTGLSLEGFGASGRVPDAIGQLT 105 (636)
T ss_dssp HHHHHHHHHHHHHHTTGGGCCCCC------CCCCCS-SCGGGTTCCTTEEECTT-CCEEEEECTTSCCEEEECGGGGGCT
T ss_pred HHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCC-CCcccccCCCCeEEcCC-CCEEEEEecCcccCCcCChHHhcCc
Confidence 3579999999999986542 2 23489876 458999 99999864 8999999999999999999999999
Q ss_pred cCcEeeCCCCcc------cC------cCChhhhCCCCCcEEEecCCcccCCCCc-ccC-C------------------CC
Q 002061 98 SLTVLSLPFNVL------SG------KLPLELSNCSNLKVLNVTGNAMVGSVPD-LSA-L------------------KN 145 (973)
Q Consensus 98 ~L~~L~Ls~n~l------~~------~~p~~l~~l~~L~~L~L~~n~l~~~~~~-l~~-l------------------~~ 145 (973)
+|++|+|++|.+ .+ .+|... +.+|+ +++++|.+.+.++. +.. + ..
T Consensus 106 ~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~ 182 (636)
T 4eco_A 106 ELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRIT 182 (636)
T ss_dssp TCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCC
T ss_pred cceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccc
Confidence 999999999976 33 556555 56677 88888877776553 331 1 12
Q ss_pred CCEEecc--CccCCCccccccccccccceEEccCCcCCCC----------------CCccccc--CCCCCCEEEcccCCC
Q 002061 146 LEIFDLS--INYFTGRFPRWVVNLTQLVSLSIGDNVYDEA----------------EIPESIG--NLKNLTYLFLAHCNL 205 (973)
Q Consensus 146 L~~L~Ls--~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~----------------~ip~~~~--~l~~L~~L~L~~n~l 205 (973)
++.+.+. .|++++ +|..++++++|++|+|++|.++.. .+|+.++ ++++|++|+|++|++
T Consensus 183 l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l 261 (636)
T 4eco_A 183 LKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPN 261 (636)
T ss_dssp CCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTT
T ss_pred hhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcC
Confidence 2222222 567777 788888888888888888887641 0778877 888888888888888
Q ss_pred CCCCChhhhccCCCCeeeccccc-ccC-CCchhhhcc------ccccEEEeeccccCCcCCc--cccccccccEEEeecc
Q 002061 206 RGRIPESISELRELGTLDICRNK-ISG-EFPRSIRKL------QKLWKIELYANNLTGELPA--ELGNLTLLQEFDISSN 275 (973)
Q Consensus 206 ~~~~~~~~~~l~~L~~L~L~~N~-l~~-~~~~~l~~l------~~L~~L~L~~N~l~~~~~~--~l~~l~~L~~L~Ls~N 275 (973)
.+.+|..++++++|++|+|++|+ +++ .+|..++++ ++|++|+|++|+++ .+|. .++++++|++|++++|
T Consensus 262 ~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N 340 (636)
T 4eco_A 262 LTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYN 340 (636)
T ss_dssp CSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSC
T ss_pred CccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCC
Confidence 88888888888888888888887 877 778877776 78888888888888 6777 7888888888888888
Q ss_pred ccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCccc-ceeeeccCCccCCCCCccccccc--ccccccccccccccc
Q 002061 276 QMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRK-LFAFSIYGNRFSGPFPENLGRYT--ALTDVDISENQFSGS 352 (973)
Q Consensus 276 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~-L~~L~l~~N~l~~~~~~~l~~l~--~L~~L~Ls~N~l~~~ 352 (973)
+++|.+| .+..+++|+.|++++|+++ .+|..++.+++ |+.|++++|+++ .+|..+..+. +|++|++++|++++.
T Consensus 341 ~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~ 417 (636)
T 4eco_A 341 QLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSV 417 (636)
T ss_dssp CCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTT
T ss_pred cCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCc
Confidence 8887777 7777888888888888887 67777777777 888888888877 6676666654 777777777777765
Q ss_pred CChhhhhhhhHHHHHhhhccCCCCccccccCccccceEeccccccccCCCccccCCCCcceEeccCCcCCCCCCCCCCCC
Q 002061 353 FPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLS 432 (973)
Q Consensus 353 ~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~ 432 (973)
+|..+.. .......+++|++|+|++|+|++..+..+..+++|+.|+|++|+++.++...+...
T Consensus 418 ~p~~l~~-----------------~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~ 480 (636)
T 4eco_A 418 DGKNFDP-----------------LDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDE 480 (636)
T ss_dssp TTCSSCT-----------------TCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEET
T ss_pred chhhhcc-----------------cccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhccc
Confidence 5543210 00111145677777777777774333344457777777777777775555444433
Q ss_pred C-------CCCEEEcccCCCCCCCChhhh--cCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCCccccc
Q 002061 433 T-------SLSQLVLQNNRFSGELPSELG--RLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGD 503 (973)
Q Consensus 433 ~-------~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 503 (973)
. +|+.|+|++|+++ .+|..+. .+++|+.|+|++|++++ +|..+..+++|++|+|++|+
T Consensus 481 ~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~----------- 547 (636)
T 4eco_A 481 NENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQR----------- 547 (636)
T ss_dssp TEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCB-----------
T ss_pred cccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCc-----------
Confidence 2 6777777777777 5666665 67777777777777765 66666677777777775554
Q ss_pred cccccchhccccccccCCCccccccCCCCeeecCCCccCCCCChhhhcccCceEEccCCccccc
Q 002061 504 CARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSGS 567 (973)
Q Consensus 504 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~L~~l~ls~N~l~~~ 567 (973)
++++|++.+.+|..+..+++|+.|+|++|+| +.+|..+. -.|+.|+|++|++.+.
T Consensus 548 -------~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~-~~L~~L~Ls~N~l~~~ 602 (636)
T 4eco_A 548 -------DAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT-PNISVLDIKDNPNISI 602 (636)
T ss_dssp -------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC-TTCCEEECCSCTTCEE
T ss_pred -------ccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh-CcCCEEECcCCCCccc
Confidence 3466777777777777777777777777777 46676654 3477777777777654
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-57 Score=557.83 Aligned_cols=500 Identities=19% Similarity=0.262 Sum_probs=385.3
Q ss_pred CchHHHHHHHHHHHhcCCCcccccCCCCCC----CCC--CCc------------ceeeeCCCCCceEEEeecCCCCCccc
Q 002061 28 SLNVETQALIQFKSKLKDPHGVLDSWKESA----DSP--CGF------------SGITCDSVTGRVTEISFDNKSLSGEI 89 (973)
Q Consensus 28 ~~~~~~~aLl~~k~~~~d~~~~~~~W~~~~----~~~--c~w------------~gv~C~~~~~~v~~l~l~~~~l~~~~ 89 (973)
...+|++||++||+++.|| +|+.++ .+| |.| .||+|+. ++||++|+|++++++|.+
T Consensus 266 ~~~~d~~ALl~~k~~l~~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~-~~~V~~L~Ls~~~L~G~i 339 (876)
T 4ecn_A 266 EYIKDYKALKAIWEALDGK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRVTGLSLAGFGAKGRV 339 (876)
T ss_dssp HHHHHHHHHHHHHHHTTGG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT-TSCEEEEECTTTCCEEEE
T ss_pred cchHHHHHHHHHHHHcCCC-----CCCcCCCcccccCCccccccccccccccCcCceEecC-CCCEEEEECccCCCCCcC
Confidence 3468999999999999887 787654 234 999 9999987 799999999999999999
Q ss_pred cccccCCccCcEeeC-CCCcccCcCChhhhCCC-CCcE---EEe------------cCCccc-----------CC-CCcc
Q 002061 90 SSSISALQSLTVLSL-PFNVLSGKLPLELSNCS-NLKV---LNV------------TGNAMV-----------GS-VPDL 140 (973)
Q Consensus 90 ~~~l~~l~~L~~L~L-s~n~l~~~~p~~l~~l~-~L~~---L~L------------~~n~l~-----------~~-~~~l 140 (973)
|++|++|++|++|+| ++|.++|..|....... .+.. ..+ ....+. .. +...
T Consensus 340 p~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~ 419 (876)
T 4ecn_A 340 PDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKK 419 (876)
T ss_dssp CGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCC
T ss_pred chHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcccccccc
Confidence 999999999999999 89999887553311110 0000 000 000000 00 0011
Q ss_pred cCCCCCCEEeccC--ccCCCccccccccccccceEEccCCcCCCC----------------CCccccc--CCCCCCEEEc
Q 002061 141 SALKNLEIFDLSI--NYFTGRFPRWVVNLTQLVSLSIGDNVYDEA----------------EIPESIG--NLKNLTYLFL 200 (973)
Q Consensus 141 ~~l~~L~~L~Ls~--n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~----------------~ip~~~~--~l~~L~~L~L 200 (973)
.....++.+.++. |.+++ +|..|.++++|++|+|++|.++.. .+|+.++ ++++|++|+|
T Consensus 420 ~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~L 498 (876)
T 4ecn_A 420 DSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVEL 498 (876)
T ss_dssp CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEE
T ss_pred ccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEEC
Confidence 2233444444444 77887 788888888888888888888741 2889888 9999999999
Q ss_pred ccCCCCCCCChhhhccCCCCeeeccccc-ccC-CCchhhhccc-------cccEEEeeccccCCcCCc--cccccccccE
Q 002061 201 AHCNLRGRIPESISELRELGTLDICRNK-ISG-EFPRSIRKLQ-------KLWKIELYANNLTGELPA--ELGNLTLLQE 269 (973)
Q Consensus 201 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~-l~~-~~~~~l~~l~-------~L~~L~L~~N~l~~~~~~--~l~~l~~L~~ 269 (973)
++|++.+.+|..|+++++|++|+|++|+ +++ .+|..+++++ +|++|+|++|+++ .+|. .++++++|+.
T Consensus 499 s~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~ 577 (876)
T 4ecn_A 499 YNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGL 577 (876)
T ss_dssp ESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCE
T ss_pred cCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCE
Confidence 9999999999999999999999999998 998 8999888877 9999999999999 8888 8999999999
Q ss_pred EEeeccccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCccc-ceeeeccCCccCCCCCcccccccc--cccccccc
Q 002061 270 FDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRK-LFAFSIYGNRFSGPFPENLGRYTA--LTDVDISE 346 (973)
Q Consensus 270 L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~-L~~L~l~~N~l~~~~~~~l~~l~~--L~~L~Ls~ 346 (973)
|+|++|+++ .+| .++++++|+.|++++|+++ .+|..+..+++ |+.|++++|+++ .+|..+..+.. |+.|+|++
T Consensus 578 L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~ 653 (876)
T 4ecn_A 578 LDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSY 653 (876)
T ss_dssp EECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCS
T ss_pred EECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcC
Confidence 999999998 788 8999999999999999999 88888999999 999999999999 78888877765 99999999
Q ss_pred ccccccCChhhhhhhhHHHHHhhhccCCCCcccccc--CccccceEeccccccccCCCccc-cCCCCcceEeccCCcCCC
Q 002061 347 NQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYA--DCKTIQRLRISDNHLSGKIPDGL-WALPNVGMLDFGDNDFTG 423 (973)
Q Consensus 347 N~l~~~~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~ 423 (973)
|++++.+|.. +..+. .+++|++|+|++|+|+ .+|..+ ..+++|+.|+|++|+++.
T Consensus 654 N~l~g~ip~l---------------------~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~~ 711 (876)
T 4ecn_A 654 NKIGSEGRNI---------------------SCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMTS 711 (876)
T ss_dssp SCTTTTSSSC---------------------SSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCSC
T ss_pred CcCCCccccc---------------------hhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCCc
Confidence 9998766542 22222 3458999999999999 556554 478999999999999996
Q ss_pred CCCCCCCCC-------CCCCEEEcccCCCCCCCChhhh--cCCCCCEEEccCCcCCCCccccccccccCCEEEcCC----
Q 002061 424 GISPLIGLS-------TSLSQLVLQNNRFSGELPSELG--RLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEE---- 490 (973)
Q Consensus 424 ~~~~~~~~~-------~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~---- 490 (973)
++...+... ++|+.|+|++|+|+ .+|..+. .+++|+.|+|++|++++ +|..+..+++|+.|+|++
T Consensus 712 ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~l 789 (876)
T 4ecn_A 712 IPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDA 789 (876)
T ss_dssp CCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCT
T ss_pred cChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCc
Confidence 666555543 38999999999999 7888887 89999999999999996 788899999999999987
Q ss_pred --cccccCCCccccccccccchhccccccccCCCccccccCCCCeeecCCCccCCCCChhhhcc-cCceEEccCCcccc
Q 002061 491 --NALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLSENQLSG 566 (973)
Q Consensus 491 --N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l-~L~~l~ls~N~l~~ 566 (973)
|++.+.+|..|.++++|+.|+|++|+| +.+|..+. ++|+.|+|++|++...-+..+... .+..+.|.+|++..
T Consensus 790 s~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~~~ 865 (876)
T 4ecn_A 790 EGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQD 865 (876)
T ss_dssp TCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTTCCEEECCTTSE
T ss_pred ccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHccccccchheeecCCCccc
Confidence 555555666666666666666666666 35555443 456666666666553333333332 24445555555443
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-56 Score=548.54 Aligned_cols=531 Identities=19% Similarity=0.198 Sum_probs=404.8
Q ss_pred CCCcceeeeCC---------CCCceEEEeecCCCCCccccccccCCccCcEeeCCCCcccCcCChhhhCCCCCcEEEecC
Q 002061 60 PCGFSGITCDS---------VTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTG 130 (973)
Q Consensus 60 ~c~w~gv~C~~---------~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~ 130 (973)
.|.+.-|.|.. ...+++.|+|+++++++..+..++.+++|++|+|++|.+++..|..|+++++|++|+|++
T Consensus 3 ~~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~ 82 (680)
T 1ziw_A 3 TVSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQH 82 (680)
T ss_dssp -CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCS
T ss_pred eeECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCC
Confidence 36666677753 235799999999999998888899999999999999999999999999999999999999
Q ss_pred CcccCCCCc-ccCCCCCCEEeccCccCCCccccccccccccceEEccCCcCCCCCCcccccCCCCCCEEEcccCCCCCCC
Q 002061 131 NAMVGSVPD-LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRI 209 (973)
Q Consensus 131 n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~ 209 (973)
|.+++.++. |+++++|++|+|++|.+++..|..|.++++|++|++++|.+... .|..++++++|++|++++|++++..
T Consensus 83 n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~ 161 (680)
T 1ziw_A 83 NELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSST-KLGTQVQLENLQELLLSNNKIQALK 161 (680)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCC-CCCSSSCCTTCCEEECCSSCCCCBC
T ss_pred CccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCccccc-CchhhcccccCCEEEccCCcccccC
Confidence 999998874 99999999999999999988889999999999999999998753 4677899999999999999999877
Q ss_pred Chhhh--ccCCCCeeecccccccCCCchhhhcc---------------------------ccccEEEeeccccCCcCCcc
Q 002061 210 PESIS--ELRELGTLDICRNKISGEFPRSIRKL---------------------------QKLWKIELYANNLTGELPAE 260 (973)
Q Consensus 210 ~~~~~--~l~~L~~L~L~~N~l~~~~~~~l~~l---------------------------~~L~~L~L~~N~l~~~~~~~ 260 (973)
+..+. .+++|++|++++|++++..|..+..+ ++|++|++++|.+++..|..
T Consensus 162 ~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~ 241 (680)
T 1ziw_A 162 SEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTT 241 (680)
T ss_dssp HHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTT
T ss_pred HHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhH
Confidence 77665 45889999999999887777666543 34566666666676666666
Q ss_pred cccccc--ccEEEeeccccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCc--------------------------
Q 002061 261 LGNLTL--LQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDM-------------------------- 312 (973)
Q Consensus 261 l~~l~~--L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l-------------------------- 312 (973)
|.+++. |++|+|++|++++..|..++.+++|++|++++|++.+..|..|..+
T Consensus 242 ~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~ 321 (680)
T 1ziw_A 242 FLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKID 321 (680)
T ss_dssp TGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEEC
T ss_pred hhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccC
Confidence 666644 7777777777776666677777777777777777766655555444
Q ss_pred -------ccceeeeccCCccCCCCCcccccccccccccccccccccc-CCh-hhhhhh-hHHHHHhh-hccCCCCccccc
Q 002061 313 -------RKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGS-FPK-YLCEKR-KLLNLLAL-SNNFSGEVPNSY 381 (973)
Q Consensus 313 -------~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~-~p~-~~~~~~-~ll~ll~l-~n~~~~~~p~~~ 381 (973)
++|+.|++++|.+++..+..|..+++|++|++++|.++.. ++. .+.... ..++.+.+ .|++.+..|..|
T Consensus 322 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~ 401 (680)
T 1ziw_A 322 DFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAF 401 (680)
T ss_dssp TTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTT
T ss_pred hhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhh
Confidence 4555555555555555555555555555555555543211 111 111110 01112222 455666667888
Q ss_pred cCccccceEeccccccccCCC-ccccCCCCcceEeccCCcCCCCCCCCCCCCCCCCEEEcccCCCC--CCCChhhhcCCC
Q 002061 382 ADCKTIQRLRISDNHLSGKIP-DGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFS--GELPSELGRLTN 458 (973)
Q Consensus 382 ~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~--~~~p~~~~~l~~ 458 (973)
..+++|++|+|++|++++.+| ..|.++++|++|++++|++++..+..|..+++|+.|++++|.+. +..|..|.++++
T Consensus 402 ~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~ 481 (680)
T 1ziw_A 402 SWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRN 481 (680)
T ss_dssp TTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTT
T ss_pred hCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCC
Confidence 889999999999999987665 67888899999999999988888888888888888888888876 567888888888
Q ss_pred CCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCC--------ccccccccccchhccccccccCCCccccccCC
Q 002061 459 LERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIP--------NEMGDCARIVDLNLARNSLSGNIPRSLSLLSS 530 (973)
Q Consensus 459 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p--------~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 530 (973)
|++|+|++|++++..+..|.++++|++|+|++|++++..+ ..|.++++|+.|+|++|+++...+..|.++++
T Consensus 482 L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~ 561 (680)
T 1ziw_A 482 LTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFE 561 (680)
T ss_dssp CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTT
T ss_pred CCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccC
Confidence 9999999999887777888888889999999988886532 23778888888888888888555567888888
Q ss_pred CCeeecCCCccCCCCChhhhccc-CceEEccCCccccccCcccc-cCCC--CccccCCCCCccCc
Q 002061 531 LNALNLSGNKLTGSIPDNLMKLK-LSSIDLSENQLSGSVPLDFL-RMGG--DGAFAGNEGLCLDQ 591 (973)
Q Consensus 531 L~~L~L~~N~l~~~~p~~l~~l~-L~~l~ls~N~l~~~~p~~~~-~~~~--~~~~~~n~~lc~~~ 591 (973)
|+.|+|++|+|++.++..+..++ |+.|+|++|++++..|..+. .+.. .-.+.+||+.|..+
T Consensus 562 L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~ 626 (680)
T 1ziw_A 562 LKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626 (680)
T ss_dssp CCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCC
T ss_pred cceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCc
Confidence 99999998988866666666665 88888888888887665443 2222 24568888888654
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-55 Score=546.74 Aligned_cols=496 Identities=19% Similarity=0.224 Sum_probs=386.6
Q ss_pred CCcceeeeCCCCCceEEEeecCCCCCccccccccCCccCcEeeCCCCcccCcC-ChhhhCCCCCcEEEecCCcccCCCC-
Q 002061 61 CGFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKL-PLELSNCSNLKVLNVTGNAMVGSVP- 138 (973)
Q Consensus 61 c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~-p~~l~~l~~L~~L~L~~n~l~~~~~- 138 (973)
|.|..|.+ ...+++.|||+++.+++..+..+..+++|++|+|++|.+.+.+ |..|+++++|++|+|++|.+.+..+
T Consensus 14 ~~L~~vP~--lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~ 91 (844)
T 3j0a_A 14 CNLTQVPQ--VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPD 91 (844)
T ss_dssp CCSSCCCS--SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTT
T ss_pred CCCCCCCC--CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHh
Confidence 56788877 5678999999999999999999999999999999999777677 7889999999999999999998755
Q ss_pred cccCCCCCCEEeccCccCCCccccc--cccccccceEEccCCcCCCCCCcccccCCCCCCEEEcccCCCCCCCChhhhcc
Q 002061 139 DLSALKNLEIFDLSINYFTGRFPRW--VVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISEL 216 (973)
Q Consensus 139 ~l~~l~~L~~L~Ls~n~l~~~~~~~--~~~l~~L~~L~l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 216 (973)
.|+++++|++|+|++|.+++..|.. |.++++|++|+|++|.+.....+..++++++|++|+|++|.+++..+..+..+
T Consensus 92 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l 171 (844)
T 3j0a_A 92 AFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPL 171 (844)
T ss_dssp SSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHH
T ss_pred HccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccc
Confidence 6999999999999999999877665 99999999999999999876666789999999999999999999999999988
Q ss_pred --CCCCeeecccccccCCCchhhhcccc------ccEEEeeccccCCcCCccccc-------------------------
Q 002061 217 --RELGTLDICRNKISGEFPRSIRKLQK------LWKIELYANNLTGELPAELGN------------------------- 263 (973)
Q Consensus 217 --~~L~~L~L~~N~l~~~~~~~l~~l~~------L~~L~L~~N~l~~~~~~~l~~------------------------- 263 (973)
++|+.|+|++|.+++..|..++.+.+ |++|++++|.+++..+..+..
T Consensus 172 ~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~ 251 (844)
T 3j0a_A 172 QGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHN 251 (844)
T ss_dssp HHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSS
T ss_pred cCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccc
Confidence 89999999999999888887776665 999999999888766655432
Q ss_pred -------------cccccEEEeeccccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeeccCCccCCCCC
Q 002061 264 -------------LTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFP 330 (973)
Q Consensus 264 -------------l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~ 330 (973)
.++|+.|+|++|.+.+..|..+..+++|+.|++++|++++..|..|..+++|+.|++++|++++..|
T Consensus 252 l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 331 (844)
T 3j0a_A 252 IKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYS 331 (844)
T ss_dssp STTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCS
T ss_pred cCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCH
Confidence 2578888888888888888888888888888888888888888888888888888888888888888
Q ss_pred ccccccccccccccccccccccCChhhhhhhhHHHHHhhhccCCCCccccccCccccceEeccccccccCCCccccCCCC
Q 002061 331 ENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPN 410 (973)
Q Consensus 331 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 410 (973)
..|..+++|+.|++++|++++..+..+..+.++. .+.+++|....++ .+++|+.|++++|+++ .+|.. ..+
T Consensus 332 ~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~-~L~Ls~N~l~~i~----~~~~L~~L~l~~N~l~-~l~~~---~~~ 402 (844)
T 3j0a_A 332 SNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQ-TLDLRDNALTTIH----FIPSIPDIFLSGNKLV-TLPKI---NLT 402 (844)
T ss_dssp CSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCC-EEEEETCCSCCCS----SCCSCSEEEEESCCCC-CCCCC---CTT
T ss_pred HHhcCCCCCCEEECCCCCCCccChhhhcCCCCCC-EEECCCCCCCccc----CCCCcchhccCCCCcc-ccccc---ccc
Confidence 8888888888888888888755544444333322 2233332222222 2555666666666665 33332 345
Q ss_pred cceEeccCCcCCCCCCC-CCCCCCCCCEEEcccCCCCCCCCh-hhhcCCCCCEEEccCCcCC-----CCccccccccccC
Q 002061 411 VGMLDFGDNDFTGGISP-LIGLSTSLSQLVLQNNRFSGELPS-ELGRLTNLERLILTNNNFS-----GKIPSALGALRQL 483 (973)
Q Consensus 411 L~~L~L~~N~l~~~~~~-~~~~~~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l~~L 483 (973)
++.|++++|++++.... .+..+++|+.|+|++|++++..+. .+..+++|+.|+|++|.++ +..+..|.++++|
T Consensus 403 l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L 482 (844)
T 3j0a_A 403 ANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHL 482 (844)
T ss_dssp CCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCE
T ss_pred cceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccc
Confidence 66666666666654322 234667777777777777754433 3455677777777777776 3344567777788
Q ss_pred CEEEcCCcccccCCCccccccccccchhccccccccCCCccccccCCCCeeecCCCccCCCCChhhhcccCceEEccCCc
Q 002061 484 SSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQ 563 (973)
Q Consensus 484 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~L~~l~ls~N~ 563 (973)
+.|+|++|+|++.+|..|.++++|+.|+|++|+|++..|..+. ++|+.|+|++|+|++.+|..+. .|+.+++++|+
T Consensus 483 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~--~L~~l~l~~Np 558 (844)
T 3j0a_A 483 QVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFV--SLSVLDITHNK 558 (844)
T ss_dssp ECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCS--SCCEEEEEEEC
T ss_pred cEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHhC--CcCEEEecCCC
Confidence 8888888888877777777788888888888888766666555 6788888888888877776654 46777888888
Q ss_pred cccccCcc
Q 002061 564 LSGSVPLD 571 (973)
Q Consensus 564 l~~~~p~~ 571 (973)
|.|.|+..
T Consensus 559 ~~C~c~~~ 566 (844)
T 3j0a_A 559 FICECELS 566 (844)
T ss_dssp CCCSSSCC
T ss_pred cccccccH
Confidence 88877753
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-56 Score=539.02 Aligned_cols=502 Identities=20% Similarity=0.175 Sum_probs=395.5
Q ss_pred CCCCc----ceeeeCC---------CCCceEEEeecCCCCCccccccccCCccCcEeeCCCCcccCcCChhhhCCCCCcE
Q 002061 59 SPCGF----SGITCDS---------VTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKV 125 (973)
Q Consensus 59 ~~c~w----~gv~C~~---------~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~ 125 (973)
++|.| ..|.|.. ...+++.|+|+++.+++..+..++++++|++|+|++|.+++..|..|+++++|++
T Consensus 5 ~~c~~~~~~~~~~c~~~~l~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~ 84 (606)
T 3vq2_A 5 NPCIEVVPNITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSN 84 (606)
T ss_dssp -CCEEEETTTEEECTTSCCSSCCTTSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCE
T ss_pred CCceecCCCCceEccCCCcccCCCCCCCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCE
Confidence 34655 3577754 2357999999999999988889999999999999999999888999999999999
Q ss_pred EEecCCcccCCCC-cccCCCCCCEEeccCccCCCccccccccccccceEEccCCcCCCCCCcccccCCCCCCEEEcccCC
Q 002061 126 LNVTGNAMVGSVP-DLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCN 204 (973)
Q Consensus 126 L~L~~n~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~ 204 (973)
|+|++|.+++.+| .|+++++|++|+|++|.+++..+..++++++|++|++++|.+....+|..++++++|++|+|++|+
T Consensus 85 L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~ 164 (606)
T 3vq2_A 85 LILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNY 164 (606)
T ss_dssp EECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSC
T ss_pred eECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCc
Confidence 9999999999855 699999999999999999988888999999999999999999877889999999999999999999
Q ss_pred CCCCCChhhhccCCCC----eeecccccccCCCchhhhccccccEEEeeccccC-CcCCccccccccccEEEe-------
Q 002061 205 LRGRIPESISELRELG----TLDICRNKISGEFPRSIRKLQKLWKIELYANNLT-GELPAELGNLTLLQEFDI------- 272 (973)
Q Consensus 205 l~~~~~~~~~~l~~L~----~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~-~~~~~~l~~l~~L~~L~L------- 272 (973)
+++..|..++.+++|+ +|++++|.+++..+..+... +|++|++++|.++ +..|..+.++++|+.+++
T Consensus 165 l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~ 243 (606)
T 3vq2_A 165 IQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKD 243 (606)
T ss_dssp CCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTT
T ss_pred ceecChhhhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhcccccccccccccccccc
Confidence 9998888888888776 79999999996555555544 8999999998775 223333333433333333
Q ss_pred --------------------------eccccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeeccCCccC
Q 002061 273 --------------------------SSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFS 326 (973)
Q Consensus 273 --------------------------s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 326 (973)
..|.+.+.+|. +..+++|+.|++++|.+.. +| .+..+++|+.|++++|.+
T Consensus 244 ~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~~-l~-~l~~~~~L~~L~l~~n~l- 319 (606)
T 3vq2_A 244 ERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIKY-LE-DVPKHFKWQSLSIIRCQL- 319 (606)
T ss_dssp SCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCCC-CC-CCCTTCCCSEEEEESCCC-
T ss_pred CCcccccChHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEEecCccchh-hh-hccccccCCEEEcccccC-
Confidence 33333333333 4444555555555555432 22 444445555555555555
Q ss_pred CCCCccccccccccccccccccccccCChhhhhhhhHHHHHhhhccCCCC--ccccccCccccceEeccccccccCCCcc
Q 002061 327 GPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGE--VPNSYADCKTIQRLRISDNHLSGKIPDG 404 (973)
Q Consensus 327 ~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~ll~l~n~~~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 404 (973)
+.+| .+ .+++|++|++++|+..+.+ .+..++++..+....|.+.+. +|..+..+++|++|+|++|.+++ +|..
T Consensus 320 ~~lp-~~-~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~ 394 (606)
T 3vq2_A 320 KQFP-TL-DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSAN 394 (606)
T ss_dssp SSCC-CC-CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCC
T ss_pred cccc-cC-CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhh
Confidence 2344 22 4444555555544333222 111222211111112222222 26677888999999999999985 6689
Q ss_pred ccCCCCcceEeccCCcCCCCCC-CCCCCCCCCCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCC-Ccccccccccc
Q 002061 405 LWALPNVGMLDFGDNDFTGGIS-PLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSG-KIPSALGALRQ 482 (973)
Q Consensus 405 ~~~l~~L~~L~L~~N~l~~~~~-~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~ 482 (973)
+..+++|+.|++++|++.+..+ ..+..+++|++|++++|++.+..|..+.++++|++|+|++|++++ .+|..|..+++
T Consensus 395 ~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~ 474 (606)
T 3vq2_A 395 FMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTN 474 (606)
T ss_dssp CTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTT
T ss_pred ccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCC
Confidence 9999999999999999999887 688999999999999999999999999999999999999999997 47889999999
Q ss_pred CCEEEcCCcccccCCCccccccccccchhccccccccCCCccccccCCCCeeecCCCccCCCCChhhhccc--CceEEcc
Q 002061 483 LSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLK--LSSIDLS 560 (973)
Q Consensus 483 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~--L~~l~ls 560 (973)
|++|+|++|++++..|..|+++++|+.|+|++|++++.+|..|..+++|+.|+|++|+|+ .+|..+..++ |+.|+++
T Consensus 475 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~ 553 (606)
T 3vq2_A 475 LTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLT 553 (606)
T ss_dssp CCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECC
T ss_pred CCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEcc
Confidence 999999999999999999999999999999999999999999999999999999999999 7887788873 9999999
Q ss_pred CCccccccCcc
Q 002061 561 ENQLSGSVPLD 571 (973)
Q Consensus 561 ~N~l~~~~p~~ 571 (973)
+|+|.|.|+..
T Consensus 554 ~N~~~c~c~~~ 564 (606)
T 3vq2_A 554 NNSVACICEHQ 564 (606)
T ss_dssp SCCCCCSSTTH
T ss_pred CCCcccCCccH
Confidence 99999999974
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-54 Score=530.49 Aligned_cols=497 Identities=20% Similarity=0.170 Sum_probs=399.4
Q ss_pred CceEEEeecCCCCCccccccccCCccCcEeeCCCCcccCcCChhhhCCCCCcEEEecCCcccCCCC-cccCCCCCCEEec
Q 002061 73 GRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVP-DLSALKNLEIFDL 151 (973)
Q Consensus 73 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~-~l~~l~~L~~L~L 151 (973)
.+++.|+|+++.+++..|..++.+++|++|+|++|.+++..+..|+.+++|++|+|++|++.+.++ .|+++++|++|+|
T Consensus 49 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 128 (680)
T 1ziw_A 49 SQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDL 128 (680)
T ss_dssp TTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEEC
T ss_pred CcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEEC
Confidence 467888999999988888888899999999999998885444578899999999999999888775 4888999999999
Q ss_pred cCccCCCccccccccccccceEEccCCcCCCCCCcccc--cCCCCCCEEEcccCCCCCCCChhhhcc-------------
Q 002061 152 SINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESI--GNLKNLTYLFLAHCNLRGRIPESISEL------------- 216 (973)
Q Consensus 152 s~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ip~~~--~~l~~L~~L~L~~n~l~~~~~~~~~~l------------- 216 (973)
++|.+++..|..+.++++|++|++++|.++.. .+..+ ..+++|++|++++|++++..|..+..+
T Consensus 129 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l 207 (680)
T 1ziw_A 129 SHNGLSSTKLGTQVQLENLQELLLSNNKIQAL-KSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQL 207 (680)
T ss_dssp CSSCCSCCCCCSSSCCTTCCEEECCSSCCCCB-CHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCC
T ss_pred CCCcccccCchhhcccccCCEEEccCCccccc-CHHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhcccccc
Confidence 99998888888888889999999988887642 23333 345778888888887777666555433
Q ss_pred --------------CCCCeeecccccccCCCchhhhcccc--ccEEEeeccccCCcCCccccccccccEEEeeccccccc
Q 002061 217 --------------RELGTLDICRNKISGEFPRSIRKLQK--LWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGK 280 (973)
Q Consensus 217 --------------~~L~~L~L~~N~l~~~~~~~l~~l~~--L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ 280 (973)
++|++|++++|++++..|..|..++. |++|+|++|++++..|..|..+++|++|++++|++.+.
T Consensus 208 ~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 287 (680)
T 1ziw_A 208 GPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHL 287 (680)
T ss_dssp HHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEE
T ss_pred ChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCcc
Confidence 33455555555555555555555543 66666666665555555555556666666665555544
Q ss_pred cCC---------------------------------ccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeeccCCccCC
Q 002061 281 LPE---------------------------------EIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSG 327 (973)
Q Consensus 281 ~p~---------------------------------~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 327 (973)
.|. .+..+++|+.|++++|++++..+..|..+++|+.|++++|.+..
T Consensus 288 ~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~ 367 (680)
T 1ziw_A 288 FSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSL 367 (680)
T ss_dssp CTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCC
T ss_pred ChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhh
Confidence 333 45667888888889999999888899999999999999998653
Q ss_pred C--CCcccccc--ccccccccccccccccCChhhhhhhhHHHHHhhhccCCCCcc-ccccCccccceEeccccccccCCC
Q 002061 328 P--FPENLGRY--TALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVP-NSYADCKTIQRLRISDNHLSGKIP 402 (973)
Q Consensus 328 ~--~~~~l~~l--~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~ll~l~n~~~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p 402 (973)
. ....+..+ ++|+.|++++|++++..|..+....++..+....|.+.+.+| ..|.++++|++|+|++|++.+..+
T Consensus 368 ~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~ 447 (680)
T 1ziw_A 368 RTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTR 447 (680)
T ss_dssp CEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCT
T ss_pred hhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeCh
Confidence 2 22334433 589999999999998888888777766554444566666665 689999999999999999999999
Q ss_pred ccccCCCCcceEeccCCcCC--CCCCCCCCCCCCCCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCcc------
Q 002061 403 DGLWALPNVGMLDFGDNDFT--GGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIP------ 474 (973)
Q Consensus 403 ~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p------ 474 (973)
..|..+++|+.|++++|.+. +..+..+..+++|+.|+|++|++++..+..|.++++|++|+|++|++++..+
T Consensus 448 ~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~ 527 (680)
T 1ziw_A 448 NSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGG 527 (680)
T ss_dssp TTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTS
T ss_pred hhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCC
Confidence 99999999999999999987 5677889999999999999999998888889999999999999999986422
Q ss_pred --ccccccccCCEEEcCCcccccCCCccccccccccchhccccccccCCCccccccCCCCeeecCCCccCCCCChhhh-c
Q 002061 475 --SALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLM-K 551 (973)
Q Consensus 475 --~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~-~ 551 (973)
..|.++++|++|+|++|+++.+.+..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++.+|..+. .
T Consensus 528 ~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~ 607 (680)
T 1ziw_A 528 PIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPA 607 (680)
T ss_dssp CCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHH
T ss_pred cchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhccc
Confidence 2478999999999999999977777899999999999999999988888899999999999999999988887776 5
Q ss_pred cc-CceEEccCCccccccCc
Q 002061 552 LK-LSSIDLSENQLSGSVPL 570 (973)
Q Consensus 552 l~-L~~l~ls~N~l~~~~p~ 570 (973)
++ |+.+++++|+|.|.|+.
T Consensus 608 ~~~L~~l~l~~N~~~c~c~~ 627 (680)
T 1ziw_A 608 FRNLTELDMRFNPFDCTCES 627 (680)
T ss_dssp HTTCSEEECTTCCCCBCCCC
T ss_pred ccccCEEEccCCCcccCCcc
Confidence 54 99999999999999984
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-54 Score=522.28 Aligned_cols=508 Identities=19% Similarity=0.182 Sum_probs=443.6
Q ss_pred EEeecCCCCCccccccccCCccCcEeeCCCCcccCcCChhhhCCCCCcEEEecCCcccCCCC-cccCCCCCCEEeccCcc
Q 002061 77 EISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVP-DLSALKNLEIFDLSINY 155 (973)
Q Consensus 77 ~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~-~l~~l~~L~~L~Ls~n~ 155 (973)
.++.++.+++ .+|..+.. ++++|+|++|.+++..|..|+++++|++|+|++|++.+..+ .|+++++|++|+|++|.
T Consensus 16 ~~~c~~~~l~-~iP~~l~~--~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~ 92 (606)
T 3t6q_A 16 TYNCENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANP 92 (606)
T ss_dssp EEECTTSCCS-SCCTTSCT--TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred eEECCCCCcc-cCcCCCCC--cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCc
Confidence 5788888887 67776654 79999999999998889999999999999999999988765 59999999999999999
Q ss_pred CCCccccccccccccceEEccCCcCCCCCCcccccCCCCCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCch
Q 002061 156 FTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPR 235 (973)
Q Consensus 156 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 235 (973)
+++..|..|.++++|++|++++|.++... |..++++++|++|+|++|++++..+..+..+++|++|++++|++++..|.
T Consensus 93 l~~~~~~~~~~l~~L~~L~L~~n~i~~l~-~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 171 (606)
T 3t6q_A 93 LIFMAETALSGPKALKHLFFIQTGISSID-FIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKE 171 (606)
T ss_dssp CSEECTTTTSSCTTCCEEECTTSCCSCGG-GSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHH
T ss_pred ccccChhhhcccccccEeeccccCcccCC-cchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChh
Confidence 99999999999999999999999997532 56789999999999999999985545555699999999999999988899
Q ss_pred hhhcccccc--EEEeeccccCCcCCccccccccccEEEeeccccc--------------------------cccCCccCC
Q 002061 236 SIRKLQKLW--KIELYANNLTGELPAELGNLTLLQEFDISSNQMY--------------------------GKLPEEIGN 287 (973)
Q Consensus 236 ~l~~l~~L~--~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~--------------------------~~~p~~~~~ 287 (973)
.++.+++|+ .|++++|.+++..|..+.. .+|+.|++++|... ...+..+..
T Consensus 172 ~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~ 250 (606)
T 3t6q_A 172 DMSSLQQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEG 250 (606)
T ss_dssp HHHTTTTCCSEEEECTTCCCCEECTTTTTT-CEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGG
T ss_pred hhhhhcccceeEEecCCCccCccChhHhhh-ccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhch
Confidence 999999999 8999999999777766554 68999999887511 011122222
Q ss_pred CC--CccEEEcccCCCCCCCCCCcCCcccceeeeccCCccCCCCCccccccccccccccccccccccCChhhhhhhhHHH
Q 002061 288 LK--NLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLN 365 (973)
Q Consensus 288 l~--~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~ 365 (973)
+. +|+.|++++|.+++..+..|+.+++|+.|++++|+++ .+|..+..+++|++|++++|++++..|..+..++.+..
T Consensus 251 l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 329 (606)
T 3t6q_A 251 LCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTH 329 (606)
T ss_dssp GGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSE
T ss_pred hhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCE
Confidence 32 7999999999999988888999999999999999999 78889999999999999999999888888888877665
Q ss_pred HHhhhccCCCCccc-cccCccccceEeccccccccCC--CccccCCCCcceEeccCCcCCCCCCCCCCCCCCCCEEEccc
Q 002061 366 LLALSNNFSGEVPN-SYADCKTIQRLRISDNHLSGKI--PDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQN 442 (973)
Q Consensus 366 ll~l~n~~~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~ 442 (973)
+...+|.+.+.+|. .+..+++|++|++++|.+++.. +..+..+++|+.|++++|++++..+..+..+++|++|++++
T Consensus 330 L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 409 (606)
T 3t6q_A 330 LSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAF 409 (606)
T ss_dssp EECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTT
T ss_pred EECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCC
Confidence 55556667767765 4899999999999999999766 88899999999999999999999999999999999999999
Q ss_pred CCCCCCCCh-hhhcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccccC---CCccccccccccchhccccccc
Q 002061 443 NRFSGELPS-ELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGS---IPNEMGDCARIVDLNLARNSLS 518 (973)
Q Consensus 443 N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~L~Ls~N~l~ 518 (973)
|++.+..|. .+..+++|++|++++|.+++..|..+..+++|++|+|++|++++. .+..+..+++|+.|+|++|+++
T Consensus 410 n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~ 489 (606)
T 3t6q_A 410 TRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLS 489 (606)
T ss_dssp CCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCC
T ss_pred CcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccC
Confidence 999977664 489999999999999999999999999999999999999999872 3467999999999999999999
Q ss_pred cCCCccccccCCCCeeecCCCccCCCCChhhhccc-CceEEccCCccccccCcccccCCC--CccccCCCCCccCc
Q 002061 519 GNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLK-LSSIDLSENQLSGSVPLDFLRMGG--DGAFAGNEGLCLDQ 591 (973)
Q Consensus 519 ~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~-L~~l~ls~N~l~~~~p~~~~~~~~--~~~~~~n~~lc~~~ 591 (973)
+..|..|..+++|+.|+|++|++++.+|..+..++ | .|+|++|++++..|..+..+.. .-.+.+||..|..+
T Consensus 490 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 564 (606)
T 3t6q_A 490 SIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS 564 (606)
T ss_dssp EECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred ccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence 99999999999999999999999999999999987 8 9999999999888865544332 24678998887543
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-53 Score=514.61 Aligned_cols=501 Identities=20% Similarity=0.181 Sum_probs=437.2
Q ss_pred EEEeecCCCCCccccccccCCccCcEeeCCCCcccCcCChhhhCCCCCcEEEecCCcccCCCC-cccCCCCCCEEeccCc
Q 002061 76 TEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVP-DLSALKNLEIFDLSIN 154 (973)
Q Consensus 76 ~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~-~l~~l~~L~~L~Ls~n 154 (973)
..++.++.+++ .+|..+. ++|++|+|++|.+++..+..|+++++|++|+|++|.+++.++ .|+++++|++|+|++|
T Consensus 14 ~~~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n 90 (606)
T 3vq2_A 14 ITYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGN 90 (606)
T ss_dssp TEEECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred CceEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCC
Confidence 46899999998 6777665 899999999999998888899999999999999999999866 5999999999999999
Q ss_pred cCCCccccccccccccceEEccCCcCCCCCCcccccCCCCCCEEEcccCCCCC-CCChhhhccCCCCeeecccccccCCC
Q 002061 155 YFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRG-RIPESISELRELGTLDICRNKISGEF 233 (973)
Q Consensus 155 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~ 233 (973)
.+++..|..|.++++|++|++++|.+.... |..++++++|++|+|++|++++ .+|..++++++|++|+|++|++++..
T Consensus 91 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~ 169 (606)
T 3vq2_A 91 PIQSFSPGSFSGLTSLENLVAVETKLASLE-SFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTIT 169 (606)
T ss_dssp CCCCCCTTSSTTCTTCCEEECTTSCCCCSS-SSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEEC
T ss_pred cccccChhhcCCcccCCEEEccCCcccccc-ccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecC
Confidence 999999999999999999999999997432 3679999999999999999986 57999999999999999999999888
Q ss_pred chhhhcccccc----EEEeeccccCCcCCccccccccccEEEeeccccc-cccCCccCCCCCccEEEc------------
Q 002061 234 PRSIRKLQKLW----KIELYANNLTGELPAELGNLTLLQEFDISSNQMY-GKLPEEIGNLKNLTVFQC------------ 296 (973)
Q Consensus 234 ~~~l~~l~~L~----~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~l------------ 296 (973)
+..++.+++|+ +|++++|.+++..+..+... +|++|++++|.+. +..|..+.++++|+.+++
T Consensus 170 ~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~ 248 (606)
T 3vq2_A 170 VNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLE 248 (606)
T ss_dssp TTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCS
T ss_pred hhhhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCccc
Confidence 88888888775 89999999996655555554 9999999999986 456666777777777665
Q ss_pred ---------------------ccCCCCCCCCCCcCCcccceeeeccCCccCCCCCccccccccccccccccccccccCCh
Q 002061 297 ---------------------FKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPK 355 (973)
Q Consensus 297 ---------------------~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~ 355 (973)
..|.+.+.+|. +..+++|+.|++++|.+.. +| .+..+++|++|++++|++ +.+|.
T Consensus 249 ~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~~-l~-~l~~~~~L~~L~l~~n~l-~~lp~ 324 (606)
T 3vq2_A 249 IFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIKY-LE-DVPKHFKWQSLSIIRCQL-KQFPT 324 (606)
T ss_dssp CCCGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCCC-CC-CCCTTCCCSEEEEESCCC-SSCCC
T ss_pred ccChHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEEecCccchh-hh-hccccccCCEEEcccccC-ccccc
Confidence 66777777777 8999999999999999974 55 899999999999999999 68884
Q ss_pred hhhhhhhHHHHHhhhcc-CCCCccccccCccccceEeccccccccC--CCccccCCCCcceEeccCCcCCCCCCCCCCCC
Q 002061 356 YLCEKRKLLNLLALSNN-FSGEVPNSYADCKTIQRLRISDNHLSGK--IPDGLWALPNVGMLDFGDNDFTGGISPLIGLS 432 (973)
Q Consensus 356 ~~~~~~~ll~ll~l~n~-~~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~ 432 (973)
. ....+. .+.++++ ..+.+ .+..+++|++|+|++|++++. .|..+..+++|+.|++++|.+++.+ ..+..+
T Consensus 325 ~--~l~~L~-~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~-~~~~~l 398 (606)
T 3vq2_A 325 L--DLPFLK-SLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMS-ANFMGL 398 (606)
T ss_dssp C--CCSSCC-EEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEEEC-CCCTTC
T ss_pred C--CCCccc-eeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccccch-hhccCC
Confidence 3 444433 3444443 44433 678999999999999999866 4889999999999999999998755 778899
Q ss_pred CCCCEEEcccCCCCCCCC-hhhhcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCccccc-CCCccccccccccch
Q 002061 433 TSLSQLVLQNNRFSGELP-SELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTG-SIPNEMGDCARIVDL 510 (973)
Q Consensus 433 ~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L 510 (973)
++|+.|++++|++.+..| ..+..+++|++|++++|++++..|..+..+++|++|++++|++++ .+|..|+.+++|+.|
T Consensus 399 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L 478 (606)
T 3vq2_A 399 EELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFL 478 (606)
T ss_dssp TTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEE
T ss_pred CCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEE
Confidence 999999999999998877 789999999999999999999999999999999999999999998 489999999999999
Q ss_pred hccccccccCCCccccccCCCCeeecCCCccCCCCChhhhccc-CceEEccCCccccccCcccccCCC---CccccCCCC
Q 002061 511 NLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLK-LSSIDLSENQLSGSVPLDFLRMGG---DGAFAGNEG 586 (973)
Q Consensus 511 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~-L~~l~ls~N~l~~~~p~~~~~~~~---~~~~~~n~~ 586 (973)
+|++|++++..|..|..+++|++|+|++|++++.+|..+..++ |+.|+|++|+++ .+|..+..+.. .-.+.+||.
T Consensus 479 ~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~ 557 (606)
T 3vq2_A 479 DLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSV 557 (606)
T ss_dssp ECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCC
T ss_pred ECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCc
Confidence 9999999999999999999999999999999998899999886 999999999999 67766666542 236799999
Q ss_pred CccCcc
Q 002061 587 LCLDQS 592 (973)
Q Consensus 587 lc~~~~ 592 (973)
.|..+.
T Consensus 558 ~c~c~~ 563 (606)
T 3vq2_A 558 ACICEH 563 (606)
T ss_dssp CCSSTT
T ss_pred ccCCcc
Confidence 987655
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=492.24 Aligned_cols=486 Identities=20% Similarity=0.211 Sum_probs=412.0
Q ss_pred CCceEEEeecCCCCCccccccccCCccCcEeeCCCCcccCcCChhhhCCCCCcEEEecCCcccCCCC-cccCCCCCCEEe
Q 002061 72 TGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVP-DLSALKNLEIFD 150 (973)
Q Consensus 72 ~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~-~l~~l~~L~~L~ 150 (973)
..+++.|+|+++.+++..+..++.+++|++|+|++|++++..|..|+++++|++|+|++|++++.++ .|+++++|++|+
T Consensus 27 ~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (570)
T 2z63_A 27 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 106 (570)
T ss_dssp CSSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEE
T ss_pred cccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccc
Confidence 3578999999999998888899999999999999999998778889999999999999999988775 599999999999
Q ss_pred ccCccCCCccccccccccccceEEccCCcCCCCCCcccccCCCCCCEEEcccCCCCCCCChhhhccCCC----Ceeeccc
Q 002061 151 LSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELREL----GTLDICR 226 (973)
Q Consensus 151 Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L----~~L~L~~ 226 (973)
+++|.+++..+..++++++|++|++++|.+....+|..++++++|++|++++|++++..+..++.+++| +.|++++
T Consensus 107 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~ 186 (570)
T 2z63_A 107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186 (570)
T ss_dssp CTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTT
T ss_pred ccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCC
Confidence 999999977776899999999999999999877789999999999999999999998888889999998 8999999
Q ss_pred ccccCCCchhhhccccccEEEeeccccCC-cCCccccccc--------------------------------cccEEEee
Q 002061 227 NKISGEFPRSIRKLQKLWKIELYANNLTG-ELPAELGNLT--------------------------------LLQEFDIS 273 (973)
Q Consensus 227 N~l~~~~~~~l~~l~~L~~L~L~~N~l~~-~~~~~l~~l~--------------------------------~L~~L~Ls 273 (973)
|.+++..|..+... +|++|++++|.... .++..+..++ .++.++++
T Consensus 187 n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~ 265 (570)
T 2z63_A 187 NPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265 (570)
T ss_dssp CCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEE
T ss_pred CCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhh
Confidence 99998888777766 89999999884331 1112222222 24566666
Q ss_pred cc-ccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeeccCCccCCCCCcccccccccccccccccccccc
Q 002061 274 SN-QMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGS 352 (973)
Q Consensus 274 ~N-~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ 352 (973)
+| .+.+..|..+..+++|+.|++++|.+. .+|..+..+ +|+.|++++|.+. .+|. ..+++|+.|++++|.+.+.
T Consensus 266 ~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~ 340 (570)
T 2z63_A 266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGNA 340 (570)
T ss_dssp ETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-SCCB--CBCSSCCEEEEESCBSCCB
T ss_pred cchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-ccCc--ccccccCEEeCcCCccccc
Confidence 66 666677778888888888888888887 567777777 8888888888887 4444 4677888888888877643
Q ss_pred CChhhhhhhhHHHHHhhhccCCCCccccccCccccceEeccccccccCC--CccccCCCCcceEeccCCcCCCCCCCCCC
Q 002061 353 FPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKI--PDGLWALPNVGMLDFGDNDFTGGISPLIG 430 (973)
Q Consensus 353 ~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 430 (973)
++ . ..+++|++|++++|++++.. |..+..+++|++|++++|++++.++. +.
T Consensus 341 ~~------------------------~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~ 393 (570)
T 2z63_A 341 FS------------------------E--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FL 393 (570)
T ss_dssp CC------------------------C--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EE
T ss_pred cc------------------------c--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-cc
Confidence 22 1 56789999999999998654 77889999999999999999987766 88
Q ss_pred CCCCCCEEEcccCCCCCCCC-hhhhcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccc-cCCCcccccccccc
Q 002061 431 LSTSLSQLVLQNNRFSGELP-SELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALT-GSIPNEMGDCARIV 508 (973)
Q Consensus 431 ~~~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~ 508 (973)
.+++|++|++++|++.+..| ..+.++++|++|++++|.+++..|..|..+++|++|+|++|+++ +.+|..+..+++|+
T Consensus 394 ~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~ 473 (570)
T 2z63_A 394 GLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT 473 (570)
T ss_dssp TCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCC
T ss_pred ccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCC
Confidence 99999999999999997766 57899999999999999999899999999999999999999998 67899999999999
Q ss_pred chhccccccccCCCccccccCCCCeeecCCCccCCCCChhhhccc-CceEEccCCccccccCcc-----cccCCCCcccc
Q 002061 509 DLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLK-LSSIDLSENQLSGSVPLD-----FLRMGGDGAFA 582 (973)
Q Consensus 509 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~-L~~l~ls~N~l~~~~p~~-----~~~~~~~~~~~ 582 (973)
.|+|++|++++..|..|..+++|+.|+|++|++++.+|..+..++ |+.|++++|+|+|.||.. |.+... ..+.
T Consensus 474 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~wl~~~~-~~~~ 552 (570)
T 2z63_A 474 FLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNS-QKEQ 552 (570)
T ss_dssp EEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTHHHHHHHHHTG-GGEE
T ss_pred EEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcchHHHHHHHHhcc-ccCC
Confidence 999999999998899999999999999999999988888888876 999999999999999964 222221 3455
Q ss_pred CCCCCccCcc
Q 002061 583 GNEGLCLDQS 592 (973)
Q Consensus 583 ~n~~lc~~~~ 592 (973)
+.+ .|..|.
T Consensus 553 ~~~-~C~~~~ 561 (570)
T 2z63_A 553 GSA-KCSGSG 561 (570)
T ss_dssp SCC-BBTTTC
T ss_pred Cch-hhCCCC
Confidence 555 887654
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-52 Score=492.96 Aligned_cols=485 Identities=19% Similarity=0.236 Sum_probs=316.8
Q ss_pred CCCcceeeeCCCCCceEEEeecCCCCCccccccccCCccCcEeeCCCCcccCcCChhhhCCCCCcEEEecCCcccCCCC-
Q 002061 60 PCGFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVP- 138 (973)
Q Consensus 60 ~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~- 138 (973)
.|.|.|| |+.. +++++ .+|+.+. ++|++|+|++|++++..|..|+.+++|++|+|++|++++.++
T Consensus 3 ~C~~~~~-c~~~----------~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~ 68 (549)
T 2z81_A 3 SCDASGV-CDGR----------SRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGD 68 (549)
T ss_dssp EECTTSE-EECT----------TSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTT
T ss_pred cCCCCce-EECC----------CCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChh
Confidence 4999998 8642 23333 3444332 456666666666665555566666666666666666655553
Q ss_pred cccCCCCCCEEeccCccCCCccccccccccccceEEccCCcCCCCCCcccccCCCCCCEEEcccCCCCCCC-ChhhhccC
Q 002061 139 DLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRI-PESISELR 217 (973)
Q Consensus 139 ~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~-~~~~~~l~ 217 (973)
.|+++++|++|||++|.+++..|..|+++++|++|++++|.+....+|..++++++|++|++++|++.+.+ +..+..++
T Consensus 69 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~ 148 (549)
T 2z81_A 69 AFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLT 148 (549)
T ss_dssp TTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCC
T ss_pred hccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhccc
Confidence 35666666666666666665555556666666666666666654445555666666666666666533233 24566666
Q ss_pred CCCeeecccccccCCCchhhhccccccEEEeeccccCCcCCcc-ccccccccEEEeecccccccc--C-CccCCCCCccE
Q 002061 218 ELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAE-LGNLTLLQEFDISSNQMYGKL--P-EEIGNLKNLTV 293 (973)
Q Consensus 218 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~-l~~l~~L~~L~Ls~N~l~~~~--p-~~~~~l~~L~~ 293 (973)
+|++|++++|++++..|..++.+++|++|+++.|.+.. +|.. +..+++|++|++++|++++.. | .....+++|+.
T Consensus 149 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~ 227 (549)
T 2z81_A 149 SLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAF-LLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKK 227 (549)
T ss_dssp EEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTT-HHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCE
T ss_pred ccCeeeccCCcccccChhhhhccccCceEecccCcccc-cchhhHhhcccccEEEccCCccccccccccchhhhhhcccc
Confidence 66666666666665566666666666666666666552 2322 234566666666666665431 1 11233455666
Q ss_pred EEcccCCCCCCCC----CCcCCcccceeeeccCCccCCCC------Ccccccccccccccccccccccc-----CChhhh
Q 002061 294 FQCFKNNFSGEFP----SGFGDMRKLFAFSIYGNRFSGPF------PENLGRYTALTDVDISENQFSGS-----FPKYLC 358 (973)
Q Consensus 294 L~l~~N~l~~~~p----~~~~~l~~L~~L~l~~N~l~~~~------~~~l~~l~~L~~L~Ls~N~l~~~-----~p~~~~ 358 (973)
|++++|.+++..+ ..+..+++|+.+++++|.+.+.. ...+..+.+|+.|+++++.+... ++.. .
T Consensus 228 L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~-~ 306 (549)
T 2z81_A 228 LAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTV-Y 306 (549)
T ss_dssp EEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHH-H
T ss_pred eeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhh-h
Confidence 6666665554322 22344455555666555554321 12234444555555555544321 0100 0
Q ss_pred hhhhHHHHHhhhccCCCCccccc-cCccccceEeccccccccCCC---ccccCCCCcceEeccCCcCCCCCC--CCCCCC
Q 002061 359 EKRKLLNLLALSNNFSGEVPNSY-ADCKTIQRLRISDNHLSGKIP---DGLWALPNVGMLDFGDNDFTGGIS--PLIGLS 432 (973)
Q Consensus 359 ~~~~ll~ll~l~n~~~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~L~~N~l~~~~~--~~~~~~ 432 (973)
.....++.+.++++..+.+|..+ ..+++|++|+|++|++++.+| ..+..+++|+.|++++|++++..+ ..+..+
T Consensus 307 ~~~~~L~~L~l~~n~l~~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l 386 (549)
T 2z81_A 307 SLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTL 386 (549)
T ss_dssp HHSTTCCEEEEESSCCCCCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGC
T ss_pred hhcccceEEEeccCccccCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcC
Confidence 11111222233334444566555 468999999999999997664 347789999999999999987653 457889
Q ss_pred CCCCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCCccccccccccchhc
Q 002061 433 TSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNL 512 (973)
Q Consensus 433 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 512 (973)
++|++|+|++|+++ .+|..+..+++|++|+|++|++++ +|..+. ++|++|+|++|+|++.+ ..+++|+.|+|
T Consensus 387 ~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~-l~~~~~--~~L~~L~Ls~N~l~~~~----~~l~~L~~L~L 458 (549)
T 2z81_A 387 KNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV-VKTCIP--QTLEVLDVSNNNLDSFS----LFLPRLQELYI 458 (549)
T ss_dssp TTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSC-CCTTSC--TTCSEEECCSSCCSCCC----CCCTTCCEEEC
T ss_pred CCCCEEECCCCCCc-cCChhhcccccccEEECCCCCccc-ccchhc--CCceEEECCCCChhhhc----ccCChhcEEEC
Confidence 99999999999999 688889999999999999999984 444432 68999999999999753 57899999999
Q ss_pred cccccccCCCccccccCCCCeeecCCCccCCCCChhhhccc-CceEEccCCccccccCc
Q 002061 513 ARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLK-LSSIDLSENQLSGSVPL 570 (973)
Q Consensus 513 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~-L~~l~ls~N~l~~~~p~ 570 (973)
++|+|+ .+|. ...+++|+.|+|++|+|++.+|..+..++ |+.|++++|+|.|.||.
T Consensus 459 s~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 515 (549)
T 2z81_A 459 SRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 515 (549)
T ss_dssp CSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHHH
T ss_pred CCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCcc
Confidence 999999 6776 56899999999999999998888888886 99999999999999994
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=504.69 Aligned_cols=459 Identities=20% Similarity=0.211 Sum_probs=399.4
Q ss_pred CceEEEeecCCCCCccc-cccccCCccCcEeeCCCCcccCcCChhhhCCCCCcEEEecCCcccCCC-Cc--ccCCCCCCE
Q 002061 73 GRVTEISFDNKSLSGEI-SSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSV-PD--LSALKNLEI 148 (973)
Q Consensus 73 ~~v~~l~l~~~~l~~~~-~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~-~~--l~~l~~L~~ 148 (973)
.+.+.|+|+++...+.+ |..++++++|++|+|++|.+++..|..|+.+++|++|+|++|.+++.. +. ++++++|++
T Consensus 48 ~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~ 127 (844)
T 3j0a_A 48 EQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTR 127 (844)
T ss_dssp CSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCE
T ss_pred ccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCE
Confidence 46889999999888888 678999999999999999999888999999999999999999998854 33 899999999
Q ss_pred EeccCccCCCccc-cccccccccceEEccCCcCCCCCCcccccCC--CCCCEEEcccCCCCCCCChhhhccCC------C
Q 002061 149 FDLSINYFTGRFP-RWVVNLTQLVSLSIGDNVYDEAEIPESIGNL--KNLTYLFLAHCNLRGRIPESISELRE------L 219 (973)
Q Consensus 149 L~Ls~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~ip~~~~~l--~~L~~L~L~~n~l~~~~~~~~~~l~~------L 219 (973)
|||++|.+++..+ ..|.++++|++|+|++|.+... .|..+..+ ++|+.|+|++|.+.+..|..++.+.+ |
T Consensus 128 L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~-~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L 206 (844)
T 3j0a_A 128 LDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLV-CEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVL 206 (844)
T ss_dssp EEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCC-CSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCB
T ss_pred EECCCCcccccccchhHhhCCCCCEEECCCCcCCee-CHHHcccccCCccceEECCCCccccccccchhhcCCccccCce
Confidence 9999999987765 6899999999999999998753 46777777 89999999999999988888777766 9
Q ss_pred CeeecccccccCCCchhhhcc--------------------------------------ccccEEEeeccccCCcCCccc
Q 002061 220 GTLDICRNKISGEFPRSIRKL--------------------------------------QKLWKIELYANNLTGELPAEL 261 (973)
Q Consensus 220 ~~L~L~~N~l~~~~~~~l~~l--------------------------------------~~L~~L~L~~N~l~~~~~~~l 261 (973)
++|+|++|++++..+..+... ++|++|+|++|.+++..+..|
T Consensus 207 ~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~ 286 (844)
T 3j0a_A 207 EILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVF 286 (844)
T ss_dssp SEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCS
T ss_pred eEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhh
Confidence 999999998887666555432 689999999999998889999
Q ss_pred cccccccEEEeeccccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeeccCCccCCCCCccccccccccc
Q 002061 262 GNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTD 341 (973)
Q Consensus 262 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~ 341 (973)
..+++|+.|+|++|++++..|..|..+++|++|++++|++++..|..|..+++|+.|++++|++++..+..|..+++|++
T Consensus 287 ~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~ 366 (844)
T 3j0a_A 287 ETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQT 366 (844)
T ss_dssp SSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCE
T ss_pred hcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCE
Confidence 99999999999999999999999999999999999999999988999999999999999999999888889999999999
Q ss_pred cccccccccccCChhhhhhhhHHHHHhhhccCCCCccccccCccccceEeccccccccCCC-ccccCCCCcceEeccCCc
Q 002061 342 VDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIP-DGLWALPNVGMLDFGDND 420 (973)
Q Consensus 342 L~Ls~N~l~~~~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~ 420 (973)
|+|++|.+++ ++. .+. ++.+.+++|....+|.. ..+++.|++++|++++... ..+..+++|+.|+|++|+
T Consensus 367 L~Ls~N~l~~-i~~----~~~-L~~L~l~~N~l~~l~~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~ 437 (844)
T 3j0a_A 367 LDLRDNALTT-IHF----IPS-IPDIFLSGNKLVTLPKI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNR 437 (844)
T ss_dssp EEEETCCSCC-CSS----CCS-CSEEEEESCCCCCCCCC---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCC
T ss_pred EECCCCCCCc-ccC----CCC-cchhccCCCCccccccc---ccccceeecccCccccCchhhhhhcCCccceeeCCCCc
Confidence 9999999984 332 122 23344555555566654 4679999999999986432 235589999999999999
Q ss_pred CCCCCCC-CCCCCCCCCEEEcccCCCC-----CCCChhhhcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccc
Q 002061 421 FTGGISP-LIGLSTSLSQLVLQNNRFS-----GELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALT 494 (973)
Q Consensus 421 l~~~~~~-~~~~~~~L~~L~L~~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 494 (973)
+++..+. .+..+++|+.|+|++|.++ +..+..|.++++|+.|+|++|++++..|..|.++++|+.|+|++|+|+
T Consensus 438 l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 517 (844)
T 3j0a_A 438 FSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT 517 (844)
T ss_dssp CCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCS
T ss_pred ccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCC
Confidence 9977654 4566899999999999997 445567889999999999999999999999999999999999999999
Q ss_pred cCCCccccccccccchhccccccccCCCccccccCCCCeeecCCCccCCCCC
Q 002061 495 GSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIP 546 (973)
Q Consensus 495 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 546 (973)
+.++..+. ++|+.|+|++|+|++.+|..| .+|+.|+|++|++....+
T Consensus 518 ~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~---~~L~~l~l~~Np~~C~c~ 564 (844)
T 3j0a_A 518 VLSHNDLP--ANLEILDISRNQLLAPNPDVF---VSLSVLDITHNKFICECE 564 (844)
T ss_dssp SCCCCCCC--SCCCEEEEEEECCCCCCSCCC---SSCCEEEEEEECCCCSSS
T ss_pred ccChhhhh--ccccEEECCCCcCCCCChhHh---CCcCEEEecCCCcccccc
Confidence 88888776 899999999999999999876 479999999999987554
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-51 Score=444.26 Aligned_cols=261 Identities=22% Similarity=0.317 Sum_probs=213.2
Q ss_pred cCCcccCcccccCceEEEEEEec-----CCCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLK-----KNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF 747 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~-----~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 747 (973)
.++++.++||+|+||+||+|++. .+++.||||+++.. ...++|.+|+.++++++|||||++++++.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 45677889999999999999974 35778999998653 34578999999999999999999999999999999
Q ss_pred EEEEccCCCchHHHHHhhhcC-----------CCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCC
Q 002061 748 LVLEYMPNGNLFQALHKRVKE-----------GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY 816 (973)
Q Consensus 748 lv~e~~~~gsL~~~l~~~~~~-----------~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~ 816 (973)
+|||||++|+|.+++..+... ....++|..+..++.|||+||+||| +++||||||||+|||+++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCC
Confidence 999999999999999754211 1235899999999999999999999 78999999999999999999
Q ss_pred CeEEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHH
Q 002061 817 EPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWV 895 (973)
Q Consensus 817 ~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~ 895 (973)
.+||+|||+++...............||++|||||++.++.|+.++|||||||++|||+| |+.||.+. ...++...+
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~--~~~~~~~~i 260 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY--SNQDVVEMI 260 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTC--CHHHHHHHH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCC--CHHHHHHHH
Confidence 999999999987654433333445679999999999999999999999999999999998 89999754 222222222
Q ss_pred HHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 002061 896 STHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADP 955 (973)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 955 (973)
.. ... ...+..++..+.+++.+||+.||++|||++||+++|+.+.+
T Consensus 261 ~~----~~~----------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~n 306 (308)
T 4gt4_A 261 RN----RQV----------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN 306 (308)
T ss_dssp HT----TCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC
T ss_pred Hc----CCC----------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccC
Confidence 21 110 01122344568899999999999999999999999997754
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-51 Score=447.74 Aligned_cols=262 Identities=24% Similarity=0.361 Sum_probs=205.7
Q ss_pred cCCcccCcccccCceEEEEEEec-----CCCcEEEEEeeecc--ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLK-----KNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL 748 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~-----~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 748 (973)
.+|.+.++||+|+||+||+|++. .+++.||||+++.. ...++|.+|++++++++|||||++++++.+++..|+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45677889999999999999875 35788999998763 345679999999999999999999999999999999
Q ss_pred EEEccCCCchHHHHHhhhcC----------CCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCe
Q 002061 749 VLEYMPNGNLFQALHKRVKE----------GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP 818 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~----------~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~ 818 (973)
|||||++|+|.++++.+... ....++|.++..++.|||+||+||| +++||||||||+|||+++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcE
Confidence 99999999999999864221 2346899999999999999999999 7899999999999999999999
Q ss_pred EEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHH
Q 002061 819 KIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVST 897 (973)
Q Consensus 819 kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~ 897 (973)
||+|||+++...............||+.|||||++.+..|+.++|||||||++|||+| |+.||... ...+....+..
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~--~~~~~~~~i~~ 275 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL--SNTEAIDCITQ 275 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSS--CHHHHHHHHHH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCC--CHHHHHHHHHc
Confidence 9999999987655443333445679999999999999999999999999999999999 89999754 11222222211
Q ss_pred HhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCC
Q 002061 898 HLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPC 956 (973)
Q Consensus 898 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~ 956 (973)
... ...+..+.+++.+++.+||+.||++|||++||+++|+.+...
T Consensus 276 ---g~~-----------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 276 ---GRE-----------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp ---TCC-----------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ---CCC-----------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 110 011123345688999999999999999999999999987544
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=444.51 Aligned_cols=261 Identities=26% Similarity=0.396 Sum_probs=212.0
Q ss_pred cCCcccCcccccCceEEEEEEec-----CCCcEEEEEeeecc--ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLK-----KNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL 748 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~-----~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 748 (973)
++|.+.+.||+|+||+||+|++. .++..||||+++.. ...++|.+|++++++++|||||++++++.+++..|+
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 46788899999999999999975 35788999998763 345679999999999999999999999999999999
Q ss_pred EEEccCCCchHHHHHhhh--------cCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEE
Q 002061 749 VLEYMPNGNLFQALHKRV--------KEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKI 820 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~--------~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl 820 (973)
|||||++|+|.++++.+. ......++|.++..++.|||+||+||| +++||||||||+|||+++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEEE
Confidence 999999999999998642 123456999999999999999999999 789999999999999999999999
Q ss_pred ecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHh
Q 002061 821 ADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHL 899 (973)
Q Consensus 821 ~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~ 899 (973)
+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||... ...++...+...
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~--~~~~~~~~i~~~- 246 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL--SNNEVIECITQG- 246 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS--CHHHHHHHHHHT-
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHHcC-
Confidence 99999987654433333334568999999999999999999999999999999999 89999754 122222222111
Q ss_pred ccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 002061 900 NNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADP 955 (973)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 955 (973)
.. ...+..++.++.+++.+||+.||++|||++||.+.|+++..
T Consensus 247 --~~-----------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 247 --RV-----------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp --CC-----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CC-----------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 10 01112334568899999999999999999999999987653
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=434.17 Aligned_cols=260 Identities=29% Similarity=0.431 Sum_probs=202.4
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeec----cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE 751 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 751 (973)
+++++.++||+|+||+||+|++.. .||||+++. ....+.|.+|++++++++|||||++++++.+ +..|+|||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 467889999999999999998763 699998864 2345679999999999999999999998754 56899999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccC
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 831 (973)
||++|+|.++++.. ...++|..+..|+.|||+||+||| +++||||||||+|||+++++.+||+|||+|+....
T Consensus 112 y~~gGsL~~~l~~~----~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 112 WCEGSSLYKHLHVQ----ETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp CCSSCBHHHHHHTS----CCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred cCCCCCHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 99999999999753 346899999999999999999999 78999999999999999999999999999987654
Q ss_pred CCCcccccccCCcccccccccccc---CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchh
Q 002061 832 SPKVSDYSCFAGTHGYIAPELAYT---CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKV 908 (973)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (973)
...........||+.|||||++.+ ..|+.++|||||||++|||+||+.||.... ... .+.........
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~--~~~---~~~~~~~~~~~---- 255 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN--NRD---QIIFMVGRGYA---- 255 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC--CHH---HHHHHHHTTCC----
T ss_pred CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCC--hHH---HHHHHHhcCCC----
Confidence 433333445689999999999864 458999999999999999999999996531 111 11111111100
Q ss_pred ccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCCC
Q 002061 909 LDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPCT 957 (973)
Q Consensus 909 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 957 (973)
.+.. ......++..+.+++.+||+.||++|||+.||+++|+.++...
T Consensus 256 -~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 256 -SPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp -CCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred -CCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 0100 1112234456889999999999999999999999998876543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=440.80 Aligned_cols=251 Identities=22% Similarity=0.330 Sum_probs=204.3
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL 750 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 750 (973)
+++|++.+.||+|+||+||+|++..+|+.||||++... ...+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 46899999999999999999999999999999998753 34567899999999999999999999999999999999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccccc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 830 (973)
|||+||+|.+++... ....+++..+..++.||+.||+||| +++||||||||+|||++.+|.+||+|||+|+...
T Consensus 103 Ey~~gg~L~~~i~~~---~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 176 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQ---KGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN 176 (350)
T ss_dssp ECCTTCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCC
T ss_pred eCCCCCcHHHHHHHc---CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeec
Confidence 999999999999753 2345788899999999999999999 7899999999999999999999999999998654
Q ss_pred CCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhcc
Q 002061 831 NSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLD 910 (973)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (973)
... ......+||+.|||||++.+..|+.++||||+||++|||++|+.||... +....+........
T Consensus 177 ~~~--~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~-----~~~~~~~~i~~~~~------- 242 (350)
T 4b9d_A 177 STV--ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG-----SMKNLVLKIISGSF------- 242 (350)
T ss_dssp HHH--HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS-----SHHHHHHHHHHTCC-------
T ss_pred CCc--ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-----CHHHHHHHHHcCCC-------
Confidence 321 1123457999999999999999999999999999999999999999653 22222222221111
Q ss_pred ccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 911 CEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 911 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
+ ........++.+++.+||+.||++|||+.|+++|
T Consensus 243 ~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 243 P----PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred C----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0111234568899999999999999999999875
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-50 Score=435.93 Aligned_cols=249 Identities=24% Similarity=0.361 Sum_probs=209.1
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeec--cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK--GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM 753 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 753 (973)
..|+..++||+|+||+||+|+++.+|+.||||++.. ....+.+.+|++++++++|||||+++++|.+++..|+|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 468888999999999999999999999999999865 344566889999999999999999999999999999999999
Q ss_pred CCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCC
Q 002061 754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833 (973)
Q Consensus 754 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 833 (973)
+||+|.+++... .+++..+..++.||+.||+||| +++||||||||+|||++.+|.+||+|||+|+......
T Consensus 154 ~gg~L~~~l~~~------~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 224 (346)
T 4fih_A 154 EGGALTDIVTHT------RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 224 (346)
T ss_dssp TTEEHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred CCCcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence 999999999752 4899999999999999999999 7899999999999999999999999999998765432
Q ss_pred CcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccc
Q 002061 834 KVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEV 913 (973)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (973)
. .....+||+.|||||++.+..|+.++||||+||++|||++|+.||... +............. +.
T Consensus 225 ~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~-----~~~~~~~~i~~~~~-------~~- 289 (346)
T 4fih_A 225 P--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE-----PPLKAMKMIRDNLP-------PR- 289 (346)
T ss_dssp C--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-----CHHHHHHHHHHSSC-------CC-
T ss_pred C--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-----CHHHHHHHHHcCCC-------CC-
Confidence 2 233468999999999999999999999999999999999999999653 11122111111111 00
Q ss_pred cCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 914 ASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 914 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
..........+.+++.+||+.||++|||+.|+++|
T Consensus 290 -~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 290 -LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp -CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 01122334568899999999999999999999987
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-50 Score=430.58 Aligned_cols=247 Identities=24% Similarity=0.339 Sum_probs=210.2
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeec-----cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL 750 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~-----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 750 (973)
++|++.+.||+|+||+||+|++..+++.||||++.+ ....+.+.+|++++++++|||||++++++++++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 569999999999999999999999999999999875 345677899999999999999999999999999999999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccccc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 830 (973)
||++||+|.+++.+. ..+++..+..++.||+.||+||| +++||||||||+|||++.++.+||+|||+|+...
T Consensus 112 Ey~~gG~L~~~i~~~-----~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~ 183 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 183 (311)
T ss_dssp CCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecC
Confidence 999999999999864 35899999999999999999999 7899999999999999999999999999998776
Q ss_pred CCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhcc
Q 002061 831 NSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLD 910 (973)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (973)
...........+||+.|||||++.+..|+.++||||+||++|||++|+.||... +..............+
T Consensus 184 ~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~-----~~~~~~~~i~~~~~~~----- 253 (311)
T 4aw0_A 184 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG-----NEGLIFAKIIKLEYDF----- 253 (311)
T ss_dssp TTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHTCCCC-----
T ss_pred CCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHcCCCCC-----
Confidence 544434445578999999999999999999999999999999999999999653 2222222222211111
Q ss_pred ccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 002061 911 CEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVV 947 (973)
Q Consensus 911 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl 947 (973)
+.....++.+++.+|++.||++|||+.|++
T Consensus 254 -------p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 254 -------PEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp -------CTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred -------CcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 112234678899999999999999999863
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=470.26 Aligned_cols=457 Identities=21% Similarity=0.255 Sum_probs=395.9
Q ss_pred EEEeecCCCCCccccccccCCccCcEeeCCCCcccCcCChhhhCCCCCcEEEecCCcccCCCC-cccCCCCCCEEeccCc
Q 002061 76 TEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVP-DLSALKNLEIFDLSIN 154 (973)
Q Consensus 76 ~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~-~l~~l~~L~~L~Ls~n 154 (973)
+.+|+++++++ .+|..+. ++|++|+|++|.+++..|..|..+++|++|+|++|++++.++ .|+++++|++|||++|
T Consensus 3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 79 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence 46899999999 6888777 899999999999998778899999999999999999998855 6999999999999999
Q ss_pred cCCCccccccccccccceEEccCCcCCCCCCcccccCCCCCCEEEcccCCCCCCCChhhhccCCC--Ceeecccccc--c
Q 002061 155 YFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELREL--GTLDICRNKI--S 230 (973)
Q Consensus 155 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L--~~L~L~~N~l--~ 230 (973)
+++ .+|.. .+++|++|++++|.+....+|..++++++|++|+|++|++++ ..+..+++| ++|++++|++ +
T Consensus 80 ~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~ 153 (520)
T 2z7x_B 80 KLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGE 153 (520)
T ss_dssp CCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTS
T ss_pred cee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeeccccccc
Confidence 999 56666 899999999999999877789999999999999999999986 567888888 9999999999 8
Q ss_pred CCCchhhhccc-cccEEEeeccccCCcCCc-cccccccccEEEeeccc-------cccccCCccCCCCCccEEEcccCCC
Q 002061 231 GEFPRSIRKLQ-KLWKIELYANNLTGELPA-ELGNLTLLQEFDISSNQ-------MYGKLPEEIGNLKNLTVFQCFKNNF 301 (973)
Q Consensus 231 ~~~~~~l~~l~-~L~~L~L~~N~l~~~~~~-~l~~l~~L~~L~Ls~N~-------l~~~~p~~~~~l~~L~~L~l~~N~l 301 (973)
+..|..+..+. +...+++++|.+.+.++. .+.++++|+.|++++|. +.+.+| .+..+++|+.|++++|.+
T Consensus 154 ~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l 232 (520)
T 2z7x_B 154 KEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIET 232 (520)
T ss_dssp SCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEE
T ss_pred ccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhcccccccc
Confidence 88898888876 455678889998876654 57889999999999998 777766 789999999999999998
Q ss_pred CCCCCCCcC---CcccceeeeccCCccCCCCCccc-----cccccccccccccccccccCC-hhhhhhhhHHHHHhhhcc
Q 002061 302 SGEFPSGFG---DMRKLFAFSIYGNRFSGPFPENL-----GRYTALTDVDISENQFSGSFP-KYLCEKRKLLNLLALSNN 372 (973)
Q Consensus 302 ~~~~p~~~~---~l~~L~~L~l~~N~l~~~~~~~l-----~~l~~L~~L~Ls~N~l~~~~p-~~~~~~~~ll~ll~l~n~ 372 (973)
++..+..+. ..++|+.|++++|++++.+|..+ +.+++|+.+++++|.+ .+| ..++...
T Consensus 233 ~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~----------- 299 (520)
T 2z7x_B 233 TWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIF----------- 299 (520)
T ss_dssp EHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHH-----------
T ss_pred CHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhccc-----------
Confidence 764332211 24589999999999999999998 9999999999999999 555 3333221
Q ss_pred CCCCccccccCccccceEeccccccccCCCccccCCCCcceEeccCCcCCCCCCCCCCCCCCCCEEEcccCCCCC--CCC
Q 002061 373 FSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSG--ELP 450 (973)
Q Consensus 373 ~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~--~~p 450 (973)
...+|+.|++++|.+.+.. .+..+++|++|++++|++++..+..++.+++|++|+|++|++++ .+|
T Consensus 300 ----------~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~ 367 (520)
T 2z7x_B 300 ----------SNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIA 367 (520)
T ss_dssp ----------HTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHH
T ss_pred ----------ccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccch
Confidence 1157999999999987432 22688999999999999999889999999999999999999996 556
Q ss_pred hhhhcCCCCCEEEccCCcCCCCccc-cccccccCCEEEcCCcccccCCCccccccccccchhccccccccCCCccccccC
Q 002061 451 SELGRLTNLERLILTNNNFSGKIPS-ALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLS 529 (973)
Q Consensus 451 ~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 529 (973)
..+..+++|++|+|++|++++.+|. .+..+++|++|+|++|++++..|..+. ++|+.|+|++|+|+ .+|..+..++
T Consensus 368 ~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~ 444 (520)
T 2z7x_B 368 EMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLE 444 (520)
T ss_dssp HHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCT
T ss_pred HHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCC
Confidence 7899999999999999999985665 588999999999999999988877765 79999999999999 7888888999
Q ss_pred CCCeeecCCCccCCCCChh-hhccc-CceEEccCCccccccCcc
Q 002061 530 SLNALNLSGNKLTGSIPDN-LMKLK-LSSIDLSENQLSGSVPLD 571 (973)
Q Consensus 530 ~L~~L~L~~N~l~~~~p~~-l~~l~-L~~l~ls~N~l~~~~p~~ 571 (973)
+|+.|+|++|+|+ .+|.. +..++ |+.|++++|+|+|.|+..
T Consensus 445 ~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~~~ 487 (520)
T 2z7x_B 445 ALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 487 (520)
T ss_dssp TCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHHHH
T ss_pred CCCEEECCCCcCC-ccCHHHhccCCcccEEECcCCCCcccCCch
Confidence 9999999999999 56665 77775 999999999999999854
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=430.79 Aligned_cols=253 Identities=21% Similarity=0.247 Sum_probs=206.6
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccC
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP 754 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 754 (973)
...|+..++||+|+||+||+|+++.+|+.||||+++.+.. ..+|++++++++|||||++++++.+++..|+|||||+
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~---~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~ 133 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF---RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE 133 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh---HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence 4567888999999999999999999999999999976432 2479999999999999999999999999999999999
Q ss_pred CCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCC-CeEEecccCcccccCCC
Q 002061 755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY-EPKIADFGVAKIAENSP 833 (973)
Q Consensus 755 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfgl~~~~~~~~ 833 (973)
||+|.++++.. ..+++..+..++.||+.||+||| +++||||||||+|||++.+| .+||+|||+|+......
T Consensus 134 gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 134 GGSLGQLIKQM-----GCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp TCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 99999999864 35899999999999999999999 88999999999999999987 69999999998775432
Q ss_pred Ccc---cccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhcc
Q 002061 834 KVS---DYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLD 910 (973)
Q Consensus 834 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (973)
... .....+||+.|||||++.+..|+.++||||+||++|||++|+.||..... ......+.. ......
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~--~~~~~~i~~---~~~~~~---- 276 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFR--GPLCLKIAS---EPPPIR---- 276 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCC--SCCHHHHHH---SCCGGG----
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH--HHHHHHHHc---CCCCch----
Confidence 211 22335799999999999999999999999999999999999999976422 111111111 111000
Q ss_pred ccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 002061 911 CEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952 (973)
Q Consensus 911 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~ 952 (973)
..+......+.+++.+||++||.+|||+.|+++++..
T Consensus 277 -----~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 277 -----EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp -----GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -----hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 1122334568889999999999999999999998865
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-49 Score=420.82 Aligned_cols=244 Identities=25% Similarity=0.327 Sum_probs=197.5
Q ss_pred cccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEe----CCeeEEEE
Q 002061 679 EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLK----GGSSFLVL 750 (973)
Q Consensus 679 ~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~~~lv~ 750 (973)
++.++||+|+||+||+|++..+++.||||++... ...+.|.+|++++++++|||||+++++|.+ +...|+||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 5667899999999999999999999999998653 345678999999999999999999999865 34689999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCC--eEecCCCCCCeeecC-CCCeEEecccCcc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP--IIHRDIKSSNILLDE-DYEPKIADFGVAK 827 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~--ivH~Dlkp~Nill~~-~~~~kl~Dfgl~~ 827 (973)
|||++|+|.+++.+. ..+++..+..++.||+.||+||| +++ ||||||||+|||++. ++.+||+|||+|+
T Consensus 109 Ey~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~ 180 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp ECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred eCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence 999999999999864 35889999999999999999999 666 999999999999985 7999999999997
Q ss_pred cccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccch
Q 002061 828 IAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLK 907 (973)
Q Consensus 828 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
..... .....+||+.|||||++.+ +|+.++|||||||++|||+||+.||.+.. .............. .
T Consensus 181 ~~~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~----~~~~~~~~i~~~~~-~-- 248 (290)
T 3fpq_A 181 LKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ----NAAQIYRRVTSGVK-P-- 248 (290)
T ss_dssp GCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS----SHHHHHHHHTTTCC-C--
T ss_pred eCCCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC----cHHHHHHHHHcCCC-C--
Confidence 54322 2234679999999999865 69999999999999999999999996431 12222221111111 0
Q ss_pred hccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 908 VLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 908 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
...+....+++.+++.+||+.||++|||+.|+++|
T Consensus 249 -------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 249 -------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01111123457889999999999999999999986
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-48 Score=463.96 Aligned_cols=476 Identities=20% Similarity=0.230 Sum_probs=393.9
Q ss_pred EeecCCCCCccccccccCCccCcEeeCCCCcccCcCChhhhCCCCCcEEEecCCcccCCCC-cccCCCCCCEEeccCccC
Q 002061 78 ISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVP-DLSALKNLEIFDLSINYF 156 (973)
Q Consensus 78 l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~-~l~~l~~L~~L~Ls~n~l 156 (973)
++.++.+++ .+|..+. +++++|+|++|.+++..+..|..+++|++|+|++|++++.++ .|+++++|++|+|++|.+
T Consensus 12 ~~c~~~~l~-~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l 88 (570)
T 2z63_A 12 YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88 (570)
T ss_dssp EECCSSCCS-SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred EEeCCCCcc-ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcC
Confidence 334444554 4555443 579999999999998888899999999999999999998876 489999999999999999
Q ss_pred CCccccccccccccceEEccCCcCCCCCCcc-cccCCCCCCEEEcccCCCCC-CCChhhhccCCCCeeecccccccCCCc
Q 002061 157 TGRFPRWVVNLTQLVSLSIGDNVYDEAEIPE-SIGNLKNLTYLFLAHCNLRG-RIPESISELRELGTLDICRNKISGEFP 234 (973)
Q Consensus 157 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~ip~-~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~ 234 (973)
++..|..|.++++|++|++++|.+.. +|. .++++++|++|+|++|.+++ .+|..|+++++|++|++++|++++..+
T Consensus 89 ~~~~~~~~~~l~~L~~L~L~~n~l~~--l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~ 166 (570)
T 2z63_A 89 QSLALGAFSGLSSLQKLVAVETNLAS--LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC 166 (570)
T ss_dssp CEECTTTTTTCTTCCEEECTTSCCCC--STTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECG
T ss_pred CccCHhhhcCcccccccccccccccc--CCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecH
Confidence 98888999999999999999999874 343 58999999999999999997 479999999999999999999998888
Q ss_pred hhhhccccc----cEEEeeccccCCcCCccccccccccEEEeecccccc-ccCCccCCCCC-------------------
Q 002061 235 RSIRKLQKL----WKIELYANNLTGELPAELGNLTLLQEFDISSNQMYG-KLPEEIGNLKN------------------- 290 (973)
Q Consensus 235 ~~l~~l~~L----~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~------------------- 290 (973)
..++.+++| ++|++++|.+++..|..+..+ +|+.|++++|.... .++..+..+++
T Consensus 167 ~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~ 245 (570)
T 2z63_A 167 TDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEK 245 (570)
T ss_dssp GGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEE
T ss_pred HHccchhccchhhhhcccCCCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhh
Confidence 899999999 899999999998888777766 89999999984321 12222333333
Q ss_pred -------------ccEEEcccC-CCCCCCCCCcCCcccceeeeccCCccCCCCCccccccccccccccccccccccCChh
Q 002061 291 -------------LTVFQCFKN-NFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKY 356 (973)
Q Consensus 291 -------------L~~L~l~~N-~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~ 356 (973)
++.++++.+ .+.+..|..+..+++|+.|++++|.++ .+|..+..+ +|++|++++|.+.
T Consensus 246 ~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~------ 317 (570)
T 2z63_A 246 FDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG------ 317 (570)
T ss_dssp CCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS------
T ss_pred cchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCccc------
Confidence 344455555 555566666777777777777777776 466666666 7777777777665
Q ss_pred hhhhhhHHHHHhhhccCCCCccccccCccccceEeccccccccCCCccccCCCCcceEeccCCcCCCCC--CCCCCCCCC
Q 002061 357 LCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGI--SPLIGLSTS 434 (973)
Q Consensus 357 ~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~~~~ 434 (973)
.+|. ..+++|++|++++|.+.+..+. ..+++|+.|++++|++++.. +..+..+++
T Consensus 318 -------------------~l~~--~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~ 374 (570)
T 2z63_A 318 -------------------QFPT--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTS 374 (570)
T ss_dssp -------------------SCCB--CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSC
T ss_pred -------------------ccCc--ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCc
Confidence 3343 4678999999999999876665 78999999999999998764 556778899
Q ss_pred CCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCcc-ccccccccCCEEEcCCcccccCCCccccccccccchhcc
Q 002061 435 LSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIP-SALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLA 513 (973)
Q Consensus 435 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 513 (973)
|++|++++|++.+..+. +..+++|++|++++|.+++..| ..+..+++|++|++++|++++..|..|.++++|+.|+|+
T Consensus 375 L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 453 (570)
T 2z63_A 375 LKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMA 453 (570)
T ss_dssp CCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECT
T ss_pred cCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECc
Confidence 99999999999965444 9999999999999999997766 578999999999999999999999999999999999999
Q ss_pred ccccc-cCCCccccccCCCCeeecCCCccCCCCChhhhccc-CceEEccCCccccccCcccccCCC--CccccCCCCCcc
Q 002061 514 RNSLS-GNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLK-LSSIDLSENQLSGSVPLDFLRMGG--DGAFAGNEGLCL 589 (973)
Q Consensus 514 ~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~-L~~l~ls~N~l~~~~p~~~~~~~~--~~~~~~n~~lc~ 589 (973)
+|+++ +.+|..|..+++|+.|+|++|++++.+|..+..++ |+.|++++|++++..|..|..+.. .-.+.+|+..|.
T Consensus 454 ~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 533 (570)
T 2z63_A 454 GNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 533 (570)
T ss_dssp TCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred CCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCC
Confidence 99998 67999999999999999999999988899998886 999999999999987766655443 235688887775
Q ss_pred Cc
Q 002061 590 DQ 591 (973)
Q Consensus 590 ~~ 591 (973)
.+
T Consensus 534 ~~ 535 (570)
T 2z63_A 534 CP 535 (570)
T ss_dssp TT
T ss_pred Cc
Confidence 44
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-49 Score=414.89 Aligned_cols=248 Identities=26% Similarity=0.335 Sum_probs=194.6
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL 748 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 748 (973)
.+++|++.+.||+|+||+||+|++..+++.||||++.+. ...+.+.+|++++++++|||||++++++.+++..|+
T Consensus 11 ~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 90 (275)
T 3hyh_A 11 HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIM 90 (275)
T ss_dssp ---CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred EeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 357899999999999999999999999999999998652 345678999999999999999999999999999999
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccc
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 828 (973)
||||+ +|+|.+++..+ ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+|+.
T Consensus 91 vmEy~-~g~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~ 161 (275)
T 3hyh_A 91 VIEYA-GNELFDYIVQR-----DKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNI 161 (275)
T ss_dssp EEECC-CEEHHHHHHHS-----CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC--
T ss_pred EEeCC-CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCee
Confidence 99999 78999999753 35899999999999999999999 78999999999999999999999999999986
Q ss_pred ccCCCCcccccccCCccccccccccccCCC-CccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccch
Q 002061 829 AENSPKVSDYSCFAGTHGYIAPELAYTCKV-SEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLK 907 (973)
Q Consensus 829 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
..... ......||+.|||||++.+..+ +.++||||+||++|||++|+.||... +...............
T Consensus 162 ~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~-----~~~~~~~~i~~~~~~~-- 231 (275)
T 3hyh_A 162 MTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE-----SIPVLFKNISNGVYTL-- 231 (275)
T ss_dssp ----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHTCCCC--
T ss_pred cCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC-----CHHHHHHHHHcCCCCC--
Confidence 64332 2234679999999999998876 57999999999999999999999653 2222222222111111
Q ss_pred hccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 908 VLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 908 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
+....+.+.+++.+|++.||++|||+.|+++|-
T Consensus 232 ----------p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp 264 (275)
T 3hyh_A 232 ----------PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDD 264 (275)
T ss_dssp ----------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCH
T ss_pred ----------CCCCCHHHHHHHHHHccCChhHCcCHHHHHcCc
Confidence 112234678899999999999999999999863
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-49 Score=437.32 Aligned_cols=249 Identities=24% Similarity=0.369 Sum_probs=209.1
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeec--cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK--GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM 753 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 753 (973)
..|+..++||+|+||+||+|+++.+|+.||||++.. ....+.+.+|++++++++|||||+++++|.+++..|+|||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 568999999999999999999999999999999865 344567899999999999999999999999999999999999
Q ss_pred CCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCC
Q 002061 754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833 (973)
Q Consensus 754 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 833 (973)
+||+|.+++... .+++..+..++.||+.||+||| +++||||||||+|||++.+|.+||+|||+|+......
T Consensus 231 ~gG~L~~~i~~~------~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 231 EGGALTDIVTHT------RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp TTEEHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred CCCcHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence 999999999743 4899999999999999999999 7899999999999999999999999999998765432
Q ss_pred CcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccc
Q 002061 834 KVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEV 913 (973)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (973)
. .....+||+.|||||++.+..|+.++|||||||++|||++|+.||... +.............. ..
T Consensus 302 ~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~-----~~~~~~~~i~~~~~~-------~~ 367 (423)
T 4fie_A 302 P--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE-----PPLKAMKMIRDNLPP-------RL 367 (423)
T ss_dssp C--CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-----CHHHHHHHHHHSCCC-------CC
T ss_pred c--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-----CHHHHHHHHHcCCCC-------CC
Confidence 2 233467999999999999999999999999999999999999999653 111221111111110 00
Q ss_pred cCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 914 ASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 914 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
.........+.+|+.+||+.||++|||+.|+++|
T Consensus 368 --~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 368 --KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp --SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1112234568899999999999999999999986
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-49 Score=474.09 Aligned_cols=453 Identities=19% Similarity=0.268 Sum_probs=365.1
Q ss_pred ccCcEeeCCCCcccCcCChhhhCCCCCcEEEecCCcccCCCCccc-----------CCCCCCEEeccCccCCCccccccc
Q 002061 97 QSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLS-----------ALKNLEIFDLSINYFTGRFPRWVV 165 (973)
Q Consensus 97 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~l~-----------~l~~L~~L~Ls~n~l~~~~~~~~~ 165 (973)
.+++.|+|++|+++|.+|.+|++|++|++|+|++|.+......++ .+.+|+ ++++.|.+.+..|..+.
T Consensus 81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~-l~l~~~~l~~~~~~~~~ 159 (636)
T 4eco_A 81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMR-MHYQKTFVDYDPREDFS 159 (636)
T ss_dssp CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHH-THHHHHHTCCCGGGGSC
T ss_pred CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHH-hhHHHhhhccCchhhHH
Confidence 478899999999999999999999999999999998732111111 145677 88999999888887776
Q ss_pred c-ccccceEEccCCcCCCCCCcccccCCCCCCEEEc--ccCCCCCCCChhhhccCCCCeeecccccccCC----------
Q 002061 166 N-LTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFL--AHCNLRGRIPESISELRELGTLDICRNKISGE---------- 232 (973)
Q Consensus 166 ~-l~~L~~L~l~~n~l~~~~ip~~~~~l~~L~~L~L--~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---------- 232 (973)
. +..+..+++....+.. .....++.+.+ .+|++++ +|..++++++|++|+|++|++++.
T Consensus 160 ~~~~~l~~~~l~~~~~~~-------~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~ 231 (636)
T 4eco_A 160 DLIKDCINSDPQQKSIKK-------SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENEN 231 (636)
T ss_dssp HHHHHHHHHCTTSCCCCC-------CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTT
T ss_pred HHHHHHhhcCcccccccc-------ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccc
Confidence 4 3445555554433321 11122333333 3578887 888888888888888888888875
Q ss_pred -------Cchhhh--ccccccEEEeeccccCCcCCccccccccccEEEeeccc-ccc-ccCCccCCC------CCccEEE
Q 002061 233 -------FPRSIR--KLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQ-MYG-KLPEEIGNL------KNLTVFQ 295 (973)
Q Consensus 233 -------~~~~l~--~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~-l~~-~~p~~~~~l------~~L~~L~ 295 (973)
+|..++ ++++|++|+|++|.+.+.+|..|+++++|++|+|++|+ +++ .+|..++++ ++|++|+
T Consensus 232 ~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~ 311 (636)
T 4eco_A 232 SEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIY 311 (636)
T ss_dssp SHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEE
T ss_pred cchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEE
Confidence 888888 88899999999998888888888888999999999998 887 788888776 8899999
Q ss_pred cccCCCCCCCCC--CcCCcccceeeeccCCccCCCCCccccccccccccccccccccccCChhhhhhhhHHHHHhhhccC
Q 002061 296 CFKNNFSGEFPS--GFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNF 373 (973)
Q Consensus 296 l~~N~l~~~~p~--~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~ll~l~n~~ 373 (973)
+++|+++ .+|. .++.+++|+.|++++|+++|.+| .++.+++|++|+|++|+++ .
T Consensus 312 L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~--------------------- 367 (636)
T 4eco_A 312 IGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-E--------------------- 367 (636)
T ss_dssp CCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-E---------------------
T ss_pred CCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-c---------------------
Confidence 9999988 7887 88889999999999999988888 8888999999999999887 3
Q ss_pred CCCccccccCccc-cceEeccccccccCCCccccCCC--CcceEeccCCcCCCCCCCCCC-------CCCCCCEEEcccC
Q 002061 374 SGEVPNSYADCKT-IQRLRISDNHLSGKIPDGLWALP--NVGMLDFGDNDFTGGISPLIG-------LSTSLSQLVLQNN 443 (973)
Q Consensus 374 ~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~L~~N~l~~~~~~~~~-------~~~~L~~L~L~~N 443 (973)
+|..+.++++ |++|+|++|+++ .+|..+..++ +|+.|++++|++++..+..+. .+++|++|+|++|
T Consensus 368 ---lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N 443 (636)
T 4eco_A 368 ---IPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNN 443 (636)
T ss_dssp ---CCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSS
T ss_pred ---ccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCC
Confidence 4556777888 999999999998 7888877755 899999999999988888777 7789999999999
Q ss_pred CCCCCCChhhhcCCCCCEEEccCCcCCCCccc-ccccc-------ccCCEEEcCCcccccCCCcccc--ccccccchhcc
Q 002061 444 RFSGELPSELGRLTNLERLILTNNNFSGKIPS-ALGAL-------RQLSSLHLEENALTGSIPNEMG--DCARIVDLNLA 513 (973)
Q Consensus 444 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l-------~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls 513 (973)
++++..+..+..+++|++|+|++|+++ .+|. .+... ++|++|+|++|+++ .+|..+. .+++|+.|+|+
T Consensus 444 ~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls 521 (636)
T 4eco_A 444 QISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLS 521 (636)
T ss_dssp CCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECC
T ss_pred ccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECC
Confidence 999555555667999999999999999 4554 44433 39999999999999 6777776 99999999999
Q ss_pred ccccccCCCccccccCCCCeeec------CCCccCCCCChhhhccc-CceEEccCCccccccCcccccCCCCccccCCCC
Q 002061 514 RNSLSGNIPRSLSLLSSLNALNL------SGNKLTGSIPDNLMKLK-LSSIDLSENQLSGSVPLDFLRMGGDGAFAGNEG 586 (973)
Q Consensus 514 ~N~l~~~~~~~~~~l~~L~~L~L------~~N~l~~~~p~~l~~l~-L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~n~~ 586 (973)
+|+|++ +|..+..+++|+.|+| ++|++.+.+|..+..++ |+.|+|++|++ +.+|..+...-..-.+.+|+.
T Consensus 522 ~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~~~L~~L~Ls~N~l 599 (636)
T 4eco_A 522 YNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKITPNISVLDIKDNPN 599 (636)
T ss_dssp SSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCCTTCCEEECCSCTT
T ss_pred CCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHhCcCCEEECcCCCC
Confidence 999997 8999999999999999 67889999999999986 99999999999 788976543222345688887
Q ss_pred CccC
Q 002061 587 LCLD 590 (973)
Q Consensus 587 lc~~ 590 (973)
.|-.
T Consensus 600 ~~~~ 603 (636)
T 4eco_A 600 ISID 603 (636)
T ss_dssp CEEE
T ss_pred cccc
Confidence 7754
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=436.64 Aligned_cols=262 Identities=27% Similarity=0.356 Sum_probs=211.8
Q ss_pred cCCcccCcccccCceEEEEEEecCC-----CcEEEEEeeecc---ccHHHHHHHHHHHHhcCC-CceeeEEEEEEeC-Ce
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKN-----AGTVAVKQLWKG---DGVKVFAAEMEILGKIRH-RNILKLYACLLKG-GS 745 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~-----~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~-~~ 745 (973)
++|++.+.||+|+||+||+|++... ++.||||++... ...+.|.+|++++++++| ||||+++++|.++ +.
T Consensus 64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~ 143 (353)
T 4ase_A 64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 143 (353)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCE
Confidence 5789999999999999999998643 367999998763 345678999999999965 9999999998764 56
Q ss_pred eEEEEEccCCCchHHHHHhhhcC-----------CCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecC
Q 002061 746 SFLVLEYMPNGNLFQALHKRVKE-----------GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE 814 (973)
Q Consensus 746 ~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~ 814 (973)
.|+|||||++|+|.++++..... ....+++..+..++.|||+||+||| +++||||||||+|||+++
T Consensus 144 ~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDLK~~NILl~~ 220 (353)
T 4ase_A 144 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSE 220 (353)
T ss_dssp CEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECG
T ss_pred EEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCccCccceeeCC
Confidence 89999999999999999864221 1345899999999999999999999 789999999999999999
Q ss_pred CCCeEEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHH
Q 002061 815 DYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVY 893 (973)
Q Consensus 815 ~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~ 893 (973)
++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||..... ...+..
T Consensus 221 ~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~-~~~~~~ 299 (353)
T 4ase_A 221 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-DEEFCR 299 (353)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC-SHHHHH
T ss_pred CCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH-HHHHHH
Confidence 99999999999987755444333445678999999999999999999999999999999998 9999975421 112222
Q ss_pred HHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 002061 894 WVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADP 955 (973)
Q Consensus 894 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 955 (973)
.+.... . ...+....+++.+++.+||+.||++|||+.||+++|+++..
T Consensus 300 ~i~~g~--~------------~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 300 RLKEGT--R------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp HHHHTC--C------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHcCC--C------------CCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 222111 0 01112234568899999999999999999999999987643
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=462.30 Aligned_cols=496 Identities=19% Similarity=0.194 Sum_probs=382.8
Q ss_pred CCcccccCCCCCCC---CCCCcc----eeeeCCC---------CCceEEEeecCCCCCccccccccCCccCcEeeCCCCc
Q 002061 45 DPHGVLDSWKESAD---SPCGFS----GITCDSV---------TGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNV 108 (973)
Q Consensus 45 d~~~~~~~W~~~~~---~~c~w~----gv~C~~~---------~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~ 108 (973)
|+...+++|+.+.+ ++|.|. .|.|... +..++.|||++|.|++..+.++.++++|++|+|++|+
T Consensus 8 ~~~~~~~~~~~~~p~~~~~c~~~~~~~~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~ 87 (635)
T 4g8a_A 8 DDDDKLAAANSSIPESWEPCVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCE 87 (635)
T ss_dssp -----------------CCSEEEETTTEEECTTSCCSSCCSSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred CCcchhhcccCCCCCCCCCccccCCCCEEECCCCCcCccCCCCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCc
Confidence 44445666654432 235443 4778642 2468999999999998777889999999999999999
Q ss_pred ccCcCChhhhCCCCCcEEEecCCcccCCCCc-ccCCCCCCEEeccCccCCCccccccccccccceEEccCCcCCCCCCcc
Q 002061 109 LSGKLPLELSNCSNLKVLNVTGNAMVGSVPD-LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPE 187 (973)
Q Consensus 109 l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ip~ 187 (973)
|++..|.+|++|++|++|+|++|++++.++. |+++++|++|+|++|++++..+..|+++++|++|++++|.+....+|.
T Consensus 88 i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~ 167 (635)
T 4g8a_A 88 IQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPE 167 (635)
T ss_dssp CCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCG
T ss_pred CCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCch
Confidence 9977778899999999999999999998875 899999999999999999888888999999999999999998888899
Q ss_pred cccCCCCCCEEEcccCCCCCCCChhhhccCCCC----eeecccccccCCCchhhhccccccEEEeeccccCCc-------
Q 002061 188 SIGNLKNLTYLFLAHCNLRGRIPESISELRELG----TLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGE------- 256 (973)
Q Consensus 188 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~----~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~------- 256 (973)
.++.+++|++|+|++|++++..+..+..+.+++ .++++.|.++...+..+ ....+..+++.+|.....
T Consensus 168 ~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~-~~~~~~~l~l~~n~~~~~~~~~~~~ 246 (635)
T 4g8a_A 168 YFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF-KEIRLHKLTLRNNFDSLNVMKTCIQ 246 (635)
T ss_dssp GGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTT-TTCEEEEEEEESCCSSHHHHHHHHH
T ss_pred hhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccc-cchhhhhhhhhcccccccccchhhc
Confidence 999999999999999999988888888776654 57888888874433333 333445555555433210
Q ss_pred ------------------------C---------------------------CccccccccccEEEeeccccccccCCcc
Q 002061 257 ------------------------L---------------------------PAELGNLTLLQEFDISSNQMYGKLPEEI 285 (973)
Q Consensus 257 ------------------------~---------------------------~~~l~~l~~L~~L~Ls~N~l~~~~p~~~ 285 (973)
. +..+..+.+++.+++.+|.+... ..+
T Consensus 247 ~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~--~~~ 324 (635)
T 4g8a_A 247 GLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERV--KDF 324 (635)
T ss_dssp TTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEEC--GGG
T ss_pred CCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhcccccccccccccccc--ccc
Confidence 0 11122233444555555544322 223
Q ss_pred CCCCCccEEEcccCCCCCCCCCCcCCcccceeeeccCCccCCCCCccccccccccccccccccccccCChhhhhhhhHHH
Q 002061 286 GNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLN 365 (973)
Q Consensus 286 ~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~ 365 (973)
....+|+.|++.+|.+.+..+. .+..|+.+++.+|.+... .....+++|+.|++++|.+...
T Consensus 325 ~~~~~L~~L~l~~~~~~~~~~~---~l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~------------- 386 (635)
T 4g8a_A 325 SYNFGWQHLELVNCKFGQFPTL---KLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFK------------- 386 (635)
T ss_dssp GSCCCCSEEEEESCEESSCCCC---BCTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEE-------------
T ss_pred ccchhhhhhhcccccccCcCcc---cchhhhhcccccccCCCC--cccccccccccchhhccccccc-------------
Confidence 4455666677776666644332 345566666666666532 2344677788888888777522
Q ss_pred HHhhhccCCCCccccccCccccceEeccccccccCCCccccCCCCcceEeccCCcCCCCCC-CCCCCCCCCCEEEcccCC
Q 002061 366 LLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGIS-PLIGLSTSLSQLVLQNNR 444 (973)
Q Consensus 366 ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~~~~L~~L~L~~N~ 444 (973)
+..+..+..+.+|++|+++.|.+. ..+..+..+++|+.++++.|+.....+ ..+..+++++.+++++|+
T Consensus 387 ---------~~~~~~~~~~~~L~~L~~~~~~~~-~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~ 456 (635)
T 4g8a_A 387 ---------GCCSQSDFGTISLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 456 (635)
T ss_dssp ---------EECCHHHHSCSCCCEEECCSCSEE-EECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSC
T ss_pred ---------cccccchhhhhhhhhhhccccccc-cccccccccccccchhhhhccccccccccccccccccccccccccc
Confidence 123344556788999999999988 456678899999999999888766544 567889999999999999
Q ss_pred CCCCCChhhhcCCCCCEEEccCCcC-CCCccccccccccCCEEEcCCcccccCCCccccccccccchhccccccccCCCc
Q 002061 445 FSGELPSELGRLTNLERLILTNNNF-SGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPR 523 (973)
Q Consensus 445 l~~~~p~~~~~l~~L~~L~Ls~N~l-~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~ 523 (973)
+.+..+..+..+++|+.|+|++|++ .+..|..|..+++|++|+|++|+|++..|.+|+++++|+.|+|++|+|++..|.
T Consensus 457 l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~ 536 (635)
T 4g8a_A 457 TRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTF 536 (635)
T ss_dssp CEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCG
T ss_pred cccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChh
Confidence 9999999999999999999999985 446788999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCeeecCCCccCCCCChhhhcc--cCceEEccCCccccccCcc
Q 002061 524 SLSLLSSLNALNLSGNKLTGSIPDNLMKL--KLSSIDLSENQLSGSVPLD 571 (973)
Q Consensus 524 ~~~~l~~L~~L~L~~N~l~~~~p~~l~~l--~L~~l~ls~N~l~~~~p~~ 571 (973)
.|..+++|++|+|++|+|++.+|..+..+ .|+.|+|++|+|+|+|...
T Consensus 537 ~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~~ 586 (635)
T 4g8a_A 537 PYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQ 586 (635)
T ss_dssp GGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGGH
T ss_pred HHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCcH
Confidence 99999999999999999999999999887 3999999999999999864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=466.89 Aligned_cols=455 Identities=18% Similarity=0.266 Sum_probs=370.0
Q ss_pred ccCcEeeCCCCcccCcCChhhhCCCCCcEEEe-cCCcccCCCCc-ccCC-CCCCE-----E---------ec-cCccCCC
Q 002061 97 QSLTVLSLPFNVLSGKLPLELSNCSNLKVLNV-TGNAMVGSVPD-LSAL-KNLEI-----F---------DL-SINYFTG 158 (973)
Q Consensus 97 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L-~~n~l~~~~~~-l~~l-~~L~~-----L---------~L-s~n~l~~ 158 (973)
.+++.|+|++|+++|.+|.+|++|++|++|+| ++|.+.|..+. .... ..+.. + +. ....+.+
T Consensus 323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~ 402 (876)
T 4ecn_A 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402 (876)
T ss_dssp SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence 57899999999999999999999999999999 99988776331 1000 00000 0 00 0011111
Q ss_pred cc-----------ccccccccccceEEccC--CcCCCCCCcccccCCCCCCEEEcccCCCCC-----------------C
Q 002061 159 RF-----------PRWVVNLTQLVSLSIGD--NVYDEAEIPESIGNLKNLTYLFLAHCNLRG-----------------R 208 (973)
Q Consensus 159 ~~-----------~~~~~~l~~L~~L~l~~--n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~-----------------~ 208 (973)
.. +........++.+.++. |.++. +|..++++++|++|+|++|++++ .
T Consensus 403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~--IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~ 480 (876)
T 4ecn_A 403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF--ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQY 480 (876)
T ss_dssp HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE--ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHH
T ss_pred HHHHHhhhCccccccccccccchhhceeccccCcccc--hhHHHhcCCCCCEEECcCCcCCCCccccccccccccccccc
Confidence 11 11112233444555544 67764 89999999999999999999998 3
Q ss_pred CChhhh--ccCCCCeeecccccccCCCchhhhccccccEEEeeccc-cCC-cCCccccccc-------cccEEEeecccc
Q 002061 209 IPESIS--ELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANN-LTG-ELPAELGNLT-------LLQEFDISSNQM 277 (973)
Q Consensus 209 ~~~~~~--~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~-l~~-~~~~~l~~l~-------~L~~L~Ls~N~l 277 (973)
+|..++ ++++|++|+|++|++.+.+|..|+++++|++|+|++|+ +++ .+|..++.++ +|++|+|++|++
T Consensus 481 iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L 560 (876)
T 4ecn_A 481 ENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNL 560 (876)
T ss_dssp TTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCC
T ss_pred CChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcC
Confidence 888887 99999999999999999999999999999999999998 998 7898777776 999999999999
Q ss_pred ccccCC--ccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeeccCCccCCCCCcccccccc-ccccccccccccccCC
Q 002061 278 YGKLPE--EIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTA-LTDVDISENQFSGSFP 354 (973)
Q Consensus 278 ~~~~p~--~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~-L~~L~Ls~N~l~~~~p 354 (973)
+ .+|. .++++++|+.|++++|+++ .+| .|+.+++|+.|++++|+++ .+|..+..+++ |+.|+|++|+++ .+|
T Consensus 561 ~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp 635 (876)
T 4ecn_A 561 E-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIP 635 (876)
T ss_dssp C-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCC
T ss_pred C-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCc
Confidence 9 8898 8999999999999999999 788 8999999999999999999 89999999999 999999999998 444
Q ss_pred hhhhhhhhHHHHHhhhccCCCCccccccCc--cccceEeccccccccCCCccc---c--CCCCcceEeccCCcCCCCCCC
Q 002061 355 KYLCEKRKLLNLLALSNNFSGEVPNSYADC--KTIQRLRISDNHLSGKIPDGL---W--ALPNVGMLDFGDNDFTGGISP 427 (973)
Q Consensus 355 ~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l--~~L~~L~Ls~N~l~~~~p~~~---~--~l~~L~~L~L~~N~l~~~~~~ 427 (973)
..+..+ ++|++|+|++|++.+.+|... . .+++|+.|+|++|+++..+..
T Consensus 636 ------------------------~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~ 691 (876)
T 4ecn_A 636 ------------------------NIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTE 691 (876)
T ss_dssp ------------------------SCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHH
T ss_pred ------------------------hhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHH
Confidence 444444 359999999999998776433 2 345999999999999977666
Q ss_pred CCCCCCCCCEEEcccCCCCCCCChhhhcC--------CCCCEEEccCCcCCCCcccccc--ccccCCEEEcCCcccccCC
Q 002061 428 LIGLSTSLSQLVLQNNRFSGELPSELGRL--------TNLERLILTNNNFSGKIPSALG--ALRQLSSLHLEENALTGSI 497 (973)
Q Consensus 428 ~~~~~~~L~~L~L~~N~l~~~~p~~~~~l--------~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~ 497 (973)
.+..+++|+.|+|++|+|+ .+|..+... ++|+.|+|++|+++ .+|..+. .+++|+.|+|++|+|++ +
T Consensus 692 ~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-l 768 (876)
T 4ecn_A 692 LFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-F 768 (876)
T ss_dssp HHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-C
T ss_pred HHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-c
Confidence 6678999999999999999 566554432 39999999999999 7888887 99999999999999997 7
Q ss_pred Cccccccccccchhccc------cccccCCCccccccCCCCeeecCCCccCCCCChhhhcccCceEEccCCccccccCcc
Q 002061 498 PNEMGDCARIVDLNLAR------NSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSGSVPLD 571 (973)
Q Consensus 498 p~~~~~l~~L~~L~Ls~------N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~L~~l~ls~N~l~~~~p~~ 571 (973)
|..+..+++|+.|+|++ |++.+.+|..|..+++|+.|+|++|+| +.+|..+.. .|+.|||++|++...-+..
T Consensus 769 p~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~~-~L~~LdLs~N~l~~i~~~~ 846 (876)
T 4ecn_A 769 PTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLTP-QLYILDIADNPNISIDVTS 846 (876)
T ss_dssp CCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCCS-SSCEEECCSCTTCEEECGG
T ss_pred chhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhcC-CCCEEECCCCCCCccChHH
Confidence 98999999999999976 889999999999999999999999999 689988653 6999999999998665544
Q ss_pred cccC--CCCccccCCCCC
Q 002061 572 FLRM--GGDGAFAGNEGL 587 (973)
Q Consensus 572 ~~~~--~~~~~~~~n~~l 587 (973)
+... .....+.+|+..
T Consensus 847 ~~~~~~~~~~~L~~n~~~ 864 (876)
T 4ecn_A 847 VCPYIEAGMYVLLYDKTQ 864 (876)
T ss_dssp GHHHHHTTCCEEECCTTS
T ss_pred ccccccchheeecCCCcc
Confidence 3221 112345555543
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=455.58 Aligned_cols=472 Identities=18% Similarity=0.188 Sum_probs=376.9
Q ss_pred CCcceeeeCC--CCCceEEEeecCCCCCccccccccCCccCcEeeCCCCcccCcCChhhhCCCCCcEEEecCCcccCCCC
Q 002061 61 CGFSGITCDS--VTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVP 138 (973)
Q Consensus 61 c~w~gv~C~~--~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~ 138 (973)
|++.+++.-+ ...+++.|+|+++++++..+..++.+++|++|+|++|++++..|..|+.+++|++|+|++|++++.++
T Consensus 12 ~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~ 91 (549)
T 2z81_A 12 GRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSS 91 (549)
T ss_dssp CTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCH
T ss_pred CCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCH
Confidence 6777776533 23589999999999999889999999999999999999998888999999999999999999999988
Q ss_pred c-ccCCCCCCEEeccCccCCC-ccccccccccccceEEccCCcCCCCCCc-ccccCCCCCCEEEcccCCCCCCCChhhhc
Q 002061 139 D-LSALKNLEIFDLSINYFTG-RFPRWVVNLTQLVSLSIGDNVYDEAEIP-ESIGNLKNLTYLFLAHCNLRGRIPESISE 215 (973)
Q Consensus 139 ~-l~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~ip-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 215 (973)
. ++++++|++|+|++|.+++ ..|..+.++++|++|++++|.+.. .+| ..++++++|++|++++|++++..|..++.
T Consensus 92 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~ 170 (549)
T 2z81_A 92 SWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFS-EIRRIDFAGLTSLNELEIKALSLRNYQSQSLKS 170 (549)
T ss_dssp HHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCC-EECTTTTTTCCEEEEEEEEETTCCEECTTTTTT
T ss_pred HHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCcccc-ccCHhhhhcccccCeeeccCCcccccChhhhhc
Confidence 6 9999999999999999987 467889999999999999998433 344 57899999999999999999999999999
Q ss_pred cCCCCeeecccccccCCCchh-hhccccccEEEeeccccCCcC--C-ccccccccccEEEeeccccccccCC----ccCC
Q 002061 216 LRELGTLDICRNKISGEFPRS-IRKLQKLWKIELYANNLTGEL--P-AELGNLTLLQEFDISSNQMYGKLPE----EIGN 287 (973)
Q Consensus 216 l~~L~~L~L~~N~l~~~~~~~-l~~l~~L~~L~L~~N~l~~~~--~-~~l~~l~~L~~L~Ls~N~l~~~~p~----~~~~ 287 (973)
+++|++|+++.|.+. .+|.. +..+++|++|++++|++++.. | .....+++|+.|++++|.+++..+. .+..
T Consensus 171 l~~L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~ 249 (549)
T 2z81_A 171 IRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRY 249 (549)
T ss_dssp CSEEEEEEEECSBST-THHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGG
T ss_pred cccCceEecccCccc-ccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhh
Confidence 999999999999987 45554 456899999999999999642 2 2234578899999999988765443 3456
Q ss_pred CCCccEEEcccCCCCCCC------CCCcCCcccceeeeccCCccCCC-----CCccccccccccccccccccccccCChh
Q 002061 288 LKNLTVFQCFKNNFSGEF------PSGFGDMRKLFAFSIYGNRFSGP-----FPENLGRYTALTDVDISENQFSGSFPKY 356 (973)
Q Consensus 288 l~~L~~L~l~~N~l~~~~------p~~~~~l~~L~~L~l~~N~l~~~-----~~~~l~~l~~L~~L~Ls~N~l~~~~p~~ 356 (973)
+++|+.+++++|.+.+.. ...+..+++|+.|.+.++.+... ++..+....+|+.|++++|+++ .+|..
T Consensus 250 ~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~ 328 (549)
T 2z81_A 250 ILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCS 328 (549)
T ss_dssp CTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-CCCHH
T ss_pred hccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccc-cCCHH
Confidence 778888888888776531 12345556666666666655421 1112233445666666666665 55555
Q ss_pred hhh-hhhHHHHHhh-hccCCCCcc---ccccCccccceEeccccccccCCC--ccccCCCCcceEeccCCcCCCCCCCCC
Q 002061 357 LCE-KRKLLNLLAL-SNNFSGEVP---NSYADCKTIQRLRISDNHLSGKIP--DGLWALPNVGMLDFGDNDFTGGISPLI 429 (973)
Q Consensus 357 ~~~-~~~ll~ll~l-~n~~~~~~p---~~~~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~~~~~ 429 (973)
++. ...+ +.+.+ .|++.+.+| ..++.+++|++|+|++|+|++..+ ..+..+++|+.|++++|++++ +|..+
T Consensus 329 ~~~~l~~L-~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~~ 406 (549)
T 2z81_A 329 FSQHLKSL-EFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHP-MPDSC 406 (549)
T ss_dssp HHHHCTTC-CEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCCC-CCSCC
T ss_pred HHhcCccc-cEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCcc-CChhh
Confidence 432 3332 22333 344444443 347889999999999999986543 568899999999999999995 56677
Q ss_pred CCCCCCCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCCccccccccccc
Q 002061 430 GLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVD 509 (973)
Q Consensus 430 ~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 509 (973)
..+++|++|+|++|++++ +|..+ .++|++|+|++|++++.+ ..+++|++|+|++|+|+ .+|. ...+++|+.
T Consensus 407 ~~~~~L~~L~Ls~N~l~~-l~~~~--~~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~ 477 (549)
T 2z81_A 407 QWPEKMRFLNLSSTGIRV-VKTCI--PQTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLV 477 (549)
T ss_dssp CCCTTCCEEECTTSCCSC-CCTTS--CTTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCE
T ss_pred cccccccEEECCCCCccc-ccchh--cCCceEEECCCCChhhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCE
Confidence 889999999999999984 45443 368999999999999653 57899999999999999 5565 467999999
Q ss_pred hhccccccccCCCccccccCCCCeeecCCCccCCCCC
Q 002061 510 LNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIP 546 (973)
Q Consensus 510 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 546 (973)
|+|++|+|++.+|..|..+++|+.|+|++|++++..|
T Consensus 478 L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 478 MKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp EECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred EecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence 9999999999999999999999999999999998887
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=421.93 Aligned_cols=265 Identities=25% Similarity=0.312 Sum_probs=200.2
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeeccccHH-HHHHHHHHHHhcCCCceeeEEEEEEeCC----eeEEEEE
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVK-VFAAEMEILGKIRHRNILKLYACLLKGG----SSFLVLE 751 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~-~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~~lv~e 751 (973)
+|.+.++||+|+||+||+|++. |+.||||++....... .+.+|+..+.+++|||||++++++.+++ ..|+|||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 5677889999999999999985 8899999987644322 2334566667889999999999997654 5799999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcC-----CCCeEecCCCCCCeeecCCCCeEEecccCc
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC-----SPPIIHRDIKSSNILLDEDYEPKIADFGVA 826 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~-----~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~ 826 (973)
||++|+|.++++.. .++|..+.+++.|+|+||+|||+.+ ..+||||||||+|||++.++.+||+|||+|
T Consensus 82 y~~~gsL~~~l~~~------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 82 YHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp CCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred CCCCCcHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 99999999999753 4899999999999999999999431 238999999999999999999999999999
Q ss_pred ccccCCCCcc--cccccCCccccccccccccC------CCCccchHHHHHHHHHHHHhCCCCCCcccC----------Cc
Q 002061 827 KIAENSPKVS--DYSCFAGTHGYIAPELAYTC------KVSEKSDVFSFGVVLLELVTGRKPVEEEYG----------DG 888 (973)
Q Consensus 827 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~~l~el~tg~~pf~~~~~----------~~ 888 (973)
+......... ......||+.|||||++.+. .++.++|||||||++|||+||..||..... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 8775543322 22345799999999998754 467899999999999999999887753211 11
Q ss_pred ccHHHHHHHHhccccccchhccccccCc-chHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 002061 889 KDIVYWVSTHLNNHENVLKVLDCEVASE-SIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADP 955 (973)
Q Consensus 889 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 955 (973)
............. ..++..... ...+..+.+.+++.+||+.||++||||.||+++|+++..
T Consensus 236 ~~~~~~~~~~~~~------~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 236 PSVEEMRKVVCEQ------KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp CCHHHHHHHHTTS------CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred chHHHHHHHHhcc------cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 1222222211111 111111111 123456678899999999999999999999999987643
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=417.14 Aligned_cols=247 Identities=27% Similarity=0.346 Sum_probs=198.1
Q ss_pred cCCcccCcccccCceEEEEEEec---CCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLK---KNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL 748 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~---~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 748 (973)
++|++.+.||+|+||+||+|++. .+++.||||++.+. ....++.+|++++++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999874 45789999998652 334568899999999999999999999999999999
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccc
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 828 (973)
|||||+||+|.+++.+. ..+++..+..++.|++.||+||| +++|+||||||+|||++.+|.+||+|||+|+.
T Consensus 104 vmEy~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~ 175 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKE 175 (304)
T ss_dssp EECCCTTCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred EEEcCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEeccccccee
Confidence 99999999999999864 35899999999999999999999 78999999999999999999999999999986
Q ss_pred ccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchh
Q 002061 829 AENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKV 908 (973)
Q Consensus 829 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (973)
...... .....+||+.|||||++.+..|+.++||||+||++|||++|+.||... +...............
T Consensus 176 ~~~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~-----~~~~~~~~i~~~~~~~--- 245 (304)
T 3ubd_A 176 SIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK-----DRKETMTMILKAKLGM--- 245 (304)
T ss_dssp -----C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHCCCCC---
T ss_pred ccCCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc-----CHHHHHHHHHcCCCCC---
Confidence 543221 223467999999999999999999999999999999999999999653 2222222222211111
Q ss_pred ccccccCcchHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 002061 909 LDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPP-----MREVVKM 949 (973)
Q Consensus 909 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt-----~~evl~~ 949 (973)
+....+++.+++.+||+.||++||| ++|+++|
T Consensus 246 ---------p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 246 ---------PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp ---------CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred ---------CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 1123456788999999999999998 4788875
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=412.83 Aligned_cols=252 Identities=23% Similarity=0.333 Sum_probs=192.7
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCC-------
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGG------- 744 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------- 744 (973)
+.+|++.+.||+|+||+||+|+++.+++.||||++... ...+.+.+|++++++++|||||+++++|.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 45789999999999999999999999999999998653 23467889999999999999999999987543
Q ss_pred -----eeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeE
Q 002061 745 -----SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPK 819 (973)
Q Consensus 745 -----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k 819 (973)
..|+|||||++|+|.+++... ......++..+..++.|+++||+||| +++||||||||+|||++.++.+|
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~--~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vK 158 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGR--CTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVK 158 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTC--CSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEE
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhc--CCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEE
Confidence 369999999999999999854 22234567778899999999999999 78999999999999999999999
Q ss_pred EecccCcccccCCCCcc----------cccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcc
Q 002061 820 IADFGVAKIAENSPKVS----------DYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGK 889 (973)
Q Consensus 820 l~Dfgl~~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~ 889 (973)
|+|||+|+......... ..+..+||+.|||||++.+..|+.++||||+||++|||++ ||....
T Consensus 159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~---- 231 (299)
T 4g31_A 159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM---- 231 (299)
T ss_dssp ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH----
T ss_pred EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc----
Confidence 99999998765432211 1233579999999999999999999999999999999996 775321
Q ss_pred cHHHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 890 DIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 890 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
+........ .. ... +....+..+.+.+++.+||+.||++|||+.|++++
T Consensus 232 ~~~~~~~~~-~~---------~~~-p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 232 ERVRTLTDV-RN---------LKF-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHHHHHHHH-HT---------TCC-CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHH-hc---------CCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111111111 11 111 12233444566789999999999999999999985
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-47 Score=446.37 Aligned_cols=436 Identities=19% Similarity=0.183 Sum_probs=380.0
Q ss_pred CceEEEeecCCCCCccccccccCCccCcEeeCCCCcccCcCChhhhCCCCCcEEEecCCcccCCCCcccCCCCCCEEecc
Q 002061 73 GRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLS 152 (973)
Q Consensus 73 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls 152 (973)
.+++.|+|+++.+++..+..+..+++|++|+|++|++++..|..|+.+++|++|+|++|++++.+.. .+++|++|+|+
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~--~l~~L~~L~L~ 98 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCH--PTVNLKHLDLS 98 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCEEECC--CCCCCSEEECC
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCceeecCcc--ccCCccEEecc
Confidence 6899999999999998888999999999999999999988899999999999999999999976665 89999999999
Q ss_pred CccCCC-ccccccccccccceEEccCCcCCCCCCcccccCCCCC--CEEEcccCCC--CCCCChhhhccC-CCCeeeccc
Q 002061 153 INYFTG-RFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNL--TYLFLAHCNL--RGRIPESISELR-ELGTLDICR 226 (973)
Q Consensus 153 ~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~ip~~~~~l~~L--~~L~L~~n~l--~~~~~~~~~~l~-~L~~L~L~~ 226 (973)
+|.+++ .+|..|+++++|++|++++|.+.. ..+..+++| ++|++++|++ ++..|..+..+. +...+++++
T Consensus 99 ~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~----~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~ 174 (520)
T 2z7x_B 99 FNAFDALPICKEFGNMSQLKFLGLSTTHLEK----SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPT 174 (520)
T ss_dssp SSCCSSCCCCGGGGGCTTCCEEEEEESSCCG----GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCS
T ss_pred CCccccccchhhhccCCcceEEEecCcccch----hhccccccceeeEEEeecccccccccccccccccccceEEEEecc
Confidence 999997 578999999999999999999864 456778888 9999999999 888888888776 345678899
Q ss_pred ccccCCCch-hhhccccccEEEeeccc-------cCCcCCccccccccccEEEeeccccccccCCccC---CCCCccEEE
Q 002061 227 NKISGEFPR-SIRKLQKLWKIELYANN-------LTGELPAELGNLTLLQEFDISSNQMYGKLPEEIG---NLKNLTVFQ 295 (973)
Q Consensus 227 N~l~~~~~~-~l~~l~~L~~L~L~~N~-------l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~ 295 (973)
|++.+.++. .+.++++|+.|++++|. +.+.+| .+..+++|+.|++++|.+++..+..+. ..++|++|+
T Consensus 175 n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~ 253 (520)
T 2z7x_B 175 NKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFS 253 (520)
T ss_dssp SSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEE
T ss_pred Ccchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhccccccccCHHHHHHHHHHhhhCcccEEE
Confidence 998876664 57889999999999998 776666 789999999999999998764433322 246899999
Q ss_pred cccCCCCCCCCCCc-----CCcccceeeeccCCccCCCCC-cccccc---ccccccccccccccccCChhhhhhhhHHHH
Q 002061 296 CFKNNFSGEFPSGF-----GDMRKLFAFSIYGNRFSGPFP-ENLGRY---TALTDVDISENQFSGSFPKYLCEKRKLLNL 366 (973)
Q Consensus 296 l~~N~l~~~~p~~~-----~~l~~L~~L~l~~N~l~~~~~-~~l~~l---~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~l 366 (973)
+++|++++.+|..+ +.+++|+.+++++|.+ .+| ..+..+ .+|+.|++++|.+...
T Consensus 254 l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~-------------- 317 (520)
T 2z7x_B 254 ISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHM-------------- 317 (520)
T ss_dssp EEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCC--------------
T ss_pred eecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCccccc--------------
Confidence 99999999999988 9999999999999999 455 555555 6799999999998621
Q ss_pred HhhhccCCCCccccccCccccceEeccccccccCCCccccCCCCcceEeccCCcCCCC--CCCCCCCCCCCCEEEcccCC
Q 002061 367 LALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGG--ISPLIGLSTSLSQLVLQNNR 444 (973)
Q Consensus 367 l~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~~~~~~~~~~L~~L~L~~N~ 444 (973)
+ .+..+++|++|+|++|++++.+|..+..+++|+.|++++|++++. .+..+..+++|++|+|++|+
T Consensus 318 -----------~-~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~ 385 (520)
T 2z7x_B 318 -----------L-CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNS 385 (520)
T ss_dssp -----------C-CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSC
T ss_pred -----------c-chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCc
Confidence 1 125778999999999999998999999999999999999999973 44668899999999999999
Q ss_pred CCCCCCh-hhhcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCCccccccccccchhccccccccCCCc
Q 002061 445 FSGELPS-ELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPR 523 (973)
Q Consensus 445 l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~ 523 (973)
+++.+|. .+..+++|++|+|++|++++..|..+. ++|++|+|++|+++ .+|..+..+++|+.|+|++|+|++..+.
T Consensus 386 l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~ 462 (520)
T 2z7x_B 386 VSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDG 462 (520)
T ss_dssp CBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTT
T ss_pred CCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHH
Confidence 9985665 488899999999999999988887765 79999999999999 7788788999999999999999954444
Q ss_pred cccccCCCCeeecCCCccCCCCC
Q 002061 524 SLSLLSSLNALNLSGNKLTGSIP 546 (973)
Q Consensus 524 ~~~~l~~L~~L~L~~N~l~~~~p 546 (973)
.|..+++|+.|+|++|++++..+
T Consensus 463 ~~~~l~~L~~L~l~~N~~~c~c~ 485 (520)
T 2z7x_B 463 IFDRLTSLQKIWLHTNPWDCSCP 485 (520)
T ss_dssp TTTTCTTCCEEECCSSCBCCCHH
T ss_pred HhccCCcccEEECcCCCCcccCC
Confidence 49999999999999999997665
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=441.25 Aligned_cols=457 Identities=21% Similarity=0.235 Sum_probs=381.9
Q ss_pred EEEeecCCCCCccccccccCCccCcEeeCCCCcccCcCChhhhCCCCCcEEEecCCcccCCCC-cccCCCCCCEEeccCc
Q 002061 76 TEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVP-DLSALKNLEIFDLSIN 154 (973)
Q Consensus 76 ~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~-~l~~l~~L~~L~Ls~n 154 (973)
..++++++++++ +|..+. ++|++|+|++|.+++..|..|+.+++|++|+|++|++++.++ .|+++++|++|||++|
T Consensus 34 ~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 110 (562)
T 3a79_B 34 SMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN 110 (562)
T ss_dssp CEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred cEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCC
Confidence 778999999995 887665 899999999999998777899999999999999999999865 5999999999999999
Q ss_pred cCCCccccccccccccceEEccCCcCCCCCCcccccCCCCCCEEEcccCCCCCCCChhhhccCCC--Ceeecccccc--c
Q 002061 155 YFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELREL--GTLDICRNKI--S 230 (973)
Q Consensus 155 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L--~~L~L~~N~l--~ 230 (973)
.++ .+|.. .+++|++|++++|.+....+|..++++++|++|+|++|++++. .+..+++| ++|++++|++ +
T Consensus 111 ~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~ 184 (562)
T 3a79_B 111 RLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIK 184 (562)
T ss_dssp CCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCC
T ss_pred cCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeeccccccc
Confidence 999 56665 8999999999999998777789999999999999999999863 45566666 9999999999 8
Q ss_pred CCCchhhhccc-cccEEEeeccccCCcCCc-cccccccccEEEeeccc-----cccccCCccCCCCCccEEEcccCCCCC
Q 002061 231 GEFPRSIRKLQ-KLWKIELYANNLTGELPA-ELGNLTLLQEFDISSNQ-----MYGKLPEEIGNLKNLTVFQCFKNNFSG 303 (973)
Q Consensus 231 ~~~~~~l~~l~-~L~~L~L~~N~l~~~~~~-~l~~l~~L~~L~Ls~N~-----l~~~~p~~~~~l~~L~~L~l~~N~l~~ 303 (973)
+..|..+..+. ....++++.|.+.+.++. .+..+++|+.|++++|+ +.+ .+..+..+++|+.+++.++.+.+
T Consensus 185 ~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~-~~~~l~~l~~L~~L~L~~~~l~~ 263 (562)
T 3a79_B 185 GGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMT-FLSELTRGPTLLNVTLQHIETTW 263 (562)
T ss_dssp SSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHH-HHHHHHSCSSCEEEEEEEEEECH
T ss_pred ccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHH-HHHHHhccCcceEEEecCCcCcH
Confidence 88888888765 223678899998876654 46789999999999995 222 23457788999999998888765
Q ss_pred CCCCC---cCCcccceeeeccCCccCCCCCccc-----cccccccccccccccccccCCh-hhhhhhhHHHHHhhhccCC
Q 002061 304 EFPSG---FGDMRKLFAFSIYGNRFSGPFPENL-----GRYTALTDVDISENQFSGSFPK-YLCEKRKLLNLLALSNNFS 374 (973)
Q Consensus 304 ~~p~~---~~~l~~L~~L~l~~N~l~~~~~~~l-----~~l~~L~~L~Ls~N~l~~~~p~-~~~~~~~ll~ll~l~n~~~ 374 (973)
..... ....++|++|++++|.+++.+|..+ ..++.|+.++++.|.+ .+|. .+....
T Consensus 264 ~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~------------- 328 (562)
T 3a79_B 264 KCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALYSVF------------- 328 (562)
T ss_dssp HHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHHH-------------
T ss_pred HHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhccccee--ecChhhhhhhh-------------
Confidence 21111 1123489999999999999999887 7888888888888887 4553 222111
Q ss_pred CCccccccCccccceEeccccccccCCCccccCCCCcceEeccCCcCCCCCCCCCCCCCCCCEEEcccCCCCCCC--Chh
Q 002061 375 GEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGEL--PSE 452 (973)
Q Consensus 375 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~--p~~ 452 (973)
...+|++|++++|.+.... ....+++|++|++++|++++..+..++.+++|++|+|++|++++.. |..
T Consensus 329 --------~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 398 (562)
T 3a79_B 329 --------AEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALM 398 (562)
T ss_dssp --------HTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHT
T ss_pred --------ccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhh
Confidence 1257999999999986322 1267899999999999999999999999999999999999999643 467
Q ss_pred hhcCCCCCEEEccCCcCCCCcc-ccccccccCCEEEcCCcccccCCCccccccccccchhccccccccCCCccccccCCC
Q 002061 453 LGRLTNLERLILTNNNFSGKIP-SALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSL 531 (973)
Q Consensus 453 ~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 531 (973)
+.++++|++|+|++|++++.+| ..+..+++|++|+|++|++++..|..+. ++|+.|+|++|+|+ .+|..+..+++|
T Consensus 399 ~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L 475 (562)
T 3a79_B 399 TKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQAL 475 (562)
T ss_dssp TTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCC
T ss_pred hcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCC
Confidence 8999999999999999998454 5688999999999999999987776654 78999999999999 677777799999
Q ss_pred CeeecCCCccCCCCChh-hhccc-CceEEccCCccccccCcc
Q 002061 532 NALNLSGNKLTGSIPDN-LMKLK-LSSIDLSENQLSGSVPLD 571 (973)
Q Consensus 532 ~~L~L~~N~l~~~~p~~-l~~l~-L~~l~ls~N~l~~~~p~~ 571 (973)
+.|+|++|+|+ .+|.. +..++ |+.|+|++|+|.|.||..
T Consensus 476 ~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~~~ 516 (562)
T 3a79_B 476 QELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTCPGI 516 (562)
T ss_dssp SEEECCSSCCC-CCCTTSTTTCTTCCCEECCSCCBCCCHHHH
T ss_pred CEEECCCCCCC-CCCHHHHhcCCCCCEEEecCCCcCCCcchH
Confidence 99999999999 56665 77776 999999999999999964
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=401.51 Aligned_cols=199 Identities=25% Similarity=0.407 Sum_probs=173.2
Q ss_pred HcCCcccCcccccCceEEEEEEec---CCCcEEEEEeeeccccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLK---KNAGTVAVKQLWKGDGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLVL 750 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~---~~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~ 750 (973)
.++|++.+.||+|+||+||+|+++ .+++.||||++.......++.+|+++++.+ +||||+++++++.++++.|+||
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvm 99 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAM 99 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEE
Confidence 467999999999999999999875 457899999998877777889999999998 6999999999999999999999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCC-CCeEEecccCcccc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDED-YEPKIADFGVAKIA 829 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfgl~~~~ 829 (973)
||+++|+|.+++. .+++..+..++.|++.||+||| +++||||||||+|||++.+ +.+||+|||+|+..
T Consensus 100 E~~~g~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~ 168 (361)
T 4f9c_A 100 PYLEHESFLDILN--------SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT 168 (361)
T ss_dssp ECCCCCCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred eCCCcccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence 9999999999884 3788999999999999999999 7899999999999999876 79999999999765
Q ss_pred cCCCCc--------------------------ccccccCCccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCC
Q 002061 830 ENSPKV--------------------------SDYSCFAGTHGYIAPELAYTC-KVSEKSDVFSFGVVLLELVTGRKPVE 882 (973)
Q Consensus 830 ~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~pf~ 882 (973)
...... ......+||+.|+|||++.+. .|+.++||||+||++|||++|+.||.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248 (361)
T ss_dssp TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence 432110 112235799999999999775 58999999999999999999999996
Q ss_pred cc
Q 002061 883 EE 884 (973)
Q Consensus 883 ~~ 884 (973)
..
T Consensus 249 ~~ 250 (361)
T 4f9c_A 249 KA 250 (361)
T ss_dssp CC
T ss_pred CC
Confidence 43
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=404.08 Aligned_cols=264 Identities=24% Similarity=0.310 Sum_probs=202.5
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEe------CCe
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLK------GGS 745 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~------~~~ 745 (973)
++|++.+.||+|+||+||+|++..+|+.||||++... ...+.+.+|++++++++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 4799999999999999999999999999999998653 334567899999999999999999998764 357
Q ss_pred eEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccC
Q 002061 746 SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGV 825 (973)
Q Consensus 746 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl 825 (973)
.|+|||||+ |+|.+++.. ...+++..+..++.||+.||+||| +++||||||||+|||++.++.+||+|||+
T Consensus 134 ~~ivmE~~~-g~L~~~i~~-----~~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHS-----SQPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp EEEEEECCS-EEHHHHHTS-----SSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEeCCC-CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecce
Confidence 899999995 789999864 346899999999999999999999 78999999999999999999999999999
Q ss_pred cccccCCCC--cccccccCCccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccc
Q 002061 826 AKIAENSPK--VSDYSCFAGTHGYIAPELAYTC-KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNH 902 (973)
Q Consensus 826 ~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 902 (973)
|+....... .......+||+.|||||++.+. .++.++||||+||++|||++|+.||.+. +..+....+.......
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~--~~~~~l~~I~~~~g~p 282 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK--NYVHQLQLIMMVLGTP 282 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS--SHHHHHHHHHHHHCCC
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCC--CHHHHHHHHHHhcCCC
Confidence 986643221 2223456899999999998875 4689999999999999999999999653 1111111111111110
Q ss_pred cc-cchh---------cc--ccccCcc----hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 903 EN-VLKV---------LD--CEVASES----IKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 903 ~~-~~~~---------~~--~~~~~~~----~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
.. .... .. +...+.. .......+.+|+.+||+.||.+|||+.|+++|-
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp 346 (398)
T 4b99_A 283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHP 346 (398)
T ss_dssp CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSG
T ss_pred ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCH
Confidence 00 0000 00 0000000 011235678999999999999999999999874
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=422.76 Aligned_cols=435 Identities=19% Similarity=0.193 Sum_probs=366.6
Q ss_pred CceEEEeecCCCCCccccccccCCccCcEeeCCCCcccCcCChhhhCCCCCcEEEecCCcccCCCCcccCCCCCCEEecc
Q 002061 73 GRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLS 152 (973)
Q Consensus 73 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls 152 (973)
.+++.|+|+++.+++..+..++.+++|++|+|++|.+++..|..|+.+++|++|+|++|+++..+.. .+++|++|||+
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~--~l~~L~~L~Ls 129 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNISCC--PMASLRHLDLS 129 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCCEECSC--CCTTCSEEECC
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCCccCcc--ccccCCEEECC
Confidence 6799999999999988888999999999999999999988899999999999999999999977766 89999999999
Q ss_pred CccCCC-ccccccccccccceEEccCCcCCCCCCcccccCCCCC--CEEEcccCCC--CCCCChhhhccC--CCCeeecc
Q 002061 153 INYFTG-RFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNL--TYLFLAHCNL--RGRIPESISELR--ELGTLDIC 225 (973)
Q Consensus 153 ~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~ip~~~~~l~~L--~~L~L~~n~l--~~~~~~~~~~l~--~L~~L~L~ 225 (973)
+|.+++ ..|..|.++++|++|++++|.+... .+..+++| ++|++++|++ ++..|..+..+. .| .++++
T Consensus 130 ~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~----~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l-~l~l~ 204 (562)
T 3a79_B 130 FNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL----DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVL-HLVFH 204 (562)
T ss_dssp SSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT----TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEE-EEEEC
T ss_pred CCCccccCchHhhcccCcccEEecCCCccccC----chhhhhhceeeEEEeecccccccccCcccccccCcceE-EEEec
Confidence 999997 4578999999999999999999753 34555555 9999999999 888888888765 33 56889
Q ss_pred cccccCCCch-hhhccccccEEEeeccc-----cCCcCCccccccccccEEEeecccccccc----CCccCCCCCccEEE
Q 002061 226 RNKISGEFPR-SIRKLQKLWKIELYANN-----LTGELPAELGNLTLLQEFDISSNQMYGKL----PEEIGNLKNLTVFQ 295 (973)
Q Consensus 226 ~N~l~~~~~~-~l~~l~~L~~L~L~~N~-----l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~ 295 (973)
+|.+.+.++. .+..+++|+.|++++|+ +.+ ....+..+++|+.|+++++.+.+.. +..+ ..++|++|+
T Consensus 205 ~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~-~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~-~~~~L~~L~ 282 (562)
T 3a79_B 205 PNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMT-FLSELTRGPTLLNVTLQHIETTWKCSVKLFQFF-WPRPVEYLN 282 (562)
T ss_dssp SSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHH-HHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHH-TTSSEEEEE
T ss_pred CccchhhhhhhcccccceEEEecccccccccchHHH-HHHHHhccCcceEEEecCCcCcHHHHHHHHHhh-hcccccEEE
Confidence 9998876665 46788999999999985 232 2345778899999999888776432 2222 235899999
Q ss_pred cccCCCCCCCCCCc-----CCcccceeeeccCCccCCCCC-cccccc---ccccccccccccccccCChhhhhhhhHHHH
Q 002061 296 CFKNNFSGEFPSGF-----GDMRKLFAFSIYGNRFSGPFP-ENLGRY---TALTDVDISENQFSGSFPKYLCEKRKLLNL 366 (973)
Q Consensus 296 l~~N~l~~~~p~~~-----~~l~~L~~L~l~~N~l~~~~~-~~l~~l---~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~l 366 (973)
+++|++++.+|..+ ..++.|+.+++..|.+ .+| ..+..+ .+|++|++++|.+...
T Consensus 283 l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~L~l~~n~~~~~-------------- 346 (562)
T 3a79_B 283 IYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALYSVFAEMNIKMLSISDTPFIHM-------------- 346 (562)
T ss_dssp EEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCCCSEEEEESSCCCCC--------------
T ss_pred EeccEeeccccchhhhcccccchheehhhccccee--ecChhhhhhhhccCcceEEEccCCCcccc--------------
Confidence 99999999999887 8888888888888888 344 333332 5799999999988621
Q ss_pred HhhhccCCCCccccccCccccceEeccccccccCCCccccCCCCcceEeccCCcCCCCC--CCCCCCCCCCCEEEcccCC
Q 002061 367 LALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGI--SPLIGLSTSLSQLVLQNNR 444 (973)
Q Consensus 367 l~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~~~~L~~L~L~~N~ 444 (973)
+ ....+++|++|+|++|++++.+|..+..+++|+.|++++|++++.. +..+..+++|++|+|++|+
T Consensus 347 -----------~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~ 414 (562)
T 3a79_B 347 -----------V-CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNS 414 (562)
T ss_dssp -----------C-CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSC
T ss_pred -----------c-CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCc
Confidence 0 1257789999999999999999999999999999999999999864 3568899999999999999
Q ss_pred CCCCCCh-hhhcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCCccccccccccchhccccccccCCCc
Q 002061 445 FSGELPS-ELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPR 523 (973)
Q Consensus 445 l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~ 523 (973)
+++.+|. .+..+++|++|+|++|++++..|..+. ++|++|+|++|+|+ .+|..+.++++|+.|+|++|+|++..+.
T Consensus 415 l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~ 491 (562)
T 3a79_B 415 LNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDG 491 (562)
T ss_dssp CBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTT
T ss_pred CCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHH
Confidence 9984554 588999999999999999987777665 79999999999999 5676666999999999999999954444
Q ss_pred cccccCCCCeeecCCCccCCCCCh
Q 002061 524 SLSLLSSLNALNLSGNKLTGSIPD 547 (973)
Q Consensus 524 ~~~~l~~L~~L~L~~N~l~~~~p~ 547 (973)
.|..+++|+.|+|++|++++..|.
T Consensus 492 ~~~~l~~L~~L~l~~N~~~c~c~~ 515 (562)
T 3a79_B 492 VFDRLTSLQYIWLHDNPWDCTCPG 515 (562)
T ss_dssp STTTCTTCCCEECCSCCBCCCHHH
T ss_pred HHhcCCCCCEEEecCCCcCCCcch
Confidence 499999999999999999987664
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=419.95 Aligned_cols=502 Identities=20% Similarity=0.194 Sum_probs=394.5
Q ss_pred EEeecCCCCCccccccccCCccCcEeeCCCCcccCcCChhhhCCCCCcEEEecCCcccCCCCc-ccCCCCCCEEeccCcc
Q 002061 77 EISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD-LSALKNLEIFDLSINY 155 (973)
Q Consensus 77 ~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~-l~~l~~L~~L~Ls~n~ 155 (973)
.++-++.+++ .+|+.|- +++++|||++|+|++..|..|.++++|++|+|++|+|++.++. |+++++|++|+|++|+
T Consensus 35 ~~~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~ 111 (635)
T 4g8a_A 35 TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 111 (635)
T ss_dssp EEECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred EEECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCc
Confidence 4567777887 6776553 4799999999999977778999999999999999999998774 9999999999999999
Q ss_pred CCCccccccccccccceEEccCCcCCCCCCc-ccccCCCCCCEEEcccCCCCC-CCChhhhccCCCCeeecccccccCCC
Q 002061 156 FTGRFPRWVVNLTQLVSLSIGDNVYDEAEIP-ESIGNLKNLTYLFLAHCNLRG-RIPESISELRELGTLDICRNKISGEF 233 (973)
Q Consensus 156 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ip-~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~ 233 (973)
+++..+.+|.++++|++|+|++|.++. +| ..|+++++|++|+|++|++++ .+|..++.+++|++|+|++|+|++..
T Consensus 112 l~~l~~~~f~~L~~L~~L~Ls~N~l~~--l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 189 (635)
T 4g8a_A 112 IQSLALGAFSGLSSLQKLVAVETNLAS--LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIY 189 (635)
T ss_dssp CCEECGGGGTTCTTCCEEECTTSCCCC--STTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEEC
T ss_pred CCCCCHHHhcCCCCCCEEECCCCcCCC--CChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccc
Confidence 998888899999999999999999974 44 468999999999999999986 46888999999999999999999888
Q ss_pred chhhhcccccc----EEEeeccccCCcCCccccccccccEEEeeccccccc-cCCccCCCCCccEEEcc-----------
Q 002061 234 PRSIRKLQKLW----KIELYANNLTGELPAELGNLTLLQEFDISSNQMYGK-LPEEIGNLKNLTVFQCF----------- 297 (973)
Q Consensus 234 ~~~l~~l~~L~----~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~l~----------- 297 (973)
+..+..+.+++ .++++.|.++...+.. .....++.+++++|..... .+..+..+..++...+.
T Consensus 190 ~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~-~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~ 268 (635)
T 4g8a_A 190 CTDLRVLHQMPLLNLSLDLSLNPMNFIQPGA-FKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLE 268 (635)
T ss_dssp GGGGHHHHTCTTCCCEEECTTCCCCEECTTT-TTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCS
T ss_pred cccccchhhhhhhhhhhhcccCcccccCccc-ccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccc
Confidence 88888877654 7889999999544444 4445678888888865422 22233444444444332
Q ss_pred -------------------cCCCCC---CCCCCcCCcccceeeeccCCccCCCCCccccccccccccccccccccccCCh
Q 002061 298 -------------------KNNFSG---EFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPK 355 (973)
Q Consensus 298 -------------------~N~l~~---~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~ 355 (973)
.+.... ..+..+..+.+++.+.+.+|.+... ..+.....|+.|++++|.+.+..+.
T Consensus 269 ~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~~~~~~~~~~ 346 (635)
T 4g8a_A 269 KFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERV--KDFSYNFGWQHLELVNCKFGQFPTL 346 (635)
T ss_dssp CCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEEC--GGGGSCCCCSEEEEESCEESSCCCC
T ss_pred cccccccccccchhhhhhhhhhhcccccchhhhhhhhcccccccccccccccc--cccccchhhhhhhcccccccCcCcc
Confidence 221111 1223344555666666666666532 2355566788888888888754443
Q ss_pred hhhhhhhHHHHHhhhccCCCCccccccCccccceEeccccccc--cCCCccccCCCCcceEeccCCcCCCCCCCCCCCCC
Q 002061 356 YLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLS--GKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLST 433 (973)
Q Consensus 356 ~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ 433 (973)
.+.... .+.+..+..+. +.....+++|+.|++++|.+. +..+..+..+.+|+.++++.|.+... +..+..++
T Consensus 347 ~l~~L~----~l~l~~n~~~~-~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~~-~~~~~~l~ 420 (635)
T 4g8a_A 347 KLKSLK----RLTFTSNKGGN-AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVITM-SSNFLGLE 420 (635)
T ss_dssp BCTTCC----EEEEESCCSCC-BCCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEEE-CSCCTTCT
T ss_pred cchhhh----hcccccccCCC-Ccccccccccccchhhccccccccccccchhhhhhhhhhhccccccccc-cccccccc
Confidence 332211 11222232222 334567899999999999986 45677778899999999999988764 44567889
Q ss_pred CCCEEEcccCCCCCCCC-hhhhcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCccc-ccCCCccccccccccchh
Q 002061 434 SLSQLVLQNNRFSGELP-SELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENAL-TGSIPNEMGDCARIVDLN 511 (973)
Q Consensus 434 ~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l-~~~~p~~~~~l~~L~~L~ 511 (973)
+|+.+++++|+.....+ ..+..+++++.++++.|.+++..+..+..++.|+.|+|++|++ .+..|..|..+++|+.|+
T Consensus 421 ~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~ 500 (635)
T 4g8a_A 421 QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 500 (635)
T ss_dssp TCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEE
T ss_pred cccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEE
Confidence 99999999988775544 5688999999999999999999999999999999999999974 556889999999999999
Q ss_pred ccccccccCCCccccccCCCCeeecCCCccCCCCChhhhccc-CceEEccCCccccccCcccccCCC---CccccCCCCC
Q 002061 512 LARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLK-LSSIDLSENQLSGSVPLDFLRMGG---DGAFAGNEGL 587 (973)
Q Consensus 512 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~-L~~l~ls~N~l~~~~p~~~~~~~~---~~~~~~n~~l 587 (973)
|++|+|++..|..|.++++|++|+|++|+|++.+|..+..++ |+.|||++|++++..|..+..+.. .-...+||+.
T Consensus 501 Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~ 580 (635)
T 4g8a_A 501 LSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 580 (635)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBC
T ss_pred CCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCc
Confidence 999999999999999999999999999999998888898886 999999999999999987766532 2357999999
Q ss_pred ccCcc
Q 002061 588 CLDQS 592 (973)
Q Consensus 588 c~~~~ 592 (973)
|....
T Consensus 581 C~C~~ 585 (635)
T 4g8a_A 581 CTCEH 585 (635)
T ss_dssp CSGGG
T ss_pred ccCCc
Confidence 86543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=412.31 Aligned_cols=251 Identities=23% Similarity=0.265 Sum_probs=204.2
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHH---HHHHHhcCCCceeeEEEEEEeCCe
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAE---MEILGKIRHRNILKLYACLLKGGS 745 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E---~~~l~~l~hpniv~l~~~~~~~~~ 745 (973)
.+++|++.+.||+|+||+||+|+++.+|+.||||++.+. .......+| +++++.++|||||+++++|.+++.
T Consensus 187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ 266 (689)
T 3v5w_A 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 266 (689)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCE
Confidence 356899999999999999999999999999999998652 233334444 556667799999999999999999
Q ss_pred eEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccC
Q 002061 746 SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGV 825 (973)
Q Consensus 746 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl 825 (973)
.|+||||++||+|.+++.+. ..+++..+..++.||+.||+||| +++||||||||+|||++.+|.+||+|||+
T Consensus 267 lylVmEy~~GGdL~~~l~~~-----~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGl 338 (689)
T 3v5w_A 267 LSFILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGL 338 (689)
T ss_dssp EEEEECCCCSCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccce
Confidence 99999999999999999864 35899999999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCCcccccccCCcccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccc
Q 002061 826 AKIAENSPKVSDYSCFAGTHGYIAPELAYT-CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHEN 904 (973)
Q Consensus 826 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 904 (973)
|+...... ....+||+.|||||++.+ ..|+.++||||+||++|||++|+.||...... +..............
T Consensus 339 A~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~--~~~~i~~~i~~~~~~ 412 (689)
T 3v5w_A 339 ACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--DKHEIDRMTLTMAVE 412 (689)
T ss_dssp CEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC--CHHHHHHHHHHCCCC
T ss_pred eeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHhhcCCCCC
Confidence 98765432 234689999999999964 57999999999999999999999999764222 222222221111111
Q ss_pred cchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHh
Q 002061 905 VLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPP-----MREVVKML 950 (973)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt-----~~evl~~L 950 (973)
.+.....++.+++.+|++.||.+|++ +.||.+|-
T Consensus 413 ------------~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hp 451 (689)
T 3v5w_A 413 ------------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESP 451 (689)
T ss_dssp ------------CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSG
T ss_pred ------------CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCc
Confidence 11123456789999999999999998 78888764
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=382.96 Aligned_cols=291 Identities=30% Similarity=0.497 Sum_probs=217.6
Q ss_pred CchHHHHHHHHHHHhcCCCcccccCCCCCCCCCCC--cceeeeCCCC--CceEEEeecCCCCCc--cccccccCCccCcE
Q 002061 28 SLNVETQALIQFKSKLKDPHGVLDSWKESADSPCG--FSGITCDSVT--GRVTEISFDNKSLSG--EISSSISALQSLTV 101 (973)
Q Consensus 28 ~~~~~~~aLl~~k~~~~d~~~~~~~W~~~~~~~c~--w~gv~C~~~~--~~v~~l~l~~~~l~~--~~~~~l~~l~~L~~ 101 (973)
|.++|++||++||+++.||. .+++|+.+. +||. |.||+|+..+ ++|+.|+|++++++| .+|+.++.+++|++
T Consensus 3 c~~~~~~aL~~~k~~~~~~~-~l~~W~~~~-~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~ 80 (313)
T 1ogq_A 3 CNPQDKQALLQIKKDLGNPT-TLSSWLPTT-DCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNF 80 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCCG-GGTTCCTTS-CTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSE
T ss_pred CCHHHHHHHHHHHHhcCCcc-cccCCCCCC-CCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCCe
Confidence 56889999999999999987 799998764 4787 9999998755 899999999999999 99999999999999
Q ss_pred eeCCC-CcccCcCChhhhCCCCCcEEEecCCcccCCCC-cccCCCCCCEEeccCccCCCccccccccccccceEEccCCc
Q 002061 102 LSLPF-NVLSGKLPLELSNCSNLKVLNVTGNAMVGSVP-DLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNV 179 (973)
Q Consensus 102 L~Ls~-n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~ 179 (973)
|+|++ |.+++.+|..|+++++|++|+|++|.+++..+ .++++++|++|+|++|.+++.+|..+..+++|++|++++|.
T Consensus 81 L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 160 (313)
T 1ogq_A 81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160 (313)
T ss_dssp EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred eeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCc
Confidence 99995 99999999999999999999999999986554 58999999999999999988777777777777777777776
Q ss_pred CCCCCCcccccCCC-CCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCchhhhccccccEEEeeccccCCcCC
Q 002061 180 YDEAEIPESIGNLK-NLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELP 258 (973)
Q Consensus 180 l~~~~ip~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 258 (973)
++. .+|..++.++ +|++|+|++|++++.+|..+..++ |++|+|++|++++..|..+..+++|++|+|++|.+++.+|
T Consensus 161 l~~-~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 238 (313)
T 1ogq_A 161 ISG-AIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG 238 (313)
T ss_dssp CEE-ECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG
T ss_pred ccC-cCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecC
Confidence 642 3566666666 667777777766666666666665 6666666666666666666666666666666666664444
Q ss_pred ccccccccccEEEeeccccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeeccCCc
Q 002061 259 AELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNR 324 (973)
Q Consensus 259 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 324 (973)
. +..+++|++|+|++|++++.+|..+..+++|++|++++|++++.+|.. +.+++|+.+++++|+
T Consensus 239 ~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 239 K-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNK 302 (313)
T ss_dssp G-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSS
T ss_pred c-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCC
Confidence 3 555566666666666666556666665666666666665555555543 444444444444444
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=398.69 Aligned_cols=408 Identities=23% Similarity=0.312 Sum_probs=250.4
Q ss_pred CceEEEeecCCCCCccccccccCCccCcEeeCCCCcccCcCChhhhCCCCC-------------cEEEecCCcccCCCCc
Q 002061 73 GRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNL-------------KVLNVTGNAMVGSVPD 139 (973)
Q Consensus 73 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L-------------~~L~L~~n~l~~~~~~ 139 (973)
.++..++++++++ |++|++++++++|++|++++|.++|.+|..++++.+| ++|++++|.+++.+..
T Consensus 11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~lp~~ 89 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLPEL 89 (454)
T ss_dssp ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCCCSC
T ss_pred ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccCCCC
Confidence 4678899999999 8999999999999999999999999999999988875 8899999988886652
Q ss_pred ccCCCCCCEEeccCccCCCccccccccccccceEEccCCcCCCCCCcccccCCCCCCEEEcccCCCCCCCChhhhccCCC
Q 002061 140 LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELREL 219 (973)
Q Consensus 140 l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 219 (973)
.++|++|++++|.+++ +|.. +++|++|++++|.++. +|.. .++|++|++++|++++ +| .++.+++|
T Consensus 90 ---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~--l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L 155 (454)
T 1jl5_A 90 ---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA--LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFL 155 (454)
T ss_dssp ---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC--CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTC
T ss_pred ---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc--ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCC
Confidence 3688899999998886 5543 3788888888888763 3322 2688888888888885 66 58888888
Q ss_pred CeeecccccccCCCchhhhccccccEEEeeccccCCcCCccccccccccEEEeeccccccccCCccCCCCCccEEEcccC
Q 002061 220 GTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKN 299 (973)
Q Consensus 220 ~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N 299 (973)
++|++++|++++ +|..+ .+|++|++++|++++ +| .++++++|++|++++|++++ +|... ++|+.|++++|
T Consensus 156 ~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~~n 225 (454)
T 1jl5_A 156 KIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP---LSLESIVAGNN 225 (454)
T ss_dssp CEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC---TTCCEEECCSS
T ss_pred CEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc---CcccEEECcCC
Confidence 888888888884 55443 488888888888885 55 57888888888888888874 44433 47888888888
Q ss_pred CCCCCCCCCcCCcccceeeeccCCccCCCCCccccccccccccccccccccccCChhhhhhhhHHHHHhhhccCCCCccc
Q 002061 300 NFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPN 379 (973)
Q Consensus 300 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~ll~l~n~~~~~~p~ 379 (973)
+++ .+| .++.+++|+.|++++|++++ +|.. .++|++|++++|++++ +| .
T Consensus 226 ~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~------------------------~ 274 (454)
T 1jl5_A 226 ILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LP------------------------E 274 (454)
T ss_dssp CCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CC------------------------C
T ss_pred cCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cC------------------------c
Confidence 888 556 37888888888888888875 4432 3678888888888873 22 1
Q ss_pred cccCccccceEeccccccccCCCccccCCCCcceEeccCCcCCCCCCCCCCCCCCCCEEEcccCCCCCCCChhhhcCCCC
Q 002061 380 SYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNL 459 (973)
Q Consensus 380 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L 459 (973)
. +++|++|++++|++++. |.. .++|+.|++++|++++.. ...++|++|++++|++++ +|.. +++|
T Consensus 275 ~---~~~L~~L~ls~N~l~~l-~~~---~~~L~~L~l~~N~l~~i~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L 339 (454)
T 1jl5_A 275 L---PQSLTFLDVSENIFSGL-SEL---PPNLYYLNASSNEIRSLC----DLPPSLEELNVSNNKLIE-LPAL---PPRL 339 (454)
T ss_dssp C---CTTCCEEECCSSCCSEE-SCC---CTTCCEEECCSSCCSEEC----CCCTTCCEEECCSSCCSC-CCCC---CTTC
T ss_pred c---cCcCCEEECcCCccCcc-cCc---CCcCCEEECcCCcCCccc----CCcCcCCEEECCCCcccc-cccc---CCcC
Confidence 1 25788888888888752 211 257888888888887632 123578888888888875 5543 4778
Q ss_pred CEEEccCCcCCCCccccccccccCCEEEcCCccccc--CCCccccccccccchhccccccccCCCccccccCCCCeeecC
Q 002061 460 ERLILTNNNFSGKIPSALGALRQLSSLHLEENALTG--SIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLS 537 (973)
Q Consensus 460 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 537 (973)
++|++++|+++ .+|. .+++|++|+|++|++++ .+|.+++. |+.|++.+.+|.. +++|+.|+|+
T Consensus 340 ~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~--------L~~n~~~~~i~~~---~~~L~~L~ls 404 (454)
T 1jl5_A 340 ERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVED--------LRMNSHLAEVPEL---PQNLKQLHVE 404 (454)
T ss_dssp CEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCE--------EECCC---------------------
T ss_pred CEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHHh--------hhhcccccccccc---cCcCCEEECC
Confidence 88888888887 4555 46788888888888887 55655543 3346666666653 4788888999
Q ss_pred CCccCC--CCChhhhcccCceEEccCCccccccCcc
Q 002061 538 GNKLTG--SIPDNLMKLKLSSIDLSENQLSGSVPLD 571 (973)
Q Consensus 538 ~N~l~~--~~p~~l~~l~L~~l~ls~N~l~~~~p~~ 571 (973)
+|++++ .+|.+ ++.|.+.+|.+.|.+|..
T Consensus 405 ~N~l~~~~~iP~s-----l~~L~~~~~~~~~~~~~~ 435 (454)
T 1jl5_A 405 TNPLREFPDIPES-----VEDLRMNSERVVDPYEFA 435 (454)
T ss_dssp ------------------------------------
T ss_pred CCcCCccccchhh-----HhheeCcCcccCCccccC
Confidence 999886 66654 455667788888777654
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=401.60 Aligned_cols=376 Identities=21% Similarity=0.205 Sum_probs=249.6
Q ss_pred CCCCEEeccCccCCCccccccccccccceEEccCCcCCCCCCcccccCCCCCCEEEcccCCCCCCCChhhhccCCCCeee
Q 002061 144 KNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLD 223 (973)
Q Consensus 144 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 223 (973)
++|++|||++|.+++..|..|.++++|++|++++|.+...--|..+.++++|++|+|++|++++..|..|+.+++|++|+
T Consensus 30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 109 (455)
T 3v47_A 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT 109 (455)
T ss_dssp TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence 34444444444444444444444444444444444432111134556666666666666666666666666666777777
Q ss_pred cccccccCCCchh--hhccccccEEEeeccccCCcCCcc-ccccccccEEEeeccccccccCCccCCC--CCccEEEccc
Q 002061 224 ICRNKISGEFPRS--IRKLQKLWKIELYANNLTGELPAE-LGNLTLLQEFDISSNQMYGKLPEEIGNL--KNLTVFQCFK 298 (973)
Q Consensus 224 L~~N~l~~~~~~~--l~~l~~L~~L~L~~N~l~~~~~~~-l~~l~~L~~L~Ls~N~l~~~~p~~~~~l--~~L~~L~l~~ 298 (973)
|++|++++..+.. +..+++|++|+|++|++++..|.. +.++++|++|++++|++++..|..+..+ .+|+.|++++
T Consensus 110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~ 189 (455)
T 3v47_A 110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSS 189 (455)
T ss_dssp CTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTT
T ss_pred CCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhcccccccccccccc
Confidence 7776666544433 566666666666666666554544 5566666666666666665555555544 4555555555
Q ss_pred CCCCCCCCCCcCCcccceeeeccCCccCCCCCccccccccccccccccccccccCChhhhhhhhHHHHHhhhccCCCCcc
Q 002061 299 NNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVP 378 (973)
Q Consensus 299 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~ll~l~n~~~~~~p 378 (973)
|.+.+..+..++. .....+..+++|++|++++|++++..|..+....
T Consensus 190 n~l~~~~~~~~~~----------------~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~----------------- 236 (455)
T 3v47_A 190 ITLQDMNEYWLGW----------------EKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAI----------------- 236 (455)
T ss_dssp CBCTTCSTTCTTH----------------HHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHT-----------------
T ss_pred Ccccccchhhccc----------------cccccccccceeeeEecCCCcccccchhhhhccc-----------------
Confidence 5555333222110 0001123456788888888888766665554321
Q ss_pred ccccCccccceEeccccccccCCCccccCCCCcceEeccCCcCCCCCCCCCC--CCCCCCEEEcccCCCCCCCChhhhcC
Q 002061 379 NSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIG--LSTSLSQLVLQNNRFSGELPSELGRL 456 (973)
Q Consensus 379 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~--~~~~L~~L~L~~N~l~~~~p~~~~~l 456 (973)
..++|+.|++++|.+.+... ..+.+.+.....+. ..++|+.|++++|++.+..|..+..+
T Consensus 237 ----~~~~L~~L~l~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l 298 (455)
T 3v47_A 237 ----AGTKIQSLILSNSYNMGSSF--------------GHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHF 298 (455)
T ss_dssp ----TTCCEEEEECTTCTTTSCCT--------------TCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTC
T ss_pred ----cccceeeEeecccccccccc--------------chhhhccCcccccccccccCceEEEecCccccccchhhcccC
Confidence 23678888888887653211 12222222222222 23678999999999988888889999
Q ss_pred CCCCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCCccccccccccchhccccccccCCCccccccCCCCeeec
Q 002061 457 TNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNL 536 (973)
Q Consensus 457 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 536 (973)
++|++|+|++|++++..|..|..+++|++|+|++|++++..|..|+++++|+.|+|++|++++..|..|..+++|++|+|
T Consensus 299 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 378 (455)
T 3v47_A 299 TDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELAL 378 (455)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEEC
Confidence 99999999999998888888999999999999999998888888999999999999999999888889999999999999
Q ss_pred CCCccCCCCChhhhccc-CceEEccCCccccccCc
Q 002061 537 SGNKLTGSIPDNLMKLK-LSSIDLSENQLSGSVPL 570 (973)
Q Consensus 537 ~~N~l~~~~p~~l~~l~-L~~l~ls~N~l~~~~p~ 570 (973)
++|+|++..+..+..++ |+.|+|++|+|+|.||.
T Consensus 379 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 413 (455)
T 3v47_A 379 DTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 413 (455)
T ss_dssp CSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred CCCccccCCHhHhccCCcccEEEccCCCcccCCCc
Confidence 99999976666677775 99999999999999984
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=413.58 Aligned_cols=253 Identities=19% Similarity=0.270 Sum_probs=210.6
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc--ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY 752 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 752 (973)
+++|++.+.||+|+||+||+|+++.+|+.||||++... ...+.+.+|+++|+.++|||||+++++|.++...|+||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 57899999999999999999999999999999998763 3456788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCC--CCeEEecccCccccc
Q 002061 753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDED--YEPKIADFGVAKIAE 830 (973)
Q Consensus 753 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~--~~~kl~Dfgl~~~~~ 830 (973)
|+||+|.+++... ...+++..+..++.||+.||+||| +++|+||||||+|||++.+ +.+||+|||+|+...
T Consensus 236 ~~gg~L~~~i~~~----~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 236 MSGGELFEKVADE----HNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308 (573)
T ss_dssp CCCCBHHHHHTCT----TSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred cCCCcHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence 9999999998642 346899999999999999999999 7899999999999999854 899999999998775
Q ss_pred CCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhcc
Q 002061 831 NSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLD 910 (973)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (973)
... .....+||+.|||||++.+..|+.++||||+||++|||++|+.||... +.............
T Consensus 309 ~~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~-----~~~~~~~~i~~~~~------- 373 (573)
T 3uto_A 309 PKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE-----NDDETLRNVKSCDW------- 373 (573)
T ss_dssp TTS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS-----SHHHHHHHHHTTCC-------
T ss_pred CCC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-----CHHHHHHHHHhCCC-------
Confidence 432 233457999999999999999999999999999999999999999653 11222222111111
Q ss_pred ccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 911 CEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 911 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
.............+.+|+.+||+.||.+|||+.|+++|-
T Consensus 374 -~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hp 412 (573)
T 3uto_A 374 -NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHP 412 (573)
T ss_dssp -CCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHST
T ss_pred -CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 011111223345678999999999999999999999973
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=401.28 Aligned_cols=369 Identities=18% Similarity=0.200 Sum_probs=285.6
Q ss_pred CCCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCC-chhhhccccccEEEeeccccCCcCCccccccccccEEE
Q 002061 193 KNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEF-PRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFD 271 (973)
Q Consensus 193 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~ 271 (973)
++|++|+|++|++++..|..|+++++|++|+|++|.+.+.+ +..|.++++|++|+|++|++++..|..|.++++|++|+
T Consensus 30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 109 (455)
T 3v47_A 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT 109 (455)
T ss_dssp TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence 56777777777777666777777777777777777776444 45677777777777777777766677777777777777
Q ss_pred eeccccccccCCc--cCCCCCccEEEcccCCCCCCCCCC-cCCcccceeeeccCCccCCCCCcccccc--cccccccccc
Q 002061 272 ISSNQMYGKLPEE--IGNLKNLTVFQCFKNNFSGEFPSG-FGDMRKLFAFSIYGNRFSGPFPENLGRY--TALTDVDISE 346 (973)
Q Consensus 272 Ls~N~l~~~~p~~--~~~l~~L~~L~l~~N~l~~~~p~~-~~~l~~L~~L~l~~N~l~~~~~~~l~~l--~~L~~L~Ls~ 346 (973)
|++|++++..|.. +.++++|++|++++|++++..|.. +..+++|+.|++++|++++..+..+..+ .+|+.|++++
T Consensus 110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~ 189 (455)
T 3v47_A 110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSS 189 (455)
T ss_dssp CTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTT
T ss_pred CCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhcccccccccccccc
Confidence 7777777644443 777777777777777777766665 6777888888888888877777777766 6788888888
Q ss_pred ccccccCChhhhhhhhHHHHHhhhccCCCCccccccCccccceEeccccccccCCCccccCC---CCcceEeccCCcCCC
Q 002061 347 NQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWAL---PNVGMLDFGDNDFTG 423 (973)
Q Consensus 347 N~l~~~~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~L~~N~l~~ 423 (973)
|.+.+..+..+.. .....+..+++|++|+|++|++++..|..+... ++|+.|++++|.+.+
T Consensus 190 n~l~~~~~~~~~~----------------~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~ 253 (455)
T 3v47_A 190 ITLQDMNEYWLGW----------------EKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMG 253 (455)
T ss_dssp CBCTTCSTTCTTH----------------HHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTS
T ss_pred Ccccccchhhccc----------------cccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccc
Confidence 8887544433221 112234567899999999999998888877664 789999999988764
Q ss_pred CCCCCCCCCCCCCEEEcccCCCCCCCChhhhcC--CCCCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCCccc
Q 002061 424 GISPLIGLSTSLSQLVLQNNRFSGELPSELGRL--TNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEM 501 (973)
Q Consensus 424 ~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 501 (973)
.. +..+.+.+..+..+..+ ++|++|++++|++++..|..|..+++|++|+|++|++++..|..|
T Consensus 254 ~~--------------~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~ 319 (455)
T 3v47_A 254 SS--------------FGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAF 319 (455)
T ss_dssp CC--------------TTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTT
T ss_pred cc--------------cchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHh
Confidence 32 22334444444445443 689999999999999999999999999999999999999999999
Q ss_pred cccccccchhccccccccCCCccccccCCCCeeecCCCccCCCCChhhhccc-CceEEccCCccccccCcccccCCC--C
Q 002061 502 GDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLK-LSSIDLSENQLSGSVPLDFLRMGG--D 578 (973)
Q Consensus 502 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~-L~~l~ls~N~l~~~~p~~~~~~~~--~ 578 (973)
.++++|+.|+|++|++++..|..|..+++|++|+|++|++++.+|..+..++ |+.|+|++|++++..+..+..+.. .
T Consensus 320 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 399 (455)
T 3v47_A 320 WGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQK 399 (455)
T ss_dssp TTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCE
T ss_pred cCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccE
Confidence 9999999999999999988899999999999999999999988899998886 999999999999765544444433 2
Q ss_pred ccccCCCCCccCc
Q 002061 579 GAFAGNEGLCLDQ 591 (973)
Q Consensus 579 ~~~~~n~~lc~~~ 591 (973)
-.+.+|+.-|..|
T Consensus 400 L~l~~N~l~~~~~ 412 (455)
T 3v47_A 400 IWLHTNPWDCSCP 412 (455)
T ss_dssp EECCSSCBCCCTT
T ss_pred EEccCCCcccCCC
Confidence 3578998888665
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=394.88 Aligned_cols=398 Identities=22% Similarity=0.284 Sum_probs=235.4
Q ss_pred ccccCCccCcEeeCCCCcccCcCChhhhCCCCCcEEEecCCcccCCCC-cccCCCCC-------------CEEeccCccC
Q 002061 91 SSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVP-DLSALKNL-------------EIFDLSINYF 156 (973)
Q Consensus 91 ~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~-~l~~l~~L-------------~~L~Ls~n~l 156 (973)
+.-...++|++|++++|.+ +.+|.+|+++++|++|++++|.+.+..| .++.+++| ++|++++|.+
T Consensus 5 p~~~~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l 83 (454)
T 1jl5_A 5 PRNVSNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGL 83 (454)
T ss_dssp ------------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCC
T ss_pred ccccccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcc
Confidence 3334568999999999999 7999999999999999999999986554 58888875 8888888888
Q ss_pred CCccccccccccccceEEccCCcCCCCCCcccccCCCCCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCchh
Q 002061 157 TGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRS 236 (973)
Q Consensus 157 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 236 (973)
++ +|.. .++|++|++++|.++. +|.. +++|++|++++|++++ +|.. .++|++|++++|++++ +| .
T Consensus 84 ~~-lp~~---~~~L~~L~l~~n~l~~--lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~ 148 (454)
T 1jl5_A 84 SS-LPEL---PPHLESLVASCNSLTE--LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-E 148 (454)
T ss_dssp SC-CCSC---CTTCSEEECCSSCCSS--CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-C
T ss_pred cc-CCCC---cCCCCEEEccCCcCCc--cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-c
Confidence 75 3332 3678888888888764 5543 3678888888888874 3321 1578888888888875 66 5
Q ss_pred hhccccccEEEeeccccCCcCCccccccccccEEEeeccccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCcccce
Q 002061 237 IRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLF 316 (973)
Q Consensus 237 l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~ 316 (973)
++++++|++|++++|++++ +|..+ ++|++|++++|++++ +| .++++++|+.|++++|++++ +|... ++|+
T Consensus 149 ~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~ 218 (454)
T 1jl5_A 149 LQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP---LSLE 218 (454)
T ss_dssp CTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC---TTCC
T ss_pred cCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc---Cccc
Confidence 7888888888888888874 55433 478888888888875 55 57788888888888888875 34322 4778
Q ss_pred eeeccCCccCCCCCccccccccccccccccccccccCChhhhhhhhHHHHHhhhccCCCCccccccCccccceEeccccc
Q 002061 317 AFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNH 396 (973)
Q Consensus 317 ~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~ 396 (973)
.|++++|.++ .+| .++.+++|++|++++|++++ +| .. +++|++|++++|+
T Consensus 219 ~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~------------------------~~---~~~L~~L~l~~N~ 268 (454)
T 1jl5_A 219 SIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LP------------------------DL---PPSLEALNVRDNY 268 (454)
T ss_dssp EEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CC------------------------SC---CTTCCEEECCSSC
T ss_pred EEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cc------------------------cc---ccccCEEECCCCc
Confidence 8888888887 555 37778888888888887763 22 11 2567888888888
Q ss_pred cccCCCccccCCCCcceEeccCCcCCCCCCCCCCCCCCCCEEEcccCCCCCCCChhhhcC-CCCCEEEccCCcCCCCccc
Q 002061 397 LSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRL-TNLERLILTNNNFSGKIPS 475 (973)
Q Consensus 397 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~ 475 (973)
+++ +|.. .++|+.|++++|++++... ..++|++|++++|++++ ++ .+ ++|++|++++|++++ +|.
T Consensus 269 l~~-l~~~---~~~L~~L~ls~N~l~~l~~----~~~~L~~L~l~~N~l~~-i~----~~~~~L~~L~Ls~N~l~~-lp~ 334 (454)
T 1jl5_A 269 LTD-LPEL---PQSLTFLDVSENIFSGLSE----LPPNLYYLNASSNEIRS-LC----DLPPSLEELNVSNNKLIE-LPA 334 (454)
T ss_dssp CSC-CCCC---CTTCCEEECCSSCCSEESC----CCTTCCEEECCSSCCSE-EC----CCCTTCCEEECCSSCCSC-CCC
T ss_pred ccc-cCcc---cCcCCEEECcCCccCcccC----cCCcCCEEECcCCcCCc-cc----CCcCcCCEEECCCCcccc-ccc
Confidence 875 4443 3677888888888776321 13577888888887774 22 23 477888888888875 444
Q ss_pred cccccccCCEEEcCCcccccCCCccccccccccchhcccccccc--CCCccccccCCCCeeecCCCccCCCCChhhhccc
Q 002061 476 ALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSG--NIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLK 553 (973)
Q Consensus 476 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 553 (973)
. +++|++|++++|++++ +|. .+++|+.|++++|++++ .+|.++.. |+.|++.|.+|..+ ..
T Consensus 335 ~---~~~L~~L~L~~N~l~~-lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~--------L~~n~~~~~i~~~~--~~ 397 (454)
T 1jl5_A 335 L---PPRLERLIASFNHLAE-VPE---LPQNLKQLHVEYNPLREFPDIPESVED--------LRMNSHLAEVPELP--QN 397 (454)
T ss_dssp C---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSSCCCCCTTCCE--------EECCC-------------
T ss_pred c---CCcCCEEECCCCcccc-ccc---hhhhccEEECCCCCCCcCCCChHHHHh--------hhhccccccccccc--Cc
Confidence 3 4677888888888774 444 36777888888888876 55655443 33466667777642 24
Q ss_pred CceEEccCCcccc--ccCcccccC
Q 002061 554 LSSIDLSENQLSG--SVPLDFLRM 575 (973)
Q Consensus 554 L~~l~ls~N~l~~--~~p~~~~~~ 575 (973)
|+.|++++|+++| .+|..+...
T Consensus 398 L~~L~ls~N~l~~~~~iP~sl~~L 421 (454)
T 1jl5_A 398 LKQLHVETNPLREFPDIPESVEDL 421 (454)
T ss_dssp ------------------------
T ss_pred CCEEECCCCcCCccccchhhHhhe
Confidence 8999999999998 888765433
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=378.78 Aligned_cols=279 Identities=34% Similarity=0.528 Sum_probs=229.2
Q ss_pred HHHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc--ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 002061 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV 749 (973)
Q Consensus 672 ~~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 749 (973)
....++|++.+.||+|+||+||+|++. +++.||||++... ...+.+.+|++++++++||||+++++++..++..++|
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 113 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILI 113 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEE
T ss_pred HHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 345679999999999999999999975 4889999987653 3457789999999999999999999999999999999
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccc
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 829 (973)
|||+++|+|.+++... ......+++..+..++.|+++||+||| +++++||||||+||+++.++.+||+|||+++..
T Consensus 114 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 189 (321)
T 2qkw_B 114 YKYMENGNLKRHLYGS-DLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKG 189 (321)
T ss_dssp EECCTTCBTGGGSSSS-CCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCTTCEEC
T ss_pred EEcCCCCcHHHHHhcc-CCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 9999999999988653 222345899999999999999999999 789999999999999999999999999999865
Q ss_pred cCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCC-cccHHHHHHHHhccccccchh
Q 002061 830 ENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGD-GKDIVYWVSTHLNNHENVLKV 908 (973)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 908 (973)
.............||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......|...... ...+...
T Consensus 190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 268 (321)
T 2qkw_B 190 TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN-NGQLEQI 268 (321)
T ss_dssp SSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT-TTCCCSS
T ss_pred ccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc-cccHHHh
Confidence 4433323333456899999999999889999999999999999999999999764322 2334444333222 2223445
Q ss_pred ccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCC
Q 002061 909 LDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPC 956 (973)
Q Consensus 909 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~ 956 (973)
+++........+....+.+++.+||+.||++|||+.|++++|+.+...
T Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 269 VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp SSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred cChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 555555555677888999999999999999999999999999976543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=373.35 Aligned_cols=282 Identities=39% Similarity=0.670 Sum_probs=231.1
Q ss_pred HHHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc---cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 002061 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL 748 (973)
Q Consensus 672 ~~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 748 (973)
....++|++.+.||+|+||+||+|+.. +++.||||++.... ....+.+|++++++++||||+++++++..++..++
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 104 (326)
T 3uim_A 26 QVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 104 (326)
T ss_dssp HTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEE
T ss_pred HHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEE
Confidence 445678999999999999999999865 48899999987632 33468899999999999999999999999999999
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccc
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 828 (973)
||||+++|+|.+++... ......+++..+..++.|++.||+|||+.+..+|+||||||+||+++.++.+||+|||+++.
T Consensus 105 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 183 (326)
T 3uim_A 105 VYPYMANGSVASCLRER-PESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 183 (326)
T ss_dssp EEECCTTCBHHHHHHCC-STTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEeccCCCHHHHHHhc-cccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccc
Confidence 99999999999999864 22344589999999999999999999943333999999999999999999999999999987
Q ss_pred ccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcc---cCCcccHHHHHHHHhcccccc
Q 002061 829 AENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEE---YGDGKDIVYWVSTHLNNHENV 905 (973)
Q Consensus 829 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~---~~~~~~~~~~~~~~~~~~~~~ 905 (973)
...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||... .........++....... ..
T Consensus 184 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~ 261 (326)
T 3uim_A 184 MDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK-KL 261 (326)
T ss_dssp CCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSC-CS
T ss_pred cCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhch-hh
Confidence 654322 2223356899999999999889999999999999999999999999642 123334455554443332 24
Q ss_pred chhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCCC
Q 002061 906 LKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPCT 957 (973)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 957 (973)
....+.........+....+.+++.+||+.||.+|||+.||+++|++.....
T Consensus 262 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~ 313 (326)
T 3uim_A 262 EALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAE 313 (326)
T ss_dssp TTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSS
T ss_pred hhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhh
Confidence 5555666656667788889999999999999999999999999999865544
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=363.86 Aligned_cols=251 Identities=23% Similarity=0.348 Sum_probs=208.5
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeec--cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK--GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY 752 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 752 (973)
..+|++.+.||+|+||+||+|++..+++.||||++.. ....+.+.+|+.++++++||||+++++++..++..|+||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 4689999999999999999999999999999999865 34566788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCC
Q 002061 753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832 (973)
Q Consensus 753 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 832 (973)
+++|+|.+++... .+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++......
T Consensus 99 ~~~~~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 99 LAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (297)
T ss_dssp CTTCBHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred CCCCCHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence 9999999999753 4788999999999999999999 789999999999999999999999999999866543
Q ss_pred CCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhcccc
Q 002061 833 PKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCE 912 (973)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (973)
.. ......||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......+... ....
T Consensus 170 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~~~~~~~~--~~~~-------- 235 (297)
T 3fxz_A 170 QS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN--PLRALYLIATN--GTPE-------- 235 (297)
T ss_dssp TC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHH--CSCC--------
T ss_pred cc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhC--CCCC--------
Confidence 22 2334579999999999999999999999999999999999999996531 11111111110 0000
Q ss_pred ccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 913 VASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 913 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
...+......+.+++.+||+.||++|||+.|++++-
T Consensus 236 --~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~ 271 (297)
T 3fxz_A 236 --LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQ 271 (297)
T ss_dssp --CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred --CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhCh
Confidence 011223345688899999999999999999999864
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=377.42 Aligned_cols=261 Identities=27% Similarity=0.386 Sum_probs=213.2
Q ss_pred HcCCcccCcccccCceEEEEEEec-------CCCcEEEEEeeecc---ccHHHHHHHHHHHHhc-CCCceeeEEEEEEeC
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLK-------KNAGTVAVKQLWKG---DGVKVFAAEMEILGKI-RHRNILKLYACLLKG 743 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~-------~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 743 (973)
.++|++.+.||+|+||+||+|++. .++..||||++... ...+.+.+|+++++++ +||||+++++++..+
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 357889999999999999999974 34567999998763 3446788999999999 899999999999999
Q ss_pred CeeEEEEEccCCCchHHHHHhhhcC-----------CCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeee
Q 002061 744 GSSFLVLEYMPNGNLFQALHKRVKE-----------GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILL 812 (973)
Q Consensus 744 ~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill 812 (973)
+..|+||||+++|+|.+++...... ....+++..+..++.|+++||+||| +++|+||||||+||++
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEE
Confidence 9999999999999999999864211 1235789999999999999999999 7899999999999999
Q ss_pred cCCCCeEEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccH
Q 002061 813 DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDI 891 (973)
Q Consensus 813 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~ 891 (973)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||... .....
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~--~~~~~ 314 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVEEL 314 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--CGGGH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCC--CHHHH
Confidence 9999999999999987655443333444567889999999999999999999999999999999 99999754 22222
Q ss_pred HHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 002061 892 VYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADAD 954 (973)
Q Consensus 892 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 954 (973)
...+.... ....+......+.+++.+||+.||++||++.|++++|+++.
T Consensus 315 ~~~~~~~~--------------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 315 FKLLKEGH--------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp HHHHHTTC--------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhcCC--------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 22221110 01111223456889999999999999999999999998764
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=371.54 Aligned_cols=263 Identities=25% Similarity=0.297 Sum_probs=207.8
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc-cHHHHHHHHHHHHhcCCCceeeEEEEEEeCC----eeEEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLKGG----SSFLV 749 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~~lv 749 (973)
..+|++.+.||+|+||+||+|++. ++.||||++.... ....+.+|+.++++++||||+++++++..+. ..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 467899999999999999999887 7899999986532 3345567889999999999999999998754 46999
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCC----------CeEecCCCCCCeeecCCCCeE
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP----------PIIHRDIKSSNILLDEDYEPK 819 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~----------~ivH~Dlkp~Nill~~~~~~k 819 (973)
|||+++|+|.++++.. .+++..+..++.|+++||+||| +. +|+||||||+||+++.++.+|
T Consensus 101 ~e~~~~g~L~~~l~~~------~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~k 171 (322)
T 3soc_A 101 TAFHEKGSLSDFLKAN------VVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC 171 (322)
T ss_dssp EECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEE
T ss_pred EecCCCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEE
Confidence 9999999999999753 4899999999999999999999 77 999999999999999999999
Q ss_pred EecccCcccccCCCCcccccccCCcccccccccccc-----CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcc-----
Q 002061 820 IADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYT-----CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGK----- 889 (973)
Q Consensus 820 l~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~----- 889 (973)
|+|||+++...............||+.|+|||++.+ ..++.++|||||||++|||++|+.||........
T Consensus 172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 251 (322)
T 3soc_A 172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251 (322)
T ss_dssp ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence 999999987765444333444679999999999876 3566789999999999999999999976432211
Q ss_pred ------cHHHHHHHHhccccccchhccccccC-cchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 002061 890 ------DIVYWVSTHLNNHENVLKVLDCEVAS-ESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADAD 954 (973)
Q Consensus 890 ------~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 954 (973)
....+......... .+.... .........+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 252 EIGQHPSLEDMQEVVVHKKK------RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp HHCSSCCHHHHHHHHTTSCC------CCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhccCCchhhhhhhhhcccC------CCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11111111111110 011100 012234567899999999999999999999999998764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=364.25 Aligned_cols=249 Identities=26% Similarity=0.335 Sum_probs=208.0
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL 750 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 750 (973)
+++|++.+.||+|+||+||+|++..+|+.||||++... ...+.+.+|+++++.++||||+++++++..++..|+||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 56899999999999999999999999999999998653 34456789999999999999999999999999999999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccccc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 830 (973)
||+++|+|.+++... ..+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++....
T Consensus 94 e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH-----GRMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp CCCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred ECCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 999999999999764 34889999999999999999999 7899999999999999999999999999998665
Q ss_pred CCCCcccccccCCccccccccccccCCCC-ccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhc
Q 002061 831 NSPKVSDYSCFAGTHGYIAPELAYTCKVS-EKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVL 909 (973)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (973)
... ......||+.|+|||++.+..+. .++||||+||++|||++|+.||... +...............
T Consensus 166 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-----~~~~~~~~i~~~~~~~---- 233 (328)
T 3fe3_A 166 VGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ-----NLKELRERVLRGKYRI---- 233 (328)
T ss_dssp SSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHCCCCC----
T ss_pred CCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhCCCCC----
Confidence 432 23345799999999999888775 7899999999999999999999653 2222222221111110
Q ss_pred cccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 910 DCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 910 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
+......+.+++.+|++.||.+|||+.|+++|-.
T Consensus 234 --------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~ 267 (328)
T 3fe3_A 234 --------PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRW 267 (328)
T ss_dssp --------CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTT
T ss_pred --------CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHh
Confidence 1112345778999999999999999999998743
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=367.69 Aligned_cols=260 Identities=26% Similarity=0.408 Sum_probs=210.5
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeec--cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK--GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY 752 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 752 (973)
.++|++.+.||+|+||+||+|++..+++.||+|++.. ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 3578889999999999999999999999999998755 34556789999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCC
Q 002061 753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832 (973)
Q Consensus 753 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 832 (973)
+++|+|.+++... ...+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 89 ~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 89 IKGGTLRGIIKSM----DSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp CTTCBHHHHHHHC----CTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred cCCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence 9999999999863 346899999999999999999999 789999999999999999999999999999866433
Q ss_pred CCcc------------cccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhc
Q 002061 833 PKVS------------DYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLN 900 (973)
Q Consensus 833 ~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 900 (973)
.... ......||+.|+|||++.+..++.++||||||+++|||++|..||................
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~--- 238 (310)
T 3s95_A 162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRG--- 238 (310)
T ss_dssp ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHH---
T ss_pred cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhc---
Confidence 2211 1113579999999999999999999999999999999999999987542211110000000
Q ss_pred cccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 002061 901 NHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADP 955 (973)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 955 (973)
..+... +......+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 239 -------~~~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 239 -------FLDRYC----PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp -------HHHHTC----CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------cccccC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 000000 11123457889999999999999999999999998753
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=377.32 Aligned_cols=365 Identities=19% Similarity=0.203 Sum_probs=242.4
Q ss_pred CCCccccccccCCccCcEeeCCCCcccCcCChhhhCCCCCcEEEecCCcccCCCCcccCCCCCCEEeccCccCCCccccc
Q 002061 84 SLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRW 163 (973)
Q Consensus 84 ~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~ 163 (973)
+..+..+..++.+++|++|+|++|.+++ +| .++.+++|++|+|++|++++.+ ++.+++|++|++++|.+++. +
T Consensus 29 ~~~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~~~--~~~l~~L~~L~Ls~N~l~~~-~-- 101 (457)
T 3bz5_A 29 EMQATDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITTLD--LSQNTNLTYLACDSNKLTNL-D-- 101 (457)
T ss_dssp TCCTTSEEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSCCC--CTTCTTCSEEECCSSCCSCC-C--
T ss_pred CcCcccccChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCeEc--cccCCCCCEEECcCCCCcee-e--
Confidence 4445556678888888888888888885 45 6888888888888888888863 78888888888888888864 3
Q ss_pred cccccccceEEccCCcCCCCCCcccccCCCCCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCchhhhccccc
Q 002061 164 VVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKL 243 (973)
Q Consensus 164 ~~~l~~L~~L~l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L 243 (973)
+.++++|++|++++|.++. +| ++.+++|++|++++|++++. + ++.+++|++|++++|+..+.+ .+..+++|
T Consensus 102 ~~~l~~L~~L~L~~N~l~~--l~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L 172 (457)
T 3bz5_A 102 VTPLTKLTYLNCDTNKLTK--LD--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQL 172 (457)
T ss_dssp CTTCTTCCEEECCSSCCSC--CC--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTTC
T ss_pred cCCCCcCCEEECCCCcCCe--ec--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCcC
Confidence 7788888888888888764 33 77788888888888888863 2 777888888888888544444 46777788
Q ss_pred cEEEeeccccCCcCCccccccccccEEEeeccccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeeccCC
Q 002061 244 WKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGN 323 (973)
Q Consensus 244 ~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N 323 (973)
++|++++|++++ +| +..+++|+.|++++|++++. .++.+++|+.|++++|++++ +| ++.+++|+.|++++|
T Consensus 173 ~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N 243 (457)
T 3bz5_A 173 TTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVN 243 (457)
T ss_dssp CEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSS
T ss_pred CEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCC
Confidence 888888888875 44 67777788888888877754 36777777777777777776 44 667777777777777
Q ss_pred ccCCCCCccccccccccccccccccccccCChhhhhhhhHHHHHhhhccCCCCccccccCccccceEeccccccccCCCc
Q 002061 324 RFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPD 403 (973)
Q Consensus 324 ~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 403 (973)
++++.. ++.+++|+.|++++|++ +.|++++|.+.+.+|
T Consensus 244 ~l~~~~---~~~l~~L~~L~l~~n~L--------------------------------------~~L~l~~n~~~~~~~- 281 (457)
T 3bz5_A 244 PLTELD---VSTLSKLTTLHCIQTDL--------------------------------------LEIDLTHNTQLIYFQ- 281 (457)
T ss_dssp CCSCCC---CTTCTTCCEEECTTCCC--------------------------------------SCCCCTTCTTCCEEE-
T ss_pred cCCCcC---HHHCCCCCEEeccCCCC--------------------------------------CEEECCCCccCCccc-
Confidence 777643 34455566666655433 344555555544444
Q ss_pred cccCCCCcceEeccCCcCCCCCCCCCCCCCCCCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCccccccccccC
Q 002061 404 GLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQL 483 (973)
Q Consensus 404 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 483 (973)
+..+++|+.|++++|...+.++. ...+|+.|++++| ++|++|+|++|++++. + ++.+++|
T Consensus 282 -~~~l~~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~l-~--l~~l~~L 341 (457)
T 3bz5_A 282 -AEGCRKIKELDVTHNTQLYLLDC---QAAGITELDLSQN-------------PKLVYLYLNNTELTEL-D--VSHNTKL 341 (457)
T ss_dssp -CTTCTTCCCCCCTTCTTCCEEEC---TTCCCSCCCCTTC-------------TTCCEEECTTCCCSCC-C--CTTCTTC
T ss_pred -ccccccCCEEECCCCcccceecc---CCCcceEechhhc-------------ccCCEEECCCCccccc-c--cccCCcC
Confidence 23445555555555544333221 1233343333333 4666666666666653 2 6666666
Q ss_pred CEEEcCCcccccCCCccccccccccchhccccccccCCCccccccCCCCeeecCCCccCCCCChh
Q 002061 484 SSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDN 548 (973)
Q Consensus 484 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~ 548 (973)
+.|++++|+|++ ++.|..|++++|+++|. ..+..|+.++|++|+|+|.+|..
T Consensus 342 ~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~ 393 (457)
T 3bz5_A 342 KSLSCVNAHIQD--------FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPD 393 (457)
T ss_dssp SEEECCSSCCCB--------CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTT
T ss_pred cEEECCCCCCCC--------ccccccccccCCcEEec-----ceeeecCccccccCcEEEEcChh
Confidence 666766666664 23455666666666654 23444555555555555555544
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=369.22 Aligned_cols=264 Identities=31% Similarity=0.476 Sum_probs=201.1
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL 750 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 750 (973)
.++|++.+.||+|+||+||+|++. ++.||||++... ...+.+.+|++++++++||||+++++++..++..++||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEEC--CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 467899999999999999999874 789999998653 23456889999999999999999999999999999999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCC--eEecCCCCCCeeecCCCCeEEecccCccc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP--IIHRDIKSSNILLDEDYEPKIADFGVAKI 828 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~--ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 828 (973)
||+++|+|.+++.... ....+++..+..++.|++.||+||| +.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 114 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSG--AREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp ECCTTCBHHHHHHSTT--HHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred ecCCCCcHHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 9999999999997531 1224889999999999999999999 778 99999999999999999999999999975
Q ss_pred ccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchh
Q 002061 829 AENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKV 908 (973)
Q Consensus 829 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (973)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..............
T Consensus 189 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~-----~~~~~~~~~~~~~~---- 257 (309)
T 3p86_A 189 KASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN-----PAQVVAAVGFKCKR---- 257 (309)
T ss_dssp ---------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC-----HHHHHHHHHHSCCC----
T ss_pred ccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhcCCC----
Confidence 43321 12234568999999999999999999999999999999999999997541 11111111111100
Q ss_pred ccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCCCCCCCC
Q 002061 909 LDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPCTDKSPD 962 (973)
Q Consensus 909 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~~~~ 962 (973)
...+......+.+++.+||+.||++|||+.|+++.|+.+.....+++.
T Consensus 258 ------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~~ 305 (309)
T 3p86_A 258 ------LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPN 305 (309)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-------
T ss_pred ------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCCC
Confidence 011122334688999999999999999999999999988765544443
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=365.48 Aligned_cols=255 Identities=25% Similarity=0.343 Sum_probs=208.3
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc---cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE 751 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 751 (973)
.++|++.+.||+|+||+||+|++..+++.||||++.... ..+.+.+|+.+++.++||||+++++++.+++..|+|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999999999999999986532 23567899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccC
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 831 (973)
|+++|+|.+++.. ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 86 ~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 157 (323)
T 3tki_A 86 YCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (323)
T ss_dssp CCTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred cCCCCcHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceecc
Confidence 9999999988864 345899999999999999999999 78999999999999999999999999999986654
Q ss_pred CCCcccccccCCccccccccccccCCC-CccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhcc
Q 002061 832 SPKVSDYSCFAGTHGYIAPELAYTCKV-SEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLD 910 (973)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (973)
...........||+.|+|||++.+..+ +.++||||+||++|||++|+.||............+... ...
T Consensus 158 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~----~~~------ 227 (323)
T 3tki_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK----KTY------ 227 (323)
T ss_dssp TTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTT----CTT------
T ss_pred CCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcc----ccc------
Confidence 433333345679999999999987775 678999999999999999999997653322222222111 000
Q ss_pred ccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 911 CEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 911 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
..........+.+++.+|++.||++|||+.|++++-.
T Consensus 228 ----~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~ 264 (323)
T 3tki_A 228 ----LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRW 264 (323)
T ss_dssp ----STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred ----CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChh
Confidence 0011223456778999999999999999999998754
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=355.89 Aligned_cols=261 Identities=26% Similarity=0.340 Sum_probs=208.8
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV 749 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 749 (973)
.++|++.+.||+|+||+||+|++..+++.||||++... ...+.+.+|+.++++++||||+++++++..++..|+|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 46799999999999999999999999999999987542 3346788999999999999999999999999999999
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccc
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 829 (973)
|||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 90 ~e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 161 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH-----GPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL 161 (294)
T ss_dssp EECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC
T ss_pred EeCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCcccc
Confidence 9999999999999764 25889999999999999999999 789999999999999999999999999999866
Q ss_pred cCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccc-cccchh
Q 002061 830 ENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNH-ENVLKV 908 (973)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 908 (973)
..... .......||+.|+|||++.+..++.++||||+|+++|||++|+.||.... ............ +...
T Consensus 162 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~-----~~~~~~~~~~~~~~~~~-- 233 (294)
T 4eqm_A 162 SETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET-----AVSIAIKHIQDSVPNVT-- 233 (294)
T ss_dssp --------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC-----HHHHHHHHHSSCCCCHH--
T ss_pred ccccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHhhccCCCcc--
Confidence 43322 12233568999999999999999999999999999999999999996541 111111111111 1100
Q ss_pred ccccccCcchHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHhhcCCCCC
Q 002061 909 LDCEVASESIKEDMIKLLKIAVVCTTKLPNLRP-PMREVVKMLADADPCT 957 (973)
Q Consensus 909 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-t~~evl~~L~~~~~~~ 957 (973)
..........+.+++.+|++.||.+|| +++++.+.|+.+....
T Consensus 234 ------~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 234 ------TDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp ------HHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred ------hhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 011122345688899999999999998 9999999999876544
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=368.39 Aligned_cols=261 Identities=26% Similarity=0.414 Sum_probs=209.6
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCc---EEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAG---TVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL 748 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~---~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 748 (973)
..+|++.+.||+|+||+||+|++..+++ .||||++... ...+.+.+|++++++++||||+++++++.+++..|+
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 4678999999999999999999975444 5999998753 345678899999999999999999999999999999
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccc
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 828 (973)
||||+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 128 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTH----DGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp EEECCTTCBHHHHHHTT----TTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EeeCCCCCcHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 99999999999999753 346899999999999999999999 78999999999999999999999999999987
Q ss_pred ccCCCCc-ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccc
Q 002061 829 AENSPKV-SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVL 906 (973)
Q Consensus 829 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 906 (973)
....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.... .......+. ....
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~--~~~~~~~~~---~~~~--- 272 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT--NRDVISSVE---EGYR--- 272 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSC--HHHHHHHHH---TTCC---
T ss_pred cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCC--HHHHHHHHH---cCCC---
Confidence 6543221 12223456788999999998999999999999999999999 999996541 111111111 1100
Q ss_pred hhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCCCC
Q 002061 907 KVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPCTD 958 (973)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~ 958 (973)
..........+.+++.+||+.||++||++.|+++.|+.+....+
T Consensus 273 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 273 --------LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred --------CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 01112234568899999999999999999999999999865443
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=360.34 Aligned_cols=249 Identities=27% Similarity=0.331 Sum_probs=207.6
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV 749 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 749 (973)
.++|++.+.||+|+||+||+|+...+++.||||++.+. .....+.+|+++++.++||||+++++++...+..|+|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 46789999999999999999999999999999998752 3456788999999999999999999999999999999
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccc
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 829 (973)
|||+++|+|.+++... ..+++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||+++..
T Consensus 84 ~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 155 (337)
T 1o6l_A 84 MEYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG 155 (337)
T ss_dssp EECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhc
Confidence 9999999999999754 35789999999999999999999 789999999999999999999999999999754
Q ss_pred cCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhc
Q 002061 830 ENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVL 909 (973)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (973)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||... +..............
T Consensus 156 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~-----~~~~~~~~i~~~~~~----- 223 (337)
T 1o6l_A 156 ISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-----DHERLFELILMEEIR----- 223 (337)
T ss_dssp CCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHCCCC-----
T ss_pred ccCC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCC-----CHHHHHHHHHcCCCC-----
Confidence 3221 1223457899999999999999999999999999999999999999653 112222222111110
Q ss_pred cccccCcchHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHh
Q 002061 910 DCEVASESIKEDMIKLLKIAVVCTTKLPNLRP-----PMREVVKML 950 (973)
Q Consensus 910 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~L 950 (973)
. +......+.+++.+|++.||++|| ++.|+++|-
T Consensus 224 ---~----p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~ 262 (337)
T 1o6l_A 224 ---F----PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 262 (337)
T ss_dssp ---C----CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred ---C----CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCC
Confidence 0 112345678899999999999999 899998863
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=358.12 Aligned_cols=272 Identities=23% Similarity=0.288 Sum_probs=214.2
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCC--eeEEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGG--SSFLVL 750 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--~~~lv~ 750 (973)
.+|++.+.||+|+||+||+|++..+++.||||++... ...+.+.+|++++++++||||+++++++.... ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 5788999999999999999999999999999998752 34567889999999999999999999988755 789999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeee----cCCCCeEEecccCc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILL----DEDYEPKIADFGVA 826 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill----~~~~~~kl~Dfgl~ 826 (973)
||+++|+|.+++.... ....+++..+..++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||++
T Consensus 89 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPS--NAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp ECCTTCBHHHHHHSGG--GTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred eCCCCCCHHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 9999999999998642 2233899999999999999999999 7899999999999999 77788999999999
Q ss_pred ccccCCCCcccccccCCccccccccccc--------cCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHH
Q 002061 827 KIAENSPKVSDYSCFAGTHGYIAPELAY--------TCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTH 898 (973)
Q Consensus 827 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~ 898 (973)
+....... .....||+.|+|||++. +..++.++|||||||++|||++|+.||.................
T Consensus 164 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 240 (319)
T 4euu_A 164 RELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (319)
T ss_dssp EECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred eecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence 87654322 23356899999999986 57789999999999999999999999975432222221111111
Q ss_pred hccccc-cc---hhc--------cccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 002061 899 LNNHEN-VL---KVL--------DCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADP 955 (973)
Q Consensus 899 ~~~~~~-~~---~~~--------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 955 (973)
...... .. ... +..............+.+++.+|++.||++|||++|++++..+...
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 111000 00 000 0011112345667788999999999999999999999999987653
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=378.70 Aligned_cols=257 Identities=25% Similarity=0.326 Sum_probs=208.9
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE 751 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 751 (973)
.++|++.+.||+|+||+||+|++..+++.||||++... ...+.+.+|++++++++||||+++++++..++..|+|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 35788999999999999999999988999999998753 233467899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccC
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 831 (973)
|+++|+|.+++... ...+++..+..++.|+++||+||| +++++||||||+||+++.++.+||+|||+++....
T Consensus 193 ~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 193 LVQGGDFLTFLRTE----GARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp CCTTCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred cCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 99999999999864 235789999999999999999999 78999999999999999999999999999976543
Q ss_pred CCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhcc
Q 002061 832 SPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLD 910 (973)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (973)
...........++..|+|||++.+..++.++|||||||++|||++ |..||.... .......+. ....
T Consensus 266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~--~~~~~~~~~----~~~~------ 333 (377)
T 3cbl_A 266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS--NQQTREFVE----KGGR------ 333 (377)
T ss_dssp SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC--HHHHHHHHH----TTCC------
T ss_pred CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHH----cCCC------
Confidence 221111122335778999999998899999999999999999998 999997541 111111111 1110
Q ss_pred ccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 002061 911 CEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADAD 954 (973)
Q Consensus 911 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 954 (973)
...+......+.+++.+||+.||++|||+.++++.|+++.
T Consensus 334 ----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 334 ----LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 0111123456888999999999999999999999998764
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=362.83 Aligned_cols=254 Identities=22% Similarity=0.257 Sum_probs=209.6
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM 753 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 753 (973)
.++|++.+.||+|+||+||+|++..+++.||+|++... .....+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 83 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence 35789999999999999999999999999999988653 34556889999999999999999999999999999999999
Q ss_pred CCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecC--CCCeEEecccCcccccC
Q 002061 754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE--DYEPKIADFGVAKIAEN 831 (973)
Q Consensus 754 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~--~~~~kl~Dfgl~~~~~~ 831 (973)
++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++. ++.+||+|||+++....
T Consensus 84 ~g~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 84 SGLDIFERINTS----AFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCBHHHHHTSS----SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 999999998642 345899999999999999999999 789999999999999987 78999999999987654
Q ss_pred CCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccc
Q 002061 832 SPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDC 911 (973)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (973)
.. ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.... ..............
T Consensus 157 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-----~~~~~~~i~~~~~~------- 221 (321)
T 1tki_A 157 GD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET-----NQQIIENIMNAEYT------- 221 (321)
T ss_dssp TC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHHHTCCC-------
T ss_pred CC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC-----HHHHHHHHHcCCCC-------
Confidence 32 2234568999999999998889999999999999999999999996531 11222211111110
Q ss_pred cccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 912 EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 912 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
............+.+++.+|++.||.+|||+.|+++|-.
T Consensus 222 -~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 260 (321)
T 1tki_A 222 -FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp -CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred -CChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChh
Confidence 001111233456889999999999999999999999754
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=364.98 Aligned_cols=253 Identities=23% Similarity=0.267 Sum_probs=208.5
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc--------cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCee
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD--------GVKVFAAEMEILGKIRHRNILKLYACLLKGGSS 746 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 746 (973)
.++|++.+.||+|+||+||+|++..+|+.||||++.... ..+.+.+|++++++++||||+++++++.++...
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 457899999999999999999999999999999987632 346789999999999999999999999999999
Q ss_pred EEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCC----CeEEec
Q 002061 747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY----EPKIAD 822 (973)
Q Consensus 747 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~----~~kl~D 822 (973)
|+||||+++|+|.+++.. ...+++..+..++.||+.||+||| +.+|+||||||+||+++.++ .+||+|
T Consensus 91 ~lv~e~~~gg~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~D 162 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQ-----KESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLID 162 (361)
T ss_dssp EEEEECCCSCBHHHHHTT-----CSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEcCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEe
Confidence 999999999999999964 245899999999999999999999 78999999999999998877 799999
Q ss_pred ccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccc
Q 002061 823 FGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNH 902 (973)
Q Consensus 823 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 902 (973)
||++....... ......||+.|+|||++.+..++.++||||+||++|+|++|..||... +............
T Consensus 163 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~-----~~~~~~~~i~~~~ 234 (361)
T 2yab_A 163 FGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD-----TKQETLANITAVS 234 (361)
T ss_dssp CSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS-----SHHHHHHHHHTTC
T ss_pred cCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhcC
Confidence 99998765432 223457999999999999989999999999999999999999999653 1111222111111
Q ss_pred cccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 903 ENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
. .............+.+++.+|++.||.+|||+.|+++|-.
T Consensus 235 ~--------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 275 (361)
T 2yab_A 235 Y--------DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275 (361)
T ss_dssp C--------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred C--------CCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcC
Confidence 1 0011111223456789999999999999999999997643
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=354.53 Aligned_cols=264 Identities=36% Similarity=0.568 Sum_probs=213.8
Q ss_pred cCcccccCceEEEEEEecCCCcEEEEEeeecc------ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccC
Q 002061 681 DNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG------DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP 754 (973)
Q Consensus 681 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 754 (973)
.+.||+|+||+||+|+.. ++.||||++... ...+.+.+|++++++++||||+++++++..++..++||||++
T Consensus 36 ~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 113 (307)
T 2nru_A 36 GNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMP 113 (307)
T ss_dssp CCEEEECSSEEEEEEESS--SCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred CCccccCCCeEEEEEEEC--CceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecC
Confidence 389999999999999874 789999988642 235678999999999999999999999999999999999999
Q ss_pred CCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCC
Q 002061 755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK 834 (973)
Q Consensus 755 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 834 (973)
+|+|.+++.... ....+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++........
T Consensus 114 ~~~L~~~l~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 188 (307)
T 2nru_A 114 NGSLLDRLSCLD--GTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188 (307)
T ss_dssp TCBHHHHHHTGG--GCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSS
T ss_pred CCcHHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEEcCCCcEEEeecccccccccccc
Confidence 999999997542 2346899999999999999999999 78999999999999999999999999999987654433
Q ss_pred cccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhcccccc
Q 002061 835 VSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVA 914 (973)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (973)
........||+.|+|||++.+ .++.++||||||+++|+|++|+.||...... .....+..........+...++...
T Consensus 189 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~- 265 (307)
T 2nru_A 189 TVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP-QLLLDIKEEIEDEEKTIEDYIDKKM- 265 (307)
T ss_dssp CEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS-SBTTHHHHHHHTTSCCHHHHSCSSC-
T ss_pred cccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcch-HHHHHHHHHhhhhhhhhhhhccccc-
Confidence 333334578999999998865 5889999999999999999999999764322 2222222222222232334444333
Q ss_pred CcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 002061 915 SESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADAD 954 (973)
Q Consensus 915 ~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 954 (973)
..........+.+++.+||+.||.+||++.+++++|+++.
T Consensus 266 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 266 NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 2334566778999999999999999999999999999865
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=358.06 Aligned_cols=262 Identities=21% Similarity=0.256 Sum_probs=206.1
Q ss_pred ccccccccccccCHHHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhc-CCCce
Q 002061 659 KWKLASFHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKI-RHRNI 733 (973)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l-~hpni 733 (973)
.+....+++...+....++|++.++||+|+||+||+|++..+++.||||++... .....+.+|+..+.++ +||||
T Consensus 40 ~~~~~~~~p~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~i 119 (311)
T 3p1a_A 40 TLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCC 119 (311)
T ss_dssp SCCCTTCCTTSSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred ccCCCCCCCCCccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcE
Confidence 344455666666666778899999999999999999999989999999987552 2233445566665555 89999
Q ss_pred eeEEEEEEeCCeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeec
Q 002061 734 LKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD 813 (973)
Q Consensus 734 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~ 813 (973)
+++++++.+++..|+||||+ +++|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++
T Consensus 120 v~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~ 191 (311)
T 3p1a_A 120 VRLEQAWEEGGILYLQTELC-GPSLQQHCEAW----GASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLG 191 (311)
T ss_dssp CCEEEEEEETTEEEEEEECC-CCBHHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEC
T ss_pred EEEEEEEEeCCEEEEEEecc-CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEC
Confidence 99999999999999999999 77999998764 345899999999999999999999 77999999999999999
Q ss_pred CCCCeEEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHH
Q 002061 814 EDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVY 893 (973)
Q Consensus 814 ~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~ 893 (973)
.++.+||+|||++....... ......||+.|+|||++.+ .++.++|||||||++|||++|..|+.... .
T Consensus 192 ~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----~--- 260 (311)
T 3p1a_A 192 PRGRCKLGDFGLLVELGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----G--- 260 (311)
T ss_dssp GGGCEEECCCTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----H---
T ss_pred CCCCEEEccceeeeecccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----H---
Confidence 99999999999987664332 2233568999999999876 78999999999999999999977664321 1
Q ss_pred HHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 894 WVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 894 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
+ .. ... ..............+.+++.+|+++||++|||+.|++++-
T Consensus 261 ~-~~-~~~---------~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp 306 (311)
T 3p1a_A 261 W-QQ-LRQ---------GYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALP 306 (311)
T ss_dssp H-HH-HTT---------TCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred H-HH-Hhc---------cCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCc
Confidence 1 00 000 0011111223346788999999999999999999999864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=373.50 Aligned_cols=262 Identities=25% Similarity=0.341 Sum_probs=209.7
Q ss_pred HHcCCcccCcccccCceEEEEEEe-----cCCCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCe
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDL-----KKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGS 745 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~-----~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 745 (973)
...+|++.+.||+|+||+||+|++ ..+++.||||++... .....+.+|+.++++++||||+++++++..+..
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 346789999999999999999994 446778999998652 344568899999999999999999999999999
Q ss_pred eEEEEEccCCCchHHHHHhhhcC--CCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCC---CeEE
Q 002061 746 SFLVLEYMPNGNLFQALHKRVKE--GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY---EPKI 820 (973)
Q Consensus 746 ~~lv~e~~~~gsL~~~l~~~~~~--~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl 820 (973)
.++||||+++|+|.+++...... ....+++..+..++.|+++||+||| +++|+||||||+||+++.++ .+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEE
Confidence 99999999999999999875321 2245899999999999999999999 78999999999999999555 5999
Q ss_pred ecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHh
Q 002061 821 ADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHL 899 (973)
Q Consensus 821 ~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~ 899 (973)
+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+.||... ........+.
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~--~~~~~~~~i~--- 300 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK--SNQEVLEFVT--- 300 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--CHHHHHHHHH---
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHH---
Confidence 99999986543333333344568999999999999999999999999999999998 99999654 1111111111
Q ss_pred ccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 002061 900 NNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADAD 954 (973)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 954 (973)
.... ..........+.+++.+||+.||++||++.||+++|+.+.
T Consensus 301 ~~~~-----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 301 SGGR-----------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp TTCC-----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCC-----------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 1110 0111123346889999999999999999999999998764
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=368.53 Aligned_cols=345 Identities=26% Similarity=0.347 Sum_probs=160.5
Q ss_pred CCccCcEeeCCCCcccCcCChhhhCCCCCcEEEecCCcccCCCCcccCCCCCCEEeccCccCCCccccccccccccceEE
Q 002061 95 ALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLS 174 (973)
Q Consensus 95 ~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 174 (973)
.+++|+.|+++++.+. .+| .+..+++|++|+|++|.+++.++ ++++++|++|++++|.+++..+ +.++++|++|+
T Consensus 44 ~l~~l~~L~l~~~~i~-~l~-~~~~l~~L~~L~Ls~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~ 118 (466)
T 1o6v_A 44 DLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQIADITP--LANLTNLTGLT 118 (466)
T ss_dssp HHHTCCEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred HhccccEEecCCCCCc-cCc-chhhhcCCCEEECCCCccCCchh-hhccccCCEEECCCCccccChh--hcCCCCCCEEE
Confidence 3555666666666665 244 35566666666666666665554 6666666666666666654333 55555555555
Q ss_pred ccCCcCCCCCCcccccCCCCCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCchhhhccccccEEEeeccccC
Q 002061 175 IGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLT 254 (973)
Q Consensus 175 l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 254 (973)
+++|.+.. ++. +.++++|++|++++|.+++ ++ .++.+++|++|+++ |.+.+.. .+.++++|++|++++|.++
T Consensus 119 L~~n~l~~--~~~-~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l~ 190 (466)
T 1o6v_A 119 LFNNQITD--IDP-LKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNKVS 190 (466)
T ss_dssp CCSSCCCC--CGG-GTTCTTCSEEEEEEEEECC-CG-GGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred CCCCCCCC--ChH-HcCCCCCCEEECCCCccCC-Ch-hhccCCcccEeecC-CcccCch--hhccCCCCCEEECcCCcCC
Confidence 55555442 222 4555555555555555553 22 24555555555553 3333221 1444555555555555544
Q ss_pred CcCCccccccccccEEEeeccccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeeccCCccCCCCCcccc
Q 002061 255 GELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLG 334 (973)
Q Consensus 255 ~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~ 334 (973)
+. ..+..+++|++|++++|.+.+..| ++.+++|+.|++++|++++. ..+..+++|+.|++++|.+++..+ +.
T Consensus 191 ~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~ 262 (466)
T 1o6v_A 191 DI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LS 262 (466)
T ss_dssp CC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GT
T ss_pred CC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hh
Confidence 22 124444555555555555443332 34444455555554444432 223444444444444444443222 34
Q ss_pred ccccccccccccccccccCChhhhhhhhHHHHHhhhccCCCCccccccCccccceEeccccccccCCCccccCCCCcceE
Q 002061 335 RYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGML 414 (973)
Q Consensus 335 ~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 414 (973)
.+++|+.|++++|++++. +. +..+++|++|+|++|++++..+ +..+++|+.|
T Consensus 263 ~l~~L~~L~l~~n~l~~~-------------------------~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L 314 (466)
T 1o6v_A 263 GLTKLTELKLGANQISNI-------------------------SP-LAGLTALTNLELNENQLEDISP--ISNLKNLTYL 314 (466)
T ss_dssp TCTTCSEEECCSSCCCCC-------------------------GG-GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEE
T ss_pred cCCCCCEEECCCCccCcc-------------------------cc-ccCCCccCeEEcCCCcccCchh--hcCCCCCCEE
Confidence 444444444444444311 01 2333444444444444443222 3344444444
Q ss_pred eccCCcCCCCCCCCCCCCCCCCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccc
Q 002061 415 DFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALT 494 (973)
Q Consensus 415 ~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 494 (973)
++++|++++..+ +..+++|+.|++++|++++. ..+..+++|+.|++++|++++..| +..+++|+.|++++|+++
T Consensus 315 ~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~ 388 (466)
T 1o6v_A 315 TLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWT 388 (466)
T ss_dssp ECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEE
T ss_pred ECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCccc
Confidence 444444443332 33344444444444444432 234444444444444444443333 444444444444444444
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=373.20 Aligned_cols=369 Identities=18% Similarity=0.193 Sum_probs=284.9
Q ss_pred CcccCcCChhhhCCCCCcEEEecCCcccCCCCcccCCCCCCEEeccCccCCCccccccccccccceEEccCCcCCCCCCc
Q 002061 107 NVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIP 186 (973)
Q Consensus 107 n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ip 186 (973)
....+..+..++++++|++|+|++|.+++.+ .++.+++|++|+|++|.+++. | +..+++|++|++++|.++.. |
T Consensus 28 ~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~--~ 101 (457)
T 3bz5_A 28 FEMQATDTISEEQLATLTSLDCHNSSITDMT-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL--D 101 (457)
T ss_dssp TTCCTTSEEEHHHHTTCCEEECCSSCCCCCT-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC--C
T ss_pred cCcCcccccChhHcCCCCEEEccCCCcccCh-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee--e
Confidence 3444555668999999999999999999874 799999999999999999874 3 88889999999999988753 3
Q ss_pred ccccCCCCCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCchhhhccccccEEEeeccccCCcCCcccccccc
Q 002061 187 ESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTL 266 (973)
Q Consensus 187 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~ 266 (973)
++++++|++|++++|++++ +| ++.+++|++|++++|++++. + ++.+++|++|++++|+..+.+ .+..+++
T Consensus 102 --~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~ 171 (457)
T 3bz5_A 102 --VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQ 171 (457)
T ss_dssp --CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTT
T ss_pred --cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCc
Confidence 7888899999999999886 44 78888899999999988863 3 778888888888888655455 4777888
Q ss_pred ccEEEeeccccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeeccCCccCCCCCcccccccccccccccc
Q 002061 267 LQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISE 346 (973)
Q Consensus 267 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~ 346 (973)
|++|++++|++++ +| +..+++|+.|++++|++++. .++.+++|+.|++++|++++ +| ++.+++|+.|++++
T Consensus 172 L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~ 242 (457)
T 3bz5_A 172 LTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSV 242 (457)
T ss_dssp CCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCS
T ss_pred CCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeC
Confidence 8888888888875 44 77788888888888888764 37777888888888888876 44 67777777777777
Q ss_pred ccccccCChhhhhhhhHHHHHhhhccCCCCccccccCccccceEeccccccccCCCccccCCCCcceEeccCCcCCCCCC
Q 002061 347 NQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGIS 426 (973)
Q Consensus 347 N~l~~~~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~ 426 (973)
|++++. | +..+++|+.|++++|+ |+.|++++|.+.+..+
T Consensus 243 N~l~~~-------------------------~--~~~l~~L~~L~l~~n~--------------L~~L~l~~n~~~~~~~ 281 (457)
T 3bz5_A 243 NPLTEL-------------------------D--VSTLSKLTTLHCIQTD--------------LLEIDLTHNTQLIYFQ 281 (457)
T ss_dssp SCCSCC-------------------------C--CTTCTTCCEEECTTCC--------------CSCCCCTTCTTCCEEE
T ss_pred CcCCCc-------------------------C--HHHCCCCCEEeccCCC--------------CCEEECCCCccCCccc
Confidence 777632 1 2345667777776654 3456777777665544
Q ss_pred CCCCCCCCCCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCCcccccccc
Q 002061 427 PLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCAR 506 (973)
Q Consensus 427 ~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 506 (973)
++.+++|+.|+|++|.+.+.+|. ..++|+.|++++| ++|++|+|++|+|++. + ++.+++
T Consensus 282 --~~~l~~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~l-~--l~~l~~ 340 (457)
T 3bz5_A 282 --AEGCRKIKELDVTHNTQLYLLDC---QAAGITELDLSQN-------------PKLVYLYLNNTELTEL-D--VSHNTK 340 (457)
T ss_dssp --CTTCTTCCCCCCTTCTTCCEEEC---TTCCCSCCCCTTC-------------TTCCEEECTTCCCSCC-C--CTTCTT
T ss_pred --ccccccCCEEECCCCcccceecc---CCCcceEechhhc-------------ccCCEEECCCCccccc-c--cccCCc
Confidence 35667788888887776666553 3345555555554 6899999999999985 3 899999
Q ss_pred ccchhccccccccCCCccccccCCCCeeecCCCccCCCCChhhhcc-cCceEEccCCccccccCcccccC
Q 002061 507 IVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLSENQLSGSVPLDFLRM 575 (973)
Q Consensus 507 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l-~L~~l~ls~N~l~~~~p~~~~~~ 575 (973)
|+.|++++|+|++ ++.|..|++++|.++|. + .+ .+..+++++|+++|.+|..+...
T Consensus 341 L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~-~----~~~~l~~l~l~~N~l~g~ip~~~~~~ 397 (457)
T 3bz5_A 341 LKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE-G----QTITMPKETLTNNSLTIAVSPDLLDQ 397 (457)
T ss_dssp CSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE-E----EEEECCCBCCBTTBEEEECCTTCBCT
T ss_pred CcEEECCCCCCCC--------ccccccccccCCcEEec-c----eeeecCccccccCcEEEEcChhHhcc
Confidence 9999999999985 35778889999999976 2 23 38889999999999999865443
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=365.03 Aligned_cols=255 Identities=21% Similarity=0.210 Sum_probs=207.3
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-------ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-------DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF 747 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 747 (973)
.++|++.+.||+|+||+||+|++..+++.||||++... ...+.+.+|+++++.++||||+++++++.+++..|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 45789999999999999999999999999999998642 14677899999999999999999999999999999
Q ss_pred EEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCC---eEEeccc
Q 002061 748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE---PKIADFG 824 (973)
Q Consensus 748 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~---~kl~Dfg 824 (973)
+||||+++|+|.+++..... ....+++..+..++.|+++||+||| +++|+||||||+||+++.++. +||+|||
T Consensus 103 lv~e~~~g~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRAD-AGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEeCCCCCCHHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCc
Confidence 99999999999998876432 2345789999999999999999999 789999999999999987654 9999999
Q ss_pred CcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccc
Q 002061 825 VAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHEN 904 (973)
Q Consensus 825 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 904 (973)
++........ ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.... . ............
T Consensus 179 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~---~~~~~i~~~~~~ 250 (351)
T 3c0i_A 179 VAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK---E---RLFEGIIKGKYK 250 (351)
T ss_dssp TCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH---H---HHHHHHHHTCCC
T ss_pred ceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH---H---HHHHHHHcCCCC
Confidence 9987654322 1233579999999999999999999999999999999999999997531 1 111111111100
Q ss_pred cchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 905 VLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
............+.+++.+||+.||++|||+.|+++|
T Consensus 251 --------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 251 --------MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp --------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --------CCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0001112234568899999999999999999999875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=367.18 Aligned_cols=256 Identities=24% Similarity=0.328 Sum_probs=202.2
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcE----EEEEeeec---cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGT----VAVKQLWK---GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF 747 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~----vavK~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 747 (973)
..+|++.+.||+|+||+||+|++..+++. ||+|.+.. ....+.+.+|++++++++||||+++++++..+. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 35789999999999999999998776665 57777654 245577899999999999999999999998764 78
Q ss_pred EEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcc
Q 002061 748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827 (973)
Q Consensus 748 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~ 827 (973)
+|+||+++|+|.+++... ...+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++
T Consensus 93 ~v~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEEECCTTCBHHHHHHHS----TTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred EEEEecCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCccee
Confidence 899999999999999764 345899999999999999999999 7899999999999999999999999999998
Q ss_pred cccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccc
Q 002061 828 IAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVL 906 (973)
Q Consensus 828 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 906 (973)
...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||... ........+.....
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~--~~~~~~~~~~~~~~------ 237 (327)
T 3poz_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--PASEISSILEKGER------ 237 (327)
T ss_dssp HHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CGGGHHHHHHTTCC------
T ss_pred EccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCC--CHHHHHHHHHcCCC------
Confidence 7765544333444567889999999999999999999999999999999 99999754 22222222221110
Q ss_pred hhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 002061 907 KVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADAD 954 (973)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 954 (973)
..........+.+++.+||+.||++||++.|++++|+.+.
T Consensus 238 --------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 238 --------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp --------CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred --------CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 0111223446888999999999999999999999998754
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=355.37 Aligned_cols=265 Identities=15% Similarity=0.133 Sum_probs=214.6
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEEEEcc
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLVLEYM 753 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~ 753 (973)
.++|++.+.||+|+||+||+|++..+++.||||++......+.+.+|+++++++ +|++++++++++..+...++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 88 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence 357899999999999999999999889999999987766667789999999999 8999999999999999999999999
Q ss_pred CCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCC-----eEEecccCccc
Q 002061 754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE-----PKIADFGVAKI 828 (973)
Q Consensus 754 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~-----~kl~Dfgl~~~ 828 (973)
+++|.+++... ...+++..+..++.|++.||+||| +++|+||||||+||+++.++. +||+|||+++.
T Consensus 89 -~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 89 -GPSLEDLLDLC----GRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp -CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred -CCCHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99999999864 235899999999999999999999 889999999999999987776 99999999987
Q ss_pred ccCCCCc-----ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccc
Q 002061 829 AENSPKV-----SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHE 903 (973)
Q Consensus 829 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 903 (973)
....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..............
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~ 238 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA--TNKQKYERIGEKKQ 238 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC--CHHHHHHHHHHHHH
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcc--ccHHHHHHHHhhcc
Confidence 6543221 1223457999999999999999999999999999999999999999764221 11111111110000
Q ss_pred ccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCC
Q 002061 904 NVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPC 956 (973)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~ 956 (973)
.. ............+.+++.+||+.||++||++.+|++.|+++...
T Consensus 239 ~~-------~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~ 284 (298)
T 1csn_A 239 ST-------PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 284 (298)
T ss_dssp HS-------CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred Cc-------cHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence 00 00000112345688999999999999999999999999987543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=371.88 Aligned_cols=262 Identities=28% Similarity=0.366 Sum_probs=209.1
Q ss_pred HcCCcccCcccccCceEEEEEE-----ecCCCcEEEEEeeeccc---cHHHHHHHHHHHHhc-CCCceeeEEEEEEeCC-
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLD-----LKKNAGTVAVKQLWKGD---GVKVFAAEMEILGKI-RHRNILKLYACLLKGG- 744 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~-----~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~- 744 (973)
.++|++.+.||+|+||.||+|+ ...+++.||||++.... ..+.+.+|+++++++ +||||+++++++.+++
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 100 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 100 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCC
Confidence 4678999999999999999999 45567899999987632 345688999999999 7999999999998755
Q ss_pred eeEEEEEccCCCchHHHHHhhhcCC-------------------------------------------------------
Q 002061 745 SSFLVLEYMPNGNLFQALHKRVKEG------------------------------------------------------- 769 (973)
Q Consensus 745 ~~~lv~e~~~~gsL~~~l~~~~~~~------------------------------------------------------- 769 (973)
..++||||+++|+|.+++.......
T Consensus 101 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (359)
T 3vhe_A 101 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 180 (359)
T ss_dssp CCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------------
T ss_pred ceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcc
Confidence 4899999999999999998642110
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCcccccccCC
Q 002061 770 ------KPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAG 843 (973)
Q Consensus 770 ------~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g 843 (973)
...+++..+..++.|+++||+||| +++|+||||||+||+++.++.+||+|||+++...............|
T Consensus 181 ~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 257 (359)
T 3vhe_A 181 APEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257 (359)
T ss_dssp ---CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEE
T ss_pred cccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCC
Confidence 112889999999999999999999 78999999999999999999999999999986654443334445668
Q ss_pred ccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhccccccCcchHHHH
Q 002061 844 THGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDM 922 (973)
Q Consensus 844 t~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (973)
|+.|+|||++.+..++.++|||||||++|||++ |+.||...... ......+.... .. ..+....
T Consensus 258 t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~~~~~~~~~~--~~------------~~~~~~~ 322 (359)
T 3vhe_A 258 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-EEFCRRLKEGT--RM------------RAPDYTT 322 (359)
T ss_dssp CGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS-HHHHHHHHHTC--CC------------CCCTTCC
T ss_pred CceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh-HHHHHHHHcCC--CC------------CCCCCCC
Confidence 899999999999999999999999999999998 99999754221 11111111110 00 0111123
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 002061 923 IKLLKIAVVCTTKLPNLRPPMREVVKMLADAD 954 (973)
Q Consensus 923 ~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 954 (973)
..+.+++.+||+.||++|||+.|++++|+++.
T Consensus 323 ~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 323 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 46888999999999999999999999998764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=350.61 Aligned_cols=258 Identities=25% Similarity=0.336 Sum_probs=210.3
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM 753 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 753 (973)
.++|++.+.||+|+||+||+|++.. +..||||++... ...+.+.+|++++++++||||+++++++..+...++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKG-QYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecC-ceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 3578999999999999999998875 678999998763 35677899999999999999999999999999999999999
Q ss_pred CCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCC
Q 002061 754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833 (973)
Q Consensus 754 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 833 (973)
++++|.+++... ...+++..+..++.|++.|++||| +.+++||||||+||+++.++.+||+|||++.......
T Consensus 86 ~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 86 SNGCLLNYLRSH----GKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp TTCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred CCCcHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 999999999764 235889999999999999999999 7899999999999999999999999999998665432
Q ss_pred CcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhcccc
Q 002061 834 KVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCE 912 (973)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (973)
. .......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||.... ............. ...+
T Consensus 159 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-----~~~~~~~~~~~~~----~~~~- 227 (268)
T 3sxs_A 159 Y-VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT-----NSEVVLKVSQGHR----LYRP- 227 (268)
T ss_dssp E-EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC-----HHHHHHHHHTTCC----CCCC-
T ss_pred h-hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC-----hHHHHHHHHcCCC----CCCC-
Confidence 2 22233456778999999998899999999999999999999 999996531 1111111111110 0001
Q ss_pred ccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCCC
Q 002061 913 VASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPCT 957 (973)
Q Consensus 913 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 957 (973)
......+.+++.+||+.||++|||+.|++++|+.+....
T Consensus 228 ------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 228 ------HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp ------TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred ------CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 112346888999999999999999999999999987543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=363.70 Aligned_cols=251 Identities=29% Similarity=0.369 Sum_probs=202.8
Q ss_pred HHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCee
Q 002061 673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSS 746 (973)
Q Consensus 673 ~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 746 (973)
..+++|++.+.||+|+||+||+|++..+++.||||++.+. ...+.+.+|..+++.+ +||||+++++++..++..
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 4467899999999999999999999999999999998753 3456678899999988 799999999999999999
Q ss_pred EEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCc
Q 002061 747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826 (973)
Q Consensus 747 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~ 826 (973)
|+||||+++|+|.+++... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||++
T Consensus 100 ~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a 171 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKS-----RRFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMC 171 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccce
Confidence 9999999999999999764 35899999999999999999999 789999999999999999999999999999
Q ss_pred ccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccc
Q 002061 827 KIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVL 906 (973)
Q Consensus 827 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 906 (973)
+...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||... +...............
T Consensus 172 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~-----~~~~~~~~i~~~~~~~- 243 (353)
T 3txo_A 172 KEGICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE-----NEDDLFEAILNDEVVY- 243 (353)
T ss_dssp BCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHCCCCC-
T ss_pred eecccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC-----CHHHHHHHHHcCCCCC-
Confidence 7543221 2233457999999999999989999999999999999999999999653 1222222222111111
Q ss_pred hhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCH------HHHHHHh
Q 002061 907 KVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPM------REVVKML 950 (973)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~------~evl~~L 950 (973)
+......+.+++.+|++.||.+||++ .|+++|-
T Consensus 244 -----------p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp 282 (353)
T 3txo_A 244 -----------PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHP 282 (353)
T ss_dssp -----------CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSG
T ss_pred -----------CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCC
Confidence 11123457889999999999999998 7887753
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=353.11 Aligned_cols=254 Identities=26% Similarity=0.371 Sum_probs=208.7
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccC
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP 754 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 754 (973)
++|++.+.||+|+||+||+|++.. ++.||||++... ...+++.+|++++++++||||+++++++.++...++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecC-CCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 578899999999999999999875 778999998763 356778999999999999999999999999999999999999
Q ss_pred CCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCC
Q 002061 755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK 834 (973)
Q Consensus 755 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 834 (973)
+|+|.+++... ...+++..+..++.|+++|++||| +.+++||||||+||+++.++.+||+|||++........
T Consensus 89 ~~~L~~~l~~~----~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 89 HGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp TCBHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred CCcHHHHHHhc----CcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEecccccccccccccc
Confidence 99999999753 345899999999999999999999 78999999999999999999999999999976543211
Q ss_pred cccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhccccc
Q 002061 835 VSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEV 913 (973)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (973)
.......+|+.|+|||++.+..++.++||||+|+++|+|++ |+.||... .............. .
T Consensus 162 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~-----~~~~~~~~~~~~~~----~----- 226 (269)
T 4hcu_A 162 -TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-----SNSEVVEDISTGFR----L----- 226 (269)
T ss_dssp -HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHHHHHHHHHTTCC----C-----
T ss_pred -ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHHHhcCcc----C-----
Confidence 12223456788999999998999999999999999999999 99999653 11122221111110 0
Q ss_pred cCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 002061 914 ASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADAD 954 (973)
Q Consensus 914 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 954 (973)
..+......+.+++.+||+.||++||++.|++++|+++.
T Consensus 227 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~ 265 (269)
T 4hcu_A 227 --YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 265 (269)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence 011112345888999999999999999999999998764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=370.43 Aligned_cols=255 Identities=21% Similarity=0.265 Sum_probs=207.0
Q ss_pred HHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 002061 673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL 748 (973)
Q Consensus 673 ~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 748 (973)
...++|++.+.||+|+||+||+|.+..+++.||+|++... ...+.+.+|++++++++||||+++++++.+++..|+
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 3456899999999999999999999999999999998763 244568899999999999999999999999999999
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeec---CCCCeEEecccC
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD---EDYEPKIADFGV 825 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~---~~~~~kl~Dfgl 825 (973)
||||+++|+|.+++... ..+++..+..++.|++.||+||| +++|+||||||+||+++ .++.+||+|||+
T Consensus 88 v~E~~~gg~L~~~i~~~-----~~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~ 159 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAR-----EYYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGL 159 (444)
T ss_dssp EECCCBCCBHHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred EEEeCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCce
Confidence 99999999999999753 35899999999999999999999 78999999999999998 467899999999
Q ss_pred cccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccccc
Q 002061 826 AKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENV 905 (973)
Q Consensus 826 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 905 (973)
+........ ......||+.|+|||++.+..++.++||||+||++|+|++|+.||... +.. ............
T Consensus 160 a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~--~~~---~~~~~i~~~~~~- 231 (444)
T 3soa_A 160 AIEVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDE--DQH---RLYQQIKAGAYD- 231 (444)
T ss_dssp CBCCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCS--SHH---HHHHHHHHTCCC-
T ss_pred eEEecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCc--cHH---HHHHHHHhCCCC-
Confidence 976654322 223457999999999999989999999999999999999999999653 111 111111111110
Q ss_pred chhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 906 LKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
............+.+++.+|++.||.+|||+.|+++|-
T Consensus 232 -------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp 269 (444)
T 3soa_A 232 -------FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHP 269 (444)
T ss_dssp -------CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSC
T ss_pred -------CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCc
Confidence 00111122345688999999999999999999999874
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=364.14 Aligned_cols=254 Identities=23% Similarity=0.346 Sum_probs=204.8
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFL 748 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l 748 (973)
..+|++.+.||+|+||+||+|+++.+++.||||++.+. ...+.+.+|..+++++ +||||+++++++.+++..|+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 56899999999999999999999999999999998763 2334578899999887 89999999999999999999
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccc
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 828 (973)
||||+++|+|.+++... ..+++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||+++.
T Consensus 131 V~E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~ 202 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 202 (396)
T ss_dssp EEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEcCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeee
Confidence 99999999999999864 35899999999999999999999 78999999999999999999999999999975
Q ss_pred ccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCc----ccHHHHHHHHhccccc
Q 002061 829 AENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDG----KDIVYWVSTHLNNHEN 904 (973)
Q Consensus 829 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~----~~~~~~~~~~~~~~~~ 904 (973)
..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||....... ................
T Consensus 203 ~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~ 280 (396)
T 4dc2_A 203 GLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR 280 (396)
T ss_dssp CCCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCC
T ss_pred cccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccC
Confidence 32221 22334679999999999999999999999999999999999999996432111 1111111111111111
Q ss_pred cchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCH------HHHHHHh
Q 002061 905 VLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPM------REVVKML 950 (973)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~------~evl~~L 950 (973)
.+......+.+++.+||+.||.+||++ .|+++|-
T Consensus 281 ------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hp 320 (396)
T 4dc2_A 281 ------------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 320 (396)
T ss_dssp ------------CCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHST
T ss_pred ------------CCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCc
Confidence 111234467889999999999999985 6777653
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=360.70 Aligned_cols=260 Identities=17% Similarity=0.145 Sum_probs=211.0
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEEEEccC
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLVLEYMP 754 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~ 754 (973)
.+|++.+.||+|+||+||+|++..+++.||||++......+.+.+|+++++++ +||||+++++++..++..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~- 87 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL- 87 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-
Confidence 57899999999999999999999999999999988766666789999999999 9999999999999999999999999
Q ss_pred CCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCC-----eEEecccCcccc
Q 002061 755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE-----PKIADFGVAKIA 829 (973)
Q Consensus 755 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~-----~kl~Dfgl~~~~ 829 (973)
+++|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++. +||+|||+++..
T Consensus 88 ~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 88 GPSLEDLFDLC----DRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred CCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 99999999853 346899999999999999999999 789999999999999998887 999999999876
Q ss_pred cCCCCcc-----cccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccc
Q 002061 830 ENSPKVS-----DYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHEN 904 (973)
Q Consensus 830 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 904 (973)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+..............
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~--~~~~~~~~~~i~~~~~~ 238 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLK--ADTLKERYQKIGDTKRA 238 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC--CSSHHHHHHHHHHHHHH
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccc--cccHHHHHHHHHhhhcc
Confidence 4432211 1234679999999999999999999999999999999999999997652 22222222111110000
Q ss_pred cchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 905 VLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
.. .... ....+ .+.+++..|++.||.+||++.+|.+.|+++
T Consensus 239 ~~---~~~~----~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 239 TP---IEVL----CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp SC---HHHH----TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred CC---HHHH----hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 00 0000 00112 788999999999999999999999999754
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=363.88 Aligned_cols=263 Identities=28% Similarity=0.377 Sum_probs=204.7
Q ss_pred HcCCcccCcccccCceEEEEEE----ecCCCcEEEEEeeecc--ccHHHHHHHHHHHHhcCCCceeeEEEEEEe--CCee
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLD----LKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLK--GGSS 746 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~----~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~ 746 (973)
..+|++.+.||+|+||+||+|+ ...+++.||||++... ...+.+.+|++++++++||||+++++++.. ....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 4578999999999999999998 4567899999998753 334678899999999999999999999865 3568
Q ss_pred EEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCc
Q 002061 747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826 (973)
Q Consensus 747 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~ 826 (973)
++||||+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 89 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC----GGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred EEEEEeCCCCCHHHHHHhc----ccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence 9999999999999999764 235899999999999999999999 789999999999999999999999999999
Q ss_pred ccccCCCCc-ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCC----------cccHHHHH
Q 002061 827 KIAENSPKV-SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGD----------GKDIVYWV 895 (973)
Q Consensus 827 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~----------~~~~~~~~ 895 (973)
+........ .......++..|+|||++.+..++.++||||||+++|||++|..||.....+ ........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 241 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH
Confidence 876543221 1222345778899999999999999999999999999999999998653110 00000011
Q ss_pred HHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 002061 896 STHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADAD 954 (973)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 954 (973)
...... ......+......+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 242 ~~~~~~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~ 290 (295)
T 3ugc_A 242 IELLKN----------NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290 (295)
T ss_dssp HHHHHT----------TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhc----------cCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 111111 1111112233457889999999999999999999999998764
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=353.03 Aligned_cols=246 Identities=26% Similarity=0.343 Sum_probs=206.8
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV 749 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 749 (973)
.++|++.+.||+|+||+||+|+...+++.||||++.+. ...+.+.+|+.+++.++||||+++++++.+....|+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 46789999999999999999999999999999998753 3456788999999999999999999999999999999
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccc
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 829 (973)
|||+++|+|.+++... ..+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++..
T Consensus 85 ~e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~ 156 (318)
T 1fot_A 85 MDYIEGGELFSLLRKS-----QRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYV 156 (318)
T ss_dssp ECCCCSCBHHHHHHHT-----SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred EeCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceec
Confidence 9999999999999753 35889999999999999999999 889999999999999999999999999999865
Q ss_pred cCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhc
Q 002061 830 ENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVL 909 (973)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (973)
... .....||+.|+|||++.+..++.++||||+||++|||++|+.||... +..............
T Consensus 157 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-----~~~~~~~~i~~~~~~----- 221 (318)
T 1fot_A 157 PDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS-----NTMKTYEKILNAELR----- 221 (318)
T ss_dssp SSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHHHHHCCCC-----
T ss_pred CCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhCCCC-----
Confidence 432 22357899999999999999999999999999999999999999653 112222222111110
Q ss_pred cccccCcchHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHh
Q 002061 910 DCEVASESIKEDMIKLLKIAVVCTTKLPNLRP-----PMREVVKML 950 (973)
Q Consensus 910 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~L 950 (973)
. +......+.+++.+|++.||.+|| ++.|+++|-
T Consensus 222 ---~----p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp 260 (318)
T 1fot_A 222 ---F----PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHP 260 (318)
T ss_dssp ---C----CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSG
T ss_pred ---C----CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCc
Confidence 0 112234678899999999999999 899999763
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=357.50 Aligned_cols=253 Identities=23% Similarity=0.276 Sum_probs=207.9
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc--------cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCee
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD--------GVKVFAAEMEILGKIRHRNILKLYACLLKGGSS 746 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 746 (973)
.++|++.+.||+|+||+||+|++..+++.||||++.... ..+.+.+|++++++++||||+++++++..+...
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 456899999999999999999999999999999986531 356789999999999999999999999999999
Q ss_pred EEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCC----CeEEec
Q 002061 747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY----EPKIAD 822 (973)
Q Consensus 747 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~----~~kl~D 822 (973)
++||||+++|+|.+++.. ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++ .+||+|
T Consensus 90 ~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 161 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE-----KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIID 161 (326)
T ss_dssp EEEEECCCSCBHHHHHTT-----SSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEcCCCCCHHHHHHh-----cCCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEE
Confidence 999999999999999864 245899999999999999999999 78999999999999999887 799999
Q ss_pred ccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccc
Q 002061 823 FGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNH 902 (973)
Q Consensus 823 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 902 (973)
||+++...... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.... ............
T Consensus 162 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-----~~~~~~~~~~~~ 233 (326)
T 2y0a_A 162 FGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT-----KQETLANVSAVN 233 (326)
T ss_dssp CTTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS-----HHHHHHHHHHTC
T ss_pred CCCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC-----HHHHHHHHHhcC
Confidence 99998765332 2233568999999999998999999999999999999999999996531 111111111111
Q ss_pred cccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 903 ENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
. .............+.+++.+|++.||++|||+.|+++|-.
T Consensus 234 ~--------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 274 (326)
T 2y0a_A 234 Y--------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274 (326)
T ss_dssp C--------CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTT
T ss_pred C--------CcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 0 0111111223456789999999999999999999998643
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=362.09 Aligned_cols=251 Identities=24% Similarity=0.317 Sum_probs=206.8
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL 748 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 748 (973)
..++|++.+.||+|+||+||+|++..+++.||||++... ...+.+.+|+++++.++||||+++++++.+.+..|+
T Consensus 13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 92 (384)
T 4fr4_A 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM 92 (384)
T ss_dssp CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 356899999999999999999999999999999998652 345678899999999999999999999999999999
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccc
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 828 (973)
||||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++..
T Consensus 93 v~e~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~ 164 (384)
T 4fr4_A 93 VVDLLLGGDLRYHLQQN-----VHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAM 164 (384)
T ss_dssp EECCCTTEEHHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeee
Confidence 99999999999999753 35899999999999999999999 78999999999999999999999999999987
Q ss_pred ccCCCCcccccccCCcccccccccccc---CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccccc
Q 002061 829 AENSPKVSDYSCFAGTHGYIAPELAYT---CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENV 905 (973)
Q Consensus 829 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 905 (973)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ................
T Consensus 165 ~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~--~~~~~~~~~~~~~~~~- 238 (384)
T 4fr4_A 165 LPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS--TSSKEIVHTFETTVVT- 238 (384)
T ss_dssp CCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTT--SCHHHHHHHHHHCCCC-
T ss_pred ccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCC--ccHHHHHHHHhhcccC-
Confidence 65432 2334679999999999864 4589999999999999999999999975422 2222222222111111
Q ss_pred chhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHH
Q 002061 906 LKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPP-MREVVKM 949 (973)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt-~~evl~~ 949 (973)
.+......+.+++.+||+.||.+||+ +.++.++
T Consensus 239 -----------~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 239 -----------YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp -----------CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred -----------CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence 11123456889999999999999998 7777653
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=355.00 Aligned_cols=274 Identities=20% Similarity=0.283 Sum_probs=196.0
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE 751 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 751 (973)
..+|++.+.||+|+||+||+|++..+++.||||++... ...+.+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 46789999999999999999999999999999998653 234678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhhhcC-CCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccccc
Q 002061 752 YMPNGNLFQALHKRVKE-GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~-~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 830 (973)
|++ |+|.+++...... ....+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 997 6999999765322 2235889999999999999999999 7899999999999999999999999999998664
Q ss_pred CCCCcccccccCCcccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccc-cc-ch
Q 002061 831 NSPKVSDYSCFAGTHGYIAPELAYT-CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHE-NV-LK 907 (973)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~-~~ 907 (973)
.... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.... .......+........ .. ..
T Consensus 160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~ 235 (317)
T 2pmi_A 160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN--DEEQLKLIFDIMGTPNESLWPS 235 (317)
T ss_dssp SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCSCCTTTCGG
T ss_pred CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhCCCChhHhhh
Confidence 3322 2233568999999999876 468999999999999999999999997541 1111111111111000 00 00
Q ss_pred h-----ccccc------------cCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--hhcCCCC
Q 002061 908 V-----LDCEV------------ASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM--LADADPC 956 (973)
Q Consensus 908 ~-----~~~~~------------~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~--L~~~~~~ 956 (973)
. ..+.. ...........+.+++.+|++.||++|||+.|++++ +.+....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 303 (317)
T 2pmi_A 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH 303 (317)
T ss_dssp GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence 0 00000 000001223568899999999999999999999986 4444333
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=360.43 Aligned_cols=250 Identities=26% Similarity=0.339 Sum_probs=206.2
Q ss_pred HHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeE
Q 002061 673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF 747 (973)
Q Consensus 673 ~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 747 (973)
..+++|++.+.||+|+||+||+|++..+++.||||++... .....+.+|+++++.++||||+++++++..++..+
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 85 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIV 85 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 3457899999999999999999999999999999998652 23457889999999999999999999999999999
Q ss_pred EEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcc
Q 002061 748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827 (973)
Q Consensus 748 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~ 827 (973)
+||||+ +|+|.+++... ..+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||++.
T Consensus 86 lv~E~~-~g~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~ 156 (336)
T 3h4j_B 86 MVIEYA-GGELFDYIVEK-----KRMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSN 156 (336)
T ss_dssp EEECCC-CEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTB
T ss_pred EEEECC-CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccce
Confidence 999999 78999998754 35889999999999999999999 7799999999999999999999999999998
Q ss_pred cccCCCCcccccccCCccccccccccccCCC-CccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccc
Q 002061 828 IAENSPKVSDYSCFAGTHGYIAPELAYTCKV-SEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVL 906 (973)
Q Consensus 828 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 906 (973)
...... ......||+.|+|||++.+..+ ++++||||+||++|+|++|+.||........ ..
T Consensus 157 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~---------------~~ 218 (336)
T 3h4j_B 157 IMTDGN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL---------------FK 218 (336)
T ss_dssp TTTTSB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC---------------BC
T ss_pred eccCCc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH---------------HH
Confidence 664432 2233568999999999988776 6899999999999999999999975421100 00
Q ss_pred hhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 907 KVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
.+..... ..+......+.+++.+|++.||.+|||+.|++++-.
T Consensus 219 ~i~~~~~--~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 261 (336)
T 3h4j_B 219 KVNSCVY--VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPW 261 (336)
T ss_dssp CCCSSCC--CCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHH
T ss_pred HHHcCCC--CCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChh
Confidence 0100100 111123456788999999999999999999998754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=365.75 Aligned_cols=264 Identities=27% Similarity=0.359 Sum_probs=211.3
Q ss_pred HcCCcccCcccccCceEEEEEEec-----CCCcEEEEEeeeccc---cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCee
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLK-----KNAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSS 746 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~-----~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 746 (973)
.++|++.+.||+|+||+||+|++. .+++.||||++.... ..+.+.+|++++++++||||+++++++..++..
T Consensus 46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 125 (343)
T 1luf_A 46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 125 (343)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCce
Confidence 467899999999999999999997 345899999987632 346788999999999999999999999999999
Q ss_pred EEEEEccCCCchHHHHHhhhcC-------------------CCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCC
Q 002061 747 FLVLEYMPNGNLFQALHKRVKE-------------------GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKS 807 (973)
Q Consensus 747 ~lv~e~~~~gsL~~~l~~~~~~-------------------~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp 807 (973)
|+||||+++|+|.+++...... ....+++..+..++.|+++||+||| +++|+||||||
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp 202 (343)
T 1luf_A 126 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLAT 202 (343)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSG
T ss_pred EEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCc
Confidence 9999999999999999864211 1256899999999999999999999 78999999999
Q ss_pred CCeeecCCCCeEEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccC
Q 002061 808 SNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYG 886 (973)
Q Consensus 808 ~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~ 886 (973)
+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus 203 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~- 281 (343)
T 1luf_A 203 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA- 281 (343)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-
T ss_pred ceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC-
Confidence 999999999999999999986644332223334567899999999998899999999999999999999 999996531
Q ss_pred CcccHHHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCCC
Q 002061 887 DGKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPCT 957 (973)
Q Consensus 887 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 957 (973)
............. . ..+......+.+++.+||+.||++||++.+++++|+++....
T Consensus 282 ----~~~~~~~~~~~~~--~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 282 ----HEEVIYYVRDGNI--L---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp ----HHHHHHHHHTTCC--C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred ----hHHHHHHHhCCCc--C---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 1111111111110 0 011123456889999999999999999999999999987644
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=369.72 Aligned_cols=257 Identities=28% Similarity=0.437 Sum_probs=197.5
Q ss_pred HcCCcccCcccccCceEEEEEEec---CCCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLK---KNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL 748 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~---~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 748 (973)
..+|++.+.||+|+||+||+|++. .++..||||++... ...+.+.+|++++++++||||+++++++..++..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 457899999999999999999987 45778999998753 345678999999999999999999999999999999
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccc
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 828 (973)
||||+++|+|.++++.. ...+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 124 v~e~~~~~sL~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKH----DAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp EEECCTTCBHHHHHHTT----TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEeCCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 99999999999999753 346899999999999999999999 78999999999999999999999999999987
Q ss_pred ccCCCCc-ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccc
Q 002061 829 AENSPKV-SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVL 906 (973)
Q Consensus 829 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 906 (973)
....... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||... ........+.. ...
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~--~~~~~~~~i~~---~~~--- 268 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM--SNQDVIKAVDE---GYR--- 268 (373)
T ss_dssp -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTC--CHHHHHHHHHT---TEE---
T ss_pred cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHc---CCC---
Confidence 6543211 11122345778999999999999999999999999999998 99999653 11111111111 100
Q ss_pred hhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 002061 907 KVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADAD 954 (973)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 954 (973)
..........+.+++.+||+.||++||++.||++.|+.+.
T Consensus 269 --------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 308 (373)
T 2qol_A 269 --------LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308 (373)
T ss_dssp --------CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence 0111123456889999999999999999999999998764
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=351.48 Aligned_cols=265 Identities=22% Similarity=0.261 Sum_probs=203.3
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE 751 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 751 (973)
++|++.+.||+|+||+||+|++..+++.||||++... .....+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 5789999999999999999999999999999998652 234678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccC
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 831 (973)
|+++ ++.+++... ...+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++....
T Consensus 82 ~~~~-~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 153 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp CCSE-EHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred cCCC-CHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence 9965 666666542 345899999999999999999999 78999999999999999999999999999986643
Q ss_pred CCCcccccccCCccccccccccccCC-CCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccc----cc
Q 002061 832 SPKVSDYSCFAGTHGYIAPELAYTCK-VSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHEN----VL 906 (973)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~----~~ 906 (973)
.. .......||+.|+|||++.+.. ++.++||||+||++|||++|..||....................... ..
T Consensus 154 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 154 PV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CC--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred cc--ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhc
Confidence 32 2233457899999999997765 79999999999999999999888643321111111111111000000 00
Q ss_pred hhcc---------ccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 907 KVLD---------CEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 907 ~~~~---------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
...+ ..............+.+++.+|++.||++|||+.|+++|-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 284 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHP 284 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCc
Confidence 0000 0000011123345678999999999999999999999863
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=354.92 Aligned_cols=249 Identities=24% Similarity=0.346 Sum_probs=205.2
Q ss_pred CcccCcccccCceEEEEEEecCCCcEEEEEeeec--cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCC
Q 002061 678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK--GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPN 755 (973)
Q Consensus 678 ~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 755 (973)
|+..+.||+|+||.||+|++..+|+.||||++.. ....+.+.+|+.++++++||||+++++++..++..++||||+++
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 126 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence 5666789999999999999998899999999865 34566788999999999999999999999999999999999999
Q ss_pred CchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCc
Q 002061 756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV 835 (973)
Q Consensus 756 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 835 (973)
|+|.+++.. ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++........
T Consensus 127 ~~L~~~l~~------~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~- 196 (321)
T 2c30_A 127 GALTDIVSQ------VRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP- 196 (321)
T ss_dssp CBHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-
T ss_pred CCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc-
Confidence 999998863 25899999999999999999999 78999999999999999999999999999986654322
Q ss_pred ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccccC
Q 002061 836 SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVAS 915 (973)
Q Consensus 836 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
......||+.|+|||++.+..++.++|||||||++|||++|+.||... +............. +..
T Consensus 197 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~-----~~~~~~~~~~~~~~-------~~~-- 261 (321)
T 2c30_A 197 -KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD-----SPVQAMKRLRDSPP-------PKL-- 261 (321)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-----CHHHHHHHHHHSSC-------CCC--
T ss_pred -ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHhcCCC-------CCc--
Confidence 223457999999999999999999999999999999999999999653 11111111111111 000
Q ss_pred cchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 916 ESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 916 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
.........+.+++.+||+.||++|||+.|++++-.
T Consensus 262 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~ 297 (321)
T 2c30_A 262 KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPF 297 (321)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 011123346788999999999999999999998744
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=362.46 Aligned_cols=253 Identities=25% Similarity=0.309 Sum_probs=207.1
Q ss_pred HHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 002061 673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL 748 (973)
Q Consensus 673 ~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 748 (973)
...++|++.+.||+|+||.||+|.+..+++.||||++... ...+.+.+|++++++++||||+++++++.+++..|+
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 4456899999999999999999999999999999998753 244668899999999999999999999999999999
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCC---CCeEEecccC
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDED---YEPKIADFGV 825 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~---~~~kl~Dfgl 825 (973)
||||+++|+|.+++... ..+++..+..++.|++.||+||| +++|+||||||+||+++.+ +.+||+|||+
T Consensus 106 v~e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~ 177 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVAR-----EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGL 177 (362)
T ss_dssp EECCCCSCBHHHHHTTC-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCc
Confidence 99999999999988642 35889999999999999999999 7899999999999999865 4599999999
Q ss_pred cccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccccc
Q 002061 826 AKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENV 905 (973)
Q Consensus 826 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 905 (973)
+....... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.... ..............
T Consensus 178 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~-----~~~~~~~i~~~~~~- 248 (362)
T 2bdw_A 178 AIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED-----QHRLYAQIKAGAYD- 248 (362)
T ss_dssp CBCCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHTCCC-
T ss_pred ceEecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHhCCCC-
Confidence 98665332 2234579999999999999899999999999999999999999996531 11111111111100
Q ss_pred chhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 906 LKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
............+.+++.+||+.||++||++.|++++
T Consensus 249 -------~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 249 -------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp -------CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0011112234567899999999999999999999876
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=365.49 Aligned_cols=357 Identities=26% Similarity=0.363 Sum_probs=212.9
Q ss_pred CCcccCcCChhhhCCCCCcEEEecCCcccCCCCcccCCCCCCEEeccCccCCCccccccccccccceEEccCCcCCCCCC
Q 002061 106 FNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEI 185 (973)
Q Consensus 106 ~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~i 185 (973)
.+.+.+.++. ..+++|+.|+++++.+...+ .+..+++|++|||++|.+++..+ +.++++|++|++++|.+.. +
T Consensus 33 ~~~~~~~i~~--~~l~~l~~L~l~~~~i~~l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~--~ 105 (466)
T 1o6v_A 33 KTNVTDTVSQ--TDLDQVTTLQADRLGIKSID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD--I 105 (466)
T ss_dssp CSSTTSEECH--HHHHTCCEEECCSSCCCCCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC--C
T ss_pred ccccccccCh--hHhccccEEecCCCCCccCc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCcccc--C
Confidence 3444444442 45678889999988887643 57888888888888888875543 6666777777776666653 3
Q ss_pred cccccCCCCCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCchhhhccccccEEEeeccccCCcCCccccccc
Q 002061 186 PESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLT 265 (973)
Q Consensus 186 p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~ 265 (973)
+. ++++++|++|++++|++++..+ +..+++|++|++++|++++ ++ .+..+++|++|+++ |.+.+.. .+.+++
T Consensus 106 ~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~-~~~~~~~--~~~~l~ 177 (466)
T 1o6v_A 106 TP-LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLSFG-NQVTDLK--PLANLT 177 (466)
T ss_dssp GG-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECC-CG-GGTTCTTCSEEEEE-ESCCCCG--GGTTCT
T ss_pred hh-hcCCCCCCEEECCCCCCCCChH--HcCCCCCCEEECCCCccCC-Ch-hhccCCcccEeecC-CcccCch--hhccCC
Confidence 33 6666666666666666664322 5666666666666666653 22 35555555555554 3333221 245555
Q ss_pred cccEEEeeccccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeeccCCccCCCCCccccccccccccccc
Q 002061 266 LLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDIS 345 (973)
Q Consensus 266 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls 345 (973)
+|++|++++|.+++. ..+. .+++|+.|++++|.+++..| ++.+++|+.|+++
T Consensus 178 ~L~~L~l~~n~l~~~--~~l~------------------------~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~ 229 (466)
T 1o6v_A 178 TLERLDISSNKVSDI--SVLA------------------------KLTNLESLIATNNQISDITP--LGILTNLDELSLN 229 (466)
T ss_dssp TCCEEECCSSCCCCC--GGGG------------------------GCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECC
T ss_pred CCCEEECcCCcCCCC--hhhc------------------------cCCCCCEEEecCCccccccc--ccccCCCCEEECC
Confidence 555555555554421 1234 44444444444444443332 4445555555555
Q ss_pred cccccccCChhhhhhhhHHHHHhhhccCCCCccccccCccccceEeccccccccCCCccccCCCCcceEeccCCcCCCCC
Q 002061 346 ENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGI 425 (973)
Q Consensus 346 ~N~l~~~~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 425 (973)
+|++++. ..+..+++|++|++++|.+++..+ +..+++|+.|++++|++++..
T Consensus 230 ~n~l~~~--------------------------~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~ 281 (466)
T 1o6v_A 230 GNQLKDI--------------------------GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS 281 (466)
T ss_dssp SSCCCCC--------------------------GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCG
T ss_pred CCCcccc--------------------------hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCccc
Confidence 5555421 123445666666666666664433 555666666666666665544
Q ss_pred CCCCCCCCCCCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCCccccccc
Q 002061 426 SPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCA 505 (973)
Q Consensus 426 ~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 505 (973)
+ +..+++|+.|+|++|++++..+ +..+++|+.|+|++|++++..| +..+++|++|++++|++++. ..+..++
T Consensus 282 ~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~ 353 (466)
T 1o6v_A 282 P--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLT 353 (466)
T ss_dssp G--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCT
T ss_pred c--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCC
Confidence 3 5566667777777777664433 6667777777777777765554 56677777777777777654 3566666
Q ss_pred cccchhccccccccCCCccccccCCCCeeecCCCccCC
Q 002061 506 RIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTG 543 (973)
Q Consensus 506 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 543 (973)
+|+.|++++|++++..| +..+++|+.|++++|++++
T Consensus 354 ~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 354 NINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp TCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEEC
T ss_pred CCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccC
Confidence 66777777776666555 6666677777777777664
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=359.86 Aligned_cols=261 Identities=26% Similarity=0.357 Sum_probs=212.2
Q ss_pred HcCCcccCcccccCceEEEEEEec-----CCCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCee
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLK-----KNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSS 746 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~-----~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 746 (973)
..+|++.+.||+|+||+||+|++. .+++.||||++... ...+.+.+|++++++++||||+++++++..++..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 357889999999999999999983 34578999998753 3346788999999999999999999999999999
Q ss_pred EEEEEccCCCchHHHHHhhhcC-------------------CCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCC
Q 002061 747 FLVLEYMPNGNLFQALHKRVKE-------------------GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKS 807 (973)
Q Consensus 747 ~lv~e~~~~gsL~~~l~~~~~~-------------------~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp 807 (973)
++||||+++|+|.+++...... ....+++..+..++.|+++||+||| +++++||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccch
Confidence 9999999999999999864221 1234889999999999999999999 78999999999
Q ss_pred CCeeecCCCCeEEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccC
Q 002061 808 SNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYG 886 (973)
Q Consensus 808 ~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~ 886 (973)
+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||+||++|||++ |+.||....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~- 257 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP- 257 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC-
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC-
Confidence 999999999999999999987655443333344567889999999999899999999999999999999 999997542
Q ss_pred CcccHHHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 002061 887 DGKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADAD 954 (973)
Q Consensus 887 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 954 (973)
.......+.... ...........+.+++.+||+.||++||++.|++++|+++.
T Consensus 258 -~~~~~~~~~~~~--------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 258 -PERLFNLLKTGH--------------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp -GGGHHHHHHTTC--------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHHHHHHhhcCC--------------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 222222221110 00111223456889999999999999999999999998763
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=365.32 Aligned_cols=256 Identities=24% Similarity=0.337 Sum_probs=204.0
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcE----EEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGT----VAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL 748 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~----vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 748 (973)
.+|++.+.||+|+||+||+|++..+++. ||+|++... .....+.+|+.++++++||||+++++++. +...++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 5788999999999999999999877766 777766442 23355778999999999999999999886 556899
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccc
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 828 (973)
||||+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 92 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH----RGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEECCTTCBSHHHHHSS----GGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEeCCCCCHHHHHHHc----cccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccc
Confidence 99999999999999753 235788899999999999999999 78999999999999999999999999999987
Q ss_pred ccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccch
Q 002061 829 AENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLK 907 (973)
Q Consensus 829 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
..............||..|+|||++.+..++.++|||||||++|||++ |+.||.... .......+......
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~~~~~~~~~~~~~------ 236 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR--LAEVPDLLEKGERL------ 236 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC--TTHHHHHHHTTCBC------
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccC--HHHHHHHHHcCCCC------
Confidence 765544444445678889999999999999999999999999999999 999997642 22222222111000
Q ss_pred hccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 002061 908 VLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADP 955 (973)
Q Consensus 908 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 955 (973)
. .+......+.+++.+||+.||.+||++.|++++|+.+..
T Consensus 237 -~-------~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 237 -A-------QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp -C-------CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred -C-------CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0 001122346789999999999999999999999987653
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=367.63 Aligned_cols=262 Identities=27% Similarity=0.376 Sum_probs=213.1
Q ss_pred HcCCcccCcccccCceEEEEEEecC-------CCcEEEEEeeecc---ccHHHHHHHHHHHHhc-CCCceeeEEEEEEeC
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKK-------NAGTVAVKQLWKG---DGVKVFAAEMEILGKI-RHRNILKLYACLLKG 743 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~-------~~~~vavK~~~~~---~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 743 (973)
.++|++.+.||+|+||+||+|++.. .+..||||++... ...+.+.+|+++++++ +||||+++++++..+
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 3578899999999999999999753 3457999998763 3346688999999999 999999999999999
Q ss_pred CeeEEEEEccCCCchHHHHHhhhcC-----------CCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeee
Q 002061 744 GSSFLVLEYMPNGNLFQALHKRVKE-----------GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILL 812 (973)
Q Consensus 744 ~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill 812 (973)
+..++||||+++|+|.+++...... ....+++..+..++.|++.||+||| +.+|+||||||+||++
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEEE
Confidence 9999999999999999999875311 1245899999999999999999999 7899999999999999
Q ss_pred cCCCCeEEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccH
Q 002061 813 DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDI 891 (973)
Q Consensus 813 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~ 891 (973)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||... ..
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~-----~~ 299 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-----PV 299 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-----CH
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-----CH
Confidence 9999999999999987755443333444567899999999999999999999999999999999 99999654 11
Q ss_pred HHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 002061 892 VYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADP 955 (973)
Q Consensus 892 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 955 (973)
............ ...+......+.+++.+||+.||++||++.|++++|+++..
T Consensus 300 ~~~~~~~~~~~~-----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 352 (382)
T 3tt0_A 300 EELFKLLKEGHR-----------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 352 (382)
T ss_dssp HHHHHHHHTTCC-----------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCC-----------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 222221111111 00111234568899999999999999999999999998753
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=374.44 Aligned_cols=256 Identities=23% Similarity=0.265 Sum_probs=206.4
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV 749 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 749 (973)
.++|++.+.||+|+||+||+|++..+++.||||++.+. .....+.+|+.++..++||||+++++++.+++..|+|
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV 152 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLV 152 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEE
Confidence 46899999999999999999999999999999998752 2233478999999999999999999999999999999
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccc
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 829 (973)
|||+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 153 ~Ey~~gg~L~~~l~~~----~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~ 225 (437)
T 4aw2_A 153 MDYYVGGDLLTLLSKF----EDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL 225 (437)
T ss_dssp ECCCTTCBHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EecCCCCcHHHHHHHc----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhhhhhc
Confidence 9999999999999753 345899999999999999999999 789999999999999999999999999999766
Q ss_pred cCCCCcccccccCCccccccccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccc
Q 002061 830 ENSPKVSDYSCFAGTHGYIAPELAY-----TCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHEN 904 (973)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 904 (973)
..... .......||+.|+|||++. +..++.++||||+||++|||++|+.||... +.............
T Consensus 226 ~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~-----~~~~~~~~i~~~~~- 298 (437)
T 4aw2_A 226 MEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE-----SLVETYGKIMNHKE- 298 (437)
T ss_dssp CTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHHHHTHHH-
T ss_pred ccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC-----ChhHHHHhhhhccc-
Confidence 44322 2223357999999999987 567899999999999999999999999653 11111111111100
Q ss_pred cchhccccccCcchHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHHh
Q 002061 905 VLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNL--RPPMREVVKML 950 (973)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rpt~~evl~~L 950 (973)
....+.. .......+.+++.+|+..+|++ ||++.|+++|-
T Consensus 299 --~~~~p~~----~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hp 340 (437)
T 4aw2_A 299 --RFQFPTQ----VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHP 340 (437)
T ss_dssp --HCCCCSS----CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSG
T ss_pred --cccCCcc----cccCCHHHHHHHHHHhcccccccCCCCHHHHhCCC
Confidence 0000111 0112345788999999988888 99999999874
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=359.87 Aligned_cols=254 Identities=22% Similarity=0.321 Sum_probs=203.1
Q ss_pred HHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeec---cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCC-----
Q 002061 673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK---GDGVKVFAAEMEILGKIRHRNILKLYACLLKGG----- 744 (973)
Q Consensus 673 ~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----- 744 (973)
+..++|++.+.||+|+||+||+|++..+++.||||++.. +...+.+.+|++++++++||||+++++++.+..
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 346789999999999999999999998999999999864 234567899999999999999999999986543
Q ss_pred ----------------------------------------------------eeEEEEEccCCCchHHHHHhhhcCCCCC
Q 002061 745 ----------------------------------------------------SSFLVLEYMPNGNLFQALHKRVKEGKPE 772 (973)
Q Consensus 745 ----------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~ 772 (973)
..++||||+++|+|.+++... .....
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~ 160 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR--CSLED 160 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTC--CSGGG
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcc--cCccc
Confidence 379999999999999999864 23344
Q ss_pred CCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCc----------ccccccC
Q 002061 773 LDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV----------SDYSCFA 842 (973)
Q Consensus 773 ~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~----------~~~~~~~ 842 (973)
.++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++........ .......
T Consensus 161 ~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T 3qd2_B 161 REHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV 237 (332)
T ss_dssp SCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC
T ss_pred hhhHHHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccC
Confidence 677788999999999999999 789999999999999999999999999999876543211 1223356
Q ss_pred CccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccccCcchHHHH
Q 002061 843 GTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDM 922 (973)
Q Consensus 843 gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (973)
||+.|+|||++.+..++.++||||+||++|||++|..|+... ....... .. ...+.......
T Consensus 238 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-------~~~~~~~-~~----------~~~~~~~~~~~ 299 (332)
T 3qd2_B 238 GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-------VRIITDV-RN----------LKFPLLFTQKY 299 (332)
T ss_dssp -CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-------HHHHHHH-HT----------TCCCHHHHHHC
T ss_pred CCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-------HHHHHHh-hc----------cCCCcccccCC
Confidence 999999999999999999999999999999999987775321 0111111 00 01112234445
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 923 IKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 923 ~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
..+.+++.+||+.||++|||+.|++++
T Consensus 300 ~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 300 PQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred hhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 667899999999999999999999985
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=353.09 Aligned_cols=264 Identities=23% Similarity=0.279 Sum_probs=203.2
Q ss_pred HHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 002061 673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL 748 (973)
Q Consensus 673 ~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 748 (973)
...++|++.+.||+|+||+||+|++.. ++.||||++... .....+.+|++++++++||||+++++++.++...++
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 96 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL 96 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEETT-SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEECC-CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence 345789999999999999999999965 889999998653 224568899999999999999999999999999999
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccc
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 828 (973)
||||++ |+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 97 v~e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 168 (311)
T 3niz_A 97 VFEFME-KDLKKVLDEN----KTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARA 168 (311)
T ss_dssp EEECCS-EEHHHHHHTC----TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEcCCC-CCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCcee
Confidence 999997 5888888643 345889999999999999999999 78999999999999999999999999999987
Q ss_pred ccCCCCcccccccCCcccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccc--c
Q 002061 829 AENSPKVSDYSCFAGTHGYIAPELAYT-CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHEN--V 905 (973)
Q Consensus 829 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~ 905 (973)
...... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... .+....+......... .
T Consensus 169 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~ 244 (311)
T 3niz_A 169 FGIPVR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTD--DDQLPKIFSILGTPNPREW 244 (311)
T ss_dssp TTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSST--TTHHHHHHHHHCCCCTTTS
T ss_pred cCCCcc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHHCCCChHHh
Confidence 643322 2233568999999999876 5689999999999999999999999976422 2222222211111100 0
Q ss_pred ch-------------hccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 906 LK-------------VLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 906 ~~-------------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
.. ................++.+++.+|+++||++|||+.|+++|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 245 PQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp GGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00 000000000011223567899999999999999999999985
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=360.00 Aligned_cols=261 Identities=23% Similarity=0.324 Sum_probs=194.6
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCc---EEEEEeeec----cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCee-
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAG---TVAVKQLWK----GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSS- 746 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~---~vavK~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~- 746 (973)
.++|++.+.||+|+||+||+|++..+++ .||||++.. ....+.+.+|++++++++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 4579999999999999999999887664 899998865 23457789999999999999999999999876654
Q ss_pred -----EEEEEccCCCchHHHHHhhhcC-CCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEE
Q 002061 747 -----FLVLEYMPNGNLFQALHKRVKE-GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKI 820 (973)
Q Consensus 747 -----~lv~e~~~~gsL~~~l~~~~~~-~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl 820 (973)
++||||+++|+|.+++...... ....+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEE
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCEEE
Confidence 9999999999999999765322 2235899999999999999999999 789999999999999999999999
Q ss_pred ecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHh
Q 002061 821 ADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHL 899 (973)
Q Consensus 821 ~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~ 899 (973)
+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |+.||.... .......+...
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~--~~~~~~~~~~~- 255 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE--NAEIYNYLIGG- 255 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--GGGHHHHHHTT-
T ss_pred eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccC--hHHHHHHHhcC-
Confidence 99999987654433333334557889999999999999999999999999999999 999997542 22222211111
Q ss_pred ccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 002061 900 NNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADAD 954 (973)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 954 (973)
.. ..........+.+++.+||+.||++|||+.++++.|+++.
T Consensus 256 --~~-----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l 297 (323)
T 3qup_A 256 --NR-----------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL 297 (323)
T ss_dssp --CC-----------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CC-----------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00 0111223456889999999999999999999999999764
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=363.31 Aligned_cols=254 Identities=28% Similarity=0.357 Sum_probs=193.0
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccC
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP 754 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 754 (973)
.++|++.+.||+|+||+||+|++..+++.||||++......+.+.+|++++++++||||+++++++..++..++||||++
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 131 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVT 131 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCC
Confidence 46789999999999999999999998999999999877667778899999999999999999999999999999999999
Q ss_pred CCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecC---CCCeEEecccCcccccC
Q 002061 755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE---DYEPKIADFGVAKIAEN 831 (973)
Q Consensus 755 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~Dfgl~~~~~~ 831 (973)
+|+|.+++.. ...+++..+..++.|++.||+||| +.+|+||||||+||+++. ++.+||+|||+++....
T Consensus 132 ~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 132 GGELFDRIVE-----KGYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp SCBHHHHHTT-----CSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred CCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 9999999864 235889999999999999999999 789999999999999975 88999999999986543
Q ss_pred CCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccc
Q 002061 832 SPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDC 911 (973)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (973)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..............
T Consensus 204 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----~~~~~~i~~~~~~~------ 270 (349)
T 2w4o_A 204 QV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD----QFMFRRILNCEYYF------ 270 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH----HHHHHHHHTTCCCC------
T ss_pred cc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc----HHHHHHHHhCCCcc------
Confidence 22 123356899999999999999999999999999999999999999654211 11111111111100
Q ss_pred cccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 912 EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 912 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
...........+.+++.+|++.||++|||+.|++++-.
T Consensus 271 --~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 308 (349)
T 2w4o_A 271 --ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPW 308 (349)
T ss_dssp --CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred --CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 00111223456889999999999999999999998743
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=364.00 Aligned_cols=265 Identities=23% Similarity=0.314 Sum_probs=210.3
Q ss_pred HcCCcccCcccccCceEEEEEEec-----CCCcEEEEEeeecc---ccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCe
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLK-----KNAGTVAVKQLWKG---DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGS 745 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~-----~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 745 (973)
.++|++.+.||+|+||+||+|++. .++..||||++... ...+.+.+|+++++++ +||||+++++++..++.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 468899999999999999999973 35678999998653 3456788999999999 89999999999999999
Q ss_pred eEEEEEccCCCchHHHHHhhhcC------------------CCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCC
Q 002061 746 SFLVLEYMPNGNLFQALHKRVKE------------------GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKS 807 (973)
Q Consensus 746 ~~lv~e~~~~gsL~~~l~~~~~~------------------~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp 807 (973)
.++||||+++|+|.+++...... ....+++..+..++.|++.||+||| +++|+||||||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp 200 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAA 200 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSG
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCh
Confidence 99999999999999999864211 0124789999999999999999999 78999999999
Q ss_pred CCeeecCCCCeEEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccC
Q 002061 808 SNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYG 886 (973)
Q Consensus 808 ~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~ 886 (973)
+||+++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 999999999999999999987654433333334567889999999999999999999999999999998 9999976422
Q ss_pred CcccHHHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCCC
Q 002061 887 DGKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPCT 957 (973)
Q Consensus 887 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 957 (973)
. ......+.... ....+......+.+++.+||+.||.+||++.|++++|+.+....
T Consensus 281 ~-~~~~~~~~~~~--------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 281 D-ANFYKLIQNGF--------------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp S-HHHHHHHHTTC--------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred H-HHHHHHHhcCC--------------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 1 11111111110 00111122456888999999999999999999999999876544
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=358.89 Aligned_cols=250 Identities=28% Similarity=0.395 Sum_probs=205.7
Q ss_pred HHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCee
Q 002061 673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSS 746 (973)
Q Consensus 673 ~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 746 (973)
...++|++.+.||+|+||+||+|+++.+++.||||++.+. ...+.+.+|..+++.+ +||||+++++++.+++..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 3457899999999999999999999999999999998763 3456678899999887 999999999999999999
Q ss_pred EEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCc
Q 002061 747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826 (973)
Q Consensus 747 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~ 826 (973)
|+||||+++|+|.+++... ..+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++
T Consensus 94 ~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a 165 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMC 165 (345)
T ss_dssp EEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhh
Confidence 9999999999999999764 35889999999999999999999 789999999999999999999999999999
Q ss_pred ccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccc
Q 002061 827 KIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVL 906 (973)
Q Consensus 827 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 906 (973)
+...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||... +...............
T Consensus 166 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~-----~~~~~~~~i~~~~~~~- 237 (345)
T 1xjd_A 166 KENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ-----DEEELFHSIRMDNPFY- 237 (345)
T ss_dssp BCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHCCCCC-
T ss_pred hhcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHHHhCCCCC-
Confidence 7543221 1233467999999999999999999999999999999999999999653 1122222221111111
Q ss_pred hhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHH-HHHHH
Q 002061 907 KVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMR-EVVKM 949 (973)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~-evl~~ 949 (973)
+......+.+++.+|++.||++||++. |+.+|
T Consensus 238 -----------p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 238 -----------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp -----------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred -----------CcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 111234678899999999999999997 77654
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=356.80 Aligned_cols=248 Identities=21% Similarity=0.269 Sum_probs=208.3
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL 748 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 748 (973)
..++|++.+.||+|+||+||+|++..+++.||||++.+. ...+.+.+|+++++.++||||+++++++.++...|+
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 118 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 356899999999999999999999999999999998653 345678899999999999999999999999999999
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccc
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 828 (973)
||||+++|+|.+++... ..+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++.
T Consensus 119 v~e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~ 190 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR 190 (350)
T ss_dssp EEECCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEcCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEccccccee
Confidence 99999999999999864 24889999999999999999999 78999999999999999999999999999986
Q ss_pred ccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchh
Q 002061 829 AENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKV 908 (973)
Q Consensus 829 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (973)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||... +..............
T Consensus 191 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~-----~~~~~~~~i~~~~~~---- 256 (350)
T 1rdq_E 191 VKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD-----QPIQIYEKIVSGKVR---- 256 (350)
T ss_dssp CSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHCCCC----
T ss_pred ccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC-----CHHHHHHHHHcCCCC----
Confidence 6432 12356899999999999999999999999999999999999999653 122222222111110
Q ss_pred ccccccCcchHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHhh
Q 002061 909 LDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPP-----MREVVKMLA 951 (973)
Q Consensus 909 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt-----~~evl~~L~ 951 (973)
. +......+.+++.+|++.||.+||+ +.|+++|-.
T Consensus 257 ----~----p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~ 296 (350)
T 1rdq_E 257 ----F----PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296 (350)
T ss_dssp ----C----CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred ----C----CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcC
Confidence 0 1122456789999999999999998 899987643
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=358.08 Aligned_cols=262 Identities=27% Similarity=0.399 Sum_probs=211.6
Q ss_pred HcCCcccCcccccCceEEEEEEe-----cCCCcEEEEEeeeccc---cHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCe
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDL-----KKNAGTVAVKQLWKGD---GVKVFAAEMEILGKI-RHRNILKLYACLLKGGS 745 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~-----~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 745 (973)
.++|++.+.||+|+||+||+|++ ..+++.||||++.... ..+.+.+|+++++++ +||||+++++++..++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 35788999999999999999985 3567899999987642 346788999999999 99999999999999999
Q ss_pred eEEEEEccCCCchHHHHHhhhc-------------CCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeee
Q 002061 746 SFLVLEYMPNGNLFQALHKRVK-------------EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILL 812 (973)
Q Consensus 746 ~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill 812 (973)
.++||||+++|+|.+++..... .....+++..+..++.|+++||+||| +++++||||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEE
Confidence 9999999999999999986421 11234899999999999999999999 7899999999999999
Q ss_pred cCCCCeEEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccH
Q 002061 813 DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDI 891 (973)
Q Consensus 813 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~ 891 (973)
+.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... ...
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~~ 257 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-SKF 257 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-HHH
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch-hHH
Confidence 9999999999999987765443333334557889999999999999999999999999999999 99999764221 111
Q ss_pred HHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 002061 892 VYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADAD 954 (973)
Q Consensus 892 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 954 (973)
...+..... ..........+.+++.+|++.||.+|||+.|++++|+++.
T Consensus 258 ~~~~~~~~~--------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 258 YKMIKEGFR--------------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp HHHHHHTCC--------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhccCCC--------------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 111111100 0011122456889999999999999999999999998754
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=350.57 Aligned_cols=265 Identities=26% Similarity=0.356 Sum_probs=205.7
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHh--cCCCceeeEEEEEEe----CCeeEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGK--IRHRNILKLYACLLK----GGSSFL 748 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~--l~hpniv~l~~~~~~----~~~~~l 748 (973)
.++|++.+.||+|+||+||+|++. ++.||||++... ....+.+|.+++.. ++||||+++++++.. ....++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l 83 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSWQ--GENVAVKIFSSR-DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL 83 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEET--TEEEEEEEECGG-GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEEC--CEEEEEEEeccc-cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence 467899999999999999999884 889999988654 34556677777766 799999999998654 345899
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcC-----CCCeEecCCCCCCeeecCCCCeEEecc
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC-----SPPIIHRDIKSSNILLDEDYEPKIADF 823 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~-----~~~ivH~Dlkp~Nill~~~~~~kl~Df 823 (973)
||||+++|+|.++++. ..+++..+..++.|++.||+|||+.. +++|+||||||+||+++.++.+||+||
T Consensus 84 v~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 84 ITHYHEMGSLYDYLQL------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp EECCCTTCBHHHHHTT------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred ehhhccCCCHHHHHhh------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeC
Confidence 9999999999999953 25899999999999999999999321 468999999999999999999999999
Q ss_pred cCcccccCCCCcc--cccccCCccccccccccccC------CCCccchHHHHHHHHHHHHhC----------CCCCCccc
Q 002061 824 GVAKIAENSPKVS--DYSCFAGTHGYIAPELAYTC------KVSEKSDVFSFGVVLLELVTG----------RKPVEEEY 885 (973)
Q Consensus 824 gl~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~~l~el~tg----------~~pf~~~~ 885 (973)
|+++......... ......||+.|+|||++.+. .++.++|||||||++|||++| +.||....
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 9997665433221 12234789999999999876 455799999999999999999 88887654
Q ss_pred CCcccHHHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 886 GDGKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 886 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
.................. ..... ...........+.+++.+||+.||++|||+.|+++.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~-~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 238 PNDPSFEDMRKVVCVDQQ-RPNIP----NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CSSCCHHHHHHHHTTSCC-CCCCC----GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcchhhhhHHHhccCC-CCCCC----hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 443333333222211111 00000 0112234567899999999999999999999999999864
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=355.98 Aligned_cols=254 Identities=24% Similarity=0.347 Sum_probs=205.2
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFL 748 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l 748 (973)
..+|++.+.||+|+||+||+|+++.+++.||||++.+. ...+.+.+|..+++++ +||||+++++++.+++..|+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 46789999999999999999999999999999998753 2345678899999988 89999999999999999999
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccc
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 828 (973)
||||+++|+|.+++... ..+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++.
T Consensus 88 v~e~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~ 159 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 159 (345)
T ss_dssp EECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBC
T ss_pred EEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEecccccc
Confidence 99999999999999764 35889999999999999999999 78999999999999999999999999999975
Q ss_pred ccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCc----ccHHHHHHHHhccccc
Q 002061 829 AENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDG----KDIVYWVSTHLNNHEN 904 (973)
Q Consensus 829 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~----~~~~~~~~~~~~~~~~ 904 (973)
..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||....... ................
T Consensus 160 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~ 237 (345)
T 3a8x_A 160 GLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR 237 (345)
T ss_dssp SCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC
T ss_pred ccCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC
Confidence 43221 12334579999999999999999999999999999999999999996531111 1111111111111110
Q ss_pred cchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCH------HHHHHHh
Q 002061 905 VLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPM------REVVKML 950 (973)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~------~evl~~L 950 (973)
.+......+.+++.+|++.||.+||++ .|+++|-
T Consensus 238 ------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp 277 (345)
T 3a8x_A 238 ------------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 277 (345)
T ss_dssp ------------CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSG
T ss_pred ------------CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCC
Confidence 111234467889999999999999995 7787663
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=362.21 Aligned_cols=262 Identities=25% Similarity=0.379 Sum_probs=210.6
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCc-----EEEEEeeecc---ccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCe
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAG-----TVAVKQLWKG---DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGS 745 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~-----~vavK~~~~~---~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 745 (973)
.++|++.+.||+|+||+||+|.+..+++ .||||++... ...+.+.+|+++++++ +||||+++++++..++.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 4688999999999999999999876554 7999998764 3456688999999999 89999999999999999
Q ss_pred eEEEEEccCCCchHHHHHhhhcC---------CCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCC
Q 002061 746 SFLVLEYMPNGNLFQALHKRVKE---------GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY 816 (973)
Q Consensus 746 ~~lv~e~~~~gsL~~~l~~~~~~---------~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~ 816 (973)
.++||||+++|+|.+++...... ....+++..+..++.|++.||+||| +.+|+||||||+||+++.++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEEEGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEECCCC
Confidence 99999999999999999764211 1235789999999999999999999 78999999999999999999
Q ss_pred CeEEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHH
Q 002061 817 EPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWV 895 (973)
Q Consensus 817 ~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~ 895 (973)
.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||...... ......+
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-~~~~~~~ 280 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN-SKFYKLV 280 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS-HHHHHHH
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh-HHHHHHH
Confidence 999999999986654433333334557889999999999999999999999999999998 99999754211 1111111
Q ss_pred HHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 002061 896 STHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADAD 954 (973)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 954 (973)
...... ..+......+.+++.+||+.||.+||++.|++++|+++.
T Consensus 281 ~~~~~~--------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 281 KDGYQM--------------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp HHTCCC--------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hcCCCC--------------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 111100 001112346788999999999999999999999998753
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=378.70 Aligned_cols=258 Identities=26% Similarity=0.351 Sum_probs=214.3
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM 753 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 753 (973)
..+|++.+.||+|+||+||+|++..++..||||++... ...+.+.+|++++++++||||+++++++..+...|+||||+
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~ 298 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 298 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEcc
Confidence 35678899999999999999999988999999998763 45678999999999999999999999999999999999999
Q ss_pred CCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCC
Q 002061 754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833 (973)
Q Consensus 754 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 833 (973)
++|+|.+++... ....+++..+..++.|+++||+||| +++|+||||||+|||++.++.+||+|||+++......
T Consensus 299 ~~g~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 299 TYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp TTCBHHHHHHHS---CTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred CCCCHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 999999999753 3345889999999999999999999 7899999999999999999999999999998664332
Q ss_pred CcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhcccc
Q 002061 834 KVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCE 912 (973)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (973)
. .......++..|+|||++.+..++.++|||||||++|||++ |+.||... +.......+...
T Consensus 373 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~--~~~~~~~~~~~~-------------- 435 (495)
T 1opk_A 373 Y-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKD-------------- 435 (495)
T ss_dssp E-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC--CGGGHHHHHHTT--------------
T ss_pred e-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcC--------------
Confidence 1 22223456789999999998899999999999999999999 99999754 222222222111
Q ss_pred ccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 002061 913 VASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADP 955 (973)
Q Consensus 913 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 955 (973)
.....+......+.+++.+||+.||++||++.++++.|+.+..
T Consensus 436 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 436 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 1111122334568899999999999999999999999998753
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=355.29 Aligned_cols=250 Identities=28% Similarity=0.323 Sum_probs=198.6
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc----------------------------cHHHHHHHHHHH
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----------------------------GVKVFAAEMEIL 725 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----------------------------~~~~~~~E~~~l 725 (973)
..++|++.+.||+|+||+||+|++..+++.||||++.... ..+.+.+|++++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 3568999999999999999999999999999999986532 135688999999
Q ss_pred HhcCCCceeeEEEEEEe--CCeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEec
Q 002061 726 GKIRHRNILKLYACLLK--GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHR 803 (973)
Q Consensus 726 ~~l~hpniv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~ 803 (973)
++++||||+++++++.+ ++..|+||||+++|+|.+++. ...+++..+..++.|+++||+||| +.+|+||
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~ 161 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT------LKPLSEDQARFYFQDLIKGIEYLH---YQKIIHR 161 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC------SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecc
Confidence 99999999999999986 568899999999999977543 236899999999999999999999 7899999
Q ss_pred CCCCCCeeecCCCCeEEecccCcccccCCCCcccccccCCccccccccccccCC---CCccchHHHHHHHHHHHHhCCCC
Q 002061 804 DIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCK---VSEKSDVFSFGVVLLELVTGRKP 880 (973)
Q Consensus 804 Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~~l~el~tg~~p 880 (973)
||||+||+++.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.|
T Consensus 162 Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p 239 (298)
T 2zv2_A 162 DIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239 (298)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCS
T ss_pred CCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence 9999999999999999999999987654322 223457899999999997665 47789999999999999999999
Q ss_pred CCcccCCcccHHHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 881 VEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 881 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
|... ................ .........+.+++.+||+.||++||++.|+++|
T Consensus 240 f~~~-----~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 240 FMDE-----RIMCLHSKIKSQALEF----------PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp SCCS-----SHHHHHHHHHHCCCCC----------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred CCCc-----cHHHHHHHHhcccCCC----------CCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 9653 1222211111111000 0011223468899999999999999999999875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=371.77 Aligned_cols=251 Identities=28% Similarity=0.406 Sum_probs=207.8
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhcCCCceeeEEEEEEeCC-eeEEEEEcc
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGG-SSFLVLEYM 753 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~~lv~e~~ 753 (973)
.++|++.+.||+|+||+||+|++. ++.||||+++.....+.+.+|++++++++||||+++++++.... ..|+||||+
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~ 269 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence 457888999999999999999986 77999999988777788999999999999999999999987665 789999999
Q ss_pred CCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCC
Q 002061 754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833 (973)
Q Consensus 754 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 833 (973)
++|+|.+++... ....+++..+..++.|+++||+||| +++++||||||+||+++.++.+||+|||+++......
T Consensus 270 ~~g~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 343 (450)
T 1k9a_A 270 AKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 343 (450)
T ss_dssp TTCBHHHHHHHH---CTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred CCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc
Confidence 999999999864 2334788999999999999999999 7899999999999999999999999999998543221
Q ss_pred CcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhcccc
Q 002061 834 KVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCE 912 (973)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (973)
....++..|+|||++.+..++.++|||||||++|||++ |+.||.... ..+....+....
T Consensus 344 -----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~--~~~~~~~i~~~~------------- 403 (450)
T 1k9a_A 344 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--LKDVVPRVEKGY------------- 403 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSC--TTTHHHHHHTTC-------------
T ss_pred -----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHcCC-------------
Confidence 12356889999999999999999999999999999998 999997542 222222221110
Q ss_pred ccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 002061 913 VASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADAD 954 (973)
Q Consensus 913 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 954 (973)
....+......+.+++.+||+.||++|||+.++++.|+++.
T Consensus 404 -~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 404 -KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 01111223456889999999999999999999999998764
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=364.77 Aligned_cols=255 Identities=23% Similarity=0.303 Sum_probs=206.6
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL 748 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 748 (973)
..++|++.+.||+|+||+||+|++..+++.||||++.+. ...+.+.+|+.+++.++||||+++++++.+++..|+
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 146 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 146 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 356899999999999999999999999999999998652 234457899999999999999999999999999999
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccc
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 828 (973)
||||+++|+|.+++... .+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++.
T Consensus 147 V~E~~~gg~L~~~l~~~------~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a~~ 217 (410)
T 3v8s_A 147 VMEYMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 217 (410)
T ss_dssp EECCCTTEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEeCCCCCcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccceeEe
Confidence 99999999999998753 4788999999999999999999 78999999999999999999999999999986
Q ss_pred ccCCCCcccccccCCccccccccccccCC----CCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccc
Q 002061 829 AENSPKVSDYSCFAGTHGYIAPELAYTCK----VSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHEN 904 (973)
Q Consensus 829 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 904 (973)
...... .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||... +..............
T Consensus 218 ~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~-----~~~~~~~~i~~~~~~ 291 (410)
T 3v8s_A 218 MNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD-----SLVGTYSKIMNHKNS 291 (410)
T ss_dssp CCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHHHHTHHHH
T ss_pred eccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC-----ChhhHHHHHHhcccc
Confidence 654322 1223467999999999997665 788999999999999999999999653 112222211111000
Q ss_pred cchhccccccCcchHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHHhh
Q 002061 905 VLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNL--RPPMREVVKMLA 951 (973)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rpt~~evl~~L~ 951 (973)
. .+ + ........+.+++.+|++.+|.+ ||++.||++|-.
T Consensus 292 ~-~~--p-----~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~ 332 (410)
T 3v8s_A 292 L-TF--P-----DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 332 (410)
T ss_dssp C-CC--C-----TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGG
T ss_pred c-cC--C-----CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCcc
Confidence 0 00 0 00122346788999999999998 999999998754
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=356.15 Aligned_cols=251 Identities=27% Similarity=0.344 Sum_probs=206.5
Q ss_pred HHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCee
Q 002061 673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSS 746 (973)
Q Consensus 673 ~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 746 (973)
....+|++.+.||+|+||+||+|++..+++.||||++.+. ...+.+.+|..++..+ +||+|+++++++...+..
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 3457899999999999999999999998999999998753 3456788999999988 899999999999999999
Q ss_pred EEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCc
Q 002061 747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826 (973)
Q Consensus 747 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~ 826 (973)
|+||||+++|+|.+++... ..+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++
T Consensus 97 ~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a 168 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMC 168 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCcc
Confidence 9999999999999999864 25889999999999999999999 789999999999999999999999999999
Q ss_pred ccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccc
Q 002061 827 KIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVL 906 (973)
Q Consensus 827 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 906 (973)
+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||... +...............
T Consensus 169 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~-----~~~~~~~~i~~~~~~~- 240 (353)
T 2i0e_A 169 KENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE-----DEDELFQSIMEHNVAY- 240 (353)
T ss_dssp BCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHCCCCC-
T ss_pred cccccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC-----CHHHHHHHHHhCCCCC-
Confidence 7543221 1233457999999999999999999999999999999999999999653 1222222222111110
Q ss_pred hhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHh
Q 002061 907 KVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPP-----MREVVKML 950 (973)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt-----~~evl~~L 950 (973)
+......+.+++.+|++.||.+||+ +.|+++|-
T Consensus 241 -----------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~ 278 (353)
T 2i0e_A 241 -----------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHA 278 (353)
T ss_dssp -----------CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSG
T ss_pred -----------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCc
Confidence 1123456788999999999999995 58888763
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=362.38 Aligned_cols=255 Identities=24% Similarity=0.262 Sum_probs=198.9
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM 753 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 753 (973)
.++|++.+.||+|+||+||+|++..+++.||||++... ...+.+.+|+.++++++||||+++++++..++..|+||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 98 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence 46899999999999999999999999999999998763 33466889999999999999999999999999999999999
Q ss_pred CCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCC--eEEecccCcccccC
Q 002061 754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE--PKIADFGVAKIAEN 831 (973)
Q Consensus 754 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~--~kl~Dfgl~~~~~~ 831 (973)
++|+|.+++... ..+++..+..++.|++.||+||| +++|+||||||+||+++.++. +||+|||+++....
T Consensus 99 ~~~~L~~~l~~~-----~~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 99 SGGELYERICNA-----GRFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred CCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 999999999754 25899999999999999999999 789999999999999987765 99999999874432
Q ss_pred CCCcccccccCCccccccccccccCCCCcc-chHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhcc
Q 002061 832 SPKVSDYSCFAGTHGYIAPELAYTCKVSEK-SDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLD 910 (973)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (973)
.. ......||+.|+|||++.+..++.+ +||||+||++|+|++|+.||..... .......+..........
T Consensus 171 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-~~~~~~~~~~~~~~~~~~----- 241 (361)
T 3uc3_A 171 HS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-PRDYRKTIQRILSVKYSI----- 241 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC-----CCCHHHHHHHHHTTCCCC-----
T ss_pred cC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCcc-HHHHHHHHHHHhcCCCCC-----
Confidence 21 2233568999999999988887765 8999999999999999999976422 222233322222111110
Q ss_pred ccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 911 CEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 911 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
.........+.+++.+||+.||++|||+.|+++|-.
T Consensus 242 -----~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~ 277 (361)
T 3uc3_A 242 -----PDDIRISPECCHLISRIFVADPATRISIPEIKTHSW 277 (361)
T ss_dssp -----CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHH
T ss_pred -----CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcc
Confidence 001112346789999999999999999999998743
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=356.76 Aligned_cols=278 Identities=17% Similarity=0.170 Sum_probs=208.0
Q ss_pred HcCCcccCcccccCceEEEEEEecC---CCcEEEEEeeeccc-------------cHHHHHHHHHHHHhcCCCceeeEEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKK---NAGTVAVKQLWKGD-------------GVKVFAAEMEILGKIRHRNILKLYA 738 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~---~~~~vavK~~~~~~-------------~~~~~~~E~~~l~~l~hpniv~l~~ 738 (973)
.++|++.+.||+|+||+||+|++.. ++..||||+..... ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 4579999999999999999999986 78899999886532 1123567888899999999999999
Q ss_pred EEEe----CCeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecC
Q 002061 739 CLLK----GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE 814 (973)
Q Consensus 739 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~ 814 (973)
++.. +...|+||||+ +++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~ 186 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN-----GTFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGY 186 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGG-----GBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEES
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEcc
Confidence 9987 67899999999 99999998754 26899999999999999999999 789999999999999998
Q ss_pred CC--CeEEecccCcccccCCCCc-----ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCC
Q 002061 815 DY--EPKIADFGVAKIAENSPKV-----SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGD 887 (973)
Q Consensus 815 ~~--~~kl~Dfgl~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~ 887 (973)
++ .+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 187 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~ 266 (345)
T 2v62_A 187 KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD 266 (345)
T ss_dssp SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC
T ss_pred CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc
Confidence 87 9999999999866432111 1123457899999999999999999999999999999999999999654222
Q ss_pred cccHHHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCCCCCCCCCCCCC
Q 002061 888 GKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPCTDKSPDNSSDK 967 (973)
Q Consensus 888 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~~~~~~s~~ 967 (973)
...............+ ........ .......+.+++.+||+.||++||++.+|++.|++......+..-+....
T Consensus 267 ~~~~~~~~~~~~~~~~---~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~d~~~~~~ 340 (345)
T 2v62_A 267 PVAVQTAKTNLLDELP---QSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPLGPLDFSTKGQ 340 (345)
T ss_dssp HHHHHHHHHHHHHTTT---HHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCCCCCCCCCTTC
T ss_pred cHHHHHHHHhhccccc---HHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcccCCCcccCCc
Confidence 2222222211111111 00000000 00234468899999999999999999999999999876554444333333
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=348.09 Aligned_cols=253 Identities=29% Similarity=0.486 Sum_probs=203.4
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc---------cHHHHHHHHHHHHhcCCCceeeEEEEEEeCC
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD---------GVKVFAAEMEILGKIRHRNILKLYACLLKGG 744 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 744 (973)
..++|++.+.||+|+||+||+|++..+++.||||++.... ..+.+.+|++++++++||||+++++++.+..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 3468899999999999999999999999999999885421 1267889999999999999999999986655
Q ss_pred eeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCC--eEecCCCCCCeeecCCCC-----
Q 002061 745 SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP--IIHRDIKSSNILLDEDYE----- 817 (973)
Q Consensus 745 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~--ivH~Dlkp~Nill~~~~~----- 817 (973)
++||||+++|+|.+++... ...+++..+..++.|++.|++||| +.+ ++||||||+||+++.++.
T Consensus 97 --~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~ 167 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLDK----AHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVC 167 (287)
T ss_dssp --EEEEECCTTCBHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCC
T ss_pred --eEEEEecCCCCHHHHHhcc----cCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCcee
Confidence 7999999999999988653 346899999999999999999999 778 999999999999988776
Q ss_pred eEEecccCcccccCCCCcccccccCCccccccccccc--cCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHH
Q 002061 818 PKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAY--TCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWV 895 (973)
Q Consensus 818 ~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~ 895 (973)
+||+|||+++.... ......||+.|+|||++. ...++.++||||+||++|||++|+.||..............
T Consensus 168 ~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 242 (287)
T 4f0f_A 168 AKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI 242 (287)
T ss_dssp EEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHH
T ss_pred EEeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHH
Confidence 99999999974432 223356899999999983 45678999999999999999999999976432211111111
Q ss_pred HHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 896 STHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
.. ... ...........+.+++.+||+.||++||++.|+++.|+++
T Consensus 243 ~~---~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 243 RE---EGL----------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HH---SCC----------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred hc---cCC----------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 11 110 0111122345688999999999999999999999999864
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=361.73 Aligned_cols=253 Identities=19% Similarity=0.231 Sum_probs=207.7
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc--ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY 752 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 752 (973)
.++|++.+.||+|+||+||+|.+..+++.||+|++... .....+.+|++++++++||||+++++++.++...++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 46899999999999999999999999999999998764 3445688999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecC--CCCeEEecccCccccc
Q 002061 753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE--DYEPKIADFGVAKIAE 830 (973)
Q Consensus 753 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~--~~~~kl~Dfgl~~~~~ 830 (973)
+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++. ++.+||+|||+++...
T Consensus 130 ~~gg~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 130 LSGGELFDRIAAE----DYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp CCCCBHHHHTTCT----TCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred CCCCcHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecC
Confidence 9999999988642 345899999999999999999999 789999999999999974 5779999999998765
Q ss_pred CCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhcc
Q 002061 831 NSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLD 910 (973)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (973)
.... .....||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..............
T Consensus 203 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~-----~~~~~~~i~~~~~~------ 268 (387)
T 1kob_A 203 PDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED-----DLETLQNVKRCDWE------ 268 (387)
T ss_dssp TTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS-----HHHHHHHHHHCCCC------
T ss_pred CCcc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC-----HHHHHHHHHhCCCC------
Confidence 4322 233468999999999999999999999999999999999999997531 11111111111110
Q ss_pred ccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 911 CEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 911 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
............+.+++.+||+.||++|||+.|++++-
T Consensus 269 --~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp 306 (387)
T 1kob_A 269 --FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHP 306 (387)
T ss_dssp --CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTST
T ss_pred --CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCc
Confidence 01111122345688999999999999999999999874
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=353.73 Aligned_cols=256 Identities=33% Similarity=0.498 Sum_probs=200.4
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccC
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP 754 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 754 (973)
.++|++.+.||+|+||+||+|++. ++.||||++..+...+.+.+|++++++++||||+++++++. +..++||||++
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 357888999999999999999986 78899999987777788999999999999999999999876 34799999999
Q ss_pred CCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCC-eEEecccCcccccCCC
Q 002061 755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE-PKIADFGVAKIAENSP 833 (973)
Q Consensus 755 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~-~kl~Dfgl~~~~~~~~ 833 (973)
+|+|.+++... ...+.+++..+..++.|+++||+|||+...++|+||||||+||+++.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~--~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~- 159 (307)
T 2eva_A 83 GGSLYNVLHGA--EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH- 159 (307)
T ss_dssp TCBHHHHHHCS--SSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred CCCHHHHHhcc--CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-
Confidence 99999999753 22234788899999999999999999432279999999999999998887 799999999755432
Q ss_pred CcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccc
Q 002061 834 KVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEV 913 (973)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (973)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||............. .......
T Consensus 160 ----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~--~~~~~~~---------- 223 (307)
T 2eva_A 160 ----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWA--VHNGTRP---------- 223 (307)
T ss_dssp ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHH--HHTTCCC----------
T ss_pred ----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHH--HhcCCCC----------
Confidence 123458999999999999999999999999999999999999997542221111111 1111110
Q ss_pred cCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 002061 914 ASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADP 955 (973)
Q Consensus 914 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 955 (973)
.........+.+++.+||+.||++|||+.|++++|+.+..
T Consensus 224 --~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 224 --PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp --CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred --CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 0111223467889999999999999999999999987653
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=360.85 Aligned_cols=273 Identities=23% Similarity=0.328 Sum_probs=198.4
Q ss_pred cCHHHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeec----cccHHHHHHHHHHHHhcC-CCceeeEEEEEEeCC
Q 002061 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKIR-HRNILKLYACLLKGG 744 (973)
Q Consensus 670 ~~~~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~----~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~ 744 (973)
++.....+|++.+.||+|+||+||+|.+..+++.||||++.. ......+.+|+.+++++. ||||+++++++..++
T Consensus 3 v~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 82 (388)
T 3oz6_A 3 VDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN 82 (388)
T ss_dssp -CHHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT
T ss_pred ccCcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC
Confidence 446678899999999999999999999999999999998854 234566789999999997 999999999997544
Q ss_pred --eeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEec
Q 002061 745 --SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIAD 822 (973)
Q Consensus 745 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 822 (973)
..|+||||++ |+|.+++... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|
T Consensus 83 ~~~~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~D 152 (388)
T 3oz6_A 83 DRDVYLVFDYME-TDLHAVIRAN------ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVAD 152 (388)
T ss_dssp SSCEEEEEECCS-EEHHHHHHHT------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECC
T ss_pred CCEEEEEecccC-cCHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecC
Confidence 7899999996 6999998753 5788899999999999999999 78999999999999999999999999
Q ss_pred ccCcccccCCCC-------------------cccccccCCcccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCC
Q 002061 823 FGVAKIAENSPK-------------------VSDYSCFAGTHGYIAPELAYT-CKVSEKSDVFSFGVVLLELVTGRKPVE 882 (973)
Q Consensus 823 fgl~~~~~~~~~-------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~pf~ 882 (973)
||+++....... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.
T Consensus 153 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 232 (388)
T 3oz6_A 153 FGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFP 232 (388)
T ss_dssp CTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCC
Confidence 999986543111 112234579999999999876 678999999999999999999999997
Q ss_pred cccCCcccHHHHHHHHhccccc--cch--------hc----------cccccCcc------------hHHHHHHHHHHHH
Q 002061 883 EEYGDGKDIVYWVSTHLNNHEN--VLK--------VL----------DCEVASES------------IKEDMIKLLKIAV 930 (973)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~~~~~--~~~--------~~----------~~~~~~~~------------~~~~~~~l~~l~~ 930 (973)
... ..+....+......... ... .+ ........ .......+.+++.
T Consensus 233 ~~~--~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~ 310 (388)
T 3oz6_A 233 GSS--TMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLD 310 (388)
T ss_dssp CSS--HHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHH
T ss_pred CCC--HHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHH
Confidence 541 11111111111100000 000 00 00000000 0022346889999
Q ss_pred HhcCCCCCCCCCHHHHHHH--hhcCC
Q 002061 931 VCTTKLPNLRPPMREVVKM--LADAD 954 (973)
Q Consensus 931 ~cl~~dP~~Rpt~~evl~~--L~~~~ 954 (973)
+||+.||++|||+.|+++| +....
T Consensus 311 ~~L~~dP~~R~t~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 311 KLLQFNPNKRISANDALKHPFVSIFH 336 (388)
T ss_dssp HHCCSSGGGSCCHHHHTTSTTTTTTC
T ss_pred HhhccCcccCCCHHHHhCCHHHHHhc
Confidence 9999999999999999998 44443
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=362.62 Aligned_cols=273 Identities=17% Similarity=0.209 Sum_probs=207.2
Q ss_pred HcCCcccCccccc--CceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 002061 675 ICNLEEDNLIGSG--GTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL 748 (973)
Q Consensus 675 ~~~~~~~~~lG~G--~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 748 (973)
.++|++.+.||+| +||+||+|++..+++.||||++... ...+.+.+|++++++++||||+++++++..++..|+
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4689999999999 9999999999999999999998753 234567889999999999999999999999999999
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccc
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 828 (973)
||||+++|+|.+++... ....+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||.+..
T Consensus 104 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTH---FMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEECCTTCBHHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEccCCCCHHHHHhhh---cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 99999999999999764 2345899999999999999999999 78999999999999999999999999998865
Q ss_pred ccCCCCc-----ccccccCCcccccccccccc--CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcc
Q 002061 829 AENSPKV-----SDYSCFAGTHGYIAPELAYT--CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNN 901 (973)
Q Consensus 829 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 901 (973)
....... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||........ ...........
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~ 256 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM-LLEKLNGTVPC 256 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH-HHHC-------
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHhcCCCCc
Confidence 4322111 11223468999999999987 6799999999999999999999999975422111 11100000000
Q ss_pred c--------c-------------ccchhcc--------c-cccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--
Q 002061 902 H--------E-------------NVLKVLD--------C-EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM-- 949 (973)
Q Consensus 902 ~--------~-------------~~~~~~~--------~-~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~-- 949 (973)
. . ....... . .............+.+++.+||+.||++|||+.|+++|
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~ 336 (389)
T 3gni_B 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 336 (389)
T ss_dssp -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGG
T ss_pred cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHH
Confidence 0 0 0000000 0 00001122334568899999999999999999999987
Q ss_pred hhcCC
Q 002061 950 LADAD 954 (973)
Q Consensus 950 L~~~~ 954 (973)
++++.
T Consensus 337 f~~~~ 341 (389)
T 3gni_B 337 FKQIK 341 (389)
T ss_dssp GGGC-
T ss_pred HHHHh
Confidence 44443
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=354.60 Aligned_cols=273 Identities=21% Similarity=0.318 Sum_probs=206.6
Q ss_pred cCHHHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeec-----cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCC
Q 002061 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKIRHRNILKLYACLLKGG 744 (973)
Q Consensus 670 ~~~~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~-----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 744 (973)
.+.....+|++.+.||+|+||+||+|.+..+++.||||++.. ....+.+.+|++++++++||||+++++++..++
T Consensus 26 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 105 (310)
T 2wqm_A 26 MGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN 105 (310)
T ss_dssp GTTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred cccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 334556789999999999999999999998899999998864 234566889999999999999999999999999
Q ss_pred eeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEeccc
Q 002061 745 SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFG 824 (973)
Q Consensus 745 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 824 (973)
..++||||+++|+|.+++..... ....+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg 181 (310)
T 2wqm_A 106 ELNIVLELADAGDLSRMIKHFKK-QKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLG 181 (310)
T ss_dssp EEEEEEECCCSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC-
T ss_pred cEEEEEecCCCCCHHHHHHHhcc-cccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEecc
Confidence 99999999999999999976422 3445889999999999999999999 7899999999999999999999999999
Q ss_pred CcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccc
Q 002061 825 VAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHEN 904 (973)
Q Consensus 825 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 904 (973)
++........ ......|++.|+|||++.+..++.++||||||+++|+|++|+.||...... ............
T Consensus 182 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~-- 254 (310)
T 2wqm_A 182 LGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCKKIEQCD-- 254 (310)
T ss_dssp -------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC---HHHHHHHHHTTC--
T ss_pred ceeeecCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh---HHHHHHHhhccc--
Confidence 9876543321 122346899999999999999999999999999999999999999754222 112211111110
Q ss_pred cchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCCCCCCC
Q 002061 905 VLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPCTDKSP 961 (973)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~~~ 961 (973)
............+.+++.+||+.||++||++.+++++|+++.+..+.++
T Consensus 255 --------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~ 303 (310)
T 2wqm_A 255 --------YPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303 (310)
T ss_dssp --------SCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred --------CCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence 0000011234468899999999999999999999999999877655444
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=350.38 Aligned_cols=255 Identities=22% Similarity=0.321 Sum_probs=205.3
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM 753 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 753 (973)
.++|++.+.||+|+||+||+|++.. +..||||++... ...+++.+|++++++++||||+++++++.++...++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETT-TEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcC-CCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 4578999999999999999998874 778999998763 35677899999999999999999999999999999999999
Q ss_pred CCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCC
Q 002061 754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833 (973)
Q Consensus 754 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 833 (973)
++|+|.+++... ...+++..+..++.|++.||+||| +++++||||||+||+++.++.+||+|||+++......
T Consensus 102 ~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 102 ANGCLLNYLREM----RHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp TTCBHHHHHHCG----GGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred CCCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 999999999753 235899999999999999999999 7899999999999999999999999999997664321
Q ss_pred CcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhcccc
Q 002061 834 KVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCE 912 (973)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (973)
. .......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||.... .. ........... .
T Consensus 175 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~--~~---~~~~~~~~~~~-------~- 240 (283)
T 3gen_A 175 Y-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT--NS---ETAEHIAQGLR-------L- 240 (283)
T ss_dssp H-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC--HH---HHHHHHHTTCC-------C-
T ss_pred c-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC--hh---HHHHHHhcccC-------C-
Confidence 1 12223456788999999998899999999999999999998 999997541 11 11111111100 0
Q ss_pred ccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 002061 913 VASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADAD 954 (973)
Q Consensus 913 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 954 (973)
..+......+.+++.+||+.||++|||+.|++++|+++.
T Consensus 241 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 241 ---YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp ---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 001112346888999999999999999999999998753
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=357.12 Aligned_cols=257 Identities=23% Similarity=0.319 Sum_probs=201.1
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEE----EEEeeec---cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTV----AVKQLWK---GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF 747 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~v----avK~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 747 (973)
..+|++.+.||+|+||+||+|++..+++.| |+|.+.. ....+.+.+|++++++++||||+++++++..+. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 357899999999999999999998777665 6665543 345678899999999999999999999998765 78
Q ss_pred EEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcc
Q 002061 748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827 (973)
Q Consensus 748 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~ 827 (973)
+|+||+++|+|.+++... ...+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++
T Consensus 93 ~v~~~~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEECCCSSCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred EEEEecCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence 899999999999999864 345889999999999999999999 7899999999999999999999999999998
Q ss_pred cccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccc
Q 002061 828 IAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVL 906 (973)
Q Consensus 828 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 906 (973)
...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||... ........+.....
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~--~~~~~~~~~~~~~~------ 237 (327)
T 3lzb_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--PASEISSILEKGER------ 237 (327)
T ss_dssp --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CGGGHHHHHHTTCC------
T ss_pred EccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCC--CHHHHHHHHHcCCC------
Confidence 7654443333344567889999999999999999999999999999999 99999764 22222222221110
Q ss_pred hhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 002061 907 KVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADP 955 (973)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 955 (973)
...+......+.+++.+||+.||.+||++.|+++.|+++..
T Consensus 238 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 238 --------LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp --------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred --------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 01111233468889999999999999999999999997653
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=371.09 Aligned_cols=347 Identities=18% Similarity=0.173 Sum_probs=224.5
Q ss_pred CCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCchhhhccccccEEEeeccccCCcCCccccccccccEEEeec
Q 002061 195 LTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISS 274 (973)
Q Consensus 195 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~ 274 (973)
-+.++.++++++ .+|..+. +++++|+|++|+|++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++
T Consensus 13 ~~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 89 (477)
T 2id5_A 13 DRAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRS 89 (477)
T ss_dssp TTEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCC
Confidence 357788888887 5665543 5778888888888776677777777777777777777766677777777777777777
Q ss_pred cccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeeccCCccCCCCCccccccccccccccccccccccCC
Q 002061 275 NQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFP 354 (973)
Q Consensus 275 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p 354 (973)
|++++..+..|.++++|++|++++|++.+..+..|..+++|+.|++++|.+++..+..|..+++|++|+|++|++++..
T Consensus 90 n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~- 168 (477)
T 2id5_A 90 NRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIP- 168 (477)
T ss_dssp SCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCC-
T ss_pred CcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccC-
Confidence 7777555555677777777777777777666666666666666666666666555555555555555555555554211
Q ss_pred hhhhhhhhHHHHHhhhccCCCCccccccCccccceEeccccccccCCCccccCCCCcceEeccCCcCCCCCCCCCCCCCC
Q 002061 355 KYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTS 434 (973)
Q Consensus 355 ~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~ 434 (973)
+..+.++++|+.|+|++|.+.+..+.. |..+++
T Consensus 169 -----------------------~~~l~~l~~L~~L~l~~n~i~~~~~~~------------------------~~~l~~ 201 (477)
T 2id5_A 169 -----------------------TEALSHLHGLIVLRLRHLNINAIRDYS------------------------FKRLYR 201 (477)
T ss_dssp -----------------------HHHHTTCTTCCEEEEESCCCCEECTTC------------------------SCSCTT
T ss_pred -----------------------hhHhcccCCCcEEeCCCCcCcEeChhh------------------------cccCcc
Confidence 112334455555555555555444444 445555
Q ss_pred CCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCCccccccccccchhccc
Q 002061 435 LSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLAR 514 (973)
Q Consensus 435 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 514 (973)
|+.|++++|.+.+.+|.......+|+.|+|++|++++..+..|..+++|++|+|++|++++..+..|.++++|+.|+|++
T Consensus 202 L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~ 281 (477)
T 2id5_A 202 LKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVG 281 (477)
T ss_dssp CCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCS
T ss_pred cceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCC
Confidence 55555555555545555544455666666666666644445666666667777777766666666666777777777777
Q ss_pred cccccCCCccccccCCCCeeecCCCccCCCCChhhhccc-CceEEccCCccccccCcccccC-CCCccccCCCCCccCcc
Q 002061 515 NSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLK-LSSIDLSENQLSGSVPLDFLRM-GGDGAFAGNEGLCLDQS 592 (973)
Q Consensus 515 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~-L~~l~ls~N~l~~~~p~~~~~~-~~~~~~~~n~~lc~~~~ 592 (973)
|++++..|..|..+++|+.|+|++|+|++..+..+..++ |+.|+|++|+|.|.|+..|..- .....+.++...|+.|.
T Consensus 282 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p~ 361 (477)
T 2id5_A 282 GQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATPE 361 (477)
T ss_dssp SCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEESG
T ss_pred CccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccchHhHHhhhhccccCccCceeCCch
Confidence 777766677777777777777777777765555555554 7777777777777776543321 11235666777776654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=346.52 Aligned_cols=249 Identities=31% Similarity=0.420 Sum_probs=193.4
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc------ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG------DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL 748 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 748 (973)
..+|++.+.||+|+||+||+|++. ++.||||++... ...+.+.+|+++++.++||||+++++++..++..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 467899999999999999999986 789999987652 234678899999999999999999999999999999
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCC---eEecCCCCCCeeecC--------CCC
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP---IIHRDIKSSNILLDE--------DYE 817 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~---ivH~Dlkp~Nill~~--------~~~ 817 (973)
||||+++++|.+++.. ..+++..+..++.|+++|++||| +.+ ++||||||+||+++. ++.
T Consensus 84 v~e~~~~~~L~~~~~~------~~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~ 154 (271)
T 3dtc_A 84 VMEFARGGPLNRVLSG------KRIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKI 154 (271)
T ss_dssp EEECCTTEEHHHHHTS------SCCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCC
T ss_pred EEEcCCCCCHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcc
Confidence 9999999999998853 35889999999999999999999 556 999999999999986 678
Q ss_pred eEEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHH
Q 002061 818 PKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVST 897 (973)
Q Consensus 818 ~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~ 897 (973)
+||+|||.+........ ....||+.|+|||++.+..++.++||||+|+++|+|++|+.||.... . ......
T Consensus 155 ~kl~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--~---~~~~~~ 225 (271)
T 3dtc_A 155 LKITDFGLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID--G---LAVAYG 225 (271)
T ss_dssp EEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC--H---HHHHHH
T ss_pred eEEccCCcccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--H---HHHHHh
Confidence 99999999976543322 23468999999999999999999999999999999999999997531 1 111111
Q ss_pred HhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 898 HLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 898 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
...... ...........+.+++.+||+.||++|||+.|++++|+++
T Consensus 226 ~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 226 VAMNKL----------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp HHTSCC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred hhcCCC----------CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 111110 0011122345688999999999999999999999999864
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=374.03 Aligned_cols=259 Identities=26% Similarity=0.400 Sum_probs=209.8
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeec-cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK-GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM 753 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 753 (973)
.++|++.+.||+|+||+||+|++.. +..||||++.. ....+.+.+|++++++++||||+++++++. ++..|+||||+
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~ 264 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM 264 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred hHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence 4577889999999999999999875 67899999876 345778999999999999999999999886 56789999999
Q ss_pred CCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCC
Q 002061 754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833 (973)
Q Consensus 754 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 833 (973)
++|+|.++++... ...+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++......
T Consensus 265 ~~g~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 265 AKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338 (454)
T ss_dssp TTCBHHHHHHSHH---HHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred CCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence 9999999997542 224788899999999999999999 7899999999999999999999999999998664321
Q ss_pred CcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhcccc
Q 002061 834 KVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCE 912 (973)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (973)
. .......++..|+|||++.+..++.++|||||||++|||++ |+.||... ........+... ..
T Consensus 339 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~--~~~~~~~~i~~~---~~--------- 403 (454)
T 1qcf_A 339 Y-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM--SNPEVIRALERG---YR--------- 403 (454)
T ss_dssp H-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--CHHHHHHHHHHT---CC---------
T ss_pred e-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcC---CC---------
Confidence 1 11223446789999999998899999999999999999999 99999653 111222221111 00
Q ss_pred ccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCCCC
Q 002061 913 VASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPCTD 958 (973)
Q Consensus 913 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~ 958 (973)
...+......+.+++.+||+.||++|||+.+|++.|+++.....
T Consensus 404 --~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~ 447 (454)
T 1qcf_A 404 --MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATE 447 (454)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSC
T ss_pred --CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhccc
Confidence 01112234568899999999999999999999999999876543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=351.69 Aligned_cols=252 Identities=24% Similarity=0.289 Sum_probs=185.8
Q ss_pred cCcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhcC-CCceeeEEEEEEeCCeeEEEEEccCCCchH
Q 002061 681 DNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIR-HRNILKLYACLLKGGSSFLVLEYMPNGNLF 759 (973)
Q Consensus 681 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~~~gsL~ 759 (973)
.+.||+|+||+||+|++..+++.||||++... ....+.+|+.+++.+. ||||+++++++.++...|+||||+++|+|.
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~ 94 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELF 94 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh-hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHH
Confidence 37899999999999999999999999998654 3456789999999997 999999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCC---CeEEecccCcccccCCCCcc
Q 002061 760 QALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY---EPKIADFGVAKIAENSPKVS 836 (973)
Q Consensus 760 ~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl~Dfgl~~~~~~~~~~~ 836 (973)
+++... ..+++..+..++.|++.||+||| +++|+||||||+||+++.++ .+||+|||+++.......
T Consensus 95 ~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-- 164 (325)
T 3kn6_A 95 ERIKKK-----KHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-- 164 (325)
T ss_dssp HHHHHC-----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--
Confidence 999753 45899999999999999999999 78999999999999998766 799999999986543322
Q ss_pred cccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCC--cccHHHHHHHHhccccccchhcccccc
Q 002061 837 DYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGD--GKDIVYWVSTHLNNHENVLKVLDCEVA 914 (973)
Q Consensus 837 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (973)
......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ............... ....
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~--------~~~~ 236 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD--------FSFE 236 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTC--------CCCC
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCC--------CCCC
Confidence 223356899999999999999999999999999999999999999764221 112222222211111 0111
Q ss_pred CcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 915 SESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 915 ~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
..........+.+++.+|++.||.+|||+.|++++-.
T Consensus 237 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w 273 (325)
T 3kn6_A 237 GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEW 273 (325)
T ss_dssp SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGG
T ss_pred cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChh
Confidence 1222344567889999999999999999999987644
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=347.76 Aligned_cols=262 Identities=25% Similarity=0.311 Sum_probs=198.9
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE 751 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 751 (973)
++|++.+.||+|+||+||+|++ .+++.||||++... ...+.+.+|++++++++||||+++++++..++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 5789999999999999999998 56889999998653 234678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccC
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 831 (973)
|++ ++|.+++... ...+++..+..++.|+++||+||| +++|+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (288)
T 1ob3_A 81 HLD-QDLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGI 152 (288)
T ss_dssp CCS-EEHHHHHHTS----TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred ecC-CCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCc
Confidence 996 5999988753 345889999999999999999999 78999999999999999999999999999976643
Q ss_pred CCCcccccccCCccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccc-----cc
Q 002061 832 SPKVSDYSCFAGTHGYIAPELAYTC-KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHE-----NV 905 (973)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~-----~~ 905 (973)
... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||.... ..+....+........ ..
T Consensus 153 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T 1ob3_A 153 PVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS--EADQLMRIFRILGTPNSKNWPNV 228 (288)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCCCTTTSTTG
T ss_pred ccc--ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHHCCCChhhchhh
Confidence 221 22334689999999998764 58999999999999999999999997531 1111111111111000 00
Q ss_pred ch--hcccccc-------CcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 906 LK--VLDCEVA-------SESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 906 ~~--~~~~~~~-------~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
.+ ..++... ..........+.+++.+|++.||++|||+.|+++|-
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 282 (288)
T 1ob3_A 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA 282 (288)
T ss_dssp GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred hcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence 00 0000000 001112345678999999999999999999999763
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=356.80 Aligned_cols=262 Identities=27% Similarity=0.399 Sum_probs=210.2
Q ss_pred HcCCcccCcccccCceEEEEEEec-------CCCcEEEEEeeecc---ccHHHHHHHHHHHHhc-CCCceeeEEEEEEeC
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLK-------KNAGTVAVKQLWKG---DGVKVFAAEMEILGKI-RHRNILKLYACLLKG 743 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~-------~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 743 (973)
.++|++.+.||+|+||+||+|++. .+++.||||++... ...+.+.+|+++++++ +||||+++++++..+
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 357899999999999999999975 35678999998763 3446688999999999 899999999999999
Q ss_pred CeeEEEEEccCCCchHHHHHhhhcC-----------CCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeee
Q 002061 744 GSSFLVLEYMPNGNLFQALHKRVKE-----------GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILL 812 (973)
Q Consensus 744 ~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill 812 (973)
+..|+||||+++|+|.+++...... ....+++..+..++.|+++||+||| +.+|+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEEE
Confidence 9999999999999999999864211 1234889999999999999999999 7899999999999999
Q ss_pred cCCCCeEEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccH
Q 002061 813 DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDI 891 (973)
Q Consensus 813 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~ 891 (973)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||... .....
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~--~~~~~ 268 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVEEL 268 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC--CHHHH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC--CHHHH
Confidence 9999999999999987655443333344567889999999998889999999999999999999 99999653 11111
Q ss_pred HHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 002061 892 VYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADP 955 (973)
Q Consensus 892 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 955 (973)
...+... .. ..........+.+++.+||+.||.+||++.|++++|+++..
T Consensus 269 ~~~~~~~---~~-----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 269 FKLLKEG---HR-----------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp HHHHHHT---CC-----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhcC---CC-----------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1111111 10 00111234568889999999999999999999999998753
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=349.89 Aligned_cols=257 Identities=26% Similarity=0.365 Sum_probs=213.3
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY 752 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 752 (973)
...+|++.+.||+|+||+||+|.+..++..||||++... ...+.+.+|++++++++||||+++++++..+...++||||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 90 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 90 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence 346789999999999999999999998999999998764 3557789999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCC
Q 002061 753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832 (973)
Q Consensus 753 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 832 (973)
+++|+|.+++... ....+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||.+......
T Consensus 91 ~~~~~L~~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 91 MTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp CTTEEHHHHHHHC---CTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred CCCCcHHHHHHhc---ccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 9999999999753 3456899999999999999999999 779999999999999999999999999999866543
Q ss_pred CCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhccc
Q 002061 833 PKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDC 911 (973)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (973)
.. .......+|+.|+|||++.+..++.++||||+|+++|+|++ |..||... +.......+....
T Consensus 165 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~--~~~~~~~~~~~~~------------ 229 (288)
T 3kfa_A 165 TY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKDY------------ 229 (288)
T ss_dssp SS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--CGGGHHHHHHTTC------------
T ss_pred cc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHhccC------------
Confidence 22 22233456789999999998999999999999999999999 99999754 2222222221110
Q ss_pred cccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 912 EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 912 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
....+......+.+++.+|++.||.+||++.|+++.|+.+
T Consensus 230 --~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 230 --RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 0111122345688999999999999999999999999865
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=348.33 Aligned_cols=267 Identities=21% Similarity=0.211 Sum_probs=202.2
Q ss_pred HHHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc-------cHHHHHHHHHHHHhcC---CCceeeEEEEEE
Q 002061 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-------GVKVFAAEMEILGKIR---HRNILKLYACLL 741 (973)
Q Consensus 672 ~~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~---hpniv~l~~~~~ 741 (973)
....++|++.+.||+|+||+||+|++..+++.||||++.... ....+.+|++++++++ ||||+++++++.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~ 84 (308)
T 3g33_A 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84 (308)
T ss_dssp -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence 445679999999999999999999999999999999986421 2346678888877764 999999999998
Q ss_pred eCC-----eeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCC
Q 002061 742 KGG-----SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY 816 (973)
Q Consensus 742 ~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~ 816 (973)
... ..++||||++ |+|.+++... ....+++..+..++.|++.||+||| +.+|+||||||+||+++.++
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~ 157 (308)
T 3g33_A 85 TSRTDREIKVTLVFEHVD-QDLRTYLDKA---PPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGG 157 (308)
T ss_dssp ECCSSSEEEEEEEEECCC-CBHHHHHHTC---CTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTS
T ss_pred ccCCCCceeEEEEehhhh-cCHHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCC
Confidence 755 5799999996 6999999753 2334899999999999999999999 78999999999999999999
Q ss_pred CeEEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHH
Q 002061 817 EPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVS 896 (973)
Q Consensus 817 ~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~ 896 (973)
.+||+|||+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..+....+.
T Consensus 158 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~i~ 232 (308)
T 3g33_A 158 TVKLADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS--EADQLGKIF 232 (308)
T ss_dssp CEEECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSS--HHHHHHHHH
T ss_pred CEEEeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHH
Confidence 99999999998664332 2234568999999999999999999999999999999999999996541 111111111
Q ss_pred HHhccccc--cchh---ccccc---c----CcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 897 THLNNHEN--VLKV---LDCEV---A----SESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 897 ~~~~~~~~--~~~~---~~~~~---~----~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
........ .... ..... . .....+....+.+++.+|+++||++|||+.|+++|-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~ 298 (308)
T 3g33_A 233 DLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHS 298 (308)
T ss_dssp HHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTST
T ss_pred HHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCc
Confidence 11111000 0000 00000 0 001112345688999999999999999999999864
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=342.09 Aligned_cols=249 Identities=30% Similarity=0.402 Sum_probs=204.6
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL 748 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 748 (973)
.+++|++.+.||+|+||+||+|++..+++.||||++... .....+.+|++++++++||||+++++++.+++..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 456889999999999999999999999999999998652 235568899999999999999999999999999999
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccc
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 828 (973)
||||+++|+|.+++... ..+++..+..++.|++.|++||| +.+++||||||+||+++.++.++|+|||++..
T Consensus 87 v~e~~~~~~l~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~ 158 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH 158 (279)
T ss_dssp EECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESC
T ss_pred EEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEecccccc
Confidence 99999999999999764 34889999999999999999999 88999999999999999999999999998865
Q ss_pred ccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchh
Q 002061 829 AENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKV 908 (973)
Q Consensus 829 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (973)
.... ......|++.|+|||++.+..++.++||||+|+++|+|++|+.||... ...............
T Consensus 159 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-----~~~~~~~~~~~~~~~---- 225 (279)
T 3fdn_A 159 APSS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN-----TYQETYKRISRVEFT---- 225 (279)
T ss_dssp C------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHHHHHTCCC----
T ss_pred CCcc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCC-----cHHHHHHHHHhCCCC----
Confidence 4332 123356899999999999999999999999999999999999999653 111111111111110
Q ss_pred ccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 909 LDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 909 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
. +......+.+++.+|++.||++||++.|+++|-.
T Consensus 226 ----~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~ 260 (279)
T 3fdn_A 226 ----F----PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 260 (279)
T ss_dssp ----C----CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHH
T ss_pred ----C----CCcCCHHHHHHHHHHhccChhhCCCHHHHhhCcc
Confidence 0 1112345778999999999999999999998765
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=344.48 Aligned_cols=255 Identities=26% Similarity=0.357 Sum_probs=208.5
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL 750 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 750 (973)
..++|++.+.||+|+||+||+|++..+++.||||++... ...+.+.+|+++++.++||||+++++++.+++..|+||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 456899999999999999999999988999999998653 33567889999999999999999999999999999999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccccc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 830 (973)
||+++++|.+++.. ...+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||.+....
T Consensus 85 e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 156 (276)
T 2yex_A 85 EYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (276)
T ss_dssp ECCTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred EecCCCcHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccC
Confidence 99999999988753 245889999999999999999999 7899999999999999999999999999998664
Q ss_pred CCCCcccccccCCccccccccccccCCC-CccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhc
Q 002061 831 NSPKVSDYSCFAGTHGYIAPELAYTCKV-SEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVL 909 (973)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (973)
............|++.|+|||++.+..+ +.++||||+|+++|||++|+.||............+.. .....
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----~~~~~---- 228 (276)
T 2yex_A 157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE----KKTYL---- 228 (276)
T ss_dssp ETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHT----TCTTS----
T ss_pred CCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhh----ccccc----
Confidence 4332223344578999999999987765 67899999999999999999999765332222222211 11000
Q ss_pred cccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 910 DCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 910 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
.........+.+++.+|++.||++|||+.|++++-
T Consensus 229 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 263 (276)
T 2yex_A 229 ------NPWKKIDSAPLALLHKILVENPSARITIPDIKKDR 263 (276)
T ss_dssp ------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred ------CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCc
Confidence 01112344678899999999999999999998864
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=342.62 Aligned_cols=252 Identities=25% Similarity=0.311 Sum_probs=206.0
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL 750 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 750 (973)
.++|++.+.||+|+||+||+|.+..+++.||+|++... ...+.+.+|++++++++||||+++++++..+...++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 46899999999999999999999999999999998653 23466789999999999999999999999999999999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCC---eEEecccCcc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE---PKIADFGVAK 827 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~---~kl~Dfgl~~ 827 (973)
||+++|+|.+++... ..+++..+..++.|++.|++||| +.+++||||||+||+++.++. +||+|||.+.
T Consensus 85 e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~ 156 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR-----EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI 156 (284)
T ss_dssp CCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred ecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence 999999999998764 35889999999999999999999 789999999999999987655 9999999997
Q ss_pred cccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccch
Q 002061 828 IAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLK 907 (973)
Q Consensus 828 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
....... .....||+.|+|||++.+..++.++||||+|+++|+|++|+.||.... . ..............
T Consensus 157 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~--~---~~~~~~~~~~~~~~-- 226 (284)
T 3kk8_A 157 EVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED--Q---HRLYAQIKAGAYDY-- 226 (284)
T ss_dssp ECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--H---HHHHHHHHHTCCCC--
T ss_pred EcccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc--h---hHHHHHHHhccccC--
Confidence 6654322 233568999999999999999999999999999999999999996531 1 11111111111000
Q ss_pred hccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 908 VLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 908 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
...........+.+++.+|++.||++|||+.|++++-
T Consensus 227 ------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 263 (284)
T 3kk8_A 227 ------PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVP 263 (284)
T ss_dssp ------CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSH
T ss_pred ------CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCc
Confidence 0011112335678999999999999999999999863
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=361.85 Aligned_cols=271 Identities=23% Similarity=0.292 Sum_probs=213.0
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCC--eeEEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGG--SSFLVL 750 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--~~~lv~ 750 (973)
.+|++.+.||+|+||+||+|++..+++.||||++... ...+.+.+|++++++++||||+++++++.... ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 5788999999999999999999999999999998752 34567889999999999999999999998755 789999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeee----cCCCCeEEecccCc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILL----DEDYEPKIADFGVA 826 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill----~~~~~~kl~Dfgl~ 826 (973)
||+++|+|.+++.... ....+++..+..++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||++
T Consensus 89 e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPS--NAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp CCCTTEEHHHHTTSGG--GTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred ecCCCCCHHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 9999999999997642 1223899999999999999999999 7899999999999999 77778999999999
Q ss_pred ccccCCCCcccccccCCcccccccccccc--------CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHH
Q 002061 827 KIAENSPKVSDYSCFAGTHGYIAPELAYT--------CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTH 898 (973)
Q Consensus 827 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~ 898 (973)
+...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||............+....
T Consensus 164 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 240 (396)
T 4eut_A 164 RELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (396)
T ss_dssp EECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred eEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence 8664332 2234568999999999865 5678899999999999999999999976533322222222111
Q ss_pred hccccccc----hhc--------cccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 002061 899 LNNHENVL----KVL--------DCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADAD 954 (973)
Q Consensus 899 ~~~~~~~~----~~~--------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 954 (973)
........ ... +..............+.+++.+|+++||++||++.|++++++++.
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il 308 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHH
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHh
Confidence 11111000 000 001111223566778889999999999999999999999998764
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=372.05 Aligned_cols=254 Identities=24% Similarity=0.282 Sum_probs=209.2
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV 749 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 749 (973)
.++|++.+.||+|+||+||+|++..+|+.||||++.+. .....+.+|++++++++||||+++++++.+++..|+|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 45788999999999999999999999999999998652 3456688999999999999999999999999999999
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccc
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 829 (973)
|||+++|+|.+++... ....+++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||+++..
T Consensus 263 mEy~~gg~L~~~l~~~---~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHM---GQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp ECCCCSCBHHHHHHSS---SSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEcCCCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceec
Confidence 9999999999999753 2345899999999999999999999 789999999999999999999999999999876
Q ss_pred cCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhc
Q 002061 830 ENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVL 909 (973)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (973)
..... .....||+.|+|||++.+..++.++||||+||++|||++|+.||....... ...............
T Consensus 337 ~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~-~~~~i~~~i~~~~~~----- 407 (576)
T 2acx_A 337 PEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KREEVERLVKEVPEE----- 407 (576)
T ss_dssp CTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC-CHHHHHHHHHHCCCC-----
T ss_pred ccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch-hHHHHHHHhhccccc-----
Confidence 54322 233579999999999999899999999999999999999999997642211 111111111111110
Q ss_pred cccccCcchHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHh
Q 002061 910 DCEVASESIKEDMIKLLKIAVVCTTKLPNLRP-----PMREVVKML 950 (973)
Q Consensus 910 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~L 950 (973)
.+......+.+++.+|++.||.+|| ++.|+++|-
T Consensus 408 -------~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~Hp 446 (576)
T 2acx_A 408 -------YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHP 446 (576)
T ss_dssp -------CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSG
T ss_pred -------CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhCh
Confidence 1112345678899999999999999 789998763
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=359.17 Aligned_cols=257 Identities=22% Similarity=0.209 Sum_probs=205.7
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL 748 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 748 (973)
..++|++.+.||+|+||+||+|+++.+++.||||++.+. ...+.+.+|..++..++||||+++++++.+++..|+
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 138 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYL 138 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 356899999999999999999999999999999998752 233457899999999999999999999999999999
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccc
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 828 (973)
||||+++|+|.+++.+. ...+++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||+++.
T Consensus 139 VmE~~~gg~L~~~l~~~----~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFGla~~ 211 (412)
T 2vd5_A 139 VMEYYVGGDLLTLLSKF----GERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLK 211 (412)
T ss_dssp EECCCCSCBHHHHHHHH----SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEcCCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeechhhee
Confidence 99999999999999864 235889999999999999999999 78999999999999999999999999999987
Q ss_pred ccCCCCcccccccCCccccccccccc-------cCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcc
Q 002061 829 AENSPKVSDYSCFAGTHGYIAPELAY-------TCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNN 901 (973)
Q Consensus 829 ~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 901 (973)
...... .......||+.|+|||++. +..++.++|||||||++|||++|+.||... +...........
T Consensus 212 ~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~-----~~~~~~~~i~~~ 285 (412)
T 2vd5_A 212 LRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD-----STAETYGKIVHY 285 (412)
T ss_dssp CCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHHHHTH
T ss_pred ccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCC-----CHHHHHHHHHhc
Confidence 654322 1223357999999999987 456899999999999999999999999653 111111111110
Q ss_pred ccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCC---CCHHHHHHHhh
Q 002061 902 HENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLR---PPMREVVKMLA 951 (973)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---pt~~evl~~L~ 951 (973)
... ...+ ........++.+++.+|+. +|.+| |++.|+++|-.
T Consensus 286 ~~~---~~~p----~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpf 330 (412)
T 2vd5_A 286 KEH---LSLP----LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPF 330 (412)
T ss_dssp HHH---CCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGG
T ss_pred ccC---cCCC----ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCC
Confidence 000 0000 0112234568889999999 99998 69999998743
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=353.26 Aligned_cols=267 Identities=23% Similarity=0.319 Sum_probs=210.1
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeec--cccHHHHHHHHHHHHhcCCCceeeEEEEEEe----CCeeEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK--GDGVKVFAAEMEILGKIRHRNILKLYACLLK----GGSSFL 748 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~~~l 748 (973)
.++|++.+.||+|+||.||+|++..+++.||||++.. ....+.+.+|++++++++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 4579999999999999999999998899999998865 3445678899999999999999999999863 347899
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccc
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 828 (973)
||||+++|+|.+++.... .....+++..+..++.|+++||+||| +.+++||||||+||+++.++.+||+|||.+..
T Consensus 108 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLK-DKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEECCTTCBHHHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEeCCCCcHHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 999999999999998642 23456899999999999999999999 78999999999999999999999999999875
Q ss_pred ccCCCCc-------ccccccCCccccccccccccCC---CCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHH
Q 002061 829 AENSPKV-------SDYSCFAGTHGYIAPELAYTCK---VSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTH 898 (973)
Q Consensus 829 ~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~ 898 (973)
....... .......||+.|+|||++.+.. ++.++||||||+++|||++|+.||.................
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 263 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQ 263 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhcc
Confidence 4321110 0112245799999999987554 68899999999999999999999965322222222222110
Q ss_pred hccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCCCCC
Q 002061 899 LNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPCTDK 959 (973)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~ 959 (973)
.. ..........+.+++.+||+.||.+||++.|++++|+.+.+....
T Consensus 264 ~~--------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 310 (317)
T 2buj_A 264 LS--------------IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310 (317)
T ss_dssp ----------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC
T ss_pred CC--------------CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCC
Confidence 00 000112235688999999999999999999999999999865543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=347.79 Aligned_cols=255 Identities=25% Similarity=0.297 Sum_probs=195.6
Q ss_pred HcCCcccCcccccCceEEEEEEecCC---CcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKN---AGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL 748 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~---~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 748 (973)
.++|++.+.||+|+||+||+|++..+ +..||||+.... ...+.+.+|+.++++++||||+++++++. ++..|+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 46789999999999999999998643 457999987653 33456889999999999999999999874 567899
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccc
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 828 (973)
||||+++|+|.+++... ...+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||+++.
T Consensus 93 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVR----KYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp EEECCTTEEHHHHHHHT----TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEecCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccc
Confidence 99999999999999753 335889999999999999999999 78999999999999999999999999999987
Q ss_pred ccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccch
Q 002061 829 AENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLK 907 (973)
Q Consensus 829 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
...... .......+++.|+|||++.+..++.++||||||+++|||++ |..||.... ..+....+... ..
T Consensus 166 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~--~~~~~~~i~~~---~~---- 235 (281)
T 1mp8_A 166 MEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK--NNDVIGRIENG---ER---- 235 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC--GGGHHHHHHTT---CC----
T ss_pred cCcccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCC--HHHHHHHHHcC---CC----
Confidence 654322 12223456789999999998899999999999999999997 999997542 22222222111 00
Q ss_pred hccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 002061 908 VLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADAD 954 (973)
Q Consensus 908 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 954 (973)
...+......+.+++.+|++.||++||++.|++++|+++.
T Consensus 236 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 236 -------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0011223456888999999999999999999999998753
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=357.78 Aligned_cols=248 Identities=23% Similarity=0.312 Sum_probs=198.3
Q ss_pred ccCcccccCceEEEEEEecCCCcEEEEEeeecc--ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCCc
Q 002061 680 EDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGN 757 (973)
Q Consensus 680 ~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gs 757 (973)
..+.||+|+||+||+|++..+++.||||++... ...+.+.+|++++++++||||+++++++..++..++||||+++|+
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 356899999999999999999999999998763 355678999999999999999999999999999999999999999
Q ss_pred hHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeee--cCCCCeEEecccCcccccCCCCc
Q 002061 758 LFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILL--DEDYEPKIADFGVAKIAENSPKV 835 (973)
Q Consensus 758 L~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill--~~~~~~kl~Dfgl~~~~~~~~~~ 835 (973)
|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||+++.......
T Consensus 173 L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~- 244 (373)
T 2x4f_A 173 LFDRIIDE----SYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK- 244 (373)
T ss_dssp EHHHHHHT----GGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB-
T ss_pred HHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc-
Confidence 99998753 235889999999999999999999 7899999999999999 5678899999999987654322
Q ss_pred ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccccC
Q 002061 836 SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVAS 915 (973)
Q Consensus 836 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... .............. ...
T Consensus 245 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~-----~~~~~~~i~~~~~~--------~~~ 309 (373)
T 2x4f_A 245 --LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN-----DAETLNNILACRWD--------LED 309 (373)
T ss_dssp --CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHHHTCCC--------SCS
T ss_pred --cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhccCC--------CCh
Confidence 223468999999999998899999999999999999999999996531 11121211111110 011
Q ss_pred cchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 916 ESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 916 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
.........+.+++.+|++.||.+||++.|++++-
T Consensus 310 ~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp 344 (373)
T 2x4f_A 310 EEFQDISEEAKEFISKLLIKEKSWRISASEALKHP 344 (373)
T ss_dssp GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 11123345688999999999999999999999853
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=341.00 Aligned_cols=250 Identities=23% Similarity=0.270 Sum_probs=205.5
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeec--cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK--GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY 752 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 752 (973)
.++|++.+.||+|+||+||+|++..++..||+|++.. ....+.+.+|++++++++||||+++++++..++..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 4578999999999999999999999999999999876 34567889999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeee---cCCCCeEEecccCcccc
Q 002061 753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILL---DEDYEPKIADFGVAKIA 829 (973)
Q Consensus 753 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~Dfgl~~~~ 829 (973)
+++++|.+++... ..+++..+..++.|++.|++||| +++++||||||+||++ +.++.+||+|||++...
T Consensus 88 ~~~~~L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 88 CTGGELFERVVHK-----RVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp CCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred cCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 9999999998764 34889999999999999999999 7899999999999999 77889999999999866
Q ss_pred cCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhc
Q 002061 830 ENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVL 909 (973)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (973)
.... ......||+.|+|||++.+. ++.++||||+|+++|||++|+.||.... ...............
T Consensus 160 ~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~---- 226 (277)
T 3f3z_A 160 KPGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPT-----DSEVMLKIREGTFTF---- 226 (277)
T ss_dssp CTTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHCCCCC----
T ss_pred cCcc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHhCCCCC----
Confidence 5432 22335689999999998654 8999999999999999999999996531 111111111111100
Q ss_pred cccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 910 DCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 910 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
...........+.+++.+|++.||++||++.|++++
T Consensus 227 ----~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 227 ----PEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp ----CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ----CchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001111234568899999999999999999999875
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=349.93 Aligned_cols=254 Identities=24% Similarity=0.324 Sum_probs=195.3
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCC----e
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGG----S 745 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~ 745 (973)
.++|++.+.||+|+||+||+|++..+++.||||++... .....+.+|++++++++||||+++++++.... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46899999999999999999999999999999998653 22356889999999999999999999987654 3
Q ss_pred eEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccC
Q 002061 746 SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGV 825 (973)
Q Consensus 746 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl 825 (973)
.|+||||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 162 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGI 162 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSC
T ss_pred cEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccC
Confidence 49999999999999999764 35889999999999999999999 78999999999999999999999999999
Q ss_pred cccccCCCCc-ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccc
Q 002061 826 AKIAENSPKV-SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHEN 904 (973)
Q Consensus 826 ~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 904 (973)
++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..............
T Consensus 163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~-----~~~~~~~~~~~~~~ 237 (311)
T 3ork_A 163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS-----PVSVAYQHVREDPI 237 (311)
T ss_dssp C------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHCCCC
T ss_pred cccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHhcCCCC
Confidence 9866543221 22233568999999999999999999999999999999999999996531 11121111111111
Q ss_pred cchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 905 VLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
... .........+.+++.+||+.||++||++.+++++
T Consensus 238 ~~~--------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~ 274 (311)
T 3ork_A 238 PPS--------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA 274 (311)
T ss_dssp CHH--------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred Ccc--------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHH
Confidence 000 0011234568899999999999999977666544
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=354.28 Aligned_cols=262 Identities=26% Similarity=0.324 Sum_probs=207.7
Q ss_pred HcCCcccCcccccCceEEEEEE----ecCCCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeC--Ce
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLD----LKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKG--GS 745 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~----~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~ 745 (973)
..+|++.+.||+|+||+||+|+ ...+++.||||++... ...+.+.+|++++++++||||+++++++... ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 3468899999999999999999 4567899999998753 3457789999999999999999999999876 66
Q ss_pred eEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccC
Q 002061 746 SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGV 825 (973)
Q Consensus 746 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl 825 (973)
.++||||+++|+|.+++... ...+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKN----KNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGL 172 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHH----TTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred EEEEEEeCCCCcHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECcccc
Confidence 89999999999999999754 245899999999999999999999 78999999999999999999999999999
Q ss_pred cccccCCCCc-ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccC---------CcccHHHHH
Q 002061 826 AKIAENSPKV-SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYG---------DGKDIVYWV 895 (973)
Q Consensus 826 ~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~---------~~~~~~~~~ 895 (973)
+......... .......||..|+|||++.+..++.++||||+|+++|||++|..|+..... .........
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL 252 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence 9877544322 222345678899999999998999999999999999999999998754310 001111111
Q ss_pred HHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 896 STHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
....... .....+......+.+++.+||+.||.+|||+.|+++.|+.+
T Consensus 253 ~~~~~~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 253 VNTLKEG----------KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHHHHTT----------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhcc----------CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 1111110 11111223345688999999999999999999999999864
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=349.85 Aligned_cols=257 Identities=19% Similarity=0.275 Sum_probs=202.1
Q ss_pred HcCCcccCcccccCceEEEEEEecCCC-------cEEEEEeeec--cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCe
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNA-------GTVAVKQLWK--GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGS 745 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~-------~~vavK~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 745 (973)
.++|++.+.||+|+||+||+|++..++ ..||+|++.. ....+.+.+|++++++++||||+++++++..++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 457889999999999999999998766 4699998865 3455778999999999999999999999999999
Q ss_pred eEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCC--------
Q 002061 746 SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE-------- 817 (973)
Q Consensus 746 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~-------- 817 (973)
.++||||+++|+|.+++... ...+++..+..++.|++.||+||| +++|+||||||+||+++.++.
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKN----KNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHT----GGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred CEEEEECCCCCCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccce
Confidence 99999999999999999864 234889999999999999999999 789999999999999998887
Q ss_pred eEEecccCcccccCCCCcccccccCCcccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHH
Q 002061 818 PKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYT-CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVS 896 (973)
Q Consensus 818 ~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~ 896 (973)
+||+|||.+...... ....||+.|+|||++.+ ..++.++||||+||++|||++|..|+.... +......
T Consensus 160 ~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~----~~~~~~~ 229 (289)
T 4fvq_A 160 IKLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL----DSQRKLQ 229 (289)
T ss_dssp EEECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTS----CHHHHHH
T ss_pred eeeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcccc----chHHHHH
Confidence 999999998654321 22357889999999987 678999999999999999999654443221 1111111
Q ss_pred HHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCCCCCCC
Q 002061 897 THLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPCTDKSP 961 (973)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~~~ 961 (973)
... ...... . .....+.+++.+||+.||++|||+.|++++|+++..+....+
T Consensus 230 ~~~-~~~~~~----~--------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~~ 281 (289)
T 4fvq_A 230 FYE-DRHQLP----A--------PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPR 281 (289)
T ss_dssp HHH-TTCCCC----C--------CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-------
T ss_pred Hhh-ccCCCC----C--------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCCC
Confidence 111 111000 0 012347789999999999999999999999999987554433
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=369.83 Aligned_cols=261 Identities=28% Similarity=0.407 Sum_probs=205.5
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM 753 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 753 (973)
.++|++.+.||+|+||+||+|.+.. +..||||++... ...+.+.+|++++++++||||+++++++.+ +..|+||||+
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~ 260 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence 3567888999999999999999986 567999998763 356789999999999999999999999876 6789999999
Q ss_pred CCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCC
Q 002061 754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833 (973)
Q Consensus 754 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 833 (973)
++|+|.+++.... ...+++..+..++.|+++||+||| +++++||||||+||+++.++.+||+|||+++......
T Consensus 261 ~~gsL~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 261 SKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp TTCBHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred cCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 9999999997531 234789999999999999999999 7899999999999999999999999999998664332
Q ss_pred CcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhcccc
Q 002061 834 KVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCE 912 (973)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (973)
. .......++..|+|||++.+..++.++|||||||++|||++ |+.||.... .......+. ...
T Consensus 335 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~--~~~~~~~i~----~~~--------- 398 (452)
T 1fmk_A 335 Y-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVLDQVE----RGY--------- 398 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHH----TTC---------
T ss_pred e-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC--HHHHHHHHH----cCC---------
Confidence 1 12223456789999999998999999999999999999999 999996531 111111111 110
Q ss_pred ccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCCCCCC
Q 002061 913 VASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPCTDKS 960 (973)
Q Consensus 913 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~~ 960 (973)
....+......+.+++.+||+.||++|||+.++++.|+++.....+.
T Consensus 399 -~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~ 445 (452)
T 1fmk_A 399 -RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 445 (452)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCC
T ss_pred -CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCcc
Confidence 00111233456889999999999999999999999999987655443
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=354.90 Aligned_cols=248 Identities=29% Similarity=0.402 Sum_probs=201.9
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL 750 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 750 (973)
..|+..+.||+|+||+||+|++..+++.||||++... ...+.+.+|++++++++||||+++++++..++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588889999999999999999988999999998642 23456889999999999999999999999999999999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccccc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 830 (973)
||++ |++.+++... ...+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++....
T Consensus 134 e~~~-g~l~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205 (348)
T ss_dssp ECCS-EEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred ecCC-CCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence 9996 7888888653 345899999999999999999999 7899999999999999999999999999997654
Q ss_pred CCCCcccccccCCccccccccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccch
Q 002061 831 NSPKVSDYSCFAGTHGYIAPELAY---TCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLK 907 (973)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
.. ....||+.|+|||++. +..++.++|||||||++|||++|+.||.... .............
T Consensus 206 ~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~-----~~~~~~~~~~~~~---- 270 (348)
T 1u5q_A 206 PA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----AMSALYHIAQNES---- 270 (348)
T ss_dssp SB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-----HHHHHHHHHHSCC----
T ss_pred CC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHhcCC----
Confidence 32 2356899999999984 5678999999999999999999999996531 1111111111111
Q ss_pred hccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 002061 908 VLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952 (973)
Q Consensus 908 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~ 952 (973)
+.. ........+.+++.+||+.||++|||+.+++++..-
T Consensus 271 ---~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~ 309 (348)
T 1u5q_A 271 ---PAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 309 (348)
T ss_dssp ---CCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred ---CCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhh
Confidence 000 011223457889999999999999999999987553
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=344.01 Aligned_cols=251 Identities=22% Similarity=0.277 Sum_probs=202.7
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeC--CeeEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKG--GSSFL 748 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~l 748 (973)
.++|++.+.||+|+||+||+|++. ++.||||++... ...+.+.+|++++++++||||+++++++..+ ...++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 467899999999999999999986 789999998753 3345788999999999999999999999876 78899
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCC--eEecCCCCCCeeecCCCCeEEecccCc
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP--IIHRDIKSSNILLDEDYEPKIADFGVA 826 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~--ivH~Dlkp~Nill~~~~~~kl~Dfgl~ 826 (973)
||||+++|+|.+++... ....+++..+..++.|++.||+||| +.+ ++||||||+||+++.++.++++|||++
T Consensus 87 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~ 160 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEG---TNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVK 160 (271)
T ss_dssp EEECCTTCBHHHHHHSC---SSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSC
T ss_pred eecccCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccce
Confidence 99999999999999753 2335899999999999999999999 677 999999999999999999999999887
Q ss_pred ccccCCCCcccccccCCccccccccccccCCCCc---cchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccc
Q 002061 827 KIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSE---KSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHE 903 (973)
Q Consensus 827 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 903 (973)
..... ....||+.|+|||++.+..++. ++|||||||++|||++|+.||.... .............
T Consensus 161 ~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~~ 228 (271)
T 3kmu_A 161 FSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS-----NMEIGMKVALEGL 228 (271)
T ss_dssp CTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC-----HHHHHHHHHHSCC
T ss_pred eeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC-----hHHHHHHHHhcCC
Confidence 54322 2246799999999998765544 7999999999999999999996531 1111111111110
Q ss_pred ccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 002061 904 NVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADP 955 (973)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 955 (973)
....+......+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 229 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 229 ----------RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp ----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred ----------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 001112234568899999999999999999999999987653
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=348.83 Aligned_cols=253 Identities=22% Similarity=0.270 Sum_probs=208.3
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc--------cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCe
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD--------GVKVFAAEMEILGKIRHRNILKLYACLLKGGS 745 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 745 (973)
..++|++.+.||+|+||+||+|++..+++.||||++.... ..+.+.+|++++++++||||+++++++..+..
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 3567899999999999999999999999999999986532 35678999999999999999999999999999
Q ss_pred eEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCC----CeEEe
Q 002061 746 SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY----EPKIA 821 (973)
Q Consensus 746 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~----~~kl~ 821 (973)
.++||||+++++|.+++... ..+++..+..++.|++.||+||| +.+++||||||+||+++.++ .+||+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~ 161 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLI 161 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTC-----SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred EEEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEc
Confidence 99999999999999999742 35889999999999999999999 78999999999999999888 79999
Q ss_pred cccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcc
Q 002061 822 DFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNN 901 (973)
Q Consensus 822 Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 901 (973)
|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||... ............
T Consensus 162 Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-----~~~~~~~~i~~~ 233 (321)
T 2a2a_A 162 DFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD-----TKQETLANITSV 233 (321)
T ss_dssp CCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS-----SHHHHHHHHHTT
T ss_pred cCccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCC-----CHHHHHHHHHhc
Confidence 9999987654322 23356899999999999999999999999999999999999999653 111121111111
Q ss_pred ccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 902 HENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
... ............+.+++.+|++.||++|||+.|++++-
T Consensus 234 ~~~--------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp 274 (321)
T 2a2a_A 234 SYD--------FDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHP 274 (321)
T ss_dssp CCC--------CCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHST
T ss_pred ccc--------cChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence 110 00111122345688999999999999999999999864
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=365.35 Aligned_cols=248 Identities=25% Similarity=0.364 Sum_probs=206.4
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL 748 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 748 (973)
..++|++.+.||+|+||+||+|++..+|+.||||++... ...+.+.+|+++++.++||||+++++++..++..|+
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 93 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM 93 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 356899999999999999999999999999999998653 235678899999999999999999999999999999
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccc
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 828 (973)
||||+++|+|.+++.. ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++..
T Consensus 94 v~E~~~gg~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~ 165 (476)
T 2y94_A 94 VMEYVSGGELFDYICK-----NGRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNM 165 (476)
T ss_dssp EEECCSSEEHHHHTTS-----SSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhh
Confidence 9999999999999864 245899999999999999999999 88999999999999999999999999999987
Q ss_pred ccCCCCcccccccCCccccccccccccCCC-CccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccch
Q 002061 829 AENSPKVSDYSCFAGTHGYIAPELAYTCKV-SEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLK 907 (973)
Q Consensus 829 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
...... .....||+.|+|||++.+..+ +.++||||+||++|||++|+.||.... .. ............
T Consensus 166 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~--~~---~~~~~i~~~~~~--- 234 (476)
T 2y94_A 166 MSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH--VP---TLFKKICDGIFY--- 234 (476)
T ss_dssp CCTTCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS--SH---HHHHHHHTTCCC---
T ss_pred cccccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC--HH---HHHHHHhcCCcC---
Confidence 654322 233569999999999988766 689999999999999999999997541 11 111111111100
Q ss_pred hccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 908 VLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 908 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
.+......+.+++.+|++.||.+|||+.|+++|
T Consensus 235 ---------~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 235 ---------TPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp ---------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ---------CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 011123457889999999999999999999985
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=354.63 Aligned_cols=264 Identities=21% Similarity=0.294 Sum_probs=212.3
Q ss_pred HHHcCCcccCcccccCceEEEEEEec-----CCCcEEEEEeeeccc---cHHHHHHHHHHHHhcCCCceeeEEEEEEeCC
Q 002061 673 EQICNLEEDNLIGSGGTGKVYRLDLK-----KNAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGG 744 (973)
Q Consensus 673 ~~~~~~~~~~~lG~G~~g~V~~a~~~-----~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 744 (973)
...++|++.+.||+|+||+||+|++. .+++.||||++.... ....+.+|++++++++||||+++++++..++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 101 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 101 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence 34568999999999999999999886 357789999987532 3456889999999999999999999999999
Q ss_pred eeEEEEEccCCCchHHHHHhhhc-----CCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeE
Q 002061 745 SSFLVLEYMPNGNLFQALHKRVK-----EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPK 819 (973)
Q Consensus 745 ~~~lv~e~~~~gsL~~~l~~~~~-----~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k 819 (973)
..++||||+++|+|.+++..... .....+++..+..++.|++.||+||| +++|+||||||+||+++.++.+|
T Consensus 102 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~~~~k 178 (322)
T 1p4o_A 102 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVK 178 (322)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEE
T ss_pred ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCCCeEE
Confidence 99999999999999999976421 11245689999999999999999999 78999999999999999999999
Q ss_pred EecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHH
Q 002061 820 IADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTH 898 (973)
Q Consensus 820 l~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~ 898 (973)
|+|||+++...............+|+.|+|||++.+..++.++||||+|+++|||++ |+.||... .........
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-----~~~~~~~~~ 253 (322)
T 1p4o_A 179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL-----SNEQVLRFV 253 (322)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-----CHHHHHHHH
T ss_pred ECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC-----CHHHHHHHH
Confidence 999999986654333233334457889999999999899999999999999999999 89999653 111111111
Q ss_pred hccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 002061 899 LNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADP 955 (973)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 955 (973)
..... ..........+.+++.+||+.||++||++.|++++|++...
T Consensus 254 ~~~~~-----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 254 MEGGL-----------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HTTCC-----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HcCCc-----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 11100 00111234568889999999999999999999999998754
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=342.17 Aligned_cols=254 Identities=24% Similarity=0.307 Sum_probs=200.9
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL 750 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 750 (973)
..++|++.+.||+|+||+||+|++..++..||+|++... ...+.+.+|++++++++||||+++++++......++||
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 346789999999999999999999999999999998763 34578899999999999999999999999999999999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeee---cCCCCeEEecccCcc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILL---DEDYEPKIADFGVAK 827 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~Dfgl~~ 827 (973)
||+++|+|.+++..... ....+++..+..++.|+++||+||| +.+|+||||||+||++ +.++.+||+|||++.
T Consensus 100 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 100 ETCEGGELLERIVSAQA-RGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp CCCSCCBHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EeCCCCcHHHHHHhhhh-cccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 99999999999975422 2346899999999999999999999 7899999999999999 456789999999997
Q ss_pred cccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccch
Q 002061 828 IAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLK 907 (973)
Q Consensus 828 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
...... ......||+.|+|||++. ..++.++||||+|+++|||++|+.||.... ................
T Consensus 176 ~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~-----~~~~~~~~~~~~~~~~- 245 (285)
T 3is5_A 176 LFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS-----LEEVQQKATYKEPNYA- 245 (285)
T ss_dssp C-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHCCCCCC-
T ss_pred ecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC-----HHHHHhhhccCCcccc-
Confidence 654432 123356899999999875 568999999999999999999999996531 1111111111111000
Q ss_pred hccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 908 VLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 908 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
. ........+.+++.+|++.||++|||+.|++++
T Consensus 246 ---~-----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 246 ---V-----ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp ---C-------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred ---c-----ccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 000123457789999999999999999999975
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=347.72 Aligned_cols=260 Identities=28% Similarity=0.432 Sum_probs=194.7
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV 749 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 749 (973)
..++|++.+.||+|+||+||+|++.. .||||++... ...+.+.+|++++++++||||+++++++ .....++|
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv 97 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV 97 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence 34679999999999999999998753 5999988642 3446788999999999999999999964 55678999
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccc
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 829 (973)
|||+++++|.+++... ...+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++...
T Consensus 98 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 98 TQWCEGSSLYHHLHAS----ETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170 (289)
T ss_dssp EECCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred EEecCCCcHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceecccc
Confidence 9999999999998643 345899999999999999999999 789999999999999999999999999999766
Q ss_pred cCCCCcccccccCCccccccccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccc
Q 002061 830 ENSPKVSDYSCFAGTHGYIAPELAY---TCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVL 906 (973)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 906 (973)
.............||+.|+|||++. +..++.++||||+|+++|||++|+.||..... .......+..... ....
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-~~~~~~~~~~~~~-~~~~- 247 (289)
T 3og7_A 171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN-RDQIIEMVGRGSL-SPDL- 247 (289)
T ss_dssp -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC-HHHHHHHHHHTSC-CCCT-
T ss_pred ccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch-HHHHHHHhccccc-Ccch-
Confidence 5433333334457899999999986 66788899999999999999999999975421 1111222111110 0000
Q ss_pred hhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 002061 907 KVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADP 955 (973)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 955 (973)
..........+.+++.+||+.||++||++.|+++.|+++..
T Consensus 248 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 248 --------SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp --------TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred --------hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 01112234568899999999999999999999999998753
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=354.80 Aligned_cols=263 Identities=23% Similarity=0.225 Sum_probs=204.7
Q ss_pred HHHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-------ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCC
Q 002061 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-------DGVKVFAAEMEILGKIRHRNILKLYACLLKGG 744 (973)
Q Consensus 672 ~~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 744 (973)
....++|++.+.||+|+||+||+|++..+++.||||++... ...+.+.+|++++++++||||+++++++.+++
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 45567899999999999999999999999999999988642 34567899999999999999999999999999
Q ss_pred eeEEEEEccCCCchHHHHHhhhcCC-----------------------------------CCCCCHHHHHHHHHHHHHHH
Q 002061 745 SSFLVLEYMPNGNLFQALHKRVKEG-----------------------------------KPELDWFRRYKIALGAAKGI 789 (973)
Q Consensus 745 ~~~lv~e~~~~gsL~~~l~~~~~~~-----------------------------------~~~~~~~~~~~i~~~ia~~l 789 (973)
..++||||+++|+|.+++....... ...+++..+..++.|+++||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 9999999999999999985321110 11235677888999999999
Q ss_pred hhhhhcCCCCeEecCCCCCCeeecCCC--CeEEecccCcccccCCCC--cccccccCCcccccccccccc--CCCCccch
Q 002061 790 AYLHHDCSPPIIHRDIKSSNILLDEDY--EPKIADFGVAKIAENSPK--VSDYSCFAGTHGYIAPELAYT--CKVSEKSD 863 (973)
Q Consensus 790 ~~LH~~~~~~ivH~Dlkp~Nill~~~~--~~kl~Dfgl~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~~~~~D 863 (973)
+||| +.+|+||||||+||+++.++ .+||+|||+++....... ........||+.|+|||++.+ ..++.++|
T Consensus 182 ~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 182 HYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence 9999 78999999999999998776 899999999986643221 112334578999999999875 67899999
Q ss_pred HHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCH
Q 002061 864 VFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPM 943 (973)
Q Consensus 864 vwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~ 943 (973)
||||||++|||++|+.||.... .............. ............+.+++.+|++.||.+||++
T Consensus 259 iwslG~il~el~~g~~pf~~~~-----~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 325 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPGVN-----DADTISQVLNKKLC--------FENPNYNVLSPLARDLLSNLLNRNVDERFDA 325 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHCCCC--------TTSGGGGGSCHHHHHHHHHHSCSCTTTSCCH
T ss_pred HHHHHHHHHHHHHCCCCCCCCC-----hHHHHHHHHhcccc--------cCCcccccCCHHHHHHHHHHcCCChhHCCCH
Confidence 9999999999999999996541 11111111111110 0011112234568899999999999999999
Q ss_pred HHHHHHh
Q 002061 944 REVVKML 950 (973)
Q Consensus 944 ~evl~~L 950 (973)
.|++++-
T Consensus 326 ~~~l~hp 332 (345)
T 3hko_A 326 MRALQHP 332 (345)
T ss_dssp HHHHHSH
T ss_pred HHHhcCh
Confidence 9999863
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=356.11 Aligned_cols=267 Identities=18% Similarity=0.230 Sum_probs=203.0
Q ss_pred HHcCCcccCcccccCceEEEEEEecCC-----CcEEEEEeeecccc-------------HHHHHHHHHHHHhcCCCceee
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKN-----AGTVAVKQLWKGDG-------------VKVFAAEMEILGKIRHRNILK 735 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~-----~~~vavK~~~~~~~-------------~~~~~~E~~~l~~l~hpniv~ 735 (973)
...+|++.+.||+|+||+||+|.+..+ ++.||||++..... ...+.+|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 445899999999999999999998764 57899999865321 112334555666778999999
Q ss_pred EEEEEEeC----CeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCee
Q 002061 736 LYACLLKG----GSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNIL 811 (973)
Q Consensus 736 l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nil 811 (973)
+++++... ...|+||||+ +++|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+|||
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nil 184 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN----AKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLL 184 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEE
Confidence 99998764 4589999999 99999999753 346899999999999999999999 789999999999999
Q ss_pred ec--CCCCeEEecccCcccccCCCCcc-----cccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcc
Q 002061 812 LD--EDYEPKIADFGVAKIAENSPKVS-----DYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEE 884 (973)
Q Consensus 812 l~--~~~~~kl~Dfgl~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~ 884 (973)
++ .++.+||+|||+++......... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 185 l~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~ 264 (364)
T 3op5_A 185 LNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN 264 (364)
T ss_dssp EESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 99 88999999999997664322111 113345999999999999999999999999999999999999999864
Q ss_pred cCCcccHHHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 002061 885 YGDGKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADAD 954 (973)
Q Consensus 885 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 954 (973)
..+. .......... ...+..+.+..... ...+..+.+++..||+.||++||++.++++.|+++.
T Consensus 265 ~~~~-~~~~~~~~~~--~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~ 328 (364)
T 3op5_A 265 LKDP-KYVRDSKIRY--RENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGL 328 (364)
T ss_dssp TTCH-HHHHHHHHHH--HHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred ccCH-HHHHHHHHHh--hhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence 3221 1111111111 11122222221110 122456888999999999999999999999988653
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=359.56 Aligned_cols=255 Identities=22% Similarity=0.285 Sum_probs=196.7
Q ss_pred HHcCCccc-CcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHh-cCCCceeeEEEEEEe----CCeeE
Q 002061 674 QICNLEED-NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGK-IRHRNILKLYACLLK----GGSSF 747 (973)
Q Consensus 674 ~~~~~~~~-~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~-l~hpniv~l~~~~~~----~~~~~ 747 (973)
..++|.+. +.||+|+||+||+|++..+++.||||++... ..+.+|++++.+ .+||||+++++++.. +...|
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc---hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 34567776 6899999999999999999999999998643 456788988754 589999999999875 56789
Q ss_pred EEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecC---CCCeEEeccc
Q 002061 748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE---DYEPKIADFG 824 (973)
Q Consensus 748 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~Dfg 824 (973)
+||||+++|+|.+++... ....+++..+..++.|++.||+||| +.+|+||||||+||+++. ++.+||+|||
T Consensus 136 lv~E~~~gg~L~~~l~~~---~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEECCCSEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEeCCCCcHHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEecc
Confidence 999999999999999753 2345899999999999999999999 789999999999999997 7899999999
Q ss_pred CcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcc--cHHHHHHHHhccc
Q 002061 825 VAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGK--DIVYWVSTHLNNH 902 (973)
Q Consensus 825 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~--~~~~~~~~~~~~~ 902 (973)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .....+......
T Consensus 210 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~- 285 (400)
T 1nxk_A 210 FAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE- 285 (400)
T ss_dssp TCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCC-
T ss_pred cccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCccc-
Confidence 998654322 22345689999999999999999999999999999999999999976532211 122221111000
Q ss_pred cccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 903 ENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
............+.+++.+||+.||++|||+.|+++|-.
T Consensus 286 ----------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 324 (400)
T 1nxk_A 286 ----------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 324 (400)
T ss_dssp ----------CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred ----------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 000111223456889999999999999999999999754
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=354.67 Aligned_cols=255 Identities=17% Similarity=0.153 Sum_probs=207.1
Q ss_pred HcCCcccCcccccCceEEEEEE-----ecCCCcEEEEEeeeccccHHHHHHHHHHHHhcC---CCceeeEEEEEEeCCee
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLD-----LKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIR---HRNILKLYACLLKGGSS 746 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~-----~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~ 746 (973)
..+|++.+.||+|+||+||+|. ...+++.||||++... ....+.+|++++++++ |+||+++++++..++..
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~ 142 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGS 142 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCE
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCc
Confidence 3578999999999999999994 5667899999998654 4557788999988886 99999999999999999
Q ss_pred EEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecC-----------C
Q 002061 747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE-----------D 815 (973)
Q Consensus 747 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~-----------~ 815 (973)
|+||||+++|+|.+++..........+++..+..++.|+++||+||| +.+|+||||||+|||++. +
T Consensus 143 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~~~~~ 219 (365)
T 3e7e_A 143 VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLS 219 (365)
T ss_dssp EEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC------C
T ss_pred EEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCcccccccc
Confidence 99999999999999998764445567999999999999999999999 889999999999999998 8
Q ss_pred CCeEEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHH
Q 002061 816 YEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWV 895 (973)
Q Consensus 816 ~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~ 895 (973)
+.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 220 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~----- 294 (365)
T 3e7e_A 220 AGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK----- 294 (365)
T ss_dssp TTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE-----
T ss_pred CCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee-----
Confidence 999999999997665433334445567999999999999999999999999999999999999999654221000
Q ss_pred HHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHhhcCC
Q 002061 896 STHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLR-PPMREVVKMLADAD 954 (973)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R-pt~~evl~~L~~~~ 954 (973)
. ........ ..+.+.+++..|++.+|.+| |+++++.+.|++..
T Consensus 295 ---------~----~~~~~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l 338 (365)
T 3e7e_A 295 ---------P----EGLFRRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338 (365)
T ss_dssp ---------E----CSCCTTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred ---------e----chhccccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence 0 01111111 13346678889999999998 67888888777653
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=353.03 Aligned_cols=263 Identities=22% Similarity=0.240 Sum_probs=205.6
Q ss_pred HHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeec-cccHHHHHHHHHHHHhcC-----CCceeeEEEEEEeCCee
Q 002061 673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK-GDGVKVFAAEMEILGKIR-----HRNILKLYACLLKGGSS 746 (973)
Q Consensus 673 ~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~-~~~~~~~~~E~~~l~~l~-----hpniv~l~~~~~~~~~~ 746 (973)
...++|++.+.||+|+||+||+|++..+++.||||++.. ....+.+.+|+++++.+. ||||+++++++...+..
T Consensus 32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~ 111 (360)
T 3llt_A 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHM 111 (360)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEE
T ss_pred EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCee
Confidence 445789999999999999999999998899999999875 334556788999999986 99999999999999999
Q ss_pred EEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecC------------
Q 002061 747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE------------ 814 (973)
Q Consensus 747 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~------------ 814 (973)
++||||+ +++|.+++... ....+++..+..++.|++.||+||| +.+|+||||||+||+++.
T Consensus 112 ~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~~~~~~ 184 (360)
T 3llt_A 112 CLIFEPL-GPSLYEIITRN---NYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRR 184 (360)
T ss_dssp EEEECCC-CCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCCEEEEEEEC
T ss_pred EEEEcCC-CCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEccccccccccchhc
Confidence 9999999 99999999864 2335889999999999999999999 789999999999999975
Q ss_pred -------------CCCeEEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCC
Q 002061 815 -------------DYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPV 881 (973)
Q Consensus 815 -------------~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf 881 (973)
++.+||+|||+++...... ....||+.|+|||++.+..++.++||||+||++|||++|+.||
T Consensus 185 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf 259 (360)
T 3llt_A 185 VTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLF 259 (360)
T ss_dssp TTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred ccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCC
Confidence 7899999999998654321 2356899999999999999999999999999999999999999
Q ss_pred CcccCCcccHHHHHHHHhccccc----------cchhcccc--------cc-------------CcchHHHHHHHHHHHH
Q 002061 882 EEEYGDGKDIVYWVSTHLNNHEN----------VLKVLDCE--------VA-------------SESIKEDMIKLLKIAV 930 (973)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~--------~~-------------~~~~~~~~~~l~~l~~ 930 (973)
.... ..+....+.......+. .....+.. .. ..........+.+++.
T Consensus 260 ~~~~--~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 337 (360)
T 3llt_A 260 RTHE--HMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLY 337 (360)
T ss_dssp CCSS--HHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHH
T ss_pred CCCc--HHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHH
Confidence 7531 11111111111110000 00000000 00 0000111256789999
Q ss_pred HhcCCCCCCCCCHHHHHHH
Q 002061 931 VCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 931 ~cl~~dP~~Rpt~~evl~~ 949 (973)
+||+.||++|||+.|+++|
T Consensus 338 ~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 338 SILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HHCCSSGGGSCCHHHHTTS
T ss_pred HHhcCChhhCCCHHHHhcC
Confidence 9999999999999999875
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=347.29 Aligned_cols=268 Identities=26% Similarity=0.350 Sum_probs=206.6
Q ss_pred HHHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhc--CCCceeeEEEEEEeC----Ce
Q 002061 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKI--RHRNILKLYACLLKG----GS 745 (973)
Q Consensus 672 ~~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l--~hpniv~l~~~~~~~----~~ 745 (973)
....++|++.+.||+|+||+||+|++. ++.||||++.... ...+.+|.+++... +||||+++++++... ..
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE-EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc-cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 344578999999999999999999986 8899999986543 34455666666554 899999999999887 78
Q ss_pred eEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCC--------CeEecCCCCCCeeecCCCC
Q 002061 746 SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP--------PIIHRDIKSSNILLDEDYE 817 (973)
Q Consensus 746 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~--------~ivH~Dlkp~Nill~~~~~ 817 (973)
.|+||||+++|+|.++++.. .+++..+..++.|++.||+||| +. +|+||||||+||+++.++.
T Consensus 110 ~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 180 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKST------TLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNGT 180 (337)
T ss_dssp EEEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred eEEEEeccCCCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCCC
Confidence 89999999999999999753 4889999999999999999999 66 9999999999999999999
Q ss_pred eEEecccCcccccCCCCccc--ccccCCccccccccccccCCCCcc------chHHHHHHHHHHHHhC----------CC
Q 002061 818 PKIADFGVAKIAENSPKVSD--YSCFAGTHGYIAPELAYTCKVSEK------SDVFSFGVVLLELVTG----------RK 879 (973)
Q Consensus 818 ~kl~Dfgl~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~------~DvwslG~~l~el~tg----------~~ 879 (973)
+||+|||+++.......... .....||+.|+|||++.+..++.+ +|||||||++|||++| +.
T Consensus 181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~ 260 (337)
T 3mdy_A 181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260 (337)
T ss_dssp EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence 99999999976644322211 223579999999999987766655 9999999999999999 66
Q ss_pred CCCcccCCcccHHHHHHHHhccccccchhccccccC-cchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCCC
Q 002061 880 PVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVAS-ESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPCT 957 (973)
Q Consensus 880 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 957 (973)
||..................... ..+.... ....+....+.+++.+||+.||++|||+.|++++|+.+....
T Consensus 261 p~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 261 PYHDLVPSDPSYEDMREIVCIKK------LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSC------CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred cHhhhcCCCCchhhhHHHHhhhc------cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 66554333333332222221111 0111111 112356778999999999999999999999999999876443
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=343.55 Aligned_cols=264 Identities=18% Similarity=0.175 Sum_probs=210.9
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhcCCCceeeEEEEE-EeCCeeEEEEEcc
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACL-LKGGSSFLVLEYM 753 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~-~~~~~~~lv~e~~ 753 (973)
.++|++.+.||+|+||+||+|++..+++.||||++......+.+.+|+++++.++|++++..+.++ ..+...++||||+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence 468999999999999999999999889999999988766667889999999999988766665554 6677889999999
Q ss_pred CCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeec---CCCCeEEecccCccccc
Q 002061 754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD---EDYEPKIADFGVAKIAE 830 (973)
Q Consensus 754 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~---~~~~~kl~Dfgl~~~~~ 830 (973)
+++|.+++... ...+++..+..++.|++.||+||| +++++||||||+||+++ .++.+||+|||++....
T Consensus 88 -~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 88 -GPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp -CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred -CCCHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99999999753 335899999999999999999999 78999999999999994 78899999999998765
Q ss_pred CCCCc-----ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCC-cccHHHHHHH-Hhcccc
Q 002061 831 NSPKV-----SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGD-GKDIVYWVST-HLNNHE 903 (973)
Q Consensus 831 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~-~~~~~~~~~~-~~~~~~ 903 (973)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .......+.. ......
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence 43321 1123457899999999999999999999999999999999999999864321 1122221111 111100
Q ss_pred ccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCCC
Q 002061 904 NVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPCT 957 (973)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 957 (973)
. .........+.+++.+||+.||++||++.++++.|+++....
T Consensus 240 ---~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 240 ---E--------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp ---H--------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ---H--------HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 0 001122356889999999999999999999999999875433
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=347.69 Aligned_cols=264 Identities=22% Similarity=0.310 Sum_probs=200.8
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc----cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL 750 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 750 (973)
+++|++.+.||+|+||+||+|++..+++.||||++.... ..+.+.+|++++++++||||+++++++..++..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 468999999999999999999999999999999886532 2456788999999999999999999999999999999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccccc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 830 (973)
||+++++|.+++... ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||.+....
T Consensus 82 e~~~~~~l~~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 153 (311)
T 4agu_A 82 EYCDHTVLHELDRYQ-----RGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLT 153 (311)
T ss_dssp ECCSEEHHHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EeCCCchHHHHHhhh-----cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhcc
Confidence 999999998887642 35889999999999999999999 7899999999999999999999999999998665
Q ss_pred CCCCcccccccCCcccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccc-------
Q 002061 831 NSPKVSDYSCFAGTHGYIAPELAYT-CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNH------- 902 (973)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~------- 902 (973)
.... ......||+.|+|||++.+ ..++.++||||+|+++|+|++|+.||.... ..+....+.......
T Consensus 154 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 229 (311)
T 4agu_A 154 GPSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKS--DVDQLYLIRKTLGDLIPRHQQV 229 (311)
T ss_dssp --------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCSCCHHHHHH
T ss_pred Cccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhcccccccccc
Confidence 3322 2233568999999999876 668999999999999999999999996542 111111111111100
Q ss_pred ----cccc--hhccccccCc---chHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 903 ----ENVL--KVLDCEVASE---SIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 903 ----~~~~--~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
.... ...++..... ........+.+++.+||+.||++|||+.|+++|-
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 286 (311)
T 4agu_A 230 FSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHP 286 (311)
T ss_dssp HHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSG
T ss_pred cccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcCh
Confidence 0000 0000000000 0122345688999999999999999999999873
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=367.19 Aligned_cols=350 Identities=17% Similarity=0.144 Sum_probs=284.0
Q ss_pred cceEEccCCcCCCCCCcccccCCCCCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCchhhhccccccEEEee
Q 002061 170 LVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELY 249 (973)
Q Consensus 170 L~~L~l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~ 249 (973)
-+.++.+++.+. .+|..+. +++++|+|++|++++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|+
T Consensus 13 ~~~v~c~~~~l~--~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~ 88 (477)
T 2id5_A 13 DRAVLCHRKRFV--AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLR 88 (477)
T ss_dssp TTEEECCSCCCS--SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCEEEeCCCCcC--cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECC
Confidence 357888888876 5677664 689999999999998889999999999999999999998889999999999999999
Q ss_pred ccccCCcCCccccccccccEEEeeccccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeeccCCccCCCC
Q 002061 250 ANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPF 329 (973)
Q Consensus 250 ~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 329 (973)
+|++++..+..|.++++|++|+|++|++.+..|..|.++++|+.|++++|.+.+..+..|..+++|+.|++++|++++..
T Consensus 89 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 168 (477)
T 2id5_A 89 SNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIP 168 (477)
T ss_dssp SSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCC
T ss_pred CCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccC
Confidence 99999766677899999999999999999999999999999999999999999998999999999999999999999888
Q ss_pred CccccccccccccccccccccccCChhhhhhhhHHHHHhhhccCCCCccccccCccccceEeccccccccCCCccccCCC
Q 002061 330 PENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALP 409 (973)
Q Consensus 330 ~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 409 (973)
+..+..+++|+.|+|++|.+++. .+..|..+++|++|++++|.+.+.+|......
T Consensus 169 ~~~l~~l~~L~~L~l~~n~i~~~------------------------~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~- 223 (477)
T 2id5_A 169 TEALSHLHGLIVLRLRHLNINAI------------------------RDYSFKRLYRLKVLEISHWPYLDTMTPNCLYG- 223 (477)
T ss_dssp HHHHTTCTTCCEEEEESCCCCEE------------------------CTTCSCSCTTCCEEEEECCTTCCEECTTTTTT-
T ss_pred hhHhcccCCCcEEeCCCCcCcEe------------------------ChhhcccCcccceeeCCCCccccccCcccccC-
Confidence 88899999999999999999843 23467788999999999998776666554333
Q ss_pred CcceEeccCCcCCCCCCCCCCCCCCCCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCccccccccccCCEEEcC
Q 002061 410 NVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLE 489 (973)
Q Consensus 410 ~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 489 (973)
.+|+.|+|++|++++..+..+..+++|+.|+|++|++++..+..|..+++|++|+|+
T Consensus 224 -----------------------~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 280 (477)
T 2id5_A 224 -----------------------LNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLV 280 (477)
T ss_dssp -----------------------CCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECC
T ss_pred -----------------------ccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECC
Confidence 356666666666664444567777777777777777776666677777777777777
Q ss_pred CcccccCCCccccccccccchhccccccccCCCccccccCCCCeeecCCCccCCCCChhhhcccCceEEccCCccccccC
Q 002061 490 ENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSGSVP 569 (973)
Q Consensus 490 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~L~~l~ls~N~l~~~~p 569 (973)
+|++++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|+++...+.....-....+++.+|...|..|
T Consensus 281 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p 360 (477)
T 2id5_A 281 GGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATP 360 (477)
T ss_dssp SSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEES
T ss_pred CCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccchHhHHhhhhccccCccCceeCCc
Confidence 77777777777777777777777777777666667777788888888888887543322111123445667778888777
Q ss_pred cc
Q 002061 570 LD 571 (973)
Q Consensus 570 ~~ 571 (973)
..
T Consensus 361 ~~ 362 (477)
T 2id5_A 361 EF 362 (477)
T ss_dssp GG
T ss_pred hH
Confidence 54
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=353.03 Aligned_cols=245 Identities=27% Similarity=0.345 Sum_probs=205.5
Q ss_pred HHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc----------cHHHHHHHHHHHHhcCCCceeeEEEEEEe
Q 002061 673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----------GVKVFAAEMEILGKIRHRNILKLYACLLK 742 (973)
Q Consensus 673 ~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----------~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 742 (973)
...++|++.+.||+|+||+||+|++..+++.||||++.... ..+.+.+|++++++++||||+++++++..
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 45678999999999999999999999999999999987632 23456789999999999999999999999
Q ss_pred CCeeEEEEEccCCC-chHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEe
Q 002061 743 GGSSFLVLEYMPNG-NLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIA 821 (973)
Q Consensus 743 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 821 (973)
++..++||||+.+| +|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~ 172 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRH-----PRLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLI 172 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTC-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEEC
T ss_pred CCEEEEEEEeCCCCccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEe
Confidence 99999999999777 999998753 35899999999999999999999 7899999999999999999999999
Q ss_pred cccCcccccCCCCcccccccCCccccccccccccCCC-CccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhc
Q 002061 822 DFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKV-SEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLN 900 (973)
Q Consensus 822 Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 900 (973)
|||++........ .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... ..
T Consensus 173 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----------~~- 237 (335)
T 3dls_A 173 DFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-----------TV- 237 (335)
T ss_dssp CCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-----------GT-
T ss_pred ecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-----------HH-
Confidence 9999987654322 223568999999999988876 7899999999999999999999965311 00
Q ss_pred cccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 901 NHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
...... +......+.+++.+||++||++|||+.|++++-.
T Consensus 238 -----~~~~~~------~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~ 277 (335)
T 3dls_A 238 -----EAAIHP------PYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPW 277 (335)
T ss_dssp -----TTCCCC------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTT
T ss_pred -----hhccCC------CcccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 000000 0112346889999999999999999999999854
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=356.39 Aligned_cols=251 Identities=24% Similarity=0.332 Sum_probs=194.4
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCC--CceeeEEEEEEeCCeeEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRH--RNILKLYACLLKGGSSFLV 749 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~~~~lv 749 (973)
.+|++.+.||+|+||+||+|.+.. ++.||||++... ...+.+.+|++++++++| |||+++++++..+...|+|
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECTT-SCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEeCC-CCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 468999999999999999999864 889999998653 234668899999999976 9999999999999999999
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccc
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 829 (973)
||+ .+|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++ ++.+||+|||+++..
T Consensus 88 ~e~-~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 88 MEC-GNIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp ECC-CSEEHHHHHHHS-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred EeC-CCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 995 588999999853 35889999999999999999999 78999999999999997 678999999999876
Q ss_pred cCCCCcccccccCCcccccccccccc-----------CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHH
Q 002061 830 ENSPKVSDYSCFAGTHGYIAPELAYT-----------CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTH 898 (973)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~ 898 (973)
.............||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... . .......
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~-~~~~~~~ 233 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN---Q-ISKLHAI 233 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS---H-HHHHHHH
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh---H-HHHHHHH
Confidence 54433333344679999999999864 6788999999999999999999999975321 1 1111111
Q ss_pred hccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 899 LNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
.. +......+......+.+++.+||+.||.+|||+.|++++..
T Consensus 234 ~~----------~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~ 276 (343)
T 3dbq_A 234 ID----------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 276 (343)
T ss_dssp HC----------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred hc----------CCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence 11 11111111111245788999999999999999999998754
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=357.21 Aligned_cols=262 Identities=27% Similarity=0.300 Sum_probs=209.3
Q ss_pred cCCcccCcccccCceEEEEEE----ecCCCcEEEEEeeecc--ccHHHHHHHHHHHHhcCCCceeeEEEEEE--eCCeeE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLD----LKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLL--KGGSSF 747 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~----~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~--~~~~~~ 747 (973)
.+|++.+.||+|+||+||+|+ ...+++.||||++... ...+.+.+|++++++++||||+++++++. .....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 578899999999999999999 4567899999998763 34456899999999999999999999886 456789
Q ss_pred EEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcc
Q 002061 748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827 (973)
Q Consensus 748 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~ 827 (973)
+||||+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.
T Consensus 103 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRH----RARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEECCTTCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred EEEeecCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccce
Confidence 999999999999999864 235899999999999999999999 7899999999999999999999999999998
Q ss_pred cccCCCCc-ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCC----------cccHHHHHH
Q 002061 828 IAENSPKV-SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGD----------GKDIVYWVS 896 (973)
Q Consensus 828 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~----------~~~~~~~~~ 896 (973)
........ .......||..|+|||++.+..++.++||||||+++|+|++|+.||.....+ ........
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 254 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL- 254 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH-
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH-
Confidence 76543322 1223356788999999999888999999999999999999999999653210 00001111
Q ss_pred HHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 002061 897 THLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADP 955 (973)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 955 (973)
+.................+.+++.+||+.||++|||+.|++++|+.+..
T Consensus 255 ----------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 255 ----------ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp ----------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred ----------HHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1111111111223345668899999999999999999999999998754
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=348.04 Aligned_cols=250 Identities=25% Similarity=0.312 Sum_probs=196.4
Q ss_pred HcCCcccCcccccCceEEEEEEec---CCCcEEEEEeeecc------ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCe
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLK---KNAGTVAVKQLWKG------DGVKVFAAEMEILGKIRHRNILKLYACLLKGGS 745 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~---~~~~~vavK~~~~~------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 745 (973)
.++|++.+.||+|+||+||+|+.. .+++.||||++... .....+.+|++++++++||||+++++++..++.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 467899999999999999999985 57899999998753 234557889999999999999999999999999
Q ss_pred eEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccC
Q 002061 746 SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGV 825 (973)
Q Consensus 746 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl 825 (973)
.|+||||+++|+|.+++... ..+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 167 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE-----GIFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGL 167 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred EEEEEeCCCCCcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCc
Confidence 99999999999999999764 34788899999999999999999 78999999999999999999999999999
Q ss_pred cccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccccc
Q 002061 826 AKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENV 905 (973)
Q Consensus 826 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 905 (973)
++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..............
T Consensus 168 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~~~~~~i~~~~~~- 239 (327)
T 3a62_A 168 CKESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN-----RKKTIDKILKCKLN- 239 (327)
T ss_dssp C------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHTCCC-
T ss_pred ccccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHhCCCC-
Confidence 875432211 1233568999999999999999999999999999999999999996531 11121111111110
Q ss_pred chhccccccCcchHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHhh
Q 002061 906 LKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRP-----PMREVVKMLA 951 (973)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~L~ 951 (973)
. +......+.+++.+||+.||.+|| ++.|+++|-.
T Consensus 240 -------~----p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~ 279 (327)
T 3a62_A 240 -------L----PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPF 279 (327)
T ss_dssp -------C----CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGG
T ss_pred -------C----CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCc
Confidence 0 112234678899999999999999 7889987643
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=344.46 Aligned_cols=264 Identities=18% Similarity=0.175 Sum_probs=206.1
Q ss_pred HHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhcCCCceeeEEEEE-EeCCeeEEEEE
Q 002061 673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACL-LKGGSSFLVLE 751 (973)
Q Consensus 673 ~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~-~~~~~~~lv~e 751 (973)
...++|++.+.||+|+||+||+|++..+++.||||+.......+.+.+|+++++.++|++++..+.++ ..++..++|||
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 34568999999999999999999999899999999887766666788999999999888776666554 67788899999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeee---cCCCCeEEecccCccc
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILL---DEDYEPKIADFGVAKI 828 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~Dfgl~~~ 828 (973)
|+ +++|.+++... ...+++..+..++.|++.||+||| +++|+||||||+||++ +.++.+||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 86 LL-GPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp CC-CCBHHHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred cc-CCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 99 99999999753 335899999999999999999999 7899999999999999 7889999999999987
Q ss_pred ccCCCCc-----ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCc-ccHHHHH-HHHhcc
Q 002061 829 AENSPKV-----SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDG-KDIVYWV-STHLNN 901 (973)
Q Consensus 829 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~-~~~~~~~-~~~~~~ 901 (973)
....... .......||+.|+|||++.+..++.++||||+||++|||++|+.||....... ......+ ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence 6543321 12234578999999999999999999999999999999999999997643221 1111111 111111
Q ss_pred ccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 002061 902 HENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADP 955 (973)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 955 (973)
.. . .........+.+++.+||+.||++||++.++++.|+++..
T Consensus 238 ~~---~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 238 PI---E--------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp CH---H--------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred hh---h--------hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 00 0 0001123568899999999999999999999999997643
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=342.03 Aligned_cols=251 Identities=28% Similarity=0.381 Sum_probs=186.2
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV 749 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 749 (973)
+++|++.+.||+|+||+||+|++..+++.||||++... ...+.+.+|++++++++||||+++++++.+++..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 46789999999999999999999888999999998653 2346788999999999999999999999999999999
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccc
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 829 (973)
|||+++++|.+++... ...+++..+..++.|+++|++||| +.+++||||||+||+++.++.+||+|||.+...
T Consensus 90 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 162 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNR----VKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQL 162 (278)
T ss_dssp EECCTTEEHHHHHHTC----SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EecCCCCcHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeec
Confidence 9999999999999753 346899999999999999999999 789999999999999999999999999999866
Q ss_pred cCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhc
Q 002061 830 ENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVL 909 (973)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (973)
..... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||....... .... ..
T Consensus 163 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~----------~~ 225 (278)
T 3cok_A 163 KMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN-----TLNK----------VV 225 (278)
T ss_dssp C------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CC
T ss_pred cCCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH-----HHHH----------Hh
Confidence 43221 1223468999999999998889999999999999999999999997542110 0000 00
Q ss_pred cccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 910 DCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 910 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
.... ..+......+.+++.+|++.||++||++.+++++-.
T Consensus 226 ~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 265 (278)
T 3cok_A 226 LADY--EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPF 265 (278)
T ss_dssp SSCC--CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTT
T ss_pred hccc--CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCcc
Confidence 0000 011122346788999999999999999999998643
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=359.95 Aligned_cols=251 Identities=23% Similarity=0.327 Sum_probs=195.7
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcC--CCceeeEEEEEEeCCeeEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIR--HRNILKLYACLLKGGSSFLV 749 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~~~~~lv 749 (973)
.+|++.+.||+|+||+||+|.+.. ++.||||++... ...+.+.+|++++++++ ||||+++++++..++..|+|
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 458999999999999999999876 889999998653 23467889999999996 59999999999999999999
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccc
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 829 (973)
|| +.+++|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+|||++ ++.+||+|||+++..
T Consensus 135 ~E-~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~ 204 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 204 (390)
T ss_dssp EE-CCSEEHHHHHHHC-----SSCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC
T ss_pred Ee-cCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccc
Confidence 99 5688999999853 35788899999999999999999 88999999999999995 589999999999876
Q ss_pred cCCCCcccccccCCcccccccccccc-----------CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHH
Q 002061 830 ENSPKVSDYSCFAGTHGYIAPELAYT-----------CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTH 898 (973)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~ 898 (973)
.............||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ........
T Consensus 205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~----~~~~~~~~ 280 (390)
T 2zmd_A 205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN----QISKLHAI 280 (390)
T ss_dssp ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC----HHHHHHHH
T ss_pred cCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH----HHHHHHHH
Confidence 54433223344579999999999865 3688999999999999999999999965321 11111111
Q ss_pred hccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 899 LNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
.... .....+......+.+++.+||+.||.+||++.|++++..
T Consensus 281 ~~~~----------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~ 323 (390)
T 2zmd_A 281 IDPN----------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 323 (390)
T ss_dssp HCTT----------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred hCcc----------ccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcC
Confidence 1111 100011111345788999999999999999999998743
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=355.04 Aligned_cols=263 Identities=28% Similarity=0.365 Sum_probs=208.9
Q ss_pred HcCCcccCcccccCceEEEEEEe-----cCCCcEEEEEeeeccc---cHHHHHHHHHHHHhc-CCCceeeEEEEEEeCC-
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDL-----KKNAGTVAVKQLWKGD---GVKVFAAEMEILGKI-RHRNILKLYACLLKGG- 744 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~-----~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~- 744 (973)
.++|++.+.||+|+||+||+|++ ..+++.||||++.... ..+.+.+|+++++++ +||||+++++++...+
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 105 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 105 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCC
Confidence 46889999999999999999985 3457899999987632 345688999999999 7999999999987754
Q ss_pred eeEEEEEccCCCchHHHHHhhhcCC-----------CCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeec
Q 002061 745 SSFLVLEYMPNGNLFQALHKRVKEG-----------KPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD 813 (973)
Q Consensus 745 ~~~lv~e~~~~gsL~~~l~~~~~~~-----------~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~ 813 (973)
..++||||+++|+|.+++....... ...+++..+..++.|+++||+||| +.+++||||||+||+++
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~ 182 (316)
T 2xir_A 106 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLS 182 (316)
T ss_dssp CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEC
T ss_pred ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEEC
Confidence 5899999999999999998642110 122789999999999999999999 78999999999999999
Q ss_pred CCCCeEEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHH
Q 002061 814 EDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIV 892 (973)
Q Consensus 814 ~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~ 892 (973)
.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+.||...... ....
T Consensus 183 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-~~~~ 261 (316)
T 2xir_A 183 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-EEFC 261 (316)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS-HHHH
T ss_pred CCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchh-HHHH
Confidence 999999999999986654433333334567889999999999999999999999999999998 99999754221 1111
Q ss_pred HHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 002061 893 YWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADP 955 (973)
Q Consensus 893 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 955 (973)
..+.... .. .........+.+++.+||+.||.+||++.|++++|+.+..
T Consensus 262 ~~~~~~~--~~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 262 RRLKEGT--RM------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp HHHHHTC--CC------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhccCc--cC------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1111110 00 0011123468889999999999999999999999987643
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=366.75 Aligned_cols=256 Identities=24% Similarity=0.290 Sum_probs=209.2
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV 749 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 749 (973)
.++|++.+.||+|+||+||+|++..+|+.||||++.+. ...+.+.+|++++++++||||+++++++...+..|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 46788999999999999999999999999999998653 3456788999999999999999999999999999999
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccc
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 829 (973)
|||++||+|.+++... ......+++..+..++.||+.||+||| +++|+||||||+||+++.+|.+||+|||+++..
T Consensus 264 mE~~~gg~L~~~l~~~-~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNV-DEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp ECCCTTCBHHHHHHTS-STTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEeccCCCHHHHHHHh-hcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 9999999999999754 222446899999999999999999999 789999999999999999999999999999876
Q ss_pred cCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhc
Q 002061 830 ENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVL 909 (973)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (973)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .................
T Consensus 340 ~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~-~~~~~~~~~~i~~~~~~----- 411 (543)
T 3c4z_A 340 KAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE-KVENKELKQRVLEQAVT----- 411 (543)
T ss_dssp CTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTC-CCCHHHHHHHHHHCCCC-----
T ss_pred cCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCcc-chhHHHHHHHHhhcccC-----
Confidence 54322 12235799999999999999999999999999999999999999976422 11222222222111110
Q ss_pred cccccCcchHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHH
Q 002061 910 DCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPM-----REVVKM 949 (973)
Q Consensus 910 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~-----~evl~~ 949 (973)
.+......+.+++.+|++.||++||++ .++++|
T Consensus 412 -------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 412 -------YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp -------CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred -------CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 111234567889999999999999964 777764
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=367.23 Aligned_cols=249 Identities=26% Similarity=0.318 Sum_probs=198.1
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV 749 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 749 (973)
.++|++.+.||+|+||+||+|++..+++.||||++... .....+.+|+++++.++||||+++++++..++..|+|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 46799999999999999999999999999999998752 3345677899999999999999999999999999999
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCC-CCeEecCCCCCCeeecCCCCeEEecccCccc
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS-PPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~-~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 828 (973)
|||+++|+|.+++... ..+++..+..++.|++.||+||| + .+|+||||||+|||++.++.+||+|||+++.
T Consensus 227 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~ 298 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE-----RVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE 298 (446)
T ss_dssp ECCCSSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred EeeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCcee
Confidence 9999999999999764 35889999999999999999999 5 7999999999999999999999999999975
Q ss_pred ccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchh
Q 002061 829 AENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKV 908 (973)
Q Consensus 829 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (973)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||... +...............
T Consensus 299 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~-----~~~~~~~~i~~~~~~~--- 368 (446)
T 4ejn_A 299 GIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-----DHEKLFELILMEEIRF--- 368 (446)
T ss_dssp TCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHCCCCC---
T ss_pred ccCCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCC-----CHHHHHHHHHhCCCCC---
Confidence 43221 2233467999999999999999999999999999999999999999653 1122222211111110
Q ss_pred ccccccCcchHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHh
Q 002061 909 LDCEVASESIKEDMIKLLKIAVVCTTKLPNLRP-----PMREVVKML 950 (973)
Q Consensus 909 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~L 950 (973)
+......+.+++.+||+.||.+|| ++.|+++|-
T Consensus 369 ---------p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp 406 (446)
T 4ejn_A 369 ---------PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHR 406 (446)
T ss_dssp ---------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred ---------CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCc
Confidence 112235678999999999999999 999999754
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=342.63 Aligned_cols=254 Identities=26% Similarity=0.368 Sum_probs=208.0
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccC
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP 754 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 754 (973)
++|++.+.||+|+||+||+|++.. ++.||||++... ...+.+.+|++++++++||||+++++++..++..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecC-CCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 578889999999999999999874 778999998764 355778999999999999999999999999999999999999
Q ss_pred CCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCC
Q 002061 755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK 834 (973)
Q Consensus 755 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 834 (973)
+++|.+++... ...+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++.......
T Consensus 87 ~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~- 158 (267)
T 3t9t_A 87 HGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ- 158 (267)
T ss_dssp TCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-
T ss_pred CCcHHHHHhhC----cccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEccccccccccccc-
Confidence 99999999754 345789999999999999999999 7899999999999999999999999999997654321
Q ss_pred cccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhccccc
Q 002061 835 VSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEV 913 (973)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (973)
........++..|+|||++.+..++.++||||+|+++|||++ |+.||... .............. .
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-----~~~~~~~~i~~~~~----~----- 224 (267)
T 3t9t_A 159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-----SNSEVVEDISTGFR----L----- 224 (267)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHHHHHHHHHTTCC----C-----
T ss_pred ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCC-----CHHHHHHHHhcCCc----C-----
Confidence 112223457789999999998899999999999999999999 89999653 11122211111110 0
Q ss_pred cCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 002061 914 ASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADAD 954 (973)
Q Consensus 914 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 954 (973)
..+......+.+++.+||+.||++||++.|++++|+++.
T Consensus 225 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 225 --YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 001112346788999999999999999999999998764
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=345.93 Aligned_cols=259 Identities=26% Similarity=0.373 Sum_probs=209.7
Q ss_pred cCHHHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhcCCCceeeEEEEEEe-------
Q 002061 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLK------- 742 (973)
Q Consensus 670 ~~~~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~------- 742 (973)
++.....+|++.+.||+|+||.||+|++..+++.||||++.... +.+.+|++++++++||||+++++++..
T Consensus 5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 5 VDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp CCHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS--GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred ccchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc--HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence 34566678999999999999999999999889999999987543 356789999999999999999998864
Q ss_pred ---------CCeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeec
Q 002061 743 ---------GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD 813 (973)
Q Consensus 743 ---------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~ 813 (973)
....++||||+++|+|.+++.... ...+++..+..++.|++.||+||| +.+++||||||+||+++
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~ 156 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR---GEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLV 156 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHGG---GSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEE
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEc
Confidence 445799999999999999997642 345889999999999999999999 78999999999999999
Q ss_pred CCCCeEEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHH
Q 002061 814 EDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVY 893 (973)
Q Consensus 814 ~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~ 893 (973)
.++.+||+|||++........ .....|++.|+|||++.+..++.++||||||+++|||++|..|+.... .
T Consensus 157 ~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-------~ 226 (284)
T 2a19_B 157 DTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS-------K 226 (284)
T ss_dssp ETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-------H
T ss_pred CCCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH-------H
Confidence 999999999999987654322 223468999999999999999999999999999999999998875321 1
Q ss_pred HHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCCCCCC
Q 002061 894 WVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPCTDKS 960 (973)
Q Consensus 894 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~~ 960 (973)
...... .. .... .....+.+++.+||+.||++||++.|++++|+.+....++.
T Consensus 227 ~~~~~~-~~---------~~~~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~ 279 (284)
T 2a19_B 227 FFTDLR-DG---------IISD----IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKN 279 (284)
T ss_dssp HHHHHH-TT---------CCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-----
T ss_pred HHHHhh-cc---------cccc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCcc
Confidence 111110 00 0101 12235778999999999999999999999999987665443
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=352.42 Aligned_cols=256 Identities=22% Similarity=0.232 Sum_probs=204.5
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEEEEc
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLVLEY 752 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~ 752 (973)
..++|++.+.||+|+||+||+|+++.+++.||||++..... ...+|++++.++ +||||+++++++.+++..|+||||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 97 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR--DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC--CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC--ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence 45679999999999999999999999999999999876432 345788998888 799999999999999999999999
Q ss_pred cCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCC----CCeEEecccCccc
Q 002061 753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDED----YEPKIADFGVAKI 828 (973)
Q Consensus 753 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~----~~~kl~Dfgl~~~ 828 (973)
+++|+|.+++... ..+++..+..++.|++.||+||| +++|+||||||+||++..+ +.+||+|||+++.
T Consensus 98 ~~gg~L~~~i~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 98 MKGGELLDKILRQ-----KFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCSCBHHHHHHTC-----TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred CCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 9999999999753 35899999999999999999999 7899999999999998543 3599999999986
Q ss_pred ccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchh
Q 002061 829 AENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKV 908 (973)
Q Consensus 829 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (973)
...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.... .................
T Consensus 170 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--~~~~~~~~~~i~~~~~~---- 241 (342)
T 2qr7_A 170 LRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGP--DDTPEEILARIGSGKFS---- 241 (342)
T ss_dssp CBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSST--TSCHHHHHHHHHHCCCC----
T ss_pred CcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCC--cCCHHHHHHHHccCCcc----
Confidence 644322 2233568999999999988889999999999999999999999997532 12222222221111110
Q ss_pred ccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 909 LDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 909 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
............+.+++.+|++.||++||++.|+++|-.
T Consensus 242 ----~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~ 280 (342)
T 2qr7_A 242 ----LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPW 280 (342)
T ss_dssp ----CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred ----cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCe
Confidence 001111223456889999999999999999999998644
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=348.88 Aligned_cols=261 Identities=21% Similarity=0.275 Sum_probs=200.0
Q ss_pred HcCCccc-CcccccCceEEEEEEecCCCcEEEEEeeecc--ccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEEE
Q 002061 675 ICNLEED-NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLVL 750 (973)
Q Consensus 675 ~~~~~~~-~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~ 750 (973)
.+.|++. +.||+|+||+||+|++..+++.||||++... ...+.+.+|++++.++ +||||+++++++.+++..|+||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3567774 7899999999999999989999999998653 3467789999999985 7999999999999999999999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCC---eEEecccCcc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE---PKIADFGVAK 827 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~---~kl~Dfgl~~ 827 (973)
||+++|+|.+++... ..+++..+..++.|++.||+||| +++|+||||||+||+++.++. +||+|||++.
T Consensus 91 e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~ 162 (316)
T 2ac3_A 91 EKMRGGSILSHIHKR-----RHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGS 162 (316)
T ss_dssp ECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred EcCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence 999999999999864 35789999999999999999999 789999999999999998776 9999999987
Q ss_pred cccCCCC-----cccccccCCcccccccccccc-----CCCCccchHHHHHHHHHHHHhCCCCCCcccCCccc-------
Q 002061 828 IAENSPK-----VSDYSCFAGTHGYIAPELAYT-----CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKD------- 890 (973)
Q Consensus 828 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~------- 890 (973)
....... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 242 (316)
T 2ac3_A 163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC 242 (316)
T ss_dssp -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CC
T ss_pred ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccc
Confidence 6542211 111223468999999999875 56889999999999999999999999764322100
Q ss_pred ---HHHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 891 ---IVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 891 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
............. .............+.+++.+|++.||++|||+.|++++-.
T Consensus 243 ~~~~~~~~~~i~~~~~--------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 298 (316)
T 2ac3_A 243 PACQNMLFESIQEGKY--------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPW 298 (316)
T ss_dssp HHHHHHHHHHHHHCCC--------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTT
T ss_pred hhHHHHHHHHHhccCc--------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChh
Confidence 0011111111000 0000011123456889999999999999999999999744
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=364.12 Aligned_cols=261 Identities=27% Similarity=0.287 Sum_probs=198.1
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeC------
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKG------ 743 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------ 743 (973)
..++|++.+.||+|+||+||+|++..+++.||||++... ...+++.+|+++++.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 357899999999999999999999999999999998752 3456788999999999999999999999654
Q ss_pred CeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecc
Q 002061 744 GSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADF 823 (973)
Q Consensus 744 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 823 (973)
...|+||||+++ ++.+.+.. .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+||
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~~-------~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DF 208 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDF 208 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC
T ss_pred CeEEEEEeCCCC-CHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEE
Confidence 457999999965 56666642 3789999999999999999999 789999999999999999999999999
Q ss_pred cCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHH-----
Q 002061 824 GVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTH----- 898 (973)
Q Consensus 824 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~----- 898 (973)
|+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.. ..+....+...
T Consensus 209 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~--~~~~~~~i~~~lg~p~ 283 (464)
T 3ttj_A 209 GLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD--YIDQWNKVIEQLGTPC 283 (464)
T ss_dssp CCC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHHCSCC
T ss_pred EeeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHhcCCCC
Confidence 9998665432 2334678999999999999999999999999999999999999997531 11111111000
Q ss_pred --------------hcccccc-----chhcccc---ccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 899 --------------LNNHENV-----LKVLDCE---VASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 899 --------------~~~~~~~-----~~~~~~~---~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
....+.. ...+... ............+.+++.+|++.||++|||+.|+++|-
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp 357 (464)
T 3ttj_A 284 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 357 (464)
T ss_dssp HHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred HHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcCh
Confidence 0000000 0000000 00111223356789999999999999999999999874
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=340.73 Aligned_cols=263 Identities=20% Similarity=0.247 Sum_probs=201.5
Q ss_pred HHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc-----cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeE
Q 002061 673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF 747 (973)
Q Consensus 673 ~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 747 (973)
...++|++.+.||+|+||+||+|++..+++.||||++.... ..+.+.+|++++++++||||+++++++..++..|
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY 110 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence 45678999999999999999999999889999999986532 2366889999999999999999999999999999
Q ss_pred EEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcc
Q 002061 748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827 (973)
Q Consensus 748 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~ 827 (973)
+||||+++++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.
T Consensus 111 lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~ 182 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQ-----GPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIAS 182 (309)
T ss_dssp EEEECCCCEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC--
T ss_pred EEEEecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCc
Confidence 999999999999999864 35889999999999999999999 7899999999999999999999999999987
Q ss_pred cccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccch
Q 002061 828 IAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLK 907 (973)
Q Consensus 828 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
....... .......|++.|+|||++.+..++.++||||||+++|||++|+.||.... .. ..............
T Consensus 183 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~-~~~~~~~~~~~~~~ 255 (309)
T 2h34_A 183 ATTDEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ-----LS-VMGAHINQAIPRPS 255 (309)
T ss_dssp ---------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH-----HH-HHHHHHHSCCCCGG
T ss_pred ccccccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch-----HH-HHHHHhccCCCCcc
Confidence 6543321 22234568999999999999999999999999999999999999997531 11 11111111110000
Q ss_pred hccccccCcchHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHhhcCCCCCC
Q 002061 908 VLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRP-PMREVVKMLADADPCTD 958 (973)
Q Consensus 908 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-t~~evl~~L~~~~~~~~ 958 (973)
.........+.+++.+||+.||++|| ++.++++.|+.......
T Consensus 256 --------~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 256 --------TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp --------GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred --------ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 11112234678899999999999999 99999999998866554
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=344.84 Aligned_cols=256 Identities=23% Similarity=0.326 Sum_probs=205.0
Q ss_pred HHHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 002061 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE 751 (973)
Q Consensus 672 ~~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 751 (973)
.....+|++.+.||+|+||+||+|++..+++.||||++......+.+.+|++++++++||||+++++++..++..|+|||
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 44556899999999999999999999999999999999887777889999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccC
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 831 (973)
|+++|+|.+++... ...+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||.+.....
T Consensus 105 ~~~~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 105 YCGAGSVSDIIRLR----NKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp CCTTEEHHHHHHHH----TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred cCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 99999999999743 345889999999999999999999 78999999999999999999999999999976643
Q ss_pred CCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccc
Q 002061 832 SPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDC 911 (973)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (973)
... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||.... ............. .
T Consensus 178 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~-------~ 243 (314)
T 3com_A 178 TMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH-----PMRAIFMIPTNPP-------P 243 (314)
T ss_dssp TBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC-----HHHHHHHHHHSCC-------C
T ss_pred hcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHhcCCC-------c
Confidence 321 2233568999999999999899999999999999999999999997531 1111111111110 0
Q ss_pred cccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 912 EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 912 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
.. .........+.+++.+||+.||.+|||+.+++++-
T Consensus 244 ~~--~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~ 280 (314)
T 3com_A 244 TF--RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHP 280 (314)
T ss_dssp CC--SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred cc--CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence 00 01112245688999999999999999999998753
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=355.07 Aligned_cols=244 Identities=26% Similarity=0.302 Sum_probs=193.0
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc-----cHHHHHHHHHH-HHhcCCCceeeEEEEEEeCCeeE
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----GVKVFAAEMEI-LGKIRHRNILKLYACLLKGGSSF 747 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~-l~~l~hpniv~l~~~~~~~~~~~ 747 (973)
..++|++.+.||+|+||+||+|+++.+++.||||++.+.. ....+.+|..+ ++.++||||+++++++.+++..|
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 3467899999999999999999999999999999987632 23445667666 56789999999999999999999
Q ss_pred EEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcc
Q 002061 748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827 (973)
Q Consensus 748 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~ 827 (973)
+||||+++|+|.+++... ..+++..+..++.||+.||+||| +++|+||||||+||+++.+|.+||+|||+++
T Consensus 116 lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~ 187 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQRE-----RCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK 187 (373)
T ss_dssp EEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCG
T ss_pred EEEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCcccc
Confidence 999999999999999764 35788899999999999999999 7899999999999999999999999999997
Q ss_pred cccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccch
Q 002061 828 IAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLK 907 (973)
Q Consensus 828 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||... +..............
T Consensus 188 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~-----~~~~~~~~i~~~~~~--- 257 (373)
T 2r5t_A 188 ENIEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR-----NTAEMYDNILNKPLQ--- 257 (373)
T ss_dssp GGBCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS-----BHHHHHHHHHHSCCC---
T ss_pred ccccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC-----CHHHHHHHHHhcccC---
Confidence 543221 1233467999999999999999999999999999999999999999653 122222222111110
Q ss_pred hccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 002061 908 VLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMR 944 (973)
Q Consensus 908 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~ 944 (973)
. .......+.+++.+|++.||.+||++.
T Consensus 258 -----~----~~~~~~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 258 -----L----KPNITNSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp -----C----CSSSCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred -----C----CCCCCHHHHHHHHHHcccCHHhCCCCC
Confidence 0 111234578899999999999999974
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=348.76 Aligned_cols=261 Identities=23% Similarity=0.311 Sum_probs=198.6
Q ss_pred HcCCcccCcccccCceEEEEEEecC---CCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCC---
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKK---NAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGG--- 744 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~---~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--- 744 (973)
..+|++.+.||+|+||+||+|++.. ++..||||++... ...+.+.+|++++++++||||+++++++.+..
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence 4578899999999999999998865 4558999998643 33466889999999999999999999987654
Q ss_pred --eeEEEEEccCCCchHHHHHhhhc-CCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEe
Q 002061 745 --SSFLVLEYMPNGNLFQALHKRVK-EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIA 821 (973)
Q Consensus 745 --~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 821 (973)
..++||||+++|+|.+++..... .....+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kl~ 189 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCVA 189 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCEEEC
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEEe
Confidence 35999999999999999965422 23456899999999999999999999 8899999999999999999999999
Q ss_pred cccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhc
Q 002061 822 DFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLN 900 (973)
Q Consensus 822 Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~ 900 (973)
|||++................+++.|+|||++.+..++.++||||||+++|||++ |..||.... .......+...
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--~~~~~~~~~~~-- 265 (313)
T 3brb_A 190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ--NHEMYDYLLHG-- 265 (313)
T ss_dssp SCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--GGGHHHHHHTT--
T ss_pred ecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCC--HHHHHHHHHcC--
Confidence 9999987654433333334567889999999999999999999999999999999 889996542 22222111111
Q ss_pred cccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 002061 901 NHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADAD 954 (973)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 954 (973)
.. ...+......+.+++.+||+.||.+||++.+++++|+++.
T Consensus 266 -~~-----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 266 -HR-----------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp -CC-----------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CC-----------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00 0111223456889999999999999999999999998764
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=353.42 Aligned_cols=265 Identities=25% Similarity=0.333 Sum_probs=205.9
Q ss_pred HHHHcCCcccCcccccCceEEEEEE-----ecCCCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeC
Q 002061 672 AEQICNLEEDNLIGSGGTGKVYRLD-----LKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKG 743 (973)
Q Consensus 672 ~~~~~~~~~~~~lG~G~~g~V~~a~-----~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 743 (973)
.....+|++.+.||+|+||+||+|+ ...+++.||||++... ....++.+|+.++++++||||+++++++..+
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 105 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence 3445789999999999999999999 4456789999998642 3456788999999999999999999999999
Q ss_pred CeeEEEEEccCCCchHHHHHhhhcC--CCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecC---CCCe
Q 002061 744 GSSFLVLEYMPNGNLFQALHKRVKE--GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE---DYEP 818 (973)
Q Consensus 744 ~~~~lv~e~~~~gsL~~~l~~~~~~--~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~ 818 (973)
...|+||||+++|+|.+++...... ....+++..+..++.|++.||+||| +.+++||||||+||+++. +..+
T Consensus 106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceE
Confidence 9999999999999999999865221 1245889999999999999999999 789999999999999984 4469
Q ss_pred EEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHH
Q 002061 819 KIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVST 897 (973)
Q Consensus 819 kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~ 897 (973)
||+|||++................||+.|+|||++.+..++.++||||||+++|||++ |+.||... ........+.
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~--~~~~~~~~~~- 259 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK--SNQEVLEFVT- 259 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--CHHHHHHHHH-
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCc--CHHHHHHHHh-
Confidence 9999999986654433333344568899999999998899999999999999999998 99999653 1111111111
Q ss_pred HhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 002061 898 HLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADP 955 (973)
Q Consensus 898 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 955 (973)
.... ..........+.+++.+||+.||.+||++.|++++++.+..
T Consensus 260 --~~~~-----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 260 --SGGR-----------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp --TTCC-----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --cCCC-----------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 1100 00111233468889999999999999999999999997643
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=350.81 Aligned_cols=257 Identities=27% Similarity=0.425 Sum_probs=199.9
Q ss_pred cCCcccCcccccCceEEEEEEecCCC----cEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNA----GTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL 748 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~----~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 748 (973)
.+|+..+.||+|+||+||+|++..++ ..||||++... .....+.+|++++++++||||+++++++...+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 46788899999999999999987543 35999998753 234568899999999999999999999999999999
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccc
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 828 (973)
||||+++|+|.+++... ...+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||+++.
T Consensus 124 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 124 ITEYMENGALDKFLREK----DGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEECCTTEEHHHHHHHT----TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEeCCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 99999999999999753 346899999999999999999999 78999999999999999999999999999987
Q ss_pred ccCCCCc-ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccc
Q 002061 829 AENSPKV-SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVL 906 (973)
Q Consensus 829 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 906 (973)
....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.... ..... ........
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~--~~~~~---~~~~~~~~--- 268 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--NHEVM---KAINDGFR--- 268 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHH---HHHHTTCC---
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC--HHHHH---HHHHCCCc---
Confidence 6543221 11223456789999999998999999999999999999999 999996531 11111 11111100
Q ss_pred hhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 002061 907 KVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADP 955 (973)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 955 (973)
..........+.+++.+||+.||++||++.|++++|+++..
T Consensus 269 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 309 (333)
T 1mqb_A 269 --------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309 (333)
T ss_dssp --------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 00111234568899999999999999999999999987643
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=346.15 Aligned_cols=260 Identities=23% Similarity=0.332 Sum_probs=207.3
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEe--CCeeEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLK--GGSSFL 748 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~l 748 (973)
.++|++.+.||+|+||+||+|++..+++.||+|++... ...+.+.+|++++++++||||+++++++.. +...|+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 46889999999999999999999999999999998652 345668899999999999999999998754 678999
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCC-----eEecCCCCCCeeecCCCCeEEecc
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP-----IIHRDIKSSNILLDEDYEPKIADF 823 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~-----ivH~Dlkp~Nill~~~~~~kl~Df 823 (973)
||||+++|+|.+++..... ....+++..+..++.|++.||+||| +.+ ++||||||+||+++.++.+||+||
T Consensus 85 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEECCTTEEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred EEeCCCCCCHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 9999999999999986532 3345899999999999999999999 556 999999999999999999999999
Q ss_pred cCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccc
Q 002061 824 GVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHE 903 (973)
Q Consensus 824 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 903 (973)
|.++....... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||.... .......+... ..
T Consensus 161 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~i~~~---~~ 233 (279)
T 2w5a_A 161 GLARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS--QKELAGKIREG---KF 233 (279)
T ss_dssp CHHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHT---CC
T ss_pred chheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC--HHHHHHHHhhc---cc
Confidence 99876643321 1223468999999999999899999999999999999999999997541 11111111111 00
Q ss_pred ccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCC
Q 002061 904 NVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPC 956 (973)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~ 956 (973)
. ..+......+.+++.+||+.||++||++.|+++++....+.
T Consensus 234 -------~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 234 -------R----RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH 275 (279)
T ss_dssp -------C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred -------c----cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence 0 01112345688999999999999999999999988766543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=338.81 Aligned_cols=250 Identities=24% Similarity=0.303 Sum_probs=203.4
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc--------ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--------DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF 747 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 747 (973)
++|++.+.||+|+||+||+|++..+++.||||++... ...+.+.+|++++++++||||+++++++..+...+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 4688999999999999999999989999999988653 13677899999999999999999999999999999
Q ss_pred EEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCC----CeEEecc
Q 002061 748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY----EPKIADF 823 (973)
Q Consensus 748 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~----~~kl~Df 823 (973)
+||||+++++|.+++... ..+++..+..++.|++.||+||| +.+++||||||+||+++.++ .+||+||
T Consensus 85 lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~df 156 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK-----ESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDF 156 (283)
T ss_dssp EEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEeecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEec
Confidence 999999999999999753 35889999999999999999999 78999999999999998877 8999999
Q ss_pred cCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccc
Q 002061 824 GVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHE 903 (973)
Q Consensus 824 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 903 (973)
|.+....... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||.... .............
T Consensus 157 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~ 228 (283)
T 3bhy_A 157 GIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET-----KQETLTNISAVNY 228 (283)
T ss_dssp TTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHHTTCC
T ss_pred ccceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc-----hHHHHHHhHhccc
Confidence 9998664432 2233568999999999998999999999999999999999999996531 1111111111110
Q ss_pred ccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 904 NVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
.............+.+++.+|++.||++||++.|++++
T Consensus 229 --------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 229 --------DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp --------CCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred --------CCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 00011112234568899999999999999999999985
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=347.77 Aligned_cols=264 Identities=21% Similarity=0.248 Sum_probs=198.2
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecccc---HHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG---VKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY 752 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 752 (973)
++|++.+.||+|+||+||+|++..+++.||||++..... ...+.+|++++++++||||+++++++..++..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 578999999999999999999998999999998865322 12345799999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCC
Q 002061 753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832 (973)
Q Consensus 753 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 832 (973)
++ |+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 153 (324)
T 3mtl_A 82 LD-KDLKQYLDDC----GNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP 153 (324)
T ss_dssp CS-EEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC---
T ss_pred cc-cCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCC
Confidence 96 6999998764 345889999999999999999999 789999999999999999999999999998755432
Q ss_pred CCcccccccCCcccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccc--ccchhc
Q 002061 833 PKVSDYSCFAGTHGYIAPELAYT-CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHE--NVLKVL 909 (973)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 909 (973)
. .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.... ..+....+........ ......
T Consensus 154 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~ 229 (324)
T 3mtl_A 154 T--KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST--VEEQLHFIFRILGTPTEETWPGIL 229 (324)
T ss_dssp -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred c--cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhCCCChHhchhhh
Confidence 2 22233568999999999876 568999999999999999999999997541 1121222211111100 000000
Q ss_pred c---------ccccC----cchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 910 D---------CEVAS----ESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 910 ~---------~~~~~----~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
. +.... .........+.+++.+|++.||++|||+.|++++-.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 284 (324)
T 3mtl_A 230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284 (324)
T ss_dssp GCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred cchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChh
Confidence 0 00000 001123456789999999999999999999998543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=350.38 Aligned_cols=259 Identities=27% Similarity=0.393 Sum_probs=206.5
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEE--EEEeeec---cccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTV--AVKQLWK---GDGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFL 748 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~v--avK~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l 748 (973)
.++|++.+.||+|+||.||+|++..++..+ |||++.. ....+.+.+|+++++++ +||||+++++++..++..|+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 468899999999999999999998878755 9998865 23456788999999999 99999999999999999999
Q ss_pred EEEccCCCchHHHHHhhhc-----------CCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCC
Q 002061 749 VLEYMPNGNLFQALHKRVK-----------EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE 817 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~-----------~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~ 817 (973)
||||+++|+|.+++..... .....+++..+..++.|+++||+||| +++|+||||||+||+++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCe
Confidence 9999999999999975420 22346899999999999999999999 789999999999999999999
Q ss_pred eEEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHH
Q 002061 818 PKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVS 896 (973)
Q Consensus 818 ~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~ 896 (973)
+||+|||+++..... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||... .......
T Consensus 181 ~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~-----~~~~~~~ 252 (327)
T 1fvr_A 181 AKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-----TCAELYE 252 (327)
T ss_dssp EEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHHHHHH
T ss_pred EEEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCC-----cHHHHHH
Confidence 999999998743221 11223456889999999998889999999999999999998 99999653 1112211
Q ss_pred HHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 002061 897 THLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADP 955 (973)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 955 (973)
....... ..........+.+++.+||+.||++||++.|++++|+++..
T Consensus 253 ~~~~~~~-----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 300 (327)
T 1fvr_A 253 KLPQGYR-----------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 300 (327)
T ss_dssp HGGGTCC-----------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhhcCCC-----------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1111100 01111233568899999999999999999999999997643
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=344.12 Aligned_cols=257 Identities=27% Similarity=0.364 Sum_probs=203.1
Q ss_pred CCcccCcccccCceEEEEEEecCCCc---EEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCee-EEE
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAG---TVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSS-FLV 749 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~---~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~-~lv 749 (973)
.|+..+.||+|+||+||+|++..+++ .||+|++... ...+.+.+|++++++++||||+++++++.+++.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 45667899999999999999765444 7999988653 3346788999999999999999999999876554 999
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccc
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 829 (973)
|||+.+|+|.+++... ...+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||+++..
T Consensus 102 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 174 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSP----QRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDI 174 (298)
T ss_dssp ECCCTTCBHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred EecccCCCHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence 9999999999999753 345789999999999999999999 789999999999999999999999999999765
Q ss_pred cCCCC--cccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccch
Q 002061 830 ENSPK--VSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLK 907 (973)
Q Consensus 830 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
..... ........+++.|+|||++.+..++.++||||+|+++|+|++|..|+.... +..+....+......
T Consensus 175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~-~~~~~~~~~~~~~~~------ 247 (298)
T 3pls_A 175 LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI-DPFDLTHFLAQGRRL------ 247 (298)
T ss_dssp TTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-CGGGHHHHHHTTCCC------
T ss_pred cCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccC-CHHHHHHHhhcCCCC------
Confidence 43221 122233567889999999999999999999999999999999665553321 222222222211100
Q ss_pred hccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 002061 908 VLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADP 955 (973)
Q Consensus 908 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 955 (973)
.........+.+++.+||+.||.+|||+.++++.|+++..
T Consensus 248 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 287 (298)
T 3pls_A 248 --------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS 287 (298)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0111223468899999999999999999999999998643
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=343.69 Aligned_cols=251 Identities=28% Similarity=0.408 Sum_probs=199.7
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhcCCCceeeEEEEEEeC-CeeEEEEEcc
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKG-GSSFLVLEYM 753 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~~lv~e~~ 753 (973)
.++|++.+.||+|+||+||+|++. ++.||||++......+.+.+|++++++++||||+++++++.+. +..++||||+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 468899999999999999999885 7899999998777778899999999999999999999987554 5789999999
Q ss_pred CCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCC
Q 002061 754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833 (973)
Q Consensus 754 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 833 (973)
++|+|.+++.... ...+++..+..++.|+++|++||| +++++||||||+||+++.++.+||+|||++.......
T Consensus 98 ~~~~L~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 171 (278)
T 1byg_A 98 AKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 171 (278)
T ss_dssp TTEEHHHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred CCCCHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeeccccccccccc
Confidence 9999999997642 223788899999999999999999 7899999999999999999999999999987554321
Q ss_pred CcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhcccc
Q 002061 834 KVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCE 912 (973)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (973)
....+++.|+|||++.+..++.++||||||+++|||++ |+.||.... ..+....+. ...
T Consensus 172 -----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~--~~~~~~~~~----~~~--------- 231 (278)
T 1byg_A 172 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--LKDVVPRVE----KGY--------- 231 (278)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC--GGGHHHHHT----TTC---------
T ss_pred -----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHh----cCC---------
Confidence 12356889999999998899999999999999999998 999997542 222221111 100
Q ss_pred ccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 002061 913 VASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADAD 954 (973)
Q Consensus 913 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 954 (973)
...........+.+++.+||+.||++||++.|+++.|+++.
T Consensus 232 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 232 -KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 01111223456889999999999999999999999998764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=342.88 Aligned_cols=255 Identities=24% Similarity=0.323 Sum_probs=204.6
Q ss_pred cCCcccC-cccccCceEEEEEEec--CCCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 002061 676 CNLEEDN-LIGSGGTGKVYRLDLK--KNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV 749 (973)
Q Consensus 676 ~~~~~~~-~lG~G~~g~V~~a~~~--~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 749 (973)
++|.+.+ .||+|+||+||+|.+. .++..||||++... ...+.+.+|++++++++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 3455555 8999999999999864 45778999998763 3456788999999999999999999998 55678999
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccc
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 829 (973)
|||+++++|.+++... ...+++..+..++.|+++||+||| +.+++||||||+||+++.++.+||+|||++...
T Consensus 88 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EECCTTEEHHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEeCCCCCHHHHHHhC----CccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 9999999999998642 345899999999999999999999 789999999999999999999999999999876
Q ss_pred cCCCCc-ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccch
Q 002061 830 ENSPKV-SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLK 907 (973)
Q Consensus 830 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
...... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.... .......+.. ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--~~~~~~~i~~----~~---- 230 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK--GPEVMAFIEQ----GK---- 230 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--THHHHHHHHT----TC----
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC--HHHHHHHHhc----CC----
Confidence 543222 12233456889999999988889999999999999999998 999997542 2222222111 10
Q ss_pred hccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 002061 908 VLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADAD 954 (973)
Q Consensus 908 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 954 (973)
....+......+.+++.+||+.||++||++.|++++|+.+.
T Consensus 231 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 271 (287)
T 1u59_A 231 ------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 271 (287)
T ss_dssp ------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00111223456889999999999999999999999999763
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=336.41 Aligned_cols=247 Identities=28% Similarity=0.368 Sum_probs=205.8
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV 749 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 749 (973)
.++|++.+.||+|+||+||+|++..+++.||||++... ...+.+.+|++++++++||||+++++++.+++..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 46789999999999999999999998999999998652 2346788999999999999999999999999999999
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccc
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 829 (973)
|||+++|+|.+++... ..+++..+..++.|++.|++||| +.+++||||||+||+++.++.+||+|||++...
T Consensus 93 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~ 164 (284)
T 2vgo_A 93 LEFAPRGELYKELQKH-----GRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHA 164 (284)
T ss_dssp ECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccC
Confidence 9999999999999764 24789999999999999999999 889999999999999999999999999998755
Q ss_pred cCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhc
Q 002061 830 ENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVL 909 (973)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (973)
.... .....|++.|+|||++.+..++.++||||+|+++|+|++|+.||.... .............
T Consensus 165 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~~~~~~~~~~~~------ 229 (284)
T 2vgo_A 165 PSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS-----HTETHRRIVNVDL------ 229 (284)
T ss_dssp SSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHHTTCC------
T ss_pred cccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC-----HhHHHHHHhcccc------
Confidence 4321 223568999999999999999999999999999999999999996531 1111111111110
Q ss_pred cccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 910 DCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 910 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
.. +......+.+++.+|++.||.+||++.|++++-
T Consensus 230 --~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~ 264 (284)
T 2vgo_A 230 --KF----PPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHP 264 (284)
T ss_dssp --CC----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCH
T ss_pred --CC----CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCH
Confidence 01 112234678899999999999999999999853
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=342.17 Aligned_cols=255 Identities=25% Similarity=0.333 Sum_probs=202.8
Q ss_pred HcCCcccCcccccCceEEEEEEecC---CCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKK---NAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL 748 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~---~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 748 (973)
.++|++.+.||+|+||+||+|++.. ++..||||++... ...+.+.+|++++++++||||+++++++.+ +..|+
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 4578999999999999999999764 3446999998763 345678899999999999999999999765 45689
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccc
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 828 (973)
||||+++++|.+++... ...+++..+..++.|+++||+||| +++++||||||+||+++.++.+||+|||++..
T Consensus 90 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 90 IMELYPYGELGHYLERN----KNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp EEECCTTCBHHHHHHHH----TTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred EEecCCCCCHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 99999999999999764 345789999999999999999999 78999999999999999999999999999986
Q ss_pred ccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccch
Q 002061 829 AENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLK 907 (973)
Q Consensus 829 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
...... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||... ...+....+......
T Consensus 163 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~--~~~~~~~~~~~~~~~------ 233 (281)
T 3cc6_A 163 IEDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL--ENKDVIGVLEKGDRL------ 233 (281)
T ss_dssp C----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS--CGGGHHHHHHHTCCC------
T ss_pred cccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccC--ChHHHHHHHhcCCCC------
Confidence 644322 12233457889999999998899999999999999999998 99999754 222222222211100
Q ss_pred hccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 002061 908 VLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADAD 954 (973)
Q Consensus 908 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 954 (973)
..+......+.+++.+||+.||++||++.|++++|+++.
T Consensus 234 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 234 --------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 001112346888999999999999999999999998753
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=337.88 Aligned_cols=253 Identities=25% Similarity=0.315 Sum_probs=201.2
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc------ccHHHHHHHHHHHHhcCCCceeeEEEEEE--eCCe
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG------DGVKVFAAEMEILGKIRHRNILKLYACLL--KGGS 745 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~------~~~~~~~~E~~~l~~l~hpniv~l~~~~~--~~~~ 745 (973)
..++|++.+.||+|+||.||+|.+..+++.||||++... ...+.+.+|++++++++||||+++++++. +...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 357899999999999999999999999999999998653 34567899999999999999999999984 4567
Q ss_pred eEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccC
Q 002061 746 SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGV 825 (973)
Q Consensus 746 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl 825 (973)
.|+||||++++ |.+++... ....+++..+..++.|++.||+||| +++++||||||+||+++.++.+||+|||.
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~ 155 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSV---PEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGV 155 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHS---TTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEEehhccCC-HHHHHHhC---cccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeecccc
Confidence 89999999766 77777653 2446899999999999999999999 78999999999999999999999999999
Q ss_pred cccccCCCCcccccccCCccccccccccccCC--CCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccc
Q 002061 826 AKIAENSPKVSDYSCFAGTHGYIAPELAYTCK--VSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHE 903 (973)
Q Consensus 826 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 903 (973)
+................||+.|+|||++.+.. ++.++||||||+++|||++|+.||... +.............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-----~~~~~~~~i~~~~~ 230 (305)
T 2wtk_C 156 AEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD-----NIYKLFENIGKGSY 230 (305)
T ss_dssp CEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCS-----SHHHHHHHHHHCCC
T ss_pred ccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCc-----hHHHHHHHHhcCCC
Confidence 98765433333334456899999999987644 477999999999999999999999753 12222211111110
Q ss_pred ccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 904 NVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
.. .......+.+++.+|++.||.+||++.|++++-
T Consensus 231 --------~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 265 (305)
T 2wtk_C 231 --------AI----PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHS 265 (305)
T ss_dssp --------CC----CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSH
T ss_pred --------CC----CCccCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 00 112234678899999999999999999999863
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=356.82 Aligned_cols=281 Identities=21% Similarity=0.227 Sum_probs=212.7
Q ss_pred cccccccccccccCHHHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-ccHHHHHHHHHHHHhcC-------
Q 002061 658 SKWKLASFHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIR------- 729 (973)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~------- 729 (973)
..+....++...++....++|++.+.||+|+||+||+|++..+++.||||++... ...+.+.+|++++++++
T Consensus 19 ~~~~~~~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~ 98 (397)
T 1wak_A 19 NDYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDP 98 (397)
T ss_dssp ---CC--CCSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCG
T ss_pred ccCCCCCceEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCC
Confidence 3344455666666666678999999999999999999999999999999998764 34567889999999985
Q ss_pred -CCceeeEEEEEE----eCCeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCC-CeEec
Q 002061 730 -HRNILKLYACLL----KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP-PIIHR 803 (973)
Q Consensus 730 -hpniv~l~~~~~----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~-~ivH~ 803 (973)
||||+++++++. .+...++||||+ ++++.+++... ....+++..+..++.|++.||+||| ++ +|+||
T Consensus 99 ~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHr 171 (397)
T 1wak_A 99 NREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKS---NYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHT 171 (397)
T ss_dssp GGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECC
T ss_pred CcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecC
Confidence 788999999987 456789999999 66777776543 2345899999999999999999999 66 99999
Q ss_pred CCCCCCeeecCCC-------------------------------------------------CeEEecccCcccccCCCC
Q 002061 804 DIKSSNILLDEDY-------------------------------------------------EPKIADFGVAKIAENSPK 834 (973)
Q Consensus 804 Dlkp~Nill~~~~-------------------------------------------------~~kl~Dfgl~~~~~~~~~ 834 (973)
||||+|||++.++ .+||+|||.++.....
T Consensus 172 Dikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-- 249 (397)
T 1wak_A 172 DIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-- 249 (397)
T ss_dssp CCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--
T ss_pred CCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--
Confidence 9999999999775 7999999999866432
Q ss_pred cccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcc----cHHHHHHHHhccccc------
Q 002061 835 VSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGK----DIVYWVSTHLNNHEN------ 904 (973)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~----~~~~~~~~~~~~~~~------ 904 (973)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ +....+.......+.
T Consensus 250 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~ 326 (397)
T 1wak_A 250 ---FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAG 326 (397)
T ss_dssp ---SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHC
T ss_pred ---CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcc
Confidence 2234689999999999999999999999999999999999999976433221 111111111111000
Q ss_pred --cchhcccc-------------------ccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 905 --VLKVLDCE-------------------VASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 905 --~~~~~~~~-------------------~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
...++... .......+....+.+++.+||+.||++|||+.|+++|-
T Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 393 (397)
T 1wak_A 327 KYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHP 393 (397)
T ss_dssp TTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSG
T ss_pred cccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCc
Confidence 00000000 00012355667899999999999999999999999763
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=338.67 Aligned_cols=247 Identities=26% Similarity=0.324 Sum_probs=198.9
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEe----CCeeEE
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLK----GGSSFL 748 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~~~l 748 (973)
.|++.+.||+|+||+||+|.+..++..||+|++... ...+.+.+|+.++++++||||+++++++.. +...++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 467788999999999999999999999999988652 345668899999999999999999999865 356899
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCC--eEecCCCCCCeeec-CCCCeEEecccC
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP--IIHRDIKSSNILLD-EDYEPKIADFGV 825 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~--ivH~Dlkp~Nill~-~~~~~kl~Dfgl 825 (973)
||||+++|+|.+++... ..+++..+..++.|++.||+||| +.+ ++||||||+||+++ .++.+||+|||+
T Consensus 107 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~ 178 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEecCCCCHHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence 99999999999999764 35789999999999999999999 667 99999999999998 789999999999
Q ss_pred cccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccccc
Q 002061 826 AKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENV 905 (973)
Q Consensus 826 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 905 (973)
+...... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.... ...............
T Consensus 179 ~~~~~~~----~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~----~~~~~~~~~~~~~~~- 248 (290)
T 1t4h_A 179 ATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ----NAAQIYRRVTSGVKP- 248 (290)
T ss_dssp GGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS----SHHHHHHHHTTTCCC-
T ss_pred ccccccc----ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcC----cHHHHHHHHhccCCc-
Confidence 9754432 1223568999999998864 58999999999999999999999996532 222222221111110
Q ss_pred chhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 906 LKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
..........+.+++.+||+.||.+|||+.|++++-
T Consensus 249 ---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 284 (290)
T 1t4h_A 249 ---------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHA 284 (290)
T ss_dssp ---------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred ---------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCc
Confidence 011111234688999999999999999999999763
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=350.21 Aligned_cols=257 Identities=22% Similarity=0.319 Sum_probs=195.3
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCC------
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGG------ 744 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------ 744 (973)
..+|++.+.||+|+||+||+|++..+|+.||||++... ...+++.+|+++++.++||||+++++++..+.
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 35789999999999999999999999999999998542 23456789999999999999999999997653
Q ss_pred eeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEeccc
Q 002061 745 SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFG 824 (973)
Q Consensus 745 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 824 (973)
..|+||||+ +++|.+++... .+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~------~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 173 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFG 173 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred eEEEEEecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeee
Confidence 469999999 88999998752 4788999999999999999999 7899999999999999999999999999
Q ss_pred CcccccCCCCcccccccCCcccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccc
Q 002061 825 VAKIAENSPKVSDYSCFAGTHGYIAPELAYT-CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHE 903 (973)
Q Consensus 825 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 903 (973)
+++..... .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.... ..+....+.......+
T Consensus 174 ~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~l~~i~~~~g~~~ 246 (367)
T 1cm8_A 174 LARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD--HLDQLKEIMKVTGTPP 246 (367)
T ss_dssp TCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHHCCCC
T ss_pred cccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHhcCCCC
Confidence 99865432 233568999999999877 679999999999999999999999997541 1111111111000000
Q ss_pred c-c---------ch-------hccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 904 N-V---------LK-------VLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 904 ~-~---------~~-------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
. . .. ...... ..........+.+++.+|++.||++|||+.|+++|
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 247 AEFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 0 0 00 000000 00112234568899999999999999999999996
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=363.09 Aligned_cols=253 Identities=27% Similarity=0.355 Sum_probs=205.9
Q ss_pred HHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeec----cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 002061 673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL 748 (973)
Q Consensus 673 ~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 748 (973)
...++|++.+.||+|+||+||+|++..+++.||||++.. ......+.+|++++++++||||+++++++..+...|+
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 98 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence 345689999999999999999999999999999999864 3456778999999999999999999999999999999
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeec---CCCCeEEecccC
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD---EDYEPKIADFGV 825 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~---~~~~~kl~Dfgl 825 (973)
||||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++ .++.+||+|||+
T Consensus 99 v~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 170 (486)
T 3mwu_A 99 VGELYTGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGL 170 (486)
T ss_dssp EECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSC
T ss_pred EEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCc
Confidence 99999999999998764 35889999999999999999999 78999999999999995 456799999999
Q ss_pred cccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccccc
Q 002061 826 AKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENV 905 (973)
Q Consensus 826 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 905 (973)
++...... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||... . .............
T Consensus 171 a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~--~---~~~~~~~i~~~~~-- 239 (486)
T 3mwu_A 171 STCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK--N---EYDILKRVETGKY-- 239 (486)
T ss_dssp TTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCS--S---HHHHHHHHHHTCC--
T ss_pred CeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC--C---HHHHHHHHHhCCC--
Confidence 98665432 2234579999999999876 5899999999999999999999999653 1 1111111111110
Q ss_pred chhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 906 LKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
.............+.+++.+||+.||.+|||+.|+++|-
T Consensus 240 ------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp 278 (486)
T 3mwu_A 240 ------AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHP 278 (486)
T ss_dssp ------CSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCH
T ss_pred ------CCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCH
Confidence 000111223345688999999999999999999999974
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=342.14 Aligned_cols=253 Identities=25% Similarity=0.298 Sum_probs=202.3
Q ss_pred cCCcccC-cccccCceEEEEEEe--cCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 002061 676 CNLEEDN-LIGSGGTGKVYRLDL--KKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL 748 (973)
Q Consensus 676 ~~~~~~~-~lG~G~~g~V~~a~~--~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 748 (973)
.+|++.+ .||+|+||+||+|.+ ..+++.||||++... ...+.+.+|+++++.++||||+++++++ ..+..++
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 4677777 899999999999954 556789999998653 2356788999999999999999999998 5667899
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccc
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 828 (973)
||||+++++|.+++... ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++..
T Consensus 95 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEECCTTEEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEeCCCCCHHHHHHhC-----cCCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 99999999999999753 34889999999999999999999 78999999999999999999999999999987
Q ss_pred ccCCCCcc-cccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccc
Q 002061 829 AENSPKVS-DYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVL 906 (973)
Q Consensus 829 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 906 (973)
........ ......+++.|+|||++.+..++.++||||||+++|||++ |+.||.... .......+. ....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--~~~~~~~~~----~~~~-- 238 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK--GSEVTAMLE----KGER-- 238 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHH----TTCC--
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHH----cCCC--
Confidence 65433221 1223456789999999988889999999999999999999 999997541 111111111 1110
Q ss_pred hhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 907 KVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
...+......+.+++.+||+.||++||++.++++.|+++
T Consensus 239 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 239 --------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred --------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 011122345688999999999999999999999999875
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=350.66 Aligned_cols=267 Identities=21% Similarity=0.238 Sum_probs=197.3
Q ss_pred HHHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc----cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeE
Q 002061 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF 747 (973)
Q Consensus 672 ~~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 747 (973)
...+++|++.+.||+|+||+||+|++..+++.||||++.... ..+.+.+|++++++++||||+++++++..+...+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 345678999999999999999999999999999999986532 2345778999999999999999999999999999
Q ss_pred EEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeec-----CCCCeEEec
Q 002061 748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD-----EDYEPKIAD 822 (973)
Q Consensus 748 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~-----~~~~~kl~D 822 (973)
+||||++ |+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++ .++.+||+|
T Consensus 110 lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~D 180 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDKN-----PDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGD 180 (329)
T ss_dssp EEEECCS-EEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECC
T ss_pred EEEecCC-CCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECc
Confidence 9999996 5999999753 34889999999999999999999 78999999999999994 455699999
Q ss_pred ccCcccccCCCCcccccccCCccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcc
Q 002061 823 FGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTC-KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNN 901 (973)
Q Consensus 823 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 901 (973)
||+++....... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||.... ..+....+......
T Consensus 181 fg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~~~~~~~~~~~ 256 (329)
T 3gbz_A 181 FGLARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDS--EIDQLFKIFEVLGL 256 (329)
T ss_dssp TTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHHCC
T ss_pred CCCccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCC--HHHHHHHHHHHhCC
Confidence 999987643322 22335679999999999874 48999999999999999999999996541 11111111111110
Q ss_pred ccc--cchh--------ccccccCcc-----hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 902 HEN--VLKV--------LDCEVASES-----IKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 902 ~~~--~~~~--------~~~~~~~~~-----~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
... .... ..+...... .......+.+++.+|++.||++|||+.|+++|-.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 321 (329)
T 3gbz_A 257 PDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321 (329)
T ss_dssp CCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred CchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcc
Confidence 000 0000 000000011 1113356789999999999999999999998643
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=351.78 Aligned_cols=265 Identities=18% Similarity=0.162 Sum_probs=208.2
Q ss_pred HcCCcccCcccccCceEEEEEEecC--------CCcEEEEEeeeccccHHHHHHHHHHHHhcCCCceee-----------
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKK--------NAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILK----------- 735 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~--------~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hpniv~----------- 735 (973)
.++|++.+.||+|+||+||+|++.. .++.||||++... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL 117 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence 3689999999999999999999987 4789999998754 35789999999999999987
Q ss_pred ----EEEEEEe-CCeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCe
Q 002061 736 ----LYACLLK-GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNI 810 (973)
Q Consensus 736 ----l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Ni 810 (973)
+++++.. +...|+||||+ +|+|.+++... ....+++..+..++.|++.||+||| +++|+||||||+||
T Consensus 118 ~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NI 190 (352)
T 2jii_A 118 AIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS---PKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENI 190 (352)
T ss_dssp SCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGE
T ss_pred CccchhhccccCCcEEEEEecCC-CcCHHHHHHhC---CcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHE
Confidence 6777766 77899999999 99999999853 1346899999999999999999999 78999999999999
Q ss_pred eecCCC--CeEEecccCcccccCCCCc-----ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCc
Q 002061 811 LLDEDY--EPKIADFGVAKIAENSPKV-----SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEE 883 (973)
Q Consensus 811 ll~~~~--~~kl~Dfgl~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~ 883 (973)
+++.++ .+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 8999999999766432211 112334789999999999999999999999999999999999999986
Q ss_pred ccCCcccHHHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 002061 884 EYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADP 955 (973)
Q Consensus 884 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 955 (973)
.......+............. ..+.... .......+.+++.+||+.||++||++.++++.|+++..
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 336 (352)
T 2jii_A 271 CLPNTEDIMKQKQKFVDKPGP---FVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQ 336 (352)
T ss_dssp GTTCHHHHHHHHHHHHHSCCC---EECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred CCcCHHHHHHHHHhccCChhh---hhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHH
Confidence 543333333332222221111 1111000 01123568889999999999999999999999998754
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=350.30 Aligned_cols=268 Identities=26% Similarity=0.339 Sum_probs=203.1
Q ss_pred cCHHHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc----cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCe
Q 002061 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYACLLKGGS 745 (973)
Q Consensus 670 ~~~~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 745 (973)
+....+++|++.+.||+|+||+||+|++..+++.||||++.... ..+.+.+|++++++++||||+++++++..++.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 98 (331)
T 4aaa_A 19 LYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKR 98 (331)
T ss_dssp CCCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred hhhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCE
Confidence 33455678999999999999999999999999999999886532 23457789999999999999999999999999
Q ss_pred eEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccC
Q 002061 746 SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGV 825 (973)
Q Consensus 746 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl 825 (973)
.++||||+++++|.++... ...+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||+
T Consensus 99 ~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 170 (331)
T 4aaa_A 99 WYLVFEFVDHTILDDLELF-----PNGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGF 170 (331)
T ss_dssp EEEEEECCSEEHHHHHHHS-----TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEEecCCcchHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCC
Confidence 9999999999998887653 235899999999999999999999 78999999999999999999999999999
Q ss_pred cccccCCCCcccccccCCccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhc----
Q 002061 826 AKIAENSPKVSDYSCFAGTHGYIAPELAYTC-KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLN---- 900 (973)
Q Consensus 826 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~---- 900 (973)
++....... ......||+.|+|||++.+. .++.++||||+||++|+|++|+.||.... ..+....+.....
T Consensus 171 ~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~ 246 (331)
T 4aaa_A 171 ARTLAAPGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS--DIDQLYHIMMCLGNLIP 246 (331)
T ss_dssp C--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCSCCH
T ss_pred ceeecCCcc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCC--cHHHHHHHHHHhCCCCh
Confidence 976543322 22335689999999998775 78999999999999999999999997542 1111111110000
Q ss_pred -------cccccchhcccccc-----CcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 901 -------NHENVLKVLDCEVA-----SESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 901 -------~~~~~~~~~~~~~~-----~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
..+.......+... ..........+.+++.+||+.||++|||+.|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 247 RHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp HHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred hhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000001100 00111235678899999999999999999999876
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=355.94 Aligned_cols=268 Identities=26% Similarity=0.332 Sum_probs=204.7
Q ss_pred CcccCcccccCceEEEEEEe----cCCCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEe--CCeeEE
Q 002061 678 LEEDNLIGSGGTGKVYRLDL----KKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLK--GGSSFL 748 (973)
Q Consensus 678 ~~~~~~lG~G~~g~V~~a~~----~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~l 748 (973)
|++.+.||+|+||+||+|.. ..+++.||||++... ...+.+.+|++++++++||||+++++++.+ ....++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 48899999999999988764 346889999998764 335668899999999999999999999987 467899
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccc
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 828 (973)
||||+++|+|.+++... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++..
T Consensus 113 v~e~~~~~~L~~~l~~~------~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH------SIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp EECCCTTCBHHHHGGGS------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEecccCCcHHHHHhhC------CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccc
Confidence 99999999999999753 3889999999999999999999 78999999999999999999999999999987
Q ss_pred ccCCCCc-ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccch
Q 002061 829 AENSPKV-SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLK 907 (973)
Q Consensus 829 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
....... .......+|..|+|||++.+..++.++||||+|+++|||++|+.||............+..... ......+
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~ 262 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQM-TVLRLTE 262 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHH-HHHHHHH
T ss_pred ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccch-hHHHHHH
Confidence 7544322 1223356788999999999989999999999999999999999999753211000000000000 0000001
Q ss_pred hccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 002061 908 VLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADP 955 (973)
Q Consensus 908 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 955 (973)
.+...............+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 263 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 310 (318)
T 3lxp_A 263 LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310 (318)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 111111111222344578899999999999999999999999998754
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=356.49 Aligned_cols=262 Identities=18% Similarity=0.194 Sum_probs=209.4
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhcCC-CceeeEEEEEEeCCeeEEEEEcc
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRH-RNILKLYACLLKGGSSFLVLEYM 753 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~~~~lv~e~~ 753 (973)
.++|++.+.||+|+||+||+|++..+++.||||++......+++.+|+++++.++| +++..+..++..++..++||||+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~ 85 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence 46899999999999999999999989999999998776666678999999999976 56666667777888999999999
Q ss_pred CCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeee---cCCCCeEEecccCccccc
Q 002061 754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILL---DEDYEPKIADFGVAKIAE 830 (973)
Q Consensus 754 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~Dfgl~~~~~ 830 (973)
+++|.+++... ...+++..+..++.||+.||+||| +++|+||||||+|||+ +.++.+||+|||+++...
T Consensus 86 -g~sL~~ll~~~----~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 86 -GPSLEDLFNFC----SRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp -CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred -CCCHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99999999753 345899999999999999999999 7899999999999999 588999999999998765
Q ss_pred CCCCc-----ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccccc
Q 002061 831 NSPKV-----SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENV 905 (973)
Q Consensus 831 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 905 (973)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+........
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~--~~~~~~~~i~~~~~-- 233 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG--TKKQKYEKISEKKV-- 233 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS--SHHHHHHHHHHHHH--
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccch--hHHHHHHHHhhccc--
Confidence 43321 1122467999999999999999999999999999999999999999765322 11111111110000
Q ss_pred chhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 906 LKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
... ..........++.+++..||+.||++||++.+|++.|+++
T Consensus 234 ~~~-----~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 234 ATS-----IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HSC-----HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred ccc-----HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 000 0001112245788999999999999999999999998865
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=342.23 Aligned_cols=250 Identities=28% Similarity=0.391 Sum_probs=207.0
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE 751 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 751 (973)
...|++.+.||+|+||+||+|++..+++.||||++... ...+.+.+|+.++++++||||+++++++..+...++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 35689999999999999999999988999999998653 345778999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccC
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 831 (973)
|+++++|.+++.. ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||.+.....
T Consensus 101 ~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 171 (303)
T 3a7i_A 101 YLGGGSALDLLEP------GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 171 (303)
T ss_dssp CCTTEEHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred eCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCc
Confidence 9999999999863 35889999999999999999999 78999999999999999999999999999976654
Q ss_pred CCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccc
Q 002061 832 SPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDC 911 (973)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (973)
... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||.... ............. +
T Consensus 172 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~-------~ 237 (303)
T 3a7i_A 172 TQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH-----PMKVLFLIPKNNP-------P 237 (303)
T ss_dssp TBC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-----HHHHHHHHHHSCC-------C
T ss_pred ccc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC-----HHHHHHHhhcCCC-------C
Confidence 321 2234568999999999999999999999999999999999999996531 1111111111110 0
Q ss_pred cccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 912 EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 912 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
.. .......+.+++.+||+.||++|||+.|++++..
T Consensus 238 ~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 238 TL----EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp CC----CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred CC----ccccCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence 11 1122345888999999999999999999998654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=338.81 Aligned_cols=252 Identities=24% Similarity=0.317 Sum_probs=208.2
Q ss_pred HHHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCee
Q 002061 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSS 746 (973)
Q Consensus 672 ~~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 746 (973)
.....+|++.+.||+|+||+||+|++..+++.||+|++... ...+.+.+|+++++.++||||+++++++.+++..
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (294)
T 2rku_A 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 90 (294)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEE
Confidence 34456899999999999999999999999999999988653 2456688999999999999999999999999999
Q ss_pred EEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCc
Q 002061 747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826 (973)
Q Consensus 747 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~ 826 (973)
++||||+++++|.+++... ..+++..+..++.|+++|++||| +.+++||||||+||+++.++.+||+|||.+
T Consensus 91 ~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 162 (294)
T 2rku_A 91 FVVLELCRRRSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 162 (294)
T ss_dssp EEEEECCTTCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCc
Confidence 9999999999999988754 35889999999999999999999 789999999999999999999999999999
Q ss_pred ccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccc
Q 002061 827 KIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVL 906 (973)
Q Consensus 827 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 906 (973)
........ ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||.... ..............
T Consensus 163 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~-- 233 (294)
T 2rku_A 163 TKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC-----LKETYLRIKKNEYS-- 233 (294)
T ss_dssp EECCSTTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHHTTCCC--
T ss_pred eecccCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHhhccCC--
Confidence 86643322 2233568999999999999889999999999999999999999996531 11111111111110
Q ss_pred hhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 907 KVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
. +......+.+++.+|++.||++||++.|++++-
T Consensus 234 ------~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~ 267 (294)
T 2rku_A 234 ------I----PKHINPVAASLIQKMLQTDPTARPTINELLNDE 267 (294)
T ss_dssp ------C----CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred ------C----ccccCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 0 112234578899999999999999999999864
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=365.42 Aligned_cols=193 Identities=26% Similarity=0.408 Sum_probs=154.8
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeC-----Cee
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKG-----GSS 746 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~ 746 (973)
++|++.+.||+|+||+||+|++..+++.||||++... ...+++.+|++++++++||||+++++++... ...
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 6899999999999999999999999999999998652 3456788999999999999999999998543 568
Q ss_pred EEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCc
Q 002061 747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826 (973)
Q Consensus 747 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~ 826 (973)
|+||||+ +|+|.+++.. ...+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 133 ~lv~e~~-~~~L~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRT-----PVYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp EEEECCC-SEEHHHHHHS-----SCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEecc-ccchhhhccc-----CCCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccc
Confidence 9999998 6799998864 245899999999999999999999 789999999999999999999999999999
Q ss_pred ccccCCCCc-------------------------ccccccCCcccccccccc-ccCCCCccchHHHHHHHHHHHHhC
Q 002061 827 KIAENSPKV-------------------------SDYSCFAGTHGYIAPELA-YTCKVSEKSDVFSFGVVLLELVTG 877 (973)
Q Consensus 827 ~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~~l~el~tg 877 (973)
+........ ......+||+.|+|||++ .+..++.++|||||||++|||++|
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 876432211 122345789999999986 566799999999999999999993
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=356.28 Aligned_cols=256 Identities=29% Similarity=0.383 Sum_probs=194.7
Q ss_pred CCcccCcccccCceEEEEEEecCC---CcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEe-CCeeEEE
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKN---AGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLK-GGSSFLV 749 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~---~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~~lv 749 (973)
.|++.+.||+|+||+||+|++..+ +..||||.+... ...+.+.+|+.++++++||||+++++++.. ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 467788999999999999998643 346899988652 345678999999999999999999998754 5678999
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccc
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 829 (973)
|||+++|+|.+++... ...+++..+..++.|+++||+||| +++|+||||||+||+++.++.+||+|||+++..
T Consensus 170 ~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp EECCTTCBHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EECCCCCCHHHHHhhc----ccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeeccccccc
Confidence 9999999999999753 345788999999999999999999 789999999999999999999999999999866
Q ss_pred cCCCCc--ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccc
Q 002061 830 ENSPKV--SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVL 906 (973)
Q Consensus 830 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 906 (973)
...... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.... ..+....+.... .
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~--~~~~~~~~~~~~---~--- 314 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN--TFDITVYLLQGR---R--- 314 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC--SSCHHHHHHTTC---C---
T ss_pred cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCC--HHHHHHHHHcCC---C---
Confidence 433211 11223457889999999999999999999999999999999 677876542 222222221110 0
Q ss_pred hhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 002061 907 KVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADP 955 (973)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 955 (973)
.. .+......+.+++.+||+.||++||++.|++++|+++..
T Consensus 315 -~~-------~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~ 355 (373)
T 3c1x_A 315 -LL-------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 355 (373)
T ss_dssp -CC-------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CC-------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 00 011223468899999999999999999999999998754
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=340.12 Aligned_cols=249 Identities=18% Similarity=0.228 Sum_probs=201.3
Q ss_pred HHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeE
Q 002061 673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSF 747 (973)
Q Consensus 673 ~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 747 (973)
...++|++.+.||+|+||+||+|++..+++.||||++... .....+.+|+..+.++ +||||+++++++.+++..+
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~ 87 (289)
T 1x8b_A 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML 87 (289)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence 4567899999999999999999999988999999998752 3456678899999999 9999999999999999999
Q ss_pred EEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCC------------
Q 002061 748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDED------------ 815 (973)
Q Consensus 748 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~------------ 815 (973)
+||||+++|+|.+++..... ....+++..+..++.|++.||+||| +++|+||||||+||+++.+
T Consensus 88 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~ 163 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYR-IMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDE 163 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC--------------
T ss_pred EEEEecCCCcHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCccccccccc
Confidence 99999999999999986422 2245899999999999999999999 7899999999999999844
Q ss_pred -------CCeEEecccCcccccCCCCcccccccCCccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccCC
Q 002061 816 -------YEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTC-KVSEKSDVFSFGVVLLELVTGRKPVEEEYGD 887 (973)
Q Consensus 816 -------~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~pf~~~~~~ 887 (973)
..+||+|||.+....... ...||+.|+|||++.+. .++.++|||||||++|+|++|..|+...
T Consensus 164 ~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--- 234 (289)
T 1x8b_A 164 DDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG--- 234 (289)
T ss_dssp ------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS---
T ss_pred ccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch---
Confidence 479999999998665432 23589999999999766 5668999999999999999998876432
Q ss_pred cccHHHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 888 GKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 888 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
...... . .... +.. +......+.+++.+||+.||++|||+.|++++-
T Consensus 235 -~~~~~~-~--~~~~--------~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 281 (289)
T 1x8b_A 235 -DQWHEI-R--QGRL--------PRI----PQVLSQEFTELLKVMIHPDPERRPSAMALVKHS 281 (289)
T ss_dssp -HHHHHH-H--TTCC--------CCC----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCT
T ss_pred -hHHHHH-H--cCCC--------CCC----CcccCHHHHHHHHHHhCCCcccCCCHHHHhhCh
Confidence 111111 1 0000 011 112234688899999999999999999999764
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=346.99 Aligned_cols=254 Identities=23% Similarity=0.347 Sum_probs=205.2
Q ss_pred HHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc----------cHHHHHHHHHHHHhc-CCCceeeEEEEEE
Q 002061 673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----------GVKVFAAEMEILGKI-RHRNILKLYACLL 741 (973)
Q Consensus 673 ~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----------~~~~~~~E~~~l~~l-~hpniv~l~~~~~ 741 (973)
....+|++.+.||+|+||.||+|++..+|+.||||++.... ..+.+.+|+.+++++ +||||+++++++.
T Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 170 (365)
T 2y7j_A 91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE 170 (365)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence 34567999999999999999999999889999999886532 135678899999999 8999999999999
Q ss_pred eCCeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEe
Q 002061 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIA 821 (973)
Q Consensus 742 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 821 (973)
.....|+||||+++|+|.+++... ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+
T Consensus 171 ~~~~~~lv~e~~~g~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~ 242 (365)
T 2y7j_A 171 SSSFMFLVFDLMRKGELFDYLTEK-----VALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLS 242 (365)
T ss_dssp BSSEEEEEECCCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEEC
T ss_pred eCCEEEEEEEeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEE
Confidence 999999999999999999999753 35889999999999999999999 7899999999999999999999999
Q ss_pred cccCcccccCCCCcccccccCCcccccccccccc------CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHH
Q 002061 822 DFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYT------CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWV 895 (973)
Q Consensus 822 Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~ 895 (973)
|||++........ .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... .....
T Consensus 243 DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~-----~~~~~ 314 (365)
T 2y7j_A 243 DFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR-----QILML 314 (365)
T ss_dssp CCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHH
T ss_pred ecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC-----HHHHH
Confidence 9999987654322 234578999999999863 358889999999999999999999996531 11111
Q ss_pred HHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 896 STHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
......... ............+.+++.+|++.||++||++.|++++-
T Consensus 315 ~~i~~~~~~--------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 361 (365)
T 2y7j_A 315 RMIMEGQYQ--------FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHP 361 (365)
T ss_dssp HHHHHTCCC--------CCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred HHHHhCCCC--------CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence 111111100 00000112235688999999999999999999999863
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=340.81 Aligned_cols=251 Identities=24% Similarity=0.303 Sum_probs=203.9
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc--ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY 752 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 752 (973)
.++|++.+.||+|+||+||+|++..+++.||||++... ...+.+.+|++++++++||||+++++++.+++..|+||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 45789999999999999999999988999999998763 2345688999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeee---cCCCCeEEecccCcccc
Q 002061 753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILL---DEDYEPKIADFGVAKIA 829 (973)
Q Consensus 753 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~Dfgl~~~~ 829 (973)
+++|+|.+++... ..+++..+..++.|++.||+||| +.+++||||||+||++ +.++.+||+|||++...
T Consensus 88 ~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 88 VSGGELFDRILER-----GVYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp CCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred CCCccHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 9999999998754 25789999999999999999999 7899999999999999 77889999999998754
Q ss_pred cCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhc
Q 002061 830 ENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVL 909 (973)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (973)
... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||.... . .............
T Consensus 160 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~---~~~~~~i~~~~~~----- 225 (304)
T 2jam_A 160 QNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET--E---SKLFEKIKEGYYE----- 225 (304)
T ss_dssp CCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC--H---HHHHHHHHHCCCC-----
T ss_pred CCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC--H---HHHHHHHHcCCCC-----
Confidence 322 2223468999999999999999999999999999999999999996531 1 1111111111100
Q ss_pred cccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 910 DCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 910 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
............+.+++.+|++.||++||++.|++++-
T Consensus 226 ---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 263 (304)
T 2jam_A 226 ---FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHP 263 (304)
T ss_dssp ---CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred ---CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence 00111122345688999999999999999999999854
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=358.28 Aligned_cols=256 Identities=25% Similarity=0.311 Sum_probs=196.9
Q ss_pred HHHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc----------cHHHHHHHHHHHHhcCCCceeeEEEEEE
Q 002061 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----------GVKVFAAEMEILGKIRHRNILKLYACLL 741 (973)
Q Consensus 672 ~~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----------~~~~~~~E~~~l~~l~hpniv~l~~~~~ 741 (973)
....++|++.+.||+|+||+||+|.+..+++.||||++.... ....+.+|++++++++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 445678999999999999999999999999999999986531 1224789999999999999999999875
Q ss_pred eCCeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCC---Ce
Q 002061 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY---EP 818 (973)
Q Consensus 742 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~ 818 (973)
.+..|+||||+++|+|.+++.. ...+++..+..++.|++.||+||| +++|+||||||+||+++.++ .+
T Consensus 211 -~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~ 281 (419)
T 3i6u_A 211 -AEDYYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLI 281 (419)
T ss_dssp -SSEEEEEEECCTTCBGGGGTSS-----SCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCE
T ss_pred -cCceEEEEEcCCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceE
Confidence 4568999999999999888753 345899999999999999999999 78999999999999997544 59
Q ss_pred EEecccCcccccCCCCcccccccCCcccccccccccc---CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHH
Q 002061 819 KIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYT---CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWV 895 (973)
Q Consensus 819 kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~ 895 (973)
||+|||+++...... ......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||...... ......+
T Consensus 282 kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~~i 357 (419)
T 3i6u_A 282 KITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ-VSLKDQI 357 (419)
T ss_dssp EECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS-CCHHHHH
T ss_pred EEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch-HHHHHHH
Confidence 999999998664332 2234578999999999853 56788999999999999999999999754221 1222221
Q ss_pred HHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 896 STHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
..... .............+.+++.+|++.||++||++.|+++|-.
T Consensus 358 ~~~~~-----------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 402 (419)
T 3i6u_A 358 TSGKY-----------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPW 402 (419)
T ss_dssp HTTCC-----------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred hcCCC-----------CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcc
Confidence 11100 0011111223456889999999999999999999998743
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=339.48 Aligned_cols=255 Identities=27% Similarity=0.381 Sum_probs=206.0
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM 753 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 753 (973)
.++|++.+.||+|+||+||+|++.. +..||||++... ...+.+.+|++++++++||||+++++++. ++..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcC-CcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence 3578899999999999999999864 678999998763 35678899999999999999999999876 45689999999
Q ss_pred CCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCC
Q 002061 754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833 (973)
Q Consensus 754 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 833 (973)
++++|.+++.... ...+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||.+.......
T Consensus 90 ~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 90 ENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (279)
T ss_dssp TTCBHHHHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred CCCCHHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence 9999999986431 125889999999999999999999 7899999999999999999999999999998765432
Q ss_pred CcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhcccc
Q 002061 834 KVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCE 912 (973)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (973)
. .......++..|+|||++.+..++.++||||||+++|||++ |+.||.... .............
T Consensus 164 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-----~~~~~~~~~~~~~--------- 228 (279)
T 1qpc_A 164 Y-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-----NPEVIQNLERGYR--------- 228 (279)
T ss_dssp E-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-----HHHHHHHHHTTCC---------
T ss_pred c-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC-----HHHHHHHHhcccC---------
Confidence 2 22223456789999999988889999999999999999999 999996531 1111111111100
Q ss_pred ccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 002061 913 VASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADAD 954 (973)
Q Consensus 913 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 954 (973)
..........+.+++.+|++.||++|||+.++++.|+++.
T Consensus 229 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 268 (279)
T 1qpc_A 229 --MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (279)
T ss_dssp --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 0011122356889999999999999999999999998764
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=375.87 Aligned_cols=258 Identities=23% Similarity=0.306 Sum_probs=202.0
Q ss_pred cccccCceEEEEEEec--CCCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCCc
Q 002061 683 LIGSGGTGKVYRLDLK--KNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGN 757 (973)
Q Consensus 683 ~lG~G~~g~V~~a~~~--~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gs 757 (973)
.||+|+||+||+|.+. .++..||||+++.. ...+.+.+|++++++++||||+++++++.. +..|+||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999876 34667999998763 356789999999999999999999999876 56899999999999
Q ss_pred hHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCc-c
Q 002061 758 LFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV-S 836 (973)
Q Consensus 758 L~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~ 836 (973)
|.+++... ...+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++........ .
T Consensus 422 L~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 494 (613)
T 2ozo_A 422 LHKFLVGK----REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 494 (613)
T ss_dssp HHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-------
T ss_pred HHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceee
Confidence 99999643 346899999999999999999999 789999999999999999999999999999876433221 1
Q ss_pred cccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhccccccC
Q 002061 837 DYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVAS 915 (973)
Q Consensus 837 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (973)
......+++.|+|||++.+..++.++|||||||++|||++ |+.||.... ..+....+... . ..
T Consensus 495 ~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~--~~~~~~~i~~~----~----------~~ 558 (613)
T 2ozo_A 495 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK--GPEVMAFIEQG----K----------RM 558 (613)
T ss_dssp -------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--SHHHHHHHHTT----C----------CC
T ss_pred eccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC--HHHHHHHHHcC----C----------CC
Confidence 1223345789999999999999999999999999999998 999997642 22222222111 1 00
Q ss_pred cchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCCCCCCCCCC
Q 002061 916 ESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPCTDKSPDNS 964 (973)
Q Consensus 916 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~~~~~~ 964 (973)
..+......+.+++.+||+.||++||++.+|++.|+.+-.......+..
T Consensus 559 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~~~~ 607 (613)
T 2ozo_A 559 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGG 607 (613)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSCCCS
T ss_pred CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccccCCc
Confidence 1112334578899999999999999999999999998654433333333
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=362.80 Aligned_cols=251 Identities=27% Similarity=0.325 Sum_probs=201.6
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV 749 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 749 (973)
..++|++.+.||+|+||+||+|++..++..||||++... .....+.+|+++++.++||||+++++++..+...|+|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 345799999999999999999999999999999998752 3456788999999999999999999999999999999
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecC---CCCeEEecccCc
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE---DYEPKIADFGVA 826 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~Dfgl~ 826 (973)
|||+++|+|.+++... ..+++..+..++.|+++||+||| +.+|+||||||+||+++. ++.+||+|||++
T Consensus 115 ~e~~~~g~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a 186 (494)
T 3lij_A 115 MECYKGGELFDEIIHR-----MKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLS 186 (494)
T ss_dssp EECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence 9999999999998754 35889999999999999999999 789999999999999976 455999999999
Q ss_pred ccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccc
Q 002061 827 KIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVL 906 (973)
Q Consensus 827 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 906 (973)
....... ......||+.|+|||++. ..++.++||||+||++|+|++|+.||.... ..............
T Consensus 187 ~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~-----~~~~~~~i~~~~~~-- 255 (494)
T 3lij_A 187 AVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT-----DQEILRKVEKGKYT-- 255 (494)
T ss_dssp EECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHTCCC--
T ss_pred eECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhCCCC--
Confidence 8765432 223457999999999986 569999999999999999999999997531 11121111111110
Q ss_pred hhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 907 KVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
............+.+++.+||+.||.+|||+.|+++|
T Consensus 256 ------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 256 ------FDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp ------CCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ------CCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 0011112334568899999999999999999999976
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=343.82 Aligned_cols=272 Identities=25% Similarity=0.323 Sum_probs=214.2
Q ss_pred cCHHHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHh--cCCCceeeEEEEEEeCC---
Q 002061 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGK--IRHRNILKLYACLLKGG--- 744 (973)
Q Consensus 670 ~~~~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~--l~hpniv~l~~~~~~~~--- 744 (973)
+.....++|++.+.||+|+||+||+|++. ++.||||++... ....+.+|+++++. ++||||+++++++..+.
T Consensus 36 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~-~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 36 VQRTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR-EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHHHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECGG-GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred ecccccccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCch-hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 33455678999999999999999999985 889999998654 34567889999887 78999999999998775
Q ss_pred -eeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcC-----CCCeEecCCCCCCeeecCCCCe
Q 002061 745 -SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC-----SPPIIHRDIKSSNILLDEDYEP 818 (973)
Q Consensus 745 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~-----~~~ivH~Dlkp~Nill~~~~~~ 818 (973)
..++||||+++|+|.+++... .+++..+..++.|++.||+|||... +.+|+||||||+||+++.++.+
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~ 186 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 186 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCE
T ss_pred ceeEEEEeecCCCcHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCE
Confidence 789999999999999999753 4889999999999999999999421 3689999999999999999999
Q ss_pred EEecccCcccccCCCCcc--cccccCCccccccccccccC------CCCccchHHHHHHHHHHHHhC----------CCC
Q 002061 819 KIADFGVAKIAENSPKVS--DYSCFAGTHGYIAPELAYTC------KVSEKSDVFSFGVVLLELVTG----------RKP 880 (973)
Q Consensus 819 kl~Dfgl~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~~l~el~tg----------~~p 880 (973)
||+|||++.......... ......||+.|+|||++.+. .++.++|||||||++|||++| +.|
T Consensus 187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p 266 (342)
T 1b6c_B 187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266 (342)
T ss_dssp EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence 999999998765443221 22345789999999998765 234689999999999999999 788
Q ss_pred CCcccCCcccHHHHHHHHhccccccchhccccccC-cchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCC
Q 002061 881 VEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVAS-ESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPC 956 (973)
Q Consensus 881 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~ 956 (973)
|............+......... .+.... ....+....+.+++.+||+.||++|||+.||+++|+++...
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 267 YYDLVPSDPSVEEMRKVVCEQKL------RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCC------CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ccccCcCcccHHHHHHHHHHHHh------CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence 87654433344444333221111 111111 11235567889999999999999999999999999987543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=353.63 Aligned_cols=265 Identities=23% Similarity=0.347 Sum_probs=205.5
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL 750 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 750 (973)
..++|++.+.||+|+||+||+|++..+++.||+|++... ...+.+.+|++++++++||||+++++++..++..++||
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 110 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 110 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence 346799999999999999999999999999999998753 33467889999999999999999999999999999999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccccc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 830 (973)
||+++|+|.+++... ..+++..+..++.|++.|++|||+ ..+|+||||||+||+++.++.+||+|||++....
T Consensus 111 e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 111 EHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp CCCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred ECCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH--hCCEEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence 999999999999764 247899999999999999999993 1389999999999999999999999999987553
Q ss_pred CCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhc----------
Q 002061 831 NSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLN---------- 900 (973)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~---------- 900 (973)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ............
T Consensus 184 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 257 (360)
T 3eqc_A 184 DS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA--KELELMFGCQVEGDAAETPPRP 257 (360)
T ss_dssp HH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCH--HHHHHHHC--------------
T ss_pred cc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHhcccccccCCCCCCCc
Confidence 22 12235689999999999999999999999999999999999999975321 111110000000
Q ss_pred ---------------ccccc----chhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 901 ---------------NHENV----LKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 901 ---------------~~~~~----~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
..... ...................+.+++.+||+.||++|||+.|+++|-.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 327 (360)
T 3eqc_A 258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 327 (360)
T ss_dssp ----------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred ccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence 00000 0000000000011123456889999999999999999999998643
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=355.45 Aligned_cols=198 Identities=25% Similarity=0.315 Sum_probs=174.0
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc-cHHHHHHHHHHHHhc------CCCceeeEEEEEEeCCeeE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKI------RHRNILKLYACLLKGGSSF 747 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l------~hpniv~l~~~~~~~~~~~ 747 (973)
..+|++.+.||+|+||+||+|++..+++.||||++.... ....+.+|+++++.+ .|+||+++++++......+
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 457999999999999999999999999999999987643 345677899988887 5779999999999999999
Q ss_pred EEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCC--eEEecccC
Q 002061 748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE--PKIADFGV 825 (973)
Q Consensus 748 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~--~kl~Dfgl 825 (973)
+||||++ ++|.+++... ....+++..+..++.|++.||+||| +.+|+||||||+|||++.++. +||+|||+
T Consensus 176 lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 176 MTFELLS-MNLYELIKKN---KFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEECCCC-CBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEeccC-CCHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence 9999995 6999999764 2345899999999999999999999 779999999999999999887 99999999
Q ss_pred cccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcc
Q 002061 826 AKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEE 884 (973)
Q Consensus 826 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~ 884 (973)
++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 249 a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 249 SCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp CEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 9755432 22356899999999999999999999999999999999999999754
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=342.55 Aligned_cols=253 Identities=22% Similarity=0.281 Sum_probs=189.0
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc----cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL 750 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 750 (973)
.++|++.+.||+|+||+||+|++..+++.||||++.... ..+.+.++...++.++||||+++++++.+++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 467899999999999999999999899999999986532 2223444555578889999999999999999999999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCC-CeEecCCCCCCeeecCCCCeEEecccCcccc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP-PIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~-~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 829 (973)
||++ |+|.+++..... ....+++..+..++.|++.|++||| ++ +++||||||+||+++.++.+||+|||++...
T Consensus 86 e~~~-~~l~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVID-KGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp ECCS-EEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred ehhc-cchHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 9996 699888875422 3456899999999999999999999 66 9999999999999999999999999999766
Q ss_pred cCCCCcccccccCCcccccccccc----ccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccccc
Q 002061 830 ENSPKVSDYSCFAGTHGYIAPELA----YTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENV 905 (973)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 905 (973)
..... .....||+.|+|||++ .+..++.++||||+||++|||++|+.||..... . .............
T Consensus 161 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~-~~~~~~~~~~~~~- 232 (290)
T 3fme_A 161 VDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT---P-FQQLKQVVEEPSP- 232 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC---H-HHHHHHHHHSCCC-
T ss_pred ccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc---h-HHHHHHHhccCCC-
Confidence 44322 2234689999999996 566789999999999999999999999964321 1 1111111111110
Q ss_pred chhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 906 LKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
..........+.+++.+|++.||++|||+.|++++
T Consensus 233 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 233 ---------QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp ---------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred ---------CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 00111234568899999999999999999999884
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=343.04 Aligned_cols=258 Identities=30% Similarity=0.384 Sum_probs=201.2
Q ss_pred HcCCcccCcccccCceEEEEEEecCC---CcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEE-eCCeeE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKN---AGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLL-KGGSSF 747 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~---~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~~ 747 (973)
..+|++.+.||+|+||+||+|++..+ ...||||++... ...+.+.+|++++++++||||+++++++. .++..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 34688899999999999999997543 346899987653 34467889999999999999999999864 566789
Q ss_pred EEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcc
Q 002061 748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827 (973)
Q Consensus 748 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~ 827 (973)
+||||+++|+|.+++... ...+++..+..++.|++.||+||| +++++||||||+||+++.++.+||+|||+++
T Consensus 104 ~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~ 176 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176 (298)
T ss_dssp EEEECCTTCBHHHHHHCT----TCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred EEEeCCCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECcccccc
Confidence 999999999999999753 345789999999999999999999 7899999999999999999999999999997
Q ss_pred cccCCCC--cccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccc
Q 002061 828 IAENSPK--VSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHEN 904 (973)
Q Consensus 828 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 904 (973)
....... ........+|+.|+|||++.+..++.++||||+|+++|||++ |..||... ...+....+......
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~~~~~~~~~--- 251 (298)
T 3f66_A 177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV--NTFDITVYLLQGRRL--- 251 (298)
T ss_dssp CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTS--CTTTHHHHHHTTCCC---
T ss_pred cccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccC--CHHHHHHHHhcCCCC---
Confidence 6643221 112233467889999999999999999999999999999999 55566543 222222221111100
Q ss_pred cchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 002061 905 VLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADP 955 (973)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 955 (973)
. .+......+.+++.+||+.||++||++.|+++.|+++..
T Consensus 252 ----~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 252 ----L-------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp ----C-------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----C-------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0 011123468889999999999999999999999998754
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=361.11 Aligned_cols=244 Identities=14% Similarity=0.143 Sum_probs=191.0
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeec-----cccHHHHHHHHH---HHHhcCCCceeeEE-------EE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEME---ILGKIRHRNILKLY-------AC 739 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~-----~~~~~~~~~E~~---~l~~l~hpniv~l~-------~~ 739 (973)
..+|++.+.||+|+||+||+|++..+++.||||++.. ....+.+.+|++ .+++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 3578899999999999999999998899999999864 234577889994 55556899999998 66
Q ss_pred EEeCCe-----------------eEEEEEccCCCchHHHHHhhhcCC--CCCCCHHHHHHHHHHHHHHHhhhhhcCCCCe
Q 002061 740 LLKGGS-----------------SFLVLEYMPNGNLFQALHKRVKEG--KPELDWFRRYKIALGAAKGIAYLHHDCSPPI 800 (973)
Q Consensus 740 ~~~~~~-----------------~~lv~e~~~~gsL~~~l~~~~~~~--~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~i 800 (973)
+..++. .|+||||+ +|+|.+++....... ...+++..+..++.|++.||+||| +++|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence 665532 78999999 689999998643221 233556888899999999999999 7899
Q ss_pred EecCCCCCCeeecCCCCeEEecccCcccccCCCCcccccccCCccccccccccccC-----------CCCccchHHHHHH
Q 002061 801 IHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTC-----------KVSEKSDVFSFGV 869 (973)
Q Consensus 801 vH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwslG~ 869 (973)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999985432 2233467 999999999887 8999999999999
Q ss_pred HHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 870 VLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 870 ~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
++|||++|+.||....... ....+... . ......+.+++.+||+.||++||++.|++++
T Consensus 302 il~elltg~~Pf~~~~~~~---------------~~~~~~~~-~-----~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALG---------------GSEWIFRS-C-----KNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHHHSSCCC------C---------------CSGGGGSS-C-----CCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHHHHHCCCCCccccccc---------------chhhhhhh-c-----cCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 9999999999996542110 00111110 0 1123468889999999999999999999874
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=370.99 Aligned_cols=260 Identities=28% Similarity=0.410 Sum_probs=209.4
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM 753 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 753 (973)
.++|++.+.||+|+||+||+|++.. +..||||++... ...+.+.+|++++++++||||+++++++.+ +..|+||||+
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 4567889999999999999999986 567999998763 356789999999999999999999999866 6789999999
Q ss_pred CCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCC
Q 002061 754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833 (973)
Q Consensus 754 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 833 (973)
++|+|.+++.... ...+++..+..++.||++||+||| +++|+||||||+|||++.++.+||+|||+++......
T Consensus 344 ~~gsL~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 344 SKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp TTEEHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred cCCcHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 9999999997531 234789999999999999999999 7899999999999999999999999999998654321
Q ss_pred CcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhcccc
Q 002061 834 KVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCE 912 (973)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (973)
........++..|+|||++.+..++.++|||||||++|||++ |+.||.... .......+. ...
T Consensus 418 -~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~--~~~~~~~i~----~~~--------- 481 (535)
T 2h8h_A 418 -YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVLDQVE----RGY--------- 481 (535)
T ss_dssp -HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC--HHHHHHHHH----TTC---------
T ss_pred -eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHH----cCC---------
Confidence 111223456789999999998999999999999999999999 999996531 111111111 110
Q ss_pred ccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCCCCC
Q 002061 913 VASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPCTDK 959 (973)
Q Consensus 913 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~ 959 (973)
...........+.+++.+||+.||++|||+.+|++.|+++.....+
T Consensus 482 -~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~ 527 (535)
T 2h8h_A 482 -RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527 (535)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred -CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCc
Confidence 0011122345688999999999999999999999999998655443
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=362.10 Aligned_cols=253 Identities=27% Similarity=0.310 Sum_probs=204.5
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc---------------ccHHHHHHHHHHHHhcCCCceeeEEE
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---------------DGVKVFAAEMEILGKIRHRNILKLYA 738 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---------------~~~~~~~~E~~~l~~l~hpniv~l~~ 738 (973)
..++|++.+.||+|+||+||+|++..+++.||||++... ...+.+.+|++++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 457899999999999999999999999999999998652 23467889999999999999999999
Q ss_pred EEEeCCeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCC--
Q 002061 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY-- 816 (973)
Q Consensus 739 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-- 816 (973)
++.++...|+||||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~ 185 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR-----HKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSL 185 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCC
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCC
Confidence 999999999999999999999999764 35899999999999999999999 78999999999999998876
Q ss_pred -CeEEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHH
Q 002061 817 -EPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWV 895 (973)
Q Consensus 817 -~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~ 895 (973)
.+||+|||++....... ......||+.|+|||++. ..++.++||||+||++|+|++|+.||... +.....
T Consensus 186 ~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~-----~~~~~~ 256 (504)
T 3q5i_A 186 LNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQ-----NDQDII 256 (504)
T ss_dssp SSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHH
T ss_pred ccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCC-----CHHHHH
Confidence 69999999998765432 223456999999999986 46899999999999999999999999753 111222
Q ss_pred HHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 896 STHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
......... ............+.+++.+|+++||.+|||+.|++++-.
T Consensus 257 ~~i~~~~~~--------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 304 (504)
T 3q5i_A 257 KKVEKGKYY--------FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRW 304 (504)
T ss_dssp HHHHHCCCC--------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HHHHcCCCC--------CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHh
Confidence 111111100 000111223456889999999999999999999998643
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=344.57 Aligned_cols=251 Identities=24% Similarity=0.322 Sum_probs=208.0
Q ss_pred HHHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCee
Q 002061 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSS 746 (973)
Q Consensus 672 ~~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 746 (973)
.....+|++.+.||+|+||+||+|++..+++.||+|++... ...+.+.+|+.++++++||||+++++++.+++..
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 116 (335)
T 2owb_A 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 116 (335)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence 34557899999999999999999999999999999998653 3456788999999999999999999999999999
Q ss_pred EEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCc
Q 002061 747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826 (973)
Q Consensus 747 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~ 826 (973)
|+||||+++++|.+++... ..+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++
T Consensus 117 ~lv~e~~~~~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 188 (335)
T 2owb_A 117 FVVLELCRRRSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 188 (335)
T ss_dssp EEEECCCTTCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEecCCCCCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCc
Confidence 9999999999999998753 35889999999999999999999 789999999999999999999999999999
Q ss_pred ccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccc
Q 002061 827 KIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVL 906 (973)
Q Consensus 827 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 906 (973)
........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||.... ...............
T Consensus 189 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~~~~~~~~~~~~~~- 260 (335)
T 2owb_A 189 TKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC-----LKETYLRIKKNEYSI- 260 (335)
T ss_dssp EECCSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHHHTCCCC-
T ss_pred eecccCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC-----HHHHHHHHhcCCCCC-
Confidence 87643322 2233568999999999999899999999999999999999999996531 111111111111100
Q ss_pred hhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 907 KVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
.......+.+++.+||+.||++||++.|++++
T Consensus 261 -----------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 261 -----------PKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp -----------CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -----------CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01123457789999999999999999999985
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=352.75 Aligned_cols=264 Identities=21% Similarity=0.266 Sum_probs=199.0
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhcCCCceeeEEEEEEe-----------
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLK----------- 742 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----------- 742 (973)
...+|++.+.||+|+||+||+|++..+++.||||++..... ...+|+++++.++||||+++++++..
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~--~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 82 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR--YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQP 82 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT--SCCHHHHHHTTCCCTTBCCEEEEEEEC----------
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc--hHHHHHHHHHHcCCCCccchhheeeecCccccccccc
Confidence 34689999999999999999999999999999998865432 23579999999999999999999844
Q ss_pred ---------------------------CCeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhc
Q 002061 743 ---------------------------GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHD 795 (973)
Q Consensus 743 ---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~ 795 (973)
....++||||++ |+|.+.+..... ....+++..+..++.|+++||+|||
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH-- 158 (383)
T 3eb0_A 83 PDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIR-SGRSIPMNLISIYIYQLFRAVGFIH-- 158 (383)
T ss_dssp ---------------------------CCEEEEEECCCS-EEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHH--
T ss_pred ccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH--
Confidence 334789999997 688888876432 3456899999999999999999999
Q ss_pred CCCCeEecCCCCCCeeec-CCCCeEEecccCcccccCCCCcccccccCCccccccccccccC-CCCccchHHHHHHHHHH
Q 002061 796 CSPPIIHRDIKSSNILLD-EDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTC-KVSEKSDVFSFGVVLLE 873 (973)
Q Consensus 796 ~~~~ivH~Dlkp~Nill~-~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~e 873 (973)
+.+|+||||||+||+++ .++.+||+|||+++....... .....||+.|+|||++.+. .++.++||||+||++||
T Consensus 159 -~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e 234 (383)
T 3eb0_A 159 -SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234 (383)
T ss_dssp -TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred -HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHH
Confidence 88999999999999998 688999999999986644322 2235689999999998765 48999999999999999
Q ss_pred HHhCCCCCCcccCCcccHHHHHHHHhcc---------ccccchhccccccCc-----chHHHHHHHHHHHHHhcCCCCCC
Q 002061 874 LVTGRKPVEEEYGDGKDIVYWVSTHLNN---------HENVLKVLDCEVASE-----SIKEDMIKLLKIAVVCTTKLPNL 939 (973)
Q Consensus 874 l~tg~~pf~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~-----~~~~~~~~l~~l~~~cl~~dP~~ 939 (973)
|++|+.||..... .......+.. ... .+...+...+..... .+......+.+++.+||++||++
T Consensus 235 ll~g~~pf~~~~~-~~~~~~i~~~-~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 235 LILGKPLFSGETS-IDQLVRIIQI-MGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HHHSSCSSCCSSH-HHHHHHHHHH-HCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HHhCCCCCCCCCh-HHHHHHHHHH-hCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 9999999975411 1111111110 000 000000000111111 11123456889999999999999
Q ss_pred CCCHHHHHHH
Q 002061 940 RPPMREVVKM 949 (973)
Q Consensus 940 Rpt~~evl~~ 949 (973)
|||+.|+++|
T Consensus 313 R~t~~e~l~h 322 (383)
T 3eb0_A 313 RINPYEAMAH 322 (383)
T ss_dssp SCCHHHHHTS
T ss_pred CCCHHHHhcC
Confidence 9999999975
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=344.82 Aligned_cols=258 Identities=20% Similarity=0.207 Sum_probs=204.4
Q ss_pred HHHHcCCccc-CcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCe
Q 002061 672 AEQICNLEED-NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGS 745 (973)
Q Consensus 672 ~~~~~~~~~~-~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 745 (973)
+...++|.+. +.||+|+||+||+|++..+++.||||++... .....+.+|+.+++++ +||||+++++++..++.
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 3445567776 8899999999999999999999999998752 3456788999999999 56999999999999999
Q ss_pred eEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecC---CCCeEEec
Q 002061 746 SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE---DYEPKIAD 822 (973)
Q Consensus 746 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~D 822 (973)
.++||||+++|+|.+++... ....+++..+..++.|++.||+||| +.+|+||||||+||+++. ++.+||+|
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL~D 177 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPE---LAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVD 177 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSC---C-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEECC
T ss_pred EEEEEEecCCCcHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEEee
Confidence 99999999999999988532 2356899999999999999999999 789999999999999998 78999999
Q ss_pred ccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccc
Q 002061 823 FGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNH 902 (973)
Q Consensus 823 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 902 (973)
||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ............
T Consensus 178 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-----~~~~~~~i~~~~ 249 (327)
T 3lm5_A 178 FGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED-----NQETYLNISQVN 249 (327)
T ss_dssp GGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHTC
T ss_pred CccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHHHhcc
Confidence 999986654322 233568999999999999999999999999999999999999996531 111111111111
Q ss_pred cccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 903 ENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
. .............+.+++.+|++.||++|||+.|++++-.
T Consensus 250 ~--------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~ 290 (327)
T 3lm5_A 250 V--------DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSW 290 (327)
T ss_dssp C--------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGG
T ss_pred c--------ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHh
Confidence 0 0111112233456888999999999999999999998744
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=354.49 Aligned_cols=198 Identities=27% Similarity=0.376 Sum_probs=168.1
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeC-----Cee
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKG-----GSS 746 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~ 746 (973)
++|++.+.||+|+||+||+|++..+++.||||++... ...+++.+|++++++++||||+++++++... ...
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 105 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL 105 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence 5799999999999999999999999999999998652 3456788999999999999999999999766 578
Q ss_pred EEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCc
Q 002061 747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826 (973)
Q Consensus 747 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~ 826 (973)
|+||||++ |+|.+++.. ...+++..+..++.||++||+||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 106 ~lv~e~~~-~~L~~~~~~-----~~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 106 YIVLEIAD-SDLKKLFKT-----PIFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEECCS-EEHHHHHHS-----SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEecCC-cCHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 99999995 699999874 245899999999999999999999 789999999999999999999999999999
Q ss_pred ccccCCCCc--------------------ccccccCCcccccccccc-ccCCCCccchHHHHHHHHHHHHhCCCCCC
Q 002061 827 KIAENSPKV--------------------SDYSCFAGTHGYIAPELA-YTCKVSEKSDVFSFGVVLLELVTGRKPVE 882 (973)
Q Consensus 827 ~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~~l~el~tg~~pf~ 882 (973)
+........ ......+||+.|+|||++ .+..++.++||||+||++|||++|..||.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 876543211 122456789999999986 56679999999999999999999766664
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=349.01 Aligned_cols=255 Identities=23% Similarity=0.313 Sum_probs=187.8
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc--ccHHHHHHHHHHHHhcC-CCceeeEEEEEE--------eCC
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIR-HRNILKLYACLL--------KGG 744 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~-hpniv~l~~~~~--------~~~ 744 (973)
.+|++.+.||+|+||+||+|++..+++.||||++... ...+.+.+|+.+++++. ||||+++++++. ...
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 4789999999999999999999988999999988553 34566889999999996 999999999984 234
Q ss_pred eeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCC--eEecCCCCCCeeecCCCCeEEec
Q 002061 745 SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP--IIHRDIKSSNILLDEDYEPKIAD 822 (973)
Q Consensus 745 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~--ivH~Dlkp~Nill~~~~~~kl~D 822 (973)
..++||||++ |+|.+++.... ....+++..+..++.|++.||+||| +.+ |+||||||+||+++.++.+||+|
T Consensus 108 ~~~lv~e~~~-g~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 108 EFLLLTELCK-GQLVEFLKKME--SRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp EEEEEEECCS-EEHHHHHHHHH--TTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred eEEEEEEecC-CCHHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEec
Confidence 5799999995 79999997642 2345899999999999999999999 777 99999999999999999999999
Q ss_pred ccCcccccCCCCcc----------cccccCCcccccccccc---ccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcc
Q 002061 823 FGVAKIAENSPKVS----------DYSCFAGTHGYIAPELA---YTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGK 889 (973)
Q Consensus 823 fgl~~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~ 889 (973)
||+++......... ......||+.|+|||++ .+..++.++|||||||++|||++|+.||.....
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--- 258 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK--- 258 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH---
Confidence 99998765432211 11134589999999998 566789999999999999999999999965311
Q ss_pred cHHHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 002061 890 DIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADP 955 (973)
Q Consensus 890 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 955 (973)
.......... .........+.+++.+||+.||++||++.|++++|+++..
T Consensus 259 --~~~~~~~~~~--------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 259 --LRIVNGKYSI--------------PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp ---------CCC--------------CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HHhhcCcccC--------------CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0111110000 0001112236789999999999999999999999998754
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=346.25 Aligned_cols=261 Identities=26% Similarity=0.281 Sum_probs=195.5
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCC-----
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGG----- 744 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----- 744 (973)
..++|++.+.||+|+||+||+|++..+++.||||++... ...+.+.+|+.+++.++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 356899999999999999999999999999999998652 33456789999999999999999999997654
Q ss_pred -eeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecc
Q 002061 745 -SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADF 823 (973)
Q Consensus 745 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 823 (973)
..|+||||++ |+|.+++.. .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+||
T Consensus 103 ~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Df 171 (371)
T 2xrw_A 103 QDVYIVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDF 171 (371)
T ss_dssp CEEEEEEECCS-EEHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred cceEEEEEcCC-CCHHHHHhh-------ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEe
Confidence 7899999996 588888752 3788999999999999999999 789999999999999999999999999
Q ss_pred cCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHH------
Q 002061 824 GVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVST------ 897 (973)
Q Consensus 824 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~------ 897 (973)
|+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||..... .+....+..
T Consensus 172 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~i~~~~~~~~ 246 (371)
T 2xrw_A 172 GLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH--IDQWNKVIEQLGTPC 246 (371)
T ss_dssp CC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHC-CCCCC
T ss_pred eccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCC
Confidence 9998654321 22335689999999999999999999999999999999999999975311 110000000
Q ss_pred -------------Hhcccccc-----chhccc---cccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 898 -------------HLNNHENV-----LKVLDC---EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 898 -------------~~~~~~~~-----~~~~~~---~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
.....+.. ...... .............+.+++.+|++.||++|||+.|+++|-
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 320 (371)
T 2xrw_A 247 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320 (371)
T ss_dssp HHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred HHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence 00000000 000000 001112233466789999999999999999999999975
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=334.43 Aligned_cols=254 Identities=22% Similarity=0.316 Sum_probs=200.6
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeecc--ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccC
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP 754 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 754 (973)
+|.....||+|+||+||+|++..+++.||||++... ...+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 455566899999999999999999999999998763 345678899999999999999999999999999999999999
Q ss_pred CCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecC-CCCeEEecccCcccccCCC
Q 002061 755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE-DYEPKIADFGVAKIAENSP 833 (973)
Q Consensus 755 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfgl~~~~~~~~ 833 (973)
+++|.+++... .....+++..+..++.|++.||+||| +.+++||||||+||+++. ++.+||+|||.+.......
T Consensus 103 ~~~L~~~l~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 103 GGSLSALLRSK--WGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp EEEHHHHHHHT--TCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred CCCHHHHHHhh--ccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 99999999764 22335678889999999999999999 789999999999999987 8999999999998664322
Q ss_pred CcccccccCCccccccccccccCC--CCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccc
Q 002061 834 KVSDYSCFAGTHGYIAPELAYTCK--VSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDC 911 (973)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (973)
. ......|++.|+|||++.+.. ++.++||||||+++|+|++|+.||..... ...............
T Consensus 178 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~-------- 245 (295)
T 2clq_A 178 P--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE--PQAAMFKVGMFKVHP-------- 245 (295)
T ss_dssp -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS--HHHHHHHHHHHCCCC--------
T ss_pred C--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc--hhHHHHhhccccccc--------
Confidence 1 123356899999999987643 88999999999999999999999975321 111111111111111
Q ss_pred cccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 912 EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 912 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
. .+......+.+++.+||+.||++||++.|++++-.
T Consensus 246 ~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~ 281 (295)
T 2clq_A 246 E----IPESMSAEAKAFILKCFEPDPDKRACANDLLVDEF 281 (295)
T ss_dssp C----CCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGG
T ss_pred c----ccccCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 1 11123456788999999999999999999997644
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=345.72 Aligned_cols=267 Identities=21% Similarity=0.268 Sum_probs=203.8
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEe--------
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLK-------- 742 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-------- 742 (973)
.++|++.+.||+|+||+||+|++..+++.||||++... .....+.+|++++++++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 56899999999999999999999999999999988552 234567899999999999999999999877
Q ss_pred CCeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEec
Q 002061 743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIAD 822 (973)
Q Consensus 743 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 822 (973)
++..|+||||++ |+|.+.+... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|
T Consensus 96 ~~~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~D 167 (351)
T 3mi9_A 96 KGSIYLVFDFCE-HDLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLAD 167 (351)
T ss_dssp -CEEEEEEECCS-EEHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECC
T ss_pred CceEEEEEeccC-CCHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEcc
Confidence 446899999996 5888877643 345899999999999999999999 78999999999999999999999999
Q ss_pred ccCcccccCCCC--cccccccCCcccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHh
Q 002061 823 FGVAKIAENSPK--VSDYSCFAGTHGYIAPELAYT-CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHL 899 (973)
Q Consensus 823 fgl~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~ 899 (973)
||+++....... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.... .......+....
T Consensus 168 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~~~~i~~~~ 245 (351)
T 3mi9_A 168 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT--EQHQLALISQLC 245 (351)
T ss_dssp CTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHH
T ss_pred chhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHh
Confidence 999987653221 222344578999999999876 458999999999999999999999997541 112222222111
Q ss_pred cccc-ccchhcc----------ccccCcchHH------HHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 900 NNHE-NVLKVLD----------CEVASESIKE------DMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 900 ~~~~-~~~~~~~----------~~~~~~~~~~------~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
.... ......+ .........+ ....+.+++.+|++.||++|||+.|++++-.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 314 (351)
T 3mi9_A 246 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 314 (351)
T ss_dssp CCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred CCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCC
Confidence 1110 0000000 0000000111 1345789999999999999999999999754
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=345.42 Aligned_cols=263 Identities=28% Similarity=0.382 Sum_probs=206.9
Q ss_pred HcCCcccCcccccCceEEEEEEe----cCCCcEEEEEeeecc--ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCC--ee
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDL----KKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGG--SS 746 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~----~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--~~ 746 (973)
..+|++.+.||+|+||+||+|+. ..+++.||||++... ...+.+.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35688999999999999999994 567899999998653 34567899999999999999999999986643 78
Q ss_pred EEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCc
Q 002061 747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826 (973)
Q Consensus 747 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~ 826 (973)
++||||+++|+|.+++... ...+++..+..++.|+++||+||| +.+++||||||+||+++.++.+||+|||++
T Consensus 120 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS----TTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred EEEEECCCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcch
Confidence 9999999999999999764 345899999999999999999999 789999999999999999999999999999
Q ss_pred ccccCCCCccc-ccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccC-------Cc---ccHHHHH
Q 002061 827 KIAENSPKVSD-YSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYG-------DG---KDIVYWV 895 (973)
Q Consensus 827 ~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~-------~~---~~~~~~~ 895 (973)
........... .....++..|+|||++.+..++.++||||||+++|||++|..||..... .. ......+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 272 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence 87654432211 2234577889999999988899999999999999999999999864310 00 0000011
Q ss_pred HHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 002061 896 STHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADAD 954 (973)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 954 (973)
....... .....+......+.+++.+||+.||++||++.|+++.|+++.
T Consensus 273 ~~~~~~~----------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 273 IELLKNN----------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp HHHHHTT----------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhhcC----------CCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111110 001112233456889999999999999999999999998753
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=332.74 Aligned_cols=247 Identities=25% Similarity=0.368 Sum_probs=197.1
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV 749 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 749 (973)
.++|++.+.||+|+||.||+|++..+++.||||++... ...+.+.+|+++++.++||||+++++++..++..|+|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 46889999999999999999999988999999998653 3456788999999999999999999999999999999
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccc
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 829 (973)
|||+++++|.+++... ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++...
T Consensus 90 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH-----GRVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 161 (276)
T ss_dssp EECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred EeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeeccccccc
Confidence 9999999999999764 24789999999999999999999 779999999999999999999999999999766
Q ss_pred cCCCCcccccccCCccccccccccccCCC-CccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchh
Q 002061 830 ENSPKVSDYSCFAGTHGYIAPELAYTCKV-SEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKV 908 (973)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (973)
..... .....|++.|+|||++.+..+ +.++||||+|+++|+|++|+.||... ................
T Consensus 162 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-----~~~~~~~~~~~~~~~~--- 230 (276)
T 2h6d_A 162 SDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE-----HVPTLFKKIRGGVFYI--- 230 (276)
T ss_dssp CC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHCCCCC---
T ss_pred CCCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC-----cHHHHHHHhhcCcccC---
Confidence 44321 223468999999999987765 58999999999999999999999653 1112211111111100
Q ss_pred ccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 909 LDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 909 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
+......+.+++.+|++.||++||++.|++++
T Consensus 231 ---------~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 231 ---------PEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ---------chhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11123457889999999999999999999986
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=343.08 Aligned_cols=261 Identities=21% Similarity=0.225 Sum_probs=203.1
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhcC-CCceeeEEEEEEe--CCeeEEEEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIR-HRNILKLYACLLK--GGSSFLVLE 751 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~--~~~~~lv~e 751 (973)
.++|++.+.||+|+||+||+|++..+++.||||++.. ...+.+.+|++++++++ ||||+++++++.. ....++|||
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e 113 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 113 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc-cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEe
Confidence 4679999999999999999999999999999999864 34567899999999997 9999999999987 667899999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCC-CeEEecccCccccc
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY-EPKIADFGVAKIAE 830 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfgl~~~~~ 830 (973)
|+++++|.+++. .+++..+..++.|++.||+||| +++|+||||||+||+++.++ .+||+|||+++...
T Consensus 114 ~~~~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 114 HVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp CCCCCCHHHHGG--------GCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred ccCchhHHHHHH--------hCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 999999988875 2788899999999999999999 78999999999999999777 89999999998665
Q ss_pred CCCCcccccccCCcccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHh----------
Q 002061 831 NSPKVSDYSCFAGTHGYIAPELAYT-CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHL---------- 899 (973)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~---------- 899 (973)
.... .....|+..|+|||++.+ ..++.++||||+||++|||++|+.||..................
T Consensus 183 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 259 (330)
T 3nsz_A 183 PGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 259 (330)
T ss_dssp TTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred CCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHH
Confidence 4322 233568999999999877 67899999999999999999999999543222111111111000
Q ss_pred --cc-ccccchhc--------cccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 900 --NN-HENVLKVL--------DCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 900 --~~-~~~~~~~~--------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
.. .+...... ...............+.+++.+|+++||++|||+.|+++|-
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp 321 (330)
T 3nsz_A 260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 321 (330)
T ss_dssp TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSG
T ss_pred hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCc
Confidence 00 00000000 00001111122356788999999999999999999999863
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=364.31 Aligned_cols=253 Identities=28% Similarity=0.370 Sum_probs=207.7
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeec-----cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL 748 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~-----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 748 (973)
..++|++.+.||+|+||+||+|++..+++.||||++.. ....+.+.+|++++++++||||+++++++...+..|+
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 45679999999999999999999999999999999864 2456778999999999999999999999999999999
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeee---cCCCCeEEecccC
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILL---DEDYEPKIADFGV 825 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~Dfgl 825 (973)
||||+++|+|.+++... ..+++..+..++.|++.||+||| +++|+||||||+||++ +.++.+||+|||+
T Consensus 104 v~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 175 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISR-----KRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGL 175 (484)
T ss_dssp EECCCCSCBHHHHHHTC-----SCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred EEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence 99999999999998743 45889999999999999999999 7899999999999999 5678999999999
Q ss_pred cccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccccc
Q 002061 826 AKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENV 905 (973)
Q Consensus 826 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 905 (973)
++....... .....||+.|+|||++.+ .++.++||||+||++|+|++|+.||... .... ...........
T Consensus 176 a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~---~~~~i~~~~~~- 245 (484)
T 3nyv_A 176 STHFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGA--NEYD---ILKKVEKGKYT- 245 (484)
T ss_dssp HHHBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHH---HHHHHHHCCCC-
T ss_pred eEEcccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCC--CHHH---HHHHHHcCCCC-
Confidence 987654422 233569999999999876 6899999999999999999999999754 1111 11111111100
Q ss_pred chhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 906 LKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
............+.+++.+|+++||.+|||+.|+++|-.
T Consensus 246 -------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~ 284 (484)
T 3nyv_A 246 -------FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEW 284 (484)
T ss_dssp -------CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred -------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChh
Confidence 011112233456889999999999999999999998654
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=347.08 Aligned_cols=267 Identities=24% Similarity=0.299 Sum_probs=197.5
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHH--HHhcCCCceeeEEEEEEe-----CCeeE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEI--LGKIRHRNILKLYACLLK-----GGSSF 747 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~--l~~l~hpniv~l~~~~~~-----~~~~~ 747 (973)
.++|++.+.||+|+||+||+|+.. ++.||||++.... ...+..|.++ +..++||||+++++++.. ....+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSLD--ERPVAVKVFSFAN-RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEET--TEEEEEEEEEGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEEC--CeEEEEEEeeccc-hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 468999999999999999999874 7899999986543 3344455555 445899999999986543 23568
Q ss_pred EEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCC---------CeEecCCCCCCeeecCCCCe
Q 002061 748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP---------PIIHRDIKSSNILLDEDYEP 818 (973)
Q Consensus 748 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~---------~ivH~Dlkp~Nill~~~~~~ 818 (973)
+||||+++|+|.+++... ..++..+..++.|+++||+||| +. +|+||||||+||+++.++.+
T Consensus 89 lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 159 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSLH------TSDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTC 159 (336)
T ss_dssp EEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCE
T ss_pred EEEecCCCCcHHHHHhhc------ccchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcE
Confidence 999999999999999754 3488899999999999999999 67 99999999999999999999
Q ss_pred EEecccCcccccCCCC------cccccccCCcccccccccccc-------CCCCccchHHHHHHHHHHHHhCCCCCCccc
Q 002061 819 KIADFGVAKIAENSPK------VSDYSCFAGTHGYIAPELAYT-------CKVSEKSDVFSFGVVLLELVTGRKPVEEEY 885 (973)
Q Consensus 819 kl~Dfgl~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~~l~el~tg~~pf~~~~ 885 (973)
||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||....
T Consensus 160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 239 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239 (336)
T ss_dssp EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence 9999999987643321 112224569999999999876 456778999999999999999987764321
Q ss_pred CCcc-------------cHHHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 002061 886 GDGK-------------DIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952 (973)
Q Consensus 886 ~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~ 952 (973)
.... ....+.. ..........+ ... ..........+.+++.+||+.||++|||+.|+++.|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ 315 (336)
T 3g2f_A 240 SVPEYQMAFQTEVGNHPTFEDMQV-LVSREKQRPKF-PEA--WKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE 315 (336)
T ss_dssp CCCCCCCTTHHHHCSSCCHHHHHH-HHTTSCCCCCC-CTT--CCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred chhHHHHhhhcccCCCchHHHHHh-hhcccccCCCC-Ccc--cccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence 1110 0111100 00000000000 000 01123456679999999999999999999999999998
Q ss_pred CCCCC
Q 002061 953 ADPCT 957 (973)
Q Consensus 953 ~~~~~ 957 (973)
+....
T Consensus 316 ll~~~ 320 (336)
T 3g2f_A 316 LMMIW 320 (336)
T ss_dssp HHHCC
T ss_pred HHHHH
Confidence 76444
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=348.45 Aligned_cols=256 Identities=25% Similarity=0.286 Sum_probs=204.8
Q ss_pred HHcCCcccCcccccCceEEEEEEec---CCCcEEEEEeeecc------ccHHHHHHHHHHHHhc-CCCceeeEEEEEEeC
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLK---KNAGTVAVKQLWKG------DGVKVFAAEMEILGKI-RHRNILKLYACLLKG 743 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~---~~~~~vavK~~~~~------~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 743 (973)
...+|++.+.||+|+||+||+|+.. .+++.||||++... ...+.+.+|+++++++ +||||+++++++..+
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 131 (355)
T 1vzo_A 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 131 (355)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence 3568999999999999999999984 47899999988642 2345677899999999 699999999999999
Q ss_pred CeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecc
Q 002061 744 GSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADF 823 (973)
Q Consensus 744 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 823 (973)
...++||||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+||
T Consensus 132 ~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Df 203 (355)
T 1vzo_A 132 TKLHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDF 203 (355)
T ss_dssp TEEEEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCS
T ss_pred ceEEEEeecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeC
Confidence 9999999999999999999864 25889999999999999999999 789999999999999999999999999
Q ss_pred cCcccccCCCCcccccccCCcccccccccccc--CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcc
Q 002061 824 GVAKIAENSPKVSDYSCFAGTHGYIAPELAYT--CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNN 901 (973)
Q Consensus 824 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 901 (973)
|+++....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .............
T Consensus 204 G~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~ 281 (355)
T 1vzo_A 204 GLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK-NSQAEISRRILKS 281 (355)
T ss_dssp SEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC-CCHHHHHHHHHHC
T ss_pred CCCeecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCcc-chHHHHHHHHhcc
Confidence 99976543221 12233569999999999985 34789999999999999999999999754221 2222222222211
Q ss_pred ccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHhh
Q 002061 902 HENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRP-----PMREVVKMLA 951 (973)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~L~ 951 (973)
... .+......+.+++.+||+.||.+|| ++.|++++..
T Consensus 282 ~~~------------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~ 324 (355)
T 1vzo_A 282 EPP------------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324 (355)
T ss_dssp CCC------------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred CCC------------CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence 111 1112334578899999999999999 9999998864
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=343.39 Aligned_cols=267 Identities=24% Similarity=0.276 Sum_probs=199.8
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc-------cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCee
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-------GVKVFAAEMEILGKIRHRNILKLYACLLKGGSS 746 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 746 (973)
...+|++.+.||+|+||+||+|++..+++.||||++.... ..+.+.+|++++++++||||+++++++...+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 4568999999999999999999999999999999986421 124678999999999999999999999999999
Q ss_pred EEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCc
Q 002061 747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826 (973)
Q Consensus 747 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~ 826 (973)
++||||+++ +|.+++... ...+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 88 ~lv~e~~~~-~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLA 159 (346)
T ss_dssp EEEEECCSE-EHHHHHTTC----CSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred EEEEEcCCC-CHHHHHHhc----CcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecccc
Confidence 999999975 888888643 345788889999999999999999 789999999999999999999999999999
Q ss_pred ccccCCCCcccccccCCccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccc-cc
Q 002061 827 KIAENSPKVSDYSCFAGTHGYIAPELAYTC-KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNH-EN 904 (973)
Q Consensus 827 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~-~~ 904 (973)
+....... ......||+.|+|||++.+. .++.++||||+||++|||++|..||..... ............... ..
T Consensus 160 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~-~~~~~~i~~~~~~~~~~~ 236 (346)
T 1ua2_A 160 KSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD-LDQLTRIFETLGTPTEEQ 236 (346)
T ss_dssp STTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCTTT
T ss_pred eeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHHcCCCChhh
Confidence 86643322 22345689999999998764 588999999999999999999999965411 111111111110000 00
Q ss_pred cc------hhccc-cccC----cchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 905 VL------KVLDC-EVAS----ESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 905 ~~------~~~~~-~~~~----~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
.. +.... .... .........+.+++.+|++.||++|||+.|++++-.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~ 294 (346)
T 1ua2_A 237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294 (346)
T ss_dssp SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChh
Confidence 00 00000 0000 001223467889999999999999999999999854
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=340.84 Aligned_cols=256 Identities=22% Similarity=0.340 Sum_probs=202.6
Q ss_pred HHHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeec--cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 002061 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK--GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV 749 (973)
Q Consensus 672 ~~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 749 (973)
....++|++.+.||+|+||+||+|++..+++.||+|++.. ....+.+.+|++++++++||||+++++++..++..++|
T Consensus 15 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp SCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred cCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence 3445789999999999999999999999999999998865 34567889999999999999999999999999999999
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccc
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 829 (973)
|||+++++|.+++... ...+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++...
T Consensus 95 ~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 167 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLEL----DRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKN 167 (302)
T ss_dssp EECCTTEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHH
T ss_pred EEeCCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCccc
Confidence 9999999999998754 235899999999999999999999 789999999999999999999999999987543
Q ss_pred cCCCCcccccccCCcccccccccc-----ccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccc
Q 002061 830 ENSPKVSDYSCFAGTHGYIAPELA-----YTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHEN 904 (973)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 904 (973)
.... .......||+.|+|||++ .+..++.++||||||+++|+|++|+.||.... ..............
T Consensus 168 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~ 240 (302)
T 2j7t_A 168 LKTL--QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN-----PMRVLLKIAKSDPP 240 (302)
T ss_dssp HHHH--HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC-----HHHHHHHHHHSCCC
T ss_pred cccc--cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC-----HHHHHHHHhccCCc
Confidence 2110 111234689999999998 36678999999999999999999999997531 11111111111110
Q ss_pred cchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 905 VLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
.. .........+.+++.+||+.||++|||+.|++++-
T Consensus 241 --~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~ 277 (302)
T 2j7t_A 241 --TL-------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHP 277 (302)
T ss_dssp --CC-------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTST
T ss_pred --cc-------CCccccCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence 00 01122345688999999999999999999998763
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=345.04 Aligned_cols=254 Identities=26% Similarity=0.367 Sum_probs=198.0
Q ss_pred HHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-ccHHHHHHHHHHHHhc-CCCceeeEEEEEEe------CC
Q 002061 673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKI-RHRNILKLYACLLK------GG 744 (973)
Q Consensus 673 ~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~------~~ 744 (973)
...++|++.+.||+|+||+||+|++..+++.||||++... ...+.+.+|+++++++ +||||+++++++.. ..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 100 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 100 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence 3457899999999999999999999988999999998653 4556789999999999 89999999999976 46
Q ss_pred eeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEeccc
Q 002061 745 SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFG 824 (973)
Q Consensus 745 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 824 (973)
..|+||||+++|+|.+++... ....+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg 174 (326)
T 2x7f_A 101 QLWLVMEFCGAGSVTDLIKNT---KGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFG 174 (326)
T ss_dssp EEEEEEECCTTEEHHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCT
T ss_pred eEEEEEEcCCCCcHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEEEeeCc
Confidence 789999999999999999864 2345888999999999999999999 7899999999999999999999999999
Q ss_pred CcccccCCCCcccccccCCccccccccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHh
Q 002061 825 VAKIAENSPKVSDYSCFAGTHGYIAPELAY-----TCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHL 899 (973)
Q Consensus 825 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~ 899 (973)
++........ ......||+.|+|||++. +..++.++|||||||++|+|++|+.||.... .........
T Consensus 175 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~ 247 (326)
T 2x7f_A 175 VSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH-----PMRALFLIP 247 (326)
T ss_dssp TTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC-----HHHHHHHHH
T ss_pred CceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc-----HHHHHHHhh
Confidence 9876543211 123356899999999986 5678999999999999999999999996431 111111111
Q ss_pred ccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 900 NNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
.... +.. ........+.+++.+||+.||.+||++.|++++
T Consensus 248 ~~~~-------~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 248 RNPA-------PRL---KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp HSCC-------CCC---SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cCcc-------ccC---CccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1100 000 011123468889999999999999999999985
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=353.57 Aligned_cols=253 Identities=9% Similarity=-0.025 Sum_probs=181.5
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc-----cHHHHHHHHHHHHhc--CCCceeeEE-------EEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----GVKVFAAEMEILGKI--RHRNILKLY-------ACLL 741 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l--~hpniv~l~-------~~~~ 741 (973)
.+|++.+.||+|+||+||+|++..+++.||||++.... ..+.+.+|+++++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 35888999999999999999999999999999987632 345567785544444 699988755 4544
Q ss_pred eC-----------------CeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHH------HHHHHHHHHHHhhhhhcCCC
Q 002061 742 KG-----------------GSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRR------YKIALGAAKGIAYLHHDCSP 798 (973)
Q Consensus 742 ~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~------~~i~~~ia~~l~~LH~~~~~ 798 (973)
.+ ...|+||||++ |+|.+++..... .+.+..+ ..++.|+++||+||| ++
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~----~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~ 213 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF----VYVFRGDEGILALHILTAQLIRLAANLQ---SK 213 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHHHH---HT
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc----ccchhhhhhhhhHHHHHHHHHHHHHHHH---HC
Confidence 33 33799999998 899999986522 2233444 677899999999999 78
Q ss_pred CeEecCCCCCCeeecCCCCeEEecccCcccccCCCCcccccccCCcccccccccccc--CCCCccchHHHHHHHHHHHHh
Q 002061 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYT--CKVSEKSDVFSFGVVLLELVT 876 (973)
Q Consensus 799 ~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~t 876 (973)
+|+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|||++
T Consensus 214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt 288 (371)
T 3q60_A 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288 (371)
T ss_dssp TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence 9999999999999999999999999999865422 113456799999999987 679999999999999999999
Q ss_pred CCCCCCcccCCcccHHHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 877 GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 877 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
|+.||......... ..........................+.+++.+||+.||++|||+.|+++|
T Consensus 289 g~~Pf~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 289 LFLPFGLVTPGIKG--------SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp SSCSTTBCCTTCTT--------CCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred CCCCCCCcCccccc--------chhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 99999765221110 000000000001111111112334568899999999999999999999864
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=371.12 Aligned_cols=250 Identities=27% Similarity=0.347 Sum_probs=207.4
Q ss_pred HHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeec-----cccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCee
Q 002061 673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSS 746 (973)
Q Consensus 673 ~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~-----~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 746 (973)
..+.+|++.+.||+|+||+||+|++..+++.||||++.+ ....+.+.+|..++..+ +||+|+++++++.+.+..
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 345789999999999999999999999999999999875 23456678899999987 799999999999999999
Q ss_pred EEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCc
Q 002061 747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826 (973)
Q Consensus 747 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~ 826 (973)
|+||||+++|+|.+++... ..+++..+..++.||+.||+||| +++||||||||+|||++.++.+||+|||++
T Consensus 418 ~lV~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla 489 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMC 489 (674)
T ss_dssp EEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTC
T ss_pred EEEEeCcCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeeccee
Confidence 9999999999999999864 35899999999999999999999 789999999999999999999999999999
Q ss_pred ccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccc
Q 002061 827 KIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVL 906 (973)
Q Consensus 827 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 906 (973)
+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||... +..............
T Consensus 490 ~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~-----~~~~~~~~i~~~~~~-- 560 (674)
T 3pfq_A 490 KENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE-----DEDELFQSIMEHNVA-- 560 (674)
T ss_dssp EECCCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHSSCCC--
T ss_pred eccccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC-----CHHHHHHHHHhCCCC--
Confidence 8543222 1233467999999999999999999999999999999999999999753 222222222222111
Q ss_pred hhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHH
Q 002061 907 KVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPM-----REVVKM 949 (973)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~-----~evl~~ 949 (973)
.+.....++.+++.+||+.||++||++ .||++|
T Consensus 561 ----------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 561 ----------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp ----------CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred ----------CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 111234568889999999999999997 788765
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=340.75 Aligned_cols=260 Identities=26% Similarity=0.340 Sum_probs=198.4
Q ss_pred HcCCcccCcccccCceEEEEEEecC-CC--cEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCee
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKK-NA--GTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSS 746 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~-~~--~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 746 (973)
.++|++.+.||+|+||+||+|++.. ++ ..||||++... ...+.+.+|++++++++||||+++++++..+. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 3578999999999999999998753 23 36999988642 34567889999999999999999999988765 8
Q ss_pred EEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCc
Q 002061 747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826 (973)
Q Consensus 747 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~ 826 (973)
++||||+++|+|.+++... ...+++..+..++.|+++||+||| +++++||||||+||+++.++.+||+|||++
T Consensus 96 ~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~ 168 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH----QGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLM 168 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH----GGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred eeeEecccCCCHHHHHHhc----cCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEcccccc
Confidence 8999999999999999864 235889999999999999999999 789999999999999999999999999999
Q ss_pred ccccCCCCcc-cccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccc
Q 002061 827 KIAENSPKVS-DYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHEN 904 (973)
Q Consensus 827 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 904 (973)
.......... ......+|..|+|||++.+..++.++||||||+++|||++ |+.||.... ..............
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-----~~~~~~~~~~~~~~ 243 (291)
T 1u46_A 169 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN-----GSQILHKIDKEGER 243 (291)
T ss_dssp EECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HHHHHHHHHTSCCC
T ss_pred ccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC-----HHHHHHHHHccCCC
Confidence 8765433221 2223457889999999998889999999999999999999 999996541 12222222111110
Q ss_pred cchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCCC
Q 002061 905 VLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPCT 957 (973)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 957 (973)
..........+.+++.+||+.||++||++.+++++|+++.+..
T Consensus 244 ----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 286 (291)
T 1u46_A 244 ----------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 286 (291)
T ss_dssp ----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred ----------CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence 0111223456889999999999999999999999999887643
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=341.26 Aligned_cols=254 Identities=28% Similarity=0.336 Sum_probs=200.4
Q ss_pred HHHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc----------cHHHHHHHHHHHHhcCCCceeeEEEEEE
Q 002061 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----------GVKVFAAEMEILGKIRHRNILKLYACLL 741 (973)
Q Consensus 672 ~~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----------~~~~~~~E~~~l~~l~hpniv~l~~~~~ 741 (973)
....++|++.+.||+|+||+||+|++..+++.||||++.... ....+.+|++++++++||||+++++++.
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 85 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 85 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc
Confidence 344568999999999999999999999999999999886421 2234789999999999999999999987
Q ss_pred eCCeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCC---e
Q 002061 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE---P 818 (973)
Q Consensus 742 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~---~ 818 (973)
.+. .|+||||+++|+|.+++.. ...+++..+..++.|++.||+||| +++++||||||+||+++.++. +
T Consensus 86 ~~~-~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~ 156 (322)
T 2ycf_A 86 AED-YYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLI 156 (322)
T ss_dssp SSS-EEEEEECCTTEETHHHHST-----TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCE
T ss_pred CCc-eEEEEecCCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeE
Confidence 655 8999999999999998864 245889999999999999999999 789999999999999987664 9
Q ss_pred EEecccCcccccCCCCcccccccCCccccccccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHH
Q 002061 819 KIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAY---TCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWV 895 (973)
Q Consensus 819 kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~ 895 (973)
||+|||++...... .......||+.|+|||++. +..++.++|||||||++|+|++|+.||...... ......+
T Consensus 157 kl~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~ 232 (322)
T 2ycf_A 157 KITDFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ-VSLKDQI 232 (322)
T ss_dssp EECCCTTCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS-SCHHHHH
T ss_pred EEccCccceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH-HHHHHHH
Confidence 99999999866432 1122346899999999974 567889999999999999999999999754221 1222222
Q ss_pred HHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 896 STHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
...... ............+.+++.+||+.||++||++.|++++
T Consensus 233 ~~~~~~-----------~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 233 TSGKYN-----------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp HHTCCC-----------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhCccc-----------cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 111000 0011112234568899999999999999999999864
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=345.27 Aligned_cols=348 Identities=16% Similarity=0.173 Sum_probs=222.4
Q ss_pred ccCCCCCCCCCCCcceeeeCCCCCceEEEeecCCCCCccccccccCCccCcEeeCCCCcccCcCChhhhCCCCCcEEEec
Q 002061 50 LDSWKESADSPCGFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVT 129 (973)
Q Consensus 50 ~~~W~~~~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~ 129 (973)
+++|....+|||.|.+..|.... +.+............-..++++++|++++|.++...+..+..+++|++|+|+
T Consensus 3 ~~~~~~~~~C~~~~~~~~c~~~~-----~~i~~~~~~~~~~~~~~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~ 77 (390)
T 3o6n_A 3 VKPRQPEYKCIDSNLQYDCVFYD-----VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLN 77 (390)
T ss_dssp ----CCEECBCC------EEEES-----CEECSSCCCCEESCSSGGGCCCSEEEEESCEESEECTHHHHHCCCCSEEECT
T ss_pred cCCCCCccceehhhhhhccceee-----eeeecccccccccccccccCCceEEEecCCchhhCChhHhcccccCcEEECC
Confidence 67899888776767666664211 2222222222222233457899999999999885444457899999999999
Q ss_pred CCcccCCCC-cccCCCCCCEEeccCccCCCccccccccccccceEEccCCcCCCCCCccc-ccCCCCCCEEEcccCCCCC
Q 002061 130 GNAMVGSVP-DLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPES-IGNLKNLTYLFLAHCNLRG 207 (973)
Q Consensus 130 ~n~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ip~~-~~~l~~L~~L~L~~n~l~~ 207 (973)
+|.+.+.++ .++.+++|++|+|++|.+++..|..|.++++|++|++++|.+. .+|.. ++++++|++|+|++|++++
T Consensus 78 ~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~--~l~~~~~~~l~~L~~L~L~~n~l~~ 155 (390)
T 3o6n_A 78 DLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS--SLPRGIFHNTPKLTTLSMSNNNLER 155 (390)
T ss_dssp TSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC--CCCTTTTTTCTTCCEEECCSSCCCB
T ss_pred CCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC--cCCHHHhcCCCCCcEEECCCCccCc
Confidence 999988776 6899999999999999999888888888888888888888886 45555 5788888888888888887
Q ss_pred CCChhhhccCCCCeeecccccccCCCchhhhccccccEEEeeccccCCcCCccccccccccEEEeeccccccccCCccCC
Q 002061 208 RIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGN 287 (973)
Q Consensus 208 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 287 (973)
..+..+..+++|++|++++|++++. .+..+++|++|++++|.+++ +...++|++|++++|.+... |...
T Consensus 156 ~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~-----~~~~~~L~~L~l~~n~l~~~-~~~~-- 224 (390)
T 3o6n_A 156 IEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVV-RGPV-- 224 (390)
T ss_dssp CCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCSE-----EECCSSCSEEECCSSCCCEE-ECCC--
T ss_pred cChhhccCCCCCCEEECCCCcCCcc---ccccccccceeecccccccc-----cCCCCcceEEECCCCeeeec-cccc--
Confidence 7777888888888888888888754 35667778888888887763 23345677777777777643 3222
Q ss_pred CCCccEEEcccCCCCCCCCCCcCCcccceeeeccCCccCCCCCccccccccccccccccccccccCChhhhhhhhHHHHH
Q 002061 288 LKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLL 367 (973)
Q Consensus 288 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~ll 367 (973)
.++|+.|++++|++++. ..+..+++|+.|++++|.+++..|..+..+++|++|+|++|++++
T Consensus 225 ~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~---------------- 286 (390)
T 3o6n_A 225 NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA---------------- 286 (390)
T ss_dssp CSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE----------------
T ss_pred cccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc----------------
Confidence 35666666666666642 345555555555555555555445555555555555555555441
Q ss_pred hhhccCCCCccccccCccccceEeccccccccCCCccccCCCCcceEeccCCcCCCCCCCCCCCCCCCCEEEcccCCCCC
Q 002061 368 ALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSG 447 (973)
Q Consensus 368 ~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~ 447 (973)
+|..+..+++|++|+|++|+++ .+|..+ ..+++|++|+|++|+++.
T Consensus 287 ---------~~~~~~~l~~L~~L~L~~n~l~-~~~~~~------------------------~~l~~L~~L~L~~N~i~~ 332 (390)
T 3o6n_A 287 ---------LNLYGQPIPTLKVLDLSHNHLL-HVERNQ------------------------PQFDRLENLYLDHNSIVT 332 (390)
T ss_dssp ---------EECSSSCCTTCCEEECCSSCCC-CCGGGH------------------------HHHTTCSEEECCSSCCCC
T ss_pred ---------cCcccCCCCCCCEEECCCCcce-ecCccc------------------------cccCcCCEEECCCCccce
Confidence 2222333444555555555544 233333 444555566666666553
Q ss_pred CCChhhhcCCCCCEEEccCCcCC
Q 002061 448 ELPSELGRLTNLERLILTNNNFS 470 (973)
Q Consensus 448 ~~p~~~~~l~~L~~L~Ls~N~l~ 470 (973)
. + +..+++|+.|++++|+++
T Consensus 333 ~-~--~~~~~~L~~L~l~~N~~~ 352 (390)
T 3o6n_A 333 L-K--LSTHHTLKNLTLSHNDWD 352 (390)
T ss_dssp C-C--CCTTCCCSEEECCSSCEE
T ss_pred e-C--chhhccCCEEEcCCCCcc
Confidence 2 2 455566666666666665
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=352.09 Aligned_cols=271 Identities=22% Similarity=0.262 Sum_probs=188.7
Q ss_pred CCcc-cCcccccCceEEEEEEec--CCCcEEEEEeeeccccHHHHHHHHHHHHhcCCCceeeEEEEEEe--CCeeEEEEE
Q 002061 677 NLEE-DNLIGSGGTGKVYRLDLK--KNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLK--GGSSFLVLE 751 (973)
Q Consensus 677 ~~~~-~~~lG~G~~g~V~~a~~~--~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~lv~e 751 (973)
.|++ .++||+|+||+||+|++. .+++.||||++........+.+|++++++++||||+++++++.. +...|+|||
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e 100 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 100 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEe
Confidence 4555 468999999999999976 46889999999876666788999999999999999999999954 678999999
Q ss_pred ccCCCchHHHHHhhhcC----CCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeee----cCCCCeEEecc
Q 002061 752 YMPNGNLFQALHKRVKE----GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILL----DEDYEPKIADF 823 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~----~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill----~~~~~~kl~Df 823 (973)
|++ |+|.+++...... ....+++..+..++.|++.||+||| +.+|+||||||+||++ +.++.+||+||
T Consensus 101 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 176 (405)
T 3rgf_A 101 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADM 176 (405)
T ss_dssp CCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEECCT
T ss_pred CCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEEEEC
Confidence 995 6888888644221 1224899999999999999999999 7899999999999999 67789999999
Q ss_pred cCcccccCCCC-cccccccCCccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccCCc--------ccHHH
Q 002061 824 GVAKIAENSPK-VSDYSCFAGTHGYIAPELAYTC-KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDG--------KDIVY 893 (973)
Q Consensus 824 gl~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~--------~~~~~ 893 (973)
|+++....... ........||+.|+|||++.+. .++.++||||+||++|||++|+.||.....+. ..+..
T Consensus 177 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~ 256 (405)
T 3rgf_A 177 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 256 (405)
T ss_dssp TCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHH
T ss_pred CCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHH
Confidence 99987653321 1223346789999999999874 58999999999999999999999997542210 11111
Q ss_pred HHHHHhccccc--cchh-------------ccccccCcchH--------HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 894 WVSTHLNNHEN--VLKV-------------LDCEVASESIK--------EDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 894 ~~~~~~~~~~~--~~~~-------------~~~~~~~~~~~--------~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
.+. ....... ...+ ........... .....+.+++.+||+.||.+|||+.|+++|-
T Consensus 257 i~~-~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp 335 (405)
T 3rgf_A 257 IFN-VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP 335 (405)
T ss_dssp HHH-HHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHH-hhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 111 1100000 0000 00000000000 0134678999999999999999999999986
Q ss_pred hc
Q 002061 951 AD 952 (973)
Q Consensus 951 ~~ 952 (973)
.=
T Consensus 336 ~f 337 (405)
T 3rgf_A 336 YF 337 (405)
T ss_dssp GG
T ss_pred hh
Confidence 53
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=344.56 Aligned_cols=335 Identities=19% Similarity=0.187 Sum_probs=240.5
Q ss_pred CCCCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCchhhhccccccEEEeeccccCCcCCccccccccccEEE
Q 002061 192 LKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFD 271 (973)
Q Consensus 192 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~ 271 (973)
++++++|++++|.++...+..+..+++|++|+|++|++++..+..|..+++|++|+|++|.+++..|..|.++++|++|+
T Consensus 44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 123 (390)
T 3o6n_A 44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 123 (390)
T ss_dssp GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEE
Confidence 56788888888887755555567778888888888887766666777777777777777777766666677777777777
Q ss_pred eeccccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeeccCCccCCCCCccccccccccccccccccccc
Q 002061 272 ISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSG 351 (973)
Q Consensus 272 Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~ 351 (973)
|++|+++...+..+.++++|++|++++|++++..+..|..+++|+.|++++|++++. .+..+++|+.|++++|.++
T Consensus 124 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~- 199 (390)
T 3o6n_A 124 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLS- 199 (390)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCS-
T ss_pred CCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeeccccccc-
Confidence 777777744444456777777777777777766666666666666666666666543 2344455555555555544
Q ss_pred cCChhhhhhhhHHHHHhhhccCCCCccccccCccccceEeccccccccCCCccccCCCCcceEeccCCcCCCCCCCCCCC
Q 002061 352 SFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGL 431 (973)
Q Consensus 352 ~~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 431 (973)
+ +...++|+.|++++|+++..+.. .
T Consensus 200 -----------------------------------------------~-----~~~~~~L~~L~l~~n~l~~~~~~---~ 224 (390)
T 3o6n_A 200 -----------------------------------------------T-----LAIPIAVEELDASHNSINVVRGP---V 224 (390)
T ss_dssp -----------------------------------------------E-----EECCSSCSEEECCSSCCCEEECC---C
T ss_pred -----------------------------------------------c-----cCCCCcceEEECCCCeeeecccc---c
Confidence 1 11223444444444444443221 2
Q ss_pred CCCCCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCCccccccccccchh
Q 002061 432 STSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLN 511 (973)
Q Consensus 432 ~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 511 (973)
.++|+.|+|++|++++. ..+..+++|++|+|++|.+++..|..|..+++|++|+|++|++++ +|..+..+++|+.|+
T Consensus 225 ~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~ 301 (390)
T 3o6n_A 225 NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLD 301 (390)
T ss_dssp CSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEE
T ss_pred cccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEE
Confidence 35788888888888753 578888899999999999988888888889999999999999885 466667888999999
Q ss_pred ccccccccCCCccccccCCCCeeecCCCccCCCCChhhhccc-CceEEccCCccccccCcccccCCCCccccCCCCCccC
Q 002061 512 LARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLK-LSSIDLSENQLSGSVPLDFLRMGGDGAFAGNEGLCLD 590 (973)
Q Consensus 512 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~-L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~n~~lc~~ 590 (973)
|++|+++ .+|..+..+++|+.|+|++|++++. | +..++ |+.|++++|+|.|.+...+.+......+.+++..|..
T Consensus 302 L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~c~~ 377 (390)
T 3o6n_A 302 LSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKI 377 (390)
T ss_dssp CCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHHHHHTTTCCTTTBCCCCSCCCT
T ss_pred CCCCcce-ecCccccccCcCCEEECCCCcccee-C--chhhccCCEEEcCCCCccchhHHHHHHHHHhhcccccCceecc
Confidence 9999998 5677788899999999999999854 4 44444 8999999999999887765555555678888888876
Q ss_pred cc
Q 002061 591 QS 592 (973)
Q Consensus 591 ~~ 592 (973)
+.
T Consensus 378 ~~ 379 (390)
T 3o6n_A 378 DY 379 (390)
T ss_dssp TC
T ss_pred cc
Confidence 44
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=345.37 Aligned_cols=264 Identities=22% Similarity=0.285 Sum_probs=203.0
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeC-----CeeE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKG-----GSSF 747 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~~ 747 (973)
.+|++.+.||+|+||+||+|++..+++.||||++... ...+.+.+|++++++++||||+++++++... ...|
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 106 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 106 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence 5799999999999999999999999999999998753 2346788999999999999999999999754 4689
Q ss_pred EEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcc
Q 002061 748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827 (973)
Q Consensus 748 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~ 827 (973)
+||||++ |+|.+++... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 107 iv~e~~~-~~L~~~l~~~------~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 107 IVQDLME-TDLYKLLKTQ------HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEECCS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEcccC-cCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceE
Confidence 9999996 6999998753 4889999999999999999999 7899999999999999999999999999998
Q ss_pred cccCCCCc-ccccccCCcccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccc-
Q 002061 828 IAENSPKV-SDYSCFAGTHGYIAPELAYT-CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHEN- 904 (973)
Q Consensus 828 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~- 904 (973)
........ .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.... ..+....+.........
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~~~~i~~~~~~~~~~ 254 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH--YLDQLNHILGILGSPSQE 254 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSS--GGGHHHHHHHHHCSCCHH
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCC--hHHHHHHHHHHhCCCCHH
Confidence 66533221 11234578999999998754 458999999999999999999999997542 22222211111111000
Q ss_pred -cc------------hhcccccc--CcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 905 -VL------------KVLDCEVA--SESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 905 -~~------------~~~~~~~~--~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
.. ........ ..........+.+++.+|++.||++|||+.|++++-.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 316 (364)
T 3qyz_A 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316 (364)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence 00 00000000 0001122456889999999999999999999998754
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-37 Score=333.20 Aligned_cols=253 Identities=26% Similarity=0.316 Sum_probs=205.3
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc-----------cHHHHHHHHHHHHhcC-CCceeeEEEEEE
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----------GVKVFAAEMEILGKIR-HRNILKLYACLL 741 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-----------~~~~~~~E~~~l~~l~-hpniv~l~~~~~ 741 (973)
..++|++.+.||+|+||.||+|++..+++.||||++.... ..+.+.+|+++++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3568999999999999999999999999999999986431 2356788999999995 999999999999
Q ss_pred eCCeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEe
Q 002061 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIA 821 (973)
Q Consensus 742 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 821 (973)
.+...++||||+++++|.+++... ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~ 166 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLT 166 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEEC
T ss_pred cCCeEEEEEeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEe
Confidence 999999999999999999999764 35889999999999999999999 7899999999999999999999999
Q ss_pred cccCcccccCCCCcccccccCCccccccccccc------cCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHH
Q 002061 822 DFGVAKIAENSPKVSDYSCFAGTHGYIAPELAY------TCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWV 895 (973)
Q Consensus 822 Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~ 895 (973)
|||.+........ .....|++.|+|||++. ...++.++||||||+++|||++|+.||.... .....
T Consensus 167 dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~~~~~ 238 (298)
T 1phk_A 167 DFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK-----QMLML 238 (298)
T ss_dssp CCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHH
T ss_pred cccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc-----HHHHH
Confidence 9999987654322 23356899999999985 4568899999999999999999999996531 11111
Q ss_pred HHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 896 STHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
......... ............+.+++.+||+.||++||++.|++++-
T Consensus 239 ~~~~~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~ 285 (298)
T 1phk_A 239 RMIMSGNYQ--------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHP 285 (298)
T ss_dssp HHHHHTCCC--------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSG
T ss_pred HHHhcCCcc--------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhCh
Confidence 111111100 00111123345688999999999999999999999754
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=351.61 Aligned_cols=264 Identities=25% Similarity=0.327 Sum_probs=197.4
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhcCCCceeeEEEEEEeC------CeeEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKG------GSSFLV 749 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~~~~lv 749 (973)
.+|++.+.||+|+||+||+|++..+++.||||++.... ....+|++++++++||||+++++++... ...++|
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv 131 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 131 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT--TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc--hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEee
Confidence 46888999999999999999999999999999986543 2235799999999999999999988542 236799
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCC-CCeEEecccCccc
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDED-YEPKIADFGVAKI 828 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfgl~~~ 828 (973)
|||+++ ++.+.+.... .....+++..+..++.|+++||+||| +++|+||||||+|||++.+ +.+||+|||+++.
T Consensus 132 ~e~~~~-~l~~~~~~~~-~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 132 LDYVPE-TVYRVARHYS-RAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EECCCE-EHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred hhcccc-cHHHHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 999964 7777765432 23456899999999999999999999 8899999999999999965 5689999999986
Q ss_pred ccCCCCcccccccCCccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHh--------
Q 002061 829 AENSPKVSDYSCFAGTHGYIAPELAYTC-KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHL-------- 899 (973)
Q Consensus 829 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~-------- 899 (973)
...... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||..... ...+...+...-
T Consensus 207 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~-~~~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 207 LVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG-VDQLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp CCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCSCCHHHHH
T ss_pred cccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHHH
Confidence 644322 2235689999999998765 789999999999999999999999975421 111111111100
Q ss_pred ccccccchhccccccCcc-----hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 900 NNHENVLKVLDCEVASES-----IKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
...+...++..+...... .......+.+++.+||+.||.+||++.|+++|-
T Consensus 283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp 338 (420)
T 1j1b_A 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 338 (420)
T ss_dssp HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCH
Confidence 000001111111111111 112245788999999999999999999999864
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=346.03 Aligned_cols=259 Identities=22% Similarity=0.295 Sum_probs=185.0
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeC------C
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKG------G 744 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~ 744 (973)
.++|++.+.||+|+||.||+|++..+|+.||||++... ...+.+.+|+++++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 36899999999999999999999999999999998652 2456778999999999999999999998654 5
Q ss_pred eeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEeccc
Q 002061 745 SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFG 824 (973)
Q Consensus 745 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 824 (973)
..|+||||+ +++|.+++.. ..+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG 177 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFG 177 (367)
T ss_dssp CCEEEEECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC--
T ss_pred eEEEEeccc-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeecc
Confidence 679999999 7899998864 35899999999999999999999 7899999999999999999999999999
Q ss_pred CcccccCCCCcccccccCCcccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccc
Q 002061 825 VAKIAENSPKVSDYSCFAGTHGYIAPELAYT-CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHE 903 (973)
Q Consensus 825 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 903 (973)
+++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.... ..+....+........
T Consensus 178 ~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~l~~i~~~~g~p~ 250 (367)
T 2fst_X 178 LARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD--HIDQLKLILRLVGTPG 250 (367)
T ss_dssp ------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCSCC
T ss_pred cccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhCCCC
Confidence 99765432 233578999999999876 678999999999999999999999996541 1111111111111000
Q ss_pred -c-cc--------hhcc--ccccCcc----hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 904 -N-VL--------KVLD--CEVASES----IKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 904 -~-~~--------~~~~--~~~~~~~----~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
. .. ..+. +...... .......+.+++.+|++.||.+|||+.|+++|-
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp 313 (367)
T 2fst_X 251 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 313 (367)
T ss_dssp HHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcCh
Confidence 0 00 0000 0000000 011235678999999999999999999999874
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=343.20 Aligned_cols=264 Identities=27% Similarity=0.401 Sum_probs=187.8
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE 751 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 751 (973)
.++|++.+.||+|+||+||+|++..+++.||||++... ...+.+.+|++++++++||||+++++++..++..++|||
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 93 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK 93 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence 46899999999999999999999888999999988653 345667899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhhhcC---CCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccc
Q 002061 752 YMPNGNLFQALHKRVKE---GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~---~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 828 (973)
|+++|+|.+++...... ....+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++..
T Consensus 94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 170 (303)
T 2vwi_A 94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAF 170 (303)
T ss_dssp CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence 99999999999753222 2345899999999999999999999 78999999999999999999999999999876
Q ss_pred ccCCCCc---ccccccCCcccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccc
Q 002061 829 AENSPKV---SDYSCFAGTHGYIAPELAYT-CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHEN 904 (973)
Q Consensus 829 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 904 (973)
....... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.... ....... ........
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~~~~~--~~~~~~~~ 246 (303)
T 2vwi_A 171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYP--PMKVLML--TLQNDPPS 246 (303)
T ss_dssp CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSC--GGGHHHH--HHTSSCCC
T ss_pred eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCc--hhhHHHH--HhccCCCc
Confidence 6433211 11233568999999999875 568999999999999999999999997542 1111111 11111110
Q ss_pred cc-hhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 905 VL-KVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 905 ~~-~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
.. ...+... .......+.+++.+||+.||.+||++.|++++
T Consensus 247 ~~~~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 247 LETGVQDKEM----LKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp TTC-----CC----CCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cccccccchh----hhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00 0011111 11223467889999999999999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=370.86 Aligned_cols=247 Identities=25% Similarity=0.297 Sum_probs=196.0
Q ss_pred CcccccCceEEEEEEec--CCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCC
Q 002061 682 NLIGSGGTGKVYRLDLK--KNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPN 755 (973)
Q Consensus 682 ~~lG~G~~g~V~~a~~~--~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 755 (973)
+.||+|+||+||+|.+. .+++.||||+++.. ...+++.+|++++++++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999654 55788999998763 235779999999999999999999999864 568899999999
Q ss_pred CchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCc
Q 002061 756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV 835 (973)
Q Consensus 756 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 835 (973)
|+|.+++... ..+++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||+++........
T Consensus 454 g~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 454 GPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 525 (635)
T ss_dssp EEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred CCHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence 9999999753 35889999999999999999999 789999999999999999999999999999876543221
Q ss_pred -ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhccccc
Q 002061 836 -SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEV 913 (973)
Q Consensus 836 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (973)
.......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.... .......+.. ..
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~--~~~~~~~i~~----~~---------- 589 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK--GSEVTAMLEK----GE---------- 589 (635)
T ss_dssp ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHHT----TC----------
T ss_pred cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHc----CC----------
Confidence 22233456789999999999999999999999999999998 999997541 1122221111 11
Q ss_pred cCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 914 ASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 914 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
....+......+.+++.+||+.||++||++.+|++.|+++
T Consensus 590 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 590 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 0011122345688999999999999999999999999864
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=343.33 Aligned_cols=272 Identities=22% Similarity=0.258 Sum_probs=193.5
Q ss_pred HHHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCe-----
Q 002061 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNILKLYACLLKGGS----- 745 (973)
Q Consensus 672 ~~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~----- 745 (973)
...+++|++.+.||+|+||+||+|++..+++.||||++... .......+|++.++.++||||+++++++.....
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 98 (360)
T 3e3p_A 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD 98 (360)
T ss_dssp HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence 56788999999999999999999999999999999988653 334556788888999999999999999866433
Q ss_pred --eEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecC-CCCeEEec
Q 002061 746 --SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE-DYEPKIAD 822 (973)
Q Consensus 746 --~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~D 822 (973)
.++||||+++ +|.+.+... ......+++..+..++.|++.|++|||.+ +++|+||||||+||+++. ++.+||+|
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~~~kl~D 175 (360)
T 3e3p_A 99 IYLNVVMEYVPD-TLHRCCRNY-YRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCD 175 (360)
T ss_dssp EEEEEEEECCSC-BHHHHHHHH-HTTTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTTEEEECC
T ss_pred eeEEEEeecccc-cHHHHHHHH-hhcccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCCcEEEee
Confidence 7899999975 565555443 23345688999999999999999999944 579999999999999997 89999999
Q ss_pred ccCcccccCCCCcccccccCCccccccccccccCC-CCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcc
Q 002061 823 FGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCK-VSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNN 901 (973)
Q Consensus 823 fgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 901 (973)
||+++....... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||..... .......+......
T Consensus 176 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-~~~~~~~~~~~~~~ 251 (360)
T 3e3p_A 176 FGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS-AGQLHEIVRVLGCP 251 (360)
T ss_dssp CTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCC
T ss_pred CCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh-HHHHHHHHHHcCCC
Confidence 999986654322 22356899999999986654 89999999999999999999999975411 11111111110000
Q ss_pred ccccc----------hhccccc------cCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 902 HENVL----------KVLDCEV------ASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 902 ~~~~~----------~~~~~~~------~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
..... ...+... ...........+.+++.+||+.||.+|||+.|+++|-
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 316 (360)
T 3e3p_A 252 SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHP 316 (360)
T ss_dssp CHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSG
T ss_pred CHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCc
Confidence 00000 0000000 0001112356789999999999999999999999873
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=342.54 Aligned_cols=205 Identities=24% Similarity=0.286 Sum_probs=175.8
Q ss_pred cCHHHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc-cHHHHHHHHHHHHhcC-CC-----ceeeEEEEEEe
Q 002061 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIR-HR-----NILKLYACLLK 742 (973)
Q Consensus 670 ~~~~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~-hp-----niv~l~~~~~~ 742 (973)
.+....++|++.+.||+|+||+||+|++..+++.||||++.... ....+.+|+++++.++ |+ +|+++++++..
T Consensus 48 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~ 127 (382)
T 2vx3_A 48 NGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF 127 (382)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred cCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence 33455789999999999999999999999999999999987643 3456778999988884 44 59999999999
Q ss_pred CCeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeec--CCCCeEE
Q 002061 743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD--EDYEPKI 820 (973)
Q Consensus 743 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~--~~~~~kl 820 (973)
++..++||||++ |+|.+++... ....+++..+..++.|++.||+|||++ +.+|+||||||+||+++ .++.+||
T Consensus 128 ~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL 202 (382)
T 2vx3_A 128 RNHLCLVFEMLS-YNLYDLLRNT---NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKI 202 (382)
T ss_dssp TTEEEEEEECCC-CBHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEE
T ss_pred CCceEEEEecCC-CCHHHHHhhc---CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEE
Confidence 999999999995 6999999864 224589999999999999999999953 46899999999999995 4778999
Q ss_pred ecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcc
Q 002061 821 ADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEE 884 (973)
Q Consensus 821 ~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~ 884 (973)
+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 203 ~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 203 VDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp CCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999866432 22356899999999999999999999999999999999999999754
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=337.40 Aligned_cols=263 Identities=22% Similarity=0.274 Sum_probs=204.6
Q ss_pred HHHcCCcccCcccccCceEEEEEEe-cCCCcEEEEEeeecc-ccHHHHHHHHHHHHhcCCC------ceeeEEEEEEeCC
Q 002061 673 EQICNLEEDNLIGSGGTGKVYRLDL-KKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHR------NILKLYACLLKGG 744 (973)
Q Consensus 673 ~~~~~~~~~~~lG~G~~g~V~~a~~-~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp------niv~l~~~~~~~~ 744 (973)
...++|++.+.||+|+||+||+|.+ ..+++.||||++... ...+.+.+|+++++.++|+ +++++++++..++
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 3446899999999999999999998 557889999998753 3456788999999998765 4999999999999
Q ss_pred eeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecC----------
Q 002061 745 SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE---------- 814 (973)
Q Consensus 745 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~---------- 814 (973)
..++||||+ +++|.+++... ....+++..+..++.|++.||+||| +++|+||||||+||+++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~ 163 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKEN---GFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPK 163 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC--
T ss_pred cEEEEEcCC-CCCHHHHHHhc---CCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCc
Confidence 999999999 89999999764 2345889999999999999999999 789999999999999987
Q ss_pred ---------CCCeEEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccc
Q 002061 815 ---------DYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEY 885 (973)
Q Consensus 815 ---------~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~ 885 (973)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 238 (339)
T 1z57_A 164 IKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238 (339)
T ss_dssp --CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred cccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 668999999999765432 223468999999999999999999999999999999999999997541
Q ss_pred CCcccHHHHHHHHhccccc-c------chhcc---cc-------------------ccCcchHHHHHHHHHHHHHhcCCC
Q 002061 886 GDGKDIVYWVSTHLNNHEN-V------LKVLD---CE-------------------VASESIKEDMIKLLKIAVVCTTKL 936 (973)
Q Consensus 886 ~~~~~~~~~~~~~~~~~~~-~------~~~~~---~~-------------------~~~~~~~~~~~~l~~l~~~cl~~d 936 (973)
.......+.......+. . ..... .. ............+.+++.+||+.|
T Consensus 239 --~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 316 (339)
T 1z57_A 239 --SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYD 316 (339)
T ss_dssp --HHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred --hHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcC
Confidence 11111111111110000 0 00000 00 000112234567899999999999
Q ss_pred CCCCCCHHHHHHH
Q 002061 937 PNLRPPMREVVKM 949 (973)
Q Consensus 937 P~~Rpt~~evl~~ 949 (973)
|.+|||+.|++++
T Consensus 317 P~~Rpt~~ell~h 329 (339)
T 1z57_A 317 PAKRITLREALKH 329 (339)
T ss_dssp TTTSCCHHHHTTS
T ss_pred cccccCHHHHhcC
Confidence 9999999999976
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=361.83 Aligned_cols=335 Identities=19% Similarity=0.183 Sum_probs=262.4
Q ss_pred CCCCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCchhhhccccccEEEeeccccCCcCCccccccccccEEE
Q 002061 192 LKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFD 271 (973)
Q Consensus 192 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~ 271 (973)
+++++.|++++|.++...+..+..+++|++|+|++|.|++..|..|+.+++|++|+|++|.+++..|..|+++++|++|+
T Consensus 50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 129 (597)
T 3oja_B 50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 129 (597)
T ss_dssp GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence 57899999999999877777788899999999999999877777888888888888888888887777788888888888
Q ss_pred eeccccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeeccCCccCCCCCccccccccccccccccccccc
Q 002061 272 ISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSG 351 (973)
Q Consensus 272 Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~ 351 (973)
|++|.+++..+..|+++++|++|++++|.+++..|..|+.+++|+.|++++|.+++.. ++.+++|+.|++++|.+++
T Consensus 130 L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~~ 206 (597)
T 3oja_B 130 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLST 206 (597)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCSE
T ss_pred eeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCcccc
Confidence 8888888655555688888888888888888777777777777777777777776532 4445556666666665542
Q ss_pred cCChhhhhhhhHHHHHhhhccCCCCccccccCccccceEeccccccccCCCccccCCCCcceEeccCCcCCCCCCCCCCC
Q 002061 352 SFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGL 431 (973)
Q Consensus 352 ~~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 431 (973)
+...++|++|++++|.++ ......
T Consensus 207 -----------------------------l~~~~~L~~L~ls~n~l~------------------------~~~~~~--- 230 (597)
T 3oja_B 207 -----------------------------LAIPIAVEELDASHNSIN------------------------VVRGPV--- 230 (597)
T ss_dssp -----------------------------EECCTTCSEEECCSSCCC------------------------EEECSC---
T ss_pred -----------------------------ccCCchhheeeccCCccc------------------------cccccc---
Confidence 111234555555555554 332221
Q ss_pred CCCCCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCCccccccccccchh
Q 002061 432 STSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLN 511 (973)
Q Consensus 432 ~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 511 (973)
.++|+.|+|++|.+++ +..+..+++|+.|+|++|.+++..|..|..+++|+.|+|++|++++ +|..+..+++|+.|+
T Consensus 231 ~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~ 307 (597)
T 3oja_B 231 NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLD 307 (597)
T ss_dssp CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEE
T ss_pred CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEE
Confidence 2578888888888875 4678889999999999999998888899999999999999999986 466777889999999
Q ss_pred ccccccccCCCccccccCCCCeeecCCCccCCCCChhhhccc-CceEEccCCccccccCcccccCCCCccccCCCCCccC
Q 002061 512 LARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLK-LSSIDLSENQLSGSVPLDFLRMGGDGAFAGNEGLCLD 590 (973)
Q Consensus 512 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~-L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~n~~lc~~ 590 (973)
|++|.++ .+|..+..+++|+.|+|++|+|++.. +..++ |+.|+|++|+|+|.+...+........+.+++..|+.
T Consensus 308 Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~L~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~C~~ 383 (597)
T 3oja_B 308 LSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK---LSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKI 383 (597)
T ss_dssp CCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC---CCTTCCCSEEECCSSCEEHHHHHHHTTTCCTTTBCCCCCCCCT
T ss_pred CCCCCCC-ccCcccccCCCCCEEECCCCCCCCcC---hhhcCCCCEEEeeCCCCCChhHHHHHHHHhhhccccccccCCc
Confidence 9999998 67788899999999999999998553 33444 8999999999999988766555555678999999987
Q ss_pred cc
Q 002061 591 QS 592 (973)
Q Consensus 591 ~~ 592 (973)
+.
T Consensus 384 ~~ 385 (597)
T 3oja_B 384 DY 385 (597)
T ss_dssp TC
T ss_pred ch
Confidence 54
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=339.48 Aligned_cols=257 Identities=26% Similarity=0.328 Sum_probs=181.9
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc---cHHHHHHHHH-HHHhcCCCceeeEEEEEEeCCeeEEEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD---GVKVFAAEME-ILGKIRHRNILKLYACLLKGGSSFLVL 750 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~lv~ 750 (973)
.++|++.+.||+|+||+||+|.+..+++.||||++.... ...++.+|+. +++.++||||+++++++..++..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 367899999999999999999999899999999987632 2334555665 677789999999999999999999999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCC-CeEecCCCCCCeeecCCCCeEEecccCcccc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP-PIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~-~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 829 (973)
||++ |+|.+++..........+++..+..++.|++.|++||| +. +++||||||+||+++.++.+||+|||+++..
T Consensus 101 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 9997 58888887543334567899999999999999999999 66 9999999999999999999999999999766
Q ss_pred cCCCCcccccccCCcccccccccc----ccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccccc
Q 002061 830 ENSPKVSDYSCFAGTHGYIAPELA----YTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENV 905 (973)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 905 (973)
..... .....||+.|+|||++ .+..++.++|||||||++|||++|+.||........ ........
T Consensus 177 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~~~~---- 245 (327)
T 3aln_A 177 VDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD----QLTQVVKG---- 245 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------CCCCCS----
T ss_pred ccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH----HHHHHhcC----
Confidence 43321 2234689999999998 466789999999999999999999999975311100 00000000
Q ss_pred chhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 906 LKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
..+.............+.+++.+||+.||++||++.|++++
T Consensus 246 ---~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 246 ---DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp ---CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred ---CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 00111111111234568899999999999999999999875
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=342.37 Aligned_cols=259 Identities=22% Similarity=0.285 Sum_probs=197.2
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCee----
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSS---- 746 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~---- 746 (973)
.++|.+.+.||+|+||+||+|++..+++.||||++... ...+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 35889999999999999999999999999999998753 2346688999999999999999999999876654
Q ss_pred --EEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEeccc
Q 002061 747 --FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFG 824 (973)
Q Consensus 747 --~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 824 (973)
|+||||++ ++|.+++.. .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg 189 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM-------EFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFG 189 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS-------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTT
T ss_pred eEEEEEcccc-ccHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecC
Confidence 99999996 688777632 3889999999999999999999 7899999999999999999999999999
Q ss_pred CcccccCCCCcccccccCCcccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccc
Q 002061 825 VAKIAENSPKVSDYSCFAGTHGYIAPELAYT-CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHE 903 (973)
Q Consensus 825 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 903 (973)
+++..... .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.... ..+....+........
T Consensus 190 ~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--~~~~~~~i~~~~~~~~ 262 (371)
T 4exu_A 190 LARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD--YLDQLTQILKVTGVPG 262 (371)
T ss_dssp CC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCCC
T ss_pred cccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhCCCc
Confidence 99755432 223568999999999887 678999999999999999999999997531 1111111111000000
Q ss_pred -ccch------------hccccccC---cchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 904 -NVLK------------VLDCEVAS---ESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 904 -~~~~------------~~~~~~~~---~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
.... ........ .........+.+++.+|++.||++|||+.|++++-.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 326 (371)
T 4exu_A 263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 326 (371)
T ss_dssp HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcc
Confidence 0000 00000000 001123467889999999999999999999998743
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=332.47 Aligned_cols=255 Identities=25% Similarity=0.410 Sum_probs=195.6
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-ccHHHHHHHHHHHHhcCCCceeeEEEEEEe----------
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNILKLYACLLK---------- 742 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~---------- 742 (973)
..++|++.+.||+|+||+||+|++..+++.||||++... ...+.+.+|++++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 356789999999999999999999988999999998653 445678899999999999999999998865
Q ss_pred ---CCeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeE
Q 002061 743 ---GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPK 819 (973)
Q Consensus 743 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k 819 (973)
....|+||||+++|+|.+++... ...+++..+..++.|+++||+||| +.+++||||||+||+++.++.+|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~k 156 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSE----NLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVK 156 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHS----CGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEE
T ss_pred cccCCceEEEEecCCCCCHHHhhhcc----ccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEE
Confidence 35679999999999999999753 345788899999999999999999 78999999999999999999999
Q ss_pred EecccCcccccCCCC------------cccccccCCccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccC
Q 002061 820 IADFGVAKIAENSPK------------VSDYSCFAGTHGYIAPELAYTC-KVSEKSDVFSFGVVLLELVTGRKPVEEEYG 886 (973)
Q Consensus 820 l~Dfgl~~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~pf~~~~~ 886 (973)
|+|||++........ ........||+.|+|||++.+. .++.++||||+||++|||++ ||...
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~-- 231 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG-- 231 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH--
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc--
Confidence 999999976543211 1122335689999999998764 68999999999999999998 55422
Q ss_pred CcccHHHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 887 DGKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 887 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
.+............. .............+.+++.+||+.||.+|||+.|++++-
T Consensus 232 --~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 285 (303)
T 1zy4_A 232 --MERVNILKKLRSVSI--------EFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSG 285 (303)
T ss_dssp --HHHHHHHHHHHSTTC--------CCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSS
T ss_pred --hhHHHHHHhcccccc--------ccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCC
Confidence 111111111111111 111111223345678899999999999999999999864
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=328.77 Aligned_cols=253 Identities=28% Similarity=0.378 Sum_probs=204.5
Q ss_pred HHHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeE
Q 002061 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF 747 (973)
Q Consensus 672 ~~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 747 (973)
....++|++.+.||+|+||+||+|++..+++.||||++... ...+.+.+|++++++++||||+++++++..+...+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 34567899999999999999999999988999999998652 35677899999999999999999999999999999
Q ss_pred EEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCC---CCeEEeccc
Q 002061 748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDED---YEPKIADFG 824 (973)
Q Consensus 748 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~---~~~kl~Dfg 824 (973)
+||||+++++|.+++... ..+++..+..++.|++.||+||| +.+++||||||+||+++.+ +.+||+|||
T Consensus 98 lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg 169 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFG 169 (287)
T ss_dssp EEECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTT
T ss_pred EEEEccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccC
Confidence 999999999999998754 25889999999999999999999 7899999999999999754 479999999
Q ss_pred CcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccc
Q 002061 825 VAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHEN 904 (973)
Q Consensus 825 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 904 (973)
++........ .....|++.|+|||++.+ .++.++||||||+++|+|++|+.||.... ..+....+.. ....
T Consensus 170 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~--~~~~~~~~~~---~~~~ 240 (287)
T 2wei_A 170 LSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN--EYDILKRVET---GKYA 240 (287)
T ss_dssp GGGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHH---CCCC
T ss_pred cceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC--HHHHHHHHHc---CCCC
Confidence 9986644322 222457899999999875 48999999999999999999999996531 1111111111 1100
Q ss_pred cchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 905 VLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
............+.+++.+|++.||++|||+.|++++
T Consensus 241 --------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 241 --------FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp --------CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred --------CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 0001112234568899999999999999999999985
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=339.90 Aligned_cols=264 Identities=22% Similarity=0.283 Sum_probs=200.4
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeC-----Cee
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKG-----GSS 746 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~ 746 (973)
.++|++.+.||+|+||+||+|++..+++.||||++... .....+.+|++++++++||||+++++++..+ ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 46899999999999999999999999999999998643 2345678999999999999999999988654 678
Q ss_pred EEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCc
Q 002061 747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826 (973)
Q Consensus 747 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~ 826 (973)
|+||||++ |+|.+++... .+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++
T Consensus 90 ~lv~e~~~-~~L~~~~~~~------~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ------MLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLA 159 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEeccC-ccHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecccc
Confidence 99999996 6999988752 5889999999999999999999 789999999999999999999999999999
Q ss_pred ccccCCCCcc--------cccccCCcccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHH
Q 002061 827 KIAENSPKVS--------DYSCFAGTHGYIAPELAYT-CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVST 897 (973)
Q Consensus 827 ~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~ 897 (973)
+......... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... .......+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~~~~~~~~ 237 (353)
T 2b9h_A 160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD--YRHQLLLIFG 237 (353)
T ss_dssp EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHH
T ss_pred cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC--cHHHHHHHHH
Confidence 8765322111 1223468999999998764 678999999999999999999999997542 1111111111
Q ss_pred Hhcccc---cc--------chhcc--cccc----CcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 898 HLNNHE---NV--------LKVLD--CEVA----SESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 898 ~~~~~~---~~--------~~~~~--~~~~----~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
...... .. .+... +... ..........+.+++.+||+.||++|||+.|++++-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 307 (353)
T 2b9h_A 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHP 307 (353)
T ss_dssp HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence 110000 00 00000 0000 000112345678999999999999999999999864
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=345.27 Aligned_cols=264 Identities=19% Similarity=0.190 Sum_probs=204.1
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecccc-------------------HHHHHHHHHHHHhcCCCcee
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG-------------------VKVFAAEMEILGKIRHRNIL 734 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~-------------------~~~~~~E~~~l~~l~hpniv 734 (973)
..++|++.+.||+|+||+||+|++ +++.||||++..... .+.+.+|++++++++||||+
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 356899999999999999999999 699999999865321 17889999999999999999
Q ss_pred eEEEEEEeCCeeEEEEEccCCCchHHHHHhh---hcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCC-CCeEecCCCCCCe
Q 002061 735 KLYACLLKGGSSFLVLEYMPNGNLFQALHKR---VKEGKPELDWFRRYKIALGAAKGIAYLHHDCS-PPIIHRDIKSSNI 810 (973)
Q Consensus 735 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~-~~ivH~Dlkp~Ni 810 (973)
++++++.+++..|+||||+++|+|.+++... .......+++..+..++.|++.||+||| + .+++||||||+||
T Consensus 107 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Ni 183 (348)
T 2pml_X 107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNI 183 (348)
T ss_dssp CCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGE
T ss_pred eEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhE
Confidence 9999999999999999999999999883211 0112456899999999999999999999 5 8999999999999
Q ss_pred eecCCCCeEEecccCcccccCCCCcccccccCCccccccccccccC-CCCc-cchHHHHHHHHHHHHhCCCCCCcccCCc
Q 002061 811 LLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTC-KVSE-KSDVFSFGVVLLELVTGRKPVEEEYGDG 888 (973)
Q Consensus 811 ll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwslG~~l~el~tg~~pf~~~~~~~ 888 (973)
+++.++.+||+|||.+...... ......|+..|+|||++.+. .++. ++||||+||++|||++|+.||......
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~- 258 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL- 258 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS-
T ss_pred EEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH-
Confidence 9999999999999999866433 22345689999999999877 6666 999999999999999999999754221
Q ss_pred ccHHHHHHHHhccccccch----hccc---cccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 889 KDIVYWVSTHLNNHENVLK----VLDC---EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 889 ~~~~~~~~~~~~~~~~~~~----~~~~---~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
.... ............ .... .............+.+++.+||+.||++||++.|++++-
T Consensus 259 ~~~~---~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp 324 (348)
T 2pml_X 259 VELF---NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHE 324 (348)
T ss_dssp HHHH---HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred HHHH---HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 1111 111111110000 0000 000000123345788999999999999999999999863
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-37 Score=346.63 Aligned_cols=268 Identities=24% Similarity=0.323 Sum_probs=196.0
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhcCCCceeeEEEEEEeCC------eeEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKGG------SSFL 748 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------~~~l 748 (973)
..+|++.+.||+|+||+||+|++..++ .||+|++..... ...+|+++++.++||||+++++++.... ..++
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~-~~aikk~~~~~~--~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESD-EVAIKKVLQDKR--FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTE-EEEEEEEECCTT--SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCC-eEEEEEEecCcc--hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 457899999999999999999998755 488888765332 2247999999999999999999986543 3789
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeec-CCCCeEEecccCcc
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD-EDYEPKIADFGVAK 827 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~kl~Dfgl~~ 827 (973)
||||++++ +.+.+.... .....+++..+..++.|+++||+||| +.+|+||||||+||+++ .++.+||+|||+++
T Consensus 116 v~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 116 VLEYVPET-VYRASRHYA-KLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEECCSEE-HHHHHHHHH-HTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EeeccCcc-HHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 99999764 444443321 22446899999999999999999999 78999999999999999 79999999999998
Q ss_pred cccCCCCcccccccCCccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhc------
Q 002061 828 IAENSPKVSDYSCFAGTHGYIAPELAYTC-KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLN------ 900 (973)
Q Consensus 828 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~------ 900 (973)
....... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||..... .......+...-.
T Consensus 191 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~l~~i~~~~g~p~~~~~ 266 (394)
T 4e7w_A 191 ILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG-IDQLVEIIKVLGTPSREQI 266 (394)
T ss_dssp ECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCHHHH
T ss_pred cccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHH
Confidence 7644322 2235689999999998765 589999999999999999999999975421 1111111111000
Q ss_pred --cccccchhccccccCcc-----hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--hhcCC
Q 002061 901 --NHENVLKVLDCEVASES-----IKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM--LADAD 954 (973)
Q Consensus 901 --~~~~~~~~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~--L~~~~ 954 (973)
..+...+...+...... .......+.+++.+||++||.+|||+.|+++| ++++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 00000000001111111 11234578899999999999999999999987 44443
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=333.65 Aligned_cols=269 Identities=20% Similarity=0.252 Sum_probs=203.5
Q ss_pred HHcCCcccCcccccCceEEEEEEec-CCCcEEEEEeeeccc----cHHHHHHHHHHHHhc---CCCceeeEEEEEE----
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLK-KNAGTVAVKQLWKGD----GVKVFAAEMEILGKI---RHRNILKLYACLL---- 741 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~-~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l---~hpniv~l~~~~~---- 741 (973)
...+|++.+.||+|+||+||+|++. .+++.||||++.... ....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 3468999999999999999999995 668899999886522 233567788887776 8999999999987
Q ss_pred -eCCeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEE
Q 002061 742 -KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKI 820 (973)
Q Consensus 742 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl 820 (973)
.....++||||++ |+|.+++... ....+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl 161 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKL 161 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEE
T ss_pred CCCceEEEEEecCC-CCHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEE
Confidence 4567899999997 6999999764 2345889999999999999999999 789999999999999999999999
Q ss_pred ecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhc
Q 002061 821 ADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLN 900 (973)
Q Consensus 821 ~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 900 (973)
+|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+....+.....
T Consensus 162 ~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~~~~~i~~~~~ 236 (326)
T 1blx_A 162 ADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS--DVDQLGKILDVIG 236 (326)
T ss_dssp CSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHC
T ss_pred ecCcccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHHHcC
Confidence 999999765432 22334568999999999999999999999999999999999999997541 1111111111111
Q ss_pred ccc--ccch-------hcc---ccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--hhcCC
Q 002061 901 NHE--NVLK-------VLD---CEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM--LADAD 954 (973)
Q Consensus 901 ~~~--~~~~-------~~~---~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~--L~~~~ 954 (973)
... .... .+. ..............+.+++.+||+.||++||++.|++++ +.++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 304 (326)
T 1blx_A 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304 (326)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred CCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence 000 0000 000 000001112234567899999999999999999999976 44443
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=333.98 Aligned_cols=263 Identities=22% Similarity=0.294 Sum_probs=193.1
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc--ccHHHHHHHHHHHHhcCCCceeeEEEEEE-----------
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLL----------- 741 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~----------- 741 (973)
.++|++.+.||+|+||+||+|++..+++.||||++... ...+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 36789999999999999999999999999999988653 34567889999999999999999999873
Q ss_pred ---eCCeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeec-CCCC
Q 002061 742 ---KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD-EDYE 817 (973)
Q Consensus 742 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~-~~~~ 817 (973)
+....|+||||++ |+|.+++.. ..+++..+..++.|++.||+||| +.+++||||||+||+++ +++.
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~ 159 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ------GPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLV 159 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc------CCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCe
Confidence 3467899999997 699998863 35788999999999999999999 78999999999999997 5679
Q ss_pred eEEecccCcccccCCCC-cccccccCCcccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHH
Q 002061 818 PKIADFGVAKIAENSPK-VSDYSCFAGTHGYIAPELAYT-CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWV 895 (973)
Q Consensus 818 ~kl~Dfgl~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~ 895 (973)
+||+|||+++....... ........+|..|+|||++.+ ..++.++|||||||++|||++|+.||.... .......+
T Consensus 160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--~~~~~~~~ 237 (320)
T 2i6l_A 160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH--ELEQMQLI 237 (320)
T ss_dssp EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHH
T ss_pred EEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC--HHHHHHHH
Confidence 99999999986643211 122233467899999998865 678999999999999999999999997542 11111111
Q ss_pred HHHhcccc---------ccchhccccc--c----CcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 896 STHLNNHE---------NVLKVLDCEV--A----SESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 896 ~~~~~~~~---------~~~~~~~~~~--~----~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
........ .......... . ..........+.+++.+|++.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 11100000 0000000000 0 00011234678899999999999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=337.13 Aligned_cols=258 Identities=21% Similarity=0.263 Sum_probs=177.8
Q ss_pred HHHcCCcccC-cccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhcCCCceeeEEEEEEe----CCeeE
Q 002061 673 EQICNLEEDN-LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLK----GGSSF 747 (973)
Q Consensus 673 ~~~~~~~~~~-~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~~~ 747 (973)
...++|++.+ .||+|+||+||+|++..+++.||||++.... ....+....++.++||||+++++++.. +...+
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH--HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH--HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 3456888854 6999999999999999999999999986532 222233344667799999999999876 45589
Q ss_pred EEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecC---CCCeEEeccc
Q 002061 748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE---DYEPKIADFG 824 (973)
Q Consensus 748 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~Dfg 824 (973)
+||||+++|+|.+++... ....+++..+..++.|++.||+||| +.+|+||||||+||+++. ++.+||+|||
T Consensus 103 lv~e~~~gg~L~~~l~~~---~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQER---GDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp EEEECCTTEEHHHHHHTC----CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEeccCCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence 999999999999999854 2346899999999999999999999 789999999999999986 4559999999
Q ss_pred CcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccc
Q 002061 825 VAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHEN 904 (973)
Q Consensus 825 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 904 (973)
+++...... .....||+.|+|||++.+..++.++||||+||++|+|++|+.||......... ...........
T Consensus 177 ~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~- 249 (336)
T 3fhr_A 177 FAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS--PGMKRRIRLGQ- 249 (336)
T ss_dssp TCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------
T ss_pred cceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh--hhHHHhhhccc-
Confidence 997654321 22356799999999998888999999999999999999999999754221110 00000000000
Q ss_pred cchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 905 VLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
..............+.+++.+|++.||.+|||+.|++++-.
T Consensus 250 ------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 290 (336)
T 3fhr_A 250 ------YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPW 290 (336)
T ss_dssp -------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred ------cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 00011111223456889999999999999999999999543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=334.70 Aligned_cols=252 Identities=23% Similarity=0.323 Sum_probs=193.9
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcC--CCceeeEEEEEEeCCeeEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIR--HRNILKLYACLLKGGSSFL 748 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~~~~~l 748 (973)
..+|++.+.||+|+||+||+|++.. ++.||||++... ...+.+.+|++++++++ ||||+++++++..++..|+
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred cceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 4578999999999999999999865 889999998653 24467889999999997 5999999999999999999
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccc
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 828 (973)
||| +.+++|.+++... ..+++..+..++.|+++||+||| +.+++||||||+||++++ +.+||+|||++..
T Consensus 106 v~e-~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~ 175 (313)
T 3cek_A 106 VME-CGNIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQ 175 (313)
T ss_dssp EEC-CCSEEHHHHHHHC-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCSSSCC
T ss_pred EEe-cCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeecccccc
Confidence 999 5588999999753 35788999999999999999999 789999999999999964 8999999999987
Q ss_pred ccCCCCcccccccCCcccccccccccc-----------CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHH
Q 002061 829 AENSPKVSDYSCFAGTHGYIAPELAYT-----------CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVST 897 (973)
Q Consensus 829 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~ 897 (973)
..............||+.|+|||++.+ ..++.++||||||+++|||++|+.||..... . ......
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---~-~~~~~~ 251 (313)
T 3cek_A 176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN---Q-ISKLHA 251 (313)
T ss_dssp --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS---H-HHHHHH
T ss_pred ccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH---H-HHHHHH
Confidence 654433222334568999999999865 4688899999999999999999999975321 1 111111
Q ss_pred HhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 898 HLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 898 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
..... .....+......+.+++.+||+.||.+||++.|++++-.
T Consensus 252 ~~~~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~ 295 (313)
T 3cek_A 252 IIDPN----------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 295 (313)
T ss_dssp HHCTT----------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HHhcc----------cccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCcc
Confidence 11111 000011111346788999999999999999999998654
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-36 Score=334.80 Aligned_cols=264 Identities=19% Similarity=0.224 Sum_probs=203.5
Q ss_pred HHHHcCCcccCcccccCceEEEEEEecCCC-cEEEEEeeecc-ccHHHHHHHHHHHHhcCCCc------eeeEEEEEEeC
Q 002061 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNA-GTVAVKQLWKG-DGVKVFAAEMEILGKIRHRN------ILKLYACLLKG 743 (973)
Q Consensus 672 ~~~~~~~~~~~~lG~G~~g~V~~a~~~~~~-~~vavK~~~~~-~~~~~~~~E~~~l~~l~hpn------iv~l~~~~~~~ 743 (973)
....++|++.+.||+|+||+||+|++..++ +.||||++... ...+.+.+|++++++++|++ ++.+++++...
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 15 DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred ceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 344578999999999999999999998766 68999998763 34566788999999997765 99999999999
Q ss_pred CeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeee-----------
Q 002061 744 GSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILL----------- 812 (973)
Q Consensus 744 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill----------- 812 (973)
+..++||||+ ++++.+++... ....+++..+..++.|++.||+||| +++|+||||||+||++
T Consensus 95 ~~~~lv~e~~-~~~l~~~l~~~---~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~ 167 (355)
T 2eu9_A 95 GHMCIAFELL-GKNTFEFLKEN---NFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNE 167 (355)
T ss_dssp TEEEEEEECC-CCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECC
T ss_pred CeEEEEEecc-CCChHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecccccccccc
Confidence 9999999999 67777777653 2345899999999999999999999 8899999999999999
Q ss_pred --------cCCCCeEEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcc
Q 002061 813 --------DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEE 884 (973)
Q Consensus 813 --------~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~ 884 (973)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (355)
T 2eu9_A 168 HKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242 (355)
T ss_dssp C-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 56789999999999764332 22356899999999999999999999999999999999999999754
Q ss_pred cCCcccHHHHHHHHhccccc-c------ch-hcccc---------------------ccCcchHHHHHHHHHHHHHhcCC
Q 002061 885 YGDGKDIVYWVSTHLNNHEN-V------LK-VLDCE---------------------VASESIKEDMIKLLKIAVVCTTK 935 (973)
Q Consensus 885 ~~~~~~~~~~~~~~~~~~~~-~------~~-~~~~~---------------------~~~~~~~~~~~~l~~l~~~cl~~ 935 (973)
. .......+.......+. . .. ..... ............+.+++.+||+.
T Consensus 243 ~--~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 320 (355)
T 2eu9_A 243 E--NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEF 320 (355)
T ss_dssp S--HHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred C--HHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcC
Confidence 2 11111111111111000 0 00 00000 00001123355788999999999
Q ss_pred CCCCCCCHHHHHHH
Q 002061 936 LPNLRPPMREVVKM 949 (973)
Q Consensus 936 dP~~Rpt~~evl~~ 949 (973)
||++|||+.|++++
T Consensus 321 dP~~Rpt~~e~l~h 334 (355)
T 2eu9_A 321 DPAQRITLAEALLH 334 (355)
T ss_dssp STTTSCCHHHHTTS
T ss_pred ChhhCcCHHHHhcC
Confidence 99999999999976
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=340.57 Aligned_cols=265 Identities=20% Similarity=0.238 Sum_probs=194.2
Q ss_pred HHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc-------------cHHHHHHHHHHHHhcCCCceeeEEEE
Q 002061 673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-------------GVKVFAAEMEILGKIRHRNILKLYAC 739 (973)
Q Consensus 673 ~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-------------~~~~~~~E~~~l~~l~hpniv~l~~~ 739 (973)
...++|++.+.||+|+||+||+|.+.. ++.||||++.... ..+.+.+|++++++++||||++++++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 445789999999999999999999876 8999999885421 12678999999999999999999999
Q ss_pred EEe-----CCeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecC
Q 002061 740 LLK-----GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE 814 (973)
Q Consensus 740 ~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~ 814 (973)
+.. ....|+||||++ |+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~ 169 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ----RIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLAD 169 (362)
T ss_dssp EEECCTTTCCEEEEEEECCS-EEHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECT
T ss_pred EEeccCCCcceEEEEEccCC-CCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEEcC
Confidence 854 236799999996 7888888743 346899999999999999999999 789999999999999999
Q ss_pred CCCeEEecccCcccccCCCCcccccccCCcccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHH
Q 002061 815 DYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYT-CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVY 893 (973)
Q Consensus 815 ~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~ 893 (973)
++.+||+|||++....... ......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.... ......
T Consensus 170 ~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~ 244 (362)
T 3pg1_A 170 NNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST--FYNQLN 244 (362)
T ss_dssp TCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHH
T ss_pred CCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC--HHHHHH
Confidence 9999999999997543322 2233568999999999876 678999999999999999999999997531 111111
Q ss_pred HHHHHhcccc----------ccchhcc---ccccC----cchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 894 WVSTHLNNHE----------NVLKVLD---CEVAS----ESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 894 ~~~~~~~~~~----------~~~~~~~---~~~~~----~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
.+........ ....... ..... .........+.+++.+|++.||++|||+.|+++|-.
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 319 (362)
T 3pg1_A 245 KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPY 319 (362)
T ss_dssp HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCch
Confidence 1111000000 0000000 00000 011122456889999999999999999999998743
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=340.63 Aligned_cols=257 Identities=23% Similarity=0.319 Sum_probs=197.3
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL 750 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 750 (973)
.++|++.+.||+|+||+||+|++.. .||||++... ...+.+.+|+.++++++||||+++++++..++..++||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 4688999999999999999999864 5999988642 23456778999999999999999999999999999999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccccc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 830 (973)
||+++++|.+++... ...+++..+..++.|++.||+||| +.+++||||||+||+++ ++.+||+|||+++...
T Consensus 109 e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 109 SLCKGRTLYSVVRDA----KIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180 (319)
T ss_dssp BCCCSEEHHHHTTSS----CCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred ecccCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence 999999999998643 345888999999999999999999 78999999999999998 6799999999987553
Q ss_pred CCC---CcccccccCCcccccccccccc---------CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHH
Q 002061 831 NSP---KVSDYSCFAGTHGYIAPELAYT---------CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTH 898 (973)
Q Consensus 831 ~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~ 898 (973)
... .........|++.|+|||++.+ ..++.++||||||+++|||++|+.||.... ........
T Consensus 181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~ 255 (319)
T 2y4i_B 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP-----AEAIIWQM 255 (319)
T ss_dssp -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC-----HHHHHHHH
T ss_pred cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHh
Confidence 221 1122233568999999999864 457889999999999999999999997531 11111111
Q ss_pred hccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCCC
Q 002061 899 LNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPCT 957 (973)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~ 957 (973)
..... +.... ......+.+++.+||+.||++|||+.+++++|+++....
T Consensus 256 ~~~~~-------~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 256 GTGMK-------PNLSQ---IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp HTTCC-------CCCCC---SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred ccCCC-------CCCCc---CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 11110 00000 012235788999999999999999999999999987654
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-36 Score=336.93 Aligned_cols=264 Identities=21% Similarity=0.252 Sum_probs=202.3
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-ccHHHHHHHHHHHHhcC-----------CCceeeEEEEEEe
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIR-----------HRNILKLYACLLK 742 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~-----------hpniv~l~~~~~~ 742 (973)
..+|++.+.||+|+||+||+|++..+++.||||++... ...+.+.+|++++++++ ||||+++++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 46899999999999999999999999999999998754 34566788999998886 8999999999876
Q ss_pred CC----eeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCC-CeEecCCCCCCeeec----
Q 002061 743 GG----SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP-PIIHRDIKSSNILLD---- 813 (973)
Q Consensus 743 ~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~-~ivH~Dlkp~Nill~---- 813 (973)
.+ ..++||||+ +++|.+++... ....+++..+..++.|++.||+||| ++ +|+||||||+||+++
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKY---EHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEET
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHh---hccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCC
Confidence 54 789999999 89999999864 2345889999999999999999999 66 999999999999995
Q ss_pred --CCCCeEEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCc---
Q 002061 814 --EDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDG--- 888 (973)
Q Consensus 814 --~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~--- 888 (973)
..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 245 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred CcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence 3447999999999866432 223468999999999999999999999999999999999999997543211
Q ss_pred --ccHHHHHHHHhccccc--------cchhcc----------cc---------ccCcchHHHHHHHHHHHHHhcCCCCCC
Q 002061 889 --KDIVYWVSTHLNNHEN--------VLKVLD----------CE---------VASESIKEDMIKLLKIAVVCTTKLPNL 939 (973)
Q Consensus 889 --~~~~~~~~~~~~~~~~--------~~~~~~----------~~---------~~~~~~~~~~~~l~~l~~~cl~~dP~~ 939 (973)
......+. .....+. ...++. .. ............+.+++.+||+.||++
T Consensus 246 ~~~~~~~~~~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 324 (373)
T 1q8y_A 246 DDDHIAQIIE-LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 324 (373)
T ss_dssp HHHHHHHHHH-HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred hHHHHHHHHH-hcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccc
Confidence 01111111 1100000 000000 00 001123466778999999999999999
Q ss_pred CCCHHHHHHHhh
Q 002061 940 RPPMREVVKMLA 951 (973)
Q Consensus 940 Rpt~~evl~~L~ 951 (973)
|||+.|+++|-.
T Consensus 325 Rpt~~ell~hp~ 336 (373)
T 1q8y_A 325 RADAGGLVNHPW 336 (373)
T ss_dssp CBCHHHHHTCGG
T ss_pred cCCHHHHhhChh
Confidence 999999999643
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=355.64 Aligned_cols=350 Identities=17% Similarity=0.214 Sum_probs=227.0
Q ss_pred CcccccCCCCCCCCCCC---cceeeeCCCCCceEEEeecCCCCCccccccccCCccCcEeeCCCCcccCcCChhhhCCCC
Q 002061 46 PHGVLDSWKESADSPCG---FSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSN 122 (973)
Q Consensus 46 ~~~~~~~W~~~~~~~c~---w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~ 122 (973)
....+++|.++.+||+. |.++.|+. .++-...... ....-..+.+++.|++++|.++...+..++.+++
T Consensus 5 ~~~~l~~~~~~~~C~~~~~~~~c~~~~~------~i~~~~~~~~--~~~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~~ 76 (597)
T 3oja_B 5 QRYNVKPRQPEYKCIDSNLQYDCVFYDV------HIDMQTQDVY--FGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQ 76 (597)
T ss_dssp ------CCCSEECCCCC--CCSEEECSC------EECSSCCCCE--ESCSSGGGCCCSEEEESSCEESEECTHHHHHCCC
T ss_pred ccccccCCCCCCcCcccCcCceeEecCc------eecccccccc--cCcccccCCCceEEEeeCCCCCCcCHHHHccCCC
Confidence 34467899987765444 55555541 1221111111 1112234788999999999998655556888999
Q ss_pred CcEEEecCCcccCCCC-cccCCCCCCEEeccCccCCCccccccccccccceEEccCCcCCCCCCccc-ccCCCCCCEEEc
Q 002061 123 LKVLNVTGNAMVGSVP-DLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPES-IGNLKNLTYLFL 200 (973)
Q Consensus 123 L~~L~L~~n~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ip~~-~~~l~~L~~L~L 200 (973)
|++|+|++|.+.+.++ .|+.+++|++|+|++|.+++..|..|+++++|++|+|++|.+. .+|.. ++++++|++|+|
T Consensus 77 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~--~l~~~~~~~l~~L~~L~L 154 (597)
T 3oja_B 77 VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS--SLPRGIFHNTPKLTTLSM 154 (597)
T ss_dssp CSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC--CCCTTTTTTCTTCCEEEC
T ss_pred CcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCC--CCCHHHhccCCCCCEEEe
Confidence 9999999999988776 6899999999999999999888888888888888888888876 44554 577888888888
Q ss_pred ccCCCCCCCChhhhccCCCCeeecccccccCCCchhhhccccccEEEeeccccCCcCCccccccccccEEEeeccccccc
Q 002061 201 AHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGK 280 (973)
Q Consensus 201 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ 280 (973)
++|.+++..|..|+.+++|++|+|++|.+++. .++.+++|++|++++|.+++ +...++|+.|++++|.+...
T Consensus 155 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~~~~l~~L~~L~l~~n~l~~-----l~~~~~L~~L~ls~n~l~~~ 226 (597)
T 3oja_B 155 SNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVV 226 (597)
T ss_dssp CSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC---CGGGCTTCSEEECCSSCCSE-----EECCTTCSEEECCSSCCCEE
T ss_pred eCCcCCCCChhhhhcCCcCcEEECcCCCCCCc---ChhhhhhhhhhhcccCcccc-----ccCCchhheeeccCCccccc
Confidence 88888877777788888888888888888754 24556777777777777663 23345677777777776533
Q ss_pred cCCccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeeccCCccCCCCCccccccccccccccccccccccCChhhhhh
Q 002061 281 LPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEK 360 (973)
Q Consensus 281 ~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 360 (973)
.+. + .++|+.|++++|.+++ +..+..+++|+.|+|++|.+++.
T Consensus 227 ~~~-~--~~~L~~L~L~~n~l~~--------------------------~~~l~~l~~L~~L~Ls~N~l~~~-------- 269 (597)
T 3oja_B 227 RGP-V--NVELTILKLQHNNLTD--------------------------TAWLLNYPGLVEVDLSYNELEKI-------- 269 (597)
T ss_dssp ECS-C--CSCCCEEECCSSCCCC--------------------------CGGGGGCTTCSEEECCSSCCCEE--------
T ss_pred ccc-c--CCCCCEEECCCCCCCC--------------------------ChhhccCCCCCEEECCCCccCCC--------
Confidence 222 1 1355555555555553 23344455555555555555432
Q ss_pred hhHHHHHhhhccCCCCccccccCccccceEeccccccccCCCccccCCCCcceEeccCCcCCCCCCCCCCCCCCCCEEEc
Q 002061 361 RKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVL 440 (973)
Q Consensus 361 ~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L 440 (973)
.|..|..+++|++|+|++|.+++ +|..+..+++|+.|+|++|.++++ +..+..+++|+.|+|
T Consensus 270 ----------------~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~~i-~~~~~~l~~L~~L~L 331 (597)
T 3oja_B 270 ----------------MYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLHV-ERNQPQFDRLENLYL 331 (597)
T ss_dssp ----------------ESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCCCC-GGGHHHHTTCSEEEC
T ss_pred ----------------CHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCCcc-CcccccCCCCCEEEC
Confidence 22334445555555555555553 344445556666666666666533 333455677777777
Q ss_pred ccCCCCCCCChhhhcCCCCCEEEccCCcCCC
Q 002061 441 QNNRFSGELPSELGRLTNLERLILTNNNFSG 471 (973)
Q Consensus 441 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 471 (973)
++|+|++. | +..+++|+.|+|++|.+.+
T Consensus 332 ~~N~l~~~-~--~~~~~~L~~L~l~~N~~~~ 359 (597)
T 3oja_B 332 DHNSIVTL-K--LSTHHTLKNLTLSHNDWDC 359 (597)
T ss_dssp CSSCCCCC-C--CCTTCCCSEEECCSSCEEH
T ss_pred CCCCCCCc-C--hhhcCCCCEEEeeCCCCCC
Confidence 77777643 2 5667888888999888874
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=335.79 Aligned_cols=258 Identities=22% Similarity=0.286 Sum_probs=196.3
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCe------
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGS------ 745 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~------ 745 (973)
.+|.+.+.||+|+||+||+|++..+|+.||||++... ...+.+.+|+.++++++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 5789999999999999999999999999999998653 234567899999999999999999999987654
Q ss_pred eEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccC
Q 002061 746 SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGV 825 (973)
Q Consensus 746 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl 825 (973)
.|+||||++ |+|.+++.. .+++..+..++.|++.||+||| +++++||||||+||+++.++.+||+|||+
T Consensus 104 ~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMGL-------KFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CEEEEECCS-EEGGGTTTS-------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred EEEEecccc-CCHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999996 688776632 3889999999999999999999 78999999999999999999999999999
Q ss_pred cccccCCCCcccccccCCcccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccc-
Q 002061 826 AKIAENSPKVSDYSCFAGTHGYIAPELAYT-CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHE- 903 (973)
Q Consensus 826 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~- 903 (973)
++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.... ..+....+........
T Consensus 173 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--~~~~~~~i~~~~~~~~~ 245 (353)
T 3coi_A 173 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD--YLDQLTQILKVTGVPGT 245 (353)
T ss_dssp TTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC--HHHHHHHHHHHHCBCCH
T ss_pred ccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhCCCCH
Confidence 9765432 223468999999999876 678999999999999999999999997542 1111111111000000
Q ss_pred ccc-h--------h---ccc---cccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 904 NVL-K--------V---LDC---EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 904 ~~~-~--------~---~~~---~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
... . . ... .............+.+++.+|++.||++|||+.|+++|-.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 308 (353)
T 3coi_A 246 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 308 (353)
T ss_dssp HHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred HHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence 000 0 0 000 0000111233567889999999999999999999998743
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=336.10 Aligned_cols=244 Identities=24% Similarity=0.340 Sum_probs=201.1
Q ss_pred HHHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc--------cHHHHHHHHHHHHhcC--CCceeeEEEEEE
Q 002061 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD--------GVKVFAAEMEILGKIR--HRNILKLYACLL 741 (973)
Q Consensus 672 ~~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--------~~~~~~~E~~~l~~l~--hpniv~l~~~~~ 741 (973)
.....+|++.+.||+|+||+||+|++..+++.||||++.... ..+.+.+|+.++++++ ||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 344568999999999999999999999999999999986632 2245678999999996 599999999999
Q ss_pred eCCeeEEEEEccCC-CchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeec-CCCCeE
Q 002061 742 KGGSSFLVLEYMPN-GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD-EDYEPK 819 (973)
Q Consensus 742 ~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~k 819 (973)
.++..++||||+.+ ++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++ .++.+|
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~k 190 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELK 190 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEE
T ss_pred cCCcEEEEEEcCCCCccHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEE
Confidence 99999999999976 8999999764 35789999999999999999999 78999999999999999 789999
Q ss_pred EecccCcccccCCCCcccccccCCccccccccccccCCC-CccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHH
Q 002061 820 IADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKV-SEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTH 898 (973)
Q Consensus 820 l~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~ 898 (973)
|+|||+++...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... ....
T Consensus 191 L~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------~~~~-- 257 (320)
T 3a99_A 191 LIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EIIR-- 257 (320)
T ss_dssp ECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHH--
T ss_pred EeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-------hhhc--
Confidence 99999998665432 223568999999999887766 678999999999999999999996531 0100
Q ss_pred hccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 899 LNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
.... . .......+.+++.+||+.||++||++.|++++-
T Consensus 258 --~~~~--------~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp 295 (320)
T 3a99_A 258 --GQVF--------F----RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHP 295 (320)
T ss_dssp --CCCC--------C----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred --cccc--------c----cccCCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 0000 0 011234678899999999999999999999864
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=331.18 Aligned_cols=280 Identities=17% Similarity=0.210 Sum_probs=212.3
Q ss_pred CCchHHHHHHHHHHHhc-CCCcccccCCC---CCCCCCCCcceeeeCC--------CCCceEEEeecCCCCCcccccccc
Q 002061 27 LSLNVETQALIQFKSKL-KDPHGVLDSWK---ESADSPCGFSGITCDS--------VTGRVTEISFDNKSLSGEISSSIS 94 (973)
Q Consensus 27 ~~~~~~~~aLl~~k~~~-~d~~~~~~~W~---~~~~~~c~w~gv~C~~--------~~~~v~~l~l~~~~l~~~~~~~l~ 94 (973)
.+..+|++||++||+++ .||.+.+++|. ....++|.|.|+.|+. ...+|+.|+|++++++ .+|+.++
T Consensus 23 ~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l~ 101 (328)
T 4fcg_A 23 TALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAF 101 (328)
T ss_dssp CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCGG
T ss_pred ccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhhh
Confidence 45678999999999998 68888889994 3445689999999952 3478999999999998 8899999
Q ss_pred CCccCcEeeCCCCcccCcCChhhhCCCCCcEEEecCCcccCCCCcccCCCCCCEEeccCccCCCccccccccccccceEE
Q 002061 95 ALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLS 174 (973)
Q Consensus 95 ~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 174 (973)
.+++|++|+|++|.++ .+|..++.+++|++|+|++|.++..++.++++++|++|+|++|++.+.+|..+...
T Consensus 102 ~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~------- 173 (328)
T 4fcg_A 102 RLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRALPASIASLNRLRELSIRACPELTELPEPLAST------- 173 (328)
T ss_dssp GGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCCCCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEE-------
T ss_pred hCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccccCcHHHhcCcCCCEEECCCCCCccccChhHhhc-------
Confidence 9999999999999999 89999999999999999999999777789999999999999998888888766541
Q ss_pred ccCCcCCCCCCcccccCCCCCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCchhhhccccccEEEeeccccC
Q 002061 175 IGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLT 254 (973)
Q Consensus 175 l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 254 (973)
.++..+.++++|++|+|++|+++ .+|..++.+++|++|+|++|+++ .+|..+..+++|++|+|++|.+.
T Consensus 174 ---------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~Ls~n~~~ 242 (328)
T 4fcg_A 174 ---------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTAL 242 (328)
T ss_dssp ---------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCGGGGGCTTCCEEECTTCTTC
T ss_pred ---------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCchhhccCCCCCEEECcCCcch
Confidence 12233455666666666666666 55666666666666666666666 34555666666666666666666
Q ss_pred CcCCccccccccccEEEeeccccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeeccCCccC
Q 002061 255 GELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFS 326 (973)
Q Consensus 255 ~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 326 (973)
+.+|..++.+++|++|+|++|.+.+.+|..+.++++|++|++++|++.+.+|..++.+++|+.+++..|.+.
T Consensus 243 ~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 243 RNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp CBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred hhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 666666666677777777776666666666666777777777777766677777777777777766665554
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=363.77 Aligned_cols=254 Identities=25% Similarity=0.304 Sum_probs=201.5
Q ss_pred HcCCcccCcccccCceEEEEEEecCC---CcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKN---AGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL 748 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~---~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 748 (973)
..+|++.+.||+|+||+||+|++..+ +..||||+.... ...+.+.+|+.++++++||||+++++++. ++..|+
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l 467 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 467 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence 46789999999999999999998643 467999987653 23467889999999999999999999985 456899
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccc
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 828 (973)
||||+++|+|.+++... ...+++..+..++.|+++||+||| +++|+||||||+||+++.++.+||+|||+++.
T Consensus 468 v~E~~~~g~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVR----KFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp EEECCTTCBHHHHHHHT----TTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred EEEcCCCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCee
Confidence 99999999999999753 335889999999999999999999 78999999999999999999999999999987
Q ss_pred ccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccch
Q 002061 829 AENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLK 907 (973)
Q Consensus 829 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
...... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.... ..+....+... ..
T Consensus 541 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~--~~~~~~~i~~~---~~---- 610 (656)
T 2j0j_A 541 MEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK--NNDVIGRIENG---ER---- 610 (656)
T ss_dssp CCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHHHHT---CC----
T ss_pred cCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHcC---CC----
Confidence 644322 12223457789999999998899999999999999999997 999997541 11221111111 00
Q ss_pred hccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 908 VLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 908 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
...+......+.+++.+||+.||++||++.|+++.|+.+
T Consensus 611 -------~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 611 -------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 001112345688999999999999999999999999875
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=331.19 Aligned_cols=244 Identities=24% Similarity=0.337 Sum_probs=193.7
Q ss_pred HHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc--------cHHHHHHHHHHHHhc----CCCceeeEEEEE
Q 002061 673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD--------GVKVFAAEMEILGKI----RHRNILKLYACL 740 (973)
Q Consensus 673 ~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--------~~~~~~~E~~~l~~l----~hpniv~l~~~~ 740 (973)
...++|++.+.||+|+||+||+|++..+++.||||++.... ....+.+|+++++++ +||||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 44568999999999999999999999889999999986532 223456799999998 899999999999
Q ss_pred EeCCeeEEEEEc-cCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeec-CCCCe
Q 002061 741 LKGGSSFLVLEY-MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD-EDYEP 818 (973)
Q Consensus 741 ~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~ 818 (973)
..++..++|||| +++++|.+++... ..+++..+..++.|+++||+||| +.+++||||||+||+++ .++.+
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITEK-----GPLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEE
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeE
Confidence 999999999999 7899999999864 24889999999999999999999 77999999999999999 88999
Q ss_pred EEecccCcccccCCCCcccccccCCccccccccccccCCCC-ccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHH
Q 002061 819 KIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVS-EKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVST 897 (973)
Q Consensus 819 kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~ 897 (973)
||+|||++....... .....|+..|+|||++.+..+. .++||||+|+++|||++|+.||.... ....
T Consensus 180 kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~~- 247 (312)
T 2iwi_A 180 KLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-------EILE- 247 (312)
T ss_dssp EECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHH-
T ss_pred EEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-------HHhh-
Confidence 999999998765432 2335689999999998877665 58999999999999999999996431 0100
Q ss_pred HhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 898 HLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 898 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
... . ........+.+++.+||+.||++||++.|++++-.
T Consensus 248 ---~~~--------~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~ 286 (312)
T 2iwi_A 248 ---AEL--------H----FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPW 286 (312)
T ss_dssp ---TCC--------C----CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTT
T ss_pred ---hcc--------C----CcccCCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 000 0 01122346788999999999999999999998654
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=329.78 Aligned_cols=252 Identities=24% Similarity=0.334 Sum_probs=181.6
Q ss_pred HHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecccc----HHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG----VKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV 749 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 749 (973)
..++|++.+.||+|+||+||+|++..+++.||||++..... .+.+.++..+++.++||||+++++++..++..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 45688999999999999999999998899999999876322 22344455678888999999999999999999999
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCC-CeEecCCCCCCeeecCCCCeEEecccCccc
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP-PIIHRDIKSSNILLDEDYEPKIADFGVAKI 828 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~-~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 828 (973)
|||+ ++.+..+.... ...+++..+..++.|+++||+||| +. +++||||||+||+++.++.+||+|||++..
T Consensus 103 ~e~~-~~~~~~l~~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 174 (318)
T 2dyl_A 103 MELM-GTCAEKLKKRM----QGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGR 174 (318)
T ss_dssp ECCC-SEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred Eecc-CCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence 9999 55565555432 345889999999999999999999 53 999999999999999999999999999976
Q ss_pred ccCCCCcccccccCCccccccccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccc
Q 002061 829 AENSPKVSDYSCFAGTHGYIAPELAY-----TCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHE 903 (973)
Q Consensus 829 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 903 (973)
...... .....||+.|+|||++. +..++.++|||||||++|||++|+.||..... .............
T Consensus 175 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~~~~~~~~ 247 (318)
T 2dyl_A 175 LVDDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT----DFEVLTKVLQEEP 247 (318)
T ss_dssp ---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS----HHHHHHHHHHSCC
T ss_pred ccCCcc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc----cHHHHHHHhccCC
Confidence 543321 22346899999999984 55688999999999999999999999975321 1111121111111
Q ss_pred ccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 904 NVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
.. . + ........+.+++.+||+.||.+||++.|++++
T Consensus 248 ~~--~--~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 248 PL--L--P-----GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp CC--C--C-----SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CC--C--C-----ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 00 0 0 001123457889999999999999999999875
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=341.64 Aligned_cols=256 Identities=22% Similarity=0.324 Sum_probs=187.3
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEEEEccCC
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLVLEYMPN 755 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~ 755 (973)
.|...+.||+|+||+||.+.. .+|+.||||++..+. .+.+.+|+++++++ +||||+++++++.+++..|+||||++
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~-~~g~~vAvK~~~~~~-~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~- 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGS-FQGRPVAVKRMLIDF-CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN- 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEE-SSSSEEEEEEEEGGG-HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-
T ss_pred eeeccCeEeeCCCeEEEEEEE-ECCeEEEEEEEcHHH-HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-
Confidence 455568899999999987544 458999999886543 45678999999886 89999999999999999999999995
Q ss_pred CchHHHHHhhhcCCCC--CCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCC-------------CCeEE
Q 002061 756 GNLFQALHKRVKEGKP--ELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDED-------------YEPKI 820 (973)
Q Consensus 756 gsL~~~l~~~~~~~~~--~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-------------~~~kl 820 (973)
|+|.+++......... ..++..+..++.||+.||+||| +.+|+||||||+||+++.+ +.+||
T Consensus 93 gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL 169 (434)
T 2rio_A 93 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169 (434)
T ss_dssp EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence 7999999764221111 1133345789999999999999 7899999999999999754 47999
Q ss_pred ecccCcccccCCCCcc--cccccCCcccccccccccc-------CCCCccchHHHHHHHHHHHHh-CCCCCCcccCCccc
Q 002061 821 ADFGVAKIAENSPKVS--DYSCFAGTHGYIAPELAYT-------CKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKD 890 (973)
Q Consensus 821 ~Dfgl~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~ 890 (973)
+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||......
T Consensus 170 ~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--- 246 (434)
T 2rio_A 170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR--- 246 (434)
T ss_dssp CCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH---
T ss_pred cccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh---
Confidence 9999998775432211 1234579999999999865 678999999999999999999 99999654211
Q ss_pred HHHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 891 IVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 891 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
......... .. .............++.+++.+|++.||.+|||+.|+++|-
T Consensus 247 ~~~i~~~~~-~~--------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp 297 (434)
T 2rio_A 247 ESNIIRGIF-SL--------DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 297 (434)
T ss_dssp HHHHHHTCC-CC--------CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred HHHHhcCCC-Cc--------ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCC
Confidence 111111110 00 0011112345567789999999999999999999999753
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=353.16 Aligned_cols=263 Identities=25% Similarity=0.300 Sum_probs=197.2
Q ss_pred HHHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEe------
Q 002061 672 AEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLK------ 742 (973)
Q Consensus 672 ~~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~------ 742 (973)
....++|++.+.||+|+||+||+|.+..+++.||||++... ...+.+.+|++++++++||||+++++++..
T Consensus 10 g~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~ 89 (676)
T 3qa8_A 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP 89 (676)
T ss_dssp -------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred CCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence 34457899999999999999999999999999999988653 345668899999999999999999998755
Q ss_pred CCeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCC---eE
Q 002061 743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYE---PK 819 (973)
Q Consensus 743 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~---~k 819 (973)
++..|+||||+++|+|.+++... .....+++..+..++.|++.||+||| +.+|+||||||+||+++.++. +|
T Consensus 90 ~~~~~LVmEy~~ggsL~~~L~~~--~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vK 164 (676)
T 3qa8_A 90 NDLPLLAMEYCEGGDLRKYLNQF--ENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHK 164 (676)
T ss_dssp TSSCCCEEECCSSCBHHHHHHSS--SCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEE
T ss_pred CCeEEEEEEeCCCCCHHHHHHhc--ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEE
Confidence 66789999999999999999864 22335788889999999999999999 789999999999999997765 99
Q ss_pred EecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHh
Q 002061 820 IADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHL 899 (973)
Q Consensus 820 l~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~ 899 (973)
|+|||.+........ .....||+.|+|||++.+..++.++||||+||++|||++|+.||.... ....|.....
T Consensus 165 L~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~----~~~~~~~~i~ 237 (676)
T 3qa8_A 165 IIDLGYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW----QPVQWHGKVR 237 (676)
T ss_dssp ECSCCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC----HHHHSSTTCC
T ss_pred Ecccccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc----chhhhhhhhh
Confidence 999999987654322 233578999999999999999999999999999999999999996431 1111100000
Q ss_pred cccc---ccchhccc--------cccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Q 002061 900 NNHE---NVLKVLDC--------EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREV 946 (973)
Q Consensus 900 ~~~~---~~~~~~~~--------~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~ev 946 (973)
.... ........ .............+.+++.+|+++||++|||+.|+
T Consensus 238 ~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 238 EKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp ------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred cccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 0000 00000000 00111233456778999999999999999999773
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=319.29 Aligned_cols=304 Identities=22% Similarity=0.317 Sum_probs=157.9
Q ss_pred CCCCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCchhhhccccccEEEeeccccCCcCCccccccccccEEE
Q 002061 192 LKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFD 271 (973)
Q Consensus 192 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~ 271 (973)
+++|++|++++|.++. ++ .+..+++|++|++++|++++. +. +..+++|++|++++|.+++ ++ .+..+++|++|+
T Consensus 43 l~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~~~-~~-~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L~~L~ 116 (347)
T 4fmz_A 43 LESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQITDI-SP-LSNLVKLTNLYIGTNKITD-IS-ALQNLTNLRELY 116 (347)
T ss_dssp HTTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEE
T ss_pred cccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCccccc-hh-hhcCCcCCEEEccCCcccC-ch-HHcCCCcCCEEE
Confidence 3444444444444442 22 244444444444444444422 22 4444444444444444442 22 344555555555
Q ss_pred eeccccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeeccCCccCCCCCccccccccccccccccccccc
Q 002061 272 ISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSG 351 (973)
Q Consensus 272 Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~ 351 (973)
+++|.+.+..+ +..+++|+.|++++|.....++ .+..+++|+.|++++|.+.+..+ +..+++|++|++++|.+++
T Consensus 117 l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~ 191 (347)
T 4fmz_A 117 LNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIED 191 (347)
T ss_dssp CTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCC
T ss_pred CcCCcccCchh--hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCcccc
Confidence 55555543221 4445555555555553332222 24555555555555555543322 5555556666666655542
Q ss_pred cCChhhhhhhhHHHHHhhhccCCCCccccccCccccceEeccccccccCCCccccCCCCcceEeccCCcCCCCCCCCCCC
Q 002061 352 SFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGL 431 (973)
Q Consensus 352 ~~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 431 (973)
. +. +..+++|++|++++|.+++..+ +..+++|+.|++++|++++..+ +..
T Consensus 192 ~-------------------------~~-~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~ 241 (347)
T 4fmz_A 192 I-------------------------SP-LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LAN 241 (347)
T ss_dssp C-------------------------GG-GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTT
T ss_pred c-------------------------cc-ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhc
Confidence 1 11 3445566666666666654333 5555566666666665554433 455
Q ss_pred CCCCCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCCccccccccccchh
Q 002061 432 STSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLN 511 (973)
Q Consensus 432 ~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 511 (973)
+++|++|++++|++++. ..+..+++|++|++++|++++. ..+..+++|++|++++|++++..|..++++++|+.|+
T Consensus 242 l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~ 317 (347)
T 4fmz_A 242 LSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLF 317 (347)
T ss_dssp CTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEE
T ss_pred CCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEE
Confidence 56666666666666532 3456666666666666666643 2456666666666666666666666666666666666
Q ss_pred ccccccccCCCccccccCCCCeeecCCCccC
Q 002061 512 LARNSLSGNIPRSLSLLSSLNALNLSGNKLT 542 (973)
Q Consensus 512 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 542 (973)
|++|++++..| +..+++|+.|++++|+|+
T Consensus 318 L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 318 LSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp CCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred ccCCccccccC--hhhhhccceeehhhhccc
Confidence 66666665444 556666666666666654
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=338.38 Aligned_cols=250 Identities=22% Similarity=0.334 Sum_probs=183.5
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEEEEccC
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLVLEYMP 754 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~ 754 (973)
.+|+..+.||+|+||+||... ..+++.||||++..+. ...+.+|+++++++ +||||+++++++.++...|+||||++
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~-~~~~~~vAvK~~~~~~-~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~ 101 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRG-MFDNRDVAVKRILPEC-FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA 101 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEE-ESSSSEEEEEEECTTT-EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred EEEecCCeeecCcCEEEEEEE-EeCCeEEEEEEECHHH-HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC
Confidence 357888999999999966433 3458899999986532 23357899999999 89999999999999999999999995
Q ss_pred CCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecC-----CCCeEEecccCcccc
Q 002061 755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE-----DYEPKIADFGVAKIA 829 (973)
Q Consensus 755 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~-----~~~~kl~Dfgl~~~~ 829 (973)
|+|.+++.... ....+..+..++.|+++||+||| +.+|+||||||+||+++. ...+||+|||+++..
T Consensus 102 -g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 102 -ATLQEYVEQKD----FAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp -EEHHHHHHSSS----CCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred -CCHHHHHHhcC----CCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 69999997541 22333455689999999999999 789999999999999953 235889999999876
Q ss_pred cCCCCc-ccccccCCccccccccccc---cCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccc
Q 002061 830 ENSPKV-SDYSCFAGTHGYIAPELAY---TCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHEN 904 (973)
Q Consensus 830 ~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 904 (973)
...... .......||+.|+|||++. +..++.++||||+||++|||++ |..||..... ... ........
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~---~~~---~~~~~~~~- 246 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ---RQA---NILLGACS- 246 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT---HHH---HHHTTCCC-
T ss_pred cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH---HHH---HHHhccCC-
Confidence 533211 2233457999999999997 4567889999999999999999 9999964311 111 11111000
Q ss_pred cchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 905 VLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
.... .........+.+++.+||+.||.+|||+.|+++|
T Consensus 247 -~~~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 247 -LDCL------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp -CTTS------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -cccc------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 0000 0112234457789999999999999999999965
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=315.91 Aligned_cols=307 Identities=24% Similarity=0.391 Sum_probs=148.8
Q ss_pred hhCCCCCcEEEecCCcccCCCCcccCCCCCCEEeccCccCCCccccccccccccceEEccCCcCCCCCCcccccCCCCCC
Q 002061 117 LSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLT 196 (973)
Q Consensus 117 l~~l~~L~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ip~~~~~l~~L~ 196 (973)
+..+++|++|++++|.+... +.+..+++|++|++++|.+++..+ +..+++|++|++++|.+.. + +.+.++++|+
T Consensus 40 ~~~l~~L~~L~l~~~~i~~~-~~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~--~-~~~~~l~~L~ 113 (347)
T 4fmz_A 40 QEELESITKLVVAGEKVASI-QGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD--I-SALQNLTNLR 113 (347)
T ss_dssp HHHHTTCSEEECCSSCCCCC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC--C-GGGTTCTTCS
T ss_pred chhcccccEEEEeCCccccc-hhhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccC--c-hHHcCCCcCC
Confidence 34455555555555555443 235555566666666665553322 4455555555555554432 2 2466667777
Q ss_pred EEEcccCCCCCCCChhhhccCCCCeeecccccccCCCchhhhccccccEEEeeccccCCcCCccccccccccEEEeeccc
Q 002061 197 YLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQ 276 (973)
Q Consensus 197 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~ 276 (973)
+|++++|++++. +. +..+++|++|++++|......+ .+..+++|++|++++|.+++..+ +..+++|++|++++|.
T Consensus 114 ~L~l~~n~i~~~-~~-~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~ 188 (347)
T 4fmz_A 114 ELYLNEDNISDI-SP-LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQ 188 (347)
T ss_dssp EEECTTSCCCCC-GG-GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSC
T ss_pred EEECcCCcccCc-hh-hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCc
Confidence 777777777643 22 6666666666666664442322 25555555555555555553222 4455555555555555
Q ss_pred cccccCCccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeeccCCccCCCCCccccccccccccccccccccccCChh
Q 002061 277 MYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKY 356 (973)
Q Consensus 277 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~ 356 (973)
+.+..+ +..+++|+.|++++| .+.+..+ +..+++|++|++++|++++
T Consensus 189 l~~~~~--~~~l~~L~~L~l~~n------------------------~l~~~~~--~~~~~~L~~L~l~~n~l~~----- 235 (347)
T 4fmz_A 189 IEDISP--LASLTSLHYFTAYVN------------------------QITDITP--VANMTRLNSLKIGNNKITD----- 235 (347)
T ss_dssp CCCCGG--GGGCTTCCEEECCSS------------------------CCCCCGG--GGGCTTCCEEECCSSCCCC-----
T ss_pred cccccc--ccCCCccceeecccC------------------------CCCCCch--hhcCCcCCEEEccCCccCC-----
Confidence 442211 333444444444444 3332222 3444444444444444441
Q ss_pred hhhhhhHHHHHhhhccCCCCccccccCccccceEeccccccccCCCccccCCCCcceEeccCCcCCCCCCCCCCCCCCCC
Q 002061 357 LCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLS 436 (973)
Q Consensus 357 ~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~ 436 (973)
++. +..+++|++|++++|.+++. ..+..+ ++|+
T Consensus 236 --------------------~~~-~~~l~~L~~L~l~~n~l~~~--~~~~~l------------------------~~L~ 268 (347)
T 4fmz_A 236 --------------------LSP-LANLSQLTWLEIGTNQISDI--NAVKDL------------------------TKLK 268 (347)
T ss_dssp --------------------CGG-GTTCTTCCEEECCSSCCCCC--GGGTTC------------------------TTCC
T ss_pred --------------------Ccc-hhcCCCCCEEECCCCccCCC--hhHhcC------------------------CCcC
Confidence 111 33444555555555555431 233334 4444
Q ss_pred EEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCCccccccccccchhccccc
Q 002061 437 QLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNS 516 (973)
Q Consensus 437 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 516 (973)
+|++++|++++. ..+..+++|+.|+|++|++++..|..+..+++|++|+|++|++++..| +..+++|+.|++++|.
T Consensus 269 ~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~ 344 (347)
T 4fmz_A 269 MLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQV 344 (347)
T ss_dssp EEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC-
T ss_pred EEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhc
Confidence 444444444432 234445555555555555554444445555555555555555554333 4445555555555555
Q ss_pred cc
Q 002061 517 LS 518 (973)
Q Consensus 517 l~ 518 (973)
|+
T Consensus 345 i~ 346 (347)
T 4fmz_A 345 IK 346 (347)
T ss_dssp --
T ss_pred cc
Confidence 43
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-35 Score=314.74 Aligned_cols=230 Identities=10% Similarity=0.054 Sum_probs=184.0
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc-----cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV 749 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 749 (973)
.++|++.+.||+|+||+||+|++..+++.||||++.... ..+.+.+|++.+++++||||+++++++..++..|+|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 367999999999999999999999999999999987632 236788999999999999999999999999999999
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccc
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 829 (973)
|||+++++|.+++... ....++..++.|++.||+||| +++|+||||||+||+++.++.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~~-------~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~----- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS-------PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA----- 174 (286)
T ss_dssp EECCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC-----
T ss_pred EEecCCCCHHHHHhcC-------CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc-----
Confidence 9999999999998532 244567889999999999999 7899999999999999999999998543
Q ss_pred cCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhc
Q 002061 830 ENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVL 909 (973)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (973)
|++ .++.++|||||||++|||++|+.||......... .......
T Consensus 175 -----------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~------------~~~~~~~ 218 (286)
T 3uqc_A 175 -----------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL------------APAERDT 218 (286)
T ss_dssp -----------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS------------EECCBCT
T ss_pred -----------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh------------HHHHHHh
Confidence 333 2688999999999999999999999764221100 0000000
Q ss_pred ccccc--CcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCC
Q 002061 910 DCEVA--SESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPC 956 (973)
Q Consensus 910 ~~~~~--~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~ 956 (973)
..... ..........+.+++.+||+.||++| |+.|+++.|+++...
T Consensus 219 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 219 AGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp TSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred ccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 01000 01112234568899999999999999 999999999986543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=312.48 Aligned_cols=234 Identities=22% Similarity=0.286 Sum_probs=183.3
Q ss_pred HHcCCccc-CcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHH-HhcCCCceeeEEEEEEe----CCeeE
Q 002061 674 QICNLEED-NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEIL-GKIRHRNILKLYACLLK----GGSSF 747 (973)
Q Consensus 674 ~~~~~~~~-~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l-~~l~hpniv~l~~~~~~----~~~~~ 747 (973)
..++|.+. +.||+|+||+||+|.+..+++.||||++... ..+.+|++++ +..+||||+++++++.. +...+
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc---HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 45677777 7799999999999999999999999998643 4567889888 55699999999999877 67789
Q ss_pred EEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecC---CCCeEEeccc
Q 002061 748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE---DYEPKIADFG 824 (973)
Q Consensus 748 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~Dfg 824 (973)
+||||+++|+|.+++... ....+++..+..++.|++.||+||| +.+|+||||||+||+++. ++.+||+|||
T Consensus 92 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEECCCCSCBHHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEeecCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 999999999999999864 2345899999999999999999999 789999999999999998 7889999999
Q ss_pred CcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccc
Q 002061 825 VAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHEN 904 (973)
Q Consensus 825 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 904 (973)
++.... +..++.++||||+||++|||++|+.||........ ....
T Consensus 166 ~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~---------~~~~-- 210 (299)
T 3m2w_A 166 FAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---------SPGM-- 210 (299)
T ss_dssp TCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC----------------CCS--
T ss_pred cccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh---------hHHH--
Confidence 886432 23467789999999999999999999965421100 0000
Q ss_pred cchhcccc--ccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 905 VLKVLDCE--VASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 905 ~~~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
...+.... ............+.+++.+||+.||++|||+.|++++-.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~ 259 (299)
T 3m2w_A 211 KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 259 (299)
T ss_dssp CCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChh
Confidence 00000010 111111233567889999999999999999999998644
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=349.93 Aligned_cols=238 Identities=22% Similarity=0.327 Sum_probs=191.9
Q ss_pred HHcCCcccCcccccCceEEEEEEecC-CCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCe----
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDLKK-NAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGS---- 745 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~~~-~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~---- 745 (973)
..++|++.+.||+|+||+||+|++.. +++.||||++... .....+.+|++++++++||||+++++++...+.
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 34689999999999999999999975 6899999988653 334567899999999999999999999987655
Q ss_pred -eEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEeccc
Q 002061 746 -SFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFG 824 (973)
Q Consensus 746 -~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 824 (973)
.|+||||+++++|.+++.. .+++..+..++.||++||+||| +++|+||||||+||+++.+ .+||+|||
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG 226 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLG 226 (681)
T ss_dssp EEEEEEECCCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCT
T ss_pred eeEEEEEeCCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecc
Confidence 6999999999999887652 5899999999999999999999 7899999999999999986 89999999
Q ss_pred CcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccc
Q 002061 825 VAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHEN 904 (973)
Q Consensus 825 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 904 (973)
+++..... ....||+.|+|||++.+.. +.++|||||||++|+|++|..||........
T Consensus 227 ~a~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~--------------- 284 (681)
T 2pzi_A 227 AVSRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL--------------- 284 (681)
T ss_dssp TCEETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC---------------
T ss_pred cchhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc---------------
Confidence 99866433 2356899999999987654 8899999999999999999988865321100
Q ss_pred cchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHhhc
Q 002061 905 VLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPP-MREVVKMLAD 952 (973)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt-~~evl~~L~~ 952 (973)
. ...........+.+++.+||++||++||+ +.++.+.+..
T Consensus 285 -~-------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 285 -P-------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp -C-------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred -c-------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 0 01112233456889999999999999995 4555554443
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-33 Score=306.04 Aligned_cols=288 Identities=23% Similarity=0.325 Sum_probs=144.6
Q ss_pred CCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCchhhhccccccEEEeeccccCCcCCccccccccccEEEee
Q 002061 194 NLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDIS 273 (973)
Q Consensus 194 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls 273 (973)
+++.+++++|.++ .+|..+. ++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|+|+
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 110 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence 3455555555554 3343332 345555555555554444455555555555555555554445555555555555555
Q ss_pred ccccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeeccCCccC--CCCCccccccccccccccccccccc
Q 002061 274 SNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFS--GPFPENLGRYTALTDVDISENQFSG 351 (973)
Q Consensus 274 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~--~~~~~~l~~l~~L~~L~Ls~N~l~~ 351 (973)
+|+++ .+|..+. ++|++|++++|++++..+..|..+++|+.|++++|.++ +..+..+..+ +|++|++++|++++
T Consensus 111 ~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~ 186 (332)
T 2ft3_A 111 KNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG 186 (332)
T ss_dssp SSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS
T ss_pred CCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc
Confidence 55555 3333333 45555555555555444444555555555555555553 2344444444 55556666655552
Q ss_pred cCChhhhhhhhHHHHHhhhccCCCCccccccCccccceEeccccccccCCCccccCCCCcceEeccCCcCCCCCCCCCCC
Q 002061 352 SFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGL 431 (973)
Q Consensus 352 ~~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 431 (973)
+| ..+. ++|++|+|++|++++..+..|..+++|+.|++++|++++.
T Consensus 187 -l~------------------------~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~------- 232 (332)
T 2ft3_A 187 -IP------------------------KDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMI------- 232 (332)
T ss_dssp -CC------------------------SSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCC-------
T ss_pred -cC------------------------cccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcC-------
Confidence 22 1111 3555555555555554445554454444444444444444
Q ss_pred CCCCCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCCcccccc------c
Q 002061 432 STSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDC------A 505 (973)
Q Consensus 432 ~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l------~ 505 (973)
.+..+..+++|++|+|++|+++ .+|..+..+++|++|++++|++++..+..|..+ .
T Consensus 233 -----------------~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~ 294 (332)
T 2ft3_A 233 -----------------ENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRA 294 (332)
T ss_dssp -----------------CTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSC
T ss_pred -----------------ChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccc
Confidence 4444444555555555555554 444445555555555555555554444444332 3
Q ss_pred cccchhccccccc--cCCCccccccCCCCeeecCCCc
Q 002061 506 RIVDLNLARNSLS--GNIPRSLSLLSSLNALNLSGNK 540 (973)
Q Consensus 506 ~L~~L~Ls~N~l~--~~~~~~~~~l~~L~~L~L~~N~ 540 (973)
.|+.|++++|.+. +..|..|..+++|+.|+|++|+
T Consensus 295 ~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 295 YYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp CBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred cccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 4556666666655 4555666666666666666663
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=327.60 Aligned_cols=243 Identities=15% Similarity=0.134 Sum_probs=180.9
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCC-Cc---------eee-----
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRH-RN---------ILK----- 735 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h-pn---------iv~----- 735 (973)
..|...+.||+|+||+||+|++..+|+.||||++... ...+.+.+|+.+++.++| ++ ++.
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 3467788999999999999999999999999988732 235678899999999976 21 111
Q ss_pred -------EEEEEEe-----CCeeEEEEEccCCCchHHHHHhhh--cCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeE
Q 002061 736 -------LYACLLK-----GGSSFLVLEYMPNGNLFQALHKRV--KEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPII 801 (973)
Q Consensus 736 -------l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~iv 801 (973)
++.++.. ....+++|+++ +++|.+++.... ......+++..+..++.|+++||+||| +++|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcc
Confidence 1111111 22457777766 789999985321 122345788899999999999999999 78999
Q ss_pred ecCCCCCCeeecCCCCeEEecccCcccccCCCCcccccccCCcccccccccc----------ccCCCCccchHHHHHHHH
Q 002061 802 HRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELA----------YTCKVSEKSDVFSFGVVL 871 (973)
Q Consensus 802 H~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DvwslG~~l 871 (973)
||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 9999999999999999999999998765432 233467 999999998 555688999999999999
Q ss_pred HHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 872 LELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 872 ~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
|||++|+.||....... ....++... ......+.+++.+||+.||++||++.|++++
T Consensus 308 ~elltg~~Pf~~~~~~~---------------~~~~~~~~~------~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALG---------------GSEWIFRSC------KNIPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHHHSSCCCCTTGGGS---------------CSGGGGSSC------CCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHCCCCCCCcchhh---------------hHHHHHhhc------ccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 99999999997542110 011111100 0123568899999999999999998777543
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-32 Score=303.90 Aligned_cols=287 Identities=19% Similarity=0.257 Sum_probs=200.0
Q ss_pred CCCeeecccccccCCCchhhhccccccEEEeeccccCCcCCccccccccccEEEeeccccccccCCccCCCCCccEEEcc
Q 002061 218 ELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCF 297 (973)
Q Consensus 218 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 297 (973)
+++.+++++|.++ .+|..+. ++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..+.++++|++|+++
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 110 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence 4666666666665 4454442 456666666666665445556666666666666666665555556666666666666
Q ss_pred cCCCCCCCCCCcCCcccceeeeccCCccCCCCCccccccccccccccccccccccCChhhhhhhhHHHHHhhhccCCCCc
Q 002061 298 KNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEV 377 (973)
Q Consensus 298 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~ll~l~n~~~~~~ 377 (973)
+|+++ .+|..+. ++|++|++++|++++..+..+
T Consensus 111 ~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~-------------------------------------------- 143 (332)
T 2ft3_A 111 KNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVF-------------------------------------------- 143 (332)
T ss_dssp SSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGG--------------------------------------------
T ss_pred CCcCC-ccCcccc--ccCCEEECCCCccCccCHhHh--------------------------------------------
Confidence 66555 2333222 444444444444443333334
Q ss_pred cccccCccccceEeccccccc--cCCCccccCCCCcceEeccCCcCCCCCCCCCCCCCCCCEEEcccCCCCCCCChhhhc
Q 002061 378 PNSYADCKTIQRLRISDNHLS--GKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGR 455 (973)
Q Consensus 378 p~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~ 455 (973)
.++++|++|++++|.++ +..|..+..+ +|+.|++++|++++.+... .++|++|+|++|++++..+..+..
T Consensus 144 ----~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~l~~~~---~~~L~~L~l~~n~i~~~~~~~l~~ 215 (332)
T 2ft3_A 144 ----SGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTGIPKDL---PETLNELHLDHNKIQAIELEDLLR 215 (332)
T ss_dssp ----SSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSSCCSSS---CSSCSCCBCCSSCCCCCCTTSSTT
T ss_pred ----CCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCccCccc---cCCCCEEECCCCcCCccCHHHhcC
Confidence 44555555555555553 2445555555 6666666666666544322 268899999999999888889999
Q ss_pred CCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCCccccccccccchhccccccccCCCccccc------cC
Q 002061 456 LTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSL------LS 529 (973)
Q Consensus 456 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~------l~ 529 (973)
+++|+.|+|++|++++..+..|..+++|++|+|++|+++ .+|..+..+++|+.|++++|+|++..+..|.. ..
T Consensus 216 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~ 294 (332)
T 2ft3_A 216 YSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRA 294 (332)
T ss_dssp CTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSC
T ss_pred CCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccc
Confidence 999999999999999888889999999999999999999 78888999999999999999999887777765 36
Q ss_pred CCCeeecCCCccC--CCCChhhhccc-CceEEccCCc
Q 002061 530 SLNALNLSGNKLT--GSIPDNLMKLK-LSSIDLSENQ 563 (973)
Q Consensus 530 ~L~~L~L~~N~l~--~~~p~~l~~l~-L~~l~ls~N~ 563 (973)
+|+.|++++|++. +..|..+..++ |+.+++++|+
T Consensus 295 ~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 295 YYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp CBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred cccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 7999999999998 67788888886 9999999985
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-32 Score=302.18 Aligned_cols=274 Identities=19% Similarity=0.261 Sum_probs=122.4
Q ss_pred CCCeeecccccccCCCchhhhccccccEEEeeccccCCcCCccccccccccEEEeeccccccccCCccCCCCCccEEEcc
Q 002061 218 ELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCF 297 (973)
Q Consensus 218 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 297 (973)
+|++|+|++|+|++..+..|+++++|++|+|++|.+++..|..|.++++|++|+|++|+++ .+|..+. ++|+.|+++
T Consensus 53 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l~ 129 (330)
T 1xku_A 53 DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVH 129 (330)
T ss_dssp TCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEECC
T ss_pred CCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhc--ccccEEECC
Confidence 3444444444444333333444444444444444444333444444444444444444444 2333222 344444444
Q ss_pred cCCCCCCCCCCcCCcccceeeeccCCccCC--CCCccccccccccccccccccccccCChhhhhhhhHHHHHhhhccCCC
Q 002061 298 KNNFSGEFPSGFGDMRKLFAFSIYGNRFSG--PFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSG 375 (973)
Q Consensus 298 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~--~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~ll~l~n~~~~ 375 (973)
+|++++..+..|..+++|+.|++++|.+.. ..+..+..+++|++|++++|.++. +|
T Consensus 130 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~-l~--------------------- 187 (330)
T 1xku_A 130 ENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IP--------------------- 187 (330)
T ss_dssp SSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CC---------------------
T ss_pred CCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc-CC---------------------
Confidence 444443333334444444444444444431 334444555555555555555541 11
Q ss_pred CccccccCccccceEeccccccccCCCccccCCCCcceEeccCCcCCCCCCCCCCCCCCCCEEEcccCCCCCCCChhhhc
Q 002061 376 EVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGR 455 (973)
Q Consensus 376 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~ 455 (973)
..+. ++|++|+|++|++++..|..|..+++|+.|++++|++++..+..+..+++|++|+|++|+++ .+|..+..
T Consensus 188 ---~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~ 261 (330)
T 1xku_A 188 ---QGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLAD 261 (330)
T ss_dssp ---SSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTT
T ss_pred ---cccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhcc
Confidence 1111 45555666666655555555555555555555555554444444444445555555555554 34444444
Q ss_pred CCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCCccccccccccchhcccccccc--CCCccccccCCCCe
Q 002061 456 LTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSG--NIPRSLSLLSSLNA 533 (973)
Q Consensus 456 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~ 533 (973)
+++|++|+|++|+|++..+..|..... ......|+.|++++|.+.. ..|..|..+.+++.
T Consensus 262 l~~L~~L~l~~N~i~~~~~~~f~~~~~------------------~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~ 323 (330)
T 1xku_A 262 HKYIQVVYLHNNNISAIGSNDFCPPGY------------------NTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAA 323 (330)
T ss_dssp CSSCCEEECCSSCCCCCCTTSSSCSSC------------------CTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGG
T ss_pred CCCcCEEECCCCcCCccChhhcCCccc------------------ccccccccceEeecCcccccccCccccccccceeE
Confidence 555555555555554443333332100 0011344455555555432 34455555666666
Q ss_pred eecCCCc
Q 002061 534 LNLSGNK 540 (973)
Q Consensus 534 L~L~~N~ 540 (973)
++|++|+
T Consensus 324 l~L~~N~ 330 (330)
T 1xku_A 324 VQLGNYK 330 (330)
T ss_dssp EEC----
T ss_pred EEecccC
Confidence 6666553
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-32 Score=300.35 Aligned_cols=288 Identities=19% Similarity=0.250 Sum_probs=186.5
Q ss_pred CCCeeecccccccCCCchhhhccccccEEEeeccccCCcCCccccccccccEEEeeccccccccCCccCCCCCccEEEcc
Q 002061 218 ELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCF 297 (973)
Q Consensus 218 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 297 (973)
+++.++++++.++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|++++..|..+.++++|++|+++
T Consensus 32 ~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (330)
T 1xku_A 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108 (330)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence 4555555555555 3443332 456666666666665555556666666666666666665556666666666666666
Q ss_pred cCCCCCCCCCCcCCcccceeeeccCCccCCCCCccccccccccccccccccccccCChhhhhhhhHHHHHhhhccCCCCc
Q 002061 298 KNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEV 377 (973)
Q Consensus 298 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~ll~l~n~~~~~~ 377 (973)
+|+++ .+|..+. ++|+.|++++|++++..+..+.
T Consensus 109 ~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~------------------------------------------- 142 (330)
T 1xku_A 109 KNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFN------------------------------------------- 142 (330)
T ss_dssp SSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHT-------------------------------------------
T ss_pred CCcCC-ccChhhc--ccccEEECCCCcccccCHhHhc-------------------------------------------
Confidence 66665 2333222 3444444444444433333344
Q ss_pred cccccCccccceEeccccccc--cCCCccccCCCCcceEeccCCcCCCCCCCCCCCCCCCCEEEcccCCCCCCCChhhhc
Q 002061 378 PNSYADCKTIQRLRISDNHLS--GKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGR 455 (973)
Q Consensus 378 p~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~ 455 (973)
++++|++|++++|+++ +..+..+..+++|+.|++++|+++..+... .++|++|+|++|++++..|..|..
T Consensus 143 -----~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~l~~~~---~~~L~~L~l~~n~l~~~~~~~~~~ 214 (330)
T 1xku_A 143 -----GLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGL---PPSLTELHLDGNKITKVDAASLKG 214 (330)
T ss_dssp -----TCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSSC---CTTCSEEECTTSCCCEECTGGGTT
T ss_pred -----CCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccccCCccc---cccCCEEECCCCcCCccCHHHhcC
Confidence 4455555555555553 244555556666666666666665543322 267888888888888777778888
Q ss_pred CCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCCccccccccccchhccccccccCCCccccc------cC
Q 002061 456 LTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSL------LS 529 (973)
Q Consensus 456 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~------l~ 529 (973)
+++|++|+|++|++++..+..+..+++|++|+|++|+++ .+|..+..+++|+.|+|++|+|++..+..|.. .+
T Consensus 215 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~ 293 (330)
T 1xku_A 215 LNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKA 293 (330)
T ss_dssp CTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSC
T ss_pred CCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccc
Confidence 888888888888887766677888888888888888887 66777888888888888888888766666653 47
Q ss_pred CCCeeecCCCccCC--CCChhhhccc-CceEEccCCc
Q 002061 530 SLNALNLSGNKLTG--SIPDNLMKLK-LSSIDLSENQ 563 (973)
Q Consensus 530 ~L~~L~L~~N~l~~--~~p~~l~~l~-L~~l~ls~N~ 563 (973)
.|+.|++++|++.. ..|..+..+. ++.++|++|+
T Consensus 294 ~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 294 SYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp CCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred cccceEeecCcccccccCccccccccceeEEEecccC
Confidence 89999999999973 5667777775 9999999985
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.98 E-value=6.5e-34 Score=316.19 Aligned_cols=243 Identities=15% Similarity=0.151 Sum_probs=186.2
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc----------cHHHHHHHHHHHHhcC---------CCceee
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----------GVKVFAAEMEILGKIR---------HRNILK 735 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----------~~~~~~~E~~~l~~l~---------hpniv~ 735 (973)
.++|++.+.||+|+||+||+|++ +++.||||++.... ..+.+.+|++++++++ ||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 46789999999999999999998 48999999987532 2377899999999886 777777
Q ss_pred EEEEEE------------------------------eCCeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 002061 736 LYACLL------------------------------KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGA 785 (973)
Q Consensus 736 l~~~~~------------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~i 785 (973)
+.+++. .++..|+||||+++|++.+.+.+ ..+++..+..++.|+
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~qi 170 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQL 170 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHHHH
Confidence 777643 26789999999999977666532 347899999999999
Q ss_pred HHHHhhhhhcCCCCeEecCCCCCCeeecCCC--------------------CeEEecccCcccccCCCCcccccccCCcc
Q 002061 786 AKGIAYLHHDCSPPIIHRDIKSSNILLDEDY--------------------EPKIADFGVAKIAENSPKVSDYSCFAGTH 845 (973)
Q Consensus 786 a~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~--------------------~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~ 845 (973)
+.||+|||+ +++|+||||||+|||++.++ .+||+|||+++..... ...||+
T Consensus 171 ~~aL~~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~ 241 (336)
T 2vuw_A 171 TASLAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCD 241 (336)
T ss_dssp HHHHHHHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCC
T ss_pred HHHHHHHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEee
Confidence 999999993 35899999999999999887 8999999999866532 246899
Q ss_pred ccccccccccCCCCccchHHHHHHH-HHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccccCcchHHHHHH
Q 002061 846 GYIAPELAYTCKVSEKSDVFSFGVV-LLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIK 924 (973)
Q Consensus 846 ~y~aPE~~~~~~~~~~~DvwslG~~-l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 924 (973)
.|+|||++.+.. +.++||||+|++ .+++++|..||.... ............. .................
T Consensus 242 ~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~----~~~~~~~~~~~~~-----~~~~~~~~~~~~~~s~~ 311 (336)
T 2vuw_A 242 VSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL----WLHYLTDKMLKQM-----TFKTKCNTPAMKQIKRK 311 (336)
T ss_dssp CTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH----HHHHHHHHHHHTC-----CCSSCCCSHHHHHHHHH
T ss_pred cccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh----hhhHHHHhhhhhh-----ccCcccchhhhhhcCHH
Confidence 999999998766 889999998777 778899999985320 0000111111000 00111122334567788
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHH-HH
Q 002061 925 LLKIAVVCTTKLPNLRPPMREVV-KM 949 (973)
Q Consensus 925 l~~l~~~cl~~dP~~Rpt~~evl-~~ 949 (973)
+.+++.+|++.| |+.|++ +|
T Consensus 312 ~~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 312 IQEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHHHHHHGGGSS-----SHHHHHHHC
T ss_pred HHHHHHHHhccC-----CHHHHHhcC
Confidence 999999999976 999998 65
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.98 E-value=1e-32 Score=302.57 Aligned_cols=250 Identities=29% Similarity=0.482 Sum_probs=131.6
Q ss_pred CCCCeeecccccccC--CCchhhhccccccEEEeec-cccCCcCCccccccccccEEEeeccccccccCCccCCCCCccE
Q 002061 217 RELGTLDICRNKISG--EFPRSIRKLQKLWKIELYA-NNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTV 293 (973)
Q Consensus 217 ~~L~~L~L~~N~l~~--~~~~~l~~l~~L~~L~L~~-N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 293 (973)
.+++.|+|++|.+++ .+|..++++++|++|+|++ |.+++.+|..|+++++|++|+|++|++++.+|..+.++++|++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence 356667777777766 6666677777777777763 6666666666666666777777766666666666666666666
Q ss_pred EEcccCCCCCCCCCCcCCcccceeeeccCCccCCCCCccccccccccccccccccccccCChhhhhhhhHHHHHhhhccC
Q 002061 294 FQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNF 373 (973)
Q Consensus 294 L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~ll~l~n~~ 373 (973)
|++++|.+++.+|..++.+++|++|++++|++++.+|..+..++
T Consensus 130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~------------------------------------ 173 (313)
T 1ogq_A 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFS------------------------------------ 173 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCC------------------------------------
T ss_pred EeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhh------------------------------------
Confidence 66666666655555555555555555555555444444444443
Q ss_pred CCCccccccCccccceEeccccccccCCCccccCCCCcceEeccCCcCCCCCCCCCCCCCCCCEEEcccCCCCCCCChhh
Q 002061 374 SGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSEL 453 (973)
Q Consensus 374 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~ 453 (973)
++|++|+|++|++++.+|..+..++ |+.|++++|++++..+..+..+++|+.|+|++|++++.+|. +
T Consensus 174 -----------~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~ 240 (313)
T 1ogq_A 174 -----------KLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-V 240 (313)
T ss_dssp -----------TTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-C
T ss_pred -----------hcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-c
Confidence 1344444444444444444443332 33333333333332333333334444444444444433222 3
Q ss_pred hcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCCccccccccccchhccccc
Q 002061 454 GRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNS 516 (973)
Q Consensus 454 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 516 (973)
..+++|++|+|++|++++.+|..|..+++|++|+|++|++++.+|.. +.+++|+.|++++|+
T Consensus 241 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 241 GLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNK 302 (313)
T ss_dssp CCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSS
T ss_pred cccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCC
Confidence 44445555555555554444555555555555555555555444443 444445555555544
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.98 E-value=2.3e-36 Score=351.82 Aligned_cols=159 Identities=16% Similarity=0.219 Sum_probs=92.1
Q ss_pred CCCcEEEecCCcccCCCC-c-ccCCCCCCEEeccCccCCCc----cccccccccccceEEccCCcCCCCCCcccccCCC-
Q 002061 121 SNLKVLNVTGNAMVGSVP-D-LSALKNLEIFDLSINYFTGR----FPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLK- 193 (973)
Q Consensus 121 ~~L~~L~L~~n~l~~~~~-~-l~~l~~L~~L~Ls~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~~ip~~~~~l~- 193 (973)
++|++|+|++|+++.... . +..+++|++|+|++|.+++. ++..+..+++|++|++++|.+....+......++
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 457777887777755432 2 56677777777777777642 3455566677777777776665332222233344
Q ss_pred ---CCCEEEcccCCCCC----CCChhhhccCCCCeeecccccccCCCchhhhc-----cccccEEEeeccccCCcC----
Q 002061 194 ---NLTYLFLAHCNLRG----RIPESISELRELGTLDICRNKISGEFPRSIRK-----LQKLWKIELYANNLTGEL---- 257 (973)
Q Consensus 194 ---~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~-----l~~L~~L~L~~N~l~~~~---- 257 (973)
+|++|+|++|+++. .++..+..+++|++|+|++|++++..+..+.. .++|++|+|++|++++..
T Consensus 83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l 162 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 162 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHH
Confidence 56666666666663 33556666666666666666665444443332 234666666666655422
Q ss_pred CccccccccccEEEeecccccc
Q 002061 258 PAELGNLTLLQEFDISSNQMYG 279 (973)
Q Consensus 258 ~~~l~~l~~L~~L~Ls~N~l~~ 279 (973)
+..+..+++|++|++++|.+.+
T Consensus 163 ~~~l~~~~~L~~L~L~~n~i~~ 184 (461)
T 1z7x_W 163 ASVLRAKPDFKELTVSNNDINE 184 (461)
T ss_dssp HHHHHHCTTCCEEECCSSBCHH
T ss_pred HHHHhhCCCCCEEECcCCCcch
Confidence 3334445555555555555543
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-35 Score=343.76 Aligned_cols=359 Identities=18% Similarity=0.202 Sum_probs=171.0
Q ss_pred ceEEEeecCCCCCcccccc-ccCCccCcEeeCCCCcccC----cCChhhhCCCCCcEEEecCCcccCCCC-cc-cCCC--
Q 002061 74 RVTEISFDNKSLSGEISSS-ISALQSLTVLSLPFNVLSG----KLPLELSNCSNLKVLNVTGNAMVGSVP-DL-SALK-- 144 (973)
Q Consensus 74 ~v~~l~l~~~~l~~~~~~~-l~~l~~L~~L~Ls~n~l~~----~~p~~l~~l~~L~~L~L~~n~l~~~~~-~l-~~l~-- 144 (973)
+++.|||++++++...... +..+++|++|+|++|++++ .++..+..+++|++|+|++|.+..... .+ ..++
T Consensus 4 ~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~ 83 (461)
T 1z7x_W 4 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 83 (461)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred cceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhC
Confidence 4566666666666544333 5566666666666666653 245556666666666666666644211 11 2233
Q ss_pred --CCCEEeccCccCCC----ccccccccccccceEEccCCcCCCCCCc---cc-ccCCCCCCEEEcccCCCCCCC----C
Q 002061 145 --NLEIFDLSINYFTG----RFPRWVVNLTQLVSLSIGDNVYDEAEIP---ES-IGNLKNLTYLFLAHCNLRGRI----P 210 (973)
Q Consensus 145 --~L~~L~Ls~n~l~~----~~~~~~~~l~~L~~L~l~~n~l~~~~ip---~~-~~~l~~L~~L~L~~n~l~~~~----~ 210 (973)
+|++|+|++|.+++ .++..+..+++|++|++++|.+....+. .. ....++|++|+|++|++++.. +
T Consensus 84 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~ 163 (461)
T 1z7x_W 84 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 163 (461)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHH
Confidence 46666666666653 3355555556666666665555321110 01 112344555555555555422 3
Q ss_pred hhhhccCCCCeeecccccccCCCchhhhc-----cccccEEEeeccccCCc----CCccccccccccEEEeecccccccc
Q 002061 211 ESISELRELGTLDICRNKISGEFPRSIRK-----LQKLWKIELYANNLTGE----LPAELGNLTLLQEFDISSNQMYGKL 281 (973)
Q Consensus 211 ~~~~~l~~L~~L~L~~N~l~~~~~~~l~~-----l~~L~~L~L~~N~l~~~----~~~~l~~l~~L~~L~Ls~N~l~~~~ 281 (973)
..+..+++|++|+|++|.+++..+..+.. .++|++|+|++|.+++. ++..+..+++|++|++++|.+.+..
T Consensus 164 ~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~ 243 (461)
T 1z7x_W 164 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 243 (461)
T ss_dssp HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHH
T ss_pred HHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHH
Confidence 33444455555555555554333333322 33555555555555432 2333444455555555555444321
Q ss_pred CCccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeeccCCccCCC----CCccccccccccccccccccccccCChhh
Q 002061 282 PEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGP----FPENLGRYTALTDVDISENQFSGSFPKYL 357 (973)
Q Consensus 282 p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~----~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~ 357 (973)
...+. +..+..+++|+.|++++|.+++. ++..+..+++|++|++++|.+++..+..+
T Consensus 244 ~~~l~-------------------~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l 304 (461)
T 1z7x_W 244 MAELC-------------------PGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLL 304 (461)
T ss_dssp HHHHH-------------------HHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHH
T ss_pred HHHHH-------------------HHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHH
Confidence 10000 11122344555555555555432 34445556666666676666654333322
Q ss_pred hhhhhHHHHHhhhccCCCCccccccCccccceEeccccccccC----CCccccCCCCcceEeccCCcCCCCCCCCCC---
Q 002061 358 CEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGK----IPDGLWALPNVGMLDFGDNDFTGGISPLIG--- 430 (973)
Q Consensus 358 ~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~--- 430 (973)
+... ....++|++|+|++|.+++. ++..+..+++|+.|++++|++++..+..+.
T Consensus 305 ~~~l-------------------~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l 365 (461)
T 1z7x_W 305 CETL-------------------LEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGL 365 (461)
T ss_dssp HHHH-------------------TSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHH
T ss_pred HHHh-------------------ccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHH
Confidence 2110 11224667777777766643 333444444444444444444332211111
Q ss_pred --CCCCCCEEEcccCCCCC----CCChhhhcCCCCCEEEccCCcCC
Q 002061 431 --LSTSLSQLVLQNNRFSG----ELPSELGRLTNLERLILTNNNFS 470 (973)
Q Consensus 431 --~~~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~ 470 (973)
..++|++|+|++|++++ .+|..+..+++|++|+|++|+++
T Consensus 366 ~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~ 411 (461)
T 1z7x_W 366 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411 (461)
T ss_dssp TSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred cCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCC
Confidence 13344555555554443 34444444444555555555444
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-33 Score=335.51 Aligned_cols=377 Identities=14% Similarity=0.118 Sum_probs=217.1
Q ss_pred CCCCCCEEeccCccCCCccccccccc--cccceEEccCCc-CCCCCCcccccCCCCCCEEEcccCCCCCC----CChhhh
Q 002061 142 ALKNLEIFDLSINYFTGRFPRWVVNL--TQLVSLSIGDNV-YDEAEIPESIGNLKNLTYLFLAHCNLRGR----IPESIS 214 (973)
Q Consensus 142 ~l~~L~~L~Ls~n~l~~~~~~~~~~l--~~L~~L~l~~n~-l~~~~ip~~~~~l~~L~~L~L~~n~l~~~----~~~~~~ 214 (973)
.+++|++|+|++|.+++..+..+... .+|++|+|+++. +....++..+.++++|++|+|++|.+++. ++..+.
T Consensus 110 ~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~ 189 (592)
T 3ogk_B 110 NLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQ 189 (592)
T ss_dssp HCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHH
T ss_pred hCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHh
Confidence 44555555555555554444444442 235555555553 22122223334556666666666665544 223345
Q ss_pred ccCCCCeeeccccccc----CCCchhhhccccccEEEeeccccCCcCCccccccccccEEEeeccccc---cccCCccCC
Q 002061 215 ELRELGTLDICRNKIS----GEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMY---GKLPEEIGN 287 (973)
Q Consensus 215 ~l~~L~~L~L~~N~l~----~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~---~~~p~~~~~ 287 (973)
.+++|++|++++|.++ +.++..+.++++|++|+|++|.+.+ ++..+..+++|++|+++.+... +..+..+..
T Consensus 190 ~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~ 268 (592)
T 3ogk_B 190 HNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVF 268 (592)
T ss_dssp HCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCC
T ss_pred cCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhc
Confidence 5566666666666665 2233344556666666666666663 4555666666666666643222 223344555
Q ss_pred CCCccEEEcccCCCCCCCCCCcCCcccceeeeccCCccCCCCC-ccccccccccccccccccccccCChhhhhhhhHHHH
Q 002061 288 LKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFP-ENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNL 366 (973)
Q Consensus 288 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~l 366 (973)
+++|+.|+++++.. ..+|..+..+++|++|++++|.+++... ..+..+++|++|+++ |.+.+..
T Consensus 269 ~~~L~~L~l~~~~~-~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~------------- 333 (592)
T 3ogk_B 269 PRKLCRLGLSYMGP-NEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRG------------- 333 (592)
T ss_dssp CTTCCEEEETTCCT-TTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHH-------------
T ss_pred cccccccCccccch-hHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHH-------------
Confidence 66666666665432 2455556666667777776666543322 234566777777776 4333110
Q ss_pred HhhhccCCCCccccccCccccceEecc-----------ccccccC-CCccccCCCCcceEeccCCcCCCCCCCCCCC-CC
Q 002061 367 LALSNNFSGEVPNSYADCKTIQRLRIS-----------DNHLSGK-IPDGLWALPNVGMLDFGDNDFTGGISPLIGL-ST 433 (973)
Q Consensus 367 l~l~n~~~~~~p~~~~~l~~L~~L~Ls-----------~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-~~ 433 (973)
++..+..+++|++|+|+ .|.+++. ++..+..+++|++|+++.|++++.....+.. ++
T Consensus 334 ----------l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~ 403 (592)
T 3ogk_B 334 ----------LEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLK 403 (592)
T ss_dssp ----------HHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCC
T ss_pred ----------HHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCC
Confidence 11112345667777777 3555432 1222334677777777777776544444433 66
Q ss_pred CCCEEEcc----cCCCCCC-----CChhhhcCCCCCEEEccCC--cCCCCccccccc-cccCCEEEcCCccccc-CCCcc
Q 002061 434 SLSQLVLQ----NNRFSGE-----LPSELGRLTNLERLILTNN--NFSGKIPSALGA-LRQLSSLHLEENALTG-SIPNE 500 (973)
Q Consensus 434 ~L~~L~L~----~N~l~~~-----~p~~~~~l~~L~~L~Ls~N--~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~-~~p~~ 500 (973)
+|+.|+|+ .|++++. ++..+.++++|++|+|++| .+++..+..+.. +++|++|+|++|++++ .++..
T Consensus 404 ~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~ 483 (592)
T 3ogk_B 404 NLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEF 483 (592)
T ss_dssp SCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHH
T ss_pred CCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHH
Confidence 77777775 5667653 2333667788888888643 355444444443 7778888888888765 23445
Q ss_pred ccccccccchhccccccccC-CCccccccCCCCeeecCCCccCCC
Q 002061 501 MGDCARIVDLNLARNSLSGN-IPRSLSLLSSLNALNLSGNKLTGS 544 (973)
Q Consensus 501 ~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~ 544 (973)
+.++++|+.|+|++|.+++. ++..+..+++|+.|+|++|++++.
T Consensus 484 ~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~ 528 (592)
T 3ogk_B 484 SRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMT 528 (592)
T ss_dssp HTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred HhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHH
Confidence 56778888888888887644 334445778888888888888754
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=291.72 Aligned_cols=286 Identities=20% Similarity=0.279 Sum_probs=237.9
Q ss_pred CCCCCCCCCCCcceeeeCCCCCceEEEeecCCCCCccccccccCCccCcEeeCCCCcccCcCChhhhCCCCCcEEEecCC
Q 002061 52 SWKESADSPCGFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGN 131 (973)
Q Consensus 52 ~W~~~~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n 131 (973)
.|... .++|.|.|+ |+- ++++++ .+|..+. ++|++|+|++|.+++..+..|..+++|++|+|++|
T Consensus 22 ~~~~~-~~~C~~~~~-c~~----------~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n 86 (353)
T 2z80_A 22 SSNQA-SLSCDRNGI-CKG----------SSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSN 86 (353)
T ss_dssp ------CCEECTTSE-EEC----------CSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTS
T ss_pred CCCcc-CCCCCCCeE-eeC----------CCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCC
Confidence 34433 356999998 753 455565 4666554 58999999999999766668999999999999999
Q ss_pred cccCCCC-cccCCCCCCEEeccCccCCCccccccccccccceEEccCCcCCCCCCcc--cccCCCCCCEEEcccC-CCCC
Q 002061 132 AMVGSVP-DLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPE--SIGNLKNLTYLFLAHC-NLRG 207 (973)
Q Consensus 132 ~l~~~~~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ip~--~~~~l~~L~~L~L~~n-~l~~ 207 (973)
++++.++ .++++++|++|+|++|.+++..+..+.++++|++|++++|.+.. +|. .+.++++|++|++++| .+++
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~--l~~~~~~~~l~~L~~L~l~~n~~~~~ 164 (353)
T 2z80_A 87 GINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKT--LGETSLFSHLTKLQILRVGNMDTFTK 164 (353)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSS--SCSSCSCTTCTTCCEEEEEESSSCCE
T ss_pred ccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcc--cCchhhhccCCCCcEEECCCCccccc
Confidence 9998766 49999999999999999997777779999999999999999974 555 7899999999999999 5776
Q ss_pred CCChhhhccCCCCeeecccccccCCCchhhhccccccEEEeeccccCCcCCccccccccccEEEeeccccccccCCccC-
Q 002061 208 RIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIG- 286 (973)
Q Consensus 208 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~- 286 (973)
..+..+..+++|++|++++|++++..|..+..+++|++|++++|.++...+..+..+++|++|++++|.+++..+..+.
T Consensus 165 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~ 244 (353)
T 2z80_A 165 IQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELST 244 (353)
T ss_dssp ECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC----
T ss_pred cCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCcccccccccccc
Confidence 7778899999999999999999988899999999999999999999854444456789999999999999976665543
Q ss_pred --CCCCccEEEcccCCCCC----CCCCCcCCcccceeeeccCCccCCCCCccccccccccccccccccccccCC
Q 002061 287 --NLKNLTVFQCFKNNFSG----EFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFP 354 (973)
Q Consensus 287 --~l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p 354 (973)
....++.+++.++.+++ .+|..+..+++|+.|++++|+++...+..|..+++|++|+|++|++.+..|
T Consensus 245 ~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 245 GETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp --CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred ccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 36778899999999886 467778899999999999999995444457999999999999999996544
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-30 Score=284.04 Aligned_cols=252 Identities=21% Similarity=0.249 Sum_probs=151.1
Q ss_pred CCCCcceeeeCCCCCceEEEeecCCCCCccccccccCCccCcEeeCCCCcccCcCChhhhCCCCCcEEEecCCcccCC--
Q 002061 59 SPCGFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGS-- 136 (973)
Q Consensus 59 ~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~-- 136 (973)
|.|.|.+|.|+.. +++ .+|..+. ++|++|+|++|+++...+..|+++++|++|+|++|.++..
T Consensus 5 C~C~~~~l~c~~~------------~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~ 69 (306)
T 2z66_A 5 CSCSGTEIRCNSK------------GLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGC 69 (306)
T ss_dssp CEEETTEEECCSS------------CCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEE
T ss_pred CeeCCCEEEcCCC------------Ccc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccC
Confidence 5589999999752 222 2343332 5788888888888743334467888888888888877643
Q ss_pred -CCcccCCCCCCEEeccCccCCCccccccccccccceEEccCCcCCCCCCcccccCCCCCCEEEcccCCCCCCCChhhhc
Q 002061 137 -VPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISE 215 (973)
Q Consensus 137 -~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 215 (973)
+..+..+++|++|+|++|.++ .+|..+..+++|++|++++|.+.....+..+..+++|++|++++|.+++..+..+..
T Consensus 70 ~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 148 (306)
T 2z66_A 70 CSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG 148 (306)
T ss_dssp EEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTT
T ss_pred cccccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhccc
Confidence 234556777777777777776 345556666666666666666653322235566666666666666666555555666
Q ss_pred cCCCCeeecccccccC-CCchhhhccccccEEEeeccccCCcCCccccccccccEEEeeccccccccCCccCCCCCccEE
Q 002061 216 LRELGTLDICRNKISG-EFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVF 294 (973)
Q Consensus 216 l~~L~~L~L~~N~l~~-~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 294 (973)
+++|++|+|++|++++ ..|..+..+++|++|+|++|++++..|..+..+++|++|+|++|++++..+..+..+++|+.|
T Consensus 149 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 228 (306)
T 2z66_A 149 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVL 228 (306)
T ss_dssp CTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEE
T ss_pred CcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEe
Confidence 6666666666666654 345555555555555555555555445555555555555555555554444445555555555
Q ss_pred EcccCCCCCCCCCCcCCcc-cceeeeccCCccC
Q 002061 295 QCFKNNFSGEFPSGFGDMR-KLFAFSIYGNRFS 326 (973)
Q Consensus 295 ~l~~N~l~~~~p~~~~~l~-~L~~L~l~~N~l~ 326 (973)
++++|++++..|..+..++ +|+.|++++|+++
T Consensus 229 ~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~ 261 (306)
T 2z66_A 229 DYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261 (306)
T ss_dssp ECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEE
T ss_pred ECCCCCCcccCHHHHHhhhccCCEEEccCCCee
Confidence 5555555555555555542 4555555555554
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-31 Score=292.75 Aligned_cols=288 Identities=18% Similarity=0.255 Sum_probs=207.0
Q ss_pred HHHHHHH-HHHHhcCCCcccccCCCCCC-CCCCCcceeeeCCCC--CceEEEeecCCCCCccccccc--cCCccCcEeeC
Q 002061 31 VETQALI-QFKSKLKDPHGVLDSWKESA-DSPCGFSGITCDSVT--GRVTEISFDNKSLSGEISSSI--SALQSLTVLSL 104 (973)
Q Consensus 31 ~~~~aLl-~~k~~~~d~~~~~~~W~~~~-~~~c~w~gv~C~~~~--~~v~~l~l~~~~l~~~~~~~l--~~l~~L~~L~L 104 (973)
..+++.. +.|.++.|+..++..|...- .++|.|.++-|.... ..+.. ..+.... .++..+ ...+++++|+|
T Consensus 12 ~~~~~~~~~~~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~--~~g~~~~-~~~~~l~~~~~~~l~~L~L 88 (328)
T 4fcg_A 12 SGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIET--RTGRALK-ATADLLEDATQPGRVALEL 88 (328)
T ss_dssp -----CCCC--CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCC--SHHHHHH-HHHHHHHHHTSTTCCEEEE
T ss_pred ccccceeeeccccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccc--cCCcchh-hhHHHHhcccccceeEEEc
Confidence 3444443 33445678888899997632 357999998884221 11111 0000000 011111 12344555555
Q ss_pred CCCcccCcCChhhhCCCCCcEEEecCCcccCCCCcccCCCCCCEEeccCccCCCccccccccccccceEEccCCcCCCCC
Q 002061 105 PFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAE 184 (973)
Q Consensus 105 s~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 184 (973)
++|.++ .+|..++++++|++|+|++|.++ .+|..+.++++|++|+|++|.+. .
T Consensus 89 ~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~------------------------~lp~~~~~l~~L~~L~Ls~n~l~--~ 141 (328)
T 4fcg_A 89 RSVPLP-QFPDQAFRLSHLQHMTIDAAGLM------------------------ELPDTMQQFAGLETLTLARNPLR--A 141 (328)
T ss_dssp ESSCCS-SCCSCGGGGTTCSEEEEESSCCC------------------------CCCSCGGGGTTCSEEEEESCCCC--C
T ss_pred cCCCch-hcChhhhhCCCCCEEECCCCCcc------------------------chhHHHhccCCCCEEECCCCccc--c
Confidence 555554 44444444555555555555444 44444555555555555555554 4
Q ss_pred CcccccCCCCCCEEEcccCCCCCCCChhhh---------ccCCCCeeecccccccCCCchhhhccccccEEEeeccccCC
Q 002061 185 IPESIGNLKNLTYLFLAHCNLRGRIPESIS---------ELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTG 255 (973)
Q Consensus 185 ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~---------~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~ 255 (973)
+|..++++++|++|+|++|++.+.+|..+. .+++|++|+|++|+++ .+|..++++++|++|+|++|.+++
T Consensus 142 lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~ 220 (328)
T 4fcg_A 142 LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA 220 (328)
T ss_dssp CCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC
T ss_pred CcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc
Confidence 567777777777777777777777777665 4999999999999999 889999999999999999999994
Q ss_pred cCCccccccccccEEEeeccccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeeccCCccCCCCCccccc
Q 002061 256 ELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGR 335 (973)
Q Consensus 256 ~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~ 335 (973)
+|..+..+++|++|+|++|.+.+.+|..++.+++|+.|++++|++.+.+|..++.+++|+.|++++|++.+.+|+.++.
T Consensus 221 -l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~ 299 (328)
T 4fcg_A 221 -LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQ 299 (328)
T ss_dssp -CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGG
T ss_pred -CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhh
Confidence 6778999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccccc
Q 002061 336 YTALTDVDISENQFS 350 (973)
Q Consensus 336 l~~L~~L~Ls~N~l~ 350 (973)
+++|+.+++..|.+.
T Consensus 300 L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 300 LPANCIILVPPHLQA 314 (328)
T ss_dssp SCTTCEEECCGGGSC
T ss_pred ccCceEEeCCHHHHH
Confidence 999999999988776
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-33 Score=336.47 Aligned_cols=451 Identities=12% Similarity=0.037 Sum_probs=330.5
Q ss_pred CCCcceeeeCCCCCceEEEeecCCCCCccccccccCCccCcEeeCCCCcc---cCcCChhhh------------CCCCCc
Q 002061 60 PCGFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVL---SGKLPLELS------------NCSNLK 124 (973)
Q Consensus 60 ~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l---~~~~p~~l~------------~l~~L~ 124 (973)
|++|.++.+.. .+ .+.+.+ ......+..+..+++|++|+|+++.. .+.+|..++ .+++|+
T Consensus 41 ck~W~~~~~~~--~~--~l~~~~-~~~~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~ 115 (592)
T 3ogk_B 41 CRRWFKIDSET--RE--HVTMAL-CYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLK 115 (592)
T ss_dssp CHHHHHHHHHH--CC--EEEESC-GGGSCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCC
T ss_pred hHHHHHhhhcc--cc--EEEEee-ccccChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCC
Confidence 45899996532 22 222322 23333445667899999999987532 133443332 789999
Q ss_pred EEEecCCcccCCCC-cccCC--CCCCEEeccCcc-CCC-ccccccccccccceEEccCCcCCCCC---CcccccCCCCCC
Q 002061 125 VLNVTGNAMVGSVP-DLSAL--KNLEIFDLSINY-FTG-RFPRWVVNLTQLVSLSIGDNVYDEAE---IPESIGNLKNLT 196 (973)
Q Consensus 125 ~L~L~~n~l~~~~~-~l~~l--~~L~~L~Ls~n~-l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~---ip~~~~~l~~L~ 196 (973)
+|+|++|.+++... .++.. ++|++|+|++|. ++. .++..+..+++|++|+|++|.+.+.. ++..+.++++|+
T Consensus 116 ~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~ 195 (592)
T 3ogk_B 116 SVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLE 195 (592)
T ss_dssp EEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCC
T ss_pred eEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCcc
Confidence 99999998865433 35553 459999999987 321 23344458899999999999886544 445667899999
Q ss_pred EEEcccCCCCCC----CChhhhccCCCCeeecccccccCCCchhhhccccccEEEeeccccC---CcCCccccccccccE
Q 002061 197 YLFLAHCNLRGR----IPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLT---GELPAELGNLTLLQE 269 (973)
Q Consensus 197 ~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~---~~~~~~l~~l~~L~~ 269 (973)
+|+|++|.+++. ++..+..+++|++|+|++|.+.+ ++..+..+++|++|+++..... +..+..+..+++|+.
T Consensus 196 ~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~ 274 (592)
T 3ogk_B 196 VLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCR 274 (592)
T ss_dssp EEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCE
T ss_pred EEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccc
Confidence 999999999843 34456788999999999999985 7889999999999999864433 344567788999999
Q ss_pred EEeeccccccccCCccCCCCCccEEEcccCCCCCCCC-CCcCCcccceeeeccCCccCCCCCcccccccccccccccc--
Q 002061 270 FDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFP-SGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISE-- 346 (973)
Q Consensus 270 L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~-- 346 (973)
|+++++... .+|..+..+++|++|++++|.+++... ..+..+++|+.|+++++...+.++..+..+++|++|+|++
T Consensus 275 L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~ 353 (592)
T 3ogk_B 275 LGLSYMGPN-EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGA 353 (592)
T ss_dssp EEETTCCTT-TGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCC
T ss_pred cCccccchh-HHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEEeecCc
Confidence 999987543 778888899999999999999876444 3468899999999994333333444456789999999993
Q ss_pred ---------ccccccCChhhhhhhhHHHHHhhhccCCCCccccccCccccceEeccccccccCCCccccC-CCCcceEec
Q 002061 347 ---------NQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWA-LPNVGMLDF 416 (973)
Q Consensus 347 ---------N~l~~~~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~L 416 (973)
|.+++... +.....+++|++|+++.|.+++..+..+.. +++|+.|++
T Consensus 354 ~~~~~~~~~~~~~~~~~-----------------------~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l 410 (592)
T 3ogk_B 354 DEQGMEDEEGLVSQRGL-----------------------IALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRL 410 (592)
T ss_dssp CSSTTSSTTCCCCHHHH-----------------------HHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEE
T ss_pred cccccccccCccCHHHH-----------------------HHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEE
Confidence 56652211 111235789999999999998777777766 899999999
Q ss_pred c----CCcCCCCCC-----CCCCCCCCCCEEEcccC--CCCCCCChhhhc-CCCCCEEEccCCcCCC-CccccccccccC
Q 002061 417 G----DNDFTGGIS-----PLIGLSTSLSQLVLQNN--RFSGELPSELGR-LTNLERLILTNNNFSG-KIPSALGALRQL 483 (973)
Q Consensus 417 ~----~N~l~~~~~-----~~~~~~~~L~~L~L~~N--~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L 483 (973)
+ .|++++.+. ..+..+++|+.|+|+++ .+++..+..+.. +++|++|+|++|++++ .++..+..+++|
T Consensus 411 ~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L 490 (592)
T 3ogk_B 411 VLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNL 490 (592)
T ss_dssp EECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTC
T ss_pred eecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCccc
Confidence 6 778876532 22556899999999853 466555555554 8999999999999985 345667889999
Q ss_pred CEEEcCCcccccC-CCccccccccccchhccccccccCCCccc-cccCCCCeeecCCCc
Q 002061 484 SSLHLEENALTGS-IPNEMGDCARIVDLNLARNSLSGNIPRSL-SLLSSLNALNLSGNK 540 (973)
Q Consensus 484 ~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~L~~N~ 540 (973)
++|+|++|.+++. ++..+..+++|+.|+|++|+++..-...+ ..++.++...+..++
T Consensus 491 ~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~~~~ 549 (592)
T 3ogk_B 491 QKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSRR 549 (592)
T ss_dssp CEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEEEEECCC-
T ss_pred CeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHHHHHHHHHhCCCcEEEEecCcc
Confidence 9999999998754 34455779999999999999986544433 456777766666553
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.4e-30 Score=279.53 Aligned_cols=184 Identities=20% Similarity=0.275 Sum_probs=94.7
Q ss_pred cccceEeccccccccCCCccccCCCCcceEeccCCcCCCCCC-CCCCCCCCCCEEEcccCCCCCCCChhhhcCCCCCEEE
Q 002061 385 KTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGIS-PLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLI 463 (973)
Q Consensus 385 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 463 (973)
++|++|+|++|.++ .+|..+..+++|++|++++|++++..+ ..+..+++|++|++++|++.+..+..+..+++|++|+
T Consensus 78 ~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 156 (306)
T 2z66_A 78 TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLK 156 (306)
T ss_dssp SCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEE
T ss_pred cccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEE
Confidence 33444444444443 233333444444444444444443332 3344445555555555555544555555555555555
Q ss_pred ccCCcCCC-CccccccccccCCEEEcCCcccccCCCccccccccccchhccccccccCCCccccccCCCCeeecCCCccC
Q 002061 464 LTNNNFSG-KIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLT 542 (973)
Q Consensus 464 Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 542 (973)
|++|.+++ ..|..+..+++|++|+|++|++++..|..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|+++
T Consensus 157 l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 236 (306)
T 2z66_A 157 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM 236 (306)
T ss_dssp CTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCC
T ss_pred CCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCc
Confidence 55555543 34555555555555555555555555555555555555555555555544445555555555555555555
Q ss_pred CCCChhhhcc--cCceEEccCCccccccC
Q 002061 543 GSIPDNLMKL--KLSSIDLSENQLSGSVP 569 (973)
Q Consensus 543 ~~~p~~l~~l--~L~~l~ls~N~l~~~~p 569 (973)
+.+|..+..+ .|+.|+|++|+|+|.++
T Consensus 237 ~~~~~~~~~~~~~L~~L~L~~N~~~~~c~ 265 (306)
T 2z66_A 237 TSKKQELQHFPSSLAFLNLTQNDFACTCE 265 (306)
T ss_dssp BCSSSSCCCCCTTCCEEECTTCCEECSGG
T ss_pred ccCHHHHHhhhccCCEEEccCCCeecccC
Confidence 5555555544 25556666666655554
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=283.59 Aligned_cols=276 Identities=18% Similarity=0.208 Sum_probs=142.2
Q ss_pred EEeeccccCCcCCccccccccccEEEeeccccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeeccCCcc
Q 002061 246 IELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRF 325 (973)
Q Consensus 246 L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l 325 (973)
.++++|.++ .+|..+. ++|++|++++|++++..+..+.++++|++|++++|++++..|..|+.+++|++|++++|++
T Consensus 36 c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l 112 (353)
T 2z80_A 36 CKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYL 112 (353)
T ss_dssp EECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred eeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcC
Confidence 344444444 3333332 2455555555555544444455555555555555555544444555555555555555555
Q ss_pred CCCCCccccccccccccccccccccccCChhhhhhhhHHHHHhhhccCCCCccccccCccccceEecccc-ccccCCCcc
Q 002061 326 SGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDN-HLSGKIPDG 404 (973)
Q Consensus 326 ~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~ 404 (973)
++..+..+..+++|++|++++|++++ +|. ...+.++++|++|++++| .+++..+..
T Consensus 113 ~~~~~~~~~~l~~L~~L~L~~n~l~~-l~~----------------------~~~~~~l~~L~~L~l~~n~~~~~~~~~~ 169 (353)
T 2z80_A 113 SNLSSSWFKPLSSLTFLNLLGNPYKT-LGE----------------------TSLFSHLTKLQILRVGNMDTFTKIQRKD 169 (353)
T ss_dssp SSCCHHHHTTCTTCSEEECTTCCCSS-SCS----------------------SCSCTTCTTCCEEEEEESSSCCEECTTT
T ss_pred CcCCHhHhCCCccCCEEECCCCCCcc-cCc----------------------hhhhccCCCCcEEECCCCccccccCHHH
Confidence 54333334555555555555555541 110 013444555555555555 344444444
Q ss_pred ccCCCCcceEeccCCcCCCCCCCCCCCCCCCCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCccccccccccCC
Q 002061 405 LWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLS 484 (973)
Q Consensus 405 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 484 (973)
|..+++|+.|++++|++++..+..+..+++|++|++++|++....+..+..+++|+.|+|++|++++..+..+..
T Consensus 170 ~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~----- 244 (353)
T 2z80_A 170 FAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELST----- 244 (353)
T ss_dssp TTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC---------
T ss_pred ccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCcccccccccccc-----
Confidence 544444444444444444444444444444444444444444222222333444555555555444332222111
Q ss_pred EEEcCCcccccCCCccccccccccchhcccccccc----CCCccccccCCCCeeecCCCccCCCCChh-hhccc-CceEE
Q 002061 485 SLHLEENALTGSIPNEMGDCARIVDLNLARNSLSG----NIPRSLSLLSSLNALNLSGNKLTGSIPDN-LMKLK-LSSID 558 (973)
Q Consensus 485 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~p~~-l~~l~-L~~l~ 558 (973)
......++.++|++|.+++ .+|..+..+++|+.|+|++|+++ .+|.. +..++ |+.|+
T Consensus 245 ----------------~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~ 307 (353)
T 2z80_A 245 ----------------GETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIW 307 (353)
T ss_dssp ------------------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEE
T ss_pred ----------------ccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEE
Confidence 0112334444444444443 46777888889999999999998 56655 46665 89999
Q ss_pred ccCCccccccC
Q 002061 559 LSENQLSGSVP 569 (973)
Q Consensus 559 ls~N~l~~~~p 569 (973)
|++|+|.|.+|
T Consensus 308 L~~N~~~~~~~ 318 (353)
T 2z80_A 308 LHTNPWDCSCP 318 (353)
T ss_dssp CCSSCBCCCHH
T ss_pred eeCCCccCcCC
Confidence 99999999888
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-28 Score=283.50 Aligned_cols=233 Identities=21% Similarity=0.200 Sum_probs=166.3
Q ss_pred cceeeeccCCccCCCCCccccccccccccccccccccccCChhhhhhhhHHHHHhhhccCCCCccccccCccccceEecc
Q 002061 314 KLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRIS 393 (973)
Q Consensus 314 ~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls 393 (973)
+++.|+|++|++++..+..|..+++|++|+|++|+|++. .+..|.++++|++|+|+
T Consensus 65 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i------------------------~~~~~~~l~~L~~L~L~ 120 (440)
T 3zyj_A 65 NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTI------------------------EIGAFNGLANLNTLELF 120 (440)
T ss_dssp TCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEE------------------------CGGGGTTCSSCCEEECC
T ss_pred CCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCcc------------------------ChhhccCCccCCEEECC
Confidence 344444444444444444455555555555555555421 12334555666666666
Q ss_pred ccccccCCCccccCCCCcceEeccCCcCCCCCCCCCCCCCCCCEEEccc-CCCCCCCChhhhcCCCCCEEEccCCcCCCC
Q 002061 394 DNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQN-NRFSGELPSELGRLTNLERLILTNNNFSGK 472 (973)
Q Consensus 394 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 472 (973)
+|+|++..+..|..+++|++|+|++|+++..++..|..+++|++|+|++ |.+....+..|.++++|++|+|++|+++ .
T Consensus 121 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~ 199 (440)
T 3zyj_A 121 DNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-E 199 (440)
T ss_dssp SSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-S
T ss_pred CCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-c
Confidence 6666655555666666666777777766666666667777777777777 4455444557788888888888888887 4
Q ss_pred ccccccccccCCEEEcCCcccccCCCccccccccccchhccccccccCCCccccccCCCCeeecCCCccCCCCChhhhcc
Q 002061 473 IPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL 552 (973)
Q Consensus 473 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l 552 (973)
+| .+..+++|++|+|++|++++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..+..+..+
T Consensus 200 ~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 278 (440)
T 3zyj_A 200 IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPL 278 (440)
T ss_dssp CC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSC
T ss_pred cc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccc
Confidence 45 47788888888888888888888888888889999999999888888888889999999999999997777777777
Q ss_pred c-CceEEccCCccccccCccc
Q 002061 553 K-LSSIDLSENQLSGSVPLDF 572 (973)
Q Consensus 553 ~-L~~l~ls~N~l~~~~p~~~ 572 (973)
+ |+.|+|++|+|.|+|...|
T Consensus 279 ~~L~~L~L~~Np~~CdC~l~~ 299 (440)
T 3zyj_A 279 HHLERIHLHHNPWNCNCDILW 299 (440)
T ss_dssp TTCCEEECCSSCEECSSTTHH
T ss_pred cCCCEEEcCCCCccCCCCchH
Confidence 5 8999999999999988653
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-28 Score=283.81 Aligned_cols=252 Identities=19% Similarity=0.178 Sum_probs=161.4
Q ss_pred ccEEEeeccccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeeccCCccCCCCCcccccccccccccccc
Q 002061 267 LQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISE 346 (973)
Q Consensus 267 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~ 346 (973)
...++.+++.++ .+|..+. ++|++|++++|+|++..+..|.++++|+.|+|++|++++..+..|
T Consensus 56 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~------------- 119 (452)
T 3zyi_A 56 FSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAF------------- 119 (452)
T ss_dssp SCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTT-------------
T ss_pred CcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhc-------------
Confidence 345556655555 4454433 355555555555555555555555555555555555544444444
Q ss_pred ccccccCChhhhhhhhHHHHHhhhccCCCCccccccCccccceEeccccccccCCCccccCCCCcceEeccCCcCCCCCC
Q 002061 347 NQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGIS 426 (973)
Q Consensus 347 N~l~~~~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~ 426 (973)
.++++|++|+|++|+|++..+..|..+++|++|+|++|+++..++
T Consensus 120 -----------------------------------~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 164 (452)
T 3zyi_A 120 -----------------------------------NGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPS 164 (452)
T ss_dssp -----------------------------------TTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECT
T ss_pred -----------------------------------cCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCH
Confidence 444555555555555554444455555555555555555555555
Q ss_pred CCCCCCCCCCEEEccc-CCCCCCCChhhhcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCCccccccc
Q 002061 427 PLIGLSTSLSQLVLQN-NRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCA 505 (973)
Q Consensus 427 ~~~~~~~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 505 (973)
..|..+++|+.|+|++ |.+....+..|.++++|++|+|++|++++ +| .+..+++|++|+|++|++++..|..|.+++
T Consensus 165 ~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 242 (452)
T 3zyi_A 165 YAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLS 242 (452)
T ss_dssp TTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-CC-CCTTCTTCCEEECTTSCCSEECGGGGTTCT
T ss_pred hHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc-cc-cccccccccEEECcCCcCcccCcccccCcc
Confidence 5556666666666666 34443444456777777777777777764 33 466777777777777777777777777777
Q ss_pred cccchhccccccccCCCccccccCCCCeeecCCCccCCCCChhhhccc-CceEEccCCccccccCcc
Q 002061 506 RIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLK-LSSIDLSENQLSGSVPLD 571 (973)
Q Consensus 506 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~-L~~l~ls~N~l~~~~p~~ 571 (973)
+|+.|+|++|++++..|..|..+++|+.|+|++|+|++..+..+..++ |+.|+|++|+|.|.|...
T Consensus 243 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~~~ 309 (452)
T 3zyi_A 243 SLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCDIL 309 (452)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECSTTTH
T ss_pred CCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCCCch
Confidence 888888888888777777788888888888888888866666666665 888888888888888764
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.96 E-value=8e-29 Score=293.65 Aligned_cols=291 Identities=22% Similarity=0.298 Sum_probs=162.4
Q ss_pred CCcccccCCCCCCCCCCCcceeeeC------CCCCceEEEeecCCCCCccccccccCCccCcEeeCCCCcccCcCChhhh
Q 002061 45 DPHGVLDSWKESADSPCGFSGITCD------SVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELS 118 (973)
Q Consensus 45 d~~~~~~~W~~~~~~~c~w~gv~C~------~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~ 118 (973)
|...++++|.... +||.|.|..|. -....++.|++++++++ .+|..+. ++|++|+|++|.|+ .+|.
T Consensus 7 ~~~~~w~~W~~~~-~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~--- 78 (622)
T 3g06_A 7 EYDAVWSAWRRAA-PAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA--- 78 (622)
T ss_dssp ---CHHHHHHHTC-CGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---
T ss_pred HHHHHHHHHHhcC-CcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---
Confidence 4456678897664 47999775431 11234677788877777 6666665 67777777777776 4555
Q ss_pred CCCCCcEEEecCCcccCCCCcccCCCCCCEEeccCccCCCccccccccccccceEEccCCcCCCCCCcccccCCCCCCEE
Q 002061 119 NCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYL 198 (973)
Q Consensus 119 ~l~~L~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ip~~~~~l~~L~~L 198 (973)
.+++|++|+|++|++++.+. .+++|++|+|++|.+++. |. .+++|+.|++++|.++. +|.. +++|++|
T Consensus 79 ~l~~L~~L~Ls~N~l~~lp~---~l~~L~~L~Ls~N~l~~l-~~---~l~~L~~L~L~~N~l~~--lp~~---l~~L~~L 146 (622)
T 3g06_A 79 LPPELRTLEVSGNQLTSLPV---LPPGLLELSIFSNPLTHL-PA---LPSGLCKLWIFGNQLTS--LPVL---PPGLQEL 146 (622)
T ss_dssp CCTTCCEEEECSCCCSCCCC---CCTTCCEEEECSCCCCCC-CC---CCTTCCEEECCSSCCSC--CCCC---CTTCCEE
T ss_pred cCCCCCEEEcCCCcCCcCCC---CCCCCCEEECcCCcCCCC-CC---CCCCcCEEECCCCCCCc--CCCC---CCCCCEE
Confidence 46777777777777766554 566777777777776642 22 34555555555555542 3332 2455555
Q ss_pred EcccCCCCCCCChhhhccCCCCeeecccccccCCCchhhhccccccEEEeeccccCCcCCccccccccccEEEeeccccc
Q 002061 199 FLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMY 278 (973)
Q Consensus 199 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~ 278 (973)
+|++|++++ +|. .+++|+.|++++|+|++ +| ..+++|+.|++++|+++
T Consensus 147 ~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~~-l~---------------------------~~~~~L~~L~Ls~N~l~ 194 (622)
T 3g06_A 147 SVSDNQLAS-LPA---LPSELCKLWAYNNQLTS-LP---------------------------MLPSGLQELSVSDNQLA 194 (622)
T ss_dssp ECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CC---------------------------CCCTTCCEEECCSSCCS
T ss_pred ECcCCcCCC-cCC---ccCCCCEEECCCCCCCC-Cc---------------------------ccCCCCcEEECCCCCCC
Confidence 555555553 222 22344555555555542 23 22344555555555544
Q ss_pred cccCCccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeeccCCccCCCCCccccccccccccccccccccccCChhhh
Q 002061 279 GKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLC 358 (973)
Q Consensus 279 ~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~ 358 (973)
+ +|.. +++|+.|++++|.++. +|.. +++|+.|++++|.|++ +| ..+++|+.|+|++|+|+ .
T Consensus 195 ~-l~~~---~~~L~~L~L~~N~l~~-l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~------ 255 (622)
T 3g06_A 195 S-LPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-S------ 255 (622)
T ss_dssp C-CCCC---CTTCCEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-C------
T ss_pred C-CCCc---cchhhEEECcCCcccc-cCCC---CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-c------
Confidence 2 2221 2445555555555542 2221 2455555555555553 33 33455666666666665 1
Q ss_pred hhhhHHHHHhhhccCCCCccccccCccccceEeccccccccCCCccccCCCCcceEeccCCcCCCCCCCC
Q 002061 359 EKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPL 428 (973)
Q Consensus 359 ~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~ 428 (973)
+|. .+++|++|+|++|+|+ .+|..|..+++|+.|+|++|.+++..+..
T Consensus 256 ------------------lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~ 303 (622)
T 3g06_A 256 ------------------LPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQA 303 (622)
T ss_dssp ------------------CCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHH
T ss_pred ------------------CCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHH
Confidence 222 2356666777777766 55666666777777777777666554443
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-29 Score=278.23 Aligned_cols=247 Identities=18% Similarity=0.196 Sum_probs=149.1
Q ss_pred cCCccCcEeeCCCCcccCcCChhhhCCCCCcEEEecCCcccC-CCC-ccc-------CCCCCCEEeccCccCCCcccccc
Q 002061 94 SALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVG-SVP-DLS-------ALKNLEIFDLSINYFTGRFPRWV 164 (973)
Q Consensus 94 ~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~-~~~-~l~-------~l~~L~~L~Ls~n~l~~~~~~~~ 164 (973)
+..++|+.|++++|.+ .+|..+... |++|+|++|.+.. ..+ .+. ++++|++|+|++|.+++.+|..+
T Consensus 40 ~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 115 (312)
T 1wwl_A 40 GGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPL 115 (312)
T ss_dssp EEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCS
T ss_pred ccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHH
Confidence 3344455555555555 444444433 5555555555522 112 122 35555555555555555555544
Q ss_pred --ccccccceEEccCCcCCCCCCcccccCC-----CCCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCC--Cch
Q 002061 165 --VNLTQLVSLSIGDNVYDEAEIPESIGNL-----KNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGE--FPR 235 (973)
Q Consensus 165 --~~l~~L~~L~l~~n~l~~~~ip~~~~~l-----~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~~~ 235 (973)
..+++|++|++++|.++.. |..++.+ ++|++|+|++|++++..|..|+.+++|++|+|++|++.+. .+.
T Consensus 116 ~~~~l~~L~~L~Ls~N~l~~~--~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 193 (312)
T 1wwl_A 116 LEATGPDLNILNLRNVSWATR--DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS 193 (312)
T ss_dssp SSCCSCCCSEEEEESCBCSSS--SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHH
T ss_pred HHhcCCCccEEEccCCCCcch--hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHH
Confidence 5555555555555555432 4445444 6677777777777766666777777777777777776544 233
Q ss_pred hh--hccccccEEEeeccccCCc--CC-ccccccccccEEEeeccccccccC-CccCCCCCccEEEcccCCCCCCCCCCc
Q 002061 236 SI--RKLQKLWKIELYANNLTGE--LP-AELGNLTLLQEFDISSNQMYGKLP-EEIGNLKNLTVFQCFKNNFSGEFPSGF 309 (973)
Q Consensus 236 ~l--~~l~~L~~L~L~~N~l~~~--~~-~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~~ 309 (973)
.+ ..+++|++|+|++|++++. ++ ..+..+++|++|+|++|++++..| ..+..+++|++|++++|+|+ .+|..+
T Consensus 194 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~ 272 (312)
T 1wwl_A 194 ALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL 272 (312)
T ss_dssp HSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSC
T ss_pred HHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhc
Confidence 33 6677777777777777621 12 233456777777777777776554 34556777777777777777 566655
Q ss_pred CCcccceeeeccCCccCCCCCccccccccccccccccccccc
Q 002061 310 GDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSG 351 (973)
Q Consensus 310 ~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~ 351 (973)
. ++|+.|++++|+|++. |. +..+++|++|+|++|++++
T Consensus 273 ~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 273 P--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp C--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred c--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 5 7777778888877765 54 7777888888888887763
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.2e-28 Score=260.70 Aligned_cols=236 Identities=20% Similarity=0.208 Sum_probs=133.2
Q ss_pred ccccEEEeeccccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeeccCCc-cCCCCCccccccccccccc
Q 002061 265 TLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNR-FSGPFPENLGRYTALTDVD 343 (973)
Q Consensus 265 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~-l~~~~~~~l~~l~~L~~L~ 343 (973)
++|++|++++|.+++..+..+.++++|++|++++|.+++..|..|..+++|++|++++|. ++...|..+..+++|++|+
T Consensus 32 ~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~ 111 (285)
T 1ozn_A 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (285)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEE
Confidence 345555555555554444445555555555555555554444555555555555555554 4444445555555555555
Q ss_pred cccccccccCChhhhhhhhHHHHHhhhccCCCCccccccCccccceEeccccccccCCCccccCCCCcceEeccCCcCCC
Q 002061 344 ISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTG 423 (973)
Q Consensus 344 Ls~N~l~~~~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 423 (973)
+++|++++. .|..+.++++|++|+|++|++++..+..|..+++|+.|++++|++++
T Consensus 112 l~~n~l~~~------------------------~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 167 (285)
T 1ozn_A 112 LDRCGLQEL------------------------GPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISS 167 (285)
T ss_dssp CTTSCCCCC------------------------CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCE
T ss_pred CCCCcCCEE------------------------CHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccc
Confidence 555555421 12334455566666666666665555555566666666666666665
Q ss_pred CCCCCCCCCCCCCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCCccccc
Q 002061 424 GISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGD 503 (973)
Q Consensus 424 ~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 503 (973)
.++..+..+++|++|+|++|++++..|..|..+++|+.|+|++|++++..+..+..+++|++|+|++|.+....+. ..-
T Consensus 168 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~-~~~ 246 (285)
T 1ozn_A 168 VPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPL 246 (285)
T ss_dssp ECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG-HHH
T ss_pred cCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCc-HHH
Confidence 5555566666677777777777666666677777777777777777765556666777777777777766632221 111
Q ss_pred cccccchhccccccccCCCccc
Q 002061 504 CARIVDLNLARNSLSGNIPRSL 525 (973)
Q Consensus 504 l~~L~~L~Ls~N~l~~~~~~~~ 525 (973)
...++.+..+.|.+....|..+
T Consensus 247 ~~~l~~~~~~~~~~~c~~p~~l 268 (285)
T 1ozn_A 247 WAWLQKFRGSSSEVPCSLPQRL 268 (285)
T ss_dssp HHHHHHCCSEECCCBEEESGGG
T ss_pred HHHHHhcccccCccccCCchHh
Confidence 2334455555555555555544
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.8e-28 Score=261.46 Aligned_cols=162 Identities=25% Similarity=0.285 Sum_probs=77.4
Q ss_pred cCccccceEeccccc-cccCCCccccCCCCcceEeccCCcCCCCCCCCCCCCCCCCEEEcccCCCCCCCChhhhcCCCCC
Q 002061 382 ADCKTIQRLRISDNH-LSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLE 460 (973)
Q Consensus 382 ~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 460 (973)
..+++|++|+|++|+ +++..|..|..+++|++|++++|++++..+..+..+++|++|+|++|++++..+..|..+++|+
T Consensus 77 ~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 156 (285)
T 1ozn_A 77 TGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLT 156 (285)
T ss_dssp TTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred CCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCcc
Confidence 334444444444443 4333344444444444444444444444444444444455555555555444444444455555
Q ss_pred EEEccCCcCCCCccccccccccCCEEEcCCcccccCCCccccccccccchhccccccccCCCccccccCCCCeeecCCCc
Q 002061 461 RLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNK 540 (973)
Q Consensus 461 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~ 540 (973)
+|+|++|++++..+..|..+++|++|+|++|++++..|..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|+
T Consensus 157 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~ 236 (285)
T 1ozn_A 157 HLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNP 236 (285)
T ss_dssp EEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSC
T ss_pred EEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCC
Confidence 55555555543333344455555555555555554444555555555555555555554444444555555555555555
Q ss_pred cCC
Q 002061 541 LTG 543 (973)
Q Consensus 541 l~~ 543 (973)
++.
T Consensus 237 ~~c 239 (285)
T 1ozn_A 237 WVC 239 (285)
T ss_dssp EEC
T ss_pred ccC
Confidence 543
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-27 Score=276.70 Aligned_cols=249 Identities=19% Similarity=0.230 Sum_probs=189.4
Q ss_pred cccEEEeeccccCCcCCccccccccccEEEeeccccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeecc
Q 002061 242 KLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIY 321 (973)
Q Consensus 242 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 321 (973)
....++.+++.++ .+|..+. ++|++|+|++|++++..|..|.++++|+.|++++|+|++..+..|.++++|+.|+|+
T Consensus 55 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~ 131 (452)
T 3zyi_A 55 QFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELF 131 (452)
T ss_dssp SSCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECC
Confidence 4567889999998 6776654 689999999999999889999999999999999999999888999999999999999
Q ss_pred CCccCCCCCccccccccccccccccccccccCChhhhhhhhHHHHHhhhccCCCCccccccCccccceEeccc-cccccC
Q 002061 322 GNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISD-NHLSGK 400 (973)
Q Consensus 322 ~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~-N~l~~~ 400 (973)
+|++++..+..|..+++|++|+|++|+|+.. .+..|.++++|++|+|++ |.+...
T Consensus 132 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~------------------------~~~~~~~l~~L~~L~l~~~~~l~~i 187 (452)
T 3zyi_A 132 DNWLTVIPSGAFEYLSKLRELWLRNNPIESI------------------------PSYAFNRVPSLMRLDLGELKKLEYI 187 (452)
T ss_dssp SSCCSBCCTTTSSSCTTCCEEECCSCCCCEE------------------------CTTTTTTCTTCCEEECCCCTTCCEE
T ss_pred CCcCCccChhhhcccCCCCEEECCCCCccee------------------------CHhHHhcCCcccEEeCCCCCCcccc
Confidence 9999876666677777777777777776621 122455566666666666 333322
Q ss_pred CCccccCCCCcceEeccCCcCCCCCCCCCCCCCCCCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCcccccccc
Q 002061 401 IPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGAL 480 (973)
Q Consensus 401 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 480 (973)
....|..+++|++|+|++|++++. | .+..+++|++|+|++|++++..|..|.++
T Consensus 188 ------------------------~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 241 (452)
T 3zyi_A 188 ------------------------SEGAFEGLFNLKYLNLGMCNIKDM-P-NLTPLVGLEELEMSGNHFPEIRPGSFHGL 241 (452)
T ss_dssp ------------------------CTTTTTTCTTCCEEECTTSCCSSC-C-CCTTCTTCCEEECTTSCCSEECGGGGTTC
T ss_pred ------------------------ChhhccCCCCCCEEECCCCccccc-c-cccccccccEEECcCCcCcccCcccccCc
Confidence 223344555566666666666532 3 36667777777777777777777777777
Q ss_pred ccCCEEEcCCcccccCCCccccccccccchhccccccccCCCccccccCCCCeeecCCCccCC
Q 002061 481 RQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTG 543 (973)
Q Consensus 481 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 543 (973)
++|++|+|++|++++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|++..
T Consensus 242 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C 304 (452)
T 3zyi_A 242 SSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNC 304 (452)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEEC
T ss_pred cCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCC
Confidence 888888888888877777778888888888888888887777777888888888888888874
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.8e-29 Score=274.24 Aligned_cols=205 Identities=15% Similarity=0.135 Sum_probs=132.4
Q ss_pred cCCCCCCEEeccCccCCCccccccccccccceEEccCCcCCCCCCccccc-------CCCCCCEEEcccCCCCCCCChhh
Q 002061 141 SALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIG-------NLKNLTYLFLAHCNLRGRIPESI 213 (973)
Q Consensus 141 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ip~~~~-------~l~~L~~L~L~~n~l~~~~~~~~ 213 (973)
+..++|+.|++++|.+ .+|..+... |+.|++++|.+....+|..+. ++++|++|+|++|++++.+|..+
T Consensus 40 ~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 115 (312)
T 1wwl_A 40 GGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPL 115 (312)
T ss_dssp EEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCS
T ss_pred ccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHH
Confidence 3445566666666666 455544443 666677777665556666665 78888888888888888888776
Q ss_pred --hccCCCCeeecccccccCCCchhhhcc-----ccccEEEeeccccCCcCCccccccccccEEEeeccccccc--cCCc
Q 002061 214 --SELRELGTLDICRNKISGEFPRSIRKL-----QKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGK--LPEE 284 (973)
Q Consensus 214 --~~l~~L~~L~L~~N~l~~~~~~~l~~l-----~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~--~p~~ 284 (973)
..+++|++|+|++|++++. |..++.+ ++|++|+|++|++++..|..|+.+++|++|+|++|++.+. .|..
T Consensus 116 ~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 194 (312)
T 1wwl_A 116 LEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISA 194 (312)
T ss_dssp SSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHH
T ss_pred HHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHH
Confidence 7888888888888888866 7777777 7888888888888877767788888888888888877654 2333
Q ss_pred c--CCCCCccEEEcccCCCCCC--CC-CCcCCcccceeeeccCCccCCCCC-cccccccccccccccccccc
Q 002061 285 I--GNLKNLTVFQCFKNNFSGE--FP-SGFGDMRKLFAFSIYGNRFSGPFP-ENLGRYTALTDVDISENQFS 350 (973)
Q Consensus 285 ~--~~l~~L~~L~l~~N~l~~~--~p-~~~~~l~~L~~L~l~~N~l~~~~~-~~l~~l~~L~~L~Ls~N~l~ 350 (973)
+ ..+++|++|++++|++++. ++ ..+..+++|+.|++++|++++..| ..+..+++|++|+|++|+|+
T Consensus 195 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~ 266 (312)
T 1wwl_A 195 LCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK 266 (312)
T ss_dssp SCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS
T ss_pred HHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC
Confidence 3 6677777777777776621 11 122344455555555555544332 22333344444444444443
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-27 Score=273.04 Aligned_cols=247 Identities=18% Similarity=0.198 Sum_probs=137.7
Q ss_pred CCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCchhhhccccccEEEeeccccCCcCCccccccccccEEEeec
Q 002061 195 LTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISS 274 (973)
Q Consensus 195 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~ 274 (973)
.+.++.++++++ .+|..+. ++++.|+|++|+|++..+..|.++++|++|+|++|.|++..+..|.++++|++|+|++
T Consensus 45 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~ 121 (440)
T 3zyj_A 45 FSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFD 121 (440)
T ss_dssp SCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCS
T ss_pred CCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCC
Confidence 344555555555 3443332 3455555555555544444455555555555555555544444455555555555555
Q ss_pred cccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeeccCC-ccCCCCCccccccccccccccccccccccC
Q 002061 275 NQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGN-RFSGPFPENLGRYTALTDVDISENQFSGSF 353 (973)
Q Consensus 275 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N-~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~ 353 (973)
|++++..+..|..+++|++|++++|+++...+..|..+++|+.|++++| .+....+..
T Consensus 122 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~--------------------- 180 (440)
T 3zyj_A 122 NRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGA--------------------- 180 (440)
T ss_dssp SCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTT---------------------
T ss_pred CcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcch---------------------
Confidence 5555433344455555555555555554433334444444444444442 222112223
Q ss_pred ChhhhhhhhHHHHHhhhccCCCCccccccCccccceEeccccccccCCCccccCCCCcceEeccCCcCCCCCCCCCCCCC
Q 002061 354 PKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLST 433 (973)
Q Consensus 354 p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ 433 (973)
|.++++|++|+|++|+|+ .+| .+..+++|+.|+|++|++++..+..|..++
T Consensus 181 ---------------------------~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 231 (440)
T 3zyj_A 181 ---------------------------FEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLM 231 (440)
T ss_dssp ---------------------------TTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCT
T ss_pred ---------------------------hhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCc
Confidence 334444455555555444 223 244555555555555555555555566667
Q ss_pred CCCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccc
Q 002061 434 SLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALT 494 (973)
Q Consensus 434 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 494 (973)
+|+.|+|++|++++..+..|.++++|+.|+|++|++++..+..|..+++|+.|+|++|.+.
T Consensus 232 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 232 HLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292 (440)
T ss_dssp TCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred cCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence 7777777777777777777777888888888888888777777788888888888888776
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.9e-27 Score=277.07 Aligned_cols=267 Identities=27% Similarity=0.401 Sum_probs=151.6
Q ss_pred CCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCchhhhccccccEEEeeccccCCcCCccccccccccEEEee
Q 002061 194 NLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDIS 273 (973)
Q Consensus 194 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls 273 (973)
+++.|++++|+++ .+|..+. ++|++|+|++|+|+ .+|. .+++|++|+|++|+|+ .+|. .+++|++|+|+
T Consensus 41 ~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls 109 (622)
T 3g06_A 41 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIF 109 (622)
T ss_dssp CCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEEC
T ss_pred CCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECc
Confidence 5777777777777 5555544 56777777777776 3443 3456666666666666 3443 45566666666
Q ss_pred ccccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeeccCCccCCCCCccccccccccccccccccccccC
Q 002061 274 SNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSF 353 (973)
Q Consensus 274 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~ 353 (973)
+|++++ +|. .+++|+.|++++|++++ +|.. +++|++|+|++|++++ +
T Consensus 110 ~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---------------------------l~~L~~L~Ls~N~l~~-l 156 (622)
T 3g06_A 110 SNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---------------------------PPGLQELSVSDNQLAS-L 156 (622)
T ss_dssp SCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---------------------------CTTCCEEECCSSCCSC-C
T ss_pred CCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---------------------------CCCCCEEECcCCcCCC-c
Confidence 666653 232 34455555555555543 2221 1344555555555441 1
Q ss_pred ChhhhhhhhHHHHHhhhccCCCCccccccCccccceEeccccccccCCCccccCCCCcceEeccCCcCCCCCCCCCCCCC
Q 002061 354 PKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLST 433 (973)
Q Consensus 354 p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ 433 (973)
| . .+++|+.|++++|.|++ +| ..+++|+.|++++|++++.+. .++
T Consensus 157 ~------------------------~---~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~l~~----~~~ 201 (622)
T 3g06_A 157 P------------------------A---LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLASLPT----LPS 201 (622)
T ss_dssp C------------------------C---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSCCCC----CCT
T ss_pred C------------------------C---ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCCCCC----ccc
Confidence 1 1 12345556666666553 33 234555555666555554332 235
Q ss_pred CCCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCCccccccccccchhcc
Q 002061 434 SLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLA 513 (973)
Q Consensus 434 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 513 (973)
+|+.|++++|.++ .+|.. +++|+.|+|++|+|++ +| ..+++|++|+|++|+|+. +|. .+++|+.|+|+
T Consensus 202 ~L~~L~L~~N~l~-~l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls 269 (622)
T 3g06_A 202 ELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVY 269 (622)
T ss_dssp TCCEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECC
T ss_pred hhhEEECcCCccc-ccCCC---CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCC
Confidence 6666666666666 33332 3567777777777764 34 344666777777777663 333 45566666777
Q ss_pred ccccccCCCccccccCCCCeeecCCCccCCCCChhhhcc
Q 002061 514 RNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL 552 (973)
Q Consensus 514 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l 552 (973)
+|+|+ .+|..|.++++|+.|+|++|++++.+|..+..+
T Consensus 270 ~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L 307 (622)
T 3g06_A 270 RNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREI 307 (622)
T ss_dssp SSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHH
T ss_pred CCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhc
Confidence 77666 556666677777777777777776666655544
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-28 Score=271.18 Aligned_cols=267 Identities=18% Similarity=0.158 Sum_probs=171.3
Q ss_pred CCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCchhhhccccccEEEeeccccCCcCCccccccccccEEEeec
Q 002061 195 LTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISS 274 (973)
Q Consensus 195 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~ 274 (973)
++.++++.+.+...+...+..+++|++|+|++|++++..|..|..+++|++|+|++|++++..+ +..+++|++|+|++
T Consensus 12 l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~ 89 (317)
T 3o53_A 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNN 89 (317)
T ss_dssp EEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCS
T ss_pred eeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcC
Confidence 4455666666654444555566678888888888877666777777778888888777775443 77777777777777
Q ss_pred cccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeeccCCccCCCCCccccccccccccccccccccccCC
Q 002061 275 NQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFP 354 (973)
Q Consensus 275 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p 354 (973)
|++++.. ..++|++|++++|++++..+.. +++|+.|++++|++++..+..+..+++
T Consensus 90 n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~---------------- 145 (317)
T 3o53_A 90 NYVQELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSR---------------- 145 (317)
T ss_dssp SEEEEEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSS----------------
T ss_pred Ccccccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCC----------------
Confidence 7776432 2366777777777766543332 344555555555555444444444444
Q ss_pred hhhhhhhhHHHHHhhhccCCCCccccccCccccceEeccccccccCCCcccc-CCCCcceEeccCCcCCCCCCCCCCCCC
Q 002061 355 KYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLW-ALPNVGMLDFGDNDFTGGISPLIGLST 433 (973)
Q Consensus 355 ~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~~~ 433 (973)
|++|+|++|++++..+..+. .+++|+.|+|++|++++.... ..++
T Consensus 146 --------------------------------L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~--~~l~ 191 (317)
T 3o53_A 146 --------------------------------VQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQ--VVFA 191 (317)
T ss_dssp --------------------------------EEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECC--CCCT
T ss_pred --------------------------------CCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcccccc--cccc
Confidence 44444444444443333332 344555555555554443221 2367
Q ss_pred CCCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccc-cCCCccccccccccchhc
Q 002061 434 SLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALT-GSIPNEMGDCARIVDLNL 512 (973)
Q Consensus 434 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L 512 (973)
+|++|+|++|++++ +|..+..+++|++|+|++|+++ .+|..+..+++|+.|+|++|+++ +.+|..+..+++|+.|++
T Consensus 192 ~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l 269 (317)
T 3o53_A 192 KLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAK 269 (317)
T ss_dssp TCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHH
T ss_pred cCCEEECCCCcCCc-chhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEEC
Confidence 78888888888874 4455778888888888888887 56777888888888888888887 667777888888888888
Q ss_pred ccc-ccccCCCc
Q 002061 513 ARN-SLSGNIPR 523 (973)
Q Consensus 513 s~N-~l~~~~~~ 523 (973)
++| .+++..|.
T Consensus 270 ~~~~~l~~~~~~ 281 (317)
T 3o53_A 270 QTVKKLTGQNEE 281 (317)
T ss_dssp HHHHHHHSSSSC
T ss_pred CCchhccCCchh
Confidence 843 56654443
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.7e-28 Score=268.08 Aligned_cols=259 Identities=18% Similarity=0.181 Sum_probs=191.2
Q ss_pred ceEEEeecCCCCCccccccccCCccCcEeeCCCCcccCcCChhhhCCCCCcEEEecCCcccCCCCcccCCCCCCEEeccC
Q 002061 74 RVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSI 153 (973)
Q Consensus 74 ~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls~ 153 (973)
+....+++++.+...+......+++|++|+|++|.+++..|..|+.+++|++|+|++|.+++.++ +..+++|++|+|++
T Consensus 11 ~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~-~~~l~~L~~L~Ls~ 89 (317)
T 3o53_A 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD-LESLSTLRTLDLNN 89 (317)
T ss_dssp EEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE-ETTCTTCCEEECCS
T ss_pred ceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh-hhhcCCCCEEECcC
Confidence 34555666777765555556677889999999999987777888899999999999998887665 88888899999998
Q ss_pred ccCCCccccccccccccceEEccCCcCCCCCCcccccCCCCCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCC
Q 002061 154 NYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEF 233 (973)
Q Consensus 154 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 233 (973)
|.+++.. ..++|++|++++|.+... + ...+++|++|++++|++++..+..++.+++|++|+|++|++++..
T Consensus 90 n~l~~l~-----~~~~L~~L~l~~n~l~~~--~--~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 160 (317)
T 3o53_A 90 NYVQELL-----VGPSIETLHAANNNISRV--S--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVN 160 (317)
T ss_dssp SEEEEEE-----ECTTCCEEECCSSCCSEE--E--ECCCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEE
T ss_pred Ccccccc-----CCCCcCEEECCCCccCCc--C--ccccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCccc
Confidence 8887432 347888888888877632 2 234677888888888888766777788888888888888887766
Q ss_pred chhhh-ccccccEEEeeccccCCcCCccccccccccEEEeeccccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCc
Q 002061 234 PRSIR-KLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDM 312 (973)
Q Consensus 234 ~~~l~-~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l 312 (973)
+..+. .+++|++|+|++|.+++. + ....+++|++|+|++|++++ +|..+..+++|+.|++++|+++ .+|..+..+
T Consensus 161 ~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l 236 (317)
T 3o53_A 161 FAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFS 236 (317)
T ss_dssp GGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCC
T ss_pred HHHHhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCCc-chhhhcccCcccEEECcCCccc-chhhHhhcC
Confidence 66653 677888888888888744 3 23347778888888888774 4455777777888888888777 456667777
Q ss_pred ccceeeeccCCccC-CCCCcccccccccccccccc
Q 002061 313 RKLFAFSIYGNRFS-GPFPENLGRYTALTDVDISE 346 (973)
Q Consensus 313 ~~L~~L~l~~N~l~-~~~~~~l~~l~~L~~L~Ls~ 346 (973)
++|+.|++++|++. +..+..+..+++|+.|++++
T Consensus 237 ~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~ 271 (317)
T 3o53_A 237 QNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQT 271 (317)
T ss_dssp TTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHH
T ss_pred CCCCEEEccCCCccCcCHHHHHhccccceEEECCC
Confidence 77777777777776 55666666777777777663
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.9e-30 Score=309.51 Aligned_cols=430 Identities=11% Similarity=0.096 Sum_probs=230.2
Q ss_pred CCCcceeeeCCCCCceEEEeecCCCCCcccc-ccccCCccCcEeeCCCCcccCc---CC------------hhhhCCCCC
Q 002061 60 PCGFSGITCDSVTGRVTEISFDNKSLSGEIS-SSISALQSLTVLSLPFNVLSGK---LP------------LELSNCSNL 123 (973)
Q Consensus 60 ~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~-~~l~~l~~L~~L~Ls~n~l~~~---~p------------~~l~~l~~L 123 (973)
|++|.++.. .....+++.+.. +..+ ..+..+++|++|+|+++..... .| .....+++|
T Consensus 34 ck~W~~~~~----~~~~~l~~~~~~--~~~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L 107 (594)
T 2p1m_B 34 CKSWYEIER----WCRRKVFIGNCY--AVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWL 107 (594)
T ss_dssp CHHHHHHHH----HHCCEEEESSTT--SSCHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTC
T ss_pred HHHHHHhhh----hhceEEeecccc--ccCHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCC
Confidence 457888832 223455554432 2222 3466788899999888753211 11 223567788
Q ss_pred cEEEecCCcccCCCC-ccc-CCCCCCEEeccCc-cCCCc-cccccccccccceEEccCCcCCCCC---CcccccCCCCCC
Q 002061 124 KVLNVTGNAMVGSVP-DLS-ALKNLEIFDLSIN-YFTGR-FPRWVVNLTQLVSLSIGDNVYDEAE---IPESIGNLKNLT 196 (973)
Q Consensus 124 ~~L~L~~n~l~~~~~-~l~-~l~~L~~L~Ls~n-~l~~~-~~~~~~~l~~L~~L~l~~n~l~~~~---ip~~~~~l~~L~ 196 (973)
++|+|++|.+++... .+. .+++|++|+|++| .++.. ++..+.++++|++|++++|.+++.. ++.....+++|+
T Consensus 108 ~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~ 187 (594)
T 2p1m_B 108 EEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLV 187 (594)
T ss_dssp CEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCC
T ss_pred CeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCc
Confidence 888888887765433 343 6788888888887 45432 3444457888888888888765433 223334667888
Q ss_pred EEEcccCCCCCCCChhh----hccCCCCeeecccc-cccCCCchhhhccccccEEEeec-------cccCCcCCcccccc
Q 002061 197 YLFLAHCNLRGRIPESI----SELRELGTLDICRN-KISGEFPRSIRKLQKLWKIELYA-------NNLTGELPAELGNL 264 (973)
Q Consensus 197 ~L~L~~n~l~~~~~~~~----~~l~~L~~L~L~~N-~l~~~~~~~l~~l~~L~~L~L~~-------N~l~~~~~~~l~~l 264 (973)
+|++++|. .......+ ..+++|++|+|++| .+++ ++..+..+++|++|+++. |.+.+ ++..+.++
T Consensus 188 ~L~l~~~~-~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~-l~~~l~~~ 264 (594)
T 2p1m_B 188 SLNISCLA-SEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSG-LSVALSGC 264 (594)
T ss_dssp EEECTTCC-SCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHH-HHHHHHTC
T ss_pred EEEecccC-CcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHH-HHHHHhcC
Confidence 88888876 21212222 34578888888877 4443 677777778888887443 33442 33456677
Q ss_pred ccccEE-EeeccccccccCCccCCCCCccEEEcccCCCCCCCCC-CcCCcccceeeeccCCccCCC-CCccccccccccc
Q 002061 265 TLLQEF-DISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPS-GFGDMRKLFAFSIYGNRFSGP-FPENLGRYTALTD 341 (973)
Q Consensus 265 ~~L~~L-~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~-~~~~l~~l~~L~~ 341 (973)
++|+.| .+..... +.++..+..+++|+.|++++|.+++.... .+..+++|+.|++++| +.+. ++.....+++|++
T Consensus 265 ~~L~~Ls~~~~~~~-~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~ 342 (594)
T 2p1m_B 265 KELRCLSGFWDAVP-AYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRE 342 (594)
T ss_dssp TTCCEEECCBTCCG-GGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCE
T ss_pred CCcccccCCcccch-hhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCE
Confidence 777777 3333222 23444444566777777777765532221 2345566666666665 3211 1111223555666
Q ss_pred ccccc---------ccccccCChhhhhhhhHHHHHhhhccCCCCccccccCccccceEeccccccccCCCcccc-CCCCc
Q 002061 342 VDISE---------NQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLW-ALPNV 411 (973)
Q Consensus 342 L~Ls~---------N~l~~~~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L 411 (973)
|++++ +.+++..... ....+++|++|+++.|.+++..+..+. .+++|
T Consensus 343 L~L~~~~~~g~~~~~~l~~~~l~~-----------------------l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L 399 (594)
T 2p1m_B 343 LRVFPSEPFVMEPNVALTEQGLVS-----------------------VSMGCPKLESVLYFCRQMTNAALITIARNRPNM 399 (594)
T ss_dssp EEEECSCTTCSSCSSCCCHHHHHH-----------------------HHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTC
T ss_pred EEEecCcccccccCCCCCHHHHHH-----------------------HHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCc
Confidence 65532 2222110000 001245566666655555543333332 24445
Q ss_pred ceEeccCCcCCCCCCCCCCCCCCCCEEEcccCCCCCCC-----ChhhhcCCCCCEEEccCCcCCCCccccccc-cccCCE
Q 002061 412 GMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGEL-----PSELGRLTNLERLILTNNNFSGKIPSALGA-LRQLSS 485 (973)
Q Consensus 412 ~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~-----p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~ 485 (973)
+.|+++.|...+ -|.+++.. +..+..+++|+.|+|++ .+++..+..+.. +++|+.
T Consensus 400 ~~L~L~~~~~~~------------------~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~ 460 (594)
T 2p1m_B 400 TRFRLCIIEPKA------------------PDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEM 460 (594)
T ss_dssp CEEEEEESSTTC------------------CCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCE
T ss_pred ceeEeecccCCC------------------cccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccE
Confidence 555544110000 03333111 11244556666666655 444333334443 566666
Q ss_pred EEcCCcccccCCCccc-cccccccchhccccccccCCCc-cccccCCCCeeecCCCccC
Q 002061 486 LHLEENALTGSIPNEM-GDCARIVDLNLARNSLSGNIPR-SLSLLSSLNALNLSGNKLT 542 (973)
Q Consensus 486 L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~ 542 (973)
|+|++|.+++..+..+ .++++|+.|+|++|.+++.... .+..+++|+.|+|++|+++
T Consensus 461 L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~ 519 (594)
T 2p1m_B 461 LSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVS 519 (594)
T ss_dssp EEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCB
T ss_pred eeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCC
Confidence 6666666654333333 4466666666666666433322 2344666777777777664
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=8.2e-28 Score=279.68 Aligned_cols=233 Identities=20% Similarity=0.197 Sum_probs=142.6
Q ss_pred CccEEEcccCCCCCCCCCCcCCcccceeeeccCCccCCCCCccccccccccccccccccccccCChhhhhhhhHHHHHhh
Q 002061 290 NLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLAL 369 (973)
Q Consensus 290 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~ll~l 369 (973)
+|+.|++++|.+++..|..|+.+++|+.|+|++|.+++..| +..+++|++|+|++|.|++.
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l----------------- 95 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQEL----------------- 95 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEE-----------------
T ss_pred CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCC-----------------
Confidence 34444444444443333344444444444444444443332 45555555666666655521
Q ss_pred hccCCCCccccccCccccceEeccccccccCCCccccCCCCcceEeccCCcCCCCCCCCCCCCCCCCEEEcccCCCCCCC
Q 002061 370 SNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGEL 449 (973)
Q Consensus 370 ~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~ 449 (973)
| ..++|++|+|++|.|++..+. .+++|+.|+|++|.+++..+..++.+++|+.|+|++|++++..
T Consensus 96 --------~----~~~~L~~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 160 (487)
T 3oja_A 96 --------L----VGPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVN 160 (487)
T ss_dssp --------E----ECTTCCEEECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEE
T ss_pred --------C----CCCCcCEEECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcC
Confidence 1 115666666666666654443 2456666666666666666666666777777777777777666
Q ss_pred Chhhh-cCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCCccccccccccchhccccccccCCCcccccc
Q 002061 450 PSELG-RLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLL 528 (973)
Q Consensus 450 p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 528 (973)
|..+. .+++|+.|+|++|.|++. | .+..+++|++|+|++|+|++.+| .+..+++|+.|+|++|+|++ +|..+..+
T Consensus 161 ~~~l~~~l~~L~~L~Ls~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l 236 (487)
T 3oja_A 161 FAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRFS 236 (487)
T ss_dssp GGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCC
T ss_pred hHHHhhhCCcccEEecCCCccccc-c-ccccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhccC
Confidence 66665 677777777777777754 2 23347777777777777776444 37777777777777777774 56667777
Q ss_pred CCCCeeecCCCccC-CCCChhhhccc-CceEEcc
Q 002061 529 SSLNALNLSGNKLT-GSIPDNLMKLK-LSSIDLS 560 (973)
Q Consensus 529 ~~L~~L~L~~N~l~-~~~p~~l~~l~-L~~l~ls 560 (973)
++|+.|+|++|+++ +.+|..+..++ ++.++++
T Consensus 237 ~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 237 QNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (487)
T ss_dssp TTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred CCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence 77788888888777 55666665554 5555554
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.7e-28 Score=284.06 Aligned_cols=185 Identities=17% Similarity=0.075 Sum_probs=132.0
Q ss_pred cccccCceEEEEEEecCCCcEEEEEeeecc------------ccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEE
Q 002061 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG------------DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLV 749 (973)
Q Consensus 683 ~lG~G~~g~V~~a~~~~~~~~vavK~~~~~------------~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv 749 (973)
..+.|++|.+.+++....|+.||||++.+. ...++|.+|+++|+++ .|+||++++++++++...|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 467788888888888777999999998652 2345689999999999 799999999999999999999
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccc
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 829 (973)
|||++|++|.+++... ..++.. +|+.||+.||+|+| ++|||||||||+|||++.+|.+||+|||+|+..
T Consensus 321 MEyv~G~~L~d~i~~~-----~~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~ 389 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAG-----EEIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTT 389 (569)
T ss_dssp EECCCSEEHHHHHHTT-----CCCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESC
T ss_pred EecCCCCcHHHHHHhC-----CCCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeC
Confidence 9999999999999853 234543 58899999999999 889999999999999999999999999999866
Q ss_pred cCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCC
Q 002061 830 ENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPV 881 (973)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf 881 (973)
..... .....+||+.|||||++.+ .+..++|+||+|++++++.++..|+
T Consensus 390 ~~~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 390 PQDCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp C---C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CCCCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 44322 2334579999999999875 4677899999999988876654443
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.94 E-value=8.6e-26 Score=242.08 Aligned_cols=215 Identities=23% Similarity=0.274 Sum_probs=140.6
Q ss_pred CCCCcceeeeCCCCCceEEEeecCCCCCccccccccCCccCcEeeCCCCcccCcCChhhhCCCCCcEEEecCCcccCCCC
Q 002061 59 SPCGFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVP 138 (973)
Q Consensus 59 ~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~ 138 (973)
++|.|.|+.|.- .+.++.+++++++++ .+|..+. ++|++|+|++|++++..+..|+.+++|++|+|++|.++..++
T Consensus 3 ~~C~~~~~~C~c-~~~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~ 78 (270)
T 2o6q_A 3 ALCKKDGGVCSC-NNNKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPA 78 (270)
T ss_dssp CCBGGGTCSBEE-ETTTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCT
T ss_pred ccCCCCCCCCEe-CCCCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeCh
Confidence 579999999964 356778999998888 4666554 578888888888876656678888888888888888877666
Q ss_pred c-ccCCCCCCEEeccCccCCCccccccccccccceEEccCCcCCCCCCcccccCCCCCCEEEcccCCCCCCCChhhhccC
Q 002061 139 D-LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELR 217 (973)
Q Consensus 139 ~-l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 217 (973)
. +..+++|++|+|++|.+++..+..|..+ ++|++|+|++|++++..+..|..++
T Consensus 79 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l-------------------------~~L~~L~l~~n~l~~~~~~~~~~l~ 133 (270)
T 2o6q_A 79 GIFKELKNLETLWVTDNKLQALPIGVFDQL-------------------------VNLAELRLDRNQLKSLPPRVFDSLT 133 (270)
T ss_dssp TTTSSCTTCCEEECCSSCCCCCCTTTTTTC-------------------------SSCCEEECCSSCCCCCCTTTTTTCT
T ss_pred hhhcCCCCCCEEECCCCcCCcCCHhHcccc-------------------------cCCCEEECCCCccCeeCHHHhCcCc
Confidence 5 5777777777777777765444444444 4555555555555544444555555
Q ss_pred CCCeeecccccccCCCchhhhccccccEEEeeccccCCcCCccccccccccEEEeeccccccccCCccCCCCCccEEEcc
Q 002061 218 ELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCF 297 (973)
Q Consensus 218 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 297 (973)
+|++|+|++|+|++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..+..+++|+.|+++
T Consensus 134 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~ 213 (270)
T 2o6q_A 134 KLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQ 213 (270)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEec
Confidence 55555555555554444445555556666666665554444455666666666666666665444456666666666666
Q ss_pred cCCCC
Q 002061 298 KNNFS 302 (973)
Q Consensus 298 ~N~l~ 302 (973)
+|.+.
T Consensus 214 ~N~~~ 218 (270)
T 2o6q_A 214 ENPWD 218 (270)
T ss_dssp SSCBC
T ss_pred CCCee
Confidence 66654
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.6e-27 Score=273.34 Aligned_cols=239 Identities=18% Similarity=0.177 Sum_probs=168.6
Q ss_pred ccCCccCcEeeCCCCcccCcCChhhhCCCCCcEEEecCCcccCCCCcccCCCCCCEEeccCccCCCccccccccccccce
Q 002061 93 ISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVS 172 (973)
Q Consensus 93 l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~ 172 (973)
...+++|++|+|++|.+++..|..|+.+++|++|+|++|.+++.++ ++.+++|++|+|++|.+++.. ..++|++
T Consensus 30 ~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~l~~l~-----~~~~L~~ 103 (487)
T 3oja_A 30 RQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD-LESLSTLRTLDLNNNYVQELL-----VGPSIET 103 (487)
T ss_dssp STTGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE-CTTCTTCCEEECCSSEEEEEE-----ECTTCCE
T ss_pred cccCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc-cccCCCCCEEEecCCcCCCCC-----CCCCcCE
Confidence 3344588999999998888777888888999999999988887665 888888888888888887533 2377788
Q ss_pred EEccCCcCCCCCCcccccCCCCCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCchhhh-ccccccEEEeecc
Q 002061 173 LSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIR-KLQKLWKIELYAN 251 (973)
Q Consensus 173 L~l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~-~l~~L~~L~L~~N 251 (973)
|++++|.+... +. ..+++|++|+|++|.+++..|..++.+++|++|+|++|.+++..|..+. .+++|++|+|++|
T Consensus 104 L~L~~N~l~~~--~~--~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N 179 (487)
T 3oja_A 104 LHAANNNISRV--SC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179 (487)
T ss_dssp EECCSSCCCCE--EE--CCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTS
T ss_pred EECcCCcCCCC--Cc--cccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCC
Confidence 88888777532 22 3456777777777777777677777777777777777777776666665 6777777777777
Q ss_pred ccCCcCCccccccccccEEEeeccccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeeccCCccC-CCCC
Q 002061 252 NLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFS-GPFP 330 (973)
Q Consensus 252 ~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~-~~~~ 330 (973)
.|++. | .+..+++|+.|+|++|.+++ +|..+..+++|+.|++++|.+++ +|..+..+++|+.|++++|.+. +.+|
T Consensus 180 ~l~~~-~-~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~ 255 (487)
T 3oja_A 180 FIYDV-K-GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLR 255 (487)
T ss_dssp CCCEE-E-CCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHH
T ss_pred ccccc-c-ccccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchH
Confidence 77754 2 23357777777777777774 34446677777777777777774 5555666666666666666665 4444
Q ss_pred ccccccccccccccc
Q 002061 331 ENLGRYTALTDVDIS 345 (973)
Q Consensus 331 ~~l~~l~~L~~L~Ls 345 (973)
..+..++.|+.++++
T Consensus 256 ~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 256 DFFSKNQRVQTVAKQ 270 (487)
T ss_dssp HHHTTCHHHHHHHHH
T ss_pred HHHHhCCCCcEEecc
Confidence 555555555555553
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.8e-29 Score=302.03 Aligned_cols=414 Identities=15% Similarity=0.133 Sum_probs=263.9
Q ss_pred cEeeCCCCcccCcCChhhhCCCCCcEEEecCCcccC---CCC-c------------ccCCCCCCEEeccCccCCCccccc
Q 002061 100 TVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVG---SVP-D------------LSALKNLEIFDLSINYFTGRFPRW 163 (973)
Q Consensus 100 ~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~---~~~-~------------l~~l~~L~~L~Ls~n~l~~~~~~~ 163 (973)
+.+++++.... ..+..+.++++|++|+|+++.... ..+ . ...+++|++|+|++|.+++..+..
T Consensus 46 ~~l~~~~~~~~-~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~ 124 (594)
T 2p1m_B 46 RKVFIGNCYAV-SPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLEL 124 (594)
T ss_dssp CEEEESSTTSS-CHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHH
T ss_pred eEEeecccccc-CHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHH
Confidence 34555443221 112357788999999999986321 111 1 236788999999999888777777
Q ss_pred cc-cccccceEEccCC-cCCCCCCcccccCCCCCCEEEcccCCCCCCCChhhh----ccCCCCeeeccccc--ccCC-Cc
Q 002061 164 VV-NLTQLVSLSIGDN-VYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESIS----ELRELGTLDICRNK--ISGE-FP 234 (973)
Q Consensus 164 ~~-~l~~L~~L~l~~n-~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~----~l~~L~~L~L~~N~--l~~~-~~ 234 (973)
+. .+++|++|++++| .++...++..+.++++|++|+|++|.+++..+..+. .+++|++|++++|. ++.. ++
T Consensus 125 l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l~ 204 (594)
T 2p1m_B 125 IAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALE 204 (594)
T ss_dssp HHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHHH
T ss_pred HHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHHH
Confidence 75 6888888888888 554434555566788888888888888766555554 45688888888886 2211 12
Q ss_pred hhhhccccccEEEeecc-ccCCcCCccccccccccEEEeecc-------ccccccCCccCCCCCccEEE-cccCCCCCCC
Q 002061 235 RSIRKLQKLWKIELYAN-NLTGELPAELGNLTLLQEFDISSN-------QMYGKLPEEIGNLKNLTVFQ-CFKNNFSGEF 305 (973)
Q Consensus 235 ~~l~~l~~L~~L~L~~N-~l~~~~~~~l~~l~~L~~L~Ls~N-------~l~~~~p~~~~~l~~L~~L~-l~~N~l~~~~ 305 (973)
..+..+++|++|+|++| .++ .++..+..+++|++|+++.+ .+.+ ++..+.++++|+.|. +.+..
T Consensus 205 ~l~~~~~~L~~L~L~~~~~~~-~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~-l~~~l~~~~~L~~Ls~~~~~~----- 277 (594)
T 2p1m_B 205 RLVTRCPNLKSLKLNRAVPLE-KLATLLQRAPQLEELGTGGYTAEVRPDVYSG-LSVALSGCKELRCLSGFWDAV----- 277 (594)
T ss_dssp HHHHHCTTCCEEECCTTSCHH-HHHHHHHHCTTCSEEECSBCCCCCCHHHHHH-HHHHHHTCTTCCEEECCBTCC-----
T ss_pred HHHHhCCCCcEEecCCCCcHH-HHHHHHhcCCcceEcccccccCccchhhHHH-HHHHHhcCCCcccccCCcccc-----
Confidence 22344578888888877 444 36666777788888875443 3332 233455555565552 22111
Q ss_pred CCCcCCcccceeeeccCCccCCCCCccccccccccccccccccccccCChhhhhhhhHHHHHhhhccCCCCccccccCcc
Q 002061 306 PSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCK 385 (973)
Q Consensus 306 p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~ 385 (973)
. +.++..+..+++|++|+|++|.+++.. ++..+..++
T Consensus 278 -------------------~-~~l~~~~~~~~~L~~L~L~~~~l~~~~-----------------------l~~~~~~~~ 314 (594)
T 2p1m_B 278 -------------------P-AYLPAVYSVCSRLTTLNLSYATVQSYD-----------------------LVKLLCQCP 314 (594)
T ss_dssp -------------------G-GGGGGGHHHHTTCCEEECTTCCCCHHH-----------------------HHHHHTTCT
T ss_pred -------------------h-hhHHHHHHhhCCCCEEEccCCCCCHHH-----------------------HHHHHhcCC
Confidence 1 122333344556666666666644211 011123456
Q ss_pred ccceEeccccccccC-CCccccCCCCcceEecc---------CCcCCCCCCCCC-CCCCCCCEEEcccCCCCCCCChhhh
Q 002061 386 TIQRLRISDNHLSGK-IPDGLWALPNVGMLDFG---------DNDFTGGISPLI-GLSTSLSQLVLQNNRFSGELPSELG 454 (973)
Q Consensus 386 ~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~---------~N~l~~~~~~~~-~~~~~L~~L~L~~N~l~~~~p~~~~ 454 (973)
+|++|++++| +.+. ++.....+++|+.|+++ .|.+++.....+ ..+++|+.|.+..|++++..+..+.
T Consensus 315 ~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~ 393 (594)
T 2p1m_B 315 KLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIA 393 (594)
T ss_dssp TCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHH
T ss_pred CcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHH
Confidence 6666666666 3321 22222235666666663 234433221112 2368899999999999876666665
Q ss_pred -cCCCCCEEEcc--C----CcCCCC-----ccccccccccCCEEEcCCcccccCCCccccc-cccccchhccccccccCC
Q 002061 455 -RLTNLERLILT--N----NNFSGK-----IPSALGALRQLSSLHLEENALTGSIPNEMGD-CARIVDLNLARNSLSGNI 521 (973)
Q Consensus 455 -~l~~L~~L~Ls--~----N~l~~~-----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~ 521 (973)
.+++|+.|+|+ + |.++.. ++..+..+++|+.|+|++ .+++..+..+.. +++|+.|+|++|.+++..
T Consensus 394 ~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~ 472 (594)
T 2p1m_B 394 RNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLG 472 (594)
T ss_dssp HHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHH
T ss_pred hhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHH
Confidence 58999999999 4 666632 222367789999999988 676655555655 889999999999998765
Q ss_pred Cccc-cccCCCCeeecCCCccCCCCChhh-hccc-CceEEccCCcccc
Q 002061 522 PRSL-SLLSSLNALNLSGNKLTGSIPDNL-MKLK-LSSIDLSENQLSG 566 (973)
Q Consensus 522 ~~~~-~~l~~L~~L~L~~N~l~~~~p~~l-~~l~-L~~l~ls~N~l~~ 566 (973)
+..+ ..+++|+.|+|++|++++..+..+ ..++ |+.|++++|+++.
T Consensus 473 ~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~ 520 (594)
T 2p1m_B 473 MHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSF 520 (594)
T ss_dssp HHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBH
T ss_pred HHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCH
Confidence 5555 679999999999999965444333 3354 9999999999854
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2.3e-25 Score=240.85 Aligned_cols=207 Identities=23% Similarity=0.249 Sum_probs=185.8
Q ss_pred ccccccccccccccccccccCChhhhhhhhHHHHHhhhccCCCCccccccCccccceEeccccccccCCCccccCCCCcc
Q 002061 333 LGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVG 412 (973)
Q Consensus 333 l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 412 (973)
+..+++++++++++|.++ . +|..+. +++++|+|++|.|++..+..|..+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~------------------------ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~ 58 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-A------------------------LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLT 58 (290)
T ss_dssp EECSTTCCEEECTTSCCS-S------------------------CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCC
T ss_pred ccccCCccEEECCCCCCC-c------------------------CCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCC
Confidence 567788889999999887 3 333332 6899999999999988899999999999
Q ss_pred eEeccCCcCCCCCCCCCCCCCCCCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcc
Q 002061 413 MLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENA 492 (973)
Q Consensus 413 ~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 492 (973)
.|+|++|++++..+. +.+++|++|+|++|+|+ .+|..+..+++|++|+|++|+|++..|..|..+++|++|+|++|+
T Consensus 59 ~L~L~~n~l~~~~~~--~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~ 135 (290)
T 1p9a_G 59 QLNLDRAELTKLQVD--GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNE 135 (290)
T ss_dssp EEECTTSCCCEEECC--SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSC
T ss_pred EEECCCCccCcccCC--CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCC
Confidence 999999999987654 78899999999999999 788889999999999999999998888999999999999999999
Q ss_pred cccCCCccccccccccchhccccccccCCCccccccCCCCeeecCCCccCCCCChhhhcc-cCceEEccCCccccccCc
Q 002061 493 LTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLSENQLSGSVPL 570 (973)
Q Consensus 493 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l-~L~~l~ls~N~l~~~~p~ 570 (973)
|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+... .|+.++|++|+|.|.|..
T Consensus 136 l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c~~ 213 (290)
T 1p9a_G 136 LKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCEI 213 (290)
T ss_dssp CCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGGG
T ss_pred CCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCcCcc
Confidence 99988888999999999999999999777778899999999999999999 677777665 499999999999999864
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.93 E-value=5.4e-25 Score=235.86 Aligned_cols=206 Identities=21% Similarity=0.277 Sum_probs=186.7
Q ss_pred cccccccccccccccCChhhhhhhhHHHHHhhhccCCCCccccccCccccceEeccccccccCCCccccCCCCcceEecc
Q 002061 338 ALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFG 417 (973)
Q Consensus 338 ~L~~L~Ls~N~l~~~~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 417 (973)
..+.+++++|.++ .+| ..+. ++|++|+|++|+|++..+..|..+++|++|+++
T Consensus 17 ~~~~l~~~~~~l~-~ip------------------------~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 69 (270)
T 2o6q_A 17 NKNSVDCSSKKLT-AIP------------------------SNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLN 69 (270)
T ss_dssp TTTEEECTTSCCS-SCC------------------------SCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECC
T ss_pred CCCEEEccCCCCC-ccC------------------------CCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECC
Confidence 4677889988887 333 3332 579999999999998888899999999999999
Q ss_pred CCcCCCCCCCCCCCCCCCCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccccCC
Q 002061 418 DNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSI 497 (973)
Q Consensus 418 ~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 497 (973)
+|+++..++..|..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|++++..
T Consensus 70 ~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~ 149 (270)
T 2o6q_A 70 DNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLP 149 (270)
T ss_dssp SSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred CCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccC
Confidence 99999988888999999999999999999888888999999999999999999888889999999999999999999888
Q ss_pred CccccccccccchhccccccccCCCccccccCCCCeeecCCCccCCCCChhhhccc-CceEEccCCccccccCc
Q 002061 498 PNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLK-LSSIDLSENQLSGSVPL 570 (973)
Q Consensus 498 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~-L~~l~ls~N~l~~~~p~ 570 (973)
+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|++++..+..+..++ |+.|+|++|+|.|.|+.
T Consensus 150 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~ 223 (270)
T 2o6q_A 150 KGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCNG 223 (270)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSSS
T ss_pred HhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCcc
Confidence 88899999999999999999988888899999999999999999977666777775 99999999999999873
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.2e-25 Score=239.91 Aligned_cols=190 Identities=20% Similarity=0.214 Sum_probs=128.8
Q ss_pred cccCccccceEeccccccccCCCccccCCCCcceEeccCCcCCCCCCCCCCCCCCCCEEEcccCCCCCCCChhhhcCCCC
Q 002061 380 SYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNL 459 (973)
Q Consensus 380 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L 459 (973)
.|.++++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|++++|++.+..+..+..+++|
T Consensus 47 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 126 (276)
T 2z62_A 47 SFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTL 126 (276)
T ss_dssp TTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTC
T ss_pred HhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCC
Confidence 34455556666666666655555556666666666666666666655666666667777777777665555566677777
Q ss_pred CEEEccCCcCCCC-ccccccccccCCEEEcCCcccccCCCcccccccccc----chhccccccccCCCccccccCCCCee
Q 002061 460 ERLILTNNNFSGK-IPSALGALRQLSSLHLEENALTGSIPNEMGDCARIV----DLNLARNSLSGNIPRSLSLLSSLNAL 534 (973)
Q Consensus 460 ~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~----~L~Ls~N~l~~~~~~~~~~l~~L~~L 534 (973)
++|+|++|++++. +|..|..+++|++|+|++|++++..+..+..+.+|+ .|++++|++++..+..+.. .+|+.|
T Consensus 127 ~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~-~~L~~L 205 (276)
T 2z62_A 127 KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLKEL 205 (276)
T ss_dssp CEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCS-CCEEEE
T ss_pred CEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccCC-CcccEE
Confidence 7777777777653 466777777777777777777766666676666666 6777788777555554443 478888
Q ss_pred ecCCCccCCCCChhhhccc-CceEEccCCccccccCc
Q 002061 535 NLSGNKLTGSIPDNLMKLK-LSSIDLSENQLSGSVPL 570 (973)
Q Consensus 535 ~L~~N~l~~~~p~~l~~l~-L~~l~ls~N~l~~~~p~ 570 (973)
+|++|++++..+..+..++ |+.|+|++|+|+|.||.
T Consensus 206 ~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~ 242 (276)
T 2z62_A 206 ALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 242 (276)
T ss_dssp ECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTT
T ss_pred ECCCCceeecCHhHhcccccccEEEccCCcccccCCc
Confidence 8888888866555566665 88888888888888873
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=7.3e-25 Score=235.84 Aligned_cols=209 Identities=21% Similarity=0.217 Sum_probs=171.7
Q ss_pred ccceeeeccCCccCCCCCccccccccccccccccccccccCChhhhhhhhHHHHHhhhccCCCCccccccCccccceEec
Q 002061 313 RKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRI 392 (973)
Q Consensus 313 ~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~L 392 (973)
++|+.|++++|.+++..+..|..+++|++|++++|++++. .+..|.++++|++|+|
T Consensus 28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~------------------------~~~~~~~l~~L~~L~L 83 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTI------------------------EDGAYQSLSHLSTLIL 83 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEE------------------------CTTTTTTCTTCCEEEC
T ss_pred CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCcc------------------------CHHHccCCcCCCEEEC
Confidence 3566666666666655555666677777777777776632 2234667778888888
Q ss_pred cccccccCCCccccCCCCcceEeccCCcCCCCCCCCCCCCCCCCEEEcccCCCCCC-CChhhhcCCCCCEEEccCCcCCC
Q 002061 393 SDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGE-LPSELGRLTNLERLILTNNNFSG 471 (973)
Q Consensus 393 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~ 471 (973)
++|++++..+..|..+++|++|++++|++++..+..+..+++|++|+|++|++++. +|..+.++++|++|+|++|++++
T Consensus 84 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~ 163 (276)
T 2z62_A 84 TGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS 163 (276)
T ss_dssp TTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCE
T ss_pred CCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCc
Confidence 88888877778888888888888888888888777788899999999999999864 58999999999999999999998
Q ss_pred CccccccccccCC----EEEcCCcccccCCCccccccccccchhccccccccCCCccccccCCCCeeecCCCccCCCCC
Q 002061 472 KIPSALGALRQLS----SLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIP 546 (973)
Q Consensus 472 ~~p~~~~~l~~L~----~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 546 (973)
..+..+..+++|+ .|++++|++++..+..+.. .+|+.|+|++|+|++..+..|..+++|+.|+|++|++++..|
T Consensus 164 ~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 164 IYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp ECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred CCHHHhhhhhhccccceeeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence 8888888888888 8999999999877776655 489999999999998777788999999999999999998765
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2.8e-25 Score=238.30 Aligned_cols=227 Identities=19% Similarity=0.205 Sum_probs=178.3
Q ss_pred ccceeeeccCCccCCCCCccccccccccccccccccccccCChhhhhhhhHHHHHhhhccCCCCccccccCccccceEec
Q 002061 313 RKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRI 392 (973)
Q Consensus 313 ~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~L 392 (973)
.++..+++.++.+.+. ..+..+++|+.|++++|.++. + ..+..+++|++|+|
T Consensus 19 ~~l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~-------------------------~-~~l~~l~~L~~L~l 70 (272)
T 3rfs_A 19 AETIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIKS-------------------------V-QGIQYLPNVRYLAL 70 (272)
T ss_dssp HHHHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCCC-------------------------C-TTGGGCTTCCEEEC
T ss_pred HHHHHHHhcCcccccc--cccccccceeeeeeCCCCccc-------------------------c-cccccCCCCcEEEC
Confidence 3444455555555432 335566777777777777651 1 23556778888888
Q ss_pred cccccccCCCccccCCCCcceEeccCCcCCCCCCCCCCCCCCCCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCC
Q 002061 393 SDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGK 472 (973)
Q Consensus 393 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 472 (973)
++|.+++. ..+..+++|++|++++|++++.++..+..+++|++|+|++|++++..+..|..+++|++|+|++|++++.
T Consensus 71 ~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 148 (272)
T 3rfs_A 71 GGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSL 148 (272)
T ss_dssp TTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred CCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCcc
Confidence 88888752 3677788888888888888887777788888888889988888877777788889999999999999877
Q ss_pred ccccccccccCCEEEcCCcccccCCCccccccccccchhccccccccCCCccccccCCCCeeecCCCccCCCCChhhhcc
Q 002061 473 IPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL 552 (973)
Q Consensus 473 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l 552 (973)
.+..|..+++|++|+|++|++++..+..|+.+++|+.|+|++|++++..|..|..+++|+.|+|++|++++..|.
T Consensus 149 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~----- 223 (272)
T 3rfs_A 149 PKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPG----- 223 (272)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT-----
T ss_pred CHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCcH-----
Confidence 777788899999999999999888888888899999999999999988888888999999999999999877663
Q ss_pred cCceEEccCCccccccCcccccC
Q 002061 553 KLSSIDLSENQLSGSVPLDFLRM 575 (973)
Q Consensus 553 ~L~~l~ls~N~l~~~~p~~~~~~ 575 (973)
++.++++.|.++|.+|..+...
T Consensus 224 -l~~l~~~~n~~~g~ip~~~~~~ 245 (272)
T 3rfs_A 224 -IRYLSEWINKHSGVVRNSAGSV 245 (272)
T ss_dssp -THHHHHHHHHTGGGBBCTTSCB
T ss_pred -HHHHHHHHHhCCCcccCccccc
Confidence 6778889999999999765443
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-24 Score=232.57 Aligned_cols=226 Identities=18% Similarity=0.194 Sum_probs=138.8
Q ss_pred CccCcEeeCCCCcccCcCChhhhCCCCCcEEEecCCcccCCCCcccCCCCCCEEeccCccCCCccccccccccccceEEc
Q 002061 96 LQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSI 175 (973)
Q Consensus 96 l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l 175 (973)
+..+..+++..+.+.+. ..+..+++|+.|++++|.+... +.++.+++|++|++++|.+++.
T Consensus 18 ~~~l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~~-~~l~~l~~L~~L~l~~n~l~~~---------------- 78 (272)
T 3rfs_A 18 FAETIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIKSV-QGIQYLPNVRYLALGGNKLHDI---------------- 78 (272)
T ss_dssp HHHHHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCCCC-TTGGGCTTCCEEECTTSCCCCC----------------
T ss_pred HHHHHHHHhcCcccccc--cccccccceeeeeeCCCCcccc-cccccCCCCcEEECCCCCCCCc----------------
Confidence 34455556666665543 2355666677777777666542 3456666666666666666531
Q ss_pred cCCcCCCCCCcccccCCCCCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCchhhhccccccEEEeeccccCC
Q 002061 176 GDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTG 255 (973)
Q Consensus 176 ~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~ 255 (973)
+.++.+++|++|+|++|++++..+..+..+++|++|+|++|++++..+..|..+++|++|+|++|++++
T Consensus 79 -----------~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 147 (272)
T 3rfs_A 79 -----------SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQS 147 (272)
T ss_dssp -----------GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred -----------hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCc
Confidence 244555556666666666665555555666666666666666665555555666666666666666665
Q ss_pred cCCccccccccccEEEeeccccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeeccCCccCCCCCccccc
Q 002061 256 ELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGR 335 (973)
Q Consensus 256 ~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~ 335 (973)
..+..+..+++|++|++++|++++..+..+..+++|+.|++++|++++..+..+..+++|+.|++++|.+.+.
T Consensus 148 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~------- 220 (272)
T 3rfs_A 148 LPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT------- 220 (272)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------
T ss_pred cCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------
Confidence 5555566666666666666666655555566666666777766666666666666677777777777766543
Q ss_pred cccccccccccccccccCChhhh
Q 002061 336 YTALTDVDISENQFSGSFPKYLC 358 (973)
Q Consensus 336 l~~L~~L~Ls~N~l~~~~p~~~~ 358 (973)
+++|+.|+++.|.++|.+|.+++
T Consensus 221 ~~~l~~l~~~~n~~~g~ip~~~~ 243 (272)
T 3rfs_A 221 CPGIRYLSEWINKHSGVVRNSAG 243 (272)
T ss_dssp TTTTHHHHHHHHHTGGGBBCTTS
T ss_pred CcHHHHHHHHHHhCCCcccCccc
Confidence 34567777777777766665543
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.91 E-value=8e-26 Score=251.04 Aligned_cols=234 Identities=15% Similarity=0.223 Sum_probs=151.0
Q ss_pred CCCcceeeeCCCCCceEEEeecCCCCCccccccccCC--ccCcEeeCCCCcccCcCChhhhCCCCCcEEEecCCcccCC-
Q 002061 60 PCGFSGITCDSVTGRVTEISFDNKSLSGEISSSISAL--QSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGS- 136 (973)
Q Consensus 60 ~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l--~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~- 136 (973)
|..|.++.|+. ..++.++++++.+. +..+..+ ++++.|++++|.+++..+. +..+++|++|+|++|.+++.
T Consensus 36 c~~W~~~~~~~--~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~ 109 (336)
T 2ast_B 36 CKRWYRLASDE--SLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVST 109 (336)
T ss_dssp CHHHHHHHTCS--TTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHH
T ss_pred HHHHHHHhcCc--hhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHH
Confidence 46899999873 45778888887776 4456666 7788888888887765554 55677788888877777542
Q ss_pred -CCcccCCCCCCEEeccCccCCCccccccccccccceEEccCC-cCCCCCCcccccCCCCCCEEEcccC-CCCCC-CChh
Q 002061 137 -VPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDN-VYDEAEIPESIGNLKNLTYLFLAHC-NLRGR-IPES 212 (973)
Q Consensus 137 -~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n-~l~~~~ip~~~~~l~~L~~L~L~~n-~l~~~-~~~~ 212 (973)
+..+..+++|++|+|++|.+++..+..+..+++|++|++++| .++...++..+.++++|++|++++| .+++. ++..
T Consensus 110 ~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~ 189 (336)
T 2ast_B 110 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVA 189 (336)
T ss_dssp HHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHH
T ss_pred HHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHH
Confidence 334677777777777777777666777777777777777777 4544345555666777777777777 66643 4555
Q ss_pred hhccC-CCCeeecccc--ccc-CCCchhhhccccccEEEeeccc-cCCcCCccccccccccEEEeeccc-cccccCCccC
Q 002061 213 ISELR-ELGTLDICRN--KIS-GEFPRSIRKLQKLWKIELYANN-LTGELPAELGNLTLLQEFDISSNQ-MYGKLPEEIG 286 (973)
Q Consensus 213 ~~~l~-~L~~L~L~~N--~l~-~~~~~~l~~l~~L~~L~L~~N~-l~~~~~~~l~~l~~L~~L~Ls~N~-l~~~~p~~~~ 286 (973)
+..++ +|++|+|++| .++ +.++..+..+++|++|++++|. +++..+..+..+++|++|++++|. +.......+.
T Consensus 190 ~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~ 269 (336)
T 2ast_B 190 VAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELG 269 (336)
T ss_dssp HHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGG
T ss_pred HHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHh
Confidence 66666 6777777666 343 3445555666666666666666 555555566666666666666663 2211112345
Q ss_pred CCCCccEEEcccC
Q 002061 287 NLKNLTVFQCFKN 299 (973)
Q Consensus 287 ~l~~L~~L~l~~N 299 (973)
++++|+.|++++|
T Consensus 270 ~~~~L~~L~l~~~ 282 (336)
T 2ast_B 270 EIPTLKTLQVFGI 282 (336)
T ss_dssp GCTTCCEEECTTS
T ss_pred cCCCCCEEeccCc
Confidence 5555555555555
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=7.3e-25 Score=256.81 Aligned_cols=184 Identities=20% Similarity=0.202 Sum_probs=144.2
Q ss_pred cccCcccccCceEEEEEEecCCCcEEEEEeeecc----------ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 002061 679 EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----------DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL 748 (973)
Q Consensus 679 ~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 748 (973)
...+.||+|+||+||+|... ++.+|+|+.... ...+++.+|++++++++||||+++..++..++..|+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~--~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYL--DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEECS--SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEEEC--CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 44678999999999999544 778999975431 113457899999999999999966666667778899
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccc
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 828 (973)
||||+++|+|.+++.. +..++.|+++||+||| +++|+||||||+||+++. .+||+|||+++.
T Consensus 417 VmE~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~ 478 (540)
T 3en9_A 417 MMSYINGKLAKDVIED-------------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKI 478 (540)
T ss_dssp EEECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEE
T ss_pred EEECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEE
Confidence 9999999999998863 3578999999999999 789999999999999999 999999999987
Q ss_pred ccCCCCcc-----cccccCCcccccccccccc--CCCCccchHHHHHHHHHHHHhCCCCCC
Q 002061 829 AENSPKVS-----DYSCFAGTHGYIAPELAYT--CKVSEKSDVFSFGVVLLELVTGRKPVE 882 (973)
Q Consensus 829 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~tg~~pf~ 882 (973)
........ ......||+.|+|||++.. ..|+..+|+|+..+-..+-+.++.+|.
T Consensus 479 ~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 479 SNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 75432111 1124578999999999976 568888999999999888888877764
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.90 E-value=6.8e-25 Score=245.82 Aligned_cols=260 Identities=16% Similarity=0.174 Sum_probs=135.2
Q ss_pred EeecCCCCCccccccccCCccCcEeeCCCCcccCcCC----hhhhCCC-CCcEEEecCCcccCCCC-cccCC-----CCC
Q 002061 78 ISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLP----LELSNCS-NLKVLNVTGNAMVGSVP-DLSAL-----KNL 146 (973)
Q Consensus 78 l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p----~~l~~l~-~L~~L~L~~n~l~~~~~-~l~~l-----~~L 146 (973)
.+++.++++|.+|..+...++|++|+|++|.+++..+ ..|..++ +|++|+|++|.+.+..+ .+..+ ++|
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L 82 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence 4566667776666666666667777777777665544 5566666 67777777776665433 24333 666
Q ss_pred CEEeccCccCCCccccccccc-----cccceEEccCCcCCCCCCccc----ccC-CCCCCEEEcccCCCCCCCChh----
Q 002061 147 EIFDLSINYFTGRFPRWVVNL-----TQLVSLSIGDNVYDEAEIPES----IGN-LKNLTYLFLAHCNLRGRIPES---- 212 (973)
Q Consensus 147 ~~L~Ls~n~l~~~~~~~~~~l-----~~L~~L~l~~n~l~~~~ip~~----~~~-l~~L~~L~L~~n~l~~~~~~~---- 212 (973)
++|+|++|.+++..+..+... ++|++|++++|.++... +.. +.. .++|++|+|++|++++..+..
T Consensus 83 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~-~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKS-SSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSC-HHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred cEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHH-HHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 666666666665555433332 55555555555554322 111 222 135555555555555322222
Q ss_pred hhccC-CCCeeecccccccCCCchhhhccccccEEEeeccccCCcCCcccccc-ccccEEEeeccccccc----cCCccC
Q 002061 213 ISELR-ELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNL-TLLQEFDISSNQMYGK----LPEEIG 286 (973)
Q Consensus 213 ~~~l~-~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l-~~L~~L~Ls~N~l~~~----~p~~~~ 286 (973)
+..++ +|++|+|++|+|++..+..+... +..+ ++|++|+|++|.+++. ++..+.
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~--------------------l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~ 221 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCAELAKF--------------------LASIPASVTSLDLSANLLGLKSYAELAYIFS 221 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHHHHHHH--------------------HHTSCTTCCEEECTTSCGGGSCHHHHHHHHH
T ss_pred HhcCCccccEeeecCCCCchhhHHHHHHH--------------------HHhCCCCCCEEECCCCCCChhHHHHHHHHHh
Confidence 22332 45555555555544444333322 1112 3444444444444431 222222
Q ss_pred C-CCCccEEEcccCCCCCCCC----CCcCCcccceeeeccCCccCCCC-------CccccccccccccccccccccccCC
Q 002061 287 N-LKNLTVFQCFKNNFSGEFP----SGFGDMRKLFAFSIYGNRFSGPF-------PENLGRYTALTDVDISENQFSGSFP 354 (973)
Q Consensus 287 ~-l~~L~~L~l~~N~l~~~~p----~~~~~l~~L~~L~l~~N~l~~~~-------~~~l~~l~~L~~L~Ls~N~l~~~~p 354 (973)
. .++|+.|++++|.+++..+ ..+..+++|+.|++++|.+.+.. +..+..+++|+.||+++|++.+..+
T Consensus 222 ~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~ 301 (362)
T 3goz_A 222 SIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHS 301 (362)
T ss_dssp HSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGC
T ss_pred cCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcch
Confidence 2 2345555555555544322 22344555666666666543322 2356677788888888888886655
Q ss_pred hhhh
Q 002061 355 KYLC 358 (973)
Q Consensus 355 ~~~~ 358 (973)
..+.
T Consensus 302 ~~~~ 305 (362)
T 3goz_A 302 IPIS 305 (362)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 5544
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2.7e-23 Score=224.53 Aligned_cols=201 Identities=23% Similarity=0.260 Sum_probs=103.3
Q ss_pred hhCCCCCcEEEecCCcccCCCCcccCCCCCCEEeccCccCCCccccccccccccceEEccCCcCCCCCCcccccCCCCCC
Q 002061 117 LSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLT 196 (973)
Q Consensus 117 l~~l~~L~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ip~~~~~l~~L~ 196 (973)
++++++|+.+++++|.++..|+.+. +++++|+|++|.+++..+..|..+++|++|++++|.++. ++.. +.+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~--~~~~-~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLTALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK--LQVD-GTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCSSCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE--EECC-SCCTTCC
T ss_pred ccccCCccEEECCCCCCCcCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCc--ccCC-CCCCcCC
Confidence 4455555555555555555554443 456666666666665555555555555555555555542 2222 4555666
Q ss_pred EEEcccCCCCCCCChhhhccCCCCeeecccccccCCCchhhhccccccEEEeeccccCCcCCccccccccccEEEeeccc
Q 002061 197 YLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQ 276 (973)
Q Consensus 197 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~ 276 (973)
+|+|++|+++ .+|..+..+++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+
T Consensus 81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 159 (290)
T 1p9a_G 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN 159 (290)
T ss_dssp EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCc
Confidence 6666666665 445555555555555555555554444445555555555555555554444444555555555555555
Q ss_pred cccccCCccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeeccCCc
Q 002061 277 MYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNR 324 (973)
Q Consensus 277 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 324 (973)
+++..+..+..+++|+.|++++|+++ .+|..+..+.+|+.|++++|.
T Consensus 160 l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np 206 (290)
T 1p9a_G 160 LTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNP 206 (290)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCC
T ss_pred CCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCC
Confidence 55333333444455555555555444 333333333333333333333
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.90 E-value=4.7e-23 Score=218.18 Aligned_cols=158 Identities=25% Similarity=0.254 Sum_probs=75.8
Q ss_pred CcceEeccCCcCCCCCCCCCCCCCCCCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCccccccccccCCEEEcC
Q 002061 410 NVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLE 489 (973)
Q Consensus 410 ~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 489 (973)
+++.|+|++|++++..+..|..+++|++|+|++|+|++..|..|..+++|++|+|++|++++..+..|..+++|++|+|+
T Consensus 36 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 115 (251)
T 3m19_A 36 DTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLG 115 (251)
T ss_dssp TCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcC
Confidence 44444444444444444444444444444444444444444444444445555555554444444444444555555555
Q ss_pred CcccccCCCccccccccccchhccccccccCCCccccccCCCCeeecCCCccCCCCChhhhccc-CceEEccCCccccc
Q 002061 490 ENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLK-LSSIDLSENQLSGS 567 (973)
Q Consensus 490 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~-L~~l~ls~N~l~~~ 567 (973)
+|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..|..+..++ |+.|+|++|+|+|.
T Consensus 116 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 116 GNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 5555444444444445555555555555444444444555555555555555544444444443 55555555555544
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.89 E-value=7.6e-23 Score=216.54 Aligned_cols=178 Identities=20% Similarity=0.247 Sum_probs=164.3
Q ss_pred HhhhccCCCCccccccCccccceEeccccccccCCCccccCCCCcceEeccCCcCCCCCCCCCCCCCCCCEEEcccCCCC
Q 002061 367 LALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFS 446 (973)
Q Consensus 367 l~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~ 446 (973)
+..+++-...+|..+. +++++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|+++
T Consensus 19 l~~~~~~l~~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 96 (251)
T 3m19_A 19 VDCQGKSLDSVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA 96 (251)
T ss_dssp EECTTCCCSSCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCC
T ss_pred EecCCCCccccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCccc
Confidence 3445666677887766 68999999999999998999999999999999999999999999999999999999999999
Q ss_pred CCCChhhhcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCCccccccccccchhccccccccCCCcccc
Q 002061 447 GELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLS 526 (973)
Q Consensus 447 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 526 (973)
+..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|+.+++|+.|+|++|+|++..+..|.
T Consensus 97 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 176 (251)
T 3m19_A 97 SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFD 176 (251)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTT
T ss_pred ccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHh
Confidence 88888999999999999999999988888899999999999999999988888999999999999999999988888999
Q ss_pred ccCCCCeeecCCCccCCCCC
Q 002061 527 LLSSLNALNLSGNKLTGSIP 546 (973)
Q Consensus 527 ~l~~L~~L~L~~N~l~~~~p 546 (973)
.+++|+.|+|++|++++...
T Consensus 177 ~l~~L~~L~l~~N~~~c~~~ 196 (251)
T 3m19_A 177 RLGKLQTITLFGNQFDCSRC 196 (251)
T ss_dssp TCTTCCEEECCSCCBCTTST
T ss_pred CCCCCCEEEeeCCceeCCcc
Confidence 99999999999999997633
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.89 E-value=2.5e-24 Score=238.98 Aligned_cols=252 Identities=15% Similarity=0.182 Sum_probs=214.9
Q ss_pred cCcEeeCCCCcccCcCChhhhCC--CCCcEEEecCCcccCCCCcccCCCCCCEEeccCccCCCc-cccccccccccceEE
Q 002061 98 SLTVLSLPFNVLSGKLPLELSNC--SNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGR-FPRWVVNLTQLVSLS 174 (973)
Q Consensus 98 ~L~~L~Ls~n~l~~~~p~~l~~l--~~L~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~-~~~~~~~l~~L~~L~ 174 (973)
.++.|++++|.+. |..+..+ ++++.|++++|.+.+.++.+..+++|++|+|++|.+++. ++..+..+++|++|+
T Consensus 48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~ 124 (336)
T 2ast_B 48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS 124 (336)
T ss_dssp TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEE
T ss_pred hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchhhccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEe
Confidence 4789999999887 5678888 999999999999999988888999999999999999876 888999999999999
Q ss_pred ccCCcCCCCCCcccccCCCCCCEEEcccC-CCCCC-CChhhhccCCCCeeecccc-cccCC-Cchhhhccc-cccEEEee
Q 002061 175 IGDNVYDEAEIPESIGNLKNLTYLFLAHC-NLRGR-IPESISELRELGTLDICRN-KISGE-FPRSIRKLQ-KLWKIELY 249 (973)
Q Consensus 175 l~~n~l~~~~ip~~~~~l~~L~~L~L~~n-~l~~~-~~~~~~~l~~L~~L~L~~N-~l~~~-~~~~l~~l~-~L~~L~L~ 249 (973)
+++|.++. ..|..++.+++|++|+|++| .+++. ++..+..+++|++|+|++| .+++. ++..+..++ +|++|+|+
T Consensus 125 L~~~~l~~-~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~ 203 (336)
T 2ast_B 125 LEGLRLSD-PIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLS 203 (336)
T ss_dssp CTTCBCCH-HHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECC
T ss_pred CcCcccCH-HHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeC
Confidence 99998764 35778899999999999999 67753 6777899999999999999 99865 677889999 99999999
Q ss_pred cc--ccC-CcCCccccccccccEEEeeccc-cccccCCccCCCCCccEEEcccCC-CCCCCCCCcCCcccceeeeccCCc
Q 002061 250 AN--NLT-GELPAELGNLTLLQEFDISSNQ-MYGKLPEEIGNLKNLTVFQCFKNN-FSGEFPSGFGDMRKLFAFSIYGNR 324 (973)
Q Consensus 250 ~N--~l~-~~~~~~l~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~l~~N~-l~~~~p~~~~~l~~L~~L~l~~N~ 324 (973)
+| .++ +.++..+..+++|++|++++|. +++..+..+.++++|+.|++++|. +.......++.+++|+.|++++|
T Consensus 204 ~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~- 282 (336)
T 2ast_B 204 GYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI- 282 (336)
T ss_dssp SCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-
T ss_pred CCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-
Confidence 99 555 4567778899999999999999 777888899999999999999995 43333336888999999999999
Q ss_pred cCCCCCcccccc-ccccccccccccccccCChhh
Q 002061 325 FSGPFPENLGRY-TALTDVDISENQFSGSFPKYL 357 (973)
Q Consensus 325 l~~~~~~~l~~l-~~L~~L~Ls~N~l~~~~p~~~ 357 (973)
++ .+.+..+ .+|+.|++++|++++..|..+
T Consensus 283 i~---~~~~~~l~~~l~~L~l~~n~l~~~~~~~~ 313 (336)
T 2ast_B 283 VP---DGTLQLLKEALPHLQINCSHFTTIARPTI 313 (336)
T ss_dssp SC---TTCHHHHHHHSTTSEESCCCSCCTTCSSC
T ss_pred cC---HHHHHHHHhhCcceEEecccCccccCCcc
Confidence 43 3345555 358889999999998777654
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.9e-24 Score=240.61 Aligned_cols=232 Identities=19% Similarity=0.218 Sum_probs=183.5
Q ss_pred CceEEEeecCCCCCcccc----ccccCCc-cCcEeeCCCCcccCcCChhhhCC-----CCCcEEEecCCcccCCCCc---
Q 002061 73 GRVTEISFDNKSLSGEIS----SSISALQ-SLTVLSLPFNVLSGKLPLELSNC-----SNLKVLNVTGNAMVGSVPD--- 139 (973)
Q Consensus 73 ~~v~~l~l~~~~l~~~~~----~~l~~l~-~L~~L~Ls~n~l~~~~p~~l~~l-----~~L~~L~L~~n~l~~~~~~--- 139 (973)
..++.|+|+++.+++..+ ..+..++ +|++|+|++|.+++..+..+..+ ++|++|+|++|.+++..+.
T Consensus 22 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~ 101 (362)
T 3goz_A 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELV 101 (362)
T ss_dssp TTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHH
T ss_pred CCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHH
Confidence 459999999999998777 7788898 99999999999998888888776 9999999999999877654
Q ss_pred --ccCC-CCCCEEeccCccCCCcccccccc-----ccccceEEccCCcCCCCC---CcccccCCC-CCCEEEcccCCCCC
Q 002061 140 --LSAL-KNLEIFDLSINYFTGRFPRWVVN-----LTQLVSLSIGDNVYDEAE---IPESIGNLK-NLTYLFLAHCNLRG 207 (973)
Q Consensus 140 --l~~l-~~L~~L~Ls~n~l~~~~~~~~~~-----l~~L~~L~l~~n~l~~~~---ip~~~~~l~-~L~~L~L~~n~l~~ 207 (973)
+..+ ++|++|+|++|.+++..+..+.. .++|++|+|++|.++... ++..+..++ +|++|+|++|++++
T Consensus 102 ~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~ 181 (362)
T 3goz_A 102 KTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLAS 181 (362)
T ss_dssp HHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGG
T ss_pred HHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCch
Confidence 4555 89999999999999877766554 369999999999997533 334456665 99999999999998
Q ss_pred CCChhhhcc-----CCCCeeecccccccCC----Cchhhhcc-ccccEEEeeccccCCcCC----ccccccccccEEEee
Q 002061 208 RIPESISEL-----RELGTLDICRNKISGE----FPRSIRKL-QKLWKIELYANNLTGELP----AELGNLTLLQEFDIS 273 (973)
Q Consensus 208 ~~~~~~~~l-----~~L~~L~L~~N~l~~~----~~~~l~~l-~~L~~L~L~~N~l~~~~~----~~l~~l~~L~~L~Ls 273 (973)
..+..+... ++|++|+|++|+|++. ++..+..+ ++|++|+|++|.+++..+ ..+..+++|+.|+|+
T Consensus 182 ~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~ 261 (362)
T 3goz_A 182 KNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLD 261 (362)
T ss_dssp SCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEE
T ss_pred hhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEec
Confidence 777655544 6999999999999864 45566664 589999999999986554 335677889999999
Q ss_pred ccccccc-------cCCccCCCCCccEEEcccCCCCCC
Q 002061 274 SNQMYGK-------LPEEIGNLKNLTVFQCFKNNFSGE 304 (973)
Q Consensus 274 ~N~l~~~-------~p~~~~~l~~L~~L~l~~N~l~~~ 304 (973)
+|.+.+. ++..+.++++|+.|++++|++.+.
T Consensus 262 ~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~ 299 (362)
T 3goz_A 262 YDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS 299 (362)
T ss_dssp HHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGG
T ss_pred cCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCc
Confidence 9985432 233455566666666666666544
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.2e-22 Score=213.48 Aligned_cols=195 Identities=14% Similarity=0.108 Sum_probs=112.3
Q ss_pred cCcEeeCCCCcccCcCChhhhCCCCCcEEEecCCc-ccCCCC-cccCCCCCCEEeccC-ccCCCccccccccccccceEE
Q 002061 98 SLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNA-MVGSVP-DLSALKNLEIFDLSI-NYFTGRFPRWVVNLTQLVSLS 174 (973)
Q Consensus 98 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~-l~~~~~-~l~~l~~L~~L~Ls~-n~l~~~~~~~~~~l~~L~~L~ 174 (973)
+|++|+|++|++++..+..|+.+++|++|+|++|+ +++.++ .|+++++|++|++++ |.+++..+..|.++++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 78888888888886656678888888888888886 766665 477778888888877 777755555555555555555
Q ss_pred ccCCcCCCCCCcccccCCCCCC---EEEcccC-CCCCCCChhhhccCCCCeeecccccccCCCchhhhcccccc-EEEee
Q 002061 175 IGDNVYDEAEIPESIGNLKNLT---YLFLAHC-NLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLW-KIELY 249 (973)
Q Consensus 175 l~~n~l~~~~ip~~~~~l~~L~---~L~L~~n-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~-~L~L~ 249 (973)
+++|.++. +|. ++.+++|+ +|++++| ++++..+..|.. +++|+ +|+++
T Consensus 112 l~~n~l~~--lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~------------------------l~~L~~~L~l~ 164 (239)
T 2xwt_C 112 IFNTGLKM--FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQG------------------------LCNETLTLKLY 164 (239)
T ss_dssp EEEECCCS--CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTT------------------------TBSSEEEEECC
T ss_pred CCCCCCcc--ccc-cccccccccccEEECCCCcchhhcCcccccc------------------------hhcceeEEEcC
Confidence 55555542 333 44444444 5555555 444433344444 44444 55555
Q ss_pred ccccCCcCCccccccccccEEEeeccc-cccccCCccCCC-CCccEEEcccCCCCCCCCCCcCCcccceeeeccCC
Q 002061 250 ANNLTGELPAELGNLTLLQEFDISSNQ-MYGKLPEEIGNL-KNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGN 323 (973)
Q Consensus 250 ~N~l~~~~~~~l~~l~~L~~L~Ls~N~-l~~~~p~~~~~l-~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N 323 (973)
+|+++ .+|......++|++|+|++|+ +++..+..|..+ ++|+.|++++|++++..+. .+++|+.|++.++
T Consensus 165 ~n~l~-~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 165 NNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNT 236 (239)
T ss_dssp SCCCC-EECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred CCCCc-ccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCc
Confidence 55444 233222222455555555553 554444455555 5555555555555533222 3445555555443
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.1e-24 Score=246.71 Aligned_cols=190 Identities=17% Similarity=0.230 Sum_probs=123.7
Q ss_pred ccccccceEEccCCcCCCC---CCcccccCCCCCCEEEcccCCCCCCCChhh----hcc---------CCCCeeeccccc
Q 002061 165 VNLTQLVSLSIGDNVYDEA---EIPESIGNLKNLTYLFLAHCNLRGRIPESI----SEL---------RELGTLDICRNK 228 (973)
Q Consensus 165 ~~l~~L~~L~l~~n~l~~~---~ip~~~~~l~~L~~L~L~~n~l~~~~~~~~----~~l---------~~L~~L~L~~N~ 228 (973)
..+++|++|+|++|.+... .+|..+..+++|++|+|++|.+++..+..+ ..+ ++|++|+|++|+
T Consensus 91 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~ 170 (386)
T 2ca6_A 91 LKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNR 170 (386)
T ss_dssp TTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSC
T ss_pred hhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCC
Confidence 4455555555555555432 244555666666666666666653333333 233 677777777777
Q ss_pred cc-CCCc---hhhhccccccEEEeeccccCC-----cCCccccccccccEEEeeccccc----cccCCccCCCCCccEEE
Q 002061 229 IS-GEFP---RSIRKLQKLWKIELYANNLTG-----ELPAELGNLTLLQEFDISSNQMY----GKLPEEIGNLKNLTVFQ 295 (973)
Q Consensus 229 l~-~~~~---~~l~~l~~L~~L~L~~N~l~~-----~~~~~l~~l~~L~~L~Ls~N~l~----~~~p~~~~~l~~L~~L~ 295 (973)
++ +.++ ..+..+++|++|+|++|+++. ..+..+..+++|++|+|++|.++ ..+|..+..+++|+.|+
T Consensus 171 l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~ 250 (386)
T 2ca6_A 171 LENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELG 250 (386)
T ss_dssp CTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEE
T ss_pred CCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEE
Confidence 76 2333 355667777777777777762 23336677777777777777775 45666777777788888
Q ss_pred cccCCCCCC----CCCCc--CCcccceeeeccCCccCC----CCCccc-cccccccccccccccccccCC
Q 002061 296 CFKNNFSGE----FPSGF--GDMRKLFAFSIYGNRFSG----PFPENL-GRYTALTDVDISENQFSGSFP 354 (973)
Q Consensus 296 l~~N~l~~~----~p~~~--~~l~~L~~L~l~~N~l~~----~~~~~l-~~l~~L~~L~Ls~N~l~~~~p 354 (973)
+++|.+++. ++..+ +.+++|+.|+|++|.+++ .+|..+ .++++|++|+|++|++++..|
T Consensus 251 L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 251 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp CTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred CCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 888877754 34445 347788888888888876 366666 567888999999998886654
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=2.8e-23 Score=227.33 Aligned_cols=225 Identities=15% Similarity=0.133 Sum_probs=184.2
Q ss_pred CccCcEeeCCCCcccCcCCh---hhhCCCCCcEEEecCCcccCCCCc-c--cCCCCCCEEeccCccCCCccc----cccc
Q 002061 96 LQSLTVLSLPFNVLSGKLPL---ELSNCSNLKVLNVTGNAMVGSVPD-L--SALKNLEIFDLSINYFTGRFP----RWVV 165 (973)
Q Consensus 96 l~~L~~L~Ls~n~l~~~~p~---~l~~l~~L~~L~L~~n~l~~~~~~-l--~~l~~L~~L~Ls~n~l~~~~~----~~~~ 165 (973)
-..++.|.++++.++...-. .+..+++|++|+|++|.+.+..+. + +.+++|++|+|++|.+++..+ ..+.
T Consensus 63 ~~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~ 142 (310)
T 4glp_A 63 ALRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQW 142 (310)
T ss_dssp SCCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTT
T ss_pred hcceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhh
Confidence 34578888888887642111 233457799999999999887664 5 899999999999999997655 4556
Q ss_pred cccccceEEccCCcCCCCCCcccccCCCCCCEEEcccCCCCCC--C--ChhhhccCCCCeeecccccccCCCch----hh
Q 002061 166 NLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGR--I--PESISELRELGTLDICRNKISGEFPR----SI 237 (973)
Q Consensus 166 ~l~~L~~L~l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~--~--~~~~~~l~~L~~L~L~~N~l~~~~~~----~l 237 (973)
.+++|++|++++|.+.. ..|..++.+++|++|+|++|++.+. + +..++.+++|++|+|++|+++ .++. .+
T Consensus 143 ~~~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~ 220 (310)
T 4glp_A 143 LKPGLKVLSIAQAHSPA-FSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALA 220 (310)
T ss_dssp BCSCCCEEEEECCSSCC-CCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHH
T ss_pred hccCCCEEEeeCCCcch-hhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHH
Confidence 89999999999999964 3457889999999999999998752 2 233478999999999999997 3333 35
Q ss_pred hccccccEEEeeccccCCcCCcccccc---ccccEEEeeccccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCccc
Q 002061 238 RKLQKLWKIELYANNLTGELPAELGNL---TLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRK 314 (973)
Q Consensus 238 ~~l~~L~~L~L~~N~l~~~~~~~l~~l---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~ 314 (973)
+.+++|++|+|++|++++..|..+..+ ++|++|+|++|+++ .+|..+. ++|+.|++++|+|++. |. +..+++
T Consensus 221 ~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~ 295 (310)
T 4glp_A 221 AAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPE 295 (310)
T ss_dssp HHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCC
T ss_pred hcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCC
Confidence 788999999999999998878887776 69999999999999 6788775 7999999999999964 33 688899
Q ss_pred ceeeeccCCccCC
Q 002061 315 LFAFSIYGNRFSG 327 (973)
Q Consensus 315 L~~L~l~~N~l~~ 327 (973)
|+.|++++|++++
T Consensus 296 L~~L~L~~N~l~~ 308 (310)
T 4glp_A 296 VDNLTLDGNPFLV 308 (310)
T ss_dssp CSCEECSSTTTSC
T ss_pred ccEEECcCCCCCC
Confidence 9999999999974
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.4e-22 Score=212.77 Aligned_cols=196 Identities=16% Similarity=0.163 Sum_probs=97.6
Q ss_pred cccEEEeeccccccccCCccCCCCCccEEEcccCC-CCCCCCCCcCCcccceeeeccC-CccCCCCCccccccccccccc
Q 002061 266 LLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNN-FSGEFPSGFGDMRKLFAFSIYG-NRFSGPFPENLGRYTALTDVD 343 (973)
Q Consensus 266 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~-l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~~~~l~~l~~L~~L~ 343 (973)
+|++|++++|++++..+..|.++++|++|++++|+ ++...+..|..+++|++|++++ |++++..+..|..+++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 44455555555544333344444455555555443 4433333444445555555544 444444444455555555555
Q ss_pred cccccccccCChhhhhhhhHHHHHhhhccCCCCccccccCccccc---eEecccc-ccccCCCccccCCCCcc-eEeccC
Q 002061 344 ISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQ---RLRISDN-HLSGKIPDGLWALPNVG-MLDFGD 418 (973)
Q Consensus 344 Ls~N~l~~~~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~---~L~Ls~N-~l~~~~p~~~~~l~~L~-~L~L~~ 418 (973)
+++|++++ +|. +..+++|+ +|++++| ++++..+..|..+++|+ .|++++
T Consensus 112 l~~n~l~~-------------------------lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~ 165 (239)
T 2xwt_C 112 IFNTGLKM-------------------------FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYN 165 (239)
T ss_dssp EEEECCCS-------------------------CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCS
T ss_pred CCCCCCcc-------------------------ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCC
Confidence 55555542 111 33334444 6666666 66555555555555555 555555
Q ss_pred CcCCCCCCCCCCCCCCCCEEEcccCC-CCCCCChhhhcC-CCCCEEEccCCcCCCCccccccccccCCEEEcCCc
Q 002061 419 NDFTGGISPLIGLSTSLSQLVLQNNR-FSGELPSELGRL-TNLERLILTNNNFSGKIPSALGALRQLSSLHLEEN 491 (973)
Q Consensus 419 N~l~~~~~~~~~~~~~L~~L~L~~N~-l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 491 (973)
|+++.+++..|.. ++|+.|+|++|+ +++..+..|.++ ++|+.|+|++|++++..+. .+++|+.|+++++
T Consensus 166 n~l~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 166 NGFTSVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNT 236 (239)
T ss_dssp CCCCEECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred CCCcccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCc
Confidence 5555444444433 455555665553 554444555555 5555566655555532222 3445555555544
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=2.3e-22 Score=220.04 Aligned_cols=206 Identities=16% Similarity=0.140 Sum_probs=100.4
Q ss_pred cccEEEeeccccCCcCCccc--cccccccEEEeeccccccccC----CccCCCCCccEEEcccCCCCCCCCCCcCCcccc
Q 002061 242 KLWKIELYANNLTGELPAEL--GNLTLLQEFDISSNQMYGKLP----EEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKL 315 (973)
Q Consensus 242 ~L~~L~L~~N~l~~~~~~~l--~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L 315 (973)
+|++|+|++|.+++..|..+ ..+++|++|+|++|.+++..+ ..+..+++|++|++++|++.+..+..|+.+++|
T Consensus 92 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L 171 (310)
T 4glp_A 92 RLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPAL 171 (310)
T ss_dssp CCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTC
T ss_pred ceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCC
Confidence 34444444444444444444 444445555555554443222 122334455555555555544444445555555
Q ss_pred eeeeccCCccCCC----CCccccccccccccccccccccccCChhhhhhhhHHHHHhhhccCCCCccccccCccccceEe
Q 002061 316 FAFSIYGNRFSGP----FPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLR 391 (973)
Q Consensus 316 ~~L~l~~N~l~~~----~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~ 391 (973)
++|++++|++.+. .+..++.+++|++|+|++|+++ .+|.... ..++.+++|++|+
T Consensus 172 ~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~--------------------~l~~~l~~L~~L~ 230 (310)
T 4glp_A 172 TSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCA--------------------ALAAAGVQPHSLD 230 (310)
T ss_dssp CEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHH--------------------HHHHHTCCCSSEE
T ss_pred CEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHH--------------------HHHhcCCCCCEEE
Confidence 5555555554321 1222355667777777777775 1111100 0134556777777
Q ss_pred ccccccccCCCccccCCCCcceEeccCCcCCCCCCCCCCCCCCCCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCC
Q 002061 392 ISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSG 471 (973)
Q Consensus 392 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 471 (973)
|++|+|++..|..+..+. .+++|++|+|++|+|+ .+|..+. ++|++|+|++|+|++
T Consensus 231 Ls~N~l~~~~p~~~~~~~---------------------~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~ 286 (310)
T 4glp_A 231 LSHNSLRATVNPSAPRCM---------------------WSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNR 286 (310)
T ss_dssp CTTSCCCCCCCSCCSSCC---------------------CCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCS
T ss_pred CCCCCCCccchhhHHhcc---------------------CcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCC
Confidence 777777766666654441 1134444444444444 3333332 455555555555553
Q ss_pred CccccccccccCCEEEcCCcccc
Q 002061 472 KIPSALGALRQLSSLHLEENALT 494 (973)
Q Consensus 472 ~~p~~~~~l~~L~~L~Ls~N~l~ 494 (973)
. |. +..+++|+.|+|++|+++
T Consensus 287 ~-~~-~~~l~~L~~L~L~~N~l~ 307 (310)
T 4glp_A 287 A-PQ-PDELPEVDNLTLDGNPFL 307 (310)
T ss_dssp C-CC-TTSCCCCSCEECSSTTTS
T ss_pred C-ch-hhhCCCccEEECcCCCCC
Confidence 2 22 444555555555555554
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.7e-24 Score=245.16 Aligned_cols=221 Identities=16% Similarity=0.203 Sum_probs=138.7
Q ss_pred cCChhhhCCCCCcEEEecCCcccCCC-----CcccCCCCCCEEeccCccCC---CccccccccccccceEEccCCcCCCC
Q 002061 112 KLPLELSNCSNLKVLNVTGNAMVGSV-----PDLSALKNLEIFDLSINYFT---GRFPRWVVNLTQLVSLSIGDNVYDEA 183 (973)
Q Consensus 112 ~~p~~l~~l~~L~~L~L~~n~l~~~~-----~~l~~l~~L~~L~Ls~n~l~---~~~~~~~~~l~~L~~L~l~~n~l~~~ 183 (973)
.++..+..+++|++|+|++|.+.... ..+..+++|++|+|++|.+. +.+|..+..
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~----------------- 85 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRL----------------- 85 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHH-----------------
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHH-----------------
Confidence 45666777777777777777765432 12556666666666665432 222222111
Q ss_pred CCcccccCCCCCCEEEcccCCCCC----CCChhhhccCCCCeeecccccccCCCchhhhc----c---------ccccEE
Q 002061 184 EIPESIGNLKNLTYLFLAHCNLRG----RIPESISELRELGTLDICRNKISGEFPRSIRK----L---------QKLWKI 246 (973)
Q Consensus 184 ~ip~~~~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~----l---------~~L~~L 246 (973)
+...+..+++|++|+|++|++++ .+|..+..+++|++|+|++|.+++..+..+.. + ++|++|
T Consensus 86 -l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L 164 (386)
T 2ca6_A 86 -LLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSI 164 (386)
T ss_dssp -HHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEE
T ss_pred -HHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEE
Confidence 12334788999999999999987 36778888999999999999987554444443 3 788888
Q ss_pred EeeccccC-CcCC---ccccccccccEEEeecccccc-----ccCCccCCCCCccEEEcccCCCC----CCCCCCcCCcc
Q 002061 247 ELYANNLT-GELP---AELGNLTLLQEFDISSNQMYG-----KLPEEIGNLKNLTVFQCFKNNFS----GEFPSGFGDMR 313 (973)
Q Consensus 247 ~L~~N~l~-~~~~---~~l~~l~~L~~L~Ls~N~l~~-----~~p~~~~~l~~L~~L~l~~N~l~----~~~p~~~~~l~ 313 (973)
+|++|+++ +.++ ..+..+++|++|+|++|+++. ..|..+..+++|+.|++++|.++ ..+|..+..++
T Consensus 165 ~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~ 244 (386)
T 2ca6_A 165 ICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWP 244 (386)
T ss_dssp ECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCT
T ss_pred ECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCC
Confidence 88888887 3344 356677788888888887762 33446666777777777777764 34444555555
Q ss_pred cceeeeccCCccCCC----CCcccc--cccccccccccccccc
Q 002061 314 KLFAFSIYGNRFSGP----FPENLG--RYTALTDVDISENQFS 350 (973)
Q Consensus 314 ~L~~L~l~~N~l~~~----~~~~l~--~l~~L~~L~Ls~N~l~ 350 (973)
+|+.|+|++|.+++. ++..+. .+++|++|+|++|.++
T Consensus 245 ~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~ 287 (386)
T 2ca6_A 245 NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE 287 (386)
T ss_dssp TCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCB
T ss_pred CcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCC
Confidence 555555555555433 223331 2444555555555544
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.87 E-value=5e-22 Score=216.81 Aligned_cols=194 Identities=22% Similarity=0.302 Sum_probs=102.5
Q ss_pred ccCCccCcEeeCCCCcccCcCChhhhCCCCCcEEEecCCcccCCCCcccCCCCCCEEeccCccCCCccccccccccccce
Q 002061 93 ISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVS 172 (973)
Q Consensus 93 l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~ 172 (973)
...+++|++|++++|.++. +| .+..+++|++|+|++|.+.+.++ +..+++|++|+|++|.+++. ..+..+++|++
T Consensus 37 ~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~-~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~ 111 (308)
T 1h6u_A 37 QADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP-LKNLTKITELELSGNPLKNV--SAIAGLQSIKT 111 (308)
T ss_dssp HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG-GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCE
T ss_pred HHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh-HccCCCCCEEEccCCcCCCc--hhhcCCCCCCE
Confidence 3456666666666666653 34 46666666666666666666555 66666666666666666542 24555555555
Q ss_pred EEccCCcCCCCCCcccccCCCCCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCchhhhccccccEEEeeccc
Q 002061 173 LSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANN 252 (973)
Q Consensus 173 L~l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~ 252 (973)
|++++|.++. ++ .+..+++|++|++++|++++..+ +..+++|++|+|++|++++..+ +..+++|++|+|++|+
T Consensus 112 L~l~~n~l~~--~~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~ 184 (308)
T 1h6u_A 112 LDLTSTQITD--VT-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNK 184 (308)
T ss_dssp EECTTSCCCC--CG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred EECCCCCCCC--ch-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCc
Confidence 5555555542 22 25555555555555555553322 5555555555555555553222 4455555555555555
Q ss_pred cCCcCCccccccccccEEEeeccccccccCCccCCCCCccEEEcccCCCC
Q 002061 253 LTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFS 302 (973)
Q Consensus 253 l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 302 (973)
+++..+ +..+++|++|+|++|++++.. .+..+++|+.|++++|.++
T Consensus 185 l~~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~ 230 (308)
T 1h6u_A 185 ISDISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTIT 230 (308)
T ss_dssp CCCCGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEE
T ss_pred cCcChh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeee
Confidence 543222 444455555555555544322 1444444444444444443
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.87 E-value=2.6e-22 Score=219.06 Aligned_cols=213 Identities=19% Similarity=0.279 Sum_probs=168.8
Q ss_pred ccCcEeeCCCCcccCcCChhhhCCCCCcEEEecCCcccCCCCcccCCCCCCEEeccCccCCCccccccccccccceEEcc
Q 002061 97 QSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIG 176 (973)
Q Consensus 97 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~ 176 (973)
..+..+.+..+.+++.+ .+..+++|++|++++|.+...+ .+..+++|++|+|++|.+++..+ +..+++|++|+++
T Consensus 19 ~~~~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~ 93 (308)
T 1h6u_A 19 ANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELS 93 (308)
T ss_dssp HHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECC
T ss_pred HHHHHHHhCCCCcCcee--cHHHcCCcCEEEeeCCCccCch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEcc
Confidence 33445566677776543 3567889999999999998754 78999999999999999986554 8899999999999
Q ss_pred CCcCCCCCCcccccCCCCCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCchhhhccccccEEEeeccccCCc
Q 002061 177 DNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGE 256 (973)
Q Consensus 177 ~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~ 256 (973)
+|.+.. + +.+..+++|++|+|++|++++. + .+..+++|++|++++|++++..+ +..+++|++|+|++|++++.
T Consensus 94 ~n~l~~--~-~~~~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~ 166 (308)
T 1h6u_A 94 GNPLKN--V-SAIAGLQSIKTLDLTSTQITDV-T-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDL 166 (308)
T ss_dssp SCCCSC--C-GGGTTCTTCCEEECTTSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC
T ss_pred CCcCCC--c-hhhcCCCCCCEEECCCCCCCCc-h-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCC
Confidence 998864 3 3688899999999999999853 3 38888999999999999885433 88888888888888888854
Q ss_pred CCccccccccccEEEeeccccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeeccCCccCC
Q 002061 257 LPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSG 327 (973)
Q Consensus 257 ~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 327 (973)
+. +..+++|+.|++++|++++..+ +..+++|++|++++|++++..+ +..+++|+.|++++|++++
T Consensus 167 -~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 167 -TP-LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp -GG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEEC
T ss_pred -hh-hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeec
Confidence 33 7888888888888888875443 7778888888888888886543 6777888888888887764
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.87 E-value=3.7e-23 Score=241.96 Aligned_cols=218 Identities=22% Similarity=0.319 Sum_probs=137.9
Q ss_pred cccccCCCCCCCCCC-----Cccee-eeCCCCCceEEEeecCCCCCccccccccCCccCcEeeCCCCcccCcCChhhhCC
Q 002061 47 HGVLDSWKESADSPC-----GFSGI-TCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNC 120 (973)
Q Consensus 47 ~~~~~~W~~~~~~~c-----~w~gv-~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l 120 (973)
...+.+|..+. .+| .|.|+ .|.. ++++.|+|+++++++ +|..+. ++|++|+|++|.|+ .+| ..+
T Consensus 30 ~~~l~~W~~~~-~~~~~~~~~~~~l~~C~~--~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l 99 (571)
T 3cvr_A 30 FSAWDKWEKQA-LPGENRNEAVSLLKECLI--NQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELP 99 (571)
T ss_dssp HHHHHHHHTTC-CTTCCHHHHHHHHHHHHH--TTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCC
T ss_pred HHHHHHHhccC-Cccccccchhhhcccccc--CCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---ccc
Confidence 34567786654 467 79999 7863 578999999999987 777664 78999999999988 677 457
Q ss_pred CCCcEEEecCCcccCCCCcccCCCCCCEEeccCccCCCccccccccccccceEEccCCcCCCCCCcccccCCCCCCEEEc
Q 002061 121 SNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFL 200 (973)
Q Consensus 121 ~~L~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ip~~~~~l~~L~~L~L 200 (973)
++|++|+|++|++++.+. +.. +|++|+|++|.+++ +|. .+++|+.|++++|.++. +|. .+++|++|+|
T Consensus 100 ~~L~~L~Ls~N~l~~ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~--lp~---~l~~L~~L~L 167 (571)
T 3cvr_A 100 ASLEYLDACDNRLSTLPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM--LPE---LPTSLEVLSV 167 (571)
T ss_dssp TTCCEEECCSSCCSCCCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC--CCC---CCTTCCEEEC
T ss_pred CCCCEEEccCCCCCCcch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc--CCC---cCCCcCEEEC
Confidence 888888888888888665 655 88888888888876 444 46666666666666653 444 4556666666
Q ss_pred ccCCCCCCCChhhhccCCCCeeecccccccCCCchhhhccccccEEEeeccccCCcCCccccccccccEEEeeccccccc
Q 002061 201 AHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGK 280 (973)
Q Consensus 201 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ 280 (973)
++|+|++ +|. |. ++|++|+|++|+|+ .+|. +.. +| +...+.|+.|+|++|+|+ .
T Consensus 168 s~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L-----------------~~~~~~L~~L~Ls~N~l~-~ 221 (571)
T 3cvr_A 168 RNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RN-----------------HHSEETEIFFRCRENRIT-H 221 (571)
T ss_dssp CSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC---------------------------CCEEEECCSSCCC-C
T ss_pred CCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hh-----------------hcccccceEEecCCCcce-e
Confidence 6666664 444 44 56666666666665 3443 332 33 000011255555555555 3
Q ss_pred cCCccCCCCCccEEEcccCCCCCCCCCCcCCc
Q 002061 281 LPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDM 312 (973)
Q Consensus 281 ~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l 312 (973)
+|..+..+++|+.|++++|.+++.+|..++.+
T Consensus 222 lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l 253 (571)
T 3cvr_A 222 IPENILSLDPTCTIILEDNPLSSRIRESLSQQ 253 (571)
T ss_dssp CCGGGGGSCTTEEEECCSSSCCHHHHHHHHHH
T ss_pred cCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHh
Confidence 45555555555555555555555555444443
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.85 E-value=7.6e-21 Score=211.70 Aligned_cols=217 Identities=16% Similarity=0.055 Sum_probs=116.8
Q ss_pred cEeeCCCCcccCcCChhhhCCCCCcEEEecCCcccCCCCc-ccCCCCCCEEeccCccCCCccccccccccccceEEccCC
Q 002061 100 TVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD-LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDN 178 (973)
Q Consensus 100 ~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n 178 (973)
++++-++++++ .+|..+ .+++++|+|++|+|+..++. |+++++|++|+|++|++.+.+|.
T Consensus 12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~---------------- 72 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEA---------------- 72 (350)
T ss_dssp TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECT----------------
T ss_pred CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccCh----------------
Confidence 44555566665 455544 24566666666666555542 55666666666666655433321
Q ss_pred cCCCCCCcccccCCCCCCE-EEcccCCCCCCCChhhhccCCCCeeecccccccCCCchhhhccccccEEEeec-cccCCc
Q 002061 179 VYDEAEIPESIGNLKNLTY-LFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYA-NNLTGE 256 (973)
Q Consensus 179 ~l~~~~ip~~~~~l~~L~~-L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~-N~l~~~ 256 (973)
..|.++++|++ +.+++|+++...|..|..+++|++|++++|+|+...+..+....++..|++.+ |+++..
T Consensus 73 --------~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l 144 (350)
T 4ay9_X 73 --------DVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTI 144 (350)
T ss_dssp --------TSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEE
T ss_pred --------hHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccc
Confidence 23444554443 34445555555555566666666666666666544444455555555666543 445533
Q ss_pred CCccccccc-cccEEEeeccccccccCCccCCCCCccEEEccc-CCCCCCCCCCcCCcccceeeeccCCccCCCCCcccc
Q 002061 257 LPAELGNLT-LLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFK-NNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLG 334 (973)
Q Consensus 257 ~~~~l~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~ 334 (973)
.+..|..+. .++.|+|++|+++ .+|.......+|+.|++++ |.++...+..|..+++|+.|++++|+|+...+..+.
T Consensus 145 ~~~~f~~~~~~l~~L~L~~N~i~-~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~ 223 (350)
T 4ay9_X 145 ERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLE 223 (350)
T ss_dssp CTTSSTTSBSSCEEEECCSSCCC-EECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCT
T ss_pred cccchhhcchhhhhhcccccccc-CCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhc
Confidence 334444443 4666666666666 3444444445666666654 344433334566666666666666666654444555
Q ss_pred cccccccccc
Q 002061 335 RYTALTDVDI 344 (973)
Q Consensus 335 ~l~~L~~L~L 344 (973)
++++|+.+++
T Consensus 224 ~L~~L~~l~~ 233 (350)
T 4ay9_X 224 NLKKLRARST 233 (350)
T ss_dssp TCCEEECTTC
T ss_pred cchHhhhccC
Confidence 5555554443
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.5e-20 Score=209.41 Aligned_cols=242 Identities=16% Similarity=0.116 Sum_probs=126.0
Q ss_pred CEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCchhhhccccccEEEeeccccCCcCC-ccccccccccE-EEee
Q 002061 196 TYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELP-AELGNLTLLQE-FDIS 273 (973)
Q Consensus 196 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~~l~~l~~L~~-L~Ls 273 (973)
++++.++++++ .+|..+ .+++++|+|++|+|+...+.+|.++++|++|+|++|++.+.+| ..|.+++++++ +.++
T Consensus 12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 34555555555 444443 2355566666666653333445555566666666665544333 34555555543 4445
Q ss_pred ccccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeeccC-CccCCCCCcccccccccccccccccccccc
Q 002061 274 SNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYG-NRFSGPFPENLGRYTALTDVDISENQFSGS 352 (973)
Q Consensus 274 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ 352 (973)
+|+++...|..|..+++|++|++++|++....+..+....++..|++.+ |++....+..|..+.
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~--------------- 153 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLS--------------- 153 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSB---------------
T ss_pred CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcc---------------
Confidence 5666555555556666666666666665544444444444444444433 233322222222221
Q ss_pred CChhhhhhhhHHHHHhhhccCCCCccccccCccccceEeccccccccCCCccccCCCCcceEecc-CCcCCCCCCCCCCC
Q 002061 353 FPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFG-DNDFTGGISPLIGL 431 (973)
Q Consensus 353 ~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~-~N~l~~~~~~~~~~ 431 (973)
..++.|+|++|+|+. +|...+...+|+.|+++ +|.++.+++..|..
T Consensus 154 --------------------------------~~l~~L~L~~N~i~~-i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~ 200 (350)
T 4ay9_X 154 --------------------------------FESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLEELPNDVFHG 200 (350)
T ss_dssp --------------------------------SSCEEEECCSSCCCE-ECTTSSTTEEEEEEECTTCTTCCCCCTTTTTT
T ss_pred --------------------------------hhhhhhccccccccC-CChhhccccchhHHhhccCCcccCCCHHHhcc
Confidence 235556666666653 33333344556666665 35555555556666
Q ss_pred CCCCCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcc
Q 002061 432 STSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENA 492 (973)
Q Consensus 432 ~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 492 (973)
+++|++|+|++|+|+...+..| .+|+.|.+.++.--..+| .+.++++|+.++++++.
T Consensus 201 l~~L~~LdLs~N~l~~lp~~~~---~~L~~L~~l~~~~l~~lP-~l~~l~~L~~l~l~~~~ 257 (350)
T 4ay9_X 201 ASGPVILDISRTRIHSLPSYGL---ENLKKLRARSTYNLKKLP-TLEKLVALMEASLTYPS 257 (350)
T ss_dssp EECCSEEECTTSCCCCCCSSSC---TTCCEEECTTCTTCCCCC-CTTTCCSCCEEECSCHH
T ss_pred CcccchhhcCCCCcCccChhhh---ccchHhhhccCCCcCcCC-CchhCcChhhCcCCCCc
Confidence 7777777777777764333333 344444443333222555 36777777888777653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=8.5e-22 Score=211.31 Aligned_cols=142 Identities=17% Similarity=0.157 Sum_probs=115.4
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc--------------------cHHHHHHHHHHHHhcCCCceeeE
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD--------------------GVKVFAAEMEILGKIRHRNILKL 736 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--------------------~~~~~~~E~~~l~~l~hpniv~l 736 (973)
.|++.+.||+|+||.||+|++ .+|+.||||++.... ....+.+|++++++++| +++
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v 166 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAV 166 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSS
T ss_pred EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCc
Confidence 456779999999999999999 779999999985421 24568899999999994 555
Q ss_pred EEEEEeCCeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCC
Q 002061 737 YACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY 816 (973)
Q Consensus 737 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~ 816 (973)
.+++.. +..|+||||+++|+|.+ +.. .....++.|++.|++||| +.+|+||||||+||+++ ++
T Consensus 167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~~-----------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~-~~ 229 (282)
T 1zar_A 167 PKVYAW-EGNAVLMELIDAKELYR-VRV-----------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS-EE 229 (282)
T ss_dssp CCEEEE-ETTEEEEECCCCEEGGG-CCC-----------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE-TT
T ss_pred CeEEec-cceEEEEEecCCCcHHH-cch-----------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE-CC
Confidence 555443 45699999999999987 421 123468999999999999 78999999999999999 99
Q ss_pred CeEEecccCcccccCCCCcccccccCCccccccccccc
Q 002061 817 EPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAY 854 (973)
Q Consensus 817 ~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 854 (973)
.+||+|||+++. +..|+|||++.
T Consensus 230 ~vkl~DFG~a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 230 GIWIIDFPQSVE---------------VGEEGWREILE 252 (282)
T ss_dssp EEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred cEEEEECCCCeE---------------CCCCCHHHHHH
Confidence 999999999862 34578999874
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.84 E-value=1e-20 Score=194.04 Aligned_cols=179 Identities=22% Similarity=0.240 Sum_probs=151.5
Q ss_pred ceEeccccccccCCCccccCCCCcceEeccCCcCCCCCCCCCCCCCCCCEEEcccCCCCCCCChhhhcCCCCCEEEccCC
Q 002061 388 QRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNN 467 (973)
Q Consensus 388 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 467 (973)
+.++.+++.++ .+|..+ .++|++|++++|++++.++..|..+++|++|+|++|++++..+..|..+++|++|+|++|
T Consensus 10 ~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 10 TTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp TEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 56788888887 455544 458899999999998888888888999999999999999777777888999999999999
Q ss_pred cCCCCccccccccccCCEEEcCCcccccCCCccccccccccchhccccccccCCCccccccCCCCeeecCCCccCCCCCh
Q 002061 468 NFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPD 547 (973)
Q Consensus 468 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~ 547 (973)
++++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|++.+..|
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~- 165 (208)
T 2o6s_A 87 QLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP- 165 (208)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTT-
T ss_pred cCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecCCC-
Confidence 9997777778899999999999999998888888999999999999999997777778899999999999999887655
Q ss_pred hhhcccCceEEccCCccccccCcccccC
Q 002061 548 NLMKLKLSSIDLSENQLSGSVPLDFLRM 575 (973)
Q Consensus 548 ~l~~l~L~~l~ls~N~l~~~~p~~~~~~ 575 (973)
.++.|+++.|+++|.+|..+...
T Consensus 166 -----~l~~L~~~~n~~~g~ip~~~~~l 188 (208)
T 2o6s_A 166 -----GIRYLSEWINKHSGVVRNSAGSV 188 (208)
T ss_dssp -----TTHHHHHHHHHCTTTBBCTTSSB
T ss_pred -----CHHHHHHHHHhCCceeeccCccc
Confidence 36788899999999999765443
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.83 E-value=1.4e-20 Score=192.96 Aligned_cols=162 Identities=20% Similarity=0.185 Sum_probs=149.6
Q ss_pred cccceEeccccccccCCCccccCCCCcceEeccCCcCCCCCCCCCCCCCCCCEEEcccCCCCCCCChhhhcCCCCCEEEc
Q 002061 385 KTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLIL 464 (973)
Q Consensus 385 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 464 (973)
++|++|+|++|++++..+..|..+++|++|++++|++++.++..|..+++|++|+|++|++++..+..|..+++|++|+|
T Consensus 28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 107 (208)
T 2o6s_A 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELAL 107 (208)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEc
Confidence 58999999999999887888899999999999999999988888999999999999999999877778899999999999
Q ss_pred cCCcCCCCccccccccccCCEEEcCCcccccCCCccccccccccchhccccccccCCCccccccCCCCeeecCCCccCCC
Q 002061 465 TNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGS 544 (973)
Q Consensus 465 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 544 (973)
++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|.+.+ .+++|+.|+++.|+++|.
T Consensus 108 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ 180 (208)
T 2o6s_A 108 NTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGV 180 (208)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTT
T ss_pred CCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCce
Confidence 9999998888889999999999999999998888889999999999999998874 466899999999999999
Q ss_pred CChhhhccc
Q 002061 545 IPDNLMKLK 553 (973)
Q Consensus 545 ~p~~l~~l~ 553 (973)
+|..+..+.
T Consensus 181 ip~~~~~l~ 189 (208)
T 2o6s_A 181 VRNSAGSVA 189 (208)
T ss_dssp BBCTTSSBC
T ss_pred eeccCcccc
Confidence 999887654
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=7.4e-21 Score=196.48 Aligned_cols=158 Identities=22% Similarity=0.275 Sum_probs=113.2
Q ss_pred CCCEEEcccCCCCCCCC-hhhhcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCCccccccccccchhc
Q 002061 434 SLSQLVLQNNRFSGELP-SELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNL 512 (973)
Q Consensus 434 ~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 512 (973)
.+++|+|++|+|++..| ..|..+++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|+.|+|
T Consensus 33 ~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 112 (220)
T 2v70_A 33 YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLML 112 (220)
T ss_dssp TCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEEC
T ss_pred CCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEEC
Confidence 45677777777765533 34677777777777777777666667777777777888878777777777777788888888
Q ss_pred cccccccCCCccccccCCCCeeecCCCccCCCCChhhhccc-CceEEccCCccccccCcccc-c-CCCCccccCCCCCcc
Q 002061 513 ARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLK-LSSIDLSENQLSGSVPLDFL-R-MGGDGAFAGNEGLCL 589 (973)
Q Consensus 513 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~-L~~l~ls~N~l~~~~p~~~~-~-~~~~~~~~~n~~lc~ 589 (973)
++|+|++..|..|..+++|+.|+|++|+|++..|..+..++ |+.|+|++|+|+|.|+..|. . +.....+.+++ .|+
T Consensus 113 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~l~~~~~~~~~~~~~~-~C~ 191 (220)
T 2v70_A 113 RSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCYLAWLGEWLRKKRIVTGNP-RCQ 191 (220)
T ss_dssp TTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGGGHHHHHHHHHSCCBCCCC-EEE
T ss_pred CCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCchHHHHHHHHhcCccccCC-ccC
Confidence 88888877777788888888888888888877777777775 88888888888888886422 1 11112234443 677
Q ss_pred Ccc
Q 002061 590 DQS 592 (973)
Q Consensus 590 ~~~ 592 (973)
.|.
T Consensus 192 ~P~ 194 (220)
T 2v70_A 192 KPY 194 (220)
T ss_dssp ESG
T ss_pred CCh
Confidence 665
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.83 E-value=1.2e-20 Score=211.03 Aligned_cols=181 Identities=25% Similarity=0.251 Sum_probs=160.7
Q ss_pred cceEeccccccccCCCccccCCCCcceEeccCCcCCCCCCCCCC-CCCCCCEEEcccCCCCCCCChhhhcCCCCCEEEcc
Q 002061 387 IQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIG-LSTSLSQLVLQNNRFSGELPSELGRLTNLERLILT 465 (973)
Q Consensus 387 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 465 (973)
-+.+++++|.|+ .+|..+. +.++.|+|++|+|++..+..+. .+++|+.|+|++|+|++..+..|.++++|++|+|+
T Consensus 20 ~~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls 96 (361)
T 2xot_A 20 SNILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLS 96 (361)
T ss_dssp TTEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECC
Confidence 468999999998 5676553 4689999999999999988887 89999999999999998888899999999999999
Q ss_pred CCcCCCCccccccccccCCEEEcCCcccccCCCccccccccccchhccccccccCCCccc---cccCCCCeeecCCCccC
Q 002061 466 NNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSL---SLLSSLNALNLSGNKLT 542 (973)
Q Consensus 466 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~---~~l~~L~~L~L~~N~l~ 542 (973)
+|+|++..+..|..+++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..| ..+++|+.|+|++|+|+
T Consensus 97 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~ 176 (361)
T 2xot_A 97 SNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK 176 (361)
T ss_dssp SSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCC
T ss_pred CCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCC
Confidence 999998778889999999999999999999999999999999999999999996555556 67999999999999999
Q ss_pred CCCChhhhccc---CceEEccCCccccccCc
Q 002061 543 GSIPDNLMKLK---LSSIDLSENQLSGSVPL 570 (973)
Q Consensus 543 ~~~p~~l~~l~---L~~l~ls~N~l~~~~p~ 570 (973)
+..+..+..++ ++.|+|++|+|.|.|..
T Consensus 177 ~l~~~~~~~l~~~~l~~l~l~~N~~~C~C~l 207 (361)
T 2xot_A 177 KLPLTDLQKLPAWVKNGLYLHNNPLECDCKL 207 (361)
T ss_dssp CCCHHHHHHSCHHHHTTEECCSSCEECCHHH
T ss_pred ccCHHHhhhccHhhcceEEecCCCccCCcCc
Confidence 76667777765 58999999999999875
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.83 E-value=1.2e-21 Score=237.95 Aligned_cols=233 Identities=15% Similarity=0.167 Sum_probs=121.7
Q ss_pred chHHHHHHHHHHHhcCCC-cccccCCCCCCCCCCCcceeeeCCCCCceEEEeecCCCCCccccccccCCccCcEe-----
Q 002061 29 LNVETQALIQFKSKLKDP-HGVLDSWKESADSPCGFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVL----- 102 (973)
Q Consensus 29 ~~~~~~aLl~~k~~~~d~-~~~~~~W~~~~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L----- 102 (973)
...++++|+++......+ ...-..|.......+.|.+++++. .+++.++|.++++.. ++..+.....|+.+
T Consensus 130 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~--~~~~~l~L~~n~~~~-~~~~~l~~l~Ls~~~i~~~ 206 (727)
T 4b8c_D 130 VDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVST--PLTPKIELFANGKDE-ANQALLQHKKLSQYSIDED 206 (727)
T ss_dssp --CCCHHHHHHHHHHHHHHTTC----------------------------------------------------------
T ss_pred cccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecC--CccceEEeeCCCCCc-chhhHhhcCccCcccccCc
Confidence 467899999999887422 333457765555568899999874 789999999998886 34433333333332
Q ss_pred eCCCCcccCcCChhhhCCCCCcEEEecCCcccCCCCcccCCCCCCEEeccCccCCCccccccccccccceEEccCCcCCC
Q 002061 103 SLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDE 182 (973)
Q Consensus 103 ~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 182 (973)
+++.|.+. ..|..+..+.+|+.|+|++|.+...++.+..+++|++|+|++|.|+ .+|..|.++++|++|+|++|.++
T Consensus 207 ~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~- 283 (727)
T 4b8c_D 207 DDIENRMV-MPKDSKYDDQLWHALDLSNLQIFNISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT- 283 (727)
T ss_dssp ----------------CCCCCCEEECTTSCCSCCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-
T ss_pred ccccccee-cChhhhccCCCCcEEECCCCCCCCCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-
Confidence 23333333 4467788888888888888888877777778888888888888888 67778888888888888888886
Q ss_pred CCCcccccCCCCCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCchhhhcccc-ccEEEeeccccCCcCCccc
Q 002061 183 AEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQK-LWKIELYANNLTGELPAEL 261 (973)
Q Consensus 183 ~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~-L~~L~L~~N~l~~~~~~~l 261 (973)
.+|..+++|++|++|+|++|.|+ .+|..|+.+++|++|+|++|.|++.+|..+..+.. +..|+|++|.+++.+|..
T Consensus 284 -~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~- 360 (727)
T 4b8c_D 284 -SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE- 360 (727)
T ss_dssp -SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-
T ss_pred -ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc-
Confidence 56788888888888888888887 66777888888888888888888777777765432 234677777777766653
Q ss_pred cccccccEEEeecc
Q 002061 262 GNLTLLQEFDISSN 275 (973)
Q Consensus 262 ~~l~~L~~L~Ls~N 275 (973)
|+.|+++.|
T Consensus 361 -----l~~l~l~~n 369 (727)
T 4b8c_D 361 -----RRFIEINTD 369 (727)
T ss_dssp --------------
T ss_pred -----cceeEeecc
Confidence 455566655
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.83 E-value=1.4e-20 Score=194.36 Aligned_cols=140 Identities=24% Similarity=0.301 Sum_probs=105.0
Q ss_pred CCCCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCCccccccccccchhc
Q 002061 433 TSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNL 512 (973)
Q Consensus 433 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 512 (973)
++|+.|+|++|+|++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|+...+..|.++++|+.|+|
T Consensus 32 ~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L 111 (220)
T 2v9t_B 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLL 111 (220)
T ss_dssp TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEEC
Confidence 45667777777777666666777777777777777777666777777777777777777777666666777777777777
Q ss_pred cccccccCCCccccccCCCCeeecCCCccCCCCChhhhccc-CceEEccCCccccccCccc
Q 002061 513 ARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLK-LSSIDLSENQLSGSVPLDF 572 (973)
Q Consensus 513 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~-L~~l~ls~N~l~~~~p~~~ 572 (973)
++|+|++..|..|..+++|+.|+|++|+|++..+..+..++ |+.|+|++|+|.|.|+..|
T Consensus 112 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~l~~ 172 (220)
T 2v9t_B 112 NANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCHLKW 172 (220)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGGGHH
T ss_pred CCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCccHH
Confidence 77777777777788888888888888888876666677665 8888888888888887643
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.83 E-value=1.8e-20 Score=219.28 Aligned_cols=189 Identities=22% Similarity=0.308 Sum_probs=131.8
Q ss_pred CCcEEEecCCcccCCCCcccCCCCCCEEeccCccCCCccccccccccccceEEccCCcCCCCCCcccccCCCCCCEEEcc
Q 002061 122 NLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLA 201 (973)
Q Consensus 122 ~L~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ip~~~~~l~~L~~L~L~ 201 (973)
+|+.|+|++|.+++.++.+. ++|++|+|++|.|+ .+| ..+++|++|++++|.++. +|. +.+ +|++|+|+
T Consensus 60 ~L~~L~Ls~n~L~~lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~--ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSSLPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST--LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSCCCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC--CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCccCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC--cch-hhc--CCCEEECC
Confidence 55555555555555444332 45555555555555 334 334556666666665543 555 443 77777777
Q ss_pred cCCCCCCCChhhhccCCCCeeecccccccCCCchhhhccccccEEEeeccccCCcCCccccccccccEEEeecccccccc
Q 002061 202 HCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKL 281 (973)
Q Consensus 202 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~ 281 (973)
+|+|++ +|. .+++|++|+|++|+|++ +|. .+++|++|+|++|+|++ +|. |. ++|+.|+|++|+|+ .+
T Consensus 129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~l 195 (571)
T 3cvr_A 129 NNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SL 195 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SC
T ss_pred CCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-ch
Confidence 777775 444 56777888888888774 554 46778888888888885 665 55 78888888888888 66
Q ss_pred CCccCCCCCc-------cEEEcccCCCCCCCCCCcCCcccceeeeccCCccCCCCCcccccccc
Q 002061 282 PEEIGNLKNL-------TVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTA 338 (973)
Q Consensus 282 p~~~~~l~~L-------~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~ 338 (973)
|. +.. +| +.|++++|+|+ .+|..+..+++|+.|+|++|++++..|..+..+..
T Consensus 196 p~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 255 (571)
T 3cvr_A 196 PA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA 255 (571)
T ss_dssp CC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred hh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence 66 554 67 99999999999 57888888999999999999999988888877654
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.81 E-value=5.3e-20 Score=190.05 Aligned_cols=157 Identities=20% Similarity=0.256 Sum_probs=143.6
Q ss_pred cceEeccccccccCCCccccCCCCcceEeccCCcCCCCCC-CCCCCCCCCCEEEcccCCCCCCCChhhhcCCCCCEEEcc
Q 002061 387 IQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGIS-PLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILT 465 (973)
Q Consensus 387 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 465 (973)
-+++++++|.++ .+|..+. +.++.|+|++|++++..+ ..|..+++|++|+|++|+|++..+..|.++++|++|+|+
T Consensus 13 ~~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls 89 (220)
T 2v70_A 13 GTTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLT 89 (220)
T ss_dssp TTEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECC
Confidence 358999999998 5676553 456899999999998854 568899999999999999998888899999999999999
Q ss_pred CCcCCCCccccccccccCCEEEcCCcccccCCCccccccccccchhccccccccCCCccccccCCCCeeecCCCccCCCC
Q 002061 466 NNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSI 545 (973)
Q Consensus 466 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 545 (973)
+|++++..+..|..+++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|++++..
T Consensus 90 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 169 (220)
T 2v70_A 90 SNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNC 169 (220)
T ss_dssp SSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSG
T ss_pred CCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCC
Confidence 99999888889999999999999999999999999999999999999999999988999999999999999999999766
Q ss_pred C
Q 002061 546 P 546 (973)
Q Consensus 546 p 546 (973)
+
T Consensus 170 ~ 170 (220)
T 2v70_A 170 Y 170 (220)
T ss_dssp G
T ss_pred c
Confidence 5
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.81 E-value=3.2e-19 Score=185.51 Aligned_cols=136 Identities=25% Similarity=0.308 Sum_probs=84.0
Q ss_pred CCCCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCCccccccccccchhc
Q 002061 433 TSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNL 512 (973)
Q Consensus 433 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 512 (973)
++|++|+|++|+|++..|..|.++++|++|+|++|+|+...+..|..+++|++|+|++|+|++..+..|..+++|+.|+|
T Consensus 40 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L 119 (229)
T 3e6j_A 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFM 119 (229)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEec
Confidence 45556666666666555555666666666666666665444455566666666666666666555555666666666666
Q ss_pred cccccccCCCccccccCCCCeeecCCCccCCCCChhhhccc-CceEEccCCccccccC
Q 002061 513 ARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLK-LSSIDLSENQLSGSVP 569 (973)
Q Consensus 513 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~-L~~l~ls~N~l~~~~p 569 (973)
++|+|+ .+|..+..+++|+.|+|++|+|++..+..+..++ |+.|+|++|+|.|.|+
T Consensus 120 s~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 120 CCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp CSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred cCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 666666 5566666666666666666666655445555554 6666666677666665
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.81 E-value=6.7e-20 Score=198.12 Aligned_cols=170 Identities=26% Similarity=0.358 Sum_probs=77.3
Q ss_pred CCCCCcEEEecCCcccCCCCcccCCCCCCEEeccCccCCCccccccccccccceEEccCCcCCCCCCcccccCCCCCCEE
Q 002061 119 NCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYL 198 (973)
Q Consensus 119 ~l~~L~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ip~~~~~l~~L~~L 198 (973)
.+++|++|++++|.+... +.+..+++|++|+|++|.+++..+ +..+++|++|++++|.++. + +.+..+++|++|
T Consensus 44 ~l~~L~~L~l~~~~i~~~-~~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~--~-~~l~~l~~L~~L 117 (291)
T 1h6t_A 44 ELNSIDQIIANNSDIKSV-QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD--L-SSLKDLKKLKSL 117 (291)
T ss_dssp HHHTCCEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC--G-GGGTTCTTCCEE
T ss_pred hcCcccEEEccCCCcccC-hhHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC--C-hhhccCCCCCEE
Confidence 344444444444444333 224444444444444444443222 4444444444444444432 1 224445555555
Q ss_pred EcccCCCCCCCChhhhccCCCCeeecccccccCCCchhhhccccccEEEeeccccCCcCCccccccccccEEEeeccccc
Q 002061 199 FLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMY 278 (973)
Q Consensus 199 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~ 278 (973)
+|++|++++. ..+..+++|++|++++|++++. ..+..+++|++|+|++|++++..+ +..+++|++|+|++|.++
T Consensus 118 ~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~ 191 (291)
T 1h6t_A 118 SLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS 191 (291)
T ss_dssp ECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred ECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCC
Confidence 5555555432 2344555555555555555432 344445555555555555543322 444555555555555554
Q ss_pred cccCCccCCCCCccEEEcccCCCC
Q 002061 279 GKLPEEIGNLKNLTVFQCFKNNFS 302 (973)
Q Consensus 279 ~~~p~~~~~l~~L~~L~l~~N~l~ 302 (973)
+ ++ .+..+++|+.|++++|+++
T Consensus 192 ~-l~-~l~~l~~L~~L~l~~n~i~ 213 (291)
T 1h6t_A 192 D-LR-ALAGLKNLDVLELFSQECL 213 (291)
T ss_dssp B-CG-GGTTCTTCSEEEEEEEEEE
T ss_pred C-Ch-hhccCCCCCEEECcCCccc
Confidence 2 22 2444445555555544444
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.81 E-value=7.8e-20 Score=197.59 Aligned_cols=188 Identities=24% Similarity=0.324 Sum_probs=158.4
Q ss_pred EEEeecCCCCCccccccccCCccCcEeeCCCCcccCcCChhhhCCCCCcEEEecCCcccCCCCcccCCCCCCEEeccCcc
Q 002061 76 TEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINY 155 (973)
Q Consensus 76 ~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls~n~ 155 (973)
..+.+....+++. ..+..+++|++|++++|.++. ++ .+..+++|++|+|++|++++.++ ++.+++|++|+|++|.
T Consensus 27 ~~~~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~-~~-~~~~l~~L~~L~L~~n~l~~~~~-l~~l~~L~~L~l~~n~ 101 (291)
T 1h6t_A 27 IKDNLKKKSVTDA--VTQNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP-LANLKNLGWLFLDENK 101 (291)
T ss_dssp HHHHTTCSCTTSE--ECHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSC
T ss_pred HHHHhcCCCcccc--cchhhcCcccEEEccCCCccc-Ch-hHhcCCCCCEEEccCCccCCCcc-cccCCCCCEEECCCCc
Confidence 3344555555543 234678999999999999974 44 58999999999999999998777 9999999999999999
Q ss_pred CCCccccccccccccceEEccCCcCCCCCCcccccCCCCCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCch
Q 002061 156 FTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPR 235 (973)
Q Consensus 156 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 235 (973)
+++. ..+..+++|++|++++|.+.. + +.+..+++|++|++++|++++. ..+..+++|++|+|++|++++..+
T Consensus 102 l~~~--~~l~~l~~L~~L~L~~n~i~~--~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~- 173 (291)
T 1h6t_A 102 VKDL--SSLKDLKKLKSLSLEHNGISD--I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP- 173 (291)
T ss_dssp CCCG--GGGTTCTTCCEEECTTSCCCC--C-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG-
T ss_pred CCCC--hhhccCCCCCEEECCCCcCCC--C-hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh-
Confidence 9863 348999999999999999875 3 5788999999999999999965 679999999999999999996554
Q ss_pred hhhccccccEEEeeccccCCcCCccccccccccEEEeecccccc
Q 002061 236 SIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYG 279 (973)
Q Consensus 236 ~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~ 279 (973)
+..+++|++|+|++|.+++ ++ .+..+++|+.|++++|++..
T Consensus 174 -l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 174 -LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp -GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEEEEEC
T ss_pred -hcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCCcccC
Confidence 8999999999999999995 44 48999999999999999875
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.81 E-value=1.1e-19 Score=215.34 Aligned_cols=187 Identities=24% Similarity=0.325 Sum_probs=108.7
Q ss_pred EEeecCCCCCccccccccCCccCcEeeCCCCcccCcCChhhhCCCCCcEEEecCCcccCCCCcccCCCCCCEEeccCccC
Q 002061 77 EISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYF 156 (973)
Q Consensus 77 ~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls~n~l 156 (973)
.+.+....+++.+ .+..|++|+.|+|++|.+.. +| .|..+++|+.|+|++|.+.+.++ +..+++|+.|+|++|.+
T Consensus 25 ~l~l~~~~i~~~~--~~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~l 99 (605)
T 1m9s_A 25 KDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP-LTNLKNLGWLFLDENKI 99 (605)
T ss_dssp HHHTTCSCTTSEE--CHHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG-GGGCTTCCEEECCSSCC
T ss_pred HHhccCCCccccc--chhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh-hccCCCCCEEECcCCCC
Confidence 3344444444332 24566666777777766653 33 46666677777777776666555 66666666666666666
Q ss_pred CCccccccccccccceEEccCCcCCCCCCcccccCCCCCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCchh
Q 002061 157 TGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRS 236 (973)
Q Consensus 157 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 236 (973)
++. ..+..+++|++|+|++|.+.. + +.+..+++|+.|+|++|++++. ..+..+++|+.|+|++|+|++..|
T Consensus 100 ~~l--~~l~~l~~L~~L~Ls~N~l~~--l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~-- 170 (605)
T 1m9s_A 100 KDL--SSLKDLKKLKSLSLEHNGISD--I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-- 170 (605)
T ss_dssp CCC--TTSTTCTTCCEEECTTSCCCC--C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--
T ss_pred CCC--hhhccCCCCCEEEecCCCCCC--C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--
Confidence 542 245666666666666666543 2 3455566666666666666543 455566666666666666654433
Q ss_pred hhccccccEEEeeccccCCcCCccccccccccEEEeecccccc
Q 002061 237 IRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYG 279 (973)
Q Consensus 237 l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~ 279 (973)
+..+++|+.|+|++|+|++. ..+..+++|+.|+|++|.+.+
T Consensus 171 l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~ 211 (605)
T 1m9s_A 171 LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLN 211 (605)
T ss_dssp GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEEC
T ss_pred hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcC
Confidence 55566666666666666532 235555666666666665553
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.81 E-value=1.3e-19 Score=187.19 Aligned_cols=153 Identities=20% Similarity=0.218 Sum_probs=142.0
Q ss_pred ceEeccccccccCCCccccCCCCcceEeccCCcCCCCCCCCCCCCCCCCEEEcccCCCCCCCChhhhcCCCCCEEEccCC
Q 002061 388 QRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNN 467 (973)
Q Consensus 388 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 467 (973)
+.+++++|.++ .+|..+. ++++.|+|++|+|++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 67899999998 5676554 78999999999999988889999999999999999999888999999999999999999
Q ss_pred cCCCCccccccccccCCEEEcCCcccccCCCccccccccccchhccccccccCCCccccccCCCCeeecCCCccCC
Q 002061 468 NFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTG 543 (973)
Q Consensus 468 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 543 (973)
+|+...+..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+++.
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence 9997777788999999999999999999999999999999999999999998888889999999999999999985
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.6e-19 Score=213.79 Aligned_cols=202 Identities=22% Similarity=0.284 Sum_probs=161.9
Q ss_pred CccCcEeeCCCCcccCcCChhhhCCCCCcEEEecCCcccCCCCcccCCCCCCEEeccCccCCCccccccccccccceEEc
Q 002061 96 LQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSI 175 (973)
Q Consensus 96 l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l 175 (973)
+..+..+.++.+.+++.++ +..|++|+.|+|++|.+...+ .++.+++|+.|+|++|.+++..+ +..+++|+.|+|
T Consensus 20 l~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~L 94 (605)
T 1m9s_A 20 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFL 94 (605)
T ss_dssp HHHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEEC
T ss_pred HHHHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCCCh-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEEC
Confidence 4556777888888876544 678999999999999998764 68999999999999999997655 889999999999
Q ss_pred cCCcCCCCCCcccccCCCCCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCchhhhccccccEEEeeccccCC
Q 002061 176 GDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTG 255 (973)
Q Consensus 176 ~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~ 255 (973)
++|.+.. + +.+..+++|++|+|++|++++. ..+..+++|+.|+|++|+|++. ..+..+++|+.|+|++|.|++
T Consensus 95 s~N~l~~--l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~ 167 (605)
T 1m9s_A 95 DENKIKD--L-SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD 167 (605)
T ss_dssp CSSCCCC--C-TTSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCC
T ss_pred cCCCCCC--C-hhhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCC
Confidence 9998864 3 3688889999999999999853 4688889999999999988854 578888888888888888886
Q ss_pred cCCccccccccccEEEeeccccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCcc
Q 002061 256 ELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMR 313 (973)
Q Consensus 256 ~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~ 313 (973)
..| +..+++|+.|+|++|++++. ..+..+++|+.|+|++|++.+.....+..+.
T Consensus 168 ~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p~~~~~~l~ 221 (605)
T 1m9s_A 168 IVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLV 221 (605)
T ss_dssp CGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCCCCCCSSCE
T ss_pred chh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCcccccccEE
Confidence 555 78888888888888888753 3577888888888888888765444444333
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.5e-19 Score=202.06 Aligned_cols=159 Identities=24% Similarity=0.168 Sum_probs=145.3
Q ss_pred cccceEeccccccccCCCcccc-CCCCcceEeccCCcCCCCCCCCCCCCCCCCEEEcccCCCCCCCChhhhcCCCCCEEE
Q 002061 385 KTIQRLRISDNHLSGKIPDGLW-ALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLI 463 (973)
Q Consensus 385 ~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 463 (973)
+.++.|+|++|+|++..+..|. .+++|+.|+|++|+|++..+..|..+++|++|+|++|+|++..+..|.++++|++|+
T Consensus 39 ~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 118 (361)
T 2xot_A 39 SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLL 118 (361)
T ss_dssp TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEE
Confidence 4589999999999988888887 999999999999999999999999999999999999999988888999999999999
Q ss_pred ccCCcCCCCccccccccccCCEEEcCCcccccCCCccc---cccccccchhccccccccCCCccccccCC--CCeeecCC
Q 002061 464 LTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEM---GDCARIVDLNLARNSLSGNIPRSLSLLSS--LNALNLSG 538 (973)
Q Consensus 464 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~---~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~--L~~L~L~~ 538 (973)
|++|+|++..|..|..+++|+.|+|++|+|++..+..| ..+++|+.|+|++|+|++..+..|..++. ++.|+|++
T Consensus 119 L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~ 198 (361)
T 2xot_A 119 LYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198 (361)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCS
T ss_pred CCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecC
Confidence 99999998889999999999999999999997766666 67999999999999999777778888887 48999999
Q ss_pred CccCC
Q 002061 539 NKLTG 543 (973)
Q Consensus 539 N~l~~ 543 (973)
|++..
T Consensus 199 N~~~C 203 (361)
T 2xot_A 199 NPLEC 203 (361)
T ss_dssp SCEEC
T ss_pred CCccC
Confidence 99984
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.3e-18 Score=180.90 Aligned_cols=158 Identities=22% Similarity=0.234 Sum_probs=144.0
Q ss_pred cccceEeccccccccCCCccccCCCCcceEeccCCcCCCCCCCCCCCCCCCCEEEcccCCCCCCCChhhhcCCCCCEEEc
Q 002061 385 KTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLIL 464 (973)
Q Consensus 385 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 464 (973)
.+-+.++.+++.++ .+|..+. ++|+.|+|++|++++..+..|..+++|++|+|++|+|+...+..|..+++|++|+|
T Consensus 19 Cs~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~L 95 (229)
T 3e6j_A 19 CSGTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDL 95 (229)
T ss_dssp EETTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred EeCCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEEC
Confidence 35678999999998 6676553 89999999999999999999999999999999999999777788899999999999
Q ss_pred cCCcCCCCccccccccccCCEEEcCCcccccCCCccccccccccchhccccccccCCCccccccCCCCeeecCCCccCCC
Q 002061 465 TNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGS 544 (973)
Q Consensus 465 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 544 (973)
++|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++++.
T Consensus 96 s~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 174 (229)
T 3e6j_A 96 GTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCE 174 (229)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTT
T ss_pred CCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCC
Confidence 999999888888999999999999999999 6788899999999999999999987778899999999999999999976
Q ss_pred CC
Q 002061 545 IP 546 (973)
Q Consensus 545 ~p 546 (973)
.+
T Consensus 175 c~ 176 (229)
T 3e6j_A 175 CR 176 (229)
T ss_dssp BG
T ss_pred cc
Confidence 65
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.76 E-value=7.7e-19 Score=186.64 Aligned_cols=171 Identities=23% Similarity=0.286 Sum_probs=121.2
Q ss_pred CCccCcEeeCCCCcccCcCChhhhCCCCCcEEEecCCcccCCCCcccCCCCCCEEeccCccCCCccccccccccccceEE
Q 002061 95 ALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLS 174 (973)
Q Consensus 95 ~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 174 (973)
.+.++..++++.|.+++ ++ .+..+++|++|++++|.++..+ .++.+++|++|+|++|.+++..+ +..+++|++|+
T Consensus 17 ~l~~l~~l~l~~~~i~~-~~-~~~~l~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~ 91 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTD-LV-SQKELSGVQNFNGDNSNIQSLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELS 91 (263)
T ss_dssp HHHHHHHHHHTCSCTTS-EE-CHHHHTTCSEEECTTSCCCCCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEE
T ss_pred HHHHHHHHHhcCCCccc-cc-chhhcCcCcEEECcCCCcccch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEE
Confidence 45666777777777764 33 5677777888888887777654 67777788888888887775544 77777777777
Q ss_pred ccCCcCCCCCCcccccCCCCCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCchhhhccccccEEEeeccccC
Q 002061 175 IGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLT 254 (973)
Q Consensus 175 l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 254 (973)
+++|.++. +|.... ++|++|+|++|++++. +.+..+++|++|+|++|+|++. + .+..+++|++|+|++|+++
T Consensus 92 L~~N~l~~--l~~~~~--~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~ 163 (263)
T 1xeu_A 92 VNRNRLKN--LNGIPS--ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEIT 163 (263)
T ss_dssp CCSSCCSC--CTTCCC--SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCC
T ss_pred CCCCccCC--cCcccc--CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCc
Confidence 77777753 333222 7788888888887753 3577778888888888887743 3 5777777777777777777
Q ss_pred CcCCccccccccccEEEeeccccccc
Q 002061 255 GELPAELGNLTLLQEFDISSNQMYGK 280 (973)
Q Consensus 255 ~~~~~~l~~l~~L~~L~Ls~N~l~~~ 280 (973)
+. ..+..+++|+.|++++|.+.+.
T Consensus 164 ~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 164 NT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp BC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred ch--HHhccCCCCCEEeCCCCcccCC
Confidence 54 5677777788888887777643
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.76 E-value=2.1e-18 Score=173.95 Aligned_cols=113 Identities=27% Similarity=0.389 Sum_probs=76.1
Q ss_pred CCCEEEcccCCCCCCCCh-hhhcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCCccccccccccchhc
Q 002061 434 SLSQLVLQNNRFSGELPS-ELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNL 512 (973)
Q Consensus 434 ~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 512 (973)
+|++|+|++|+|++..+. .|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|+.|+|
T Consensus 30 ~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 109 (192)
T 1w8a_A 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL 109 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEEC
Confidence 566666666666655443 3666677777777777777666666777777777777777777666666666667777777
Q ss_pred cccccccCCCccccccCCCCeeecCCCccCCCCC
Q 002061 513 ARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIP 546 (973)
Q Consensus 513 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 546 (973)
++|+|++..|..|..+++|++|+|++|++++..+
T Consensus 110 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 110 YDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 7777766666666667777777777776665544
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=8e-20 Score=215.15 Aligned_cols=216 Identities=21% Similarity=0.198 Sum_probs=153.1
Q ss_pred CCcccceeeeccCCccCCCCCccccccccccccccccccccccCChhhhhhhhHHHHHhhhccCCCCccccccCccccce
Q 002061 310 GDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQR 389 (973)
Q Consensus 310 ~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~ 389 (973)
...++|+.|+|++|+++ .+|..++.+++|+.|++++|..... +..+....+..+..|..++.+++|+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~-----------l~~ll~~~~~~~~~~~~l~~l~~L~~ 413 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLT-----------IILLMRALDPLLYEKETLQYFSTLKA 413 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHH-----------HHHHHHHHCTGGGHHHHHHHHHHHHH
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhh-----------HHHHHHhcccccCCHHHHHHHHhccc
Confidence 45677778888888887 6788888888888888876642111 11122234566677788888888888
Q ss_pred Ee-ccccccccCCCccccCCCCcceEeccCCcCCCCCCCCCCCCCCCCEEEcccCCCCCCCChhhhcCCCCCEEEccCCc
Q 002061 390 LR-ISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNN 468 (973)
Q Consensus 390 L~-Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 468 (973)
|+ ++.|.+. +|..+.+++|.++..++ ..|+.|+|++|+|++ +|. ++.+++|+.|+|++|+
T Consensus 414 L~~l~~n~~~-----------~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~ 474 (567)
T 1dce_A 414 VDPMRAAYLD-----------DLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNR 474 (567)
T ss_dssp HCGGGHHHHH-----------HHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSC
T ss_pred Ccchhhcccc-----------hhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccc
Confidence 88 7777653 35555666666654332 247788888888875 555 7888888888888888
Q ss_pred CCCCccccccccccCCEEEcCCcccccCCCccccccccccchhccccccccCC-CccccccCCCCeeecCCCccCCCCCh
Q 002061 469 FSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNI-PRSLSLLSSLNALNLSGNKLTGSIPD 547 (973)
Q Consensus 469 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~p~ 547 (973)
|+ .+|..|+.+++|+.|+|++|+|++ +| .++.+++|+.|+|++|+|++.. |..|..+++|+.|+|++|+|++.+|.
T Consensus 475 l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~ 551 (567)
T 1dce_A 475 LR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGI 551 (567)
T ss_dssp CC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSC
T ss_pred cc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccH
Confidence 87 667788888888888888888886 45 7788888888888888888766 78888888888888888888865553
Q ss_pred h---hhccc-CceEEc
Q 002061 548 N---LMKLK-LSSIDL 559 (973)
Q Consensus 548 ~---l~~l~-L~~l~l 559 (973)
. +..++ |+.||+
T Consensus 552 ~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 552 QERLAEMLPSVSSILT 567 (567)
T ss_dssp TTHHHHHCTTCSEEEC
T ss_pred HHHHHHHCcccCccCC
Confidence 2 12233 666654
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.75 E-value=2.8e-18 Score=173.95 Aligned_cols=155 Identities=16% Similarity=0.232 Sum_probs=116.3
Q ss_pred cccCccccceEeccccccccCCCccccCCCCcceEeccCCcCCCCCCCCCCCCCCCCEEEcccCCCCCCCChhhhcCCCC
Q 002061 380 SYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNL 459 (973)
Q Consensus 380 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L 459 (973)
..+.+++|++|++++|.|+ .+| .+..+++|++|++++|.++.. +.+..+++|++|++++|++++..|..++.+++|
T Consensus 39 ~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L 114 (197)
T 4ezg_A 39 TEAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSL 114 (197)
T ss_dssp BHHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSCC--GGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTC
T ss_pred ChhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCcc--hhhhcCCCCCEEEeECCccCcccChhhcCCCCC
Confidence 4477889999999999998 555 688888888888888866543 356777888888888888877677778888888
Q ss_pred CEEEccCCcCCCCccccccccccCCEEEcCCcc-cccCCCccccccccccchhccccccccCCCccccccCCCCeeecCC
Q 002061 460 ERLILTNNNFSGKIPSALGALRQLSSLHLEENA-LTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSG 538 (973)
Q Consensus 460 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 538 (973)
++|+|++|++++..|..+..+++|++|+|++|+ ++ .+| .+..+++|+.|++++|++++ ++ .+..+++|+.|++++
T Consensus 115 ~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~ 190 (197)
T 4ezg_A 115 TLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFS 190 (197)
T ss_dssp CEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECB
T ss_pred CEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeC
Confidence 888888888877677777888888888888887 55 344 57777777777777777774 33 567777777777777
Q ss_pred CccC
Q 002061 539 NKLT 542 (973)
Q Consensus 539 N~l~ 542 (973)
|++.
T Consensus 191 N~i~ 194 (197)
T 4ezg_A 191 QTIG 194 (197)
T ss_dssp C---
T ss_pred cccC
Confidence 7765
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=7.2e-20 Score=215.53 Aligned_cols=190 Identities=18% Similarity=0.203 Sum_probs=158.2
Q ss_pred cccccccccccccccccccCChhhhhhhhHHHHHhhhccCCCCccccccCccccceEeccccc-------------cccC
Q 002061 334 GRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNH-------------LSGK 400 (973)
Q Consensus 334 ~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~-------------l~~~ 400 (973)
..+++|+.|+|++|+|+ .+|..+..+.. |+.|++++|. +.+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~------------------------L~~L~l~~n~~l~~l~~ll~~~~~~~~ 400 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKE------------------------LQELEPENKWCLLTIILLMRALDPLLY 400 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHH------------------------HHHHCTTCHHHHHHHHHHHHHHCTGGG
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHH------------------------HHHhccccchhhhhHHHHHHhcccccC
Confidence 56789999999999997 56666555544 4444443332 5567
Q ss_pred CCccccCCCCcceEe-ccCCcCCCCCCCCCCCCCCCCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCccccccc
Q 002061 401 IPDGLWALPNVGMLD-FGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGA 479 (973)
Q Consensus 401 ~p~~~~~l~~L~~L~-L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 479 (973)
+|..+..+++|+.|+ ++.|.+ .+|+.+.+++|.++.. |. ..|+.|+|++|+|++ +|. |+.
T Consensus 401 ~~~~l~~l~~L~~L~~l~~n~~-----------~~L~~l~l~~n~i~~l-~~-----~~L~~L~Ls~n~l~~-lp~-~~~ 461 (567)
T 1dce_A 401 EKETLQYFSTLKAVDPMRAAYL-----------DDLRSKFLLENSVLKM-EY-----ADVRVLHLAHKDLTV-LCH-LEQ 461 (567)
T ss_dssp HHHHHHHHHHHHHHCGGGHHHH-----------HHHHHHHHHHHHHHHH-HH-----TTCSEEECTTSCCSS-CCC-GGG
T ss_pred CHHHHHHHHhcccCcchhhccc-----------chhhhhhhhccccccc-Cc-----cCceEEEecCCCCCC-CcC-ccc
Confidence 888888899999998 777755 3577788888888742 21 259999999999996 676 999
Q ss_pred cccCCEEEcCCcccccCCCccccccccccchhccccccccCCCccccccCCCCeeecCCCccCCCC-Chhhhccc-CceE
Q 002061 480 LRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSI-PDNLMKLK-LSSI 557 (973)
Q Consensus 480 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-p~~l~~l~-L~~l 557 (973)
+++|+.|+|++|+|+ .+|..|+++++|+.|+|++|+|++ +| .|..+++|+.|+|++|+|++.+ |..+..++ |+.|
T Consensus 462 l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L 538 (567)
T 1dce_A 462 LLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLL 538 (567)
T ss_dssp GTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEE
T ss_pred cccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEE
Confidence 999999999999999 789999999999999999999996 67 8999999999999999999877 99999986 9999
Q ss_pred EccCCccccccCc
Q 002061 558 DLSENQLSGSVPL 570 (973)
Q Consensus 558 ~ls~N~l~~~~p~ 570 (973)
+|++|++++.+|.
T Consensus 539 ~L~~N~l~~~~~~ 551 (567)
T 1dce_A 539 NLQGNSLCQEEGI 551 (567)
T ss_dssp ECTTSGGGGSSSC
T ss_pred EecCCcCCCCccH
Confidence 9999999998764
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.75 E-value=1.1e-18 Score=175.98 Aligned_cols=154 Identities=23% Similarity=0.392 Sum_probs=132.3
Q ss_pred CEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCccc-cccccccCCEEEcCCcccccCCCccccccccccchhccc
Q 002061 436 SQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPS-ALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLAR 514 (973)
Q Consensus 436 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 514 (973)
+.+++++|+++ .+|..+.. +|++|+|++|+|++..+. .|..+++|++|+|++|+|++..|..|.++++|+.|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 78899999997 66765543 899999999999977664 599999999999999999999999999999999999999
Q ss_pred cccccCCCccccccCCCCeeecCCCccCCCCChhhhccc-CceEEccCCccccccCcccc-cCCCCccccCCCCCccCcc
Q 002061 515 NSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLK-LSSIDLSENQLSGSVPLDFL-RMGGDGAFAGNEGLCLDQS 592 (973)
Q Consensus 515 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~-L~~l~ls~N~l~~~~p~~~~-~~~~~~~~~~n~~lc~~~~ 592 (973)
|+|++..+..|..+++|++|+|++|+|++.+|..+..++ |+.|+|++|+|+|.++..|. .+-....+.++...|+.|.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P~ 167 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPS 167 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSST
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCCh
Confidence 999999999999999999999999999999999998886 99999999999999996532 1111124556667787765
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.75 E-value=1.9e-18 Score=183.53 Aligned_cols=168 Identities=21% Similarity=0.288 Sum_probs=146.7
Q ss_pred ceEEEeecCCCCCccccccccCCccCcEeeCCCCcccCcCChhhhCCCCCcEEEecCCcccCCCCcccCCCCCCEEeccC
Q 002061 74 RVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSI 153 (973)
Q Consensus 74 ~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls~ 153 (973)
.++.+++.++.+++.. .+..+++|++|++++|.++ .+| .++.+++|++|+|++|++++.++ ++.+++|++|+|++
T Consensus 20 ~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~-l~~l~~L~~L~L~~ 94 (263)
T 1xeu_A 20 NAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP-LKDLTKLEELSVNR 94 (263)
T ss_dssp HHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG-GTTCSSCCEEECCS
T ss_pred HHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh-hccCCCCCEEECCC
Confidence 3566778888887543 6889999999999999998 466 79999999999999999999887 99999999999999
Q ss_pred ccCCCccccccccccccceEEccCCcCCCCCCcccccCCCCCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCC
Q 002061 154 NYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEF 233 (973)
Q Consensus 154 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 233 (973)
|.+++. |. +.. ++|++|++++|.++. + +.+..+++|++|+|++|++++. + .+..+++|++|+|++|+|++.
T Consensus 95 N~l~~l-~~-~~~-~~L~~L~L~~N~l~~--~-~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~- 165 (263)
T 1xeu_A 95 NRLKNL-NG-IPS-ACLSRLFLDNNELRD--T-DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT- 165 (263)
T ss_dssp SCCSCC-TT-CCC-SSCCEEECCSSCCSB--S-GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC-
T ss_pred CccCCc-Cc-ccc-CcccEEEccCCccCC--C-hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch-
Confidence 999864 33 233 999999999999975 3 4699999999999999999964 4 799999999999999999966
Q ss_pred chhhhccccccEEEeeccccCCc
Q 002061 234 PRSIRKLQKLWKIELYANNLTGE 256 (973)
Q Consensus 234 ~~~l~~l~~L~~L~L~~N~l~~~ 256 (973)
..+..+++|++|++++|.+++.
T Consensus 166 -~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 166 -GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp -TTSTTCCCCCEEEEEEEEEECC
T ss_pred -HHhccCCCCCEEeCCCCcccCC
Confidence 7799999999999999999955
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.73 E-value=1.2e-18 Score=211.82 Aligned_cols=154 Identities=21% Similarity=0.259 Sum_probs=115.9
Q ss_pred CccccccCccccceEeccccccccCCCccccCCCCcceEeccCCcCCCCCCCCCCCCCCCCEEEcccCCCCCCCChhhhc
Q 002061 376 EVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGR 455 (973)
Q Consensus 376 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~ 455 (973)
..|..+..++.|+.|+|++|.|. .+|..++.+++|++|+|++|+|+ .+|..|+.+++|++|+|++|+|+ .+|..|++
T Consensus 215 ~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~ 291 (727)
T 4b8c_D 215 MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGS 291 (727)
T ss_dssp -------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGG
T ss_pred cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcC
Confidence 55677888899999999999998 67777778999999999999988 55677788889999999999998 67888888
Q ss_pred CCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCCcccccccc-ccchhccccccccCCCccccccCCCCee
Q 002061 456 LTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCAR-IVDLNLARNSLSGNIPRSLSLLSSLNAL 534 (973)
Q Consensus 456 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 534 (973)
+++|++|+|++|.|+ .+|..|+.+++|+.|+|++|+|++.+|..+..+.. +..|+|++|.+++.+|.. |+.|
T Consensus 292 l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l 364 (727)
T 4b8c_D 292 CFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFI 364 (727)
T ss_dssp GTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC----------
T ss_pred CCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc------ccee
Confidence 999999999999887 67777888999999999999998888888766533 245788899888877764 4556
Q ss_pred ecCCC
Q 002061 535 NLSGN 539 (973)
Q Consensus 535 ~L~~N 539 (973)
++++|
T Consensus 365 ~l~~n 369 (727)
T 4b8c_D 365 EINTD 369 (727)
T ss_dssp -----
T ss_pred Eeecc
Confidence 67666
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.73 E-value=7.6e-18 Score=170.80 Aligned_cols=152 Identities=18% Similarity=0.237 Sum_probs=73.5
Q ss_pred hCCCCCcEEEecCCcccCCCCcccCCCCCCEEeccCccCCCccccccccccccceEEccCCcCCCCCCcccccCCCCCCE
Q 002061 118 SNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTY 197 (973)
Q Consensus 118 ~~l~~L~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ip~~~~~l~~L~~ 197 (973)
+.+++|++|++++|.+...+ .+..+++|++|++++|.++. +..+..+++|++
T Consensus 41 ~~l~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~l~~n~~~~---------------------------~~~l~~l~~L~~ 92 (197)
T 4ezg_A 41 AQMNSLTYITLANINVTDLT-GIEYAHNIKDLTINNIHATN---------------------------YNPISGLSNLER 92 (197)
T ss_dssp HHHHTCCEEEEESSCCSCCT-TGGGCTTCSEEEEESCCCSC---------------------------CGGGTTCTTCCE
T ss_pred hhcCCccEEeccCCCccChH-HHhcCCCCCEEEccCCCCCc---------------------------chhhhcCCCCCE
Confidence 45556666666666665433 45555666666666654431 123444444444
Q ss_pred EEcccCCCCCCCChhhhccCCCCeeecccccccCCCchhhhccccccEEEeeccc-cCCcCCccccccccccEEEeeccc
Q 002061 198 LFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANN-LTGELPAELGNLTLLQEFDISSNQ 276 (973)
Q Consensus 198 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~-l~~~~~~~l~~l~~L~~L~Ls~N~ 276 (973)
|++++|++++..+..++.+++|++|+|++|++++..|..++.+++|++|+|++|. ++ .+| .+..+++|++|++++|+
T Consensus 93 L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~ 170 (197)
T 4ezg_A 93 LRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDG 170 (197)
T ss_dssp EEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBC
T ss_pred EEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCC
Confidence 4444444444344444455555555555555544444444445555555555554 33 222 34445555555555555
Q ss_pred cccccCCccCCCCCccEEEcccCCC
Q 002061 277 MYGKLPEEIGNLKNLTVFQCFKNNF 301 (973)
Q Consensus 277 l~~~~p~~~~~l~~L~~L~l~~N~l 301 (973)
+++ ++ .+..+++|+.|++++|+|
T Consensus 171 i~~-~~-~l~~l~~L~~L~l~~N~i 193 (197)
T 4ezg_A 171 VHD-YR-GIEDFPKLNQLYAFSQTI 193 (197)
T ss_dssp CCC-CT-TGGGCSSCCEEEECBC--
T ss_pred CcC-hH-HhccCCCCCEEEeeCccc
Confidence 442 22 344444444444444444
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.71 E-value=2.8e-18 Score=189.16 Aligned_cols=287 Identities=12% Similarity=0.048 Sum_probs=147.0
Q ss_pred CCCCCEEEcccCCCCCCCChhhhc-cCCCCeeeccccccc--CCCchhhhccccccEEEeeccccCCcCCccccc-----
Q 002061 192 LKNLTYLFLAHCNLRGRIPESISE-LRELGTLDICRNKIS--GEFPRSIRKLQKLWKIELYANNLTGELPAELGN----- 263 (973)
Q Consensus 192 l~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L~L~~N~l~--~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~----- 263 (973)
+.+++.|.++++ +...-...+.. +++|++|||++|+|. ...... ++.++.+.+..|.|. +..|.+
T Consensus 24 ~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~---~~~~~~~~~~~~~I~---~~aF~~~~~~~ 96 (329)
T 3sb4_A 24 ANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGT---YPNGKFYIYMANFVP---AYAFSNVVNGV 96 (329)
T ss_dssp HHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSS---SGGGCCEEECTTEEC---TTTTEEEETTE
T ss_pred hCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCcccc---ccccccccccccccC---HHHhccccccc
Confidence 456777777654 22111123333 566777777777766 211111 222444455555332 234555
Q ss_pred ---cccccEEEeeccccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeeccCCcc----CCCCCcccccc
Q 002061 264 ---LTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRF----SGPFPENLGRY 336 (973)
Q Consensus 264 ---l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l----~~~~~~~l~~l 336 (973)
+++|+.|+|.+ .++...+..|.++++|+.+++.+|.+....+.+|.++.++..+.+..+.. .......|..+
T Consensus 97 ~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~ 175 (329)
T 3sb4_A 97 TKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEG 175 (329)
T ss_dssp EEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEES
T ss_pred ccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccc
Confidence 66666666666 56555555566666666666666666655555666665555555444211 11222333334
Q ss_pred cccc-ccccccccccccCChhhhhhhhHHHHHhhhccCCCCccccccCccccceEeccccccccCCCccccCCCCcceEe
Q 002061 337 TALT-DVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLD 415 (973)
Q Consensus 337 ~~L~-~L~Ls~N~l~~~~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 415 (973)
..|+ .+.+.... .++..+. ..-....++..+.+.++-.. .....+.
T Consensus 176 ~~L~~~i~~~~~~---~l~~~~~--------------------~~~~~~~~~~~l~~~~~l~~-~~~~~l~--------- 222 (329)
T 3sb4_A 176 EPLETTIQVGAMG---KLEDEIM--------------------KAGLQPRDINFLTIEGKLDN-ADFKLIR--------- 222 (329)
T ss_dssp CCCEEEEEECTTC---CHHHHHH--------------------HTTCCGGGCSEEEEEECCCH-HHHHHHH---------
T ss_pred cccceeEEecCCC---cHHHHHh--------------------hcccCccccceEEEeeeecH-HHHHHHH---------
Confidence 4443 22222111 1111100 00012233444444433111 0000000
Q ss_pred ccCCcCCCCCCCCCCCCCCCCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCccccccccccCC-EEEcCCcccc
Q 002061 416 FGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLS-SLHLEENALT 494 (973)
Q Consensus 416 L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~-~L~Ls~N~l~ 494 (973)
..+++|+.|+|++|+++.+.+..|.++++|+.|+|.+| ++.+.+.+|.++++|+ .|++.+ .++
T Consensus 223 --------------~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~ 286 (329)
T 3sb4_A 223 --------------DYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVT 286 (329)
T ss_dssp --------------HHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCC
T ss_pred --------------HhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cce
Confidence 12455666666666666555556666666666666666 5545555666666666 666666 565
Q ss_pred cCCCccccccccccchhccccccccCCCccccccCCCCeee
Q 002061 495 GSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALN 535 (973)
Q Consensus 495 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 535 (973)
.+.+.+|.+|++|+.+++++|+++...+.+|.++++|+.++
T Consensus 287 ~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 287 AIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp EECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred EEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence 56666677777777777777777666666677777777665
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.71 E-value=5.7e-18 Score=186.75 Aligned_cols=292 Identities=10% Similarity=0.033 Sum_probs=190.6
Q ss_pred Ccccccccc--ccccceEEccCCcCCCCCCcccccC-CCCCCEEEcccCCCC--CCCChhhhccCCCCeeecccccccCC
Q 002061 158 GRFPRWVVN--LTQLVSLSIGDNVYDEAEIPESIGN-LKNLTYLFLAHCNLR--GRIPESISELRELGTLDICRNKISGE 232 (973)
Q Consensus 158 ~~~~~~~~~--l~~L~~L~l~~n~l~~~~ip~~~~~-l~~L~~L~L~~n~l~--~~~~~~~~~l~~L~~L~L~~N~l~~~ 232 (973)
|.++..+.. +.+|++|.++++- ....+ ..+.. +++|++|+|++|++. ...+. .++.+..+.+..|.|.
T Consensus 13 g~l~~~l~~~~~~~l~~L~l~g~i-~~~~~-~~l~~~l~~L~~LdLs~n~i~~~~~~~~---~~~~~~~~~~~~~~I~-- 85 (329)
T 3sb4_A 13 GTLISMMTEEEANSITHLTLTGKL-NAEDF-RHLRDEFPSLKVLDISNAEIKMYSGKAG---TYPNGKFYIYMANFVP-- 85 (329)
T ss_dssp TCGGGGSCHHHHHHCSEEEEEEEE-CHHHH-HHHHHSCTTCCEEEEEEEEECCEEESSS---SSGGGCCEEECTTEEC--
T ss_pred CcHHhhccchhhCceeEEEEeccc-cHHHH-HHHHHhhccCeEEecCcceeEEecCccc---cccccccccccccccC--
Confidence 344444543 7889999998752 21122 23434 889999999999998 22222 2233556666666543
Q ss_pred Cchhhhc--------cccccEEEeeccccCCcCCccccccccccEEEeeccccccccCCccCCCCCccEEEcccCC----
Q 002061 233 FPRSIRK--------LQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNN---- 300 (973)
Q Consensus 233 ~~~~l~~--------l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~---- 300 (973)
+.+|.+ +++|+.|+|.+ .++...+..|.++++|+.|+++.|.+....+..|.++.++..+....+.
T Consensus 86 -~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~ 163 (329)
T 3sb4_A 86 -AYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRF 163 (329)
T ss_dssp -TTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHT
T ss_pred -HHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhc
Confidence 456777 99999999999 8887777889999999999999999987888889998888888776632
Q ss_pred CCCCCCCCcCCcccce-eeeccCCccCCCCCccc----cccccccccccccccccccCChhhhhhhhHHHHHhhhccCCC
Q 002061 301 FSGEFPSGFGDMRKLF-AFSIYGNRFSGPFPENL----GRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSG 375 (973)
Q Consensus 301 l~~~~p~~~~~l~~L~-~L~l~~N~l~~~~~~~l----~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~ll~l~n~~~~ 375 (973)
........|.++..|+ .+.+.... .++..+ ....+++.+.+.++-.. . .+ .
T Consensus 164 ~~~i~~~~f~~~~~L~~~i~~~~~~---~l~~~~~~~~~~~~~~~~l~~~~~l~~-~---~~---~-------------- 219 (329)
T 3sb4_A 164 KNRWEHFAFIEGEPLETTIQVGAMG---KLEDEIMKAGLQPRDINFLTIEGKLDN-A---DF---K-------------- 219 (329)
T ss_dssp STTTTTSCEEESCCCEEEEEECTTC---CHHHHHHHTTCCGGGCSEEEEEECCCH-H---HH---H--------------
T ss_pred cccccccccccccccceeEEecCCC---cHHHHHhhcccCccccceEEEeeeecH-H---HH---H--------------
Confidence 2333445677777777 45443321 112111 12344455555443211 0 00 0
Q ss_pred CccccccCccccceEeccccccccCCCccccCCCCcceEeccCCcCCCCCCCCCCCCCCCC-EEEcccCCCCCCCChhhh
Q 002061 376 EVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLS-QLVLQNNRFSGELPSELG 454 (973)
Q Consensus 376 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~-~L~L~~N~l~~~~p~~~~ 454 (973)
.....+++|++|+|++|+++.+.+..|.++++|+.|+|.+| ++.+....|.++++|+ .+++.+ +++.+.+.+|.
T Consensus 220 ---~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~ 294 (329)
T 3sb4_A 220 ---LIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFM 294 (329)
T ss_dssp ---HHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTT
T ss_pred ---HHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhh
Confidence 00113688999999999998777777877877777777776 6666666677777776 777666 55555556666
Q ss_pred cCCCCCEEEccCCcCCCCccccccccccCCEEE
Q 002061 455 RLTNLERLILTNNNFSGKIPSALGALRQLSSLH 487 (973)
Q Consensus 455 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 487 (973)
++++|+.|++++|+++.+.+.+|.++++|+.|+
T Consensus 295 ~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 295 GCDNLRYVLATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp TCTTEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred CCccCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence 666666666666666655555666666666655
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.8e-17 Score=167.08 Aligned_cols=132 Identities=23% Similarity=0.368 Sum_probs=98.2
Q ss_pred CEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCCccccccccccchhcccc
Q 002061 436 SQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARN 515 (973)
Q Consensus 436 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 515 (973)
+.+++++|+++ .+|..+. ++|++|+|++|+|+ .+|..|.++++|++|+|++|+|++..+..|.++++|+.|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 45666667666 4454332 46777777777776 56677777777777777777777777777777778888888888
Q ss_pred ccccCCCccccccCCCCeeecCCCccCCCCChhhhccc-CceEEccCCccccccCcc
Q 002061 516 SLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLK-LSSIDLSENQLSGSVPLD 571 (973)
Q Consensus 516 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~-L~~l~ls~N~l~~~~p~~ 571 (973)
+|++..|..|..+++|+.|+|++|+|++..+..+..++ |+.|+|++|+|.|.|...
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~l~ 145 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCNMQ 145 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGGGH
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCcCH
Confidence 88777777788888888888888888865555676665 888888899998888764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=1.7e-17 Score=175.71 Aligned_cols=136 Identities=17% Similarity=0.204 Sum_probs=104.7
Q ss_pred CcccCcccccCceEEEEEEecCCCcE--EEEEeeeccc-c-------------------------HHHHHHHHHHHHhcC
Q 002061 678 LEEDNLIGSGGTGKVYRLDLKKNAGT--VAVKQLWKGD-G-------------------------VKVFAAEMEILGKIR 729 (973)
Q Consensus 678 ~~~~~~lG~G~~g~V~~a~~~~~~~~--vavK~~~~~~-~-------------------------~~~~~~E~~~l~~l~ 729 (973)
|++.+.||+|+||.||+|.+..+|+. ||||+++... . ...+.+|+++++++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999999666888 9999864321 0 125788999999998
Q ss_pred CCce--eeEEEEEEeCCeeEEEEEccCC-C----chHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEe
Q 002061 730 HRNI--LKLYACLLKGGSSFLVLEYMPN-G----NLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIH 802 (973)
Q Consensus 730 hpni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH 802 (973)
|+++ ..++++ ...++||||+.+ | +|.++... .++.....++.|++.|++|||. +.+|+|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~--~~givH 194 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQ--EAELVH 194 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHH--TSCEEC
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHH--HCCEEe
Confidence 8764 333332 356899999942 4 66655432 1233556889999999999994 459999
Q ss_pred cCCCCCCeeecCCCCeEEecccCcccc
Q 002061 803 RDIKSSNILLDEDYEPKIADFGVAKIA 829 (973)
Q Consensus 803 ~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 829 (973)
|||||+|||++. .++|+|||+|...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999998 9999999999754
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.68 E-value=1.5e-16 Score=156.79 Aligned_cols=135 Identities=21% Similarity=0.232 Sum_probs=101.6
Q ss_pred CCccCcEeeCCCCccc-CcCChhhhCCCCCcEEEecCCcccCCCCcccCCCCCCEEeccCccCCCccccccccccccceE
Q 002061 95 ALQSLTVLSLPFNVLS-GKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSL 173 (973)
Q Consensus 95 ~l~~L~~L~Ls~n~l~-~~~p~~l~~l~~L~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 173 (973)
..++|++|+|++|.++ +.+|..+..+++|++|+|++|.+++. +.++.+++|++|+|++|.+++.+|..+..+++|++|
T Consensus 22 ~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100 (168)
T ss_dssp CTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC-SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred CcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh-hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence 3477888888888887 77888888888888899888888877 778888888888888888887677777777777777
Q ss_pred EccCCcCCCCCCcccccCCCCCCEEEcccCCCCCCCC---hhhhccCCCCeeeccccccc
Q 002061 174 SIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIP---ESISELRELGTLDICRNKIS 230 (973)
Q Consensus 174 ~l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~~---~~~~~l~~L~~L~L~~N~l~ 230 (973)
++++|.++....+..+..+++|++|++++|.+++..+ ..+..+++|++|++++|.+.
T Consensus 101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 7777777643333566777777777777777775444 36666777777777776665
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.67 E-value=2.5e-16 Score=155.20 Aligned_cols=133 Identities=20% Similarity=0.163 Sum_probs=108.7
Q ss_pred ccccceEeccccccc-cCCCccccCCCCcceEeccCCcCCCCCCCCCCCCCCCCEEEcccCCCCCCCChhhhcCCCCCEE
Q 002061 384 CKTIQRLRISDNHLS-GKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERL 462 (973)
Q Consensus 384 l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 462 (973)
.++|++|+|++|+++ +.+|..+..+++|+.|++++|++++. ..+..+++|++|+|++|++++.+|..+..+++|++|
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence 378999999999998 67888888899999999999998876 677888889999999998887788888888888888
Q ss_pred EccCCcCCCCc-cccccccccCCEEEcCCcccccCCC---ccccccccccchhccccccc
Q 002061 463 ILTNNNFSGKI-PSALGALRQLSSLHLEENALTGSIP---NEMGDCARIVDLNLARNSLS 518 (973)
Q Consensus 463 ~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls~N~l~ 518 (973)
+|++|++++.. +..+..+++|++|++++|++++..+ ..+..+++|+.|++++|.+.
T Consensus 101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 88888888543 2678888888888888888886555 46777777777777777776
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.66 E-value=3.7e-16 Score=157.35 Aligned_cols=111 Identities=26% Similarity=0.316 Sum_probs=101.4
Q ss_pred CCCCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCCccccccccccchhc
Q 002061 433 TSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNL 512 (973)
Q Consensus 433 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 512 (973)
++|++|+|++|+|+ .+|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..|..|.++++|+.|+|
T Consensus 31 ~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L 109 (193)
T 2wfh_A 31 RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSL 109 (193)
T ss_dssp TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEEC
Confidence 57889999999998 67789999999999999999999888889999999999999999999988899999999999999
Q ss_pred cccccccCCCccccccCCCCeeecCCCccCCC
Q 002061 513 ARNSLSGNIPRSLSLLSSLNALNLSGNKLTGS 544 (973)
Q Consensus 513 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 544 (973)
++|+|++..+..|..+++|+.|+|++|++...
T Consensus 110 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~ 141 (193)
T 2wfh_A 110 HGNDISVVPEGAFNDLSALSHLAIGANPLYCD 141 (193)
T ss_dssp CSSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred CCCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence 99999977777899999999999999999853
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.65 E-value=2e-16 Score=152.35 Aligned_cols=130 Identities=22% Similarity=0.242 Sum_probs=97.8
Q ss_pred CCccCcEeeCCCCccc-CcCChhhhCCCCCcEEEecCCcccCCCCcccCCCCCCEEeccCccCCCccccccccccccceE
Q 002061 95 ALQSLTVLSLPFNVLS-GKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSL 173 (973)
Q Consensus 95 ~l~~L~~L~Ls~n~l~-~~~p~~l~~l~~L~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 173 (973)
..++|++|++++|.++ +.+|..+..+++|++|+|++|.+++. +.++.+++|++|+|++|.+++.+|..+..+++|++|
T Consensus 15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC-TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc-hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 3477889999999888 78888888889999999999988877 678888888999998888887677777777777777
Q ss_pred EccCCcCCCCCCcccccCCCCCCEEEcccCCCCCCCC---hhhhccCCCCeeecc
Q 002061 174 SIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIP---ESISELRELGTLDIC 225 (973)
Q Consensus 174 ~l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~~---~~~~~l~~L~~L~L~ 225 (973)
++++|.++....+..++.+++|++|++++|++++..+ ..+..+++|++|+++
T Consensus 94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 7777777543333566667777777777777765544 456666666666664
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.64 E-value=6.3e-16 Score=153.66 Aligned_cols=131 Identities=21% Similarity=0.279 Sum_probs=68.5
Q ss_pred CEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCCccccccccccchhcccc
Q 002061 436 SQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARN 515 (973)
Q Consensus 436 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 515 (973)
+.+++++|+++ .+|..+ .++|+.|++++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|
T Consensus 10 ~~l~~~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 86 (177)
T 2o6r_A 10 TEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86 (177)
T ss_dssp TEEECCSSCCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence 34444455444 233222 234555555555555444444555555555555555555444444555555555555555
Q ss_pred ccccCCCccccccCCCCeeecCCCccCCCCChhhhccc-CceEEccCCccccccC
Q 002061 516 SLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLK-LSSIDLSENQLSGSVP 569 (973)
Q Consensus 516 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~-L~~l~ls~N~l~~~~p 569 (973)
+|++..+..|..+++|+.|+|++|++++..+..+..++ |+.|+|++|+|.|.+|
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 55554444555555666666666666544443344443 5666666666666555
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.64 E-value=5.2e-16 Score=149.45 Aligned_cols=129 Identities=21% Similarity=0.184 Sum_probs=97.7
Q ss_pred CccccceEeccccccc-cCCCccccCCCCcceEeccCCcCCCCCCCCCCCCCCCCEEEcccCCCCCCCChhhhcCCCCCE
Q 002061 383 DCKTIQRLRISDNHLS-GKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLER 461 (973)
Q Consensus 383 ~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 461 (973)
..++|++|++++|.++ +.+|..+..+++|+.|++++|++++. ..+..+++|++|+|++|++++.+|..+..+++|++
T Consensus 15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~ 92 (149)
T 2je0_A 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTH 92 (149)
T ss_dssp CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCE
T ss_pred CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCE
Confidence 3478999999999998 77888888888888888888888876 66777788888888888887667777777788888
Q ss_pred EEccCCcCCCC-ccccccccccCCEEEcCCcccccCCC---ccccccccccchhcc
Q 002061 462 LILTNNNFSGK-IPSALGALRQLSSLHLEENALTGSIP---NEMGDCARIVDLNLA 513 (973)
Q Consensus 462 L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls 513 (973)
|++++|++++. .+..+..+++|++|++++|++++..+ ..+..+++|+.|+++
T Consensus 93 L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 93 LNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp EECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred EECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 88888887753 33667777777777777777776554 456666666666655
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.63 E-value=1.1e-15 Score=151.88 Aligned_cols=131 Identities=22% Similarity=0.271 Sum_probs=103.2
Q ss_pred eEeccCCcCCCCCCCCCCCCCCCCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcc
Q 002061 413 MLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENA 492 (973)
Q Consensus 413 ~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 492 (973)
.+++++|+++..+.. ..++|++|++++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|+
T Consensus 11 ~l~~~~~~l~~~p~~---~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~ 87 (177)
T 2o6r_A 11 EIRCNSKGLTSVPTG---IPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENK 87 (177)
T ss_dssp EEECCSSCCSSCCTT---CCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEecCCCCccCCCC---CCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCC
Confidence 344444444433321 23578888888888887666777888888888888888887777778888889999999998
Q ss_pred cccCCCccccccccccchhccccccccCCCccccccCCCCeeecCCCccCCCCC
Q 002061 493 LTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIP 546 (973)
Q Consensus 493 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 546 (973)
|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++++..|
T Consensus 88 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 88 LQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred ccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 888777788888999999999999987777777889999999999999997666
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.60 E-value=9.2e-15 Score=164.41 Aligned_cols=87 Identities=13% Similarity=0.175 Sum_probs=36.4
Q ss_pred ChhhhcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCCccccccccccchhccccccccCCCccccccC
Q 002061 450 PSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLS 529 (973)
Q Consensus 450 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 529 (973)
+..|.++++|+.++|. |.++.+...+|.++++|+.++|..| ++.+.+.+|.++ +|+.+++++|.+....+..|.+++
T Consensus 293 ~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~ 369 (401)
T 4fdw_A 293 PYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFP 369 (401)
T ss_dssp TTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSC
T ss_pred HHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCC
Confidence 3344444444444444 2233333344444444444444332 333334444444 444444444444433334444332
Q ss_pred -CCCeeecCCC
Q 002061 530 -SLNALNLSGN 539 (973)
Q Consensus 530 -~L~~L~L~~N 539 (973)
+++.|++..|
T Consensus 370 ~~l~~l~vp~~ 380 (401)
T 4fdw_A 370 DDITVIRVPAE 380 (401)
T ss_dssp TTCCEEEECGG
T ss_pred CCccEEEeCHH
Confidence 3444444333
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.59 E-value=1.5e-14 Score=162.63 Aligned_cols=263 Identities=8% Similarity=0.102 Sum_probs=185.0
Q ss_pred ccccEEEeeccccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeeccCCccCCCCCcccccccccccccc
Q 002061 265 TLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDI 344 (973)
Q Consensus 265 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L 344 (973)
..++.+.+.. .++......|.+. +|+.+.+..| ++.....+|.+. +|+.+.+.. .++...+.+|..+.+|+.+++
T Consensus 113 ~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l 187 (401)
T 4fdw_A 113 KGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADL 187 (401)
T ss_dssp SSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEEC
T ss_pred CCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeec
Confidence 4445555443 2333444445543 5666665544 544444555553 466666654 455455566777777777777
Q ss_pred ccccccccCChhhhhhhhHHHHHhhhccCCCCccccccCccccceEeccccccccCCCccccCCCCcceEeccCCcCCCC
Q 002061 345 SENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGG 424 (973)
Q Consensus 345 s~N~l~~~~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 424 (973)
++|+++ .+|. ..|. +.+|+.+.|..+ ++.+...+|.++++|+.+++..| ++.+
T Consensus 188 ~~n~l~-~I~~-----------------------~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I 240 (401)
T 4fdw_A 188 SKTKIT-KLPA-----------------------STFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTI 240 (401)
T ss_dssp TTSCCS-EECT-----------------------TTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEE
T ss_pred CCCcce-Eech-----------------------hhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCc
Confidence 777666 2221 1233 467777888744 66566777888888888888764 6666
Q ss_pred CCCCCCCCCCCCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCC-----CCccccccccccCCEEEcCCcccccCCCc
Q 002061 425 ISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFS-----GKIPSALGALRQLSSLHLEENALTGSIPN 499 (973)
Q Consensus 425 ~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 499 (973)
....|.. .+|+.+.| .|.++...+.+|.++++|+.+++.+|.+. .+.+.+|.++++|+.++|. |.++.+...
T Consensus 241 ~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~ 317 (401)
T 4fdw_A 241 GQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQG 317 (401)
T ss_dssp CTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTT
T ss_pred ccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhh
Confidence 6677777 78999999 45677677888999999999999988775 4567789999999999999 458878889
Q ss_pred cccccccccchhccccccccCCCccccccCCCCeeecCCCccCCCCChhhhccc--CceEEccCCcc
Q 002061 500 EMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLK--LSSIDLSENQL 564 (973)
Q Consensus 500 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~--L~~l~ls~N~l 564 (973)
+|.++.+|+.++|..| ++...+.+|.++ +|+.+++++|.+....+..|..++ +..|++-.|.+
T Consensus 318 aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~ 382 (401)
T 4fdw_A 318 LLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESV 382 (401)
T ss_dssp TTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGH
T ss_pred hhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHH
Confidence 9999999999999665 776778899999 999999999998865556666653 67777765544
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.55 E-value=7.7e-15 Score=145.59 Aligned_cols=134 Identities=22% Similarity=0.277 Sum_probs=84.5
Q ss_pred cccCccccceEeccccccccCCCccccCCCCcceEeccCCcCCCCCCCCCCCCCCCCEEEcccCCCCCCCChhhhcCCCC
Q 002061 380 SYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNL 459 (973)
Q Consensus 380 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L 459 (973)
.+.++.+|++|+|++|+++. +|......++|+.|++++|++++. +.+..+++|++|+|++|+|++..+..+..+++|
T Consensus 14 ~~~~~~~L~~L~l~~n~l~~-i~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EEECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hcCCcCCceEEEeeCCCCch-hHHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 45667788888888888874 454332233777777777777764 456666777777777777765544555667777
Q ss_pred CEEEccCCcCCCCccc--cccccccCCEEEcCCcccccCCCc----cccccccccchhccccccc
Q 002061 460 ERLILTNNNFSGKIPS--ALGALRQLSSLHLEENALTGSIPN----EMGDCARIVDLNLARNSLS 518 (973)
Q Consensus 460 ~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~Ls~N~l~ 518 (973)
++|+|++|+|+ .+|. .+..+++|+.|++++|.++. +|. .+..+++|+.||+++|.+.
T Consensus 91 ~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 91 TELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCHH
Confidence 77777777775 3444 56666666666666666653 333 2555555555555555543
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.55 E-value=1e-15 Score=167.57 Aligned_cols=136 Identities=15% Similarity=0.118 Sum_probs=98.4
Q ss_pred CcccCcccccCceEEEEEEecCCCcEEEEEeeeccc----------------cHH--------HHHHHHHHHHhcCCCce
Q 002061 678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----------------GVK--------VFAAEMEILGKIRHRNI 733 (973)
Q Consensus 678 ~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----------------~~~--------~~~~E~~~l~~l~hpni 733 (973)
|++...||+|+||.||+|.+.. |+.||||+++... ... ...+|...+.++.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~-G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEK-GKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTT-CCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECCC-CCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 8899999999999999999864 8999999864310 001 12356777777755544
Q ss_pred eeEEEEEEeCCeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeec
Q 002061 734 LKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD 813 (973)
Q Consensus 734 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~ 813 (973)
....-+... ..++||||++|++|.++.. . .....++.|++.+|.++| +.+||||||||.|||++
T Consensus 176 ~vp~p~~~~--~~~LVME~i~G~~L~~l~~---------~--~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~ 239 (397)
T 4gyi_A 176 PVPEPIAQS--RHTIVMSLVDALPMRQVSS---------V--PDPASLYADLIALILRLA---KHGLIHGDFNEFNILIR 239 (397)
T ss_dssp SCCCEEEEE--TTEEEEECCSCEEGGGCCC---------C--SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE
T ss_pred CCCeeeecc--CceEEEEecCCccHhhhcc---------c--HHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEe
Confidence 322111111 2479999999988854321 1 123467899999999999 77999999999999998
Q ss_pred CCC----------CeEEecccCccccc
Q 002061 814 EDY----------EPKIADFGVAKIAE 830 (973)
Q Consensus 814 ~~~----------~~kl~Dfgl~~~~~ 830 (973)
+++ .+.|.||+-+....
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred CCCCcccccccccceEEEEeCCcccCC
Confidence 876 38999999876543
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.54 E-value=6.1e-14 Score=158.51 Aligned_cols=303 Identities=10% Similarity=0.023 Sum_probs=146.0
Q ss_pred ccCCCCCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCchhhhccccccEEEeeccccCCcCCcccccccccc
Q 002061 189 IGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQ 268 (973)
Q Consensus 189 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~ 268 (973)
|.++++|+.++|.++ ++.....+|..+++|+.+.+..+ +......+|.....+..... +.+.......|.++++|+
T Consensus 90 F~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~~~~~~~~--~~~~~i~~~aF~~c~~L~ 165 (394)
T 4fs7_A 90 FENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCDFKEITIP--EGVTVIGDEAFATCESLE 165 (394)
T ss_dssp TTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCCCSEEECC--TTCCEECTTTTTTCTTCC
T ss_pred hhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeecccccccccC--ccccccchhhhcccCCCc
Confidence 344444444444322 33233344555555555444332 22223333443332221111 111212234555666666
Q ss_pred EEEeeccccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeeccCCccCCCCCcccccccccccccccccc
Q 002061 269 EFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQ 348 (973)
Q Consensus 269 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~ 348 (973)
.+.+..+.. ......|.++.+|+.+.+..| ++.....+|.++..|+.+.+..+... +.+.......|+.+.+..+.
T Consensus 166 ~i~l~~~~~-~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~~ 241 (394)
T 4fs7_A 166 YVSLPDSME-TLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY--LGDFALSKTGVKNIIIPDSF 241 (394)
T ss_dssp EEECCTTCC-EECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE--ECTTTTTTCCCCEEEECTTC
T ss_pred EEecCCccc-eeccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceE--eehhhcccCCCceEEECCCc
Confidence 666654432 234444555555665555443 33333445555555555554443322 11122222334444332211
Q ss_pred ccccCChhhhhhhhHHHHHhhhccCCCCccccccCccccceEeccccccccCCCccccCCCCcceEeccCCcCCCCCCCC
Q 002061 349 FSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPL 428 (973)
Q Consensus 349 l~~~~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~ 428 (973)
- ......|..+..|+.+.+..+... .....|.....++.+.+..+.+ ....
T Consensus 242 ~-------------------------~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i---~~~~ 292 (394)
T 4fs7_A 242 T-------------------------ELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIV---PEKT 292 (394)
T ss_dssp C-------------------------EECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEE---CTTT
T ss_pred e-------------------------ecccccccccccceeEEcCCCcce-eeccccccccccceeccCceee---cccc
Confidence 1 112234556666666666665443 4555566666666666555432 2334
Q ss_pred CCCCCCCCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCCcccccccccc
Q 002061 429 IGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIV 508 (973)
Q Consensus 429 ~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 508 (973)
|....+|+.+.+.++ ++.+...+|.++.+|+.++|.++ ++.+-..+|.++.+|+.+++..| ++.+...+|.++.+|+
T Consensus 293 F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~ 369 (394)
T 4fs7_A 293 FYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLK 369 (394)
T ss_dssp TTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCC
T ss_pred ccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCC
Confidence 555666666666543 44444556666666666666533 44344556666666666666555 5545556666666666
Q ss_pred chhccccccccCCCccccccCCCCe
Q 002061 509 DLNLARNSLSGNIPRSLSLLSSLNA 533 (973)
Q Consensus 509 ~L~Ls~N~l~~~~~~~~~~l~~L~~ 533 (973)
.+++..+ ++ .+...|.++++|+.
T Consensus 370 ~i~lp~~-~~-~~~~~F~~c~~L~~ 392 (394)
T 4fs7_A 370 KVELPKR-LE-QYRYDFEDTTKFKW 392 (394)
T ss_dssp EEEEEGG-GG-GGGGGBCTTCEEEE
T ss_pred EEEECCC-CE-EhhheecCCCCCcE
Confidence 6666544 22 23345555555554
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.54 E-value=1.4e-16 Score=161.54 Aligned_cols=86 Identities=23% Similarity=0.226 Sum_probs=49.6
Q ss_pred ccCCccCcEeeCCCCcccCcCCh------hhhCCCCCcEEEecCCcccCCCCcccCCCCCCEEeccCccCCCcccccccc
Q 002061 93 ISALQSLTVLSLPFNVLSGKLPL------ELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVN 166 (973)
Q Consensus 93 l~~l~~L~~L~Ls~n~l~~~~p~------~l~~l~~L~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~ 166 (973)
+.....++.++++.+.++|.+|. .++.+++|++|+|++|.+++.+ .+..+++|++|++++|.++ .+|..+..
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~ 91 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKIS-SLSGMENLRILSLGRNLIK-KIENLDAV 91 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESCCC-CHHHHTTCCEEEEEEEEEC-SCSSHHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcccc-ccccCCCCCEEECCCCCcc-cccchhhc
Confidence 34455666666666666665554 6666666666666666666644 5666666666666666665 33444444
Q ss_pred ccccceEEccCCcC
Q 002061 167 LTQLVSLSIGDNVY 180 (973)
Q Consensus 167 l~~L~~L~l~~n~l 180 (973)
+++|++|++++|.+
T Consensus 92 ~~~L~~L~L~~N~l 105 (198)
T 1ds9_A 92 ADTLEELWISYNQI 105 (198)
T ss_dssp HHHCSEEEEEEEEC
T ss_pred CCcCCEEECcCCcC
Confidence 44444444444444
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.53 E-value=1.4e-14 Score=143.68 Aligned_cols=133 Identities=17% Similarity=0.183 Sum_probs=86.5
Q ss_pred cccCCccCcEeeCCCCcccCcCChhhhCCC-CCcEEEecCCcccCCCCcccCCCCCCEEeccCccCCCcccccccccccc
Q 002061 92 SISALQSLTVLSLPFNVLSGKLPLELSNCS-NLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQL 170 (973)
Q Consensus 92 ~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~-~L~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L 170 (973)
.+..+.+|++|+|++|+++ .+|. +..+. +|++|+|++|.+++. +.++.+++|++|+|++|.+++..+..+..+++|
T Consensus 14 ~~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hcCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc-cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 4556777788888888777 3454 44444 788888888877765 567777777777777777775444445666666
Q ss_pred ceEEccCCcCCCCCCcc--cccCCCCCCEEEcccCCCCCCCChh----hhccCCCCeeeccccccc
Q 002061 171 VSLSIGDNVYDEAEIPE--SIGNLKNLTYLFLAHCNLRGRIPES----ISELRELGTLDICRNKIS 230 (973)
Q Consensus 171 ~~L~l~~n~l~~~~ip~--~~~~l~~L~~L~L~~n~l~~~~~~~----~~~l~~L~~L~L~~N~l~ 230 (973)
++|++++|.+. .+|. .+..+++|++|++++|.++ .+|.. +..+++|++||+++|.+.
T Consensus 91 ~~L~L~~N~i~--~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 91 TELILTNNSLV--ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CEEECCSCCCC--CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CEEECCCCcCC--cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 66666666664 3444 5666666666666666665 33432 566666666666666554
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.52 E-value=3.9e-16 Score=158.29 Aligned_cols=136 Identities=22% Similarity=0.279 Sum_probs=72.1
Q ss_pred CCCCCCEEeccCccCCCcccc------ccccccccceEEccCCcCCCCCCcccccCCCCCCEEEcccCCCCCCCChhhhc
Q 002061 142 ALKNLEIFDLSINYFTGRFPR------WVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISE 215 (973)
Q Consensus 142 ~l~~L~~L~Ls~n~l~~~~~~------~~~~l~~L~~L~l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 215 (973)
...+++.++++.+.+++..|. .+..+++|++|++++|.+.. +| .+.++++|++|++++|+++ .+|..+..
T Consensus 16 ~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~--l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~ 91 (198)
T 1ds9_A 16 ERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK--IS-SLSGMENLRILSLGRNLIK-KIENLDAV 91 (198)
T ss_dssp HTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC--CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHH
T ss_pred hcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc--cc-ccccCCCCCEEECCCCCcc-cccchhhc
Confidence 344455555555555544433 45555555555555555442 34 5555555666666666555 44555555
Q ss_pred cCCCCeeecccccccCCCchhhhccccccEEEeeccccCCcCC-ccccccccccEEEeeccccccccCC
Q 002061 216 LRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELP-AELGNLTLLQEFDISSNQMYGKLPE 283 (973)
Q Consensus 216 l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~~l~~l~~L~~L~Ls~N~l~~~~p~ 283 (973)
+++|++|+|++|++++ +| .+..+++|++|+|++|++++..+ ..+..+++|++|++++|.+.+..|.
T Consensus 92 ~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~ 158 (198)
T 1ds9_A 92 ADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp HHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHT
T ss_pred CCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccccccc
Confidence 5566666666666653 33 45555666666666666553221 3455556666666666665544443
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.50 E-value=3.6e-14 Score=139.59 Aligned_cols=107 Identities=21% Similarity=0.262 Sum_probs=66.2
Q ss_pred CCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCCccccccccccchhccc
Q 002061 435 LSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLAR 514 (973)
Q Consensus 435 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 514 (973)
.+.+++++|+++ .+|..+ .++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..|.++++|+.|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 456677777766 345444 25666666666666666666666666666666666666655555566666666666666
Q ss_pred cccccCCCccccccCCCCeeecCCCccCCC
Q 002061 515 NSLSGNIPRSLSLLSSLNALNLSGNKLTGS 544 (973)
Q Consensus 515 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 544 (973)
|+|++..+..|..+++|+.|+|++|+++..
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 117 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCA 117 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence 666655555566666666666666666543
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.48 E-value=7e-14 Score=137.54 Aligned_cols=109 Identities=20% Similarity=0.249 Sum_probs=92.3
Q ss_pred CCCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCCccccccccccchhccccccccCCCccccccCCCCeeecC
Q 002061 458 NLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLS 537 (973)
Q Consensus 458 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 537 (973)
..+.|++++|.++ .+|..+. ++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|++|+|+
T Consensus 10 ~~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~ 86 (170)
T 3g39_A 10 SGTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN 86 (170)
T ss_dssp ETTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence 3578899999998 4666553 788999999999998888889999999999999999997777788889999999999
Q ss_pred CCccCCCCChhhhccc-CceEEccCCccccccC
Q 002061 538 GNKLTGSIPDNLMKLK-LSSIDLSENQLSGSVP 569 (973)
Q Consensus 538 ~N~l~~~~p~~l~~l~-L~~l~ls~N~l~~~~p 569 (973)
+|+|++..|..+..++ |+.|+|++|+|+|.++
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 87 DNQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred CCccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 9999976666777775 8999999999998887
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.48 E-value=4.1e-13 Score=151.71 Aligned_cols=310 Identities=10% Similarity=0.027 Sum_probs=185.1
Q ss_pred cccCCCCCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCchhhhccccccEEEeeccccCCcCCccccccccc
Q 002061 188 SIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLL 267 (973)
Q Consensus 188 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L 267 (973)
.|.++++|+.+.|.. .++.+...+|.++++|+.++|.++ ++.....+|.++.+|+.+.+..+ +.......|.++..+
T Consensus 66 AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~~~ 142 (394)
T 4fs7_A 66 AFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCDFK 142 (394)
T ss_dssp TTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCCCS
T ss_pred HhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeeccccc
Confidence 355566666666653 355455567888888888888755 55455567777777777666544 333444556665443
Q ss_pred cEEEeeccccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeeccCCccCCCCCccccccccccccccccc
Q 002061 268 QEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISEN 347 (973)
Q Consensus 268 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N 347 (973)
+..... .........|.++++|+.+.+.++. .......|.++.+|+.+.+..| ++......|..+..|+.+.+..+
T Consensus 143 ~~~~~~--~~~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~ 218 (394)
T 4fs7_A 143 EITIPE--GVTVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNS 218 (394)
T ss_dssp EEECCT--TCCEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTT
T ss_pred ccccCc--cccccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCC
Confidence 332222 2222445567777777777776543 3344556777777777777655 44344556666777776666554
Q ss_pred cccccCChhhhhhhhHHHHHhhhccCCCCccccccCccccceEeccccccccCCCccccCCCCcceEeccCCcCCCCCCC
Q 002061 348 QFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISP 427 (973)
Q Consensus 348 ~l~~~~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~ 427 (973)
... +.........|+.+.+..+. +.+....|.....++.+.+..+.. .+...
T Consensus 219 ~~~--------------------------i~~~~~~~~~l~~i~ip~~~-~~i~~~~f~~~~~l~~~~~~~~~~-~i~~~ 270 (394)
T 4fs7_A 219 LYY--------------------------LGDFALSKTGVKNIIIPDSF-TELGKSVFYGCTDLESISIQNNKL-RIGGS 270 (394)
T ss_dssp CCE--------------------------ECTTTTTTCCCCEEEECTTC-CEECSSTTTTCSSCCEEEECCTTC-EECSC
T ss_pred ceE--------------------------eehhhcccCCCceEEECCCc-eecccccccccccceeEEcCCCcc-eeecc
Confidence 432 11222334566666665433 334455666677777777765532 34455
Q ss_pred CCCCCCCCCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCCccccccccc
Q 002061 428 LIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARI 507 (973)
Q Consensus 428 ~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 507 (973)
.|.....++.+.+..+.+ ....|..+.+|+.+.+.++ ++.+...+|.++.+|+.++|.++ ++.+-..+|.++.+|
T Consensus 271 ~F~~~~~l~~~~~~~~~i---~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L 345 (394)
T 4fs7_A 271 LFYNCSGLKKVIYGSVIV---PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSL 345 (394)
T ss_dssp TTTTCTTCCEEEECSSEE---CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTC
T ss_pred ccccccccceeccCceee---ccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCC
Confidence 566666677766655443 2345666677777777654 44344556777777777777543 555556667777777
Q ss_pred cchhccccccccCCCccccccCCCCeeecCC
Q 002061 508 VDLNLARNSLSGNIPRSLSLLSSLNALNLSG 538 (973)
Q Consensus 508 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 538 (973)
+.+++..| ++..-..+|.++++|+.+++..
T Consensus 346 ~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~ 375 (394)
T 4fs7_A 346 SNINFPLS-LRKIGANAFQGCINLKKVELPK 375 (394)
T ss_dssp CEECCCTT-CCEECTTTBTTCTTCCEEEEEG
T ss_pred CEEEECcc-ccEehHHHhhCCCCCCEEEECC
Confidence 77777665 5545556677777777776643
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.46 E-value=1.2e-13 Score=136.36 Aligned_cols=106 Identities=25% Similarity=0.308 Sum_probs=76.9
Q ss_pred CCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCCccccccccccchhccc
Q 002061 435 LSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLAR 514 (973)
Q Consensus 435 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 514 (973)
-+.+++++|+++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|+++.+..|.++++|+.|+|++
T Consensus 14 ~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 14 QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 367788888876 5565543 6777888888888777777777777777777777777766666667777777777777
Q ss_pred cccccCCCccccccCCCCeeecCCCccCC
Q 002061 515 NSLSGNIPRSLSLLSSLNALNLSGNKLTG 543 (973)
Q Consensus 515 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 543 (973)
|+|++..+..|..+++|+.|+|++|+++.
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c 119 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDC 119 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBCT
T ss_pred CccceeCHHHhccccCCCEEEeCCCCccc
Confidence 77776555557777777777777777763
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.46 E-value=1.4e-13 Score=135.74 Aligned_cols=107 Identities=21% Similarity=0.257 Sum_probs=81.6
Q ss_pred CEEEccCCcCCCCccccccccccCCEEEcCCcccccCCCccccccccccchhccccccccCCCccccccCCCCeeecCCC
Q 002061 460 ERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGN 539 (973)
Q Consensus 460 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 539 (973)
+.+++++|+++ .+|..+. ++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 67888888886 5665554 67888888888888777778888888888888888888666666778888888888888
Q ss_pred ccCCCCChhhhccc-CceEEccCCccccccC
Q 002061 540 KLTGSIPDNLMKLK-LSSIDLSENQLSGSVP 569 (973)
Q Consensus 540 ~l~~~~p~~l~~l~-L~~l~ls~N~l~~~~p 569 (973)
+|++.++..+..++ |+.|+|++|+|.|.++
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~ 122 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCECR 122 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcccccc
Confidence 88865555576665 8888888888887776
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.38 E-value=9.3e-13 Score=146.19 Aligned_cols=93 Identities=24% Similarity=0.262 Sum_probs=44.4
Q ss_pred ccccccCCEEEcCC-cccccCCCccccccccccchhccccccccCCCccccccCCCCeeecCCCccCCCCChhhhcccCc
Q 002061 477 LGALRQLSSLHLEE-NALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLS 555 (973)
Q Consensus 477 ~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~L~ 555 (973)
+..+++|++|+|++ |+|++..+..|+++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++.+|..+..++|+
T Consensus 27 l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~L~ 106 (347)
T 2ifg_A 27 LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQ 106 (347)
T ss_dssp SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCCCC
T ss_pred CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeCHHHcccCCce
Confidence 44444444444443 44444444444444444444444444444444444555555555555555554333334334455
Q ss_pred eEEccCCccccccC
Q 002061 556 SIDLSENQLSGSVP 569 (973)
Q Consensus 556 ~l~ls~N~l~~~~p 569 (973)
.|+|++|+|.|.|+
T Consensus 107 ~l~l~~N~~~c~c~ 120 (347)
T 2ifg_A 107 ELVLSGNPLHCSCA 120 (347)
T ss_dssp EEECCSSCCCCCGG
T ss_pred EEEeeCCCccCCCc
Confidence 55555555555554
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.32 E-value=1.7e-14 Score=160.62 Aligned_cols=135 Identities=15% Similarity=0.134 Sum_probs=68.8
Q ss_pred CCCCcEEEecCCcccCCCC-cc----c-CCCCCCEEeccCccCCCccccccc-cccccceEEccCCcCCCCCCc---ccc
Q 002061 120 CSNLKVLNVTGNAMVGSVP-DL----S-ALKNLEIFDLSINYFTGRFPRWVV-NLTQLVSLSIGDNVYDEAEIP---ESI 189 (973)
Q Consensus 120 l~~L~~L~L~~n~l~~~~~-~l----~-~l~~L~~L~Ls~n~l~~~~~~~~~-~l~~L~~L~l~~n~l~~~~ip---~~~ 189 (973)
+++|++|+|++|.++.... .+ . ..++|++|||++|.+++.....+. .+++|++|+|++|.++..... ..+
T Consensus 71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L 150 (372)
T 3un9_A 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL 150 (372)
T ss_dssp HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence 3567788888877754322 12 2 235777777777777654333332 355666666666665432210 111
Q ss_pred -cCCCCCCEEEcccCCCCCC----CChhhhccCCCCeeecccccccCCC----chhhhccccccEEEeeccccC
Q 002061 190 -GNLKNLTYLFLAHCNLRGR----IPESISELRELGTLDICRNKISGEF----PRSIRKLQKLWKIELYANNLT 254 (973)
Q Consensus 190 -~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~----~~~l~~l~~L~~L~L~~N~l~ 254 (973)
...++|++|+|++|.|+.. ++..+..+++|++|+|++|+|++.. +..+...++|++|+|++|.|+
T Consensus 151 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~ 224 (372)
T 3un9_A 151 LHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAG 224 (372)
T ss_dssp HSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCC
T ss_pred HhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCC
Confidence 2345566666666655431 2223344555555555555554322 233334444444444444444
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.30 E-value=3.5e-14 Score=158.15 Aligned_cols=166 Identities=20% Similarity=0.212 Sum_probs=110.9
Q ss_pred CccCcEeeCCCCcccCcCChhhhCC-----CCCcEEEecCCcccCCC-Cc-ccCCCCCCEEeccCccCCCccccccc---
Q 002061 96 LQSLTVLSLPFNVLSGKLPLELSNC-----SNLKVLNVTGNAMVGSV-PD-LSALKNLEIFDLSINYFTGRFPRWVV--- 165 (973)
Q Consensus 96 l~~L~~L~Ls~n~l~~~~p~~l~~l-----~~L~~L~L~~n~l~~~~-~~-l~~l~~L~~L~Ls~n~l~~~~~~~~~--- 165 (973)
+++|++|+|++|.++......|... .+|++|+|++|.++... .. ...+++|++|+|++|.+++.....+.
T Consensus 71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L 150 (372)
T 3un9_A 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL 150 (372)
T ss_dssp HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence 3567778888877765443343333 67888888888774322 12 23456788888888888765554443
Q ss_pred --cccccceEEccCCcCCCCC---CcccccCCCCCCEEEcccCCCCCC----CChhhhccCCCCeeecccccccCCC---
Q 002061 166 --NLTQLVSLSIGDNVYDEAE---IPESIGNLKNLTYLFLAHCNLRGR----IPESISELRELGTLDICRNKISGEF--- 233 (973)
Q Consensus 166 --~l~~L~~L~l~~n~l~~~~---ip~~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~--- 233 (973)
..++|++|+|++|.++... ++..+..+++|++|+|++|.|+.. ++..+...++|++|+|++|.|++..
T Consensus 151 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~ 230 (372)
T 3un9_A 151 LHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALA 230 (372)
T ss_dssp HSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHH
T ss_pred HhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHH
Confidence 3567888888888775422 344557788899999999988743 2456677788999999999987543
Q ss_pred -chhhhccccccEEEeeccccCCcCCccc
Q 002061 234 -PRSIRKLQKLWKIELYANNLTGELPAEL 261 (973)
Q Consensus 234 -~~~l~~l~~L~~L~L~~N~l~~~~~~~l 261 (973)
+..+...++|++|+|++|.|++.....+
T Consensus 231 l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L 259 (372)
T 3un9_A 231 LARAAREHPSLELLHLYFNELSSEGRQVL 259 (372)
T ss_dssp HHHHHHHCSSCCEEECTTSSCCHHHHHHH
T ss_pred HHHHHHhCCCCCEEeccCCCCCHHHHHHH
Confidence 3344456777778887777775444333
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.30 E-value=2.6e-12 Score=142.54 Aligned_cols=131 Identities=24% Similarity=0.223 Sum_probs=98.8
Q ss_pred EEEcccC-CCCCCCChhhhcCCCCCEEEccC-CcCCCCccccccccccCCEEEcCCcccccCCCccccccccccchhccc
Q 002061 437 QLVLQNN-RFSGELPSELGRLTNLERLILTN-NNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLAR 514 (973)
Q Consensus 437 ~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 514 (973)
.++++++ +|+ .+|. +..+++|+.|+|++ |+|++..+..|.++++|+.|+|++|+|++.+|..|.++++|+.|+|++
T Consensus 12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 4577777 777 4666 88888888888886 888877778888888888888888888888888888888888888999
Q ss_pred cccccCCCccccccCCCCeeecCCCccCCCCC-hhhhcc-cCceEEccCCccccccCc
Q 002061 515 NSLSGNIPRSLSLLSSLNALNLSGNKLTGSIP-DNLMKL-KLSSIDLSENQLSGSVPL 570 (973)
Q Consensus 515 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l-~L~~l~ls~N~l~~~~p~ 570 (973)
|+|++..+..|..++ |+.|+|++|+|..... .+|..+ ......+..++++|..|.
T Consensus 90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~~ 146 (347)
T 2ifg_A 90 NALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQG 146 (347)
T ss_dssp SCCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSS
T ss_pred CccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCCCh
Confidence 988876666676666 9999999999984332 222222 133344556777777765
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.27 E-value=1.4e-10 Score=130.74 Aligned_cols=132 Identities=12% Similarity=0.253 Sum_probs=57.4
Q ss_pred ccccCccccceEeccccccccCCCccccCCCCcceEeccCCcCCCCCCCCCCCCCCCCEEEcccCCCCCCCChhhhcCCC
Q 002061 379 NSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTN 458 (973)
Q Consensus 379 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~ 458 (973)
.+|.++..|+.+.+.++..+ +...+|.+++.|+.+.+. +.++.+... +|.++.+
T Consensus 259 ~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~------------------------aF~~c~~ 312 (394)
T 4gt6_A 259 HAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPES------------------------VFAGCIS 312 (394)
T ss_dssp TTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTT------------------------TTTTCTT
T ss_pred ceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCce------------------------eecCCCC
Confidence 34555555666555544332 344445455555555543 233333444 4444555
Q ss_pred CCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCCccccccccccchhccccccccCCCccccccCCCCeeecCC
Q 002061 459 LERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSG 538 (973)
Q Consensus 459 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 538 (973)
|+.++|..+ ++.+-..+|.++.+|+.+.+..+ ++.+-..+|.++.+|+.+++.+|.... ..|....+|+.+.+..
T Consensus 313 L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~ 387 (394)
T 4gt6_A 313 LKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAP 387 (394)
T ss_dssp CCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC-------
T ss_pred cCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCC
Confidence 555555432 33233344555555555555433 443444455555555555555543321 2344555555555555
Q ss_pred Ccc
Q 002061 539 NKL 541 (973)
Q Consensus 539 N~l 541 (973)
|.+
T Consensus 388 ~~~ 390 (394)
T 4gt6_A 388 GSI 390 (394)
T ss_dssp ---
T ss_pred CCE
Confidence 443
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.26 E-value=7.4e-11 Score=133.14 Aligned_cols=134 Identities=11% Similarity=0.176 Sum_probs=95.1
Q ss_pred CCCCCCCCCCCCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCCcccccc
Q 002061 425 ISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDC 504 (973)
Q Consensus 425 ~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 504 (973)
....|..+..|+.+.+.++... ....+|.++++|+.+.+. +.++.+...+|.++.+|+.++|..+ ++.+-..+|.++
T Consensus 257 ~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C 333 (394)
T 4gt6_A 257 ETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGC 333 (394)
T ss_dssp CTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTC
T ss_pred ccceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCC
Confidence 3445666777788777665443 566788889999999996 4566566779999999999999865 776778899999
Q ss_pred ccccchhccccccccCCCccccccCCCCeeecCCCccCCCCChhhhcccCceEEccCCcc
Q 002061 505 ARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQL 564 (973)
Q Consensus 505 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~L~~l~ls~N~l 564 (973)
.+|+.+.+..+ ++..-..+|.++++|+.+++.+|.... ........|+.+.+..|.+
T Consensus 334 ~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~--~~~~~~~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 334 EQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW--NAISTDSGLQNLPVAPGSI 390 (394)
T ss_dssp TTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH--HTCBCCCCC----------
T ss_pred CCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh--hhhhccCCCCEEEeCCCCE
Confidence 99999999765 776667899999999999999987641 1112223477777766544
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=99.17 E-value=1.4e-11 Score=135.78 Aligned_cols=181 Identities=17% Similarity=0.162 Sum_probs=106.2
Q ss_pred CCceEEEeecCCCCCc-c-------ccccccCCccCcEeeCCCCccc---------CcCChhhhCCCCCcEEEecCCccc
Q 002061 72 TGRVTEISFDNKSLSG-E-------ISSSISALQSLTVLSLPFNVLS---------GKLPLELSNCSNLKVLNVTGNAMV 134 (973)
Q Consensus 72 ~~~v~~l~l~~~~l~~-~-------~~~~l~~l~~L~~L~Ls~n~l~---------~~~p~~l~~l~~L~~L~L~~n~l~ 134 (973)
..+|++|.+......| . +.+++..+++|+.|.+..+... +.++..+..+++|+.|+|++|.-.
T Consensus 106 ~~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l 185 (362)
T 2ra8_A 106 LPSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL 185 (362)
T ss_dssp GGGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC
T ss_pred chhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc
Confidence 4578999988766653 2 2445677899999999765431 235556788899999999887322
Q ss_pred CCCCcccCCCCCCEEeccCccCCCccccccc--cccccceEEccC--CcCC-CC---CCcccc--cCCCCCCEEEcccCC
Q 002061 135 GSVPDLSALKNLEIFDLSINYFTGRFPRWVV--NLTQLVSLSIGD--NVYD-EA---EIPESI--GNLKNLTYLFLAHCN 204 (973)
Q Consensus 135 ~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~--~l~~L~~L~l~~--n~l~-~~---~ip~~~--~~l~~L~~L~L~~n~ 204 (973)
..++ +. +++|++|+|..|.++......+. .+++|++|+|+. |... .. .+...+ ..+++|++|+|++|.
T Consensus 186 ~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~ 263 (362)
T 2ra8_A 186 SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAE 263 (362)
T ss_dssp BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCT
T ss_pred eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCC
Confidence 2222 43 78899999888887655444454 678888888753 2111 10 111122 235666666666666
Q ss_pred CCCCCChhhh---ccCCCCeeecccccccCCC----chhhhccccccEEEeeccccC
Q 002061 205 LRGRIPESIS---ELRELGTLDICRNKISGEF----PRSIRKLQKLWKIELYANNLT 254 (973)
Q Consensus 205 l~~~~~~~~~---~l~~L~~L~L~~N~l~~~~----~~~l~~l~~L~~L~L~~N~l~ 254 (973)
+++..+..+. .+++|++|+|+.|.|++.. +..+..+++|+.|+|++|.|+
T Consensus 264 i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~ 320 (362)
T 2ra8_A 264 EQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320 (362)
T ss_dssp THHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred CchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence 6533333332 3455666666666555432 222234455555555555554
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.10 E-value=1.9e-10 Score=121.86 Aligned_cols=143 Identities=17% Similarity=0.057 Sum_probs=111.3
Q ss_pred HHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc--ccHHHHHHHHHHHHhcC-CCceeeEEEEEEeCCeeEEE
Q 002061 673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIR-HRNILKLYACLLKGGSSFLV 749 (973)
Q Consensus 673 ~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv 749 (973)
..+..|++...++.|+.+.||++... ++.+++|+.... .....+.+|+++++.+. +..+.++++++..++..|+|
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 34567888888899999999999755 679999987642 33446889999999984 67788899999888899999
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhc----------------------------------
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHD---------------------------------- 795 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~---------------------------------- 795 (973)
|||++|.++.+... +......++.+++++++.||+-
T Consensus 89 ~e~i~G~~l~~~~~----------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T 3tm0_A 89 MSEADGVLCSEEYE----------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EECCSSEEHHHHCC----------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred EEecCCeehhhccC----------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence 99999999876521 0112236778899999999961
Q ss_pred ----------------------CCCCeEecCCCCCCeeecCCCCeEEecccCcc
Q 002061 796 ----------------------CSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827 (973)
Q Consensus 796 ----------------------~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~ 827 (973)
....++|+|++|.||+++++..+.|.||+.+.
T Consensus 159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01458999999999999876556799999764
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.03 E-value=6.4e-09 Score=116.57 Aligned_cols=129 Identities=15% Similarity=0.186 Sum_probs=56.2
Q ss_pred ccCccccceEeccccccccCCCccccCCCCcceEeccCCcCCCCCCCCCCCCCCCCEEEcccCCCCCCCChhhhcCCCCC
Q 002061 381 YADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLE 460 (973)
Q Consensus 381 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 460 (973)
+..+..|+.+.+..+ +..+....|.+...|+.+.+..+ ++.+....|....+|+.+.+..+ +.......|.++.+|+
T Consensus 213 f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~ 289 (379)
T 4h09_A 213 FSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLT 289 (379)
T ss_dssp TTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCC
T ss_pred cccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccc
Confidence 344445555554433 22233344444445555544433 33333444444444444444322 3323333444444455
Q ss_pred EEEccCCcCCCCccccccccccCCEEEcCCcccccCCCccccccccccchhcc
Q 002061 461 RLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLA 513 (973)
Q Consensus 461 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 513 (973)
.+.+.++.++.+...+|.++.+|+.+.|..+ ++.+-..+|.++.+|+.+.+.
T Consensus 290 ~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip 341 (379)
T 4h09_A 290 KVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYP 341 (379)
T ss_dssp EEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCC
T ss_pred cccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEEC
Confidence 5444444444333344444444444444332 333333444444444444443
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.99 E-value=1.1e-08 Score=114.63 Aligned_cols=159 Identities=14% Similarity=0.116 Sum_probs=121.6
Q ss_pred cccccCccccceEeccccccccCCCccccCCCCcceEeccCCcCCCCCCCCCCCCCCCCEEEcccCCCCCCCChhhhcCC
Q 002061 378 PNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLT 457 (973)
Q Consensus 378 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~ 457 (973)
...+..+..+..+.+..+.-. .....+....+|+.+.+..+ +..+....|.....|+.+.+..+ ++.....+|.++.
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~ 263 (379)
T 4h09_A 187 LESYPAAKTGTEFTIPSTVKT-VTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCT 263 (379)
T ss_dssp EEECCTTCCCSEEECCTTCCE-ECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCT
T ss_pred eccccccccccccccccceeE-Eeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceee
Confidence 344555666776666554433 55667777888888888655 55566677788889999999776 6656677888899
Q ss_pred CCCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCCccccccccccchhccccccccCCCccccccCCCCeeecC
Q 002061 458 NLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLS 537 (973)
Q Consensus 458 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 537 (973)
+|+.+.+..+ ++.....+|.++.+|+.+.+.++.++.+...+|.++.+|+.++|..+ ++..-..+|.++++|+.+.+.
T Consensus 264 ~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip 341 (379)
T 4h09_A 264 ALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYP 341 (379)
T ss_dssp TCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCC
T ss_pred hhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEEC
Confidence 9999998754 55456678889999999999988888788888999999999999765 765667789999999998886
Q ss_pred CCccC
Q 002061 538 GNKLT 542 (973)
Q Consensus 538 ~N~l~ 542 (973)
.+ ++
T Consensus 342 ~~-v~ 345 (379)
T 4h09_A 342 KS-IT 345 (379)
T ss_dssp TT-CC
T ss_pred Cc-cC
Confidence 54 55
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.97 E-value=9e-10 Score=116.58 Aligned_cols=136 Identities=17% Similarity=0.180 Sum_probs=96.5
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhcCCCc--eeeEEEEEEeCCeeEEEEEccC
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRN--ILKLYACLLKGGSSFLVLEYMP 754 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~~~~~~~~~lv~e~~~ 754 (973)
.+.+....+.|..+.||++... +|..+++|+.... ....+.+|+++++.+.+.+ +.+++++...++..++||||++
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~-~g~~~vlK~~~~~-~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~ 98 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSG-ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 98 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECT-TSCCEEEEEECSC-TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred CCceEecccCCCCceEEEEecC-CCCeEEEEeCCcc-cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecC
Confidence 3444333345666999999754 4678999986554 3356789999999986544 4568888887788999999999
Q ss_pred CCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcC--------------------------------------
Q 002061 755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC-------------------------------------- 796 (973)
Q Consensus 755 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~-------------------------------------- 796 (973)
|.++. .. ..+ ...++.++++.++.+|+..
T Consensus 99 G~~l~--~~--------~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 99 GQDLL--SS--------HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp SEETT--TS--------CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred CcccC--cC--------cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 98884 11 011 1245666777777777421
Q ss_pred -----------------CCCeEecCCCCCCeeecCCCCeEEecccCcc
Q 002061 797 -----------------SPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827 (973)
Q Consensus 797 -----------------~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~ 827 (973)
...++|+|++|.||++++++.+.|.||+.+.
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1239999999999999877667799999864
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.90 E-value=4.8e-10 Score=123.53 Aligned_cols=137 Identities=16% Similarity=0.144 Sum_probs=58.8
Q ss_pred ccccCCCCCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCchhhh--ccccccEEEeec--cccCCc-----C
Q 002061 187 ESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIR--KLQKLWKIELYA--NNLTGE-----L 257 (973)
Q Consensus 187 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~--~l~~L~~L~L~~--N~l~~~-----~ 257 (973)
..+..+++|+.|+|++|.-. .++. + .+++|++|+|..|.++......+. .+++|++|+|+. |...+. +
T Consensus 166 ~ll~~~P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l 242 (362)
T 2ra8_A 166 PVLDAMPLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVF 242 (362)
T ss_dssp HHHHTCTTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGT
T ss_pred HHHhcCCCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHH
Confidence 33444455555555544211 1111 2 245555555555555433333333 455555555542 111100 0
Q ss_pred Cccc--cccccccEEEeeccccccccCCccC---CCCCccEEEcccCCCCCC----CCCCcCCcccceeeeccCCccC
Q 002061 258 PAEL--GNLTLLQEFDISSNQMYGKLPEEIG---NLKNLTVFQCFKNNFSGE----FPSGFGDMRKLFAFSIYGNRFS 326 (973)
Q Consensus 258 ~~~l--~~l~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~ 326 (973)
...+ ..+++|+.|+|++|.+.+..+..+. .+++|++|+|+.|.+++. ++..+..+++|+.|++++|.|+
T Consensus 243 ~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~ 320 (362)
T 2ra8_A 243 RPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320 (362)
T ss_dssp GGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred HHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence 0111 1345566666666555432222221 345555555555555542 2222234455555555555544
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.90 E-value=2.9e-11 Score=126.16 Aligned_cols=161 Identities=17% Similarity=0.200 Sum_probs=77.9
Q ss_pred CCCcceeeeCCCCCceEEEeecC---CCCCccccc-cccCCccCcEeeCCCCcccCcCCh-hhhCCCCCcE--EEecCCc
Q 002061 60 PCGFSGITCDSVTGRVTEISFDN---KSLSGEISS-SISALQSLTVLSLPFNVLSGKLPL-ELSNCSNLKV--LNVTGNA 132 (973)
Q Consensus 60 ~c~w~gv~C~~~~~~v~~l~l~~---~~l~~~~~~-~l~~l~~L~~L~Ls~n~l~~~~p~-~l~~l~~L~~--L~L~~n~ 132 (973)
.|.|.|+.|+....+|+.+...+ ..+.|.+.+ .+..++. .|..++|.-++.+.- .|...+.|+. ++++.|.
T Consensus 77 l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~ 154 (267)
T 3rw6_A 77 LKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNR 154 (267)
T ss_dssp HHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTS
T ss_pred HHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCCH
Confidence 48899999997666887766655 334444432 3333332 233333333322221 1333333333 4444443
Q ss_pred ccCCCC---c-ccCCCCCCEEeccCccCCCccccccccccccceEEccCCcCCCCCCcccccCCCCCCEEEcccCCCCCC
Q 002061 133 MVGSVP---D-LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGR 208 (973)
Q Consensus 133 l~~~~~---~-l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~ 208 (973)
...... . ..++++|+.|+|++|.|++.. .+|..+..+++|+.|+|++|+|++.
T Consensus 155 ~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~-----------------------~l~~~~~~l~~L~~L~Ls~N~i~~~ 211 (267)
T 3rw6_A 155 RSCMAATLRIIEENIPELLSLNLSNNRLYRLD-----------------------DMSSIVQKAPNLKILNLSGNELKSE 211 (267)
T ss_dssp HHHHHHHHHHHHHHCTTCCEEECTTSCCCCCG-----------------------GGTTHHHHSTTCCEEECTTSCCCSG
T ss_pred HHHHHHHHHHHHhhCCCCCEEECCCCCCCCCc-----------------------cchhHHhhCCCCCEEECCCCccCCc
Confidence 221111 1 133455555555555555411 1233444555555555555555533
Q ss_pred CChhhhccC--CCCeeecccccccCCCc-------hhhhccccccEEE
Q 002061 209 IPESISELR--ELGTLDICRNKISGEFP-------RSIRKLQKLWKIE 247 (973)
Q Consensus 209 ~~~~~~~l~--~L~~L~L~~N~l~~~~~-------~~l~~l~~L~~L~ 247 (973)
..+..++ +|++|+|++|.+.+.+| ..+..+++|+.||
T Consensus 212 --~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 212 --RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp --GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred --hhhhhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 2333333 56666666666654443 2355666666554
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.82 E-value=2.6e-09 Score=115.73 Aligned_cols=187 Identities=21% Similarity=0.170 Sum_probs=119.2
Q ss_pred cCcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhcC-CCc--eeeEEEEEEeCC---eeEEEEEccC
Q 002061 681 DNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIR-HRN--ILKLYACLLKGG---SSFLVLEYMP 754 (973)
Q Consensus 681 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~-hpn--iv~l~~~~~~~~---~~~lv~e~~~ 754 (973)
.+.++.|....||++. ..+++|+.........+.+|+++++.+. +.. +.+++.....+. ..|+||||++
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 3568999999999863 4689998665545677899999998883 332 233444333322 3489999999
Q ss_pred CCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhc---------------------------------------
Q 002061 755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHD--------------------------------------- 795 (973)
Q Consensus 755 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~--------------------------------------- 795 (973)
|.++.+.... .++..++..++.++++.++.||+-
T Consensus 100 G~~l~~~~~~-------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 100 GVPLTPLLLN-------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CEECCHHHHH-------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred CeECCccccc-------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 9988754321 245556666677777777777641
Q ss_pred ----------------CCCCeEecCCCCCCeeecC--CCCeEEecccCcccccCCCCcccccc-c---CC---------c
Q 002061 796 ----------------CSPPIIHRDIKSSNILLDE--DYEPKIADFGVAKIAENSPKVSDYSC-F---AG---------T 844 (973)
Q Consensus 796 ----------------~~~~ivH~Dlkp~Nill~~--~~~~kl~Dfgl~~~~~~~~~~~~~~~-~---~g---------t 844 (973)
....++|+|++|.||++++ +..+.+.||+.+..-.+. ....... . .+ .
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-~Dl~~~~~~~~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-NDFISLMEDDEEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-HHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-HHHHHHHhhccccCHHHHHHHHHH
Confidence 1235899999999999998 456789999988643221 1000000 0 00 0
Q ss_pred ccccc-ccccccCCCCccchHHHHHHHHHHHHhCCCCCC
Q 002061 845 HGYIA-PELAYTCKVSEKSDVFSFGVVLLELVTGRKPVE 882 (973)
Q Consensus 845 ~~y~a-PE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~ 882 (973)
.++.. |+.... .....+.|++|.++|.+.+|..+|-
T Consensus 252 Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 252 YKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred cCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 01111 222111 1123689999999999999987763
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.79 E-value=1.1e-08 Score=113.58 Aligned_cols=139 Identities=17% Similarity=0.272 Sum_probs=104.4
Q ss_pred cCcccccCceEEEEEEecCCCcEEEEEeee--cc---ccHHHHHHHHHHHHhcC--CCceeeEEEEEEeC---CeeEEEE
Q 002061 681 DNLIGSGGTGKVYRLDLKKNAGTVAVKQLW--KG---DGVKVFAAEMEILGKIR--HRNILKLYACLLKG---GSSFLVL 750 (973)
Q Consensus 681 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~--~~---~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~---~~~~lv~ 750 (973)
.+.++.|.++.||+.... +..+++|+.. .. .....+.+|+.+++.+. +..+.+++.++.+. +..|+||
T Consensus 43 ~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred EEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 467899999999998876 4688999876 32 22346788999999996 45577888887765 4589999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcC----------------------------------
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC---------------------------------- 796 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~---------------------------------- 796 (973)
||++|..+.+. ....++...+..++.+++++|+.||+..
T Consensus 121 e~v~G~~l~~~-------~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 121 EFVSGRVLWDQ-------SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp ECCCCBCCCCT-------TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred EecCCeecCCC-------ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 99998776431 1223567778888999999999999620
Q ss_pred ---------------------CCCeEecCCCCCCeeecCCCC--eEEecccCccc
Q 002061 797 ---------------------SPPIIHRDIKSSNILLDEDYE--PKIADFGVAKI 828 (973)
Q Consensus 797 ---------------------~~~ivH~Dlkp~Nill~~~~~--~kl~Dfgl~~~ 828 (973)
...++|+|+++.||+++.++. +.|.||+.+..
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 256999999999999998753 68999998863
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.56 E-value=6e-09 Score=103.52 Aligned_cols=122 Identities=12% Similarity=0.094 Sum_probs=71.8
Q ss_pred cccccccCCccCcEeeCCCC-cccCc----CChhhhCCCCCcEEEecCCcccCC-----CCcccCCCCCCEEeccCccCC
Q 002061 88 EISSSISALQSLTVLSLPFN-VLSGK----LPLELSNCSNLKVLNVTGNAMVGS-----VPDLSALKNLEIFDLSINYFT 157 (973)
Q Consensus 88 ~~~~~l~~l~~L~~L~Ls~n-~l~~~----~p~~l~~l~~L~~L~L~~n~l~~~-----~~~l~~l~~L~~L~Ls~n~l~ 157 (973)
.+...+...+.|++|+|++| .++.. +...+...++|++|+|++|.+... ...+...++|++|+|++|.|+
T Consensus 27 ~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~ 106 (185)
T 1io0_A 27 TLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 106 (185)
T ss_dssp HHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred HHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCC
Confidence 44555666777888888877 77542 334455566666777666666321 112344455666666666555
Q ss_pred CccccccccccccceEEccCCcCCCCCCcccccCCCCCCEEEc--ccCCCCCC----CChhhhccCCCCeeeccccccc
Q 002061 158 GRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFL--AHCNLRGR----IPESISELRELGTLDICRNKIS 230 (973)
Q Consensus 158 ~~~~~~~~~l~~L~~L~l~~n~l~~~~ip~~~~~l~~L~~L~L--~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~ 230 (973)
+.... .+.+.+...++|++|+| ++|.|+.. +...+...++|++|+|++|.|.
T Consensus 107 ~~g~~---------------------~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 107 GSGIL---------------------ALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHH---------------------HHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHH---------------------HHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 32111 12344555566777777 66777643 2344555678888888888875
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.37 E-value=6.4e-08 Score=96.04 Aligned_cols=40 Identities=18% Similarity=0.157 Sum_probs=19.5
Q ss_pred CCCCCCEEEcccCCCCCC----CChhhhccCCCCeeec--cccccc
Q 002061 191 NLKNLTYLFLAHCNLRGR----IPESISELRELGTLDI--CRNKIS 230 (973)
Q Consensus 191 ~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L--~~N~l~ 230 (973)
..++|++|+|++|.|+.. +...+...++|++|+| ++|.|+
T Consensus 91 ~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~ 136 (185)
T 1io0_A 91 VNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLG 136 (185)
T ss_dssp HCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred hCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCC
Confidence 334555555555555432 2333444455555555 455554
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.33 E-value=9.2e-08 Score=99.64 Aligned_cols=41 Identities=27% Similarity=0.341 Sum_probs=21.4
Q ss_pred cCCCCCEEEccCCcCCC--CccccccccccCCEEEcCCccccc
Q 002061 455 RLTNLERLILTNNNFSG--KIPSALGALRQLSSLHLEENALTG 495 (973)
Q Consensus 455 ~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~ 495 (973)
++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++
T Consensus 168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~ 210 (267)
T 3rw6_A 168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS 210 (267)
T ss_dssp HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCS
T ss_pred hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCC
Confidence 44555555555555554 223444455555555555555553
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.27 E-value=3.9e-06 Score=88.90 Aligned_cols=135 Identities=21% Similarity=0.165 Sum_probs=93.8
Q ss_pred cccccCce-EEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhcC-CCceeeEEEEEEeCCeeEEEEEccCCCchHH
Q 002061 683 LIGSGGTG-KVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIR-HRNILKLYACLLKGGSSFLVLEYMPNGNLFQ 760 (973)
Q Consensus 683 ~lG~G~~g-~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~ 760 (973)
.+..|..| .||+......+..++||+... .....+.+|+..++.+. +--+-++++++.+++..|+|||+++|.++.+
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~ 109 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG-SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQ 109 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET-HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC-CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccc
Confidence 34556555 699988877677899997543 34556889999998884 3335677888888899999999999988776
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhc---------------------------------------------
Q 002061 761 ALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHD--------------------------------------------- 795 (973)
Q Consensus 761 ~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~--------------------------------------------- 795 (973)
..... ......++.+++..++.||+-
T Consensus 110 ~~~~~---------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 110 VLEEY---------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHC---------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccCC---------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 54321 011123344444444444421
Q ss_pred ----------CCCCeEecCCCCCCeeecCCCCeEEecccCcc
Q 002061 796 ----------CSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827 (973)
Q Consensus 796 ----------~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~ 827 (973)
....++|+|+.+.||+++.++.+-|.||+.+.
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 01237899999999999987777799999764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.27 E-value=4e-06 Score=90.42 Aligned_cols=75 Identities=15% Similarity=0.106 Sum_probs=56.2
Q ss_pred cCcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhcCCC---ceeeEEEEEE-eCCeeEEEEEccCCC
Q 002061 681 DNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHR---NILKLYACLL-KGGSSFLVLEYMPNG 756 (973)
Q Consensus 681 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp---niv~l~~~~~-~~~~~~lv~e~~~~g 756 (973)
.+.++.|....||+. ++.++||+.........+.+|+++++.+.+. .+-+++.+.. ..+..++||||++|.
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 356788999999988 4678999864444556789999999999642 2445566554 455678999999998
Q ss_pred chHH
Q 002061 757 NLFQ 760 (973)
Q Consensus 757 sL~~ 760 (973)
++.+
T Consensus 99 ~l~~ 102 (306)
T 3tdw_A 99 ILGE 102 (306)
T ss_dssp ECHH
T ss_pred ECch
Confidence 8865
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.87 E-value=5.9e-06 Score=79.62 Aligned_cols=82 Identities=11% Similarity=0.164 Sum_probs=39.8
Q ss_pred CCCEEEcccCCCCCCCChhhhccCCCCeeeccccc-ccCCCchhhhcc----ccccEEEeeccc-cCCcCCccccccccc
Q 002061 194 NLTYLFLAHCNLRGRIPESISELRELGTLDICRNK-ISGEFPRSIRKL----QKLWKIELYANN-LTGELPAELGNLTLL 267 (973)
Q Consensus 194 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~l~~l----~~L~~L~L~~N~-l~~~~~~~l~~l~~L 267 (973)
+|++|+|++|.++..--..+..+++|++|+|++|. |++..-..++.+ ++|++|+|++|. ||+..-..+..+++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 45555555555544333444555555555555552 443333334332 245555555542 544333344455555
Q ss_pred cEEEeecc
Q 002061 268 QEFDISSN 275 (973)
Q Consensus 268 ~~L~Ls~N 275 (973)
++|+|+++
T Consensus 142 ~~L~L~~c 149 (176)
T 3e4g_A 142 KYLFLSDL 149 (176)
T ss_dssp CEEEEESC
T ss_pred CEEECCCC
Confidence 55555554
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.81 E-value=8.5e-06 Score=78.50 Aligned_cols=64 Identities=14% Similarity=0.236 Sum_probs=35.8
Q ss_pred ccCCCCCCEEEcccCC-CCCCCChhhhcc----CCCCeeecccc-cccCCCchhhhccccccEEEeeccc
Q 002061 189 IGNLKNLTYLFLAHCN-LRGRIPESISEL----RELGTLDICRN-KISGEFPRSIRKLQKLWKIELYANN 252 (973)
Q Consensus 189 ~~~l~~L~~L~L~~n~-l~~~~~~~~~~l----~~L~~L~L~~N-~l~~~~~~~l~~l~~L~~L~L~~N~ 252 (973)
+.++++|++|+|++|. ++...-..++.+ ++|++|+|++| +|++..-..+.++++|++|+|+++.
T Consensus 81 L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L~~L~L~~c~ 150 (176)
T 3e4g_A 81 MEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNLKYLFLSDLP 150 (176)
T ss_dssp GTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTCCEEEEESCT
T ss_pred hcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCCCEEECCCCC
Confidence 4455666666666653 443322334433 24666666665 3665555556666677777776654
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.74 E-value=3.8e-05 Score=84.85 Aligned_cols=79 Identities=9% Similarity=0.155 Sum_probs=55.2
Q ss_pred cCcc-cccCceEEEEEEec--C----CCcEEEEEeeeccc-----cHHHHHHHHHHHHhcC-C--CceeeEEEEEEeC--
Q 002061 681 DNLI-GSGGTGKVYRLDLK--K----NAGTVAVKQLWKGD-----GVKVFAAEMEILGKIR-H--RNILKLYACLLKG-- 743 (973)
Q Consensus 681 ~~~l-G~G~~g~V~~a~~~--~----~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~-h--pniv~l~~~~~~~-- 743 (973)
.+.| +.|....+|+.... . +++.+++|+..... ....+.+|+.+++.+. + ..+.+++.+..++
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88889999988764 1 15678999765432 1245788999998884 3 3466777776554
Q ss_pred -CeeEEEEEccCCCchH
Q 002061 744 -GSSFLVLEYMPNGNLF 759 (973)
Q Consensus 744 -~~~~lv~e~~~~gsL~ 759 (973)
+..|+||||++|..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3578999999887653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.72 E-value=0.00025 Score=77.64 Aligned_cols=142 Identities=17% Similarity=0.206 Sum_probs=81.3
Q ss_pred CcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhcC-----CCceeeEE-E--EEEeCCeeEEEEEcc
Q 002061 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIR-----HRNILKLY-A--CLLKGGSSFLVLEYM 753 (973)
Q Consensus 682 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~-----hpniv~l~-~--~~~~~~~~~lv~e~~ 753 (973)
+.|+.|..+.||+.... +..+++|+.... ...+..|+.+++.+. .|.++... + +...++..++||||+
T Consensus 38 ~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~--~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTD--SGAVCLKRIHRP--EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp EECC----CEEEEEEET--TEEEEEEEECSC--HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eeccccccCcEEEEEeC--CCCEEEEecCCC--HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 45666778999998875 346899987653 234445666665553 34444311 0 123466789999999
Q ss_pred CCCchH--------------HHHHhhhcCC--C-------CCCCHHHHH-------------------------------
Q 002061 754 PNGNLF--------------QALHKRVKEG--K-------PELDWFRRY------------------------------- 779 (973)
Q Consensus 754 ~~gsL~--------------~~l~~~~~~~--~-------~~~~~~~~~------------------------------- 779 (973)
+|.++. ..++...... . ....|....
T Consensus 114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 193 (346)
T 2q83_A 114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID 193 (346)
T ss_dssp CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence 986542 1122211110 0 011232110
Q ss_pred HHHHHHHHHHhhhhh----------cCCCCeEecCCCCCCeeecCCCCeEEecccCcc
Q 002061 780 KIALGAAKGIAYLHH----------DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827 (973)
Q Consensus 780 ~i~~~ia~~l~~LH~----------~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~ 827 (973)
.+..++..++++++. .....++|+|+++.||+++.++.+.+.||+.+.
T Consensus 194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111123345666652 025789999999999999888899999999764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.68 E-value=0.00014 Score=81.59 Aligned_cols=74 Identities=14% Similarity=0.139 Sum_probs=49.6
Q ss_pred cCcccccCceEEEEEEecCCCcEEEEEeeecc---------ccHHHHHHHHHHHHhcCC--Ccee-eEEEEEEeCCeeEE
Q 002061 681 DNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---------DGVKVFAAEMEILGKIRH--RNIL-KLYACLLKGGSSFL 748 (973)
Q Consensus 681 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---------~~~~~~~~E~~~l~~l~h--pniv-~l~~~~~~~~~~~l 748 (973)
.+.||.|..+.||++.....++.|+||..... ....++.+|.++++.+.. |..+ +++.+ +++..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 45789999999999987655788999975431 123456789999988742 3333 44443 3455689
Q ss_pred EEEccCCC
Q 002061 749 VLEYMPNG 756 (973)
Q Consensus 749 v~e~~~~g 756 (973)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999774
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.32 E-value=4.6e-05 Score=74.83 Aligned_cols=121 Identities=12% Similarity=0.098 Sum_probs=67.9
Q ss_pred ccccccCCccCcEeeCCCC-cccCc----CChhhhCCCCCcEEEecCCcccCCC-----CcccCCCCCCEEeccCccCCC
Q 002061 89 ISSSISALQSLTVLSLPFN-VLSGK----LPLELSNCSNLKVLNVTGNAMVGSV-----PDLSALKNLEIFDLSINYFTG 158 (973)
Q Consensus 89 ~~~~l~~l~~L~~L~Ls~n-~l~~~----~p~~l~~l~~L~~L~L~~n~l~~~~-----~~l~~l~~L~~L~Ls~n~l~~ 158 (973)
+...+..-+.|++|+|++| .|... +-.++..-+.|+.|+|++|.|...- ..+..-+.|++|+|++|.|.+
T Consensus 33 l~~ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~ 112 (197)
T 1pgv_A 33 INRLREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTP 112 (197)
T ss_dssp HHHHHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCH
T ss_pred HHHHHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCH
Confidence 3344555677778888774 66532 3344555666777777777664211 123344566666666666653
Q ss_pred ccccccccccccceEEccCCcCCCCCCcccccCCCCCCEEEcccCCC---CC----CCChhhhccCCCCeeeccccccc
Q 002061 159 RFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNL---RG----RIPESISELRELGTLDICRNKIS 230 (973)
Q Consensus 159 ~~~~~~~~l~~L~~L~l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l---~~----~~~~~~~~l~~L~~L~L~~N~l~ 230 (973)
..... +-+.+..-+.|++|+|++|.. .. .+.+.+..-+.|+.|+++.|.+.
T Consensus 113 ~Ga~a---------------------la~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 113 ELLAR---------------------LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp HHHHH---------------------HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HHHHH---------------------HHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence 32221 122344445677777775532 31 13345566678888888877654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.28 E-value=0.0033 Score=67.18 Aligned_cols=140 Identities=20% Similarity=0.242 Sum_probs=92.3
Q ss_pred cCcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhcC---CCceeeEEEEEEeCCeeEEEEEccCCCc
Q 002061 681 DNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIR---HRNILKLYACLLKGGSSFLVLEYMPNGN 757 (973)
Q Consensus 681 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~lv~e~~~~gs 757 (973)
.+.|+.|....+|+.... ++.++||+.... ....+.+|++.++.+. ...+.+++++...++..++||||+++..
T Consensus 41 ~~~l~gG~~n~~y~v~~~--~~~~vlK~~~~~-~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDE--VQTVFVKINERS-YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp EEEECCSSSSEEEEEESS--SCEEEEEEEEGG-GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred eEEeCCccceeeeEEEEC--CCeEEEEeCCcc-cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence 467899999999998763 678999976543 4667889999998883 3567788888887888999999999876
Q ss_pred hH--------H---HHHhhhcCC-----------------CCCCCHHHHH---HHHHH----------------HHHH-H
Q 002061 758 LF--------Q---ALHKRVKEG-----------------KPELDWFRRY---KIALG----------------AAKG-I 789 (973)
Q Consensus 758 L~--------~---~l~~~~~~~-----------------~~~~~~~~~~---~i~~~----------------ia~~-l 789 (973)
+. + .++...... ...-+|.... ++..+ ++.. .
T Consensus 118 ~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~ 197 (312)
T 3jr1_A 118 NKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVA 197 (312)
T ss_dssp CCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHH
T ss_pred CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHH
Confidence 52 1 122211100 0112454432 11111 1111 1
Q ss_pred hhhhh-cCCCCeEecCCCCCCeeecCCCCeEEeccc
Q 002061 790 AYLHH-DCSPPIIHRDIKSSNILLDEDYEPKIADFG 824 (973)
Q Consensus 790 ~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 824 (973)
..|.. .....++|+|+.+.|++++.++ +.|.|++
T Consensus 198 ~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 198 DTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 23321 1246799999999999999887 8899974
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.07 E-value=0.00067 Score=62.22 Aligned_cols=61 Identities=26% Similarity=0.336 Sum_probs=42.3
Q ss_pred chhccccccc-cCCCccccccCCCCeeecCCCccCCCCChhhhccc-CceEEccCCccccccCcc
Q 002061 509 DLNLARNSLS-GNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLK-LSSIDLSENQLSGSVPLD 571 (973)
Q Consensus 509 ~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~-L~~l~ls~N~l~~~~p~~ 571 (973)
.++.+++.|+ ..+|..+ -++|+.|+|++|+|+...+..|..++ |+.|+|++|+|.|++...
T Consensus 12 ~v~Cs~~~L~~~~vP~~l--p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC~l~ 74 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAF--PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDCRLV 74 (130)
T ss_dssp EEECCSSCCCTTTSCSCC--CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSGGGH
T ss_pred EEEeCCCCCccccCCCCC--CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccCccH
Confidence 4566666665 2344332 23588888888888865555666665 888999999999988864
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.05 E-value=0.00019 Score=70.53 Aligned_cols=16 Identities=19% Similarity=0.086 Sum_probs=8.2
Q ss_pred ccccccccEEEeeccc
Q 002061 261 LGNLTLLQEFDISSNQ 276 (973)
Q Consensus 261 l~~l~~L~~L~Ls~N~ 276 (973)
+..-+.|+.|+++.|.
T Consensus 153 L~~N~tL~~L~l~~~~ 168 (197)
T 1pgv_A 153 IEENESLLRVGISFAS 168 (197)
T ss_dssp HHHCSSCCEEECCCCC
T ss_pred HHhCCCcCeEeccCCC
Confidence 3344555555555554
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.00 E-value=0.0021 Score=72.35 Aligned_cols=77 Identities=14% Similarity=0.191 Sum_probs=48.3
Q ss_pred CCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCcccccccCC--ccccccccccccC---CCCccchHHHHHHHH
Q 002061 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAG--THGYIAPELAYTC---KVSEKSDVFSFGVVL 871 (973)
Q Consensus 797 ~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~~~DvwslG~~l 871 (973)
...++|+|++|.||+++.++ +++.||+.+..-.+. .+.....+ ...|.+|+..... ......++.+....+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~---~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG---FDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH---HHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH---HHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 67899999999999999876 999999988633221 11111111 2346666654311 111234556778888
Q ss_pred HHHHhC
Q 002061 872 LELVTG 877 (973)
Q Consensus 872 ~el~tg 877 (973)
|+.+++
T Consensus 307 ~~~y~~ 312 (420)
T 2pyw_A 307 WNLFNK 312 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 887765
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.95 E-value=0.0024 Score=67.80 Aligned_cols=76 Identities=17% Similarity=0.154 Sum_probs=53.6
Q ss_pred CcccCcccccCceEEEEEEecCCCcEEEEEeeecc--ccHHHHHHHHHHHHhcCCC---ceeeEEEEEEeCCeeEEEEEc
Q 002061 678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHR---NILKLYACLLKGGSSFLVLEY 752 (973)
Q Consensus 678 ~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp---niv~l~~~~~~~~~~~lv~e~ 752 (973)
...++.+|.|..+.||+....+ |+.|+||+.... .....+.+|+..|+.+.-. -+.+++++ . ..++||||
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~D-G~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e~ 91 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELAD-GTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAMEW 91 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETT-SCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEEC
T ss_pred eEEEEecCCCCCeEEEEEEECC-CCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEEe
Confidence 3445778999999999998764 889999976542 2335688999999988421 23344443 2 24789999
Q ss_pred cCCCch
Q 002061 753 MPNGNL 758 (973)
Q Consensus 753 ~~~gsL 758 (973)
++++..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.80 E-value=0.0026 Score=67.96 Aligned_cols=70 Identities=16% Similarity=0.138 Sum_probs=44.9
Q ss_pred cCcccccCceEEEEEEecCCCcEEEEEeeeccc-cHHHHHHHHHHHHhcCCCcee-eEEEEEEeCCeeEEEEEcc-CCCc
Q 002061 681 DNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNIL-KLYACLLKGGSSFLVLEYM-PNGN 757 (973)
Q Consensus 681 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~hpniv-~l~~~~~~~~~~~lv~e~~-~~gs 757 (973)
.+.|+.|....+|+. +.+++|+..... ..-...+|+.+++.+...++. +++++ .++.-++|+||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 577899999999998 468899765421 111235788888777433333 44443 343457899999 6655
Q ss_pred h
Q 002061 758 L 758 (973)
Q Consensus 758 L 758 (973)
+
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.70 E-value=0.0089 Score=64.64 Aligned_cols=142 Identities=17% Similarity=0.179 Sum_probs=81.1
Q ss_pred CcccccCceEEEEEEecCCCcEEEEEeeecc-ccHHHHHHHHHHHHhcCCCc--eeeEEEE-----EEeCCeeEEEEEcc
Q 002061 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRN--ILKLYAC-----LLKGGSSFLVLEYM 753 (973)
Q Consensus 682 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hpn--iv~l~~~-----~~~~~~~~lv~e~~ 753 (973)
..++ |....||+....+ |+.+++|+.... .....+..|..+++.+.... +.+++.. ...++..+++|||+
T Consensus 32 ~~l~-g~~n~~y~v~~~~-g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDED-RRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTT-CCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCC-CCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3466 8888999886643 667999987643 34566778888888774222 3333332 22355678999999
Q ss_pred CCCchH-----H------H---HHhhhcC----CCCCCCHHHH----------------------HHHHHHHHHHHhhhh
Q 002061 754 PNGNLF-----Q------A---LHKRVKE----GKPELDWFRR----------------------YKIALGAAKGIAYLH 793 (973)
Q Consensus 754 ~~gsL~-----~------~---l~~~~~~----~~~~~~~~~~----------------------~~i~~~ia~~l~~LH 793 (973)
+|..+. . . ++..... ..+..++... ...+.+++..++-.-
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 876542 1 1 1211110 0112222211 011111111122111
Q ss_pred h-cCCCCeEecCCCCCCeeecCCCCeEEecccCcc
Q 002061 794 H-DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827 (973)
Q Consensus 794 ~-~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~ 827 (973)
. .....++|+|+++.||+++ + .+.+.||+.+.
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 0 1145689999999999999 4 89999999775
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.64 E-value=0.0036 Score=70.51 Aligned_cols=73 Identities=21% Similarity=0.310 Sum_probs=49.6
Q ss_pred CcccccCceEEEEEEecC-------CCcEEEEEeeeccccHHHHHHHHHHHHhcCCCce-eeEEEEEEeCCeeEEEEEcc
Q 002061 682 NLIGSGGTGKVYRLDLKK-------NAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNI-LKLYACLLKGGSSFLVLEYM 753 (973)
Q Consensus 682 ~~lG~G~~g~V~~a~~~~-------~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~lv~e~~ 753 (973)
+.|+.|....||++.... .++.+++|+.........+.+|..+++.+...++ .++++.+.. .+||||+
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l 154 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYI 154 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEe
Confidence 467888899999998753 2568999987442222556689999988853333 455655432 3899999
Q ss_pred CCCch
Q 002061 754 PNGNL 758 (973)
Q Consensus 754 ~~gsL 758 (973)
+|.++
T Consensus 155 ~G~~l 159 (429)
T 1nw1_A 155 PSRPL 159 (429)
T ss_dssp CEEEC
T ss_pred CCccc
Confidence 86444
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.64 E-value=0.0064 Score=65.59 Aligned_cols=145 Identities=14% Similarity=0.125 Sum_probs=79.8
Q ss_pred cCcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhcCCCc--eeeEEE------EEEeCCeeEEEEEc
Q 002061 681 DNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRN--ILKLYA------CLLKGGSSFLVLEY 752 (973)
Q Consensus 681 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~------~~~~~~~~~lv~e~ 752 (973)
.+.|+.|....+|+....+ ..+++|+.........+..|+.+++.+.... +.+++. +...++..+++|+|
T Consensus 27 ~~~i~~G~~n~~~~v~~~~--g~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTTK--DPLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEEECC---EEEEEEEESS--CCEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eeccCCCcccceEEEEeCC--ccEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 3557788889999998653 3788998765333445677888887764212 222221 11234567899999
Q ss_pred cCCCchHH--------------HHHhhhcC-CCCC------CCHHHHHH------------HHHHHHHHHhhhhhc----
Q 002061 753 MPNGNLFQ--------------ALHKRVKE-GKPE------LDWFRRYK------------IALGAAKGIAYLHHD---- 795 (973)
Q Consensus 753 ~~~gsL~~--------------~l~~~~~~-~~~~------~~~~~~~~------------i~~~ia~~l~~LH~~---- 795 (973)
++|..+.. .++..... ..+. ..|..... +...+.+.+++++..
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 98865311 12221100 0000 11322110 001133344444421
Q ss_pred CCCCeEecCCCCCCeeecCCCCeEEecccCcc
Q 002061 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827 (973)
Q Consensus 796 ~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~ 827 (973)
...+++|+|+.+.||++++++.+.+.||+.+.
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 13579999999999999987666899999764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.35 E-value=0.023 Score=55.86 Aligned_cols=103 Identities=15% Similarity=0.135 Sum_probs=66.8
Q ss_pred CchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCc
Q 002061 756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV 835 (973)
Q Consensus 756 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 835 (973)
-+|.+.|..+ +.++++++++.++.|.+.+|.-.-.. ..-..+=+.|..|++..+|.|...+ +.+.
T Consensus 33 vSL~eIL~~~----~~PlsEEqaWALc~Qc~~~L~~~~~~--~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------- 97 (229)
T 2yle_A 33 LSLEEILRLY----NQPINEEQAWAVCYQCCGSLRAAARR--RQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------- 97 (229)
T ss_dssp EEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCSGGGEEEETTSCEEECC-C-----------
T ss_pred ccHHHHHHHc----CCCcCHHHHHHHHHHHHHHHHhhhhc--ccCCceecCCcceEEecCCceeccc-cccc--------
Confidence 3899999876 56799999999999999988776211 1111233446889999999887764 1110
Q ss_pred ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCC
Q 002061 836 SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKP 880 (973)
Q Consensus 836 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p 880 (973)
.....+.|||... ...+.+.=|||+|+++|.-+-=..|
T Consensus 98 ------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ---------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1123466888763 3456788999999999998864343
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.35 E-value=0.0085 Score=65.84 Aligned_cols=142 Identities=18% Similarity=0.199 Sum_probs=81.7
Q ss_pred CcccccCceEEEEEEecC-------CCcEEEEEeeec-cccHHHHHHHHHHHHhcCCCc-eeeEEEEEEeCCeeEEEEEc
Q 002061 682 NLIGSGGTGKVYRLDLKK-------NAGTVAVKQLWK-GDGVKVFAAEMEILGKIRHRN-ILKLYACLLKGGSSFLVLEY 752 (973)
Q Consensus 682 ~~lG~G~~g~V~~a~~~~-------~~~~vavK~~~~-~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~~~lv~e~ 752 (973)
+.+..|-...+|+..... +++.|++|+... ........+|.++++.+.-.+ ..++++++.+ .+||||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~ 131 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY 131 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence 457778888899988752 357899998633 124556678999998884222 2455555443 289999
Q ss_pred cCCCchHH--------------HH---HhhhcCCCCCCC--HHHHHHHHHHHHH-------------------HHhhhh-
Q 002061 753 MPNGNLFQ--------------AL---HKRVKEGKPELD--WFRRYKIALGAAK-------------------GIAYLH- 793 (973)
Q Consensus 753 ~~~gsL~~--------------~l---~~~~~~~~~~~~--~~~~~~i~~~ia~-------------------~l~~LH- 793 (973)
++|.++.. .+ +........... |.++.++..++.. .++.+.
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 99866531 11 111000011122 3444444443321 122222
Q ss_pred ---h-cCCCCeEecCCCCCCeeecCC----CCeEEecccCcc
Q 002061 794 ---H-DCSPPIIHRDIKSSNILLDED----YEPKIADFGVAK 827 (973)
Q Consensus 794 ---~-~~~~~ivH~Dlkp~Nill~~~----~~~kl~Dfgl~~ 827 (973)
. .....++|+|+.+.||+++.+ +.+.+.||..+.
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 1 113468999999999999876 789999999875
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.30 E-value=0.0075 Score=55.14 Aligned_cols=56 Identities=27% Similarity=0.395 Sum_probs=31.0
Q ss_pred EEEcccCCCC-CCCChhhhcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccc
Q 002061 437 QLVLQNNRFS-GELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALT 494 (973)
Q Consensus 437 ~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 494 (973)
.++.+++.++ ..+|..+ -++|+.|+|++|+|+.+.+..|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~l--p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAF--PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCC--CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCC--CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 4455555554 1233222 124666666666666555556666666666777766654
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.11 E-value=0.023 Score=61.51 Aligned_cols=143 Identities=14% Similarity=0.149 Sum_probs=72.2
Q ss_pred CcccccCceE-EEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhcCCC--ceeeEEEEEEeCCeeEEEEEccCCCch
Q 002061 682 NLIGSGGTGK-VYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHR--NILKLYACLLKGGSSFLVLEYMPNGNL 758 (973)
Q Consensus 682 ~~lG~G~~g~-V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp--niv~l~~~~~~~~~~~lv~e~~~~gsL 758 (973)
+.|+.|+... +|+.... +++.+++|...... ...+..|+.+++.+... .+.+++.+....+ +++||++.+..+
T Consensus 24 ~~l~gg~s~~~~~r~~~~-~~~~~vlk~~~~~~-~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~l 99 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSP-TGAKAVLMDWSPEE-GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDALF 99 (333)
T ss_dssp CC--------CCEEEECT-TCCEEEEEECCTTT-TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCBH
T ss_pred eECCCCCCCceEEEEEcC-CCCeEEEEECCCCC-CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcch
Confidence 4566665554 6676542 25577777644321 13345677777776422 2345555533333 789999977676
Q ss_pred HHHHHhhhc-----------------C----CCCCCCHHHHH-------H-H------------HHHHHHHHhhhh---h
Q 002061 759 FQALHKRVK-----------------E----GKPELDWFRRY-------K-I------------ALGAAKGIAYLH---H 794 (973)
Q Consensus 759 ~~~l~~~~~-----------------~----~~~~~~~~~~~-------~-i------------~~~ia~~l~~LH---~ 794 (973)
.+++..... . ..+.++..... . + ...+...++.+. .
T Consensus 100 ~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~ 179 (333)
T 3csv_A 100 TEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQL 179 (333)
T ss_dssp HHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHC
T ss_pred HHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcc
Confidence 654432100 0 01112211100 0 0 001111222221 1
Q ss_pred cCCCCeEecCCCCCCeeecCC----CCeEEecccCccc
Q 002061 795 DCSPPIIHRDIKSSNILLDED----YEPKIADFGVAKI 828 (973)
Q Consensus 795 ~~~~~ivH~Dlkp~Nill~~~----~~~kl~Dfgl~~~ 828 (973)
.....++|||+.+.||+++.+ +.+.+.||+.+..
T Consensus 180 ~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 180 EGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred cCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 114679999999999999875 6789999998863
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.94 E-value=0.017 Score=65.19 Aligned_cols=74 Identities=16% Similarity=0.139 Sum_probs=48.1
Q ss_pred cCcccccCceEEEEEEecCCCcEEEEEeeeccc-cHHHHHHHHHHHHhcCCCce-eeEEEEEEeCCeeEEEEEccCCCch
Q 002061 681 DNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNI-LKLYACLLKGGSSFLVLEYMPNGNL 758 (973)
Q Consensus 681 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~lv~e~~~~gsL 758 (973)
.+.|+.|-...+|++.....+..+++|+..... ..-...+|..+++.+...++ .++++++. + .+||||++|.++
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 356888999999999876545789999764321 11122589999998865444 35666552 2 359999987555
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.66 E-value=0.013 Score=64.45 Aligned_cols=73 Identities=19% Similarity=0.181 Sum_probs=43.7
Q ss_pred CcccccCceEEEEEEecC--------CCcEEEEEeeeccc-cHHHHHHHHHHHHhcCCCce-eeEEEEEEeCCeeEEEEE
Q 002061 682 NLIGSGGTGKVYRLDLKK--------NAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNI-LKLYACLLKGGSSFLVLE 751 (973)
Q Consensus 682 ~~lG~G~~g~V~~a~~~~--------~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~lv~e 751 (973)
+.++.|....+|+..... .++.+++|+..... ......+|.++++.+...++ .++++.. + -++|||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e 114 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEE 114 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEE
Confidence 457888889999998753 12688899765422 11124678888888743333 3555543 2 268999
Q ss_pred ccCCCch
Q 002061 752 YMPNGNL 758 (973)
Q Consensus 752 ~~~~gsL 758 (973)
|++|.++
T Consensus 115 ~i~G~~l 121 (369)
T 3c5i_A 115 WLYGDPL 121 (369)
T ss_dssp CCCSEEC
T ss_pred EecCCcC
Confidence 9987544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=94.95 E-value=0.082 Score=57.24 Aligned_cols=68 Identities=10% Similarity=0.120 Sum_probs=43.7
Q ss_pred cccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhcC---CCceeeEEEE------EEeCCeeEEEEEccCC
Q 002061 685 GSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIR---HRNILKLYAC------LLKGGSSFLVLEYMPN 755 (973)
Q Consensus 685 G~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~------~~~~~~~~lv~e~~~~ 755 (973)
|.|....||+....+ | .+++|+...... .+|+.+++.+. -|.+.+++.. ...++..+++|||++|
T Consensus 32 G~g~~N~vy~v~~~~-g-~~vLK~~~~~~~----~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G 105 (339)
T 3i1a_A 32 GADTNAFAYQADSES-K-SYFIKLKYGYHD----EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHA 105 (339)
T ss_dssp TSCSSCEEEEEECSS-C-EEEEEEEECSSC----CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCC
T ss_pred cCccccceEEEEeCC-C-CEEEEEecCccc----hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCC
Confidence 445578999998654 4 899997655331 45666666653 1224444432 2345678999999998
Q ss_pred Cch
Q 002061 756 GNL 758 (973)
Q Consensus 756 gsL 758 (973)
..+
T Consensus 106 ~~~ 108 (339)
T 3i1a_A 106 PNG 108 (339)
T ss_dssp CBT
T ss_pred CcC
Confidence 765
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=92.25 E-value=0.37 Score=53.53 Aligned_cols=73 Identities=15% Similarity=0.151 Sum_probs=46.6
Q ss_pred CcccccCceEEEEEEecCC-------CcEEEEEeeecc-ccHHHHHHHHHHHHhcCCCce-eeEEEEEEeCCeeEEEEEc
Q 002061 682 NLIGSGGTGKVYRLDLKKN-------AGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNI-LKLYACLLKGGSSFLVLEY 752 (973)
Q Consensus 682 ~~lG~G~~g~V~~a~~~~~-------~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~lv~e~ 752 (973)
+.+..|-...+|+...... ++.|++|+.... ...-...+|.++++.+.-.++ .++++.+ . -++||||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ef 151 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEEF 151 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEEC
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEEE
Confidence 4567788889999887631 468999976432 111224678888888843233 3444432 2 2789999
Q ss_pred cCCCch
Q 002061 753 MPNGNL 758 (973)
Q Consensus 753 ~~~gsL 758 (973)
++|..+
T Consensus 152 I~G~~l 157 (424)
T 3mes_A 152 IDGEPL 157 (424)
T ss_dssp CCSEEC
T ss_pred eCCccC
Confidence 998764
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=86.59 E-value=1.5 Score=48.34 Aligned_cols=29 Identities=31% Similarity=0.453 Sum_probs=24.7
Q ss_pred CeEecCCCCCCeee------cCCCCeEEecccCcc
Q 002061 799 PIIHRDIKSSNILL------DEDYEPKIADFGVAK 827 (973)
Q Consensus 799 ~ivH~Dlkp~Nill------~~~~~~kl~Dfgl~~ 827 (973)
.++|+|+.+.||++ +++..+.+.||.+|.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 36799999999999 446679999999886
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 973 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-63 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-57 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-57 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-57 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-56 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-56 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-56 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-56 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-55 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-55 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-55 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 8e-55 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-54 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-54 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-54 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-54 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-54 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-53 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-53 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-52 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-52 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-52 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 9e-52 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-51 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-49 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-49 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-49 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-48 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-48 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-48 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-47 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-46 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-46 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-44 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-43 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-42 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-42 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-42 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-42 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-41 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-41 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-40 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-40 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-39 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-39 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-38 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-38 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-38 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-37 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-36 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-36 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-35 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-34 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-32 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-31 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-31 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-28 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-27 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-25 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-22 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-24 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-21 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-11 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-04 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-20 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-17 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-17 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-16 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-16 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-08 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 7e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-15 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-10 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-15 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-10 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 6e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 8e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 7e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.001 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 8e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.002 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.003 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.003 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 7e-05 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 1e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.001 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.003 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 4e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 2e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 4e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 9e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.002 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.003 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (542), Expect = 4e-63
Identities = 74/281 (26%), Positives = 120/281 (42%), Gaps = 29/281 (10%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKIRHRN 732
+ IGSG G VY+ G VAVK L ++ F E+ +L K RH N
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
IL +V ++ +L+ LH + + + + IA A+G+ YL
Sbjct: 66 ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHII----ETKFEMIKLIDIARQTAQGMDYL 120
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL 852
H IIHRD+KS+NI L ED KI DFG+A + + +G+ ++APE+
Sbjct: 121 HA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177
Query: 853 AYT---CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVL 909
S +SDV++FG+VL EL+TG+ P + + + +
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY-----SNINNRDQIIFMVGRGYLSPDLS 232
Query: 910 DCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950
+ + M +L+ C K + RP +++ +
Sbjct: 233 KV---RSNCPKAMKRLMA---ECLKKKRDERPLFPQILASI 267
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 1e-57
Identities = 70/279 (25%), Positives = 133/279 (47%), Gaps = 29/279 (10%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILK 735
L+ +G+G G+V+ + VAVK L +G F AE ++ +++H+ +++
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHD 795
LYA + + +++ EYM NG+L L +L + +A A+G+A++
Sbjct: 73 LYAVVTQEPI-YIITEYMENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIE-- 126
Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYT 855
IHRD++++NIL+ + KIADFG+A++ E++ + + + APE
Sbjct: 127 -ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EYTAREGAKFPIKWTAPEAINY 184
Query: 856 CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCE--V 913
+ KSDV+SFG++L E+VT + + N E + + V
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYP--------------GMTNPEVIQNLERGYRMV 230
Query: 914 ASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952
++ E++ +L++ +C + P RP + +L D
Sbjct: 231 RPDNCPEELYQLMR---LCWKERPEDRPTFDYLRSVLED 266
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 1e-57
Identities = 70/277 (25%), Positives = 117/277 (42%), Gaps = 33/277 (11%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKL 736
L+ IG G G V D + N VAVK + + F AE ++ ++RH N+++L
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDYRGN--KVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQL 65
Query: 737 Y-ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHD 795
+ + G ++V EYM G+L L R G+ L K +L + + YL
Sbjct: 66 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLE-- 120
Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYT 855
+HRD+ + N+L+ ED K++DFG+ K A S + APE
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALRE 174
Query: 856 CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEV-- 913
K S KSDV+SFG++L E+ + + + + V +V
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPR--------------IPLKDVVPRVEKGYKMD 220
Query: 914 ASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950
A + + +++K C +RP ++ + L
Sbjct: 221 APDGCPPAVYEVMKN---CWHLDAAMRPSFLQLREQL 254
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 5e-57
Identities = 61/282 (21%), Positives = 121/282 (42%), Gaps = 31/282 (10%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRN 732
+ E IG+G G+ ++ K + + K+L G ++ +E+ +L +++H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 733 ILKLYACLL--KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
I++ Y ++ + ++V+EY G+L + K KE + LD ++ +
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQY-LDEEFVLRVMTQLTLALK 123
Query: 791 YLH--HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
H D ++HRD+K +N+ LD K+ DFG+A+I + + F GT Y+
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA--KAFVGTPYYM 181
Query: 849 APELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKV 908
+PE +EKSD++S G +L EL P + E K+
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF---------------SQKELAGKI 226
Query: 909 LDCEVAS--ESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVK 948
+ + +++ +++ RP + E+++
Sbjct: 227 REGKFRRIPYRYSDELNEIIT---RMLNLKDYHRPSVEEILE 265
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 1e-56
Identities = 73/296 (24%), Positives = 120/296 (40%), Gaps = 33/296 (11%)
Query: 678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFA-AEMEILGKIRHRNILKL 736
L+E IG G G+V+R + VAVK + F AE+ +RH NIL
Sbjct: 7 LQE--SIGKGRFGEVWRGKWRGE--EVAVKIFSSREERSWFREAEIYQTVMLRHENILGF 62
Query: 737 YACLLKGGSS----FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
A K + +LV +Y +G+LF L++ + K+AL A G+A+L
Sbjct: 63 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHL 116
Query: 793 HHDC-----SPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSC--FAGTH 845
H + P I HRD+KS NIL+ ++ IAD G+A +++ D + GT
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 846 GYIAPELAYTC------KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHL 899
Y+APE+ + +++D+++ G+V E+ V +
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236
Query: 900 NNHENVLKVLDCEV-----ASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950
+ E V + ++ E + + KI C R + K L
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 1e-56
Identities = 63/272 (23%), Positives = 115/272 (42%), Gaps = 14/272 (5%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK---GDGVKVFAAEMEILGKIRHRNI 733
+ E+ + +G+G G V+++ K + +A K + E+++L + I
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 734 LKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
+ Y G + +E+M G+L Q L K + + K+++ KG+ YL
Sbjct: 67 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-----IPEQILGKVSIAVIKGLTYLR 121
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELA 853
I+HRD+K SNIL++ E K+ DFGV+ +S S F GT Y++PE
Sbjct: 122 EKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS----FVGTRSYMSPERL 175
Query: 854 YTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEV 913
S +SD++S G+ L+E+ GR P+ ++++ + E +
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235
Query: 914 ASESIKEDMIKLLKIAVVCTTKLPNLRPPMRE 945
S D + I + + P +
Sbjct: 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPS 267
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 2e-56
Identities = 67/284 (23%), Positives = 122/284 (42%), Gaps = 28/284 (9%)
Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKI 728
ID L IGSG G V+ VA+K + +G + F E E++ K+
Sbjct: 2 IDPS---ELTFVQEIGSGQFGLVHLGYWLNK-DKVAIKTIREGAMSEEDFIEEAEVMMKL 57
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
H +++LY L+ LV E+M +G L L + + + L +G
Sbjct: 58 SHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQ----RGLFAAETLLGMCLDVCEG 113
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
+ + +IHRD+ + N L+ E+ K++DFG+ + + + + + +
Sbjct: 114 ---MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYTSSTGTKFPVKWA 169
Query: 849 APELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKV 908
+PE+ + S KSDV+SFGV++ E+ + K E ++V +ST ++
Sbjct: 170 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-SNSEVVEDISTG-------FRL 221
Query: 909 LDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952
+AS + + M C + P RP +++ LA+
Sbjct: 222 YKPRLASTHVYQIMNH-------CWKERPEDRPAFSRLLRQLAE 258
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 193 bits (492), Expect = 4e-56
Identities = 66/275 (24%), Positives = 122/275 (44%), Gaps = 23/275 (8%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG-VKVFAAEMEILGKIRHRNILK 735
++ + +G G G+VY KK + TVAVK L + V+ F E ++ +I+H N+++
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 77
Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHD 795
L + +++ E+M GNL L + + E+ +A + + YL
Sbjct: 78 LLGVCTREPPFYIITEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLE-- 132
Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYT 855
IHRD+ + N L+ E++ K+ADFG++++ + ++ + APE
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA-HAGAKFPIKWTAPESLAY 190
Query: 856 CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVAS 915
K S KSDV++FGV+L E+ T + V ++L+ +
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMSPYPG---------------IDLSQVYELLEKDYRM 235
Query: 916 ESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950
E + K+ ++ C P+ RP E+ +
Sbjct: 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 192 bits (489), Expect = 1e-55
Identities = 66/287 (22%), Positives = 126/287 (43%), Gaps = 33/287 (11%)
Query: 674 QICNLEEDNLIGSGGTGKVYRLDLKKNAGT---VAVKQLWKG---DGVKVFAAEMEILGK 727
I ++ + +IG+G G+V LK VA+K L G + F +E I+G+
Sbjct: 24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQ 83
Query: 728 IRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAK 787
H N++ L + K ++ E+M NG+L L + + + + G A
Sbjct: 84 FDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF----TVIQLVGMLRGIAA 139
Query: 788 GIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYS---CFAGT 844
G+ YL +HRD+ + NIL++ + K++DFG+++ E+ Y+
Sbjct: 140 GMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIP 196
Query: 845 HGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHE 903
+ APE K + SDV+S+G+V+ E+++ G +P + ++
Sbjct: 197 IRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM----------------TNQ 240
Query: 904 NVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950
+V+ ++ + + L ++ + C K N RP ++V L
Sbjct: 241 DVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 192 bits (488), Expect = 2e-55
Identities = 73/303 (24%), Positives = 125/303 (41%), Gaps = 49/303 (16%)
Query: 677 NLEEDNLIGSGGTGKVYR-----LDLKKNAGTVAVKQLWK---GDGVKVFAAEMEILGKI 728
N+E IG G G+V++ L + VAVK L + D F E ++ +
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKR-------------------VKEG 769
+ NI+KL G L+ EYM G+L + L G
Sbjct: 74 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133
Query: 770 KPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829
P L + IA A G+AYL +HRD+ + N L+ E+ KIADFG+++
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNI 190
Query: 830 ENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGK 889
++ A ++ PE + + + +SDV+++GVVL E+ +
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG----- 245
Query: 890 DIVYWVSTHLNNHENVLKVLDCEVAS--ESIKEDMIKLLKIAVVCTTKLPNLRPPMREVV 947
+ + E + V D + + E+ ++ L+++ C +KLP RP +
Sbjct: 246 ---------MAHEEVIYYVRDGNILACPENCPLELYNLMRL---CWSKLPADRPSFCSIH 293
Query: 948 KML 950
++L
Sbjct: 294 RIL 296
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 2e-55
Identities = 78/298 (26%), Positives = 120/298 (40%), Gaps = 32/298 (10%)
Query: 662 LASFHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGT---VAVKQLWKG---DGV 715
+ + H+ I + + + +IG G G VY L N G AVK L + V
Sbjct: 14 VQAVQHVVIGPSSL-IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV 72
Query: 716 KVFAAEMEILGKIRHRNILKLY-ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELD 774
F E I+ H N+L L CL GS +VL YM +G+L +
Sbjct: 73 SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE----THNPT 128
Query: 775 WFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK 834
L AKG + S +HRD+ + N +LDE + K+ADFG+A+ +
Sbjct: 129 VKDLIGFGLQVAKG---MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185
Query: 835 VSDYSC--FAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIV 892
S ++ ++A E T K + KSDV+SFGV+L EL+T P +
Sbjct: 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTF 241
Query: 893 YWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950
L ++L E + + E + + C +RP E+V +
Sbjct: 242 DITVYLLQGR----RLLQPEYCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRI 288
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (482), Expect = 8e-55
Identities = 68/290 (23%), Positives = 131/290 (45%), Gaps = 33/290 (11%)
Query: 669 DIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAG----TVAVKQLWKG---DGVKVFAAE 721
+I + +IG+G G+VY+ LK ++G VA+K L G F E
Sbjct: 3 EIHPSCV---TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGE 59
Query: 722 MEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKI 781
I+G+ H NI++L + K ++ EYM NG L + L ++ E + +
Sbjct: 60 AGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK----DGEFSVLQLVGM 115
Query: 782 ALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSC- 840
G A G+ + + +HRD+ + NIL++ + K++DFG++++ E+ P+ + +
Sbjct: 116 LRGIAAGM---KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG 172
Query: 841 FAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLN 900
+ APE K + SDV+SFG+V+ E++T + E
Sbjct: 173 GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL--------------- 217
Query: 901 NHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950
++ V+K ++ + + + ++ + C + RP ++V +L
Sbjct: 218 SNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 1e-54
Identities = 70/296 (23%), Positives = 118/296 (39%), Gaps = 39/296 (13%)
Query: 677 NLEEDNLIGSGGTGKVYR-----LDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKI 728
L +G+G GKV L A TVAVK L + +E+++L +
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83
Query: 729 -RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKR-------------VKEGKPELD 774
H NI+ L GG + ++ EY G+L L ++ +++ + LD
Sbjct: 84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 775 WFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK 834
+ AKG+A+L S IHRD+ + NILL KI DFG+A+ +N
Sbjct: 144 LEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200
Query: 835 VSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYW 894
++APE + C + +SDV+S+G+ L EL +
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP----------- 249
Query: 895 VSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950
+ K++ S + ++ I C P RP +++V+++
Sbjct: 250 ---GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 2e-54
Identities = 71/277 (25%), Positives = 120/277 (43%), Gaps = 25/277 (9%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILK 735
+L + +G G G+V+ VA+K L G + F E +++ K+RH +++
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 76
Query: 736 LYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHD 795
LYA + ++V EYM G+L L L + +A A G+AY+
Sbjct: 77 LYAVV-SEEPIYIVTEYMSKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVERM 132
Query: 796 CSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYT 855
+HRD++++NIL+ E+ K+ADFG+A++ E++ + + + APE A
Sbjct: 133 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDN-EYTARQGAKFPIKWTAPEAALY 188
Query: 856 CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVAS 915
+ + KSDV+SFG++L EL T + + VL ++
Sbjct: 189 GRFTIKSDVWSFGILLTELTTKGRVPYPG---------------MVNREVLDQVERGYRM 233
Query: 916 ESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952
E L + C K P RP + L D
Sbjct: 234 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 270
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 4e-54
Identities = 79/278 (28%), Positives = 117/278 (42%), Gaps = 36/278 (12%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHR 731
+ E +G G G VY K++ +A+K L+K E+EI +RH
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66
Query: 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAY 791
NIL+LY +L+LEY P G +++ L K K D R A ++Y
Sbjct: 67 NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYITELANALSY 121
Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPE 851
H S +IHRDIK N+LL E KIADFG + A +S + GT Y+ PE
Sbjct: 122 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPE 174
Query: 852 LAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDC 911
+ EK D++S GV+ E + G+ P E E ++
Sbjct: 175 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---------------TYQETYKRISRV 219
Query: 912 EVA-SESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVK 948
E + + E L+ P+ RP +REV++
Sbjct: 220 EFTFPDFVTEGARDLIS---RLLKHNPSQRPMLREVLE 254
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 7e-54
Identities = 59/284 (20%), Positives = 118/284 (41%), Gaps = 28/284 (9%)
Query: 670 IDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKI 728
ID + +L +G+G G V + VA+K + +G F E +++ +
Sbjct: 1 IDPK---DLTFLKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMSEDEFIEEAKVMMNL 56
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
H +++LY K F++ EYM NG L L + + + ++ +
Sbjct: 57 SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM----RHRFQTQQLLEMCKDVCEA 112
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
+ YL +HRD+ + N L+++ K++DFG+++ + S +
Sbjct: 113 MEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWS 168
Query: 849 APELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKV 908
PE+ K S KSD+++FGV++ E+ + K E + + + + L++
Sbjct: 169 PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA--------EHIAQGLRL 220
Query: 909 LDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952
+ASE + I C + + RP + ++ + D
Sbjct: 221 YRPHLASEKVYT-------IMYSCWHEKADERPTFKILLSNILD 257
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 7e-54
Identities = 70/281 (24%), Positives = 109/281 (38%), Gaps = 36/281 (12%)
Query: 678 LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKIRHRNI 733
L+ D IG G VY+ + VA +L + F E E+L ++H NI
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 734 LKLYACLL----KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGI 789
++ Y LV E M +G L L + + KG+
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGL 125
Query: 790 AYLHHDCSPPIIHRDIKSSNILL-DEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
+LH PPIIHRD+K NI + KI D G+A + S GT ++
Sbjct: 126 QFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFM 180
Query: 849 APELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKV 908
APE+ Y K E DV++FG+ +LE+ T P E N + +
Sbjct: 181 APEM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQ---------------NAAQIYRR 224
Query: 909 LDCEVASESIKEDMIKLLK-IAVVCTTKLPNLRPPMREVVK 948
+ V S + I +K I C + + R +++++
Sbjct: 225 VTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 1e-53
Identities = 70/303 (23%), Positives = 123/303 (40%), Gaps = 43/303 (14%)
Query: 665 FHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAG--TVAVKQLWKG---DGVKVFA 719
+ +D + +++ ++IG G G+V + +KK+ A+K++ + D + FA
Sbjct: 4 YPVLDWN-----DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA 58
Query: 720 AEMEILGKI-RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKR-----------VK 767
E+E+L K+ H NI+ L G +L +EY P+GNL L K
Sbjct: 59 GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 118
Query: 768 EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827
L + A A+G + + IHRD+ + NIL+ E+Y KIADFG+++
Sbjct: 119 STASTLSSQQLLHFAADVARG---MDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 175
Query: 828 IAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGD 887
E K + ++A E + SDV+S+GV+L E+V+
Sbjct: 176 GQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG--- 229
Query: 888 GKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVV 947
+ + L E ++ + C + P RP +++
Sbjct: 230 ------------MTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 277
Query: 948 KML 950
L
Sbjct: 278 VSL 280
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 4e-53
Identities = 63/302 (20%), Positives = 109/302 (36%), Gaps = 44/302 (14%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGT-----VAVKQLWKG---DGVKVFAAEMEILGKI 728
NLE ++GSG GKV + T VAVK L + + +E++++ ++
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 729 -RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVK------------------EG 769
H NI+ L G +L+ EY G+L L + + E
Sbjct: 98 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 770 KPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829
L + A AKG+ +L +HRD+ + N+L+ KI DFG+A+
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDI 214
Query: 830 ENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGK 889
+ ++APE + + KSDV+S+G++L E+ +
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG----- 269
Query: 890 DIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949
+ N K++ + ++ I C RP +
Sbjct: 270 ---------IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
Query: 950 LA 951
L
Sbjct: 321 LG 322
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 3e-52
Identities = 67/276 (24%), Positives = 113/276 (40%), Gaps = 26/276 (9%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNI 733
+ + +G G G+V + VAVK + D + E+ I + H N+
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 734 LKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
+K Y +G +L LEY G LF + + + + G+ YLH
Sbjct: 66 VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLH 120
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELA 853
I HRDIK N+LLDE KI+DFG+A + + + + GT Y+APEL
Sbjct: 121 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 854 YTCKV-SEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCE 912
+ +E DV+S G+VL ++ G P ++ ++ W E + +
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK-------EKKTYLNPWK 230
Query: 913 VASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVK 948
+ + K+L + P+ R + ++ K
Sbjct: 231 KIDSAPLALLHKIL-------VENPSARITIPDIKK 259
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 183 bits (465), Expect = 4e-52
Identities = 69/278 (24%), Positives = 115/278 (41%), Gaps = 37/278 (13%)
Query: 679 EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKIRHRNI 733
+ IG G G VY +N+ VA+K++ + + E+ L K+RH N
Sbjct: 18 SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT 77
Query: 734 LKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
++ C L+ +++LV+EY + L + GA +G+AYLH
Sbjct: 78 IQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-----LQEVEIAAVTHGALQGLAYLH 132
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELA 853
S +IHRD+K+ NILL E K+ DFG A I + + F GT ++APE+
Sbjct: 133 ---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEVI 183
Query: 854 YTC---KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLD 910
+ K DV+S G+ +EL + P + ++ ++ +
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPP------------LFNMNAMSALYHIAQNES 231
Query: 911 CEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVK 948
+ S E + C K+P RP ++K
Sbjct: 232 PALQSGHWSEYFRNFVDS---CLQKIPQDRPTSEVLLK 266
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 7e-52
Identities = 65/294 (22%), Positives = 118/294 (40%), Gaps = 36/294 (12%)
Query: 665 FHHI--DIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD--GVKVFAA 720
+ H+ D++ E + +G G GKVY+ K+ + A K + ++ +
Sbjct: 1 YEHVTRDLNPEDFWEIIG--ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMV 58
Query: 721 EMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYK 780
E++IL H NI+KL + ++++E+ G + + + + L +
Sbjct: 59 EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL----ERPLTESQIQV 114
Query: 781 IALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSC 840
+ + YLH IIHRD+K+ NIL D + K+ADFGV+ + +
Sbjct: 115 VCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRRDS 169
Query: 841 FAGTHGYIAPELAYTC-----KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWV 895
F GT ++APE+ K+DV+S G+ L+E+ P E
Sbjct: 170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL----------- 218
Query: 896 STHLNNHENVLKVLDCEVASESIKEDMIKLLK-IAVVCTTKLPNLRPPMREVVK 948
N +LK+ E + + K C K + R ++++
Sbjct: 219 ----NPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 9e-52
Identities = 66/279 (23%), Positives = 109/279 (39%), Gaps = 33/279 (11%)
Query: 680 EDNLIGSGGTGKVYR--LDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKIRHRNI 733
ED +GSG G V + +KK TVAVK L AE ++ ++ + I
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 734 LKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
+++ + S LV+E G L + L + + ++ + G+ YL
Sbjct: 71 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH-----VKDKNIIELVHQVSMGMKYLE 124
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK-IAENSPKVSDYSCFAGTHGYIAPEL 852
+HRD+ + N+LL + KI+DFG++K + + + + APE
Sbjct: 125 E---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 181
Query: 853 AYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDC 911
K S KSDV+SFGV++ E + G+KP G ++ +
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM--KGSEVTAMLEKGERMG--------- 230
Query: 912 EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950
+M L+ + C T RP V L
Sbjct: 231 --CPAGCPREMYDLMNL---CWTYDVENRPGFAAVELRL 264
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 1e-51
Identities = 61/278 (21%), Positives = 119/278 (42%), Gaps = 31/278 (11%)
Query: 680 EDNLIGSGGTGKVYR--LDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNIL 734
D +G G G V + ++K VA+K L +G + E +I+ ++ + I+
Sbjct: 13 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 72
Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHH 794
+L + + LV+E G L + L + + E+ ++ + G+ YL
Sbjct: 73 RLIGVC-QAEALMLVMEMAGGGPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEE 127
Query: 795 DCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK-IAENSPKVSDYSCFAGTHGYIAPELA 853
+HRD+ + N+LL + KI+DFG++K + + + S + APE
Sbjct: 128 ---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 184
Query: 854 YTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCE 912
K S +SDV+S+GV + E ++ G+KP ++ G +++ ++ K ++C
Sbjct: 185 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM--KGPEVMAFIEQG--------KRMEC- 233
Query: 913 VASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950
++ L+ C RP V + +
Sbjct: 234 --PPECPPELYALMSD---CWIYKWEDRPDFLTVEQRM 266
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 2e-49
Identities = 59/279 (21%), Positives = 108/279 (38%), Gaps = 30/279 (10%)
Query: 679 EEDNLIGSGGTGKVYR----LDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHR 731
++ ++GSG G VY+ + +K VA+K+L + K E ++ + +
Sbjct: 12 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 71
Query: 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAY 791
++ +L L + L+ + MP G L + + K + + AKG+ Y
Sbjct: 72 HVCRLLGICLTS-TVQLITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNY 126
Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPE 851
L ++HRD+ + N+L+ KI DFG+AK+ K ++A E
Sbjct: 127 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 852 LAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDC 911
+ +SDV+S+GV + EL+T + + +L+
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG---------------IPASEISSILEK 228
Query: 912 EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950
I + I V C + RP RE++
Sbjct: 229 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 2e-49
Identities = 73/286 (25%), Positives = 112/286 (39%), Gaps = 31/286 (10%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGT---VAVKQLWK-----GDGVKVFAAEMEILGKI 728
+L +G G G V R + +G VAVK L + + F E+ + +
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
HRN+++LY +L +V E P G+L L K +G L RY A+ A+G
Sbjct: 69 DHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKH--QGHFLLGTLSRY--AVQVAEG 123
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK-IAENSPKVSDYSCFAGTHGY 847
+ YL S IHRD+ + N+LL KI DFG+ + + +N +
Sbjct: 124 MGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 848 IAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLK 907
APE T S SD + FGV L E+ T + LN + + K
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG--------------LNGSQILHK 226
Query: 908 VLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953
+ ++ + + V C P RP + L +A
Sbjct: 227 IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 3e-49
Identities = 64/276 (23%), Positives = 106/276 (38%), Gaps = 32/276 (11%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHR 731
+ + ++G G V + A+K L K + V E +++ ++ H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAY 791
+KLY + L Y NG L + + K G + R Y A+ ++
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI---GSFDETCTRFY-----TAEIVSA 120
Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPE 851
L + IIHRD+K NILL+ED +I DFG AK+ K + + F GT Y++PE
Sbjct: 121 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180
Query: 852 LAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDC 911
L + SD+++ G ++ +LV G P N + K++
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG---------------NEYLIFQKIIKL 225
Query: 912 EVA-SESIKEDMIKLLKIAVVCTTKLPNLRPPMREV 946
E E L++ R E+
Sbjct: 226 EYDFPEKFFPKARDLVEK---LLVLDATKRLGCEEM 258
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 3e-48
Identities = 64/285 (22%), Positives = 115/285 (40%), Gaps = 31/285 (10%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD--GVKVFAAEMEILGKIRHRNILKLYAC 739
IG G +G VY VA++Q+ ++ E+ ++ + ++ NI+
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 740 LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP 799
L G ++V+EY+ G+L + + D + + + + +LH S
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCM------DEGQIAAVCRECLQALEFLH---SNQ 136
Query: 800 IIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVS 859
+IHRDIKS NILL D K+ DFG + +P+ S S GT ++APE+
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAYG 194
Query: 860 EKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESIK 919
K D++S G++ +E++ G P E N + +
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNE---------------NPLRALYLIATNGTPELQNP 239
Query: 920 EDMIKLLK-IAVVCTTKLPNLRPPMREVVKM--LADADPCTDKSP 961
E + + + C R +E+++ L A P + +P
Sbjct: 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTP 284
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 3e-48
Identities = 57/289 (19%), Positives = 117/289 (40%), Gaps = 35/289 (12%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLK-----KNAGTVAVKQLWKG---DGVKVFAAEMEILGKI 728
+ +G G G VY K + VA+K + + F E ++ +
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 80
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVK-----EGKPELDWFRRYKIAL 783
++++L + +G + +++E M G+L L + ++A
Sbjct: 81 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 140
Query: 784 GAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAG 843
A G+AYL + +HRD+ + N ++ ED+ KI DFG+ + +
Sbjct: 141 EIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 197
Query: 844 THGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHE 903
+++PE + SDV+SFGVVL E+ T + + L+N +
Sbjct: 198 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ--------------GLSNEQ 243
Query: 904 NVLKVLDCEV--ASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950
+ V++ + ++ + + +L+++ C P +RP E++ +
Sbjct: 244 VLRFVMEGGLLDKPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSI 289
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 5e-48
Identities = 71/296 (23%), Positives = 118/296 (39%), Gaps = 40/296 (13%)
Query: 677 NLEEDNLIGSGGTGKVYR-------LDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILG 726
L +G G G+V D VAVK L + +EME++
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73
Query: 727 KI-RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEG-----------KPELD 774
I +H+NI+ L + G ++++EY GNL + L R G + +L
Sbjct: 74 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133
Query: 775 WFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK 834
A A+G + + S IHRD+ + N+L+ ED KIADFG+A+ +
Sbjct: 134 SKDLVSCAYQVARG---MEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 835 VSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYW 894
+ ++APE + + +SDV+SFGV+L E+ T
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG---------- 240
Query: 895 VSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950
E + K+L + +L + C +P+ RP +++V+ L
Sbjct: 241 -----VPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 1e-47
Identities = 75/317 (23%), Positives = 120/317 (37%), Gaps = 49/317 (15%)
Query: 657 SSKWKLASFHHIDIDAEQICNLEEDNLIGSGGTGKVYR-----LDLKKNAGTVAVKQLWK 711
+SKW + + L+ +G G G+V +D TVAVK L +
Sbjct: 5 ASKW--------EFPRD---RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE 53
Query: 712 G---DGVKVFAAEMEILGKIRHRNILKLY--ACLLKGGSSFLVLEYMPNGNLFQALHKRV 766
G + +E++IL I H + AC GG +++E+ GNL L +
Sbjct: 54 GATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR 113
Query: 767 KEGKPE-----------LDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDED 815
E P L + AKG+ +L S IHRD+ + NILL E
Sbjct: 114 NEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEK 170
Query: 816 YEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELV 875
KI DFG+A+ P ++APE + + +SDV+SFGV+L E+
Sbjct: 171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 230
Query: 876 TGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTK 935
+ + E + L + ++ + + C
Sbjct: 231 SLGASPYP--------------GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHG 276
Query: 936 LPNLRPPMREVVKMLAD 952
P+ RP E+V+ L +
Sbjct: 277 EPSQRPTFSELVEHLGN 293
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 168 bits (426), Expect = 2e-46
Identities = 59/306 (19%), Positives = 115/306 (37%), Gaps = 38/306 (12%)
Query: 653 EKEVSSKWKLASFHHIDIDAEQICN-LEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK 711
+ V WK ++I + + + + +G+G G V+R+ + A K +
Sbjct: 2 DNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT 61
Query: 712 GD--GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEG 769
+ E++ + +RH ++ L+ ++ E+M G LF+ +
Sbjct: 62 PHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE---- 117
Query: 770 KPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILL--DEDYEPKIADFGVAK 827
++ + KG+ ++H + +H D+K NI+ E K+ DFG+
Sbjct: 118 HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTA 174
Query: 828 IAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGD 887
+ GT + APE+A V +D++S GV+ L++G P E
Sbjct: 175 HLDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE--- 228
Query: 888 GKDIVYWVSTHLNNHENVLKVLDCEV-----ASESIKEDMIKLLKIAVVCTTKLPNLRPP 942
N+ E + V C+ A I ED ++ PN R
Sbjct: 229 ------------NDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR---KLLLADPNTRMT 273
Query: 943 MREVVK 948
+ + ++
Sbjct: 274 IHQALE 279
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 3e-46
Identities = 60/284 (21%), Positives = 111/284 (39%), Gaps = 34/284 (11%)
Query: 677 NLEEDNLIGSGGTGKVYR---LDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRH 730
+E IG G G V++ + + A VA+K + F E + + H
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 67
Query: 731 RNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
+I+KL + + ++++E G L L R LD A + +A
Sbjct: 68 PHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYS----LDLASLILYAYQLSTALA 122
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
YL S +HRDI + N+L+ + K+ DFG+++ E+S S ++AP
Sbjct: 123 YLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-SKGKLPIKWMAP 178
Query: 851 ELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLD 910
E + + SDV+ FGV + E++ + + N++ + ++ +
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ--------------GVKNNDVIGRIEN 224
Query: 911 CEVAS--ESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952
E + + L+ C P+ RP E+ L+
Sbjct: 225 GERLPMPPNCPPTLYSLMT---KCWAYDPSRRPRFTELKAQLST 265
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 162 bits (412), Expect = 1e-44
Identities = 58/310 (18%), Positives = 112/310 (36%), Gaps = 38/310 (12%)
Query: 649 MENGEKEVSSKWKLASFHHIDIDAEQICNL-EEDNLIGSGGTGKVYRLDLKKNAGTVAVK 707
+ + +K WK +++ + + + +GSG G V+R K K
Sbjct: 1 INDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAK 60
Query: 708 QLWKGDGV--KVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKR 765
+ + E+ I+ ++ H ++ L+ L+LE++ G LF +
Sbjct: 61 FINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAE 120
Query: 766 VKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP--KIADF 823
++ A +G+ ++H I+H DIK NI+ + KI DF
Sbjct: 121 ----DYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDF 173
Query: 824 GVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEE 883
G+A T + APE+ V +D+++ GV+ L++G P
Sbjct: 174 GLATKLNPD---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG 230
Query: 884 EYGDGKDIVYWVSTHLNNHENVLKVLDCEV-----ASESIKEDMIKLLKIAVVCTTKLPN 938
E ++ E + V C+ A S+ + +K K P
Sbjct: 231 E---------------DDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIK---NLLQKEPR 272
Query: 939 LRPPMREVVK 948
R + + ++
Sbjct: 273 KRLTVHDALE 282
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 3e-43
Identities = 57/274 (20%), Positives = 103/274 (37%), Gaps = 36/274 (13%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQL-WKGDGVKVFAAEMEILGKIRHRNILKLYACLL 741
+G G G V+R + T K + KG + E+ IL RHRNIL L+
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPII 801
++ E++ ++F+ ++ EL+ + + +LH S I
Sbjct: 72 SMEELVMIFEFISGLDIFERINTS----AFELNEREIVSYVHQVCEALQFLH---SHNIG 124
Query: 802 HRDIKSSNILLD--EDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVS 859
H DI+ NI+ KI +FG A+ + ++ Y APE+ VS
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG---DNFRLLFTAPEYYAPEVHQHDVVS 181
Query: 860 EKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEV-----A 914
+D++S G ++ L++G P E N + + +++ E A
Sbjct: 182 TATDMWSLGTLVYVLLSGINPFLAE---------------TNQQIIENIMNAEYTFDEEA 226
Query: 915 SESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVK 948
+ I + + + K R E ++
Sbjct: 227 FKEISIEAMDFVD---RLLVKERKSRMTASEALQ 257
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 154 bits (391), Expect = 3e-42
Identities = 68/275 (24%), Positives = 114/275 (41%), Gaps = 37/275 (13%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHR 731
+ + +G+G G+V+ + + N A+K L K V+ E +L + H
Sbjct: 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 64
Query: 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAY 791
I++++ F++++Y+ G LF L K F AA+
Sbjct: 65 FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS--------QRFPNPVAKFYAAEVCLA 116
Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPE 851
L + S II+RD+K NILLD++ KI DFG AK + GT YIAPE
Sbjct: 117 LEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPDYIAPE 171
Query: 852 LAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDC 911
+ T ++ D +SFG+++ E++ G P + N + K+L+
Sbjct: 172 VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS---------------NTMKTYEKILNA 216
Query: 912 EVA-SESIKEDMIKLLKIAVVCTTKLPNLRPPMRE 945
E+ ED+ LL T+ + R +
Sbjct: 217 ELRFPPFFNEDVKDLLSR---LITRDLSQRLGNLQ 248
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 4e-42
Identities = 73/278 (26%), Positives = 119/278 (42%), Gaps = 33/278 (11%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGK-IRH 730
+ ++G G GKV+ + KK A+K L K D V+ E +L H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 731 RNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIA 790
+ ++ + F V+EY+ G+L + K D R A G+
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-----FDLSRATFYAAEIILGLQ 117
Query: 791 YLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
+L S I++RD+K NILLD+D KIADFG+ K EN + + F GT YIAP
Sbjct: 118 FL---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNTFCGTPDYIAP 172
Query: 851 ELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLD 910
E+ K + D +SFGV+L E++ G+ P + D +++ + + D
Sbjct: 173 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ--DEEELFHSIRM------------D 218
Query: 911 CEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVK 948
++++ LL + P R +R ++
Sbjct: 219 NPFYPRWLEKEAKDLLVK---LFVREPEKRLGVRGDIR 253
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 152 bits (386), Expect = 5e-42
Identities = 68/290 (23%), Positives = 110/290 (37%), Gaps = 42/290 (14%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKV-----------FAAEMEIL 725
N E ++G G + V R K AVK + G E++IL
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 726 GKIR-HRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALG 784
K+ H NI++L FLV + M G LF L ++V L KI
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-----LSEKETRKIMRA 118
Query: 785 AAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGT 844
+ I LH I+HRD+K NILLD+D K+ DFG + + GT
Sbjct: 119 LLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG---EKLREVCGT 172
Query: 845 HGYIAPELAYT------CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTH 898
Y+APE+ ++ D++S GV++ L+ G P + + +
Sbjct: 173 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF-----WHRKQMLMLRMI 227
Query: 899 LNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVK 948
++ + + S+++K+ + + L P R E +
Sbjct: 228 MSGNYQFGSPEWDDY-SDTVKDLVSRFL-------VVQPQKRYTAEEALA 269
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 153 bits (388), Expect = 6e-42
Identities = 58/270 (21%), Positives = 106/270 (39%), Gaps = 24/270 (8%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYA 738
+++G+G +V + K+ VA+K + K E+ +L KI+H NI+ L
Sbjct: 15 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
GG +L+++ + G LF + ++ ++ + YLH
Sbjct: 75 IYESGGHLYLIMQLVSGGELFDRIVEKGF-----YTERDASRLIFQVLDAVKYLHDLGIV 129
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKV 858
+ LDED + I+DFG++K+ + S GT GY+APE+
Sbjct: 130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAPEVLAQKPY 186
Query: 859 SEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASESI 918
S+ D +S GV+ L+ G P ++ L ++ S+S
Sbjct: 187 SKAVDCWSIGVIAYILLCGYPPFY-----DENDAKLFEQILKAEYEFDSPYWDDI-SDSA 240
Query: 919 KEDMIKLLKIAVVCTTKLPNLRPPMREVVK 948
K+ + L+ K P R + ++
Sbjct: 241 KDFIRHLM-------EKDPEKRFTCEQALQ 263
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 151 bits (383), Expect = 1e-41
Identities = 63/281 (22%), Positives = 111/281 (39%), Gaps = 36/281 (12%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLY 737
++G GG +V+ + VAVK L F E + + H I+ +Y
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 738 ACLL----KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLH 793
G ++V+EY+ L +H + R ++ A + + +
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-----MTPKRAIEVIADACQALNFS- 127
Query: 794 HDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK-IAENSPKVSDYSCFAGTHGYIAPEL 852
IIHRD+K +NI++ K+ DFG+A+ IA++ V+ + GT Y++PE
Sbjct: 128 --HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 185
Query: 853 AYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCE 912
A V +SDV+S G VL E++TG P + + + + +
Sbjct: 186 ARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD---------------SPVSVAYQHVRED 230
Query: 913 VASESIKEDMI--KLLKIAVVCTTKLPNLRPP-MREVVKML 950
S + + + L + + K P R E+ L
Sbjct: 231 PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 271
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 7e-41
Identities = 58/271 (21%), Positives = 100/271 (36%), Gaps = 23/271 (8%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKI-RHRNILKLYACL- 740
++G G GKV ++ K+ A+K L E+E+ + + +I+++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKML---QDCPKARREVELHWRASQCPHIVRIVDVYE 75
Query: 741 ---LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
+V+E + G LF + R G +I + I YLH S
Sbjct: 76 NLYAGRKCLLIVMECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLH---S 129
Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCK 857
I HRD+K N+L I A+ + + + T Y+APE+ K
Sbjct: 130 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK 189
Query: 858 VSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASES 917
+ D++S GV++ L+ G P G I + T + + + SE
Sbjct: 190 YDKSCDMWSLGVIMYILLCGYPPFYSN--HGLAISPGMKTRIRMGQYEFPNPEWSEVSEE 247
Query: 918 IKEDMIKLLKIAVVCTTKLPNLRPPMREVVK 948
+K + LL P R + E +
Sbjct: 248 VKMLIRNLL-------KTEPTQRMTITEFMN 271
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 151 bits (382), Expect = 1e-40
Identities = 57/274 (20%), Positives = 103/274 (37%), Gaps = 35/274 (12%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAE---MEILGKI 728
+ +IG GG G+VY A+K L K G + E + ++
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 729 RHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
I+ + +L+ M G+L L + + ++ ++ G
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE-----IILG 119
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYI 848
+ ++H + +++RD+K +NILLDE +I+D G+A GTHGY+
Sbjct: 120 LEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK----KKPHASVGTHGYM 172
Query: 849 APE-LAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLK 907
APE L +D FS G +L +L+ G P + K + ++ +
Sbjct: 173 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP--- 229
Query: 908 VLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRP 941
+S ++ LL+ + N R
Sbjct: 230 --------DSFSPELRSLLE---GLLQRDVNRRL 252
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 147 bits (371), Expect = 9e-40
Identities = 51/280 (18%), Positives = 86/280 (30%), Gaps = 26/280 (9%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILK-LYACLL 741
IGSG G +Y VA+K E +I ++ + + C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA 73
Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPII 801
+G + +V+E + + +A I Y+H S I
Sbjct: 74 EGDYNVMVMELLGPSLEDLFNFC-----SRKFSLKTVLLLADQMISRIEYIH---SKNFI 125
Query: 802 HRDIKSSNIL---LDEDYEPKIADFGVAKIAENSPKVSDY-----SCFAGTHGYIAPELA 853
HRD+K N L + I DFG+AK ++ GT Y +
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185
Query: 854 YTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEV 913
+ S + D+ S G VL+ G P + K Y EV
Sbjct: 186 LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE------RISEKKMSTPIEV 239
Query: 914 ASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953
+ + L C + + +P + ++ +
Sbjct: 240 LCKGYPSEFATYLNF---CRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 1e-39
Identities = 59/293 (20%), Positives = 112/293 (38%), Gaps = 35/293 (11%)
Query: 679 EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-------DGVKVFAAEMEILGKIRHR 731
E+ + +G G VY+ K VA+K++ G + E+++L ++ H
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAY 791
NI+ L + LV ++M + Y + +
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNS---LVLTPSHIKAYMLMT-----LQG 112
Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPE 851
L + I+HRD+K +N+LLDE+ K+ADFG+AK + + Y+ T Y APE
Sbjct: 113 LEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTHQVVTRWYRAPE 170
Query: 852 LAYTCKV-SEKSDVFSFGVVLLELVTGRKP------------VEEEYGDGKDIVYWVSTH 898
L + ++ D+++ G +L EL+ + E G + +
Sbjct: 171 LLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 230
Query: 899 LNNHENV--LKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949
L ++ + + +D++ L++ P R + +KM
Sbjct: 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQ---GLFLFNPCARITATQALKM 280
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 1e-39
Identities = 58/278 (20%), Positives = 107/278 (38%), Gaps = 36/278 (12%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWK--------GDGVKVFAAEMEILGKIRHRNIL 734
+GSG V + K A K + K G + E+ IL +I+H N++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 735 KLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHH 794
L+ L+LE + G LF L ++ + + + + +++
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEK---ESLTEEEATEF-----LKQILNGVYY 128
Query: 795 DCSPPIIHRDIKSSNILLDEDYEP----KIADFGVAKIAENSPKVSDYSCFAGTHGYIAP 850
S I H D+K NI+L + P KI DFG+A + +++ GT ++AP
Sbjct: 129 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---NEFKNIFGTPEFVAP 185
Query: 851 ELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLD 910
E+ + ++D++S GV+ L++G P + L N V +
Sbjct: 186 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---------TKQETLANVSAVNYEFE 236
Query: 911 CEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVK 948
E S ++ K P R +++ ++
Sbjct: 237 DEYFSN-TSALAKDFIR---RLLVKDPKKRMTIQDSLQ 270
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 1e-38
Identities = 61/210 (29%), Positives = 90/210 (42%), Gaps = 18/210 (8%)
Query: 679 EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYA 738
+ +IG+G G VY+ L + VA+K++ + + E++I+ K+ H NI++L
Sbjct: 23 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFKNRELQIMRKLDHCNIVRLRY 80
Query: 739 CLLKGGSS------FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
G LVL+Y+P A H + L + +AY+
Sbjct: 81 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT--LPVIYVKLYMYQLFRSLAYI 138
Query: 793 HHDCSPPIIHRDIKSSNILLDED-YEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAP- 850
H S I HRDIK N+LLD D K+ DFG AK Y C Y AP
Sbjct: 139 H---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS---RYYRAPE 192
Query: 851 ELAYTCKVSEKSDVFSFGVVLLELVTGRKP 880
+ + DV+S G VL EL+ G+
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPI 222
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 143 bits (361), Expect = 2e-38
Identities = 40/282 (14%), Positives = 83/282 (29%), Gaps = 28/282 (9%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRN-ILKLYACLL 741
IG G G ++ N VA+K + E + I +Y
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ 71
Query: 742 KGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPII 801
+G + LV++ + + + A + +H ++
Sbjct: 72 EGLHNVLVIDLLGPSL-----EDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLV 123
Query: 802 HRDIKSSNILLDEDYEP-----KIADFGVAKIAENSPKVS-----DYSCFAGTHGYIAPE 851
+RDIK N L+ + DFG+ K + + +GT Y++
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 852 LAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDC 911
+ S + D+ + G V + + G P + +T+ +E + +
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGSLPWQ---------GLKAATNKQKYERIGEKKQS 234
Query: 912 EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953
E + K + P + + +
Sbjct: 235 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 4e-38
Identities = 57/213 (26%), Positives = 88/213 (41%), Gaps = 15/213 (7%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHR 731
+ + L+G G GKV + K A+K L K D V E +L RH
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 732 NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAY 791
+ L V+EY G LF L + + ++ A+ ++
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY--------GAEIVSA 117
Query: 792 LHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPE 851
L + S +++RDIK N++LD+D KI DFG+ K + C GT Y+APE
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC--GTPEYLAPE 175
Query: 852 LAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEE 884
+ D + GVV+ E++ GR P +
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 208
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 5e-38
Identities = 60/279 (21%), Positives = 116/279 (41%), Gaps = 14/279 (5%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDG---VKVFAAEMEILGKIRHRNILKLYA 738
+ IG G G V N VA+K++ + + E++IL + RH NI+ +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
+ + Y+ + L+K +K L +G+ Y+H S
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH--LSNDHICYFLYQILRGLKYIH---SA 128
Query: 799 PIIHRDIKSSNILLDEDYEPKIADFGVAKIA-ENSPKVSDYSCFAGTHGYIAPELAYT-C 856
++HRD+K SN+LL+ + KI DFG+A++A + + + T Y APE+
Sbjct: 129 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 188
Query: 857 KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVASE 916
++ D++S G +L E+++ R + D + + L + + L+C + +
Sbjct: 189 GYTKSIDIWSVGCILAEMLSNRPIFPGK--HYLDQLNHILGILGSPSQ--EDLNCIINLK 244
Query: 917 SIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADP 955
+ + K V PN +++ + +P
Sbjct: 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNP 283
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 4e-37
Identities = 62/289 (21%), Positives = 115/289 (39%), Gaps = 26/289 (8%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRN 732
N ++ IG G G VY+ K VA+K++ E+ +L ++ H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
I+KL + +LV E++ + +L + + G + +G+A+
Sbjct: 63 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTG---IPLPLIKSYLFQLLQGLAFC 118
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL 852
S ++HRD+K N+L++ + K+ADFG+A+ V Y+ T Y APE+
Sbjct: 119 ---HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEI 173
Query: 853 AYTCK-VSEKSDVFSFGVVLLELVTGRKP------------VEEEYGDGKDIVYWVSTHL 899
CK S D++S G + E+VT R + G ++V+ T +
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233
Query: 900 NNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVK 948
+++ + S+ + + PN R + +
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 1e-36
Identities = 59/300 (19%), Positives = 105/300 (35%), Gaps = 35/300 (11%)
Query: 675 ICNLEED----NLIGSGGTGKVYRLDLKKNAGT-VAVKQLWKGDGVKVFA-------AEM 722
+C ++ IG G GKV++ KN G VA+K++ G + A +
Sbjct: 2 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61
Query: 723 EILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQ-ALHKRVKEGKPELDWFRRYKI 781
L H N+++L+ + + ++ Q K +P + +
Sbjct: 62 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121
Query: 782 ALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCF 841
+G+ +LH S ++HRD+K NIL+ + K+ADFG+A+I +
Sbjct: 122 MFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA---LTSV 175
Query: 842 AGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKP-------------VEEEYGDG 888
T Y APE+ + D++S G + E+ + ++ G
Sbjct: 176 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 235
Query: 889 KDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVK 948
++ + E I E LL C T P R +
Sbjct: 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLK---CLTFNPAKRISAYSALS 292
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (342), Expect = 4e-36
Identities = 56/278 (20%), Positives = 101/278 (36%), Gaps = 46/278 (16%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--------DGVKVFAAEMEILGKIR--HRN 732
L+GSGG G VY + VA+K + K E+ +L K+
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 733 ILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
+++L + S L+LE + L + + +
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHC 126
Query: 793 HHDCSPPIIHRDIKSSNILLDED-YEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPE 851
+ ++HRDIK NIL+D + E K+ DFG + +++ Y+ F GT Y PE
Sbjct: 127 ---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPE 179
Query: 852 -LAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLD 910
+ Y + V+S G++L ++V G P + + + +
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIP------------FEHDEEIIRGQVFFR--- 224
Query: 911 CEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVK 948
+ + + L++ C P+ RP E+
Sbjct: 225 -----QRVSSECQHLIRW---CLALRPSDRPTFEEIQN 254
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 133 bits (334), Expect = 5e-35
Identities = 59/283 (20%), Positives = 101/283 (35%), Gaps = 26/283 (9%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLY 737
IG G G VY+ T A+K++ E+ IL +++H NI+KLY
Sbjct: 8 EKIGEGTYGVVYKAQNNYGE-TFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
+ LV E++ + L+ L GIAY H
Sbjct: 67 DVIHTKKRLVLVFEHLDQDLKKLLDVC-----EGGLESVTAKSFLLQLLNGIAYCH---D 118
Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCK 857
++HRD+K N+L++ + E KIADFG+A+ + + L + K
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVLMGSKK 177
Query: 858 VSEKSDVFSFGVVLLELVTGRKP------------VEEEYGDGKDIVYWVSTHLNNHENV 905
S D++S G + E+V G + G + T L ++
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237
Query: 906 LKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVK 948
V + +K + + PN R ++ ++
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 1e-34
Identities = 48/214 (22%), Positives = 89/214 (41%), Gaps = 23/214 (10%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKIRHRNILKLY 737
IG G G+V++ +K VA+K++ E++IL ++H N++ L
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 738 AC--------LLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGI 789
GS +LV ++ + + K L +R L +
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL---VKFTLSEIKRVMQML-----L 127
Query: 790 AYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI--AENSPKVSDYSCFAGTHGY 847
L++ I+HRD+K++N+L+ D K+ADFG+A+ + + + Y+ T Y
Sbjct: 128 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187
Query: 848 IAPELAYTCK-VSEKSDVFSFGVVLLELVTGRKP 880
PEL + D++ G ++ E+ T
Sbjct: 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 221
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 3e-34
Identities = 56/288 (19%), Positives = 108/288 (37%), Gaps = 34/288 (11%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD----GVKVFAAEMEILGKIRHRNILKLY 737
IG G G V++ ++ VA+K++ D E+ +L +++H+NI++L+
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 738 ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCS 797
L LV E+ G + + + + + + L S
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCN---GDLDPEIVKSF-----LFQLLKGLGFCHS 119
Query: 798 PPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCK 857
++HRD+K N+L++ + E K+A+FG+A+ V YS T Y P++ + K
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 858 V-SEKSDVFSFGVVLLELVTGRKP-------------VEEEYGDGKDIVYWVSTHLNNHE 903
+ S D++S G + EL +P + G + + T L +++
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237
Query: 904 NVL---KVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVK 948
+ LL+ P R E ++
Sbjct: 238 PYPMYPATTSLVNVVPKLNATGRDLLQ---NLLKCNPVQRISAEEALQ 282
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 127 bits (321), Expect = 1e-32
Identities = 54/237 (22%), Positives = 99/237 (41%), Gaps = 23/237 (9%)
Query: 649 MENGEKEVSSKWKLASFHHIDIDAEQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQ 708
+ +++ KW+ S + +D + +G+G G+V + K++ A+K
Sbjct: 19 LAKAKEDFLKKWETPSQNTAQLD-----QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKI 73
Query: 709 LWKGDGVKV-----FAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPNGNLFQALH 763
L K VK+ E IL + ++KL + ++V+EY+ G +F L
Sbjct: 74 LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR 133
Query: 764 KRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADF 823
+ + A YLH S +I+RD+K N+L+D+ ++ DF
Sbjct: 134 RIGR-----FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 824 GVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKP 880
G AK GT +APE+ + ++ D ++ GV++ E+ G P
Sbjct: 186 GFAK-----RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 3e-31
Identities = 58/216 (26%), Positives = 93/216 (43%), Gaps = 21/216 (9%)
Query: 677 NLEEDNLIGSGGTGKVYRLDLKKNAGT---VAVKQLWKG------DGVKVFAAEMEILGK 727
N E ++G+G GKV+ + T A+K L K + E ++L
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 728 IRHR-NILKLYACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAA 786
IR ++ L+ L+L+Y+ G LF L +R + E +
Sbjct: 85 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER--FTEHEVQIY------VG 136
Query: 787 KGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHG 846
+ + L H II+RDIK NILLD + + DFG++K + + F GT
Sbjct: 137 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF-VADETERAYDFCGTIE 195
Query: 847 YIAPELAYTCK--VSEKSDVFSFGVVLLELVTGRKP 880
Y+AP++ + D +S GV++ EL+TG P
Sbjct: 196 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 5e-31
Identities = 58/209 (27%), Positives = 98/209 (46%), Gaps = 26/209 (12%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYA 738
+GSG G V + VA+K+L++ K E+ +L +RH N++ L
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 739 CLLKGGSS------FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
+ +LV+ +M G L K K L R + KG+ Y+
Sbjct: 85 VFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEK-----LGEDRIQFLVYQMLKGLRYI 137
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL 852
H + IIHRD+K N+ ++ED E KI DFG+A+ A+ S+ + + T Y APE+
Sbjct: 138 H---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD-----SEMTGYVVTRWYRAPEV 189
Query: 853 AY-TCKVSEKSDVFSFGVVLLELVTGRKP 880
+ ++ D++S G ++ E++TG+
Sbjct: 190 ILNWMRYTQTVDIWSVGCIMAEMITGKTL 218
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 119 bits (298), Expect = 7e-30
Identities = 46/204 (22%), Positives = 82/204 (40%), Gaps = 20/204 (9%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIR-HRNILKLYACL 740
+G G +V+ N V VK L K E++IL +R NI+ L +
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKILKPVK-KKKIKREIKILENLRGGPNIITLADIV 99
Query: 741 LKGGSS--FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSP 798
S LV E++ N + Q L + K + Y H
Sbjct: 100 KDPVSRTPALVFEHVNNTDFKQLYQT--------LTDYDIRFYMYEILKALDYCHSMG-- 149
Query: 799 PIIHRDIKSSNILLD-EDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCK 857
I+HRD+K N+++D E + ++ D+G+A+ +Y+ + + PEL +
Sbjct: 150 -IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG---QEYNVRVASRYFKGPELLVDYQ 205
Query: 858 -VSEKSDVFSFGVVLLELVTGRKP 880
D++S G +L ++ ++P
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEP 229
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 7e-29
Identities = 57/229 (24%), Positives = 91/229 (39%), Gaps = 27/229 (11%)
Query: 665 FHHIDIDAEQICNL---EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKV 717
F+ +++ L + IGSG G V VA+K+L + K
Sbjct: 3 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR 62
Query: 718 FAAEMEILGKIRHRNILKLYACLLKGGSS------FLVLEYMPNGNLFQALHKRVKEGKP 771
E+ ++ + H+NI+ L + +LV+E M +
Sbjct: 63 AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------ 116
Query: 772 ELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831
D R + GI +LH IIHRD+K SNI++ D KI DFG+A+ A
Sbjct: 117 --DHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171
Query: 832 SPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKP 880
S + + T Y APE+ E D++S G ++ E+V +
Sbjct: 172 SFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 114 bits (285), Expect = 6e-28
Identities = 52/290 (17%), Positives = 97/290 (33%), Gaps = 24/290 (8%)
Query: 683 LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGV-KVFAAEMEILGKIRHRNILKLYACLL 741
+G G V+ N VA+K + + E+++L ++ + K +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 742 KG-------------GSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKG 788
+V+ + G AL K+ + L + ++ L G
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL--LLG 137
Query: 789 IAYLHHDCSPPIIHRDIKSSNILLD-EDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGY 847
+ Y+H C IIH DIK N+L++ D + +A + Y+ T Y
Sbjct: 138 LDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195
Query: 848 IAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLK 907
+PE+ +D++S ++ EL+TG E D H+ +L
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE---PDEGHSYTKDDDHIAQIIELLG 252
Query: 908 VLDCEVA--SESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADP 955
L + + + + + K L + E K D
Sbjct: 253 ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAK 302
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 2e-27
Identities = 60/284 (21%), Positives = 115/284 (40%), Gaps = 28/284 (9%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLY 737
+ +GSG G V K VAVK+L + K E+ +L ++H N++ L
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 738 ACL-----LKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYL 792
L+ + ++ ++ +L + + +L + +G+ Y+
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYI 137
Query: 793 HHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPEL 852
H S IIHRD+K SN+ ++ED E KI DFG+A+ ++ A +
Sbjct: 138 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEIM 190
Query: 853 AYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCE 912
++ D++S G ++ EL+TGR G D + + L L +
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRLVGTPGAELLKK 245
Query: 913 VASESIKEDMIKLLKI-AVVCTTKLPNLRPPMREVVKMLADADP 955
++SES + + L ++ + P ++++ + D
Sbjct: 246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDS 289
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 105 bits (261), Expect = 3e-25
Identities = 71/306 (23%), Positives = 114/306 (37%), Gaps = 35/306 (11%)
Query: 32 ETQALIQFKSKLKDPHGVLDSWKESADSPCGFS--GITCD--SVTGRVTEISFDNKSLSG 87
+ QAL+Q K L +P L SW + D C + G+ CD + T RV + +L
Sbjct: 7 DKQALLQIKKDLGNPT-TLSSWLPTTD-CCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64
Query: 88 --EISSSISALQSLTVLSLPFNV-LSGKLPLELSNCSNLKVLNVTGNAMVGSVPDL-SAL 143
I SS++ L L L + L G +P ++ + L L +T + G++PD S +
Sbjct: 65 PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI 124
Query: 144 KNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHC 203
K L D S N +G P + +L LV ++ N IP+S G+ L
Sbjct: 125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN-RISGAIPDSYGSFSKLFTSMTISR 183
Query: 204 N-----------------------LRGRIPESISELRELGTLDICRNKISGEFPRSIRKL 240
N + + + +
Sbjct: 184 NRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLS 243
Query: 241 QKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNN 300
+ L ++L N + G LP L L L ++S N + G++P + GNL+ V N
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNK 302
Query: 301 FSGEFP 306
P
Sbjct: 303 CLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 95.6 bits (236), Expect = 5e-22
Identities = 61/279 (21%), Positives = 94/279 (33%), Gaps = 5/279 (1%)
Query: 223 DICRNKISGEFPRSIRKLQKLWKIELYANNLTG--ELPAELGNLTLLQEFDISSN-QMYG 279
D C G + + ++ ++L NL +P+ L NL L I + G
Sbjct: 32 DCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVG 91
Query: 280 KLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTAL 339
+P I L L N SG P ++ L N SG P ++ L
Sbjct: 92 PIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNL 151
Query: 340 TDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSG 399
+ N+ SG+ P KL + +S N + + +S N L G
Sbjct: 152 VGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEG 211
Query: 400 KIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNL 459
+ N + N + + L+NNR G LP L +L L
Sbjct: 212 DASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLD-LRNNRIYGTLPQGLTQLKFL 270
Query: 460 ERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIP 498
L ++ NN G+IP G L++ N P
Sbjct: 271 HSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 72.1 bits (175), Expect = 4e-14
Identities = 54/279 (19%), Positives = 94/279 (33%), Gaps = 6/279 (2%)
Query: 296 CFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPF--PENLGRYTALTDVDISENQFSGSF 353
C + G ++ + G P+ P +L L + I
Sbjct: 33 CCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGP 92
Query: 354 PKYLCEKRKLLNLLALSNNFSGEVPNS-YADCKTIQRLRISDNHLSGKIPDGLWALPNVG 412
K L+ L +++ + KT+ L S N LSG +P + +LPN+
Sbjct: 93 IPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLV 152
Query: 413 MLDFGDNDFTGGISPLIGLSTSLSQ-LVLQNNRFSGELPSELGRLTNLERLILTNNNFSG 471
+ F N +G I G + L + + NR +G++P L + N
Sbjct: 153 GITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGD 212
Query: 472 KIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSL 531
+ + + +DL N + G +P+ L+ L L
Sbjct: 213 ASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLR--NNRIYGTLPQGLTQLKFL 270
Query: 532 NALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSGSVPL 570
++LN+S N L G IP + + N+ PL
Sbjct: 271 HSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPL 309
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 102 bits (254), Expect = 8e-24
Identities = 94/399 (23%), Positives = 146/399 (36%), Gaps = 33/399 (8%)
Query: 94 SALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSI 153
+AL L ++ + ++ + L + S+ + L NL + S
Sbjct: 19 TALAEKMKTVLGKTNVTDTVSQ--TDLDQVTTLQADRLG-IKSIDGVEYLNNLTQINFSN 75
Query: 154 NYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESI 213
N T P + NLT+LV + + +N + ++ NL LT ++ +
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 214 SELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDIS 273
++ N IS S + + L NLT L+ DIS
Sbjct: 134 LNRL-----ELSSNTISDISALSGLTSLQQLSFGNQVTD-----LKPLANLTTLERLDIS 183
Query: 274 SNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENL 333
SN++ + L NL N S P G + L S+ GN+ L
Sbjct: 184 SNKVSD--ISVLAKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTL 237
Query: 334 GRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRIS 393
T LTD+D++ NQ S P L KL L +N S P + T L +
Sbjct: 238 ASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNEN 295
Query: 394 DNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSEL 453
+ L N+ L N+ + ISP+ L T L +L NN+ S S L
Sbjct: 296 QLE----DISPISNLKNLTYLTLYFNNIS-DISPVSSL-TKLQRLFFANNKVSD--VSSL 347
Query: 454 GRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENA 492
LTN+ L +N S P L L +++ L L + A
Sbjct: 348 ANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQA 384
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 98.2 bits (243), Expect = 3e-22
Identities = 78/402 (19%), Positives = 137/402 (34%), Gaps = 35/402 (8%)
Query: 138 PDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTY 197
D +AL L T + +L Q+ +L + + + L NLT
Sbjct: 17 TD-TALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRL---GIKSIDGVEYLNNLTQ 70
Query: 198 LFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGEL 257
+ ++ L P + L +L + + N+I+ P + + L
Sbjct: 71 INFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPL 128
Query: 258 PAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFA 317
+++ ++ +I L LT Q ++ L
Sbjct: 129 K---------NLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLER 179
Query: 318 FSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEV 377
I N+ L + T L + + NQ S P + L+L N
Sbjct: 180 LDISSNKV--SDISVLAKLTNLESLIATNNQISDITPLGILTNLDELSL--NGNQLKD-- 233
Query: 378 PNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQ 437
+ A + L +++N +S P L L + L G N + ISPL GL+ +
Sbjct: 234 IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQIS-NISPLAGLTALTNL 290
Query: 438 LVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSI 497
+ +N S L LT L L NN S P + +L +L L N ++
Sbjct: 291 ELNENQLEDISPISNLKNLTYLT---LYFNNISDISP--VSSLTKLQRLFFANNKVSD-- 343
Query: 498 PNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGN 539
+ + + I L+ N +S P L+ L+ + L L+
Sbjct: 344 VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 97.0 bits (240), Expect = 5e-22
Identities = 68/368 (18%), Positives = 115/368 (31%), Gaps = 50/368 (13%)
Query: 240 LQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKN 299
L + K L N+T + +L + + K + + L NLT N
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNN 76
Query: 300 NFSGEFPSGFGDMRKL--FAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYL 357
+ P ++ KL + P + + L
Sbjct: 77 QLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 134
Query: 358 CEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWA---------- 407
N ++ + SG +L+ + +
Sbjct: 135 NRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLA 194
Query: 408 -LPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTN 466
L N+ L +N + I T+L +L L N+ L LTNL L L N
Sbjct: 195 KLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLAN 250
Query: 467 NNFSGKIPSALGALRQLSSLHLEENALTGSIP--------------------NEMGDCAR 506
N S P L L +L+ L L N ++ P + + +
Sbjct: 251 NQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKN 308
Query: 507 IVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLK-LSSIDLSENQLS 565
+ L L N++S P +S L+ L L + NK++ +L L ++ + NQ+S
Sbjct: 309 LTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQIS 364
Query: 566 GSVPLDFL 573
PL L
Sbjct: 365 DLTPLANL 372
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 94.7 bits (234), Expect = 4e-21
Identities = 70/409 (17%), Positives = 129/409 (31%), Gaps = 57/409 (13%)
Query: 166 NLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDIC 225
L + + +G + S +L +T L ++ + + L L ++
Sbjct: 20 ALAEKMKTVLGKTNVTD---TVSQTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFS 74
Query: 226 RNKISGEFP----RSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKL 281
N+++ P + + L L Q DI + L
Sbjct: 75 NNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 134
Query: 282 PEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRY----- 336
+ ++ S + S + L + N
Sbjct: 135 NRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLA 194
Query: 337 --TALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISD 394
T L + + NQ S P + L+L N + A + L +++
Sbjct: 195 KLTNLESLIATNNQISDITPLGILTNLDELSLN--GNQLKD--IGTLASLTNLTDLDLAN 250
Query: 395 NHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELG 454
N +S P L L + L G N + ISPL GL+ + + +N S L
Sbjct: 251 NQISNLAP--LSGLTKLTELKLGANQISN-ISPLAGLTALTNLELNENQLEDISPISNLK 307
Query: 455 RLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLAR 514
LT L L NN S P + +L +L L N ++
Sbjct: 308 NLTYLT---LYFNNISDISP--VSSLTKLQRLFFANNKVSD------------------- 343
Query: 515 NSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL-KLSSIDLSEN 562
SL+ L+++N L+ N+++ P L L +++ + L++
Sbjct: 344 -------VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 64.6 bits (156), Expect = 2e-11
Identities = 43/202 (21%), Positives = 72/202 (35%), Gaps = 32/202 (15%)
Query: 47 HGVLDSWKESADSPCGFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPF 106
L + + + S IT + + E+S + L ++++L +LT L L
Sbjct: 193 LAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLAN 250
Query: 107 NVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLS---------------------ALKN 145
N +S PL S + L L + N + P LKN
Sbjct: 251 NQISNLAPL--SGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKN 308
Query: 146 LEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNL 205
L L N + P V +LT+L L +N + S+ NL N+ +L H +
Sbjct: 309 LTYLTLYFNNISDISP--VSSLTKLQRLFFANN---KVSDVSSLANLTNINWLSAGHNQI 363
Query: 206 RGRIPESISELRELGTLDICRN 227
P ++ L + L +
Sbjct: 364 SDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 8e-04
Identities = 18/71 (25%), Positives = 31/71 (43%), Gaps = 5/71 (7%)
Query: 505 ARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLK-LSSIDLSENQ 563
A + L + +++ + S + L + L + SI D + L L+ I+ S NQ
Sbjct: 22 AEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQ 77
Query: 564 LSGSVPLDFLR 574
L+ PL L
Sbjct: 78 LTDITPLKNLT 88
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 90.9 bits (224), Expect = 2e-20
Identities = 47/290 (16%), Positives = 91/290 (31%), Gaps = 16/290 (5%)
Query: 225 CRNKISGEFPRSI-RKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPE 283
C + + P+ + L L N +T + NL L + +N++ P
Sbjct: 17 CSDLGLEKVPKDLPPDTALLD---LQNNKITEIKDGDFKNLKNLHTLILINNKISKISPG 73
Query: 284 EIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVD 343
L L KN +++L + L + + ++
Sbjct: 74 AFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV-ELG 132
Query: 344 ISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPD 403
+ + SG +K L+ + +++ +P ++ L + N ++
Sbjct: 133 TNPLKSSGIENGAFQGMKK-LSYIRIADTNITTIPQGL--PPSLTELHLDGNKITKVDAA 189
Query: 404 GLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLI 463
L L N+ L N + + + + L +L L NN+ P L ++ +
Sbjct: 190 SLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV-PGGLADHKYIQVVY 248
Query: 464 LTNNNFSG------KIPSALGALRQLSSLHLEENALT-GSIPNEMGDCAR 506
L NNN S P S + L N + I C
Sbjct: 249 LHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVY 298
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 86.6 bits (213), Expect = 5e-19
Identities = 63/318 (19%), Positives = 113/318 (35%), Gaps = 41/318 (12%)
Query: 251 NNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFG 310
L ++P +L D+ +N++ + NLKNL N S P F
Sbjct: 20 LGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFA 76
Query: 311 DMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALS 370
+ KL + N+ + L + + S L + ++ L
Sbjct: 77 PLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLN-QMIVVELGTNP 135
Query: 371 NNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIG 430
SG ++ K + +RI+D +++ IP GL
Sbjct: 136 LKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP------------------------ 170
Query: 431 LSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEE 490
SL++L L N+ + + L L NL +L L+ N+ S +L L LHL
Sbjct: 171 --PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNN 228
Query: 491 NALTGSIPNEMGDCARIVDLNLARNSLSG------NIPRSLSLLSSLNALNLSGNKLT-G 543
N L +P + D I + L N++S P + +S + ++L N +
Sbjct: 229 NKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW 287
Query: 544 SIPDNLMKL--KLSSIDL 559
I + + +++ L
Sbjct: 288 EIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 82.4 bits (202), Expect = 1e-17
Identities = 50/306 (16%), Positives = 101/306 (33%), Gaps = 49/306 (16%)
Query: 185 IPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLW 244
NLKNL L L + + P + + L +L L + +N++ + + LQ+L
Sbjct: 47 KDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELR 106
Query: 245 KIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGE 304
E + + L + +++ SG
Sbjct: 107 VHENEITKVRKSVFNGLNQMIVVE-------------------------LGTNPLKSSGI 141
Query: 305 FPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLL 364
F M+KL I + +LT++ + N+ + L L
Sbjct: 142 ENGAFQGMKKLSYIRIADTNITTIPQGLP---PSLTELHLDGNKITKVDAASLKGLNNLA 198
Query: 365 NLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGG 424
L N+ S S A+ ++ L +++N L K+P GL + ++ +N+ +
Sbjct: 199 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA- 256
Query: 425 ISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNN--NFSGKIPSALGALRQ 482
+ +N F P + + + L +N + PS +
Sbjct: 257 ---------------IGSNDFCP--PGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYV 299
Query: 483 LSSLHL 488
+++ L
Sbjct: 300 RAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 80.9 bits (198), Expect = 4e-17
Identities = 50/286 (17%), Positives = 96/286 (33%), Gaps = 21/286 (7%)
Query: 290 NLTVFQCFKNNFSGEFPSGFG-DMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQ 348
+L V QC + P D L + N+ + + L + + N+
Sbjct: 11 HLRVVQCSDLGLE-KVPKDLPPDTALL---DLQNNKITEIKDGDFKNLKNLHTLILINNK 66
Query: 349 FSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWAL 408
S P KL L N Q LR+ +N ++ L
Sbjct: 67 ISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTL---QELRVHENEITKVRKSVFNGL 123
Query: 409 PNVGMLDFGD--NDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTN 466
+ +++ G +G + LS + + + + +P L +L L L
Sbjct: 124 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDG 180
Query: 467 NNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLS 526
N + ++L L L+ L L N+++ + + + +L+L N L +P L+
Sbjct: 181 NKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLA 239
Query: 527 LLSSLNALNLSGNKLTGSIPD-------NLMKLKLSSIDLSENQLS 565
+ + L N ++ + N K S + L N +
Sbjct: 240 DHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 79.7 bits (195), Expect = 1e-16
Identities = 55/264 (20%), Positives = 100/264 (37%), Gaps = 10/264 (3%)
Query: 329 FPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQ 388
P++L +D+ N+ + + L L+ ++N S P ++A ++
Sbjct: 25 VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82
Query: 389 RLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQN--NRFS 446
RL +S N L +P+ + + L +N+ T + + + L + S
Sbjct: 83 RLYLSKNQLKE-LPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSS 139
Query: 447 GELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCAR 506
G + L + + + N + IP G L+ LHL+ N +T +
Sbjct: 140 GIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNN 196
Query: 507 IVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSG 566
+ L L+ NS+S SL+ L L+L+ NKL + + L N +S
Sbjct: 197 LAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISA 256
Query: 567 SVPLDFLRMGGDGAFAGNEGLCLD 590
DF G + A G+ L
Sbjct: 257 IGSNDFCPPGYNTKKASYSGVSLF 280
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 79.3 bits (194), Expect = 1e-16
Identities = 46/282 (16%), Positives = 89/282 (31%), Gaps = 16/282 (5%)
Query: 76 TEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVG 135
+ + L ++ + +L L N ++ + N NL L + N +
Sbjct: 13 RVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69
Query: 136 SVPD-LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKN 194
P + L LE LS N + L +L ++ + N
Sbjct: 70 ISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVF--NGLNQMI 127
Query: 195 LTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLT 254
+ L G + +++L + I I+ P+ + L ++ L N +T
Sbjct: 128 VVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT 184
Query: 255 GELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRK 314
A L L L + +S N + + N +L N + P G D +
Sbjct: 185 KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKY 243
Query: 315 LFAFSIYGNRFSG------PFPENLGRYTALTDVDISENQFS 350
+ ++ N S P + + + V + N
Sbjct: 244 IQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 55.4 bits (132), Expect = 1e-08
Identities = 25/128 (19%), Positives = 48/128 (37%), Gaps = 2/128 (1%)
Query: 448 ELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARI 507
++P +L + L L NN + L+ L +L L N ++ P ++
Sbjct: 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 508 VDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSGS 567
L L++N L + L L K+ S+ + L ++ + + + + SG
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI 141
Query: 568 VPLDFLRM 575
F M
Sbjct: 142 ENGAFQGM 149
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.9 bits (203), Expect = 7e-18
Identities = 54/264 (20%), Positives = 87/264 (32%), Gaps = 7/264 (2%)
Query: 113 LPLELSNCSNLKVLNVTGNAMVGSVPD-LSALKNLEIFDLSINYFTGRFPRWVVNLTQLV 171
+P+ + + + + + GN + A +NL I L N L L
Sbjct: 26 VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 172 SLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISG 231
L + DN + P + L L L L C L+ P L L L + N +
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143
Query: 232 EFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNL 291
+ R L L + L+ N ++ L L + N++ P +L L
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203
Query: 292 TVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSG 351
F NN S +R L + N + + L S ++
Sbjct: 204 MTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD-CRARPLWAWLQKFRGSSSEVPC 262
Query: 352 SFPKYLCEKRKLLNLLALSNNFSG 375
S P+ L R L L +N+ G
Sbjct: 263 SLPQRL-AGRDLKRL--AANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.2 bits (183), Expect = 3e-15
Identities = 52/245 (21%), Positives = 83/245 (33%), Gaps = 3/245 (1%)
Query: 329 FPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQ 388
P + + + + N+ S R L L SN + ++ ++
Sbjct: 26 VPVGIPAAS--QRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 389 RLRISDNHLSGKI-PDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSG 447
+L +SDN + P L + L L +L L LQ+N
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143
Query: 448 ELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARI 507
L NL L L N S A L L L L +N + P+ D R+
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203
Query: 508 VDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSGS 567
+ L L N+LS +L+ L +L L L+ N + L S +++ S
Sbjct: 204 MTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCS 263
Query: 568 VPLDF 572
+P
Sbjct: 264 LPQRL 268
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.6 bits (145), Expect = 2e-10
Identities = 44/216 (20%), Positives = 66/216 (30%), Gaps = 26/216 (12%)
Query: 385 KTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNR 444
QR+ + N +S A N+ +L N + L QL L +N
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 445 FSGEL-PSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGD 503
+ P+ L L L L P L L L+L++NAL + D
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151
Query: 504 CARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL----------- 552
+ L L N +S R+ L SL+ L L N++ P L
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211
Query: 553 --------------KLSSIDLSENQLSGSVPLDFLR 574
L + L++N L
Sbjct: 212 NLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLW 247
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 73.7 bits (180), Expect = 2e-15
Identities = 25/166 (15%), Positives = 51/166 (30%), Gaps = 33/166 (19%)
Query: 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQL------------WKGDGVKVFAAEMEILGKIR 729
L+G G V+ +K G VK + G F+ +
Sbjct: 6 KLMGEGKESAVFNCYSEKF-GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 730 HRNILKLY----ACLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGA 785
R + KL + + +++E + L++ ++
Sbjct: 65 FRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV------------RVENPDEVLDMI 112
Query: 786 AKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831
+ +A +H I+H D+ N+L+ + I DF +
Sbjct: 113 LEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGE 154
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.9 bits (146), Expect = 2e-10
Identities = 40/264 (15%), Positives = 81/264 (30%), Gaps = 17/264 (6%)
Query: 186 PESIGNL--KNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGE-FPRSIRKLQK 242
P+ G L + + + + E S R + +D+ + I + + K
Sbjct: 14 PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVSTLHGILSQCSK 72
Query: 243 LWKIELYANNLTGELPAELGNLTLLQEFDISS--NQMYGKLPEEIGNLKNLTVF------ 294
L + L L+ + L + L ++S L + + L
Sbjct: 73 LQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCF 132
Query: 295 QCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFP 354
+ + + +L N + R L +D+S++ +
Sbjct: 133 DFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDC 192
Query: 355 KYLCEKRKLLNLLALSN--NFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVG 412
+ L L+LS + E + T++ L++ G + ALP+
Sbjct: 193 FQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPH-- 250
Query: 413 MLDFGDNDFTGGISPLIGLSTSLS 436
L + FT P IG +
Sbjct: 251 -LQINCSHFTTIARPTIGNKKNQE 273
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.3 bits (129), Expect = 2e-08
Identities = 34/271 (12%), Positives = 78/271 (28%), Gaps = 14/271 (5%)
Query: 126 LNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEI 185
L++TG + V + + F ++ + ++ + + ++V + + +
Sbjct: 5 LDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTL 63
Query: 186 PESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDI--CRNKISGEFPRSIRKLQKL 243
+ L L L L I ++++ L L++ C + +L
Sbjct: 64 HGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRL 123
Query: 244 WKIELYANNLTG------ELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCF 297
++ L + +T L N L + NL
Sbjct: 124 DELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLS 183
Query: 298 KN-NFSGEFPSGFGDMRKLFAFSIYG-NRFSGPFPENLGRYTALTDVDISENQFSGSFPK 355
+ + F + L S+ LG L + + G+
Sbjct: 184 DSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQL 243
Query: 356 YLCEKRKLLNLLALSNNFSGEVPNSYADCKT 386
K L +L ++F+ + + K
Sbjct: 244 ---LKEALPHLQINCSHFTTIARPTIGNKKN 271
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.9 bits (115), Expect = 1e-06
Identities = 21/102 (20%), Positives = 35/102 (34%), Gaps = 5/102 (4%)
Query: 388 QRLRISDNHLSGKIPDGLWALPNVGMLDFG-DNDFTGGISPLIGLSTSLSQLVLQNNRFS 446
Q L ++ +L PD L + G++ F F + + L N+
Sbjct: 3 QTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIE 59
Query: 447 GE-LPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLH 487
L L + + L+ L L S I + L L L+
Sbjct: 60 VSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 101
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.6 bits (109), Expect = 6e-06
Identities = 41/272 (15%), Positives = 82/272 (30%), Gaps = 23/272 (8%)
Query: 69 DSVTGRVTEISFDNKSLSG----EISSSISALQSLTVLSLPFNVLSGK-LPLELSNCSNL 123
VTGR+ + + + + + L +V+ L LS CS L
Sbjct: 14 PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKL 73
Query: 124 KVLNVTGNAMVGSVPD-LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDE 182
+ L++ G + + + L+ NL +LS F L+ L + +
Sbjct: 74 QNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFA-LQTLLSSCSRLDELNLSWCF 132
Query: 183 AEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRN---------KISGEF 233
+ + + NL G + +
Sbjct: 133 DFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDC 192
Query: 234 PRSIRKLQKLWKIEL-YANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLT 292
+ +L L + L ++ E ELG + L+ + G L L +L
Sbjct: 193 FQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQ 252
Query: 293 VFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNR 324
+ ++F+ G+ + I+G +
Sbjct: 253 I---NCSHFTTIARPTIGNKKNQ---EIWGIK 278
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.1 bits (92), Expect = 8e-04
Identities = 11/65 (16%), Positives = 26/65 (40%), Gaps = 1/65 (1%)
Query: 510 LNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSGSVP 569
L+L +L ++ L L + A + + + ++ ++ +DLS + + S
Sbjct: 5 LDLTGKNLHPDVTGRL-LSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTL 63
Query: 570 LDFLR 574
L
Sbjct: 64 HGILS 68
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.3 bits (134), Expect = 4e-09
Identities = 45/211 (21%), Positives = 70/211 (33%), Gaps = 9/211 (4%)
Query: 284 EIGNLKNLTVFQCFKNNFSGEFPSGFG-DMRKLFAFSIYGNRFSGPFPENLGRYTALTDV 342
E+ + + C K N + P D L + N L YT LT +
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPKDTTIL---HLSENLLYTFSLATLMPYTRLTQL 60
Query: 343 DISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIP 402
++ + + +L L LS+N +P + L +S N L+
Sbjct: 61 NLDRAEL---TKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPL 117
Query: 403 DGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERL 462
L L + L N+ L+ + L +L L NN + L L NL+ L
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177
Query: 463 ILTNNNFSGKIPSALGALRQLSSLHLEENAL 493
+L N+ IP L L N
Sbjct: 178 LLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.3 bits (134), Expect = 5e-09
Identities = 45/235 (19%), Positives = 73/235 (31%), Gaps = 32/235 (13%)
Query: 67 TCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVL 126
V + E++ D ++L+ + + T+L L N+L L + L L
Sbjct: 5 EVSKVASHL-EVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQL 60
Query: 127 NVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIP 186
N+ A + + L L DLS N
Sbjct: 61 NL-DRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPAL----------------- 102
Query: 187 ESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKI 246
T L ++ L ++ L EL L + N++ P + KL K+
Sbjct: 103 ---------TVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKL 153
Query: 247 ELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNF 301
L NNLT L L L + N +Y +P+ L N +
Sbjct: 154 SLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.1 bits (131), Expect = 1e-08
Identities = 37/210 (17%), Positives = 79/210 (37%), Gaps = 7/210 (3%)
Query: 116 ELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSI 175
E+S ++ +N + ++P K+ I LS N ++ T+L L++
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPP-DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 176 GDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPR 235
+ ++ ++ L L +L + D+ N+++
Sbjct: 63 DRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVL----DVSFNRLTSLPLG 118
Query: 236 SIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQ 295
++R L +L ++ L N L P L L++ +++N + + L+NL
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 296 CFKNNFSGEFPSGFGDMRKLFAFSIYGNRF 325
+N+ P GF L ++GN +
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.2 bits (126), Expect = 4e-08
Identities = 31/208 (14%), Positives = 63/208 (30%), Gaps = 7/208 (3%)
Query: 188 SIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIE 247
+ + + + NL +P + ++ L + N + ++ +L +
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLT--Q 59
Query: 248 LYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPS 307
L + G L +L D+S NQ+ TV N +
Sbjct: 60 LNLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPAL-TVLDVSFNRLTSLPLG 118
Query: 308 GFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLL 367
+ +L + GN P L L + ++ N + L + L+ L
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLN-GLENLDTL 177
Query: 368 ALSNNFSGEVPNSYADCKTIQRLRISDN 395
L N +P + + + N
Sbjct: 178 LLQENSLYTIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.8 bits (125), Expect = 5e-08
Identities = 37/189 (19%), Positives = 59/189 (31%), Gaps = 7/189 (3%)
Query: 184 EIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKL 243
+P + K+ T L L+ L ++ L L++ R ++ + L L
Sbjct: 24 ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL--TKLQVDGTLPVL 79
Query: 244 WKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSG 303
++L N L L L D+S N++ + L L N
Sbjct: 80 GTLDLSHNQLQSLPLLG-QTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKT 138
Query: 304 EFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKL 363
P KL S+ N + L L + + EN + PK L
Sbjct: 139 LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFF-GSHL 196
Query: 364 LNLLALSNN 372
L L N
Sbjct: 197 LPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.6 bits (109), Expect = 7e-06
Identities = 36/191 (18%), Positives = 56/191 (29%), Gaps = 47/191 (24%)
Query: 430 GLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNN--------------------- 468
L + L L N + L T L +L L
Sbjct: 28 DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHN 87
Query: 469 ------------------------FSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDC 504
+ AL L +L L+L+ N L P +
Sbjct: 88 QLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPT 147
Query: 505 ARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLK-LSSIDLSENQ 563
++ L+LA N+L+ L+ L +L+ L L N L +IP L L N
Sbjct: 148 PKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNP 206
Query: 564 LSGSVPLDFLR 574
+ + + R
Sbjct: 207 WLCNCEILYFR 217
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 56.8 bits (135), Expect = 5e-09
Identities = 50/321 (15%), Positives = 91/321 (28%), Gaps = 25/321 (7%)
Query: 193 KNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANN 252
+ L L + L +PE L L N ++ E P + L+ L
Sbjct: 38 RQAHELELNNLGLS-SLPELPPHLESL---VASCNSLT-ELPELPQSLKSLLVDNNNLKA 92
Query: 253 LTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDM 312
L+ P + + + I N +G +
Sbjct: 93 LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQL 152
Query: 313 RKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNN 372
+L + N + + + + + L E + L L + +
Sbjct: 153 EELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYAD 212
Query: 373 FSGEVPNSYADCKTIQRLRISDNHLS-----------GKIPDGLWALPNVGMLDFGDNDF 421
+ + + L + + N
Sbjct: 213 NNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNAS 272
Query: 422 TGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALR 481
+ I L L SL +L + NN+ ELP+ LERLI + N+ + ++P L+
Sbjct: 273 SNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPELPQNLK 327
Query: 482 QLSSLHLEENALTGSIPNEMG 502
LH+E N L P+
Sbjct: 328 ---QLHVEYNPLR-EFPDIPE 344
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 56.4 bits (134), Expect = 8e-09
Identities = 53/366 (14%), Positives = 102/366 (27%), Gaps = 55/366 (15%)
Query: 120 CSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNV 179
L + + S+P+L +LE S N T
Sbjct: 37 DRQAHELELNNLGL-SSLPEL--PPHLESLVASCNSLT---------------------- 71
Query: 180 YDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRK 239
E+PE +LK+L L P + +S + +
Sbjct: 72 ----ELPELPQSLKSLLVDNNNLKALSDLPPL------------LEYLGVSNNQLEKLPE 115
Query: 240 LQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKN 299
LQ +++ + + I++ + E+ NL LT N
Sbjct: 116 LQNSSFLKIIDVD---NNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNN 172
Query: 300 NFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCE 359
+ + +I L A ++ + S
Sbjct: 173 SLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVR 232
Query: 360 KRKLLNLLALSNNFSGEVPN--SYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFG 417
L +L L + + + ++ + N S +I P++ L+
Sbjct: 233 DNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVS 292
Query: 418 DNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSAL 477
+N L L L +L+ N + E+P NL++L + N + P
Sbjct: 293 NNKLIE----LPALPPRLERLIASFNHLA-EVPELPQ---NLKQLHVEYNPLR-EFPDIP 343
Query: 478 GALRQL 483
++ L
Sbjct: 344 ESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 50.2 bits (118), Expect = 6e-07
Identities = 23/95 (24%), Positives = 40/95 (42%), Gaps = 10/95 (10%)
Query: 464 LTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPR 523
N S +I S L L++ N L +P R+ L + N L+ +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVP- 320
Query: 524 SLSLLSSLNALNLSGNKLTG--SIPDNLMKLKLSS 556
L +L L++ N L IP+++ L+++S
Sbjct: 321 --ELPQNLKQLHVEYNPLREFPDIPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.4 bits (108), Expect = 1e-05
Identities = 19/80 (23%), Positives = 31/80 (38%), Gaps = 7/80 (8%)
Query: 487 HLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIP 546
NA + I + + +LN++ N L +P +L L L S N L +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELP---ALPPRLERLIASFNHLA-EVP 320
Query: 547 DNLMKLKLSSIDLSENQLSG 566
+ LK + + N L
Sbjct: 321 ELPQNLK--QLHVEYNPLRE 338
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 41.7 bits (96), Expect = 3e-04
Identities = 24/116 (20%), Positives = 39/116 (33%), Gaps = 33/116 (28%)
Query: 104 LPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRW 163
N S ++ +L+ LNV+ N ++ +P L LE S N+
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPAL--PPRLERLIASFNHLA------ 317
Query: 164 VVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELREL 219
E+PE NLK L + + LR P+ + +L
Sbjct: 318 --------------------EVPELPQNLK---QLHVEYNPLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.8 bits (91), Expect = 0.001
Identities = 51/326 (15%), Positives = 92/326 (28%), Gaps = 29/326 (8%)
Query: 98 SLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFT 157
L L LS LP + L+ L + N++ +P+L ++L+ + N
Sbjct: 39 QAHELELNNLGLS-SLPELPPH---LESLVASCNSLT-ELPEL--PQSLKSLLVDNNNLK 91
Query: 158 GRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISE-- 215
+ VS + + + + + L +
Sbjct: 92 ALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQ 151
Query: 216 ---LRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDI 272
L EL L + L + A N E EL NL L
Sbjct: 152 LEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYA 211
Query: 273 SSNQMYGKLPEEIGNLKNLTVFQCFKNNFSG--------EFPSGFGDMRKLFAFSIYGNR 324
+N + + + F + +L Y N
Sbjct: 212 DNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNA 271
Query: 325 FSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADC 384
S +L ++++S N+ P L L S N EVP
Sbjct: 272 SSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR----LERLIASFNHLAEVPEL---P 323
Query: 385 KTIQRLRISDNHLSGKIPDGLWALPN 410
+ +++L + N L + PD ++ +
Sbjct: 324 QNLKQLHVEYNPLR-EFPDIPESVED 348
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 52.8 bits (126), Expect = 6e-09
Identities = 30/118 (25%), Positives = 47/118 (39%), Gaps = 8/118 (6%)
Query: 438 LVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSI 497
L L + + L +L + L L++N P+ L ALR L L +N
Sbjct: 3 LHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDN--ALEN 57
Query: 498 PNEMGDCARIVDLNLARNSL-SGNIPRSLSLLSSLNALNLSGNKLTG--SIPDNLMKL 552
+ + + R+ +L L N L + L L LNL GN L I + L ++
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 50.5 bits (120), Expect = 4e-08
Identities = 24/119 (20%), Positives = 43/119 (36%), Gaps = 5/119 (4%)
Query: 101 VLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRF 160
VL L L+ L + L+++ N + P L+AL+ LE+ S N
Sbjct: 2 VLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD 59
Query: 161 PRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELREL 219
+ Q + L +N ++ + + + L L L +L L E+
Sbjct: 60 GVANLPRLQELLLC--NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.1 bits (106), Expect = 3e-06
Identities = 23/109 (21%), Positives = 41/109 (37%), Gaps = 5/109 (4%)
Query: 184 EIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKL 243
+ + L +T+L L+H LR P +++ LR L L N + E + L +L
Sbjct: 11 TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNAL--ENVDGVANLPRL 67
Query: 244 WKIELYANNLTG-ELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNL 291
++ L N L L + L ++ N + L +
Sbjct: 68 QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 40.9 bits (95), Expect = 8e-05
Identities = 27/124 (21%), Positives = 41/124 (33%), Gaps = 8/124 (6%)
Query: 367 LALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGIS 426
L L++ + + + L +S N L P L AL + +L DN
Sbjct: 3 LHLAHKDLTVLCH-LEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVDG 60
Query: 427 PLIGLSTSLSQLVLQNNRF-SGELPSELGRLTNLERLILTNNNFSGK---IPSALGALRQ 482
L +L+L NNR L L L L N+ + L
Sbjct: 61 VAN--LPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPS 118
Query: 483 LSSL 486
+SS+
Sbjct: 119 VSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 40.1 bits (93), Expect = 2e-04
Identities = 22/107 (20%), Positives = 40/107 (37%), Gaps = 7/107 (6%)
Query: 462 LILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNI 521
L L + + + + L L ++ L L N L P + + L + N+
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNA--LEN 57
Query: 522 PRSLSLLSSLNALNLSGNKLTG-SIPDNLMKL-KLSSIDLSENQLSG 566
++ L L L L N+L + L+ +L ++L N L
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 38.5 bits (89), Expect = 6e-04
Identities = 20/109 (18%), Positives = 42/109 (38%), Gaps = 6/109 (5%)
Query: 197 YLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGE 256
L LAH +L + + +L + LD+ N++ P ++ L+ L ++ N L
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENV 58
Query: 257 LPAELGNLTLLQEFDISSNQM-YGKLPEEIGNLKNLTVFQCFKNNFSGE 304
QE + +N++ + + + L + N+ E
Sbjct: 59 DGVANLPRL--QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.0 bits (85), Expect = 0.002
Identities = 24/112 (21%), Positives = 45/112 (40%), Gaps = 5/112 (4%)
Query: 91 SSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFD 150
+ L +T L L N L P L+ L+VL + N + +V ++ L L+
Sbjct: 14 CHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDN-ALENVDGVANLPRLQELL 71
Query: 151 LSINYFTG-RFPRWVVNLTQLVSLSIGDN--VYDEAEIPESIGNLKNLTYLF 199
L N + +V+ +LV L++ N +E L +++ +
Sbjct: 72 LCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 123
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 36.6 bits (84), Expect = 0.003
Identities = 22/115 (19%), Positives = 46/115 (40%), Gaps = 9/115 (7%)
Query: 330 PENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNL-LALSNNFSGEVPNSYADCKTIQ 388
+L + +T +D+S N+ P L L + +++ + E + A+ +Q
Sbjct: 13 LCHLEQLLLVTHLDLSHNRLRALPP----ALAALRCLEVLQASDNALENVDGVANLPRLQ 68
Query: 389 RLRISDNHL-SGKIPDGLWALPNVGMLDFGDNDFT---GGISPLIGLSTSLSQLV 439
L + +N L L + P + +L+ N G L + S+S ++
Sbjct: 69 ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 123
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 53.1 bits (126), Expect = 3e-08
Identities = 41/227 (18%), Positives = 70/227 (30%), Gaps = 18/227 (7%)
Query: 240 LQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKN 299
L KI +N+T + +L + + E + L NL + N
Sbjct: 18 LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGV--TTIEGVQYLNNLIGLELKDN 73
Query: 300 NFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCE 359
+ P S + +D++ Q + P
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIK----TLDLTSTQITDVTPLAGLS 129
Query: 360 KRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDN 419
++L ++ N +S + L L + L DN
Sbjct: 130 NLQVLY------LDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDN 183
Query: 420 DFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTN 466
+ ISPL L +L ++ L+NN+ S P L +NL + LTN
Sbjct: 184 KISD-ISPLASL-PNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.4 bits (106), Expect = 1e-05
Identities = 28/215 (13%), Positives = 57/215 (26%), Gaps = 21/215 (9%)
Query: 166 NLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDIC 225
L + ++ G + + + +L +T L + E + L L L++
Sbjct: 17 ALANAIKIAAGKSNVTD---TVTQADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELK 71
Query: 226 RNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEI 285
N+I+ P ++ + TL ++ +
Sbjct: 72 DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131
Query: 286 GNLKNLTVFQCFKNNF--------------SGEFPSGFGDMRKLFAFSIYGNRFSGPFPE 331
L + + ++ KL N+ S P
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP- 190
Query: 332 NLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNL 366
L L +V + NQ S P ++ L
Sbjct: 191 -LASLPNLIEVHLKNNQISDVSPLANTSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 44.3 bits (103), Expect = 3e-05
Identities = 29/212 (13%), Positives = 72/212 (33%), Gaps = 20/212 (9%)
Query: 95 ALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSIN 154
AL + ++ + ++ + ++ + L+ G + ++ + L NL +L N
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQ--ADLDGITTLSAFGTGVT-TIEGVQYLNNLIGLELKDN 73
Query: 155 YFT------GRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGR 208
T + L+ ++ ++ + + + LA +
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 209 IPESISELRELGTLDIC-------RNKISGEFPRSIRKLQKLWKIELYANNLTGELPAEL 261
+ ++++ + L + L KL ++ N ++ P L
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--L 191
Query: 262 GNLTLLQEFDISSNQMYGKLPEEIGNLKNLTV 293
+L L E + +NQ+ P + N NL +
Sbjct: 192 ASLPNLIEVHLKNNQISDVSP--LANTSNLFI 221
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 5e-04
Identities = 38/226 (16%), Positives = 71/226 (31%), Gaps = 18/226 (7%)
Query: 287 NLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISE 346
L N K+N + D+ + S +G + E + L +++ +
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 347 NQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLW 406
NQ K L + + N A + L
Sbjct: 73 NQI------TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLA 126
Query: 407 ALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTN 466
L N+ +L N I+ + L+ + L + L L+ L L +
Sbjct: 127 GLSNLQVLYLDLNQ----ITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADD 182
Query: 467 NNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNL 512
N S P L +L L +HL+ N ++ P + + + + + L
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.4 bits (126), Expect = 8e-08
Identities = 19/94 (20%), Positives = 33/94 (35%), Gaps = 5/94 (5%)
Query: 432 STSLSQLVLQNNRFSGELPSEL-GRLTNLERLILTNNNFSGK----IPSALGALRQLSSL 486
S + L +Q S +EL L + + L + + I SAL L+ L
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 487 HLEENALTGSIPNEMGDCARIVDLNLARNSLSGN 520
+L N L + + + + + SL
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.4 bits (118), Expect = 8e-07
Identities = 19/111 (17%), Positives = 39/111 (35%), Gaps = 22/111 (19%)
Query: 458 NLERLILTNNNFSGK-IPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNS 516
+++ L + S L L+Q + L++ LT +
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARC------------------ 44
Query: 517 LSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMK-LKLSSIDLSENQLSG 566
+I +L + +L LNL N+L +++ L+ S + + L
Sbjct: 45 --KDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.8 bits (114), Expect = 2e-06
Identities = 14/97 (14%), Positives = 30/97 (30%), Gaps = 5/97 (5%)
Query: 410 NVGMLDFGDNDFT-GGISPLIGLSTSLSQLVLQNNRFSGE----LPSELGRLTNLERLIL 464
++ LD + + + L+ L + L + + + S L L L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 465 TNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEM 501
+N + Q S +++ +L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGA 99
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.9 bits (109), Expect = 9e-06
Identities = 14/90 (15%), Positives = 31/90 (34%), Gaps = 4/90 (4%)
Query: 170 LVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGR----IPESISELRELGTLDIC 225
+ SL I +A E + L+ + L C L I ++ L L++
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 226 RNKISGEFPRSIRKLQKLWKIELYANNLTG 255
N++ + + + ++ +L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.5 bits (108), Expect = 1e-05
Identities = 18/78 (23%), Positives = 32/78 (41%), Gaps = 9/78 (11%)
Query: 414 LDFGDNDFTG----GISPLIGLSTSLSQLVLQNNRFSGELPSELGR-----LTNLERLIL 464
L D D + ++ + + SL +L L NN +L LE+L+L
Sbjct: 374 LWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVL 433
Query: 465 TNNNFSGKIPSALGALRQ 482
+ +S ++ L AL +
Sbjct: 434 YDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.5 bits (108), Expect = 1e-05
Identities = 17/80 (21%), Positives = 29/80 (36%), Gaps = 9/80 (11%)
Query: 433 TSLSQLVLQNNRFSGE----LPSELGRLTNLERLILTNNNFSGKIPSALG-ALRQ----L 483
+ L L L + S L + L +L L L+NN L ++RQ L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 484 SSLHLEENALTGSIPNEMGD 503
L L + + + + +
Sbjct: 429 EQLVLYDIYWSEEMEDRLQA 448
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.0 bits (104), Expect = 3e-05
Identities = 16/70 (22%), Positives = 27/70 (38%), Gaps = 10/70 (14%)
Query: 510 LNLARNSLSGN----IPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL------KLSSIDL 559
L LA +S + + +L SL L+LS N L + L++ L + L
Sbjct: 374 LWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVL 433
Query: 560 SENQLSGSVP 569
+ S +
Sbjct: 434 YDIYWSEEME 443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (103), Expect = 4e-05
Identities = 18/103 (17%), Positives = 30/103 (29%), Gaps = 23/103 (22%)
Query: 457 TNLERLILTNNNFSGK----IPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNL 512
+ L L L + + S + + L A L L L N L + ++ + R
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVR------ 422
Query: 513 ARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLS 555
L L L + + D L L+
Sbjct: 423 -------------QPGCLLEQLVLYDIYWSEEMEDRLQALEKD 452
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (101), Expect = 8e-05
Identities = 14/76 (18%), Positives = 30/76 (39%), Gaps = 5/76 (6%)
Query: 218 ELGTLDICRNKISGE-FPRSIRKLQKLWKIELYANNLTGE----LPAELGNLTLLQEFDI 272
++ +LDI ++S + + LQ+ + L LT + + L L E ++
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 273 SSNQMYGKLPEEIGNL 288
SN++ +
Sbjct: 63 RSNELGDVGVHCVLQG 78
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 1e-04
Identities = 13/64 (20%), Positives = 23/64 (35%), Gaps = 6/64 (9%)
Query: 510 LNLARNSLSGN-IPRSLSLLSSLNALNLSGNKLTGSIPDNLMKL-----KLSSIDLSENQ 563
L++ LS L LL + L LT + ++ L+ ++L N+
Sbjct: 7 LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66
Query: 564 LSGS 567
L
Sbjct: 67 LGDV 70
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 2e-04
Identities = 15/88 (17%), Positives = 32/88 (36%), Gaps = 8/88 (9%)
Query: 163 WVVNLTQLVSLSIGDNVYDEA---EIPESIGNLKNLTYLFLAHCNLRGRIPESISE-LRE 218
+ L L + D ++ + ++ +L L L++ L + E +R+
Sbjct: 364 LGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQ 423
Query: 219 ----LGTLDICRNKISGEFPRSIRKLQK 242
L L + S E ++ L+K
Sbjct: 424 PGCLLEQLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (89), Expect = 0.002
Identities = 16/119 (13%), Positives = 32/119 (26%), Gaps = 23/119 (19%)
Query: 294 FQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSG----PFPENLGRYTALTDVDISENQF 349
+ L + S L +L ++D+S N
Sbjct: 350 NRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCL 409
Query: 350 SGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWAL 408
+ L E ++ +++L + D + S ++ D L AL
Sbjct: 410 GDAGILQLVE--------SVRQPGC-----------LLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (89), Expect = 0.002
Identities = 10/110 (9%), Positives = 27/110 (24%), Gaps = 21/110 (19%)
Query: 267 LQEFDISSNQMYGK-LPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRF 325
+Q DI ++ E + L+ V + +
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSA------------- 50
Query: 326 SGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSG 375
L AL ++++ N+ + + + + +
Sbjct: 51 -------LRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 46.0 bits (107), Expect = 1e-05
Identities = 51/375 (13%), Positives = 92/375 (24%), Gaps = 53/375 (14%)
Query: 122 NLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYD 181
+LK+ +T L +++ LS N RW
Sbjct: 9 SLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARW------------------ 50
Query: 182 EAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQ 241
+ E+I + K+L + E LR L ++ K
Sbjct: 51 ---LSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQ--------------ALLKCP 93
Query: 242 KLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNF 301
KL + L N L + L + G + + N
Sbjct: 94 KLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKK 153
Query: 302 SGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKR 361
+ P + + ++ + E
Sbjct: 154 AKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLL----------HTVKMVQNGIRPEGI 203
Query: 362 KLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDF 421
+ L L L+ +V + + T L L + + G
Sbjct: 204 EHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAV 263
Query: 422 TGGISPLIGLSTSLSQLVLQNNRFSGELPSEL-----GRLTNLERLILTNNNFSGKIPSA 476
S L + L L LQ N + L ++ +L L L N F +
Sbjct: 264 VDAFSKLE--NIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF-SEEDDV 320
Query: 477 LGALRQLSSLHLEEN 491
+ +R++ S
Sbjct: 321 VDEIREVFSTRGRGE 335
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.9 bits (99), Expect = 1e-04
Identities = 51/338 (15%), Positives = 92/338 (27%), Gaps = 46/338 (13%)
Query: 242 KLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIG-------NLKNLTVF 294
K K++ + A L ++E +S N + + + +L+
Sbjct: 8 KSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67
Query: 295 QCFKNNFSGEFP-------SGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISEN 347
F E P KL + N F E L + +
Sbjct: 68 DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLY 127
Query: 348 QFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWA 407
+ K N + P + RL K
Sbjct: 128 LHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRL 187
Query: 408 LPNV------GMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLER 461
L V + ++ G++ L Q + S L L NL
Sbjct: 188 LHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRE 247
Query: 462 LILTNNNFSGKIPSALG-ALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGN 520
L L + S + +A+ A +L ++ L+ L L N + +
Sbjct: 248 LGLNDCLLSARGAAAVVDAFSKLENIGLQT-------------------LRLQYNEIELD 288
Query: 521 IPRSL-----SLLSSLNALNLSGNKLTGSIPDNLMKLK 553
R+L + L L L+GN+ D + +++
Sbjct: 289 AVRTLKTVIDEKMPDLLFLELNGNRF-SEEDDVVDEIR 325
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.6 bits (98), Expect = 2e-04
Identities = 32/304 (10%), Positives = 65/304 (21%), Gaps = 29/304 (9%)
Query: 209 IPESISELRELGTLDICRNKISGE----FPRSIRKLQKLWKIELYAN---NLTGELPAEL 261
+ + E + + + N I E +I + L E + E+P L
Sbjct: 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL 82
Query: 262 GNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIY 321
L + + + + K+ + I
Sbjct: 83 RLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIA 142
Query: 322 GNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSY 381
+ L + N+ K + + LL +
Sbjct: 143 RALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEG 202
Query: 382 ADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQ 441
+ ++ L + D + L + L
Sbjct: 203 IEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLREL-----------GLN 251
Query: 442 NNRFSGELPSELGR------LTNLERLILTNNNFSGKIPSALGA-----LRQLSSLHLEE 490
+ S + + L+ L L N L + L L L
Sbjct: 252 DCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNG 311
Query: 491 NALT 494
N +
Sbjct: 312 NRFS 315
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.7 bits (88), Expect = 0.003
Identities = 7/66 (10%), Positives = 25/66 (37%), Gaps = 8/66 (12%)
Query: 434 SLSQLVLQNNRFSGE----LPSELGRLTNLERLILTNNNFSGK----IPSALGALRQLSS 485
S+ L+ + + E + + L +++ ++L+ N + + + + + L
Sbjct: 4 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63
Query: 486 LHLEEN 491
+
Sbjct: 64 AEFSDI 69
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.8 bits (97), Expect = 7e-05
Identities = 21/137 (15%), Positives = 48/137 (35%), Gaps = 5/137 (3%)
Query: 90 SSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIF 149
++ + L L + + + ++ + N + + L+ L+
Sbjct: 11 AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDN-EIRKLDGFPLLRRLKTL 68
Query: 150 DLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAH---CNLR 206
++ N L L L + +N E + + +LK+LTYL + N +
Sbjct: 69 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128
Query: 207 GRIPESISELRELGTLD 223
I ++ ++ LD
Sbjct: 129 HYRLYVIYKVPQVRVLD 145
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.3 bits (95), Expect = 1e-04
Identities = 16/138 (11%), Positives = 32/138 (23%), Gaps = 3/138 (2%)
Query: 225 CRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAEL-GNLTLLQEFDISSNQMYGKLPE 283
C + + + + L ++ + L L L+ I + + P+
Sbjct: 15 CTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD 74
Query: 284 EIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPF-PENLGRYTALTDV 342
L+ N L + GN L R+
Sbjct: 75 AFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLG 133
Query: 343 DISENQFSGSFPKYLCEK 360
+ E + L
Sbjct: 134 GVPEQKLQCHGQGPLAHM 151
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.2 bits (87), Expect = 0.001
Identities = 17/151 (11%), Positives = 40/151 (26%), Gaps = 4/151 (2%)
Query: 120 CSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVV-NLTQLVSLSIGDN 178
L T + + S+ L +NL + + L +L +L+I +
Sbjct: 7 PHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 179 VYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKIS-GEFPRSI 237
+ N + + L L + N + R +
Sbjct: 67 GLRFVAPDAFHFTPRLSRLNL--SFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWL 124
Query: 238 RKLQKLWKIELYANNLTGELPAELGNLTLLQ 268
++ ++ + L L ++
Sbjct: 125 QRWEEEGLGGVPEQKLQCHGQGPLAHMPNAS 155
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.5 bits (85), Expect = 0.003
Identities = 29/140 (20%), Positives = 50/140 (35%), Gaps = 5/140 (3%)
Query: 433 TSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPS-ALGALRQLSSLHLEEN 491
S L + + L NL L + N + L L +L +L + ++
Sbjct: 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 492 ALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKL--TGSIPDNL 549
L P+ R+ LNL+ N+L ++ SL L LSGN L + ++
Sbjct: 67 GLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRWLQ 125
Query: 550 MKLKLSSIDLSENQLSGSVP 569
+ + E +L
Sbjct: 126 RWEEEGLGGVPEQKLQCHGQ 145
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.0 bits (95), Expect = 2e-04
Identities = 23/124 (18%), Positives = 47/124 (37%), Gaps = 3/124 (2%)
Query: 112 KLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLV 171
+L L +S + + + S PDL A + + + N+ +L+
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGL-RSDPDLVAQNIDVVLNRR-SSMAATLRIIEENIPELL 68
Query: 172 SLSI-GDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKIS 230
SL++ + +Y ++ + NL L L+ L+ + +L L + N +S
Sbjct: 69 SLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS 128
Query: 231 GEFP 234
F
Sbjct: 129 DTFR 132
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.8 bits (92), Expect = 4e-04
Identities = 24/113 (21%), Positives = 40/113 (35%), Gaps = 7/113 (6%)
Query: 438 LVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTG-- 495
L L+ R +L L R ++ + + + +L SL+L N L
Sbjct: 27 LDLKGLRSDPDL-VAQNIDVVLNRR----SSMAATLRIIEENIPELLSLNLSNNRLYRLD 81
Query: 496 SIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDN 548
+ + + + LNL+ N L L L L GN L+ + D
Sbjct: 82 DMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQ 134
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 41.3 bits (95), Expect = 2e-04
Identities = 29/160 (18%), Positives = 52/160 (32%), Gaps = 28/160 (17%)
Query: 430 GLSTSLSQLVLQNNRFSGEL-PSELGRLTNLERLI------------------------L 464
+ ++L+L +N GRL +L +L L
Sbjct: 26 DIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQL 85
Query: 465 TNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRS 524
N L QL +L+L +N ++ +P + LNLA N + N
Sbjct: 86 GENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH-L 144
Query: 525 LSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQL 564
L +L+G P + +++ DL ++
Sbjct: 145 AWFAEWLRKKSLNGGAARCGAPSKVRDVQIK--DLPHSEF 182
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.2 bits (95), Expect = 2e-04
Identities = 39/200 (19%), Positives = 67/200 (33%), Gaps = 16/200 (8%)
Query: 94 SALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSI 153
+AL L ++ + ++ + L + S+ + L NL + S
Sbjct: 15 TALAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRL-GIKSIDGVEYLNNLTQINFSN 71
Query: 154 NYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESI 213
N T P + D + + +I + L N + + +
Sbjct: 72 NQLTDITPLKNLTKLV-------DILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPL 124
Query: 214 SELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDIS 273
L L L++ N IS S + +N +T P L NLT L+ DIS
Sbjct: 125 KNLTNLNRLELSSNTISDISALSGLTSLQQLNF--SSNQVTDLKP--LANLTTLERLDIS 180
Query: 274 SNQMYGKLPEEIGNLKNLTV 293
SN++ + L NL
Sbjct: 181 SNKVSD--ISVLAKLTNLES 198
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 4e-04
Identities = 32/223 (14%), Positives = 55/223 (24%), Gaps = 40/223 (17%)
Query: 240 LQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKN 299
L + K L N+T + +L + + K + + L NLT N
Sbjct: 17 LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNN 72
Query: 300 NFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCE 359
+ P + P
Sbjct: 73 QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTG---------------------- 110
Query: 360 KRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDN 419
K + L + + + +
Sbjct: 111 -----------LTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSS 159
Query: 420 DFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERL 462
+ + PL L T+L +L + +N+ S S L +LTNLE L
Sbjct: 160 NQVTDLKPLANL-TTLERLDISSNKVSD--ISVLAKLTNLESL 199
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 9e-04
Identities = 25/214 (11%), Positives = 56/214 (26%), Gaps = 22/214 (10%)
Query: 281 LPEEIG------NLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLG 334
+P I K + + ++ + + +
Sbjct: 10 VPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQ--GIQ 65
Query: 335 RYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISD 394
+T + ++ N+ + P L L + ++
Sbjct: 66 YLPNVTKLFLNGNKLTDIKP---------LANLKNLGWLFLDENKVKDLSSLKDLKKLKS 116
Query: 395 NHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELG 454
L + L ++ L+ + + + + ++ L
Sbjct: 117 LSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIV-PLA 175
Query: 455 RLTNLERLILTNNNFSGKIPSALGALRQLSSLHL 488
LT L+ L L+ N+ S AL L+ L L L
Sbjct: 176 GLTKLQNLYLSKNHISD--LRALAGLKNLDVLEL 207
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 0.002
Identities = 28/213 (13%), Positives = 65/213 (30%), Gaps = 22/213 (10%)
Query: 209 IPESISE------LRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELG 262
+P I + E ++ + ++ ++ +L + +I +++ +
Sbjct: 10 VPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQ 65
Query: 263 NLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYG 322
L + + ++ N++ I L NL + + K
Sbjct: 66 YLPNVTKLFLNGNKLTD-----IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLE 120
Query: 323 NRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYA 382
+ L L + + N+ + K L+ + A
Sbjct: 121 HNGI-SDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLS----LEDNQISDIVPLA 175
Query: 383 DCKTIQRLRISDNHLSGKIPDGLWALPNVGMLD 415
+Q L +S NH+S L L N+ +L+
Sbjct: 176 GLTKLQNLYLSKNHISD--LRALAGLKNLDVLE 206
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.003
Identities = 38/212 (17%), Positives = 73/212 (34%), Gaps = 26/212 (12%)
Query: 55 ESADSPCGFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLP 114
E+ P I D + + KS++ ++ + L S+ + + +
Sbjct: 6 ETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG 63
Query: 115 LELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFT----------------- 157
++ N+ L + GN + + L+ LKNL L N
Sbjct: 64 IQ--YLPNVTKLFLNGNKLTD-IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLE 120
Query: 158 GRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELR 217
+ L L L ++ + L L L L + +P ++ L
Sbjct: 121 HNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLT 178
Query: 218 ELGTLDICRNKISGEFPRSIRKLQKLWKIELY 249
+L L + +N IS R++ L+ L +EL+
Sbjct: 179 KLQNLYLSKNHISD--LRALAGLKNLDVLELF 208
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 973 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.97 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.96 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.93 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.91 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.88 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.84 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.84 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.82 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.78 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.78 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.77 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.77 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.76 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.76 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.75 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.75 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.74 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.74 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.72 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.72 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.58 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.54 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.52 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.52 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.51 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.5 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.49 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.48 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.41 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.35 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.34 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.33 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.49 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.41 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.05 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.68 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.61 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.56 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.33 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.84 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.75 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.83 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.8 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.87 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=421.20 Aligned_cols=253 Identities=26% Similarity=0.360 Sum_probs=207.3
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE 751 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 751 (973)
+++|++.+.||+|+||+||+|+++.+|+.||||++... ...+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 35799999999999999999999999999999998653 234568899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccC
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 831 (973)
|+++|+|.+++.. ...+++..+..++.|+++||+||| +++|+||||||+|||+++++.+||+|||+|+....
T Consensus 84 y~~gg~L~~~l~~-----~~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~ 155 (271)
T d1nvra_ 84 YCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRY 155 (271)
T ss_dssp CCTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred ccCCCcHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeecc
Confidence 9999999998864 346899999999999999999999 78999999999999999999999999999987755
Q ss_pred CCCcccccccCCccccccccccccCCC-CccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhcc
Q 002061 832 SPKVSDYSCFAGTHGYIAPELAYTCKV-SEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLD 910 (973)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (973)
..........+||+.|+|||++.+..+ +.++||||+||++|||++|+.||............. .....
T Consensus 156 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~----~~~~~------- 224 (271)
T d1nvra_ 156 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW----KEKKT------- 224 (271)
T ss_dssp TTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHH----HTTCT-------
T ss_pred CCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHH----hcCCC-------
Confidence 443344455689999999999988876 578999999999999999999997543222111111 11110
Q ss_pred ccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 911 CEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 911 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
...........+.+++.+||+.||++|||++|+++|
T Consensus 225 ---~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 225 ---YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp ---TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 001112223567789999999999999999999875
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=410.34 Aligned_cols=246 Identities=30% Similarity=0.418 Sum_probs=208.3
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeec-----cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV 749 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~-----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 749 (973)
+++|++.+.||+|+||+||+|+++.+++.||||++.+ ....+.+.+|++++++++||||+++++++.+++..|+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 4578999999999999999999999999999999864 23456788999999999999999999999999999999
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccc
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 829 (973)
|||+++|+|.+++... ..+++..+..++.||++||+||| +++|+||||||+|||++.++.+||+|||+|+..
T Consensus 85 mEy~~~g~L~~~l~~~-----~~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~ 156 (263)
T d2j4za1 85 LEYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA 156 (263)
T ss_dssp EECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCC
T ss_pred EeecCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeec
Confidence 9999999999999864 35899999999999999999999 789999999999999999999999999999765
Q ss_pred cCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhc
Q 002061 830 ENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVL 909 (973)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (973)
.... .....||+.|+|||++.+..++.++||||+||++|||++|+.||... +...............
T Consensus 157 ~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~-----~~~~~~~~i~~~~~~~---- 223 (263)
T d2j4za1 157 PSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN-----TYQETYKRISRVEFTF---- 223 (263)
T ss_dssp CCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHHHHTTCCCC----
T ss_pred CCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC-----CHHHHHHHHHcCCCCC----
Confidence 4332 23457999999999999999999999999999999999999999643 2222222221111111
Q ss_pred cccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 910 DCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 910 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
+....+++.+++.+||++||++|||++|+++|
T Consensus 224 --------p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 224 --------PDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp --------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred --------CccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 11223567889999999999999999999975
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=415.29 Aligned_cols=260 Identities=28% Similarity=0.432 Sum_probs=202.0
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeec----cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK----GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL 750 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 750 (973)
.++|++.+.||+|+||+||+|+.+. .||||+++. +...+.|.+|++++++++|||||++++++.+ +..++||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~ 82 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT 82 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS---EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC---EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence 3578999999999999999998653 699999864 3456788999999999999999999998654 5689999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccccc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 830 (973)
||+++|+|.+++... ...+++..+..++.|||+||+||| +++||||||||+|||++.++.+||+|||+|+...
T Consensus 83 Ey~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 83 QWCEGSSLYHHLHII----ETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155 (276)
T ss_dssp ECCCEEEHHHHHHTS----CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred ecCCCCCHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeecc
Confidence 999999999999753 346899999999999999999999 7899999999999999999999999999998765
Q ss_pred CCCCcccccccCCcccccccccccc---CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccch
Q 002061 831 NSPKVSDYSCFAGTHGYIAPELAYT---CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLK 907 (973)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
............||+.|||||++.+ ..|+.++|||||||++|||+||+.||..... .......+... ...+..
T Consensus 156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~-~~~~~~~~~~~-~~~p~~-- 231 (276)
T d1uwha_ 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN-RDQIIFMVGRG-YLSPDL-- 231 (276)
T ss_dssp ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-HHHHHHHHHHT-SCCCCG--
T ss_pred ccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh-HHHHHHHHhcC-CCCCcc--
Confidence 4433334445679999999999864 3588999999999999999999999975311 11111111111 111100
Q ss_pred hccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCC
Q 002061 908 VLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPC 956 (973)
Q Consensus 908 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~ 956 (973)
.......++.+.+++.+||+.||++|||++||+++|+.+...
T Consensus 232 -------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 232 -------SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp -------GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -------hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 011122345688999999999999999999999999987643
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-48 Score=413.05 Aligned_cols=249 Identities=23% Similarity=0.327 Sum_probs=208.2
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeec--cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK--GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM 753 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 753 (973)
.+|++.+.||+|+||+||+|++..+|+.||||++.. ....+.+.+|++++++++||||+++++++.+++..|+||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 479999999999999999999999999999999865 345567899999999999999999999999999999999999
Q ss_pred CCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCC
Q 002061 754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833 (973)
Q Consensus 754 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 833 (973)
++|+|.+++... .+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~gg~L~~~~~~~------~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 100 AGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp TTCBHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence 999999987642 4889999999999999999999 7899999999999999999999999999998765432
Q ss_pred CcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccc
Q 002061 834 KVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEV 913 (973)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (973)
. ......||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..............
T Consensus 171 ~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~-----~~~~~~~~~~~~~~--------- 234 (293)
T d1yhwa1 171 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN-----PLRALYLIATNGTP--------- 234 (293)
T ss_dssp C--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-----HHHHHHHHHHHCSC---------
T ss_pred c--cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC-----HHHHHHHHHhCCCC---------
Confidence 2 2334579999999999999999999999999999999999999996431 11111111111110
Q ss_pred cCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 914 ASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 914 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
....+......+.+++.+||++||++|||+.|+++|
T Consensus 235 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 001122334568899999999999999999999876
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-48 Score=417.90 Aligned_cols=258 Identities=25% Similarity=0.331 Sum_probs=213.2
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeec-cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccC
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK-GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP 754 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 754 (973)
++|++.+.||+|+||+||+|++..+++.||||++.. ....+++.+|++++++++|||||++++++.+++..|+||||++
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~ 96 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 96 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeeccc
Confidence 478889999999999999999999899999999876 3456789999999999999999999999999999999999999
Q ss_pred CCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCC
Q 002061 755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK 834 (973)
Q Consensus 755 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 834 (973)
+|+|.+++... ....+++..+..++.|||+||+||| +++|+||||||+|||+++++.+||+|||+|+.......
T Consensus 97 ~g~l~~~l~~~---~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 97 YGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp TCBHHHHHHHS---CTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred CcchHHHhhhc---cccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence 99999999753 3456899999999999999999999 78999999999999999999999999999987654322
Q ss_pred cccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhcccccc
Q 002061 835 VSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVA 914 (973)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (973)
.......|++.|+|||++.+..++.++|||||||++|||++|..||.... +...+...+. .. ..
T Consensus 171 -~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~-~~~~~~~~i~----~~----------~~ 234 (287)
T d1opja_ 171 -TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLE----KD----------YR 234 (287)
T ss_dssp -EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC-CHHHHHHHHH----TT----------CC
T ss_pred -eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc-hHHHHHHHHh----cC----------CC
Confidence 22333458899999999999999999999999999999999777764321 1111111111 11 11
Q ss_pred CcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 002061 915 SESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADP 955 (973)
Q Consensus 915 ~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 955 (973)
...+.....++.+++.+||+.||++|||++||++.|+.+..
T Consensus 235 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 235 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11122234568899999999999999999999999988743
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-48 Score=411.56 Aligned_cols=253 Identities=26% Similarity=0.379 Sum_probs=198.0
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeec-cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccC
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK-GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP 754 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 754 (973)
++|++.+.||+|+||+||+|++.. ++.||||++.. ....+++.+|++++++++||||+++++++..++..|+||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETT-TEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECC-CCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 467889999999999999999875 67899999876 3456789999999999999999999999999999999999999
Q ss_pred CCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCC
Q 002061 755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK 834 (973)
Q Consensus 755 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 834 (973)
+|+|.+++... ...+++..+..++.|+|+||+|+| +++|+||||||+||++++++.+||+|||+++.......
T Consensus 84 ~g~L~~~l~~~----~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 84 HGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp TCBHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred CCcHHHHhhcc----ccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 99999998753 346889999999999999999999 78999999999999999999999999999987654322
Q ss_pred cccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhC-CCCCCcccCCcccHHHHHHHHhccccccchhccccc
Q 002061 835 VSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTG-RKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEV 913 (973)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (973)
. ......||+.|+|||++.+..++.++|||||||++|||+|+ +.||... ........+... .. ...+
T Consensus 157 ~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~--~~~~~~~~i~~~---~~----~~~p-- 224 (263)
T d1sm2a_ 157 T-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR--SNSEVVEDISTG---FR----LYKP-- 224 (263)
T ss_dssp ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC--CHHHHHHHHHHT---CC----CCCC--
T ss_pred e-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC--CHHHHHHHHHhc---CC----CCCc--
Confidence 2 22335689999999999999999999999999999999995 5555332 111222222111 10 0011
Q ss_pred cCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 914 ASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 914 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
....+++.+++.+||+.||++|||++||+++|+++
T Consensus 225 -----~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 225 -----RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp -----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 12234688999999999999999999999999875
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=413.81 Aligned_cols=255 Identities=24% Similarity=0.358 Sum_probs=195.2
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEe--CCeeEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLK--GGSSFLV 749 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~lv 749 (973)
++|++.+.||+|+||+||+|+++.+|+.||||++... ...+.+.+|++++++++||||+++++++.+ +...|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 5789999999999999999999999999999998653 234568899999999999999999999865 4568999
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcC--CCCeEecCCCCCCeeecCCCCeEEecccCcc
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC--SPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~--~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~ 827 (973)
|||+++|+|.+++..... ....+++..++.++.|++.||+|||+.. ..+|+||||||+|||++.++.+||+|||+++
T Consensus 84 mEy~~~g~L~~~i~~~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 84 MEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EECCTTEEHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EecCCCCcHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 999999999999976432 2446899999999999999999999531 2359999999999999999999999999998
Q ss_pred cccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccch
Q 002061 828 IAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLK 907 (973)
Q Consensus 828 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||... ...+....+.. ...
T Consensus 163 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~--~~~~~~~~i~~---~~~---- 231 (269)
T d2java1 163 ILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF--SQKELAGKIRE---GKF---- 231 (269)
T ss_dssp HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHH---TCC----
T ss_pred ecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCC--CHHHHHHHHHc---CCC----
Confidence 7654322 223467999999999999999999999999999999999999999653 11121111111 110
Q ss_pred hccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 908 VLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 908 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
+ ..+....+++.+++.+||+.||.+|||++|+++|
T Consensus 232 ---~----~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 232 ---R----RIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp ---C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---C----CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 0 0111234568899999999999999999999875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=410.20 Aligned_cols=251 Identities=23% Similarity=0.324 Sum_probs=206.5
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeec--cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK--GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM 753 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 753 (973)
+.|++.+.||+|+||+||+|++..+++.||||++.. ....+.+.+|++++++++|||||++++++.+++..|+||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 368899999999999999999999999999999865 345577899999999999999999999999999999999999
Q ss_pred CCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCC
Q 002061 754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833 (973)
Q Consensus 754 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 833 (973)
++|+|.+++.+. ...+++..+..++.||++||+||| +++|+||||||+|||++.++.+||+|||+|+......
T Consensus 92 ~~g~L~~~~~~~----~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 92 AGGAVDAVMLEL----ERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164 (288)
T ss_dssp TTEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred CCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCCc
Confidence 999999998754 235899999999999999999999 7899999999999999999999999999997553221
Q ss_pred CcccccccCCccccccccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchh
Q 002061 834 KVSDYSCFAGTHGYIAPELAY-----TCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKV 908 (973)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (973)
.......||+.|+|||++. +..|+.++||||+||++|||++|+.||.... ..+....+ ......
T Consensus 165 --~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~--~~~~~~~i---~~~~~~---- 233 (288)
T d2jfla1 165 --QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN--PMRVLLKI---AKSEPP---- 233 (288)
T ss_dssp --HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSC--GGGHHHHH---HHSCCC----
T ss_pred --ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCC--HHHHHHHH---HcCCCC----
Confidence 1223467999999999984 4568899999999999999999999997541 22221111 111110
Q ss_pred ccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 909 LDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 909 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
....+......+.+++.+||+.||++|||+.|+++|
T Consensus 234 -----~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 234 -----TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp -----CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -----CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 001122334568899999999999999999999986
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.1e-48 Score=416.47 Aligned_cols=256 Identities=25% Similarity=0.387 Sum_probs=198.1
Q ss_pred cCCcccCcccccCceEEEEEEecCCCc---EEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAG---TVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV 749 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~---~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 749 (973)
++|++.+.||+|+||+||+|+++.+++ .||||++... ...+.|.+|++++++++|||||++++++..++..|+|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 467888999999999999999976554 5899987653 3456789999999999999999999999999999999
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccc
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 829 (973)
|||+++|+|.+++... ...+++.++..++.|||+||+||| +++|+||||||+|||++.++.+||+|||+++..
T Consensus 106 ~Ey~~~g~L~~~~~~~----~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQN----DGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp EECCTTEEHHHHHHTT----TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEecCCCcceeeeccc----cCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEc
Confidence 9999999999988753 346899999999999999999999 789999999999999999999999999999876
Q ss_pred cCCCCccc---ccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhcccccc
Q 002061 830 ENSPKVSD---YSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENV 905 (973)
Q Consensus 830 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 905 (973)
........ .....||+.|+|||++.+..++.++|||||||++|||+| |+.||.+. ...++...+.. ..
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~--~~~~~~~~i~~----~~-- 250 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM--TNQDVINAIEQ----DY-- 250 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHHHT----TC--
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCC--CHHHHHHHHHc----CC--
Confidence 54332221 222457899999999999999999999999999999998 89999754 11222222211 11
Q ss_pred chhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 002061 906 LKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADAD 954 (973)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 954 (973)
....+.+....+.+++.+||+.||++|||++||+++|+++.
T Consensus 251 --------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l 291 (299)
T d1jpaa_ 251 --------RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 291 (299)
T ss_dssp --------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred --------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 01112233456889999999999999999999999998764
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-48 Score=410.79 Aligned_cols=248 Identities=24% Similarity=0.338 Sum_probs=204.5
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeec-----cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL 750 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~-----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 750 (973)
++|++.+.||+|+||+||+|++..+++.||||++.+ +...+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 468999999999999999999999999999999864 345567899999999999999999999999999999999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccccc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 830 (973)
||+++|+|.+++... ..+++..+..++.|++.||+||| +++||||||||+||++++++.+||+|||+|+...
T Consensus 88 Ey~~gg~L~~~~~~~-----~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 159 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 159 (288)
T ss_dssp CCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EccCCCCHHHhhhcc-----CCCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecc
Confidence 999999999998764 35899999999999999999999 7899999999999999999999999999998776
Q ss_pred CCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhcc
Q 002061 831 NSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLD 910 (973)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (973)
............||+.|+|||++.+..++.++||||+||++|||++|+.||... +..............
T Consensus 160 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-----~~~~~~~~i~~~~~~------ 228 (288)
T d1uu3a_ 160 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG-----NEYLIFQKIIKLEYD------ 228 (288)
T ss_dssp ----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHTTCCC------
T ss_pred cCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc-----CHHHHHHHHHcCCCC------
Confidence 544434444567999999999999999999999999999999999999999753 222222222111111
Q ss_pred ccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 002061 911 CEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVK 948 (973)
Q Consensus 911 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~ 948 (973)
. +....+++.+++.+||+.||++|||+.|+++
T Consensus 229 --~----p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 229 --F----PEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp --C----CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred --C----CccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 1 1123446789999999999999999998643
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-47 Score=400.64 Aligned_cols=253 Identities=21% Similarity=0.347 Sum_probs=210.6
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeec-cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccC
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK-GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP 754 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 754 (973)
++|++.++||+|+||+||+|+++ +++.||||+++. ....++|.+|++++++++||||+++++++.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 47899999999999999999986 478999999876 3456789999999999999999999999999999999999999
Q ss_pred CCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCC
Q 002061 755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK 834 (973)
Q Consensus 755 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 834 (973)
+|+|.+++... ...+++..+..++.|+|+||+||| +++|+||||||+||+++.++.+||+|||+++.......
T Consensus 83 ~g~l~~~~~~~----~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 83 NGCLLNYLREM----RHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp TEEHHHHHHSG----GGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred CCcHHHhhhcc----ccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence 99999998653 345789999999999999999999 78999999999999999999999999999986654322
Q ss_pred cccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhccccc
Q 002061 835 VSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEV 913 (973)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (973)
.......||+.|+|||++.+..++.++|||||||++|||+| |+.||... ...++...+. .... ...+
T Consensus 156 -~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~--~~~~~~~~i~----~~~~---~~~p-- 223 (258)
T d1k2pa_ 156 -TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF--TNSETAEHIA----QGLR---LYRP-- 223 (258)
T ss_dssp -CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS--CHHHHHHHHH----TTCC---CCCC--
T ss_pred -eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCC--CHHHHHHHHH----hCCC---CCCc--
Confidence 22334568999999999999999999999999999999998 89999754 1222222221 1110 0111
Q ss_pred cCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 914 ASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 914 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
....+++.+++.+||+.||++|||++|++++|.++
T Consensus 224 -----~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 224 -----HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp -----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred -----ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 12235688999999999999999999999999764
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=418.50 Aligned_cols=258 Identities=24% Similarity=0.338 Sum_probs=207.7
Q ss_pred cCCcccCcccccCceEEEEEEecCCCc-----EEEEEeeec---cccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCee
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAG-----TVAVKQLWK---GDGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSS 746 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~-----~vavK~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 746 (973)
++|++.+.||+|+||+||+|++...++ .||||++.. ......+.+|+.++.++ +|||||++++++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 478899999999999999999875443 699998855 23445788999999998 899999999999999999
Q ss_pred EEEEEccCCCchHHHHHhhhc------------------CCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCC
Q 002061 747 FLVLEYMPNGNLFQALHKRVK------------------EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSS 808 (973)
Q Consensus 747 ~lv~e~~~~gsL~~~l~~~~~------------------~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~ 808 (973)
|+||||+++|+|.++++.... .....+++..+..++.||++||+||| +++||||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCchh
Confidence 999999999999999976421 11235889999999999999999999 789999999999
Q ss_pred CeeecCCCCeEEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCC
Q 002061 809 NILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGD 887 (973)
Q Consensus 809 Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~ 887 (973)
||+++.++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||+| |+.||.+...
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~- 272 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV- 272 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC-
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH-
Confidence 99999999999999999987665544333444568999999999999999999999999999999998 8999975421
Q ss_pred cccHHHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 888 GKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 888 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
...+...+... .....+....+++.+++.+||+.||++|||++||+++|.
T Consensus 273 ~~~~~~~~~~~--------------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 DANFYKLIQNG--------------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp SHHHHHHHHTT--------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHhcC--------------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 11222222111 111112223456889999999999999999999999985
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-47 Score=401.11 Aligned_cols=244 Identities=25% Similarity=0.327 Sum_probs=196.3
Q ss_pred cccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEe----CCeeEEEE
Q 002061 679 EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLK----GGSSFLVL 750 (973)
Q Consensus 679 ~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~~~lv~ 750 (973)
++.++||+|+||+||+|++..+++.||||++... ...+.+.+|++++++++||||+++++++.. +...|+||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 5566899999999999999999999999998653 234578899999999999999999999865 34679999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCC--eEecCCCCCCeeec-CCCCeEEecccCcc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPP--IIHRDIKSSNILLD-EDYEPKIADFGVAK 827 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~--ivH~Dlkp~Nill~-~~~~~kl~Dfgl~~ 827 (973)
||+++|+|.+++.+. ..+++..+..++.||++||+||| +++ |+||||||+|||++ .++.+||+|||+++
T Consensus 92 E~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163 (270)
T ss_dssp ECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred eCCCCCcHHHHHhcc-----ccccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence 999999999999764 35889999999999999999999 666 99999999999997 47899999999997
Q ss_pred cccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccch
Q 002061 828 IAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLK 907 (973)
Q Consensus 828 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
..... ......||+.|+|||++.+ +++.++||||+||++|||++|+.||.... +......... ....
T Consensus 164 ~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~----~~~~~~~~i~-~~~~--- 230 (270)
T d1t4ha_ 164 LKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ----NAAQIYRRVT-SGVK--- 230 (270)
T ss_dssp GCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS----SHHHHHHHHT-TTCC---
T ss_pred eccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc----cHHHHHHHHH-cCCC---
Confidence 54332 2234679999999999865 59999999999999999999999996431 1111111111 1110
Q ss_pred hccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 908 VLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 908 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
.........+++.+++.+||++||++|||+.|+++|
T Consensus 231 ------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 231 ------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp ------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ------CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 001111223457889999999999999999999875
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=416.92 Aligned_cols=264 Identities=23% Similarity=0.363 Sum_probs=205.5
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE 751 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 751 (973)
.++|++.+.||+|+||+||+|++..+|+.||||+++.. .....+.+|++++++++|||||+++++|.++++.|+|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 35789999999999999999999999999999998653 335678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccC
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 831 (973)
|+++|+|.+++.+. ..+++..+..++.|++.||+|||+ .++|+||||||+|||++.++.+||+|||+|+....
T Consensus 85 y~~gg~L~~~l~~~-----~~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp CCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred cCCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 99999999999864 358999999999999999999994 24899999999999999999999999999986643
Q ss_pred CCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHH--HHHh----------
Q 002061 832 SPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWV--STHL---------- 899 (973)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~--~~~~---------- 899 (973)
. .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.............. ....
T Consensus 158 ~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
T d1s9ja_ 158 S----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233 (322)
T ss_dssp H----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred C----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence 2 12235799999999999999999999999999999999999999975422111000000 0000
Q ss_pred ---------cccc--ccchh----ccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 900 ---------NNHE--NVLKV----LDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 900 ---------~~~~--~~~~~----~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
.... ...+. ...............++.+++.+|++.||++|||++|+++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0000 00000 00000000001123568889999999999999999999986
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-47 Score=405.94 Aligned_cols=254 Identities=26% Similarity=0.383 Sum_probs=204.2
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeec-cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccC
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK-GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMP 754 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 754 (973)
++|++.+.||+|+||+||+|+++. ++.||||++.. ....+.|.+|++++++++|||||++++++.+ +..|+||||++
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~ 90 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HHeEEeEEEecCCCcEEEEEEECC-CCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence 578889999999999999999874 77899999876 3456789999999999999999999998754 56799999999
Q ss_pred CCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCC
Q 002061 755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPK 834 (973)
Q Consensus 755 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 834 (973)
+|+|.+++.... ...+++..+..++.|||+||+||| +++|+||||||+|||+++++.+||+|||+|+.......
T Consensus 91 ~g~L~~~~~~~~---~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~ 164 (272)
T d1qpca_ 91 NGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (272)
T ss_dssp TCBHHHHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CCcHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCCcc
Confidence 999999876432 234899999999999999999999 78999999999999999999999999999987754322
Q ss_pred cccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhcccccc
Q 002061 835 VSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEVA 914 (973)
Q Consensus 835 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (973)
.......||+.|+|||++.+..++.++|||||||++|||+||..|+.... ........+. ....
T Consensus 165 -~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~-~~~~~~~~i~---~~~~----------- 228 (272)
T d1qpca_ 165 -TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-TNPEVIQNLE---RGYR----------- 228 (272)
T ss_dssp -ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC-CHHHHHHHHH---TTCC-----------
T ss_pred -ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC-CHHHHHHHHH---hcCC-----------
Confidence 22334578999999999999999999999999999999999666553321 1111111111 1100
Q ss_pred CcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 915 SESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 915 ~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
...+....+++.+++.+||+.||++|||++||++.|+++
T Consensus 229 ~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 011112345688999999999999999999999998763
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-47 Score=404.56 Aligned_cols=253 Identities=24% Similarity=0.324 Sum_probs=203.6
Q ss_pred CCcccC-cccccCceEEEEEEecC--CCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 002061 677 NLEEDN-LIGSGGTGKVYRLDLKK--NAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL 750 (973)
Q Consensus 677 ~~~~~~-~lG~G~~g~V~~a~~~~--~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 750 (973)
+|.+.+ +||+|+||+||+|.++. ++..||||+++.. ...++|.+|++++++++|||||++++++.. +..|+||
T Consensus 9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvm 87 (285)
T d1u59a_ 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 87 (285)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEE
T ss_pred CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEE
Confidence 445555 49999999999998753 3557999998653 345678999999999999999999999865 4689999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccccc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 830 (973)
||+++|+|.+++... ...+++..+..++.|+|+||+||| +++|+||||||+||+++.++.+||+|||+++...
T Consensus 88 E~~~~g~L~~~l~~~----~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 88 EMAGGGPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp ECCTTEEHHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EeCCCCcHHHHhhcc----ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhccc
Confidence 999999999998642 346899999999999999999999 7899999999999999999999999999998775
Q ss_pred CCCCc-ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchh
Q 002061 831 NSPKV-SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKV 908 (973)
Q Consensus 831 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (973)
..... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.... ..++...+. ....
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~--~~~~~~~i~----~~~~---- 230 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK--GPEVMAFIE----QGKR---- 230 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--THHHHHHHH----TTCC----
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC--HHHHHHHHH----cCCC----
Confidence 44322 22234568999999999999999999999999999999998 999997542 222222221 1110
Q ss_pred ccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 909 LDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 909 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
...+...+.++.+++.+||+.||++|||+.+|++.|+..
T Consensus 231 ------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 231 ------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp ------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 111123345688999999999999999999999988754
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-47 Score=407.91 Aligned_cols=259 Identities=26% Similarity=0.394 Sum_probs=200.8
Q ss_pred cCCcccCcccccCceEEEEEEecCCC----cEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNA----GTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL 748 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~----~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 748 (973)
..|+..+.||+|+||+||+|+++.++ ..||||++... ....+|.+|++++++++|||||++++++.+++..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 46788899999999999999987644 46999998653 334568899999999999999999999999999999
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccc
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 828 (973)
||||+++|++.+++... ...+++..+..++.|+|.|++||| +++|+||||||+|||++.++.+||+|||+++.
T Consensus 87 v~e~~~~~~l~~~~~~~----~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 87 ITEYMENGALDKFLREK----DGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEECCTTEEHHHHHHHT----TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEecccCcchhhhhcc----cccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhc
Confidence 99999999999988653 346899999999999999999999 78999999999999999999999999999987
Q ss_pred ccCCCCc-ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccch
Q 002061 829 AENSPKV-SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLK 907 (973)
Q Consensus 829 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
....... .......||+.|+|||++.+..++.++|||||||++|||++|..|+.... ....+...+...
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~-~~~~~~~~i~~~--------- 229 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL-SNHEVMKAINDG--------- 229 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-CHHHHHHHHHTT---------
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC-CHHHHHHHHhcc---------
Confidence 6543221 22233568999999999999999999999999999999999766654321 111122111111
Q ss_pred hccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCC
Q 002061 908 VLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPC 956 (973)
Q Consensus 908 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~ 956 (973)
.....+...+..+.+++.+||++||++|||+.||++.|+++...
T Consensus 230 -----~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 230 -----FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp -----CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -----CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 01111222345688999999999999999999999999887543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.6e-47 Score=409.86 Aligned_cols=245 Identities=28% Similarity=0.390 Sum_probs=201.6
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVL 750 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 750 (973)
..|+..+.||+|+||+||+|++..+++.||||++... ...+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 3588999999999999999999999999999998652 23456889999999999999999999999999999999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccccc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAE 830 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 830 (973)
|||++|++..++... ..+++..+..++.||++||+||| +++||||||||+|||++.++.+||+|||+++...
T Consensus 95 E~~~~g~l~~~~~~~-----~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (309)
T ss_dssp ECCSEEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred EecCCCchHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccC
Confidence 999999997766542 45899999999999999999999 7899999999999999999999999999997654
Q ss_pred CCCCcccccccCCcccccccccccc---CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccch
Q 002061 831 NSPKVSDYSCFAGTHGYIAPELAYT---CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLK 907 (973)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
.. ....||+.|+|||++.+ +.|+.++|||||||++|||++|+.||.... .............
T Consensus 167 ~~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~-----~~~~~~~i~~~~~---- 231 (309)
T d1u5ra_ 167 PA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----AMSALYHIAQNES---- 231 (309)
T ss_dssp SB------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-----HHHHHHHHHHSCC----
T ss_pred CC------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHhCCC----
Confidence 32 23579999999999864 458999999999999999999999996531 1111111111111
Q ss_pred hccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 908 VLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 908 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
+.. ......+.+.+++.+||+.||++|||++|+++|
T Consensus 232 ---~~~---~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 232 ---PAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp ---CCC---SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ---CCC---CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 000 011224568899999999999999999999875
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.3e-47 Score=408.74 Aligned_cols=251 Identities=25% Similarity=0.339 Sum_probs=193.3
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE 751 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 751 (973)
.+.|++.+.||+|+||+||+|+++.+++.||||++... ...+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 35699999999999999999999999999999998753 234567899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeec---CCCCeEEecccCccc
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD---EDYEPKIADFGVAKI 828 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~---~~~~~kl~Dfgl~~~ 828 (973)
|++||+|.+++.. ...+++..+..++.|++.||+||| +++|+||||||+||++. +++.+||+|||+++.
T Consensus 88 ~~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~ 159 (307)
T d1a06a_ 88 LVSGGELFDRIVE-----KGFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159 (307)
T ss_dssp CCCSCBHHHHHHT-----CSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred ccCCCcHHHhhhc-----ccCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEE
Confidence 9999999999974 346899999999999999999999 78999999999999995 478999999999986
Q ss_pred ccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchh
Q 002061 829 AENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKV 908 (973)
Q Consensus 829 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (973)
...... .....||+.|+|||++.+..|+.++||||+||++|||++|+.||... ................
T Consensus 160 ~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-----~~~~~~~~i~~~~~~~--- 228 (307)
T d1a06a_ 160 EDPGSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE-----NDAKLFEQILKAEYEF--- 228 (307)
T ss_dssp ----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS-----SHHHHHHHHHTTCCCC---
T ss_pred ccCCCe---eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCC-----CHHHHHHHHhccCCCC---
Confidence 644322 23357999999999999999999999999999999999999999653 1111212111111110
Q ss_pred ccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 909 LDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 909 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
.........+.+.+++.+||+.||++|||+.|+++|
T Consensus 229 -----~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 229 -----DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp -----CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -----CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 011112334568899999999999999999999997
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.3e-46 Score=410.09 Aligned_cols=252 Identities=19% Similarity=0.278 Sum_probs=209.6
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc--ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY 752 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 752 (973)
+++|++.+.||+|+||+||+|++..+|+.||||++... ...+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 56899999999999999999999999999999998663 3456788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecC--CCCeEEecccCccccc
Q 002061 753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE--DYEPKIADFGVAKIAE 830 (973)
Q Consensus 753 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~--~~~~kl~Dfgl~~~~~ 830 (973)
+++|+|.+++... ...+++..+..++.||+.||+||| +++||||||||+|||++. ++.+||+|||+++...
T Consensus 105 ~~gg~L~~~l~~~----~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~ 177 (350)
T d1koaa2 105 MSGGELFEKVADE----HNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177 (350)
T ss_dssp CCSCBHHHHHTCT----TSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred CCCCCHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence 9999999998642 345899999999999999999999 789999999999999964 6789999999998765
Q ss_pred CCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhcc
Q 002061 831 NSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLD 910 (973)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (973)
... ......||+.|||||++.+..++.++||||+||++|||++|+.||... +..............
T Consensus 178 ~~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~-----~~~~~~~~i~~~~~~------ 243 (350)
T d1koaa2 178 PKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE-----NDDETLRNVKSCDWN------ 243 (350)
T ss_dssp TTS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHTCCC------
T ss_pred ccc---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC-----CHHHHHHHHHhCCCC------
Confidence 432 223467999999999999999999999999999999999999999643 122222222111111
Q ss_pred ccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 911 CEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 911 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
..........+.+.+++.+||+.||++|||++|+++|
T Consensus 244 --~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 244 --MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp --SCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred --CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0111112234567899999999999999999999997
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=399.90 Aligned_cols=246 Identities=25% Similarity=0.307 Sum_probs=197.4
Q ss_pred CcccccCceEEEEEEec--CCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCC
Q 002061 682 NLIGSGGTGKVYRLDLK--KNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYMPN 755 (973)
Q Consensus 682 ~~lG~G~~g~V~~a~~~--~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 755 (973)
++||+|+||+||+|.++ .+++.||||+++.. ...+++.+|++++++++|||||++++++.. +..|+||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 46999999999999875 34578999998652 234678999999999999999999999865 467899999999
Q ss_pred CchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCCCc
Q 002061 756 GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSPKV 835 (973)
Q Consensus 756 gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 835 (973)
|+|.++++.. ..+++..+..++.|||.||+||| +++|+||||||+||+++.++.+|++|||+++........
T Consensus 92 g~L~~~l~~~-----~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 92 GPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163 (277)
T ss_dssp EEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred CcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence 9999999753 35899999999999999999999 789999999999999999999999999999876544332
Q ss_pred -ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhccccc
Q 002061 836 -SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEV 913 (973)
Q Consensus 836 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (973)
.......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+. ...++...+. ....
T Consensus 164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~--~~~~~~~~i~----~~~~--------- 228 (277)
T d1xbba_ 164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM--KGSEVTAMLE----KGER--------- 228 (277)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC--CHHHHHHHHH----TTCC---------
T ss_pred cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCC--CHHHHHHHHH----cCCC---------
Confidence 22334578999999999999999999999999999999998 89999754 1222222221 1110
Q ss_pred cCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhc
Q 002061 914 ASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLAD 952 (973)
Q Consensus 914 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~ 952 (973)
...+...+.++.+++.+||+.||++|||+++|++.|+.
T Consensus 229 -~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 229 -MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred -CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 11112234568899999999999999999999988764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-46 Score=399.55 Aligned_cols=250 Identities=23% Similarity=0.289 Sum_probs=207.9
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc--------ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--------DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF 747 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 747 (973)
++|++.+.||+|+||+||+|+++.+|+.||||++.+. ...+.+.+|++++++++|||||++++++.+++..|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 5799999999999999999999999999999998642 23567899999999999999999999999999999
Q ss_pred EEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCC----CeEEecc
Q 002061 748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY----EPKIADF 823 (973)
Q Consensus 748 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~----~~kl~Df 823 (973)
+||||+++|+|.+++... ..+++..+..++.|++.||+||| +++|+||||||+||+++.++ .+|++||
T Consensus 90 iv~E~~~gg~L~~~i~~~-----~~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEcCCCccccchhccc-----cccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecch
Confidence 999999999999999764 35899999999999999999999 78999999999999998776 4999999
Q ss_pred cCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccc
Q 002061 824 GVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHE 903 (973)
Q Consensus 824 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 903 (973)
|+++....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||... +.............
T Consensus 162 G~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-----~~~~~~~~i~~~~~ 233 (293)
T d1jksa_ 162 GLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD-----TKQETLANVSAVNY 233 (293)
T ss_dssp TTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHTTCC
T ss_pred hhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCC-----CHHHHHHHHHhcCC
Confidence 99987654322 23457899999999999999999999999999999999999999753 11112111111111
Q ss_pred ccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 904 NVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
.............+.+++.+||+.||++|||+.|+++|
T Consensus 234 --------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 234 --------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp --------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --------CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01111122334567899999999999999999999986
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.8e-46 Score=408.46 Aligned_cols=252 Identities=20% Similarity=0.246 Sum_probs=208.7
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc--ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY 752 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 752 (973)
.++|++.+.||+|+||+||+|++..+|+.||||++... .+...+.+|++++++++||||+++++++.+++..|+||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 45799999999999999999999999999999998764 3445678999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeec--CCCCeEEecccCccccc
Q 002061 753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD--EDYEPKIADFGVAKIAE 830 (973)
Q Consensus 753 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~--~~~~~kl~Dfgl~~~~~ 830 (973)
+++|+|.+++... ...+++..+..++.||+.||+||| +++||||||||+|||++ .++.+||+|||+|+...
T Consensus 108 ~~gg~L~~~~~~~----~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~ 180 (352)
T d1koba_ 108 LSGGELFDRIAAE----DYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180 (352)
T ss_dssp CCCCBHHHHTTCT----TCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred CCCChHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecC
Confidence 9999998877542 345899999999999999999999 78999999999999998 57899999999998775
Q ss_pred CCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhcc
Q 002061 831 NSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLD 910 (973)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (973)
.... .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+. +..............
T Consensus 181 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~-----~~~~~~~~i~~~~~~------ 246 (352)
T d1koba_ 181 PDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE-----DDLETLQNVKRCDWE------ 246 (352)
T ss_dssp TTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS-----SHHHHHHHHHHCCCC------
T ss_pred CCCc---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhCCCC------
Confidence 4322 23357899999999999999999999999999999999999999653 111111111111110
Q ss_pred ccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 911 CEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 911 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
............+.+++.+||++||.+|||+.|+++|
T Consensus 247 --~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 247 --FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp --CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred --CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111122334567899999999999999999999986
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-45 Score=399.93 Aligned_cols=248 Identities=27% Similarity=0.332 Sum_probs=208.9
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeec-----cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV 749 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~-----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 749 (973)
+++|++.+.||+|+||+||+|+++.+++.||||++.+ ....+.+.+|+.++++++||||+++++++.+++..|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 5689999999999999999999999999999999875 23567788999999999999999999999999999999
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccc
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 829 (973)
|||+++|+|.+++... ..+++..+..++.|++.||+||| +++||||||||+|||++.+|.+||+|||+|+..
T Consensus 84 ~ey~~gg~L~~~~~~~-----~~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~ 155 (337)
T d1o6la_ 84 MEYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG 155 (337)
T ss_dssp EECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred eeccCCCchhhhhhcc-----cCCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeeccccccc
Confidence 9999999999999864 35788899999999999999999 789999999999999999999999999999865
Q ss_pred cCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhc
Q 002061 830 ENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVL 909 (973)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (973)
..... .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||... +...............
T Consensus 156 ~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~-----~~~~~~~~i~~~~~~~---- 224 (337)
T d1o6la_ 156 ISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-----DHERLFELILMEEIRF---- 224 (337)
T ss_dssp CCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHCCCCC----
T ss_pred ccCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCc-----CHHHHHHHHhcCCCCC----
Confidence 43322 223467999999999999999999999999999999999999999754 2222222222111111
Q ss_pred cccccCcchHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 002061 910 DCEVASESIKEDMIKLLKIAVVCTTKLPNLRPP-----MREVVKM 949 (973)
Q Consensus 910 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt-----~~evl~~ 949 (973)
+.....++.+++.+||++||.+||+ +.|+++|
T Consensus 225 --------p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 225 --------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp --------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --------CccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 1123446788999999999999994 8899886
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-46 Score=396.62 Aligned_cols=260 Identities=27% Similarity=0.386 Sum_probs=203.5
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM 753 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 753 (973)
.++|++.+.||+|+||+||+|+++. ++.||||++... ...+.|.+|+.++++++|||||++++++.+ +..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECC-CCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 3578999999999999999999976 467999998763 456789999999999999999999999854 5689999999
Q ss_pred CCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCC
Q 002061 754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833 (973)
Q Consensus 754 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 833 (973)
++|+|.+++.... ...++|..+..++.|||+||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 94 ~~g~l~~~~~~~~---~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 94 SKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp TTCBHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred CCCchhhhhhhcc---cccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence 9999999987542 235899999999999999999999 7899999999999999999999999999998664332
Q ss_pred CcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccccc
Q 002061 834 KVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCEV 913 (973)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (973)
. .......||+.|+|||++.++.++.++|||||||++|||++|..||.... ........+. ....
T Consensus 168 ~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~-~~~~~~~~i~---~~~~---------- 232 (285)
T d1fmka3 168 Y-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVE---RGYR---------- 232 (285)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-CHHHHHHHHH---TTCC----------
T ss_pred c-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC-CHHHHHHHHH---hcCC----------
Confidence 2 22334568999999999999999999999999999999999766664321 1111222221 1110
Q ss_pred cCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCCCC
Q 002061 914 ASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPCTD 958 (973)
Q Consensus 914 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~ 958 (973)
...+....+++.+++.+||+.||++||++++|++.|+..-...+
T Consensus 233 -~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 233 -MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred -CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence 01112234568899999999999999999999999998765443
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=395.01 Aligned_cols=251 Identities=28% Similarity=0.410 Sum_probs=201.1
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhcCCCceeeEEEEEEe-CCeeEEEEEcc
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLK-GGSSFLVLEYM 753 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~~lv~e~~ 753 (973)
.++|++.+.||+|+||+||+|+++ |..||||+++.+...+.+.+|++++++++||||+++++++.+ .+..|+||||+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 356788999999999999999986 779999999888888889999999999999999999999865 45689999999
Q ss_pred CCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCC
Q 002061 754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833 (973)
Q Consensus 754 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 833 (973)
++|+|.+++.... ...+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+|++|||+++.....
T Consensus 84 ~~g~L~~~l~~~~---~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~- 156 (262)
T d1byga_ 84 AKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 156 (262)
T ss_dssp TTEEHHHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred CCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCC-
Confidence 9999999997542 234899999999999999999999 789999999999999999999999999999865432
Q ss_pred CcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchhcccc
Q 002061 834 KVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDCE 912 (973)
Q Consensus 834 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (973)
.....+|..|+|||++.+..+++++|||||||++|||+| |+.||... ...++...+...
T Consensus 157 ----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~--~~~~~~~~i~~~-------------- 216 (262)
T d1byga_ 157 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPRVEKG-------------- 216 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS--CGGGHHHHHTTT--------------
T ss_pred ----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC--CHHHHHHHHHcC--------------
Confidence 222457889999999999999999999999999999998 78887653 333443333211
Q ss_pred ccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 002061 913 VASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADAD 954 (973)
Q Consensus 913 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 954 (973)
.....+.....++.+++.+||+.||.+|||+.|++++|++++
T Consensus 217 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 217 YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 011112223356889999999999999999999999998763
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4e-45 Score=396.26 Aligned_cols=245 Identities=26% Similarity=0.345 Sum_probs=207.0
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeec-----cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV 749 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~-----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 749 (973)
+++|++.+.||+|+||+||+|+++.+|+.||||++.+ ....+.+.+|+.++++++||||+++++++.+++..|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 4679999999999999999999999999999999865 34567789999999999999999999999999999999
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccc
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 829 (973)
|||++||+|.+++... ..+++..+..++.||+.|++||| +++|+||||||+|||++.+|.+||+|||+|+..
T Consensus 83 mE~~~gg~l~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~ 154 (316)
T d1fota_ 83 MDYIEGGELFSLLRKS-----QRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYV 154 (316)
T ss_dssp ECCCCSCBHHHHHHHT-----SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred eeecCCcccccccccc-----ccccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEe
Confidence 9999999999988753 35678888899999999999999 889999999999999999999999999999876
Q ss_pred cCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhc
Q 002061 830 ENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVL 909 (973)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (973)
.... ....||+.|+|||++.+..|+.++||||+||++|||++|+.||... +...............
T Consensus 155 ~~~~-----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~-----~~~~~~~~i~~~~~~~---- 220 (316)
T d1fota_ 155 PDVT-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS-----NTMKTYEKILNAELRF---- 220 (316)
T ss_dssp SSCB-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHHHHHCCCCC----
T ss_pred cccc-----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc-----CHHHHHHHHHcCCCCC----
Confidence 5432 2357999999999999999999999999999999999999999653 2222222222111111
Q ss_pred cccccCcchHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 002061 910 DCEVASESIKEDMIKLLKIAVVCTTKLPNLRP-----PMREVVKM 949 (973)
Q Consensus 910 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~ 949 (973)
+....+.+.+++.+|+++||.+|+ |++|+++|
T Consensus 221 --------p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 221 --------PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp --------CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred --------CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 112234578899999999999996 89999886
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-46 Score=403.69 Aligned_cols=254 Identities=24% Similarity=0.338 Sum_probs=203.3
Q ss_pred cCCcccCcccccCceEEEEEEecCCCc----EEEEEeeec---cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAG----TVAVKQLWK---GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFL 748 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~----~vavK~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 748 (973)
.+|++.+.||+|+||+||+|++..+|+ .||||++.. ....+++.+|++++++++|||||++++++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 468999999999999999999987765 588888754 34567899999999999999999999998765 5678
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccc
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 828 (973)
+|||+.+|+|.+++... ...+++..+..++.|||.||+||| +++||||||||+||+++.++.+||+|||+++.
T Consensus 88 v~e~~~~~~l~~~~~~~----~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~ 160 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 160 (317)
T ss_dssp EEECCTTCBHHHHHHHT----SSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred EEEeccCCccccccccc----ccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeecccccee
Confidence 89999999999988753 456899999999999999999999 78999999999999999999999999999987
Q ss_pred ccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccch
Q 002061 829 AENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLK 907 (973)
Q Consensus 829 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
..............||+.|+|||++.++.++.++|||||||++|||+| |+.||... ....+...+.....
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~--~~~~~~~~i~~~~~------- 231 (317)
T d1xkka_ 161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--PASEISSILEKGER------- 231 (317)
T ss_dssp TTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS--CGGGHHHHHHHTCC-------
T ss_pred cccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCC--CHHHHHHHHHcCCC-------
Confidence 765444333344568999999999999999999999999999999998 88998754 22233333222110
Q ss_pred hccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 908 VLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 908 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
...+......+.+++.+||+.||++|||+.|++++|+.+
T Consensus 232 -------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 232 -------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp -------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 011122345688999999999999999999999998765
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-45 Score=399.02 Aligned_cols=260 Identities=27% Similarity=0.404 Sum_probs=208.7
Q ss_pred cCCcccCcccccCceEEEEEEec-----CCCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLK-----KNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF 747 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~-----~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 747 (973)
++|++.+.||+|+||+||+|+++ .+++.||||++... ...+++.+|++++++++||||+++++++..+...+
T Consensus 13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 92 (301)
T d1lufa_ 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC 92 (301)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceE
Confidence 47899999999999999999976 34678999998753 23467899999999999999999999999999999
Q ss_pred EEEEccCCCchHHHHHhhhc-------------------CCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCC
Q 002061 748 LVLEYMPNGNLFQALHKRVK-------------------EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSS 808 (973)
Q Consensus 748 lv~e~~~~gsL~~~l~~~~~-------------------~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~ 808 (973)
+||||+++|+|.+++..... .....+++..+..++.|+|.||+||| ++++|||||||+
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivHrDlKp~ 169 (301)
T d1lufa_ 93 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATR 169 (301)
T ss_dssp EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGG
T ss_pred EEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEeeEEccc
Confidence 99999999999999975311 12334789999999999999999999 789999999999
Q ss_pred CeeecCCCCeEEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCC-CCCCcccCC
Q 002061 809 NILLDEDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGR-KPVEEEYGD 887 (973)
Q Consensus 809 Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~-~pf~~~~~~ 887 (973)
|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|. .||... .
T Consensus 170 NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~--~ 247 (301)
T d1lufa_ 170 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM--A 247 (301)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS--C
T ss_pred ceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCC--C
Confidence 9999999999999999998665443333344567899999999999999999999999999999999986 566543 1
Q ss_pred cccHHHHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 002061 888 GKDIVYWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADAD 954 (973)
Q Consensus 888 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 954 (973)
.......+. .... ...+...+.++.+++.+||+.||++||||.||+++|+++.
T Consensus 248 ~~e~~~~v~----~~~~----------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 248 HEEVIYYVR----DGNI----------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HHHHHHHHH----TTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHHHHHHH----cCCC----------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 122222211 1110 0111223346889999999999999999999999999874
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.1e-44 Score=387.48 Aligned_cols=257 Identities=25% Similarity=0.327 Sum_probs=202.3
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCC----ee
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAEMEILGKIRHRNILKLYACLLKGG----SS 746 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~ 746 (973)
++|++.+.||+|+||+||+|++..+++.||||++... ...+.+.+|++++++++||||+++++++...+ ..
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 5699999999999999999999999999999998652 23456889999999999999999999987654 47
Q ss_pred EEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCc
Q 002061 747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826 (973)
Q Consensus 747 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~ 826 (973)
|+||||++||+|.+++... ..+++..+..++.|++.||+||| +++|+||||||+||+++.++.++++|||.+
T Consensus 87 ~lvmE~~~g~~L~~~~~~~-----~~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEECCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEECCCCCEehhhhccc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhh
Confidence 9999999999999988764 35899999999999999999999 789999999999999999999999999998
Q ss_pred ccccCCCC-cccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccccc
Q 002061 827 KIAENSPK-VSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENV 905 (973)
Q Consensus 827 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 905 (973)
........ ........||+.|+|||++.+..+++++||||+||++|||+||+.||... +...............
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~-----~~~~~~~~~~~~~~~~ 233 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD-----SPVSVAYQHVREDPIP 233 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS-----SHHHHHHHHHHCCCCC
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCc-----CHHHHHHHHHhcCCCC
Confidence 75543322 12233467999999999999999999999999999999999999999643 2222222222222211
Q ss_pred chhccccccCcchHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHhhcC
Q 002061 906 LKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRP-PMREVVKMLADA 953 (973)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-t~~evl~~L~~~ 953 (973)
... .....++++.+++.+|+++||++|| +++++.+.|.++
T Consensus 234 ~~~--------~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 234 PSA--------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp GGG--------TSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred Cch--------hccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 111 1112345688999999999999999 899999888765
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-45 Score=396.58 Aligned_cols=260 Identities=27% Similarity=0.356 Sum_probs=198.6
Q ss_pred cCCcccCcccccCceEEEEEEecC-----CCcEEEEEeeecc---ccHHHHHHHHHHHHhc-CCCceeeEEEEEEeC-Ce
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKK-----NAGTVAVKQLWKG---DGVKVFAAEMEILGKI-RHRNILKLYACLLKG-GS 745 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~-----~~~~vavK~~~~~---~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~-~~ 745 (973)
++|++.+.||+|+||+||+|++.. +++.||||++... ...+.+.+|..++.++ +||||+.+++++.++ ..
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 578999999999999999999764 3568999998653 3345677888888777 689999999988664 46
Q ss_pred eEEEEEccCCCchHHHHHhhhcC-----------CCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecC
Q 002061 746 SFLVLEYMPNGNLFQALHKRVKE-----------GKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE 814 (973)
Q Consensus 746 ~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~ 814 (973)
.++||||+++|+|.++++..... ....+++..+..++.||++||+||| +++||||||||+|||++.
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSE 169 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECG
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccceeECC
Confidence 89999999999999999764321 1335889999999999999999999 789999999999999999
Q ss_pred CCCeEEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhC-CCCCCcccCCcccHHH
Q 002061 815 DYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTG-RKPVEEEYGDGKDIVY 893 (973)
Q Consensus 815 ~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg-~~pf~~~~~~~~~~~~ 893 (973)
++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++| ..||..... ...+..
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~-~~~~~~ 248 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-DEEFCR 248 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC-SHHHHH
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH-HHHHHH
Confidence 999999999999876655444444556799999999999999999999999999999999996 457754321 112222
Q ss_pred HHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 894 WVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 894 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
.+.... . ...+....+++.+++.+||+.||++|||++|++++|+++
T Consensus 249 ~~~~~~--~------------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 249 RLKEGT--R------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp HHHHTC--C------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhcCC--C------------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 221110 0 011112344688999999999999999999999999875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.5e-44 Score=383.95 Aligned_cols=250 Identities=26% Similarity=0.327 Sum_probs=205.7
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc-----------cHHHHHHHHHHHHhcC-CCceeeEEEEEEeC
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-----------GVKVFAAEMEILGKIR-HRNILKLYACLLKG 743 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-----------~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~ 743 (973)
++|++.+.||+|+||+||+|++..+++.||||++.... ..+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 57899999999999999999999999999999986521 1235788999999997 99999999999999
Q ss_pred CeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecc
Q 002061 744 GSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADF 823 (973)
Q Consensus 744 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 823 (973)
+..|+||||+++|+|.++++.+ ..+++..+..++.||++||+||| +++|+||||||+||+++.++.+||+||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DF 154 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDF 154 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred cceEEEEEcCCCchHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccc
Confidence 9999999999999999999764 35899999999999999999999 789999999999999999999999999
Q ss_pred cCcccccCCCCcccccccCCcccccccccccc------CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHH
Q 002061 824 GVAKIAENSPKVSDYSCFAGTHGYIAPELAYT------CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVST 897 (973)
Q Consensus 824 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~ 897 (973)
|+++....... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.... .......
T Consensus 155 G~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~-----~~~~~~~ 226 (277)
T d1phka_ 155 GFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK-----QMLMLRM 226 (277)
T ss_dssp TTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHH
T ss_pred hheeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC-----HHHHHHH
Confidence 99987754322 234679999999999853 347889999999999999999999997541 1111111
Q ss_pred HhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 898 HLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 898 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
....... ..........+++.+++.+||++||++|||+.|+++|
T Consensus 227 i~~~~~~--------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 227 IMSGNYQ--------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHHTCCC--------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHhCCCC--------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1111110 0111122344578899999999999999999999886
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=391.11 Aligned_cols=255 Identities=27% Similarity=0.358 Sum_probs=197.5
Q ss_pred cCCcccCcccccCceEEEEEEecCC---CcEEEEEeeec-----cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKN---AGTVAVKQLWK-----GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSF 747 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~---~~~vavK~~~~-----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 747 (973)
++|++.+.||+|+||+||+|++..+ ...||||++.+ ++..++|.+|++++++++||||+++++++.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 4688999999999999999987532 34689998865 2345678999999999999999999999965 4678
Q ss_pred EEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcc
Q 002061 748 LVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827 (973)
Q Consensus 748 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~ 827 (973)
+||||+++|++.+++..+ ...+++..+..++.|+|+||+||| +++|+||||||+||+++.++.+||+|||+++
T Consensus 87 lv~e~~~~~~l~~~~~~~----~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH----QGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp EEEECCTTCBHHHHHHHH----GGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeeeecCcchhhhhhcc----cCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhh
Confidence 999999999999988764 345899999999999999999999 7899999999999999999999999999998
Q ss_pred cccCCCCcc-cccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhcccccc
Q 002061 828 IAENSPKVS-DYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENV 905 (973)
Q Consensus 828 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 905 (973)
......... ......|+..|+|||++.+..++.++|||||||++|||+| |+.||... ... ............
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~--~~~---~~~~~i~~~~~~- 233 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL--NGS---QILHKIDKEGER- 233 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC--CHH---HHHHHHHTSCCC-
T ss_pred hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc--CHH---HHHHHHHhCCCC-
Confidence 775543322 2233467889999999999999999999999999999998 89999653 222 222222111111
Q ss_pred chhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 906 LKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
...+...+..+.+++.+||+.||++|||+.||.+.|++.
T Consensus 234 ---------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 234 ---------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 111122335688999999999999999999999999864
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-45 Score=390.80 Aligned_cols=253 Identities=25% Similarity=0.316 Sum_probs=196.0
Q ss_pred cCCcccCcccccCceEEEEEEecCC---CcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKN---AGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV 749 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~---~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 749 (973)
++|++.+.||+|+||+||+|++..+ +..||||++... ...+.+.+|++++++++||||+++++++. ++..|+|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence 4788999999999999999998643 456899988652 33467899999999999999999999985 4678999
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccc
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 829 (973)
|||+++|+|.+++... ...+++..+..++.||++||+||| +++++||||||+||+++.++.+||+|||+++..
T Consensus 86 ~E~~~~g~l~~~~~~~----~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVR----KYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EECCTTEEHHHHHHHT----TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEeccCCcHHhhhhcc----CCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheec
Confidence 9999999999988653 346899999999999999999999 789999999999999999999999999999876
Q ss_pred cCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHHHHHHHHhccccccchh
Q 002061 830 ENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIVYWVSTHLNNHENVLKV 908 (973)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (973)
..... .......||+.|+|||++.+..++.++|||||||++|||++ |..||... ...++...+... ..
T Consensus 159 ~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~--~~~~~~~~i~~~----~~---- 227 (273)
T d1mp8a_ 159 EDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV--KNNDVIGRIENG----ER---- 227 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC--CGGGHHHHHHTT----CC----
T ss_pred cCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCC--CHHHHHHHHHcC----CC----
Confidence 54322 22334568999999999999999999999999999999998 89999754 222332222211 10
Q ss_pred ccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 909 LDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 909 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
...+...+..+.+++.+||+.||++|||+.||+++|+.+
T Consensus 228 ------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 228 ------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 011122345688999999999999999999999999875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=395.89 Aligned_cols=254 Identities=24% Similarity=0.313 Sum_probs=202.9
Q ss_pred HcCCcccC-cccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhc-CCCceeeEEEEEEe----CCeeEE
Q 002061 675 ICNLEEDN-LIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKI-RHRNILKLYACLLK----GGSSFL 748 (973)
Q Consensus 675 ~~~~~~~~-~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~----~~~~~l 748 (973)
+++|++.. .||+|+||+||+|++..+++.||||++... ..+.+|++++.++ +||||++++++|.+ +...|+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~---~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~i 86 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 86 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS---HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc---HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEE
Confidence 56888875 599999999999999999999999998643 4567899987655 89999999999875 456899
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecC---CCCeEEecccC
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE---DYEPKIADFGV 825 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~Dfgl 825 (973)
|||||+||+|.+++..+ +...+++..+..++.|++.||+||| +++|+||||||+||+++. ++.+||+|||+
T Consensus 87 vmEy~~gg~L~~~i~~~---~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 87 VMECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEECCCSEEHHHHHHSC---SCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEECCCCCcHHHHHHhc---CCCCcCHHHHHHHHHHHHHHHHHHH---HcCCccccccccccccccccccccccccccce
Confidence 99999999999999753 3346899999999999999999999 789999999999999985 56799999999
Q ss_pred cccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccccc
Q 002061 826 AKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENV 905 (973)
Q Consensus 826 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 905 (973)
|+....... .....||+.|+|||++.+..|+.++||||+||++|+|+||+.||..... ...............
T Consensus 161 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~--~~~~~~~~~~i~~~~-- 233 (335)
T d2ozaa1 161 AKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG--LAISPGMKTRIRMGQ-- 233 (335)
T ss_dssp CEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTC--C--------CCCSCS--
T ss_pred eeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCH--HHHHHHHHHHHhcCC--
Confidence 987654322 2345799999999999999999999999999999999999999975421 111111111111100
Q ss_pred chhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 906 LKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
............+++.+++.+|+++||++|||+.|+++|
T Consensus 234 -----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 234 -----YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp -----SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -----CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 111122234456778999999999999999999999986
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-45 Score=395.42 Aligned_cols=252 Identities=22% Similarity=0.267 Sum_probs=207.8
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc-cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEYM 753 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 753 (973)
.++|++.+.||+|+||+||+|++..+++.||||++.... +...+.+|++++++++||||+++++++.+++..|+|||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 467999999999999999999999999999999987643 3456789999999999999999999999999999999999
Q ss_pred CCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCC--CCeEEecccCcccccC
Q 002061 754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDED--YEPKIADFGVAKIAEN 831 (973)
Q Consensus 754 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~--~~~kl~Dfgl~~~~~~ 831 (973)
+||+|.+++... ...+++.++..++.||++||+||| +++|+||||||+|||++.+ ..+||+|||+++....
T Consensus 84 ~gg~L~~~i~~~----~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 84 SGLDIFERINTS----AFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCBHHHHHTSS----SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 999999999643 335899999999999999999999 7899999999999999854 4799999999987654
Q ss_pred CCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccc
Q 002061 832 SPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDC 911 (973)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (973)
... .....+|+.|+|||...+..++.++||||+||++|+|++|+.||... +...............
T Consensus 157 ~~~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~-----~~~~~~~~i~~~~~~~------ 222 (321)
T d1tkia_ 157 GDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE-----TNQQIIENIMNAEYTF------ 222 (321)
T ss_dssp TCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHHHHHTCCCC------
T ss_pred CCc---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhCCCCC------
Confidence 322 23356899999999999999999999999999999999999999654 1112222221111110
Q ss_pred cccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 912 EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 912 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
..........++.+++.+|+++||++|||+.|+++|
T Consensus 223 --~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 223 --DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp --CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --ChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011112234568899999999999999999999985
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.6e-44 Score=399.18 Aligned_cols=249 Identities=24% Similarity=0.277 Sum_probs=201.5
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc-----ccHHHHHHH---HHHHHhcCCCceeeEEEEEEeCCee
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG-----DGVKVFAAE---MEILGKIRHRNILKLYACLLKGGSS 746 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~E---~~~l~~l~hpniv~l~~~~~~~~~~ 746 (973)
+++|++.+.||+|+||+||+|++..+|+.||||++.+. .....+.+| +++++.++|||||++++++.+++..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 46899999999999999999999999999999998642 223334444 6667777899999999999999999
Q ss_pred EEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCc
Q 002061 747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826 (973)
Q Consensus 747 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~ 826 (973)
|+||||+++|+|.+++... ..+++..+..++.||+.||+||| +++||||||||+|||++.+|.+||+|||+|
T Consensus 83 ~ivmE~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla 154 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLA 154 (364)
T ss_dssp EEEECCCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTC
T ss_pred EEEEEecCCCcHHHHHHhc-----ccccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeecee
Confidence 9999999999999999764 35788899999999999999999 789999999999999999999999999999
Q ss_pred ccccCCCCcccccccCCcccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccccc
Q 002061 827 KIAENSPKVSDYSCFAGTHGYIAPELAYT-CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENV 905 (973)
Q Consensus 827 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 905 (973)
+...... .....||+.|+|||++.+ ..|+.++||||+||++|||+||+.||..... .+.............
T Consensus 155 ~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~--~~~~~~~~~~~~~~~-- 226 (364)
T d1omwa3 155 CDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT--KDKHEIDRMTLTMAV-- 226 (364)
T ss_dssp EECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS--SCHHHHHHHSSSCCC--
T ss_pred eecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhcccCCC--
Confidence 8765432 233579999999999864 5689999999999999999999999976422 222222221111111
Q ss_pred chhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 002061 906 LKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPP-----MREVVKM 949 (973)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt-----~~evl~~ 949 (973)
..+....+.+.+++.+||+.||.+||| +.|+++|
T Consensus 227 ----------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 227 ----------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp ----------CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred ----------CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 011123446789999999999999999 6899875
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-44 Score=396.54 Aligned_cols=245 Identities=20% Similarity=0.272 Sum_probs=207.8
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeec-----cccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLV 749 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~-----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 749 (973)
+++|++++.||+|+||+||+|+++.+|+.||||++.+ ....+.+.+|+++++.++||||+++++++......++|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 4689999999999999999999999999999999865 23456788999999999999999999999999999999
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccc
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 829 (973)
|||+.+|+|.+++... ..+++..+..++.||+.||+||| +++||||||||+|||++.++.+||+|||+|+..
T Consensus 120 ~e~~~~g~l~~~l~~~-----~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~ 191 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191 (350)
T ss_dssp EECCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred cccccccchhhhHhhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeec
Confidence 9999999999999764 35899999999999999999999 789999999999999999999999999999876
Q ss_pred cCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhc
Q 002061 830 ENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVL 909 (973)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (973)
... .....||+.|||||++.+..++.++||||+||++|||++|+.||... +...............
T Consensus 192 ~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~-----~~~~~~~~i~~~~~~~---- 257 (350)
T d1rdqe_ 192 KGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD-----QPIQIYEKIVSGKVRF---- 257 (350)
T ss_dssp SSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHCCCCC----
T ss_pred ccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc-----CHHHHHHHHhcCCCCC----
Confidence 533 22357999999999999999999999999999999999999999643 2222222221111110
Q ss_pred cccccCcchHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 002061 910 DCEVASESIKEDMIKLLKIAVVCTTKLPNLRP-----PMREVVKM 949 (973)
Q Consensus 910 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~ 949 (973)
+......+.+++.+||+.||.+|+ |++|+++|
T Consensus 258 --------p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 258 --------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp --------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred --------CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 112345678999999999999994 89999975
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-44 Score=391.91 Aligned_cols=246 Identities=28% Similarity=0.400 Sum_probs=204.0
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeec-----cccHHHHHHHHHHHH-hcCCCceeeEEEEEEeCCeeEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK-----GDGVKVFAAEMEILG-KIRHRNILKLYACLLKGGSSFLV 749 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~-----~~~~~~~~~E~~~l~-~l~hpniv~l~~~~~~~~~~~lv 749 (973)
++|++.+.||+|+||+||+|++..+++.||||++.+ ....+.+.+|..++. .++||||+++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 579999999999999999999999999999999864 344556777777765 68999999999999999999999
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccc
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIA 829 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 829 (973)
|||+++|+|.+++... ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++..
T Consensus 82 mEy~~~g~L~~~i~~~-----~~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~ 153 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 153 (320)
T ss_dssp EECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EeecCCCcHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhc
Confidence 9999999999999864 34788899999999999999999 789999999999999999999999999999865
Q ss_pred cCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhc
Q 002061 830 ENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVL 909 (973)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (973)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||... +...............
T Consensus 154 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~-----~~~~~~~~i~~~~~~~---- 222 (320)
T d1xjda_ 154 MLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ-----DEEELFHSIRMDNPFY---- 222 (320)
T ss_dssp CCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHCCCCC----
T ss_pred cccc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCC-----CHHHHHHHHHcCCCCC----
Confidence 4332 2233457999999999999999999999999999999999999999653 2222222222111111
Q ss_pred cccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHH-HHHH
Q 002061 910 DCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMR-EVVK 948 (973)
Q Consensus 910 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~-evl~ 948 (973)
+.....++.+++.+||+.||++||++. |+++
T Consensus 223 --------p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 223 --------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp --------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred --------CccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 112245678999999999999999995 7765
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-45 Score=392.55 Aligned_cols=259 Identities=27% Similarity=0.388 Sum_probs=206.1
Q ss_pred cCCcccCcccccCceEEEEEEecCCC-------cEEEEEeeecc---ccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCC
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNA-------GTVAVKQLWKG---DGVKVFAAEMEILGKI-RHRNILKLYACLLKGG 744 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~-------~~vavK~~~~~---~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 744 (973)
++|++.+.||+|+||.||+|+...++ ..||||++..+ .....+.+|+..+.++ +|||||++++++.+++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 57889999999999999999976443 47999998763 3346688899999888 8999999999999999
Q ss_pred eeEEEEEccCCCchHHHHHhhhc-----------CCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeec
Q 002061 745 SSFLVLEYMPNGNLFQALHKRVK-----------EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD 813 (973)
Q Consensus 745 ~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~ 813 (973)
..++||||+++|+|.+++..+.. .....+++..+..++.|+|+||+||| +++||||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceeec
Confidence 99999999999999999976421 12345899999999999999999999 78999999999999999
Q ss_pred CCCCeEEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccCCcccHH
Q 002061 814 EDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVT-GRKPVEEEYGDGKDIV 892 (973)
Q Consensus 814 ~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~pf~~~~~~~~~~~ 892 (973)
.++.+||+|||+++...............||+.|+|||++.++.|+.++|||||||++|||++ |+.||.... .....
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~--~~~~~ 247 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP--VEELF 247 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHHHH
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC--HHHHH
Confidence 999999999999987766554444455678999999999999999999999999999999998 788886431 11111
Q ss_pred HHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 893 YWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 893 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
.. ...... ...+......+.+++.+||++||++|||+.||++.|+++
T Consensus 248 ~~----i~~~~~----------~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 248 KL----LKEGHR----------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp HH----HHTTCC----------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH----HHcCCC----------CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 11 111111 011112345688999999999999999999999999876
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=392.96 Aligned_cols=257 Identities=27% Similarity=0.379 Sum_probs=205.0
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcE--EEEEeeec---cccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGT--VAVKQLWK---GDGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSSFLV 749 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~--vavK~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv 749 (973)
++|++.++||+|+||+||+|+++.++.. ||||++.. +...+.+.+|+++++++ +||||+++++++.+++..|+|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 6788999999999999999999887764 77887754 33556799999999998 799999999999999999999
Q ss_pred EEccCCCchHHHHHhhh-----------cCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCe
Q 002061 750 LEYMPNGNLFQALHKRV-----------KEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP 818 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~-----------~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~ 818 (973)
|||+++|+|.++++... ......+++..+..++.|||+|++|+| +++|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCce
Confidence 99999999999997531 123456899999999999999999999 7899999999999999999999
Q ss_pred EEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCC-CCCcccCCcccHHHHHHH
Q 002061 819 KIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRK-PVEEEYGDGKDIVYWVST 897 (973)
Q Consensus 819 kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~-pf~~~~~~~~~~~~~~~~ 897 (973)
||+|||+++...... ......||..|+|||.+.+..++.++|||||||++|||++|.. ||... +.......
T Consensus 167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~-----~~~~~~~~ 238 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-----TCAELYEK 238 (309)
T ss_dssp EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHHHHHHH
T ss_pred EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Confidence 999999997554322 2223468999999999999999999999999999999999764 66432 22222221
Q ss_pred HhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 002061 898 HLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADAD 954 (973)
Q Consensus 898 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 954 (973)
... .. ....+....+++.+++.+||+.||++|||+.||+++|+++.
T Consensus 239 i~~-~~----------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 239 LPQ-GY----------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp GGG-TC----------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHh-cC----------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 111 11 11112223456889999999999999999999999998764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-44 Score=391.12 Aligned_cols=260 Identities=27% Similarity=0.389 Sum_probs=210.4
Q ss_pred cCCcccCcccccCceEEEEEEec-----CCCcEEEEEeeecc---ccHHHHHHHHHHHHhc-CCCceeeEEEEEEeCCee
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLK-----KNAGTVAVKQLWKG---DGVKVFAAEMEILGKI-RHRNILKLYACLLKGGSS 746 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~-----~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 746 (973)
++|++.++||+|+||.||+|++. .+++.||||+++.. .....+.+|+.+++++ +|||||++++++.++...
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 57888999999999999999864 45678999998763 3445688999999999 699999999999999999
Q ss_pred EEEEEccCCCchHHHHHhhhc-------------CCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeec
Q 002061 747 FLVLEYMPNGNLFQALHKRVK-------------EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLD 813 (973)
Q Consensus 747 ~lv~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~ 813 (973)
++||||+++|+|.++++.... .....+++..+..++.|||+|++||| ++++|||||||+||+++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccccccccccc
Confidence 999999999999999986421 12335889999999999999999999 78999999999999999
Q ss_pred CCCCeEEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhC-CCCCCcccCCcccHH
Q 002061 814 EDYEPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTG-RKPVEEEYGDGKDIV 892 (973)
Q Consensus 814 ~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg-~~pf~~~~~~~~~~~ 892 (973)
.++.+|++|||.++...............||+.|+|||++.+..++.++|||||||++|||+|+ ++||... .....+.
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~-~~~~~~~ 258 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM-PVDSKFY 258 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-CSSHHHH
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC-CHHHHHH
Confidence 9999999999999877655444444456789999999999999999999999999999999995 5555432 2222222
Q ss_pred HHHHHHhccccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 893 YWVSTHLNNHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 893 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
..+.... ....+......+.+++.+||++||.+|||+.||+++|++.
T Consensus 259 ~~i~~~~--------------~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 259 KMIKEGF--------------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp HHHHHTC--------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhcCC--------------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 2222211 1111122345688999999999999999999999999864
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-44 Score=387.15 Aligned_cols=254 Identities=29% Similarity=0.374 Sum_probs=201.6
Q ss_pred cCcccccCceEEEEEEecCCC---cEEEEEeeec---cccHHHHHHHHHHHHhcCCCceeeEEEEEEe-CCeeEEEEEcc
Q 002061 681 DNLIGSGGTGKVYRLDLKKNA---GTVAVKQLWK---GDGVKVFAAEMEILGKIRHRNILKLYACLLK-GGSSFLVLEYM 753 (973)
Q Consensus 681 ~~~lG~G~~g~V~~a~~~~~~---~~vavK~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~~lv~e~~ 753 (973)
.++||+|+||+||+|++..++ ..||||++.. ....++|.+|++++++++||||+++++++.. +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 467999999999999986543 3699999864 3345679999999999999999999999875 56889999999
Q ss_pred CCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCCC
Q 002061 754 PNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENSP 833 (973)
Q Consensus 754 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 833 (973)
++|+|.+++... ....++..+..++.|+|+||.|+| +.+|+||||||+|||+++++.+||+|||+++......
T Consensus 112 ~~g~l~~~~~~~----~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 112 KHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp TTCBHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred ecCchhhhhccc----cccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 999999998753 445778889999999999999999 7899999999999999999999999999998765432
Q ss_pred Cc--ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccchhccc
Q 002061 834 KV--SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVLKVLDC 911 (973)
Q Consensus 834 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (973)
.. .......||+.|+|||++.+..++.++||||||+++|||+||..||..... ..+....+... .. .
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~-~~~~~~~i~~g----~~---~--- 253 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-TFDITVYLLQG----RR---L--- 253 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHTT----CC---C---
T ss_pred cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC-HHHHHHHHHcC----CC---C---
Confidence 22 122335689999999999999999999999999999999998888764321 12222222111 10 0
Q ss_pred cccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCCC
Q 002061 912 EVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADPC 956 (973)
Q Consensus 912 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~ 956 (973)
..+.....++.+++.+||+.||++||++.||+++|+.+...
T Consensus 254 ----~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 254 ----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ----CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 01112234688999999999999999999999999988643
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-44 Score=388.32 Aligned_cols=262 Identities=21% Similarity=0.287 Sum_probs=212.5
Q ss_pred HcCCcccCcccccCceEEEEEEecC-----CCcEEEEEeeeccc---cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCee
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKK-----NAGTVAVKQLWKGD---GVKVFAAEMEILGKIRHRNILKLYACLLKGGSS 746 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~-----~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 746 (973)
.++|++.+.||+|+||+||+|.+.. ++..||||+++... ....+.+|++++++++||||+++++++..++..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 3678899999999999999999852 35689999987632 334688999999999999999999999999999
Q ss_pred EEEEEccCCCchHHHHHhhhc-----CCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEe
Q 002061 747 FLVLEYMPNGNLFQALHKRVK-----EGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIA 821 (973)
Q Consensus 747 ~lv~e~~~~gsL~~~l~~~~~-----~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 821 (973)
++||||+++|+|.+++..... .....+++..+..++.|+|+||+||| +++|+||||||+|||+++++.+||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEEEe
Confidence 999999999999999875421 22335789999999999999999999 7899999999999999999999999
Q ss_pred cccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCC-CCCCcccCCcccHHHHHHHHhc
Q 002061 822 DFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGR-KPVEEEYGDGKDIVYWVSTHLN 900 (973)
Q Consensus 822 Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~-~pf~~~~~~~~~~~~~~~~~~~ 900 (973)
|||+++...............||+.|+|||.+.+..++.++|||||||++|||+||. .||... ...+.......
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~-----~~~~~~~~i~~ 250 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL-----SNEQVLRFVME 250 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-----CHHHHHHHHHT
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHHh
Confidence 999998776554444445567899999999999999999999999999999999985 666543 22222221111
Q ss_pred cccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCCC
Q 002061 901 NHENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADADP 955 (973)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~ 955 (973)
... ...+......+.+++.+||+.+|++|||+.||+++|++...
T Consensus 251 -~~~----------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 251 -GGL----------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp -TCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred -CCC----------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 110 01112234568899999999999999999999999998744
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-44 Score=387.58 Aligned_cols=264 Identities=25% Similarity=0.310 Sum_probs=199.4
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHH--HHHHHHhcCCCceeeEEEEEEeCC----eeEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAA--EMEILGKIRHRNILKLYACLLKGG----SSFLV 749 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~--E~~~l~~l~hpniv~l~~~~~~~~----~~~lv 749 (973)
.+|...+.||+|+||+||+|++. |+.||||++..... ..+.+ |+..+..++||||+++++++.+++ ..|+|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~--g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 35677889999999999999974 88999999865433 33444 444556789999999999997643 57999
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcC-----CCCeEecCCCCCCeeecCCCCeEEeccc
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDC-----SPPIIHRDIKSSNILLDEDYEPKIADFG 824 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~-----~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 824 (973)
|||+++|+|.+++++. .++|..+..++.|+|.||+|+|+.+ +++||||||||+|||++.++.+||+|||
T Consensus 80 ~Ey~~~g~L~~~l~~~------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EecccCCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence 9999999999999853 4899999999999999999999521 3699999999999999999999999999
Q ss_pred CcccccCCCCcc--cccccCCccccccccccccC------CCCccchHHHHHHHHHHHHhCCCCCCcccCCc--------
Q 002061 825 VAKIAENSPKVS--DYSCFAGTHGYIAPELAYTC------KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDG-------- 888 (973)
Q Consensus 825 l~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~-------- 888 (973)
+++......... ......||+.|+|||++.+. .++.++|||||||++|||+||..||.......
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~ 233 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence 998775543322 23346799999999998654 26778999999999999999998875432110
Q ss_pred --ccHHHHHHHHhccccccchhccccccC-cchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcCC
Q 002061 889 --KDIVYWVSTHLNNHENVLKVLDCEVAS-ESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADAD 954 (973)
Q Consensus 889 --~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~ 954 (973)
...... ....... ...+.... ....+....+.+++.+||+.||++|||+.||+++|+++.
T Consensus 234 ~~~~~~~~-~~~~~~~-----~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 234 SDPSVEEM-RKVVCEQ-----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp SSCCHHHH-HHHHTTS-----CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccchHHHH-HHHHhcc-----ccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 111111 1111111 11111111 113345667889999999999999999999999998764
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-43 Score=381.21 Aligned_cols=268 Identities=23% Similarity=0.314 Sum_probs=204.2
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE 751 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 751 (973)
++|++.+.||+|+||+||+|++..+++.||||++... ...+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5899999999999999999999999999999998653 235678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccC
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 831 (973)
|+.+ ++.+++... ....+++..+..++.|++.||+||| +++||||||||+|||++.++.+||+|||.|+....
T Consensus 82 ~~~~-~~~~~~~~~---~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~ 154 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDAS---ALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 154 (298)
T ss_dssp CCSE-EHHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred ecCC-chhhhhhhh---cccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccC
Confidence 9965 555555432 2445899999999999999999999 78999999999999999999999999999986643
Q ss_pred CCCcccccccCCccccccccccccCC-CCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccc-c-cchh
Q 002061 832 SPKVSDYSCFAGTHGYIAPELAYTCK-VSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHE-N-VLKV 908 (973)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~-~-~~~~ 908 (973)
.. .......||+.|+|||++.... ++.++||||+||++|+|++|+.||... +..+....+........ . ....
T Consensus 155 ~~--~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~ 230 (298)
T d1gz8a_ 155 PV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD--SEIDQLFRIFRTLGTPDEVVWPGV 230 (298)
T ss_dssp CS--BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred Cc--ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCC--CHHHHHHHHHHhcCCCchhhcccc
Confidence 32 2233457999999999877665 578999999999999999999999653 11111111111100000 0 0000
Q ss_pred c-----cc---cccCcc----hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--hhcCC
Q 002061 909 L-----DC---EVASES----IKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM--LADAD 954 (973)
Q Consensus 909 ~-----~~---~~~~~~----~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~--L~~~~ 954 (973)
. .. ...... .....+.+.+++.+|++.||++|||++|+++| ++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~ 290 (298)
T d1gz8a_ 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290 (298)
T ss_dssp GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCC
Confidence 0 00 000000 11223568899999999999999999999998 65553
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=384.10 Aligned_cols=258 Identities=24% Similarity=0.273 Sum_probs=195.6
Q ss_pred ccCcccccCceEEEEEEecCCCcEEEEEeeeccc-------cHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 002061 680 EDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-------GVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLEY 752 (973)
Q Consensus 680 ~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 752 (973)
.++.||+|+||+||+|+++.+|+.||||++.... ..+.+.+|++++++++|||||++++++..++..|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3578999999999999999999999999986521 134688999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccCC
Q 002061 753 MPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAENS 832 (973)
Q Consensus 753 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 832 (973)
++++++..+.. ....+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~~~~~~~~-----~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~ 153 (299)
T d1ua2a_ 82 METDLEVIIKD-----NSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 153 (299)
T ss_dssp CSEEHHHHHTT-----CCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred hcchHHhhhhh-----cccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCC
Confidence 98877655543 2345788889999999999999999 789999999999999999999999999999766543
Q ss_pred CCcccccccCCcccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccc--ccc---
Q 002061 833 PKVSDYSCFAGTHGYIAPELAYT-CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHE--NVL--- 906 (973)
Q Consensus 833 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~--- 906 (973)
.. .....+||+.|+|||++.+ ..++.++||||+||++|||++|+.||... ...+....+........ ...
T Consensus 154 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~--~~~~~l~~i~~~~~~~~~~~~~~~~ 229 (299)
T d1ua2a_ 154 NR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD--SDLDQLTRIFETLGTPTEEQWPDMC 229 (299)
T ss_dssp CC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred cc--cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCC--CHHHHHHHHHHhcCCCChhhccchh
Confidence 22 2233578999999999865 45799999999999999999999999653 11111111111110000 000
Q ss_pred hh---c-cccccCcc----hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 907 KV---L-DCEVASES----IKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 907 ~~---~-~~~~~~~~----~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
.. . ........ .....+.+.+++.+|++.||++|||++|+++|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 00 0 00000000 11224568899999999999999999999986
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-43 Score=376.47 Aligned_cols=239 Identities=25% Similarity=0.353 Sum_probs=197.5
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc--------cHHHHHHHHHHHHhcC--CCceeeEEEEEEeCCe
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD--------GVKVFAAEMEILGKIR--HRNILKLYACLLKGGS 745 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--------~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~~~ 745 (973)
++|++.+.||+|+||+||+|++..+++.||||++.... ...++.+|++++++++ ||||+++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 47999999999999999999999999999999986521 1234678999999996 8999999999999999
Q ss_pred eEEEEEccCC-CchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecC-CCCeEEecc
Q 002061 746 SFLVLEYMPN-GNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE-DYEPKIADF 823 (973)
Q Consensus 746 ~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Df 823 (973)
.|+||||+.+ +++.+++... ..+++..+..++.|+++||+||| +++|+||||||+||+++. ++.+||+||
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~-----~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred EEEEEEeccCcchHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECcc
Confidence 9999999976 5788888753 35899999999999999999999 789999999999999985 479999999
Q ss_pred cCcccccCCCCcccccccCCccccccccccccCCC-CccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccc
Q 002061 824 GVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKV-SEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNH 902 (973)
Q Consensus 824 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 902 (973)
|+++..... ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||.... .... ..
T Consensus 156 G~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------~i~~----~~ 220 (273)
T d1xwsa_ 156 GSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EIIR----GQ 220 (273)
T ss_dssp TTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHH----CC
T ss_pred ccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------HHhh----cc
Confidence 999865433 2234679999999999987766 567899999999999999999996531 0111 11
Q ss_pred cccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 903 ENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
.. .. .....++.+++.+||+.||++|||++|+++|
T Consensus 221 ~~--------~~----~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 221 VF--------FR----QRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp CC--------CS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cC--------CC----CCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 00 00 1123467889999999999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-42 Score=377.47 Aligned_cols=269 Identities=20% Similarity=0.231 Sum_probs=200.9
Q ss_pred HcCCcccCcccccCceEEEEEEecCC-CcEEEEEeeecc----ccHHHHHHHHHHHHhc---CCCceeeEEEEEEe----
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKN-AGTVAVKQLWKG----DGVKVFAAEMEILGKI---RHRNILKLYACLLK---- 742 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~-~~~vavK~~~~~----~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~---- 742 (973)
.++|++.+.||+|+||+||+|++..+ ++.||||++... .....+.+|+++++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 36899999999999999999999755 667999998652 2233566788887766 79999999999853
Q ss_pred -CCeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEe
Q 002061 743 -GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIA 821 (973)
Q Consensus 743 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 821 (973)
....+++|||++++.+...... ....+++..+..++.|++.||+||| +++||||||||+|||++.++.+||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~----~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~ 158 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV----PEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLA 158 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS----CTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCceEEEEEEeccCCchhhhhhc----cCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeec
Confidence 3467999999988776554432 3456889999999999999999999 7899999999999999999999999
Q ss_pred cccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcc
Q 002061 822 DFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNN 901 (973)
Q Consensus 822 Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 901 (973)
|||.++..... .......||+.|+|||++.+..|+.++||||+||++|||++|+.||.... ..+....+......
T Consensus 159 dfg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~--~~~~~~~i~~~~~~ 233 (305)
T d1blxa_ 159 DFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS--DVDQLGKILDVIGL 233 (305)
T ss_dssp SCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCC
T ss_pred chhhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCC--HHHHHHHHHHhhCC
Confidence 99998754332 23345679999999999999999999999999999999999999997531 11111111111100
Q ss_pred ccc--------cc-hhcc---ccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--hhcCCC
Q 002061 902 HEN--------VL-KVLD---CEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM--LADADP 955 (973)
Q Consensus 902 ~~~--------~~-~~~~---~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~--L~~~~~ 955 (973)
... .. .... ............+.+.+|+.+||++||++|||+.|+++| ++++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301 (305)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred CchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence 000 00 0000 000001112234567889999999999999999999987 555543
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=5.3e-42 Score=374.69 Aligned_cols=292 Identities=30% Similarity=0.499 Sum_probs=211.4
Q ss_pred CCchHHHHHHHHHHHhcCCCcccccCCCCCCCCCC--CcceeeeCCCC--CceEEEeecCCCCCc--cccccccCCccCc
Q 002061 27 LSLNVETQALIQFKSKLKDPHGVLDSWKESADSPC--GFSGITCDSVT--GRVTEISFDNKSLSG--EISSSISALQSLT 100 (973)
Q Consensus 27 ~~~~~~~~aLl~~k~~~~d~~~~~~~W~~~~~~~c--~w~gv~C~~~~--~~v~~l~l~~~~l~~--~~~~~l~~l~~L~ 100 (973)
.|.++|++||++||+++.||. .+++|..++| || .|+||+|+..+ +||++|+|++++++| .+|++|++|++|+
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~~-~l~sW~~~~d-~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~ 79 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNPT-TLSSWLPTTD-CCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN 79 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GGTTCCTTSC-TTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCS
T ss_pred CCCHHHHHHHHHHHHHCCCCC-cCCCCCCCCC-CCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCcccc
Confidence 367899999999999999986 6999987664 67 59999998744 489999999999998 5789999999999
Q ss_pred EeeCCC-CcccCcCChhhhCCCCCcEEEecCCcccCCCCc-ccCCCCCCEEeccCccCCCccccccccccccceEEccCC
Q 002061 101 VLSLPF-NVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPD-LSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDN 178 (973)
Q Consensus 101 ~L~Ls~-n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n 178 (973)
+|+|++ |+++|.+|.+|++|++|++|+|++|++.+.++. +..+.+|+.++++.|.+.+.+|..+.++++|+.+++++|
T Consensus 80 ~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n 159 (313)
T d1ogqa_ 80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159 (313)
T ss_dssp EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred ccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeecccc
Confidence 999986 899999999999999999999999999887764 788899999999999888777777777777777777776
Q ss_pred cCCCCCCcccccCCCCC-CEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCchhhhccccccEEEeeccccCCcC
Q 002061 179 VYDEAEIPESIGNLKNL-TYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGEL 257 (973)
Q Consensus 179 ~l~~~~ip~~~~~l~~L-~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~ 257 (973)
.+.. .+|..+..+.++ +.+++++|++++..|..+..+..+ .+++++|.+.+.+|..+..+++|+.+++++|.+++.+
T Consensus 160 ~l~~-~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~ 237 (313)
T d1ogqa_ 160 RISG-AIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL 237 (313)
T ss_dssp CCEE-ECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBG
T ss_pred cccc-ccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccc
Confidence 6642 356666665554 566666666666666666555433 4666666666666666666666666666666665443
Q ss_pred CccccccccccEEEeeccccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeeccCCc
Q 002061 258 PAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNR 324 (973)
Q Consensus 258 ~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 324 (973)
| .++.+++|+.|+|++|+++|.+|..++++++|++|+|++|+|+|.+|. ++.+++|+.+++++|+
T Consensus 238 ~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 238 G-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNK 302 (313)
T ss_dssp G-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSS
T ss_pred c-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCc
Confidence 3 455556666666666666655666666666666666665555555542 3444444444444443
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.2e-42 Score=370.46 Aligned_cols=261 Identities=24% Similarity=0.276 Sum_probs=198.0
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE 751 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 751 (973)
++|++.++||+|+||+||+|+++ +++.||||++... ...+++.+|+.++++++||||+++++++..++..+++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 58999999999999999999987 5899999998653 235678999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccC
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 831 (973)
|+.++.+..+... ...+++..+..++.||+.||+||| +.+||||||||+|||++.++.+|++|||.+.....
T Consensus 81 ~~~~~~~~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~ 152 (286)
T d1ob3a_ 81 HLDQDLKKLLDVC-----EGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGI 152 (286)
T ss_dssp CCSEEHHHHHHTS-----TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred eehhhhHHHHHhh-----cCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceeccc
Confidence 9977666555442 356899999999999999999999 78999999999999999999999999999987644
Q ss_pred CCCcccccccCCccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccc--c---cc
Q 002061 832 SPKVSDYSCFAGTHGYIAPELAYTC-KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNH--E---NV 905 (973)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~--~---~~ 905 (973)
... ......|++.|+|||++.+. .++.++||||+||++|||++|+.||.+.. ..+....+....... . ..
T Consensus 153 ~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~ 228 (286)
T d1ob3a_ 153 PVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS--EADQLMRIFRILGTPNSKNWPNV 228 (286)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCCCTTTSTTG
T ss_pred Ccc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCC--HHHHHHHHHHhhCCCChhhccch
Confidence 322 22334689999999998754 56899999999999999999999997531 111111111111000 0 00
Q ss_pred chh---------ccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 906 LKV---------LDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 906 ~~~---------~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
... ..+...........+.+.+++.+|++.||++|||++|+++|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 00000011112234567899999999999999999999875
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-41 Score=374.97 Aligned_cols=266 Identities=22% Similarity=0.315 Sum_probs=197.2
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCC------
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGG------ 744 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------ 744 (973)
.++|++++.||+|+||+||+|++..+|+.||||+++.. ...+.+.+|++++++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 46899999999999999999999999999999998753 33457889999999999999999999997654
Q ss_pred eeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEeccc
Q 002061 745 SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFG 824 (973)
Q Consensus 745 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 824 (973)
+.|+||||+ +++|..+.+. ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+|++|||
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg 166 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFG 166 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred eEEEEEecc-cccHHHHHHh------ccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhccccccccccccc
Confidence 569999999 6788777754 25899999999999999999999 7899999999999999999999999999
Q ss_pred CcccccCCCCcccccccCCccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccc
Q 002061 825 VAKIAENSPKVSDYSCFAGTHGYIAPELAYTC-KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHE 903 (973)
Q Consensus 825 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 903 (973)
+++..... .+...||+.|+|||++.+. .++.++||||+||++|||++|+.||.... ..+............+
T Consensus 167 ~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~--~~~~~~~~~~~~~~~~ 239 (346)
T d1cm8a_ 167 LARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD--HLDQLKEIMKVTGTPP 239 (346)
T ss_dssp TCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHHCCCC
T ss_pred ceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCC--hHHHHHHHHhccCCCc
Confidence 99866443 2345789999999998764 56899999999999999999999996541 1111111000000000
Q ss_pred -cc------------chhc---cccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--hhcCCCCC
Q 002061 904 -NV------------LKVL---DCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM--LADADPCT 957 (973)
Q Consensus 904 -~~------------~~~~---~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~--L~~~~~~~ 957 (973)
.. .... ...............+.+|+.+|++.||++|||+.|+++| ++++....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~ 311 (346)
T d1cm8a_ 240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE 311 (346)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC---
T ss_pred HHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCcc
Confidence 00 0000 0000000111223457789999999999999999999998 66665443
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-41 Score=373.75 Aligned_cols=267 Identities=24% Similarity=0.314 Sum_probs=197.3
Q ss_pred CCcccCcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhcCCCceeeEEEEEEeC------CeeEEEE
Q 002061 677 NLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNILKLYACLLKG------GSSFLVL 750 (973)
Q Consensus 677 ~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~~~~lv~ 750 (973)
+|+..++||+|+||+||+|++..+|+.||||++..+.. ...+|++++++++||||++++++|... .+.|+||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 98 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 98 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS--SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch--HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEE
Confidence 68888999999999999999999999999999876432 235899999999999999999998542 3578999
Q ss_pred EccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCC-CeEEecccCcccc
Q 002061 751 EYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY-EPKIADFGVAKIA 829 (973)
Q Consensus 751 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfgl~~~~ 829 (973)
||++++. .+.+... ......+++..+..++.||+.||+||| +++|+||||||+|||++.++ .+||+|||+++..
T Consensus 99 Ey~~~~~-~~~l~~~-~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 99 DYVPETV-YRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp ECCSEEH-HHHHHHH-HHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred eccCCcc-HHHHHhh-hhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9997654 4444322 123456899999999999999999999 89999999999999999775 8999999999876
Q ss_pred cCCCCcccccccCCcccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHH-----------H
Q 002061 830 ENSPKVSDYSCFAGTHGYIAPELAYT-CKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVS-----------T 897 (973)
Q Consensus 830 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~-----------~ 897 (973)
..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... ...+...+. .
T Consensus 174 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~-~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 174 VRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG-VDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH-HHHHHHHHHHHCCCCHHHHHH
T ss_pred cCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH-HHHHHHHHHHhCCChHHhhhh
Confidence 54322 233578999999998765 5689999999999999999999999965421 011111111 0
Q ss_pred Hhcccc--ccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--hhcCC
Q 002061 898 HLNNHE--NVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM--LADAD 954 (973)
Q Consensus 898 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~--L~~~~ 954 (973)
...... ...................+.+.+++.+|+++||++|||+.|+++| ++++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 000000 0000000000001112234568899999999999999999999986 45543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.9e-41 Score=362.16 Aligned_cols=260 Identities=15% Similarity=0.157 Sum_probs=208.6
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhcCC-CceeeEEEEEEeCCeeEEEEEccC
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRH-RNILKLYACLLKGGSSFLVLEYMP 754 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~~~~lv~e~~~ 754 (973)
++|++.+.||+|+||+||+|++..+++.||||++......+.+.+|++.++.++| +|++.+++++..+...++||||+
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~- 83 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL- 83 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-
Confidence 5799999999999999999999999999999998776666678899999999965 89999999999999999999999
Q ss_pred CCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecC-----CCCeEEecccCcccc
Q 002061 755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE-----DYEPKIADFGVAKIA 829 (973)
Q Consensus 755 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~-----~~~~kl~Dfgl~~~~ 829 (973)
+++|.+++... ...+++..+..++.|++.||+||| +++|+||||||+||+++. ++.+||+|||+|+..
T Consensus 84 ~~~l~~~~~~~----~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 84 GPSLEDLLDLC----GRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred CCCHHHHHHhh----ccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 78999988753 345889999999999999999999 899999999999999974 578999999999876
Q ss_pred cCCCCc-----ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccH-HHHHHHHhcccc
Q 002061 830 ENSPKV-----SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDI-VYWVSTHLNNHE 903 (973)
Q Consensus 830 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~-~~~~~~~~~~~~ 903 (973)
...... .......||+.|||||++.+..++.++|||||||++|||++|+.||.......... ...+.... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~-~~~ 235 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK-QST 235 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH-HHS
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhcc-CCC
Confidence 533211 12334679999999999999999999999999999999999999997643221111 11111110 000
Q ss_pred ccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 904 NVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
...+ .....++++.+++..|++.+|++||+++.+.+.|+++
T Consensus 236 ~~~~---------l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 236 PLRE---------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp CHHH---------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred ChHH---------hcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 0000 0112234688899999999999999999988887764
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.1e-41 Score=365.22 Aligned_cols=261 Identities=20% Similarity=0.197 Sum_probs=201.1
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhcCCCc-eeeEEEEEEeCCeeEEEEEccC
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRN-ILKLYACLLKGGSSFLVLEYMP 754 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~~~lv~e~~~ 754 (973)
++|++.+.||+|+||+||+|++..+++.||||++......+++.+|+++++.++|++ |+.+.+++.+++..++||||+
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~- 85 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL- 85 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-
Confidence 469999999999999999999999999999999877666667889999999997666 555566667888999999999
Q ss_pred CCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecC---CCCeEEecccCcccccC
Q 002061 755 NGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDE---DYEPKIADFGVAKIAEN 831 (973)
Q Consensus 755 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~Dfgl~~~~~~ 831 (973)
+|++.+.+... ...+++..+..++.|++.||+||| +++|+||||||+|||++. +..+|++|||+|+....
T Consensus 86 ~~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 86 GPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred CCchhhhhhhc----cCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 56776666542 346899999999999999999999 789999999999999864 55799999999987754
Q ss_pred CCCc-----ccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccc
Q 002061 832 SPKV-----SDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVL 906 (973)
Q Consensus 832 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 906 (973)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........................
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence 3321 12234579999999999999999999999999999999999999997643221111110000000000000
Q ss_pred hhccccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhhcC
Q 002061 907 KVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKMLADA 953 (973)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~ 953 (973)
......++++.+++..||+.+|++||+++++.+.|+.+
T Consensus 239 ---------~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 239 ---------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp ---------HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred ---------HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 00112335688899999999999999999888877754
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-41 Score=369.14 Aligned_cols=269 Identities=21% Similarity=0.257 Sum_probs=198.9
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc---ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCC----eeEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG---DGVKVFAAEMEILGKIRHRNILKLYACLLKGG----SSFL 748 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~~l 748 (973)
.+|++++.||+|+||+||+|++..+|+.||||++... ...+++.+|++++++++||||+++++++.... ..++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 4699999999999999999999999999999998753 23457889999999999999999999987643 2345
Q ss_pred EEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCccc
Q 002061 749 VLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKI 828 (973)
Q Consensus 749 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 828 (973)
+++|+.+|+|.+++..+ .+++..+..++.|+++||+||| +++||||||||+|||++.++.+||+|||+++.
T Consensus 88 l~~~~~~g~L~~~l~~~------~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKTQ------HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEECCCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEeecCCchhhhhhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceee
Confidence 55667799999999753 4899999999999999999999 78999999999999999999999999999976
Q ss_pred ccCCCCc-ccccccCCccccccccccc-cCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccccc
Q 002061 829 AENSPKV-SDYSCFAGTHGYIAPELAY-TCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHENVL 906 (973)
Q Consensus 829 ~~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 906 (973)
....... .......||+.|+|||++. +..++.++||||+||++|||++|+.||..... .+................
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~ 236 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY--LDQLNHILGILGSPSQED 236 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCSCCHHH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCH--HHHHHHHhhhccCCChhh
Confidence 5433221 2233467999999999985 45678999999999999999999999965421 111111100000000000
Q ss_pred ----------h-h-ccccccCc----chHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--hhcCCC
Q 002061 907 ----------K-V-LDCEVASE----SIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM--LADADP 955 (973)
Q Consensus 907 ----------~-~-~~~~~~~~----~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~--L~~~~~ 955 (973)
. . ..+..... .......++.+++.+|++.||++|||+.|+++| +++...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~ 303 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence 0 0 00000000 011122467899999999999999999999998 555443
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-41 Score=366.25 Aligned_cols=267 Identities=20% Similarity=0.226 Sum_probs=198.5
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEe--------
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLK-------- 742 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-------- 742 (973)
+++|++.+.||+|+||+||+|++..+|+.||||++..+ ....++.+|++++++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 57999999999999999999999999999999988542 345678899999999999999999998855
Q ss_pred CCeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEec
Q 002061 743 GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIAD 822 (973)
Q Consensus 743 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 822 (973)
+...|+||||++++.+..+.. ....++...+..++.|++.||+||| +++|+||||||+|||++.++.+|++|
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~-----~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~d 160 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSN-----VLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLAD 160 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTC-----TTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECC
T ss_pred CceEEEEEeccCCCccchhhh-----cccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeee
Confidence 346799999998776654332 2346788899999999999999999 78999999999999999999999999
Q ss_pred ccCcccccCCCCc--ccccccCCccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHh
Q 002061 823 FGVAKIAENSPKV--SDYSCFAGTHGYIAPELAYTC-KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHL 899 (973)
Q Consensus 823 fgl~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~ 899 (973)
||+++........ .......||+.|+|||++.+. .+++++||||+||++|||++|+.||... ........+....
T Consensus 161 fg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~--~~~~~~~~i~~~~ 238 (318)
T d3blha1 161 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN--TEQHQLALISQLC 238 (318)
T ss_dssp CTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHHH
T ss_pred cceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCC--CHHHHHHHHHHhc
Confidence 9999766533221 122235699999999998765 6899999999999999999999999653 1111111111111
Q ss_pred cccc-ccchh----------ccccccCcchH------HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhh
Q 002061 900 NNHE-NVLKV----------LDCEVASESIK------EDMIKLLKIAVVCTTKLPNLRPPMREVVKMLA 951 (973)
Q Consensus 900 ~~~~-~~~~~----------~~~~~~~~~~~------~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~ 951 (973)
.... ..... ........... .....+.+++.+|+++||++|||++|+++|-.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpf 307 (318)
T d3blha1 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 307 (318)
T ss_dssp CCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred CCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChh
Confidence 1100 00000 00000011111 11345678999999999999999999999854
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-41 Score=365.46 Aligned_cols=254 Identities=25% Similarity=0.293 Sum_probs=203.3
Q ss_pred HHcCCcccCcccccCceEEEEEEe---cCCCcEEEEEeeecc------ccHHHHHHHHHHHHhcCC-CceeeEEEEEEeC
Q 002061 674 QICNLEEDNLIGSGGTGKVYRLDL---KKNAGTVAVKQLWKG------DGVKVFAAEMEILGKIRH-RNILKLYACLLKG 743 (973)
Q Consensus 674 ~~~~~~~~~~lG~G~~g~V~~a~~---~~~~~~vavK~~~~~------~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~ 743 (973)
.+++|++.+.||+|+||+||+|+. +.+|+.||||+++.. ...+.+.+|++++++++| |||+++++++.+.
T Consensus 22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~ 101 (322)
T d1vzoa_ 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 101 (322)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence 357899999999999999999987 346889999988542 345668899999999976 8999999999999
Q ss_pred CeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecc
Q 002061 744 GSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADF 823 (973)
Q Consensus 744 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 823 (973)
...++||||+.+|+|.+++... ..++...+..++.|++.|++|+| +.+|+||||||+||+++.++.+||+||
T Consensus 102 ~~~~~v~e~~~~~~L~~~i~~~-----~~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DF 173 (322)
T d1vzoa_ 102 TKLHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDF 173 (322)
T ss_dssp TEEEEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCS
T ss_pred CceeeeeecccccHHHHHHHhc-----ccccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeec
Confidence 9999999999999999999865 24577888899999999999999 789999999999999999999999999
Q ss_pred cCcccccCCCCcccccccCCccccccccccccC--CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcc
Q 002061 824 GVAKIAENSPKVSDYSCFAGTHGYIAPELAYTC--KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNN 901 (973)
Q Consensus 824 gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 901 (973)
|+++....... .......|++.|+|||.+.+. .++.++||||+||++|||++|+.||...... .............
T Consensus 174 G~a~~~~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~-~~~~~i~~~~~~~ 251 (322)
T d1vzoa_ 174 GLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK-NSQAEISRRILKS 251 (322)
T ss_dssp SEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC-CCHHHHHHHHHHC
T ss_pred cchhhhccccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcccC
Confidence 99986643322 223345789999999998754 4678999999999999999999999765322 2222222222111
Q ss_pred ccccchhccccccCcchHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 002061 902 HENVLKVLDCEVASESIKEDMIKLLKIAVVCTTKLPNLRP-----PMREVVKM 949 (973)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~ 949 (973)
... .+.....++.+++.+||++||++|| |++|+++|
T Consensus 252 ~~~------------~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 252 EPP------------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp CCC------------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred CCC------------CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 111 1123355788899999999999999 58999885
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-41 Score=361.32 Aligned_cols=263 Identities=22% Similarity=0.252 Sum_probs=205.1
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKGGSSFLVLE 751 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 751 (973)
++|++.+.||+|+||+||+|++..+++.||||+++.. ....++.+|+.+++.++||||+++++++......++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5799999999999999999999999999999998652 345678999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCcccccC
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVAKIAEN 831 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 831 (973)
++.++++..++... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+|++|||.++....
T Consensus 82 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~ 153 (292)
T d1unla_ 82 FCDQDLKKYFDSCN-----GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp CCSEEHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred eccccccccccccc-----cccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccC
Confidence 99999988877643 45788999999999999999999 78999999999999999999999999999987654
Q ss_pred CCCcccccccCCccccccccccccCC-CCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhccccc-----c
Q 002061 832 SPKVSDYSCFAGTHGYIAPELAYTCK-VSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHEN-----V 905 (973)
Q Consensus 832 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~ 905 (973)
... ......++..|+|||++.+.. ++.++||||+||++|||++|+.||.... +..+....+......... .
T Consensus 154 ~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 230 (292)
T d1unla_ 154 PVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN-DVDDQLKRIFRLLGTPTEEQWPSM 230 (292)
T ss_dssp CCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS-SHHHHHHHHHHHHCCCCTTTCTTG
T ss_pred CCc--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCC-CHHHHHHHHHhhcCCCChhhhhhh
Confidence 332 222345788999999987665 6899999999999999999999985421 111111111111111000 0
Q ss_pred chhc---------cccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 906 LKVL---------DCEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 906 ~~~~---------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
.... .............+.+.+++.+|+++||.+|||++|+++|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 0001111122334567889999999999999999999986
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.7e-40 Score=364.44 Aligned_cols=260 Identities=21% Similarity=0.232 Sum_probs=199.6
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhcC-CCceeeEEEEEEeC--CeeEEEEE
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIR-HRNILKLYACLLKG--GSSFLVLE 751 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~--~~~~lv~e 751 (973)
.++|++.++||+|+||+||+|++..+++.||||+++.. ..+++.+|++++++++ ||||+++++++... ...++|||
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 46899999999999999999999999999999998654 3567889999999995 99999999999753 56899999
Q ss_pred ccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCC-CeEEecccCccccc
Q 002061 752 YMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDY-EPKIADFGVAKIAE 830 (973)
Q Consensus 752 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfgl~~~~~ 830 (973)
|+++|+|.++. ..+++..+..++.||+.||+||| +++|+||||||+|||++.++ .+|++|||+|+...
T Consensus 113 ~~~~~~L~~~~--------~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 113 HVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp CCCSCBGGGTT--------TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred ecCCCcHHHHh--------cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceecc
Confidence 99999986543 24889999999999999999999 78999999999999998755 69999999998765
Q ss_pred CCCCcccccccCCccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHH------------HH
Q 002061 831 NSPKVSDYSCFAGTHGYIAPELAYTC-KVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWV------------ST 897 (973)
Q Consensus 831 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~------------~~ 897 (973)
.... .....+|+.|+|||++.+. .++.++||||+||++|||++|+.||.............. ..
T Consensus 182 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 182 PGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp TTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred CCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence 4422 3345689999999998765 479999999999999999999999975422111111100 00
Q ss_pred H-hccccccchhcc--------ccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 002061 898 H-LNNHENVLKVLD--------CEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM 949 (973)
Q Consensus 898 ~-~~~~~~~~~~~~--------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 949 (973)
. ............ .............++.+|+.+|++.||++|||++|+++|
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 000000000000 000111112234568899999999999999999999985
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-40 Score=366.55 Aligned_cols=260 Identities=27% Similarity=0.280 Sum_probs=192.7
Q ss_pred HcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEe------CC
Q 002061 675 ICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLK------GG 744 (973)
Q Consensus 675 ~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~------~~ 744 (973)
.++|++.++||+|+||+||+|++..+|+.||||++... ....++.+|+.++++++||||++++++|.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 36899999999999999999999999999999998753 334568899999999999999999999964 36
Q ss_pred eeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEeccc
Q 002061 745 SSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFG 824 (973)
Q Consensus 745 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 824 (973)
+.|+||||+.++ +.+.+. ..+++..+..++.|++.||+||| ++||+||||||+|||++.++.+|++|||
T Consensus 96 ~~~iv~Ey~~~~-l~~~~~-------~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~ 164 (355)
T d2b1pa1 96 DVYLVMELMDAN-LCQVIQ-------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_dssp EEEEEEECCSEE-HHHHHT-------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred eeEEEEeccchH-HHHhhh-------cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechh
Confidence 789999999655 444443 24789999999999999999999 7899999999999999999999999999
Q ss_pred CcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHH--------
Q 002061 825 VAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVS-------- 896 (973)
Q Consensus 825 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~-------- 896 (973)
+++..... .......||+.|+|||++.+..+++++||||+||++|||++|+.||.... .......+.
T Consensus 165 ~~~~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~--~~~~~~~i~~~~~~~~~ 239 (355)
T d2b1pa1 165 LARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD--YIDQWNKVIEQLGTPCP 239 (355)
T ss_dssp C------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHHCCCCH
T ss_pred hhhccccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC--HHHHHHHHHHhccCCCH
Confidence 98755433 22334578999999999999999999999999999999999999996431 111100000
Q ss_pred -----------HHhcccc-----ccchhcc---ccccCcchHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 002061 897 -----------THLNNHE-----NVLKVLD---CEVASESIKEDMIKLLKIAVVCTTKLPNLRPPMREVVKML 950 (973)
Q Consensus 897 -----------~~~~~~~-----~~~~~~~---~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L 950 (973)
....... ....... ..............+.+|+.+|++.||++|||++|+++|-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hp 312 (355)
T d2b1pa1 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 312 (355)
T ss_dssp HHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred HHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCc
Confidence 0000000 0000000 0111122344567889999999999999999999999884
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-39 Score=357.12 Aligned_cols=262 Identities=23% Similarity=0.302 Sum_probs=196.0
Q ss_pred cCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc----ccHHHHHHHHHHHHhcCCCceeeEEEEEEeC-----Cee
Q 002061 676 CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG----DGVKVFAAEMEILGKIRHRNILKLYACLLKG-----GSS 746 (973)
Q Consensus 676 ~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~ 746 (973)
++|++.++||+|+||+||+|++..+|+.||||++... ...+++.+|++++++++||||+++++++... ...
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~ 97 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence 5799999999999999999999999999999998753 2345678999999999999999999998643 344
Q ss_pred EEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCeEEecccCc
Q 002061 747 FLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEPKIADFGVA 826 (973)
Q Consensus 747 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~ 826 (973)
+++|+|+.+|+|.+++.. ..+++..+..++.||+.||+||| +++|+||||||+||+++.++.+|++|||.+
T Consensus 98 ~~i~~~~~gg~L~~~~~~------~~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 98 VYLVTHLMGADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CEEEEECCSEEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred EEEEEeecCCchhhhccc------ccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchh
Confidence 667778889999999853 25899999999999999999999 789999999999999999999999999998
Q ss_pred ccccCCCCcccccccCCccccccccccccCC-CCccchHHHHHHHHHHHHhCCCCCCcccCCcccHHHHHHHHhcccc-c
Q 002061 827 KIAENSPKVSDYSCFAGTHGYIAPELAYTCK-VSEKSDVFSFGVVLLELVTGRKPVEEEYGDGKDIVYWVSTHLNNHE-N 904 (973)
Q Consensus 827 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~-~ 904 (973)
..... ......|++.|+|||+..+.. ++.++||||+||++|+|++|+.||... +.......+........ .
T Consensus 169 ~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~--~~~~~~~~i~~~~~~~~~~ 241 (348)
T d2gfsa1 169 RHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT--DHIDQLKLILRLVGTPGAE 241 (348)
T ss_dssp -CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHHHCCCCHH
T ss_pred cccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCC--CHHHHHHHHHHhcCCCChH
Confidence 75432 223356899999999876654 688999999999999999999999653 11111111111110000 0
Q ss_pred cch---------hcc--ccccCcc----hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--hhcC
Q 002061 905 VLK---------VLD--CEVASES----IKEDMIKLLKIAVVCTTKLPNLRPPMREVVKM--LADA 953 (973)
Q Consensus 905 ~~~---------~~~--~~~~~~~----~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~--L~~~ 953 (973)
... ... ....... .......+.+|+.+|++.||.+|||+.|+++| +.+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp HHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 000 000 0000000 01123567899999999999999999999996 4444
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.1e-35 Score=331.27 Aligned_cols=278 Identities=21% Similarity=0.233 Sum_probs=200.5
Q ss_pred cccccCHHHH-cCCcccCcccccCceEEEEEEecCCCcEEEEEeeeccc-cHHHHHHHHHHHHhcC-----------CCc
Q 002061 666 HHIDIDAEQI-CNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGD-GVKVFAAEMEILGKIR-----------HRN 732 (973)
Q Consensus 666 ~~~~~~~~~~-~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~-----------hpn 732 (973)
++..+++... ++|+++++||+|+||+||+|++..+|+.||||+++.+. ..+.+.+|++++++++ |||
T Consensus 2 ~p~~~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~ 81 (362)
T d1q8ya_ 2 HPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANH 81 (362)
T ss_dssp CCCCTTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred CCCCCCCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCc
Confidence 4445544433 46999999999999999999999999999999997653 3456788999988875 578
Q ss_pred eeeEEEEEEe--CCeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCe
Q 002061 733 ILKLYACLLK--GGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNI 810 (973)
Q Consensus 733 iv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Ni 810 (973)
|+++++++.. ....+++|+++..+......... .....+++..+..++.|++.|++|||+ ..+|+||||||+||
T Consensus 82 iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NI 157 (362)
T d1q8ya_ 82 ILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKK--YEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENV 157 (362)
T ss_dssp BCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGE
T ss_pred eEEEEEEeeeccccceeeeeeeccccccccccccc--ccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHe
Confidence 9999988764 45667777776665544433322 344567889999999999999999995 37999999999999
Q ss_pred eecCCC------CeEEecccCcccccCCCCcccccccCCccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcc
Q 002061 811 LLDEDY------EPKIADFGVAKIAENSPKVSDYSCFAGTHGYIAPELAYTCKVSEKSDVFSFGVVLLELVTGRKPVEEE 884 (973)
Q Consensus 811 ll~~~~------~~kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~pf~~~ 884 (973)
|++.++ .++++|||.+...... .....||+.|+|||++.+..++.++||||+||++++|++|+.||...
T Consensus 158 ll~~~~~~~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~ 232 (362)
T d1q8ya_ 158 LMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 232 (362)
T ss_dssp EEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred eeeccCcccccceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCC
Confidence 998665 3999999998755432 22356899999999999999999999999999999999999999764
Q ss_pred cCCc-c-c---HHHHHHHHhcc--------ccccchhcc---------c----------cccCcchHHHHHHHHHHHHHh
Q 002061 885 YGDG-K-D---IVYWVSTHLNN--------HENVLKVLD---------C----------EVASESIKEDMIKLLKIAVVC 932 (973)
Q Consensus 885 ~~~~-~-~---~~~~~~~~~~~--------~~~~~~~~~---------~----------~~~~~~~~~~~~~l~~l~~~c 932 (973)
.+.. . . ....+. .... ........+ . .............+.+|+.+|
T Consensus 233 ~~~~~~~~~~~~~~~~~-~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~m 311 (362)
T d1q8ya_ 233 EGHSYTKDDDHIAQIIE-LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPM 311 (362)
T ss_dssp ------CHHHHHHHHHH-HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGG
T ss_pred ccccccchhHHHHHHHH-HhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHH
Confidence 3211 0 1 111110 0000 000000000 0 001112355677899999999
Q ss_pred cCCCCCCCCCHHHHHHH--hhcC
Q 002061 933 TTKLPNLRPPMREVVKM--LADA 953 (973)
Q Consensus 933 l~~dP~~Rpt~~evl~~--L~~~ 953 (973)
+.+||.+|||++|+++| +++.
T Consensus 312 L~~dP~~Rpta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 312 LQLDPRKRADAGGLVNHPWLKDT 334 (362)
T ss_dssp GCSSTTTCBCHHHHHTCGGGTTC
T ss_pred CCCChhHCcCHHHHhcCcccCCC
Confidence 99999999999999997 5443
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.97 E-value=4.7e-29 Score=279.94 Aligned_cols=356 Identities=24% Similarity=0.311 Sum_probs=182.7
Q ss_pred eCCCCcccCcCChhhhCCCCCcEEEecCCcccCCCCcccCCCCCCEEeccCccCCCccccccccccccceEEccCCcCCC
Q 002061 103 SLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDE 182 (973)
Q Consensus 103 ~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 182 (973)
.+..+.+++.+. ...+.+|++|+++++.|+.. +.+..+++|++|||++|++++.. .+.++++|++|++++|.+..
T Consensus 28 ~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~l-~gl~~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i~~ 102 (384)
T d2omza2 28 VLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI-DGVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIAD 102 (384)
T ss_dssp HTTCSSTTSEEC--HHHHTTCCEEECCSSCCCCC-TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC
T ss_pred HhCCCCCCCccC--HHHhCCCCEEECCCCCCCCc-cccccCCCCCEEeCcCCcCCCCc--cccCCccccccccccccccc
Confidence 455555655443 24556677777777777653 45667777777777777776432 25555556666665555542
Q ss_pred CCCcccccCCCCCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCchhhhccccccEEEeeccccCCcCCcccc
Q 002061 183 AEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELG 262 (973)
Q Consensus 183 ~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~ 262 (973)
++ .++.+++|+.|++++|.+++..+ ......+..+....|.+....+................. ....+.
T Consensus 103 --i~-~l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~ 172 (384)
T d2omza2 103 --IT-PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVT-----DLKPLA 172 (384)
T ss_dssp --CG-GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCC-----CCGGGT
T ss_pred --cc-ccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccc-----hhhhhc
Confidence 22 35666666666666666664322 233445555555555554322222111111111111111 111222
Q ss_pred ccccccEEEeeccccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeeccCCccCCCCCcccccccccccc
Q 002061 263 NLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDV 342 (973)
Q Consensus 263 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L 342 (973)
..+.........|... ....+ ..+++++.+++++|.+++..| +...++|++|
T Consensus 173 ~~~~~~~~~~~~~~~~--~~~~~------------------------~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L 224 (384)
T d2omza2 173 NLTTLERLDISSNKVS--DISVL------------------------AKLTNLESLIATNNQISDITP--LGILTNLDEL 224 (384)
T ss_dssp TCTTCCEEECCSSCCC--CCGGG------------------------GGCTTCSEEECCSSCCCCCGG--GGGCTTCCEE
T ss_pred cccccccccccccccc--ccccc------------------------ccccccceeeccCCccCCCCc--ccccCCCCEE
Confidence 2333333333333321 22223 333444444444444443222 2333445555
Q ss_pred ccccccccccCChhhhhhhhHHHHHhhhccCCCCccccccCccccceEeccccccccCCCccccCCCCcceEeccCCcCC
Q 002061 343 DISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFT 422 (973)
Q Consensus 343 ~Ls~N~l~~~~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 422 (973)
++++|+++. + ..+..+++|+.|++++|++++..+ +..+++|+.|++++|+++
T Consensus 225 ~l~~n~l~~-------------------------~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~ 276 (384)
T d2omza2 225 SLNGNQLKD-------------------------I-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQIS 276 (384)
T ss_dssp ECCSSCCCC-------------------------C-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCC
T ss_pred ECCCCCCCC-------------------------c-chhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccC
Confidence 555554441 0 123344555555555555553222 444555555555555555
Q ss_pred CCCCCCCCCCCCCCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCCcccc
Q 002061 423 GGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMG 502 (973)
Q Consensus 423 ~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 502 (973)
+..+ +..++.++.+++++|++++ ...+..+++++.|++++|++++.. .+..+++|++|++++|+|++ ++ .++
T Consensus 277 ~~~~--~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~ 348 (384)
T d2omza2 277 NISP--LAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLA 348 (384)
T ss_dssp CCGG--GTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGG
T ss_pred CCCc--ccccccccccccccccccc--ccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHc
Confidence 4322 3445566666666666653 234566666666666666666443 25666666666666666663 22 466
Q ss_pred ccccccchhccccccccCCCccccccCCCCeeecCCC
Q 002061 503 DCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGN 539 (973)
Q Consensus 503 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 539 (973)
++++|+.|++++|+|++..| +.++++|+.|+|++|
T Consensus 349 ~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 349 NLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp GCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred CCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 66666666666666665443 666666777776666
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=1e-28 Score=277.14 Aligned_cols=358 Identities=22% Similarity=0.266 Sum_probs=219.1
Q ss_pred EEeecCCCCCccccccccCCccCcEeeCCCCcccCcCChhhhCCCCCcEEEecCCcccCCCCcccCCCCCCEEeccCccC
Q 002061 77 EISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYF 156 (973)
Q Consensus 77 ~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls~n~l 156 (973)
...+...++++.+. ...+.+|++|++++++|+. + +.+..+++|++|+|++|+|++.++ ++++++|++|++++|++
T Consensus 26 ~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l~~-l~~L~~L~~L~L~~n~i 100 (384)
T d2omza2 26 KTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQI 100 (384)
T ss_dssp HHHTTCSSTTSEEC--HHHHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCC
T ss_pred HHHhCCCCCCCccC--HHHhCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCCCcc-ccCCccccccccccccc
Confidence 34555566666553 3567788889998888874 3 468888899999999998887654 88889999999999988
Q ss_pred CCccccccccccccceEEccCCcCCCCCCcccccCCCCCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCchh
Q 002061 157 TGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRS 236 (973)
Q Consensus 157 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 236 (973)
++.. .++.+++|+.|+++++.+... ........+..+....|.+....+................ .....
T Consensus 101 ~~i~--~l~~l~~L~~L~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~-----~~~~~ 170 (384)
T d2omza2 101 ADIT--PLANLTNLTGLTLFNNQITDI---DPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQV-----TDLKP 170 (384)
T ss_dssp CCCG--GGTTCTTCCEEECCSSCCCCC---GGGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESC-----CCCGG
T ss_pred cccc--ccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccccc-----chhhh
Confidence 8643 378889999999988887642 3345567788888888887744333222222222222111 12234
Q ss_pred hhccccccEEEeeccccCCcCCccccccccccEEEeeccccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCcccce
Q 002061 237 IRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLF 316 (973)
Q Consensus 237 l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~ 316 (973)
+.............|... ....+..+++++.+++++|.+++..| +...++|+.|++++|.++.. ..+..+++|+
T Consensus 171 ~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~ 244 (384)
T d2omza2 171 LANLTTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLT 244 (384)
T ss_dssp GTTCTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCS
T ss_pred hccccccccccccccccc--cccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccc
Confidence 455555556666666554 34556778888888888888875543 34556777777777776642 2455555666
Q ss_pred eeeccCCccCCCCCccccccccccccccccccccccCChhhhhhhhHHHHHhhhccCCCCccccccCccccceEeccccc
Q 002061 317 AFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNH 396 (973)
Q Consensus 317 ~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~ 396 (973)
.|++++|.+++.. .+..+++|++|++++|++++.. .+..++.++.+++++|+
T Consensus 245 ~L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l~~~~--------------------------~~~~~~~l~~l~~~~n~ 296 (384)
T d2omza2 245 DLDLANNQISNLA--PLSGLTKLTELKLGANQISNIS--------------------------PLAGLTALTNLELNENQ 296 (384)
T ss_dssp EEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCCG--------------------------GGTTCTTCSEEECCSSC
T ss_pred hhccccCccCCCC--cccccccCCEeeccCcccCCCC--------------------------ccccccccccccccccc
Confidence 6666666555322 2444455555555555544210 12233444445555544
Q ss_pred cccCCCccccCCCCcceEeccCCcCCCCCCCCCCCCCCCCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCcccc
Q 002061 397 LSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSA 476 (973)
Q Consensus 397 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 476 (973)
++ +. ..+..+++++.|++++|++++.. .+..+++|++|++++|+|++ ++ .
T Consensus 297 l~------------------------~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~ 346 (384)
T d2omza2 297 LE------------------------DI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-S 346 (384)
T ss_dssp CS------------------------CC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-G
T ss_pred cc------------------------cc--cccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-h
Confidence 44 32 12344555666666666665432 25566666666666666653 33 4
Q ss_pred ccccccCCEEEcCCcccccCCCccccccccccchhcccc
Q 002061 477 LGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARN 515 (973)
Q Consensus 477 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 515 (973)
+.++++|++|++++|+|++..| +.++++|+.|+|++|
T Consensus 347 l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 347 LANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp GGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred HcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 6666666666666666665443 566666666666666
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.96 E-value=1e-29 Score=276.58 Aligned_cols=249 Identities=29% Similarity=0.479 Sum_probs=125.3
Q ss_pred CCCeeecccccccC--CCchhhhccccccEEEeec-cccCCcCCccccccccccEEEeeccccccccCCccCCCCCccEE
Q 002061 218 ELGTLDICRNKISG--EFPRSIRKLQKLWKIELYA-NNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVF 294 (973)
Q Consensus 218 ~L~~L~L~~N~l~~--~~~~~l~~l~~L~~L~L~~-N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 294 (973)
+++.|+|++|.+++ .+|..++++++|++|+|++ |+++|.+|..|+++++|++|+|++|++.+..+..+..+.+|+.+
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l 130 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence 46666777776665 3556666666666666664 56666666666666666666666666665555555555666666
Q ss_pred EcccCCCCCCCCCCcCCcccceeeeccCCccCCCCCccccccccccccccccccccccCChhhhhhhhHHHHHhhhccCC
Q 002061 295 QCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFS 374 (973)
Q Consensus 295 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~ll~l~n~~~ 374 (973)
+++.|.+.+.+|..++.++.|+.+++++|.+.+.+|..+..+..+
T Consensus 131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l----------------------------------- 175 (313)
T d1ogqa_ 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL----------------------------------- 175 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTT-----------------------------------
T ss_pred ccccccccccCchhhccCcccceeecccccccccccccccccccc-----------------------------------
Confidence 655555555555444444444444444444444444333333332
Q ss_pred CCccccccCccccceEeccccccccCCCccccCCCCcceEeccCCcCCCCCCCCCCCCCCCCEEEcccCCCCCCCChhhh
Q 002061 375 GEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELG 454 (973)
Q Consensus 375 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~ 454 (973)
++.+++++|++++..|..+..+..+ .+++++|.+.+.++..+..+++|+.+++++|.+.+.+| .++
T Consensus 176 ------------~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~ 241 (313)
T d1ogqa_ 176 ------------FTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVG 241 (313)
T ss_dssp ------------CCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCC
T ss_pred ------------ccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccc-ccc
Confidence 2444555555554444444333221 23333333333333333344444444444444443322 344
Q ss_pred cCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCCccccccccccchhccccc
Q 002061 455 RLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNS 516 (973)
Q Consensus 455 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 516 (973)
.+++|+.|+|++|+++|.+|..|+++++|++|+|++|+|+|.+|. ++++.+|+.+++++|+
T Consensus 242 ~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 242 LSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNK 302 (313)
T ss_dssp CCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSS
T ss_pred cccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCc
Confidence 444455555555555444444455555555555555555444442 3444444444444443
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.93 E-value=1.7e-25 Score=242.09 Aligned_cols=121 Identities=21% Similarity=0.249 Sum_probs=60.7
Q ss_pred CCcceEeccCCcCCCCCCCCCCCCCCCCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCccccccccccCCEEEc
Q 002061 409 PNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHL 488 (973)
Q Consensus 409 ~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 488 (973)
++|+.|++++|.+++..+..|..++.++.|++++|.+.+..+..+.++++|++|+|++|+|+ .+|.+|..+++|++|+|
T Consensus 171 ~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~L 249 (305)
T d1xkua_ 171 PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYL 249 (305)
T ss_dssp TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEEC
T ss_pred CccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEEC
Confidence 34444444444444444444444455555555555555544555555555555555555555 33445555555555555
Q ss_pred CCcccccCCCccc------cccccccchhccccccc--cCCCccccccCC
Q 002061 489 EENALTGSIPNEM------GDCARIVDLNLARNSLS--GNIPRSLSLLSS 530 (973)
Q Consensus 489 s~N~l~~~~p~~~------~~l~~L~~L~Ls~N~l~--~~~~~~~~~l~~ 530 (973)
++|+|+.+....| ..+.+|+.|+|++|.++ ...|.+|.-+..
T Consensus 250 s~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~~~~~f~~~~~ 299 (305)
T d1xkua_ 250 HNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYV 299 (305)
T ss_dssp CSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCC
T ss_pred CCCccCccChhhccCcchhcccCCCCEEECCCCcCccCcCCHhHhccccc
Confidence 5555554332222 33455666666666554 234444444333
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.93 E-value=1.4e-25 Score=242.58 Aligned_cols=148 Identities=23% Similarity=0.299 Sum_probs=113.9
Q ss_pred CCccccCCCCcceEeccCCcCCCCCCCCCCCCCCCCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCcccccccc
Q 002061 401 IPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGAL 480 (973)
Q Consensus 401 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 480 (973)
.+..+..+++|+.+++++|+++.... ...++|+.|++++|.+.+..+..|.+++.++.|++++|.+++..+..+.++
T Consensus 142 ~~~~~~~l~~L~~l~l~~n~l~~l~~---~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l 218 (305)
T d1xkua_ 142 ENGAFQGMKKLSYIRIADTNITTIPQ---GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANT 218 (305)
T ss_dssp CTTGGGGCTTCCEEECCSSCCCSCCS---SCCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGS
T ss_pred CccccccccccCccccccCCccccCc---ccCCccCEEECCCCcCCCCChhHhhcccccccccccccccccccccccccc
Confidence 34455556666666666666654432 235789999999999988888889999999999999999988888888999
Q ss_pred ccCCEEEcCCcccccCCCccccccccccchhccccccccCCCccc------cccCCCCeeecCCCccC--CCCChhhhcc
Q 002061 481 RQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSL------SLLSSLNALNLSGNKLT--GSIPDNLMKL 552 (973)
Q Consensus 481 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~------~~l~~L~~L~L~~N~l~--~~~p~~l~~l 552 (973)
++|++|+|++|+|+ .+|.+|.++++|+.|+|++|+|+......| ..+.+|+.|+|++|+++ ...|..|..+
T Consensus 219 ~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~~~~~f~~~ 297 (305)
T d1xkua_ 219 PHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCV 297 (305)
T ss_dssp TTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTC
T ss_pred ccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccCcCCHhHhccc
Confidence 99999999999998 457788999999999999999986544443 45778999999999886 2444455544
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=8.9e-25 Score=233.49 Aligned_cols=266 Identities=20% Similarity=0.220 Sum_probs=159.0
Q ss_pred EeeccccCCcCCccccccccccEEEeeccccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeecc-CCcc
Q 002061 247 ELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIY-GNRF 325 (973)
Q Consensus 247 ~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~-~N~l 325 (973)
+.++++++ .+|..+. +++++|+|++|+|+...+..|.++++|++|++++|++....+..+..+..+..+... .|.+
T Consensus 17 ~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~ 93 (284)
T d1ozna_ 17 SCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93 (284)
T ss_dssp ECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTC
T ss_pred EcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccccccc
Confidence 34444444 3444332 345666666666654444556666666666666666665555555555555555443 3445
Q ss_pred CCCCCccccccccccccccccccccccCChhhhhhhhHHHHHhhhccCCCCccccccCccccceEeccccccccCCCccc
Q 002061 326 SGPFPENLGRYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGL 405 (973)
Q Consensus 326 ~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 405 (973)
+...+..|..+++|++|++++|.+... .+..+..+++|+.+++++|+|+++.+..|
T Consensus 94 ~~l~~~~~~~l~~L~~L~l~~n~~~~~------------------------~~~~~~~~~~L~~l~l~~N~l~~i~~~~f 149 (284)
T d1ozna_ 94 RSVDPATFHGLGRLHTLHLDRCGLQEL------------------------GPGLFRGLAALQYLYLQDNALQALPDDTF 149 (284)
T ss_dssp CCCCTTTTTTCTTCCEEECTTSCCCCC------------------------CTTTTTTCTTCCEEECCSSCCCCCCTTTT
T ss_pred ccccchhhcccccCCEEecCCcccccc------------------------cccccchhcccchhhhccccccccChhHh
Confidence 555555566666666666666665421 12234455666777777777765556666
Q ss_pred cCCCCcceEeccCCcCCCCCCCCCCCCCCCCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCccccccccccCCE
Q 002061 406 WALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSS 485 (973)
Q Consensus 406 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 485 (973)
..+++|+.|++++|++++.++..|..+++|+.+++++|++++..|..|.++++|++|++++|++++..+..|..+++|++
T Consensus 150 ~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~ 229 (284)
T d1ozna_ 150 RDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQY 229 (284)
T ss_dssp TTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCE
T ss_pred ccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCE
Confidence 66667777777777777666666777777777777777777777777777777777777777777767777777777777
Q ss_pred EEcCCcccccCCCccccccccccchhccccccccCCCccccccCCCCeeecCCCccCC
Q 002061 486 LHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTG 543 (973)
Q Consensus 486 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 543 (973)
|+|++|.+...-+ .-.-...++.+....++++...|..+. ....++|+.|.|+|
T Consensus 230 L~l~~N~l~C~C~-~~~l~~~l~~~~~~~~~~~C~~p~~l~---g~~l~~l~~~~l~g 283 (284)
T d1ozna_ 230 LRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQRLA---GRDLKRLAANDLQG 283 (284)
T ss_dssp EECCSSCEECSGG-GHHHHHHHHHCCSEECCCBEEESGGGT---TCBGGGSCGGGSCC
T ss_pred EEecCCCCCCCcc-chHHHHHHHhCcCCCCceEeCCchHHc---CCccccCCHHHCCC
Confidence 7777777764221 111122345555555555555555443 23444455555543
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=6.9e-25 Score=234.33 Aligned_cols=192 Identities=19% Similarity=0.222 Sum_probs=127.3
Q ss_pred cccCccccceEeccccccccCCCccccCCCCcceEec-cCCcCCCCCCCCCCCCCCCCEEEcccCCCCCCCChhhhcCCC
Q 002061 380 SYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDF-GDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTN 458 (973)
Q Consensus 380 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L-~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~ 458 (973)
+|.++++|++|++++|+|.+..+..+..++.+..++. ..|.++...+..|..+++|++|++++|.+....+..+....+
T Consensus 51 ~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~ 130 (284)
T d1ozna_ 51 SFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAA 130 (284)
T ss_dssp TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTT
T ss_pred HhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEecCCcccccccccccchhcc
Confidence 3445555666666666665555555555555555544 344555555566666666777777777666555666666667
Q ss_pred CCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCCccccccccccchhccccccccCCCccccccCCCCeeecCC
Q 002061 459 LERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSG 538 (973)
Q Consensus 459 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 538 (973)
|+.+++++|+++++.+..|..+++|+.|+|++|++++..+.+|.++++|+.+++++|++++..|..|.++++|++|++++
T Consensus 131 L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~ 210 (284)
T d1ozna_ 131 LQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFA 210 (284)
T ss_dssp CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred cchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccc
Confidence 77777777777665566666777777777777777766667777777777777777777766677777777777777777
Q ss_pred CccCCCCChhhhccc-CceEEccCCccccccCcc
Q 002061 539 NKLTGSIPDNLMKLK-LSSIDLSENQLSGSVPLD 571 (973)
Q Consensus 539 N~l~~~~p~~l~~l~-L~~l~ls~N~l~~~~p~~ 571 (973)
|++++..|..+..++ |+.|+|++|+|.|+|+..
T Consensus 211 N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~ 244 (284)
T d1ozna_ 211 NNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR 244 (284)
T ss_dssp SCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH
T ss_pred cccccccccccccccccCEEEecCCCCCCCccch
Confidence 777766666666654 777777777777777653
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=1.8e-24 Score=228.49 Aligned_cols=206 Identities=23% Similarity=0.245 Sum_probs=182.3
Q ss_pred ccccccccccccccccccCChhhhhhhhHHHHHhhhccCCCCccccccCccccceEeccccccccCCCccccCCCCcceE
Q 002061 335 RYTALTDVDISENQFSGSFPKYLCEKRKLLNLLALSNNFSGEVPNSYADCKTIQRLRISDNHLSGKIPDGLWALPNVGML 414 (973)
Q Consensus 335 ~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ll~ll~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 414 (973)
....+.++|.+++.|+ .+| ..+. +++++|+|++|+|++..+..|..+++|++|
T Consensus 8 ~~~~~~~v~C~~~~L~-~iP------------------------~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L 60 (266)
T d1p9ag_ 8 KVASHLEVNCDKRNLT-ALP------------------------PDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQL 60 (266)
T ss_dssp CSTTCCEEECTTSCCS-SCC------------------------SCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEE
T ss_pred ccCCCeEEEccCCCCC-eeC------------------------cCcC--cCCCEEECcCCcCCCcCHHHhhcccccccc
Confidence 3445566788888887 334 3332 579999999999998777889999999999
Q ss_pred eccCCcCCCCCCCCCCCCCCCCEEEcccCCCCCCCChhhhcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccc
Q 002061 415 DFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALT 494 (973)
Q Consensus 415 ~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 494 (973)
+|++|+|+... .++.+++|++|+|++|+++ ..+..+.++++|++|++++|.+.+..+..+..+.++++|++++|.++
T Consensus 61 ~L~~N~l~~l~--~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~ 137 (266)
T d1p9ag_ 61 NLDRAELTKLQ--VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK 137 (266)
T ss_dssp ECTTSCCCEEE--CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCC
T ss_pred ccccccccccc--ccccccccccccccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccc
Confidence 99999998654 3578999999999999998 56778999999999999999999888889999999999999999999
Q ss_pred cCCCccccccccccchhccccccccCCCccccccCCCCeeecCCCccCCCCChhhhccc-CceEEccCCccccccCcc
Q 002061 495 GSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLK-LSSIDLSENQLSGSVPLD 571 (973)
Q Consensus 495 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~-L~~l~ls~N~l~~~~p~~ 571 (973)
...+..+..+++|+.|++++|+|++..+..|..+++|++|+|++|+|+ .+|..+..++ |+.|+|++|||.|+|...
T Consensus 138 ~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC~~~ 214 (266)
T d1p9ag_ 138 TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCEIL 214 (266)
T ss_dssp CCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGGGH
T ss_pred eeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCcchH
Confidence 988999999999999999999999888899999999999999999999 7888877775 999999999999998753
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=3.2e-22 Score=210.98 Aligned_cols=198 Identities=23% Similarity=0.250 Sum_probs=102.3
Q ss_pred CCCCcEEEecCCcccCCCCcccCCCCCCEEeccCccCCCccccccccccccceEEccCCcCCCCCCcccccCCCCCCEEE
Q 002061 120 CSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLF 199 (973)
Q Consensus 120 l~~L~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ip~~~~~l~~L~~L~ 199 (973)
.+.+...+.++++++..|+.+. ++|++|||++|.|++..+..|.++++|++|+|++|.++. +| .++.+++|++|+
T Consensus 9 ~~~~~~v~C~~~~L~~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~--l~-~~~~l~~L~~L~ 83 (266)
T d1p9ag_ 9 VASHLEVNCDKRNLTALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK--LQ-VDGTLPVLGTLD 83 (266)
T ss_dssp STTCCEEECTTSCCSSCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE--EE-CCSCCTTCCEEE
T ss_pred cCCCeEEEccCCCCCeeCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc--cc-cccccccccccc
Confidence 3444445555555555544443 356666666666665444555555555555555555542 22 234566666666
Q ss_pred cccCCCCCCCChhhhccCCCCeeecccccccCCCchhhhccccccEEEeeccccCCcCCccccccccccEEEeecccccc
Q 002061 200 LAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYG 279 (973)
Q Consensus 200 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~ 279 (973)
|++|+++ ..+..+..+++|++|++++|.+....+..+..+.++++|++++|.++...+..+..+++|+.|++++|++++
T Consensus 84 Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~ 162 (266)
T d1p9ag_ 84 LSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTE 162 (266)
T ss_dssp CCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSC
T ss_pred ccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccc
Confidence 6666665 334455556666666666665554444444555555555555555554444444445555555555555554
Q ss_pred ccCCccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeeccCCc
Q 002061 280 KLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIYGNR 324 (973)
Q Consensus 280 ~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 324 (973)
..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|.
T Consensus 163 ~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np 206 (266)
T d1p9ag_ 163 LPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNP 206 (266)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCC
T ss_pred cCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCC
Confidence 44444444455555555555444 334333344444444444433
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.84 E-value=2.1e-19 Score=197.78 Aligned_cols=137 Identities=23% Similarity=0.205 Sum_probs=70.6
Q ss_pred cCcEeeCCCCcccCcCChhhhCCCCCcEEEecCCcccCCCCcccCCCCCCEEeccCccCCCccccccccccccceEEccC
Q 002061 98 SLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGD 177 (973)
Q Consensus 98 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~ 177 (973)
++++|||++|+++ .+|+. +++|++|+|++|+|+..|.. +.+|+.|++++|.++
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~~lp~~---~~~L~~L~l~~n~l~-------------------- 91 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLTELPEL---PQSLKSLLVDNNNLK-------------------- 91 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCSSCCCC---CTTCCEEECCSSCCS--------------------
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCcccccc---hhhhhhhhhhhcccc--------------------
Confidence 4666666666665 45532 34555555555555544322 234444455444443
Q ss_pred CcCCCCCCcccccCCCCCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCchhhhccccccEEEeeccccCCcC
Q 002061 178 NVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGEL 257 (973)
Q Consensus 178 n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~ 257 (973)
.+++. .+.|++|++++|.++ .+|. ++.+++|++|++++|.++.. +.. ...+..+.+..+... .
T Consensus 92 ------~l~~l---p~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~-~~~---~~~l~~l~~~~~~~~--~ 154 (353)
T d1jl5a_ 92 ------ALSDL---PPLLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLKKL-PDL---PPSLEFIAAGNNQLE--E 154 (353)
T ss_dssp ------CCCSC---CTTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCS--S
T ss_pred ------hhhhh---ccccccccccccccc-cccc-hhhhccceeecccccccccc-ccc---cccccchhhcccccc--c
Confidence 11110 135777777777776 3443 46677777777777766532 221 234444444444433 2
Q ss_pred CccccccccccEEEeeccccc
Q 002061 258 PAELGNLTLLQEFDISSNQMY 278 (973)
Q Consensus 258 ~~~l~~l~~L~~L~Ls~N~l~ 278 (973)
+..+..++.++.|++++|.+.
T Consensus 155 ~~~l~~l~~l~~L~l~~n~~~ 175 (353)
T d1jl5a_ 155 LPELQNLPFLTAIYADNNSLK 175 (353)
T ss_dssp CCCCTTCTTCCEEECCSSCCS
T ss_pred cccccccccceeccccccccc
Confidence 233445555555555555544
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.84 E-value=6.8e-19 Score=193.60 Aligned_cols=137 Identities=22% Similarity=0.271 Sum_probs=94.7
Q ss_pred ceEEEeecCCCCCccccccccCCccCcEeeCCCCcccCcCChhhhCCCCCcEEEecCCcccCCCCcccCCCCCCEEeccC
Q 002061 74 RVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSI 153 (973)
Q Consensus 74 ~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls~ 153 (973)
++++|||++++++ .+|+. +++|++|+|++|+|+ .+|.. +.+|+.|++++|+++.... + .+.|++||+++
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~~l~~-l--p~~L~~L~L~~ 107 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLKALSD-L--PPLLEYLGVSN 107 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSCCCS-C--CTTCCEEECCS
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccchhhh-h--ccccccccccc
Confidence 5779999999998 57754 578999999999999 77865 4689999999999876542 2 14689999999
Q ss_pred ccCCCccccccccccccceEEccCCcCCCCCCcccccCCCCCCEEEcccCCCCCCCChhhhccCCCCeeeccccccc
Q 002061 154 NYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKIS 230 (973)
Q Consensus 154 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 230 (973)
|.++. +|. ++.+++|++|+++++.+.. .|. ....+..+.+.++... .+..+..++.++.|++++|.+.
T Consensus 108 n~l~~-lp~-~~~l~~L~~L~l~~~~~~~--~~~---~~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~ 175 (353)
T d1jl5a_ 108 NQLEK-LPE-LQNSSFLKIIDVDNNSLKK--LPD---LPPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLK 175 (353)
T ss_dssp SCCSS-CCC-CTTCTTCCEEECCSSCCSC--CCC---CCTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCS
T ss_pred ccccc-ccc-hhhhccceeeccccccccc--ccc---ccccccchhhcccccc--ccccccccccceeccccccccc
Confidence 98874 343 5667777777777776542 222 2345556666555543 2334555666666666666554
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.82 E-value=3.1e-21 Score=192.14 Aligned_cols=160 Identities=18% Similarity=0.183 Sum_probs=117.5
Q ss_pred cccCcccccCceEEEEEEecCCCcEEEEEeeecc--------------------ccHHHHHHHHHHHHhcCCCceeeEEE
Q 002061 679 EEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--------------------DGVKVFAAEMEILGKIRHRNILKLYA 738 (973)
Q Consensus 679 ~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--------------------~~~~~~~~E~~~l~~l~hpniv~l~~ 738 (973)
.+.++||+|+||+||+|++. +|+.||||+++.. .......+|...+.++.|++++..++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred hhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 46789999999999999986 4889999976431 01123456888999999999998876
Q ss_pred EEEeCCeeEEEEEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhcCCCCeEecCCCCCCeeecCCCCe
Q 002061 739 CLLKGGSSFLVLEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHDCSPPIIHRDIKSSNILLDEDYEP 818 (973)
Q Consensus 739 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~ 818 (973)
+.. .+++|||++++.+.+ ++......++.|++++++||| +.+|+||||||+|||++++ .+
T Consensus 82 ~~~----~~lvme~~~~~~~~~------------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~ 141 (191)
T d1zara2 82 WEG----NAVLMELIDAKELYR------------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GI 141 (191)
T ss_dssp EET----TEEEEECCCCEEGGG------------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EE
T ss_pred ecC----CEEEEEeeccccccc------------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CE
Confidence 532 379999998765422 233345678999999999999 7899999999999999965 48
Q ss_pred EEecccCcccccCCCCcccccccCCccccccc--c---ccccCCCCccchHHHHHH
Q 002061 819 KIADFGVAKIAENSPKVSDYSCFAGTHGYIAP--E---LAYTCKVSEKSDVFSFGV 869 (973)
Q Consensus 819 kl~Dfgl~~~~~~~~~~~~~~~~~gt~~y~aP--E---~~~~~~~~~~~DvwslG~ 869 (973)
+++|||.|+....... ..|... + .+..+.|+.++|+||..-
T Consensus 142 ~liDFG~a~~~~~~~~----------~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 142 WIIDFPQSVEVGEEGW----------REILERDVRNIITYFSRTYRTEKDINSAID 187 (191)
T ss_dssp EECCCTTCEETTSTTH----------HHHHHHHHHHHHHHHHHHHCCCCCHHHHHH
T ss_pred EEEECCCcccCCCCCc----------HHHHHHHHHHHHHHHcCCCCCcccHHHHHH
Confidence 9999999976543211 011111 0 123467888999999653
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.78 E-value=1.8e-22 Score=231.17 Aligned_cols=185 Identities=23% Similarity=0.214 Sum_probs=93.8
Q ss_pred cccceEecccccccc-----CCCccccCCCCcceEeccCCcCCCCCC----CCCCCCCCCCEEEcccCCCCCCCChhh--
Q 002061 385 KTIQRLRISDNHLSG-----KIPDGLWALPNVGMLDFGDNDFTGGIS----PLIGLSTSLSQLVLQNNRFSGELPSEL-- 453 (973)
Q Consensus 385 ~~L~~L~Ls~N~l~~-----~~p~~~~~l~~L~~L~L~~N~l~~~~~----~~~~~~~~L~~L~L~~N~l~~~~p~~~-- 453 (973)
+.++.+++++|++.. ..+..+.....++.+++++|.+..... ..+...+.++.+++++|.+.......+
T Consensus 226 ~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~ 305 (460)
T d1z7xw1 226 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCE 305 (460)
T ss_dssp TTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHH
T ss_pred ccccccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhc
Confidence 445555555554421 112222334455555555555443211 112234556666666666542222111
Q ss_pred ---hcCCCCCEEEccCCcCCCCccc----cccccccCCEEEcCCcccccC----CCcccc-ccccccchhccccccccC-
Q 002061 454 ---GRLTNLERLILTNNNFSGKIPS----ALGALRQLSSLHLEENALTGS----IPNEMG-DCARIVDLNLARNSLSGN- 520 (973)
Q Consensus 454 ---~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~Ls~N~l~~~- 520 (973)
.....|+.+++++|.++..... .+...++|++|+|++|+++.. ++..+. ....|+.|+|++|+|+..
T Consensus 306 ~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~ 385 (460)
T d1z7xw1 306 TLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSS 385 (460)
T ss_dssp HHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHH
T ss_pred cccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHH
Confidence 1234566667766666533222 233445677777777766532 222222 345577777777777532
Q ss_pred ---CCccccccCCCCeeecCCCccCCCCChhhh----c--ccCceEEccCCccccccC
Q 002061 521 ---IPRSLSLLSSLNALNLSGNKLTGSIPDNLM----K--LKLSSIDLSENQLSGSVP 569 (973)
Q Consensus 521 ---~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~----~--l~L~~l~ls~N~l~~~~p 569 (973)
++..+..+++|++|+|++|+|+......+. . ..|+.|++++|++....+
T Consensus 386 ~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~~~ 443 (460)
T d1z7xw1 386 CSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEME 443 (460)
T ss_dssp HHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHH
T ss_pred HHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHHHH
Confidence 344455667777777777777632222221 1 137777777777775544
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.78 E-value=6.9e-19 Score=180.42 Aligned_cols=202 Identities=18% Similarity=0.259 Sum_probs=95.6
Q ss_pred eeCCCCcccCcCChhhhCCCCCcEEEecCCcccCCCCcccCCCCCCEEeccCccCCCccccccccccccceEEccCCcCC
Q 002061 102 LSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYD 181 (973)
Q Consensus 102 L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 181 (973)
++++.+++++.+ .++.+.+|+.|++.+|+++.. +.+..+++|++|++++|.+++..| +..+++|+.+++++|.++
T Consensus 24 ~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l-~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~ 98 (227)
T d1h6ua2 24 IAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI-EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK 98 (227)
T ss_dssp HHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS
T ss_pred HHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcc-hhHhcCCCCcEeecCCceeecccc--cccccccccccccccccc
Confidence 344444444322 233444455555555554433 334455555555555555543322 444445555555544443
Q ss_pred CCCCcccccCCCCCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCchhhhccccccEEEeeccccCCcCCccc
Q 002061 182 EAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAEL 261 (973)
Q Consensus 182 ~~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l 261 (973)
. + +.+.++++|+.+++++|...+. ..+...+.++.+.++.+.+... ..+...++|++|++++|.+++.. .+
T Consensus 99 ~--i-~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~--~l 169 (227)
T d1h6ua2 99 N--V-SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLT--PL 169 (227)
T ss_dssp C--C-GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCCG--GG
T ss_pred c--c-cccccccccccccccccccccc--chhccccchhhhhchhhhhchh--hhhccccccccccccccccccch--hh
Confidence 2 2 2344555555555555555432 2244445555555555555422 22444555555555555554221 24
Q ss_pred cccccccEEEeeccccccccCCccCCCCCccEEEcccCCCCCCCCCCcCCcccceeeecc
Q 002061 262 GNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFKNNFSGEFPSGFGDMRKLFAFSIY 321 (973)
Q Consensus 262 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 321 (973)
+++++|++|+|++|++++. + .+.++++|++|++++|++++.. .++++++|+.|+++
T Consensus 170 ~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~--~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 170 ANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLT 225 (227)
T ss_dssp TTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEE
T ss_pred cccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCCc--ccccCCCCCEEEee
Confidence 5555555555555555432 1 2455555555555555555322 14444455544443
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.77 E-value=1.1e-18 Score=178.98 Aligned_cols=207 Identities=19% Similarity=0.267 Sum_probs=171.8
Q ss_pred ceEEEeecCCCCCccccccccCCccCcEeeCCCCcccCcCChhhhCCCCCcEEEecCCcccCCCCcccCCCCCCEEeccC
Q 002061 74 RVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSI 153 (973)
Q Consensus 74 ~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls~ 153 (973)
.|+.+++...++++.+ .+..+.+|+.|++++|+|+. + ..+..+++|++|+|++|++++..+ +..+++|+++++++
T Consensus 20 ~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l-~~l~~l~~L~~L~ls~n~i~~~~~-l~~l~~l~~l~~~~ 94 (227)
T d1h6ua2 20 NAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-I-EGVQYLNNLIGLELKDNQITDLAP-LKNLTKITELELSG 94 (227)
T ss_dssp HHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG-GTTCCSCCEEECCS
T ss_pred HHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCc-c-hhHhcCCCCcEeecCCceeecccc-cccccccccccccc
Confidence 3556677777777654 56788999999999999984 5 469999999999999999987654 89999999999999
Q ss_pred ccCCCccccccccccccceEEccCCcCCCCCCcccccCCCCCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCC
Q 002061 154 NYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEF 233 (973)
Q Consensus 154 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 233 (973)
|.++.. ..+..+++|+.++++++.... ...+...+.++.+.++++.+... ..+...++|++|++++|++++..
T Consensus 95 n~~~~i--~~l~~l~~L~~l~l~~~~~~~---~~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~ 167 (227)
T d1h6ua2 95 NPLKNV--SAIAGLQSIKTLDLTSTQITD---VTPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLT 167 (227)
T ss_dssp CCCSCC--GGGTTCTTCCEEECTTSCCCC---CGGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCCG
T ss_pred cccccc--ccccccccccccccccccccc---cchhccccchhhhhchhhhhchh--hhhccccccccccccccccccch
Confidence 998743 468899999999999987753 24577789999999999998743 34788899999999999997433
Q ss_pred chhhhccccccEEEeeccccCCcCCccccccccccEEEeeccccccccCCccCCCCCccEEEccc
Q 002061 234 PRSIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCFK 298 (973)
Q Consensus 234 ~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 298 (973)
.++++++|++|+|++|++++ ++ .+.++++|++|+|++|++++.. .+.++++|+.|++++
T Consensus 168 --~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~i~--~l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 168 --PLANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTN 226 (227)
T ss_dssp --GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEE
T ss_pred --hhcccccceecccCCCccCC-Ch-hhcCCCCCCEEECcCCcCCCCc--ccccCCCCCEEEeeC
Confidence 48899999999999999985 43 4889999999999999998543 388999999999874
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.77 E-value=2e-19 Score=178.97 Aligned_cols=139 Identities=24% Similarity=0.316 Sum_probs=76.4
Q ss_pred CCCCEEEcccCCCCC-CCChhhhcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCCccccccccccchh
Q 002061 433 TSLSQLVLQNNRFSG-ELPSELGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLN 511 (973)
Q Consensus 433 ~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 511 (973)
+++++|+|++|+|++ ..+..|.++++|+.|+|++|++++..+..|..+++|++|+|++|+|+++.|.+|.++++|+.|+
T Consensus 29 ~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~ 108 (192)
T d1w8aa_ 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLN 108 (192)
T ss_dssp TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEE
T ss_pred CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccc
Confidence 345555555555543 2334455556666666666666555555566666666666666666655555566666666666
Q ss_pred ccccccccCCCccccccCCCCeeecCCCccCCCCChhhhcccCceEEccCCccccccCcc
Q 002061 512 LARNSLSGNIPRSLSLLSSLNALNLSGNKLTGSIPDNLMKLKLSSIDLSENQLSGSVPLD 571 (973)
Q Consensus 512 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~L~~l~ls~N~l~~~~p~~ 571 (973)
|++|+|++..|.+|..+++|++|+|++|++....+.......++.+.+..|.+.|..|..
T Consensus 109 L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~~p~~ 168 (192)
T d1w8aa_ 109 LYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSK 168 (192)
T ss_dssp CCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSSTT
T ss_pred cCCccccccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeEeCCChh
Confidence 666666655555566666666666666666533322211111444455555666555543
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.76 E-value=9.1e-19 Score=174.16 Aligned_cols=178 Identities=21% Similarity=0.279 Sum_probs=151.3
Q ss_pred ccceEeccccccccCCCccccCCCCcceEeccCCcCCC-CCCCCCCCCCCCCEEEcccCCCCCCCChhhhcCCCCCEEEc
Q 002061 386 TIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTG-GISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNLERLIL 464 (973)
Q Consensus 386 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 464 (973)
..++++.++|+++ .+|..+. +++++|+|++|+|++ .....|..+++|+.|+|++|++.+..+..|..+++|++|+|
T Consensus 9 ~~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L 85 (192)
T d1w8aa_ 9 EGTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQL 85 (192)
T ss_dssp ETTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred cCCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeee
Confidence 4568999999999 6777653 689999999999986 55667899999999999999999999999999999999999
Q ss_pred cCCcCCCCccccccccccCCEEEcCCcccccCCCccccccccccchhccccccccCCCccccccCCCCeeecCCCccCCC
Q 002061 465 TNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLSGNKLTGS 544 (973)
Q Consensus 465 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 544 (973)
++|+|+.+.|.+|.++++|++|+|++|+|+++.|.+|..+++|++|+|++|.+....+. ..-...++.+.+..|.++..
T Consensus 86 s~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~-~~~~~~l~~~~l~~~~~~c~ 164 (192)
T d1w8aa_ 86 GENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL-AWFAEWLRKKSLNGGAARCG 164 (192)
T ss_dssp CSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG-HHHHHHHHHHCCSGGGCBBC
T ss_pred ccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccch-HHHhhhhhhhcccCCCeEeC
Confidence 99999988888999999999999999999999999999999999999999999854332 22233467788899999888
Q ss_pred CChhhhcccCceEEccCCccccccC
Q 002061 545 IPDNLMKLKLSSIDLSENQLSGSVP 569 (973)
Q Consensus 545 ~p~~l~~l~L~~l~ls~N~l~~~~p 569 (973)
.|..+..+ +.++|+.|.+.|..+
T Consensus 165 ~p~~l~~~--~l~~L~~n~l~C~~~ 187 (192)
T d1w8aa_ 165 APSKVRDV--QIKDLPHSEFKCSSE 187 (192)
T ss_dssp SSTTTTTS--BGGGSCTTTCCCCCC
T ss_pred CChhhcCC--EeeecCHhhCcCCCC
Confidence 88776554 456889999988655
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=7.7e-19 Score=182.18 Aligned_cols=223 Identities=17% Similarity=0.125 Sum_probs=128.7
Q ss_pred CCCcceeeeCCCCCceEEEeecCCCCCccccccccCCccCcEeeCCCCcccCcCChhhhCCCCCcEEEecCCcccCCCC-
Q 002061 60 PCGFSGITCDSVTGRVTEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVP- 138 (973)
Q Consensus 60 ~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~- 138 (973)
-|.+..|.|. +.+++ .+|+.+. +++++|+|++|.|+...+..|.++++|++|+|++|.+...++
T Consensus 7 ~C~~~~i~c~------------~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~ 71 (242)
T d1xwdc1 7 HCSNRVFLCQ------------ESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEA 71 (242)
T ss_dssp EECSSEEEEE------------SCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECS
T ss_pred CCcCCEEEEe------------CCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeec
Confidence 3666666664 34444 4555442 467888888888874334467788888888888887765433
Q ss_pred -cccCCCCCCEEeccC-ccCCCccccccccccccceEEccCCcCCCCCCcccccCCCCCCEEEcccCCCCCCCChhhhcc
Q 002061 139 -DLSALKNLEIFDLSI-NYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISEL 216 (973)
Q Consensus 139 -~l~~l~~L~~L~Ls~-n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 216 (973)
.|.+++++++|++.. |.+....+..|.++++|++|++++|.+........+. .+
T Consensus 72 ~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~------------------------~l 127 (242)
T d1xwdc1 72 DVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH------------------------SL 127 (242)
T ss_dssp SSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTC------------------------BS
T ss_pred cccccccccccccccccccccccccccccccccccccccchhhhcccccccccc------------------------cc
Confidence 367777777777653 5565555555555555555555555443222112222 33
Q ss_pred CCCCeeecccccccCCCchhhhccc-cccEEEeeccccCCcCCccccccccccEE-EeeccccccccCCccCCCCCccEE
Q 002061 217 RELGTLDICRNKISGEFPRSIRKLQ-KLWKIELYANNLTGELPAELGNLTLLQEF-DISSNQMYGKLPEEIGNLKNLTVF 294 (973)
Q Consensus 217 ~~L~~L~L~~N~l~~~~~~~l~~l~-~L~~L~L~~N~l~~~~~~~l~~l~~L~~L-~Ls~N~l~~~~p~~~~~l~~L~~L 294 (973)
+.+..+..+++++....+..+..++ .++.|++++|+++. ++......++++++ ++++|+++...+..|.++++|++|
T Consensus 128 ~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~-i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L 206 (242)
T d1xwdc1 128 QKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVIL 206 (242)
T ss_dssp SCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE-ECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEE
T ss_pred cccccccccccccccccccccccccccceeeecccccccc-cccccccchhhhccccccccccccccHHHhcCCCCCCEE
Confidence 3333444444444433334444433 55666666666663 33333334444444 456666764444456777777777
Q ss_pred EcccCCCCCCCCCCcCCcccceeeeccC
Q 002061 295 QCFKNNFSGEFPSGFGDMRKLFAFSIYG 322 (973)
Q Consensus 295 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~ 322 (973)
++++|+|+...+..|.++++|+.+++.+
T Consensus 207 ~Ls~N~l~~l~~~~~~~l~~L~~l~~~~ 234 (242)
T d1xwdc1 207 DISRTRIHSLPSYGLENLKKLRARSTYN 234 (242)
T ss_dssp ECTTSCCCCCCSSSCTTCCEEESSSEES
T ss_pred ECCCCcCCccCHHHHcCCcccccCcCCC
Confidence 7777777755555677777777776643
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=3.8e-21 Score=220.01 Aligned_cols=108 Identities=19% Similarity=0.239 Sum_probs=54.9
Q ss_pred ceEEEeecCCCCCccc-cccccCCccCcEeeCCCCcccC----cCChhhhCCCCCcEEEecCCcccCC-----CCccc-C
Q 002061 74 RVTEISFDNKSLSGEI-SSSISALQSLTVLSLPFNVLSG----KLPLELSNCSNLKVLNVTGNAMVGS-----VPDLS-A 142 (973)
Q Consensus 74 ~v~~l~l~~~~l~~~~-~~~l~~l~~L~~L~Ls~n~l~~----~~p~~l~~l~~L~~L~L~~n~l~~~-----~~~l~-~ 142 (973)
++..||++.+++++.. ..-+..++++++|+|++|+++. .++..+..+++|++|||++|.|+.. ...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 4566666666666532 2334455666666666666652 2334455666666666666655321 01111 1
Q ss_pred CCCCCEEeccCccCCCc----cccccccccccceEEccCCcCC
Q 002061 143 LKNLEIFDLSINYFTGR----FPRWVVNLTQLVSLSIGDNVYD 181 (973)
Q Consensus 143 l~~L~~L~Ls~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~ 181 (973)
..+|++|+|++|.+++. ++..+..+++|++|++++|.++
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccch
Confidence 23566666666665532 2333444555555555555443
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=6.2e-18 Score=175.19 Aligned_cols=220 Identities=16% Similarity=0.054 Sum_probs=149.3
Q ss_pred cEEEecCCcccCCCCcccCCCCCCEEeccCccCCCccccccccccccceEEccCCcCCCCCCcccccCCCCCCEEEccc-
Q 002061 124 KVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAH- 202 (973)
Q Consensus 124 ~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ip~~~~~l~~L~~L~L~~- 202 (973)
+.++.+++.++..|+.+. +++++|||++|.++...+..|.++++|++|++++|.+...--+..+.+++++++|.+..
T Consensus 11 ~~i~c~~~~l~~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~ 88 (242)
T d1xwdc1 11 RVFLCQESKVTEIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 88 (242)
T ss_dssp SEEEEESCSCSSCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECC
T ss_pred CEEEEeCCCCCCcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccc
Confidence 344444444444443332 34555555555554433344555555555555555443211134566777777777654
Q ss_pred CCCCCCCChhhhccCCCCeeecccccccCCCc-hhhhccccccEEEeeccccCCcCCccccccc-cccEEEeeccccccc
Q 002061 203 CNLRGRIPESISELRELGTLDICRNKISGEFP-RSIRKLQKLWKIELYANNLTGELPAELGNLT-LLQEFDISSNQMYGK 280 (973)
Q Consensus 203 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~-~L~~L~Ls~N~l~~~ 280 (973)
|++....+..|..+++|++|++++|++....+ ..+..+..+..+...++.+....+..|..++ .++.|++++|+++.
T Consensus 89 n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~- 167 (242)
T d1xwdc1 89 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE- 167 (242)
T ss_dssp TTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE-
T ss_pred ccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccc-
Confidence 56776677778888888888888888874433 2345667777788888888866667777664 79999999999985
Q ss_pred cCCccCCCCCccEE-EcccCCCCCCCCCCcCCcccceeeeccCCccCCCCCcccccccccccccccc
Q 002061 281 LPEEIGNLKNLTVF-QCFKNNFSGEFPSGFGDMRKLFAFSIYGNRFSGPFPENLGRYTALTDVDISE 346 (973)
Q Consensus 281 ~p~~~~~l~~L~~L-~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~Ls~ 346 (973)
++....+..+++.+ .+++|+++...+..|.++++|+.|++++|+|+...+..|.++++|+.+++.+
T Consensus 168 i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~ 234 (242)
T d1xwdc1 168 IHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN 234 (242)
T ss_dssp ECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEES
T ss_pred cccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCCC
Confidence 44444455565555 5788889866667799999999999999999977777899999999988854
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.74 E-value=4.6e-18 Score=171.58 Aligned_cols=180 Identities=24% Similarity=0.307 Sum_probs=94.2
Q ss_pred eeCCCCcccCcCChhhhCCCCCcEEEecCCcccCCCCcccCCCCCCEEeccCccCCCccccccccccccceEEccCCcCC
Q 002061 102 LSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVYD 181 (973)
Q Consensus 102 L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 181 (973)
..+..+.+++.++. ..+.+|++|++++|.++... .+..+++|++|+|++|.+++.. .++.+++|++|++++|+++
T Consensus 29 ~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~-~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~ 103 (210)
T d1h6ta2 29 DNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQ-GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVK 103 (210)
T ss_dssp HHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCCT-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred HHhCcCccCCccCH--HHhcCccEEECcCCCCCCch-hHhhCCCCCEEeCCCccccCcc--ccccCcccccccccccccc
Confidence 34444555444332 23445555555555555432 3555556666666666555422 2445555555555555554
Q ss_pred CCCCcccccCCCCCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCchhhhccccccEEEeeccccCCcCCccc
Q 002061 182 EAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAEL 261 (973)
Q Consensus 182 ~~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l 261 (973)
. +| .+.++++|+.|++++|.+.. + ..+..+++|+.+++++|.+++ +..+..+++|+++++++|++++. + .+
T Consensus 104 ~--l~-~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i-~-~l 174 (210)
T d1h6ta2 104 D--LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDI-V-PL 174 (210)
T ss_dssp C--GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCC-G-GG
T ss_pred c--cc-cccccccccccccccccccc-c-ccccccccccccccccccccc--ccccccccccccccccccccccc-c-cc
Confidence 2 32 35556666666666666542 2 345556666666666666542 22345555666666666665532 2 25
Q ss_pred cccccccEEEeeccccccccCCccCCCCCccEEEcc
Q 002061 262 GNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVFQCF 297 (973)
Q Consensus 262 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 297 (973)
.++++|++|+|++|++++ +| .+.++++|++|+++
T Consensus 175 ~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 175 AGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELF 208 (210)
T ss_dssp TTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEE
T ss_pred cCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEcc
Confidence 556666666666666552 22 35555555555554
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.74 E-value=6.7e-18 Score=170.36 Aligned_cols=183 Identities=24% Similarity=0.318 Sum_probs=150.2
Q ss_pred EEEeecCCCCCccccccccCCccCcEeeCCCCcccCcCChhhhCCCCCcEEEecCCcccCCCCcccCCCCCCEEeccCcc
Q 002061 76 TEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINY 155 (973)
Q Consensus 76 ~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls~n~ 155 (973)
+...+..+.+++.++. ..+.+|++|++++|.+++ ++ .+..+++|++|+|++|++++.+ .++.+++|++|++++|+
T Consensus 27 i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~l~-~~~~l~~L~~L~l~~n~ 101 (210)
T d1h6ta2 27 IKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIK-PLANLKNLGWLFLDENK 101 (210)
T ss_dssp HHHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSC
T ss_pred HHHHhCcCccCCccCH--HHhcCccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccCcc-ccccCcccccccccccc
Confidence 3445566666665543 457889999999999974 33 5888999999999999998855 57889999999999999
Q ss_pred CCCccccccccccccceEEccCCcCCCCCCcccccCCCCCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCch
Q 002061 156 FTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPR 235 (973)
Q Consensus 156 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 235 (973)
+++ +| .+.++++|+.|++++|.+.. + ..+..+++|+.+++++|.+++ +..+..+++|+++++++|++++. +
T Consensus 102 i~~-l~-~l~~l~~L~~L~l~~~~~~~--~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i-~- 172 (210)
T d1h6ta2 102 VKD-LS-SLKDLKKLKSLSLEHNGISD--I-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDI-V- 172 (210)
T ss_dssp CCC-GG-GGTTCTTCCEEECTTSCCCC--C-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCC-G-
T ss_pred ccc-cc-cccccccccccccccccccc--c-ccccccccccccccccccccc--ccccccccccccccccccccccc-c-
Confidence 985 34 58889999999999998753 2 568889999999999999984 34678899999999999999853 3
Q ss_pred hhhccccccEEEeeccccCCcCCccccccccccEEEeec
Q 002061 236 SIRKLQKLWKIELYANNLTGELPAELGNLTLLQEFDISS 274 (973)
Q Consensus 236 ~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~ 274 (973)
.+.++++|++|+|++|+|+. ++ .+.++++|++|+|++
T Consensus 173 ~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 173 PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred cccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence 38899999999999999984 55 589999999999975
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.72 E-value=1e-17 Score=167.47 Aligned_cols=178 Identities=26% Similarity=0.370 Sum_probs=98.3
Q ss_pred EeeCCCCcccCcCChhhhCCCCCcEEEecCCcccCCCCcccCCCCCCEEeccCccCCCccccccccccccceEEccCCcC
Q 002061 101 VLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNVY 180 (973)
Q Consensus 101 ~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l 180 (973)
.+.++.+.+++.++ ...+.++++|++++|.++.. +.++.+++|++|++++|++++..| +.++++|++|++++|.+
T Consensus 22 ~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~ 96 (199)
T d2omxa2 22 KTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQI 96 (199)
T ss_dssp HHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred HHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCCc-cccccCCCcCcCccccccccCccc--ccCCccccccccccccc
Confidence 34455555554332 23455666666666666542 345566666666666666654332 55566666666666555
Q ss_pred CCCCCcccccCCCCCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCchhhhccccccEEEeeccccCCcCCcc
Q 002061 181 DEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAE 260 (973)
Q Consensus 181 ~~~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~ 260 (973)
.. ++ .+.++++|+.|++++|.+... ..+..+++|+.|++++|++.. + ..+..+++|++|++.+|++++. + .
T Consensus 97 ~~--~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~l-~-~ 167 (199)
T d2omxa2 97 AD--IT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVTDL-K-P 167 (199)
T ss_dssp CC--CG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCCC-G-G
T ss_pred cc--cc-ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhcc-c-ccccccccccccccccccccCC-c-c
Confidence 32 22 355666666666666666532 235566666666666666652 2 2455566666666666666532 2 2
Q ss_pred ccccccccEEEeeccccccccCCccCCCCCccEE
Q 002061 261 LGNLTLLQEFDISSNQMYGKLPEEIGNLKNLTVF 294 (973)
Q Consensus 261 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 294 (973)
++++++|++|++++|++++ ++ .++.+++|+.|
T Consensus 168 l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 168 LANLTTLERLDISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp GTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred ccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence 5566666666666666653 22 34555555543
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.72 E-value=2.4e-17 Score=164.67 Aligned_cols=179 Identities=21% Similarity=0.312 Sum_probs=144.3
Q ss_pred EEEeecCCCCCccccccccCCccCcEeeCCCCcccCcCChhhhCCCCCcEEEecCCcccCCCCcccCCCCCCEEeccCcc
Q 002061 76 TEISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINY 155 (973)
Q Consensus 76 ~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls~n~ 155 (973)
+...+..+++++.++ ...+.+|++|++++|+++. + ..+..+++|++|+|++|++++.++ ++++++|++|++++|.
T Consensus 21 i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~-l~~l~~L~~L~l~~n~ 95 (199)
T d2omxa2 21 MKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQ 95 (199)
T ss_dssp HHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSC
T ss_pred HHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc-ccCCcccccccccccc
Confidence 444566666666543 3567889999999999874 3 358889999999999999987654 8899999999999998
Q ss_pred CCCccccccccccccceEEccCCcCCCCCCcccccCCCCCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCch
Q 002061 156 FTGRFPRWVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPR 235 (973)
Q Consensus 156 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 235 (973)
+... + .+.++++|+.|++++|.+.. ...+..+++|+.|++++|++.. + +.+..+++|++|++++|++++. +
T Consensus 96 ~~~~-~-~l~~l~~L~~L~l~~~~~~~---~~~~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~l-~- 166 (199)
T d2omxa2 96 IADI-T-PLANLTNLTGLTLFNNQITD---IDPLKNLTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVTDL-K- 166 (199)
T ss_dssp CCCC-G-GGTTCTTCSEEECCSSCCCC---CGGGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCCC-G-
T ss_pred cccc-c-cccccccccccccccccccc---ccccchhhhhHHhhhhhhhhcc-c-ccccccccccccccccccccCC-c-
Confidence 8753 2 48899999999999988753 2457889999999999999974 3 4688999999999999999853 3
Q ss_pred hhhccccccEEEeeccccCCcCCccccccccccEE
Q 002061 236 SIRKLQKLWKIELYANNLTGELPAELGNLTLLQEF 270 (973)
Q Consensus 236 ~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L 270 (973)
.++++++|++|++++|++++ ++ .++.+++|++|
T Consensus 167 ~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 167 PLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred cccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence 48899999999999999985 44 57888888876
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.58 E-value=1.9e-16 Score=167.51 Aligned_cols=221 Identities=15% Similarity=0.248 Sum_probs=106.0
Q ss_pred EEeecCCCCCccccccccCCccCcEeeCCCCcccCcCChhhhCCCCCcEEEecCCcccCCC-C-cccCCCCCCEEeccCc
Q 002061 77 EISFDNKSLSGEISSSISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSV-P-DLSALKNLEIFDLSIN 154 (973)
Q Consensus 77 ~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~-~-~l~~l~~L~~L~Ls~n 154 (973)
.+||+++.+.+.....+.. ..+..+.++...+...+ .......+|++|||+++.++... . -+..+++|++|+|++|
T Consensus 4 ~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~-~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~ 81 (284)
T d2astb2 4 TLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPL-AEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGL 81 (284)
T ss_dssp EEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCC-CSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTC
T ss_pred EEECCCCCCCchHHHHHHh-ccceEeeccccccccch-hhhccCCCCCEEECCCCccCHHHHHHHHHhCCCccccccccc
Confidence 4566666555433332221 12344555544443222 22333446666666666654321 1 2456666666666666
Q ss_pred cCCCccccccccccccceEEccCC-cCCCCCCcccccCCCCCCEEEcccCC-CCCC-CChhhhcc-CCCCeeecccc--c
Q 002061 155 YFTGRFPRWVVNLTQLVSLSIGDN-VYDEAEIPESIGNLKNLTYLFLAHCN-LRGR-IPESISEL-RELGTLDICRN--K 228 (973)
Q Consensus 155 ~l~~~~~~~~~~l~~L~~L~l~~n-~l~~~~ip~~~~~l~~L~~L~L~~n~-l~~~-~~~~~~~l-~~L~~L~L~~N--~ 228 (973)
.+++..+..++.+++|++|+++++ .+++..+.....++++|++|++++|. ++.. +...+... ++|+.|+++++ .
T Consensus 82 ~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~ 161 (284)
T d2astb2 82 RLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKN 161 (284)
T ss_dssp BCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGG
T ss_pred CCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhcccccc
Confidence 666555566666666666666653 34333333333455666666666642 2211 11122222 45666666543 2
Q ss_pred ccCC-CchhhhccccccEEEeecc-ccCCcCCccccccccccEEEeecc-ccccccCCccCCCCCccEEEcccC
Q 002061 229 ISGE-FPRSIRKLQKLWKIELYAN-NLTGELPAELGNLTLLQEFDISSN-QMYGKLPEEIGNLKNLTVFQCFKN 299 (973)
Q Consensus 229 l~~~-~~~~l~~l~~L~~L~L~~N-~l~~~~~~~l~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~l~~N 299 (973)
++.. +...+.++++|++|++++| .+++.....+.++++|++|+|+++ .+++.....++++++|+.|+++++
T Consensus 162 i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 162 LQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp SCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred cccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 3221 1122234455555555543 344444445555555555555552 344444444444555555555443
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.54 E-value=1.3e-15 Score=160.98 Aligned_cols=248 Identities=16% Similarity=0.192 Sum_probs=175.0
Q ss_pred cEeeCCCCcccCcCChhhhCCCCCcEEEecCCcccCCCCcccCCCCCCEEeccCccCCCc-cccccccccccceEEccCC
Q 002061 100 TVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGR-FPRWVVNLTQLVSLSIGDN 178 (973)
Q Consensus 100 ~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~-~~~~~~~l~~L~~L~l~~n 178 (973)
++|||+++.+.......+.. ..+..+.++...+...........+|++|||++|.+++. +...+..+++|++|+++++
T Consensus 3 ~~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~ 81 (284)
T d2astb2 3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGL 81 (284)
T ss_dssp SEEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTC
T ss_pred CEEECCCCCCCchHHHHHHh-ccceEeeccccccccchhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCccccccccc
Confidence 57899999886433333322 246677887777765555556678999999999998754 4556788999999999999
Q ss_pred cCCCCCCcccccCCCCCCEEEcccC-CCCCC-CChhhhccCCCCeeecccc-cccCC-Cchhhhcc-ccccEEEeecc--
Q 002061 179 VYDEAEIPESIGNLKNLTYLFLAHC-NLRGR-IPESISELRELGTLDICRN-KISGE-FPRSIRKL-QKLWKIELYAN-- 251 (973)
Q Consensus 179 ~l~~~~ip~~~~~l~~L~~L~L~~n-~l~~~-~~~~~~~l~~L~~L~L~~N-~l~~~-~~~~l~~l-~~L~~L~L~~N-- 251 (973)
.+++ ..+..++.+++|++|+|++| .++.. +..-...+++|++|+++++ .++.. +...+... ++|+.|+++++
T Consensus 82 ~l~~-~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~ 160 (284)
T d2astb2 82 RLSD-PIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRK 160 (284)
T ss_dssp BCCH-HHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGG
T ss_pred CCCc-HHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhccccc
Confidence 8764 34577888999999999996 55532 1222457899999999986 45432 22334443 68999999864
Q ss_pred ccCCc-CCccccccccccEEEeecc-ccccccCCccCCCCCccEEEcccC-CCCCCCCCCcCCcccceeeeccCCccCCC
Q 002061 252 NLTGE-LPAELGNLTLLQEFDISSN-QMYGKLPEEIGNLKNLTVFQCFKN-NFSGEFPSGFGDMRKLFAFSIYGNRFSGP 328 (973)
Q Consensus 252 ~l~~~-~~~~l~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~l~~N-~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 328 (973)
.++.. +...+.++++|++|++++| .+++.....+.++++|++|+++++ ++++.....++.+++|+.|+++++ ++.
T Consensus 161 ~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~d- 238 (284)
T d2astb2 161 NLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPD- 238 (284)
T ss_dssp GSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCT-
T ss_pred ccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC-CCH-
Confidence 45432 2233456899999999986 577777888889999999999984 677766677888899999999887 332
Q ss_pred CCcccccc-ccccccccccccccccC
Q 002061 329 FPENLGRY-TALTDVDISENQFSGSF 353 (973)
Q Consensus 329 ~~~~l~~l-~~L~~L~Ls~N~l~~~~ 353 (973)
..+..+ ..+..|.+..+.++...
T Consensus 239 --~~l~~l~~~lp~L~i~~~~ls~~~ 262 (284)
T d2astb2 239 --GTLQLLKEALPHLQINCSHFTTIA 262 (284)
T ss_dssp --TCHHHHHHHSTTSEESCCCSCCTT
T ss_pred --HHHHHHHHhCccccccCccCCCCC
Confidence 222222 23455566777776443
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=8.1e-15 Score=140.05 Aligned_cols=130 Identities=15% Similarity=0.126 Sum_probs=79.9
Q ss_pred cccCCccCcEeeCCCCcccCcCChhhhCCCCCcEEEecCCcccCCCCcccCCCCCCEEeccCccCCCccccccccccccc
Q 002061 92 SISALQSLTVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLV 171 (973)
Q Consensus 92 ~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 171 (973)
.+.+...|++|+|++|+|+ .+|..+..+++|++|+|++|+|+.. +.+..+++|++|++++|.+++..+..+..+++|+
T Consensus 13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc-CCcccCcchhhhhcccccccCCCccccccccccc
Confidence 3556667778888888877 4566667777788888888877654 4577777777777777777755444455666666
Q ss_pred eEEccCCcCCCCCCcccccCCCCCCEEEcccCCCCCCC---ChhhhccCCCCeee
Q 002061 172 SLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGRI---PESISELRELGTLD 223 (973)
Q Consensus 172 ~L~l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~---~~~~~~l~~L~~L~ 223 (973)
+|++++|.+....-...+..+++|++|++++|.++... +..+..+++|++||
T Consensus 91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred cceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 66666666643211124455556666666666554221 11344455555444
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.52 E-value=3.2e-14 Score=129.02 Aligned_cols=118 Identities=25% Similarity=0.291 Sum_probs=61.0
Q ss_pred cEeeCCCCcccCcCChhhhCCCCCcEEEecCCcccCCCCcccCCCCCCEEeccCccCCCccccccccccccceEEccCCc
Q 002061 100 TVLSLPFNVLSGKLPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFTGRFPRWVVNLTQLVSLSIGDNV 179 (973)
Q Consensus 100 ~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~ 179 (973)
|+|+|++|+++ .++ .++.+++|++|++++|+++..++.++.+++|++|++++|.+++
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~~lp~~~~~l~~L~~L~l~~N~i~~--------------------- 57 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALEN--------------------- 57 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCC---------------------
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccCcchhhhhhhhcccccccccccccc---------------------
Confidence 35566666665 333 3555666666666666665555555555555555555555553
Q ss_pred CCCCCCcccccCCCCCCEEEcccCCCCCCC-ChhhhccCCCCeeecccccccCC---CchhhhccccccEE
Q 002061 180 YDEAEIPESIGNLKNLTYLFLAHCNLRGRI-PESISELRELGTLDICRNKISGE---FPRSIRKLQKLWKI 246 (973)
Q Consensus 180 l~~~~ip~~~~~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~---~~~~l~~l~~L~~L 246 (973)
+| .++.+++|++|++++|+++... ...+..+++|++|++++|.++.. ....+..+++|+.|
T Consensus 58 -----l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L 122 (124)
T d1dcea3 58 -----VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122 (124)
T ss_dssp -----CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred -----cC-ccccccccCeEECCCCccCCCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence 22 2445555555555555555322 13455555566666666555422 12223345555544
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.51 E-value=4.9e-16 Score=169.80 Aligned_cols=95 Identities=17% Similarity=0.255 Sum_probs=56.9
Q ss_pred cCChhhhCCCCCcEEEecCCcccCC-----CCcccCCCCCCEEeccCccCCCc----------cccccccccccceEEcc
Q 002061 112 KLPLELSNCSNLKVLNVTGNAMVGS-----VPDLSALKNLEIFDLSINYFTGR----------FPRWVVNLTQLVSLSIG 176 (973)
Q Consensus 112 ~~p~~l~~l~~L~~L~L~~n~l~~~-----~~~l~~l~~L~~L~Ls~n~l~~~----------~~~~~~~l~~L~~L~l~ 176 (973)
.+...+.+...|+.|+|++|.+... ...+...++|+.|+++++..... +...+...++|++|+|+
T Consensus 22 ~l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~ 101 (344)
T d2ca6a1 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 101 (344)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccc
Confidence 4566778888899999999887431 22467778888888887765421 11223345556666666
Q ss_pred CCcCCCCC---CcccccCCCCCCEEEcccCCCC
Q 002061 177 DNVYDEAE---IPESIGNLKNLTYLFLAHCNLR 206 (973)
Q Consensus 177 ~n~l~~~~---ip~~~~~l~~L~~L~L~~n~l~ 206 (973)
+|.++... +...+...++|++|++++|.++
T Consensus 102 ~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~ 134 (344)
T d2ca6a1 102 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLG 134 (344)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCH
T ss_pred ccccccccccchhhhhcccccchheeccccccc
Confidence 66554332 1223334555666666665543
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.50 E-value=1.4e-14 Score=138.44 Aligned_cols=112 Identities=25% Similarity=0.279 Sum_probs=78.5
Q ss_pred cccCccccceEeccccccccCCCccccCCCCcceEeccCCcCCCCCCCCCCCCCCCCEEEcccCCCCCCCChhhhcCCCC
Q 002061 380 SYADCKTIQRLRISDNHLSGKIPDGLWALPNVGMLDFGDNDFTGGISPLIGLSTSLSQLVLQNNRFSGELPSELGRLTNL 459 (973)
Q Consensus 380 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L 459 (973)
.|.++.++++|+|++|+|+ .++..+..+++|+.|+|++|+|+.. +.+..+++|++|++++|+++...+..+..+++|
T Consensus 13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCcccccccccc
Confidence 3567778888999999888 4566667778888888888887754 235667777777777777775555556667777
Q ss_pred CEEEccCCcCCCCcc-ccccccccCCEEEcCCcccc
Q 002061 460 ERLILTNNNFSGKIP-SALGALRQLSSLHLEENALT 494 (973)
Q Consensus 460 ~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~ 494 (973)
+.|+|++|+|+.... ..+..+++|++|++++|.++
T Consensus 90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 90 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred ccceeccccccccccccccccccccchhhcCCCccc
Confidence 777777777763211 35666667777777777665
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.49 E-value=1.5e-15 Score=165.76 Aligned_cols=243 Identities=16% Similarity=0.164 Sum_probs=148.8
Q ss_pred cccccccCCccCcEeeCCCCcccCc----CChhhhCCCCCcEEEecCCcccCCC-----------CcccCCCCCCEEecc
Q 002061 88 EISSSISALQSLTVLSLPFNVLSGK----LPLELSNCSNLKVLNVTGNAMVGSV-----------PDLSALKNLEIFDLS 152 (973)
Q Consensus 88 ~~~~~l~~l~~L~~L~Ls~n~l~~~----~p~~l~~l~~L~~L~L~~n~l~~~~-----------~~l~~l~~L~~L~Ls 152 (973)
.+...+.....|+.|+|++|.++.. +-..+...++|+.|+++++...... ..+...++|++|||+
T Consensus 22 ~l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~ 101 (344)
T d2ca6a1 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 101 (344)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccc
Confidence 3455678899999999999998653 3345677899999999988654322 124567899999999
Q ss_pred CccCCCc----cccccccccccceEEccCCcCCCCCCc---c---------cccCCCCCCEEEcccCCCCCC----CChh
Q 002061 153 INYFTGR----FPRWVVNLTQLVSLSIGDNVYDEAEIP---E---------SIGNLKNLTYLFLAHCNLRGR----IPES 212 (973)
Q Consensus 153 ~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~~ip---~---------~~~~l~~L~~L~L~~n~l~~~----~~~~ 212 (973)
+|.++.. +...+...++|++|++++|.+...... . .....+.|+.|.+++|+++.. +...
T Consensus 102 ~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~ 181 (344)
T d2ca6a1 102 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT 181 (344)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHH
T ss_pred ccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccch
Confidence 9999865 344556789999999999987432100 0 113456788888888877632 2233
Q ss_pred hhccCCCCeeecccccccCC-----CchhhhccccccEEEeeccccCCc----CCccccccccccEEEeeccccccccCC
Q 002061 213 ISELRELGTLDICRNKISGE-----FPRSIRKLQKLWKIELYANNLTGE----LPAELGNLTLLQEFDISSNQMYGKLPE 283 (973)
Q Consensus 213 ~~~l~~L~~L~L~~N~l~~~-----~~~~l~~l~~L~~L~L~~N~l~~~----~~~~l~~l~~L~~L~Ls~N~l~~~~p~ 283 (973)
+...+.|++|+|++|+|+.. +...+...++|++|+|++|.++.. +...+..+++|++|+|++|.+++....
T Consensus 182 l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~ 261 (344)
T d2ca6a1 182 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAA 261 (344)
T ss_dssp HHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHH
T ss_pred hhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhH
Confidence 45566777777777776532 222344556666666666665422 223344555666666666655433222
Q ss_pred ccCCCCCccEEEcccCCCCCCCCCCcC--CcccceeeeccCCccCCCC----Cccc-ccccccccccccccccc
Q 002061 284 EIGNLKNLTVFQCFKNNFSGEFPSGFG--DMRKLFAFSIYGNRFSGPF----PENL-GRYTALTDVDISENQFS 350 (973)
Q Consensus 284 ~~~~l~~L~~L~l~~N~l~~~~p~~~~--~l~~L~~L~l~~N~l~~~~----~~~l-~~l~~L~~L~Ls~N~l~ 350 (973)
.+.. .+. ..+.|+.|++++|+|+... ...+ .++++|+.|+|++|++.
T Consensus 262 ~l~~--------------------~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 262 AVVD--------------------AFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp HHHH--------------------HHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred HHHH--------------------HhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence 2210 111 1234555555555544221 1222 24567888888888876
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.48 E-value=5.6e-14 Score=127.38 Aligned_cols=87 Identities=33% Similarity=0.447 Sum_probs=35.8
Q ss_pred hhcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccccCCCccccccccccchhccccccccCCC-ccccccCCC
Q 002061 453 LGRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIP-RSLSLLSSL 531 (973)
Q Consensus 453 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L 531 (973)
+..+++|++|++++|+|+ .+|..|..+++|+.|++++|+|++. | .++.+++|+.|++++|+|+.... ..+..+++|
T Consensus 16 l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L 92 (124)
T d1dcea3 16 LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRL 92 (124)
T ss_dssp GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTC
T ss_pred cccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-C-ccccccccCeEECCCCccCCCCCchhhcCCCCC
Confidence 334444444444444443 2233344444444444444444322 1 23444444444444444442211 234444445
Q ss_pred CeeecCCCccC
Q 002061 532 NALNLSGNKLT 542 (973)
Q Consensus 532 ~~L~L~~N~l~ 542 (973)
+.|++++|+++
T Consensus 93 ~~L~l~~N~i~ 103 (124)
T d1dcea3 93 VLLNLQGNSLC 103 (124)
T ss_dssp CEEECTTSGGG
T ss_pred CEEECCCCcCC
Confidence 55555555444
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.41 E-value=3.3e-13 Score=127.76 Aligned_cols=112 Identities=22% Similarity=0.210 Sum_probs=79.8
Q ss_pred CCEEEccCCcCCCCccccccccccCCEEEcCCc-ccccCCCccccccccccchhccccccccCCCccccccCCCCeeecC
Q 002061 459 LERLILTNNNFSGKIPSALGALRQLSSLHLEEN-ALTGSIPNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSLNALNLS 537 (973)
Q Consensus 459 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 537 (973)
.+.++.+++.++ ..|..+..+++|++|++++| .|+.+.+.+|.++++|+.|+|++|+|+...|.+|..+++|++|+|+
T Consensus 10 ~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls 88 (156)
T d2ifga3 10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (156)
T ss_dssp SSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceecc
Confidence 445666666665 44556666677777777655 4666666677777777777777777776667778888888888888
Q ss_pred CCccCCCCChhhhcccCceEEccCCccccccCcc
Q 002061 538 GNKLTGSIPDNLMKLKLSSIDLSENQLSGSVPLD 571 (973)
Q Consensus 538 ~N~l~~~~p~~l~~l~L~~l~ls~N~l~~~~p~~ 571 (973)
+|+|+...+..+..++++.|+|++|+|.|.|...
T Consensus 89 ~N~l~~l~~~~~~~~~l~~L~L~~Np~~C~C~~~ 122 (156)
T d2ifga3 89 FNALESLSWKTVQGLSLQELVLSGNPLHCSCALR 122 (156)
T ss_dssp SSCCSCCCSTTTCSCCCCEEECCSSCCCCCGGGH
T ss_pred CCCCcccChhhhccccccccccCCCcccCCchHH
Confidence 8888854555555567888888888888887653
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.35 E-value=2e-14 Score=142.40 Aligned_cols=44 Identities=27% Similarity=0.348 Sum_probs=24.5
Q ss_pred CChhhhCCCCCcEEEecCCcccCCCCcccCCCCCCEEeccCccCC
Q 002061 113 LPLELSNCSNLKVLNVTGNAMVGSVPDLSALKNLEIFDLSINYFT 157 (973)
Q Consensus 113 ~p~~l~~l~~L~~L~L~~n~l~~~~~~l~~l~~L~~L~Ls~n~l~ 157 (973)
+|..++.+++|++|+|++|+|+.. +.+..+++|++|+|++|.++
T Consensus 40 l~~sl~~L~~L~~L~Ls~n~I~~i-~~l~~l~~L~~L~Ls~N~i~ 83 (198)
T d1m9la_ 40 MDATLSTLKACKHLALSTNNIEKI-SSLSGMENLRILSLGRNLIK 83 (198)
T ss_dssp CHHHHHHTTTCCEEECSEEEESCC-CCHHHHTTCCEEECCEEEEC
T ss_pred hhhHHhcccccceeECcccCCCCc-ccccCCccccChhhcccccc
Confidence 344555566666666666665543 34555555555555555554
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.34 E-value=1.2e-12 Score=123.90 Aligned_cols=108 Identities=25% Similarity=0.231 Sum_probs=91.3
Q ss_pred CCCCEEEcccCCCCCCCChhhhcCCCCCEEEccCC-cCCCCccccccccccCCEEEcCCcccccCCCccccccccccchh
Q 002061 433 TSLSQLVLQNNRFSGELPSELGRLTNLERLILTNN-NFSGKIPSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLN 511 (973)
Q Consensus 433 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 511 (973)
...+.++.+++.+. ..|..+..+++|++|++++| .|+.+.+.+|.++++|+.|+|++|+|+.+.|.+|..+++|+.|+
T Consensus 8 ~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~ 86 (156)
T d2ifga3 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN 86 (156)
T ss_dssp SSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEE
T ss_pred CCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccccee
Confidence 34566888888887 56778888899999999766 48877778899999999999999999998899999999999999
Q ss_pred ccccccccCCCccccccCCCCeeecCCCccC
Q 002061 512 LARNSLSGNIPRSLSLLSSLNALNLSGNKLT 542 (973)
Q Consensus 512 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 542 (973)
|++|+|+...+..|.. .+|+.|+|++|++.
T Consensus 87 Ls~N~l~~l~~~~~~~-~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 87 LSFNALESLSWKTVQG-LSLQELVLSGNPLH 116 (156)
T ss_dssp CCSSCCSCCCSTTTCS-CCCCEEECCSSCCC
T ss_pred ccCCCCcccChhhhcc-ccccccccCCCccc
Confidence 9999999655555654 47999999999996
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.33 E-value=4.1e-14 Score=140.10 Aligned_cols=113 Identities=20% Similarity=0.238 Sum_probs=54.8
Q ss_pred CcccccCCCCCCEEEcccCCCCCCCChhhhccCCCCeeecccccccCCCchhhhccccccEEEeeccccCCcCCcccccc
Q 002061 185 IPESIGNLKNLTYLFLAHCNLRGRIPESISELRELGTLDICRNKISGEFPRSIRKLQKLWKIELYANNLTGELPAELGNL 264 (973)
Q Consensus 185 ip~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l 264 (973)
+|..+..+++|++|+|++|+|+. ++ .+..+++|++|+|++|+|+ .+|..+..+++|++|++++|+|+. + ..+..+
T Consensus 40 l~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~l 114 (198)
T d1m9la_ 40 MDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEKL 114 (198)
T ss_dssp CHHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHHH
T ss_pred hhhHHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-cccccc
Confidence 34445555555555555555552 22 3555555555555555554 334333444455555555555552 2 224455
Q ss_pred ccccEEEeeccccccccC-CccCCCCCccEEEcccCCCC
Q 002061 265 TLLQEFDISSNQMYGKLP-EEIGNLKNLTVFQCFKNNFS 302 (973)
Q Consensus 265 ~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~ 302 (973)
++|+.|++++|+++.... ..+..+++|+.|++++|.+.
T Consensus 115 ~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 115 VNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp HHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred ccccccccccchhccccccccccCCCccceeecCCCccc
Confidence 555555555555542211 23444555555555555443
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.49 E-value=5.1e-09 Score=99.12 Aligned_cols=91 Identities=24% Similarity=0.201 Sum_probs=51.4
Q ss_pred CChhhhcCCCCCEEEccCCcCCCCc--cccccccccCCEEEcCCcccccCCCccccccccccchhccccccccCCCc---
Q 002061 449 LPSELGRLTNLERLILTNNNFSGKI--PSALGALRQLSSLHLEENALTGSIPNEMGDCARIVDLNLARNSLSGNIPR--- 523 (973)
Q Consensus 449 ~p~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~--- 523 (973)
++..+..+++|++|+|++|+|+... +..+..+++|+.|+|++|+|+...+-.+.+..+|+.|+|++|.++.....
T Consensus 57 l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~ 136 (162)
T d1koha1 57 LRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQST 136 (162)
T ss_dssp HHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHH
T ss_pred hHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchh
Confidence 3344456677777777777776432 34455666677777777766644333333444566666666666544332
Q ss_pred ----cccccCCCCeeecCCCcc
Q 002061 524 ----SLSLLSSLNALNLSGNKL 541 (973)
Q Consensus 524 ----~~~~l~~L~~L~L~~N~l 541 (973)
.+..+|+|+.|| |+.+
T Consensus 137 y~~~i~~~~P~L~~LD--g~~v 156 (162)
T d1koha1 137 YISAIRERFPKLLRLD--GHEL 156 (162)
T ss_dssp HHHHHHTTSTTCCEET--TEEC
T ss_pred HHHHHHHHCCCCCEEC--cCCC
Confidence 134566666554 4444
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.41 E-value=9.7e-09 Score=97.10 Aligned_cols=92 Identities=20% Similarity=0.087 Sum_probs=60.6
Q ss_pred hcCCCCCEEEccCCcCCCCccccccccccCCEEEcCCcccccCC--CccccccccccchhccccccccCCCccccccCCC
Q 002061 454 GRLTNLERLILTNNNFSGKIPSALGALRQLSSLHLEENALTGSI--PNEMGDCARIVDLNLARNSLSGNIPRSLSLLSSL 531 (973)
Q Consensus 454 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 531 (973)
..+..+..++..+|... .++..+..+++|++|+|++|+|+... +..+..+++|+.|+|++|+|+...+-.+.....|
T Consensus 39 ~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L 117 (162)
T d1koha1 39 VAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKL 117 (162)
T ss_dssp TTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCC
T ss_pred hhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhcccc
Confidence 33344444445444443 45555667888888888888888643 3446677888888888888885444344455678
Q ss_pred CeeecCCCccCCCCC
Q 002061 532 NALNLSGNKLTGSIP 546 (973)
Q Consensus 532 ~~L~L~~N~l~~~~p 546 (973)
+.|+|++|++++...
T Consensus 118 ~~L~L~~Npl~~~~~ 132 (162)
T d1koha1 118 EELWLDGNSLSDTFR 132 (162)
T ss_dssp SSCCCTTSTTSSSSS
T ss_pred ceeecCCCCcCcCcc
Confidence 888888888875544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.05 E-value=7e-06 Score=83.86 Aligned_cols=143 Identities=17% Similarity=0.060 Sum_probs=91.9
Q ss_pred HHHcCCcccCcccccCceEEEEEEecCCCcEEEEEeeecc--ccHHHHHHHHHHHHhcC-CCceeeEEEEEEeCCeeEEE
Q 002061 673 EQICNLEEDNLIGSGGTGKVYRLDLKKNAGTVAVKQLWKG--DGVKVFAAEMEILGKIR-HRNILKLYACLLKGGSSFLV 749 (973)
Q Consensus 673 ~~~~~~~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv 749 (973)
..+..|+..+..+-++.+.||+.... ++.++||+.... .....+.+|...++.+. +--+-+++++...++..++|
T Consensus 11 ~~~~~~~~~~~~~G~s~~~v~rv~~~--~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv 88 (263)
T d1j7la_ 11 KLIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHTTSEEEECSCCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HhhhceEEEEcCCCCCCCcEEEEEeC--CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEE
Confidence 34556666655444445789987643 667888977553 23445778999888774 33355677778888899999
Q ss_pred EEccCCCchHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhhhhc----------------------------------
Q 002061 750 LEYMPNGNLFQALHKRVKEGKPELDWFRRYKIALGAAKGIAYLHHD---------------------------------- 795 (973)
Q Consensus 750 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~~ia~~l~~LH~~---------------------------------- 795 (973)
|++++|.++.+.... .... ..++.++++.++.||+.
T Consensus 89 ~~~l~G~~~~~~~~~-------~~~~---~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 89 MSEADGVLCSEEYED-------EQSP---EKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EECCSSEEHHHHTTT-------CSCH---HHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEecccccccccccc-------cccH---HHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 999998877543211 0011 11223333333333320
Q ss_pred ----------------------CCCCeEecCCCCCCeeecCCCCeEEecccCcc
Q 002061 796 ----------------------CSPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827 (973)
Q Consensus 796 ----------------------~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~ 827 (973)
....++|+|+.|.||++++++.+-|.||+.+.
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 01237899999999999987667799999764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.68 E-value=3.7e-05 Score=77.80 Aligned_cols=74 Identities=18% Similarity=0.235 Sum_probs=52.4
Q ss_pred cccccCc-eEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhcCC--CceeeEEEEEEeCCeeEEEEEccCCCch
Q 002061 683 LIGSGGT-GKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRH--RNILKLYACLLKGGSSFLVLEYMPNGNL 758 (973)
Q Consensus 683 ~lG~G~~-g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~~~~lv~e~~~~gsL 758 (973)
.+..|.. +.||+..... +..+++|.... .....+.+|+..++.+.. -.+-+++++..+++..++||+|++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~-~~~~vlK~~~~-~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQG-RPVLFVKTDLS-GALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTT-SCCEEEEEECS-CTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCC-CCEEEEEeCCc-cCHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3455554 6789988654 66788886544 334457788888887743 3355677777888889999999988765
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.61 E-value=1.3e-05 Score=75.30 Aligned_cols=17 Identities=24% Similarity=0.335 Sum_probs=7.9
Q ss_pred cCCCCCCEEeccCccCC
Q 002061 141 SALKNLEIFDLSINYFT 157 (973)
Q Consensus 141 ~~l~~L~~L~Ls~n~l~ 157 (973)
...++|++|+|++|.+.
T Consensus 41 ~~n~~L~~L~Ls~n~l~ 57 (167)
T d1pgva_ 41 CNSKHIEKFSLANTAIS 57 (167)
T ss_dssp TTCSCCCEEECTTSCCB
T ss_pred hhCCccceeeccccccc
Confidence 33444455555444443
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.56 E-value=1.5e-05 Score=74.93 Aligned_cols=115 Identities=12% Similarity=0.090 Sum_probs=69.4
Q ss_pred cCCccCcEeeCCCC-cccCc----CChhhhCCCCCcEEEecCCcccCC-CC----cccCCCCCCEEeccCccCCCccccc
Q 002061 94 SALQSLTVLSLPFN-VLSGK----LPLELSNCSNLKVLNVTGNAMVGS-VP----DLSALKNLEIFDLSINYFTGRFPRW 163 (973)
Q Consensus 94 ~~l~~L~~L~Ls~n-~l~~~----~p~~l~~l~~L~~L~L~~n~l~~~-~~----~l~~l~~L~~L~Ls~n~l~~~~~~~ 163 (973)
.+.++|++|+|+++ .++.. +-..+...++|++|+|++|.+... .. .+...+.|++|+|++|.+++.....
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence 44578889999874 56543 334567778899999999988531 11 2455677888888888876432221
Q ss_pred cccccccceEEccCCcCCCCCCcccccCCCCCCEEEcccCCCCCC-------CChhhhccCCCCeeecccccc
Q 002061 164 VVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFLAHCNLRGR-------IPESISELRELGTLDICRNKI 229 (973)
Q Consensus 164 ~~~l~~L~~L~l~~n~l~~~~ip~~~~~l~~L~~L~L~~n~l~~~-------~~~~~~~l~~L~~L~L~~N~l 229 (973)
+ -..+...++|++|+|++|.+... +...+...++|+.|+++.+..
T Consensus 92 l---------------------~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 92 L---------------------LRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp H---------------------HHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred H---------------------HHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence 1 12333445566666666554422 223444556777777766543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.33 E-value=0.00041 Score=74.63 Aligned_cols=76 Identities=14% Similarity=0.151 Sum_probs=49.3
Q ss_pred cCcccccCceEEEEEEecCCCcEEEEEeeec---------cccHHHHHHHHHHHHhcC-C-C-ceeeEEEEEEeCCeeEE
Q 002061 681 DNLIGSGGTGKVYRLDLKKNAGTVAVKQLWK---------GDGVKVFAAEMEILGKIR-H-R-NILKLYACLLKGGSSFL 748 (973)
Q Consensus 681 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~---------~~~~~~~~~E~~~l~~l~-h-p-niv~l~~~~~~~~~~~l 748 (973)
.+.||.|....||++.....++.|+||.... +....+...|++.++.+. + | .+.+++.+ +++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 3468999999999999887788999996532 112345567888887762 2 3 34444443 4556689
Q ss_pred EEEccCCCch
Q 002061 749 VLEYMPNGNL 758 (973)
Q Consensus 749 v~e~~~~gsL 758 (973)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987544
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.84 E-value=9.6e-05 Score=69.14 Aligned_cols=40 Identities=15% Similarity=0.124 Sum_probs=17.2
Q ss_pred CCCCCCEEEcccCCCCCC----CChhhhccCCCCeeeccccccc
Q 002061 191 NLKNLTYLFLAHCNLRGR----IPESISELRELGTLDICRNKIS 230 (973)
Q Consensus 191 ~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~ 230 (973)
..++|++|+|++|.++.. +...+...++++.|++++|.++
T Consensus 44 ~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~ 87 (166)
T d1io0a_ 44 TNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 87 (166)
T ss_dssp TCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred cCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccccc
Confidence 344445555555444421 1122333444555555555443
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.75 E-value=0.00014 Score=67.99 Aligned_cols=116 Identities=14% Similarity=0.107 Sum_probs=58.1
Q ss_pred ccCCccCcEeeCCC-CcccCc----CChhhhCCCCCcEEEecCCcccCCC-----CcccCCCCCCEEeccCccCCCcccc
Q 002061 93 ISALQSLTVLSLPF-NVLSGK----LPLELSNCSNLKVLNVTGNAMVGSV-----PDLSALKNLEIFDLSINYFTGRFPR 162 (973)
Q Consensus 93 l~~l~~L~~L~Ls~-n~l~~~----~p~~l~~l~~L~~L~L~~n~l~~~~-----~~l~~l~~L~~L~Ls~n~l~~~~~~ 162 (973)
..+.+.|++|+|++ +.++.. +-.++...++|++|+|++|.+.... ..+...+.++.+++++|.++.....
T Consensus 13 ~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~ 92 (166)
T d1io0a_ 13 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL 92 (166)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH
T ss_pred HhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHH
Confidence 34456666666665 345432 2223445566666666666553211 1134445555555555555422111
Q ss_pred ccccccccceEEccCCcCCCCCCcccccCCCCCCEEEc--ccCCCCC----CCChhhhccCCCCeeecccccc
Q 002061 163 WVVNLTQLVSLSIGDNVYDEAEIPESIGNLKNLTYLFL--AHCNLRG----RIPESISELRELGTLDICRNKI 229 (973)
Q Consensus 163 ~~~~l~~L~~L~l~~n~l~~~~ip~~~~~l~~L~~L~L--~~n~l~~----~~~~~~~~l~~L~~L~L~~N~l 229 (973)
.+-+.+...++|+.++| ++|.+.. .+...+...++|++|+++.+..
T Consensus 93 ---------------------~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 93 ---------------------ALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp ---------------------HHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred ---------------------HHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 11233445566665444 3445542 2334456677788887776654
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.83 E-value=0.011 Score=62.98 Aligned_cols=73 Identities=21% Similarity=0.301 Sum_probs=50.2
Q ss_pred CcccccCceEEEEEEecC-------CCcEEEEEeeeccccHHHHHHHHHHHHhcCCCcee-eEEEEEEeCCeeEEEEEcc
Q 002061 682 NLIGSGGTGKVYRLDLKK-------NAGTVAVKQLWKGDGVKVFAAEMEILGKIRHRNIL-KLYACLLKGGSSFLVLEYM 753 (973)
Q Consensus 682 ~~lG~G~~g~V~~a~~~~-------~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hpniv-~l~~~~~~~~~~~lv~e~~ 753 (973)
+.|+-|-.-.+|++.... ..+.|.+++.-.....-...+|..+++.+.-.++. ++++++.. .+||||+
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi 123 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYI 123 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEe
Confidence 568888889999998753 23567777665444444567899999888533444 66666542 5899999
Q ss_pred CCCch
Q 002061 754 PNGNL 758 (973)
Q Consensus 754 ~~gsL 758 (973)
+|..+
T Consensus 124 ~g~~l 128 (395)
T d1nw1a_ 124 PSRPL 128 (395)
T ss_dssp CEEEC
T ss_pred ccccC
Confidence 87554
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.80 E-value=0.013 Score=60.64 Aligned_cols=136 Identities=16% Similarity=0.175 Sum_probs=77.3
Q ss_pred ceEEEEEEecCCCcEEEEEeeecc-ccHHHHHHHHHHHHhcCCCce--eeEE-----EEEEeCCeeEEEEEccCCCchH-
Q 002061 689 TGKVYRLDLKKNAGTVAVKQLWKG-DGVKVFAAEMEILGKIRHRNI--LKLY-----ACLLKGGSSFLVLEYMPNGNLF- 759 (973)
Q Consensus 689 ~g~V~~a~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hpni--v~l~-----~~~~~~~~~~lv~e~~~~gsL~- 759 (973)
--.||++...+ |+.|++|+.... ...+++..|.+.+..+....+ +..+ ..+..++..+.+++|++|..+.
T Consensus 35 EN~vy~v~~~d-g~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDED-RRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTT-CCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCC-CCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 35899998864 888999987654 345678889998887742211 1111 1234566789999999775431
Q ss_pred ----H---------HHHhhhc----CCCCCCCHH----------------------HHHHHHHHHHHHHhhh-hhcCCCC
Q 002061 760 ----Q---------ALHKRVK----EGKPELDWF----------------------RRYKIALGAAKGIAYL-HHDCSPP 799 (973)
Q Consensus 760 ----~---------~l~~~~~----~~~~~~~~~----------------------~~~~i~~~ia~~l~~L-H~~~~~~ 799 (973)
. .++.... ......++. .....+.++...+.-. .+....+
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 1 1111100 011111211 1112222222222221 1222457
Q ss_pred eEecCCCCCCeeecCCCCeEEecccCcc
Q 002061 800 IIHRDIKSSNILLDEDYEPKIADFGVAK 827 (973)
Q Consensus 800 ivH~Dlkp~Nill~~~~~~kl~Dfgl~~ 827 (973)
+||+|+.+.||+++++ ..+.||+-+.
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred eecCCCCcccEEEeCC--ceEEechhcc
Confidence 8999999999999753 4588999775
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.87 E-value=0.018 Score=59.26 Aligned_cols=144 Identities=15% Similarity=0.057 Sum_probs=74.4
Q ss_pred CcccccCceEEEEEEecCCCcEEEEEeeeccccHHHHHHHHHHHHhcCC-----CceeeEE---EEEEeCCeeEEEEEcc
Q 002061 682 NLIGSGGTGKVYRLDLKKNAGTVAVKQLWKGDGVKVFAAEMEILGKIRH-----RNILKLY---ACLLKGGSSFLVLEYM 753 (973)
Q Consensus 682 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h-----pniv~l~---~~~~~~~~~~lv~e~~ 753 (973)
+.|..|---+.|+.+..+ ..+++|+.......+.+..|++++..+.. |..+... .+...+...+.++.+.
T Consensus 24 ~~i~~G~~N~ny~v~t~~--g~yVLri~~~~~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~ 101 (316)
T d2ppqa1 24 KGIAEGVENSNFLLHTTK--DPLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL 101 (316)
T ss_dssp EEECC---EEEEEEEESS--CCEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred ecCCCCcccCeEEEEECC--CcEEEEEcCCCCCHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeeec
Confidence 344567778899988764 46899987654445566777888777742 2222110 1122345567777777
Q ss_pred CCCchHH--------------HHHhhhcCC--CC--CCCH------------------HHHHHHHHHHHHHHhhhh-hcC
Q 002061 754 PNGNLFQ--------------ALHKRVKEG--KP--ELDW------------------FRRYKIALGAAKGIAYLH-HDC 796 (973)
Q Consensus 754 ~~gsL~~--------------~l~~~~~~~--~~--~~~~------------------~~~~~i~~~ia~~l~~LH-~~~ 796 (973)
.+..... .++...... .. .... ......+......+.-.+ ...
T Consensus 102 ~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L 181 (316)
T d2ppqa1 102 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL 181 (316)
T ss_dssp CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred ccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCcccc
Confidence 6643311 011000000 00 0000 001111112222222222 123
Q ss_pred CCCeEecCCCCCCeeecCCCCeEEecccCcc
Q 002061 797 SPPIIHRDIKSSNILLDEDYEPKIADFGVAK 827 (973)
Q Consensus 797 ~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl~~ 827 (973)
..++||+|+.++||+++.+...-|.||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 5689999999999999998777899999774
|